PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhou, X; Matskova, L; Rathje, LS; Xiao, X; Gish, G; Werner, M; Ignatyev, I; Yu, N; Zhao, W; Tian, F; Hou, B; Zhang, Z; Pawson, T; Chen, F; Ernberg, I				Zhou, X.; Matskova, L.; Rathje, L-Sz; Xiao, X.; Gish, G.; Werner, M.; Ignatyev, I.; Yu, N.; Zhao, W.; Tian, F.; Hou, B.; Zhang, Z.; Pawson, T.; Chen, F.; Ernberg, I.			SYK interaction with ITG beta 4 suppressed by Epstein-Barr virus LMP2A modulates migration and invasion of nasopharyngeal carcinoma cells	ONCOGENE			English	Article							MEMBRANE-PROTEIN 2A; BREAST-CANCER PROGRESSION; BETA(4) INTEGRIN SUBUNIT; TYROSINE KINASE; ALPHA(6)BETA(4) INTEGRIN; ALPHA-6-BETA-4 INTEGRIN; CYTOPLASMIC DOMAIN; EPITHELIAL-CELLS; SIGNAL-TRANSDUCTION; ENCODED LMP2A	Epstein-Barr virus (EBV)-encoded Latent Membrane Protein 2A (LMP2A) is an EBV latency-associated protein regularly expressed in nasopharyngeal carcinoma (NPC). In B cells, LMP2A activity resembles that of a constitutively activated antigen receptor, which recruits the Syk tyrosine kinase to activate a set of downstream signaling pathways. LMP2A also downregulates cellular Syk levels. In the present study, we demonstrate that Syk interacts with the integrin beta 4 subunit (ITG beta 4) of integrin alpha 6 beta 4 in epithelial cells and that concurrent LMP2A expression interferes with this interaction by competitive binding to Syk. We find that both Syk and LMP2A have an effect on ITG beta 4 cell surface expression. However, in LMP2A expressing cells, ITG beta 4 remains concentrated at the cellular protrusions, an expression pattern characteristic of motile cells, including NPC-derived epithelial cells. This effect of LMP2A on ITG beta 4 localization is associated with a greater propensity for migration and invasion in-vitro, and may contribute to the invasive property of LMP2A-expressing NPC.	[Zhou, X.; Matskova, L.; Rathje, L-Sz; Xiao, X.; Werner, M.; Ignatyev, I.; Chen, F.; Ernberg, I.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, SE-17177 Stockholm, Sweden; [Zhou, X.; Xiao, X.; Yu, N.; Zhao, W.; Tian, F.; Hou, B.; Zhang, Z.] Guangxi Med Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Nanning, Peoples R China; [Gish, G.; Pawson, T.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Karolinska Institutet; Guangxi Medical University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Ernberg, I (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, SE-17177 Stockholm, Sweden.	ingemar.ernberg@ki.se	Gish, Gerald D/C-7228-2017; Zhou, Xiaoying/Y-4217-2019; Pawson, Tony J/E-4578-2013; Matskova, Liudmila/J-3843-2017; Matskova, Liudmila/AAF-4201-2020	Zhou, Xiaoying/0000-0003-3298-5089; Matskova, Liudmila/0000-0002-3174-1560; Matskova, Liudmila/0000-0002-3174-1560; Zhao Rathje, Li-Sophie/0000-0002-8258-8914	Swedish Cancer Society; Swedish Research Council; Karolinska Institutet Research funds; Maths O Sundqvist family foundation; National Key Basic Research Program of China [2012CB526607]; Guangxi Natural Science Foundation [2013GXNSFGA019002]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet Research funds; Maths O Sundqvist family foundation; National Key Basic Research Program of China(National Basic Research Program of China); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This work was supported by the Swedish Cancer Society, the Swedish Research Council, Karolinska Institutet Research funds and by the Maths O Sundqvist family foundation; National Key Basic Research Program of China (2012CB526607) and Guangxi Natural Science Foundation (2013GXNSFGA019002). We thank Gosta Winberg for valuable comments to the manuscript.	Allen MD, 2005, J VIROL, V79, P1789, DOI 10.1128/JVI.79.3.1789-1802.2005; Bertotti A, 2005, CANCER RES, V65, P10674, DOI 10.1158/0008-5472.CAN-05-2827; Bon G, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1651; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Brennan B, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-23; Buettner M, 2006, VIRCHOWS ARCH, V449, P513, DOI 10.1007/s00428-006-0294-2; BUSSON P, 1992, J VIROL, V66, P3257, DOI 10.1128/JVI.66.5.3257-3262.1992; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chami M, 2006, BBA-MOL CELL RES, V1763, P1344, DOI 10.1016/j.bbamcr.2006.09.025; Chao C, 1996, CANCER RES, V56, P4811; CLARK EA, 1994, J BIOL CHEM, V269, P28859; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Dawson CW, 2001, VIROLOGY, V289, P192, DOI 10.1006/viro.2001.1142; Draheim KM, 2010, ONCOGENE, V29, P5032, DOI 10.1038/onc.2010.250; Du ZM, 2012, HEAD NECK-J SCI SPEC, V34, P1456, DOI 10.1002/hed.21953; Dutta U, 2008, CANCER RES, V68, P8779, DOI 10.1158/0008-5472.CAN-08-2125; Dykstra ML, 2001, IMMUNITY, V14, P57, DOI 10.1016/S1074-7613(01)00089-9; Ephstein Y, 2013, J BIOL CHEM, V288, P2191, DOI 10.1074/jbc.M112.404780; FLUCK M, 1995, BIOCHEM BIOPH RES CO, V213, P273, DOI 10.1006/bbrc.1995.2126; Fotheringham JA, 2012, J VIROL, V86, P10308, DOI 10.1128/JVI.00853-12; Fruehling S, 1997, VIROLOGY, V235, P241, DOI 10.1006/viro.1997.8690; Fung LF, 2000, LIFE SCI, V67, P923, DOI 10.1016/S0024-3205(00)00684-6; Galan JA, 2011, J AM SOC MASS SPECTR, V22, P319, DOI 10.1007/s13361-010-0030-7; GIANCOTTI FG, 1992, J CELL BIOL, V118, P951, DOI 10.1083/jcb.118.4.951; Giancotti FG, 2007, TRENDS PHARMACOL SCI, V28, P506, DOI 10.1016/j.tips.2007.08.004; Grenklo S, 2008, EUR J CELL BIOL, V87, P905, DOI 10.1016/j.ejcb.2008.06.006; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Heussinger N, 2004, J PATHOL, V203, P696, DOI 10.1002/path.1569; Hino R, 2009, CANCER RES, V69, P2766, DOI 10.1158/0008-5472.CAN-08-3070; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Ikeda M, 2001, J VIROL, V75, P5711, DOI 10.1128/JVI.75.12.5711-5718.2001; Kashyap T, 2011, LAB INVEST, V91, P1414, DOI 10.1038/labinvest.2011.104; Kong QL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000940; Koster J, 2001, J INVEST DERMATOL, V117, P1405, DOI 10.1046/j.0022-202x.2001.01567.x; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Li Q, 2013, ONCOGENE, V32, P1772, DOI 10.1038/onc.2012.205; LIN TH, 1995, J BIOL CHEM, V270, P16189, DOI 10.1074/jbc.270.27.16189; Lo AKF, 2001, CANCER LETT, V163, P117, DOI 10.1016/S0304-3835(00)00683-2; Lu J, 2006, J BIOL CHEM, V281, P8806, DOI 10.1074/jbc.M507305200; Lynch DT, 2002, J GEN VIROL, V83, P1025, DOI 10.1099/0022-1317-83-5-1025; MAINIERO F, 1995, EMBO J, V14, P4470, DOI 10.1002/j.1460-2075.1995.tb00126.x; Matskova L, 2001, J VIROL, V75, P10941, DOI 10.1128/JVI.75.22.10941-10949.2001; Matskova LV, 2007, ONCOGENE, V26, P4908, DOI 10.1038/sj.onc.1210298; Merdek KD, 2007, J BIOL CHEM, V282, P30322, DOI 10.1074/jbc.M703156200; Moroni M, 2004, CANCER RES, V64, P7346, DOI 10.1158/0008-5472.CAN-03-3520; Murgia C, 1998, EMBO J, V17, P3940, DOI 10.1093/emboj/17.14.3940; Nakaya T, 2013, VIRUS RES, V174, P108, DOI 10.1016/j.virusres.2013.03.009; Neuhaus B, 2011, CELL MOL LIFE SCI, V68, P3757, DOI 10.1007/s00018-011-0676-8; Nievers MG, 1998, J CELL SCI, V111, P1659; Pegtel DM, 2005, J VIROL, V79, P15430, DOI 10.1128/JVI.79.24.15430-15442.2005; POTTS AJ, 1994, EXP CELL RES, V212, P2, DOI 10.1006/excr.1994.1111; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Scholle F, 2000, J VIROL, V74, P10681, DOI 10.1128/JVI.74.22.10681-10689.2000; Soung YH, 2011, CURR PROTEIN PEPT SC, V12, P23; SPINARDI L, 1993, MOL BIOL CELL, V4, P871, DOI 10.1091/mbc.4.9.871; Tohyama Y, 2009, J BIOCHEM, V145, P267, DOI 10.1093/jb/mvp001; Underwood RA, 2009, J HISTOCHEM CYTOCHEM, V57, P123, DOI 10.1369/jhc.2008.952176; Utskarpen A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010944; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012; Yan SR, 1997, J IMMUNOL, V158, P1902; Yang XF, 2009, J CELL SCI, V122, P2473, DOI 10.1242/jcs.049148; Yang XQ, 2010, MOL CELL BIOL, V30, P5306, DOI 10.1128/MCB.00326-10; Yoon SO, 2005, CANCER RES, V65, P2761, DOI 10.1158/0008-5472.CAN-04-4122; Yoshioka T, 2013, J CLIN INVEST, V123, P682, DOI 10.1172/JCI60720; Zhao JH, 2013, CANCER-AM CANCER SOC, V119, P304, DOI 10.1002/cncr.27724	66	15	16	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2015	34	34					4491	4499		10.1038/onc.2014.380	http://dx.doi.org/10.1038/onc.2014.380			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BR	25531330				2022-12-26	WOS:000360189200008
J	Pandey, G; Makhija, E; George, N; Chakravarti, B; Godbole, MM; Ecelbarger, CM; Tiwari, S				Pandey, Gaurav; Makhija, Ekta; George, Nelson; Chakravarti, Bandana; Godbole, Madan M.; Ecelbarger, Carolyn M.; Tiwari, Swasti			Insulin Regulates Nitric Oxide Production in the Kidney Collecting Duct Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; FACTOR-I RECEPTOR; BLOOD-PRESSURE; IGF-I; NO PRODUCTION; TYROSINE PHOSPHORYLATION; ENDOTHELIAL-CELLS; RENAL-DISEASE; SYNTHASE; MICE	The kidney is an important organ for arterial blood pressure (BP) maintenance. Reduced NO generation in the kidney is associated with hypertension in insulin resistance. NO is a critical regulator of vascular tone; however, whether insulin regulates NO production in the renal inner medullary collecting duct (IMCD), the segment with the greatest enzymatic activity for NO production in kidney, is not clear. Using an NO-sensitive 4-amino-5-methylarnino-2',7'-difluorofluorescein (DAF-FM) fluorescent dye, we found that insulin increased NO production in mouse IMCD cells (mIMCD) in a time- and dose-dependent manner. A concomitant dose-dependent increase in the NO metabolite (N0x) was also observed in the medium from insulin-stimulated cells. NO production peaked in mIMCD cells at a dose of 100 nM insulin with simultaneously increased NOx levels in the medium. At this dose, insulin significantly increased p-eNOS(Ser1177) levels in mIMCD cells. Pretreatment of cells with a PI 3-kinase inhibitor or insulin receptor silencing with RNA interference abolished these effects of insulin, whereas insulin-like growth factor-1 receptor (IGF-IR) silencing had no effect. We also showed that chronic insulin infusion to normal C57BL/6J mice resulted in increased endothelial NOS (eNOS) protein levels and NO production in the inner medulla. However, insulin-infused IRK() mice, with targeted deletion of insulin receptor from tubule epithelial cells of the kidney, had similar to 50% reduced eNOS protein levels in their inner medulla along with a significant rise in BP relative to WT littermates. We have previously reported increased baseline BP and reduced urine NOx in IRK() mice. Thus, reduced insulin receptor signaling in IMCD could contribute to hypertension in the insulin-resistant state.	[Pandey, Gaurav; Makhija, Ekta; George, Nelson; Chakravarti, Bandana; Godbole, Madan M.; Tiwari, Swasti] Sanjay Gandhi Postgrad Inst Med Sci, Dept Mol Med & Biotechnol, 4th Fl,PMMSY Bldg, Lucknow 226014, Uttar Pradesh, India; [Ecelbarger, Carolyn M.] Georgetown Univ, Dept Med, Div Endocrinol & Metab, Washington, DC USA	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Georgetown University	Tiwari, S (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Mol Med & Biotechnol, 4th Fl,PMMSY Bldg, Lucknow 226014, Uttar Pradesh, India.	tiwaris@sgpgi.ac.in			Ramalingaswami grant from the Department of Biotechnology; University Grant Commission; Research Fellowship SERB-Fast Track Grant from the Government of India; National Institutes of Health [R01 DK082507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082507] Funding Source: NIH RePORTER	Ramalingaswami grant from the Department of Biotechnology; University Grant Commission(University Grants Commission, India); Research Fellowship SERB-Fast Track Grant from the Government of India; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Ramalingaswami grant from the Department of Biotechnology (to S. T.).r Supported by a Research Fellowship from the University Grant Commission.r Supported by a Research Fellowship SERB-Fast Track Grant from the Government of India.r Supported by National Institutes of Health Grant R01 DK082507.	Abbas A, 2011, DIABETES, V60, P2169, DOI 10.2337/db11-0197; BODEN G, 1994, J CLIN ENDOCR METAB, V78, P657, DOI 10.1210/jc.78.3.657; Cai ZQ, 2000, AM J PHYSIOL-RENAL, V279, pF270, DOI 10.1152/ajprenal.2000.279.2.F270; COHEN DM, 1994, J BIOL CHEM, V269, P25865; Cowley AW, 2003, AM J PHYSIOL-REG I, V284, pR1355, DOI 10.1152/ajpregu.00701.2002; Ecelbarger CA, 2001, J AM SOC NEPHROL, V12, P207, DOI 10.1681/ASN.V122207; Ecelbarger CA, 2000, AM J PHYSIOL-RENAL, V279, pF46, DOI 10.1152/ajprenal.2000.279.1.F46; Elkayam U, 1996, J AM COLL CARDIOL, V28, P176, DOI 10.1016/0735-1097(96)00092-7; Erdely A, 2004, DIABETOLOGIA, V47, P1672, DOI 10.1007/s00125-004-1509-1; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Frikke-Schmidt H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076060; GARVEY WT, 1986, DIABETES, V35, P258, DOI 10.2337/diabetes.35.3.258; Gatenby VK, 2013, PFLUG ARCH EUR J PHY, V465, P1065, DOI 10.1007/s00424-013-1218-z; GAVIN JR, 1974, P NATL ACAD SCI USA, V71, P84, DOI 10.1073/pnas.71.1.84; GIORGINO F, 1993, J CLIN INVEST, V91, P2020, DOI 10.1172/JCI116424; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Grote CW, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-15; Johansson GS, 2008, MOL CELL ENDOCRINOL, V296, P58, DOI 10.1016/j.mce.2008.07.012; Kalani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060177; Kaulfuss S, 2009, MOL CANCER THER, V8, P821, DOI 10.1158/1535-7163.MCT-09-0058; Kikawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095451; Kojima H, 1998, NEUROREPORT, V9, P3345, DOI 10.1097/00001756-199810260-00001; Kuboki K, 2000, CIRCULATION, V101, P676, DOI 10.1161/01.CIR.101.6.676; Li GL, 2005, ENDOCRINOLOGY, V146, P4690, DOI 10.1210/en.2005-0505; Li LJ, 2013, AM J PHYSIOL-RENAL, V304, pF279, DOI 10.1152/ajprenal.00161.2012; Li LJ, 2012, AM J PHYSIOL-REG I, V303, pR505, DOI 10.1152/ajpregu.00033.2012; Lin SY, 1997, CHINESE MED J-PEKING, V110, P515; MATTSON DL, 1994, AM J PHYSIOL, V266, pH1918, DOI 10.1152/ajpheart.1994.266.5.H1918; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Muniyappa R, 2012, DIABETES, V61, P2225, DOI 10.2337/db12-0654; Nagoshi T, 2005, J CLIN INVEST, V115, P2128, DOI 10.1172/JCI23073; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Repetto S, 2005, BIOCHEM BIOPH RES CO, V337, P849, DOI 10.1016/j.bbrc.2005.09.125; Rojas FA, 2003, ENDOCRINE, V21, P115, DOI 10.1385/ENDO:21:2:115; Scherrer U, 1997, CIRCULATION, V96, P4104; Schmetterer L, 1997, DIABETES, V46, P1868, DOI 10.2337/diabetes.46.11.1868; Schmidt RJ, 2000, KIDNEY INT, V58, P1261, DOI 10.1046/j.1523-1755.2000.00281.x; Schmidt RJ, 1999, AM J PHYSIOL-RENAL, V276, pF794, DOI 10.1152/ajprenal.1999.276.5.F794; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; Song J, 2006, AM J PHYSIOL-RENAL, V290, pF1055, DOI 10.1152/ajprenal.00108.2005; Tan Dun-Yong, 2000, Shengli Xuebao, V52, P103; ter Maaten JC, 2000, EUR J CLIN INVEST, V30, P1090, DOI 10.1046/j.1365-2362.2000.00749.x; ter Maaten JC, 2001, J HYPERTENS, V19, P1633, DOI 10.1097/00004872-200109000-00016; Tiwari S, 2008, P NATL ACAD SCI USA, V105, P6469, DOI 10.1073/pnas.0711283105; Tiwari S, 2007, AM J PHYSIOL-RENAL, V293, pF178, DOI 10.1152/ajprenal.00447.2006; Tiwari S, 2013, J AM SOC NEPHROL, V24, P1209, DOI 10.1681/ASN.2012060628; Tiwari S, 2009, AM J NEPHROL, V30, P554, DOI 10.1159/000252776; Trujillo J, 2005, AM J PHYSIOL-RENAL, V288, pF108, DOI 10.1152/ajprenal.00077.2004; Tsuchiya A, 2014, J ENDOCRINOL, V220, P49, DOI 10.1530/JOE-13-0172; Turini P, 2007, SWISS MED WKLY, V137, P700, DOI 2007/49/smw-11950; Uawithya P, 2008, PHYSIOL GENOMICS, V32, P229, DOI 10.1152/physiolgenomics.00201.2007; VENKATESAN N, 1995, METABOLISM, V44, P75, DOI 10.1016/0026-0495(95)90292-9; Wang Y, 2004, NITRIC OXIDE-BIOL CH, V10, P25, DOI 10.1016/j.niox.2004.02.001; Wu F, 1999, AM J PHYSIOL-RENAL, V276, pF874, DOI 10.1152/ajprenal.1999.276.6.F874; ZEIDEL ML, 1987, AM J PHYSIOL, V252, pF551, DOI 10.1152/ajprenal.1987.252.3.F551; Zimpelmann J, 2003, AM J PHYSIOL-RENAL, V285, pF1160, DOI 10.1152/ajprenal.00077.2003	57	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5582	5591		10.1074/jbc.M114.592741	http://dx.doi.org/10.1074/jbc.M114.592741			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25533472	Green Published, hybrid			2022-12-26	WOS:000350044200029
J	Akhtar, P; Dorogi, M; Pawlak, K; Kovacs, L; Bota, A; Kiss, T; Garab, G; Lambrev, PH				Akhtar, Parveen; Dorogi, Marta; Pawlak, Krzysztof; Kovacs, Laszlo; Bota, Attila; Kiss, Terez; Garab, Gyozo; Lambrev, Petar H.			Pigment Interactions in Light-harvesting Complex II in Different Molecular Environments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPHYLL-A/B COMPLEX; PHOTOPROTECTIVE ENERGY-DISSIPATION; TIME-RESOLVED FLUORESCENCE; PHOTOSYSTEM-II; THYLAKOID MEMBRANES; HIGHER-PLANTS; CHLOROPLAST MEMBRANES; CIRCULAR-DICHROISM; EXCITATION-ENERGY; NONBILAYER LIPIDS	Extraction of plant light-harvesting complex II (LHCII) from the native thylakoid membrane or from aggregates by the use of surfactants brings about significant changes in the excitonic circular dichroism (CD) spectrum and fluorescence quantum yield. To elucidate the cause of these changes, e.g. trimer-trimer contacts or surfactant-induced structural perturbations, we compared the CD spectra and fluorescence kinetics of LHCII aggregates, artificial and native LHCII-lipid membranes, and LHCII solubilized in different detergents or trapped in polymer gel. By this means we were able to identify CD spectral changes specific to LHCII-LHCII interactions, at (-)-437 and (+)-484 nm, and changes specific to the interaction with the detergent n-dodecyl-beta-maltoside (beta-DM) or membrane lipids, at (+)-447 and (-)-494 nm. The latter change is attributed to the conformational change of the LHCII-bound carotenoid neoxanthin, by analyzing the CD spectra of neoxanthin-deficient plant thylakoid membranes. The neoxanthin-specific band at (-)-494 nm was not pronounced in LHCII in detergent-free gels or solubilized in the alpha isomer of DM but was present when LHCII was reconstituted in membranes composed of phosphatidylcholine or plant thylakoid lipids, indicating that the conformation of neoxanthin is sensitive to the molecular environment. Neither the aggregation-specific CD bands, nor the surfactant-specific bands were positively associated with the onset of fluorescence quenching, which could be triggered without invoking such spectral changes. Significant quenching was not active in reconstituted LHCII proteoliposomes, whereas a high degree of energetic connectivity, depending on the lipid: protein ratio, in these membranes allows for efficient light harvesting.	[Akhtar, Parveen; Dorogi, Marta; Pawlak, Krzysztof; Kovacs, Laszlo; Garab, Gyozo; Lambrev, Petar H.] Hungarian Acad Sci, Biol Res Ctr, H-6726 Szeged, Hungary; [Bota, Attila; Kiss, Terez] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Mat & Environm Chem, H-1117 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Lambrev, PH (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Temesvari Krt 62, H-6726 Szeged, Hungary.	lambrev@brc.hu	Garab, Gyozo/AAN-5132-2021; Kovács, Laszlo/M-2619-2016; Akhtar, Parveen/AHD-5996-2022; Lambrev, Petar H./D-3071-2017	Kovács, Laszlo/0000-0002-7337-5626; Akhtar, Parveen/0000-0002-3264-7154; Lambrev, Petar H./0000-0001-5147-153X; Garab, Gyozo/0000-0002-3869-9959	Hungarian Scientific Research Fund [OTKA-PD 104530, TAMOP-4.2.2.A-11/1/KONV-2012-0060]; Hungarian National Innovation Office; A*STAR Singapore [TET_10-1-2011-0279]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Innovation Office; A*STAR Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Hungarian Scientific Research Fund Grants OTKA-PD 104530 and TAMOP-4.2.2.A-11/1/KONV-2012-0060 and Hungarian National Innovation Office and A*STAR Singapore Grant TET_10-1-2011-0279.	Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; Aro EM, 2003, ANTIOXID REDOX SIGN, V5, P55, DOI 10.1089/152308603321223540; BARBER J, 1982, ANNU REV PLANT PHYS, V33, P261, DOI 10.1146/annurev.pp.33.060182.001401; Barzda V, 1996, BIOCHEMISTRY-US, V35, P8981, DOI 10.1021/bi960114g; Barzda V, 1996, BBA-BIOENERGETICS, V1273, P231, DOI 10.1016/0005-2728(95)00147-6; Belgio E, 2012, BIOPHYS J, V102, P2761, DOI 10.1016/j.bpj.2012.05.004; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Garab G, 2000, TRENDS PLANT SCI, V5, P489, DOI 10.1016/S1360-1385(00)01767-2; Garab G, 1999, AUST J PLANT PHYSIOL, V26, P649, DOI 10.1071/PP99069; Garab G, 2009, PHOTOSYNTH RES, V101, P135, DOI 10.1007/s11120-009-9424-4; Georgakopoulou S, 2007, BIOCHEMISTRY-US, V46, P4745, DOI 10.1021/bi062031y; Haferkamp S, 2010, J BIOL CHEM, V285, P17020, DOI 10.1074/jbc.M109.077750; Hobe S, 2006, J BIOL CHEM, V281, P25156, DOI 10.1074/jbc.M604828200; Holzwarth AR, 2009, CHEM PHYS LETT, V483, P262, DOI 10.1016/j.cplett.2009.10.085; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Ilioaia C, 2008, J BIOL CHEM, V283, P29505, DOI 10.1074/jbc.M802438200; Ilioaia C, 2011, J BIOL CHEM, V286, P27247, DOI 10.1074/jbc.M111.234617; Johnson MP, 2012, PLANTA, V235, P193, DOI 10.1007/s00425-011-1502-0; Kirchhoff H, 2013, PLANT PHYSIOL, V161, P497, DOI 10.1104/pp.112.207548; Lambrev PH, 2007, BBA-BIOENERGETICS, V1767, P847, DOI 10.1016/j.bbabio.2007.01.010; Lambrev PH, 2011, BBA-BIOENERGETICS, V1807, P1022, DOI 10.1016/j.bbabio.2011.05.003; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; MULLET JE, 1980, BIOCHIM BIOPHYS ACTA, V589, P100, DOI 10.1016/0005-2728(80)90135-8; Mustardy L, 2003, TRENDS PLANT SCI, V8, P117, DOI 10.1016/S1360-1385(03)00015-3; NUSSBERGER S, 1994, BIOCHEMISTRY-US, V33, P14775, DOI 10.1021/bi00253a016; Opacic M, 2014, J MEMBRANE BIOL, V247, P1031, DOI 10.1007/s00232-014-9712-6; Pagliano C, 2012, BBA-BIOENERGETICS, V1817, P1506, DOI 10.1016/j.bbabio.2011.11.001; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2006, J BIOL CHEM, V281, P14981, DOI 10.1074/jbc.M511415200; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P39, DOI 10.1016/0167-4838(92)90496-Z; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; RUBAN AV, 1995, BIOCHEMISTRY-US, V34, P2333, DOI 10.1021/bi00007a029; Ruban AV, 1997, BBA-BIOENERGETICS, V1321, P61, DOI 10.1016/S0005-2728(97)00047-9; Rutkauskas D, 2012, CHEM PHYS, V404, P123, DOI 10.1016/j.chemphys.2012.05.002; Simidjiev I, 2000, P NATL ACAD SCI USA, V97, P1473, DOI 10.1073/pnas.97.4.1473; Wilk L, 2013, P NATL ACAD SCI USA, V110, P5452, DOI 10.1073/pnas.1205561110; Yang CH, 2008, BBA-BIOENERGETICS, V1777, P1463, DOI 10.1016/j.bbabio.2008.08.009; Yang CH, 2006, BBA-BIOENERGETICS, V1757, P1642, DOI 10.1016/j.bbabio.2006.08.010; Zhou F, 2009, PHOTOSYNTH RES, V99, P185, DOI 10.1007/s11120-008-9388-9	45	52	52	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4877	4886		10.1074/jbc.M114.607770	http://dx.doi.org/10.1074/jbc.M114.607770			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25525277	hybrid, Green Published			2022-12-26	WOS:000350042000032
J	Cionni, M; Menke, C; Stottmann, RW				Cionni, Megan; Menke, Chelsea; Stottmann, Rolf W.			The Mouse MC13 Mutant Is a Novel ENU Mutation in Collagen Type II, Alpha 1	PLOS ONE			English	Article							STICKLER SYNDROME ARTHROOPHTHALMOPATHY; COL2A1 GENE; PROCOLLAGEN COL2A1; TRANSGENIC MICE; PHENOTYPE; SCREEN; INACTIVATION; MUTAGENESIS; CODON	Phenotype-driven mutagenesis experiments are a powerful approach to identifying novel alleles in a variety of contexts. The traditional disadvantage of this approach has been the subsequent task of identifying the affected locus in the mutants of interest. Recent advances in bioinformatics and sequencing have reduced the burden of cloning these ENU mutants. Here we report our experience with an ENU mutagenesis experiment and the rapid identification of a mutation in a previously known gene. A combination of mapping the mutation with a high-density SNP panel and a candidate gene approach has identified a mutation in collagen type II, alpha I (Col2a1). Col2a1 has previously been studied in the mouse and our mutant phenotype closely resembles mutations made in the Col2a1 locus.	[Cionni, Megan; Menke, Chelsea; Stottmann, Rolf W.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH 45229 USA; [Stottmann, Rolf W.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Stottmann, RW (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH 45229 USA.	rolf.stottmann@cchmc.org	Stottmann, Rolf/U-6589-2019; Stottmann, Rolf/GRO-3453-2022	Stottmann, Rolf/0000-0003-4512-6806	Cincinnati Children's Research Foundation; National Institutes of Health [R01NS085023]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085023] Funding Source: NIH RePORTER	Cincinnati Children's Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Cincinnati Children's Research Foundation (Change the Outcome Fund and Trustee Grant Program) and the National Institutes of Health (R01NS085023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; AHMAD NN, 1993, AM J HUM GENET, V52, P39; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; BROWN DM, 1992, ARCH OPHTHALMOL-CHIC, V110, P1589, DOI 10.1001/archopht.1992.01080230089027; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; Dwyer ND, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-3; FRANCOMANO C A, 1987, Genomics, V1, P293, DOI 10.1016/0888-7543(87)90027-9; Ha S., 2013, CEREB CORTEX; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hoornaert KP, 2006, J MED GENET, V43, P406, DOI 10.1136/jmg.2005.035717; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Kaarniranta K, 2006, EXP EYE RES, V83, P297, DOI 10.1016/j.exer.2005.11.027; Kamp A, 2010, HUM MOL GENET, V19, P3105, DOI 10.1093/hmg/ddq211; Kannu P, 2012, J PAEDIATR CHILD H, V48, pE38, DOI 10.1111/j.1440-1754.2010.01979.x; KORKKO J, 1993, AM J HUM GENET, V53, P55; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; Nagy A., 2003, MANIPULATING MOUSE E; RITVANIEMI P, 1993, GENOMICS, V17, P218, DOI 10.1006/geno.1993.1306; Stottmann RW, 2011, GENETICS, V188, P615, DOI 10.1534/genetics.111.126862; Stottmann RW, 2010, METHOD ENZYMOL, V477, P329, DOI 10.1016/S0076-6879(10)77017-8; VANDENBERG P, 1991, P NATL ACAD SCI USA, V88, P7640, DOI 10.1073/pnas.88.17.7640; Williams CJ, 1996, AM J MED GENET, V63, P461, DOI 10.1002/(SICI)1096-8628(19960614)63:3<461::AID-AJMG9>3.0.CO;2-U	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116104	10.1371/journal.pone.0116104	http://dx.doi.org/10.1371/journal.pone.0116104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541700	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900142
J	Ditekemena, J; Luhata, C; Bonane, W; Kiumbu, M; Tshefu, A; Colebunders, R; Koole, O				Ditekemena, John; Luhata, Christophe; Bonane, William; Kiumbu, Modeste; Tshefu, Antoinette; Colebunders, Robert; Koole, Olivier			Antiretroviral Treatment Program Retention among HIV-Infected Children in the Democratic Republic of Congo	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; FOLLOW-UP; MORTALITY; THERAPY; OUTCOMES; EXPERIENCE	Background: Retaining patients with HIV infection in care is still a major challenge in sub-Saharan Africa, particularly in the Democratic Republic of Congo (DRC) where the antiretroviral treatment (ART) coverage is low. Monitoring retention is an important tool for evaluating the quality of care. Methods and Findings: A review of medical records of HIV -infected children was performed in three health facilities in the DRC: the Amo-Congo Health center, the Monkole Clinic in Kinshasa, and the HEAL Africa Clinic in Goma. Medical records of 720 children were included. Kaplan Meier curves were constructed with the probability of retention at 6 months, 1 year, 2 years and 3 years. Retention rates were: 88.2% (95% CI: 85.1%-90.8%) at 6 months; 85% (95% CI: 81.5%-87.6%) at one year; 79.4% (95% CI: 75.5%-82.8%) at two years and 74.7% (95% CI: 70.5%-78.5%) at 3 years. The retention varied across study sites: 88.2%, 66.6% and 92.5% at 6 months; 84%, 59% and 90% at 12 months and 75.7%, 56.3% and 85.8% at 24 months respectively for Amo-Congo/Kasavubu, Monkole facility and HEAL Africa. After multivariable Cox regression four variables remained independently associated with attrition: study site, CD4 cell count,350 cells/mu L, children younger than 2 years and children whose caregivers were member of an independent church. Conclusions: Attrition remains a challenge for pediatric HIV positive patients in ART programs in DRC. In addition, the low coverage of pediatric treatment exacerbates the situation of pediatric HIV/AIDS.	[Ditekemena, John] Elizabeth Glaser Paediat AIDS Fdn, Kinshasa, DEM REP CONGO; [Luhata, Christophe; Kiumbu, Modeste; Tshefu, Antoinette] Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Bonane, William] Heal Africa, Goma, DEM REP CONGO; [Colebunders, Robert] Univ Antwerp, B-2020 Antwerp, Belgium; [Koole, Olivier] London Sch Hyg & Trop Med, London WC1, England	University of Antwerp; University of London; London School of Hygiene & Tropical Medicine	Ditekemena, J (corresponding author), Elizabeth Glaser Paediat AIDS Fdn, Kinshasa, DEM REP CONGO.	Jditekemena@pedaids.org		Koole, Olivier/0000-0002-1122-5382; Colebunders, Robert/0000-0002-1919-1340	General Direction of Cooperation and Development (GDCD) from the Belgium Technical Cooperation	General Direction of Cooperation and Development (GDCD) from the Belgium Technical Cooperation	This study was carried out with funding provided by the General Direction of Cooperation and Development (GDCD) from the Belgium Technical Cooperation. GDCD didn't have any role in study design, data collection and analysis, manuscript development or decision to publish.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Arrive E, 2008, JAIDS-J ACQ IMM DEF, V49, P523, DOI 10.1097/QAI.0b013e31818aadce; Baveewo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019089; Cowburn C, 2007, ARCH DIS CHILD, V92, P234, DOI 10.1136/adc.2005.074856; Davies MA, 2009, SAMJ S AFR MED J, V99, P730; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Ditekemena J, 2011, INT J STD AIDS, V22, P165, DOI 10.1258/ijsa.2010.010379; Ekouevi DK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-519; Eley B, 2004, SAMJ S AFR MED J, V94, P643; Ellis J, 2007, ANN TROP PAEDIATR, V27, P261, DOI 10.1179/146532807X245643; Fassinou P, 2004, AIDS, V18, P1905, DOI 10.1097/00002030-200409240-00006; Fatti G, 2012, J INT AIDS SOC, V15, P265, DOI 10.7448/IAS.15.2.17381; Fenner L, 2010, JAIDS-J ACQ IMM DEF, V54, P524, DOI 10.1097/QAI.0b013e3181e0c4cf; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Koole O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040971; Mbaye AD, 2005, ARCH PEDIATRIE, V12, P404, DOI 10.1016/j.arcped.2005.01.011; McNairy ML, 2013, JAIDS-J ACQ IMM DEF, V62, pE70, DOI 10.1097/QAI.0b013e318278bcb0; Ministeres du plan et de la Sante, 2007, ENQ DEM SANT 2007; Musheke M, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17366; Niekerk NKMV, 2006, J TROP PEDIATRICS, V52, P3, DOI 10.1093/tropej/fmi047; O'Brien DP, 2006, AIDS, V20, P1955, DOI 10.1097/01.aids.0000247117.66585.ce; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Sauvageot D, 2010, PEDIATRICS, V125, pE1039, DOI 10.1542/peds.2009-1062; Shroufi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064717; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; UNAIDS, 2013, PROGR REP GLOB PLAN; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; World Health Organization, 2021, ANT DRUGS TREAT PREG	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e113877	10.1371/journal.pone.0113877	http://dx.doi.org/10.1371/journal.pone.0113877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541707	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000347239900007
J	Fichna, JP; Karolczak, J; Potulska-Chromik, A; Miszta, P; Berdynski, M; Sikorska, A; Filipek, S; Redowicz, MJ; Kaminska, A; Zekanowski, C				Fichna, Jakub Piotr; Karolczak, Justyna; Potulska-Chromik, Anna; Miszta, Przemyslaw; Berdynski, Mariusz; Sikorska, Agata; Filipek, Slawomir; Redowicz, Maria Jolanta; Kaminska, Anna; Zekanowski, Cezary			Two Desmin Gene Mutations Associated with Myofibrillar Myopathies in Polish Families	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; MISSENSE MUTATION; SKELETAL; ARCHITECTURE; DYNAMICS; DELETION; PATIENT; DOMAIN; BLOCK	Desmin is a muscle-specific intermediate filament protein which forms a network connecting the sarcomere, T tubules, sarcolemma, nuclear membrane, mitochondria and other organelles. Mutations in the gene coding for desmin (DES) cause skeletal myopathies often combined with cardiomyopathy, or isolated cardiomyopathies. The molecular pathomechanisms of the disease remain ambiguous. Here, we describe and comprehensively characterize two DES mutations found in Polish patients with a clinical diagnosis of desminopathy. The study group comprised 16 individuals representing three families. Two mutations were identified: a novel missense mutation (Q348P) and a small deletion of nine nucleotides (A357_E359del), previously described by us in the Polish population. A common ancestry of all the families bearing the A357_E359del mutation was confirmed. Both mutations were predicted to be pathogenic using a bioinformatics approach, including molecular dynamics simulations which helped to rationalize abnormal behavior at molecular level. To test the impact of the mutations on DES expression and the intracellular distribution of desmin muscle biopsies were investigated. Elevated desmin levels as well as its atypical localization in muscle fibers were observed. Additional staining for M-cadherin, a-actinin, and myosin heavy chains confirmed severe disruption of myofibrill organization. The abnormalities were more prominent in the Q348P muscle, where both small atrophic fibers as well large fibers with centrally localized nuclei were observed. We propose that the mutations affect desmin structure and cause its aberrant folding and subsequent aggregation, triggering disruption of myofibrils organization.	[Fichna, Jakub Piotr; Berdynski, Mariusz; Zekanowski, Cezary] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurodegenerat Disorders, Warsaw, Poland; [Karolczak, Justyna; Sikorska, Agata; Redowicz, Maria Jolanta] Polish Acad Sci, Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland; [Potulska-Chromik, Anna; Kaminska, Anna] Med Univ Warsaw, Dept Neurol, Warsaw, Poland; [Miszta, Przemyslaw; Filipek, Slawomir] Univ Warsaw, Fac Chem, Warsaw, Poland; [Miszta, Przemyslaw; Filipek, Slawomir] Univ Warsaw, Biol & Chem Res Ctr, Warsaw, Poland; [Kaminska, Anna] Polish Acad Sci, Mossakowski Med Res Ctr, Neuromuscular Unit, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Medical University of Warsaw; University of Warsaw; University of Warsaw; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Zekanowski, C (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurodegenerat Disorders, Warsaw, Poland.	c.zekanowski@imdik.pan.pl	Berdyński, Mariusz/W-2382-2018; Sikorska, Agata/AAU-2962-2021; Fichna, Jakub P/X-7524-2018; Redowicz, Maria Jolanta/R-4083-2016; Redowicz, Maria Jolanta/AAM-8020-2020; Filipek, Slawomir/A-2985-2008	Berdyński, Mariusz/0000-0003-2076-4318; Fichna, Jakub P/0000-0002-4077-4807; Redowicz, Maria Jolanta/0000-0001-5834-471X; Potulska-Chromik, Anna/0000-0002-8332-1090; Zekanowski, Cezary/0000-0001-7332-8494; Sikorska, Agata/0000-0001-7737-9918; Filipek, Slawomir/0000-0003-3147-3858	National Science Centre (Poland) [2012/05/D/NZ4/02978, 2013/09/B/NZ4/03258]; National Scientific Leading Centre (KNOW-MMRC); Ministry of Science and Higher Education	National Science Centre (Poland)(National Science Centre, Poland); National Scientific Leading Centre (KNOW-MMRC); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Funding: This work was supported by the National Science Centre (Poland) grants 2012/05/D/NZ4/02978 and 2013/09/B/NZ4/03258 (CZ, MJR, AS, JK), as well as by the National Scientific Leading Centre (KNOW-MMRC) project (JPF). This work was also supported by a statutory grant to the Department of Neurology, Medical University of Warsaw from the Ministry of Science and Higher Education (APC, AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M., 2017, COMPUTER SIMULATIONS, V2nd; Antonarakis SE, 2010, VOGEL AND MOTULSKY'S HUMAN GENETICS, FOURTH EDITION, P319, DOI 10.1007/978-3-540-37654-5_10; Arslan M, 2011, COMPUT METHOD BIOMEC, V14, P483, DOI 10.1080/10255842.2011.560147; Bar H, 2005, HUM MOL GENET, V14, P1251, DOI 10.1093/hmg/ddi136; Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Cao LL, 2013, CLIN NEUROPATHOL, V32, P9, DOI 10.5414/NP300514; Chernyatina AA, 2012, P NATL ACAD SCI USA, V109, P13620, DOI 10.1073/pnas.1206836109; Clemen CS, 2013, ACTA NEUROPATHOL, V125, P47, DOI 10.1007/s00401-012-1057-6; Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M; Dagvadorj A, 2003, MUSCLE NERVE, V27, P669, DOI 10.1002/mus.10370; Dalakas MC, 2003, NEUROMUSCULAR DISORD, V13, P252, DOI 10.1016/S0960-8966(02)00271-7; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fidzianska A, 2005, NEUROMUSCULAR DISORD, V15, P525, DOI 10.1016/j.nmd.2005.05.006; Fuchs E, 1996, ANNU REV GENET, V30, P197, DOI 10.1146/annurev.genet.30.1.197; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kaminska A, 2004, HUM GENET, V114, P306, DOI 10.1007/s00439-003-1057-7; Klaavuniemi T, 2006, EXP CELL RES, V312, P1299, DOI 10.1016/j.yexcr.2005.12.036; LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197; LI ZL, 1989, GENE, V78, P243; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312; Olive M, 2013, CURR OPIN NEUROL, V26, P527, DOI 10.1097/WCO.0b013e328364d6b1; Otten E, 2010, HEART RHYTHM, V7, P1058, DOI 10.1016/j.hrthm.2010.04.023; Pawelzyk P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093194; Pruszczyk P, 2007, INT J CARDIOL, V117, P244, DOI 10.1016/j.ijcard.2006.05.019; Purevjav E, 2012, HUM MOL GENET, V21, P2039, DOI 10.1093/hmg/dds022; Raguz S, 1998, DEV BIOL, V201, P26, DOI 10.1006/dbio.1998.8964; Schroder R, 2009, BRAIN PATHOL, V19, P483, DOI 10.1111/j.1750-3639.2009.00289.x; Segard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076361; Selcen D, 2004, NEUROLOGY, V62, P1363, DOI 10.1212/01.WNL.0000123576.74801.75; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Shatunov A, 2009, EUR J HUM GENET, V17, P656, DOI 10.1038/ejhg.2008.226; Sjoberg G, 1999, HUM MOL GENET, V8, P2191, DOI 10.1093/hmg/8.12.2191; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Taylor MRG, 2007, CIRCULATION, V115, P1244, DOI 10.1161/CIRCULATIONAHA.106.646778; van Spaendonck-Zwarts KY, 2011, CLIN GENET, V80, P354, DOI 10.1111/j.1399-0004.2010.01512.x; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; VIEGASPEQUIGNOT E, 1989, HUM GENET, V83, P33, DOI 10.1007/BF00274143	43	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115470	10.1371/journal.pone.0115470	http://dx.doi.org/10.1371/journal.pone.0115470			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541946	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900047
J	Posevitz-Fejfar, A; Posevitz, V; Gross, CC; Bhatia, U; Kurth, F; Schutte, V; Bar-Or, A; Meuth, SG; Wiendl, H				Posevitz-Fejfar, Anita; Posevitz, Vilmos; Gross, Catharina C.; Bhatia, Urvashi; Kurth, Frank; Schuette, Verena; Bar-Or, Amit; Meuth, Sven G.; Wiendl, Heinz			Effects of Blood Transportation on Human Peripheral Mononuclear Cell Yield, Phenotype and Function: Implications for Immune Cell Biobanking	PLOS ONE			English	Article							MULTICENTER CLINICAL-TRIALS; LYMPHOCYTE IMMUNOPHENOTYPE; PROLIFERATIVE RESPONSES; VIABILITY; CRYOPRESERVATION; EXPRESSION; CD4(+); MECHANISM; FREQUENCY; RECOVERY	Human biospecimen collection, processing and preservation are rapidly emerging subjects providing essential support to clinical as well as basic researchers. Unlike collection of other biospecimens (e.g. DNA and serum), biobanking of viable immune cells, such as peripheral blood mononuclear cells (PBMC) and/or isolated immune cell subsets is still in its infancy. While certain aspects of processing and freezing conditions have been studied in the past years, little is known about the effect of blood transportation on immune cell survival, phenotype and specific functions. However, especially for multicentric and cooperative projects it is vital to precisely know those effects. In this study we investigated the effect of blood shipping and pre-processing delay on immune cell phenotype and function both on cellular and subcellular levels. Peripheral blood was collected from healthy volunteers (n=9): at a distal location (shipped overnight) and in the central laboratory (processed immediately). PBMC were processed in the central laboratory and analyzed post-cryopreservation. We analyzed yield, major immune subset distribution, proliferative capacity of T cells, cytokine pattern and T-cell receptor signal transduction. Results show that overnight transportation of blood samples does not globally compromise T-cell subsets as they largely retain their phenotype and proliferative capacity. However, NK and B cell frequencies, the production of certain PBMC-derived cytokines and IL-6 mediated cytokine signaling pathway are altered due to transportation. Various control experiments have been carried out to compare issues related to shipping versus pre-processing delay on site. Our results suggest the implementation of appropriate controls when using multicenter logistics for blood transportation aiming at subsequent isolation of viable immune cells, e.g. in multicenter clinical trials or studies analyzing immune cells/subsets. One important conclusion might be that despite changes due to overnight shipment, highly standardized central processing (and analysis) could be superior to multicentric de-central processing with more difficult standardization.	[Posevitz-Fejfar, Anita; Posevitz, Vilmos; Gross, Catharina C.; Bhatia, Urvashi; Kurth, Frank; Schuette, Verena; Meuth, Sven G.; Wiendl, Heinz] Univ Hosp Muenster, Dept Neurol, Munster, Germany; [Bar-Or, Amit] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada	University of Munster; McGill University	Posevitz-Fejfar, A (corresponding author), Univ Hosp Muenster, Dept Neurol, Albert Schweitzer Campus 1, Munster, Germany.	anita.posevitz-fejfar@ukmuenster.de; heinz.wiendl@ukmuenster.de	Wiendl, Heinz/AAX-6041-2021; Bar-Or, Amit/AIC-1416-2022; Meuth, Sven G/HHM-8941-2022	Meuth, Sven G/0000-0003-2571-3501; Wiendl, Heinz/0000-0003-4310-3432; Gross, Catharina/0000-0002-4872-9189	Kompetenznetz Multiple Sklerose (Competence Network for Multiple Sclerosis) - Federal Ministry of Education and Research [FKZ01GI1308B]; CRC128 Transregional Collaborative Research Center Program of the Deutsche Forschungsgemeinschaft [Z02]	Kompetenznetz Multiple Sklerose (Competence Network for Multiple Sclerosis) - Federal Ministry of Education and Research; CRC128 Transregional Collaborative Research Center Program of the Deutsche Forschungsgemeinschaft	This work was supported by the Kompetenznetz Multiple Sklerose (Competence Network for Multiple Sclerosis) funded by the Federal Ministry of Education and Research (FKZ01GI1308B to HW), and by the CRC128 Transregional Collaborative Research Center Program of the Deutsche Forschungsgemeinschaft (Project Z02 to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betensky RA, 2000, CLIN DIAGN LAB IMMUN, V7, P759, DOI 10.1128/CDLI.7.5.759-763.2000; Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003; Costantini A, 2003, J IMMUNOL METHODS, V278, P145, DOI 10.1016/S0022-1759(03)00202-3; Duggleby RC, 2007, IMMUNOLOGY, V121, P129, DOI 10.1111/j.1365-2567.2006.02550.x; Germann A, 2011, BIOPRESERV BIOBANK, V9, P229, DOI 10.1089/bio.2010.0033; Jeurink PV, 2008, CRYOBIOLOGY, V57, P91, DOI 10.1016/j.cryobiol.2008.06.002; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kleeberger CA, 1999, CLIN DIAGN LAB IMMUN, V6, P14, DOI 10.1128/CDLI.6.1.14-19.1999; Kreher CR, 2003, J IMMUNOL METHODS, V278, P79, DOI 10.1016/S0022-1759(03)00226-6; Kutscher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076215; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-17; McKenna KC, 2009, J IMMUNOL METHODS, V341, P68, DOI 10.1016/j.jim.2008.10.019; Naranbhai V, 2011, J IMMUNOL METHODS, V366, P28, DOI 10.1016/j.jim.2011.01.001; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Olemukan RE, 2010, CLIN VACCINE IMMUNOL, V17, P910, DOI 10.1128/CVI.00492-09; Olson WC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-26; Owen RE, 2007, J IMMUNOL METHODS, V326, P93, DOI 10.1016/j.jim.2007.07.012; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Posevitz V, 2008, J IMMUNOL, V180, P1634, DOI 10.4049/jimmunol.180.3.1634; Posevitz-Fejfar A, 2008, EUR J IMMUNOL, V38, P250, DOI 10.1002/eji.200636664; Reimann KA, 2000, CLIN DIAGN LAB IMMUN, V7, P352, DOI 10.1128/CDLI.7.3.352-359.2000; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Schmielau J, 2001, CANCER RES, V61, P4756; Weinberg A, 2000, CLIN DIAGN LAB IMMUN, V7, P714, DOI 10.1128/CDLI.7.4.714-716.2000; Weinberg A, 2009, CLIN VACCINE IMMUNOL, V16, P1176, DOI 10.1128/CVI.00342-08; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505	27	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115920	10.1371/journal.pone.0115920	http://dx.doi.org/10.1371/journal.pone.0115920			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541968	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900110
J	Villanueva, AA; Priya, S				Villanueva, Alex A.; Priya, Shashank			Cyanea capillata Bell Kinematics Analysis through Corrected In Situ Imaging and Modeling Using Strategic Discretization Techniques	PLOS ONE			English	Article							SWIMMING PERFORMANCE; JET PROPULSION; FLOW PATTERNS; JELLYFISH; MORPHOLOGY; FLIGHT; AERODYNAMICS; ORGANIZATION; LOCOMOTION; ENERGETICS	Obtaining accurate kinematic data of animals is essential for many biological studies and bio-inspired engineering. Many animals, however, are either too large or too delicate to transport to controlled environments where accurate kinematic data can be easily obtained. Often, in situ recordings are the only means available but are often subject to multi-axis motion and relative magnification changes with time leading to large discrepancies in the animal kinematics. Techniques to compensate for these artifacts were applied to a large jellyfish, Cyanea capillata, freely swimming in ocean waters. The bell kinematics were captured by digitizing exumbrella profiles for two full swimming cycles. Magnification was accounted for by tracking a reference point on the ocean floor and by observing the C. capillata exumbrella arclength in order to have a constant scale through the swimming cycles. A linear fit of the top bell section was used to find the body angle with respect to the camera coordinate system. Bell margin trajectories over two swimming cycles confirmed the accuracy of the correction techniques. The corrected profiles were filtered and interpolated to provide a set of time-dependent points along the bell. Discrete models of the exumbrella were used to analyze the bell kinematics. Exumbrella discretization was conducted using three different methods. Fourier series were fitted to the discretized models and subsequently used to analyze the bell kinematics of the C. capillata. The analysis showed that the bell did not deform uniformly over time with different segments lagging behind each other. Looping of the bell trajectory between contraction and relaxation was also present through most of the exumbrella. The bell margin had the largest looping with an outer path during contraction and inner path during relaxation. The subumbrella volume was approximated based on the exumbrella kinematics and was found to increase during contraction.	[Villanueva, Alex A.; Priya, Shashank] Virginia Tech, CEHMS, BMDL, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Priya, S (corresponding author), Virginia Tech, CEHMS, BMDL, Blacksburg, VA 24061 USA.	spriya@vt.edu	Priya, S/GQH-7176-2022	Priya, Shashank/0000-0003-1367-3434	Office of Naval Research [N00014-08-1-0654]	Office of Naval Research(Office of Naval Research)	Funding: Financial support came from the Office of Naval Research through grant #N00014-08-1-0654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajcar T, 2009, HYDROBIOLOGIA, V616, P279, DOI 10.1007/s10750-008-9589-4; Blough T, 2011, BIOL BULL-US, V220, P6, DOI 10.1086/BBLv220n1p6; Chapra SC, 2005, APPL NUMERICAL METHO; Colin SP, 2002, J EXP BIOL, V205, P427; COSTELLO JH, 1994, MAR BIOL, V121, P327, DOI 10.1007/BF00346741; Costello JH, 1995, MAR BIOL, V124, P399, DOI 10.1007/BF00363913; Dabiri JO, 2005, J EXP BIOL, V208, P1257, DOI 10.1242/jeb.01519; Dabiri JO, 2003, J EXP BIOL, V206, P3675, DOI 10.1242/jeb.00597; Dabiri JO, 2007, J EXP BIOL, V210, P1868, DOI 10.1242/jeb.003772; DANIEL TL, 1983, CAN J ZOOL, V61, P1406, DOI 10.1139/z83-190; DEMONT ME, 1988, J EXP BIOL, V134, P313; Ford MD, 2000, SCI MAR, V64, P47; Fry SN, 2005, J EXP BIOL, V208, P2303, DOI 10.1242/jeb.01612; Fu YQ, 2007, ADV INTEL SYS RES, DOI 10.2991/iske.2007.210; GLADFELTER WB, 1972, HELGOLAND WISS MEER, V23, P38, DOI 10.1007/BF01616310; GLADFELTER WB, 1972, MAR BIOL, V14, P150, DOI 10.1007/BF00373214; Guo SX, 2003, IEEE-ASME T MECH, V8, P136, DOI 10.1109/TMECH.2003.809134; Herschlag G, 2011, J THEOR BIOL, V285, P84, DOI 10.1016/j.jtbi.2011.05.035; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; Katija K, 2009, NATURE, V460, P624, DOI 10.1038/nature08207; KRAMP PL, 1961, J MAR BIOL ASSOC UK, V40, P7, DOI 10.1017/S0025315400007347; Luhmann T., 2006, CLOSE RANGE PHOTOGRA; Acuna JL, 2011, SCIENCE, V333, P1627, DOI 10.1126/science.1205134; Marut K, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/9/094021; Mayor AG, 1910, MEDUSAE WORLD; McHenry MJ, 2003, J EXP BIOL, V206, P4125, DOI 10.1242/jeb.00649; Mittal R, 2006, BIOINSPIR BIOMIM, V1, pS35, DOI 10.1088/1748-3182/1/4/S05; Nauen JC, 2002, J EXP BIOL, V205, P3271; NORBERG UM, 1976, J EXP BIOL, V65, P179; Pivkin IV, 2005, LECT NOTES COMPUT SC, V3515, P689; Poelma C, 2006, EXP FLUIDS, V41, P213, DOI 10.1007/s00348-006-0172-3; Rosenberger LJ, 2001, J EXP BIOL, V204, P379; Russell F. S., 1970, MEDUSAE BRIT ISLES, V2; Sahin M, 2009, J EXP BIOL, V212, P2656, DOI 10.1242/jeb.025536; Sathirapongsasuti J, 2004, MATH EXPLANATION MIL; Satterlie RA, 2005, BIOL BULL-US, V209, P154, DOI 10.2307/3593133; Satterlie RA, 2008, J EXP BIOL, V211, P3467, DOI 10.1242/jeb.018952; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Tian XD, 2006, BIOINSPIR BIOMIM, V1, pS10, DOI 10.1088/1748-3182/1/4/S02; Tobalske BW, 2003, J AVIAN BIOL, V34, P177, DOI 10.1034/j.1600-048X.2003.03006.x; Villanueva A., 2010, 2010 IEEE International Conference on Robotics and Biomimetics (ROBIO), P1124, DOI 10.1109/ROBIO.2010.5723486; Villanueva AA, 2014, PLOS ONE, V9; Villanueva A, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/3/036004; Villanueva AA, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/4/046005; WEBB PW, 1993, J EXP BIOL, V178, P97; Wilson MM, 2011, INT J NONLIN MECH, V46, P557, DOI 10.1016/j.ijnonlinmec.2010.12.005	46	1	1	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115220	10.1371/journal.pone.0115220	http://dx.doi.org/10.1371/journal.pone.0115220			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541980	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900026
J	Chidlow, G; Wood, JPM; Casson, RJ				Chidlow, Glyn; Wood, John P. M.; Casson, Robert J.			Expression of Inducible Heat Shock Proteins Hsp27 and Hsp70 in the Visual Pathway of Rats Subjected to Various Models of Retinal Ganglion Cell Injury	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; METHYL-D-ASPARTATE; OPTIC-NERVE; GLAUCOMA MODEL; SPATIOTEMPORAL CHARACTERIZATION; NEURONAL DEGENERATION; TRANSIENT ISCHEMIA; MESSENGER-RNA; PROTECTS; HEAT-SHOCK-PROTEIN-27	Inducible heat shock proteins (Hsps) are upregulated in the central nervous system in response to a wide variety of injuries. Surprisingly, however, no coherent picture has emerged regarding the magnitude, duration and cellular distribution of inducible Hsps in the visual system following injury to retinal ganglion cells (RGCs). The current study sought, therefore, to achieve the following two objectives. The first aim of this study was to systematically characterise the patterns of Hsp27 and -70 expression in the retina and optic nerve in four discrete models of retinal ganglion cell (RGC) degeneration: axonal injury (ON crush), somato-dendritic injury (NMDA-induced excitotoxicity), chronic hypoperfusion (bilateral occlusion of the carotid arteris) and experimental glaucoma. The second aim was to document Hsp27 and -70 expression in the optic tract, the subcortical retinorecipient areas of the brain, and the visual cortex during Wallerian degeneration of RGC axons. Hsp27 was robustly upregulated in the retina in each injury paradigm, with the chronic models, 2VO and experimental glaucoma, displaying a more persistent Hsp27 transcriptional response than the acute models. Hsp27 expression was always associated with astrocytes and with a subset of RGCs in each of the models excluding NMDA. Hsp27 was present within astrocytes of the optic nerve/optic tract in control rats. During Wallerian degeneration, Hsp27 was upregulated in the optic nerve/optic tract and expressed de novo by astrocytes in the lateral geniculate nucleus and the stratum opticum of the superior colliculus. Conversely, the results of our study indicate Hsp70 was minimally induced in any of the models of injury, either in the retina, or in the optic nerve/optic tract, or in the subcortical, retinorecipient areas of the brain. The findings of the present study augment our understanding of the involvement of Hsp27 and Hsp70 in the response of the visual system to RGC degeneration.	[Chidlow, Glyn; Wood, John P. M.; Casson, Robert J.] South Australian Inst Ophthalmol, Hanson Inst, Ctr Neurol Dis, Ophthalm Res Labs, Adelaide, SA 5000, Australia; [Chidlow, Glyn; Wood, John P. M.; Casson, Robert J.] Univ Adelaide, Dept Ophthalmol & Visual Sci, Adelaide, SA 5000, Australia	Hanson Institute; University of Adelaide	Chidlow, G (corresponding author), South Australian Inst Ophthalmol, Hanson Inst, Ctr Neurol Dis, Ophthalm Res Labs, Frome Rd, Adelaide, SA 5000, Australia.	glyn.chidlow@health.sa.gov.au			National Health and Medical Research Council [APP1050982]; Ophthalmic Research Institute of Ophthalmology	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Ophthalmology	Support from the National Health and Medical Research Council (project grant: APP1050982) and the Ophthalmic Research Institute of Ophthalmology is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2008, NEUROSCI LETT, V433, P11, DOI 10.1016/j.neulet.2007.12.045; Aviles-Trigueros M, 2003, EXP NEUROL, V184, P767, DOI 10.1016/S0014-4886(03)00298-X; Bernstein SL, 2003, INVEST OPHTH VIS SCI, V44, P4153, DOI 10.1167/iovs.03-0274; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P3784, DOI 10.1167/iovs.09-4894; Caprioli J, 1996, INVEST OPHTH VIS SCI, V37, P2376; Chidlow G, 2003, BRAIN RES, V963, P298, DOI 10.1016/S0006-8993(02)04052-0; Chidlow G, 2008, INVEST OPHTH VIS SCI, V49, P762, DOI 10.1167/iovs.07-0726; Chidlow G, 2011, J HISTOCHEM CYTOCHEM, V59, P884, DOI 10.1369/0022155411418115; Chidlow G, 2011, ACTA NEUROPATHOL, V121, P737, DOI 10.1007/s00401-011-0807-1; Chidlow G, 2010, INVEST OPHTH VIS SCI, V51, P1483, DOI 10.1167/iovs.09-4603; Costigan M, 1998, J NEUROSCI, V18, P5891; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; Currie RW, 2000, BRAIN RES, V863, P169, DOI 10.1016/S0006-8993(00)02133-8; Dean DO, 1999, INVEST OPHTH VIS SCI, V40, P2952; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fei Z, 2001, J CLIN NEUROSCI, V8, P250, DOI 10.1054/jocn.2000.0760; Franklin TB, 2005, INT J HYPERTHER, V21, P379, DOI 10.1080/02656730500069955; Hecker JG, 2011, CELL STRESS CHAPERON, V16, P119, DOI 10.1007/s12192-010-0224-8; Holman MC, 2010, INVEST OPHTH VIS SCI, V51, P2197, DOI 10.1167/iovs.09-4191; Hopkins DA, 1998, EXP NEUROL, V153, P173, DOI 10.1006/exnr.1998.6870; Huang W, 2007, INVEST OPHTH VIS SCI, V48, P4129, DOI 10.1167/iovs.06-0606; Ishii Y, 2003, INVEST OPHTH VIS SCI, V44, P1982, DOI 10.1167/iovs.02-0912; Ito Y, 2008, CNS NEUROSCI THER, V14, P192, DOI 10.1111/j.1755-5949.2008.00050.x; Ito Y, 2010, CNS NEUROSCI THER, V16, P103, DOI 10.1111/j.1755-5949.2009.00081.x; Kalesnykas G, 2008, NEUROSCIENCE, V155, P937, DOI 10.1016/j.neuroscience.2008.06.038; Kalesnykas G, 2007, NEUROSCIENCE, V150, P692, DOI 10.1016/j.neuroscience.2007.09.078; Kretz A, 2005, NEUROBIOL DIS; Krueger AMR, 1999, MOL BRAIN RES, V71, P265, DOI 10.1016/S0169-328X(99)00198-9; Krueger-Naug AMR, 2002, NEUROSCIENCE, V110, P653, DOI 10.1016/S0306-4522(01)00453-5; Krueger-Naug AMR, 2003, NEUROSCIENCE, V116, P49, DOI 10.1016/S0306-4522(02)00582-1; Kwong JMK, 2003, BRAIN RES, V970, P119, DOI 10.1016/S0006-8993(03)02298-4; LAWSON LJ, 1994, J NEUROCYTOL, V23, P729, DOI 10.1007/BF01268086; Levkovitch-Verbin H, 2002, INVEST OPHTH VIS SCI, V43, P402; Lewden O, 1998, OPHTHALMIC RES, V30, P291, DOI 10.1159/000055487; Li Y, 2003, INVEST OPHTH VIS SCI, V44, P1299, DOI 10.1167/iovs.02-0235; Liu M, 2014, CURR EYE RES; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Herrera MPL, 2002, EXP NEUROL, V178, P243, DOI 10.1006/exnr.2002.8043; MOORE RY, 1994, J COMP NEUROL, V344, P403, DOI 10.1002/cne.903440306; O'Reilly AM, 2010, MOL NEUROBIOL, V42, P124, DOI 10.1007/s12035-010-8143-3; Park KH, 2001, INVEST OPHTH VIS SCI, V42, P1522; Plumier JCL, 1996, NEUROSCIENCE, V75, P849, DOI 10.1016/0306-4522(96)00317-X; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Schlamp CL, 2001, MOL VIS, V7, P192; Schmeer C, 2008, INVEST OPHTH VIS SCI, V49, P4971, DOI 10.1167/iovs.07-1597; SCHMIDTKASTNER R, 1993, INT J DEV NEUROSCI, V11, P157, DOI 10.1016/0736-5748(93)90076-P; Shimazawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030526; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Wang X, 2000, BRAIN RES, V878, P136, DOI 10.1016/S0006-8993(00)02727-X; Whitlock NA, 2005, INVEST OPHTH VIS SCI, V46, P1092, DOI 10.1167/iovs.04-0043; Yamamoto H, 2006, EXP EYE RES, V82, P767, DOI 10.1016/j.exer.2005.09.019; Zhang SD, 2009, BRAIN RES, V1303, P131, DOI 10.1016/j.brainres.2009.09.029; Zhao L, 2006, NEUROSCI LETT, V404, P44, DOI 10.1016/j.neulet.2006.05.044	54	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114838	10.1371/journal.pone.0114838	http://dx.doi.org/10.1371/journal.pone.0114838			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535743	gold, Green Published, Green Submitted			2022-12-26	WOS:000348563300023
J	Mezaal, YS; Eyyuboglu, HT; Ali, JK				Mezaal, Yaqeen S.; Eyyuboglu, Halil T.; Ali, Jawad K.			Wide Bandpass and Narrow Bandstop Microstrip Filters Based on Hilbert Fractal Geometry: Design and Simulation Results	PLOS ONE			English	Article								This paper presents new Wide Bandpass Filter (WBPF) and Narrow Bandstop Filter (NBSF) incorporating two microstrip resonators, each resonator is based on 2nd iteration of Hilbert fractal geometry. The type of filter as pass or reject band has been adjusted by coupling gap parameter (d) between Hilbert resonators using a substrate with a dielectric constant of 10.8 and a thickness of 1.27 mm. Numerical simulation results as well as a parametric study of d parameter on filter type and frequency responses are presented and studied. WBPF has designed at resonant frequencies of 2 and 2.2 GHz with a bandwidth of 0.52 GHz, -28 dB return loss and -0.125 dB insertion loss while NBSF has designed for electrical specifications of 2.37 GHz center frequency, 20 MHz rejection bandwidth, -0.1873 dB return loss and 13.746 dB insertion loss. The proposed technique offers a new alternative to construct low-cost high-performance filter devices, suitable for a wide range of wireless communication systems.	[Mezaal, Yaqeen S.; Eyyuboglu, Halil T.] Cankaya Univ, Elect & Commun Engn Dept, Ankara, Turkey; [Mezaal, Yaqeen S.; Ali, Jawad K.] Univ Technol Baghdad, Dept Elect Engn, Microwave Res Grp, Baghdad, Iraq	Cankaya University; University of Technology- Iraq	Mezaal, YS (corresponding author), Cankaya Univ, Elect & Commun Engn Dept, Ankara, Turkey.	yakeen_sbah@yahoo.com	Mezaal, Yaqeen Sabah/O-5095-2019; Ali, Jawad K./C-6710-2009	Mezaal, Yaqeen Sabah/0000-0002-9953-9975; Ali, Jawad K./0000-0002-6900-6844	Scientific and Technological Research Council of Turkey (TUBITAK) [B.14.2. TBT.0.06.01.03-215.01-24962]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work is supported by the Scientific and Technological Research Council of Turkey (TUBITAK) for PhD Research Fellowship for Foreign Citizens Program under Fund Reference (B.14.2. TBT.0.06.01.03-215.01-24962). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Jawad K., 2009, 2009 3rd IEEE International Symposium on Microwave, Antenna, Propagation and EMC Technologies for Wireless Communications (MAPE 2009), P1019, DOI 10.1109/MAPE.2009.5355854; Ali J. K., 2008, 5TH INT MULTI C SYST, P1; Ali JK, 2012, PR ELECTROMAGN RES S, P888; Barra M., 2004, THESIS U NAPOLI; Chang K., 2004, MICROWAVE RING CIRCU; Chen J, 2007, PROG ELECTROMAGN RES, V70, P269, DOI 10.2528/PIER07012603; Dong Yan, 2010, Proceedings 2010 IEEE Youth Conference on Information, Computing and Telecommunications (YC-ICT 2010), P5, DOI 10.1109/YCICT.2010.5713138; Eryilmaz GM, 2009, MICROW OPT TECHN LET, V51, P1470; Ghosh B., 2011, 2011 IEEE International Workshop on Electromagnetics; Applications and Student Innovation (iWEM 2011), P89, DOI 10.1109/iWEM.2011.6021445; Haiwen L., 2010, PROCEEDINGS OF INTER, P184; Hong J.-S., 2001, WILEY MICRO; Jarry P., 2009, DESIGN REALIZATIONS; Kwon .K, 2006, J KOREAN ELECTROMAGN, V6; Liu JC, 2007, MICROW OPT TECHN LET, V49, P1890, DOI 10.1002/mop.22630; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Mezaal Y. S., 2009, INT J ADV COMPUT TEC, V1, P35; Mezaal YS, 2014, IETE J RES, V60, P257, DOI 10.1080/03772063.2014.922018; Mezaal YS, 2013, INT C ADV COMPUT COM, P343, DOI 10.1109/ACCT.2013.54; Waterhouse R. B., 2003, MICROSTRIP PATCH ANT	19	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115412	10.1371/journal.pone.0115412	http://dx.doi.org/10.1371/journal.pone.0115412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536436	Green Published, gold			2022-12-26	WOS:000348563300039
J	Xu, Y; Fu, LR; Jia, MH; Dai, GY; Wang, Q; Huang, P; Zheng, H; Peng, ZH; Wang, L; Yu, RB; Wang, N				Xu, Yin; Fu, Li Ru; Jia, Manhong; Dai, Genyin; Wang, Qing; Huang, Peng; Zheng, Hui; Peng, Zhihang; Wang, Lu; Yu, Rongbin; Wang, Ning			HIV Prevalence and Associated Factors among Foreign Brides from Burma in Yunnan Province, China	PLOS ONE			English	Article							RISK BEHAVIORS; INFECTION; SYPHILIS; HIV/AIDS; SEX; EPIDEMIC; COUPLES; DEHONG; MEN	Background: Many Burmese women have migrated to Yunnan Province and married local residents over the past few decades; however, limited information is available on their HIV prevalence and ability to cope with HIV. This study aims to assess the prevalence of HIV and knowledge related to AIDS, as well as to discover possible risk factors of HIV infection among foreign brides from Burma in Yunnan Province. Methods: A cross-sectional study was taken of all Burmese cross-border wives residing in Tengchong County using standardized questionnaires. HIV and syphilis testing was conducted at the same time. Results: Among 600 Burmese brides, the HIV prevalence was 2.17%. Those aged 21-30, those with higher education levels and those who had resided in China less than one year had higher infection rates. The AIDS awareness rate of 39.50% was very low in this population. Only 28.67% of participants had ever been involved in prevention services. The rate of condom use was low. Classification by age, education, occupation, prior HIV testing and prior use of HIV prevention services showed a statistically significant association with mean knowledge score (p<0.05). Residing in China less than one year (OR=3.86, 95% CI=1.09-13.70) and having casual sex in the last year (OR=10.49, 95% CI=1.20-91.59) were risk factors for HIV infection. Conclusions: Burmese brides in China are not only exposed to a high risk of HIV infection, but also seriously lack response capabilities. Educational interventions and control efforts are practical approaches that need to be strengthened among this population.	[Xu, Yin; Dai, Genyin; Wang, Qing; Huang, Peng; Zheng, Hui; Peng, Zhihang; Yu, Rongbin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Fu, Li Ru; Jia, Manhong] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Peoples R China; [Wang, Lu; Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Nanjing Medical University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Peng, ZH (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	zhihangpeng@njmu.edn.cn; wangning_12@126.com			Natural Science Foundation of China [81001288]; National S&T Major Project Foundation of China [2012ZX10001-001, 2011ZX10004-902]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Province Health Development Project with Science and Education [ZX201109]; National Science and Technology Support Program [2011BAI09B02]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Project Foundation of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Province Health Development Project with Science and Education; National Science and Technology Support Program	This work was supported in part by Natural Science Foundation of China (81001288), National S&T Major Project Foundation of China (No. 2012ZX10001-001 and No. 2011ZX10004-902), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Jiangsu Province Health Development Project with Science and Education (NO. ZX201109), and National Science and Technology Support Program (2011BAI09B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Bai ZH, 2011, J KUNMING U SCI TECH, V11, P12; Beyrer C, 2003, JAIDS-J ACQ IMM DEF, V32, P311, DOI 10.1097/00126334-200303010-00011; China A.I.D.S, 2012, RESP PROGR REP MIN H; Dean K, 2005, POLIT GEOGR, V24, P808, DOI 10.1016/j.polgeo.2005.06.004; Duan S, 2012, SEX HEALTH, V9, P481, DOI 10.1071/SH12065; Duan S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-180; Feng L, 2011, THESIS CHINESE CDCP; Ford K, 2012, INT J MIGR HEALTH SO, V8, P127, DOI 10.1108/17479891211267311; Fu LR, 2011, CHINESE J AIDS STD, V17, P316; Fu ZH, 2011, AIDS BEHAV, V15, P1017, DOI 10.1007/s10461-010-9797-6; He N., 2012, CHINESE J AIDS STD, V18, P156; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Jin X, 2010, JAIDS-J ACQ IMM DEF, V53, P131, DOI 10.1097/QAI.0b013e3181b3552a; Jun P, 2010, MED SOC, V7; Lao YF, 2012, INFECT DIS INFORM, V25, P360; Lin F, 2010, CHINESE J AIDS STD, V5, P515; Liu SY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-250; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; Schofer H, 1996, GENITOURIN MED, V72, P176; Tan S, 2010, THESIS KUNMING MED U; Tucker JD, 2005, AIDS, V19, P539, DOI 10.1097/01.aids.0000163929.84154.87; Wang L, 2012, AIDS CARE, V24, P1059, DOI 10.1080/09540121.2012.661837; Wang LL, 2009, CHIN J PHM, V25, P170; *WHO, EP FACT SHEET HIV AI; Xiao Y, 2007, SOC SCI MED, V64, P665, DOI 10.1016/j.socscimed.2006.09.019; Zetola NM, 2007, CLIN INFECT DIS, V44, P1222, DOI 10.1086/513427; Zhou H, 2007, SEX TRANSM INFECT, V83, P476, DOI 10.1136/sti.2007.026187	29	8	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115599	10.1371/journal.pone.0115599	http://dx.doi.org/10.1371/journal.pone.0115599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25536087	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300054
J	Kramer, C; Jordan, D; Kretschmer, A; Lehmeyer, V; Kellermann, K; Schaller, SJ; Blobner, M; Kochs, EF; Fink, H				Kramer, Christopher; Jordan, Denis; Kretschmer, Alexander; Lehmeyer, Veronika; Kellermann, Kristine; Schaller, Stephan J.; Blobner, Manfred; Kochs, Eberhard F.; Fink, Heidrun			Electromyographic Permutation Entropy Quantifies Diaphragmatic Denervation and Reinnervation	PLOS ONE			English	Article							ACCESSORY PHRENIC-NERVE; APPROXIMATE ENTROPY; POWER SPECTRUM; MUSCLE-FIBERS; RAT; ELECTROENCEPHALOGRAM; UNCONSCIOUSNESS; PARALYSIS	Spontaneous reinnervation after diaphragmatic paralysis due to trauma, surgery, tumors and spinal cord injuries is frequently observed. A possible explanation could be collateral reinnervation, since the diaphragm is commonly double-innervated by the (accessory) phrenic nerve. Permutation entropy (PeEn), a complexity measure for time series, may reflect a functional state of neuromuscular transmission by quantifying the complexity of interactions across neural and muscular networks. In an established rat model, electromyographic signals of the diaphragm after phrenicotomy were analyzed using PeEn quantifying denervation and reinnervation. Thirty-three anesthetized rats were unilaterally phrenicotomized. After 1, 3, 9, 27 and 81 days, diaphragmatic electromyographic PeEn was analyzed in vivo from sternal, mid-costal and crural areas of both hemidiaphragms. After euthanasia of the animals, both hemidiaphragms were dissected for fiber type evaluation. The electromyographic incidence of an accessory phrenic nerve was 76%. At day 1 after phrenicotomy, PeEn (normalized values) was significantly diminished in the sternal (median: 0.69; interquartile range: 0.66-0.75) and mid-costal area (0.68; 0.66-0.72) compared to the non-denervated side (0.84; 0.78-0.90) at threshold p<0.05. In the crural area, innervated by the accessory phrenic nerve, PeEn remained unchanged (0.79; 0.72-0.86). During reinnervation over 81 days, PeEn normalized in the mid-costal area (0.84; 0.77-0.86), whereas it remained reduced in the sternal area (0.77; 0.70-0.81). Fiber type grouping, a histological sign for reinnervation, was found in the mid-costal area in 20% after 27 days and in 80% after 81 days. Collateral reinnervation can restore diaphragm activity after phrenicotomy. Electromyographic PeEn represents a new, distinctive assessment characterizing intramuscular function following denervation and reinnervation.	[Kramer, Christopher; Jordan, Denis; Kretschmer, Alexander; Lehmeyer, Veronika; Kellermann, Kristine; Schaller, Stephan J.; Blobner, Manfred; Kochs, Eberhard F.; Fink, Heidrun] Tech Univ Munich, Klinikum Rechts Isar, Klin Anaesthesiol, D-81675 Munich, Germany	Technical University of Munich; University of Munich	Jordan, D (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Klin Anaesthesiol, Ismaninger Str 22, D-81675 Munich, Germany.	d.jordan@lrz.tu-muenchen.de	Blobner, Manfred/R-4411-2017; Kretschmer, Alexander/AAU-5922-2021; Schaller, Stefan J/L-8054-2019	Blobner, Manfred/0000-0002-0370-5247; Schaller, Stefan J/0000-0002-6683-9584; Lewald, Heidrun/0000-0002-5192-425X				BALLANTYNE JP, 1982, MUSCLE NERVE, V5, pS127; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Cao YH, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046217; Chen R, 1996, MUSCLE NERVE, V19, P324, DOI 10.1002/(SICI)1097-4598(199603)19:3<324::AID-MUS7>3.0.CO;2-F; De Bie G, 2007, AM J OTOLARYNG, V28, P357, DOI 10.1016/j.amjoto.2006.10.007; DOUGLASS BE, 1960, DIS CHEST, V37, P295; Elefteriades J, 2008, J CARDIOVASC SURG, V49, P289; FUGLSANGFREDERIKSEN A, 1990, J NEUROL SCI, V97, P81, DOI 10.1016/0022-510X(90)90100-2; GIBSON GJ, 1989, THORAX, V44, P960, DOI 10.1136/thx.44.11.960; Goebel HH, 2013, MUSCLE DISEASE: PATHOLOGY AND GENETICS, 2ND EDITION, P1, DOI 10.1002/9781118635469; GOTTSCHALL J, 1977, ANAT EMBRYOL, V151, P63, DOI 10.1007/BF00315298; HAGG GM, 1992, J APPL PHYSIOL, V73, P1211, DOI 10.1152/jappl.1992.73.4.1211; HARPER NJN, 1987, BRIT J ANAESTH, V59, P200, DOI 10.1093/bja/59.2.200; IWASAKI Y, 1991, INT J NEUROSCI, V58, P165, DOI 10.3109/00207459108985432; Jordan D, 2013, BIOMED TECH BERL; Jordan D, 2013, ANESTHESIOLOGY, V119, P1031, DOI 10.1097/ALN.0b013e3182a7ca92; Jordan D, 2008, ANESTHESIOLOGY, V109, P1014, DOI 10.1097/ALN.0b013e31818d6c55; Kaufman MR, 2011, CHEST, V140, P191, DOI 10.1378/chest.10-2765; Kreuzer M, 2014, J CLIN MONIT COMPUT; KUGELBERG E, 1970, J NEUROL NEUROSUR PS, V33, P319, DOI 10.1136/jnnp.33.3.319; Li D, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046010; Loukas M, 2006, ANN THORAC SURG, V82, P1870, DOI 10.1016/j.athoracsur.2006.05.098; LULLMANNRAUCH R, 1971, Z ZELLFORSCH MIK ANA, V121, P593, DOI 10.1007/BF00560162; Marie JP, 1997, RESP PHYSIOL, V109, P139, DOI 10.1016/S0034-5687(97)00048-0; Merino-Ramirez MA, 2007, MUSCLE NERVE, V36, P267, DOI 10.1002/mus.20754; Nayak Soubhagya R, 2008, Acta Medica (Hradec Kralove), V51, P181; Olofsen E, 2008, BRIT J ANAESTH, V101, P810, DOI 10.1093/bja/aen290; Polla B, 2004, THORAX, V59, P808, DOI 10.1136/thx.2003.009894; Reilingh TSD, 1998, J PEDIATR SURG, V33, P602, DOI 10.1016/S0022-3468(98)90325-6; Stevens Robert D, 2009, Crit Care Med, V37, pS299, DOI 10.1097/CCM.0b013e3181b6ef67; Thakor NV, 2004, ANNU REV BIOMED ENG, V6, P453, DOI 10.1146/annurev.bioeng.5.040202.121601; Xie HB, 2010, ANN BIOMED ENG, V38, P1483, DOI 10.1007/s10439-010-9933-5; Zhan WZ, 1997, J APPL PHYSIOL, V82, P1145, DOI 10.1152/jappl.1997.82.4.1145; Zhou P, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066010	35	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115754	10.1371/journal.pone.0115754	http://dx.doi.org/10.1371/journal.pone.0115754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532023	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100104
J	Pan, J; Bhardwaj, M; Nagabhyru, P; Grossman, RB; Schardl, CL				Pan, Juan; Bhardwaj, Minakshi; Nagabhyru, Padmaja; Grossman, Robert B.; Schardl, Christopher L.			Enzymes from Fungal and Plant Origin Required for Chemical Diversification of Insecticidal Loline Alkaloids in Grass-Epichloe Symbiota	PLOS ONE			English	Article							NEOTYPHODIUM-UNCINATUM; MEADOW FESCUE; IN-VITRO; ENDOPHYTE; BIOSYNTHESIS; ARUNDINACEA; PREVALENCE; CURRENCIES; SEQUENCE; HYBRID	The lolines are a class of bioprotective alkaloids that are produced by Epichloe species, fungal endophytes of grasses. These alkaloids are saturated 1-aminopyrrolizidines with a C2 to C7 ether bridge, and are structurally differentiated by the various modifications of the 1-amino group: -NH2 (norloline), -NHCH3 (loline), -N(CH3)(2) (N-methylloline), -N(CH3)Ac (N-acetylloline), -NHAc (N-acetylnorloline), and -N(CH3)CHO (N-formylloline). Other than the LoIP cytochrome P450, which is required for conversion of N-methylloline to N-formylloline, the enzymatic steps for loline diversification have not yet been established. Through isotopic labeling, we determined that N-acetylnorloline is the first fully cyclized loline alkaloid, implying that deacetylation, methylation, and acetylation steps are all involved in loline alkaloid diversification. Two genes of the loline alkaloid biosynthesis (LOL) gene cluster, lolN and lolM, were predicted to encode an N-acetamidase (deacetylase) and a methyltransferase, respectively. A knockout strain lacking both lolN and lolM stopped the biosynthesis at N-acetylnorloline, and complementation with the two wild-type genes restored production of N-formylloline and N-acetylloline. These results indicated that lolN and lolM are required in the steps from N-acetylnorloline to other lolines. The function of LolM as an N-methyltransferase was confirmed by its heterologous expression in yeast resulting in conversion of norloline to loline, and of loline to N-methylloline. One of the more abundant lolines, N-acetylloline, was observed in some but not all plants with symbiotic Epichloe siegelii, and when provided with exogenous loline, asymbiotic meadow fescue (Lolium pratense) plants produced N-acetylloline, suggesting that a plant acetyltransferase catalyzes	[Pan, Juan; Nagabhyru, Padmaja] Univ Kentucky, Dept Plant Pathol, Lexington, KY 40506 USA; [Bhardwaj, Minakshi; Grossman, Robert B.; Schardl, Christopher L.] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky	Schardl, CL (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.	schardl@uky.edu	Pan, Juan/GSN-8862-2022; Schardl, Christopher L/P-5655-2014	Schardl, Christopher L/0000-0003-2197-0842; Bhardwaj, Minakshi/0000-0001-6544-7370	Kentucky's National Science Foundation Experimental Program [0814194]; National Institute of General Medical Sciences [R01GM086888]; United States Department of Agriculture [2012-6701319384]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086888] Funding Source: NIH RePORTER	Kentucky's National Science Foundation Experimental Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Kentucky's National Science Foundation Experimental Program to Stimulate Competitive Research grant 0814194 (http://www.kynsfepscor.org/), and National Institute of General Medical Sciences grant R01GM086888, and United States Department of Agriculture grant 2012-6701319384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN ZQ, 1993, APPL ENVIRON MICROB, V59, P1540, DOI 10.1128/AEM.59.5.1540-1548.1993; Ball O. J. P., 1999, Proceedings of the Fifty Second New Zealand Plant Protection Conference, Auckland Airport Centra, Auckland, New Zealand, 10-12 August, 1999, P264; Blankenship JD, 2005, CHEMBIOCHEM, V6, P1016, DOI 10.1002/cbic.200400327; Blankenship JD, 2001, PHYTOCHEMISTRY, V58, P395, DOI 10.1016/S0031-9422(01)00272-2; Bultman TL, 2009, ENTOMOL EXP APPL, V130, P173, DOI 10.1111/j.1570-7458.2008.00802.x; Bultman TL, 1997, OIKOS, V78, P170, DOI 10.2307/3545812; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Faulkner JR, 2006, CHEMBIOCHEM, V7, P1078, DOI 10.1002/cbic.200600066; Georghiou GP., 1972, ANNU REV ECOL EVOL S, V3, P133, DOI DOI 10.1146/ANNUREV.ES.03.110172.001025; Ghimire SR, 2011, MYCOLOGIA, V103, P75, DOI 10.3852/10-154; Hopp T. P., 1988, NAT BIOTECHNOL, V6, P1204, DOI DOI 10.1038/NBT1088-1204; Inoue I, 2002, PLANT CELL, V14, P1869, DOI 10.1105/tpc.002576; Jensen J. G., 2009, New Zealand Plant Protection, V62, P12; Kang Y, 2011, MYCOLOGIA, V103, P1341, DOI 10.3852/10-352; LATCH GCM, 1985, ANN APPL BIOL, V107, P17, DOI 10.1111/j.1744-7348.1985.tb01543.x; Moon CD, 2004, MOL ECOL, V13, P1455, DOI 10.1111/j.1365-294X.2004.02138.x; Pan J, 2014, PHYTOCHEMISTRY, V98, P60, DOI 10.1016/j.phytochem.2013.11.015; Panaccione DG, 2001, P NATL ACAD SCI USA, V98, P12820, DOI 10.1073/pnas.221198698; Pogany J, 2008, P NATL ACAD SCI USA, V105, P19956, DOI 10.1073/pnas.0810851105; Popay A. J., 2009, New Zealand Plant Protection, V62, P19; Rajendran KS, 2004, VIROLOGY, V326, P250, DOI 10.1016/j.virol.2004.06.018; RIBAS I., 1953, FARMACOGNOSIA [MADRID], V13, P367; RIEDELL WE, 1991, J ENTOMOL SCI, V26, P122, DOI 10.18474/0749-8004-26.1.122; Schardl CL, 2007, PHYTOCHEMISTRY, V68, P980, DOI 10.1016/j.phytochem.2007.01.010; Schardl CL, 2013, TOXINS, V5, P1064, DOI 10.3390/toxins5061064; Schardl CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003323; Schardl CL, 2010, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0001324.pub2, DOI 10.1002/9780470015902.A0001324.PUB2]; SIKORSKI RS, 1989, GENETICS, V122, P19; Spiering MJ, 2008, FUNGAL GENET BIOL, V45, P1307, DOI 10.1016/j.fgb.2008.07.001; Spiering MJ, 2005, GENETICS, V169, P1403, DOI 10.1534/genetics.104.035972; Spiering MJ, 2002, FUNGAL GENET BIOL, V36, P242, DOI 10.1016/S1087-1845(02)00023-3; Starnes JH, 2012, GENETICS, V191, P389, DOI 10.1534/genetics.111.137950; TSAI HF, 1992, CURR GENET, V22, P399, DOI 10.1007/BF00352441; VEEN G, 1992, Z NATURFORSCH C, V47, P341; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	35	16	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115590	10.1371/journal.pone.0115590	http://dx.doi.org/10.1371/journal.pone.0115590			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531527	Green Submitted, gold, Green Published			2022-12-26	WOS:000348845100080
J	Zhang, X; Song, F; Taxipalati, M; Wei, W; Feng, FQ				Zhang, Xi; Song, Fei; Taxipalati, Maierhaba; Wei, Wei; Feng, Fengqin			Comparative Study of Surface-Active Properties and Antimicrobial Activities of Disaccharide Monoesters	PLOS ONE			English	Article							FATTY-ACID ESTERS; ETHYLENEDIAMINETETRAACETIC ACID; REGIOSELECTIVE ACYLATION; ESSENTIAL OILS; SUCROSE; CARBOHYDRATE; DERIVATIVES; MONOLAURIN; SOLVENT; MALTOSE	The objective of this research was to determine the effect of sugar or fatty acid in sugar ester compounds on the surface-active properties and antimicrobial activities of these compounds. Disaccharides of medium-chain fatty acid monoesters were synthesized through transesterifications by immobilized lipase (Lipozyme TLIM) to yield nine monoesters for subsequent study. Their antimicrobial activities were investigated using three pathogenic microorganisms: Staphylococcus aureus, Escherichia coli O157:H7 and Candida albicans. Their surface-active properties including air-water surface tension, critical micelle concentration, and foaming and emulsion power and stability were also studied. The results showed that all of the tested monoesters were more effective against Staphylococcus aureus (Gram-positive bacterium) than against Escherichia coli O157:H7 (Gram-negative bacterium). The results demonstrated that the carbon chain length was the most important factor influencing the surface properties, whereas degree of esterification and hydrophilic groups showed little effect.	[Zhang, Xi; Song, Fei; Taxipalati, Maierhaba; Wei, Wei; Feng, Fengqin] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Xi] Yunnan Coll Tradit Chinese Med, Kunming, Yunnan, Peoples R China; [Zhang, Xi; Taxipalati, Maierhaba; Wei, Wei; Feng, Fengqin] Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Hangzhou 310003, Zhejiang, Peoples R China; [Song, Fei] Synutra Int Inc, Beijing Inst Nutr, Beijing, Peoples R China; [Feng, Fengqin] Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Yunnan University of Chinese Medicine; Zhejiang University; Zhejiang University	Feng, FQ (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	fengfq@zju.edu.cn			program of National Natural Science Foundation of China [31071501]; Key Innovation Team of Science and Technology in Zhejiang Province [2010R50032]; Zhejiang Key Laboratory for Agro-Food Processing [2010R50032]	program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Innovation Team of Science and Technology in Zhejiang Province; Zhejiang Key Laboratory for Agro-Food Processing	This work was supported by the program of National Natural Science Foundation of China (Project No. 31071501), Key Innovation Team of Science and Technology in Zhejiang Province (No. 2010R50032), and Zhejiang Key Laboratory for Agro-Food Processing (No. 2010R50032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerra N, 2008, COLLOID SURFACE A, V327, P134, DOI 10.1016/j.colsurfa.2008.06.012; Branen AL, 1980, FOOD TECHNOL, P51; Branen JK, 2004, INT J FOOD MICROBIOL, V90, P63, DOI 10.1016/S0168-1605(03)00172-7; CONLEY AJ, 1973, ANTIMICROB AGENTS CH, V4, P501, DOI 10.1128/AAC.4.5.501; Devulapalle KS, 2004, CARBOHYD RES, V339, P1029, DOI 10.1016/j.carres.2004.01.007; Ducret A, 1996, J AM OIL CHEM SOC, V73, P109, DOI 10.1007/BF02523456; Ferrer M, 2005, ENZYME MICROB TECH, V36, P391, DOI 10.1016/j.enzmictec.2004.02.009; Ferrer M, 1999, BIOTECHNOL BIOENG, V65, P10, DOI 10.1002/(SICI)1097-0290(19991005)65:1&lt;10::AID-BIT2&gt;3.0.CO;2-L; Ferrer M, 2000, TETRAHEDRON, V56, P4053, DOI 10.1016/S0040-4020(00)00319-7; Garofalakis G, 2000, J COLLOID INTERF SCI, V229, P391, DOI 10.1006/jcis.2000.7035; Griffin W.C., 1949, J SOC COSMET CHEM, V1, P311; Habulin M, 2008, J SUPERCRIT FLUID, V45, P338, DOI 10.1016/j.supflu.2008.01.002; Hathcox AK, 1996, FOOD MICROBIOL, V13, P213, DOI 10.1006/fmic.1996.0027; Herrington TM, 1991, MICROEMULSIONS EMULS, P82; Huband FA, 1998, FOOD HYDROCOLLOIDS, V12, P237; KANAZAWA A, 1995, J APPL BACTERIOL, V78, P55, DOI 10.1111/j.1365-2672.1995.tb01673.x; KATO N, 1975, J FERMENT TECHNOL, V53, P793; Kempen SEHJ, 2013, J AGR FOOD CHEM, V61, P7829; Kempen SEHJ, 2013, FOOD BIOPHYSICS; Kim JE, 1998, BIOTECHNOL BIOENG, V57, P121, DOI 10.1002/(SICI)1097-0290(19980105)57:1&lt;121::AID-BIT15&gt;3.0.CO;2-N; Kjellin URM, 2001, LANGMUIR, V17, P1941, DOI 10.1021/la001309z; Li YK, 2004, TENSIDE SURFACT DET, V41, P26; [刘巧瑜 Liu Qiaoyu], 2010, [食品工业科技, Science & Technology of Food Industry], V31, P313; McNaught AD, 1997, COMPENDIUM CHEM TERM, DOI DOI 10.1351/GOLDBOOK; Nobmann P, 2009, INT J FOOD MICROBIOL, V128, P440, DOI 10.1016/j.ijfoodmicro.2008.10.008; Ouattara B, 1997, INT J FOOD MICROBIOL, V37, P155, DOI 10.1016/S0168-1605(97)00070-6; Plou FJ, 2002, J BIOTECHNOL, V96, P55, DOI 10.1016/S0168-1656(02)00037-8; Preuss HG, 2005, MOL CELL BIOCHEM, V272, P29, DOI 10.1007/s11010-005-6604-1; RICH JO, 1995, BIOTECHNOL BIOENG, V45, P426, DOI 10.1002/bit.260450507; Rodriguez E, 2004, J APPL MICROBIOL, V96, P903, DOI 10.1111/j.1365-2672.2004.02207.x; RUSSELL AD, 1991, J APPL BACTERIOL, V71, P191, DOI 10.1111/j.1365-2672.1991.tb04447.x; Neta NDS, 2012, FOOD HYDROCOLLOID, V27, P324, DOI 10.1016/j.foodhyd.2011.10.009; Seino H, 1984, J AM OIL CHEM SOC, V73, P1481; Smith A, 2008, CARBOHYD RES, V343, P2557, DOI 10.1016/j.carres.2008.07.012; Soultani S, 2003, COLLOID SURFACE A, V227, P35, DOI 10.1016/S0927-7757(03)00360-1; WANG YF, 1988, J AM CHEM SOC, V110, P7200, DOI 10.1021/ja00229a041; Watanabe T, 1999, FOODS FOOD INGREDIEN, V180, P18; WoudenbergvanOosterom M, 1996, BIOTECHNOL BIOENG, V49, P328, DOI 10.1002/(SICI)1097-0290(19960205)49:3&lt;328::AID-BIT11&gt;3.0.CO;2-A; Zhang H, 2012, J ZHEJIANG UNIV-SC B, V13, P83, DOI 10.1631/jzus.B1100049	39	35	37	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114845	10.1371/journal.pone.0114845	http://dx.doi.org/10.1371/journal.pone.0114845			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531369	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845100028
J	Atomi, T; Noriuchi, M; Oba, K; Atomi, Y; Kikuchi, Y				Atomi, Tomoaki; Noriuchi, Madoka; Oba, Kentaro; Atomi, Yoriko; Kikuchi, Yoshiaki			Self-Recognition of One's Own Fall Recruits the Genuine Bodily Crisis- Related Brain Activity	PLOS ONE			English	Article							PARIETOINSULAR VESTIBULAR CORTEX; PARABRACHIAL NUCLEUS; NEURAL MECHANISMS; BODY SCHEMA; REPRESENTATIONS; RESPONSES; MOTION; STIMULATION; ANXIETY; MICROSTIMULATION	While bipedalism is a fundamental evolutionary adaptation thought to be essential for the development of the human brain, the erect body is always an inch or two away from falling. Although the neural mechanism for automatically detecting one's own body instability is an important consideration, there have thus far been few functional neuroimaging studies because of the restrictions placed on participants' movements. Here, we used functional magnetic resonance imaging to investigate the neural substrate underlying whole body instability, based on the self-recognition paradigm that uses video stimuli consisting of one's own and others' whole bodies depicted in stable and unstable states. Analyses revealed significant activity in the regions which would be activated during genuine unstable bodily states: The right parieto- insular vestibular cortex, inferior frontal junction, posterior insula and parabrachial nucleus. We argue that these right-lateralized cortical and brainstem regions mediate vestibular information processing for detection of vestibular anomalies, defensive motor responding in which the necessary motor responses are automatically prepared/simulated to protect one's own body, and sympathetic activity as a form of alarm response during whole body instability.	[Atomi, Tomoaki; Noriuchi, Madoka; Oba, Kentaro; Kikuchi, Yoshiaki] Tokyo Metropolitan Univ, Dept Frontier Hlth Sci, Div Human Hlth Sci, Grad Sch, Tokyo 158, Japan; [Atomi, Tomoaki] Teikyo Univ Sci, Fac Med Sci, Dept Phys Therapy, Uenohara, Japan; [Oba, Kentaro] Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Div Med Neuroimage Anal, Sendai, Miyagi 980, Japan; [Atomi, Yoriko] Tokyo Univ Agr & Technol, Fac & Grad Sch Engn, Dept Mat Hlth Sci, Tokyo, Japan	Tokyo Metropolitan University; Tohoku University; Tokyo University of Agriculture & Technology	Kikuchi, Y (corresponding author), Tokyo Metropolitan Univ, Dept Frontier Hlth Sci, Div Human Hlth Sci, Grad Sch, Tokyo 158, Japan.	ykikuchi@tmu.ac.jp	Atomi, Yoriko/AAF-4783-2019	Atomi, Yoriko/0000-0003-3808-6543; Kikuichi, Yoshiaki/0000-0002-8770-139X; xing zhi, shi zhi/0000-0003-3289-5681	Ministry of Education, Science, Sports and Culture [25291109, 2013-2015]; Grants-in-Aid for Scientific Research [26840160, 26560323] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B) (No. 25291109, 2013-2015 to YK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBARIAN S, 1992, J COMP NEUROL, V326, P423, DOI 10.1002/cne.903260308; Aspell JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006488; Balaban CD, 2002, PHYSIOL BEHAV, V77, P469, DOI 10.1016/S0031-9384(02)00935-6; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; Berlucchi G, 2010, EXP BRAIN RES, V200, P25, DOI 10.1007/s00221-009-1970-7; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Bishop SJ, 2007, CEREB CORTEX, V17, P1595, DOI 10.1093/cercor/bhl070; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Bottini G, 2001, BRAIN, V124, P1182, DOI 10.1093/brain/124.6.1182; Buxbaum LJ, 2003, NEUROPSYCHOLOGIA, V41, P1091, DOI 10.1016/S0028-3932(02)00314-7; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; CHAMBERLIN NL, 1992, J COMP NEUROL, V326, P245, DOI 10.1002/cne.903260207; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; Chen AH, 2010, J NEUROSCI, V30, P3022, DOI 10.1523/JNEUROSCI.4029-09.2010; Costantini M, 2005, CEREB CORTEX, V15, P1761, DOI 10.1093/cercor/bhi053; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT NEUROSCI, V3; Critchley HD, 2005, BRAIN, V128, P75, DOI 10.1093/brain/awh324; Damasio AR, 1999, SCI AM, V281, P112, DOI 10.1038/scientificamerican1299-112; Daprati E, 2007, EXP BRAIN RES, V177, P31, DOI 10.1007/s00221-006-0646-9; DARWIN C, 1965, EXPRESSION EMOTION M; Dieterich M, 2008, BRAIN, V131, P2538, DOI 10.1093/brain/awn042; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Downing PE, 2006, SOC NEUROSCI, V1, P52, DOI 10.1080/17470910600668854; Felician O, 2004, ANN NEUROL, V55, P749, DOI 10.1002/ana.20109; Frassinetti F, 2008, J COGNITIVE NEUROSCI, V20, P1507, DOI 10.1162/jocn.2008.20067; Fujii N, 1998, P NATL ACAD SCI USA, V95, P12034, DOI 10.1073/pnas.95.20.12034; Gallagher S, 1995, J MIND BEHAV, V16, P369; GALLAGHER S, 1986, J MIND BEHAV, V7, P541; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Grezes J, 2007, NEUROIMAGE, V35, P959, DOI 10.1016/j.neuroimage.2006.11.030; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P537; GULDIN WO, 1992, J COMP NEUROL, V326, P375, DOI 10.1002/cne.903260306; HEILMAN KM, 1982, NEUROLOGY, V32, P342, DOI 10.1212/WNL.32.4.342; Hodzic A, 2009, NEUROIMAGE, V45, P1264, DOI 10.1016/j.neuroimage.2009.01.027; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Jokisch D, 2006, PERCEPTION, V35, P911, DOI 10.1068/p5540; Kammers MPM, 2006, NEUROPSYCHOLOGIA, V44, P2430, DOI 10.1016/j.neuropsychologia.2006.04.009; Knoblich G, 2003, CONSCIOUS COGN, V12, P620, DOI 10.1016/S1053-8100(03)00070-9; Kovacs G, 2008, CEREB CORTEX, V18, P1779, DOI 10.1093/cercor/bhm203; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Lobel E, 1998, J NEUROPHYSIOL, V80, P2699, DOI 10.1152/jn.1998.80.5.2699; Lopez C, 2012, NEUROSCIENCE, V212, P159, DOI 10.1016/j.neuroscience.2012.03.028; Loula F, 2005, J EXP PSYCHOL HUMAN, V31, P210, DOI 10.1037/0096-1523.31.1.210; Mangina CA, 1996, INT J PSYCHOPHYSIOL, V22, P1, DOI 10.1016/0167-8760(96)00022-0; Maurer C, 2006, EXP BRAIN RES, V171, P231, DOI 10.1007/s00221-005-0256-y; McCaig RG, 2011, NEUROIMAGE, V55, P1298, DOI 10.1016/j.neuroimage.2010.12.016; McCandless CH, 2010, EXP BRAIN RES, V202, P271, DOI 10.1007/s00221-009-2130-9; Myers A, 2008, NEUROIMAGE, V42, P1669, DOI 10.1016/j.neuroimage.2008.05.045; Naito E, 2005, J NEUROPHYSIOL, V93, P1020, DOI 10.1152/jn.00637.2004; Oppenheimer S, 2006, CLIN AUTON RES, V16, P6, DOI 10.1007/s10286-006-0276-0; Paillard J., 1991, BRAIN SPACE, P163; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Pfeiffer C, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00031; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Raposo A, 2011, SOC COGN AFFECT NEUR, V6, P260, DOI 10.1093/scan/nsq033; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Schwoebel J, 2005, J COGNITIVE NEUROSCI, V17, P543, DOI 10.1162/0898929053467587; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; Zhang ZH, 1998, BRAIN RES, V813, P73, DOI 10.1016/S0006-8993(98)00996-2; Zhang ZH, 2000, BRAIN RES, V863, P25, DOI 10.1016/S0006-8993(00)02068-0	73	2	3	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115303	10.1371/journal.pone.0115303	http://dx.doi.org/10.1371/journal.pone.0115303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8WK	25525808	Green Published, gold			2022-12-26	WOS:000347186200021
J	Maraula, G; Lana, D; Coppi, E; Gentile, F; Mello, T; Melani, A; Galli, A; Giovannini, MG; Pedata, F; Pugliese, AM				Maraula, Giovanna; Lana, Daniele; Coppi, Elisabetta; Gentile, Francesca; Mello, Tommaso; Melani, Alessia; Galli, Andrea; Giovannini, Maria Grazia; Pedata, Felicita; Pugliese, Anna Maria			The Selective Antagonism of P2X(7) and P2Y(1) Receptors Prevents Synaptic Failure and Affects Cell Proliferation Induced by Oxygen and Glucose Deprivation in Rat Dentate Gyrus	PLOS ONE			English	Article							NEURAL STEM-CELLS; LONG-TERM POTENTIATION; NEURONS IN-VITRO; GLUTAMATE RELEASE; ADULT NEUROGENESIS; BRAIN ISCHEMIA; P2X7 RECEPTORS; EXTRACELLULAR CONCENTRATIONS; HIPPOCAMPAL NEUROGENESIS; PURINERGIC RECEPTORS	Purinergic P2X and P2Y receptors are broadly expressed on both neurons and glial cells in the central nervous system (CNS), including dentate gyrus (DG). The aim of this research was to determine the synaptic and proliferative response of the DG to severe oxygen and glucose deprivation (OGD) in acute rat hippocampal slices and to investigate the contribution of P2X(7) and P2Y(1) receptor antagonism to recovery of synaptic activity after OGD. Extracellular field excitatory post-synaptic potentials (fEPSPs) in granule cells of the DG were recorded from rat hippocampal slices. Nine-min OGD elicited an irreversible loss of fEPSP and was invariably followed by the appearance of anoxic depolarization (AD). Application of MRS2179 (selective antagonist of P2Y(1) receptor) and BBG (selective antagonist of P2X(7) receptor), before and during OGD, prevented AD appearance and allowed a significant recovery of neurotransmission after 9-min OGD. The effects of 9-min OGD on proliferation and maturation of cells localized in the subgranular zone (SGZ) of slices prepared from rats treated with 5-Bromo-2'-deoxyuridine (BrdU) were investigated. Slices were further incubated with an immature neuron marker, doublecortin (DCX). The number of BrdU(+) cells in the SGZ was significantly decreased 6 hours after OGD. This effect was antagonized by BBG, but not by MRS2179. Twenty-four hours after 9-min OGD, the number of BrdU(+) cells returned to control values and a significant increase of DCX immunofluorescence was	[Maraula, Giovanna; Gentile, Francesca; Melani, Alessia; Pedata, Felicita; Pugliese, Anna Maria] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, NEUROFARBA, Div Pharmacol & Toxicol, Florence, Italy; [Lana, Daniele; Coppi, Elisabetta; Giovannini, Maria Grazia] Univ Florence, Dept Hlth Sci, Clin Pharmacol & Oncol Unit, Florence, Italy; [Mello, Tommaso; Galli, Andrea] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy	University of Florence; University of Florence; University of Florence	Pugliese, AM (corresponding author), Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, NEUROFARBA, Div Pharmacol & Toxicol, Florence, Italy.	annamaria.pugliese@unifi.it	Coppi, Elisabetta/K-6705-2016; Mello, Tommaso/AAO-7831-2021; Galli, Andrea/AAC-1623-2019; Mello, Tommaso/I-4715-2012	Coppi, Elisabetta/0000-0003-4434-5919; Mello, Tommaso/0000-0002-6192-6902; Mello, Tommaso/0000-0002-6192-6902; Lana, Daniele/0000-0002-5193-0019; Galli, Andrea/0000-0001-5416-6290; PUGLIESE, ANNA MARIA/0000-0001-7554-5740; Pedata, Felicita/0000-0002-6841-3712	Italian Ministry of Health; Fondazione Ente Cassa di Risparmio di Firenze, Italy	Italian Ministry of Health(Ministry of Health, Italy); Fondazione Ente Cassa di Risparmio di Firenze, Italy(Fondazione Cassa Risparmio Firenze)	This investigation was supported by grants from Italian Ministry of Health; Fondazione Ente Cassa di Risparmio di Firenze (FP, AMP), Italy.	ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; AUER RN, 1989, J NEUROSCI, V9, P1641; Ballerini P, 2005, INT J IMMUNOPATH PH, V18, P255, DOI 10.1177/039463200501800208; Bartley J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-15; Boyer JL, 1998, BRIT J PHARMACOL, V124, P1, DOI 10.1038/sj.bjp.0701837; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Burnstock G, 2008, PURINERG SIGNAL, V4, P79, DOI 10.1007/s11302-007-9094-7; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Carmo MRS, 2014, EUR J NEUROSCI, V39, P614, DOI 10.1111/ejn.12435; Chechneva O, 2006, NEUROBIOL DIS, V23, P247, DOI 10.1016/j.nbd.2006.02.015; Cho JH, 2010, NEUROREPORT, V21, P865, DOI 10.1097/WNR.0b013e32833d9142; Cohen D, 2008, DEV NEUROSCI-BASEL, V30, P187, DOI 10.1159/000109862; Coppi E, 2007, PURINERG SIGNAL, V3, P203, DOI 10.1007/s11302-006-9049-4; Csolle C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066547; De Simone R, 2010, J NEUROCHEM, V115, P450, DOI 10.1111/j.1471-4159.2010.06937.x; del Puerto A, 2012, J CELL SCI, V125, P176, DOI 10.1242/jcs.091736; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; Domercq M, 2010, GLIA, V58, P730, DOI 10.1002/glia.20958; Farkas E, 2008, J CEREBR BLOOD F MET, V28, P251, DOI 10.1038/sj.jcbfm.9600569; Fellin Tommaso, 2006, Novartis Found Symp, V276, P208; Frenguelli BG, 2007, J NEUROCHEM, V101, P1400, DOI 10.1111/j.1471-4159.2006.04425.x; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Giovannini MG, 2003, J NEUROSCI, V23, P9016; Giovannini MG, 2001, J NEUROSCI, V21, P7053, DOI 10.1523/JNEUROSCI.21-18-07053.2001; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kharlamov A, 2002, EXP BRAIN RES, V147, P353, DOI 10.1007/s00221-002-1251-1; Klempin F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025760; Kuboyama K, 2011, J CEREBR BLOOD F MET, V31, P1930, DOI 10.1038/jcbfm.2011.49; Lammer A, 2006, EUR J NEUROSCI, V23, P2824, DOI 10.1111/j.1460-9568.2006.04825.x; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; LIPTON P, 1982, J PHYSIOL-LONDON, V325, P51, DOI 10.1113/jphysiol.1982.sp014135; Liu JL, 1998, J NEUROSCI, V18, P7768; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; Maraula G, 2013, NEUROPHARMACOLOGY, V67, P511, DOI 10.1016/j.neuropharm.2012.12.002; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Melani A, 2012, EXP NEUROL, V233, P193, DOI 10.1016/j.expneurol.2011.09.036; Miras-Portugal MT, 2003, NEUROCHEM RES, V28, P1597, DOI 10.1023/A:1025690913206; Mishra SK, 2006, DEVELOPMENT, V133, P675, DOI 10.1242/dev.02233; Moore D, 2000, J COMP NEUROL, V421, P374, DOI 10.1002/(SICI)1096-9861(20000605)421:3<374::AID-CNE6>3.0.CO;2-Z; Moran-Jimenez MJ, 2000, MOL BRAIN RES, V78, P50, DOI 10.1016/S0169-328X(00)00067-X; Okano H, 2008, PHILOS T R SOC B, V363, P2111, DOI 10.1098/rstb.2008.2264; Pedata F, 2007, PURINERG SIGNAL, V3, P299, DOI 10.1007/s11302-007-9085-8; Pugliese AM, 2009, BRIT J PHARMACOL, V157, P818, DOI 10.1111/j.1476-5381.2009.00218.x; Pugliese AM, 2003, BRIT J PHARMACOL, V140, P305, DOI 10.1038/sj.bjp.0705442; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; Sharp FR, 2002, DEV BRAIN RES, V134, P23, DOI 10.1016/S0165-3806(01)00286-3; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; SICK TJ, 1987, BRAIN RES, V418, P227, DOI 10.1016/0006-8993(87)90090-4; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sperlagh B, 2007, NEUROSCIENCE, V149, P99, DOI 10.1016/j.neuroscience.2007.07.035; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Sun Jing-Jun, 2008, Neurosci Bull, V24, P231, DOI 10.1007/s12264-008-0430-x; Sun SH, 1999, J NEUROCHEM, V73, P334, DOI 10.1046/j.1471-4159.1999.0730334.x; Suyama S, 2012, J NEUROSCI, V32, P9238, DOI 10.1523/JNEUROSCI.4001-11.2012; Takagi Y, 1999, BRAIN RES, V831, P283, DOI 10.1016/S0006-8993(99)01411-0; Tanaka E, 1997, J NEUROPHYSIOL, V78, P891, DOI 10.1152/jn.1997.78.2.891; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tonazzini I, 2007, EUR J NEUROSCI, V26, P890, DOI 10.1111/j.1460-9568.2007.05697.x; Traini C, 2011, EUR J NEUROSCI, V33, P2203, DOI 10.1111/j.1460-9568.2011.07667.x; Tsao HK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.274; Wang S, 2005, EXP BRAIN RES, V165, P250, DOI 10.1007/s00221-005-2296-8; Yamamoto S, 1997, J NEUROPHYSIOL, V78, P903, DOI 10.1152/jn.1997.78.2.903; Zeng JW, 2008, J NEUROCHEM, V106, P2106, DOI 10.1111/j.1471-4159.2008.05560.x; Zheng W, 2013, J CEREBR BLOOD F MET, V33, P600, DOI 10.1038/jcbfm.2012.214	75	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115273	10.1371/journal.pone.0115273	http://dx.doi.org/10.1371/journal.pone.0115273			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526634	gold, Green Published, Green Submitted			2022-12-26	WOS:000347186200020
J	Knorr, RL; Nakatogawa, H; Ohsumi, Y; Lipowsky, R; Baumgart, T; Dimova, R				Knorr, Roland L.; Nakatogawa, Hitoshi; Ohsumi, Yoshinori; Lipowsky, Reinhard; Baumgart, Tobias; Dimova, Rumiana			Membrane Morphology Is Actively Transformed by Covalent Binding of the Protein Atg8 to PE-Lipids	PLOS ONE			English	Article							AUTOPHAGOSOME FORMATION; AMPHIPATHIC HELICES; EARLY STEPS; VESICLES; MECHANISM; DOMAIN	Autophagy is a cellular degradation pathway involving the shape transformation of lipid bilayers. During the onset of autophagy, the water-soluble protein Atg8 binds covalently to phosphatdylethanolamines (PEs) in the membrane in an ubiquitin-like reaction coupled to ATP hydrolysis. We reconstituted the Atg8 conjugation system in giant and nm-sized vesicles with a minimal set of enzymes and observed that formation of Atg8-PE on giant vesicles can cause substantial tubulation of membranes even in the absence of Atg12-Atg5-Atg16. Our findings show that ubiquitin-like processes can actively change properties of lipid membranes and that membrane crowding by proteins can be dynamically regulated in cells. Furthermore we provide evidence for curvature sorting of Atg8-PE. Curvature generation and sorting are directly linked to organelle shapes and, thus, to biological function. Our results suggest that a positive feedback exists between the ubiquitin-like reaction and the membrane curvature, which is important for dynamic shape changes of cell membranes, such as those involved in the formation of autophagosomes.	[Knorr, Roland L.; Lipowsky, Reinhard; Dimova, Rumiana] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany; [Nakatogawa, Hitoshi; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 227, Japan; [Baumgart, Tobias] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	Max Planck Society; Tokyo Institute of Technology; University of Pennsylvania	Knorr, RL (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany.	knorr@mpikg.mpg.de; dimova@mpikg.mpg.de	Dimova, Rumiana/C-4330-2008; Nakatogawa, Hitoshi/D-5155-2015; Ohsumi, Yoshinori/C-6449-2009	Dimova, Rumiana/0000-0002-3872-8502; Nakatogawa, Hitoshi/0000-0002-5828-0741; Ohsumi, Yoshinori/0000-0003-2384-2166; Lipowsky, Reinhard/0000-0001-8417-8567	German Science Foundation [1524]; NIH [GM 097552]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097552] Funding Source: NIH RePORTER	German Science Foundation(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the German Science Foundation within the framework of IGRTG 1524 and by NIH grant GM 097552. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Baumgart T, 2011, ANNU REV PHYS CHEM, V62, P483, DOI 10.1146/annurev.physchem.012809.103450; Capraro BR, 2010, J AM CHEM SOC, V132, P1200, DOI 10.1021/ja907936c; Dimova R, 2007, SOFT MATTER, V3, P817, DOI 10.1039/b703580b; Galush WJ, 2008, BIOPHYS J, V95, P2512, DOI 10.1529/biophysj.108.131540; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Jensen MB, 2011, J BIOL CHEM, V286, P42603, DOI 10.1074/jbc.M111.271130; Kaufmann A, 2014, CELL, V156, P469, DOI 10.1016/j.cell.2013.12.022; Knorr RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032753; Knorr RL, 2010, SOFT MATTER, V6, P1990, DOI 10.1039/b925929e; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Kunding AH, 2008, BIOPHYS J, V95, P1176, DOI 10.1529/biophysj.108.128819; LAI MZ, 1985, BIOCHEMISTRY-US, V24, P1654, DOI 10.1021/bi00328a013; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lipowsky R, 1996, PHYS REV LETT, V77, P1652, DOI 10.1103/PhysRevLett.77.1652; Lipowsky R, 2013, FARADAY DISCUSS, V161, P305, DOI 10.1039/c2fd20105d; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Nakatogawa H, 2012, METHODS MOL BIOL, V832, P519, DOI 10.1007/978-1-61779-474-2_37; Nath S, 2014, NAT CELL BIOL, V16, P415, DOI 10.1038/ncb2940; Nikolaus J, 2010, BIOPHYS J, V98, P1192, DOI 10.1016/j.bpj.2009.11.042; Rauch J, 2003, J BIOL CHEM, V278, P47508, DOI 10.1074/jbc.M308089200; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; S Nath JD, 2013, BIOPHYSICAL J, V104; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Sorre B, 2012, P NATL ACAD SCI USA, V109, P173, DOI 10.1073/pnas.1103594108; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; WAUGH R, 1979, BIOPHYS J, V26, P115, DOI 10.1016/S0006-3495(79)85239-X; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xie ZP, 2009, AUTOPHAGY, V5, P217, DOI 10.4161/auto.5.2.7201; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814	37	45	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115357	10.1371/journal.pone.0115357	http://dx.doi.org/10.1371/journal.pone.0115357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522362	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845600037
J	Lu, L; Sirish, P; Zhang, Z; Woltz, RL; Li, N; Timofeyev, V; Knowlton, AA; Zhang, XD; Yamoah, EN; Chiamvimonvat, N				Lu, Ling; Sirish, Padmini; Zhang, Zheng; Woltz, Ryan L.; Li, Ning; Timofeyev, Valeriy; Knowlton, Anne A.; Zhang, Xiao-Dong; Yamoah, Ebenezer N.; Chiamvimonvat, Nipavan			Regulation of Gene Transcription by Voltage-gated L-type Calcium Channel, Ca(v)1.3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNEL; ACTIVATED POTASSIUM CHANNELS; C-TERMINAL DOMAIN; NULL MUTANT MICE; SMALL-CONDUCTANCE; CA2+ CHANNELS; FUNCTIONAL ROLES; ATRIAL-FIBRILLATION; SK2 CHANNEL; CONGENITAL DEAFNESS	Ca(v)1.3 L-type Ca2+ channel is known to be highly expressed in neurons and neuroendocrine cells. However, we have previously demonstrated that the Ca(v)1.3 channel is also expressed in atria and pacemaking cells in the heart. The significance of the tissue-specific expression of the channel is underpinned by our previous demonstration of atrial fibrillation in a Ca(v)1.3 null mutant mouse model. Indeed, a recent study has confirmed the critical roles of Ca(v)1.3 in the human heart (Baig, S. M., Koschak, A., Lieb, A., Gebhart, M., Dafinger, C., Nuberg, G., Ali, A., Ahmad, I., Sinnegger-Brauns, M. J., Brandt, N., Engel, J., Mangoni, M. E., Farooq, M., Khan, H. U., Nuberg, P., Striessnig, J., and Bolz, H. J. (2011) Nat. Neurosci. 14, 77-84). These studies suggest that detailed knowledge of Ca(v)1.3 may have broad therapeutic ramifications in the treatment of cardiac arrhythmias. Here, we tested the hypothesis that there is a functional crosstalk between the Ca(v)1.3 channel and a small conductance Ca2+ activated K+ channel (SK2), which we have documented to be highly expressed in human and mouse atrial myocytes. Specifically, we tested the hypothesis that the C terminus of Ca(v)1.3 may translocate to the nucleus where it functions as a transcriptional factor. Here, we reported for the first time that the C terminus of Ca(v)1.3 translocates to the nucleus where it functions as a transcriptional regulator to modulate the function of Ca2+-activated K+ channels in atrial myocytes. Nuclear translocation of the C-terminal domain of Ca(v)1.3 is directly regulated by intracellular Ca2+. Utilizing a Ca(v)1.3 null mutant mouse model, we demonstrate that ablation of Ca(v)1.3 results in a decrease in the protein expression of myosin light chain 2, which interacts and increases the membrane localization of SK2 channels.	[Lu, Ling; Sirish, Padmini; Zhang, Zheng; Woltz, Ryan L.; Li, Ning; Timofeyev, Valeriy; Knowlton, Anne A.; Zhang, Xiao-Dong; Chiamvimonvat, Nipavan] Univ Calif Davis, Div Cardiovasc Med, Dept Internal Med, Davis, CA 95616 USA; [Knowlton, Anne A.; Chiamvimonvat, Nipavan] Northern Calif Hlth Care Syst, Dept Vet Affairs, Mather, CA 95655 USA; [Yamoah, Ebenezer N.] Univ Nevada, Sch Med, Dept Physiol, Reno, NV 89557 USA; [Lu, Ling] Nanjing Normal Univ, Coll Life Sci, Nanjing 210046, Jiangsu, Peoples R China	University of California System; University of California Davis; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nanjing Normal University	Lu, L (corresponding author), Univ Calif Davis, Div Cardiovasc Med, Dept Internal Med, Davis, CA 95616 USA.	linglu@njnu.edu.cn; enyamoah@gmail.com; nchiamvimonvat@ucdavis.edu	Lu, Ling/AGU-8326-2022	Lu, Ling/0000-0002-2891-7326; Chiamvimonvat, Nipavan/0000-0001-9499-8817; Sirish, Padmini/0000-0002-9216-279X; woltz, ryan/0000-0002-0446-2478	National Institutes of Health [R01 HL85727, R01 HL85844, R01 HL077281, HL079071, R01 DC003826, R01 DC007592, R01 DC010386, R01 HL85844S1]; Veterans Affairs Merit Review Grant [I01 BX000576]; Howard Hughes Medical Institute; American Heart Association Western States Affiliate; American Heart Association Western States Affiliate [14BGIA18870087]; Calcium Signaling Chinese Grant [NSFC81330035]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085844, R01HL085727, T32HL086350, R01HL079071, R01HL075274, R01HL077281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010386, R01DC003826, R01DC010917, R01DC007592] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Heart Association Western States Affiliate(American Heart Association); American Heart Association Western States Affiliate(American Heart Association); Calcium Signaling Chinese Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL85727 and R01 HL85844, and Veterans Affairs Merit Review Grant I01 BX000576 (to N. C.), National Institutes of Health Grants R01 HL077281 and HL079071 (to A. K.), National Institutes of Health Grants R01 DC003826, R01 DC007592, and R01 DC010386 (to E. Y.), National Institutes of Health Grant R01 HL85844S1 (to R. L. W.), a Howard Hughes Medical Institute Med-into-Grad Training Program to the University of California Davis and an American Heart Association Western States Affiliate Predoctoral Fellowship Award (to P. S.), American Heart Association Western States Affiliate Beginning Grant-in-Aid 14BGIA18870087 (to X. D. Z.), and Calcium Signaling Chinese Grant NSFC81330035 (to L. L.).	Baig SM, 2011, NAT NEUROSCI, V14, P77, DOI 10.1038/nn.2694; Chua SK, 2011, CIRC RES, V108, P971, DOI 10.1161/CIRCRESAHA.110.238386; Cunha SR, 2011, CIRCULATION, V124, P1212, DOI 10.1161/CIRCULATIONAHA.111.023986; Diness JG, 2010, CIRC-ARRHYTHMIA ELEC, V3, P380, DOI 10.1161/CIRCEP.110.957407; Dolmetsch R, 2003, SCI STKE, V166, ppe4, DOI DOI 10.1016/J.NEURON.2016.01.011; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; ELLINOR PT, 1993, NATURE, V363, P455, DOI 10.1038/363455a0; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gomez-Ospina N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060526; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kikuchi K, 2005, CIRCULATION, V111, P264, DOI 10.1161/01.CIR.0000153338.47507.83; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kordasiewicz HB, 2006, HUM MOL GENET, V15, P1587, DOI 10.1093/hmg/ddl080; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Kubodera T, 2003, NEUROSCI LETT, V341, P74, DOI 10.1016/S0304-3940(03)00156-3; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Lu L, 2007, CIRC RES, V100, P112, DOI 10.1161/01.RES.0000253095.44186.72; Lu L, 2009, P NATL ACAD SCI USA, V106, P18402, DOI 10.1073/pnas.0908207106; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; MILLER RJ, 1992, J BIOL CHEM, V267, P1403; Namkung Y, 2001, J CLIN INVEST, V108, P1015, DOI 10.1172/JCI13310; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Ozgen N, 2007, CARDIOVASC RES, V75, P758, DOI 10.1016/j.cardiores.2007.05.008; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Rafizadeh S, 2014, P NATL ACAD SCI USA, V111, P9989, DOI 10.1073/pnas.1323541111; Rimini R, 2000, MOL BRAIN RES, V85, P218, DOI 10.1016/S0169-328X(00)00255-2; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shmukler BE, 2001, BBA-GENE STRUCT EXPR, V1518, P36, DOI 10.1016/S0167-4781(01)00166-X; Sirish P, 2012, J MOL CELL CARDIOL, V52, P264, DOI 10.1016/j.yjmcc.2011.10.012; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Strobaek D, 2000, BRIT J PHARMACOL, V129, P991, DOI 10.1038/sj.bjp.0703120; Takimoto K, 1997, J MOL CELL CARDIOL, V29, P3035, DOI 10.1006/jmcc.1997.0532; Tuteja D, 2005, AM J PHYSIOL-HEART C, V289, pH2714, DOI 10.1152/ajpheart.00534.2005; Tuteja D, 2010, CIRC RES, V107, P851, DOI 10.1161/CIRCRESAHA.109.215269; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Xu YF, 2005, J PHYSIOL-LONDON, V562, P745, DOI 10.1113/jphysiol.2004.076216; Xu YF, 2003, J BIOL CHEM, V278, P49085, DOI 10.1074/jbc.M307508200; Zhang Q, 2008, CIRC RES, V102, P465, DOI 10.1161/CIRCRESAHA.107.161778; Zhang QA, 2011, J MOL CELL CARDIOL, V50, P194, DOI 10.1016/j.yjmcc.2010.10.002; Zhang Z, 2005, CIRCULATION, V112, P1936, DOI 10.1161/CIRCULATIONAHA.105.540070; Zhang Z, 2002, CIRC RES, V90, P981, DOI 10.1161/01.RES.0000018003.14304.E2	58	31	32	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4663	4676		10.1074/jbc.M114.586883	http://dx.doi.org/10.1074/jbc.M114.586883			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25538241	hybrid, Green Published			2022-12-26	WOS:000350042000011
J	Borrok, MJ; Wu, YL; Beyaz, N; Yu, XQ; Oganesyan, V; Dall'Acqua, WF; Tsui, P				Borrok, M. Jack; Wu, Yanli; Beyaz, Nurten; Yu, Xiang-Qing; Oganesyan, Vaheh; Dall'Acqua, William F.; Tsui, Ping			pH-dependent Binding Engineering Reveals an FcRn Affinity Threshold That Governs IgG Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM HALF-LIFE; I-RELATED RECEPTOR; MONOCLONAL-ANTIBODIES; CYNOMOLGUS MONKEYS; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN-G; MICE; COMPLEX; PHARMACOKINETICS; VARIANTS	The Fc domain of IgG has been the target of multiple mutational studies aimed at altering the pH-dependent IgG/FcRn interaction to modulate IgG pharmacokinetics. These studies have yielded antibody variants with disparate pharmacokinetic characteristics, ranging from extended in vivo half-life to those exhibiting extremely rapid clearance. To better understand pH-dependent binding parameters that govern these outcomes and limit FcRn-mediated half-life extension, we generated a panel of novel Fc variants with high affinity binding at acidic pH that vary in pH 7.4 affinities and assessed pharmacokinetic outcomes. Pharmacokinetic studies in human FcRn transgenic mice and cynomolgus monkeys showed that multiple variants with increased FcRn affinities at acidic pH exhibited extended serum half-lives relative to the parental IgG. Importantly, the results reveal an underappreciated affinity threshold of neutral pH binding that determines IgG recycling efficiency. Variants with pH 7.4 FcRn affinities below this threshold recycle efficiently and can exhibit increased serum persistence. Increasing neutral pH FcRn affinity beyond this threshold reduced serum persistence by offsetting the benefits of increased pH 6.0 binding. Ultra-high affinity binding to FcRn at both acidic and neutral pH leads to rapid serum clearance.	[Borrok, M. Jack; Wu, Yanli; Beyaz, Nurten; Oganesyan, Vaheh; Dall'Acqua, William F.; Tsui, Ping] Medimmune Inc, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA; [Yu, Xiang-Qing] Medimmune Inc, Clin Pharmacol & Drug Metab & Pharmacokinet, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Dall'Acqua, WF (corresponding author), Medimmune Inc, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.	dallacquaw@medimmune.com; tsuip@medimmune.com						Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dahiyat B. I., 2014, United States Patent Publication, Patent No. [US8637641 B2, 8637641]; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Datta-Mannan A, 2007, J BIOL CHEM, V282, P1709, DOI 10.1074/jbc.M607161200; Datta-Mannan A, 2007, DRUG METAB DISPOS, V35, P86, DOI 10.1124/dmd.106.011734; Datta-Mannan A, 2012, DRUG METAB DISPOS, V40, P1545, DOI 10.1124/dmd.112.045864; Deng R, 2010, DRUG METAB DISPOS, V38, P600, DOI 10.1124/dmd.109.031310; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Ghetie V, 1996, EUR J IMMUNOL, V26, P690, DOI 10.1002/eji.1830260327; Gurbaxani B, 2006, MOL IMMUNOL, V43, P1462, DOI 10.1016/j.molimm.2005.07.032; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; Igawa T, 2010, PROTEIN ENG DES SEL, V23, P385, DOI 10.1093/protein/gzq009; Igawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063236; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Israel EJ, 1996, IMMUNOLOGY, V89, P573, DOI 10.1046/j.1365-2567.1996.d01-775.x; Kabat E. A., 1991, NIH PUBLICATION 91 3, V91-3442; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Medesan C, 1997, J IMMUNOL, V158, P2211; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Oganesyan V, 2009, MOL IMMUNOL, V46, P1750, DOI 10.1016/j.molimm.2009.01.026; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Strohl WR, 2009, CURR OPIN BIOTECH, V20, P685, DOI 10.1016/j.copbio.2009.10.011; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; Tedder TF, 2009, United States Patent Application Publication, Patent No. [US2009/0136516 A1, 20090136516]; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; Wang WR, 2011, DRUG METAB DISPOS, V39, P1469, DOI 10.1124/dmd.111.039453; Wu H, 2007, J MOL BIOL, V368, P652, DOI 10.1016/j.jmb.2007.02.024; Yeung YA, 2010, CANCER RES, V70, P3269, DOI 10.1158/0008-5472.CAN-09-4580; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	41	66	90	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4282	4290		10.1074/jbc.M114.603712	http://dx.doi.org/10.1074/jbc.M114.603712			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25538249	Green Published, hybrid			2022-12-26	WOS:000349458400038
J	Jakob, RP; Koch, JR; Burmann, BM; Schmidpeter, PAM; Hunkeler, M; Hiller, S; Schmid, FX; Maier, T				Jakob, Roman P.; Koch, Johanna R.; Burmann, Bjoern M.; Schmidpeter, Philipp A. M.; Hunkeler, Moritz; Hiller, Sebastian; Schmid, Franz X.; Maier, Timm			Dimeric Structure of the Bacterial Extracellular Foldase PrsA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL CIS/TRANS ISOMERASE; VIRULENCE FACTOR SECRETION; OUTER-MEMBRANE PROTEIN; NMR SOLUTION STRUCTURE; BACILLUS-SUBTILIS; TRIGGER FACTOR; CRYSTALLOGRAPHIC STRUCTURE; CATALYTIC MECHANISM; ENZYMATIC CATALYSIS; FUNCTIONAL-ANALYSIS	Secretion of proteins into the membrane-cell wall space is essential for cell wall biosynthesis and pathogenicity in Gram-positive bacteria. Folding and maturation of many secreted proteins depend on a single extracellular foldase, the PrsA protein. PrsA is a 30-kDa protein, lipid anchored to the outer leaflet of the cell membrane. The crystal structure of Bacillus subtilis PrsA reveals a central catalytic parvulin-type prolyl isomerase domain, which is inserted into a larger composite NC domain formed by the N- and C-terminal regions. This domain architecture resembles, despite a lack of sequence conservation, both trigger factor, a ribosome-binding bacterial chaperone, and SurA, a periplasmic chaperone in Gram-negative bacteria. Two main structural differences are observed in that the N-terminal arm of PrsA is substantially shortened relative to the trigger factor and SurA and in that PrsA is found to dimerize in a unique fashion via its NC domain. Dimerization leads to a large, bowl-shaped crevice, which might be involved in vivo in protecting substrate proteins from aggregation. NMRexperiments reveal a direct, dynamic interaction of both the parvulin and the NC domain with secretion propeptides, which have been implicated in substrate targeting to PrsA.	[Jakob, Roman P.; Burmann, Bjoern M.; Hunkeler, Moritz; Hiller, Sebastian; Maier, Timm] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Koch, Johanna R.; Schmidpeter, Philipp A. M.; Schmid, Franz X.] Univ Bayreuth, Lab Biochem, D-95440 Bayreuth, Germany; [Koch, Johanna R.; Schmidpeter, Philipp A. M.; Schmid, Franz X.] Univ Bayreuth, Bayreuther Zentrum Mol Biowissensch, D-95440 Bayreuth, Germany	University of Basel; University of Bayreuth; University of Bayreuth	Jakob, RP (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	roman.jakob@unibas.ch; timm.maier@unibas.ch	Schmidpeter, Philipp/Q-5540-2019; Hiller, Sebastian/B-3573-2008; Burmann, Björn M./AAR-7399-2020; Burmann, Björn M./AAI-7760-2021; Maier, Timm/A-8835-2016; Burmann, Björn/M-8913-2015	Schmidpeter, Philipp/0000-0003-2871-9706; Hiller, Sebastian/0000-0002-6709-4684; Burmann, Björn M./0000-0002-3135-7964; Maier, Timm/0000-0002-7459-1363; Burmann, Björn/0000-0002-3135-7964; Hunkeler, Moritz/0000-0003-0246-1188; Jakob, Roman/0000-0002-6451-8656	Swiss National Science Foundation [PP00P3_152989, R'EQUIP 145023]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants PP00P3_152989 and R'EQUIP 145023.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alonzo F, 2011, MOL MICROBIOL, V80, P1530, DOI 10.1111/j.1365-2958.2011.07665.x; Alonzo F, 2010, INFECT IMMUN, V78, P4944, DOI 10.1128/IAI.00532-10; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; Behrens-Kneip S, 2010, INT J MED MICROBIOL, V300, P421, DOI 10.1016/j.ijmm.2010.04.012; Bitto E, 2002, STRUCTURE, V10, P1489, DOI 10.1016/S0969-2126(02)00877-8; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Burmann BM, 2013, NAT STRUCT MOL BIOL, V20, P1265, DOI 10.1038/nsmb.2677; Cahoon LA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00013; Ceh-Pavia E, 2013, INT J MOL SCI, V14, P16685, DOI 10.3390/ijms140816685; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Drouault S, 2002, APPL ENVIRON MICROB, V68, P3932, DOI 10.1128/AEM.68.8.3932-3942.2002; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emelyanov VV, 2004, IUBMB LIFE, V56, P215, DOI 10.1080/15216540410001699321; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Fernandez C, 2001, P NATL ACAD SCI USA, V98, P2358, DOI 10.1073/pnas.051629298; Forster BM, 2012, MOL MICROBIOL, V84, P405, DOI 10.1111/j.1365-2958.2012.08040.x; Freudl R, 2013, RES MICROBIOL, V164, P664, DOI 10.1016/j.resmic.2013.03.014; Giuseppe PO, 2011, J STRUCT BIOL, V173, P312, DOI 10.1016/j.jsb.2010.10.009; Goemans C, 2014, BBA-MOL CELL RES, V1843, P1517, DOI 10.1016/j.bbamcr.2013.10.014; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Guo L, 2013, MOL ORAL MICROBIOL, V28, P154, DOI 10.1111/omi.12014; HARRIS GS, 1990, J BIOL CHEM, V265, P15909; Heikkinen O, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-17; Hodak H, 2008, J MOL BIOL, V376, P414, DOI 10.1016/j.jmb.2007.10.088; Hottenrott S, 1997, J BIOL CHEM, V272, P15697, DOI 10.1074/jbc.272.25.15697; Hyyrylainen HL, 2010, MOL MICROBIOL, V77, P108, DOI 10.1111/j.1365-2958.2010.07188.x; JACOBS M, 1993, MOL MICROBIOL, V8, P957, DOI 10.1111/j.1365-2958.1993.tb01640.x; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jakob RP, 2009, P NATL ACAD SCI USA, V106, P20282, DOI 10.1073/pnas.0909544106; Jousselin A, 2012, ANTIMICROB AGENTS CH, V56, P3629, DOI 10.1128/AAC.06264-11; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kakeshita H, 2011, BIOTECHNOL LETT, V33, P1847, DOI 10.1007/s10529-011-0636-2; Kakeshita H, 2011, APPL MICROBIOL BIOT, V89, P1509, DOI 10.1007/s00253-010-2954-z; Kale A, 2011, J BIOL CHEM, V286, P21254, DOI 10.1074/jbc.M111.220442; Kather I, 2008, J MOL BIOL, V381, P1040, DOI 10.1016/j.jmb.2008.06.073; Keller R., 2004, COMPUTER AIDED RESON, V1; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P6475, DOI 10.1021/bi00479a020; Kovermann M, 2013, BIOL CHEM, V394, P965, DOI 10.1515/hsz-2013-0137; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhlewein A, 2004, PROTEIN SCI, V13, P2378, DOI 10.1110/ps.04756704; Landrieu I, 2002, J MOL BIOL, V320, P321, DOI 10.1016/S0022-2836(02)00429-1; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; Lee D, 2006, J MAGN RESON, V178, P72, DOI 10.1016/j.jmr.2005.08.014; Leskela S, 1999, MOL MICROBIOL, V31, P1075, DOI 10.1046/j.1365-2958.1999.01247.x; Li Z, 2005, BIOCHEMISTRY-US, V44, P6180, DOI 10.1021/bi050115l; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Matias VRF, 2005, MOL MICROBIOL, V56, P240, DOI 10.1111/j.1365-2958.2005.04535.x; Mayr LM, 1996, BIOCHEMISTRY-US, V35, P5550, DOI 10.1021/bi953035y; MUCKE M, 1994, BIOCHEMISTRY-US, V33, P14608; MUCKE M, 1992, BIOCHEMISTRY-US, V31, P7848; Mueller JW, 2011, J AM CHEM SOC, V133, P20096, DOI 10.1021/ja2086195; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; RAHFELD JU, 1994, FEBS LETT, V352, P180, DOI 10.1016/0014-5793(94)00932-5; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Sarvas M, 2004, BBA-MOL CELL RES, V1694, P311, DOI 10.1016/j.bbamcr.2004.04.009; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; SCHMID FX, 1993, ANNU REV BIOPH BIOM, V22, P123, DOI 10.1146/annurev.bb.22.060193.001011; SCHMID FX, 1993, ADV PROTEIN CHEM, V44, P25, DOI 10.1016/S0065-3233(08)60563-X; Schmid FX, 2002, ADV PROTEIN CHEM, V59, P243; Schmidpeter PAM, 2011, BIOCHEMISTRY-US, V50, P4796, DOI 10.1021/bi200442q; Scholz C, 1997, J MOL BIOL, V273, P752, DOI 10.1006/jmbi.1997.1301; Scholz C, 1997, EMBO J, V16, P54, DOI 10.1093/emboj/16.1.54; Sekerina E, 2000, J MOL BIOL, V301, P1003, DOI 10.1006/jmbi.2000.4013; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tossavainen H, 2006, FEBS LETT, V580, P1822, DOI 10.1016/j.febslet.2006.02.042; Uchida T, 1999, FEBS LETT, V446, P278, DOI 10.1016/S0014-5793(99)00239-2; Vitikainen M, 2004, J BIOL CHEM, V279, P19302, DOI 10.1074/jbc.M400861200; Vitikainen M, 2001, J BACTERIOL, V183, P1881, DOI 10.1128/JB.183.6.1881-1890.2001; Weininger U, 2010, PROTEIN SCI, V19, P6, DOI 10.1002/pro.277; Williams RC, 2003, J BIOL CHEM, V278, P18056, DOI 10.1074/jbc.M301244200; Wu SC, 1998, J BACTERIOL, V180, P2830, DOI 10.1128/JB.180.11.2830-2835.1998; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zoldak G, 2009, BIOCHEMISTRY-US, V48, P10423, DOI 10.1021/bi9014242; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	87	24	25	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3278	3292		10.1074/jbc.M114.622910	http://dx.doi.org/10.1074/jbc.M114.622910			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525259	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000349456000009
J	Albrechtova, J; Albrecht, T; Dureje, L; Pallazola, VA; Pialek, J				Albrechtova, Jana; Albrecht, Tomas; Dureje, Ludovit; Pallazola, Vincent A.; Pialek, Jaroslav			Sperm Morphology in Two House Mouse Subspecies: Do Wild-Derived Strains and Wild Mice Tell the Same Story?	PLOS ONE			English	Article							MUS-MUSCULUS-MUSCULUS; MULTIPLE PATERNITY; SWIMMING VELOCITY; HYBRID ZONE; COMPETITION; COMMON; SIZE; EVOLUTIONARY; PHENOTYPES; FERTILITY	Being subject to intense post-copulatory selection, sperm size is a principal determining component of male fitness. Although previous studies have presented comparative sperm size data at higher taxonomic levels, information on the evolution of sperm size within species is generally lacking. Here, we studied two house mouse subspecies, Mus musculus musculus and Mus musculus domesticus, which undergo incipient speciation. We measured four sperm dimensions from cauda epididymis smears of 28 wild-caught mice of both subspecies. As inbred mouse strains are frequently used as proxies for exploring evolutionary processes, we further studied four wild-derived inbred strains from each subspecies. The subspecies differed significantly in terms of sperm head length and midpiece length, and these differences were consistent for wild mice and wild-derived strains pooled over genomes. When the inbred strains were analyzed individually, however, their strain-specific values were in some cases significantly shifted from subspecies-specific values derived from wild mice. We conclude that: (1) the size of sperm components differ in the two house mouse subspecies studied, and that (2) wild-derived strains reflect this natural polymorphism, serving as a potential tool to identify the genetic variation driving these evolutionary processes. Nevertheless, we suggest that more strains should be used in future experiments to account for natural variation and to avoid confounding results due to reduced variability and/or founder effect in the individual strains.	[Albrechtova, Jana; Albrecht, Tomas; Dureje, Ludovit; Pialek, Jaroslav] Acad Sci Czech Republ, Inst Vertebrate Biol, Res Facil Studenec, Brno, Czech Republic; [Albrechtova, Jana; Albrecht, Tomas] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Pallazola, Vincent A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Pallazola, Vincent A.] Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA	Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Charles University Prague; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Albrechtova, J (corresponding author), Acad Sci Czech Republ, Inst Vertebrate Biol, Res Facil Studenec, Brno, Czech Republic.	jana.brehova@seznam.cz	Piálek, Jaroslav/AAP-8636-2020; Albrecht, Tomas/A-1130-2011; Pialek, Jaroslav/B-1237-2008; Dureje, Ludovit/F-9726-2014	Pialek, Jaroslav/0000-0002-0829-7481; Albrecht, Tomas/0000-0002-9213-0034	Czech Science Foundation [206-08-0640]; National Science Foundation [DEB0746560]	Czech Science Foundation(Grant Agency of the Czech Republic); National Science Foundation(National Science Foundation (NSF))	Research was supported by the Czech Science Foundation (206-08-0640) (JP), and the National Science Foundation (DEB0746560) (VAP). The funders had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Albrechtova J, 2012, P ROY SOC B-BIOL SCI, V279, P4803, DOI 10.1098/rspb.2012.1802; Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; Baird SJE, 2012, EVOLUTION HOUSE MOUS, P334; BEATTY RA, 1963, J REPROD FERTIL, V6, P261, DOI 10.1530/jrf.0.0060261; BEATTY RA, 1970, BIOL REV, V45, P73, DOI 10.1111/j.1469-185X.1970.tb01076.x; Birkhead TR, 2010, J ZOOL, V281, P78, DOI 10.1111/j.1469-7998.2010.00701.x; Birkhead TR, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P1; Birkhead TR, 1998, SPERM COMPETITION SE; Bozikova E, 2005, BIOL J LINN SOC, V84, P363, DOI 10.1111/j.1095-8312.2005.00440.x; BRADEN A. W. H., 1959, AUSTRALIAN JOUR BIOL SCI, V12, P65; Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020; Cucchi T., 2012, EVOLUTION HOUSE MOUS, P65, DOI DOI 10.1017/CBO9781139044547.005; CUMMINS JM, 1985, J REPROD FERTIL, V75, P153, DOI 10.1530/jrf.0.0750153; Dean MD, 2006, MOL ECOL, V15, P4141, DOI 10.1111/j.1365-294X.2006.03068.x; Dean MD, 2009, EVOLUTION, V63, P20, DOI 10.1111/j.1558-5646.2008.00499.x; Dureje L, 2012, FOLIA ZOOL, V61, P308; Duvaux L, 2011, MOL ECOL, V20, P5248, DOI 10.1111/j.1365-294X.2011.05343.x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Festing MFV, 1996, GENETIC VARIANTS STR, P1577; Firman RC, 2008, J EVOLUTION BIOL, V21, P1524, DOI 10.1111/j.1420-9101.2008.01612.x; Firman RC, 2010, BIOL LETTERS, V6, P513, DOI 10.1098/rsbl.2009.1027; Gage MJG, 1998, P ROY SOC B-BIOL SCI, V265, P97, DOI 10.1098/rspb.1998.0269; Geraldes A, 2011, MOL ECOL, V20, P4722, DOI 10.1111/j.1365-294X.2011.05285.x; Geraldes A, 2008, MOL ECOL, V17, P5349, DOI 10.1111/j.1365-294X.2008.04005.x; Montoto LG, 2011, REPRODUCTION, V142, P819, DOI 10.1530/REP-11-0232; Montoto LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018173; Gregorova S, 2000, FOLIA BIOL-PRAGUE, V46, P31; Higginson DM, 2012, P NATL ACAD SCI USA, V109, P4538, DOI 10.1073/pnas.1111474109; ILLISSON L, 1969, AUST J BIOL SCI, V22, P947, DOI 10.1071/BI9690947; Immler S, 2012, P ROY SOC B-BIOL SCI, V279, P4174, DOI 10.1098/rspb.2012.1398; Immler S, 2011, P NATL ACAD SCI USA, V108, P5325, DOI 10.1073/pnas.1009059108; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kleven O, 2008, EVOLUTION, V62, P494, DOI 10.1111/j.1558-5646.2007.00287.x; Laskemoen T, 2013, BEHAV ECOL SOCIOBIOL, V67, P301, DOI 10.1007/s00265-012-1450-0; Laskemoen T, 2010, BEHAV ECOL SOCIOBIOL, V64, P1473, DOI 10.1007/s00265-010-0962-8; Lupold S, 2009, P R SOC B, V276, P1175, DOI 10.1098/rspb.2008.1645; Lundrigan BL, 2002, SYST BIOL, V51, P410, DOI 10.1080/10635150290069878; Macholan M, 2007, EVOLUTION, V61, P746, DOI 10.1111/j.1558-5646.2007.00065.x; Macholan M, 2011, EVOLUTION, V65, P1428, DOI 10.1111/j.1558-5646.2011.01228.x; Malo AF, 2006, BIOL LETTERS, V2, P246, DOI 10.1098/rsbl.2006.0449; Manser A, 2011, EVOLUTION, V65, P2435, DOI 10.1111/j.1558-5646.2011.01336.x; Mossman J, 2009, EVOLUTION, V63, P2730, DOI 10.1111/j.1558-5646.2009.00753.x; Munclinger P, 2003, MAMM GENOME, V14, P359, DOI 10.1007/s00335-002-3065-7; Munclinger P, 2002, FOLIA ZOOL, V51, P81; NAPIER RA, 1961, J REPROD FERTIL, V2, P273, DOI 10.1530/jrf.0.0020273; Osadchuk LV, 2010, B EXP BIOL MED+, V149, P739, DOI 10.1007/s10517-010-1040-y; Pialek J, 2008, J HERED, V99, P34, DOI 10.1093/jhered/esm083; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P69, DOI 10.1016/B978-0-12-372568-4.00003-3; Rolland C, 2003, BEHAVIOUR, V140, P1371, DOI 10.1163/156853903771980639; Suzuki H., 2012, EVOLUTION HOUSE MOUS, P35, DOI DOI 10.1017/CBO9781139044547.004; Thonhauser KE, 2014, ECOL EVOL, V4, P200, DOI 10.1002/ece3.920; Turner LM, 2012, EVOLUTION, V66, P443, DOI 10.1111/j.1558-5646.2011.01445.x; Ward PI, 1998, HEREDITY, V80, P655, DOI 10.1046/j.1365-2540.1998.00401.x; White MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000729; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847	55	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115669	10.1371/journal.pone.0115669	http://dx.doi.org/10.1371/journal.pone.0115669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541964	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900068
J	Awor, P; Wamani, H; Tylleskar, T; Jagoe, G; Peterson, S				Awor, Phyllis; Wamani, Henry; Tylleskar, Thorkild; Jagoe, George; Peterson, Stefan			Increased Access to Care and Appropriateness of Treatment at Private Sector Drug Shops with Integrated Management of Malaria, Pneumonia and Diarrhoea: A Quasi-Experimental Study in Uganda	PLOS ONE			English	Article							COMMUNITY CASE-MANAGEMENT; CHILDREN; STRATEGY; IMPACT; FEVER	Introduction: Drug shops are a major source of care for children in low income countries but they provide sub-standard care. We assessed the feasibility and effect on quality of care of introducing diagnostics and pre-packaged paediatric-dosage drugs for malaria, pneumonia and diarrhoea at drug shops in Uganda. Methods: We adopted and implemented the integrated community case management (iCCM) intervention within registered drug shops. Attendants were trained to perform malaria rapid diagnostic tests (RDTs) in each fever case and count respiratory rate in each case of cough with fast/difficult breathing, before dispensing recommended treatment. Using a quasi-experimental design in one intervention and one non-intervention district, we conducted before and after exit interviews for drug seller practices and household surveys for treatment-seeking practices in May-June 2011 and May-June 2012. Survey adjusted generalized linear models and difference-in-difference analysis was used. Results: 3759 (1604 before/2155 after) household interviews and 943 (163 before/780 after) exit interviews were conducted with caretakers of children under-5. At baseline, no child at a drug shop received any diagnostic testing before treatment in both districts. After the intervention, while no child in the non-intervention district received a diagnostic test, 87.7% (95% CI 79.0-96.4) of children with fever at the intervention district drug shops had a parasitological diagnosis of malaria, prior to treatment. The prevalence ratios of the effect of the intervention on treatment of cough and fast breathing with amoxicillin and diarrhoea with ORS/zinc at the drug shop were 2.8 (2.0-3.9), and 12.8 (4.2-38.6) respectively. From the household survey, the prevalence ratio of the intervention effect on use of RDTs was 3.2 (1.9-5.4); Artemisinin Combination Therapy for malaria was 0.74 (0.65-0.84), and ORS/zinc for diarrhoea was 2.3 (1.2-4.7). Conclusion: iCCM can be utilized to improve access and appropriateness of care for children at drug shops.	[Awor, Phyllis; Tylleskar, Thorkild] Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Hlth Care, Bergen, Norway; [Awor, Phyllis; Wamani, Henry; Peterson, Stefan] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Jagoe, George] Med Malaria Venture, Geneva, Switzerland; [Peterson, Stefan] Global Hlth, Karolinska Inst, Stockholm, Sweden; [Peterson, Stefan] Uppsala Univ, Int Maternal & Child Hlth Unit, Uppsala, Sweden	University of Bergen; Makerere University; Karolinska Institutet; Uppsala University	Awor, P (corresponding author), Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Hlth Care, Bergen, Norway.	aworphyllis@yahoo.co.uk	Tylleskär, Thorkild/S-5529-2017	Tylleskär, Thorkild/0000-0003-4801-4324; Peterson, Stefan/0000-0001-7203-3096	Einhorn Family Foundation - Sweden; Norwegian Quota Scheme	Einhorn Family Foundation - Sweden; Norwegian Quota Scheme	Funding: The authors are grateful to the Einhorn Family Foundation - Sweden for funding this study, to Medicines for Malaria Venture - Switzerland for extensive field support, and to the Norwegian Quota Scheme for PhD scholarship for PA. The Einhorn Family Foundation had no role in study design, data collection, data analysis, interpretation or writing the report. Medicines for Malaria Venture participated in all the above stages. The corresponding author had full access to all the data in the study and had the final responsibility for the decision to submit for publication.	Arrow KJ, 2012, LANCET, V380, P1889, DOI 10.1016/S0140-6736(12)61843-1; Awor P, 2012, AM J TROP MED HYG, V87, P92, DOI 10.4269/ajtmh.2012.11-0791; Bennett S, 2014, TROP MED INT HLTH; Bloom G, 2011, HEALTH POLICY PLANN, V26, pi45, DOI 10.1093/heapol/czr025; CAPSS, 2011, CLOS AFF GAP ENS AFF; Chinbuah MA, 2012, AM J TROP MED HYG, V87, P11, DOI 10.4269/ajtmh.2012.12-0078; DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1; Fink G, 2013, HLTH POLICY PLAN; Forsberg BC, 2011, HEALTH POLICY PLANN, V26, pi1, DOI 10.1093/heapol/czr050; Global-Fund, 2012, BOARD APPR INT AMFM; Global-Fund, 2011, AFF MED FAC MAL; I.O.M IoMotNA, 2004, SAV LIV BUYING TIM E; Kamal-Yanni MM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-414; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marsh DR, 2012, AM J TROP MED HYG, V87, P2, DOI 10.4269/ajtmh.2012.12-0504; Meessen B, 2011, HEALTH POLICY PLANN, V26, pi30, DOI 10.1093/heapol/czr026; MoH, 2010, INT COMM CAS MAN CHI; Mukanga David, 2012, Am J Trop Med Hyg, V87, P21, DOI 10.4269/ajtmh.2012.11-0816; Oxfam, 2012, SALT SUG MAL PILLS A; Rutebemberwa E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-45; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Smith F, 2009, PHARM WORLD SCI, V31, P351, DOI 10.1007/s11096-009-9294-z; Talisuna AO, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-356; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WHO, 2005, INT MAN CHILDH ILLN; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization, 2013, WHO INFORMAL CONSULT; Young M, 2012, AM J TROP MED HYG, V87, P6, DOI 10.4269/ajtmh.2012.12-0221	30	41	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115440	10.1371/journal.pone.0115440	http://dx.doi.org/10.1371/journal.pone.0115440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541703	gold, Green Published, Green Submitted			2022-12-26	WOS:000347239900043
J	Li, XF; Guan, LL; Chang, H; Zhang, B				Li, Xiaofei; Guan, Lili; Chang, Hui; Zhang, Bo			Core Self-Evaluation and Burnout among Nurses: The Mediating Role of Coping Styles	PLOS ONE			English	Article							OCCUPATIONAL STRESS; JOB-SATISFACTION; PERSONALITY; STRATEGIES; PERFORMANCE; TURNOVER; CHINA	Objectives: This study aimed to determine the potential association between core self-evaluation and the burnout syndrome among Chinese nurses, and the mediating role of coping styles in this relationship. Methods: A cross-sectional survey was conducted in Shenyang, China, from May to July, 2013. A questionnaire which consisted of the Maslach Burnout Inventory-General Survey (MBI-GS), the Core Self-Evaluation Scale (CSE), and the Simplified Coping Style Questionnaire (CSQ), was completed by a total of 1,559 nurses. Hierarchical linear regression analyses and the Sobel test were performed to determine the mediating role of coping styles on the relationship between CSE and burnout. Results: Nurses who had higher self-evaluation characteristics, reported less emotional exhaustion and cynicism, and higher professional efficacy. Coping style had a partial mediating effect on the relationship between CSE and the burnout syndrome among nurses. Conclusions: Core self-evaluation had effects on burnout and coping style was a mediating factor in this relationship among Chinese nurses. Therefore, the improvement of coping strategies may be helpful in the prevention of burnout among nurses, thus enhancing professional performance.	[Li, Xiaofei] China Med Univ, Affiliated Hosp 1, Emergency Dept, Shenyang, Peoples R China; [Guan, Lili] Huaiyin Adv Vocat & Tech Sch Hlth, Fac Nursing, Huaian, Peoples R China; [Chang, Hui] Ctr Hlth Educ Liaoning Prov, Social Educ Dept, Shenyang, Peoples R China; [Zhang, Bo] China Med Univ, Affiliated Hosp 1, Dept Nursing, Shenyang, Peoples R China	China Medical University; China Medical University	Zhang, B (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Nursing, Shenyang, Peoples R China.	1345596429@qq.com	Li, xiaofei/GXF-7187-2022					Bakker AB, 2006, J SOC PSYCHOL, V146, P31, DOI 10.3200/SOCP.146.1.31-50; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Best RG, 2005, J OCCUP HEALTH PSYCH, V10, P441, DOI 10.1037/1076-8998.10.4.441; Cohen J., 2003, APPL MULTIPLE REGRES; Du J., 2012, PSYCHOL RES CHINESE, V5, P54; Erez A, 2001, J APPL PSYCHOL, V86, P1270, DOI 10.1037/0021-9010.86.6.1270; FOLKMAN S, 1988, J PERS SOC PSYCHOL, V54, P466, DOI 10.1037/0022-3514.54.3.466; Garrosa E, 2010, INT J NURS STUD, V47, P205, DOI 10.1016/j.ijnurstu.2009.05.014; Gibbons C, 2010, INT J NURS STUD, V47, P1299, DOI 10.1016/j.ijnurstu.2010.02.015; Hurtz GM, 2000, J APPL PSYCHOL, V85, P869, DOI 10.1037/0021-9010.85.6.869; Judge TA, 2003, PERS PSYCHOL, V56, P303, DOI 10.1111/j.1744-6570.2003.tb00152.x; Judge TA, 2000, J APPL PSYCHOL, V85, P237, DOI 10.1037//0021-9010.85.2.237; Judge TA, 2009, J APPL PSYCHOL, V94, P742, DOI 10.1037/a0015497; Kacmar KM, 2009, J APPL PSYCHOL, V94, P1572, DOI 10.1037/a0017498; Kammeyer-Mueller JD, 2009, J APPL PSYCHOL, V94, P177, DOI 10.1037/a0013214; Kulbe J, 2001, Home Healthc Nurse, V19, P707, DOI 10.1097/00004045-200111000-00016; Laschinger HKS, 2007, J NURS ADMIN, V37, P221, DOI 10.1097/01.NNA.0000269746.63007.08; Laschinger HKS, 2008, J NURS MANAGE, V16, P601, DOI 10.1111/j.1365-2834.2008.00904.x; Leiter MP, 2009, J NURS MANAGE, V17, P331, DOI 10.1111/j.1365-2834.2009.01004.x; Lian PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087152; Lin QH, 2013, J OCCUP HEALTH, V55, P458, DOI 10.1539/joh.12-0287-OA; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Payne N, 2001, J ADV NURS, V33, P396, DOI 10.1046/j.1365-2648.2001.01677.x; Pejuskovic B, 2011, PSYCHIAT DANUB, V23, P389; Peng J., 2014, J HLTH PSYCHOL; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd Edn.; Gomes SDS, 2013, REV LAT-AM ENFERM, V21, P1282, DOI 10.1590/0104-1169.2742.2365; Thiruchelvi A, 2012, SPAN J PSYCHOL, V15, P156, DOI 10.5209/rev_SJOP.2012.v15.n1.37302; Wang S., 2013, INT J NURS PRACT; Wang WR, 2011, APPL NURS RES, V24, P238, DOI 10.1016/j.apnr.2009.09.003; Wang Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-915; Wong D F, 2001, Int J Nurs Pract, V7, P188, DOI 10.1046/j.1440-172X.2001.00298.x; Wu SY, 2007, J ADV NURS, V59, P233, DOI 10.1111/j.1365-2648.2007.04301.x; [谢文 Xie Wen], 2005, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V14, P462; Xie Y., 1998, CHINESE J CLIN PSYCH, V6, P114, DOI DOI 10.16128/J.CNKI.1005-3611.1998.02.018; Xie ZY, 2011, J ADV NURS, V67, P1537, DOI 10.1111/j.1365-2648.2010.05576.x; Zhao XF, 2013, PSYCHIAT GENET, V23, P214, DOI 10.1097/YPG.0b013e328364365d	37	43	45	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115799	10.1371/journal.pone.0115799	http://dx.doi.org/10.1371/journal.pone.0115799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25541990	gold, Green Published, Green Submitted			2022-12-26	WOS:000347239900090
J	McFadden, JW; Aja, S; Li, Q; Bandaru, VVR; Kim, EK; Haughey, NJ; Kuhajda, FP; Ronnett, GV				McFadden, Joseph W.; Aja, Susan; Li, Qun; Bandaru, Veera V. R.; Kim, Eun-Kyoung; Haughey, Norman J.; Kuhajda, Francis P.; Ronnett, Gabriele V.			Increasing Fatty Acid Oxidation Remodels the Hypothalamic Neurometabolome to Mitigate Stress and Inflammation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; DIET-INDUCED OBESITY; CARNITINE PALMITOYLTRANSFERASE-I; REGULATES FOOD-INTAKE; INSULIN-RESISTANCE; LIVER-DISEASE; MITOCHONDRIAL DYSFUNCTION; SYNTHASE INHIBITOR; LIPID-ACCUMULATION	Modification of hypothalamic fatty acid (FA) metabolism can improve energy homeostasis and prevent hyperphagia and excessive weight gain in diet-induced obesity (DIO) from a diet high in saturated fatty acids. We have shown previously that C75, a stimulator of carnitine palmitoyl transferase-1 (CPT-1) and fatty acid oxidation (FAOx), exerts at least some of its hypophagic effects via neuronal mechanisms in the hypothalamus. In the present work, we characterized the effects of C75 and another anorexigenic compound, the glycerol-3-phosphate acyltransferase (GPAT) inhibitor FSG67, on FA metabolism, metabolomics profiles, and metabolic stress responses in cultured hypothalamic neurons and hypothalamic neuronal cell lines during lipid excess with palmitate. Both compounds enhanced palmitate oxidation, increased ATP, and inactivated AMP-activated protein kinase (AMPK) in hypothalamic neurons in vitro. Lipidomics and untargeted metabolomics revealed that enhanced catabolism of FA decreased palmitate availability and prevented the production of fatty acylglycerols, ceramides, and cholesterol esters, lipids that are associated with lipotoxicity-provoked metabolic stress. This improved metabolic signature was accompanied by increased levels of reactive oxygen species (ROS), and yet favorable changes in oxidative stress, overt ER stress, and inflammation. We propose that enhancing FAOx in hypothalamic neurons exposed to excess lipids promotes metabolic remodeling that reduces local inflammatory and cell stress responses. This shift would restore mitochondrial function such that increased FAOx can produce hypothalamic neuronal ATP and lead to decreased food intake and body weight to improve systemic metabolism.	[McFadden, Joseph W.; Aja, Susan; Li, Qun; Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA; [McFadden, Joseph W.; Aja, Susan; Li, Qun; Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Bandaru, Veera V. R.; Haughey, Norman J.; Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Kuhajda, Francis P.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Kuhajda, Francis P.; Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Kim, Eun-Kyoung; Ronnett, Gabriele V.] Daegu Gyeongbuk Inst Sci & Technol, Dept Brain Sci, Taegu, South Korea	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Aja, S (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA.	saja1@jhmi.edu			National Institutes of Health National Institute of Neurological Disorders and Stroke [R01 NS041079]; FASgen, Inc.; Korean Ministry of Education, Science, and Technology [10-BD-04]; Agilent Technologies; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041079] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FASgen, Inc.; Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Agilent Technologies; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This work was supported by National Institutes of Health National Institute of Neurological Disorders and Stroke Grant R01 NS041079 to GVR; Sponsored Research Agreement between FASgen, Inc. to GVR; and a Research Collaboration funded by grant #10-BD-04 from Korean Ministry of Education, Science, and Technology, between SA and the Daegu-Gyeongbuk Institute of Science and Technology (DGIST) Convergence Science Center. Agilent Technologies provided support through a University Relations Grant to GVR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Aja S, 2008, AM J PHYSIOL-REG I, V294, pR352, DOI 10.1152/ajpregu.00862.2006; Aja S, 2006, AM J PHYSIOL-REG I, V291, pR148, DOI 10.1152/ajpregu.00041.2006; Alkhouri N, 2013, LIVER INT, V33, P79, DOI 10.1111/liv.12024; Bandaru VVR, 2011, J NEUROIMMUNE PHARM, V6, P640, DOI 10.1007/s11481-011-9289-0; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Bentebibel A, 2006, BIOCHEMISTRY-US, V45, P4339, DOI 10.1021/bi052186q; Blazquez C, 1998, J NEUROCHEM, V71, P1597; Chakravarthy MV, 2009, J LIPID RES, V50, P630, DOI 10.1194/jlr.M800379-JLR200; Choi SS, 2008, CURR OPIN LIPIDOL, V19, P295, DOI 10.1097/MOL.0b013e3282ff5e55; Choi SJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1122, DOI 10.1152/ajpendo.00006.2010; Cintra DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030571; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Downs SM, 2009, MOL REPROD DEV, V76, P844, DOI 10.1002/mrd.21047; Ebert D, 2003, J NEUROSCI, V23, P5928; Gao S, 2011, P NATL ACAD SCI USA, V108, P9691, DOI 10.1073/pnas.1103267108; Hamamura K, 2007, FEBS LETT, V581, P1769, DOI 10.1016/j.febslet.2007.03.063; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P1117, DOI 10.1097/01.WCB.0000089600.87125.AD; Idrovo JP, 2012, J SURG RES, V177, P157, DOI 10.1016/j.jss.2012.05.053; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kim EK, 2002, AM J PHYSIOL-ENDOC M, V283, pE867, DOI 10.1152/ajpendo.00178.2002; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kleman AM, 2008, J NEUROSCI METH, V167, P292, DOI 10.1016/j.jneumeth.2007.08.028; Kuhajda FP, 2011, AM J PHYSIOL-REG I, V301, pR116, DOI 10.1152/ajpregu.00147.2011; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Landree LE, 2004, J BIOL CHEM, V279, P3817, DOI 10.1074/jbc.M310991200; Le Foll C, 2009, AM J PHYSIOL-REG I, V297, pR655, DOI 10.1152/ajpregu.00223.2009; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Linden D, 2006, FASEB J, V20, P434, DOI 10.1096/fj.05-4568com; Lopez M, 2007, BIOESSAYS, V29, P248, DOI 10.1002/bies.20539; MacLean DB, 2004, BRAIN RES, V1020, P1, DOI 10.1016/j.brainres.2004.04.041; Makowski K, 2013, CHIRALITY, V25, P281, DOI 10.1002/chir.22139; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mera P, 2009, BIOCHEM PHARMACOL, V77, P1084, DOI 10.1016/j.bcp.2008.11.020; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Miller I, 2004, NEUROREPORT, V15, P925, DOI 10.1097/00001756-200404090-00038; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nicot C, 2004, BIOCHEM BIOPH RES CO, V325, P660, DOI 10.1016/j.bbrc.2004.10.085; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Puig T, 2008, BREAST CANCER RES TR, V109, P471, DOI 10.1007/s10549-007-9678-5; Ramirez S, 2013, DIABETES, V62, P2329, DOI 10.2337/db12-1451; Ronnett GV, 2005, PHYSIOL BEHAV, V85, P25, DOI 10.1016/j.physbeh.2005.04.014; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Sies H, 2005, J NUTR, V135, P969, DOI 10.1093/jn/135.5.969; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Thupari JN, 2004, AM J PHYSIOL-ENDOC M, V287, pE97, DOI 10.1152/ajpendo.00261.2003; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; Tu YJ, 2005, ENDOCRINOLOGY, V146, P486, DOI 10.1210/en.2004-0976; Usuki F, 2013, SCI REP-UK, V3, DOI 10.1038/srep02346; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103; Won JC, 2009, OBESITY, V17, P1861, DOI 10.1038/oby.2009.194; Wydysh EA, 2009, J MED CHEM, V52, P3317, DOI 10.1021/jm900251a; Yang NY, 2005, J PHARMACOL EXP THER, V312, P127, DOI 10.1124/jpet.104.074104; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhu J, 2012, J NEUROSCI RES, V90, P422, DOI 10.1002/jnr.22765	72	41	42	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115642	10.1371/journal.pone.0115642	http://dx.doi.org/10.1371/journal.pone.0115642			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541737	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900061
J	Sui, YJ; Sun, MY; Wu, F; Yang, LF; Di, WH; Zhang, GZ; Zhong, LL; Ma, ZM; Zheng, JH; Fang, XD; Ma, TH				Sui, Yujie; Sun, Meiyan; Wu, Fei; Yang, Longfei; Di, Weihua; Zhang, Guizhen; Zhong, Lili; Ma, Zhiming; Zheng, Jinhao; Fang, Xuedong; Ma, Tonghui			Inhibition of TMEM16A Expression Suppresses Growth and Invasion in Human Colorectal Cancer Cells	PLOS ONE			English	Article							CA2+-ACTIVATED CL-CHANNEL; TRANSCRIPTOME ANALYSIS; CHLORIDE CHANNELS; CONTRIBUTES; CARCINOMA; MARKER; IDENTIFICATION; PATTERNS; ACINAR; 11Q13	Metastasis leads to poor prognosis in colorectal cancer patients, and there is a growing need for new therapeutic targets. TMEM16A (ANO1, DOG1 or TAOS2) has recently been identified as a calcium-activated chloride channel (CaCC) and is reported to be overexpressed in several malignancies; however, its expression and function in colorectal cancer (CRC) remains unclear. In this study, we found expression of TMEM16A mRNA and protein in high-metastatic-potential SW620, HCT116 and LS174T cells, but not in primary HCT8 and SW480 cells, using RT-PCR, western blotting and immunofluorescence labeling. Patch-clamp recordings detected CaCC currents regulated by intracellular Ca2+ and voltage in SW620 cells. Knockdown of TMEM16A by short hairpin RNAs (shRNA) resulted in the suppression of growth, migration and invasion of SW620 cells as detected by MTT, wound-healing and transwell assays. Mechanistically, TMEM16A depletion was accompanied by the dysregulation of phospho-MEK, phospho-ERK1/2 and cyclin D1 expression. Flow cytometry analysis showed that SW620 cells were inhibited from the G1 to S phase of the cell cycle in the TMEM16A shRNA group compared with the control group. In conclusion, our results indicate that TMEM16A CaCC is involved in growth, migration and invasion of metastatic CRC cells and provide evidence for TMEM16A as a potential drug target for treating metastatic colorectal carcinoma.	[Sui, Yujie; Sun, Meiyan; Yang, Longfei; Di, Weihua; Zhang, Guizhen; Zhong, Lili; Ma, Tonghui] Jilin Univ, Bethune Hosp 2, Key Lab Mol & Chem Genet Crit Human Dis Jilin Pro, Changchun 130023, Peoples R China; [Wu, Fei] Jilin Univ, Bethune Hosp 2, Dept Gynecol & Obstet, Changchun 130023, Peoples R China; [Ma, Zhiming; Zheng, Jinhao; Fang, Xuedong] Jilin Univ, Bethune Hosp 2, Dept Gen Surg, Changchun 130023, Peoples R China; [Fang, Xuedong] Jilin Univ, China Japan Friendship Hosp, Dept Gen Surg, Changchun 130023, Peoples R China; [Ma, Tonghui] Dalian Med Univ, Coll Basic Med Sci, Dalian, Peoples R China	Jilin University; Jilin University; Jilin University; China-Japan Friendship Hospital; Jilin University; Dalian Medical University	Fang, XD (corresponding author), Jilin Univ, Bethune Hosp 2, Dept Gen Surg, Changchun 130023, Peoples R China.	fangxuedong@medmail.com.cn; tonghuima@dlmedu.edu.cn	Yang, Longfei/B-4223-2018	Yang, Longfei/0000-0003-4153-9670; Ma, Tonghui/0000-0001-9338-1030	National Natural Science Foundation of China [81173109, 31471099, 31301179]; China Postdoctoral Science Foundation [2014M551198]; Jilin Province health and Family Planning Commission Project [2014Q024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jilin Province health and Family Planning Commission Project	Funding: This study was supported by National Natural Science Foundation of China (No. 81173109, 31471099, and 31301179), China Postdoctoral Science Foundation (No. 2014M551198), and Jilin Province health and Family Planning Commission Project (No. 2014Q024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERVALL JA, 1995, CANCER, V76, P853, DOI 10.1002/1097-0142(19950901)76:5<853::AID-CNCR2820760520>3.0.CO;2-6; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Bulley S, 2012, CIRC RES, V111, P1027, DOI 10.1161/CIRCRESAHA.112.277145; Cai K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-208; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; Carneiro A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-98; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Chenevert J, 2012, MODERN PATHOL, V25, P919, DOI 10.1038/modpathol.2012.57; Chiang PC, 2013, LASER SURG MED, V45, P38, DOI 10.1002/lsm.22112; Dauner K, 2012, CELL TISSUE RES, V347, P327, DOI 10.1007/s00441-012-1324-9; Davis AJ, 2013, BRIT J PHARMACOL, V168, P773, DOI 10.1111/j.1476-5381.2012.02199.x; Dutta AK, 2011, J BIOL CHEM, V286, P766, DOI 10.1074/jbc.M110.164970; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferrera L, 2010, PHYSIOLOGY, V25, P357, DOI 10.1152/physiol.00030.2010; Fiorelli G, 1999, J STEROID BIOCHEM, V71, P223, DOI 10.1016/S0960-0760(99)00144-2; Forrest AS, 2012, AM J PHYSIOL-CELL PH, V303, pC1229, DOI 10.1152/ajpcell.00044.2012; Gaur S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-21; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Guang RJ, 2000, CANCER RES, V60, P749; Hewitt RE, 2000, J PATHOL, V192, P446; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066439; Karpinski P, 2008, J APPL GENET, V49, P1, DOI 10.1007/BF03195243; Katoh M, 2004, INT J ONCOL, V24, P1345; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Knowles LM, 2013, MOL CANCER RES, V11, P194, DOI 10.1158/1541-7786.MCR-12-0300; Kumar S, 2012, BIOORGAN MED CHEM, V20, P4237, DOI 10.1016/j.bmc.2012.05.074; Leanza L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00227; Li M, 2013, EUR J GYNAECOL ONCOL, V34, P60; Liu W, 2012, INHIBITION CA 2 ACTI; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Ousingsawat J, 2011, CELL PHYSIOL BIOCHEM, V28, P715, DOI 10.1159/000335765; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Peng C, 2007, MOL CELL BIOCHEM, V303, P141, DOI 10.1007/s11010-007-9466-x; Rajput A, 2008, J SURG RES, V147, P276, DOI 10.1016/j.jss.2007.04.021; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Terashima H, 2013, P NATL ACAD SCI US; Thomas-Gatewood C, 2011, AM J PHYSIOL-HEART C, V301, pH1819, DOI 10.1152/ajpheart.00404.2011; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Wang M, 2012, CIRCULATION, V125, P697, DOI 10.1161/CIRCULATIONAHA.111.041806; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	54	86	88	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115443	10.1371/journal.pone.0115443	http://dx.doi.org/10.1371/journal.pone.0115443			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541940	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900044
J	Corsiero, E; Sutcliffe, N; Pitzalis, C; Bombardieri, M				Corsiero, Elisa; Sutcliffe, Nurhan; Pitzalis, Costantino; Bombardieri, Michele			Accumulation of Self-Reactive Naive and Memory B Cell Reveals Sequential Defects in B Cell Tolerance Checkpoints in Sjogren's Syndrome	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SALIVARY-GLANDS; AUTOANTIBODY PRODUCTION; MONOCLONAL-ANTIBODIES; RHEUMATOID-ARTHRITIS; EXPRESSION; AUTOREACTIVITY; PROLIFERATION; ORGANIZATION; PRECURSORS	Sjogren's syndrome (SS) is an autoimmune disease characterised by breach of self-tolerance towards nuclear antigens resulting in high affinity circulating autoantibodies. Although peripheral B cell disturbances have been described in SS, with predominance of naive and reduction of memory B cells, the stage at which errors in B cell tolerance checkpoints accumulate in SS is unknown. Here we determined the frequency of self-and poly-reactive B cells in the circulating naive and memory compartment of SS patients. Single CD27 - IgD+ naive, CD27+IgD+ memory unswitched and CD27+IgD- memory switched B cells were sorted by FACS from the peripheral blood of 7 SS patients. To detect the frequency of polyreactive and autoreactive clones, paired Ig V-H and V-L genes were amplified, cloned and expressed as recombinant monoclonal antibodies (rmAbs) displaying identical specificity of the original B cells. IgV(H) and V-L gene usage and immunoreactivity of SS rmAbs were compared with those obtained from healthy donors (HD). From a total of 353 V-H and 293 V-L individual sequences, we obtained 114 rmAbs from circulating naive (n=66) and memory (n=48) B cells of SS patients. Analysis of the Ig V gene repertoire did not show significant differences in SS vs. HD B cells. In SS patients, circulating naive B cells (with germline V-H and V-L genes) displayed a significant accumulation of clones autoreactive against Hep-2 cells compared to HD (43.1% vs. 25%). Moreover, we demonstrated a progressive increase in the frequency of circulating anti-nuclear naive (9.3%), memory unswitched (22.2%) and memory switched (27.3%) B cells in SS patients. Overall, these data provide novel evidence supporting the existence of both early and late defects in B cell tolerance checkpoints in patients with SS resulting in the accumulation of autoreactive naive and memory B cells.	[Corsiero, Elisa; Sutcliffe, Nurhan; Pitzalis, Costantino; Bombardieri, Michele] Queen Mary Univ London, John Vane Sci Ctr, Barts & London Sch Med & Dent, Ctr Expt Med & Rheumatol,William Harvey Res Inst, London EC1M 6BQ, England	University of London; Queen Mary University London	Corsiero, E (corresponding author), Queen Mary Univ London, John Vane Sci Ctr, Barts & London Sch Med & Dent, Ctr Expt Med & Rheumatol,William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	e.corsiero@qmul.ac.uk; m.bombardieri@qmul.ac.uk	Corsiero, Elisa/ACG-1815-2022	Corsiero, Elisa/0000-0003-2092-6778; Pitzalis, Costantino/0000-0003-1326-5051	Arthritis Research UK [18237, 20089]; William Harvey Research Foundation; EMBO [ASTF 318-2010]; EFIS-IL	Arthritis Research UK(Versus Arthritis); William Harvey Research Foundation; EMBO(European Molecular Biology Organization (EMBO)); EFIS-IL	This work was funded by grants number 18237 and 20089 from Arthritis Research UK (http://www.arthritisresearchuk.org) to MB and the William Harvey Research Foundation. EC was recipient of short-term travel fellowships from EMBO (ASTF 318-2010) and EFIS-IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone F, 2005, ARTHRITIS RHEUM-US, V52, P1773, DOI 10.1002/art.21062; Bombardieri M, 2007, J IMMUNOL, V179, P4929, DOI 10.4049/jimmunol.179.7.4929; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; CHANG B, 1994, IMMUNOL TODAY, V15, P367, DOI 10.1016/0167-5699(94)90175-9; Dawson L, 2005, ARTHRITIS RHEUM-US, V52, P2984, DOI 10.1002/art.21347; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Haneji N, 1997, SCIENCE, V276, P604, DOI 10.1126/science.276.5312.604; Hansen A, 2003, SCAND J IMMUNOL, V57, P470, DOI 10.1046/j.1365-3083.2003.01226.x; Hansen A, 2002, ARTHRITIS RHEUM-US, V46, P2160, DOI 10.1002/art.10445; Hansen A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2210; Hansen A, 2010, AUTOIMMUN REV, V9, P600, DOI 10.1016/j.autrev.2010.05.005; Kessel A, 2012, AUTOIMMUN REV, V11, P670, DOI 10.1016/j.autrev.2011.11.018; Le Pottier L, 2009, J IMMUNOL, V182, P3540, DOI 10.4049/jimmunol.0803588; Lossos IS, 2000, J IMMUNOL, V165, P5122, DOI 10.4049/jimmunol.165.9.5122; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Mouquet H, 2011, CELL MOL LIFE SCI; Mouquet H, 2012, CELL MOL LIFE SCI, V69, P1435, DOI 10.1007/s00018-011-0872-6; Pijpe J, 2005, ARTHRITIS RHEUM-US, V52, P2740, DOI 10.1002/art.21260; Rogosch T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00176; Routsias JG, 2010, EUR J CLIN INVEST, V40, P1026, DOI 10.1111/j.1365-2362.2010.02342.x; Salomonsson S, 2003, ARTHRITIS RHEUM-US, V48, P3187, DOI 10.1002/art.11311; Samuels J, 2005, J EXP MED, V201, P1659, DOI 10.1084/jem.20042321; Scheid JF, 2011, P NATL ACAD SCI USA, V108, P18044, DOI 10.1073/pnas.1113395108; Stott DI, 1998, J CLIN INVEST, V102, P938, DOI 10.1172/JCI3234; Takemoto F, 2007, NEPHRON PHYSIOL, V106, P63, DOI 10.1159/000104873; Theander E, 2011, ANN RHEUM DIS, V70, P1363, DOI 10.1136/ard.2010.144782; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Tsuboi H, 2012, MOD RHEUMATOL, V22, P264, DOI 10.1007/s10165-011-0514-8; Tsuiji M, 2006, J EXP MED, V203, P393, DOI 10.1084/jem.20052033; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Youinou P, 2010, ARTHRITIS RHEUM-US, V62, P2605, DOI 10.1002/art.27564; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251	35	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114575	10.1371/journal.pone.0114575	http://dx.doi.org/10.1371/journal.pone.0114575			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535746	Green Submitted, Green Published, gold			2022-12-26	WOS:000348563300014
J	Domenici, L; Origlia, N; Falsini, B; Cerri, E; Barloscio, D; Fabiani, C; Sanso, M; Giovannini, L				Domenici, Luciano; Origlia, Nicola; Falsini, Benedetto; Cerri, Elisa; Barloscio, Davide; Fabiani, Carlotta; Sanso, Marco; Giovannini, Luca			Rescue of Retinal Function by BDNF in a Mouse Model of Glaucoma	PLOS ONE			English	Article							GANGLION-CELL SURVIVAL; OPTIC-NERVE INJURY; NEUROTROPHIC FACTOR; PATTERN ELECTRORETINOGRAM; DBA/2J MOUSE; AXONAL-TRANSPORT; VISUAL-ACUITY; RECEPTOR TRKB; GROWTH-FACTOR; MICE	Vision loss in glaucoma is caused by progressive dysfunction of retinal ganglion cells (RGCs) and optic nerve atrophy. Here, we investigated the effectiveness of BDNF treatment to preserve vision in a glaucoma experimental model. As an established experimental model, we used the DBA/2J mouse, which develops chronic intraocular pressure (IOP) elevation that mimics primary open-angle glaucoma (POAG). IOP was measured at different ages in DBA/2J mice. Visual function was monitored using the steady-state Pattern Electroretinogram (P-ERG) and visual cortical evoked potentials (VEP). RGC alterations were assessed using Brn3 immunolabeling, and confocal microscope analysis. Human recombinant BDNF was dissolved in physiological solution (0.9% NaCl); the effects of repeated intravitreal injections and topical eye BDNF applications were independently evaluated in DBA/2J mice with ocular hypertension. BDNF level was measured in retinal homogenate by ELISA and western blot. We found a progressive decline of P-ERG and VEP responses in DBA/2J mice between 4 and 7 months of age, in relationship with the development of ocular hypertension and the reduction of Brn3 immunopositive RGCs. Conversely, repeated intravitreal injections (BDNF concentration=2 mu g/mu l, volume=1 mu l, for each injection; 1 injection every four days, three injections over two weeks) and topical eye application of BDNF eye-drops (12 mu g/mu l, 5 ml eye-drop every 48 h for two weeks) were able to rescue visual responses in 7 month DBA/2J mice. In particular, BDNF topical eye treatment recovered P-ERG and VEP impairment increasing the number of Brn3 immunopositive RGCs. We showed that BDNF effects were independent of IOP reduction. Thus, topical eye treatment with BDNF represents a promisingly safe and feasible strategy to preserve visual function and diminish RGC vulnerability to ocular hypertension.	[Domenici, Luciano; Origlia, Nicola; Cerri, Elisa; Barloscio, Davide; Fabiani, Carlotta] CNR, Inst Neurosci, I-56100 Pisa, Italy; [Domenici, Luciano] Univ Aquila, Dept Appl Clin Sci & Biotechnol DISCAB, I-67100 Laquila, Italy; [Falsini, Benedetto] Catholic Univ, Policlin Gemelli, Inst Ophthalmol, Rome, Italy; [Sanso, Marco; Giovannini, Luca] Univ Pisa, Dept Translat Res New Technol Med & Surg, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of L'Aquila; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Pisa	Domenici, L (corresponding author), CNR, Inst Neurosci, I-56100 Pisa, Italy.	domenici@in.cnr.it	Falsini, Benedetto/V-1070-2019; Falsini, Benedetto/AAC-5907-2022	Falsini, Benedetto/0000-0002-1694-1062; Falsini, Benedetto/0000-0002-3569-4968; Domenici, Luciano/0000-0003-2923-9421	Italian Ministry of Research (grant PRIN); intramural grant (CNR, Neuroscience Institute)	Italian Ministry of Research (grant PRIN); intramural grant (CNR, Neuroscience Institute)	This work was supported by the Italian Ministry of Research (grant PRIN, 2010) to Luciano Domenici (Title: Physiology and physiopathology of BDNF: towards the development of new therapeutic strategies) and intramural grant (CNR, Neuroscience Institute) to Nicola Origlia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Atorf J, 2013, DOC OPHTHALMOL, V126, P221, DOI 10.1007/s10633-013-9380-3; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; BAKER CL, 1988, J PHYSIOL-LONDON, V407, P155, DOI 10.1113/jphysiol.1988.sp017408; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Butowt R, 2005, MOL CELL NEUROSCI, V29, P11, DOI 10.1016/j.mcn.2005.02.004; Caleo M, 2000, CURR BIOL, V10, P1155, DOI 10.1016/S0960-9822(00)00713-2; Cellerino A, 1998, J NEUROSCI, V18, P3351; Cellerino A, 1997, J COMP NEUROL, V386, P149; Chou TH, 2013, INVEST OPHTH VIS SCI, V54, P1236, DOI 10.1167/iovs.12-11188; Coleman JE, 2009, NEUROSCIENCE, V161, P561, DOI 10.1016/j.neuroscience.2009.03.045; Damiani D, 2012, J COMP NEUROL, V520, P1406, DOI 10.1002/cne.22802; DOMENICI L, 1991, EXP BRAIN RES, V86, P579; Falsini B, 1999, EUR J NEUROL, V6, P151, DOI 10.1111/j.1468-1331.1999.tb00008.x; Frankfort BJ, 2013, INVEST OPHTH VIS SCI, V54, P762, DOI 10.1167/iovs.12-10581; Guo Y, 2009, EXP EYE RES, V89, P921, DOI 10.1016/j.exer.2009.08.003; Kezic JM, 2013, INVEST OPHTH VIS SCI, V54, P3028, DOI 10.1167/iovs.13-11865; Kim H, 2004, J BIOL CHEM, V279, P33538, DOI 10.1074/jbc.M404115200; Ko ML, 2001, NEUROSCI LETT, V305, P139, DOI 10.1016/S0304-3940(01)01830-4; Lambiase A, 2005, INVEST OPHTH VIS SCI, V46, P3800, DOI 10.1167/iovs.05-0301; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; MAFFEI L, 1982, EXP BRAIN RES, V48, P327; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Origlia N, 2012, INVEST OPHTH VIS SCI, V53, P1211, DOI 10.1167/iovs.11-8007; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489; PEREZ MTR, 1995, NEUROSCI LETT, V183, P96, DOI 10.1016/0304-3940(94)11123-Z; Porciatti V, 1996, P NATL ACAD SCI USA, V93, P14955, DOI 10.1073/pnas.93.25.14955; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Porciatti V, 2007, INVEST OPHTH VIS SCI, V48, P745, DOI 10.1167/iovs.06-0733; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Rudzinski M, 2004, J NEUROBIOL, V58, P341, DOI 10.1002/neu.10293; Saleh M, 2007, INVEST OPHTH VIS SCI, V48, P4564, DOI 10.1167/iovs.07-0483; Sanchez-Migallon MC, 2011, EXP EYE RES, V92, P260, DOI 10.1016/j.exer.2011.02.001; Schlamp CL, 2006, BMC NEUROSCI, P7; Scholz M, 2008, INVEST OPHTH VIS SCI, V49, P255; SIEVING PA, 1987, J NEUROPHYSIOL, V57, P104, DOI 10.1152/jn.1987.57.1.104; Surgucheva I, 2008, MOL VIS, V14, P1540; Ventura LM, 2013, J GLAUCOMA, V22, P219, DOI 10.1097/IJG.0b013e318237c89f; Wahlin KJ, 2001, EXP EYE RES, V73, P693, DOI 10.1006/exer.2001.1078; Weber AJ, 2008, J PHYSIOL-LONDON, V586, P4393, DOI 10.1113/jphysiol.2008.156729; Weber AJ, 2010, INVEST OPHTH VIS SCI, V51, P327, DOI 10.1167/iovs.09-3740; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Zhang CW, 2005, INVEST OPHTH VIS SCI, V46, P1497, DOI 10.1167/iovs.04-0664	51	81	83	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115579	10.1371/journal.pone.0115579	http://dx.doi.org/10.1371/journal.pone.0115579			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536045	Green Submitted, gold, Green Published			2022-12-26	WOS:000348563300052
J	Holm, G; Andersson, M; Ekberg, M; Fagrell, B; Sjoberg, J; Bottai, M; Bjorkholm, M				Holm, Goran; Andersson, Margareta; Ekberg, Monica; Fagrell, Bengt; Sjoberg, Jan; Bottai, Matteo; Bjorkholm, Magnus			Setae from Larvae of the Northern Processionary Moth (Thaumetopoea pinivora, TP) Stimulate Proliferation of Human Blood Lymphocytes In Vitro	PLOS ONE			English	Article							CATERPILLAR	Larvae of the Northern pine processionary moth (Thaumetopoea pinivora, TP) carry microscopic needles (setae), which by penetrating skin and mucous membranes, may cause inflammatory/immune derived symptoms in man. In the present study the stimulatory effects of setae on human blood lymphocytes in vitro was investigated. Blood mononuclear cells were separated from venous blood or buffy coat of ten healthy individuals, six previously exposed to setae and four with no known exposure. Lymphoproliferation was measured as uptake of H-3-thymidine. Setae were prepared from TP larvae. Setae and saline setae extracts stimulated proliferation of T-lymphocytes in the presence of monocytic cells. Stimulation was pronounced in cells from persons who had been exposed to setae, and weak in cells from non-exposed donors. Chitin also induced lymphocyte proliferation in most donors, but to a lesser extent and independently of donor's previous exposure to setae. In conclusion, setae contain molecules that in the presence of monocytes activate human T-lymphocytes to proliferation. The antigenic nature of stimulatory molecules was supported by the significantly stronger lymphocyte response in persons previously exposed to setae than in non-exposed donors. The nature of such molecules remains to be defined.	[Holm, Goran; Andersson, Margareta; Ekberg, Monica; Fagrell, Bengt; Sjoberg, Jan; Bjorkholm, Magnus] Karolinska Univ, Hosp Solna, Ctr Mol Med, Dept Med,Div Hematol, Stockholm, Sweden; [Holm, Goran; Andersson, Margareta; Ekberg, Monica; Fagrell, Bengt; Sjoberg, Jan; Bjorkholm, Magnus] Karolinska Inst, Stockholm, Sweden; [Bottai, Matteo] Karolinska Inst, Inst Enviromental Med, Div Biostat, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Holm, G (corresponding author), Karolinska Univ, Hosp Solna, Ctr Mol Med, Dept Med,Div Hematol, Stockholm, Sweden.	goran.holm@ki.se			Torsten and Ragnar Soderberg Foundations, Stockholm, Sweden	Torsten and Ragnar Soderberg Foundations, Stockholm, Sweden	This work was supported by the Torsten and Ragnar Soderberg Foundations, Stockholm, Sweden.	Battisti A, 2011, ANNU REV ENTOMOL, V56, P203, DOI 10.1146/annurev-ento-120709-144844; Fagrell B, 2008, CONTACT DERMATITIS, V59, P290, DOI 10.1111/j.1600-0536.2008.01423.x; Holm Goran, 2009, Lakartidningen, V106, P1891; Rodriguez-Mahillo AI, 2012, CONTACT DERMATITIS, V67, P367, DOI 10.1111/j.1600-0536.2012.02107.x; Larsson Stig, 2006, Entomologisk Tidskrift, V127, P1; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Maier H, 2003, BRIT J DERMATOL, V149, P990, DOI 10.1111/j.1365-2133.2003.05673.x; Natsuaki M, 2002, J DERMATOL, V29, P471, DOI 10.1111/j.1346-8138.2002.tb00311.x; Vega JM, 1997, ALLERGY, V52, P1244, DOI 10.1111/j.1398-9995.1997.tb02532.x	9	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e113977	10.1371/journal.pone.0113977	http://dx.doi.org/10.1371/journal.pone.0113977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531291	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100007
J	Karpel-Massler, G; Pareja, F; Aime, P; Shu, C; Chau, L; Westhoff, MA; Halatsch, ME; Crary, JF; Canoll, P; Siegelin, MD				Karpel-Massler, Georg; Pareja, Fresia; Aime, Pascaline; Shu, Chang; Chau, Lily; Westhoff, Mike-Andrew; Halatsch, Marc-Eric; Crary, John F.; Canoll, Peter; Siegelin, Markus D.			PARP Inhibition Restores Extrinsic Apoptotic Sensitivity in Glioblastoma	PLOS ONE			English	Article							DIPHOSPHATE-RIBOSE) POLYMERASE EXPRESSION; DEATH RECEPTOR 5; PHASE-II TRIAL; MONOCLONAL-ANTIBODY; CANCER-CELLS; MALIGNANT GLIOMA; DOWN-REGULATION; LIGAND; TRAIL; TEMOZOLOMIDE	Background: Resistance to apoptosis is a paramount issue in the treatment of Glioblastoma (GBM). We show that targeting PARP by the small molecule inhibitors, Olaparib (AZD-2281) or PJ34, reduces proliferation and lowers the apoptotic threshold of GBM cells in vitro and in vivo. Methods: The sensitizing effects of PARP inhibition on TRAIL-mediated apoptosis and potential toxicity were analyzed using viability assays and flow cytometry in established GBM cell lines, low-passage neurospheres and astrocytes in vitro. Molecular analyses included western blots and gene silencing. In vivo, effects on tumor growth were examined in a murine subcutaneous xenograft model. Results: The combination treatment of PARP inhibitors and TRAIL led to an increased cell death with activation of caspases and inhibition of formation of neurospheres when compared to single-agent treatment. Mechanistically, pharmacological PARP inhibition elicited a nuclear stress response with upregulation of down-stream DNA-stress response proteins, e.g., CCAAT enhancer binding protein (C/EBP) homology protein (CHOP). Furthermore, Olaparib and PJ34 increased protein levels of DR5 in a concentration and time-dependent manner. In turn, siRNA-mediated suppression of DR5 mitigated the effects of TRAIL/PARP inhibitor-mediated apoptosis. In addition, suppression of PARP-1 levels enhanced TRAIL-mediated apoptosis in malignant glioma cells. Treatment of human astrocytes with the combination of TRAIL/PARP inhibitors did not cause toxicity. Finally, the combination treatment of TRAIL and PJ34 significantly reduced tumor growth in vivo when compared to treatment with each agent alone. Conclusions: PARP inhibition represents a promising avenue to overcome apoptotic resistance in GBM.	[Karpel-Massler, Georg; Pareja, Fresia; Aime, Pascaline; Shu, Chang; Chau, Lily; Crary, John F.; Canoll, Peter; Siegelin, Markus D.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Westhoff, Mike-Andrew] Univ Ulm, Dept Pediat & Adolescent Med, Med Ctr, D-89069 Ulm, Germany; [Halatsch, Marc-Eric] Univ Ulm, Dept Neurosurg, Med Ctr, D-89069 Ulm, Germany	Columbia University; Ulm University; Ulm University	Siegelin, MD (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA.	ms4169@cumc.columbia.edu	Westhoff, Mike-Andrew/ABA-9272-2021; Halatsch, Marc-Eric/B-7807-2008	Westhoff, Mike-Andrew/0000-0003-3256-7100; 	American Association for Cancer Research [13-20-23-SIEG]; American Brain Tumor Association (American Brain Tumor Translational Grant) [ABTA CU13-0098]; Irving Cancer Institute (CTO Pilot Award); National Institutes of Health [NINDS K08NS083732]; Mildred-Scheel-Postdoktorandenprogramm, Deutsche Krebshilfe (GK-M); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS083732] Funding Source: NIH RePORTER	American Association for Cancer Research; American Brain Tumor Association (American Brain Tumor Translational Grant); Irving Cancer Institute (CTO Pilot Award); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mildred-Scheel-Postdoktorandenprogramm, Deutsche Krebshilfe (GK-M); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by American Association for Cancer Research (13-20-23-SIEG) (MDS), American Brain Tumor Association (American Brain Tumor Translational Grant ABTA CU13-0098) (MDS), Irving Cancer Institute (2013 CTO Pilot Award) (MDS), National Institutes of Health NINDS K08NS083732 (MDS) and Fellowship award from Mildred-Scheel-Postdoktorandenprogramm, Deutsche Krebshilfe (GK-M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004828; Bangert A, 2012, ONCOGENE, V31, P4677, DOI 10.1038/onc.2011.614; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Capper D, 2009, ACTA NEUROPATHOL, V117, P445, DOI 10.1007/s00401-009-0494-3; Eckhardt I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.457; Edagawa M, 2014, J BIOL CHEM, V289, P21544, DOI 10.1074/jbc.M114.558890; El-Zawahry A, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-2; Elias A, 2009, CLIN CANCER RES, V15, P5457, DOI 10.1158/1078-0432.CCR-09-1125; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Gan A, 2013, HUM PATHOL, V44, P1638, DOI 10.1016/j.humpath.2013.01.015; Gilbert CA, 2010, CANCER RES, V70, P6870, DOI 10.1158/0008-5472.CAN-10-1378; Happold C, 2014, MOL CANCER THER, V13, P948, DOI 10.1158/1535-7163.MCT-13-0772; Hastak K, 2010, CANCER RES, V70, P7970, DOI 10.1158/0008-5472.CAN-09-4521; Jensen SA, 2014, P NATL ACAD SCI USA, V111, P5682, DOI 10.1073/pnas.1316700111; Koschny R, 2007, CLIN CANCER RES, V13, P3403, DOI 10.1158/1078-0432.CCR-07-0251; Lavrik IN, 2008, J BIOL CHEM, V283, P26401, DOI 10.1074/jbc.M800823200; Lin TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063966; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; Merchant MS, 2012, J CLIN ONCOL, V30, P4141, DOI 10.1200/JCO.2012.44.1055; Mihaliak AM, 2010, CANCER LETT, V296, P168, DOI 10.1016/j.canlet.2010.04.005; Murai J, 2014, J PHARMACOL EXP THER, V349, P408, DOI 10.1124/jpet.113.210146; Newsom-Davis T, 2009, APOPTOSIS, V14, P607, DOI 10.1007/s10495-009-0321-2; Palacios C, 2006, CANCER RES, V66, P8858, DOI 10.1158/0008-5472.CAN-06-0808; Pareja F, 2014, MOL CANCER RES, V12, P987, DOI 10.1158/1541-7786.MCR-13-0650; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Qi L, 2011, APOPTOSIS, V16, P1150, DOI 10.1007/s10495-011-0645-6; Russo AL, 2009, CLIN CANCER RES, V15, P607, DOI 10.1158/1078-0432.CCR-08-2079; Saito R, 2004, CANCER RES, V64, P6858, DOI 10.1158/0008-5472.CAN-04-1683; Sheng Z, 2010, NAT MED, V16, P671, DOI 10.1038/nm.2158; Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855; Siegelin MD, 2009, NEURO-ONCOLOGY, V11, P122, DOI 10.1215/15228517-2008-085; Siegelin MD, 2012, EXPERT OPIN THER TAR, V16, P801, DOI 10.1517/14728222.2012.703655; Song JH, 2008, J BIOL CHEM, V283, P25003, DOI 10.1074/jbc.M802511200; Stuckey DW, 2013, TRENDS MOL MED, V19, P685, DOI 10.1016/j.molmed.2013.08.007; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tagscherer KE, 2008, ONCOGENE, V27, P6646, DOI 10.1038/onc.2008.259; Tolcher AW, 2007, J CLIN ONCOL, V25, P1390, DOI 10.1200/JCO.2006.08.8898; Trarbach T, 2010, BRIT J CANCER, V102, P506, DOI 10.1038/sj.bjc.6605507; von Minckwitz G, 2011, J CLIN ONCOL, V29, P2150, DOI 10.1200/JCO.2010.31.9079; von Pawel J, 2014, CLIN LUNG CANCER, V15, P188, DOI 10.1016/j.cllc.2013.12.005; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Xu S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju162; Yuan KY, 2013, CLIN CANCER RES, V19, P4750, DOI 10.1158/1078-0432.CCR-13-0516	43	35	35	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114583	10.1371/journal.pone.0114583	http://dx.doi.org/10.1371/journal.pone.0114583			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531448	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100019
J	Roine, A; Saviauk, T; Kumpulainen, P; Karjalainen, M; Tuokko, A; Aittoniemi, J; Vuento, R; Lekkala, J; Lehtimaki, T; Tammela, TL; Oksala, NKJ				Roine, Antti; Saviauk, Taavi; Kumpulainen, Pekka; Karjalainen, Markus; Tuokko, Antti; Aittoniemi, Janne; Vuento, Risto; Lekkala, Jukka; Lehtimaki, Terho; Tammela, Teuvo L.; Oksala, Niku K. J.			Rapid and Accurate Detection of Urinary Pathogens by Mobile IMS-Based Electronic Nose: A Proof-of-Principle Study	PLOS ONE			English	Article							ISOLATES IN-VITRO; TRACT-INFECTIONS; GAS SENSORS; IDENTIFICATION; SPECTROMETRY; DIAGNOSIS	Urinary tract infection (UTI) is a common disease with significant morbidity and economic burden, accounting for a significant part of the workload in clinical microbiology laboratories. Current clinical chemisty point-of-care diagnostics rely on imperfect dipstick analysis which only provides indirect and insensitive evidence of urinary bacterial pathogens. An electronic nose (eNose) is a handheld device mimicking mammalian olfaction that potentially offers affordable and rapid analysis of samples without preparation at athmospheric pressure. In this study we demonstrate the applicability of ion mobility spectrometry (IMS) -based eNose to discriminate the most common UTI pathogens from gaseous headspace of culture plates rapidly and without sample preparation. We gathered a total of 101 culture samples containing four most common UTI bacteries: E. coli, S. saprophyticus, E. faecalis, Klebsiella spp and sterile culture plates. The samples were analyzed using ChemPro 100i device, consisting of IMS cell and six semiconductor sensors. Data analysis was conducted by linear discriminant analysis (LDA) and logistic regression (LR). The results were validated by leave-one-out and 5-fold cross validation analysis. In discrimination of sterile and bacterial samples sensitivity of 95% and specificity of 97% were achieved. The bacterial species were identified with sensitivity of 95% and specificity of 96% using eNose as compared to urine bacterial cultures. In conclusion: These findings strongly demonstrate the ability of our eNose to discriminate bacterial cultures and provides a proof of principle to use this method in urinanalysis of UTI.	[Roine, Antti; Saviauk, Taavi; Tuokko, Antti; Lehtimaki, Terho] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kumpulainen, Pekka; Karjalainen, Markus; Lekkala, Jukka] Tampere Univ Technol, Dept Automat Sci & Engn, FIN-33101 Tampere, Finland; [Aittoniemi, Janne; Vuento, Risto] Fimlab Labs, Dept Clin Microbiol, Tampere, Finland; [Lehtimaki, Terho] Fimlab Labs, Dept Clin Chem, Tampere, Finland; [Tammela, Teuvo L.; Oksala, Niku K. J.] Univ Tampere, Sch Med, Dept Surg, FIN-33101 Tampere, Finland; [Tammela, Teuvo L.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Oksala, Niku K. J.] Tampere Univ Hosp, Dept Vasc Surg, Tampere, Finland	Tampere University; Tampere University; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital	Roine, A (corresponding author), Univ Tampere, Sch Med, FIN-33101 Tampere, Finland.	antti.roine@uta.fi	Lekkala, Jukka/G-4263-2014; Lehtimäki, Terho/AAD-1094-2022; Roine, Antti/AAU-5071-2020	Lekkala, Jukka/0000-0001-9293-2240; Lehtimäki, Terho/0000-0002-2555-4427; Roine, Antti/0000-0002-1811-2671; Kumpulainen, Pekka/0000-0003-4121-2707	Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital [9N035, X51001]; Tekes - the Finnish Funding Agency for Innovation for project "DiagNOSE - from extrasensory olfactory cues to status of wellbeing" for Tampere University of Technology [1010/31/2013]; University of Tampere [564/31/2013]	Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital; Tekes - the Finnish Funding Agency for Innovation for project "DiagNOSE - from extrasensory olfactory cues to status of wellbeing" for Tampere University of Technology; University of Tampere	This study was funded by the Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (grants 9N035 and X51001 for TL) and Tekes - the Finnish Funding Agency for Innovation for project "DiagNOSE - from extrasensory olfactory cues to status of wellbeing" project number 1010/31/2013 for Tampere University of Technology and 564/31/2013 for University of Tampere. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aathithan S, 2001, J CLIN MICROBIOL, V39, P2590, DOI 10.1128/JCM.39.7.2590-2593.2001; Arasaradnam R. P., 2012, Journal of Medical Engineering & Technology, V36, P333, DOI 10.3109/03091902.2012.690015; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Bishop C. M, 2006, PATTERN RECOGNITION; Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311; Bruins M, 2009, EUR J CLIN MICROBIOL, V28, P775, DOI 10.1007/s10096-009-0700-1; Deville Walter L J M, 2004, BMC Urol, V4, P4, DOI 10.1186/1471-2490-4-4; Dutta R, 2002, BIOMED ENG ONLINE, V1, DOI 10.1186/1475-925X-1-4; Foxman B, 2002, AM J MED, V113, p5S; Geerlings SE, 1999, J MED MICROBIOL, V48, P535, DOI 10.1099/00222615-48-6-535; Gibson TD, 1997, SENSOR ACTUAT B-CHEM, V44, P413, DOI 10.1016/S0925-4005(97)00235-9; Grabe M, 2008, GUIDELINES MANAGEMEN; Hajek V, 1996, INT J SYST BACTERIOL, V46, P792, DOI 10.1099/00207713-46-3-792; Jackson J.E., 1991, WILEY SERIES PROBABI; Kodogiannis V, 2005, INT J NEURAL SYST, V15, P363, DOI 10.1142/S0129065705000347; Kodogiannis VS, 2005, J INTELL FUZZY SYST, V16, P1; Lykos P, 2001, J MICROBIOL, V39, P213; Mach KE, 2011, TRENDS PHARMACOL SCI, V32, P330, DOI 10.1016/j.tips.2011.03.001; Murray PR, 2012, J MOL DIAGN, V14, P419, DOI 10.1016/j.jmoldx.2012.03.007; Pavlou A, 2002, LETT APPL MICROBIOL, V35, P366, DOI 10.1046/j.1472-765X.2002.01197.x; Pavlou AK, 2002, BIOSENS BIOELECTRON, V17, P893, DOI 10.1016/S0956-5663(02)00078-7; Roine A, 2014, J UROLOGY, V192, P230, DOI 10.1016/j.juro.2014.01.113; Roine A, 2012, FUTURE ONCOL, V8, P1157, DOI [10.2217/FON.12.93, 10.2217/fon.12.93]; Ronald A, 2003, DM-DIS MON, V49, P71, DOI 10.1067/mda.2003.8; Schiffman S. S., 2000, EFFECTIVENESS ELECT, P1; Turner APF, 2004, NAT REV MICROBIOL, V2, P161, DOI 10.1038/nrmicro823; Utriainen M, 2003, SENSOR ACTUAT B-CHEM, V93, P17, DOI 10.1016/S0925-4005(03)00337-X; VernatRossi V, 1996, SENSOR ACTUAT B-CHEM, V37, P43, DOI 10.1016/S0925-4005(97)80070-6; Wilson AD, 2011, SENSORS-BASEL, V11, P1105, DOI 10.3390/s110101105	29	30	30	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114279	10.1371/journal.pone.0114279	http://dx.doi.org/10.1371/journal.pone.0114279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526592	Green Submitted, Green Published, gold			2022-12-26	WOS:000347186200003
J	Dalenberg, JR; Gutjar, S; ter Horst, GJ; de Graaf, K; Renken, RJ; Jager, G				Dalenberg, Jelle R.; Gutjar, Swetlana; ter Horst, Gert J.; de Graaf, Kees; Renken, Remco J.; Jager, Gerry			Evoked Emotions Predict Food Choice	PLOS ONE			English	Article							CONSUMPTION; WORDS; FACES; MODEL	In the current study we show that non-verbal food-evoked emotion scores significantly improve food choice prediction over merely liking scores. Previous research has shown that liking measures correlate with choice. However, liking is no strong predictor for food choice in real life environments. Therefore, the focus within recent studies shifted towards using emotion-profiling methods that successfully can discriminate between products that are equally liked. However, it is unclear how well scores from emotion-profiling methods predict actual food choice and/or consumption. To test this, we proposed to decompose emotion scores into valence and arousal scores using Principal Component Analysis (PCA) and apply Multinomial Logit Models (MLM) to estimate food choice using liking, valence, and arousal as possible predictors. For this analysis, we used an existing data set comprised of liking and food-evoked emotions scores from 123 participants, who rated 7 unlabeled breakfast drinks. Liking scores were measured using a 100-mm visual analogue scale, while food-evoked emotions were measured using 2 existing emotion-profiling methods: a verbal and a non-verbal method (EsSense Profile and PrEmo, respectively). After 7 days, participants were asked to choose 1 breakfast drink from the experiment to consume during breakfast in a simulated restaurant environment. Cross validation showed that we were able to correctly predict individualized food choice (1 out of 7 products) for over 50% of the participants. This number increased to nearly 80% when looking at the top 2 candidates. Model comparisons showed that evoked emotions better predict food choice than perceived liking alone. However, the strongest predictive strength was achieved by the combination of evoked emotions and liking. Furthermore we showed that non-verbal food-evoked emotion scores more accurately predict food choice than verbal food-evoked emotions scores.	[Dalenberg, Jelle R.; Gutjar, Swetlana; ter Horst, Gert J.; de Graaf, Kees; Renken, Remco J.; Jager, Gerry] Top Inst Food & Nutr, Wageningen, Netherlands; [Dalenberg, Jelle R.; ter Horst, Gert J.; Renken, Remco J.] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Gutjar, Swetlana; de Graaf, Kees; Jager, Gerry] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands	Top Institute Food & Nutrition; University of Groningen; Wageningen University & Research	Dalenberg, JR (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	j.r.dalenberg@umcg.nl		Renken, Remco Jan/0000-0002-7777-9484; Dalenberg, Jelle R./0000-0001-8580-5358	TI Food and Nutrition; Danone and FrieslandCampina	TI Food and Nutrition; Danone and FrieslandCampina(Danone Nutricia)	Funding was realized by TI Food and Nutrition: http://www.tifn.nl/. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The sponsors Danone and FrieslandCampina did have a role in the study design. More specifically: the choice of stimuli, which were produced by these sponsors. Danone and FrieslandCampina had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DISCRETE CHOICE METH; Bhumiratana N, 2014, FOOD RES INT, V61, P83, DOI 10.1016/j.foodres.2014.03.008; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cardello AV, 2012, FOOD QUAL PREFER, V24, P243, DOI 10.1016/j.foodqual.2011.12.002; de Graaf C, 2005, APPETITE, V44, P23, DOI 10.1016/j.appet.2004.08.008; Desmet P., 2003, FUNOLOGY ENJOYMENT, P111, DOI [DOI 10.1007/1-4020-2967-5_12, 10.1007/1-4020-2967-5_12]; Desmet PMA, 2008, APPETITE, V50, P290, DOI 10.1016/j.appet.2007.08.003; Desmet Pieter M. A., 2007, KNOWLEDGE TECHNOLOGY, V20, P141, DOI DOI 10.1007/S12130-007-9018-4; Desmet PMA, 2000, ADV CONSUM RES, V27, P111; Fruhholz S, 2011, BIOL PSYCHOL, V87, P265, DOI 10.1016/j.biopsycho.2011.03.008; Gutjar S, 2014, APPETITE, V80, P109, DOI 10.1016/j.appet.2014.05.006; HAUSMAN J, 1984, ECONOMETRICA, V52, P1219, DOI 10.2307/1910997; Jiang Y, 2014, TRENDS FOOD SCI TECH, V36, P15, DOI 10.1016/j.tifs.2013.12.005; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; King SC, 2010, FOOD QUAL PREFER, V21, P168, DOI 10.1016/j.foodqual.2009.02.005; Koster EP, 2009, FOOD QUAL PREFER, V20, P70, DOI 10.1016/j.foodqual.2007.11.002; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Larsen R.J., 1992, EMOTION, P25; Levy CM, 2006, ACTA PSYCHOL, V123, P394, DOI 10.1016/j.actpsy.2006.06.006; Manzocco L, 2013, FOOD QUAL PREFER, V28, P17, DOI 10.1016/j.foodqual.2012.08.014; McFadden D., 1974, J PUBLIC ECON, V3, P303, DOI [10.1016/0047-2727(74)90003-6, DOI 10.1016/0047-2727(74)90003-6]; McFadden D, 1978, BEHAV TRAVEL MODELLI, P279, DOI DOI 10.4324/9781003156055-18; MESQUITA B, 1992, PSYCHOL BULL, V112, P179, DOI 10.1037/0033-2909.112.2.179; Ng M, 2013, FOOD QUAL PREFER, V28, P193, DOI 10.1016/j.foodqual.2012.08.012; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Rellecke J, 2011, BRAIN COGNITION, V77, P23, DOI 10.1016/j.bandc.2011.07.001; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schifferstein HNJ, 2010, FOOD QUAL PREFER, V21, P1100, DOI 10.1016/j.foodqual.2010.07.004; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; Thomson DMH, 2010, FOOD QUAL PREFER, V21, P1117, DOI 10.1016/j.foodqual.2010.04.011; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; Zandstra EH, 1999, FOOD QUAL PREFER, V10, P411, DOI 10.1016/S0950-3293(98)00050-0	34	95	96	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115388	10.1371/journal.pone.0115388	http://dx.doi.org/10.1371/journal.pone.0115388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA4AC	25521352	Green Published, gold			2022-12-26	WOS:000348845600040
J	Oleson, EM; Slrovic, A; Bayless, AR; Hildebrand, JA				Oleson, Erin M.; Slrovic, Ana; Bayless, Alexandra R.; Hildebrand, John A.			Synchronous Seasonal Change in Fin Whale Song in the North Pacific	PLOS ONE			English	Article							BALAENOPTERA-PHYSALUS; HUMPBACK WHALES; GEOGRAPHIC-VARIATION; BLUE; CALLS; FREQUENCY; HAWAIIAN	Fin whale (Balaenoptera physalus) song consists of down-swept pulses arranged into stereotypic sequences that can be characterized according to the interval between successive pulses. As in blue (B. musculus) and humpback whales (Megaptera novaeangliae), these song sequences may be geographically distinct and may correlate with population boundaries in some regions. We measured inter-pulse intervals of fin whale songs within year-round acoustic datasets collected between 2000 and 2006 in three regions of the eastern North Pacific: Southern California, the Bering Sea, and Hawaii. A distinctive song type that was recorded in all three regions is characterized by singlet and doublet inter-pulse intervals that increase seasonally, then annually reset to the same shorter intervals at the beginning of each season. This song type was recorded in the Bering Sea and off Southern California from September through May and off Hawaii from December through April, with the song interval generally synchronized across all monitoring locations. The broad geographic and seasonal occurrence of this particular fin whale song type may represent a single population broadly distributed throughout the eastern Pacific with no clear seasonal migratory pattern. Previous studies attempting to infer population structure of fin whales in the North Pacific using synchronous individual song samples have been unsuccessful, likely because they did not account for the seasonal lengthening in song intervals observed here.	[Oleson, Erin M.] NOAA Fisheries, Pacific Islands Fisheries Sci Ctr, Protected Species Div, Honolulu, HI USA; [Slrovic, Ana; Hildebrand, John A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Bayless, Alexandra R.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hawaii System; University of Hawaii Manoa	Oleson, EM (corresponding author), NOAA Fisheries, Pacific Islands Fisheries Sci Ctr, Protected Species Div, Honolulu, HI USA.	erin.oleson@noaa.gov	Oleson, Erin/AAA-9681-2019	Oleson, Erin/0000-0002-4889-6059; Hildebrand, John/0000-0002-5418-9799	NOAA Fisheries Pacific Islands Fisheries Science Center; Alaska Department of Fish and Wildlife; United States Navy Chief of Naval Operations Environmental Compliance [CNO-N45]; Strategic Environmental Research and Development Program (SERDP)	NOAA Fisheries Pacific Islands Fisheries Science Center; Alaska Department of Fish and Wildlife; United States Navy Chief of Naval Operations Environmental Compliance; Strategic Environmental Research and Development Program (SERDP)	The Ecosystem and Oceanography and Protected Species Divisions at NOAA Fisheries Pacific Islands Fisheries Science Center supported deployment of HARPs at Cross Seamount and provided salary support for E. Oleson and A. Bayless during a portion of this work. The Alaska Department of Fish and Wildlife provided funds for the deployment and maintenance of HARPs in the Bering Sea. United States Navy Chief of Naval Operations Environmental Compliance (CNO-N45) and the Strategic Environmental Research and Development Program (SERDP) provided funds for deployment and maintenance of ARPs and HARPs off Hawaii Island and in the Southern California Bight. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J., 2001, ANIMAL BEHAV EVOLUTI, V7th ed.; Aroyan JL, 2000, ACOUSTIC MODELS SOUN, P485; Beecher MD, 1996, ANIMAL BEHAV, V52; Castellote M, 2012, MAR MAMMAL SCI, V28, P325, DOI 10.1111/j.1748-7692.2011.00491.x; Cerchio S, 2001, ANIM BEHAV, V62, P313, DOI 10.1006/anbe.2001.1747; Cholewiak DM, 1998, THESIS CORNELL U ITH; Connor RC, 2000, CETACEAN SOCIETIES, P247; Croll DA, 2002, NATURE, V417, P809, DOI 10.1038/417809a; Darling J.D., 1983, THESIS U CALIFORNIA; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Delarue J, 2009, J ACOUST SOC AM, V125, P1774, DOI 10.1121/1.3068454; EDDS P L, 1988, Bioacoustics, V1, P131; Gavrilov AN, 2012, J ACOUST SOC AM, V131, P4476, DOI 10.1121/1.4707425; Gedamke J, 2001, J ACOUST SOC AM, V109, P3038, DOI 10.1121/1.1371763; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; Hatch L. T., 2004, SC56SD8 INT WHAL COM; Helweg DA, 1998, BEHAVIOUR, V135, P1; Hoaglin D.C., 1983, UNDERSTANDING ROBUST; Hut RA, 2011, PHILOS T R SOC B, V366, P2141, DOI 10.1098/rstb.2010.0409; KARSCH FJ, 1989, BIOL REPROD, V41, P1034, DOI 10.1095/biolreprod41.6.1034; Kellogg R, 1929, SMITHSONIAN I ANN RE, V1928, P457; KREBS JR, 1981, ANIM BEHAV, V29, P918, DOI 10.1016/S0003-3472(81)80029-2; Laws R. M., 1961, Discovery Reports, V31, P327; McDonald Mark A., 2006, Journal of Cetacean Research and Management, V8, P55; McDonald Mark A., 2009, Endangered Species Research, V9, P13, DOI 10.3354/esr00217; Mizroch SA, 2009, MAMMAL REV, V39, P193, DOI 10.1111/j.1365-2907.2009.00147.x; Moore SE, 1998, MAR MAMMAL SCI, V14, P617, DOI 10.1111/j.1748-7692.1998.tb00749.x; Morano JL, 2012, J ACOUST SOC AM, V132, P1207, DOI 10.1121/1.4730890; Nieukirk SL, 2012, J ACOUST SOC AM, V131, P1102, DOI 10.1121/1.3672648; Ohsumi S., 1958, Scientific Reports of the Whales Research Institute Tokyo, VNo. 13, P97; Oleson EM, 2003, MAR MAMMAL SCI, V19, P407; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; PAYNE K, 1985, Z TIERPSYCHOL, V68, P89; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Rankin S, 2005, J ACOUST SOC AM, V118, P3346, DOI 10.1121/1.2046747; Sears R., 2002, ENCY MARINE MAMMALS, P112; Simon M, 2010, J ACOUST SOC AM, V128, P3200, DOI 10.1121/1.3495946; Sirovic A, 2004, DEEP-SEA RES PT II, V51, P2327, DOI 10.1016/j.dsr2.2004.08.005; Sirovic A, 2009, MAR MAMMAL SCI, V25, P125, DOI 10.1111/j.1748-7692.2008.00239.x; SMALS AGH, 1976, J CLIN ENDOCR METAB, V42, P979, DOI 10.1210/jcem-42-5-979; Smith JN, 2008, ANIMAL BEHAV, V76; THOMPSON PO, 1992, J ACOUST SOC AM, V92, P3051, DOI 10.1121/1.404201; Tomilin AJ, 1957, ZVERI SSSR PRILEZHAS; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; WATKINS WA, 1987, J ACOUST SOC AM, V82, P1901, DOI 10.1121/1.395685; WATKINS WA, 1981, SCI REP WHALES RES, V33, P83; Watkins William A., 2000, Oceanography, V13, P62; Wiggins S, 2003, MAR TECHNOL SOC J, V37, P13, DOI 10.4031/002533203787537375; Wiggins SM, 2007, HIGH FREQUENCY ACOUS, P551; Winn H.E., 1976, Cetology, VNo. 19, P1	50	37	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115678	10.1371/journal.pone.0115678	http://dx.doi.org/10.1371/journal.pone.0115678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521493	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845600053
J	Wade, MA; Sunter, NJ; Fordham, SE; Long, A; Masic, D; Russell, LJ; Harrison, CJ; Rand, V; Elstob, C; Bown, N; Rowe, D; Lowe, C; Cuthbert, G; Bennett, S; Crosier, S; Bacon, CM; Onel, K; Scott, K; Scott, D; Travis, LB; May, FEB; Allan, JM				Wade, M. A.; Sunter, N. J.; Fordham, S. E.; Long, A.; Masic, D.; Russell, L. J.; Harrison, C. J.; Rand, V.; Elstob, C.; Bown, N.; Rowe, D.; Lowe, C.; Cuthbert, G.; Bennett, S.; Crosier, S.; Bacon, C. M.; Onel, K.; Scott, K.; Scott, D.; Travis, L. B.; May, F. E. B.; Allan, J. M.			c-MYC is a radiosensitive locus in human breast cells	ONCOGENE			English	Article							ATOMIC-BOMB SURVIVORS; COMPARATIVE GENOMIC HYBRIDIZATION; INDUCED NEOPLASTIC TRANSFORMATION; IONIZING-RADIATION; ALLELIC IMBALANCE; TUMOR PROGRESSION; EPITHELIAL-CELLS; GENE-EXPRESSION; CANCER RISK; AMPLIFICATION	Ionising radiation is a potent human carcinogen. Epidemiological studies have shown that adolescent and young women are at increased risk of developing breast cancer following exposure to ionising radiation compared with older women, and that risk is dose-dependent. Although it is well understood which individuals are at risk of radiation-induced breast carcinogenesis, the molecular genetic mechanisms that underlie cell transformation are less clear. To identify genetic alterations potentially responsible for driving radiogenic breast transformation, we exposed the human breast epithelial cell line MCF-10A to fractionated doses of X-rays and examined the copy number and cytogenetic alterations. We identified numerous alterations of c-MYC that included high-level focal amplification associated with increased protein expression. c-MYC amplification was also observed in primary human mammary epithelial cells following exposure to radiation. We also demonstrate that the frequency and magnitude of c-MYC amplification and c-MYC protein expression is significantly higher in breast cancer with antecedent radiation exposure compared with breast cancer without a radiation aetiology. Our data also demonstrate extensive intratumor heterogeneity with respect to c-MYC copy number in radiogenic breast cancer, suggesting continuous evolution at this locus during disease development and progression. Taken together, these data identify c-MYC as a radiosensitive locus, implicating this oncogenic transcription factor in the aetiology of radiogenic breast cancer.	[Wade, M. A.; Sunter, N. J.; Fordham, S. E.; Long, A.; Masic, D.; Russell, L. J.; Harrison, C. J.; Rand, V.; Elstob, C.; Crosier, S.; Bacon, C. M.; May, F. E. B.; Allan, J. M.] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bown, N.; Rowe, D.; Lowe, C.; Cuthbert, G.; Bennett, S.] Newcastle Univ, Inst Med Genet, Northern Genet Serv, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Onel, K.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Scott, K.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Scott, D.] Harrogate Dist Hosp, Harrogate & Dist NHS Fdn Trust, Dept Histopathol, Harrogate, Yorks, England; [Travis, L. B.] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA; [Travis, L. B.] Univ Rochester, Med Ctr, Rubin Ctr Canc Survivorship, James P Wilmot Canc Ctr, Rochester, NY 14642 USA	Newcastle University - UK; Newcastle University - UK; University of Chicago; University of York - UK; University of Rochester; University of Rochester	Allan, JM (corresponding author), Newcastle Univ, Northern Inst Canc Res, Paul OGorman Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	james.allan@newcastle.ac.uk	Wade, Mark/AAA-2685-2019; Russell, Lisa/L-2122-2019	Wade, Mark/0000-0002-4245-097X; Russell, Lisa/0000-0002-3421-3288; Allan, James/0000-0002-7580-5087; Bacon, Chris/0000-0002-8268-2812; Elstob, Claire/0000-0003-4252-493X; Fordham, Sarah/0000-0002-3778-8634; Rand, Vikki/0000-0002-2198-8949	Medical Research Council; Newcastle Healthcare Charity; Leukaemia and Lymphoma Research	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newcastle Healthcare Charity; Leukaemia and Lymphoma Research	This work was supported by grants from the Medical Research Council (to JMA and FEBM), the Newcastle Healthcare Charity (to JMA and FEBM) and specialist programme funding from Leukaemia and Lymphoma Research (to JMA).	Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Behrens C, 2000, CANCER EPIDEM BIOMAR, V9, P1027; Berg T, 2011, CURR TOP MICROBIOL, V348, P139, DOI 10.1007/82_2010_90; Best T, 2011, NAT MED, V17, P941, DOI 10.1038/nm.2407; Broeks A, 2010, INT J RADIAT ONCOL, V76, P540, DOI 10.1016/j.ijrobp.2009.09.004; Camats N, 2006, MUTAT RES-FUND MOL M, V595, P156, DOI 10.1016/j.mrfmmm.2005.11.002; Carmichael A, 2003, EUR J SURG ONCOL, V29, P475, DOI 10.1016/S0748-7983(03)00010-6; Chiang CS, 1998, MOL DIAGN, V3, P21, DOI 10.1016/S1084-8592(98)80023-4; Chrzan P, 2001, CLIN BIOCHEM, V34, P557, DOI 10.1016/S0009-9120(01)00260-0; Cowell JK, 2005, CANCER GENET CYTOGEN, V163, P23, DOI 10.1016/j.cancergencyto.2005.04.019; Davey RA, 2004, ANTICANCER RES, V24, P465; DAVIS FG, 1989, CANCER RES, V49, P6130; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; ERISMAN MD, 1985, MOL CELL BIOL, V5, P1969, DOI 10.1128/MCB.5.8.1969; FELBER M, 1992, RADIAT RES, V131, P297, DOI 10.2307/3578419; Ferber MJ, 2004, CANCER GENET CYTOGEN, V154, P1, DOI 10.1016/j.cancergencyto.2004.01.028; Guo TH, 2011, GENE CHROMOSOME CANC, V50, P25, DOI 10.1002/gcc.20827; HOFFMAN DA, 1989, J NATL CANCER I, V81, P1307, DOI 10.1093/jnci/81.17.1307; HRUBEC Z, 1989, CANCER RES, V49, P229; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kim BY, 2011, ONCOL REP, V26, P1587, DOI 10.3892/or.2011.1432; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; Li ZZ, 2012, NEOPLASIA, V14, P1190, DOI 10.1593/neo.121258; Ma HY, 2008, BREAST CANCER RES TR, V109, P77, DOI 10.1007/s10549-007-9625-5; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miura S, 2008, CANCER-AM CANCER SOC, V112, P2143, DOI 10.1002/cncr.23414; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Oikawa M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-168; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; Roy D, 2006, INT J ONCOL, V28, P667; Roy D, 2003, INT J CANCER, V103, P730, DOI 10.1002/ijc.10895; Roy D, 2001, CARCINOGENESIS, V22, P1685, DOI 10.1093/carcin/22.10.1685; SAUTER G, 1995, AM J PATHOL, V146, P1131; Schleger C, 2002, MODERN PATHOL, V15, P462, DOI 10.1038/modpathol.3880547; SOULE HD, 1990, CANCER RES, V50, P6075; TOKUNAGA M, 1994, RADIAT RES, V138, P209, DOI 10.2307/3578591; Travis LB, 2003, JAMA-J AM MED ASSOC, V290, P465, DOI 10.1001/jama.290.4.465; Unger K, 2010, ENDOCR-RELAT CANCER, V17, P87, DOI 10.1677/ERC-09-0065; Varma G, 2005, BRIT J CANCER, V93, P699, DOI 10.1038/sj.bjc.6602784; Wang WJ, 2013, CANCER RES, V73, P1219, DOI 10.1158/0008-5472.CAN-12-1408; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Xu Jinhua, 2010, Genes Cancer, V1, P629, DOI 10.1177/1947601910378691	45	19	19	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 17	2015	34	38					4985	4994		10.1038/onc.2014.427	http://dx.doi.org/10.1038/onc.2014.427			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9QZ	25531321	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000361693000008
J	Walkup, WG; Washburn, L; Sweredoski, MJ; Carlisle, HJ; Graham, RL; Hess, S; Kennedy, MB				Walkup, Ward G.; Washburn, Lorraine; Sweredoski, Michael J.; Carlisle, Holly J.; Graham, Robert L.; Hess, Sonja; Kennedy, Mary B.			Phosphorylation of Synaptic GTPase-activating Protein (synGAP) by Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) and Cyclin-dependent Kinase 5 (CDK5) Alters the Ratio of Its GAP Activity toward Ras and Rap GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA RECEPTOR; HIPPOCAMPAL-NEURONS; CRYSTAL-STRUCTURE; MUTATIONS; PLASTICITY; DOMAIN; STIMULATION; INHIBITION; CALPAIN; CLONING	synGAP is a neuron-specific Ras and Rap GTPase-activating protein (GAP) found in high concentrations in the postsynaptic density (PSD) fraction from the mammalian forebrain. We have previously shown that, in situ in the PSD fraction or in recombinant form in Sf9 cell membranes, synGAP is phosphorylated by Ca2+/calmodulin-dependent protein kinase II (CaMKII), another prominent component of the PSD. Here, we show that recombinant synGAP (r-synGAP), lacking 102 residues at the N terminus, can be purified in soluble form and is phosphorylated by cyclin-dependent kinase 5 (CDK5) as well as by CaMKII. Phosphorylation of r-synGAP by CaMKII increases its HRas GAP activity by 25% and its Rap1 GAP activity by 76%. Conversely, phosphorylation by CDK5 increases r-synGAP's HRas GAP activity by 98% and its Rap1 GAP activity by 20%. Thus, phosphorylation by both kinases increases synGAP activity; CaMKII shifts the relative GAP activity toward inactivation of Rap1, and CDK5 shifts the relative activity toward inactivation of HRas. GAPactivity toward Rap2 is not altered by phosphorylation by either kinase. CDK5 phosphorylates synGAP primarily at two sites, Ser-773 and Ser-802. Phosphorylation at Ser-773 inhibits r-synGAP activity, and phosphorylation at Ser-802 increases it. However, the net effect of concurrent phosphorylation of both sites, Ser-773 and Ser-802, is an increase in GAP activity. synGAP is phosphorylated at Ser-773 and Ser-802 in the PSD fraction, and its phosphorylation by CDK5 and CaMKII is differentially regulated by activation of NMDA-type glutamate receptors in cultured neurons.	[Walkup, Ward G.; Washburn, Lorraine; Carlisle, Holly J.; Kennedy, Mary B.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Sweredoski, Michael J.; Graham, Robert L.; Hess, Sonja] CALTECH, Proteome Explorat Lab, Pasadena, CA 91125 USA; [Sweredoski, Michael J.; Graham, Robert L.; Hess, Sonja] CALTECH, Beckman Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Kennedy, MB (corresponding author), CALTECH, Div Biol & Biol Engn 216 76, Pasadena, CA 91125 USA.	kennedym@its.caltech.edu		Carlisle, Holly/0000-0001-8798-9445	Gordon and Betty Moore Foundation [GBMF775]; Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095095] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr. Jost Vielmetter and Michael Anaya of the Beckman Institute Protein Expression Center, Dr. Jie Zhou of the Protein/Peptide Microanalytical Laboratory, and Leslie Schenker of the Kennedy laboratory for technical assistance. The Proteome Exploration Laboratory is supported by the Gordon and Betty Moore Foundation through grant GBMF775 and the Beckman Institute.	Adamec E, 1998, MOL BRAIN RES, V54, P35, DOI 10.1016/S0169-328X(97)00304-5; Angelo M, 2006, J NEUROCHEM, V99, P353, DOI 10.1111/j.1471-4159.2006.04040.x; Berryer MH, 2013, HUM MUTAT, V34, P385, DOI 10.1002/humu.22248; BOLLAG G, 1995, METHOD ENZYMOL, V255, P161; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brinkmann T, 2002, J BIOL CHEM, V277, P12525, DOI 10.1074/jbc.M109176200; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Carlisle HJ, 2011, J NEUROSCI, V31, P16194, DOI 10.1523/JNEUROSCI.5877-10.2011; Carlisle HJ, 2008, J NEUROSCI, V28, P13673, DOI 10.1523/JNEUROSCI.4695-08.2008; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Chen YC, 2005, MOL CELL NEUROSCI, V28, P215, DOI 10.1016/j.mcn.2004.08.012; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Clement JP, 2012, CELL, V151, P709, DOI 10.1016/j.cell.2012.08.045; Collins MO, 2009, SCIENCE, V325, P1635, DOI 10.1126/science.1180331; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Dhavan R, 2002, J NEUROSCI, V22, P7879; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Fersht A, 1999, STRUCTURE MECH PROTE, P362; Frech M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; Hamdan FF, 2011, BIOL PSYCHIAT, V69, P898, DOI 10.1016/j.biopsych.2010.11.015; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; JOHN J, 1989, J BIOL CHEM, V264, P13086; Kalli A, 2012, PROTEOMICS, V12, P21, DOI 10.1002/pmic.201100464; Kennedy M. B., 2013, COLD SPRING HARB PER; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim JH, 2003, J NEUROSCI, V23, P1119; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; LEUPOLD CM, 1983, EUR J BIOCHEM, V135, P237, DOI 10.1111/j.1432-1033.1983.tb07643.x; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; MILLER SG, 1985, J BIOL CHEM, V260, P9039; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Penzes P, 2011, MOL CELL NEUROSCI, V46, P368, DOI 10.1016/j.mcn.2010.11.008; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Savitski MM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003830; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Timm W, 2010, ANAL CHEM, V82, P3977, DOI 10.1021/ac100118u; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wei FY, 2005, J NEUROCHEM, V93, P502, DOI 10.1111/j.1471-4159.2005.03058.x; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Yaman E, 2009, FEBS J, V276, P4607, DOI 10.1111/j.1742-4658.2009.07166.x; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	60	46	47	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4908	4927		10.1074/jbc.M114.614420	http://dx.doi.org/10.1074/jbc.M114.614420			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25533468	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000350042000035
J	Inagaki, T; Iwasaki, S; Matsumura, Y; Kawamura, T; Tanaka, T; Abe, Y; Yamasaki, A; Tsurutani, Y; Yoshida, A; Chikaoka, Y; Nakamura, K; Magoori, K; Nakaki, R; Osborne, TF; Fukami, K; Aburatani, H; Kodama, T; Sakai, J				Inagaki, Takeshi; Iwasaki, Satoshi; Matsumura, Yoshihiro; Kawamura, Takeshi; Tanaka, Toshiya; Abe, Yohei; Yamasaki, Ayumu; Tsurutani, Yuya; Yoshida, Ayano; Chikaoka, Yoko; Nakamura, Kanako; Magoori, Kenta; Nakaki, Ryo; Osborne, Timothy F.; Fukami, Kiyoko; Aburatani, Hiroyuki; Kodama, Tatsuhiko; Sakai, Juro			The FBXL10/KDM2B Scaffolding Protein Associates with Novel Polycomb Repressive Complex-1 to Regulate Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEMETHYLASE FBXL10; H2A UBIQUITYLATION; GENE-EXPRESSION; PPAR-GAMMA; CELL-CYCLE; ADIPOCYTE DIFFERENTIATION; UBIQUITIN LIGASES; DOWN-REGULATION; PRC1 COMPLEX; CPG ISLANDS	Polycomb repressive complex 1 (PRC1) plays an essential role in the epigenetic repression of gene expression during development and cellular differentiation via multiple effector mechanisms, including ubiquitination of H2A and chromatin compaction. However, whether it regulates the stepwise progression of adipogenesis is unknown. Here, we show that FBXL10/KDM2B is an anti-adipogenic factor that is up-regulated during the early phase of 3T3-L1 preadipocyte differentiation and in adipose tissue in a diet-induced model of obesity. Interestingly, inhibition of adipogenesis does not require the JmjC demethylase domain of FBXL10, but it does require the F-box and leucine-rich repeat domains, which we show recruit a noncanonical polycomb repressive complex 1 (PRC1) containing RING1B, SKP1, PCGF1, and BCOR. Knockdown of either RING1B or SKP1 prevented FBXL10-mediated repression of 3T3-L1 preadipocyte differentiation indicating that PRC1 formation mediates the inhibitory effect of FBXL10 on adipogenesis. Using ChIP-seq, we show that FBXL10 recruits RING1B to key specific genomic loci surrounding the key cell cycle and the adipogenic genes Cdk1, Uhrf1, Pparg1, and Pparg2 to repress adipogenesis. These results suggest that FBXL10 represses adipogenesis by targeting a noncanonical PRC1 complex to repress key genes (e.g. Pparg) that control conversion of pluripotent cells into the adipogenic lineage.	[Inagaki, Takeshi; Iwasaki, Satoshi; Matsumura, Yoshihiro; Tanaka, Toshiya; Abe, Yohei; Yamasaki, Ayumu; Tsurutani, Yuya; Yoshida, Ayano; Nakamura, Kanako; Magoori, Kenta; Sakai, Juro] Univ Tokyo, Res Ctr Adv Sci & Technol, Div Metab Med, Tokyo 1538904, Japan; [Kawamura, Takeshi; Tanaka, Toshiya; Chikaoka, Yoko; Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Tokyo 1538904, Japan; [Nakaki, Ryo; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo 1538904, Japan; [Inagaki, Takeshi; Tanaka, Toshiya; Magoori, Kenta; Aburatani, Hiroyuki; Sakai, Juro] Univ Tokyo, Translat Syst Biol & Med Initiat, Ctr Dis Biol & Integrat Med, Tokyo 1538904, Japan; [Osborne, Timothy F.] Sanford Burnham Med Res Inst, Metab Dis Program, Orlando, FL 32827 USA; [Yoshida, Ayano; Nakamura, Kanako; Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignals, Tokyo 1920392, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Sanford Burnham Prebys Medical Discovery Institute; Tokyo University of Pharmacy & Life Sciences	Inagaki, T (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Div Metab Med, Tokyo 1538904, Japan.	inagaki@lsbm.org; jmsakai-tky@umin.ac.jp	Inagaki, Takeshi/J-8802-2013	Inagaki, Takeshi/0000-0003-1711-8286; Matsumura, Yoshihiro/0000-0002-3108-0440; Sakai, Juro/0000-0003-4043-1035	Ministry of Education, Culture, Sports, Science and Technology of Japan [22229009, 25291002, 25126704]; Grants-in-Aid for Scientific Research [14J05296, 26116708] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research (S) 22229009 and (B) 25291002, Grant-in-aid for Scientific Research on Innovative Areas 25126704, and a grant for Translational Systems Biology and Medicine Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arima Y, 2004, GENES CELLS, V9, P131, DOI 10.1111/j.1356-9597.2004.00710.x; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Bonapace IM, 2002, J CELL BIOL, V157, P909, DOI 10.1083/jcb.200201025; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Daigo K, 2011, J BIOL CHEM, V286, P674, DOI 10.1074/jbc.M110.154732; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Ge R, 2011, CELL DEATH DIFFER, V18, P1184, DOI 10.1038/cdd.2010.185; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; Hoang Stephen A, 2011, BMC Res Notes, V4, P288, DOI 10.1186/1756-0500-4-288; Hochegger H, 2007, J CELL BIOL, V178, P257, DOI 10.1083/jcb.200702034; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iguchi H, 2005, J BIOL CHEM, V280, P37669, DOI 10.1074/jbc.M505392200; Iguchi H, 2007, J BIOL CHEM, V282, P19052, DOI 10.1074/jbc.M700460200; Janzer A, 2012, J BIOL CHEM, V287, P30984, DOI 10.1074/jbc.M112.341040; King IFG, 2005, MOL CELL BIOL, V25, P6578, DOI 10.1128/MCB.25.15.6578-6591.2005; Kitagawa J, 2010, J CLIN EXP HEMATOP, V50, P99, DOI 10.3960/jslrt.50.99; Kliewer SA, 1998, CURR OPIN GENET DEV, V8, P576, DOI 10.1016/S0959-437X(98)80014-2; Konuma T, 2011, EXP HEMATOL, V39, P697, DOI 10.1016/j.exphem.2011.03.008; Koyama-Nasu R, 2007, NAT CELL BIOL, V9, P1074, DOI 10.1038/ncb1628; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Ohguchi H, 2008, MOL CELL BIOL, V28, P3917, DOI 10.1128/MCB.02154-07; Okamura M, 2010, ORGANOGENESIS, V6, P24, DOI 10.4161/org.6.1.11121; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Tanaka T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05412; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Watanabe-Okochi N, 2008, BLOOD, V111, P4297, DOI 10.1182/blood-2007-01-068346; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	59	27	30	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4163	4177		10.1074/jbc.M114.626929	http://dx.doi.org/10.1074/jbc.M114.626929			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25533466	hybrid, Green Published			2022-12-26	WOS:000349458400028
J	Fisher, OS; Liu, WZ; Zhang, R; Stiegler, AL; Ghedia, S; Weber, JL; Boggon, TJ				Fisher, Oriana S.; Liu, Weizhi; Zhang, Rong; Stiegler, Amy L.; Ghedia, Sondhya; Weber, James L.; Boggon, Titus J.			Structural Basis for the Disruption of the Cerebral Cavernous Malformations 2 (CCM2) Interaction with Krev Interaction Trapped 1 (KRIT1) by Disease-associated Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Crystallography; Genetic Disease; Protein Complex; Protein-Protein Interaction; Cerebral Cavernous Malformations; PTB Domain; Point Mutation	PHOSPHOTYROSINE-BINDING DOMAIN; TRUNCATING MUTATIONS; 2-HIT MECHANISM; ENCODING KRIT1; PROTEIN; GENE; PATHOGENESIS; COMPLEX; RECOGNITION; HEART	Background: Mutations in Krev interaction trapped 1 (KRIT1) and cerebral cavernous malformations 2 (CCM2) are associated with CCM disease. Results: The CCM2-KRIT1 interaction is characterized structurally and biochemically. Conclusion: CCM2 preferentially binds the third NPX(Y/F) motif of KRIT1, and disease-associated mutations destabilize this interaction. Significance: These data may inform future studies into the biology of CCM disease. Familial cerebral cavernous malformations (CCMs) are predominantly neurovascular lesions and are associated with mutations within the KRIT1, CCM2, and PDCD10 genes. The protein products of KRIT1 and CCM2 (Krev interaction trapped 1 (KRIT1) and cerebral cavernous malformations 2 (CCM2), respectively) directly interact with each other. Disease-associated mutations in KRIT1 and CCM2 mostly result in loss of their protein products, although rare missense point mutations can also occur. From gene sequencing of patients known or suspected to have one or more CCMs, we discover a series of missense point mutations in KRIT1 and CCM2 that result in missense mutations in the CCM2 and KRIT1 proteins. To place these mutations in the context of the molecular level interactions of CCM2 and KRIT1, we map the interaction of KRIT1 and CCM2 and find that the CCM2 phosphotyrosine binding (PTB) domain displays a preference toward the third of the three KRIT1 NPX(Y/F) motifs. We determine the 2.75 co-crystal structure of the CCM2 PTB domain with a peptide corresponding to KRIT1(NPX(Y/F)3), revealing a Dab-like PTB fold for CCM2 and its interaction with KRIT1(NPX(Y/F)3). We find that several disease-associated missense mutations in CCM2 have the potential to interrupt the KRIT1-CCM2 interaction by destabilizing the CCM2 PTB domain and that a KRIT1 mutation also disrupts this interaction. We therefore provide new insights into the architecture of CCM2 and how the CCM complex is disrupted in CCM disease.	[Fisher, Oriana S.; Liu, Weizhi; Zhang, Rong; Stiegler, Amy L.; Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Ghedia, Sondhya] Royal N Shore Hosp, Dept Clin Genet, St Leonards, NSW 2065, Australia; [Weber, James L.] PreventionGenetics, Marshfield, WI 54449 USA	Yale University; Royal North Shore Hospital	Boggon, TJ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	titus.boggon@yale.edu		Fisher, Oriana/0000-0003-3215-0831	National Institutes of Health [NS085078]; National Institutes of Health Training Grant [GM007324]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS085078 (to T. J. B.) and National Institutes of Health Training Grant GM007324 (to O. S. F.).; Supported in part by a National Science Foundation graduate research fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crose LES, 2009, J BIOL CHEM, V284, P13301, DOI 10.1074/jbc.C900009200; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Domingues F, 2008, ARQ NEURO-PSIQUIAT, V66, P795, DOI 10.1590/S0004-282X2008000600003; Draheim KM, 2014, J CELL SCI, V127, P701, DOI 10.1242/jcs.138388; Dvir H, 2012, P NATL ACAD SCI USA, V109, P6916, DOI 10.1073/pnas.1114128109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer A, 2013, TRENDS MOL MED, V19, P302, DOI 10.1016/j.molmed.2013.02.004; Fisher OS, 2014, CELL MOL LIFE SCI, V71, P1881, DOI 10.1007/s00018-013-1532-9; Fisher OS, 2013, FEBS LETT, V587, P272, DOI 10.1016/j.febslet.2012.12.011; Gault J, 2005, STROKE, V36, P872, DOI 10.1161/01.STR.0000157586.20479.fd; Gingras AR, 2013, J BIOL CHEM, V288, P23639, DOI 10.1074/jbc.M113.462911; Gingras AR, 2012, J CELL BIOL, V199, P39, DOI 10.1083/jcb.201205109; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kim J, 2011, J CELL SCI, V124, P3929, DOI 10.1242/jcs.095471; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Li XF, 2012, J BIOL CHEM, V287, P22317, DOI 10.1074/jbc.M112.361295; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Liu WZ, 2013, ACTA CRYSTALLOGR F, V69, P494, DOI 10.1107/S1744309113010762; Liu WZ, 2013, MOL CELL, V49, P719, DOI 10.1016/j.molcel.2012.12.005; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mondejar R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086286; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OTTEN P, 1989, NEUROCHIRURGIE, V35, P82; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Riant F, 2013, NEUROGENETICS, V14, P133, DOI 10.1007/s10048-013-0362-0; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Shi N, 2004, J BIOL CHEM, V279, P4962, DOI 10.1074/jbc.M311030200; Stahl S, 2008, HUM MUTAT, V29, P709, DOI 10.1002/humu.20712; Stiegler AL, 2014, J BIOL CHEM, V289, P25362, DOI 10.1074/jbc.M114.584011; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang J, 2007, NEUROSURGERY, V60, P353, DOI 10.1227/01.NEU.0000249268.11074.83; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141	51	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2842	2853		10.1074/jbc.M114.616433	http://dx.doi.org/10.1074/jbc.M114.616433			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25525273	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000349310700025
J	Wang, HZ; Graham, I; Hastings, R; Gunewardena, S; Brinkmeier, ML; Conn, PM; Camper, SA; Kumar, TR				Wang, Huizhen; Graham, Ian; Hastings, Richard; Gunewardena, Sumedha; Brinkmeier, Michelle L.; Conn, P. Michael; Camper, Sally A.; Kumar, T. Rajendra			Gonadotrope-specific Deletion of Dicer Results in Severely Suppressed Gonadotropins and Fertility Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycoprotein; MicroRNA (miRNA); Pituitary Gland; Reproduction; Secretion	FOLLICLE-STIMULATING-HORMONE; BETA-SUBUNIT GENE; RECEPTOR KNOCKOUT MICE; PITUITARY DEVELOPMENT; TRANSCRIPTIONAL REGULATION; MOLECULAR-MECHANISMS; TARGETED DISRUPTION; SOMATIC-CELLS; EXPRESSION; ACTIVIN	Background: DICER mediates microRNA production, and its functional role in gonadotropes is not known. Results: Deletion of Dicer in gonadotropes leads to suppression of gonadotropin synthesis and secretion and results in fertility defects. Conclusion: DICER-dependent microRNAs are critical for gonadotropin homeostasis and fertility. Significance: Understanding how microRNAs regulate gonadotropin homeostasis provides a new approach to enhance or block fertility in mammals. Pituitary gonadotropins follicle-stimulating hormone and luteinizing hormone are heterodimeric glycoproteins expressed in gonadotropes. They act on gonads and promote their development and functions including steroidogenesis and gametogenesis. Although transcriptional regulation of gonadotropin subunits has been well studied, the post-transcriptional regulation of gonadotropin subunits is not well understood. To test if microRNAs regulate the hormone-specific gonadotropin subunits in vivo, we deleted Dicer in gonadotropes by a Cre-lox genetic approach. We found that many of the DICER-dependent microRNAs, predicted in silico to bind gonadotropin subunit mRNAs, were suppressed in purified gonadotropes of mutant mice. Loss of DICER-dependent microRNAs in gonadotropes resulted in profound suppression of gonadotropin- subunit proteins and, consequently, the heterodimeric hormone secretion. In addition to suppression of basal levels, interestingly, the post-gonadectomy-induced rise in pituitary gonadotropin synthesis and secretion were both abolished in mutants, indicating a defective gonadal negative feedback control. Furthermore, mutants lacking Dicer in gonadotropes displayed severely reduced fertility and were rescued with exogenous hormones confirming that the fertility defects were secondary to suppressed gonadotropins. Our studies reveal that DICER-dependent microRNAs are essential for gonadotropin homeostasis and fertility in mice. Our studies also implicate microRNAs in gonadal feedback control of gonadotropin synthesis and secretion. Thus, DICER-dependent microRNAs confer a new layer of transcriptional and post-transcriptional regulation in gonadotropes to orchestrate the hypothalamus-pituitary-gonadal axis physiology.	[Wang, Huizhen; Graham, Ian; Gunewardena, Sumedha; Kumar, T. Rajendra] Univ Kansas, Med Ctr, Dept Mol Physiol, Kansas City, KS 66160 USA; [Wang, Huizhen; Graham, Ian; Gunewardena, Sumedha; Kumar, T. Rajendra] Univ Kansas, Med Ctr, Dept Integrat Physiol, Kansas City, KS 66160 USA; [Kumar, T. Rajendra] Univ Kansas, Med Ctr, Ctr Reprod Sci, Inst Reprod Hlth & Regenerat Med, Kansas City, KS 66160 USA; [Hastings, Richard] Univ Kansas, Med Ctr, Flow Cytometry Core Lab, Kansas City, KS 66160 USA; [Brinkmeier, Michelle L.; Camper, Sally A.] Univ Michigan, Dept Mol & Human Genet, Ann Arbor, MI 48109 USA; [Conn, P. Michael] Texas Tech Univ, Dept Internal Med, Lubbock, TX 79430 USA; [Conn, P. Michael] Texas Tech Univ, Dept Cell Biol, Lubbock, TX 79430 USA; [Conn, P. Michael] Texas Tech Univ, Dept Biochem, Lubbock, TX 79430 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Michigan System; University of Michigan; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University	Kumar, TR (corresponding author), Univ Kansas, Med Ctr, 3901 Rainbow Blvd,HLSIC Bldg 3073, Kansas City, KS 66160 USA.	tkumar@kumc.edu		Brinkmeier, Michelle/0000-0001-9505-4682; Camper, Sally/0000-0001-8556-3379	National Institutes of Health [HD056082, HD069751, AG029531, CA166557]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD028934, R01HD034283, U54HD028934, R03HD069751] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028934, R03HD056082] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA166557, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG029531] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HD056082, HD069751, AG029531, and CA166557 (to T. R. K.).	Arriola DJ, 2012, J BIOL CHEM, V287, P33424, DOI 10.1074/jbc.M112.362103; Bailey JS, 2004, MOL ENDOCRINOL, V18, P1158, DOI 10.1210/me.2003-0442; Bakke M, 2001, MOL CELL ENDOCRINOL, V179, P33, DOI 10.1016/S0303-7207(01)00468-3; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Bilezikjian LM, 2012, MOL CELL ENDOCRINOL, V359, P43, DOI 10.1016/j.mce.2012.01.025; Bottoni A, 2007, J CELL PHYSIOL, V210, P370, DOI 10.1002/jcp.20832; Bousfield GR, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1581; CARROLL RS, 1991, ENDOCRINOLOGY, V129, P1721, DOI 10.1210/endo-129-4-1721; Charles MA, 2008, GENESIS, V46, P507, DOI 10.1002/dvg.20398; Ciccone NA, 2009, CURR OPIN ENDOCRINOL, V16, P321, DOI 10.1097/MED.0b013e32832d88fb; Coss D, 2010, TRENDS ENDOCRIN MET, V21, P562, DOI 10.1016/j.tem.2010.05.006; Davis SW, 2010, MOL CELL ENDOCRINOL, V323, P4, DOI 10.1016/j.mce.2009.12.012; Di Ieva A, 2014, NEUROSURGERY, V75, P181, DOI 10.1227/NEU.0000000000000369; Drouin J, 2006, FRONT HORM RES, V35, P74, DOI 10.1159/000094310; Flemr M, 2013, CELL, V155, P807, DOI 10.1016/j.cell.2013.10.001; Fortin J, 2014, FASEB J, V28, P3396, DOI 10.1096/fj.14-249532; Foulkes WD, 2014, NAT REV CANCER, V14, P662, DOI 10.1038/nrc3802; Gadelha MR, 2013, J ENDOCRINOL INVEST, V36, P889, DOI 10.1007/BF03346759; Godoy J, 2011, MOL ENDOCRINOL, V25, P810, DOI 10.1210/me.2010-0352; Gonzalez G, 2009, MOL REPROD DEV, V76, P678, DOI 10.1002/mrd.21010; Gonzalez-Gonzalez E, 2008, BBA-GENE REGUL MECH, V1779, P306, DOI 10.1016/j.bbagrm.2008.01.007; Graham KE, 1999, J ENDOCRINOL, V162, pR1, DOI 10.1677/joe.0.162R001; Gregory SJ, 2004, SEMIN REPROD MED, V 22, P253, DOI 10.1055/s-2004-831901; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hannon GJ, 2006, COLD SPRING HARB SYM, V71, P551, DOI 10.1101/sqb.2006.71.064; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P1257, DOI 10.1210/me.2011-0099; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; HE L, 2004, NAT REV GENET, V5, P522; Hewitt SC, 2003, REPRODUCTION, V125, P143, DOI 10.1530/rep.0.1250143; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Huang HJ, 2001, ENDOCRINOLOGY, V142, P2267, DOI 10.1210/en.142.6.2267; Jacobs SBR, 2003, MOL ENDOCRINOL, V17, P1470, DOI 10.1210/me.2002-0286; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; Kim GJ, 2010, INT J DEV BIOL, V54, P867, DOI 10.1387/ijdb.092874gk; Koopman P, 2001, EXS, V91, P25; KUMAR TR, 1992, MOL ENDOCRINOL, V6, P81, DOI 10.1210/me.6.1.81; Kumar TR, 2005, REPRODUCTION, V130, P293, DOI 10.1530/rep.1.00660; Kumar TR, 2006, MOL CELL ENDOCRINOL, V247, P103, DOI 10.1016/j.mce.2005.12.006; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Kumar TR, 2005, ENDOCRINE, V26, P227, DOI 10.1385/ENDO:26:3:227; Kumar TR, 2001, ENDOCRINOLOGY, V142, P3512, DOI 10.1210/en.142.8.3512; KUMAR TR, 1995, NEUROENDOCRINOLOGY, V61, P628, DOI 10.1159/000126889; KUMAR TR, 1993, MOL ENDOCRINOL, V7, P898, DOI 10.1210/me.7.7.898; Lau E., 2014, NAT REV GENET, V15, P642; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Lei ZM, 2001, MOL ENDOCRINOL, V15, P184, DOI 10.1210/me.15.1.184; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024883; Liu HC, 2010, J ASSIST REPROD GEN, V27, P571, DOI 10.1007/s10815-010-9456-x; Luense LJ, 2009, TRENDS ENDOCRIN MET, V20, P265, DOI 10.1016/j.tem.2009.05.001; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Ma XP, 2004, P NATL ACAD SCI USA, V101, P17294, DOI 10.1073/pnas.0404743101; McClelland K, 2012, ASIAN J ANDROL, V14, P164, DOI 10.1038/aja.2011.169; Melamed P, 2006, MOL CELL ENDOCRINOL, V252, P167, DOI 10.1016/j.mce.2006.03.024; Mollard P, 2012, TRENDS ENDOCRIN MET, V23, P261, DOI 10.1016/j.tem.2012.02.004; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; O'Shaughnessy PJ, 2010, REPRODUCTION, V139, P177, DOI 10.1530/REP-09-0377; OSHAUGHNESSY PJ, 1992, J ENDOCRINOL, V135, P517, DOI 10.1677/joe.0.1350517; Otsuka M, 2008, J CLIN INVEST, V118, P1944, DOI 10.1172/JCI33680; Panneerdoss S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041146; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; Perez-Millan MI, 2013, GENESIS, V51, P785, DOI 10.1002/dvg.22425; Pernasetti F, 2001, ENDOCRINOLOGY, V142, P2284, DOI 10.1210/en.142.6.2284; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Salisbury TB, 2008, MOL ENDOCRINOL, V22, P1295, DOI 10.1210/me.2007-0515; Schneeberger M, 2013, MOL METAB, V2, P74, DOI 10.1016/j.molmet.2012.10.001; Shenoy A, 2014, NAT REV MOL CELL BIO, V15, P565, DOI 10.1038/nrm3854; Spady TJ, 2004, MOL ENDOCRINOL, V18, P925, DOI 10.1210/me.2003-0115; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Suszko MI, 2003, MOL ENDOCRINOL, V17, P318, DOI 10.1210/me.2002-0081; Svingen T, 2013, GENE DEV, V27, P2409, DOI 10.1101/gad.228080.113; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Thompson IR, 2014, MOL CELL ENDOCRINOL, V385, P28, DOI 10.1016/j.mce.2013.09.012; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang HZ, 2014, P NATL ACAD SCI USA, V111, P5735, DOI 10.1073/pnas.1321404111; Watkins-Chow DE, 1998, TRENDS GENET, V14, P284, DOI 10.1016/S0168-9525(98)01476-0; WEISS J, 1995, ENDOCRINOLOGY, V136, P1885, DOI 10.1210/en.136.5.1885; Wen S, 2008, ENDOCRINOLOGY, V149, P2701, DOI 10.1210/en.2007-1502; West BE, 2004, ENDOCRINOLOGY, V145, P4866, DOI 10.1210/en.2004-0598; Wreford NG, 2001, ENDOCRINOLOGY, V142, P2916, DOI 10.1210/en.142.7.2916; Xie HM, 2013, MOL ENDOCRINOL, V27, P422, DOI 10.1210/me.2012-1289; Ye RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057156; Yuen T, 2009, MOL CELL ENDOCRINOL, V302, P12, DOI 10.1016/j.mce.2008.12.013; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172; Zhang LF, 2013, INT J MOL SCI, V14, P20326, DOI 10.3390/ijms141020326; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006; Zhu XY, 2005, CURR OPIN GENET DEV, V15, P332, DOI 10.1016/j.gde.2005.04.011	93	35	36	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2699	2714		10.1074/jbc.M114.621565	http://dx.doi.org/10.1074/jbc.M114.621565			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25525274	Green Published, hybrid			2022-12-26	WOS:000349310700014
J	Andersson, S; Nilsson, K; Fagerberg, L; Hallstrom, BM; Sundstrom, C; Danielsson, A; Edlund, K; Uhlen, M; Asplund, A				Andersson, Sandra; Nilsson, Kenneth; Fagerberg, Linn; Hallstrom, Bjorn M.; Sundstrom, Christer; Danielsson, Angelika; Edlund, Karolina; Uhlen, Mathias; Asplund, Anna			The Transcriptomic and Proteomic Landscapes of Bone Marrow and Secondary Lymphoid Tissues	PLOS ONE			English	Article							HUMAN PROTEIN ATLAS; CALDAG-GEFI; EXPRESSION; GENE; MOUSE; RECEPTOR; IDENTIFICATION; LEUKEMIA; HEMOGEN; ANTIGEN	Background: The sequencing of the human genome has opened doors for global gene expression profiling, and the immense amount of data will lay an important ground for future studies of normal and diseased tissues. The Human Protein Atlas project aims to systematically map the human gene and protein expression landscape in a multitude of normal healthy tissues as well as cancers, enabling the characterization of both housekeeping genes and genes that display a tissue-specific expression pattern. This article focuses on identifying and describing genes with an elevated expression in four lymphohematopoietic tissue types (bone marrow, lymph node, spleen and appendix), based on the Human Protein Atlas-strategy that combines high throughput transcriptomics with affinity-based proteomics. Results: An enriched or enhanced expression in one or more of the lymphohematopoietic tissues, compared to other tissue-types, was seen for 693 out of 20,050 genes, and the highest levels of expression were found in bone marrow for neutrophilic and erythrocytic genes. A majority of these genes were found to constitute well-characterized genes with known functions in lymphatic or hematopoietic cells, while others are not previously studied, as exemplified by C19ORF59. Conclusions: In this paper we present a strategy of combining next generation RNA-sequencing with in situ affinity-based proteomics in order to identify and describe new gene targets for further research on lymphatic or hematopoietic cells and tissues. The results constitute lists of genes with enriched or enhanced expression in the four lymphohematopoietic tissues, exemplified also on protein level with immunohistochemical images.	[Andersson, Sandra; Nilsson, Kenneth; Sundstrom, Christer; Danielsson, Angelika; Edlund, Karolina; Asplund, Anna] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Andersson, Sandra; Danielsson, Angelika; Asplund, Anna] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Edlund, Karolina] Dortmund TU, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Fagerberg, Linn; Hallstrom, Bjorn M.; Uhlen, Mathias] Royal Inst Technol, Sci Life Lab, Stockholm, Sweden	Uppsala University; Uppsala University; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Royal Institute of Technology	Asplund, A (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	anna.asplund@igp.uu.se	Uhlen, Mathias/B-3262-2016; Uhlen, Mathias/AAV-8746-2021	Uhlen, Mathias/0000-0002-4858-8056; Fagerberg, Linn/0000-0003-0198-7137	Knut and Alice Wallenberg Foundation [KAW2008.0143]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Knut and Alice Wallenberg Foundation (KAW2008.0143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2009, MODERN PATHOL, V22, P206, DOI 10.1038/modpathol.2008.148; [Anonymous], 2012, SICKLE WINDOWED ADAP; [Anonymous], 2014, ARRAYEXPRESS DATABAS; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bain BJ, 1996, BONE MARROW PATHOLOG, Vviii; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Carbo C, 2010, J LEUKOCYTE BIOL, V88, P313, DOI 10.1189/jlb.0110049; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Csepanyi-Komi R, 2012, BLOOD, V119, P573, DOI 10.1182/blood-2010-12-324053; De Braekeleer E, 2007, LEUKEMIA, V21, P2220, DOI 10.1038/sj.leu.2404773; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Facchetti F, 2002, P NATL ACAD SCI USA, V99, P3776, DOI 10.1073/pnas.022042699; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; GALLAGHER R, 1979, BLOOD, V54, P713; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Goto M, 2010, HUM REPROD, V25, P1884, DOI 10.1093/humrep/deq138; Gregory RW, 2012, GPLOTS VARIOUS R PRO; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; Kampf C., 2004, CLIN PROTEOM, V1, P285, DOI DOI 10.1385/CP:1:3-4:285; Katoh M, 2004, INT J MOL MED, V14, P333; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Krupp M, 2012, BIOINFORMATICS, V28, P1184, DOI 10.1093/bioinformatics/bts084; LEE YTN, 1978, WESTERN J MED, V129, P374; Li K, 2005, GENOMICS, V86, P68, DOI 10.1016/j.ygeno.2005.03.006; Mechenthaler I, 2008, CELL MOL LIFE SCI, V65, P1826, DOI 10.1007/s00018-008-8157-4; Mechetina LV, 2002, EUR J IMMUNOL, V32, P87, DOI 10.1002/1521-4141(200201)32:1<87::AID-IMMU87>3.0.CO;2-#; Meijer B, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/907078; Nakata T, 2013, P NATL ACAD SCI USA, V110, P3417, DOI 10.1073/pnas.1218714110; Parkinson H, 2005, NUCLEIC ACIDS RES, V33, pD553; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Ponten F, 2011, J INTERN MED, V270, P428, DOI 10.1111/j.1365-2796.2011.02427.x; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; R Core Team, 2021, R LANGUAGE ENV STAT; Saeki H, 1999, J IMMUNOL, V162, P2472; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Steininger H, 2004, PATHOL RES PRACT, V200, P479, DOI 10.1016/j.prp.2004.04.004; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Takase H, 2012, BLOOD, V120, P914, DOI 10.1182/blood-2011-12-398156; TEDDER TF, 1988, P NATL ACAD SCI USA, V85, P208, DOI 10.1073/pnas.85.1.208; TEDDER TF, 1989, J IMMUNOL, V143, P712; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; THORNE KJI, 1976, INFECT IMMUN, V14, P555, DOI 10.1128/IAI.14.2.555-563.1976; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Virgilio L, 1998, P NATL ACAD SCI USA, V95, P3885, DOI 10.1073/pnas.95.7.3885; WILDE CG, 1989, J BIOL CHEM, V264, P11200; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xiao L, 2013, ANGIOGENESIS; Yang LV, 2003, DEV DYNAM, V228, P606, DOI 10.1002/dvdy.10399; Yang LV, 2001, MECH DEVELOP, V104, P105, DOI 10.1016/S0925-4773(01)00376-8; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	62	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115911	10.1371/journal.pone.0115911	http://dx.doi.org/10.1371/journal.pone.0115911			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541736	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900109
J	Beane, OS; Fonseca, VC; Cooper, LL; Koren, G; Darling, EM				Beane, Olivia S.; Fonseca, Vera C.; Cooper, Leroy L.; Koren, Gideon; Darling, Eric M.			Impact of Aging on the Regenerative Properties of Bone Marrow-, Muscle-, and Adipose-Derived Mesenchymal Stem/Stromal Cells	PLOS ONE			English	Article							STEM-CELLS; STROMAL CELLS; IN-VITRO; CHONDROGENIC DIFFERENTIATION; PROLIFERATION RATE; CARTILAGE REPAIR; TISSUE; AGE; TRANSCRIPTION; ENRICHMENT	Mesenchymal stem/stromal cells (MSCs) are promising cell sources for regenerative therapies due to their multipotency and ready availability, but their application can be complicated by patient-specific factors like age or illness. MSCs have been investigated for the treatment of many musculoskeletal disorders, including osteoarthritis and osteoporosis. Due to the prevalence of these diseases in older populations, researchers have studied how aging affects MSC properties and have found that proliferation and differentiation potential are impaired. However, these effects have never been compared among MSCs isolated from multiple tissue sources in the same, healthy donor. Revealing differences in how MSCs are affected by age could help identify an optimal cell source for musculoskeletal therapies targeting older patients. MSCs were isolated from young and old rabbit bone marrow, muscle, and adipose tissue. Cell yield and viability were quantified after isolation procedures, and expansion properties were assessed using assays for proliferation, senescence, and colony formation. Multipotency was also examined using lineage-specific stains and spectrophotometry of metabolites. Results were compared between age groups and among MSC sources. Results showed that MSCs are differentially influenced by aging, with bone marrow-derived stem cells having impaired proliferation, senescence, and chondrogenic response, whereas muscle-derived stem cells and adipose-derived stem cells exhibited no negative effects. While age reduced overall cell yield and adipogenic potential of all MSC populations, osteogenesis and clonogenicity remained unchanged. These findings indicate the importance of age as a factor when designing cell-based therapies for older patients.	[Beane, Olivia S.; Darling, Eric M.] Brown Univ, Ctr Biomed Engn, Providence, RI 02912 USA; [Fonseca, Vera C.; Darling, Eric M.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Cooper, Leroy L.; Koren, Gideon] Brown Univ, Rhode Isl Hosp, Cardiovasc Res Ctr, Alpert Med Sch, Providence, RI 02903 USA; [Darling, Eric M.] Brown Univ, Dept Orthopaed, Providence, RI 02912 USA; [Darling, Eric M.] Brown Univ, Sch Engn, Providence, RI 02912 USA	Brown University; Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Darling, EM (corresponding author), Brown Univ, Ctr Biomed Engn, Providence, RI 02912 USA.	Eric_Darling@brown.edu	Koren, Gideon/AAG-7726-2019	Koren, Gideon/0000-0002-9234-0875; Darling, Eric/0000-0002-3932-8623	National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR063642]; National Institute of General Medical Sciences [P20 GM104937]; National Science Foundation (CAREER Award) [CBET1253189]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation (CAREER Award)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by awards from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR063642 for EMD), National Institute of General Medical Sciences (P20 GM104937 for EMD), and National Science Foundation (CAREER Award, CBET1253189 for EMD). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or National Science Foundation. The funders had no role in study design, data collection and analysis, decision publish, or preparation of the manuscript.	Al Faqeh H, 2012, EXP GERONTOL, V47, P458, DOI 10.1016/j.exger.2012.03.018; Antebi B, 2014, CURR OSTEOPOROS REP, V12, P41, DOI 10.1007/s11914-013-0184-x; Aronowitz JA, 2013, PLAST RECONSTR SURG, V132, p932E, DOI 10.1097/PRS.0b013e3182a80652; Asumda FZ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-44; Awad HA, 2003, TISSUE ENG, V9, P1301, DOI 10.1089/10763270360728215; Baer PC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/812693; Bourzac C, 2010, EQUINE VET J, V42, P519, DOI 10.1111/j.2042-3306.2010.00098.x; Buschmann J, 2013, CYTOTHERAPY, V15, P1098, DOI 10.1016/j.jcyt.2013.04.009; Chen HT, 2012, J CELL MOL MED, V16, DOI 10.1111/j.1582-4934.2011.01335.x; Choudhery MS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-8; de Girolamo L, 2009, CYTOTHERAPY, V11, P793, DOI 10.3109/14653240903079393; Dexheimer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022980; Doi K, 2014, CYTOTHERAPY, V16, P381, DOI 10.1016/j.jcyt.2013.09.002; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Gao XQ, 2013, CELL TRANSPLANT, V22, P2393, DOI 10.3727/096368912X658854; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Gonzalez-Cruz RD, 2012, P NATL ACAD SCI USA, V109, pE1523, DOI 10.1073/pnas.1120349109; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Gupta PK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt116; Higashimoto T, 2007, GENE THER, V14, P1298, DOI 10.1038/sj.gt.3302979; Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313; Huang SC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-18; Huang WB, 2004, EXP CELL RES, V299, P325, DOI 10.1016/j.yexcr.2004.04.051; Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272; Jackson WM, 2010, EXPERT OPIN BIOL TH, V10, P505, DOI 10.1517/14712591003610606; Kanthilal M, 2014, CELL MOL BIOENG, V7, P585, DOI 10.1007/s12195-014-0350-y; Kim HP, 2012, CURR STEM CELL RES T, V7, P165; Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60; Lavasani M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1611; Lee Tsung-Han, 2013, BMC Res Notes, V6, P528, DOI 10.1186/1756-0500-6-528; Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005; Lim YW, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.128; Markarian CF, 2014, BIOTECHNOL LETT, V36, P693, DOI 10.1007/s10529-013-1425-x; Mendes SC, 2002, TISSUE ENG, V8, P911, DOI 10.1089/107632702320934010; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Murphy JM, 2002, ARTHRITIS RHEUM-US, V46, P704, DOI 10.1002/art.10118; Ng LWC, 2009, HUM REPROD, V24, P1164, DOI 10.1093/humrep/dep001; Nilsson SK, 1997, BLOOD, V89, P4013, DOI 10.1182/blood.V89.11.4013; PATE DW, 1993, CLIN RES, V41, pA347; Patrascu JM, 2013, J BIOMED MATER RES B, V101, P1310, DOI 10.1002/jbm.b.32944; Pei ZJ, 2012, NUCL MED BIOL, V39, P813, DOI 10.1016/j.nucmedbio.2011.12.014; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Peng LY, 2008, STEM CELLS DEV, V17, P761, DOI 10.1089/scd.2007.0217; Pierini M, 2012, CYTOTHERAPY, V14, P686, DOI 10.3109/14653249.2012.677821; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rouger K, 2007, J HISTOCHEM CYTOCHEM, V55, P607, DOI 10.1369/jhc.6A6954.2007; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Savarino L, 2007, BIOMATERIALS, V28, P3101, DOI 10.1016/j.biomaterials.2007.03.011; Shi YY, 2005, PLAST RECONSTR SURG, V116, P1686, DOI 10.1097/01.prs.0000185606.03222.a9; Siegel G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-146; Trivisonno A, 2014, AESTHET SURG J, V34, P601, DOI 10.1177/1090820X14528000; Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614; Valorani MG, 2012, CELL PROLIFERAT, V45, P225, DOI 10.1111/j.1365-2184.2012.00817.x; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Vidal MA, 2012, STEM CELLS DEV, V21, P273, DOI 10.1089/scd.2010.0589; Winter A, 2003, ARTHRITIS RHEUM-US, V48, P418, DOI 10.1002/art.10767; Wu W, 2013, PLAST RECONSTR SURG, V131, P27, DOI 10.1097/PRS.0b013e3182729cfc; Yu JM, 2011, AGING CELL, V10, P66, DOI 10.1111/j.1474-9726.2010.00646.x; Yukata K, 2014, BONE, V62, P79, DOI 10.1016/j.bone.2014.02.002; Zhang WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088794; Zheng HJ, 2007, J GERONTOL A-BIOL, V62, P136, DOI 10.1093/gerona/62.2.136; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x; Zhu M, 2009, J TISSUE ENG REGEN M, V3, P290, DOI 10.1002/term.165; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	65	204	211	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115963	10.1371/journal.pone.0115963	http://dx.doi.org/10.1371/journal.pone.0115963			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541697	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900118
J	Liao, LS; Cheng, YY; Liu, SY; Zhou, JN; An, SW; Lv, MF; Chen, YF; Gu, YF; Chen, SH; Zhang, LH				Liao, Lisheng; Cheng, Yingying; Liu, Shiyin; Zhou, Jianuan; An, Shuwen; Lv, Mingfa; Chen, Yufan; Gu, Yanfang; Chen, Shaohua; Zhang, Lian-Hui			Production of Novel Antibiotics Zeamines through Optimizing Dickeya zeae Fermentation Conditions	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; ERWINIA-CHRYSANTHEMI; SIGNAL MOLECULE; SUCROSE; OPTIMIZATION; ORGANIZATION; VIRULENCE; BACTERIA; SYNTHASE; STRAIN	Dickeya zeae strain EC1 was recently shown to produce a new type of phytotoxins designated as zeamine and zeamine II, which are potent wide-spectrum antibiotics against Gram-positive and Gram-negative bacterial pathogens, suggesting their promising potential as clinical medicines. In this study, the optimized medium composition and culture conditions for biosynthesis of novel antibiotics zeamines have been established by using response surface methodology, largely increasing the yield of zeamines from original about 7.35 mu g.mL(-1) in minimal medium to about 150 mu g.mL(-1) in LS5 medium. The study identified the major factors contributing to zeamines production, which include nitrate, sucrose, asparaginate, mineral elements Mg2+ and K+, and optimized amount of phosphate. In addition, the results showed that overexpression of zmsK in D. zeae strain EC1 could further increase zeamines yield to about 180 mu g.mL(-1) in LS5 medium. The findings from this study could facilitate further characterization and utilization of these two novel antibiotics, and also provide useful clues for understanding the regulatory mechanisms that govern D. zeae virulence.	[Liao, Lisheng; Cheng, Yingying; Liu, Shiyin; Zhou, Jianuan; Lv, Mingfa; Chen, Yufan; Gu, Yanfang; Chen, Shaohua; Zhang, Lian-Hui] South China Agr Univ, Coll Nat Resources & Environm, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou, Guangdong, Peoples R China; [An, Shuwen; Zhang, Lian-Hui] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Zhang, Lian-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	South China Agricultural University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Chen, SH (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou, Guangdong, Peoples R China.	shchen@scau.edu.cn; lianhui@imcb.a-star.edu.sg	Liu, Shiyin/AAT-4278-2020; Chen, Shaohua/AAQ-9860-2021	Chen, Shaohua/0000-0001-8306-2626; CHEN, YUFAN/0000-0001-9669-7380	National Natural Science Foundation of China [31270170, 31201479]; Joint Research Council, Agency of Science, Technology and Research (A*Star), Singapore [10/03/FG/06/03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Joint Research Council, Agency of Science, Technology and Research (A*Star), Singapore	This work is funded by the National Natural Science Foundation of China (grant number 31270170, 31201479) and the Joint Research Council, Agency of Science, Technology and Research (A*Star), Singapore (grant number 10/03/FG/06/03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Chen SH, 2013, BIORESOURCE TECHNOL, V132, P16, DOI 10.1016/j.biortech.2013.01.002; Chen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050456; Chen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030862; Chen SH, 2011, BIORESOURCE TECHNOL, V102, P8110, DOI 10.1016/j.biortech.2011.06.055; Chen SH, 2011, APPL MICROBIOL BIOT, V90, P1471, DOI 10.1007/s00253-011-3136-3; Cheng YY, 2013, MOL PLANT MICROBE IN, V26, P1294, DOI 10.1094/MPMI-04-13-0098-R; Chiou TJ, 1998, P NATL ACAD SCI USA, V95, P4784, DOI 10.1073/pnas.95.8.4784; Dragisic MJ, 2014, PLANT SCI, V223, P49; Gao H, 2009, BIORESOURCE TECHNOL, V100, P4012, DOI 10.1016/j.biortech.2009.03.013; GOTO M, 1979, PHYTOPATHOLOGY, V69, P213, DOI 10.1094/Phyto-69-213; Hussain MBBM, 2008, J BACTERIOL, V190, P1045, DOI 10.1128/JB.01472-07; Kocal N, 2008, PLANT PHYSIOL, V148, P1523, DOI 10.1104/pp.108.127977; Lalonde S, 1999, PLANT CELL, V11, P707, DOI 10.1105/tpc.11.4.707; Liu GQ, 2007, APPL MICROBIOL BIOT, V74, P78, DOI 10.1007/s00253-006-0661-6; Liu SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026825; Livermore D, 2004, NAT REV MICROBIOL, V2, P73, DOI 10.1038/nrmicro798; Masschelein J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054143; Powers JH, 2004, CLIN MICROBIOL INFEC, V10, P23, DOI 10.1111/j.1465-0691.2004.1007.x; RAHME LG, 1992, J BACTERIOL, V174, P3499, DOI 10.1128/JB.174.11.3499-3507.1992; Reid SJ, 2005, APPL MICROBIOL BIOT, V67, P312, DOI 10.1007/s00253-004-1885-y; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Tognetti JA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23316; Wind J, 2010, PHYTOCHEMISTRY, V71, P1610, DOI 10.1016/j.phytochem.2010.07.007; Wu J, 2010, CHEM COMMUN, V46, P333, DOI 10.1039/b916307g; XIAO YX, 1992, J BACTERIOL, V174, P1734, DOI 10.1128/jb.174.6.1734-1741.1992; Yang ZP, 2004, PLANT MOL BIOL, V54, P441, DOI 10.1023/B:PLAN.0000036375.40006.d3; Zhou JU, 2011, MOL PLANT MICROBE IN, V24, P1156, DOI 10.1094/MPMI-04-11-0087	28	21	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116047	10.1371/journal.pone.0116047	http://dx.doi.org/10.1371/journal.pone.0116047			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541733	Green Submitted, gold, Green Published			2022-12-26	WOS:000347239900133
J	Perez-Gonzalez, J; Costa, V; Santos, P; Slate, J; Carranza, J; Fernandez-Llario, P; Zsolnai, A; Monteiro, NM; Anton, I; Buzgo, J; Varga, G; Beja-Pereira, A				Perez-Gonzalez, Javier; Costa, Vania; Santos, Pedro; Slate, Jon; Carranza, Juan; Fernandez-Llario, Pedro; Zsolnai, Attila; Monteiro, Nuno M.; Anton, Istvan; Buzgo, Jozsef; Varga, Gyula; Beja-Pereira, Albano			Males and Females Contribute Unequally to Offspring Genetic Diversity in the Polygynandrous Mating System of Wild Boar	PLOS ONE			English	Article							MULTIPLE PATERNITY; PARENTAGE ANALYSIS; SEXUAL SELECTION; REPRODUCTIVE SUCCESS; POPULATION; EVOLUTION; HETEROZYGOSITY; CONSEQUENCES; VARIABILITY; INFERENCE	The maintenance of genetic diversity across generations depends on both the number of reproducing males and females. Variance in reproductive success, multiple paternity and litter size can all affect the relative contributions of male and female parents to genetic variation of progeny. The mating system of the wild boar (Sus scrofa) has been described as polygynous, although evidence of multiple paternity in litters has been found. Using 14 microsatellite markers, we evaluated the contribution of males and females to genetic variation in the next generation in independent wild boar populations from the Iberian Peninsula and Hungary. Genetic contributions of males and females were obtained by distinguishing the paternal and maternal genetic component inherited by the progeny. We found that the paternally inherited genetic component of progeny was more diverse than the maternally inherited component. Simulations showed that this finding might be due to a sampling bias. However, after controlling for the bias by fitting both the genetic diversity in the adult population and the number of reproductive individuals in the models, paternally inherited genotypes remained more diverse than those inherited maternally. Our results suggest new insights into how promiscuous mating systems can help maintain genetic variation.	[Perez-Gonzalez, Javier; Carranza, Juan] Univ Cordoba, CRCP, Ungulate Res Unit, Cordoba, Spain; [Perez-Gonzalez, Javier; Slate, Jon] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Perez-Gonzalez, Javier; Carranza, Juan; Fernandez-Llario, Pedro] Univ Extremadura, Biol & Ethol Unit, Caceres, Spain; [Perez-Gonzalez, Javier] MIMC, Guarderia Rural Mancomunidad Integral Municipios, Calamonte, Spain; [Costa, Vania; Monteiro, Nuno M.; Beja-Pereira, Albano] Univ Porto, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Santos, Pedro] Univ Evora, ICAAM, Evora, Portugal; [Fernandez-Llario, Pedro] Innovac Gest & Conservac Ungulados SL, Caceres, Spain; [Zsolnai, Attila; Anton, Istvan] Res Inst Anim Breeding & Nutr, Herceghalom, Hungary; [Zsolnai, Attila] Univ Kaposvar, Kaposvar, Hungary; [Monteiro, Nuno M.] Univ Fernando Pessoa, Fac Hlth Sci, Ctr Invest Biomed CEBIMED, Oporto, Portugal; [Buzgo, Jozsef; Varga, Gyula] Forest Management & Wood Ind Share Co, SEFAG, Somogyi Erdo Fafeldolgozo Gazdasag, Kaposvar, Hungary	Universidad de Cordoba; University of Sheffield; Universidad de Extremadura; Universidade do Porto; University of Evora; Kaposvar University; Universidade Fernando Pessoa	Perez-Gonzalez, J (corresponding author), Univ Cordoba, CRCP, Ungulate Res Unit, Cordoba, Spain.	jpergon@gmail.com	Zsolnai, Attila/F-6441-2011; Slate, Jon/D-2925-2012; Monteiro, Nuno/A-2900-2009; Carranza, Juan/E-4472-2010; Beja-Pereira, Albano/B-3681-2008; Pérez-González, Javier/AAF-6106-2020; Costa, Vania/L-8074-2013	Zsolnai, Attila/0000-0002-8382-1503; Slate, Jon/0000-0003-3356-5123; Monteiro, Nuno/0000-0001-6994-4673; Beja-Pereira, Albano/0000-0002-1607-7382; Santos, Pedro/0000-0001-7907-5133; Carranza, Juan/0000-0002-0368-7173; Costa, Vania/0000-0001-6032-8321; Perez-Gonzalez, Javier/0000-0003-0624-835X	Innovacion en Gestion y Conservacion de Ungulados S.L.; SEFAG Forest Management and Wood Industry Share Company	Innovacion en Gestion y Conservacion de Ungulados S.L.; SEFAG Forest Management and Wood Industry Share Company	Funding: Co-author Pedro Fernandez-Llario is employed by Innovacion en Gestion y Conservacion de Ungulados S.L. Co-authors Jozsef Buzgo and Gyula Varga are employed by SEFAG Forest Management and Wood Industry Share Company. Innovacion en Gestion y Conservacion de Ungulados S.L. and SEFAG Forest Management and Wood Industry Share Company provided support in the form of salaries for authors PF-L, JB and GV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Allendorf F., 2007, CONSERVATION GENETIC; Balloux F, 2003, GENETICS, V165, P2313; Barrete C, 1986, J MAMMAL, V67, P512; BIRKHEAD TR, 1993, J THEOR BIOL, V161, P51, DOI 10.1006/jtbi.1993.1039; Braga C, 2010, EUR J WILDLIFE RES, V56, P465, DOI 10.1007/s10344-010-0373-1; BRITON J, 1994, BIOL CONSERV, V69, P267, DOI 10.1016/0006-3207(94)90426-X; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Carranza J, 1996, AM NAT, V148, P81, DOI 10.1086/285912; Charpentier M, 2005, P NATL ACAD SCI USA, V102, P16723, DOI 10.1073/pnas.0507205102; CHESSER RK, 1991, GENETICS, V127, P437; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Costa Vania, 2012, BMC Res Notes, V5, P479, DOI 10.1186/1756-0500-5-479; DARDAILLON M, 1988, Z SAUGETIERKD, V53, P22; DELCROIX I, 1990, J REPROD FERTIL, V89, P613, DOI 10.1530/jrf.0.0890613; Delgado R, 2008, MAMM BIOL, V73, P169, DOI 10.1016/j.mambio.2007.07.008; Delgado-Acevedo J, 2010, WILDLIFE RES, V37, P539, DOI 10.1071/WR10052; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fernandez J, 2006, MOL ECOL, V15, P1657, DOI 10.1111/j.1365-294X.2006.02873.x; Fernandez-Llario P, 2005, J ETHOL, V23, P9, DOI 10.1007/s10164-004-0121-7; Fernandez-Llario P, 1990, MISC ZOOL, V19, P9; Fitzpatrick JL, 2009, BIOL LETTERS, V5, P320, DOI 10.1098/rsbl.2008.0734; Fiumera AC, 2001, GENET RES, V78, P163, DOI 10.1017/S0016672301005237; Griffiths SW, 2001, P ROY SOC B-BIOL SCI, V268, P1293, DOI 10.1098/rspb.2001.1660; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hampton J, 2004, WILDLIFE RES, V31, P375, DOI 10.1071/WR03099; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jones AG, 2001, P NATL ACAD SCI USA, V98, P9151, DOI 10.1073/pnas.171310198; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Karl SA, 2008, MOL ECOL, V17, P3973, DOI 10.1111/j.1365-294X.2008.03902.x; Lotterhos KE, 2011, EVOLUTION, V65, P1693, DOI 10.1111/j.1558-5646.2011.01249.x; Lowe A., 2004, ECOLOGICAL GENETICS; Martinez M, 2005, BIOL LETTERS, V1, P353, DOI 10.1098/rsbl.2005.0330; McLeod L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006347; Moore JA, 2008, CONSERV GENET, V9, P1243, DOI 10.1007/s10592-007-9452-6; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; Pearse DE, 2006, CHELONIAN CONSERV BI, V5, P232, DOI 10.2744/1071-8443(2006)5[232:PIAOPO]2.0.CO;2; Pearse DE, 2009, MOL ECOL, V18, P3124, DOI 10.1111/j.1365-294X.2009.04268.x; Perez-Gonzalez J, 2009, MOL ECOL, V18, P1591, DOI 10.1111/j.1365-294X.2009.04150.x; Poteaux C, 2009, J ZOOL, V278, P116, DOI 10.1111/j.1469-7998.2009.00553.x; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2012, R LANG ENV STAT COMP; Sauermann U, 2001, HUM GENET, V108, P249, DOI 10.1007/s004390100485; SCHMIDHEMPEL P, 1994, PHILOS T R SOC B, V346, P313, DOI 10.1098/rstb.1994.0148; Storz JF, 2001, EVOLUTION, V55, P1224; SUGG DW, 1994, GENETICS, V137, P1147; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; WAPLES RS, 1987, COPEIA, P1068, DOI 10.2307/1445580; Wright S, 1931, GENETICS, V16, P0097	52	9	9	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115394	10.1371/journal.pone.0115394	http://dx.doi.org/10.1371/journal.pone.0115394			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541986	Green Published, gold, Green Accepted			2022-12-26	WOS:000347239900038
J	Olsen, PA; Solberg, NT; Lund, K; Vehus, T; Gelazauskaite, M; Wilson, SR; Krauss, S				Olsen, Petter Angell; Solberg, Nina Therese; Lund, Kaja; Vehus, Tore; Gelazauskaite, Monika; Wilson, Steven Ray; Krauss, Stefan			Implications of Targeted Genomic Disruption of beta-Catenin in BxPC-3 Pancreatic Adenocarcinoma Cells	PLOS ONE			English	Article							WNT SIGNALING PATHWAYS; ZINC-FINGER NUCLEASES; GAMMA-CATENIN; PROTEIN INTERACTIONS; ADHERENS JUNCTIONS; P120 CATENIN; CANCER; GENE; EXPRESSION; PLAKOGLOBIN	Pancreatic adenocarcinoma (PA) is among the most aggressive human tumors with an overall 5-year survival rate of <5% and available treatments are only minimal effective. WNT/beta-catenin signaling has been identified as one of 12 core signaling pathways that are commonly mutated in PA. To obtain more insight into the role of WNT/beta-catenin signaling in PA we established human PA cell lines that are deficient of the central canonical WNT signaling protein beta-catenin by using zinc-finger nuclease (ZFN) mediated targeted genomic disruption in the beta-catenin gene (CTNNB1). Five individual CTNNB1 gene disrupted clones (BxPC3 Delta CTNNB1) were established from a BxPC-3 founder cell line. Despite the complete absence of beta-catenin, all clones displayed normal cell cycle distribution profiles, overall normal morphology and no elevated levels of apoptosis although increased doubling times were observed in three of the five BxPC3 Delta CTNNB1 clones. This confirms that WNT/ beta-catenin signaling is not mandatory for long term cell growth and survival in BxPC-3 cells. Despite a normal morphology of the beta-catenin deficient cell lines, quantitative proteomic analysis combined with pathway analysis showed a significant down regulation of proteins implied in cell adhesion combined with an up-regulation of plakoglobin. Treatment of BxPC3 Delta CTNNB1 cell lines with siRNA for plakoglobin induced morphological changes compatible with a deficiency in the formation of functional cell to cell contacts. In addition, a re-localization of E-cadherin from membranous in untreated to accumulation in cytoplasmatic puncta in plakoglobin siRNA treated BxPC3 Delta CTNNB1 cells was observed. In conclusion we describe in beta-catenin deficient BxPC-3 cells a rescue function for plakoglobin on cell to cell contacts and maintaining the localization of E-cadherin at the cellular surface, but not on canonical WNT signaling as measured by TFC/LEF mediated transcription.	[Olsen, Petter Angell; Solberg, Nina Therese; Lund, Kaja; Gelazauskaite, Monika; Krauss, Stefan] Oslo Univ Hosp, Rigshosp, Unit Cell Signaling, Canc Stem Cell Innovat Ctr SFI CAST, Oslo, Norway; [Vehus, Tore; Wilson, Steven Ray] Univ Oslo, Dept Chem, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo	Olsen, PA (corresponding author), Oslo Univ Hosp, Rigshosp, Unit Cell Signaling, Canc Stem Cell Innovat Ctr SFI CAST, Oslo, Norway.	petter.angell.olsen@rr-research.no	wilson, steven/D-6614-2012; Olsen, Petter Angell/AAO-1378-2020	wilson, steven/0000-0002-9755-1188; Olsen, Petter Angell/0000-0001-6976-5472; Krauss, Stefan/0000-0001-6992-8091	Research Council of Norway [174938/O30, 226290/O30]; Norwegian Cancer Society [2327614]	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	Support was provided by The Research Council of Norway, grant nos. 174938/O30 and 226290/O30 [http://www.forskningsradet.no/en/Home_page/1177315753906] and The Norwegian Cancer Society, grant no. 2327614 [https://kreftforeningen.no/en/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2012, FRONT BIOSCI-LANDMRK, V17, P784, DOI 10.2741/3957; Arensman MD, 2014, ONCOGENE, V33, P899, DOI 10.1038/onc.2013.23; Boon EMJ, 2002, CANCER RES, V62, P5126; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Choi HJ, 2009, J BIOL CHEM, V284, P31776, DOI 10.1074/jbc.M109.047928; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fukunaga Y, 2005, CELL STRUCT FUNCT, V30, P25, DOI 10.1247/csf.30.25; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Ghadimi BM, 1999, AM J PATHOL, V154, P525, DOI 10.1016/S0002-9440(10)65298-4; Griffin CA, 2007, CYTOGENET GENOME RES, V118, P148, DOI 10.1159/000108295; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kodama S, 1999, J BIOL CHEM, V274, P27682, DOI 10.1074/jbc.274.39.27682; Kruger U, 2007, OLIGONUCLEOTIDES, V17, P237, DOI 10.1089/oli.2006.0065; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Li Y, 2011, ONCOGENE, V30, P2633, DOI 10.1038/onc.2010.632; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Mahendram S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065320; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Olsen PA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-35; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Pieters T, 2012, FRONT BIOSCI-LANDMRK, V17, P1669, DOI 10.2741/4012; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; STADDON JM, 1995, J CELL BIOL, V130, P369, DOI 10.1083/jcb.130.2.369; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wickline ED, 2013, NEOPLASIA, V15, P421, DOI 10.1593/neo.122098; Wickline ED, 2011, J HEPATOL, V55, P1256, DOI 10.1016/j.jhep.2011.03.014; Williams BO, 2000, ONCOGENE, V19, P5720, DOI 10.1038/sj.onc.1203921; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xue YZ, 2013, TUMOR BIOL, V34, P895, DOI 10.1007/s13277-012-0624-8; Zasadil LM, 2013, SEMIN CELL DEV BIOL, V24, P370, DOI 10.1016/j.semcdb.2013.02.001; Zhou JB, 2007, AM J PHYSIOL-HEART C, V292, pH270, DOI 10.1152/ajpheart.00576.2006; Zhurinsky J, 2000, J CELL SCI, V113, P3127	53	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115496	10.1371/journal.pone.0115496	http://dx.doi.org/10.1371/journal.pone.0115496			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536063	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300045
J	Zhao, YY; Chen, H; Tian, T; Chen, DQ; Bai, X; Wei, F				Zhao, Ying-Yong; Chen, Hua; Tian, Ting; Chen, Dan-Qian; Bai, Xu; Wei, Feng			A Pharmaco-Metabonomic Study on Chronic Kidney Disease and Therapeutic Effect of Ergone by UPLC-QTOF/HDMS	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; POLYUNSATURATED FATTY-ACIDS; OXIDATIVE STRESS; MASS-SPECTROMETRY; URINARY METABONOMICS; POLYPORUS-UMBELLATUS; SERUM METABONOMICS; EXPERIMENTAL-MODEL; METABOLIC-CHANGES; PORIA-COCOS	Chronic kidney disease (CKD) is an important public health problem. Ergone has been proved to prevent the progression of CKD. UPLC-QTOF/HDMS was employed for metabolic profiling of adenine-induced CKD and to investigate the nephroprotective effects of ergone. Pharmacology parameters including blood biochemistry, histopathological evaluation and Western blot analysis were performed concurrently. The UPLC-MS data were analyzed by partial least squares-discriminate analysis, correlation analysis, heatmap analysis and mapped to KEGG pathways. Blood and serum biochemistry were observed to be significantly different in the CKD group than in the control group. In conjunction with biochemistry, histopathology and protein expression results, identified metabolites indicated perturbations in fatty acid metabolism, purine metabolism and amino acid metabolism as changes associated with adenine-induced CKD and the interventions of ergone. Upregulated expression of TGF-beta 1, ED-1, CTGF, bFGF and collagen I was observed in the CKD group. However, downregulated expression of these proteins was observed after oral administration of ergone. These results suggest that expression changes in these proteins had implications for fatty acid metabolism, purine metabolism and amino acid metabolism in the development of CKD and that ergone treatment could delay the development of CKD by normalizing or blocking abnormal changes in biomarker metabolites and protein expression in the CKD group.	[Zhao, Ying-Yong; Chen, Hua; Tian, Ting; Chen, Dan-Qian] Northwest Univ, Coll Life Sci, Minist Educ, Key Lab Resource Biol & Biotechnol Western China, Xian, Peoples R China; [Wei, Feng] State Food & Drug Adm, Natl Inst Food & Drug Control, Beijing, Peoples R China; [Bai, Xu] Waters Technol Shanghai Ltd, Solut Ctr, Shanghai, Peoples R China	Northwest University Xi'an; National Institute of Food & Drug Control - China	Zhao, YY (corresponding author), Northwest Univ, Coll Life Sci, Minist Educ, Key Lab Resource Biol & Biotechnol Western China, Xian, Peoples R China.	zyy@nwu.edu.cn	Zhao, Ying-Yong/I-3590-2019; Chen, Hua/Q-6933-2018; Zhao, Ying-Yong/I-9326-2014; Chen, Dan-Qian/HCH-6571-2022	Zhao, Ying-Yong/0000-0002-0239-7342; Chen, Hua/0000-0001-5564-4610; Zhao, Ying-Yong/0000-0002-0239-7342; 	New Century Excellent Talents in University [NCET-13-0954]; Changjiang Scholars and Innovative Research Team in University [IRT1174]; Ministry of Education of China; National Natural Science Foundation of China [J1210063, 81202909, 81274025, 81001622]; "As a Major New Drug to Create a Major National Science and Technology Special'' [2014ZX09304-307-02]; China Postdoctoral Science Foundation [2012M521831]; Key Program for the International S&T Cooperation Projects of Shaanxi Province [2013KW31-01]; Natural Science Foundation of Shaanxi Provincial Education Department [2013JK0811]; Administration of Traditional Chinese Medicine of Shaanxi [13-ZY006]	New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "As a Major New Drug to Create a Major National Science and Technology Special''; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Key Program for the International S&T Cooperation Projects of Shaanxi Province; Natural Science Foundation of Shaanxi Provincial Education Department; Administration of Traditional Chinese Medicine of Shaanxi	This study was supported by the Program for the New Century Excellent Talents in University (NCET-13-0954) and the Changjiang Scholars and Innovative Research Team in University (IRT1174) from Ministry of Education of China, the National Natural Science Foundation of China (J1210063, 81202909, 81274025, 81001622), the project "As a Major New Drug to Create a Major National Science and Technology Special'' (2014ZX09304-307-02), the China Postdoctoral Science Foundation (2012M521831), the Key Program for the International S&T Cooperation Projects of Shaanxi Province (2013KW31-01), the Natural Science Foundation of Shaanxi Provincial Education Department (2013JK0811) and the Administration of Traditional Chinese Medicine of Shaanxi (13-ZY006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminzadeh MA, 2014, XENOBIOTICA, V44, P570, DOI 10.3109/00498254.2013.852705; Bok JW, 1999, PHYTOCHEMISTRY, V51, P891, DOI 10.1016/S0031-9422(99)00128-4; Calder PC, 2003, LIPIDS, V38, P343, DOI 10.1007/s11745-003-1068-y; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Chen H, 2014, ADV CLIN CHEM, V66, P101, DOI 10.1016/B978-0-12-801401-1.00004-9; DYERBERG J, 1986, NUTR REV, V44, P125, DOI 10.1111/j.1753-4887.1986.tb07603.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Iida Shuji, 2006, Clin Exp Nephrol, V10, P262, DOI 10.1007/s10157-006-0441-8; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; Jia LW, 2008, METABOLOMICS, V4, P183, DOI 10.1007/s11306-008-0110-x; Kielstein JT, 2008, CURR OPIN NEPHROL HY, V17, P609, DOI 10.1097/MNH.0b013e328314b6ca; Kikuchi K, 2010, J CHROMATOGR B, V878, P2997, DOI 10.1016/j.jchromb.2010.09.006; Kim TH, 2012, ARCH TOXICOL, V86, P1885, DOI 10.1007/s00204-012-0910-7; Lenz EM, 2005, BIOMARKERS, V10, P173, DOI 10.1080/13547500500094034; Ma C, 2010, FOOD CHEM TOXICOL, V48, P2988, DOI 10.1016/j.fct.2010.07.038; Marescau B, 1997, METABOLISM, V46, P1024, DOI 10.1016/S0026-0495(97)90273-0; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Miyazaki T, 1997, KIDNEY INT, V52, pS15; Nakamura N, 2008, IN VIVO, V22, P609; Nenseter MS, 1996, CURR OPIN LIPIDOL, V7, P8, DOI 10.1097/00041433-199602000-00003; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Priante G, 2009, J NEPHROL, V22, P137; Quang DN, 2008, NAT PROD RES, V22, P901, DOI 10.1080/14786410701642706; Rhee EP, 2010, J AM SOC NEPHROL, V21, P1041, DOI 10.1681/ASN.2009111132; Romieu I, 2008, ENVIRON HEALTH PERSP, V116, P1237, DOI 10.1289/ehp.10578; Shidfar F, 2008, East Mediterr Health J, V14, P305; Sui WG, 2012, CLINICS, V67, P363, DOI 10.6061/clinics/2012(04)10; Tumur Z, 2010, AM J NEPHROL, V31, P435, DOI 10.1159/000299798; Vanholder R, 2001, KIDNEY INT, V59, pS266, DOI 10.1046/j.1523-1755.2001.59780266.x; Wu IW, 2011, NEPHROL DIAL TRANSPL, V26, P938, DOI 10.1093/ndt/gfq580; WYNGAARDEN JB, 1957, ARCH BIOCHEM BIOPHYS, V70, P150, DOI 10.1016/0003-9861(57)90088-7; YOKOZAWA T, 1986, NEPHRON, V44, P230, DOI 10.1159/000183992; Zhao T, 2012, J PHARMACEUT BIOMED, V60, P32, DOI 10.1016/j.jpba.2011.11.010; Zhao YY, 2014, CLIN BIOCHEM, V47, P16, DOI 10.1016/j.clinbiochem.2014.07.019; Zhao YY, 2014, ADV CLIN CHEM, V65, P69, DOI 10.1016/B978-0-12-800141-7.00003-6; Zhao YY, 2014, CHEM-BIOL INTERACT, V215, P7, DOI 10.1016/j.cbi.2014.02.014; Zhao YY, 2013, J ETHNOPHARMACOL, V149, P35, DOI 10.1016/j.jep.2013.06.031; Zhao YY, 2013, J ETHNOPHARMACOL, V148, P403, DOI 10.1016/j.jep.2013.04.018; Zhao YY, 2013, CLIN CHIM ACTA, V422, P59, DOI 10.1016/j.cca.2013.03.033; Zhao YY, 2013, J PHARMACEUT BIOMED, V81-82, P202, DOI 10.1016/j.jpba.2013.03.028; Zhao YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059617; Zhao YY, 2013, J PROTEOME RES, V12, P692, DOI 10.1021/pr3007792; Zhao YY, 2012, PROCESS BIOCHEM, V47, P1980, DOI 10.1016/j.procbio.2012.07.008; Zhao YY, 2012, CLIN CHIM ACTA, V413, P1438, DOI 10.1016/j.cca.2012.06.005; Zhao YY, 2012, J SEP SCI, V35, P1619, DOI 10.1002/jssc.201200131; Zhao YY, 2012, BIOMARKERS, V17, P48, DOI 10.3109/1354750X.2011.637180; Zhao YY, 2012, CLIN CHIM ACTA, V413, P642, DOI 10.1016/j.cca.2011.12.014; Zhao YY, 2011, J PHARM PHARMACOL, V63, P1581, DOI 10.1111/j.2042-7158.2011.01361.x; Zhao YY, 2011, BBA-GEN SUBJECTS, V1810, P384, DOI 10.1016/j.bbagen.2010.12.005; Zhao YY, 2010, PLANTA MED, V76, P1755, DOI 10.1055/s-0030-1249926; Zhao YY, 2010, BIOMED CHROMATOGR, V24, P1120, DOI 10.1002/bmc.1414; Zhao YY, 2010, ANAL CHIM ACTA, V675, P199, DOI 10.1016/j.aca.2010.07.029; Zhao YY, 2010, J CHROMATOGR B, V878, P29, DOI 10.1016/j.jchromb.2009.11.013; Zhao YY, 2009, J ETHNOPHARMACOL, V126, P184, DOI 10.1016/j.jep.2009.07.033; Zhao YY, 2009, PHARMAZIE, V64, P366, DOI 10.1691/ph.2009.8364	55	51	52	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115467	10.1371/journal.pone.0115467	http://dx.doi.org/10.1371/journal.pone.0115467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535749	gold, Green Submitted, Green Published			2022-12-26	WOS:000348563300041
J	Calvino-Nunez, C; Dominguez-del-Toro, E				Calvino-Nunez, Cristina; Dominguez-del-Toro, Eduardo			Clonidine Treatment Delays Postnatal Motor Development and Blocks Short-Term Memory in Young Mice	PLOS ONE			English	Article							OBJECT RECOGNITION MEMORY; PREPULSE INHIBITION; LOCUS-COERULEUS; DEVELOPING RAT; KNOCKOUT MICE; 4-PLATE TEST; BRAIN-STEM; RECEPTOR; ANXIETY; BEHAVIOR	During the development of the nervous system, the perinatal period is particularly sensitive as neuronal connections are still forming in the brain of the neonate. Alpha2-adrenergic receptors are overexpressed temporarily in proliferative zones in the developing brain, reaching a peak during the first postnatal week of life. Both stimulation and blocking of these receptors during this period alter the development of neural circuits, affecting synaptic connectivity and neuronal responses. They even affect motor and cognitive skills later on in the adult. It's especially important to look for the early neurological consequences resulting from such modifications, because they may go unnoticed. The main objective of the present study has been to reaffirm the importance of the maturation of alpha-adrenergic system in mice, by carrying out a comprehensive examination of motor, behavioral and cognitive effects in neonates, during early postnatal development, following chronic administration of the drug Clonidine, an alpha2 adrenergic system agonist. Our study shows that mice treated postnatally with clonidine present a temporal delay in the appearance of developmental markers, a slow execution of vestibular reflexes during first postnatal week of life and a blockade of the short term memory in the novel object recognition task. Shortly after the treatment the startle response is hyperreactive.	[Calvino-Nunez, Cristina; Dominguez-del-Toro, Eduardo] Univ Pablo Olavide, Div Neurociencias, Seville, Spain	Universidad Pablo de Olavide	Dominguez-del-Toro, E (corresponding author), Univ Pablo Olavide, Div Neurociencias, Seville, Spain.	edomtor@upo.es			Fundacion Conocimiento y Cultura;  [BFU2007-67173]	Fundacion Conocimiento y Cultura; 	This work was supported by Spanish BFU2007-67173 grant and the Fundacion Conocimiento y Cultura. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RG, 1996, COMP BIOCHEM PHYS C, V114, P123, DOI 10.1016/0742-8413(96)00013-8; Ansermino M, 2003, PAEDIATR ANAESTH, V13, P561, DOI 10.1046/j.1460-9592.2003.01048.x; Balemans MCM, 2010, BEHAV BRAIN RES, V208, P47, DOI 10.1016/j.bbr.2009.11.008; Bourin M, 2005, PHARMACOL BIOCHEM BE, V81, P645, DOI 10.1016/j.pbb.2005.04.015; Dornelles A, 2007, NEUROBIOL LEARN MEM, V88, P137, DOI 10.1016/j.nlm.2007.01.005; Dygalo N. N., 2000, Ontogenez, V31, P53; Dygalo NN, 2004, DEV BRAIN RES, V152, P225, DOI 10.1016/j.devbrainres.2004.06.018; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; FOX M. W., 1965, ANIM BEHAV, V13, P234; Fuentes S, 2007, TOXICOL SCI, V98, P589, DOI 10.1093/toxsci/kfm121; Gilsbach R, 2009, MOL PHARMACOL, V75, P1160, DOI 10.1124/mol.109.054544; Gleason G, 2010, P NATL ACAD SCI USA, V107, P7592, DOI 10.1073/pnas.0914805107; GORTER JA, 1990, BRAIN RES, V535, P62, DOI 10.1016/0006-8993(90)91824-Z; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Happe HK, 1999, J PHARMACOL EXP THER, V288, P1134; Happe HK, 2004, NEUROSCIENCE, V123, P167, DOI 10.1016/j.neuroscience.2003.09.004; Harris AC, 2004, PSYCHOPHARMACOLOGY, V171, P140, DOI 10.1007/s00213-003-1573-0; Head GA, 1999, ANN NY ACAD SCI, V881, P279, DOI 10.1111/j.1749-6632.1999.tb09370.x; Iushkova A A, 1995, Fiziol Zh Im I M Sechenova, V81, P7; Jacquin TD, 1996, NEURON, V17, P747, DOI 10.1016/S0896-6273(00)80206-8; Jentsch JD, 2004, PSYCHOPHARMACOLOGY, V175, P76, DOI 10.1007/s00213-004-1772-3; Kang EH, 2005, PROG NEURO-PSYCHOPH, V29, P733, DOI 10.1016/j.pnpbp.2005.04.027; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Lakhlani PP, 1997, P NATL ACAD SCI USA, V94, P9950, DOI 10.1073/pnas.94.18.9950; Lee SB, 2009, J COMP NEUROL, V514, P387, DOI 10.1002/cne.22012; Mas-Nieto M, 2005, NEUROSCIENCE, V135, P305; Masse F, 2006, PSYCHOPHARMACOLOGY, V183, P471, DOI 10.1007/s00213-005-0220-3; Maze M, 2001, CRIT CARE CLIN, V17, P881, DOI 10.1016/S0749-0704(05)70185-8; Menshanov PN, 2007, J NEUROSCI METH, V164, P299, DOI 10.1016/j.jneumeth.2007.04.014; MIRMIRAN M, 1987, DEV PHARMACOL THERAP, V10, P377, DOI 10.1159/000457767; MIRMIRAN M, 1985, NEUROBEH TOXICOL TER, V7, P677; Morrissey MJ, 2004, MED HYPOTHESES, V62, P876, DOI 10.1016/j.mehy.2004.01.014; Muigg P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005346; NOMURA Y, 1980, N-S ARCH PHARMACOL, V313, P33, DOI 10.1007/BF00505802; Porras-Garcia E, 2005, EUR J NEUROSCI, V21, P979, DOI 10.1111/j.1460-9568.2005.03940.x; Roozendaal B, 2008, NEUROBIOL LEARN MEM, V90, P576, DOI 10.1016/j.nlm.2008.06.010; Shishkina GT, 2004, BEHAV NEUROSCI, V118, P1285, DOI 10.1037/0735-7044.118.6.1285; Shishkina GT, 2001, J NEUROSCI, V21, P726, DOI 10.1523/JNEUROSCI.21-02-00726.2001; SOTOMOYANO R, 1991, BRAIN RES BULL, V26, P259, DOI 10.1016/0361-9230(91)90236-D; Steckler T, 1998, PROG NEUROBIOL, V54, P289, DOI 10.1016/S0301-0082(97)00060-9; Tamashiro KLK, 2000, BIOL REPROD, V63, P328, DOI 10.1095/biolreprod63.1.328; Tanaka M, 2000, EUR J PHARMACOL, V405, P397, DOI 10.1016/S0014-2999(00)00569-0; Thomas AJ, 2000, DEV BRAIN RES, V120, P181, DOI 10.1016/S0165-3806(00)00008-0; UHDE TW, 1989, ARCH GEN PSYCHIAT, V46, P170; VELLEY L, 1991, PROG BRAIN RES, V88, P555; Zelena D, 2009, INT J DEV NEUROSCI, V27, P175, DOI 10.1016/j.ijdevneu.2008.11.003	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114869	10.1371/journal.pone.0114869	http://dx.doi.org/10.1371/journal.pone.0114869			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531525	gold, Green Submitted, Green Published			2022-12-26	WOS:000348845100030
J	Jain, V; Basak, S; Bhandari, S; Bharti, PK; Thomas, T; Singh, MP; Singh, N				Jain, Vidhan; Basak, Sanjay; Bhandari, Sneha; Bharti, Praveen K.; Thomas, Trilok; Singh, Mrigendra P.; Singh, Neeru			Burden of Complicated Malaria in a Densely Forested Bastar Region of Chhattisgarh State (Central India)	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CEREBRAL MALARIA; CHILDREN; ADULTS; AREA; ROURKELA; PATTERNS; VIVAX; AGE	Background: A prospective study on severe and complicated malaria was undertaken in the tribal dominated area of Bastar division, Chhattisgarh (CG), Central India, with an objective to understand the clinical epidemiology of complicated malaria in patients attending at a referral hospital. Methods: Blood smears, collected from the general medicine and pediatric wards of a government tertiary health care facility located in Jagdalpur, CG, were microscopically examined for malaria parasite from July 2010 to December 2013. The Plasmodium falciparum positive malaria cases who met enrollment criteria and provided written informed consent were enrolled under different malaria categories following WHO guidelines. PCR was performed to reconfirm the presence of P. falciparum mono infection among enrolled cases. Univariate and multivariate logistic regression analysis was done to identify different risk factors using STATA 11.0. Results: A total of 40,924 cases were screened for malaria. The prevalence of malaria and P. falciparum associated complicated malaria (severe and cerebral both) in the hospital was 6% and 0.81%, respectively. P. falciparum malaria prevalence, severity and associated mortality in this region peaked at the age of>4-5 years and declined with increasing age. P. falciparum malaria was significantly more prevalent in children than adults (P<0.00001). Among adults, males had significantly more P. falciparum malaria than females (P<0.00001). Case fatality rate due to cerebral malaria and severe malaria was, respectively, 32% and 9% among PCR confirmed mono P. falciparum cases. Coma was the only independent predictor of mortality in multivariate regression analysis. Mortality was significantly associated with multi-organ complication score (P=0.0003). Conclusion: This study has revealed that the pattern of morbidity and mortality in this part of India is very different from earlier reported studies from India. We find that the peak morbidity and mortality in younger children regardless of seasonality. This suggests that this age group needs special care for control and clinical management.	[Jain, Vidhan; Bhandari, Sneha; Bharti, Praveen K.; Thomas, Trilok; Singh, Neeru] ICMR, RMRCT, Jabalpur, Madhya Pradesh, India; [Basak, Sanjay] Maharani Hosp, Dist Malaria Off, Chhattisgarh, India; [Basak, Sanjay] Associated Med Coll Jagdalpur, Chhattisgarh, India; [Singh, Mrigendra P.] Natl Inst Malaria Res, Field Unit, Jabalpur, Madhya Pradesh, India	Indian Council of Medical Research (ICMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Singh, N (corresponding author), ICMR, RMRCT, Jabalpur, Madhya Pradesh, India.	oicmrc@yahoo.co.in		Singh, Mrigendra/0000-0003-4336-4413	Indian council of Medical research (ICMR), India	Indian council of Medical research (ICMR), India(Indian Council of Medical Research (ICMR))	This work was funded under "Tribal Sub plan'' by Indian council of Medical research (ICMR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SH, 2004, MALARIA HEMATOLOGICA, P17; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; D'Alessandro U, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-400; Hanson J, 2010, CLIN INFECT DIS, V50, P679, DOI 10.1086/649928; Hay SI, 2010, LANCET, V376, P1716, DOI 10.1016/S0140-6736(10)61084-7; Imbert P, 1997, T ROY SOC TROP MED H, V91, P22, DOI 10.1016/S0035-9203(97)90380-1; Jain V, 2008, AM J TROP MED HYG, V79, P636; Kendjo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058686; Kochar DK, 2014, J VECTOR DIS, V51, P200; Kochar Dhanpat, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P259; KULKARNI S M, 1987, Indian Journal of Malariology, V24, P163; Lucchi NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031848; Manning L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029203; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Medana IM, 2010, HISTOPATHOLOGY, V57, P282, DOI 10.1111/j.1365-2559.2010.03619.x; Mishra SK, 2007, ANN TROP MED PARASIT, V101, P187, DOI 10.1179/136485907X157004; Mohanty S, 2003, T ROY SOC TROP MED H, V97, P69, DOI 10.1016/S0035-9203(03)90027-7; Mohapatra PK, 2001, NATL MED J INDIA, V14, P139; Nanda N, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-215; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; NVBDCP, 2013, DIAGN TREATM MAL 201; NVBDCP, 2012, MAL SIT; Pathak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035592; Singh J., 1944, Indian Medical Gazette, V79, P102; Singh N, 2004, VECTOR-BORNE ZOONOT, V4, P239, DOI 10.1089/1530366042162506; Singh N, 2004, ICMR B, V34, P1; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073730; Singh R, 2013, TROP MED INT HEALTH, V18, P1416, DOI 10.1111/tmi.12184; Singh V, 2009, TRENDS PARASITOL, V25, P452, DOI 10.1016/j.pt.2009.06.004; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Tripathy R, 2007, PEDIATRICS, V120, pE454, DOI 10.1542/peds.2006-3171; WHO, 2012, MAN SEV MAL PRACT HD, P5	34	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115266	10.1371/journal.pone.0115266	http://dx.doi.org/10.1371/journal.pone.0115266			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531373	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845100048
J	Jimenez-Maldonado, A; de Alvarez-Buylla, ER; Montero, S; Melnikov, V; Castro-Rodriguez, E; Gamboa-Dominguez, A; Rodriguez-Hernandez, A; Lemus, M; Murguia, JM				Jimenez-Maldonado, Alberto; Roces de Alvarez-Buylla, Elena; Montero, Sergio; Melnikov, Valery; Castro-Rodriguez, Elena; Gamboa-Dominguez, Armando; Rodriguez-Hernandez, Alejandrina; Lemus, Monica; Muniz Murguia, Jesus			Chronic Exercise Increases Plasma Brain-Derived Neurotrophic Factor Levels, Pancreatic Islet Size, and Insulin Tolerance in a TrkB-Dependent Manner	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BETA-CELL FUNCTION; SKELETAL-MUSCLE; SIGNAL-TRANSDUCTION; BDNF; EXPRESSION; LIVER; RESISTANCE; SECRETION; PHOSPHORYLATION	Background: Physical exercise improves glucose metabolism and insulin sensitivity. Brain-derived neurotrophic factor (BDNF) enhances insulin activity in diabetic rodents. Because physical exercise modifies BDNF production, this study aimed to investigate the effects of chronic exercise on plasma BDNF levels and the possible effects on insulin tolerance modification in healthy rats. Methods: Wistar rats were divided into five groups: control (sedentary, C); moderate-intensity training (MIT); MIT plus K252A TrkB blocker (MITK); highintensity training (HIT); and HIT plus K252a (HITK). Training comprised 8 weeks of treadmill running. Plasma BDNF levels (ELISA assay), glucose tolerance, insulin tolerance, and immunohistochemistry for insulin and the pancreatic islet area were evaluated in all groups. In addition, Bdnf mRNA expression in the skeletal muscle was measured. Principal Findings: Chronic treadmill exercise significantly increased plasma BDNF levels and insulin tolerance, and both effects were attenuated by TrkB blocking. In the MIT and HIT groups, a significant TrkB-dependent pancreatic islet enlargement was observed. MIT rats exhibited increased liver glycogen levels following insulin administration in a TrkB-independent manner. Conclusions/Significance: Chronic physical exercise exerted remarkable effects on insulin regulation by inducing significant increases in the pancreatic islet size and insulin sensitivity in a TrkB-dependent manner. A threshold for the induction of BNDF in response to physical exercise exists in certain muscle groups. To the best of our knowledge, these are the first results to reveal a role for TrkB in the chronic exercise-mediated insulin regulation in healthy rats.	[Jimenez-Maldonado, Alberto; Roces de Alvarez-Buylla, Elena; Montero, Sergio; Castro-Rodriguez, Elena; Lemus, Monica; Muniz Murguia, Jesus] Univ Colima, Ctr Univ Invest Biomed, Colima, Mexico; [Melnikov, Valery; Rodriguez-Hernandez, Alejandrina] Univ Colima, Fac Med, Colima, Mexico; [Gamboa-Dominguez, Armando] Inst Nacl Nutr & Ciencias Med Salvador Zubiran, Dept Patol, Mexico City, DF, Mexico	Universidad de Colima; Universidad de Colima; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Murguia, JM (corresponding author), Univ Colima, Ctr Univ Invest Biomed, Colima, Mexico.	jesusmuniz@hotmail.com		Lemus, Monica/0000-0001-9536-3020; Montero, Sergio/0000-0002-4776-6236; Alvarez-Buylla Roces, Maria Elena/0000-0002-7938-6473; Melnikov, Valery/0000-0002-0869-6394	CONACYT [49936-Q]; FRABA [798/12]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FRABA	This work was partly supported by CONACYT 49936-Q, and FRABA 798/12 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Beaudry JL, 2012, DIABETES-METAB RES, V28, P560, DOI 10.1002/dmrr.2310; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Calegari VC, 2011, J ENDOCRINOL, V208, P257, DOI 10.1530/JOE-10-0450; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chibalin AV, 2000, P NATL ACAD SCI USA, V97, P38, DOI 10.1073/pnas.97.1.38; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; Correia PR, 2011, NEUROSCI BULL, V27, P325, DOI 10.1007/s12264-011-1531-5; Coskun O, 2004, TOHOKU J EXP MED, V203, P145, DOI 10.1620/tjem.203.145; Cuppini R, 2007, ARCH ITAL BIOL, V145, P99; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; De Souza CT, 2010, J PHYSIOL-LONDON, V588, P2239, DOI 10.1113/jphysiol.2009.183996; Farese RV, 2001, EXP BIOL MED, V226, P283, DOI 10.1177/153537020122600404; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; Gomez-Pinilla F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032298; Hanyu O, 2003, DIABETES OBES METAB, V5, P27, DOI 10.1046/j.1463-1326.2003.00238.x; Hawley JA, 2008, ACTA PHYSIOL, V192, P127, DOI 10.1111/j.1748-1716.2007.01783.x; Cardenas CMH, 2009, J PANCREAS, V10, P321; Hoene M, 2009, J PHYSIOL-LONDON, V587, P241, DOI 10.1113/jphysiol.2008.160275; Howarth FC, 2009, J PANCREAS, V10, P485; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942; Kim H, 2004, DIABETES, V53, pS60, DOI 10.2337/diabetes.53.2007.S60; Kiraly MA, 2010, AM J PHYSIOL-ENDOC M, V298, pE671, DOI 10.1152/ajpendo.90575.2008; KORANYI LI, 1991, DIABETES, V40, P401, DOI 10.2337/diabetes.40.3.401; Krisan AD, 2004, J APPL PHYSIOL, V96, P1691, DOI 10.1152/japplphysiol.01054.2003; Kump DS, 2004, J PHYSL, V562, P829; Leibiger B, 2002, BIOCHEM SOC T, V30, P312, DOI 10.1042/bst0300312; Leite ND, 2013, CELL PHYSIOL BIOCHEM, V31, P242, DOI 10.1159/000343365; Luciano E, 2002, EUR J ENDOCRINOL, V147, P149, DOI 10.1530/eje.0.1470149; Lucini C, 2003, ANAT EMBRYOL, V206, P311, DOI 10.1007/s00429-002-0304-3; Luo J, 2006, CELL METAB, V3, P355, DOI 10.1016/j.cmet.2006.04.003; Marini M, 2010, EUR J TRANSL MYOL, V20, P105, DOI 10.4081/bam.2010.3.105; Matthews VB, 2009, DIABETOLOGIA, V52, P1409, DOI 10.1007/s00125-009-1364-1; Melloul D, 2004, ANN NY ACAD SCI, V1014, P28, DOI 10.1196/annals.1294.003; Mousavi K, 2004, AM J PHYSIOL-CELL PH, V287, pC22, DOI 10.1152/ajpcell.00583.2003; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Nakagawa T, 2000, DIABETES, V49, P436, DOI 10.2337/diabetes.49.3.436; Ogborn DI, 2010, MUSCLE NERVE, V41, P385, DOI 10.1002/mus.21503; Park SM, 2007, J APPL PHYSIOL, V103, P1764, DOI 10.1152/japplphysiol.00434.2007; Peeters A, 2010, PPAR RES, V2010, DOI 10.1155/2010/572405; Peres SB, 2005, J APPL PHYSIOL, V98, P1037, DOI 10.1152/japplphysiol.00536.2004; Pierucci D, 2001, DIABETOLOGIA, V44, P1281, DOI 10.1007/s001250100650; Podolin DA, 2001, AM J PHYSIOL-ENDOC M, V281, pE516, DOI 10.1152/ajpendo.2001.281.3.E516; Qin B, 2007, EXP BIOL MED, V232, P1330, DOI 10.3181/0704-RM-107; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rolland JF, 2002, J BIOL CHEM, V277, P38373, DOI 10.1074/jbc.M203888200; Sakuma K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/201696; Seifert T, 2010, AM J PHYSIOL-REG I, V298, pR372, DOI 10.1152/ajpregu.00525.2009; Skurat AV, 2000, DIABETES, V49, P1096, DOI 10.2337/diabetes.49.7.1096; Suefuji M, 2012, BIOCHEM BIOPH RES CO, V421, P801, DOI 10.1016/j.bbrc.2012.04.091; Thomson DM, 2009, J PHYSIOL-LONDON, V587, P2077, DOI 10.1113/jphysiol.2008.166512; Tsuchida A, 2001, DIABETOLOGIA, V44, P555, DOI 10.1007/s001250051661; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Zoladz JA, 2008, J PHYSIOL PHARMACOL, V59, P119; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727; Zywert A, 2011, PHYSIOL RES, V60, P905, DOI 10.33549/physiolres.932165	63	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115177	10.1371/journal.pone.0115177	http://dx.doi.org/10.1371/journal.pone.0115177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531651	gold, Green Published			2022-12-26	WOS:000348845100041
J	Gonzalez-Rosa, JM; Guzman-Martinez, G; Marques, IJ; Sanchez-Iranzo, H; Jimenez-Borreguero, LJ; Mercader, N				Manuel Gonzalez-Rosa, Juan; Guzman-Martinez, Gabriela; Joao Marques, Ines; Sanchez-Iranzo, Hector; Jesus Jimenez-Borreguero, Luis; Mercader, Nadia			Use of Echocardiography Reveals Reestablishment of Ventricular Pumping Efficiency and Partial Ventricular Wall Motion Recovery upon Ventricular Cryoinjury in the Zebrafish	PLOS ONE			English	Article							HEART REGENERATION; ADULT ZEBRAFISH; MYOCARDIAL-INFARCTION; CARDIAC REGENERATION; GENE; REPRODUCIBILITY; EXPRESSION; DISEASE	Aims: While zebrafish embryos are amenable to in vivo imaging, allowing the study of morphogenetic processes during development, intravital imaging of adults is hampered by their small size and loss of transparency. The use of adult zebrafish as a vertebrate model of cardiac disease and regeneration is increasing at high speed. It is therefore of great importance to establish appropriate and robust methods to measure cardiac function parameters. Methods and Results: Here we describe the use of 2D-echocardiography to study the fractional volume shortening and segmental wall motion of the ventricle. Our data show that 2D-echocardiography can be used to evaluate cardiac injury and also to study recovery of cardiac function. Interestingly, our results show that while global systolic function recovered following cardiac cryoinjury, ventricular wall motion was only partially restored. Conclusion: Cryoinjury leads to long-lasting impairment of cardiac contraction, partially mimicking the consequences of myocardial infarction in humans. Functional assessment of heart regeneration by echocardiography allows a deeper understanding of the mechanisms of cardiac regeneration and has the advantage of being easily transferable to other cardiovascular zebrafish disease models.	[Manuel Gonzalez-Rosa, Juan; Joao Marques, Ines; Sanchez-Iranzo, Hector; Mercader, Nadia] Ctr Nacl Invest Cardiovasc, Dept Cardiovasc Dev & Repair Atherothrombosis & I, Madrid, Spain; [Guzman-Martinez, Gabriela; Jesus Jimenez-Borreguero, Luis] Ctr Nacl Invest Cardiovasc, Dept Epidemiol Atherothrombosis & Imaging, Madrid, Spain; [Guzman-Martinez, Gabriela] Univ Hosp La Paz, Dept Cardiol, Madrid, Spain; [Jesus Jimenez-Borreguero, Luis] Hosp La Princesa, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Hospital Universitario La Paz; Hospital de La Princesa	Jimenez-Borreguero, LJ (corresponding author), Ctr Nacl Invest Cardiovasc, Dept Epidemiol Atherothrombosis & Imaging, Madrid, Spain.	ljborreguero@cnic.es; nmercader@cnic.es	Guzman, Gabriela/AAC-9084-2022; Gonzalez-Rosa, Juan Manuel/F-5332-2018; Sánchez-Iranzo, Héctor/L-8429-2014; Marques, Ines J./X-6325-2019; Marques, Ines Joao/L-8392-2014; Jimenez-Borreguero, Luis Jesus/L-8107-2014; Mercader, Nadia/L-2728-2014	Gonzalez-Rosa, Juan Manuel/0000-0002-2453-5670; Sánchez-Iranzo, Héctor/0000-0003-2032-0231; Marques, Ines J./0000-0003-1254-9394; Marques, Ines Joao/0000-0003-1254-9394; Guzman-Martinez, Gabriela/0000-0003-1077-7959; Jimenez-Borreguero, Luis Jesus/0000-0001-5870-237X; Mercader, Nadia/0000-0002-0905-6399	Fundacion CNIC Carlos III; Fundacion ProCNIC; Spanish Ministry of Economy and Competitiveness (Tercel) [BFU2011-25297, FPU AP2008-00546, FPU12/03007]; Community of Madrid [FIBROTEAM S2010/BMD-2321, PIEF-GA-2012-330728]; ERC [337703 - zebraHeart]	Fundacion CNIC Carlos III; Fundacion ProCNIC; Spanish Ministry of Economy and Competitiveness (Tercel); Community of Madrid(Comunidad de Madrid); ERC(European Research Council (ERC)European Commission)	Funding was from the Fundacion CNIC Carlos III, the Fundacion ProCNIC, the Spanish Ministry of Economy and Competitiveness (Tercel and BFU2011-25297 to N.M., FPU AP2008-00546 to J.M.G.-R. and FPU12/03007 to H.S-I.), the Community of Madrid (FIBROTEAM S2010/BMD-2321 to N.M), PIEF-GA-2012-330728 to I.J.M. and an ERC Starting grant 337703 - zebraHeart to N.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; Cao H, 2014, INTEGR BIOL CAMB; Chablais F, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-21; Choi WY, 2012, CURR TOP DEV BIOL, V100, P319, DOI 10.1016/B978-0-12-387786-4.00010-5; De Sutter J, 1999, HEART, V81, P533, DOI 10.1136/hrt.81.5.533; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; GORDON EP, 1983, J AM COLL CARDIOL, V2, P506, DOI 10.1016/S0735-1097(83)80278-2; Gupta V, 2013, CURR BIOL, V23, P1221, DOI 10.1016/j.cub.2013.05.028; Hoage T, 2012, METHODS MOL BIOL, V843, P11, DOI 10.1007/978-1-61779-523-7_2; Houweling AC, 2005, CARDIOVASC RES, V67, P583, DOI 10.1016/j.cardiores.2005.06.013; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Huang WC, 2010, ZEBRAFISH, V7, P297, DOI 10.1089/zeb.2010.0653; Jennings RB, 1990, CIRCULATION, V82, P112; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lindekleiv H, 2012, J CARDIOVASC ELECTR, V23, P846, DOI 10.1111/j.1540-8167.2012.02308.x; Liu TY, 2013, IEEE T ULTRASON FERR, V60, P1827, DOI 10.1109/TUFFC.2013.2769; Mably JD, 2003, CURR BIOL, V13, P2138, DOI 10.1016/j.cub.2003.11.055; Mallo M, 2000, DEVELOPMENT, V127, P4127; Gonzalez-Rosa JM, 2012, NAT PROTOC, V7, P782, DOI 10.1038/nprot.2012.025; Gonzalez-Rosa JM, 2011, DEVELOPMENT, V138, P1663, DOI 10.1242/dev.060897; Parente V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053748; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Schnabel K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018503; Sedmera D, 2011, DEV DYNAM, V240, P1322, DOI 10.1002/dvdy.22650; Steeds RP, 2011, BRIT J RADIOL, V84, P237; Sun L, 2008, ULTRASOUND MED BIOL, V34, P31, DOI 10.1016/j.ultrasmedbio.2007.07.002; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Wasmeier GH, 2007, CORONARY ARTERY DIS, V18, P283, DOI 10.1097/MCA.0b013e3280d5a7e3; Yu F, 2010, ANN BIOMED ENG, V38, P2346, DOI 10.1007/s10439-010-9993-6; ZELLER R, 1987, GENE DEV, V1, P693, DOI 10.1101/gad.1.7.693	36	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115604	10.1371/journal.pone.0115604	http://dx.doi.org/10.1371/journal.pone.0115604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532015	gold, Green Published			2022-12-26	WOS:000348845100084
J	Nehdi, A; Sean, P; Linares, I; Colina, R; Jaramillo, M; Alain, T				Nehdi, Atef; Sean, Polen; Linares, Izzar; Colina, Rodney; Jaramillo, Maritza; Alain, Tommy			Deficiency in Either 4E-BP1 or 4E-BP2 Augments Innate Antiviral Immune Responses	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; CAP-DEPENDENT TRANSLATION; P70 S6 KINASE; I-INTERFERON; INITIATION-FACTORS; MAMMALIAN TARGET; PHAS-I; PHOSPHORYLATION; PROTEIN; CELLS	Genetic deletion of both 4E-BP1 and 4E-BP2 was found to protect cells against viral infections. Here we demonstrate that the individual loss of either 4E-BP1 or 4E-BP2 in mouse embryonic fibroblasts (MEFs) is sufficient to confer viral resistance. shRNA-mediated silencing of 4E-BP1 or 4E-BP2 renders MEFs resistant to viruses, and compared to wild type cells, MEFs knockout for either 4E-BP1 or 4E-BP2 exhibit enhanced translation of Irf-7 and consequently increased innate immune response to viruses. Accordingly, the replication of vesicular stomatitis virus, encephalomyocarditis virus, influenza virus and Sindbis virus is markedly suppressed in these cells. Importantly, expression of either 4E-BP1 or 4E-BP2 in double knockout or respective single knockout cells diminishes their resistance to viral infection. Our data show that loss of 4E-BP1 or 4E-BP2 potentiates innate antiviral immunity. These results provide further evidence for translational control of innate immunity and support targeting translational effectors as an antiviral strategy.	[Nehdi, Atef; Sean, Polen] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Nehdi, Atef; Sean, Polen] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Nehdi, Atef] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Coll Med, Riyadh 11426, Saudi Arabia; [Linares, Izzar; Alain, Tommy] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Colina, Rodney] Univ Republ, Lab Virol Mol PDU, Salto 50000, Uruguay; [Jaramillo, Maritza] INRS, Frappier Res Ctr, Inst Armand, Laval, PQ, Canada	McGill University; McGill University; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); University of Ottawa; Children's Hospital of Eastern Ontario; Universidad de la Republica, Uruguay; University of Quebec; Institut national de la recherche scientifique (INRS)	Nehdi, A (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.	atef0002@gmail.com; tommy@arc.cheo.ca	Nehdi, Atef/GWZ-1906-2022; Jaramillo, Maritza/T-7467-2019	Jaramillo, Maritza/0000-0002-1910-5684; Colina, Rodney/0000-0003-3731-5383	CIHR Fellowship; ANII [FCE_543]; Agencia Nacional de Investigacion e Innovacion Uruguay; NSERC; CHEO Foundation; Cancer Research Society	CIHR Fellowship(Canadian Institutes of Health Research (CIHR)); ANII; Agencia Nacional de Investigacion e Innovacion Uruguay; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CHEO Foundation; Cancer Research Society	A. Nehdi was a recipient of a CIHR Fellowship. This research was funded by grants from ANII FCE_543, Agencia Nacional de Investigacion e Innovacion Uruguay to R. Colina, from the NSERC to M. Jaramillo, and from the CHEO Foundation and the Cancer Research Society to T. Alain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Alain T, 2012, CANCER RES, V72, P6468, DOI 10.1158/0008-5472.CAN-12-2395; Alain T, 2010, P NATL ACAD SCI USA, V107, P1576, DOI 10.1073/pnas.0912344107; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Grolleau A, 1999, J IMMUNOL, V162, P3491; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ioannou Y, 2000, ARTHRITIS RHEUM-US, V43, P1431, DOI 10.1002/1529-0131(200007)43:7<1431::AID-ANR3>3.0.CO;2-E; Judge A, 2008, HUM GENE THER, V19, P111, DOI 10.1089/hum.2007.179; Katze MG, 2002, J INTERF CYTOK RES, V22, P283, DOI 10.1089/107999002753675695; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kaur S, 2008, J IMMUNOL, V181, P7316, DOI 10.4049/jimmunol.181.10.7316; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaur S, 2012, P NATL ACAD SCI USA, V109, P7723, DOI 10.1073/pnas.1118122109; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Kroczynska B, 2009, MOL CELL BIOL; Kusaba H, 2005, J BIOL CHEM, V280, P1037, DOI 10.1074/jbc.M405204200; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Lin TA, 1996, J BIOL CHEM, V271, P30199, DOI 10.1074/jbc.271.47.30199; MADER S, 1995, MOL CELL BIOL, V15, P4990; Magagnin MG, 2008, PROTEOMICS, V8, P1019, DOI 10.1002/pmic.200700551; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Matsumoto A, 2009, J GASTROENTEROL, V44, P856, DOI 10.1007/s00535-009-0075-1; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Pestova TV, 2000, CELL MOL LIFE SCI, V57, P651, DOI 10.1007/PL00000726; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; Proud CG, 2009, BIOCHEM SOC T, V37, P227, DOI 10.1042/BST0370227; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Schaefer Martin, 2008, Curr Drug Abuse Rev, V1, P177; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; SHATKIN AJ, 1985, CELL, V40, P223, DOI 10.1016/0092-8674(85)90132-1; SONENBERG N, 1979, P NATL ACAD SCI USA, V76, P4345, DOI 10.1073/pnas.76.9.4345; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Yonezawa K, 2003, CURR TOP MICROBIOL, V279, P271	55	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114854	10.1371/journal.pone.0114854	http://dx.doi.org/10.1371/journal.pone.0114854			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531441	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000348845100029
J	Halupka, L; Halupka, K; Klimczuk, E; Sztwiertnia, H				Halupka, Lucyna; Halupka, Konrad; Klimczuk, Ewelina; Sztwiertnia, Hanna			Coping with Shifting Nest Predation Refuges by European Reed Warblers Acrocephalus scirpaceus	PLOS ONE			English	Article							SITE SELECTION; BREEDING DISPERSAL; SYLVIA-ATRICAPILLA; CLUTCH SIZE; SUCCESS; RISK; PARASITISM; SONGBIRDS; SURVIVAL; BIRDS	Predation, the most important source of nest mortality in altricial birds, has been a subject of numerous studies during past decades. However, the temporal dynamics between changing predation pressures and parental responses remain poorly understood. We analysed characteristics of 524 nests of European reed warblers monitored during six consecutive breeding seasons in the same area, and found some support for the shifting nest predation refuge hypothesis. Nest site characteristics were correlated with nest fate, but a nest with the same nest-site attributes could be relatively safe in one season and vulnerable to predation in another. Thus nest predation refuges were ephemeral and there was no between-season consistency in nest predation patterns. Reed warblers that lost their first nests in a given season did not disperse farther for the subsequent reproductive attempt, compared to successful individuals, but they introduced more changes to their second nest sites. In subsequent nests, predation risk remained constant for birds that changed nest-site characteristics, but increased for those that did not. At the between-season temporal scale, individual birds did not perform better with age in terms of reducing nest predation risk. We conclude that the experience acquired in previous years may not be useful, given that nest predation refuges are not stable.	[Halupka, Lucyna] Univ Wroclaw, Ornithol Stn, PL-50138 Wroclaw, Poland; [Halupka, Konrad; Sztwiertnia, Hanna] Univ Wroclaw, Dept Behav Ecol, PL-50138 Wroclaw, Poland; [Klimczuk, Ewelina] Univ Wroclaw, Museum Nat Hist, PL-50138 Wroclaw, Poland	University of Wroclaw; University of Wroclaw; University of Wroclaw	Halupka, L (corresponding author), Univ Wroclaw, Ornithol Stn, PL-50138 Wroclaw, Poland.	lucyna.halupka@uni.wroc.pl	Halupka, Konrad/E-2534-2018	Halupka, Lucyna/0000-0002-8043-8111; Halupka, Konrad/0000-0001-5139-1134	University of Wroclaw [1018/S/IZ/2006-12]	University of Wroclaw	The study was funded by the University of Wroclaw (project 1018/S/IZ/2006-12). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Barrientos R, 2009, ACTA OECOL, V35, P499, DOI 10.1016/j.actao.2009.03.005; Benson TJ, 2010, J ANIM ECOL, V79, P225, DOI 10.1111/j.1365-2656.2009.01604.x; Berry D A, 1985, BANDIT PROBLEMS SEQU; BERRY DA, 1972, ANN MATH STAT, V43, P871, DOI 10.1214/aoms/1177692553; Buler JJ, 2000, AUK, V117, P739, DOI 10.1642/0004-8038(2000)117[0739:PONAAN]2.0.CO;2; Chalfoun AD, 2010, OECOLOGIA, V163, P885, DOI 10.1007/s00442-010-1679-0; Chase MK, 2002, CONDOR, V104, P103, DOI 10.1650/0010-5422(2002)104[0103:NSSANS]2.0.CO;2; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Cornelius C, 2008, CONDOR, V110, P615, DOI 10.1525/cond.2008.8608; Cox WA, 2012, AUK, V129, P147, DOI 10.1525/auk.2012.11169; Cresswell W, 1997, ANIM BEHAV, V53, P93, DOI 10.1006/anbe.1996.0281; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Fisher RJ, 2006, OECOLOGIA, V147, P744, DOI 10.1007/s00442-005-0310-2; Forstmeier W, 2004, OIKOS, V104, P487, DOI 10.1111/j.0030-1299.1999.12698.x; Gill F. B., 1995, ORNITHOLOGY; Grant TA, 2005, AUK, V122, P661, DOI 10.1642/0004-8038(2005)122[0661:TVIPNS]2.0.CO;2; Gregoire A, 2007, OSTRICH, V78, P633, DOI 10.2989/OSTRICH.2007.78.3.10.321; GREIGSMITH PW, 1982, ORNIS SCAND, V13, P232, DOI 10.2307/3676304; Haas CA, 1998, AUK, V115, P929, DOI 10.2307/4089511; Halupka K, 1998, FOLIA ZOOL, V47, P29; Halupka K, 2009, J AVIAN BIOL, V40, P658, DOI 10.1111/j.1600-048X.2009.04772.x; Halupka L, 2014, ORNIS FENNICA, V91, P187; Honza M, 1998, BIRD STUDY, V45, P104, DOI 10.1080/00063659809461083; Hoover JP, 2003, ECOLOGY, V84, P416, DOI 10.1890/0012-9658(2003)084[0416:DRFSFI]2.0.CO;2; Horie S, 2012, IBIS, V154, P285, DOI 10.1111/j.1474-919X.2011.01204.x; Kearns LJ, 2013, J ORNITHOL, V154, P163, DOI 10.1007/s10336-012-0882-7; KELLY JP, 1993, CONDOR, V95, P83, DOI 10.2307/1369389; Kleinbaum DG, 1996, SURVIVAL ANAL SELF L; MARZLUFF JM, 1988, ANIM BEHAV, V36, P1, DOI 10.1016/S0003-3472(88)80244-6; Naiwanga D, 2004, OSTRICH, V75, P269, DOI 10.2989/00306520409485454; NILSSON SG, 1984, ORNIS SCAND, V15, P167, DOI 10.2307/3675958; Nur N, 2004, CONDOR, V106, P457, DOI 10.1650/7336; Oien IJ, 1996, J ANIM ECOL, V65, P147, DOI 10.2307/5717; Pelech SA, 2010, OIKOS, V119, P841, DOI 10.1111/j.1600-0706.2009.17786.x; Peterson BL, 2004, J FIELD ORNITHOL, V75, P89, DOI 10.1648/0273-8570-75.1.89; Pope TL, 2013, CONDOR, V115, P155, DOI 10.1525/cond.2012.110141; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REDONDO T, 1988, ANIM BEHAV, V36, P653, DOI 10.1016/S0003-3472(88)80147-7; Remes V, 2005, IBIS, V147, P213, DOI 10.1111/j.1474-919x.2004.00339; Remes V, 2012, J AVIAN BIOL, V43, P435, DOI 10.1111/j.1600-048X.2012.05599.x; Richardson TW, 2007, WEST N AM NATURALIST, V67, P251, DOI 10.3398/1527-0904(2007)67[251:YPCCCQ]2.0.CO;2; Rodewald AD, 2011, CONDOR, V113, P899, DOI 10.1525/cond.2011.100132; Roos S, 2002, OECOLOGIA, V133, P608, DOI 10.1007/s00442-002-1056-8; Roper James J., 2003, Ornitologia Neotropical, V14, P1; Schaefer T, 2004, BIRD STUDY, V51, P170, DOI 10.1080/00063650409461349; Schmidt KA, 2006, OECOLOGIA, V148, P22, DOI 10.1007/s00442-005-0340-9; SCHULZEHAGEN K, 1992, J ORNITHOL, V133, P237, DOI 10.1007/BF01645635; SchulzeHagen K, 1996, J ORNITHOL, V137, P181, DOI 10.1007/BF01653633; Sperry JH, 2008, J AVIAN BIOL, V39, P379, DOI 10.1111/j.0908-8857.2008.04451.x; Stokke BG, 2007, OIKOS, V116, P913, DOI 10.1111/j.0030-1299.2007.15832.x; Styrsky JN, 2005, CONDOR, V107, P133, DOI 10.1650/7609; Therneau T. M., 2014, PACKAGE SURVIVAL R P; Thompson FR, 2004, CONSERV BIOL, V18, P373, DOI 10.1111/j.1523-1739.2004.00167.x; Wegrzyn E, 2011, ARDEOLA, V58, P113; Weidinger K, 2010, OIKOS, V119, P138, DOI 10.1111/j.1600-0706.2009.17649.x; Weidinger K, 2009, IBIS, V151, P352, DOI 10.1111/j.1474-919X.2009.00907.x; Wesolowski T, 2009, BIRD STUDY, V56, P26, DOI 10.1080/00063650802681540; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wilson RR, 1998, CONDOR, V100, P673, DOI 10.2307/1369748; Wyllie L., 1975, British Birds, V68, P369	61	16	18	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115456	10.1371/journal.pone.0115456	http://dx.doi.org/10.1371/journal.pone.0115456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522327	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845600048
J	Li, K; Jia, R; Li, MH; Zheng, YM; Miao, CH; Yao, YF; Ji, HL; Geng, YQ; Qiao, WT; Albritton, LM; Liang, C; Liu, SL				Li, Kun; Jia, Rui; Li, Minghua; Zheng, Yi-Min; Miao, Chunhui; Yao, Yunfang; Ji, Hong-Long; Geng, Yunqi; Qiao, Wentao; Albritton, Lorraine M.; Liang, Chen; Liu, Shan-Lu			A Sorting Signal Suppresses IFITM1 Restriction of Viral Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED TRANSMEMBRANE PROTEIN-3; N-TERMINAL REGION; INFLUENZA-A VIRUS; WEST NILE VIRUS; DENGUE VIRUS; ANTIVIRAL ACTIVITY; CYTOPLASMIC TAIL; S-PALMITOYLATION; LOW PH; INFECTION	The interferon-induced transmembrane proteins (IFITMs) broadly inhibit virus infections, particularly at the viral entry level. However, despite this shared ability to inhibit fusion, IFITMs differ in the potency and breadth of viruses restricted, an anomaly that is not fully understood. Here, we show that differences in the range of viruses restricted by IFITM1 are regulated by a C-terminal non-canonical dibasic sorting signal KRXX that suppresses restriction of some viruses by governing its intracellular distribution. Replacing the two basic residues with alanine (KR/AA) increased restriction of jaagsiekte sheep retrovirus and 10A1 amphotropic murine leukemia virus. Deconvolution microscopy revealed an altered subcellular distribution for KR/AA, with fewer molecules in LAMP1-positive lysosomes balanced by increased levels in CD63-positive multivesicular bodies, where jaagsiekte sheep retrovirus pseudovirions are colocalized. IFITM1 binds to cellular adaptor protein complex 3 (AP-3), an association that is lost when the dibasic motif is altered. Although knockdown of AP-3 itself decreases some virus entry, expression of parental IFITM1, but not its KR/AA mutant, potentiates inhibition of viral infections in AP-3 knockdown cells. By using the substituted cysteine accessibility method, we provide evidence that IFITM1 adopts more than one membrane topology co-existing in cellular membranes. Because the C-terminal dibasic sorting signal is unique to human IFITM1, our results provide novel insight into understanding the species-and virus-specific antiviral effect of IFITMs.	[Liu, Shan-Lu] Univ Missouri, Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Jia, Rui; Yao, Yunfang; Geng, Yunqi; Qiao, Wentao] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Mol Microbiol & Biotechnol, Tianjin 300071, Peoples R China; [Jia, Rui; Yao, Yunfang; Geng, Yunqi; Qiao, Wentao] Nankai Univ, Coll Life Sci, Key Lab Microbial Funct Genom Tianjin, Tianjin 300071, Peoples R China; [Ji, Hong-Long] Univ Texas Hlth Sci Ctr, Texas Lung Injury Inst, Dept Cellular & Mol Biol, Tyler, TX 75708 USA; [Albritton, Lorraine M.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Liang, Chen] McGill AIDS Ctr, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Liang, Chen] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	University of Missouri System; University of Missouri Columbia; Nankai University; Nankai University; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Tennessee System; University of Tennessee Health Science Center; Lady Davis Institute; McGill University; McGill University	Liu, SL (corresponding author), Univ Missouri, Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA.	liushan@missouri.edu	Liu, Shan-Lu/L-5923-2016; Li, Minghua/M-8776-2016; Li, Kun/E-5255-2017	Liu, Shan-Lu/0000-0003-1620-3817; Li, Kun/0000-0002-8582-2913; Jia, Rui/0000-0002-1797-4069; Miao, Chunhui/0000-0003-4503-2180	National Institutes of Health [AI 105584, AI 112381, AI 109464]; Canadian Institutes of Health Research [MOP-77649]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112381, R56AI107095, R21AI105584, R21AI109464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 105584, AI 112381, and AI 109464 (to S. L. L.). This work was also supported by Canadian Institutes of Health Research Grant MOP-77649 (to C. L. and S. L. L.).	Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Anafu AA, 2013, J BIOL CHEM, V288, P17261, DOI 10.1074/jbc.M112.438515; Bailey CC, 2013, J BIOL CHEM, V288, P32184, DOI 10.1074/jbc.M113.514356; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; Bertrand P, 2008, J VIROL, V82, P2555, DOI 10.1128/JVI.01853-07; Bogdanov M, 2010, METHODS MOL BIOL, V619, P79, DOI 10.1007/978-1-60327-412-8_5; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chowdhury JB, 2012, J VIROL, V86, P10221, DOI 10.1128/JVI.00882-12; Chutiwitoonchai N, 2013, MICROBES INFECT, V15, P280, DOI 10.1016/j.micinf.2012.12.003; Cote M, 2008, J VIROL, V82, P9023, DOI 10.1128/JVI.00648-08; Cote M, 2008, J VIROL, V82, P2543, DOI 10.1128/JVI.01852-07; Cote M, 2012, J BIOL CHEM, V287, P7640, DOI 10.1074/jbc.M111.334722; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Jackson LP, 2012, DEV CELL, V23, P1255, DOI 10.1016/j.devcel.2012.10.017; Janaka SK, 2013, J VIROL, V87, P12805, DOI 10.1128/JVI.01847-13; Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Kreis TE, 1995, ANNU REV CELL DEV BI, V11, P677, DOI 10.1146/annurev.cb.11.110195.003333; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mills TC, 2014, J INFECT DIS, V209, P1028, DOI 10.1093/infdis/jit468; Mudhasani R, 2013, J VIROL, V87, P8451, DOI 10.1128/JVI.03382-12; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Raychoudhuri A, 2011, J VIROL, V85, P12881, DOI 10.1128/JVI.05633-11; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Weston S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104341; Wilkins C, 2013, HEPATOLOGY, V57, P461, DOI 10.1002/hep.26066; Williams DEJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110096; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111; Zhou HX, 2010, J VIROL, V84, P3542, DOI 10.1128/JVI.02570-09	46	28	28	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4248	4259		10.1074/jbc.M114.630780	http://dx.doi.org/10.1074/jbc.M114.630780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25527505	Green Published, hybrid			2022-12-26	WOS:000349458400035
J	Woeller, CF; O'Loughlin, CW; Roztocil, E; Feldon, SE; Phipps, RP				Woeller, Collynn F.; O'Loughlin, Charles W.; Roztocil, Elisa; Feldon, Steven E.; Phipps, Richard P.			Salinomycin and Other Polyether Ionophores Are a New Class of Antiscarring Agent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SIGNALING PATHWAY; EXTRACELLULAR-MATRIX; TISSUE-REPAIR; MYOFIBROBLAST; FIBROBLASTS; INHIBITOR; EYE; CONTRACTION; EXPRESSION	Although scarring is a component of wound healing, excessive scar formation is a debilitating condition that results in pain, loss of tissue function, and even death. Many tissues, including the lungs, heart, skin, and eyes, can develop excessive scar tissue as a result of tissue injury, chronic inflammation, or autoimmune disease. Unfortunately, there are few, if any, effective treatments to prevent excess scarring, and new treatment strategies are needed. Using HEK293FT cells stably transfected with a TGF beta-dependent luciferase reporter, we performed a small molecule screen to identify novel compounds with antiscarring activity. We discovered that the polyether ionophore salinomycin potently inhibited the formation of scar-forming myofibroblasts. Salinomycin (250 nM) blocked TGF beta-dependent expression of the cardinal myofibroblast products alpha smooth muscle actin, calponin, and collagen in primary human fibroblasts without causing cell death. Salinomycin blocked phosphorylation and activation of TAK1 and p38, two proteins fundamentally involved in signaling myofibroblast and scar formation. Expression of constitutively active mitogen activated kinase kinase 6, which activates p38 MAPK, attenuated the ability of salinomycin to block myofibroblast formation, demonstrating that salinomycin targets the p38 kinase pathway to disrupt TGF beta signaling. These data identify salinomycin and other polyether ionophores as novel potential antiscarring therapeutics.	[Woeller, Collynn F.; Phipps, Richard P.] Univ Rochester, Dept Environm Med, Rochester, NY 14642 USA; [O'Loughlin, Charles W.; Roztocil, Elisa; Feldon, Steven E.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Flaum Eye Inst, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Phipps, RP (corresponding author), Univ Rochester, Dept Environm Med, 601 Elmwood Ave, Rochester, NY 14642 USA.	Richard_Phipps@urmc.rochester.edu	Woeller, Collynn/U-3877-2019	Woeller, Collynn/0000-0001-7197-5057; Feldon, Steven/0000-0003-0603-9312	National Institutes of Health [ES-023032, EY-023239, ES-001247]; Research to Prevent Blindness; Rochester/Finger Lakes Eye and Tissue Bank; NATIONAL EYE INSTITUTE [R01EY023239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247, R21ES023032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Rochester/Finger Lakes Eye and Tissue Bank; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES-023032 and EY-023239, and ES-001247. This work was also supported by an unrestricted grant from the Research to Prevent Blindness and by a research grant from the Rochester/Finger Lakes Eye and Tissue Bank.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Antoszczak M, 2014, EUR J MED CHEM, V76, P435, DOI 10.1016/j.ejmech.2014.02.031; Baglole CJ, 2006, IMMUNOL INVEST, V35, P297, DOI 10.1080/08820130600754960; Bourlier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031274; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Choi ME, 2012, SEMIN NEPHROL, V32, P244, DOI 10.1016/j.semnephrol.2012.04.003; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Fan HN, 2013, EUR REV MED PHARMACO, V17, P644; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; Fuchs D, 2009, BIOCHEM BIOPH RES CO, V390, P743, DOI 10.1016/j.bbrc.2009.10.042; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; George SJ, 2009, J MOL CELL CARDIOL, V46, P610, DOI 10.1016/j.yjmcc.2009.02.008; Gu L, 2007, ACTA PHARMACOL SIN, V28, P382, DOI 10.1111/j.1745-7254.2007.00468.x; Guo NX, 2011, J BIOL CHEM, V286, P18856, DOI 10.1074/jbc.M110.179317; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Huczynski A, 2012, CHEM BIOL DRUG DES, V79, P235, DOI 10.1111/j.1747-0285.2011.01287.x; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; Knirschova R, 2007, FOLIA MICROBIOL, V52, P359, DOI 10.1007/BF02932090; Kuriyan AE, 2008, CURR OPIN OPHTHALMOL, V19, P499, DOI 10.1097/ICU.0b013e3283131557; Kuriyan AE, 2008, THYROID, V18, P911, DOI 10.1089/thy.2007.0325; Kuriyan AE, 2013, INVEST OPHTH VIS SCI, V54, P7370, DOI 10.1167/iovs.13-12741; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lehmann GM, 2008, THYROID, V18, P959, DOI 10.1089/thy.2007.0407; Lehmann GM, 2010, AM J PHYSIOL-CELL PH, V299, pC672, DOI 10.1152/ajpcell.00451.2009; Li JH, 2006, AM J PATHOL, V169, P1527, DOI 10.2353/ajpath.2006.060169; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuoka H, 2002, AM J PHYSIOL-LUNG C, V283, pL103, DOI 10.1152/ajplung.00187.2001; Micallef L, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S5; MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894; Moran N, 2011, NAT BIOTECHNOL, V29, P301, DOI 10.1038/nbt0411-301; Mortier L, 2005, RAPID COMMUN MASS SP, V19, P533, DOI 10.1002/rcm.1819; Naujokat C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/950658; Naujokat C, 2010, MOL MED REP, V3, P555, DOI 10.3892/mmr_00000296; Niessen FB, 1999, PLAST RECONSTR SURG, V104, P1435, DOI 10.1097/00006534-199910000-00031; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Schimmer AD, 2012, CL LYMPH MYELOM LEUK, V12, P330, DOI 10.1016/j.clml.2012.05.005; Shi-wen X, 2009, ARTHRITIS RHEUM-US, V60, P234, DOI 10.1002/art.24223; Smith RS, 1997, AM J PATHOL, V151, P317; Sundaresh V, 2013, J CLIN ENDOCR METAB, V98, P3671, DOI 10.1210/jc.2013-1954; Tanaka N, 2002, EMBO REP, V3, P785, DOI 10.1093/embo-reports/kvf153; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Usuki J, 2012, J NIPPON MED SCH, V79, P46, DOI 10.1272/jnms.79.46; Wang Y, 2011, MED CHEM, V7, P106, DOI 10.2174/157340611794859307; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Yang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077300; Zhang SS, 2003, J CLIN INVEST, V111, P833, DOI 10.1172/JCI200316290	54	27	27	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3563	3575		10.1074/jbc.M114.601872	http://dx.doi.org/10.1074/jbc.M114.601872			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25538236	Green Published, hybrid			2022-12-26	WOS:000349456000030
J	Singh, KK; Lovren, F; Pan, Y; Quan, A; Ramadan, A; Matkar, PN; Ehsan, M; Sandhu, P; Mantella, LE; Gupta, N; Teoh, H; Parotto, M; Tabuchi, A; Kuebler, WM; Al-Omran, M; Finkel, T; Verma, S				Singh, Krishna K.; Lovren, Fina; Pan, Yi; Quan, Adrian; Ramadan, Azza; Matkar, Pratiek N.; Ehsan, Mehroz; Sandhu, Paul; Mantella, Laura E.; Gupta, Nandini; Teoh, Hwee; Parotto, Matteo; Tabuchi, Arata; Kuebler, Wolfgang M.; Al-Omran, Mohammed; Finkel, Toren; Verma, Subodh			The Essential Autophagy Gene ATG7 Modulates Organ Fibrosis via Regulation of Endothelial-to-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Autophagy-related Protein 7 (ATG7); Endothelial Cell; Gene Silencing; Pulmonary Fibrosis; Endothelial-to-mesenchymal Transition	PULMONARY-FIBROSIS; SYSTEMIC-SCLEROSIS; SHEAR-STRESS; PATHOGENESIS; CONTRIBUTES; COLLAGEN; LUNG; TRANSFORMATION; FIBROBLASTS; IMPAIRMENT	Background: Endothelial-to-mesenchymal transition (EndMT) is implicated in the development of organ fibrosis. Results: Loss of the autophagy gene ATG7 promotes EndMT and up-regulates TGF signaling and the associated pro-fibrotic genes. Endothelial-specific ATG7 knock-out mice exhibited increased bleomycin-induced pulmonary fibrosis. Conclusion:ATG7 is a novel regulator of EndMT-induced organ fibrosis. Significance: Intact endothelial autophagy prevents aberrant EndMT and represents a potential target to limit organ fibrosis. Pulmonary fibrosis is a progressive disease characterized by fibroblast proliferation and excess deposition of collagen and other extracellular matrix components. Although the origin of fibroblasts is multifactorial, recent data implicate endothelial-to-mesenchymal transition as an important source of fibroblasts. We report herein that loss of the essential autophagy gene ATG7 in endothelial cells (ECs) leads to impaired autophagic flux accompanied by marked changes in EC architecture, loss of endothelial, and gain of mesenchymal markers consistent with endothelial-to-mesenchymal transition. Loss of ATG7 also up-regulates TGF signaling and key pro-fibrotic genes in vitro. In vivo, EC-specific ATG7 knock-out mice exhibit a basal reduction in endothelial-specific markers and demonstrate an increased susceptibility to bleomycin-induced pulmonary fibrosis and collagen accumulation. Our findings help define the role of endothelial autophagy as a potential therapeutic target to limit organ fibrosis, a condition for which presently there are no effective available treatments.	[Singh, Krishna K.; Lovren, Fina; Pan, Yi; Quan, Adrian; Ramadan, Azza; Ehsan, Mehroz; Sandhu, Paul; Mantella, Laura E.; Gupta, Nandini; Teoh, Hwee; Verma, Subodh] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Div Cardiac Surg, Toronto, ON M5B 1W8, Canada; [Singh, Krishna K.; Al-Omran, Mohammed] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Div Vasc Surg, Toronto, ON M5B 1W8, Canada; [Matkar, Pratiek N.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Div Cardiol, Toronto, ON M5B 1W8, Canada; [Teoh, Hwee] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Div Endocrinol & Metab, Toronto, ON M5B 1W8, Canada; [Singh, Krishna K.; Lovren, Fina; Pan, Yi; Quan, Adrian; Ramadan, Azza; Ehsan, Mehroz; Sandhu, Paul; Mantella, Laura E.; Gupta, Nandini; Teoh, Hwee; Tabuchi, Arata; Kuebler, Wolfgang M.; Al-Omran, Mohammed; Verma, Subodh] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Dept Surg, Toronto, ON M5B 1W8, Canada; [Matkar, Pratiek N.; Teoh, Hwee] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Dept Med, Toronto, ON M5B 1W8, Canada; [Matkar, Pratiek N.; Teoh, Hwee] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Singh, Krishna K.; Kuebler, Wolfgang M.; Al-Omran, Mohammed; Verma, Subodh] Univ Toronto, Dept Surg, Toronto, ON M5S 2J7, Canada; [Kuebler, Wolfgang M.] Univ Toronto, Dept Physiol, Toronto, ON M5S 2J7, Canada; [Parotto, Matteo] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON M5S 2J7, Canada; [Kuebler, Wolfgang M.] Charite, Inst Physiol, D-10117 Berlin, Germany; [Al-Omran, Mohammed; Verma, Subodh] King Saud Univ, Li Ka Shing Collaborat Res Program, Riyadh 12372, Saudi Arabia; [Finkel, Toren] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; King Saud University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Verma, S (corresponding author), St Michaels Hosp, Div Cardiac Surg, 8th Floor,Bond Wing,30 Bond St, Toronto, ON M5B 1W8, Canada.	vermasu@smh.ca	Pan, Yi/AAJ-2341-2021; Teoh, Hwee/F-2498-2018	Quan, Adrian/0000-0001-8008-028X; Parotto, Matteo/0000-0003-1165-4264; Teoh, Hwee/0000-0003-1036-4767; Kuebler, Wolfgang/0000-0003-4100-2961; Ramadan, Azza/0000-0001-5988-7783	Heart and Stroke Foundation of Canada [G-13-0003003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005012] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by in part by the Heart and Stroke Foundation of Canada Grant G-13-0003003 (to S. V.).	Abada A, 2014, EMBO REP, V15, P839, DOI 10.15252/embr.201439076; Araya J, 2013, INTERNAL MED, V52, P2295, DOI 10.2169/internalmedicine.52.1118; Araya J, 2013, AM J PHYSIOL-LUNG C, V304, pL56, DOI 10.1152/ajplung.00213.2012; Bharath LP, 2014, CAN J PHYSIOL PHARM, V92, P605, DOI 10.1139/cjpp-2014-0017; Chen F, 2014, CELL PHYSIOL BIOCHEM, V33, P1058, DOI 10.1159/000358676; Chen PY, 2012, CELL REP, V2, P1684, DOI 10.1016/j.celrep.2012.10.021; Cooley BC, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006927; Dolhnikoff M, 1999, AM J RESP CRIT CARE, V160, P1750, DOI 10.1164/ajrccm.160.5.9812040; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Goumans MJ, 2008, TRENDS CARDIOVAS MED, V18, P293, DOI 10.1016/j.tcm.2009.01.001; Guo FX, 2014, ANN BIOMED ENG, V42, P1978, DOI 10.1007/s10439-014-1033-5; Hashimoto N, 2010, AM J RESP CELL MOL, V43, P161, DOI 10.1165/rcmb.2009-0031OC; Hayashi S, 2009, ARTERIOSCL THROM VAS, V29, P1909, DOI 10.1161/ATVBAHA.109.188516; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HERMAN EH, 1995, TOXICOLOGY, V98, P163, DOI 10.1016/0300-483X(94)02987-6; Imanishi Y, 2009, J ARTIF ORGANS, V12, P187, DOI 10.1007/s10047-009-0465-4; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jia W, 2011, J IMMUNOL, V186, P5313, DOI 10.4049/jimmunol.1002404; Kato H, 2014, J THORAC CARDIOV SUR, V148, P245, DOI 10.1016/j.jtcvs.2013.08.046; Kaushik S, 2011, CELL METAB, V14, P173, DOI 10.1016/j.cmet.2011.06.008; Kirshenbaum LA, 2012, J CARDIOVASC PHARM, V60, P109, DOI 10.1097/FJC.0b013e31825f6faa; Kizu A, 2009, AM J PATHOL, V175, P1371, DOI 10.2353/ajpath.2009.090698; Klionsky DJ, 2008, AUTOPHAGY, V4, P740, DOI 10.4161/auto.6398; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; LaRocca TJ, 2012, J PHYSIOL-LONDON, V590, P3305, DOI 10.1113/jphysiol.2012.229690; Lee JG, 2006, EXP EYE RES, V83, P1309, DOI 10.1016/j.exer.2006.04.007; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li J, 2013, CARCINOGENESIS, V34, P1343, DOI 10.1093/carcin/bgt063; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Manali ED, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-33; MARKWALD RR, 1975, DEV BIOL, V42, P160, DOI 10.1016/0012-1606(75)90321-8; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Medici D, 2011, BIOCHEM J, V437, P515, DOI 10.1042/BJ20101500; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Miyazono K, 2000, CYTOKINE GROWTH F R, V11, P15, DOI 10.1016/S1359-6101(99)00025-8; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nataraj D, 2010, AM J RESP CELL MOL, V43, P129, DOI 10.1165/rcmb.2010-0044ED; Neel BA, 2013, TRENDS ENDOCRIN MET, V24, P635, DOI 10.1016/j.tem.2013.09.004; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; PHAN SH, 1985, J CLIN INVEST, V76, P241, DOI 10.1172/JCI111953; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P63, DOI 10.1164/arrd.1983.127.1.63; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P614, DOI 10.1164/arrd.1983.127.5.614; SCHRIER DJ, 1982, J IMMUNOL, V129, P2156; Singh KK, 2014, J THORAC CARDIOV SUR, V147, P1065, DOI 10.1016/j.jtcvs.2013.04.042; Singh KK, 2013, J THORAC CARDIOV SUR, V146, P949, DOI 10.1016/j.jtcvs.2012.12.064; Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850; Sudano I, 2010, SWISS MED WKLY, V140, P139, DOI [smw-12966, 10.4414/smw.2010.13122]; Torisu T, 2013, NAT MED, V19, P1281, DOI 10.1038/nm.3288; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Vita JA, 2011, CIRCULATION, V124, pE906, DOI 10.1161/CIRCULATIONAHA.111.078824; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Wei J, 2011, AUTOIMMUN REV, V10, P267, DOI 10.1016/j.autrev.2010.09.015; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513	70	69	71	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2547	2559		10.1074/jbc.M114.604603	http://dx.doi.org/10.1074/jbc.M114.604603			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25527499	Green Published, hybrid			2022-12-26	WOS:000349310700003
J	Bjursell, M; Xu, XF; Admyre, T; Bottcher, G; Lundin, S; Nilsson, R; Stone, VM; Morgan, NG; Lam, YY; Storlien, LH; Linden, D; Smith, DM; Bohlooly-Y, M; Oscarsson, J				Bjursell, Mikael; Xu, Xiufeng; Admyre, Therese; Bottcher, Gerhard; Lundin, Sofia; Nilsson, Ralf; Stone, Virginia M.; Morgan, Noel G.; Lam, Yan Y.; Storlien, Leonard H.; Linden, Daniel; Smith, David M.; Bohlooly-Y, Mohammad; Oscarsson, Jan			The Beneficial Effects of n-3 Polyunsaturated Fatty Acids on Diet Induced Obesity and Impaired Glucose Control Do Not Require Gpr120	PLOS ONE			English	Article							INSULIN-RESISTANCE; FISH-OIL; MICE; RECEPTOR; OMEGA-3-FATTY-ACIDS; SECRETION; DISEASE; MOUSE; INFLAMMATION; DYSFUNCTION	GPR120 (Ffar4) has been postulated to represent an important receptor mediating the improved metabolic profile seen upon ingestion of a diet enriched in polyunsaturated fatty acids (PUFAs). GPR120 is highly expressed in the digestive system, adipose tissue, lung and macrophages and also present in the endocrine pancreas. A new Gpr120 deficient mouse model on pure C57bl/6N background was developed to investigate the importance of the receptor for long-term feeding with a diet enriched with fish oil. Male Gpr120 deficient mice were fed two different high fat diets (HFDs) for 18 weeks. The diets contained lipids that were mainly saturated (SAT) or mainly n-3 polyunsaturated fatty acids (PUFA). Body composition, as well as glucose, lipid and energy metabolism, was studied. As expected, wild type mice fed the PUFA HFD gained less body weight and had lower body fat mass, hepatic lipid levels, plasma cholesterol and insulin levels and better glucose tolerance as compared to those fed the SAT HFD. Gpr120 deficient mice showed a similar improvement on the PUFA HFD as was observed for wild type mice. If anything, the Gpr120 deficient mice responded better to the PUFA HFD as compared to wild type mice with respect to liver fat content, plasma glucose levels and islet morphology. Gpr120 deficient animals were found to have similar energy, glucose and lipid metabolism when fed HFD PUFA compared to wild type mice. Therefore, GPR120 appears to be dispensable for the improved metabolic profile associated with intake of a diet enriched in n-3 PUFA fatty acids.	[Bjursell, Mikael; Xu, Xiufeng; Admyre, Therese; Bottcher, Gerhard; Lundin, Sofia; Nilsson, Ralf; Linden, Daniel; Smith, David M.; Bohlooly-Y, Mohammad; Oscarsson, Jan] AstraZeneca R&D, Molndal, Sweden; [Stone, Virginia M.; Morgan, Noel G.] Univ Exeter, Sch Med, Exeter EX2 5DW, Devon, England; [Storlien, Leonard H.] Univ Sydney, Sydney, NSW 2006, Australia; [Lam, Yan Y.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	AstraZeneca; University of Exeter; University of Sydney; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Bjursell, M (corresponding author), AstraZeneca R&D, Molndal, Sweden.	mikael.bjursell@astrazeneca.com		Smith, David/0000-0001-6831-280X; Morgan, Noel/0000-0003-1537-8113; Stone, Virginia M/0000-0003-3091-2142				Bellenger J, 2011, DIABETES, V60, P1090, DOI 10.2337/db10-0901; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bjursell M, 2006, DIABETES, V55, P725, DOI 10.2337/diabetes.55.03.06.db05-1302; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Bjursell M, 2006, BIOCHEM BIOPH RES CO, V348, P359, DOI 10.1016/j.bbrc.2006.07.090; Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Burns RN, 2010, BIOCHEM BIOPH RES CO, V396, P1030, DOI 10.1016/j.bbrc.2010.05.057; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Carpentier YA, 2006, AM J CLIN NUTR, V83, p1499S, DOI 10.1093/ajcn/83.6.1499S; Couet C, 1997, INT J OBESITY, V21, P637, DOI 10.1038/sj.ijo.0800451; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; Duca FA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039748; Flachs P, 2013, BBA-MOL CELL BIOL L, V1831, P986, DOI 10.1016/j.bbalip.2013.02.003; Gerdin AK, 2006, BIOCHEM BIOPH RES CO, V349, P825, DOI 10.1016/j.bbrc.2006.08.103; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Huang XF, 2004, DIABETES OBES METAB, V6, P35, DOI 10.1111/j.1463-1326.2004.00312.x; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Janovska P, 2013, PHYSIOL RES, V62, P153, DOI 10.33549/physiolres.932464; Kato T, 2008, DIABETES, V57, P2382, DOI 10.2337/db06-1806; Kim EH, 2012, BIOCHEM PHARMACOL, V84, P1359, DOI 10.1016/j.bcp.2012.08.029; Lamping KG, 2013, DIABETES OBES METAB, V15, P144, DOI 10.1111/dom.12004; Lofgren L, 2012, J LIPID RES, V53, P1690, DOI 10.1194/jlr.D023036; Miyauchi S, 2009, N-S ARCH PHARMACOL, V379, P427, DOI 10.1007/s00210-008-0390-8; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; PAN DA, 1994, J NUTR, V124, P1555, DOI 10.1093/jn/124.9.1555; Perez-Martinez P, 2010, BBA-MOL CELL BIOL L, V1801, P362, DOI 10.1016/j.bbalip.2009.09.010; Rossmeisl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038834; Scacheri PC, 2001, GENESIS, V30, P259, DOI 10.1002/gene.1072; Stone VM, 2014, DIABETOLOGIA; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Suckow AT, 2014, J BIOL CHEM; Superko HR, 2013, CIRCULATION, V128, P2154, DOI 10.1161/CIRCULATIONAHA.113.002731; Sykaras AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042373; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; White PJ, 2010, DIABETES, V59, P3066, DOI 10.2337/db10-0054; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797	43	49	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e114942	10.1371/journal.pone.0114942	http://dx.doi.org/10.1371/journal.pone.0114942			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541716	gold, Green Published, Green Submitted			2022-12-26	WOS:000347239900016
J	Lu, J; Wei, HM; Wu, JJ; Jamil, MFA; Tan, ML; Adenan, MI; Wong, P; Shim, W				Lu, Jun; Wei, Heming; Wu, Jianjun; Jamil, Mohd Fadzly Amar; Tan, Mei Lan; Adenan, Mohd Ilham; Wong, Philip; Shim, Winston			Evaluation of the Cardiotoxicity of Mitragynine and Its Analogues Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							CARDIAC POTASSIUM CHANNEL; LONG-QT SYNDROME; SPECIOSA-KORTH; HERG; KRATOM; TRAFFICKING; MECHANISMS; EXTRACTS; LEAVES; MICE	Introduction: Mitragynine is a major bioactive compound of Kratom, which is derived from the leave extracts of Mitragyna speciosa Korth or Mitragyna speciosa (M. speciosa), a medicinal plant from South East Asia used legally in many countries as stimulant with opioid-like effects for the treatment of chronic pain and opioid-withdrawal symptoms. Fatal incidents with Mitragynine have been associated with cardiac arrest. In this study, we determined the cardiotoxicity of Mitragynine and other chemical constituents isolated using human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Methods and Results: The rapid delayed rectifier potassium current (l(Kr)), L-type Ca2+ current (I-Ca,(L)) and action potential duration (APD) were measured by whole cell patch-clamp. The expression of KCNH2 and cytotoxicity was determined by real-time PCR and Caspase activity measurements. After significant I-Kr suppression by Mitragynine (10 mu M) was confirmed in hERG-HEK cells, we systematically examined the effects of Mitragynine and other chemical constituents in hiPSC-CMs. Mitragynine, Paynantheine, Speciogynine and Speciociliatine, dosage-dependently (0.1 similar to 100 mu M) suppressed I-Kr in hiPSC-CMs by 67%,84% with IC50 ranged from 0.91 to 2.47 mu M. Moreover, Mitragynine (10 mu M) significantly prolonged APD at 50 and 90% repolarization (APD50 and APD90) (439.0 +/- 11.6 vs. 585.2 +/- 45.5 ms and 536.0 +/- 22.6 vs. 705.9 +/- 46.1 ms, respectively) and induced arrhythmia, without altering the L-type Ca2+ current. Neither the expression, and intracellular distribution of KCNH2/Kv11.1, nor the Caspase 3 activity were significantly affected by Mitragynine. Conclusions: Our study indicates that Mitragynine and its analogues may potentiate Torsade de Pointes through inhibition of IKr in human cardiomyocytes.	[Lu, Jun; Wei, Heming; Wu, Jianjun; Wong, Philip; Shim, Winston] Natl Heart Ctr Singapore, Natl Heart Res Inst Singapore, Singapore, Singapore; [Wei, Heming; Wong, Philip; Shim, Winston] DUKE NUS Grad Med Sch Singapore, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Tan, Mei Lan; Adenan, Mohd Ilham] Minist Sci Technol & Innovat MOSTI, Malaysian Inst Pharmaceut & Nutraceut, George Town, Malaysia; [Jamil, Mohd Fadzly Amar; Tan, Mei Lan] Univ Sains Malaysia, Adv Med & Dent Inst, George Town, Malaysia	National Heart Centre Singapore; National University of Singapore; Universiti Sains Malaysia	Tan, ML (corresponding author), Minist Sci Technol & Innovat MOSTI, Malaysian Inst Pharmaceut & Nutraceut, George Town, Malaysia.	tanml@usm.my; winston.shim.s.n@nhcs.com.sg	Wu, Jian/AAU-5221-2020; Lan, Tan Mei/E-3500-2012; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Lan, Tan Mei/0000-0001-6565-699X; Wu, Jian/0000-0002-3394-1507	National Research Foundation [NRF2008-CRP003-02]; National Medical Research Council [NMRC EDG10may050]; Ministry of Science, Technology and Innovation Malaysia	National Research Foundation; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Science, Technology and Innovation Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This work was supported by the National Research Foundation (Grant number NRF2008-CRP003-02) and National Medical Research Council (Grant number NMRC EDG10may050) of Singapore; and the Ministry of Science, Technology and Innovation Malaysia (Sciencefund Grant to Tan Mei Lan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2012, J ETHNOPHARMACOL, V141, P446, DOI 10.1016/j.jep.2012.03.009; Arndt T, 2011, FORENSIC SCI INT, V208, P47, DOI 10.1016/j.forsciint.2010.10.025; Azizi J, 2010, MOLECULES, V15, P432, DOI 10.3390/molecules15010432; Bellin M, 2013, EMBO J, V32, P3161, DOI 10.1038/emboj.2013.240; Boyer EW, 2008, ADDICTION, V103, P1048, DOI 10.1111/j.1360-0443.2008.02209.x; Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280; Chan K B, 2005, Bull Narc, V57, P249; Charbit B, 2008, ANESTHESIOLOGY, V109, P206, DOI 10.1097/ALN.0b013e31817fd8c8; Cubeddu Luigi X, 2003, Am J Ther, V10, P452, DOI 10.1097/00045391-200311000-00013; de Moraes NV, 2009, J CHROMATOGR B, V877, P2593, DOI 10.1016/j.jchromb.2009.06.023; Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013; Harizal SN, 2010, J ETHNOPHARMACOL, V131, P404, DOI 10.1016/j.jep.2010.07.013; Holler JM, 2011, J ANAL TOXICOL, V35, P54, DOI 10.1093/anatox/35.1.54; Idayu NF, 2011, PHYTOMEDICINE, V18, P402, DOI 10.1016/j.phymed.2010.08.011; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Jamil MF, 2013, J ETHNOPHARMACOL; Kong WM, 2011, MOLECULES, V16, P7344, DOI 10.3390/molecules16097344; Kronstrand R, 2011, J ANAL TOXICOL, V35, P242, DOI 10.1093/anatox/35.4.242; Kumarnsit E, 2007, FITOTERAPIA, V78, P182, DOI 10.1016/j.fitote.2006.11.012; Leon F, 2009, NAT PROD COMMUN, V4, P907; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Mehta A, 2011, CARDIOVASC RES, V91, P577, DOI 10.1093/cvr/cvr132; Mercola M, 2013, CIRC RES, V112, P534, DOI 10.1161/CIRCRESAHA.111.250266; Neerman MF, 2013, J FORENSIC SCI, V58, pS278, DOI 10.1111/1556-4029.12009; Nelsen JL, 2010, J MED TOXICOL, V6, P424, DOI 10.1007/s13181-010-0079-5; Parthasarathy S, 2009, MOLECULES, V14, P3964, DOI 10.3390/molecules14103964; Perry M, 2010, J PHYSIOL-LONDON, V588, P3157, DOI 10.1113/jphysiol.2010.194670; Philipp AA, 2011, ANAL BIOANAL CHEM, V400, P127, DOI 10.1007/s00216-010-4464-3; Philipp AA, 2010, J MASS SPECTROM, V45, P1344, DOI 10.1002/jms.1848; Rosenbaum CD, 2012, J MED TOXICOL, V8, P15, DOI 10.1007/s13181-011-0202-2; Roy ML, 1996, CIRCULATION, V94, P817, DOI 10.1161/01.CIR.94.4.817; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Steele DF, 2007, J PHYSIOL-LONDON, V582, P17, DOI 10.1113/jphysiol.2007.130245; SUWANLERT S, 1975, B NARCOTICS, V27, P21; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takayama H, 2004, CHEM PHARM BULL, V52, P916, DOI 10.1248/cpb.52.916; Thomas D, 2003, CARDIOVASC RES, V60, P235, DOI 10.1016/j.cardiores.2003.08.002; Tie H, 2000, BRIT J PHARMACOL, V130, P1967, DOI 10.1038/sj.bjp.0703470; Utar Z, 2011, J ETHNOPHARMACOL, V136, P75, DOI 10.1016/j.jep.2011.04.011; Wei HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050641	40	41	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115648	10.1371/journal.pone.0115648	http://dx.doi.org/10.1371/journal.pone.0115648			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535742	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300059
J	Aziz, A; Siddique, JI; Aziz, T				Aziz, Asim; Siddique, J. I.; Aziz, Taha			Steady Boundary Layer Slip Flow along with Heat and Mass Transfer over a Flat Porous Plate Embedded in a Porous Medium	PLOS ONE			English	Article							NATURAL-CONVECTION; FORCED-CONVECTION; NON-DARCIAN; VERTICAL-PLATE; POROSITY	In this paper, a simplified model of an incompressible fluid flow along with heat and mass transfer past a porous flat plate embedded in a Darcy type porous medium is investigated. The velocity, thermal and mass slip conditions are utilized that has not been discussed in the literature before. The similarity transformations are used to transform the governing partial differential equations (PDEs) into a nonlinear ordinary differential equations (ODEs). The resulting system of ODEs is then reduced to a system of first order differential equations which was solved numerically by using Matlab bvp4c code. The effects of permeability, suction/injection parameter, velocity parameter and slip parameter on the structure of velocity, temperature and mass transfer rates are examined with the aid of several graphs. Moreover, observations based on Schmidt number and Soret number are also presented. The result shows, the increase in permeability of the porous medium increase the velocity and decrease the temperature profile. This happens due to a decrease in drag of the fluid flow. In the case of heat transfer, the increase in permeability and slip parameter causes an increase in heat transfer. However for the case of increase in thermal slip parameter there is a decrease in heat transfer. An increase in the mass slip parameter causes a decrease in the concentration field. The suction and injection parameter has similar effect on concentration profile as for the case of velocity profile.	[Aziz, Asim] Natl Univ Sci & Technol, Coll Elect & Mech Engn, Rawalpindi 46000, Pakistan; [Siddique, J. I.] Penn State Univ, Dept Math, York, PA 17403 USA; [Aziz, Taha] Univ Witwatersrand, Sch Computat & Appl Math, DST NRF Ctr Excellence Math & Stat Sci, ZA-2050 Johannesburg, South Africa; [Aziz, Taha] Natl Univ Sci & Technol, Sch Nat Sci, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Witwatersrand; National University of Sciences & Technology - Pakistan	Aziz, A (corresponding author), Natl Univ Sci & Technol, Coll Elect & Mech Engn, Rawalpindi 46000, Pakistan.	aaziz@ceme.nust.edu.pk	Aziz, Taha/AAD-5198-2020	Aziz, Asim/0000-0002-2798-5191; Aziz, Taha/0000-0003-0519-1320				ABUSITTA AMM, 1994, APPL MATH COMPUT, V64, P73, DOI 10.1016/0096-3003(94)90140-6; Alazmi B, 2004, J HEAT TRANS-T ASME, V126, P389, DOI 10.1115/1.1723470; Ali F., 2013, PLOS ONE, P8; Andersson HI, 2002, ACTA MECH, V158, P121, DOI 10.1007/BF01463174; Aziz A, 2009, COMMUN NONLINEAR SCI, V14, P1064, DOI 10.1016/j.cnsns.2008.05.003; BEAVERS GS, 1967, J FLUID MECH, V30, P197, DOI 10.1017/S0022112067001375; Bhattacharyya K, 2011, J PETROL SCI ENG, V78, P304, DOI 10.1016/j.petrol.2011.06.009; Blasius H., 1908, GRENZSCHICHTEN FLUSS, V1256; Cortell R, 2005, APPL MATH COMPUT, V170, P706, DOI 10.1016/j.amc.2004.12.037; Cortell R, 2008, CHINESE PHYS LETT, V25, P1340, DOI 10.1088/0256-307X/25/4/048; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Falkner VM, 1931, PHILOS MAG, V12, P865; GEBHART B, 1971, INT J HEAT MASS TRAN, V14, P2025, DOI 10.1016/0017-9310(71)90026-3; GEORGANTOPOULOS GA, 1981, ASTROPHYS SPACE SCI, V74, P357, DOI 10.1007/BF00656444; GUPTA PS, 1977, CAN J CHEM ENG, V55, P744, DOI 10.1002/cjce.5450550619; Hajmohammadi MR, 2014, INT J HEAT MASS TRAN, V75, P97, DOI 10.1016/j.ijheatmasstransfer.2014.03.065; Hajmohammadi MR, 2014, APPL MATH COMPUT, V239, P126, DOI 10.1016/j.amc.2014.04.060; Hajmohammadi MR, 2014, HEAT TRANSFER ENG, V35, P863, DOI 10.1080/01457632.2014.852896; Hajmohammadi MR, 2014, J MECH SCI TECHNOL, V28, P1849, DOI 10.1007/s12206-014-0332-y; Hajmohammadi MR, 2013, P I MECH ENG C-J MEC, V227, P492, DOI 10.1177/0954406212463514; HONG JT, 1987, J HEAT TRANS-T ASME, V109, P356, DOI 10.1115/1.3248088; Howarth L, 1938, PROC R SOC LON SER-A, V164, P0547, DOI 10.1098/rspa.1938.0037; Ingham D. B., 1998, TRANSPORT PHENOMENA; Ishak A, 2010, APPL MATH COMPUT, V217, P837, DOI 10.1016/j.amc.2010.06.026; KAVIANY M, 1987, J HEAT TRANS-T ASME, V109, P345, DOI 10.1115/1.3248086; KAVIANY M, 1987, INT J HEAT MASS TRAN, V30, P967, DOI 10.1016/0017-9310(87)90015-9; Khaled ARA, 2003, INT J HEAT MASS TRAN, V46, P4989, DOI 10.1016/S0017-9310(03)00301-6; Khan AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108715; Khan WA, 2014, APPL NANOSCI, V4, P633, DOI 10.1007/s13204-013-0242-9; Khan ZH, 2009, HT2008: PROCEEDINGS OF THE ASME SUMMER HEAT TRANSFER CONFERENCE, VOL 1, P301, DOI 10.1115/HT2008-56448; KUMARI M, 1990, ACTA MECH, V84, P201, DOI 10.1007/BF01176098; Luna N, 2005, INT J THERM SCI, V44, P656, DOI 10.1016/j.ijthermalsci.2004.12.008; Magyari E, 2011, COMMUN NONLINEAR SCI, V16, P599, DOI 10.1016/j.cnsns.2010.03.020; Martin MJ, 2006, J THERMOPHYS HEAT TR, V20, P710, DOI 10.2514/1.22968; Nadeem S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069811; Nield D.A., 1998, CONVECTION POROUS ME; Pal D, 2010, COMMUN NONLINEAR SCI, V15, P1813, DOI 10.1016/j.cnsns.2009.07.011; Prandtl L., 1905, VERH 3 INT MATH K HE, P484; Qasim M., 2014, PLOS ONE, V9; Qasim M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059393; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; Vafai K., 2000, HDB POROUS MEDIA, V1st; Wang CY, 2002, CHEM ENG SCI, V57, P3745, DOI 10.1016/S0009-2509(02)00267-1; Yao SS, 2011, COMMUN NONLINEAR SCI, V16, P752, DOI 10.1016/j.cnsns.2010.05.028	44	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114544	10.1371/journal.pone.0114544	http://dx.doi.org/10.1371/journal.pone.0114544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531301	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100017
J	Jensik, PJ; Vargas, JD; Reardon, SN; Rajamanickam, S; Huggenvik, JI; Collard, MW				Jensik, Philip J.; Vargas, Jesse D.; Reardon, Sara N.; Rajamanickam, Shivakumar; Huggenvik, Jodi I.; Collard, Michael W.			DEAF1 Binds Unmethylated and Variably Spaced CpG Dinucleotide Motifs	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; FACTOR-I DEAF-1; TRANSCRIPTIONAL REGULATION; CYTOSINE METHYLATION; SAND DOMAIN; PROTEIN; GENES; EXPRESSION; SITES; NUDR	DEAF1 is a transcriptional regulator associated with autoimmune and neurological disorders and is known to bind TTCG motifs. To further ascertain preferred DEAF1 DNA ligands, we screened a random oligonucleotide library containing an "anchored'' CpG motif. We identified a binding consensus that generally conformed to a repeated TTCGGG motif, with the two invariant CpG dinucleotides separated by 6-11 nucleotides. Alteration of the consensus surrounding the dual CpG dinucleotides, or cytosine methylation of a single CpG half-site, eliminated DEAF1 binding. A sequence within the Htr1a promoter that resembles the binding consensus but contains a single CpG motif was confirmed to have low affinity binding with DEAF1. A DEAF1 binding consensus was identified in the EIF4G3 promoter and ChIP assay showed endogenous DEAF1 was bound to the region. We conclude that DEAF1 preferentially binds variably spaced and unmethylated CpG-containing half-sites when they occur within an appropriate consensus.	[Jensik, Philip J.; Vargas, Jesse D.; Reardon, Sara N.; Rajamanickam, Shivakumar; Huggenvik, Jodi I.; Collard, Michael W.] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Jensik, PJ (corresponding author), So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.	pjensik@siumed.edu		Vargas, Jesse/0000-0002-3671-6778	National Institutes of Health [CA89438, CA137556, HD060122]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD060122] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R15CA137556, R01CA089438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA89438, CA137556, and HD060122 to JH and MC (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00199; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barker HE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-94; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Burnett E, 2001, J MOL BIOL, V314, P1029, DOI 10.1006/jmbi.2000.5198; CROSS SH, 1995, CURR OPIN GENET DEV, V5, P309, DOI 10.1016/0959-437X(95)80044-1; Cubeddu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039218; Czesak M, 2012, J BIOL CHEM, V287, P6615, DOI 10.1074/jbc.M111.293027; Goswami DB, 2010, J NEUROCHEM, V112, P397, DOI 10.1111/j.1471-4159.2009.06462.x; Gross CT, 1996, EMBO J, V15, P1961, DOI 10.1002/j.1460-2075.1996.tb00547.x; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Huggenvik JI, 1998, MOL ENDOCRINOL, V12, P1619, DOI 10.1210/me.12.10.1619; Jensik PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033404; Jensik PJ, 2004, J BIOL CHEM, V279, P32692, DOI 10.1074/jbc.M400946200; Joseph S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109108; Joseph S, 2014, BIOMOL NMR ASSIGN, V8, P141, DOI 10.1007/s12104-013-9470-x; Kateb F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054715; Lemonde S, 2003, J NEUROSCI, V23, P8788; Lo Surdo P, 2003, MOL ENDOCRINOL, V17, P1283, DOI 10.1210/me.2002-0409; Manne U, 2001, CLIN CANCER RES, V7, P3495; Medvedeva YA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-119; Michelson RJ, 1999, J BIOL CHEM, V274, P30510, DOI 10.1074/jbc.274.43.30510; Ordureau A, 2013, J BIOL CHEM, V288, P24569, DOI 10.1074/jbc.M113.479550; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Sen N, 2009, BIOINFORMATION, V3, P415, DOI 10.6026/97320630003415; Szewczyk B, 2009, INT J NEUROPSYCHOPH, V12, P155, DOI 10.1017/S1461145708009012; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Veraksa A, 2002, GENESIS, V33, P67, DOI 10.1002/gene.10090; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Vulto-van Silfhout AT, 2014, AM J HUM GENET, V94, P649, DOI 10.1016/j.ajhg.2014.03.013; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Yip L, 2013, J MOL CELL BIOL, V5, P99, DOI 10.1093/jmcb/mjs052; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115908	10.1371/journal.pone.0115908	http://dx.doi.org/10.1371/journal.pone.0115908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531106	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100116
J	Liu, XJ; Zheng, YB; Li, Y; Wu, SY; Zhen, YS				Liu, Xiu-Jun; Zheng, Yan-Bo; Li, Yi; Wu, Shu-Ying; Zhen, Yong-Su			A Multifunctional Drug Combination Shows Highly Potent Therapeutic Efficacy against Human Cancer Xenografts in Athymic Mice	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; BESTATIN; TARGET; DIPYRIDAMOLE; ANGIOGENESIS; INHIBITOR	The tumor microenvironment plays a crucial role during tumor development. Integrated combination of drugs that target tumor microenvironment is a promising approach to anticancer therapy. Here, we report a multifunctional combination of low-cytotoxic drugs composed of dipyridamole, bestatin and dexamethasone (DBDx) which mainly acts on the tumor microenvironment shows highly potent antitumor efficacy in vivo. In mouse hepatoma H22 model, the triple drug combination showed synergistic and highly potent antitumor efficacy. The combination indices of various combinations of the triple drugs were between 0.2 and 0.5. DBDx inhibited the growth of a panel of human tumor xenografts and showed no obvious systemic toxicity. At tolerated doses, DBDx suppressed the growth of human hepatocellular carcinoma BEL-7402, HepG2, and lung adenocarcinoma A549 xenografts by 94.5%, 93.7% and 96.9%, respectively. Clonogenic assay demonstrated that DBDx showed weak cytotoxicity. Western blot showed that Flk1 and Nos3 were down-regulated in the DBDx-treated group. Proteomic analysis showed that DBDx mainly affected the metabolic process and immune system process; in addition, the angiogenesis and VEGF signaling pathway were also affected. Conclusively, DBDx, a multifunctional drug combination of three low-cytotoxic drugs, shows synergistic and highly potent antitumor efficacy evidently mediated by the modulation of tumor microenvironment. Based on its low-cytotoxic attributes and its broad-spectrum antitumor therapeutic efficacy, this multifunctional combination might be useful in the treatment of cancers, especially those refractory to conventional chemotherapeutics.	[Zhen, Yong-Su] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhen, YS (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China.	zhenysm@126.com		Zheng, Yan-Bo/0000-0001-9552-8411	"Significant new drugs development'' Major Science and Technology Projects of China [2012ZX09301002]; National Natural Science Foundation of China [81201665]	"Significant new drugs development'' Major Science and Technology Projects of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the "Significant new drugs development'' Major Science and Technology Projects of China (No. 2012ZX09301002, http://www.nmp.gov.cn) and the National Natural Science Foundation of China (No. 81201665, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro MS, 2013, CANCER TREAT REV, V39, P113, DOI 10.1016/j.ctrv.2012.09.002; Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Aozuka Y, 2004, CANCER LETT, V216, P35, DOI 10.1016/j.canlet.2004.06.050; Blansfield JA, 2008, CLIN CANCER RES, V14, P270, DOI 10.1158/1078-0432.CCR-07-1562; CAO SS, 1989, CANCER CHEMOTH PHARM, V24, P181, DOI 10.1007/BF00300240; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Fan Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093264; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Furuse K, 1993, Gan To Kagaku Ryoho, V20, P1187; Gus-Brautbar Y, 2012, MOL CELL, V45, P610, DOI 10.1016/j.molcel.2012.01.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Mangiameli DP, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-38; Mayer LD, 2006, MOL CANCER THER, V5, P1854, DOI 10.1158/1535-7163.MCT-06-0118; OZONO S, 1990, ACTA ONCOL, V29, P813, DOI 10.3109/02841869009093006; Reisfeld Ralph A., 2013, Critical Reviews in Oncogenesis, V18, P115; Spano D, 2013, CLIN EXP METASTAS, V30, P47, DOI 10.1007/s10585-012-9506-0; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; TALMADGE JE, 1986, CANCER RES, V46, P4505; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Yano A, 2006, CLIN CANCER RES, V12, P3003, DOI 10.1158/1078-0432.CCR-05-2085; Zheng Yan-Bo, 2012, Yao Xue Xue Bao, V47, P1593	24	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115790	10.1371/journal.pone.0115790	http://dx.doi.org/10.1371/journal.pone.0115790			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531414	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845100108
J	Wehner, T; Steiner, M; Ignatius, A; Claes, L				Wehner, Tim; Steiner, Malte; Ignatius, Anita; Claes, Lutz			Prediction of the Time Course of Callus Stiffness as a Function of Mechanical Parameters in Experimental Rat Fracture Healing Studies - A Numerical Study	PLOS ONE			English	Article							TISSUE DIFFERENTIATION; GAP SIZE; BONE; MODEL; SIMULATION; STABILITY; FIXATION; STIMULI; TRAUMA; CELL	Numerous experimental fracture healing studies are performed on rats, in which different experimental, mechanical parameters are applied, thereby prohibiting direct comparison between each other. Numerical fracture healing simulation models are able to predict courses of fracture healing and offer support for pre-planning animal experiments and for post-hoc comparison between outcomes of different in vivo studies. The aims of this study are to adapt a pre-existing fracture healing simulation algorithm for sheep and humans to the rat, to corroborate it using the data of numerous different rat experiments, and to provide healing predictions for future rat experiments. First, material properties of different tissue types involved were adjusted by comparing experimentally measured callus stiffness to respective simulated values obtained in three finite element (FE) models. This yielded values for Young's moduli of cortical bone, woven bone, cartilage, and connective tissue of 15,750 MPa, 1,000 MPa, 5 MPa, and 1 MPa, respectively. Next, thresholds in the underlying mechanoregulatory tissue differentiation rules were calibrated by modifying model parameters so that predicted fracture callus stiffness matched experimental data from a study that used rigid and flexible fixators. This resulted in strain thresholds at higher magnitudes than in models for sheep and humans. The resulting numerical model was then used to simulate numerous fracture healing scenarios from literature, showing a considerable mismatch in only 6 of 21 cases. Based on this corroborated model, a fit curve function was derived which predicts the increase of callus stiffness dependent on bodyweight, fixation stiffness, and fracture gap size. By mathematically predicting the time course of the healing process prior to the animal studies, the data presented in this work provides support for planning new fracture healing experiments in rats. Furthermore, it allows one to transfer and compare new in vivo findings to previously performed studies with differing mechanical parameters.	[Wehner, Tim; Steiner, Malte; Ignatius, Anita; Claes, Lutz] Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthoped Res & Biomechan, Ulm, Germany	Ulm University	Steiner, M (corresponding author), Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthoped Res & Biomechan, Ulm, Germany.	malte.steiner@uni-ulm.de	Claes, Lutz/O-4697-2014; Ignatius, Anita/M-6012-2013	Ignatius, Anita/0000-0002-4782-1979; Aegerter, Christof/0000-0002-7200-7987	German Research Foundation [WE 4859/1-1]	German Research Foundation(German Research Foundation (DFG))	This work was funded by the German Research Foundation (WE 4859/1-1), www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372; Checa S, 2011, J BIOMECH, V44, P1237, DOI 10.1016/j.jbiomech.2011.02.074; Checa S, 2009, ANN BIOMED ENG, V37, P129, DOI 10.1007/s10439-008-9594-9; Claes L, 1997, J ORTHOP RES, V15, P577, DOI 10.1002/jor.1100150414; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; Claes L, 2009, J ORTHOP RES, V27, P22, DOI 10.1002/jor.20712; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Geris L, 2010, BIOMECH MODEL MECHAN, V9, P713, DOI 10.1007/s10237-010-0208-8; Gomez-Benito MJ, 2005, J THEOR BIOL, V235, P105, DOI 10.1016/j.jtbi.2004.12.023; GOODSHIP AE, 1985, J BONE JOINT SURG BR, V67, P650, DOI 10.1302/0301-620X.67B4.4030869; Harrison LJ, 2003, J ORTHOP TRAUMA, V17, P11, DOI 10.1097/00005131-200301000-00003; Isaksson H, 2008, J THEOR BIOL, V252, P230, DOI 10.1016/j.jtbi.2008.01.030; Kaspar K, 2007, BIOMED TECH, V52, P383, DOI 10.1515/BMT.2007.063; Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6; Leong PL, 2008, ACTA BIOMATER, V4, P1569, DOI 10.1016/j.actbio.2008.02.030; Mark H, 2005, ACTA ORTHOP, V76, P428, DOI 10.1080/17453670510041349; Mehta M, 2011, CLIN ORTHOP RELAT R, V469, P3102, DOI 10.1007/s11999-011-1914-y; Mehta M, 2011, ARCH ORTHOP TRAUM SU, V131, P121, DOI 10.1007/s00402-010-1155-7; ONI OOA, 1991, CLIN ORTHOP RELAT R, P278; Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6; Recknagel S, 2013, J ORTHOP RES, V31, P465, DOI 10.1002/jor.22242; Recknagel S, 2012, J ORTHOP RES, V30, P581, DOI 10.1002/jor.21561; Recknagel S, 2011, J ORTHOP RES, V29, P734, DOI 10.1002/jor.21299; RUBIN CT, 1987, J ORTHOPAED RES, V5, P300, DOI 10.1002/jor.1100050217; Shefelbine SJ, 2005, J BIOMECH, V38, P2440, DOI 10.1016/j.jbiomech.2004.10.019; Simon U, 2011, COMPUT METHOD BIOMEC, V14, P79, DOI 10.1080/10255842.2010.499865; Smit TH, 2002, J BIOMECH, V35, P829, DOI 10.1016/S0021-9290(02)00021-0; Steiner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101370; Steiner M, 2014, J ORTHOP RES, V32, P865, DOI 10.1002/jor.22617; Steiner M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0389; Strube P, 2008, BONE, V42, P758, DOI 10.1016/S0021-9290(08)70350-6; Strube P, 2009, BONE, V45, P1065, DOI 10.1016/j.bone.2009.08.005; Wehner T, 2014, J ORTHOP RE IN PRESS; Wehner T, 2014, J ORTHOP RES, V32, P1589, DOI 10.1002/jor.22721; Wehner T, 2012, J ORTHOP RES, V30, P569, DOI 10.1002/jor.21568; Wehner T, 2010, J BIOMECH, V43, P2473, DOI 10.1016/j.jbiomech.2010.05.028; Wehner T, 2010, CLIN BIOMECH, V25, P606, DOI 10.1016/j.clinbiomech.2010.03.003	37	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115695	10.1371/journal.pone.0115695	http://dx.doi.org/10.1371/journal.pone.0115695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532060	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100095
J	Zhang, XW; Wang, DF; Zhao, SN; Shen, ZC				Zhang, Xianwen; Wang, Dongfang; Zhao, Sinan; Shen, Zhicheng			A Double Built-In Containment Strategy for Production of Recombinant Proteins in Transgenic Rice	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; USE RESTRICTION TECHNOLOGIES; HUMAN SERUM-ALBUMIN; GENE FLOW; ORYZA-SATIVA; LARGE-SCALE; EXPRESSION; MAIZE; TRANSFORMATION; PURIFICATION	Using transgenic rice as a bioreactor for mass production of pharmaceutical proteins could potentially reduce the cost of production significantly. However, a major concern over the bioreactor transgenic rice is the risk of its unintended spreading into environment and into food or feed supplies. Here we report a mitigating method to prevent unwanted transgenic rice spreading by a double built-in containment strategy, which sets a selectively termination method and a visual tag technology in the T-DNA for transformation. We created transgenic rice with an inserted T-DNA that harbors a human proinsulin gene fused with the far-red fluorescent protein gene mKate_S158A, an RNAi cassette suppressing the expression of the rice bentazon detoxification enzyme CYP81A6, and an EPSPS gene as the selection marker for transformation. Herbicide spray tests indicated that such transgenic rice plants can be killed selectively by a spray of bentazon at regular field application dosage for rice weed control. Moreover, the transgenic rice seeds were bright red in color due to the fused far-red fluorescent protein, and could be easily visualized under daylight by naked eyes. Thus, the transgenic rice plants reported in this study could be selectively killed by a commonly used herbicide during their growth stage, and their seeds may be detected visually during processing and consumption after harvest. This double built-in containment strategy may greatly enhance the confinement of the transgenic rice.	[Zhang, Xianwen; Wang, Dongfang; Zhao, Sinan; Shen, Zhicheng] Zhejiang Univ, Coll Agr & Biotechnol, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Shen, ZC (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	zcshen@zju.edu.cn	zhang, xian/GYA-0290-2022		Department of Agriculture of China [2014ZX08011-006]	Department of Agriculture of China	This work was supported by the Grant from the Department of Agriculture of China (2014ZX08011-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boothe J, 2010, PLANT BIOTECHNOL J, V8, P588, DOI 10.1111/j.1467-7652.2010.00511.x; Breyer D, 2009, J MED PLANTS RES, V3, P825; Chase CD, 2006, TRENDS PLANT SCI, V11, P7, DOI 10.1016/j.tplants.2005.11.003; Chebolu S, 2009, CURR TOP MICROBIOL, V332, P33, DOI 10.1007/978-3-540-70868-1_3; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; DEZOETEN GA, 1989, VIROLOGY, V172, P213, DOI 10.1016/0042-6822(89)90123-2; Feil B, 2003, EUPHYTICA, V130, P163, DOI 10.1023/A:1022843504598; Franz N, 2001, CHEM WEEK, V163, P33; Gressel J, 2010, PLANT SCI, V179, P630, DOI 10.1016/j.plantsci.2010.02.012; Grevich JJ, 2005, CRIT REV PLANT SCI, V24, P83, DOI 10.1080/07352680590935387; Ha SH, 2010, PLANT BIOTECHNOL J, V8, P928, DOI 10.1111/j.1467-7652.2010.00543.x; Haider N, 2009, CURR GENET, V55, P139, DOI 10.1007/s00294-009-0230-5; He Y, 2011, P NATL ACAD SCI USA, V108, P19078, DOI 10.1073/pnas.1109736108; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hileman B, 2003, CHEM ENG NEWS, V81, P30; Hills MJ, 2007, TRENDS PLANT SCI, V12, P177, DOI 10.1016/j.tplants.2007.02.002; Hood EE, 1997, MOL BREEDING, V3, P291, DOI 10.1023/A:1009676322162; Jach G, 2001, PLANT J, V28, P483, DOI 10.1046/j.1365-313X.2001.01153.x; Kamle S, 2013, GENE, V522, P123, DOI 10.1016/j.gene.2013.03.107; Kuo YC, 2013, INT J MOL SCI, V14, P8719, DOI 10.3390/ijms14058719; Lau OS, 2009, BIOTECHNOL ADV, V27, P1015, DOI 10.1016/j.biotechadv.2009.05.005; Lin CY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001818; Lin CY, 2010, PROTEIN EXPRES PURIF, V74, P60, DOI 10.1016/j.pep.2010.04.015; Liu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031625; Luo H, 2005, MOL BREEDING, V16, P185, DOI 10.1007/s11032-005-4784-8; Ma JKC, 2005, EMBO REP, V6, P593, DOI 10.1038/sj.embor.7400470; Mallory-Smith C, 2008, PEST MANAG SCI, V64, P428, DOI 10.1002/ps.1517; Mann DGJ, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-17; Murphy DJ, 2007, PLANT BIOTECHNOL J, V5, P555, DOI 10.1111/j.1467-7652.2007.00278.x; Nishizawa K, 2006, PLANT CELL REP, V25, P1355, DOI 10.1007/s00299-006-0210-x; Ou JQ, 2014, PLANT CELL REP, V33, P585, DOI 10.1007/s00299-013-1559-2; Pan G, 2006, PLANT MOL BIOL, V61, P933, DOI 10.1007/s11103-006-0058-z; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; Qian BJ, 2008, TRANSGENIC RES, V17, P621, DOI 10.1007/s11248-007-9135-6; Ramessar Koreen, 2008, Phytochemistry Reviews, V7, P579, DOI 10.1007/s11101-008-9087-3; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Sang Y, 2013, PLANT BIOTECHNOL J, V11, P649, DOI 10.1111/pbi.12084; Stewart CN, 2001, PLANT CELL REP, V20, P376, DOI 10.1007/s002990100346; Stoger E, 2005, CURR OPIN BIOTECH, V16, P167, DOI 10.1016/j.copbio.2005.01.005; Szymczak- Workman AL, 2012, COLD SPRING HARBOR P, V2012; von der Lippe M, 2007, ECOGRAPHY, V30, P483, DOI 10.1111/j.2007.0906-7590.05072.x; Woodard SL, 2003, BIOTECHNOL APPL BIOC, V38, P123, DOI 10.1042/BA20030026; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x; Yang Y, 2014, PLANT BIOTECHNOL J, V12, P963, DOI 10.1111/pbi.12204; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang NY, 2003, EUPHYTICA, V130, P35, DOI 10.1023/A:1022371104679; Zhang Q, 2013, J ZHEJIANG UNIV-SC B, V14, P867, DOI 10.1631/jzus.B1300090; Zhang Q, 2012, PROTEIN EXPRES PURIF, V82, P279, DOI 10.1016/j.pep.2012.01.011	53	3	3	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115459	10.1371/journal.pone.0115459	http://dx.doi.org/10.1371/journal.pone.0115459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531447	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100069
J	Baumer, N; Baumer, S; Berkenfeld, F; Stehling, M; Kohler, G; Berdel, WE; Muller-Tidow, C; Tschanter, P				Baeumer, Nicole; Baeumer, Sebastian; Berkenfeld, Frank; Stehling, Martin; Koehler, Gabriele; Berdel, Wolfgang E.; Mueller-Tidow, Carsten; Tschanter, Petra			Maintenance of Leukemia-Initiating Cells Is Regulated by the CDK Inhibitor Inca1	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; CYCLIN-DEPENDENT KINASES; MURINE MODEL; SELF-RENEWAL; IN-VIVO; FLT3; GENE; DIFFERENTIATION; P21(CIP1/WAF1)	Functional differences between healthy progenitor and cancer initiating cells may provide unique opportunities for targeted therapy approaches. Hematopoietic stem cells are tightly controlled by a network of CDK inhibitors that govern proliferation and prevent stem cell exhaustion. Loss of Inca1 led to an increased number of short-term hematopoietic stem cells in older mice, but Inca1 seems largely dispensable for normal hematopoiesis. On the other hand, Inca1-deficiency enhanced cell cycling upon cytotoxic stress and accelerated bone marrow exhaustion. Moreover, AML1-ETO9a-induced proliferation was not sustained in Inca1-deficient cells in vivo. As a consequence, leukemia induction and leukemia maintenance were severely impaired in Inca1(-/-) bone marrow cells. The re-initiation of leukemia was also significantly inhibited in absence of Inca1(-/-) in MLL-AF9- and c-myc/BCL2-positive leukemia mouse models. These findings indicate distinct functional properties of Inca1 in normal hematopoietic cells compared to leukemia initiating cells. Such functional differences might be used to design specific therapy approaches in leukemia.	[Baeumer, Nicole; Baeumer, Sebastian; Berkenfeld, Frank; Berdel, Wolfgang E.; Mueller-Tidow, Carsten; Tschanter, Petra] Univ Munster, Dept Med A, D-48129 Munster, Germany; [Baeumer, Nicole; Mueller-Tidow, Carsten; Tschanter, Petra] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48129 Munster, Germany; [Berkenfeld, Frank; Stehling, Martin] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48129 Munster, Germany; [Berkenfeld, Frank] Univ Munster, Fac Med, D-48129 Munster, Germany; [Mueller-Tidow, Carsten; Tschanter, Petra] Univ Halle Wittenberg, Dept Med 4, D-06120 Halle, Germany; [Koehler, Gabriele] Clin Ctr Fulda, Inst Pathol, D-36043 Fulda, Germany	University of Munster; University of Munster; Max Planck Society; University of Munster; Martin Luther University Halle Wittenberg	Baumer, N (corresponding author), Univ Munster, Dept Med A, D-48129 Munster, Germany.	nbaeumer@uni-muenster.de; Carsten.Mueller-Tidow@UK-Halle.de	Baeumer, Sebastian/GYU-0544-2022; Müller-Tidow, Carsten/O-7207-2018	Müller-Tidow, Carsten/0000-0002-7166-5232	IZKF at the University of Munster; Deutsche Forschungsgemeinschaft [Mu1328/6-1]; Deutsche Forschungsgemeinschaft, DFG EXC Cells in Motion - Cluster of Excellence, Munster, Germany [1003]	IZKF at the University of Munster; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft, DFG EXC Cells in Motion - Cluster of Excellence, Munster, Germany	This work is supported by grants from the IZKF at the University of Munster (http://campus.uni-muenster.de/izkf.html), and the Deutsche Forschungsgemeinschaft (Mu1328/6-1; www.dfg.de). Work of W.E.B. is supported by the Deutsche Forschungsgemeinschaft, DFG EXC 1003 Cells in Motion - Cluster of Excellence, Munster, Germany (www.dfg.de). The authors disclose all commercial affiliation and competing financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2008, LEUKEMIA, V22, P78, DOI 10.1038/sj.leu.2404988; Baumer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094993; Baumer N, 2011, J BIOL CHEM, V286, P28210, DOI 10.1074/jbc.M110.203471; Berthet C, 2007, MOL CELL BIOL, V27, P5079, DOI 10.1128/MCB.00029-07; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Bruyere C, 2013, CURR OPIN CELL BIOL, V25, P772, DOI 10.1016/j.ceb.2013.08.004; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; de Guzman CG, 2002, MOL CELL BIOL, V22, P5506, DOI 10.1128/MCB.22.15.5506-5517.2002; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Grundler R, 2005, BLOOD, V105, P4792, DOI 10.1182/blood-2004-11-4430; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Lee BH, 2007, CANCER CELL, V12, P367, DOI 10.1016/j.ccr.2007.08.031; LERNER C, 1990, EXP HEMATOL, V18, P114; Leung AYH, 2013, LEUKEMIA, V27, P260, DOI 10.1038/leu.2012.195; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Metzelder SK, 2012, LEUKEMIA, V26, P2353, DOI 10.1038/leu.2012.105; Nakamura M, 2001, LEUKEMIA, V15, P1136, DOI 10.1038/sj.leu.2402160; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Nishida S, 2006, BLOOD, V107, P3303, DOI 10.1182/blood-2005-04-1656; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Schemionek M, 2010, BLOOD, V115, P3185, DOI 10.1182/blood-2009-04-215376; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Steffen B, 2011, BLOOD, V117, P4328, DOI 10.1182/blood-2009-09-242545; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Tallen G, 2014, FEBS LETT, V588, P2728, DOI 10.1016/j.febslet.2014.03.011; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Walkley CR, 2006, P NATL ACAD SCI USA, V103, P9057, DOI 10.1073/pnas.0603389103; Worch J, 2004, ONCOGENE, V23, P9162, DOI 10.1038/sj.onc.1208164; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Yu H, 2006, BLOOD, V107, P1200, DOI 10.1182/blood-2005-02-0685; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021505; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115578	10.1371/journal.pone.0115578	http://dx.doi.org/10.1371/journal.pone.0115578			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525809	Green Submitted, Green Published, gold			2022-12-26	WOS:000347186200036
J	Lindberg, MH; Wettergren, L; Wiklander, M; Svedhem-Johansson, V; Eriksson, LE				Lindberg, Maria H.; Wettergren, Lena; Wiklander, Maria; Svedhem-Johansson, Veronica; Eriksson, Lars E.			Psychometric Evaluation of the HIV Stigma Scale in a Swedish Context	PLOS ONE			English	Article							QUALITY-OF-LIFE; YOUNG MEN; HEALTH; HIV/AIDS; SAMPLE; EXPERIENCES; FRAMEWORK; IMPACT; WOMEN	Background: HIV-related stigma has negative consequences for infected people's lives and is a barrier to HIV prevention. Therefore valid and reliable instruments to measure stigma are needed to enable mapping of HIV stigma. This study aimed to evaluate the psychometric properties of the HIV stigma scale in a Swedish context with regard to construct validity, data quality, and reliability. Methods: The HIV stigma scale, developed by Berger, Ferrans, and Lashley (2001), was distributed to a cross-sectional sample of people living with HIV in Sweden (n=194). The psychometric evaluation included exploratory factor analysis together with an analysis of the distribution of scores, convergent validity by correlations between the HIV stigma scale and measures of emotional well-being, and an analysis of missing items and floor and ceiling effects. Reliability was assessed using Cronbach's alpha. Results: The exploratory factor analysis suggested a four-factor solution, similar to the original scale, with the dimensions personalised stigma, disclosure concerns, negative self-image, and concerns with public attitudes. One item had unacceptably low loadings and was excluded. Correlations between stigma dimensions and emotional well-being were all in the expected direction and ranged between -0.494 and -0.210. The instrument generated data of acceptable quality except for participants who had not disclosed their HIV status to anybody. In line with the original scale, all subscales demonstrated acceptable internal consistency with Cronbach's alpha 0.87-0.96. Conclusion: A 39-item version of the HIV stigma scale used in a Swedish context showed satisfactory construct validity and reliability. Response alternatives are suggested to be slightly revised for items assuming the disclosure of diagnosis to another person. We recommend that people that have not disclosed should skip all questions belonging to the dimension personalised stigma. Our analysis confirmed construct validity of the instrument even without this dimension.	[Lindberg, Maria H.; Wettergren, Lena; Wiklander, Maria; Eriksson, Lars E.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Wiklander, Maria] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden; [Svedhem-Johansson, Veronica; Eriksson, Lars E.] Karolinska Univ Hosp, Dept Infect Dis, Huddinge, Sweden; [Svedhem-Johansson, Veronica] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden; [Eriksson, Lars E.] City Univ London, Sch Hlth Sci, London EC1V 0HB, England	Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; City University London	Eriksson, LE (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden.	lars.eriksson@ki.se	Wiklander, Maria/N-1634-2014; Reinius, Maria/AAA-2277-2022	Wiklander, Maria/0000-0002-8250-3773; Reinius, Maria/0000-0003-0864-8701	National Research School in Health Care Sciences, Karolinska Institutet, Stockholm, Sweden	National Research School in Health Care Sciences, Karolinska Institutet, Stockholm, Sweden	The study was financially supported by the National Research School in Health Care Sciences, Karolinska Institutet, Stockholm, Sweden (partial PhD studentship grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; BRORSSON B, 1993, QUAL LIFE RES, V2, P33, DOI 10.1007/BF00642887; Buseh AG, 2008, PUBLIC HEALTH NURS, V25, P409, DOI 10.1111/j.1525-1446.2008.00725.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dowshen N, 2009, AIDS PATIENT CARE ST, V23, P371, DOI 10.1089/apc.2008.0256; Earnshaw VA, 2013, AIDS BEHAV, V17, P1785, DOI 10.1007/s10461-013-0437-9; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Emlet CA, 2007, AIDS PATIENT CARE ST, V21, P740, DOI 10.1089/apc.2007.0010; Eriksson Lars E, 2005, Health Qual Life Outcomes, V3, P32, DOI 10.1186/1477-7525-3-32; Eriksson LE, 2000, J ADV NURS, V32, P1213, DOI 10.1046/j.1365-2648.2000.01592.x; Eriksson LE, 2012, POSITIVE LIFE STATE; Fife BL, 2000, J HEALTH SOC BEHAV, V41, P50, DOI 10.2307/2676360; Fonteyn Marsha E, 1993, QUAL HEALTH RES, V3, P430, DOI 10.1177/104973239300300403; Fortenberry JD, 2002, AM J PUBLIC HEALTH, V92, P378, DOI 10.2105/AJPH.92.3.378; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Holzemer WL, 2009, J ASSOC NURSE AIDS C, V20, P161, DOI 10.1016/j.jana.2009.02.002; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Maughan-Brown B, 2014, AIDS BEHAV, V18, P958, DOI 10.1007/s10461-013-0636-4; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; R Core Team, 2021, R LANGUAGE ENV STAT; Raiche G, 2011, R PACKAGE PARALLEL A; Saris-Baglama RN., 2004, SF HLTH OUTCOMES SCO, DOI Lincoln; Sayles JN, 2008, AIDS BEHAV, V12, P748, DOI 10.1007/s10461-008-9375-3; Sowell RL, 1997, PUBLIC HEALTH NURS, V14, P302, DOI 10.1111/j.1525-1446.1997.tb00379.x; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Vanable PA, 2006, AIDS BEHAV, V10, P473, DOI 10.1007/s10461-006-9099-1; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P945, DOI 10.1016/S0895-4356(98)00085-7; Wiklander M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-195; Willis BG, 2005, COGNITIVE INTERVIEWI; Wright K, 2007, J ADOLESCENT HEALTH, V40, P96, DOI 10.1016/j.jadohealth.2006.08.001	35	26	27	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114867	10.1371/journal.pone.0114867	http://dx.doi.org/10.1371/journal.pone.0114867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA4AC	25522127	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000348845600009
J	Woo, HG; Kim, SS; Cho, H; Kwon, SM; Cho, HJ; Ahn, SJ; Park, ES; Lee, JS; Cho, SW; Cheong, JY				Woo, Hyun Goo; Kim, Soon Sun; Cho, Hyunwoo; Kwon, So Mee; Cho, Hyo Jung; Ahn, Seun Joo; Park, Eun Sung; Lee, Ju-Seog; Cho, Sung Won; Cheong, Jae Youn			Profiling of Exome Mutations Associated with Progression of HBV-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							BETA-CATENIN MUTATIONS; DNA-SEQUENCING DATA; HEPATITIS-B-VIRUS; RECURRENT MUTATIONS; SOMATIC MUTATIONS; TUMOR PROGRESSION; GENOME; CANCER; LIVER; GENES	Recent advances in sequencing technology have allowed us to profile genome-wide mutations of various cancer types, revealing huge heterogeneity of cancer genome variations. However, its heterogeneous landscape of somatic mutations according to liver cancer progression is not fully understood. Here, we profiled the mutations and gene expressions of early and advanced hepatocellular carcinoma (HCC) related with Hepatitis B-viral infection. Integrative analysis was performed with whole-exome sequencing and gene expression profiles of the 12 cases of early and advanced HCCs and paired non-tumoral adjacent liver tissues. A total of 293 tumor-specific somatic variants and 202 non-tumoral variants were identified. The tumor-specific variants were found to be enriched at chromosome 1q particularly in the advanced HCC, compared to the non-tumoral variants. Functional enrichment analysis revealed frequent mutations at the genes encoding cytoskeleton organization, cell adhesion, and cell cycle-related genes. In addition, to elucidate actionable somatic mutations, we performed an integrative analysis of gene mutations and gene expression profiles together. This revealed the 48 mutated genes which were differentially mutated with concomitant gene expression enrichment. Of these, CTNNB1 was found to have a pivotal role in the differential progression of the HCC subgroup. In conclusion, our integrative analysis of whole-exome sequencing and transcriptome profiles could provide actionable mutations which might play pivotal roles in the heterogeneous progression of HCC.	[Woo, Hyun Goo; Cho, Hyunwoo; Kwon, So Mee] Ajou Univ, Dept Physiol, Sch Med, Suwon 441749, South Korea; [Kim, Soon Sun; Ahn, Seun Joo; Cho, Sung Won; Cheong, Jae Youn] Ajou Univ, Dept Gastroenterol, Sch Med, Suwon 441749, South Korea; [Woo, Hyun Goo; Cho, Hyunwoo; Kwon, So Mee; Cho, Hyo Jung] Ajou Univ, Grad Sch Biomed Sci, Sch Med, Suwon 441749, South Korea; [Park, Eun Sung] Yonsei Univ, Coll Med, Inst Med Convergence, Seoul, South Korea; [Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Ajou University; Ajou University; Ajou University; Yonsei University; Yonsei University Health System; University of Texas System; UTMD Anderson Cancer Center	Cheong, JY (corresponding author), Ajou Univ, Dept Gastroenterol, Sch Med, Suwon 441749, South Korea.	jaeyoun620@gmail.com	Woo, Hyun Goo/AEJ-7372-2022; Woo, Hyun Goo | 우현구/I-8954-2019; Lee, Ju-Seog/X-1786-2018	Woo, Hyun Goo/0000-0002-0916-893X; Woo, Hyun Goo | 우현구/0000-0002-0916-893X; Lee, Ju-Seog/0000-0002-5666-9753	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111574]	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant (A111574) of the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Calvisi DF, 2001, CANCER RES, V61, P2085; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Cleary SP, 2013, HEPATOLOGY, V58, P1693, DOI 10.1002/hep.26540; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gartner JJ, 2013, P NATL ACAD SCI USA, V110, P13481, DOI 10.1073/pnas.1304227110; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang H, 1999, AM J PATHOL, V155, P1795, DOI 10.1016/S0002-9440(10)65496-X; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Ikeda A, 2014, GASTROENTEROLOGY, V146, P222, DOI 10.1053/j.gastro.2013.09.025; Inagawa S, 2002, CLIN CANCER RES, V8, P450; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Kwon So Mee, 2012, Genomics & Informatics, V10, P69, DOI 10.5808/GI.2012.10.2.69; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Nakagawa H, 2013, CANCER LETT, V340, P234, DOI 10.1016/j.canlet.2012.10.035; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Poon TCW, 2006, GASTROENTEROLOGY, V131, P1262, DOI 10.1053/j.gastro.2006.08.014; Sung WK, 2012, NAT GENET; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Tao Y, 2011, P NATL ACAD SCI USA, V108, P12042, DOI 10.1073/pnas.1108715108; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang QG, 2013, GENOME MED, V5, DOI 10.1186/gm495; Woo HG, 2011, GASTROENTEROLOGY, V140, P1063, DOI 10.1053/j.gastro.2010.11.034; Woo HG, 2010, CANCER RES, V70, P3034, DOI 10.1158/0008-5472.CAN-09-2823; Woo HG, 2009, CANCER RES, V69, P4059, DOI 10.1158/0008-5472.CAN-09-0164; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622	40	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115152	10.1371/journal.pone.0115152	http://dx.doi.org/10.1371/journal.pone.0115152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521761	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845600019
J	Yin, T; Shi, PF; Gou, SM; Shen, Q; Wang, CY				Yin, Tao; Shi, Pengfei; Gou, Shanmiao; Shen, Qiang; Wang, Chunyou			Dendritic Cells Loaded with Pancreatic Cancer Stem Cells (CSCs) Lysates Induce Antitumor Immune Killing Effect In Vitro	PLOS ONE			English	Article							INITIATING CELLS; RESISTANCE; GLIOBLASTOMA; POPULATIONS; VACCINATION; MELANOMA; CD133	According to the cancer stem cells (CSCs) theory, malignant tumors may be heterogeneous in which a small population of CSCs drive the progression of cancer. Because of their intrinsic abilities, CSCs may survive a variety of treatments and then lead to therapeutic resistance and cancer recurrence. Pancreatic CSCs have been reported to be responsible for the malignant behaviors of pancreatic cancer, including suppression of immune protection. Thus, development of immune strategies to eradicate pancreatic CSCs may be of great value for the treatment of pancreatic cancer. In this study, we enriched pancreatic CSCs by culturing Panc-1 cells under sphere-forming conditions. Panc-1 CSCs expressed low levels of HLA-ABC and CD86, as measured by flow cytometry analysis. We further found that the Panc-1 CSCs modulate immunity by inhibiting lymphocyte proliferation which is promoted by phytohemagglutinin (PHA) and anti-CD3 monoclonal antibodies. The monocyte derived dendritic cells (DCs) were charged with total lysates generated from Panc-1 CSCs obtained from tumor sphere culturing. After co-culturing with lymphocytes at different ratios, the Panc-1 CSCs lysates modified DC effectively promoted lymphocyte proliferation. The activating efficiency reached 72.4% and 74.7% at the ratios of 1: 10 and 1: 20 with lymphocytes. The activated lymphocytes secreted high levels of INF-gamma and IL-2, which are strong antitumor cytokines. Moreover, Panc-1 CSCs lysates modified DC induced significant cytotoxic effects of lymphocytes on Panc-1 CSCs and parental Panc-1 cells, respectively, as shown by lactate dehydrogenase (LDH) assay. Our study demonstrates that the development of CSCs-based vaccine is a promising strategy for treating pancreatic cancer.	[Yin, Tao; Shi, Pengfei; Gou, Shanmiao; Wang, Chunyou] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Pancreat Dis Inst,Dept Gen Surg, Wuhan 430074, Hubei, Peoples R China; [Shen, Qiang] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA	Huazhong University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center	Yin, T (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Pancreat Dis Inst,Dept Gen Surg, 1277 Jiefang Ave, Wuhan 430074, Hubei, Peoples R China.	ytwhun@126.com; chunyouwang52@126.com		Shen, Qiang/0000-0002-1491-5434	National Natural Science Foundation of China [30801100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (No. 30801100).	Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Goldszmid RS, 2003, J IMMUNOL, V171, P5940, DOI 10.4049/jimmunol.171.11.5940; Gou SM, 2007, PANCREAS, V34, P429, DOI 10.1097/MPA.0b013e318033f9f4; Hayashi T, 2002, CLIN IMMUNOL, V104, P14, DOI 10.1006/clim.2002.5224; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Lee HJ, 2011, J KOREAN SURG SOC, V81, P263, DOI 10.4174/jkss.2011.81.4.263; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Mimeault M, 2007, J CELL MOL MED, V11, P981, DOI 10.1111/j.1582-4934.2007.00088.x; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Schatton T, 2010, CANCER RES, V70, P697, DOI 10.1158/0008-5472.CAN-09-1592; Simeone DM, 2008, CLIN CANCER RES, V14, P5646, DOI 10.1158/1078-0432.CCR-08-0584; Spisek R, 2007, J EXP MED, V204, P831, DOI 10.1084/jem.20062387; Vik-Mo EO, 2013, CANCER IMMUNOL IMMUN, V62, P1499, DOI 10.1007/s00262-013-1453-3; Wei J, 2010, CLIN CANCER RES, V16, P461, DOI 10.1158/1078-0432.CCR-09-1983; Wei J, 2010, MOL CANCER THER, V9, P67, DOI 10.1158/1535-7163.MCT-09-0734; Wu AH, 2007, J NEURO-ONCOL, V83, P121, DOI 10.1007/s11060-006-9265-3; Xu QJ, 2009, STEM CELLS, V27, P1734, DOI 10.1002/stem.102; Yin T, 2011, INT J MOL SCI, V12, P1595, DOI 10.3390/ijms12031595	21	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114581	10.1371/journal.pone.0114581	http://dx.doi.org/10.1371/journal.pone.0114581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521461	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845600004
J	Gourlay, K; Hu, JG; Arantes, V; Penttila, M; Saddler, JN				Gourlay, Keith; Hu, Jinguang; Arantes, Valdeir; Penttila, Merja; Saddler, Jack N.			The Use of Carbohydrate Binding Modules (CBMs) to Monitor Changes in Fragmentation and Cellulose Fiber Surface Morphology during Cellulase- and Swollenin-induced Deconstruction of Lignocellulosic Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellulase; Cellulose; Enzyme; Fungi; Microbiology; Amorphogenesis; Cellulose Binding Modules; Fiber Dislocations; Swollenin; Fragmentation; Carbohydrate Binding Modules (CBMs); Confocal Microscopy	ENZYMATIC-HYDROLYSIS; PULP FIBERS; AMORPHOGENESIS STEP; CRYSTAL-STRUCTURE; PROTEIN; DISLOCATIONS; ACCESSIBILITY; DISRUPTION; INSIGHTS; EXPANSIN	Background: Fiber fragmentation is thought to occur at dislocations, which are potential targets for the non-hydrolytic protein, Swollenin. Results: Changes in cellulose morphology within dislocations were assessed using fluorescent CBMs; Swollenin appeared to promote fragmentation at these sites. Conclusion: Swollenin targets and disrupts cellulose at fiber dislocations. Significance: Fragmentation is a key step in cellulose deconstruction and is enhanced by the actions of Swollenin. Although the actions of many of the hydrolytic enzymes involved in cellulose hydrolysis are relatively well understood, the contributions that amorphogenesis-inducing proteins might contribute to cellulose deconstruction are still relatively undefined. Earlier work has shown that disruptive proteins, such as the non-hydrolytic non-oxidative protein Swollenin, can open up and disaggregate the less-ordered regions of lignocellulosic substrates. Within the cellulosic fraction, relatively disordered, amorphous regions known as dislocations are known to occur along the length of the fibers. It was postulated that Swollenin might act synergistically with hydrolytic enzymes to initiate biomass deconstruction within these dislocation regions. Carbohydrate binding modules (CBMs) that preferentially bind to cellulosic substructures were fluorescently labeled. They were imaged, using confocal microscopy, to assess the distribution of crystalline and amorphous cellulose at the fiber surface, as well as to track changes in surface morphology over the course of enzymatic hydrolysis and fiber fragmentation. Swollenin was shown to promote targeted disruption of the cellulosic structure at fiber dislocations.	[Gourlay, Keith; Hu, Jinguang; Arantes, Valdeir; Saddler, Jack N.] Univ British Columbia, Fac Forestry, Dept Wood Sci, Forest Prod Biotechnol Bioenergy Grp, Vancouver, BC V6T 1Z4, Canada; [Penttila, Merja] VTT Tech Res Ctr Finland, FI-02044 Espoo, Vtt, Finland	University of British Columbia; VTT Technical Research Center Finland	Saddler, JN (corresponding author), Univ British Columbia, Fac Forestry, Dept Wood Sci, Forest Prod Biotechnol Bioenergy Grp, 2424 Main Mall, Vancouver, BC V6T 1Z4, Canada.	jack.saddler@ubc.ca	Penttilä, Merja E/A-4710-2013; Arantes, Valdeir/A-3442-2015	Arantes, Valdeir/0000-0001-9565-1006; Hu, Jinguang/0000-0001-8033-7102; Penttila, Merja/0000-0002-6929-1032	Natural Sciences and Engineering Council [16]; fungi of Canada (NSERC); Bioconversion Network	Natural Sciences and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); fungi of Canada (NSERC); Bioconversion Network	This work was supported by the Natural Sciences and Engineering Council (16)), and fungi of Canada (NSERC) and the Bioconversion Network.	Ander P, 2008, BIORESOURCES, V3, P477; Arantes V, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-87; Arantes V, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-3; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Baley C, 2004, J MATER SCI, V39, P331, DOI 10.1023/B:JMSC.0000007768.63055.ae; BEREZIN I V, 1977, Biokhimiya, V42, P1631; Berlin A, 2006, BIOTECHNOL BIOENG, V93, P880, DOI 10.1002/bit.20783; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Clarke K, 2011, BIOMASS BIOENERG, V35, P3943, DOI 10.1016/j.biombioe.2011.06.007; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Del Rio LF, 2012, BIORESOURCE TECHNOL, V107, P235, DOI 10.1016/j.biortech.2011.12.057; DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096; Ding SY, 2006, BIOTECHNIQUES, V41, P435, DOI 10.2144/000112244; Du RY, 2013, RSC ADV, V3, P1871, DOI 10.1039/c2ra21781c; Eder M, 2008, HOLZFORSCHUNG, V62, P77, DOI 10.1515/HF.2008.011; Filonova L, 2007, BIOMACROMOLECULES, V8, P91, DOI 10.1021/bm060632z; Fox JM, 2013, NAT CHEM BIOL, V9, P356, DOI 10.1038/nchembio.1227; Gao SH, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-24; Gourlay K, 2013, BIORESOURCE TECHNOL, V142, P498, DOI 10.1016/j.biortech.2013.05.053; Gourlay K, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-51; HALLIWELL G, 1970, BIOCHEM J, V116, P35, DOI 10.1042/bj1160035; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hidayat BJ, 2012, CELLULOSE, V19, P1481, DOI 10.1007/s10570-012-9740-2; Hilden L, 2003, BIOTECHNOL LETT, V25, P553, DOI 10.1023/A:1022846304826; Hu JG, 2014, ENERG ENVIRON SCI, V7, P2308, DOI 10.1039/c4ee00891j; Hu JG, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-36; Huang WD, 2011, ENERG ENVIRON SCI, V4, P784, DOI 10.1039/c0ee00069h; Jager G, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-33; Kang K, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-42; Karlsson J, 2001, EUR J BIOCHEM, V268, P6498, DOI 10.1046/j.0014-2956.2001.02605.x; Kawakubo T, 2010, BIOTECHNOL BIOENG, V105, P499, DOI 10.1002/bit.22550; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Kristensen JB, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-11; Lee HJ, 2010, MOL CELLS, V29, P379, DOI 10.1007/s10059-010-0033-z; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; McLean BW, 2002, J BIOL CHEM, V277, P50245, DOI 10.1074/jbc.M204433200; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nyholm K, 2001, NORD PULP PAP RES J, V16, P376, DOI 10.3183/npprj-2001-16-04-p376-384; ONG E, 1993, BIOTECHNOL BIOENG, V42, P401, DOI 10.1002/bit.260420402; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Quiroz-Castaneda RE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-8; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Starcher B, 2001, ANAL BIOCHEM, V292, P125, DOI 10.1006/abio.2001.5050; Thygesen LG, 2007, J MATER SCI, V42, P558, DOI 10.1007/s10853-006-1113-5; Thygesen LG, 2011, J IND MICROBIOL BIOT, V38, P975, DOI 10.1007/s10295-010-0870-y; Tozzi EJ, 2014, AICHE J, V60, P1582, DOI 10.1002/aic.14374; Tu MB, 2007, BIOTECHNOL PROGR, V23, P1130, DOI 10.1021/bp070129d; WALKER LP, 1992, BIOTECHNOL BIOENG, V40, P1019, DOI 10.1002/bit.260400905	49	35	35	0	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2938	2945		10.1074/jbc.M114.627604	http://dx.doi.org/10.1074/jbc.M114.627604			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25527502	Green Published, hybrid			2022-12-26	WOS:000349310700032
J	Basson, M; Farley, JH				Basson, Marinelle; Farley, Jessica H.			A Standardised Abundance Index from Commercial Spotting Data of Southern Bluefin Tuna (Thunnus maccoyii): Random Effects to the Rescue	PLOS ONE			English	Article							THYNNUS; CATCH	Commercial aerial spotting of surface schools of juvenile southern bluefin tuna (SBT), Thunnus maccoyii, is conducted as part of fishing operations in the Great Australian Bight in summer. This provides the opportunity to efficiently collect large amounts of data on sightings of SBT. The data can potentially be used to construct a time-series index of relative abundance by standardising the data for issues such as weather, spotter ability and ocean conditions. Unlike a statistically designed survey, the commercial spotting is governed by business considerations and fishing operations. The SBT dataset is therefore highly unbalanced with regard to spotters operating in each season. This complicates the standardisation of the data, particularly with regard to interactions between covariates. We show how a generalized additive model with random effects can simplify both the fitting of the model and the construction of an index, while also avoiding the need to leave out strata or interaction terms that are important. The approach is applicable to standardisation of more traditional catch and effort data.	[Basson, Marinelle; Farley, Jessica H.] CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Farley, JH (corresponding author), CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia.	jessica.farley@csiro.au	Farley, Jessica/E-4957-2014	Farley, Jessica/0000-0002-5047-746X	Australian Fisheries Management Authority; Australian Government Department of Agriculture; CSIRO's Wealth from Ocean Flagship	Australian Fisheries Management Authority; Australian Government Department of Agriculture(Australian Government); CSIRO's Wealth from Ocean Flagship	This work was supported by funding from the Australian Fisheries Management Authority, the Australian Government Department of Agriculture and CSIRO's Wealth from Ocean Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, 18 ANN M COMM COMM C; [Anonymous], 2001, 2 M STOCK ASS GROUP; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2008, 9 M STOCK ASS GROUP; Basson M., 2012, SPATIAL INTERACTIONS; Bravington M, 2002, 3 CCSBT STOCK ASS GR; Candy SG, 2004, CCAMLR SCI, V11, P59; Caton A.E., 1991, WORLD M STOCK ASSESS, V7, P181; Eveson JP, 2013, 18 M CCSBT SCI COMM; Glencross BD, 2002, J WORLD AQUACULT SOC, V33, P138, DOI 10.1111/j.1749-7345.2002.tb00488.x; Gunn J, 2001, TUNA PHYSL ECOLOGY E, P167, DOI DOI 10.1016/S1546-5098(01)19006-0; Hartog J.R., 2011, SDODE SPATIAL DYNAMI; Hobday A, 2004, 9 M CCSBT SCI COMM 1; Jorgensen B., 1997, THEORY DISPERSION MO; Klaer N, 2002, R991498 CSIRO; LO NCH, 1992, CAN J FISH AQUAT SCI, V49, P2515, DOI 10.1139/f92-278; LUTCAVAGE M, 1995, FISH B-NOAA, V93, P495; Lutcavage M, 1997, COLL SCI PAP INT COM, V46, P332; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Royer F, 2004, MAR ECOL PROG SER, V269, P249, DOI 10.3354/meps269249; Schick RS, 2004, FISH OCEANOGR, V13, P225, DOI 10.1111/j.1365-2419.2004.00290.x; SQUIRE JL, 1993, FISH B-NOAA, V91, P348; Venables WN, 2004, FISH RES, V70, P319, DOI 10.1016/j.fishres.2004.08.011; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	25	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116245	10.1371/journal.pone.0116245	http://dx.doi.org/10.1371/journal.pone.0116245			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541730	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900157
J	Bancone, G; Chu, CS; Somsakchaicharoen, R; Chowwiwat, N; Parker, DM; Charunwatthana, P; White, NJ; Nosten, FH				Bancone, Germana; Chu, Cindy S.; Somsakchaicharoen, Raweewan; Chowwiwat, Nongnud; Parker, Daniel M.; Charunwatthana, Prakaykaew; White, Nicholas J.; Nosten, Francois H.			Characterization of G6PD Genotypes and Phenotypes on the Northwestern Thailand-Myanmar Border	PLOS ONE			English	Article							MOLECULAR HETEROGENEITY; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; COMMON VARIANT; MUTATIONS; POLYMORPHISM; BURMESE; MAHIDOL	Mutations in the glucose-6-phosphate dehydrogenase (G6PD) gene result in red blood cells with increased susceptibility to oxidative damage. Significant haemolysis can be caused by primaquine and other 8-aminoquinoline antimalarials used for the radical treatment of Plasmodium vivax malaria. The distribution and phenotypes of mutations causing G6PD deficiency in the male population of migrants and refugees in a malaria endemic region on the Thailand-Myanmar border were characterized. Blood samples for G6PD fluorescent spot test (FST), G6PD genotyping, and malaria testing were taken from 504 unrelated males of Karen and Burman ethnicities presenting to the outpatient clinics. The overall frequency of G6PD deficiency by the FST was 13.7%. Among the deficient subjects, almost 90% had the Mahidol variant (487G>A) genotype. The remaining subjects had Chinese-4 (392G>T), Viangchan (871G>A), Acores (595A>G), Seattle (844G>C) and Mediterranean (563C>T) variants. Quantification of G6PD activity was performed using a modification of the standard spectrophotometric assay on a subset of 24 samples with Mahidol, Viangchan, Seattle and Chinese-4 mutations; all samples showed a residual enzymatic activity below 10% of normal and were diagnosed correctly by the FST. Further studies are needed to characterise the haemolytic risk of using 8-aminoquinolines in patients with these genotypes.	[Bancone, Germana; Chu, Cindy S.; Somsakchaicharoen, Raweewan; Chowwiwat, Nongnud; Parker, Daniel M.; Nosten, Francois H.] Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand; [Charunwatthana, Prakaykaew; White, Nicholas J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [White, Nicholas J.; Nosten, Francois H.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Bancone, G (corresponding author), Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand.	germana@tropmedres.ac	Parker, Daniel M./B-5471-2013; Chu, Cindy S/E-3135-2014; Nosten, Francois/AAC-5509-2019; White, Nick/AAC-6527-2019	Parker, Daniel M./0000-0002-5352-7338; Chu, Cindy S/0000-0001-9465-8214; Nosten, Francois/0000-0002-7951-0745; White, Nick/0000-0002-1897-1978; Bancone, Germana/0000-0003-4550-0431	Wellcome Trust [089179]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by the Wellcome Trust (Programme Grant 089179) and was part of the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algur N, 2012, J PEDIATR-US, V161, P197, DOI 10.1016/j.jpeds.2012.02.045; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; BEUTLER E, 1977, BRIT J HAEMATOL, V35, P331, DOI 10.1111/j.1365-2141.1977.tb00589.x; BEUTLER E, 1990, AM J HUM GENET, V47, P1008; Cabrera VM, 1996, HUM HERED, V46, P197, DOI 10.1159/000154353; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CAPPELLINI MD, 1995, HUM GENET, V95, P440, DOI 10.1007/BF00208972; Carrara VI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001398; Chesher Douglas, 2008, Clin Biochem Rev, V29 Suppl 1, pS23; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; De Araujo C, 2006, HAEMATOL-HEMATOL J, V91, P262; Howes RE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-418; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Huang CS, 1996, AM J HEMATOL, V51, P19, DOI 10.1002/(SICI)1096-8652(199601)51:1<19::AID-AJH4>3.0.CO;2-A; Huang YX, 2008, MOL GENET METAB, V93, P44, DOI 10.1016/j.ymgme.2007.08.122; Iwai K, 2001, HUM GENET, V108, P445, DOI 10.1007/s004390100527; Jalloh A, 2008, J HUM GENET, V53, P675, DOI 10.1007/s10038-008-0294-y; Jamornthanyawat N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088605; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028357; Laosombat V, 2005, BLOOD CELL MOL DIS, V34, P191, DOI 10.1016/j.bcmd.2004.11.001; Luzzatto L, 2009, GLUCOSE 6 PHOSPHATE; Manco L, 2007, HAEMATOLOGICA, V92, P1713, DOI 10.3324/haematol.11670; Matsuoka H, 2005, J HUM GENET, V50, P468, DOI 10.1007/s10038-005-0279-z; Matsuoka H, 2004, J HUM GENET, V49, P544, DOI 10.1007/s10038-004-0187-7; Matsuoka H, 2007, ACTA MED OKAYAMA, V61, P213; Menounos P, 2000, HUM HERED, V50, P237, DOI 10.1159/000022922; Nguyen TH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-152; Nuchprayoon I, 2002, Hum Mutat, V19, P185, DOI 10.1002/humu.9010; Nuchprayoon I, 2008, J HUM GENET, V53, P48, DOI 10.1007/s10038-007-0217-3; PANICH V, 1972, Journal of the Medical Association of Thailand, V55, P576; Phompradit P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-368; SALVIDIO E, 1969, ACTA HAEMATOL-BASEL, V41, P331, DOI 10.1159/000208870; Sanders S, 1997, MUTAT RES-FUND MOL M, V374, P79, DOI 10.1016/S0027-5107(96)00222-9; Sriprawat K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-115; VULLIAMY TJ, 1989, NUCLEIC ACIDS RES, V17, P5868, DOI 10.1093/nar/17.14.5868; Yan TZ, 2006, HAEMATOLOGICA, V91, P1321	36	56	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e0116063	10.1371/journal.pone.0116063	http://dx.doi.org/10.1371/journal.pone.0116063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536053	Green Published, gold			2022-12-26	WOS:000348563300098
J	Du, JH; Forster, B; Rourke, L; Howitt, SM; Price, GD				Du, Jiahui; Foerster, Britta; Rourke, Loraine; Howitt, Susan M.; Price, G. Dean			Characterisation of Cyanobacterial Bicarbonate Transporters in E. coli Shows that SbtA Homologs Are Functional in This Heterologous Expression System	PLOS ONE			English	Article							STRAIN PCC 7942; GLNK COMPLEX REVEALS; ESCHERICHIA-COLI; CO2 FIXATION; IDENTIFICATION; GENES; PHOTOSYNTHESIS; CARBOXYSOMES; COMPONENTS; DIVERSITY	Cyanobacterial HCO3- transporters BCT1, SbtA and BicA are important components of cyanobacterial CO2-concentration mechanisms. They also show potential in applications aimed at improving photosynthetic rates and yield when expressed in the chloroplasts of C3 crop species. The present study investigated the feasibility of using Escherichia coli to assess function of a range of SbtA and BicA transporters in a heterologous expression system, ultimately for selection of transporters suitable for chloroplast expression. Here, we demonstrate that six beta-forms of SbtA are active in E. coli, although other tested bicarbonate transporters were inactive. The sbtA clones were derived from Synechococcus sp. WH5701, Cyanobium sp. PCC7001, Cyanobium sp. PCC6307, Synechococcus elongatus PCC7942, Synechocystis sp. PCC6803, and Synechococcus sp. PCC7002. The six SbtA homologs varied in bicarbonate uptake kinetics and sodium requirements in E. coli. In particular, SbtA from PCC7001 showed the lowest uptake affinity and highest flux rate and was capable of increasing the internal inorganic carbon pool by more than 8 mM relative to controls lacking transporters. Importantly, we were able to show that the SbtB protein (encoded by a companion gene near sbtA) binds to SbtA and suppresses bicarbonate uptake function of SbtA in E. coli, suggesting a role in post-translational regulation of SbtA, possibly as an inhibitor in the dark. This study established E. coli as a heterologous expression and analysis system for HCO3- transporters from cyanobacteria, and identified several SbtA transporters as useful for expression in the chloroplast inner envelope membranes of higher plants.	[Du, Jiahui; Foerster, Britta; Rourke, Loraine; Howitt, Susan M.; Price, G. Dean] Australian Natl Univ, Plant Sci Div, Realizing Increased Photosynthet Efficiency RIPE, Res Sch Biol, Canberra, ACT 2601, Australia	Australian National University	Price, GD (corresponding author), Australian Natl Univ, Plant Sci Div, Realizing Increased Photosynthet Efficiency RIPE, Res Sch Biol, Linnaeus Bldg 134, Canberra, ACT 2601, Australia.	dean.price@anu.edu.au	Price, G Dean/C-9505-2009; Förster, Britta/O-7908-2015	Price, G Dean/0000-0001-5906-4912; 	Australian Research Council	Australian Research Council(Australian Research Council)	Funding provided by an Australian Research Council to GDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; Durand A, 2006, J BIOL CHEM, V281, P29558, DOI 10.1074/jbc.M602477200; Evans JR, 1996, PLANT PHYSIOL, V110, P339, DOI 10.1104/pp.110.2.339; Herrera-Estrella LR, 2000, PLANT PHYSIOL, V124, P923, DOI 10.1104/pp.124.3.923; Imamura T, 2006, ENCY SURFACE COLLOID; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Karley AJ, 2000, TRENDS PLANT SCI, V5, P465, DOI 10.1016/S1360-1385(00)01758-1; Kimball BA, 2002, ADV AGRON, V77, P293, DOI 10.1016/S0065-2113(02)77017-X; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Maeda S, 1998, J BACTERIOL, V180, P4080, DOI 10.1128/JB.180.16.4080-4088.1998; Maeda S, 2000, J BIOL CHEM, V275, P20551, DOI 10.1074/jbc.M003034200; Merlin C, 2003, J BACTERIOL, V185, P6415, DOI 10.1128/JB.185.21.6415-6424.2003; Narayanan M, 2013, J BIOL CHEM, V288, P14310, DOI 10.1074/jbc.M113.467803; Omata T, 1999, P NATL ACAD SCI USA, V96, P13571, DOI 10.1073/pnas.96.23.13571; Pengelly JJL, 2014, J EXP BOT, V65, P3071, DOI 10.1093/jxb/eru156; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Price GD, 2014, MOL MEMBR BIOL, V31, P177, DOI 10.3109/09687688.2014.953222; Price GD, 2013, J EXP BOT, V64, P753, DOI 10.1093/jxb/ers257; Price GD, 2011, MOL MEMBR BIOL, V28, P265, DOI 10.3109/09687688.2011.593049; Price GD, 2011, PLANT PHYSIOL, V155, P20, DOI 10.1104/pp.110.164681; Price GD, 2004, P NATL ACAD SCI USA, V101, P18228, DOI 10.1073/pnas.0405211101; PRICE GD, 1989, PLANT PHYSIOL, V89, P37, DOI 10.1104/pp.89.1.37; Radchenko M, 2011, BIOCHEM SOC T, V39, P189, DOI 10.1042/BST0390189; Rae BD, 2013, J MOL MICROB BIOTECH, V23, P300, DOI 10.1159/000351342; Rae BD, 2011, PHOTOSYNTH RES, V109, P59, DOI 10.1007/s11120-011-9641-5; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rolland N, 2003, PHOTOSYNTH RES, V78, P205, DOI 10.1023/B:PRES.0000006891.12416.6c; Schwarz D, 2011, PLANT PHYSIOL, V155, P1640, DOI 10.1104/pp.110.170225; Shelden MC, 2010, MOL MEMBR BIOL, V27, P11, DOI 10.3109/09687680903400120; Shibata M, 2002, J BIOL CHEM, V277, P18658, DOI 10.1074/jbc.M112468200; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Whitehead L, 2014, PLANT PHYSIOL, V165, P398, DOI 10.1104/pp.114.237941; YOKOTA A, 1985, BIOCHEM BIOPH RES CO, V131, P1075, DOI 10.1016/0006-291X(85)90200-1; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206; ZWAIG N, 1970, J BACTERIOL, V102, P753, DOI 10.1128/JB.102.3.753-759.1970	37	47	50	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115905	10.1371/journal.pone.0115905	http://dx.doi.org/10.1371/journal.pone.0115905			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536191	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300083
J	de la Cruz, ML; Perez, A; Bezos, J; Pages, E; Casal, C; Carpintero, J; Romero, B; Dominguez, L; Barker, CM; Diaz, R; Alvarez, J				Luisa de la Cruz, Maria; Perez, Andres; Bezos, Javier; Pages, Enrique; Casal, Carmen; Carpintero, Jesus; Romero, Beatriz; Dominguez, Lucas; Barker, Christopher M.; Diaz, Rosa; Alvarez, Julio			Spatial Dynamics of Bovine Tuberculosis in the Autonomous Community of Madrid, Spain (2010-2012)	PLOS ONE			English	Article							WITHIN-HERD TRANSMISSION; TO-CATTLE TRANSMISSION; MYCOBACTERIUM-BOVIS; SIMULATION-MODEL; WILD BOAR; 4 AREAS; EPIDEMIOLOGY; SPOLIGOTYPE; ERADICATION; POPULATION	Progress in control of bovine tuberculosis (bTB) is often not uniform, usually due to the effect of one or more sometimes unknown epidemiological factors impairing the success of eradication programs. Use of spatial analysis can help to identify clusters of persistence of disease, leading to the identification of these factors thus allowing the implementation of targeted control measures, and may provide some insights of disease transmission, particularly when combined with molecular typing techniques. Here, the spatial dynamics of bTB in a high prevalence region of Spain were assessed during a three year period (2010-2012) using data from the eradication campaigns to detect clusters of positive bTB herds and of those infected with certain Mycobacterium bovis strains (characterized using spoligotyping and VNTR typing). In addition, the within-herd transmission coefficient (b) was estimated in infected herds and its spatial distribution and association with other potential outbreak and herd variables was evaluated. Significant clustering of positive herds was identified in the three years of the study in the same location ("high risk area''). Three spoligotypes (SB0339, SB0121 and SB1142) accounted for >70% of the outbreaks detected in the three years. VNTR subtyping revealed the presence of few but highly prevalent strains within the high risk area, suggesting maintained transmission in the area. The spatial autocorrelation found in the distribution of the estimated within-herd transmission coefficients in herds located within distances,14 km and the results of the spatial regression analysis, support the hypothesis of shared local factors affecting disease transmission in farms located at a close proximity.	[Luisa de la Cruz, Maria; Bezos, Javier; Casal, Carmen; Romero, Beatriz] Univ Complutense, Ctr Vigilancia Sanitaria Vet VISAVET, E-28040 Madrid, Spain; [Perez, Andres; Alvarez, Julio] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Bezos, Javier] MAEVA SERVET SL, Madrid, Spain; [Pages, Enrique; Carpintero, Jesus; Dominguez, Lucas; Diaz, Rosa] Consejeria Medio Ambiente Vivienda & Ordenac Terr, Direcc Gen Medio Ambiente, Area Ganaderia, Madrid, Spain; [Dominguez, Lucas] Univ Complutense, Fac Vet, Dept Sanidad Anim, E-28040 Madrid, Spain; [Barker, Christopher M.] Univ Calif Davis, Sch Vet Med, Ctr Vectorborne Dis, Davis, CA 95616 USA; [Barker, Christopher M.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	Complutense University of Madrid; University of Minnesota System; University of Minnesota Twin Cities; Complutense University of Madrid; University of California System; University of California Davis; University of California System; University of California Davis	Alvarez, J (corresponding author), Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA.	jalvarez@umn.edu	Perez, Andres/HGD-8377-2022; Garrido, Javier Bezos/Q-2536-2019; Casal Comendador, Carmen/E-8998-2016; de la Cruz, María Luisa/Q-5725-2016; Romero, Beatriz/J-5942-2015; studies, IT VISAVET Account for bibliometric/C-3115-2014; Alvarez, Julio/H-8292-2013; de la Cruz, María Luisa/AAH-6542-2020; Bezos, Javier/K-1335-2014; Dominguez Rodriguez, Lucas/B-9668-2014	Casal Comendador, Carmen/0000-0003-2433-2870; de la Cruz, María Luisa/0000-0002-0206-1750; Romero, Beatriz/0000-0001-5263-1806; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Alvarez, Julio/0000-0002-8999-9417; de la Cruz, María Luisa/0000-0002-0206-1750; Bezos, Javier/0000-0003-1913-0545; Dominguez Rodriguez, Lucas/0000-0001-8843-0010	USDA National Institute of Food and Agriculture [2013-67015-21244]; Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center; National Institutes of Health	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was partly supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-67015-21244 from the USDA National Institute of Food and Agriculture. CMB also acknowledges support from the Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2014, ECOL INDIC, V36, P594, DOI 10.1016/j.ecolind.2013.09.019; Allepuz A, 2011, PREV VET MED, V100, P44, DOI 10.1016/j.prevetmed.2011.02.012; Alvarez J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-100; Alvarez J, 2012, VET MICROBIOL, V155, P38, DOI 10.1016/j.vetmic.2011.07.034; [Anonymous], 2006, SANCO102002006; Barlow ND, 1997, PREV VET MED, V32, P57, DOI 10.1016/S0167-5877(97)00002-0; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Bivand R., 2020, SPDEP SPATIAL DEPEND; Bivand RS, 2008, USE R, P1; Bosch J, 2012, FOLIA ZOOL, V61, P138, DOI 10.25225/fozo.v61.i2.a7.2012; COCHRANE D, 1949, J AM STAT ASSOC, V44, P32, DOI 10.2307/2280349; Collins JD, 2006, VET MICROBIOL, V112, P369, DOI 10.1016/j.vetmic.2005.11.041; Consejeria de Medio Ambiente y Ordenacion del Territorio C, 2013, BOCM, V73, P77; CORNER LA, 1988, VET MICROBIOL, V18, P127, DOI 10.1016/0378-1135(88)90058-2; Cousins DV, 2001, TUBERCULOSIS, V81, P5, DOI 10.1054/tube.2000.0261; deJong MCM, 1995, PREV VET MED, V25, P183, DOI 10.1016/0167-5877(95)00538-2; Dommergues L, 2012, TRANSBOUND EMERG DIS, V59, P292, DOI 10.1111/j.1865-1682.2011.01269.x; Duarte EL, 2008, VET MICROBIOL, V130, P415, DOI 10.1016/j.vetmic.2008.02.012; Duarte EL, 2010, VET MICROBIOL, V143, P299, DOI 10.1016/j.vetmic.2009.11.027; European Food Safety Authority European Centre for Disease Prevention and Control, 2013, EFSA J, V11, P1, DOI DOI 10.2903/J.EFSA.2013.3158; Fischer EAJ, 2005, PREV VET MED, V67, P283, DOI 10.1016/j.prevetmed.2004.12.002; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Goodchild AV, 2001, TUBERCULOSIS, V81, P23, DOI 10.1054/tube.2000.0256; Hewinson RG, 2006, VET MICROBIOL, V112, P127, DOI 10.1016/j.vetmic.2005.11.050; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2009, SATSCAN TM V8 0 SOFT; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; MASLOW JN, 1993, CLIN INFECT DIS, V17, P153, DOI 10.1093/clinids/17.2.153; Menzies FD, 2000, VET J, V160, P92, DOI 10.1053/tvjl.2000.0482; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Olea-Popelka FJ, 2005, PREV VET MED, V71, P57, DOI 10.1016/j.prevetmed.2005.05.008; Olea-Popelka FJ, 2004, PREV VET MED, V63, P163, DOI 10.1016/j.prevetmed.2004.03.001; Olea-Popelka FJ, 2003, PREV VET MED, V59, P103, DOI 10.1016/S0167-5877(03)00055-2; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Perez AM, 2002, PREV VET MED, V56, P63, DOI 10.1016/S0167-5877(02)00124-1; Perez AM, 2002, PREV VET MED, V54, P361, DOI 10.1016/S0167-5877(02)00043-0; Pfeiffer DU, 2013, TRANSBOUND EMERG DIS, V60, P104, DOI 10.1111/tbed.12105; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramirez-Villaescusa AM, 2009, PREV VET MED, V92, P188, DOI 10.1016/j.prevetmed.2009.08.011; Rodriguez S, 2011, EMERG INFECT DIS, V17, P532, DOI 10.3201/eid1703.100618; Rodriguez S, 2010, VET MICROBIOL, V141, P89, DOI 10.1016/j.vetmic.2009.08.007; Rodriguez-Campos S, 2013, J CLIN MICROBIOL, V51, P3658, DOI 10.1128/JCM.01271-13; Rodriguez-Campos S, 2012, INFECT GENET EVOL, V12, P877, DOI 10.1016/j.meegid.2011.10.008; Romero B, 2008, VET MICROBIOL, V132, P87, DOI 10.1016/j.vetmic.2008.04.032; Schabenberger O., 2005, STAT METHODS SPATIAL; Smith NH, 2012, INFECT GENET EVOL, V12, P857, DOI 10.1016/j.meegid.2011.09.007; Smith NH, 2011, INFECT GENET EVOL, V11, P1340, DOI 10.1016/j.meegid.2011.04.027; Srinivasan S., 2008, ENCY GIS, DOI [10.1007/978-0-387-35973-1_1294, DOI 10.1007/978-0-387-35973-1_1294]; Ward MP, 2000, PREV VET MED, V43, P225, DOI 10.1016/S0167-5877(99)00111-7; Wright DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074503	54	28	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115632	10.1371/journal.pone.0115632	http://dx.doi.org/10.1371/journal.pone.0115632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536514	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000348563300058
J	Sayler, KA; Barbet, AF; Chamberlain, C; Clapp, WL; Alleman, R; Loeb, JC; Lednicky, JA				Sayler, Katherine A.; Barbet, Anthony F.; Chamberlain, Casey; Clapp, William L.; Alleman, Rick; Loeb, Julia C.; Lednicky, John A.			Isolation of Tacaribe Virus, a Caribbean Arenavirus, from Host-Seeking Amblyomma americanum Ticks in Florida	PLOS ONE			English	Article							ARGENTINE HEMORRHAGIC-FEVER; JUNIN VIRUS; GUINEA-PIGS; INFECTION; REPLICATION; PROTECTION; RESERVOIR; EVOLUTION	Arenaviridae are a family of single stranded RNA viruses of mammals and boid snakes. Twenty-nine distinct mammalian arenaviruses have been identified, many of which cause severe hemorrhagic disease in humans, particularly in parts of sub-Saharan Africa, and in Central and South America. Humans typically become infected with an arenavirus through contact with excreta from infected rodents. Tacaribe virus (TCRV) is an arenavirus that was first isolated from bats and mosquitoes during a rabies surveillance survey conducted in Trinidad from 1956 to 1958. Tacaribe virus is unusual because it has never been associated with a rodent host and since that one time isolation, the virus has not been isolated from any vertebrate or invertebrate hosts. We report the re-isolation of the virus from a pool of 100 host-seeking Amblyomma americanum (lone star ticks) collected in a Florida state park in 2012. TCRV was isolated in two cell lines and its complete genome was sequenced. The tick-derived isolate is nearly identical to the only remaining isolate from Trinidad (TRVL-11573), with 99.6% nucleotide identity across the genome. A quantitative RT-PCR assay was developed to test for viral RNA in hostseeking ticks collected from 3 Florida state parks. Virus RNA was detected in 56/500 (11.2%) of surveyed ticks. As this virus was isolated from ticks that parasitize humans, the ability of the tick to transmit the virus to people should be evaluated. Furthermore, reservoir hosts for the virus need to be identified in order to develop risk assessment models of human infection.	[Sayler, Katherine A.; Alleman, Rick] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA; [Sayler, Katherine A.; Barbet, Anthony F.; Chamberlain, Casey] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL USA; [Clapp, William L.] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA; [Sayler, Katherine A.; Loeb, Julia C.; Lednicky, John A.] Univ Florida, Dept Environm & Global Hlth, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Sayler, Katherine A.; Barbet, Anthony F.; Lednicky, John A.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Sayler, KA (corresponding author), Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA.	saylerk@ufl.edu	Lednicky, John A/C-5678-2012; Chamberlain, Casey/ABD-2813-2020	Chamberlain, Casey/0000-0002-3633-8594	University of Florida College of Veterinary Medicine	University of Florida College of Veterinary Medicine(University of Florida)	The University of Florida College of Veterinary Medicine internal "bridge grant'' awarded to Dr. Anthony Barbet was used to fund this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON LMC, 1991, J GEN VIROL, V72, P2025, DOI 10.1099/0022-1317-72-8-2025; Bowen MD, 1996, VIROLOGY, V219, P285, DOI 10.1006/viro.1996.0248; Bowen MD, 1997, MOL PHYLOGENET EVOL, V8, P301, DOI 10.1006/mpev.1997.0436; CARBALLAL G, 1987, J MED VIROL, V23, P257, DOI 10.1002/jmv.1890230308; Charrel RN, 2010, VET MICROBIOL, V140, P213, DOI 10.1016/j.vetmic.2009.08.027; Cogswell-Hawkinson A, 2012, J VIROL, V86, P5791, DOI 10.1128/JVI.00201-12; COTO CE, 1980, J INFECT DIS, V141, P389, DOI 10.1093/infdis/141.3.389; DOWNS WG, 1963, AM J TROP MED HYG, V12, P640, DOI 10.4269/ajtmh.1963.12.640; Enria DA, 2008, ANTIVIR RES, V78, P132, DOI 10.1016/j.antiviral.2007.10.010; FRANZEFERNANDEZ MT, 1987, VIRUS RES, V7, P309, DOI 10.1016/0168-1702(87)90045-1; GINSBERG HS, 1989, EXP APPL ACAROL, V7, P313, DOI 10.1007/BF01197925; Grant A, 2012, VIRUSES-BASEL, V4, P2317, DOI 10.3390/v4102317; Harmon B, 2013, J BIOL CHEM, V288, P8702, DOI 10.1074/jbc.M112.444760; Holland J, 1998, VIRUS GENES, V16, P13, DOI 10.1023/A:1007989407305; HOTCHIN J, 1973, INFECT IMMUN, V7, P825, DOI 10.1128/IAI.7.5.825-826.1973; Liang YY, 2009, ANN NY ACAD SCI, V1171, pE65, DOI 10.1111/j.1749-6632.2009.05051.x; Lopez N, 2000, J GEN VIROL, V81, P1273, DOI 10.1099/0022-1317-81-5-1273; Martinez-Sobrido L, 2009, J VIROL, V83, P11330, DOI 10.1128/JVI.00763-09; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Milazzo ML, 2011, EMERG INFECT DIS, V17, P1417, DOI 10.3201/eid1708.110285; MILLS JN, 1994, AM J TROP MED HYG, V51, P554, DOI 10.4269/ajtmh.1994.51.554; MILLS JN, 1992, AM J TROP MED HYG, V47, P749, DOI 10.4269/ajtmh.1992.47.749; Sang R, 2006, EMERG INFECT DIS, V12, P1074, DOI 10.3201/eid1207.060253; Swei A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062083; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Zapata JC, 2013, VIRUSES-BASEL, V5, P241, DOI 10.3390/v5010241	26	32	32	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115769	10.1371/journal.pone.0115769	http://dx.doi.org/10.1371/journal.pone.0115769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536075	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300073
J	Xu, YN; Liu, SR; Yi, HL; Wang, JD; Dong, P; Li, XY; Yin, SK				Xu, Yanan; Liu, Suru; Yi, Hongliang; Wang, Jiadong; Dong, Pin; Li, Xiaoyan; Yin, Shankai			Human Papillomavirus Infection in 674 Chinese Patients with Laryngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							NECK-CANCER; HEAD; PREVALENCE; SURVIVAL; RISK; SENSITIVITY	Objectives: Previous reports suggest a strong association between human papillomavirus (HPV) and the etiology of laryngeal squamous cell carcinoma (LSCC). However, clinical data regarding the HPV infection rate among LSCC patients remain largely inconsistent. Methods: In total, 674 LSCC patients from three major hospitals in Shanghai were enrolled in this study. We determined the patients' HPV infection status using immunohistochemistry and the GenoArray HPV genotyping assay and calculated their long-term survival rate using the Kaplan-Meier method. Results: The total P16-positive rate according to immunostaining results was 7.57% (51/674). None of the P16-negative patients were HPV-positive according to the HPV genotyping test. The rate of HPV infection among patients with LSCC was 4.9% (33/674). HPV infection was more common among nonsmokers (P<0.05), nondrinkers (P<0.05), and patients with supraglottic LSCC (P<0.05). Of the 33 HPV-positive patients, 28 (84.8%) were infected with HPV-16, 2 with HPV-18, 1 with HPV-31, 1 with HPV-33 and 1 with HPV-45. The 3-year overall survival rate and progression-free survival rate were higher in HPV-positive than HPV-negative patients, but the difference was not statistically significant (76.3% vs. 70.7%, P=0.30 and 65.1% vs. 58.3%, P=0.37, respectively). Conclusion: HPV was not a main causal factor in LSCC carcinogenesis in this Chinese population. HPV infection did not alter patients' overall survival or progression-free survival rates in this study.	[Xu, Yanan; Liu, Suru; Yi, Hongliang; Yin, Shankai] Shanghai Jiao Tong Univ, Dept Otolaryngol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Xu, Yanan; Wang, Jiadong] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Head & Neck Surg, Shanghai 200030, Peoples R China; [Dong, Pin] Shanghai Jiao Tong Univ, Dept Otolaryngol Head & Neck Surg, Affiliated Peoples Hosp 1, Shanghai 200030, Peoples R China; [Xu, Yanan; Liu, Suru; Yi, Hongliang; Wang, Jiadong; Dong, Pin; Yin, Shankai] Shanghai Jiao Tong Univ, Otolaryngol Inst, Shanghai 200030, Peoples R China; [Li, Xiaoyan] Shanghai Jiao Tong Univ, Childrens Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, JD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Head & Neck Surg, Shanghai 200030, Peoples R China.	drjiadongw@aliyun.com; dongpin64@aliyun.com; yinshankai@china.com						Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Azvolinsky A, 2013, JNCI-J NATL CANCER I, V105, P1335, DOI 10.1093/jnci/djt260; Barrera R, 2014, INT J CHEM ENG, V2014, DOI 10.1155/2014/192057; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Chang YL, 2009, VACCINE, V27, P4355, DOI 10.1016/j.vaccine.2009.03.008; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Guihard S, 2012, INT J ONCOL, V41, P1531, DOI 10.3892/ijo.2012.1584; Halec G, 2013, BRIT J CANCER, V109, P172, DOI 10.1038/bjc.2013.296; Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P9; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Li W, 2003, AM J PATHOL, V163, P2185, DOI 10.1016/S0002-9440(10)63576-6; Li XW, 2013, J INFECT DIS, V207, P479, DOI 10.1093/infdis/jis698; Liu SS, 2010, J CLIN MICROBIOL, V48, P758, DOI 10.1128/JCM.00989-09; Marklund L, 2012, CANCER MED-US, V1, P82, DOI 10.1002/cam4.2; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Maxwell JH, 2010, CLIN CANCER RES, V16, P1226, DOI 10.1158/1078-0432.CCR-09-2350; Ribeiro KB, 2011, INT J EPIDEMIOL, V40, P489, DOI 10.1093/ije/dyq249; Rischin D, 2009, 2009 ASCO ANN M ORL; Schache AG, 2011, CLIN CANCER RES, V17, P6262, DOI 10.1158/1078-0432.CCR-11-0388; Sethi S, 2012, INT J CANCER, V131, P1179, DOI 10.1002/ijc.26500; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; Snow AN, 2010, ADV ANAT PATHOL, V17, P394, DOI 10.1097/PAP.0b013e3181f895c1; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Wei W, 2012, ONCOL REP, V28, P1750, DOI 10.3892/or.2012.1990; Wilson DD, 2012, ARCH OTOLARYNGOL, V138, P556, DOI 10.1001/archoto.2012.950	30	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115914	10.1371/journal.pone.0115914	http://dx.doi.org/10.1371/journal.pone.0115914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536405	gold, Green Submitted, Green Published			2022-12-26	WOS:000348563300085
J	Amornwichet, N; Oike, T; Shibata, A; Ogiwara, H; Tsuchiya, N; Yamauchi, M; Saitoh, Y; Sekine, R; Isono, M; Yoshida, Y; Ohno, T; Kohno, T; Nakano, T				Amornwichet, Napapat; Oike, Takahiro; Shibata, Atsushi; Ogiwara, Hideaki; Tsuchiya, Naoto; Yamauchi, Motohiro; Saitoh, Yuka; Sekine, Ryota; Isono, Mayu; Yoshida, Yukari; Ohno, Tatsuya; Kohno, Takashi; Nakano, Takashi			Carbon-Ion Beam Irradiation Kills X-Ray-Resistant p53-Null Cancer Cells by Inducing Mitotic Catastrophe	PLOS ONE			English	Article							RADIATION-THERAPY; DNA-DAMAGE; P53 STATUS; REPLICATION STRESS; GLIOBLASTOMA CELLS; CYCLE CHECKPOINTS; IN-VITRO; CARCINOMA; OPTIMIZATION; SENSITIVITY	Background and Purpose: To understand the mechanisms involved in the strong killing effect of carbon-ion beam irradiation on cancer cells with TP53 tumor suppressor gene deficiencies. Materials and Methods: DNA damage responses after carbon-ion beam or X-ray irradiation in isogenic HCT116 colorectal cancer cell lines with and without TP53 (p53(+/+) and p53(-/-), respectively) were analyzed as follows: cell survival by clonogenic assay, cell death modes by morphologic observation of DAPI-stained nuclei, DNA double-strand breaks (DSBs) by immunostaining of phosphorylated H2AX (gamma H2AX), and cell cycle by flow cytometry and immunostaining of Ser10-phosphorylated histone H3. Results: The p53(-/-) cells were more resistant than the p53(+/+) cells to X-ray irradiation, while the sensitivities of the p53(+/+) and p53(-/-) cells to carbon-ion beam irradiation were comparable. X-ray and carbon-ion beam irradiations predominantly induced apoptosis of the p53(+/+) cells but not the p53(-/-) cells. In the p53(-/-) cells, carbon-ion beam irradiation, but not X-ray irradiation, markedly induced mitotic catastrophe that was associated with premature mitotic entry with harboring long-retained DSBs at 24 h post-irradiation. Conclusions: Efficient induction of mitotic catastrophe in apoptosis-resistant p53-deficient cells implies a strong cancer cell-killing effect of carbon-ion beam irradiation that is independent of the p53 status, suggesting its biological advantage over X-ray treatment.	[Amornwichet, Napapat; Oike, Takahiro; Saitoh, Yuka; Nakano, Takashi] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma, Japan; [Amornwichet, Napapat] Chulalongkorn Univ, Dept Radiol, Bangkok, Thailand; [Oike, Takahiro; Ogiwara, Hideaki; Tsuchiya, Naoto; Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 104, Japan; [Shibata, Atsushi; Sekine, Ryota] Gunma Univ, Adv Sci Res Leaders Dev Unit, Maebashi, Gunma, Japan; [Yamauchi, Motohiro] Nagasaki Univ, Atom Bomb Dis Inst, Div Radiat Biol & Protect, Nagasaki 852, Japan; [Isono, Mayu; Yoshida, Yukari; Ohno, Tatsuya] Gunma Univ, Heavy Ion Med Ctr, Maebashi, Gunma, Japan	Gunma University; Chulalongkorn University; National Cancer Center - Japan; Gunma University; Nagasaki University; Gunma University	Oike, T (corresponding author), Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma, Japan.	oiketakahiro@gmail.com	真由, 磯野/GPG-2740-2022; Shibata, Atsushi/AAX-1283-2021	Shibata, Atsushi/0000-0001-8912-6977; Amornwichet, Napapat/0000-0002-4285-4886; Ogiwara, Hideaki/0000-0003-0860-1807	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation, and Scientific Research on Innovative Areas [22131006]; Japan Society for the Promotion of Science [10643471]; Grants-in-Aid for Scientific Research [26670549] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation, and Scientific Research on Innovative Areas; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan for programs for Leading Graduate Schools, Cultivating Global Leaders in Heavy Ion Therapeutics and Engineering, and for Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation, and Scientific Research on Innovative Areas (22131006). This work was also supported by Grants-in-Aid from the Japan Society for the Promotion of Science for Young Scientists (B) KAKENHI [10643471]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CIATTO S, 1982, ACTA RADIOL ONCOL, V21, P105, DOI 10.3109/02841868209133991; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, P16; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Huerta S, 2013, SURGERY, V154, P143, DOI 10.1016/j.surg.2013.03.012; Huerta S, 2010, DIGEST LIVER DIS, V42, P679, DOI 10.1016/j.dld.2010.02.003; Ishikawa H, 2001, CANCER-AM CANCER SOC, V91, P80, DOI 10.1002/1097-0142(20010101)91:1<80::AID-CNCR11>3.0.CO;2-E; Kurioka D, 2014, SCI REP-UK, V4, DOI 10.1038/srep06111; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Loeffler JS, 2013, NAT REV CLIN ONCOL, V10, P411, DOI 10.1038/nrclinonc.2013.79; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Maalouf M, 2009, INT J RADIAT ONCOL, V74, P200, DOI 10.1016/j.ijrobp.2009.01.012; Mak RH, 2011, ONCOLOGIST, V16, P886, DOI 10.1634/theoncologist.2011-0040; Nakajima NI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070107; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; Oike T, 2012, INT J RADIAT ONCOL, V84, P815, DOI 10.1016/j.ijrobp.2012.01.017; Oishi T, 2008, NEUROPATHOLOGY, V28, P408, DOI 10.1111/j.1440-1789.2008.00899.x; Russo AL, 2009, CLIN CANCER RES, V15, P607, DOI 10.1158/1078-0432.CCR-08-2079; Sawai Y, 2013, ONCOL REP, V29, P941, DOI 10.3892/or.2012.2195; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Takahashi A, 2004, INT J RADIAT ONCOL, V60, P591, DOI 10.1016/j.ijrobp.2004.05.062; Takahashi A, 2001, INT J RADIAT BIOL, V77, P1043, DOI 10.1080/09553000110066095; Takahashi T, 2010, ANTICANCER RES, V30, P1961; Terato Hiroaki, 2004, Biol Sci Space, V18, P206, DOI 10.2187/bss.18.206; Torres-Roca JF, 2012, PERS MED, V9, P547, DOI 10.2217/PME.12.55; Wouters B.G., 2009, BASIC CLIN RADIOBIOL, Vfourth, P27; Yamada S, 2014, CARBON ION RADIOTHER, P203; Yamakawa N, 2008, CANCER SCI, V99, P1455, DOI 10.1111/j.1349-7006.2008.00818.x; Yamauchi M, 2011, BIOCHEM BIOPH RES CO, V416, P111, DOI 10.1016/j.bbrc.2011.11.006	36	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115121	10.1371/journal.pone.0115121	http://dx.doi.org/10.1371/journal.pone.0115121			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531293	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100037
J	Chen, JJ; Huang, H; Zhao, LB; Zhou, DZ; Yang, YT; Zheng, P; Yang, DY; He, P; Zhou, JJ; Fang, L; Xie, P				Chen, Jian-jun; Huang, Hua; Zhao, Li-bo; Zhou, De-zhi; Yang, Yong-tao; Zheng, Peng; Yang, De-yu; He, Peng; Zhou, Jing-jing; Fang, Liang; Xie, Peng			Sex-Specific Urinary Biomarkers for Diagnosing Bipolar Disorder	PLOS ONE			English	Article							METABONOMICS; BRAIN	Sex-based differences are prominent in affective disorders, but there are no biomarkers available to support sex-specific, laboratory-based diagnostics for male and female bipolar disorder (BD) patients. Here, a NMR-based metabonomic approach was used to preliminarily identify sex-specific urinary metabolite biomarkers for diagnosing male and female BD patients. A male-specific biomarker panel consisting of four metabolites (alpha-hydroxybutyrate, choline, formate, and N-methylnicotinamide) effectively discriminated between male BD and healthy controls (HC) subjects, achieving an area under the receiver operating characteristic curve (AUC) of 0.942. A female-specific biomarkers panel consisting of four metabolites (alpha-hydroxybutyrate, oxalacetate, acetone, and N-methylnicotinamide) effectively discriminated between female BD and HC subjects, achieving an AUC of 0.909. The male-specific biomarker panel displayed low discriminatory power in the female group, and the female-specific biomarker panel displayed low discriminatory power in the male group. Moreover, several other metabolites showed different trends between male and female BD subjects. These findings suggest that male and female BD patients have distinct biomarker fingerprints and that these two sex-specific biomarker panels may serve as effective diagnostic tools in distinguishing male and female BD patients from their healthy counterparts. Our work may provide a window into the mechanisms underlying the pathoetiology of BD in both men and women.	[Chen, Jian-jun; Yang, De-yu; He, Peng; Zhou, Jing-jing; Fang, Liang; Xie, Peng] Chongqing Med Univ, Yongchuan Hosp, Dept Neurol, Chongqing, Peoples R China; [Huang, Hua; Zhao, Li-bo; Zhou, De-zhi; Yang, Yong-tao; Zheng, Peng; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Chen, Jian-jun; Huang, Hua; Zhao, Li-bo; Zhou, De-zhi; Yang, Yong-tao; Zheng, Peng; Yang, De-yu; He, Peng; Zhou, Jing-jing; Fang, Liang; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Chen, Jian-jun; Huang, Hua; Zhao, Li-bo; Zhou, De-zhi; Yang, Yong-tao; Zheng, Peng; Yang, De-yu; He, Peng; Zhou, Jing-jing; Fang, Liang; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Chongqing Med Univ, Yongchuan Hosp, Dept Neurol, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn	chen, jian-jun/J-9118-2019	chen, jian-jun/0000-0002-6439-5123	Chongqing Science & Technology Commission [cstc2014jcyjA10102]; National Youth Division [31300881]; Postdoctoral Fund [XM201101003]; National Basic Research Program of China (973 Program) [2009CB918300]	Chongqing Science & Technology Commission(Natural Science Foundation Project of CQ CSTC); National Youth Division; Postdoctoral Fund; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the Chongqing Science & Technology Commission (cstc2014jcyjA10102), the National Youth Division (31300881), the Postdoctoral Fund (XM201101003), and the National Basic Research Program of China (973 Program, grant no. 2009CB918300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Chen JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05855; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Cloarec O, 2012, MOL CELL PROTEOMICS, V11; Farooqui AA, 2000, CHEM PHYS LIPIDS, V106, P1, DOI 10.1016/S0009-3084(00)00128-6; Ge YC, 2008, STAT SINICA, V18, P881; Grigoroiu-Serbanescu M, 2005, AM J MED GENET B, V133B, P6, DOI 10.1002/ajmg.b.30133; Hilty, 2000, Prim Care Update Ob Gyns, V7, P105, DOI 10.1016/S1068-607X(00)00030-5; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P161, DOI 10.4088/JCP.v64n0209; Jia HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063624; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Lan MJ, 2009, MOL PSYCHIATR, V14, P269, DOI 10.1038/sj.mp.4002130; Mackay CE, 2010, BIPOLAR DISORD, V12, P306, DOI 10.1111/j.1399-5618.2010.00804.x; Maes M, 1998, ACTA PSYCHIAT SCAND, V97, P302, DOI 10.1111/j.1600-0447.1998.tb10004.x; Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nierenberg AA, 2013, AUST NZ J PSYCHIAT, V47, P26, DOI 10.1177/0004867412449303; Oquendo MA, 2006, ACTA PSYCHIAT SCAND, V114, P151, DOI 10.1111/j.1600-0447.2006.00829.x; Roiser JP, 2005, NEUROPSYCHOPHARMACOL, V30, P775, DOI 10.1038/sj.npp.1300659; Sharma V, 2012, J CLIN PSYCHIAT, V73, P1447, DOI 10.4088/JCP.11r07499; Sharma Verinder, 2009, Can J Clin Pharmacol, V16, pe33; Sussulini A, 2009, ANAL CHEM, V81, P9755, DOI 10.1021/ac901502j; Teatero ML, 2014, BIPOLAR DISORD, V16, P22, DOI 10.1111/bdi.12138; Yang J, 2013, MOL PSYCHIATR, V18, P67, DOI 10.1038/mp.2011.131; Yap IKS, 2010, J PROTEOME RES, V9, P2996, DOI 10.1021/pr901188e; Zheng P, 2013, METABOLOMICS, V9, P800, DOI 10.1007/s11306-013-0508-y; Zheng P, 2013, MOL CELL PROTEOMICS, V12, P207, DOI 10.1074/mcp.M112.021816; Zheng P, 2012, J PROTEOME RES, V11, P1741, DOI 10.1021/pr2010082	30	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115221	10.1371/journal.pone.0115221	http://dx.doi.org/10.1371/journal.pone.0115221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531985	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100044
J	Cuccio, V; Ambrosecchia, M; Ferri, F; Carapezza, M; Lo Piparo, F; Fogassi, L; Gallese, V				Cuccio, Valentina; Ambrosecchia, Marianna; Ferri, Francesca; Carapezza, Marco; Lo Piparo, Franco; Fogassi, Leonardo; Gallese, Vittorio			How the Context Matters. Literal and Figurative Meaning in the Embodied Language Paradigm	PLOS ONE			English	Article							ACTION-RELATED SENTENCES; MOTOR SYSTEM; PREMOTOR CORTICES; MIRROR NEURONS; ACTION WORDS; CROSS-TALK; COMPREHENSION; VERB; MODULATION; IDIOMS	The involvement of the sensorimotor system in language understanding has been widely demonstrated. However, the role of context in these studies has only recently started to be addressed. Though words are bearers of a semantic potential, meaning is the product of a pragmatic process. It needs to be situated in a context to be disambiguated. The aim of this study was to test the hypothesis that embodied simulation occurring during linguistic processing is contextually modulated to the extent that the same sentence, depending on the context of utterance, leads to the activation of different effector-specific brain motor areas. In order to test this hypothesis, we asked subjects to give a motor response with the hand or the foot to the presentation of ambiguous idioms containing action-related words when these are preceded by context sentences. The results directly support our hypothesis only in relation to the comprehension of hand-related action sentences.	[Cuccio, Valentina; Ambrosecchia, Marianna; Ferri, Francesca; Fogassi, Leonardo; Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Cuccio, Valentina; Carapezza, Marco; Lo Piparo, Franco] Univ Palermo, Dept Humanities, Palermo, Italy; [Ferri, Francesca] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada	University of Parma; University of Palermo; University of Ottawa	Cuccio, V (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	vale.cuccio@libero.it	Gallese, Vittorio/ABD-5097-2021; Cuccio, Valentina/AAT-8722-2020; Ferri, Francesca/AAC-2527-2022; FOGASSI, Leonardo/K-3541-2018	Gallese, Vittorio/0000-0003-4815-3607; Cuccio, Valentina/0000-0001-7908-4216; Ferri, Francesca/0000-0003-1821-5870; FOGASSI, Leonardo/0000-0003-3348-039X	European Union	European Union(European Commission)	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The research was supported by the European Union grant TESIS to VG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin John, 1960, DO THINGS WORDS; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barsalou LW, 2010, TOP COGN SCI, V2, P716, DOI 10.1111/j.1756-8765.2010.01115.x; Bonini L, 2011, J NEUROSCI, V31, P5876, DOI 10.1523/JNEUROSCI.5186-10.2011; Bonini L, 2010, CEREB CORTEX, V20, P1372, DOI 10.1093/cercor/bhp200; Borreggine KL, 2006, COGNITIVE SCI, V30, P1097, DOI 10.1207/s15516709cog0000_91; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Boulenger V, 2012, NEUROIMAGE, V59, P3502, DOI 10.1016/j.neuroimage.2011.11.011; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Cacciari C, 2011, BRAIN LANG, V119, P149, DOI 10.1016/j.bandl.2011.05.004; Cain K, 2009, J EXP CHILD PSYCHOL, V102, P280, DOI 10.1016/j.jecp.2008.08.001; Chersi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027652; Cuccio V, 2012, BIOLINGUISTICS, V6, P259; Cunnings I, 2012, SECOND LANG RES, V28, P369, DOI 10.1177/0267658312443651; Dalla Volta R, 2009, EXP BRAIN RES, V196, P403, DOI 10.1007/s00221-009-1864-8; de Vega M, 2013, PSYCHOL RES-PSYCH FO, V77, P20, DOI 10.1007/s00426-011-0356-1; Desai RH, 2013, NEUROIMAGE, V83, P862, DOI 10.1016/j.neuroimage.2013.07.044; Desai RH, 2011, J COGNITIVE NEUROSCI, V23, P2376, DOI 10.1162/jocn.2010.21596; Egorova N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00086; Fodor J, 1983, MODULARITY MIND; Fogassi L, 2007, CURR DIR PSYCHOL SCI, V16, P136, DOI 10.1111/j.1467-8721.2007.00491.x; Frege G, 1892, SENSE REFERENCE, V1997, P25; Frege J.L., 1959, FDN ARITHMETIC; Gallese V, 2011, TRENDS COGN SCI, V15, P512, DOI 10.1016/j.tics.2011.09.003; Gallese V, 2008, SOC NEUROSCI-UK, V3, P317, DOI 10.1080/17470910701563608; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Gibbs Jr RW, 2002, J MENT IMAGERY, V26, P82; Gibbs Jr RW, 2002, J MENTAL IMAGERY, V26, P1; Gibbs R., 2006, EMBODIMENT COGNITIVE; Gibbs R.W., 2012, INTERPRETING FIGURAT, DOI 10.1017/CBO9781139168779; Gibbs RW, 2010, STUD HIST PHILOS SCI, V41, P305, DOI 10.1016/j.shpsa.2010.07.004; GIBBS RW, 1992, J MEM LANG, V31, P485, DOI 10.1016/0749-596X(92)90025-S; GIBBS RW, 1990, COGNITION, V36, P35, DOI 10.1016/0010-0277(90)90053-M; Gibbs RW, 2003, BRAIN LANG, V84, P1, DOI 10.1016/S0093-934X(02)00517-5; GIBBS RW, 1985, J PSYCHOLINGUIST RES, V14, P465, DOI 10.1007/BF01666721; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 2013, PERSPECT PSYCHOL SCI, V8, P573, DOI 10.1177/1745691613498098; Glenberg AM, 2012, CORTEX, V48, P905, DOI 10.1016/j.cortex.2011.04.010; Grodzinsky Y, 2006, CURR OPIN NEUROBIOL, V16, P240, DOI 10.1016/j.conb.2006.03.007; Guan CQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075183; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Kaschak MP, 2008, J MEM LANG, V58, P862, DOI 10.1016/j.jml.2006.12.002; Kemmerer D, 2008, BRAIN LANG, V107, P16, DOI 10.1016/j.bandl.2007.09.003; Kiefer M, 2012, CORTEX, V48, P805, DOI 10.1016/j.cortex.2011.04.006; Kuperberg GR, 2008, BIOL PSYCHIAT, V64, P407, DOI 10.1016/j.biopsych.2008.03.018; Lepore Ernest, 2005, INSENSITIVE SEMANTIC; Meteyard L, 2009, BRAIN LANG, V110, P121, DOI 10.1016/j.bandl.2009.03.007; Mirabella G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035403; Nazir TA, 2008, Q J EXP PSYCHOL, V61, P933, DOI 10.1080/17470210701625667; NUNBERG G, 1994, LANGUAGE, V70, P491, DOI 10.2307/416483; Papeo L, 2012, J COGNITIVE NEUROSCI, V24, P2348, DOI 10.1162/jocn_a_00291; Papeo L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004508; Pulvermuller F, 2001, BRAIN LANG, V78, P143, DOI 10.1006/brln.2000.2390; Pylyshyn Z., 1984, COMPUTATION COGNITIO; Raposo A, 2009, NEUROPSYCHOLOGIA, V47, P388, DOI 10.1016/j.neuropsychologia.2008.09.017; RASTIER Francois, 2001, ARTS SCI TEXTE; Rizzo S, 2007, BRAIN RES BULL, V71, P523, DOI 10.1016/j.brainresbull.2006.11.006; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Sato M, 2008, BRAIN LANG, V105, P83, DOI 10.1016/j.bandl.2007.10.001; Temple JG, 1999, J PSYCHOLINGUIST RES, V28, P41, DOI 10.1023/A:1023287420088; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Vachon F, 2012, J COGNITIVE NEUROSCI, V24, P611, DOI 10.1162/jocn_a_00149; van Ackeren MJ, 2012, J COGNITIVE NEUROSCI, V24, P2237, DOI 10.1162/jocn_a_00274; Van Dam WO, 2010, EMBODIED GROUNDED CO, V57; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005; Wittgenstein L, 1953, PHILOS UNTERSUCHUNGE; Wurm MF, 2012, J COGNITIVE NEUROSCI, V24, P1548, DOI 10.1162/jocn_a_00232	71	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115381	10.1371/journal.pone.0115381	http://dx.doi.org/10.1371/journal.pone.0115381			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531530	Green Accepted, Green Published, gold			2022-12-26	WOS:000348845100060
J	Perez-Ramos, IM; Aponte, C; Garcia, LV; Padilla-Diaz, CM; Maranon, T				Perez-Ramos, Ignacio M.; Aponte, Cristina; Garcia, Luis V.; Padilla-Diaz, Carmen M.; Maranon, Teodoro			Why Is Seed Production So Variable among Individuals? A Ten-Year Study with Oaks Reveals the Importance of Soil Environment	PLOS ONE			English	Article							ACORN PRODUCTION; EVOLUTIONARY ECOLOGY; WIND POLLINATION; PREDATION; PATTERNS; REPRODUCTION; PHENOLOGY; REMOVAL; GROWTH; MODEL	Mast-seeding species exhibit not only a large inter-annual variability in seed production but also considerable variability among individuals within the same year. However, very little is known about the causes and consequences for population dynamics of this potentially large between-individual variability. Here, we quantified seed production over ten consecutive years in two Mediterranean oak species - the deciduous Quercus canariensis and the evergreen Q. suber - that coexist in forests of southern Spain. First, we calibrated likelihood models to identify which abiotic and biotic variables best explain the magnitude (hereafter seed productivity) and temporal variation of seed production at the individual level (hereafter CVi), and infer whether reproductive effort results from the available soil resources for the plant or is primarily determined by selectively favoured strategies. Second, we explored the contribution of between-individual variability in seed production as a potential mechanism of satiation for predispersal seed predators. We found that Q. canariensis trees inhabiting moister and more fertile soils were more productive than those growing in more resource-limited sites. Regarding temporal variation, individuals of the two studied oak species inhabiting these resource-rich environments also exhibited larger values of CVi. Interestingly, we detected a satiating effect on granivorous insects at the tree level in Q. suber, which was evident in those years where between-individual variability in acorn production was higher. These findings suggest that individual seed production (both in terms of seed productivity and inter-annual variability) is strongly dependent on soil resource heterogeneity (at least for one of the two studied oak species) with potential repercussions for recruitment and population dynamics. However, other external factors (such as soil heterogeneity in pathogen abundance) or certain inherent characteristics of the tree might be also involved in this process.	[Perez-Ramos, Ignacio M.; Garcia, Luis V.; Padilla-Diaz, Carmen M.; Maranon, Teodoro] CSIC, IRNAS, E-41080 Seville, Spain; [Aponte, Cristina] Univ Melbourne, Dept Forest & Ecosyst Sci, Melbourne, Vic, Australia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); University of Melbourne	Perez-Ramos, IM (corresponding author), CSIC, IRNAS, E-41080 Seville, Spain.	imperez@irnase.csic.es	Garcia, Luis V/A-4252-2008; Aponte, Cristina/AAV-5567-2020; PADILLA-DIAZ, CARMEN M./C-6762-2019; Perez-Ramos, Ignacio M/H-6048-2015; Aponte, Cristina/I-1586-2014; García, Luis V/GQA-9712-2022; Maranon, Teodoro/K-6648-2014	Garcia, Luis V/0000-0002-5514-2941; Aponte, Cristina/0000-0002-8457-7573; PADILLA-DIAZ, CARMEN M./0000-0002-7220-8041; Perez-Ramos, Ignacio M/0000-0003-2332-7818; Aponte, Cristina/0000-0002-8457-7573; Maranon, Teodoro/0000-0002-7751-9316	Andalusian Government; Spanish MEC project Heteromed [REN2002-4041-C02-02]; Spanish MEC project Dinamed [CGL2005-5830-C03-01]; Spanish MEC project Interbos [CGL2008-04503-C03-01]; Spanish MEC project Diverbos [CGL2011-30285-C02]; Andalusian project [Anasinque-PE2010-RNM-5782]; European FEDER	Andalusian Government; Spanish MEC project Heteromed; Spanish MEC project Dinamed; Spanish MEC project Interbos; Spanish MEC project Diverbos; Andalusian project; European FEDER(European Commission)	This study was supported by a postdoctoral contract of the Andalusian Government to IMPR, by the Spanish MEC projects Heteromed (REN2002-4041-C02-02), Dinamed (CGL2005-5830-C03-01), Interbos (CGL2008-04503-C03-01) and Diverbos (CGL2011-30285-C02), by the Andalusian Anasinque-PE2010-RNM-5782 project and the European FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson WG, 2003, ECOLOGY, V84, P2476, DOI 10.1890/01-0707; Aponte C, 2010, BIOGEOCHEMISTRY, V101, P77, DOI 10.1007/s10533-010-9418-5; Buonaccorsi JP, 2003, J THEOR BIOL, V224, P107, DOI 10.1016/S0022-5193(03)00148-6; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carevic FS, 2010, AGROFOREST SYST, V78, P299, DOI 10.1007/s10457-009-9245-7; Edwards AWF, 1992, LIKELIHOOD; Espelta JM, 2009, J ECOL, V97, P1416, DOI 10.1111/j.1365-2745.2009.01564.x; Espelta JM, 2008, ECOLOGY, V89, P805, DOI 10.1890/07-0217.1; Fernandez-Martinez M, 2012, ACTA OECOL, V43, P51, DOI 10.1016/j.actao.2012.05.006; Garcia-Mozo H, 2012, ANN AGR ENV MED, V19, P403; Gomez-Aparicio L, 2012, NEW PHYTOL, V194, P1014, DOI 10.1111/j.1469-8137.2012.04108.x; GOODRUM PD, 1971, J WILDLIFE MANAGE, V35, P520, DOI 10.2307/3799707; Greenberg CH, 2000, FOREST ECOL MANAG, V132, P199, DOI 10.1016/S0378-1127(99)00226-1; Healy WM, 1999, FOREST ECOL MANAG, V116, P1, DOI 10.1016/S0378-1127(98)00460-5; HERRERA CM, 1994, ECOL MONOGR, V64, P315, DOI 10.2307/2937165; Isagi Y, 1997, J THEOR BIOL, V187, P231, DOI 10.1006/jtbi.1997.0442; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Kelly D, 2001, ECOLOGY, V82, P117, DOI 10.1890/0012-9658(2001)082[0117:ETWPBO]2.0.CO;2; Knapp EE, 2001, OECOLOGIA, V128, P48, DOI 10.1007/s004420000623; Knops JMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043492; Kobe RK, 2006, OECOLOGIA, V147, P119, DOI 10.1007/s00442-005-0252-8; Koenig WD, 2000, AM NAT, V155, P59, DOI 10.1086/303302; Koenig WD, 2003, OIKOS, V102, P581, DOI 10.1034/j.1600-0706.2003.12272.x; Koenig WD, 1996, CAN J FOREST RES, V26, P1677, DOI 10.1139/x26-189; MULDER J, 1994, SCOPE SER, V51, P107; Murphy L, 2012, LIKELIHOOD METHODS M; NILSSON SG, 1987, ECOLOGY, V68, P260, DOI 10.2307/1939256; Norton DA, 1988, FUNCT ECOL, V2, P399, DOI 10.2307/2389413; Pausas J., 2009, CORK OAK WOODLANDS E, P115; Perea R, 2011, FOREST ECOL MANAG, V262, P1251, DOI 10.1016/j.foreco.2011.06.022; Perez-Ramos IM, 2010, ECOLOGY, V91, P3057, DOI 10.1890/09-2313.1; Perez-Ramos IM, 2008, OIKOS, V117, P1386, DOI 10.1111/j.0030-1299.2008.16370.x; Perez-Ramos IM, 2008, FOREST ECOL MANAG, V255, P3506, DOI 10.1016/j.foreco.2008.02.032; Perez-Ramos IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077197; Perez-Ramos IM, 2010, J VEG SCI, V21, P419, DOI 10.1111/j.1654-1103.2009.01165.x; Perez-Ramos IM, 2007, THESIS U SEVILLE SPA; Pons J, 2012, OECOLOGIA, V169, P723, DOI 10.1007/s00442-011-2244-1; Pulido FJ, 2005, REGENERATION MEDITER; Sala A, 1996, AGR FOREST METEOROL, V78, P203, DOI 10.1016/0168-1923(95)02250-3; Sala A, 2012, NEW PHYTOL, V196, P189, DOI 10.1111/j.1469-8137.2012.04257.x; Sanchez-Humanes B, 2011, FORESTRY, V84, P73, DOI 10.1093/forestry/cpq045; Satake A, 2000, J THEOR BIOL, V203, P63, DOI 10.1006/jtbi.1999.1066; Satake A, 2008, ECOL RES, V23, P3, DOI 10.1007/s11284-007-0397-5; SILVERTOWN JW, 1980, BIOL J LINN SOC, V14, P235, DOI 10.1111/j.1095-8312.1980.tb00107.x; Smaill SJ, 2011, J ECOL, V99, P870, DOI 10.1111/j.1365-2745.2011.01803.x; SORK VL, 1993, VEGETATIO, V108, P133; SORK VL, 1993, ECOLOGY, V74, P528, DOI 10.2307/1939313; Thomas GW, 1996, METHODS SOIL ANAL PA, P475; Urbieta IR, 2008, CAN J FOREST RES, V38, P2382, DOI 10.1139/X08-089; Urbieta IR, 2008, J BIOGEOGR, V35, P1688, DOI 10.1111/j.1365-2699.2008.01914.x	52	24	24	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115371	10.1371/journal.pone.0115371	http://dx.doi.org/10.1371/journal.pone.0115371			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532130	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100055
J	Chon, SJ; Choi, YR; Roh, YH; Yun, BH; Cho, S; Choi, YS; Lee, BS; Seo, SK				Chon, Seung Joo; Choi, Yun Rak; Roh, Yun Ho; Yun, Bo Hyon; Cho, SiHyun; Choi, Young Sik; Lee, Byung Seok; Seo, Seok Kyo			Association between Levels of Serum Ferritin and Bone Mineral Density in Korean Premenopausal and Postmenopausal Women: KNHANES 2008-2010	PLOS ONE			English	Article							IRON; PERIMENOPAUSAL; DISEASE; MEN; MENOPAUSE; RATES	Background: As women go through menopause, serum estrogen decreases and ferritin increases. Decreased serum estrogen is well known to cause detrimental effects on bone health; however, data on the associations of serum ferritin with BMD before and after menopause are still lacking. Therefore, this study aimed to investigate the association between serum ferritin levels and BMD in premenopausal and postmenopausal Korean women. Methods: This study was performed using data from the 2008-2010 Korean National Health and Nutrition Examination Survey, including 7300 women (4229 premenopausal and 3071 postmenopausal). BMD was measured using dual X-ray absorptiometry at the femur and the lumbar spine, and serum ferritin levels were measured by chemiluminescent immunoassay. Results: Median serum ferritin levels in postmenopausal women were higher than those in premenopausal women despite the same age ranges. Serum ferritin levels were only significantly correlated with BMD on the lumbar spine (beta=20.189, pvalue=0.005) in premenopausal women after adjusting confounding factors. Additionally, BMD on the lumbar spine had tended to decrease as serum ferritin quartiles increase (P for trend=0.035) in premenopausal women after adjusting confounding factors. On the other hand, there were no significant associations between serum ferritin levels and BMD on the total femur and, femur neck in premenopausal women, and BMD on the total femur, femur neck, and lumbar spine in postmenopausal women. Conclusion: Increased serum ferritin levels were significantly associated with BMD in premenopausal women, particularly on the lumbar spine, but not in postmenopausal women.	[Chon, Seung Joo; Yun, Bo Hyon; Choi, Young Sik; Lee, Byung Seok; Seo, Seok Kyo] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Severance Hosp, Seoul, South Korea; [Choi, Yun Rak] Yonsei Univ, Coll Med, Dept Orthopaed Surg, Severance Hosp, Seoul, South Korea; [Roh, Yun Ho] Yonsei Univ, Coll Med, Dept Biostat Collaborat, Seoul, South Korea; [Cho, SiHyun] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Gangnam Severance Hosp, Seoul, South Korea; [Chon, Seung Joo; Yun, Bo Hyon; Cho, SiHyun; Choi, Young Sik; Lee, Byung Seok; Seo, Seok Kyo] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Seo, SK (corresponding author), Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Severance Hosp, Seoul, South Korea.	TUDEOLSEO@yuhs.ac	Choi, Yun-Rak/AAG-9914-2019	Seo, Seok Kyo/0000-0003-3404-0484; Choi, Young Sik/0000-0002-1157-4822; Yun, Bo Hyon/0000-0001-5703-797X; LEE, Byung Seok/0000-0001-6001-2079; Cho, SiHyun/0000-0003-2718-6645				Barton J. C., 2010, HDB IRON OVERLOAD DI, P28; Bjornerem A, 2011, BONE, V49, P1125, DOI 10.1016/j.bone.2011.08.009; CUMMINGS SR, 1989, ARCH INTERN MED, V149, P2445, DOI 10.1001/archinte.149.11.2445; D'Amelio P, 2008, BONE, V43, P1010, DOI 10.1016/j.bone.2008.08.107; Goral V, 2010, WORLD J GASTROENTERO, V16, P1639, DOI 10.3748/wjg.v16.i13.1639; Guggenbuhl P, 2005, OSTEOPOROSIS INT, V16, P1809, DOI 10.1007/s00198-005-1934-0; Guggenbuhl P, 2011, OSTEOPOROSIS INT, V22, P2313, DOI 10.1007/s00198-010-1456-2; Guthrie JR, 2004, OSTEOPOROSIS INT, V15, P881, DOI 10.1007/s00198-004-1624-3; Halle M, 1997, ATHEROSCLEROSIS, V128, P235, DOI 10.1016/S0021-9150(96)05994-1; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; IPAQ Core Group, 2005, GUIDL DAT PROC AN IN; Jian JL, 2009, ANTIOXID REDOX SIGN, V11, P2939, DOI [10.1089/ars.2009.2576, 10.1089/ARS.2009.2576]; Karabulut A, 2010, GYNECOL ENDOCRINOL, V26, P307, DOI 10.3109/09513590903511471; Katsumata S, 2006, BIOSCI BIOTECH BIOCH, V70, P2547, DOI 10.1271/bbb.60221; Kim BJ, 2013, OSTEOPOROSIS INT, V24, P2627, DOI 10.1007/s00198-013-2363-0; Kim BJ, 2012, J BONE MINER RES, V27, P2279, DOI 10.1002/jbmr.1692; Li GF, 2012, OSTEOPOROSIS INT, V23, P2403, DOI 10.1007/s00198-012-1982-1; Loria I, 2010, TRANSPL P, V42, P1191, DOI 10.1016/j.transproceed.2010.03.096; Low LCK, 1997, J PEDIATR ENDOCR MET, V10, P175; Mahachoklertwattana P, 2003, J CLIN ENDOCR METAB, V88, P3966, DOI 10.1210/jc.2002-021548; Mazzuoli G, 2000, BONE, V26, P381, DOI 10.1016/S8756-3282(00)00242-8; McCance RA, 1938, J PHYSIOL-LONDON, V94, P148, DOI 10.1113/jphysiol.1938.sp003669; MILMAN N, 1992, ANN HEMATOL, V64, P22, DOI 10.1007/BF01811467; Milman N, 1992, ANN HEMATOL, V63, P103; MOSEKILDE L, 1990, BONE, V11, P67, DOI 10.1016/8756-3282(90)90052-Z; Nelson HD, 2008, LANCET, V371, P760, DOI 10.1016/S0140-6736(08)60346-3; PECK WA, 1993, AM J MED, V94, P646; Recker R, 2000, J BONE MINER RES, V15, P1965, DOI 10.1359/jbmr.2000.15.10.1965; Riggs BL, 2008, J BONE MINER RES, V23, P205, DOI 10.1359/JBMR.071020; RIGGS BL, 1986, J CLIN INVEST, V77, P1487, DOI 10.1172/JCI112462; Rizzoli R, 1997, LANCET, V349, pS20, DOI 10.1016/S0140-6736(97)90007-6; Sadat-Ali M, 2011, BIOMETALS, V24, P19, DOI 10.1007/s10534-010-9391-4; Sarrai M, 2007, BRIT J HAEMATOL, V136, P666, DOI 10.1111/j.1365-2141.2006.06487.x; SCHNITZLER CM, 1994, J BONE MINER RES, V9, P1865; SEIDMAN H, 1985, CA-CANCER J CLIN, V35, P36, DOI 10.3322/canjclin.35.1.36; Seifert-Klauss V, 2012, CLIMACTERIC, V15, P433, DOI 10.3109/13697137.2012.658110; Sirola J, 2003, MATURITAS, V45, P159, DOI 10.1016/S0378-5122(03)00150-6; Soules Michael R., 2001, Fertility and Sterility, V76, P874, DOI 10.1016/S0015-0282(01)02909-0; Sowers M, 1998, J BONE MINER RES, V13, P1134, DOI 10.1359/jbmr.1998.13.7.1134; Tiosano D, 2001, J ENDOCRINOL INVEST, V24, P716, DOI 10.1007/BF03343916; Weinberg Eugene D, 2008, Pediatr Endocrinol Rev, V6 Suppl 1, P81; World Health Organization, 1994, WHO TECHN REP SER, V843	42	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114972	10.1371/journal.pone.0114972	http://dx.doi.org/10.1371/journal.pone.0114972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522357	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845600012
J	Habeck, M; Haviv, H; Katz, A; Kapri-Pardes, E; Ayciriex, S; Shevchenko, A; Ogawa, H; Toyoshima, C; Karlish, SJD				Habeck, Michael; Haviv, Haim; Katz, Adriana; Kapri-Pardes, Einat; Ayciriex, Sophie; Shevchenko, Andrej; Ogawa, Haruo; Toyoshima, Chikashi; Karlish, Steven J. D.			Stimulation, Inhibition, or Stabilization of Na,K-ATPase Caused by Specific Lipid Interactions at Distinct Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-POTASSIUM PUMP; CRYSTAL-STRUCTURE; MOLECULAR ACTIVITY; K+-ATPASE; PROTEIN INTERACTIONS; MEMBRANE-PROTEINS; NA+,K+-ATPASE; CHOLESTEROL; BINDING; KIDNEY	The activity of membrane proteins such as Na,K-ATPase depends strongly on the surrounding lipid environment. Interactions can be annular, depending on the physical properties of the membrane, or specific with lipids bound in pockets between transmembrane domains. This paper describes three specific lipid-protein interactions using purified recombinant Na, K-ATPase. (a) Thermal stability of the Na, K-ATPase depends crucially on a specific interaction with 18:0/18:1 phosphatidylserine (1-stearoyl-2-oleoyl-sn-glycero-3-phospho-L-serine; SOPS) and cholesterol, which strongly amplifies stabilization. We show here that cholesterol associates with SOPS, FXYD1, and the alpha subunit between trans-membrane segments alpha TM8 and -10 to stabilize the protein. (b) Polyunsaturated neutral lipids stimulate Na, K-ATPase turnover by >60%. A screen of the lipid specificity showed that 18:0/20:4 and 18:0/22:6 phosphatidyle-thanolamine (PE) are the optimal phospholipids for this effect. (c) Saturated phosphatidylcholine and sphingomyelin, but not saturated phosphatidylserine or PE, inhibit Na,K-ATPase activity by 70-80%. This effect depends strongly on the presence of cholesterol. Analysis of the Na,K-ATPase activity and E-1-E-2 conformational transitions reveals the kinetic mechanisms of these effects. Both stimulatory and inhibitory lipids poise the conformational equilibrium toward E-2, but their detailed mechanisms of action are different. PE accelerates the rate of E-1 -> E2P but does not affect E-2(2K) ATP -> E(1)3NaATP, whereas sphingomyelin inhibits the rate of E-2(2K) ATP -> E(1)3NaATP, with very little effect on E-1 -> E2P. We discuss these lipid effects in relation to recent crystal structures of Na,K-ATPase and propose that there are three separate sites for the specific lipid interactions, with potential physiological roles to regulate activity and stability of the pump.	[Habeck, Michael; Haviv, Haim; Katz, Adriana; Kapri-Pardes, Einat; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel; [Ayciriex, Sophie; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Ogawa, Haruo; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Weizmann Institute of Science; Max Planck Society; University of Tokyo	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel.	Steven.Karlish@weizmann.ac.il	Ayciriex, Sophie/C-1804-2017; Toyoshima, Chikashi/R-4153-2019	Ayciriex, Sophie/0000-0003-4813-5900; Habeck, Michael/0000-0002-4586-0499; Toyoshima, Chikashi/0000-0001-9640-0778	Minerva Foundation	Minerva Foundation	Supported by the Minerva Foundation.	Adamian L, 2011, BBA-BIOMEMBRANES, V1808, P1092, DOI 10.1016/j.bbamem.2010.12.008; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Apell HJ, 2004, BIOELECTROCHEMISTRY, V63, P149, DOI 10.1016/j.bioelechem.2003.09.021; Barrera NP, 2013, TRENDS CELL BIOL, V23, P1, DOI 10.1016/j.tcb.2012.08.007; Belogus T, 2009, J BIOL CHEM, V284, P31038, DOI 10.1074/jbc.M109.050054; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BUHLER R, 1991, J MEMBRANE BIOL, V121, P141, DOI 10.1007/BF01870529; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Cirri E, 2011, BIOCHEMISTRY-US, V50, P3736, DOI 10.1021/bi2001714; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; CORNELIUS F, 1995, BBA-BIOMEMBRANES, V1235, P205, DOI 10.1016/0005-2736(95)80006-2; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Cornelius F, 2008, BIOCHEMISTRY-US, V47, P1652, DOI 10.1021/bi702128x; Donnet C, 2001, J BIOL CHEM, V276, P7357, DOI 10.1074/jbc.M009131200; Drachmann ND, 2014, FEBS J, V281, P4249, DOI 10.1111/febs.12957; Durr KL, 2009, J BIOL CHEM, V284, P3842, DOI 10.1074/jbc.M808101200; Else PL, 2003, ANN NY ACAD SCI, V986, P525, DOI 10.1111/j.1749-6632.2003.tb07240.x; Esmann M, 2006, CHEM PHYS LIPIDS, V141, P94, DOI 10.1016/j.chemphyslip.2006.02.018; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Forbush B 3rd, 1991, Soc Gen Physiol Ser, V46, P210; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; GOLDSHLEGER R, 1995, BIOCHEMISTRY-US, V34, P8668, DOI 10.1021/bi00027a016; Habeck M, 2009, BIOCHEMISTRY-US, V48, P9147, DOI 10.1021/bi901148k; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Haviv H, 2013, J BIOL CHEM, V288, P10073, DOI 10.1074/jbc.M112.446997; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; Jorgensen P L, 1988, Prog Clin Biol Res, V268A, P19; JORGENSEN PL, 1986, BIOCHEMISTRY-US, V25, P2889; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kapri-Pardes E, 2011, J BIOL CHEM, V286, P42888, DOI 10.1074/jbc.M111.293852; KARLISH SJD, 1980, J BIOENERG BIOMEMBR, V12, P111, DOI 10.1007/BF00744678; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2011, BIOCHEM SOC T, V39, P761, DOI 10.1042/BST0390761; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liu LJ, 2011, BIOCHEMISTRY-US, V50, P8664, DOI 10.1021/bi2009008; Lupfert C, 2001, BIOPHYS J, V81, P2069, DOI 10.1016/S0006-3495(01)75856-0; Mishra NK, 2011, J BIOL CHEM, V286, P9699, DOI 10.1074/jbc.M110.184234; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nealon JR, 2008, J EXP BIOL, V211, P3195, DOI 10.1242/jeb.019968; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Post RL, 1996, AM J PHYSIOL-CELL PH, V271, pC1415, DOI 10.1152/ajpcell.1996.271.5.C1415; POST RL, 1972, J BIOL CHEM, V247, P6530; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Song YL, 2014, PROTEIN SCI, V23, P1, DOI 10.1002/pro.2385; Sonntag Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1307; STARLING AP, 1995, BIOCHEM J, V310, P875, DOI 10.1042/bj3100875; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Turner N, 2003, ANN NY ACAD SCI, V986, P606, DOI 10.1111/j.1749-6632.2003.tb07260.x; Turner N, 2006, PHYSIOL BIOCHEM ZOOL, V79, P522, DOI 10.1086/502815; WHEELER KP, 1970, J PHYSIOL-LONDON, V207, P303, DOI 10.1113/jphysiol.1970.sp009063; Winther AML, 2010, J BIOL CHEM, V285, P28883, DOI 10.1074/jbc.M110.136242; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; YABUUCHI H, 1968, J LIPID RES, V9, P65; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004	69	46	51	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4829	4842		10.1074/jbc.M114.611384	http://dx.doi.org/10.1074/jbc.M114.611384			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25533463	hybrid, Green Published			2022-12-26	WOS:000350042000028
J	Ravi, A; Kaushik, S; Ravichandran, A; Pan, CQ; Low, BC				Ravi, Archna; Kaushik, Shelly; Ravichandran, Aarthi; Pan, Catherine Qiurong; Low, Boon Chuan			Epidermal Growth Factor Activates the Rho GTPase-activating Protein (GAP) Deleted in Liver Cancer 1 via Focal Adhesion Kinase and Protein Phosphatase 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; CELL-MIGRATION; DLC1; BINDING; DOMAIN; GENE; RAS; PHOSPHORYLATION; TUMORIGENESIS; CYTOSKELETON	Deleted in Liver Cancer 1 (DLC1) is a RHO GTPase-activating protein (GAP) that negatively regulates RHO. Through its GAP activity, it modulates the actin cytoskeleton network and focal adhesion dynamics, ultimately leading to suppression of cell invasion and metastasis. Despite its presence in various structural and signaling components, little is known about how the activity of DLC1 is regulated at focal adhesions. Here we show that EGF stimulation activates the GAP activity of DLC1 through a concerted mechanism involving DLC1 phosphorylation by MEK/ERK and its subsequent dephosphorylation by protein phosphatase 2A (PP2A) and inhibition of focal adhesion kinase by MEK/ERK to allow the binding between DLC1 and PP2A. Phosphoproteomics and mutation studies revealed that threonine 301 and serine 308 on DLC1, known previously to be mutated in certain cancers, are required for DLC1-PP2A interaction and the subsequent activation of DLC1 upon their dephosphorylation. The intricate interplay of this "MEK/ERK-focal adhesion kinase-DLC1-PP2A" quartet provides a novel checkpoint in the spatiotemporal control of cell spreading and cell motility.	[Ravi, Archna; Kaushik, Shelly; Low, Boon Chuan] Natl Univ Singapore, Dept Biol Sci, Cell Signaling & Dev Biol Lab, Singapore 117543, Singapore; [Ravi, Archna; Kaushik, Shelly; Ravichandran, Aarthi; Pan, Catherine Qiurong; Low, Boon Chuan] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore	National University of Singapore; National University of Singapore	Low, BC (corresponding author), Natl Univ Singapore, Mechanobiol Inst, 5A Engn Dr, Singapore 117411, Singapore.	dbslowbc@nus.edu.sg	Low, Boon Chuan/AAU-7685-2021; Ravi, Archna/P-4801-2018; Kaushik, Shelly/O-4307-2019; Low, Boon Chuan/H-8049-2012	Low, Boon Chuan/0000-0003-0756-096X; Ravi, Archna/0000-0002-4336-5320; Low, Boon Chuan/0000-0003-0756-096X; Kaushik, Shelly/0000-0002-8967-3265	Mechanobiology Institute (Singapore); Ministry of Education (Singapore) Academic Research Fund [T208A3121]	Mechanobiology Institute (Singapore); Ministry of Education (Singapore) Academic Research Fund(Ministry of Education, Singapore)	This work was supported by grants from The Mechanobiology Institute (Singapore) and by Ministry of Education (Singapore) Academic Research Fund T208A3121 (to B. C. L.). This work was also supported by a graduate fellowship (to A. R.).	Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cao X, 2012, P NATL ACAD SCI USA, V109, P1455, DOI 10.1073/pnas.1114368109; Chan LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005572; Du XL, 2012, CANCER RES, V72, P4405, DOI 10.1158/0008-5472.CAN-12-0777; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jaiswal M, 2014, J BIOL CHEM, V289, P6839, DOI 10.1074/jbc.M113.527655; Kaushik S, 2014, CYTOSKELETON, V71, P677, DOI 10.1002/cm.21201; Kim T, 2009, CANCER METAST REV, V28, P77, DOI 10.1007/s10555-008-9167-2; Kim TY, 2008, J BIOL CHEM, V283, P32762, DOI 10.1074/jbc.M800617200; Ko FCF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2604; Ko FCF, 2010, GASTROENTEROLOGY, V139, P1397, DOI 10.1053/j.gastro.2010.06.051; Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408; Li GR, 2011, P NATL ACAD SCI USA, V108, P17129, DOI 10.1073/pnas.1112122108; Liao YC, 2008, CANCER RES, V68, P7718, DOI 10.1158/0008-5472.CAN-08-2042; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Orr AW, 2004, J BIOL CHEM, V279, P48983, DOI 10.1074/jbc.M404881200; Pan CQ, 2012, CELL SIGNAL, V24, P2143, DOI 10.1016/j.cellsig.2012.06.002; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; SHIMA H, 1994, P NATL ACAD SCI USA, V91, P9267, DOI 10.1073/pnas.91.20.9267; Takeuchi T, 2009, BIOORGAN MED CHEM, V17, P8113, DOI 10.1016/j.bmc.2009.09.050; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wong CM, 2003, CANCER RES, V63, P7646; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zarich N, 2006, MOL BIOL CELL, V17, P3591, DOI 10.1091/mbc.E05-12-1104; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zhang T, 2009, CANCER LETT, V283, P59, DOI 10.1016/j.canlet.2009.03.025; Zheng YH, 2009, MOL CELL, V35, P11, DOI 10.1016/j.molcel.2009.06.013; Zhong D, 2009, J CELL SCI, V122, P414, DOI 10.1242/jcs.027482; Zhou X, 2008, INT J ONCOL, V32, P1285	44	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4149	4162		10.1074/jbc.M114.616839	http://dx.doi.org/10.1074/jbc.M114.616839			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25525271	Green Published, hybrid			2022-12-26	WOS:000349458400027
J	Kawasaki, K; Ushioda, R; Ito, S; Ikeda, K; Masago, Y; Nagata, K				Kawasaki, Kunito; Ushioda, Ryo; Ito, Shinya; Ikeda, Kazuo; Masago, Yusaku; Nagata, Kazuhiro			Deletion of the Collagen-specific Molecular Chaperone Hsp47 Causes Endoplasmic Reticulum Stress-mediated Apoptosis of Hepatic Stellate Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; CARBOXYL-TERMINAL PROPEPTIDE; A-COUPLED LIPOSOMES; I COLLAGEN; TRANSMEMBRANE PROTEIN; OSTEOGENESIS IMPERFECTA; INTESTINAL FIBROSIS; LIVER FIBROSIS; UP-REGULATION; PROCOLLAGEN	Chronic liver injury, often caused by alcoholism and viral hepatitis, causes liver fibrosis via the induction of collagen production. In liver fibrosis, hepatic stellate cells (HSCs) are activated and transform into myofibroblasts, which actively produce and secrete collagen into the extracellular matrix. Hsp47 (heat shock protein 47) is a collagen-specific molecular chaperone that is essential for the maturation and secretion of collagen. Here, we used the Cre-LoxP system to disrupt the Hsp47 gene in isolated HSCs from Hsp47 floxed mice. Immature type I procollagen accumulated and partially aggregated in Hsp47-KO HSCs. This accumulation was augmented when autophagy was inhibited, which induced expression of the endoplasmic reticulum (ER) stress-inducible proteins BiP (immunoglobulin heavy chain-binding protein) and Grp94 (94-kDa glucose-regulated protein). The inhibition of autophagy in Hsp47-KO HSCs also induced CHOP (CCAAT/enhancer-binding protein homologous protein), which is an ER stress-induced transcription factor responsible for apoptosis. These data suggest that apoptosis is induced through ER stress by procollagen accumulation in Hsp47-KO HSCs when autophagy is inhibited. Thus, Hsp47 could be a promising therapeutic target in liver fibrosis.	[Kawasaki, Kunito; Ushioda, Ryo; Ito, Shinya; Masago, Yusaku; Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan; [Kawasaki, Kunito; Ito, Shinya; Masago, Yusaku] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068507, Japan; [Ikeda, Kazuo] Osaka City Univ, Grad Sch Med, Dept Anat & Regenerat Biol, Abeno Ku, Osaka 5458585, Japan; [Nagata, Kazuhiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Kyoto Sangyo University; Kyoto University; Osaka Metropolitan University; Japan Science & Technology Agency (JST)	Ushioda, R (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan.	ryo3ussy3@cc.kyoto-su.ac.jp; nagata@cc.kyoto-su.ac.jp		Masago, Yusaku/0000-0002-0173-9179; Ushioda, Ryo/0000-0003-2775-8746	Japan Society for the Promotion of Science [24227009, 24121725, 26111521, 25840079];  [11J05697]; Grants-in-Aid for Scientific Research [15H01545] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (S) 24227009 from the Japan Society for the Promotion of Science (to K. N.), Grants-in-Aid for Scientific Research on Innovative Areas 24121725 and 26111521 and for Scientific Research for Young Scientists (B) 25840079 from the Japan Society for the Promotion of Science (to R. U.), and Grant-in-Aid for Japan Society for the Promotion of Science Fellows 11J05697 (to S. I.).	CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; FERREIRA LR, 1994, J CELL BIOCHEM, V56, P518, DOI 10.1002/jcb.240560412; Fitzgerald J, 1999, J BIOL CHEM, V274, P27392, DOI 10.1074/jbc.274.39.27392; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gotoh T, 2006, ARTERIOSCL THROM VAS, V26, P1439, DOI 10.1161/01.ATV.0000223900.67024.15; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hernandez-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044; Honzawa Y, 2014, GUT, V63, P1902, DOI 10.1136/gutjnl-2013-305632; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Ishiwatari H, 2013, GUT, V62, P1328, DOI 10.1136/gutjnl-2011-301746; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kinoshita K, 2007, GUT, V56, P396, DOI 10.1136/gut.2005.085704; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Kitamura H, 2011, BIOCHEM BIOPH RES CO, V404, P599, DOI 10.1016/j.bbrc.2010.12.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642; LAMANDE SR, 1993, BIOCHEM J, V293, P387, DOI 10.1042/bj2930387; Marutani T, 2004, J CELL SCI, V117, P5913, DOI 10.1242/jcs.01514; Masago Y, 2012, J CELL SCI, V125, P1118, DOI 10.1242/jcs.089748; MASUDA H, 1994, J CLIN INVEST, V94, P2481, DOI 10.1172/JCI117617; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; Mehtani S, 1998, J BIOL CHEM, V273, P13236, DOI 10.1074/jbc.273.21.13236; MORI K, 1993, CELL, V74, P743; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Nagata K, 1996, TRENDS BIOCHEM SCI, V21, P23, DOI 10.1016/0968-0004(96)80881-4; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; NAGATA K, 1986, J CELL BIOL, V103, P223, DOI 10.1083/jcb.103.1.223; Naitoh M, 2001, BIOCHEM BIOPH RES CO, V280, P1316, DOI 10.1006/bbrc.2001.4257; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; Perez F, 2002, J CELL BIOL, V156, P631, DOI 10.1083/jcb.200111003; Radaeva S, 2007, AM J PHYSIOL-GASTR L, V293, pG809, DOI 10.1152/ajpgi.00212.2007; SAGA S, 1987, J CELL BIOL, V105, P517, DOI 10.1083/jcb.105.1.517; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Sunamoto M, 1998, LAB INVEST, V78, P967; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204; Thoen LFR, 2011, J HEPATOL, V55, P1353, DOI 10.1016/j.jhep.2011.07.010; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Wake K, 1980, Int Rev Cytol, V66, P303; Walmsley AR, 1999, J BIOL CHEM, V274, P14884, DOI 10.1074/jbc.274.21.14884; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637	50	58	64	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3639	3646		10.1074/jbc.M114.592139	http://dx.doi.org/10.1074/jbc.M114.592139			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525267	Green Published, hybrid			2022-12-26	WOS:000349456000036
J	Zhang, JL; Yuan, CF; Wu, JG; Elsayed, Z; Fu, Z				Zhang, Jinglei; Yuan, Chengfu; Wu, Jianguo; Elsayed, Zeinab; Fu, Zheng			Polo-like Kinase 1-mediated Phosphorylation of Forkhead Box Protein M1b Antagonizes Its SUMOylation and Facilitates Its Mitotic Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; SUMO-1 MODIFICATION; TRANSCRIPTION FACTOR; CELL-CYCLE; IN-VIVO; FOXM1; BINDING; DOMAIN; PROGRESSION; REQUIRES	Transcription factor Forkhead box protein M1b (FoxM1b) plays an important role during mitotic entry and progression. Our previous studies identified polo-like kinase 1 (PLK1) as a major regulator of FoxM1b. During G(2)/M transition, PLK1 directly interacts with and phosphorylates FoxM1b, resulting in full activation of the transactivation capacity of FoxM1b. Such a vital regulatory mechanism is essential for timely mitotic entry and progression. However, the molecular mechanism by which PLK1-mediated phosphorylation enhances the transcriptional activity of FoxM1b remains to be determined. We demonstrate that FoxM1b can be SUMOylated in vitro and in vivo, preferentially by SUMO-1. SUMOylation of FoxM1b was found to occur at multiple sites, leading to suppression of FoxM1b transcriptional activity. Such a posttranslational modification of FoxM1b was antagonized by PLK1-mediated phosphorylation. By immunofluorescence staining and subcellular fractionation, we demonstrate that SUMO conjugation promotes cytosolic translocation of FoxM1b. Moreover, SUMO modification of FoxM1b facilitates the ubiquitin-mediated proteasomal degradation of FoxM1b. PLK1-mediated phosphorylation of FoxM1b abrogates the inhibitory effect on FoxM1b by SUMO modification, thereby promoting its nuclear translocation and preventing its proteolytic degradation in the cytoplasm. Such an antagonistic regulatory mechanism is essential for the mitotic function of FoxM1b, ensuring timely mitotic entry and progression. Taken together, our studies have revealed a working mechanism by which PLK1 positively regulates the activity and level of FoxM1b, which would greatly facilitate therapeutic interventions that focus on targeting the PLK1-mediated and/or FoxM1-mediated signaling network.	[Zhang, Jinglei; Yuan, Chengfu; Wu, Jianguo; Elsayed, Zeinab; Fu, Zheng] Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Inst Mol Genet,Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University	Fu, Z (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, 401 Coll St, Richmond, VA 23298 USA.	zfu@vcu.edu	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	NCI Cancer Center/National Institutes of Health [P30CA016059]; Department of Defense Prostate Cancer Research Program [PC094435]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER	NCI Cancer Center/National Institutes of Health; Department of Defense Prostate Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI Cancer Center/National Institutes of Health Support Grant P30CA016059 (to the Virginia Commonwealth University Massey Cancer Center). This work was also supported by Department of Defense Prostate Cancer Research Program Grant PC094435 (to Z. F.).	Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Endter C, 2001, P NATL ACAD SCI USA, V98, P11312, DOI 10.1073/pnas.191361798; Everett RD, 1999, J CELL SCI, V112, P4581; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Matsui Y, 2012, EUR J CELL BIOL, V91, P413, DOI 10.1016/j.ejcb.2011.12.008; Miteva M, 2010, SUBCELL BIOCHEM, V54, P195, DOI 10.1007/978-1-4419-6676-6_16; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Myatt SS, 2014, ONCOGENE, V33, P4316, DOI 10.1038/onc.2013.546; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Park HJ, 2008, ONCOGENE, V27, P1696, DOI 10.1038/sj.onc.1210814; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Schimmel J, 2014, MOL CELL, V53, P1053, DOI 10.1016/j.molcel.2014.02.001; Sobko A, 2002, DEV CELL, V2, P745, DOI 10.1016/S1534-5807(02)00186-7; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Wang CM, 2014, INT J MOL SCI, V15, P10233, DOI 10.3390/ijms150610233; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Wierstra I, 2007, BIOL CHEM, V388, P805, DOI 10.1515/BC.2007.094; Wierstra I, 2007, BIOCHEM BIOPH RES CO, V352, P61, DOI 10.1016/j.bbrc.2006.10.151; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Yuan CF, 2012, MOL CELL BIOCHEM, V359, P333, DOI 10.1007/s11010-011-1027-7; Yurchenko V, 2006, MOL CELL BIOL, V26, P1786, DOI 10.1128/MCB.26.5.1786-1794.2006	38	24	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3708	3719		10.1074/jbc.M114.634386	http://dx.doi.org/10.1074/jbc.M114.634386			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533473	Green Published, hybrid			2022-12-26	WOS:000349456000042
J	Grunert, T; Monahan, A; Lassnig, C; Vogl, C; Muller, M; Ehling-Schulz, M				Grunert, Tom; Monahan, Avril; Lassnig, Caroline; Vogl, Claus; Mueller, Mathias; Ehling-Schulz, Monika			Deciphering Host Genotype-Specific Impacts on the Metabolic Fingerprint of Listeria monocytogenes by FTIR Spectroscopy	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; IR SPECTROSCOPY; IDENTIFICATION; BACTERIA; TYPHIMURIUM	Bacterial pathogens are known for their wide range of strategies to specifically adapt to host environments and infection sites. An in-depth understanding of these adaptation mechanisms is crucial for the development of effective therapeutics and new prevention measures. In this study, we assessed the suitability of Fourier Transform Infrared (FTIR) spectroscopy for monitoring metabolic adaptations of the bacterial pathogen Listeria monocytogenes to specific host genotypes and for exploring the potential of FTIR spectroscopy to gain novel insights into the host-pathogen interaction. Three different mouse genotypes, showing different susceptibility to L. monocytogenes infections, were challenged with L. monocytogenes and re-isolated bacteria were subjected to FTIR spectroscopy. The bacteria from mice with different survival characteristics showed distinct IR spectral patterns, reflecting specific changes in the backbone conformation and the hydrogen-bonding pattern of the protein secondary structure in the bacterial cell. Coupling FTIR spectroscopy with chemometrics allowed us to link bacterial metabolic fingerprints with host infection susceptibility and to decipher longtime memory effects of the host on the bacteria. After prolonged cultivation of host-passaged bacteria under standard laboratory conditions, the host's imprint on bacterial metabolism vanished, which suggests a revertible metabolic adaptation of bacteria to host environment and loss of host environment triggered memory effects over time. In summary, our work demonstrates the potential and power of FTIR spectroscopy to be used as a fast, simple and highly discriminatory tool to investigate the mechanism of bacterial host adaptation on a macromolar and metabolic level.	[Grunert, Tom; Ehling-Schulz, Monika] Univ Vet Med Vienna, Inst Microbiol, Dept Pathobiol, Vienna, Austria; [Monahan, Avril; Lassnig, Caroline; Vogl, Claus; Mueller, Mathias] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Dept Biomed Sci, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Ehling-Schulz, M (corresponding author), Univ Vet Med Vienna, Inst Microbiol, Dept Pathobiol, Vienna, Austria.	monika.ehling-schulz@vetmeduni.ac.at	Ehling-Schulz, Monika/J-3592-2014; Grunert, Tom/N-1452-2018; Grunert, Tom/AAS-4748-2020; Grunert, Tom/AFQ-4195-2022	Grunert, Tom/0000-0001-5722-6631; Grunert, Tom/0000-0001-5722-6631; Grunert, Tom/0000-0001-5722-6631; Ehling-Schulz, Monika/0000-0001-7384-0594; Muller, Mathias/0000-0002-7879-3552	University of Veterinary Medicine Vienna, Vienna, Austria; Austrian Science Fund (FWF) [SFB-F28]	University of Veterinary Medicine Vienna, Vienna, Austria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	AM was supported by the postdoctoral program of the University of Veterinary Medicine Vienna, Vienna, Austria (www.vetmeduni.ac.at) and MM by a grant of the Austrian Science Fund (FWF) SFB-F28 (www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz T, 2014, MOL MICROBIOL, V93, P1093, DOI 10.1111/mmi.12695; Al-Qadiri HM, 2008, J FOOD SCI, V73, pM54, DOI 10.1111/j.1750-3841.2007.00640.x; Alvarez-Ordonez A, 2011, J MICROBIOL METH, V84, P369, DOI 10.1016/j.mimet.2011.01.009; Alvarez-Ordonez A, 2010, INT J FOOD MICROBIOL, V142, P97, DOI 10.1016/j.ijfoodmicro.2010.06.008; Beekes M, 2007, VET MICROBIOL, V123, P305, DOI 10.1016/j.vetmic.2007.04.010; Bosch A, 2010, J BIOPHOTONICS, V3, P522, DOI 10.1002/jbio.201000027; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; Ehling-Schulz M, 2005, MICROBIOL-SGM, V151, P183, DOI 10.1099/mic.0.27607-0; Fricker M, 2011, INT J FOOD MICROBIOL, V145, pS24, DOI 10.1016/j.ijfoodmicro.2010.08.025; Grunert T, 2013, J CLIN MICROBIOL, V51, P2261, DOI 10.1128/JCM.00581-13; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; KONGSHAVN PAL, 1985, IMMUNOL LETT, V11, P181, DOI 10.1016/0165-2478(85)90166-X; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; Lasch P., 2015, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A0117.PUB2; Lu XN, 2011, FOOD MICROBIOL, V28, P537, DOI 10.1016/j.fm.2010.11.002; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; Oberreuter H, 2002, INT J SYST EVOL MICR, V52, P91, DOI 10.1099/00207713-52-1-91; Semper C, 2014, MOL CELL BIOL, V34, P2235, DOI 10.1128/MCB.00295-14; Serra D, 2007, ANAL BIOANAL CHEM, V387, P1759, DOI 10.1007/s00216-006-1079-9; Serra DO, 2008, PROTEOMICS, V8, P4995, DOI 10.1002/pmic.200800218; Strobl B, 2011, FRONT BIOSCI-LANDMRK, V16, P3224, DOI 10.2741/3908; Wenning M., 2008, VIB SPECTROSC, P71; Wenning M, 2013, APPL MICROBIOL BIOT, V97, P7111, DOI 10.1007/s00253-013-5087-3	25	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115959	10.1371/journal.pone.0115959	http://dx.doi.org/10.1371/journal.pone.0115959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541972	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900116
J	Lappas, M				Lappas, Martha			GSK3 beta Is Increased in Adipose Tissue and Skeletal Muscle from Women with Gestational Diabetes Where It Regulates the Inflammatory Response	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; PREEXISTING MATERNAL OBESITY; FACTOR-KAPPA-B; INSULIN-RESISTANCE; PROINFLAMMATORY CYTOKINES; PERIODONTAL-DISEASE; ADHESION MOLECULES; GLUCOSE-METABOLISM; HUMAN PLACENTA; TNF-ALPHA	Infection and inflammation, through their ability to increase pro-inflammatory cytokines and chemokines and adhesion molecules, are thought to play a central role in the pathophysiology of insulin resistance and type 2 diabetes. Recent studies have shown that glycogen synthase kinase 3 (GSK3) plays a central role in regulating this inflammation. There are, however, no studies on the role of GSK3 in pregnancies complicated by gestational diabetes mellitus (GDM). Thus, the aims of this study were (i) to determine whether GSK3 is increased in adipose tissue and skeletal muscle from women with GDM; and (ii) to investigate the effect of GSK3 inhibition on inflammation in the presence of inflammation induced by bacterial endotoxin lipopolysaccharide (LPS) or the pro-inflammatory cytokine IL-1 beta. Human omental adipose tissue and skeletal muscle were obtained from normal glucose tolerant (NGT) women and BMI-matched women with diet-control GDM at the time of Caesarean section. Western blotting was performed to determine GSK3 protein expression. Tissue explants were performed to determine the effect of the GSK3 inhibitor CHIR99021 on markers of inflammation. When compared to women with NGT, omental adipose tissue and skeletal muscle obtained from women with diet-controlled GDM had significantly higher GSK3 beta activity as evidenced by a decrease in the expression of GSK3 beta phosphorylated at serine 9. The GSK3 inhibitor CHIR99021 significantly reduced the gene expression and secretion of the pro-inflammatory cytokines TNF-alpha, IL-1 beta and IL-6; the pro-inflammatory chemokines IL-8 and MCP-1; and the adhesion molecules ICAM-1 and VCAM-1 in tissues stimulated with LPS or IL-1 beta. In conclusion, GSK3 activity is increased in GDM adipose tissue and skeletal muscle and regulates infection- and inflammation-induced pro-inflammatory mediators.	[Lappas, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Obstet Nutr & Endocrinol Grp, Melbourne, Vic 3010, Australia; [Lappas, Martha] Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia	University of Melbourne	Lappas, M (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Obstet Nutr & Endocrinol Grp, Melbourne, Vic 3010, Australia.	mlappas@unimelb.edu.au	Sánchez-Margalet, Victor/AAB-9986-2021	Sánchez-Margalet, Victor/0000-0001-8638-8680	National Health and Medical Research Council (NHMRC) [1047025]; Medical Research Foundation for Women and Babies	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Foundation for Women and Babies	Associate Professor Martha Lappas was a recipient of a Career Development Fellowship from National Health and Medical Research Council (NHMRC; grant no. 1047025). The work described in this manuscript was funded by the Medical Research Foundation for Women and Babies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwunobi AO, 2000, J CLIN ENDOCR METAB, V85, P3770, DOI 10.1210/jc.85.10.3770; Ategbo JM, 2006, J CLIN ENDOCR METAB, V91, P4137, DOI 10.1210/jc.2006-0980; Aye ILMH, 2013, MOL CELL ENDOCRINOL, V381, P46, DOI 10.1016/j.mce.2013.07.013; Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V300, pL910, DOI 10.1152/ajplung.00232.2010; Balamurugan K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2677; Bari MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101327; Barker G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042943; Basu S, 2011, OBESITY, V19, P476, DOI 10.1038/oby.2010.215; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Catalano PM, 1999, AM J OBSTET GYNECOL, V180, P903, DOI 10.1016/S0002-9378(99)70662-9; Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7; Catalano PM, 2003, J NUTR, V133, p1674S, DOI 10.1093/jn/133.5.1674S; Catalano PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE522, DOI 10.1152/ajpendo.00124.2001; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cline GW, 2002, DIABETES, V51, P2903, DOI 10.2337/diabetes.51.10.2903; Colomiere M, 2010, J MOL ENDOCRINOL, V44, P213, DOI 10.1677/JME-09-0091; Cortes-Vieyra R, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-23; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Dugo L, 2006, SHOCK, V25, P485, DOI 10.1097/01.shk.0000209545.29671.31; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Green HF, 2012, NEUROCHEM INT, V61, P666, DOI 10.1016/j.neuint.2012.07.003; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jones HN, 2009, AM J PHYSIOL-CELL PH, V297, pC1228, DOI 10.1152/ajpcell.00195.2009; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kacimi R, 1998, CIRC RES, V82, P576, DOI 10.1161/01.RES.82.5.576; Kautzky-Willer A, 1997, J CLIN ENDOCR METAB, V82, P4117, DOI 10.1210/jc.82.12.4117; Kim SJ, 2014, TOXICOLOGY, V320, P74, DOI 10.1016/j.tox.2014.01.013; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; Klein K, 2008, PRENATAL DIAG, V28, P845, DOI 10.1002/pd.2064; Krauss T, 2002, CLIN CHEM, V48, P1418; Kuzmicki M, 2009, GYNECOL ENDOCRINOL, V25, P258, DOI 10.1080/09513590802653825; Lager S, 2011, PLACENTA, V32, P121, DOI 10.1016/j.placenta.2010.10.012; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Lappas M, 2005, J ENDOCRINOL, V186, P457, DOI 10.1677/joe.1.06227; Lappas M, 2005, ENDOCRINOLOGY, V146, P1491, DOI 10.1210/en.2004-0809; Lappas M, 2004, J CLIN ENDOCR METAB, V89, P5627, DOI 10.1210/jc.2003-032097; Lappas M, 2005, ENDOCRINOLOGY, V146, P3334, DOI 10.1210/en.2005-0406; Lappas M, 2014, J ENDOCRINOL, V222, P99, DOI 10.1530/JOE-14-0179; Lappas M, 2014, METABOLISM, V63, P860, DOI 10.1016/j.metabol.2014.03.007; Lappas M, 2014, METABOLISM, V63, P250, DOI 10.1016/j.metabol.2013.10.001; Lappas M, 2014, MOL CELL ENDOCRINOL, V382, P74, DOI 10.1016/j.mce.2013.09.011; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Leinonen E, 2003, ATHEROSCLEROSIS, V166, P387, DOI 10.1016/S0021-9150(02)00371-4; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Metzger BE, 2007, CLIN OBSTET GYNECOL, V50, P972, DOI 10.1097/GRF.0b013e31815a61d6; Mordwinkin NM, 2013, J MATERN-FETAL NEO M, V26, P507, DOI 10.3109/14767058.2012.736564; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Patel S, 2009, PHARMACOL REP, V61, P595, DOI 10.1016/S1734-1140(09)70111-2; Radaelli T, 2006, J SOC GYNECOL INVEST, V13, P53, DOI 10.1016/j.jsgi.2005.10.003; Radaelli T, 2003, DIABETES, V52, P2951, DOI 10.2337/diabetes.52.12.2951; Ramirez SH, 2010, AM J PATHOL, V176, P881, DOI 10.2353/ajpath.2010.090671; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Retnakaran R, 2003, J CLIN ENDOCR METAB, V88, P3507, DOI 10.1210/jc.2003-030186; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Vitoratos N, 2008, HORM-INT J ENDOCRINO, V7, P230, DOI 10.14310/horm.2002.1202; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xiong X, 2006, AM J OBSTET GYNECOL, V195, P1086, DOI 10.1016/j.ajog.2006.06.035; Xiong X, 2009, J PERIODONTOL, V80, P1742, DOI 10.1902/jop.2009.090250	68	40	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115854	10.1371/journal.pone.0115854	http://dx.doi.org/10.1371/journal.pone.0115854			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541965	Green Published, gold			2022-12-26	WOS:000347239900098
J	Schablon, A; Nienhaus, A; Ringshausen, FC; Preisser, AM; Peters, C				Schablon, Anja; Nienhaus, Albert; Ringshausen, Felix C.; Preisser, Alexandra M.; Peters, Claudia			Occupational Screening for Tuberculosis and the Use of a Borderline Zone for Interpretation of the IGRA in German Healthcare Workers	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; WITHIN-SUBJECT VARIABILITY; LATENT TUBERCULOSIS; SKIN-TEST; TB INFECTION; RISK-FACTORS; PREVALENCE; CONVERSIONS; CHALLENGES; STUDENTS	Introduction: Healthcare workers (HCWs) in low incidence countries with contact to patients with tuberculosis (TB) are considered a high-risk group for latent TB infection (LTBI) and therefore are routinely screened for LTBI. The German Occupational TB Network data is analyzed in order to estimate the prevalence and incidence of LTBI and to evaluate putative risk factors for a positive IGRA and the performance of IGRA in serial testing. Methods: 3,823 HCWs were screened with the Quantiferon Gold in Tube (QFT) at least once; a second QFT was performed on 817 HCWs either in the course of contact tracing or serial examination. Risk factors for a positive QFT were assessed by a questionnaire. Results: We observed a prevalence of LTBI of 8.3%. Putative risk factors for a positive QFT result were age >55 years (OR 6.89), foreign country of birth (OR 2.39), personal history of TB (OR 6.23) and workplace, e.g. internal medicine (OR 1.40), infection ward (OR 1.8) or geriatric care (OR 1.8). Of those repeatedly tested, 88.2% (721/817) tested consistently QFT-negative and 47 were consistently QFT-positive (5.8%). A conversion was observed in 2.8% (n=21 of 742 with a negative first QFT) and a reversion occurred in 37.3% (n=28 of 75 with a positive first QFT). Defining a conversion as an increase of the specific interferon concentration from <0.2 to >0.7 IU/ml, the conversion rate decreased to 1.2% (n=8). Analogous to this, the reversion rate decreased to 18.8% (n=9). Discussion: In countries with a low incidence of TB and high hygiene standards, the LTBI infection risk for HCWs seems low. Introducing a borderline zone from 0.2 to <= 0.7 IU/ml may help to avoid unnecessary X-rays and preventive chemotherapy. No case of active TB was detected. Therefore, it might be reasonable to further restrict TB screening to HCWs who had unprotected contact with infectious patients or materials.	[Schablon, Anja; Nienhaus, Albert; Peters, Claudia] Univ Med Ctr Hamburg Eppendorf UKE, Ctr Excellence Hlth Serv Res Nursing CVcare, Hamburg, Germany; [Nienhaus, Albert] Inst Statutory Accid Insurance & Prevent Hlth & W, Principles Prevent & Rehabil Dept GPR, Hamburg, Germany; [Ringshausen, Felix C.] Hannover Med Sch, Dept Resp Med, Hannover, NH, Germany; [Preisser, Alexandra M.] Univ Med Ctr Hamburg Eppendorf UKE, Inst Occupat & Maritime Med, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf	Nienhaus, A (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Ctr Excellence Hlth Serv Res Nursing CVcare, Hamburg, Germany.	a.nienhaus@uke.de	Ringshausen, Felix C./AAA-9154-2021	Ringshausen, Felix C./0000-0001-9084-4968	Institution for Statutory Accident Insurance and Prevention in the Health and Welfare services (BGW) on an annual basis to maintain the working group at the UKE; social security system in Germany	Institution for Statutory Accident Insurance and Prevention in the Health and Welfare services (BGW) on an annual basis to maintain the working group at the UKE; social security system in Germany	Funding: No special funds were received for this study. However, the Institute for Health Services Research in Dermatology and Nursing of the University Medical Centre Hamburg-Eppendorf (UKE) receives an unrestricted fund from the Institution for Statutory Accident Insurance and Prevention in the Health and Welfare services (BGW) on an annual basis to maintain the working group at the UKE. The funds are provided by a non-profit organization that is part of the social security system in Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Brodhun B, 2012, RKI BERICHT EPIDEMIO; Costa JT, 2009, EUR RESPIR J, V34, P1423, DOI 10.1183/09031936.00053809; Costa JT, 2011, J OCCUP MED TOXICOL, V6, DOI 10.1186/1745-6673-6-19; Diel R, 2002, J CLIN MICROBIOL, V40, P532, DOI 10.1128/JCM.40.2.532-539.2002; Diel R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-35; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Durando P, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-443; Fong KS, 2012, CHEST, V142, P55, DOI 10.1378/chest.11-0992; Franchi A, 2007, INT ARCH OCC ENV HEA, V80, P533, DOI 10.1007/s00420-006-0160-1; Gran G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-353; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Joshi M, 2012, CAN RESPIR J, V19, P84, DOI 10.1155/2012/576324; Lamberti M, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/s12995-014-0034-5; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Moucaut A, 2013, J OCCUP MED TOXICOL, V8, DOI 10.1186/1745-6673-8-12; Nienhaus A, 2007, Pneumologie, V61, P219, DOI 10.1055/s-2007-959161; Nienhaus A, 2011, Pneumologie, V65, P726, DOI 10.1055/s-0031-1291392; Nienhaus A, 2013, J OCCUP MED TOXICOL, V8, DOI 10.1186/1745-6673-8-1; Nienhaus A, 2013, EXPERT REV ANTI-INFE, V11, P37, DOI [10.1586/ERI.12.150, 10.1586/eri.12.150]; Nienhaus A, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-8; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2013, CAN J RESPIR CRIT CA, P1; Pai M, 2013, OCCUP MED-OXFORD, V63, P458, DOI 10.1093/occmed/kqt105; Rafiza S, 2012, INT J TUBERC LUNG D, V16, P163, DOI 10.5588/ijtld.11.0364; Ringshausen FC, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-6; Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11; Ringshausen Felix C, 2009, J Occup Med Toxicol, V4, P11, DOI 10.1186/1745-6673-4-11; Schablon A, 2010, GMS HYG INFECT CONTR, V5; Schablon A, 2013, GMS HYG INFECT CONTR, V8, DOI 10.3205/dgkh000217; Schablon A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-107; Seidler A, 2005, RESPIRATION, V72, P431, DOI 10.1159/000086261; Slater ML, 2013, AM J RESP CRIT CARE, V188, P1005, DOI 10.1164/rccm.201305-0831OC; Soborg B, 2007, SCAND J INFECT DIS, V39, P554, DOI 10.1080/00365540601148483; Tagmouti S, 2014, ANN AM THORAC SOC, V4; Thanassi W, 2012, PULM MED, V2012, DOI 10.1155/2012/291294; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Zwerling A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054748; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	40	42	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115322	10.1371/journal.pone.0115322	http://dx.doi.org/10.1371/journal.pone.0115322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541947	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900035
J	Wittmann, BM; Stirdivant, SM; Mitchell, MW; Wulff, JE; McDunn, JE; Li, Z; Dennis-Barrie, A; Neri, BP; Milburn, MV; Lotan, Y; Wolfert, RL				Wittmann, Bryan M.; Stirdivant, Steven M.; Mitchell, Matthew W.; Wulff, Jacob E.; McDunn, Jonathan E.; Li, Zhen; Dennis-Barrie, Aphrihl; Neri, Bruce P.; Milburn, Michael V.; Lotan, Yair; Wolfert, Robert L.			Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine	PLOS ONE			English	Article							ISOCITRATE DEHYDROGENASE MUTATIONS; INVASIVE UROTHELIAL CARCINOMA; EAU GUIDELINES; MANAGEMENT; IDENTIFICATION; DIAGNOSIS; SARCOSINE	Bladder cancer (BCa) is a common malignancy worldwide and has a high probability of recurrence after initial diagnosis and treatment. As a result, recurrent surveillance, primarily involving repeated cystoscopies, is a critical component of post diagnosis patient management. Since cystoscopy is invasive, expensive and a possible deterrent to patient compliance with regular follow-up screening, new non-invasive technologies to aid in the detection of recurrent and/or primary bladder cancer are strongly needed. In this study, mass spectrometry based metabolomics was employed to identify biochemical signatures in human urine that differentiate bladder cancer from non-cancer controls. Over 1000 distinct compounds were measured including 587 named compounds of known chemical identity. Initial biomarker identification was conducted using a 332 subject sample set of retrospective urine samples (cohort 1), which included 66 BCa positive samples. A set of 25 candidate biomarkers was selected based on statistical significance, fold difference and metabolic pathway coverage. The 25 candidate biomarkers were tested against an independent urine sample set (cohort 2) using random forest analysis, with palmitoyl sphingomyelin, lactate, adenosine and succinate providing the strongest predictive power for differentiating cohort 2 cancer from non-cancer urines. Cohort 2 metabolite profiling revealed additional metabolites, including arachidonate, that were higher in cohort 2 cancer vs. non-cancer controls, but were below quantitation limits in the cohort 1 profiling. Metabolites related to lipid metabolism may be especially interesting biomarkers. The results suggest that urine metabolites may provide a much needed non-invasive adjunct diagnostic to cystoscopy for detection of bladder cancer and recurrent disease management.	[Wittmann, Bryan M.; Stirdivant, Steven M.; Mitchell, Matthew W.; Wulff, Jacob E.; McDunn, Jonathan E.; Li, Zhen; Neri, Bruce P.; Milburn, Michael V.; Wolfert, Robert L.] Metabolon Inc, Durham, NC 27713 USA; [Dennis-Barrie, Aphrihl; Lotan, Yair] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA	Metabolon; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wittmann, BM (corresponding author), Metabolon Inc, Durham, NC 27713 USA.	bwittmann@metabolon.com		Mitchell, Matthew/0000-0002-2681-4091	 [NIH 1R01-CA151489-01];  [NIH/NCRR 5 UL1 RR24982-02]; NATIONAL CANCER INSTITUTE [R01CA151489] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for sample collection and annotation was supported by grants NIH 1R01-CA151489-01 (Bogdan Czerniak PI), and NIH/NCRR 5 UL1 RR24982-02 (YL co-investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Metabolon acquired samples on fee per sample basis.	Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Brausi M, 2011, J UROLOGY, V186, P2158, DOI 10.1016/j.juro.2011.07.076; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083; Chamie K, 2011, CANCER-AM CANCER SOC, V117, P5392, DOI 10.1002/cncr.26198; Chatterjee S, 1999, J BIOL CHEM, V274, P37407, DOI 10.1074/jbc.274.52.37407; Chen TL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004945; DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.immunol.2.1.335; DiNardo CD, 2013, BLOOD, V121, P4917, DOI 10.1182/blood-2013-03-493197; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Ganti S, 2012, CANCER RES, V72, P3471, DOI 10.1158/0008-5472.CAN-11-3105; Ganti S, 2011, UROL ONCOL-SEMIN ORI, V29, P551, DOI 10.1016/j.urolonc.2011.05.013; Gaston KE, 2004, UROLOGY, V63, P1009, DOI 10.1016/j.urology.2003.12.004; Gazzaniga P, 2012, ANN ONCOL, V23, P2352, DOI 10.1093/annonc/mdr619; Hall MC, 2007, J UROLOGY, V178, P2314, DOI 10.1016/j.juro.2007.09.003; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holecek M, 2002, NUTRITION, V18, P130, DOI 10.1016/S0899-9007(01)00767-5; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang ZZ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007922; Issaq HJ, 2008, J UROLOGY, V179, P2422, DOI 10.1016/j.juro.2008.01.084; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Khan AP, 2013, NEOPLASIA, V15, P491, DOI 10.1593/neo.13314; Kim K, 2011, OMICS, V15, P293, DOI 10.1089/omi.2010.0094; LANDAAS S, 1975, SCAND J CLIN LAB INV, V35, P259, DOI 10.3109/00365517509095738; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; LINARDIC CM, 1994, J BIOL CHEM, V269, P23530; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; McDunn JE, 2013, PROSTATE, V73, P1547, DOI 10.1002/pros.22704; Milburn MV, 2012, GENETICS MEETS METAB, P177; MITCHELL GA, 1995, CLIN INVEST MED, V18, P193; Pasikanti KK, 2010, J PROTEOME RES, V9, P2988, DOI 10.1021/pr901173v; Putluri N, 2011, CANCER RES, V71, P7376, DOI 10.1158/0008-5472.CAN-11-1154; R Core Team, 2021, R LANGUAGE ENV STAT; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Scher H, 1998, ONCOLOGY-NY, V12, P225; Schroeder MA, 2012, CIRC-CARDIOVASC IMAG, V5, P201, DOI 10.1161/CIRCIMAGING.111.969451; Sengupta S, 2006, UROLOGY, V67, P48, DOI 10.1016/j.urology.2006.01.041; Shore ND, 2012, RES REP UROL, V4, P49, DOI 10.2147/RRU.S36006; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Srivastava S, 2010, CANCER BIOMARK, V6, P11, DOI 10.3233/CBM-2009-0115; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; van der Poel H G, 2001, Curr Opin Urol, V11, P503, DOI 10.1097/00042307-200109000-00009; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365	47	73	74	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115870	10.1371/journal.pone.0115870	http://dx.doi.org/10.1371/journal.pone.0115870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541698	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900100
J	Broekman, BFP; Wang, CQ; Li, Y; Rifkin-Graboi, A; Saw, SM; Chong, YS; Kwek, K; Gluckman, PD; Fortier, MV; Meaney, MJ; Qiu, AQ				Broekman, Birit F. P.; Wang, Changqing; Li, Yue; Rifkin-Graboi, Anne; Saw, Seang Mei; Chong, Yap-Seng; Kwek, Kenneth; Gluckman, Peter D.; Fortier, Marielle V.; Meaney, Michael J.; Qiu, Anqi		GUSTO Study Grp	Gestational Age and Neonatal Brain Microstructure in Term Born Infants: A Birth Cohort Study	PLOS ONE			English	Article							WHITE-MATTER DEVELOPMENT; HUMAN FETAL-BRAIN; DIFFUSION-TENSOR; CORPUS-CALLOSUM; PRETERM INFANTS; INTERNAL CAPSULE; EQUIVALENT AGE; MRI; ABNORMALITIES; TRACTOGRAPHY	Objective: Understanding healthy brain development in utero is crucial in order to detect abnormal developmental trajectories due to developmental disorders. However, in most studies neuroimaging was done after a significant postnatal period, and in those studies that performed neuroimaging on fetuses, the quality of data has been affected due to complications of scanning during pregnancy. To understand healthy brain development between 37-41 weeks of gestational age, our study assessed the in utero growth of the brain in healthy term born babies with DTI scanning soon after birth. Methods: A cohort of 93 infants recruited from maternity hospitals in Singapore underwent diffusion tensor imaging between 5 to 17 days after birth. We did a cross-sectional examination of white matter microstructure of the brain among healthy term infants as a function of gestational age via voxel-based analysis on fractional anisotropy. Results: Greater gestational age at birth in term infants was associated with larger fractional anisotropy values in early developing brain regions, when corrected for age at scan. Specifically, it was associated with a cluster located at the corpus callosum (corrected p<0.001), as well as another cluster spanning areas of the anterior corona radiata, anterior limb of internal capsule, and external capsule (corrected p<0.001). Conclusions: Our findings show variation in brain maturation associated with gestational age amongst 'term' infants, with increased brain maturation when born with a relatively higher gestational age in comparison to those infants born with a relatively younger gestational age. Future studies should explore if these differences in brain maturation between 37 and 41 weeks of gestational age will persist over time due to development outside the womb.	[Broekman, Birit F. P.] Natl Univ Hlth Syst, Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore; [Wang, Changqing; Li, Yue; Qiu, Anqi] Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore; [Broekman, Birit F. P.; Rifkin-Graboi, Anne; Gluckman, Peter D.; Meaney, Michael J.; Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Saw, Seang Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Chong, Yap-Seng] Natl Univ Hlth Syst, Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore, Singapore; [Kwek, Kenneth] KK Womens & Childrens Hosp, Dept Maternal Fetal Med, Singapore, Singapore; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Fortier, Marielle V.] KK Womens & Childrens Hosp, Dept Diagnost & Intervent Imaging, Singapore, Singapore; [Meaney, Michael J.] McGill Univ, Dept Psychiat & Neurol, Montreal, PQ, Canada; [Meaney, Michael J.] McGill Univ, Dept Neurosurg, Montreal, PQ H3A 2T5, Canada; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; National University of Singapore; KK Women's & Children's Hospital; University of Auckland; KK Women's & Children's Hospital; McGill University; McGill University; National University of Singapore	Qiu, AQ (corresponding author), Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore.	bieqa@nus.edu.sg	Lee, Yung Seng/F-2169-2014; Chew, Fook Tim/E-7259-2010; Rifkin-Graboi, Anne/AFM-0959-2022; Henry, Christiani Jeyakumar/AHB-2632-2022; Rifkin-Graboi, Anne/AAH-3658-2022; Qiu, Anqi/H-2267-2011; Meaney, Michael/N-5931-2019; Inskip, Hazel/L-5467-2018; Venkatesh, Sudhakar/T-9385-2019; Hsu, Chin-ying/E-7855-2016	Lee, Yung Seng/0000-0002-1253-0557; Chew, Fook Tim/0000-0003-1337-5146; Henry, Christiani Jeyakumar/0000-0002-1602-0140; Qiu, Anqi/0000-0002-0215-6338; Inskip, Hazel/0000-0001-8897-1749; TINT, Mya Thway/0000-0002-9548-7186; Godfrey, Keith/0000-0002-4643-0618; Richmond, Jenny/0000-0002-5808-4249; BISWAS, ARIJIT/0000-0002-3311-2135; Rifkin-Graboi, Anne/0000-0002-7641-4678; Ferguson-Smith, Anne/0000-0002-7608-5894; Venkatesh, Sudhakar/0000-0002-7514-1030; Morton, Susan/0000-0002-2231-7020; Tan, Kok Hian/0000-0003-1945-0266; Yap, Fabian/0000-0003-1083-7958; Amutha, Chinnaiah/0000-0003-1395-2089; Shek, Lynette/0000-0001-9064-8983; Kapur, Jeevesh/0000-0002-5696-0233; Hsu, Chin-ying/0000-0001-7367-3204; Chong, Yap Seng/0000-0002-7232-8473; SOH, SHU E/0000-0002-0790-4200	National Medical Research Council (NMRC) [NMRC/TCR/004-NUS/2008, NMRC/CBRG/0039/2013]; Young Investigator Award at the National University of Singapore [NUSYIA FY10 P07]; National University of Singapore MOE AcRF Tier 1; Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2012-T2-2-130]; MRC [MC_UU_12011/4] Funding Source: UKRI; Medical Research Council [MC_UU_12011/4] Funding Source: researchfish	National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Young Investigator Award at the National University of Singapore(National University of Singapore); National University of Singapore MOE AcRF Tier 1(Ministry of Education, SingaporeNational University of Singapore); Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is supported by National Medical Research Council (NMRC; NMRC/TCR/004-NUS/2008, NMRC/CBRG/0039/2013), the Young Investigator Award at the National University of Singapore (NUSYIA FY10 P07), the National University of Singapore MOE AcRF Tier 1, and Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2012-T2-2-130). The funding agencies did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby A, 2009, AM J NEURORADIOL, V30, P1780, DOI 10.3174/ajnr.A1660; Alderson RM, 2007, J ABNORM CHILD PSYCH, V35, P745, DOI 10.1007/s10802-007-9131-6; Bai J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047816; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Bonifacio SL, 2010, J PEDIATR-US, V157, P726, DOI 10.1016/j.jpeds.2010.05.026; Bulas D, 2013, SEMIN PERINATOL, V37, P301, DOI 10.1053/j.semperi.2013.06.005; Caldu X, 2006, J CHILD NEUROL, V21, P406, DOI 10.1177/08830738060210050801; de Bruine FT, 2011, EUR RADIOL, V21, P538, DOI 10.1007/s00330-010-1945-x; Du J, 2011, NEUROIMAGE, V56, P162, DOI 10.1016/j.neuroimage.2011.01.067; Dubois J, 2014, NEUROSCIENCE, V276, P48, DOI 10.1016/j.neuroscience.2013.12.044; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Dudink J, 2007, PEDIATR RADIOL, V37, P1216, DOI 10.1007/s00247-007-0626-7; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Floresco SB, 1999, J NEUROSCI, V19, P11061, DOI 10.1523/JNEUROSCI.19-24-11061.1999; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Griffiths PD, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130168; Hasegawa T, 2011, PEDIATR RES, V69, P249, DOI 10.1203/PDR.0b013e3182084e54; Holland D, 2014, JAMA NEUROL; Hoon AH, 2009, DEV MED CHILD NEUROL, V51, P697, DOI 10.1111/j.1469-8749.2009.03306.x; Horsch S, 2007, ACTA PAEDIATR, V96, P979, DOI 10.1111/j.1651-2227.2007.00294.x; Huang H, 2006, NEUROIMAGE, V33, P27, DOI 10.1016/j.neuroimage.2006.06.009; Huang H, 2009, J NEUROSCI, V29, P4263, DOI 10.1523/JNEUROSCI.2769-08.2009; Jo HM, 2012, NEURORADIOLOGY, V54, P997, DOI 10.1007/s00234-012-1042-8; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Kasprian G, 2008, NEUROIMAGE, V43, P213, DOI 10.1016/j.neuroimage.2008.07.026; Kato S, 2011, J NEUROSCI, V31, P17169, DOI 10.1523/JNEUROSCI.4005-11.2011; Kaur S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085807; Kierans William J, 2008, BMC Pregnancy Childbirth, V8, P1, DOI 10.1186/1471-2393-8-1; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; Lepomaki V, 2012, PEDIATR RADIOL, V42, P692, DOI 10.1007/s00247-012-2352-z; Matthew APG, 2011, PLOS ONE, V6; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Miao XL, 2014, INT J DEV NEUROSCI, V34, P42, DOI 10.1016/j.ijdevneu.2014.01.004; Nagy Z, 2009, PEDIATRICS, V124, pE964, DOI 10.1542/peds.2008-3801; Narberhaus A, 2007, J CHILD NEUROL, V22, P761, DOI 10.1177/0883073807304006; Nossin-Manor R, 2013, NEUROIMAGE, V64, P505, DOI 10.1016/j.neuroimage.2012.08.086; Oishi K, 2011, NEUROIMAGE, V56, P8, DOI 10.1016/j.neuroimage.2011.01.051; Partridge SC, 2004, NEUROIMAGE, V22, P1302, DOI 10.1016/j.neuroimage.2004.02.038; Perenyi A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002499; Phua DYL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036502; Qiu AQ, 2013, NEUROIMAGE, V65, P315, DOI 10.1016/j.neuroimage.2012.09.032; Raisanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060660; Rose J, 2014, NEUROIMAGE, V86, P244, DOI 10.1016/j.neuroimage.2013.09.053; Rose J, 2009, DEV MED CHILD NEUROL, V51, P526, DOI 10.1111/j.1469-8749.2008.03231.x; Rose O, 2013, PEDIATRICS, V131, pE1475, DOI 10.1542/peds.2012-3215; Shim SY, 2012, NEONATOLOGY, V102, P309, DOI 10.1159/000341867; SHINOHARA T, 1977, APPL NEUROPHYSIOL, V39, P251; Skiold B, 2010, ACTA PAEDIATR, V99, P842, DOI 10.1111/j.1651-2227.2009.01634.x; Soh SE, 2013, INT J EPIDEMIOL; Soria-Pastor S, 2008, INT J DEV NEUROSCI, V26, P647, DOI 10.1016/j.ijdevneu.2008.08.001; Tang YC, 2010, NEUROIMAGE, V51, P33, DOI 10.1016/j.neuroimage.2010.01.111; Thomason ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094423; van den Berg G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037002; van Pul C, 2012, AM J NEURORADIOL, V33, P678, DOI 10.3174/ajnr.A2859; VANDERKNAAP MS, 1990, NEURORADIOLOGY, V31, P459, DOI 10.1007/BF00340123	57	22	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115229	10.1371/journal.pone.0115229	http://dx.doi.org/10.1371/journal.pone.0115229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535959	Green Submitted, Green Published, gold			2022-12-26	WOS:000348563300033
J	Hu, J; Li, M; Han, TX; Chen, JW; Ye, LX; Wang, Q; Zhou, YK				Hu, Jia; Li, Mei; Han, Tian-xu; Chen, Jian-wei; Ye, Lin-xiang; Wang, Qi; Zhou, Yi-kai			Benchmark Dose Estimation for Cadmium-Induced Renal Tubular Damage among Environmental Cadmium-Exposed Women Aged 35-54 Years in Two Counties of China	PLOS ONE			English	Article							URINARY CADMIUM; RESPONSE RELATIONSHIP; GENDER-DIFFERENCES; FOLLOW-UP; DYSFUNCTION; BIOMARKERS; TOXICITY; RISK; BETA(2)-MICROGLOBULINURIA; GLUCOSAMINIDASE	Background: A number of factors, including gender, age, smoking habits, and occupational exposure, affect the levels of urinary cadmium. Few studies have considered these influences when calculating the benchmark dose (BMD) of cadmium. In the present study, we aimed to calculate BMDs and their 95% lower confidence bounds (BMDLs) for cadmium-induced renal tubular effects in an age-specific population in south-central China. Methods: In this study, urinary cadmium, beta 2-microglobulin, and N-acetyl-beta-D-glucosaminidase levels were measured in morning urine samples from 490 randomly selected non-smoking women aged 35-54 years. Participants were selected using stratified cluster sampling in two counties (counties A and B) in China. Multiple regression and logistic regression analyses were used to investigate the dose-response relationship between urinary cadmium levels and tubular effects. BMDs/BMDLs corresponding to an additional risk (benchmark response) of 5% and 10% were calculated with assumed cut-off values of the 84th and 90th percentile of urinary beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase levels of the controls. Results: Urinary levels of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase increased significantly with increasing levels of urinary cadmium. Age was not associated with urinary cadmium levels, possibly because of the narrow age range included in this study. Based on urinary beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase, BMDs and BMDLs of urinary cadmium ranged from 2.08 to 3.80 (1.41-2.18) mu g/g cr for subjects in county A and from 0.99 to 3.34 (0.74-1.91) mu g/g cr for those in county B. The predetermined benchmark response of 0.05 and the 90th percentiles of urinary beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase levels of the subjects not exposed to cadmium (i.e., the control group) served as cut-off values. Conclusions: The obtained BMDs of urinary cadmium were similar to the reference point of 1 mu g/g cr, as suggested by the European Food Safety Authority, indicating that cadmium exposure must be reduced to protect human health.	[Hu, Jia; Li, Mei; Han, Tian-xu; Chen, Jian-wei; Zhou, Yi-kai] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth,Inst Environm Med, Wuhan 430074, Peoples R China; [Ye, Lin-xiang; Wang, Qi] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, Q (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	lwq95@126.com; zhouyk@mails.tjmu.edu.cn	Burdmann, Emmanuel/AAY-1966-2020; Burdmann, Emmanuel/B-7023-2009	Burdmann, Emmanuel/0000-0002-7644-8579; Hu, Jia/0000-0001-5779-257X	Special Fund for the Environmental Protection Research in the Public Interest [201109058]; National Natural Science Foundation of China [81102185]; Fundamental Research Funds for the Central Universities [2011QN202]	Special Fund for the Environmental Protection Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study was supported by the Special Fund for the Environmental Protection Research in the Public Interest (Grant no. of 201109058), the National Natural Science Foundation of China (Grant no. of 81102185), and the Fundamental Research Funds for the Central Universities (Grant no. of 2011QN202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson AA, 2005, ENVIRON HEALTH PERSP, V113, P1627, DOI 10.1289/ehp.8033; Bernard A, 2004, BIOMETALS, V17, P519, DOI 10.1023/B:BIOM.0000045731.75602.b9; BERNARD A, 1995, OCCUP ENVIRON MED, V52, P177, DOI 10.1136/oem.52.3.177; Bernard A, 2008, INDIAN J MED RES, V128, P557; Bernard A, 2008, J TOXICOL ENV HEAL A, V71, P1259, DOI 10.1080/15287390802211885; BONSNES RW, 1945, J BIOL CHEM, V158, P581; Cho YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075087, 10.1371/journal.pone.0081560]; CRUMP KS, 1984, FUND APPL TOXICOL, V4, P854, DOI 10.1016/0272-0590(84)90107-6; Crump KS, 1995, USE BENCHMARK DOSE A; Filipsson AF, 2003, CRIT REV TOXICOL, V33, P505, DOI 10.1080/10408440390242360; Galazyn-Sidorczuk M, 2008, ENVIRON MONIT ASSESS, V137, P481, DOI 10.1007/s10661-007-9783-2; Gallagher CM, 2011, ENVIRON RES, V111, P702, DOI 10.1016/j.envres.2011.03.007; Gamo M, 2006, ENVIRON RES, V101, P104, DOI 10.1016/j.envres.2005.09.004; Hayano M, 1996, ARCH ENVIRON HEALTH, V51, P162, DOI 10.1080/00039896.1996.9936011; Hellstrom L, 2007, SCI TOTAL ENVIRON, V373, P447, DOI 10.1016/j.scitotenv.2006.11.028; Hong F, 2004, BIOMETALS, V17, P573, DOI 10.1023/B:BIOM.0000045741.22924.d8; Hotz P, 1999, LANCET, V354, P1508, DOI 10.1016/S0140-6736(99)91145-5; ISHIZAKI M, 1989, TOXICOLOGY, V58, P121, DOI 10.1016/0300-483X(89)90002-4; IWATA K, 1993, ARCH ENVIRON HEALTH, V48, P157, DOI 10.1080/00039896.1993.9940814; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Jin TY, 2002, BIOMETALS, V15, P397, DOI 10.1023/A:1020229923095; Ju YR, 2012, J HAZARD MATER, V227, P353, DOI 10.1016/j.jhazmat.2012.05.060; Julin B, 2011, ENV HLTH, V10; KIDO T, 1988, ARCH ENVIRON HEALTH, V43, P213, DOI 10.1080/00039896.1988.9934935; Kippler M, 2007, TOXICOL APPL PHARM, V222, P221, DOI 10.1016/j.taap.2007.04.009; Kobayashi E, 2008, BIOL TRACE ELEM RES, V124, P164, DOI 10.1007/s12011-008-8125-8; Kobayashi E, 2006, J APPL TOXICOL, V26, P351, DOI 10.1002/jat.1147; Kobayashi E, 2006, ENVIRON RES, V101, P401, DOI 10.1016/j.envres.2005.12.002; Liang YH, 2012, ENVIRON HEALTH PERSP, V120, P223, DOI 10.1289/ehp.1103699; Moriguchi J, 2009, TOXICOL LETT, V190, P1, DOI 10.1016/j.toxlet.2009.05.009; MUELLER PW, 1989, NEPHRON, V52, P45, DOI 10.1159/000185581; Nishijo M, 2004, MOL CELL BIOCHEM, V255, P87, DOI 10.1023/B:MCBI.0000007264.37170.39; Olsson IM, 2002, ENVIRON HEALTH PERSP, V110, P1185, DOI 10.1289/ehp.021101185; Prozialeck WC, 2010, BIOMETALS, V23, P793, DOI 10.1007/s10534-010-9288-2; Satarug S, 2003, TOXICOL LETT, V137, P65, DOI 10.1016/S0378-4274(02)00381-8; Satarug S, 2004, ENVIRON HEALTH PERSP, V112, P1099, DOI 10.1289/ehp.6751; Satarug Soisungwan, 2011, Ciênc. saúde coletiva, V16, P2587, DOI 10.1590/S1413-81232011000500029; Shimizu A, 2006, INT J ENVIRON HEAL R, V16, P329, DOI 10.1080/09603120600869174; Suwazono Y, 2000, ENVIRON RES, V84, P44, DOI 10.1006/enrs.2000.4086; Suwazono Y, 2006, ENVIRON HEALTH PERSP, V114, P1072, DOI 10.1289/ehp.9028; Suwazono Y, 2010, TOXICOL LETT, V198, P40, DOI 10.1016/j.toxlet.2010.04.015; Trzcinka-Ochocka M, 2004, ENVIRON RES, V95, P143, DOI 10.1016/j.envres.2003.10.003; TUCKER SM, 1975, CLIN CHIM ACTA, V62, P333, DOI 10.1016/0009-8981(75)90245-4; Vahter M, 2007, ENVIRON RES, V104, P85, DOI 10.1016/j.envres.2006.08.003; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087817; Yamanaka O, 1998, ENVIRON RES, V77, P1, DOI 10.1006/enrs.1998.3839	47	5	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115794	10.1371/journal.pone.0115794	http://dx.doi.org/10.1371/journal.pone.0115794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536107	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300074
J	Kim, JE; Kim, UJ; Kim, HK; Cho, SK; An, JH; Kang, SJ; Park, KH; Jung, SI; Jang, HC				Kim, Ji Eun; Kim, Uh Jin; Kim, Hee Kyung; Cho, Soo Kyung; An, Joon Hwan; Kang, Seung-Ji; Park, Kyung-Hwa; Jung, Sook-In; Jang, Hee-Chang			Predictors of Viral Pneumonia in Patients with Community-Acquired Pneumonia	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; ANTIVIRAL THERAPY; INFLUENZA; ADULTS; ETIOLOGY; BACTERIAL; OUTCOMES; VIRUSES; CT	Background: Viruses are increasingly recognized as major causes of community-acquired pneumonia (CAP). Few studies have investigated the clinical predictors of viral pneumonia, and the results have been inconsistent. In this study, the clinical predictors of viral pneumonia were investigated in terms of their utility as indicators for viral pneumonia in patients with CAP. Methods: Adult patients (>= 18 years old) with CAP, tested by polymerase chain reaction (PCR) for respiratory virus, at two teaching hospitals between October 2010 and May 2013, were identified retrospectively. Demographic and clinical data were collected by reviewing the hospital electronic medical records. Results: During the study period, 456 patients with CAP were identified who met the definition, and 327 (72%) patients were tested using the respiratory virus PCR detection test. Viral pneumonia (n=60) was associated with rhinorrhea, a higher lymphocyte fraction in the white blood cells, lower serum creatinine and ground-glass opacity (GGO) in radiology results, compared to non-viral pneumonia (n=250) (p < 0.05, each). In a multivariate analysis, rhinorrhea (Odd ratio (OR) 3.52; 95% Confidence interval (CI), 1.58-7.87) and GGO (OR 4.68; 95% CI, 2.48-8.89) were revealed as independent risk factors for viral pneumonia in patients with CAP. The sensitivity, specificity, positive-and negative-predictive values (PPV and NPV) of rhinorrhea were 22, 91, 36 and 83%: the sensitivity, specificity, PPV and NPV of GGO were and 43, 84, 40 and 86%, respectively. Conclusion: Symptom of rhinorrhea and GGO predicted viral pneumonia in patients with CAP. The high specificity of rhinorrhea and GGO suggested that these could be useful indicators for empirical antiviral therapy.	[Kim, Ji Eun; Kim, Uh Jin; Kim, Hee Kyung; Cho, Soo Kyung; An, Joon Hwan; Kang, Seung-Ji; Park, Kyung-Hwa; Jung, Sook-In; Jang, Hee-Chang] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea	Chonnam National University	Jang, HC (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea.	haroc153@naver.com		Kang, Seung ji/0000-0002-3298-0520; Jang, Hee-Chang/0000-0002-3407-8493				Albrich WC, 2012, ARCH INTERN MED, V172, P715, DOI 10.1001/archinternmed.2012.770; An Joon Hwan, 2013, Chonnam Med J, V49, P96, DOI 10.4068/cmj.2013.49.2.96; Cesario TC, 2012, CLIN INFECT DIS, V55, P107, DOI 10.1093/cid/cis297; Choi SH, 2012, AM J RESP CRIT CARE, V186, P325, DOI 10.1164/rccm.201112-2240OC; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Franquet T, 2011, RADIOLOGY, V260, P18, DOI 10.1148/radiol.11092149; Gueller S, 2013, TRANSPL INFECT DIS, V15, P435, DOI 10.1111/tid.12092; Guthrie R, 2001, CHEST, V120, P2021, DOI 10.1378/chest.120.6.2021; Iglesias ALH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021838; Hong HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095865; Hong Seung-Dok, 2011, Chonnam Med J, V47, P127, DOI 10.4068/cmj.2011.47.2.127; Huijskens EGW, 2014, J MED MICROBIOL, V63, P441, DOI 10.1099/jmm.0.067108-0; Ison MG, 2013, INFLUENZA OTHER RESP, V7, P7, DOI 10.1111/irv.12046; Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; Kang SJ, 2013, JPN J INFECT DIS, V66, P425, DOI 10.7883/yoken.66.425; Kim EA, 2002, RADIOGRAPHICS, V22, pS137, DOI 10.1148/radiographics.22.suppl_1.g02oc15s137; Kim HK, 2013, J CLIN MICROBIOL, V51, P1137, DOI 10.1128/JCM.02958-12; Laskowski M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089651; Lee N, 2010, THORAX, V65, P510, DOI 10.1136/thx.2009.130799; Leibovici L, 2014, CLIN MICROBIOL INFEC; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Miller WT, 2011, AM J ROENTGENOL, V197, P1088, DOI 10.2214/AJR.11.6501; Musher DM, 2013, J INFECTION, V67, P11, DOI 10.1016/j.jinf.2013.03.003; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Pavia AT, 2013, INFECT DIS CLIN N AM, V27, P157, DOI 10.1016/j.idc.2012.11.007; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Sandrock C, 2008, CHEST, V133, P1221, DOI 10.1378/chest.07-0778; Sandrock CE, 2008, RESP CARE, V53, P40; Sangil A, 2012, EUR J CLIN MICROBIOL, V31, P2765, DOI 10.1007/s10096-012-1626-6; Shiley KT, 2010, J THORAC IMAG, V25, P68, DOI 10.1097/RTI.0b013e3181b0ba8b; Singanayagam A, 2013, LANCET RESP MED, V1, P653, DOI 10.1016/S2213-2600(13)70084-5; Templeton KE, 2005, CLIN INFECT DIS, V41, P345, DOI 10.1086/431588; You JHS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033123; Zhang Q, 2013, BIOMED REP, V1, P723, DOI 10.3892/br.2013.128; Zhou WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079477	38	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114710	10.1371/journal.pone.0114710	http://dx.doi.org/10.1371/journal.pone.0114710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531901	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100023
J	Mura, M; Hopkins, TG; Michael, T; Abd-Latip, N; Weir, J; Aboagye, E; Mauri, F; Jameson, C; Sturge, J; Gabra, H; Bushell, M; Willis, AE; Curry, E; Blagden, SP				Mura, M.; Hopkins, T. G.; Michael, T.; Abd-Latip, N.; Weir, J.; Aboagye, E.; Mauri, F.; Jameson, C.; Sturge, J.; Gabra, H.; Bushell, M.; Willis, A. E.; Curry, E.; Blagden, S. P.			LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression	ONCOGENE			English	Article							MESSENGER-RNA STABILITY; GENE-EXPRESSION; EARLY-STAGE; TARGET; TRANSLATION; SPECIMENS; PROTEINS; SURVIVAL; REVEALS; PATHWAY	RNA-binding proteins (RBPs) bind to and post-transcriptionally regulate the stability of mRNAs. La-related protein 1 (LARP1) is a conserved RBP that interacts with poly-A-binding protein and is known to regulate 5'-terminal oligopyrimidine tract (TOP) mRNA translation. Here, we show that LARP1 is complexed to 3000 mRNAs enriched for cancer pathways. A prominent member of the LARP1 interactome is mTOR whose mRNA transcript is stabilized by LARP1. At a functional level, we show that LARP1 promotes cell migration, invasion, anchorage-independent growth and in vivo tumorigenesis. Furthermore, we show that LARP1 expression is elevated in epithelial cancers such as cervical and non-small cell lung cancers, where its expression correlates with disease progression and adverse prognosis, respectively. We therefore conclude that, through the post-transcriptional regulation of genes such as mTOR within cancer pathways, LARP1 contributes to cancer progression.	[Mura, M.; Hopkins, T. G.; Michael, T.; Abd-Latip, N.; Gabra, H.; Curry, E.; Blagden, S. P.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Ovarian Canc Act Res Ctr, Div Canc, London W12 0NN, England; [Weir, J.] Charing Cross Hosp, Imperial Coll Healthcare NHS Trust, Dept Cellular Pathol, London, England; [Aboagye, E.; Sturge, J.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Canc Res UK Labs, Div Canc, London W12 0NN, England; [Mauri, F.] Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, Ctr Pathol, London W12 0NN, England; [Jameson, C.] Univ Coll London Hosp, Dept Histopathol, London, England; [Sturge, J.] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Bushell, M.; Willis, A. E.] Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England	Imperial College London; Imperial College London; Cancer Research UK; Imperial College London; Imperial College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Hull; University of Leicester	Blagden, SP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Ovarian Canc Act Res Ctr, Div Canc, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.	s.blagden@imperial.ac.uk	Blagden, Sarah Patricia/I-2096-2019; Latip, Normala Abd/O-1425-2017	Latip, Normala Abd/0000-0003-4957-5369; Curry, Edward/0000-0002-5603-6956; Mauri, Francesco/0000-0003-4818-8500; Sturge, Justin/0000-0002-2657-1106; ABOAGYE, Eric/0000-0003-2276-6771; Willis, Anne/0000-0002-1470-8531; Gabra, Hani/0000-0002-3322-4399	Wellbeing of Women [RG1319]; Wellcome Trust-GSK Imperial College TMT Fellowship Scheme [PS1903]; Cancer Research UK; Department of Health [C37/A7283]; Ovarian Cancer Action; Biotechnology and Biological Sciences Research Council [BB/H024980/1] Funding Source: researchfish; Medical Research Council [MC_UP_A600_1024, MC_UP_A600_1023] Funding Source: researchfish; Ovarian Cancer Action [OCA10] Funding Source: researchfish; BBSRC [BB/H024980/1] Funding Source: UKRI; MRC [MC_UP_A600_1023, MC_UP_A600_1024] Funding Source: UKRI	Wellbeing of Women(Wellbeing of Women (WoW)); Wellcome Trust-GSK Imperial College TMT Fellowship Scheme; Cancer Research UK(Cancer Research UK); Department of Health; Ovarian Cancer Action(Ovarian Cancer Action); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Ovarian Cancer Action(Ovarian Cancer Action); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MM was funded by The Wellbeing of Women (RG1319). TGH was funded by the Wellcome Trust-GSK Imperial College TMT Fellowship Scheme (PS1903). The Division of Cancer at Imperial College London, Imperial College Healthcare NHS Trust is an Experimental Cancer Medicine Centre (ECMC) supported by funds from Cancer Research UK and the Department of Health (C37/A7283) and forms part of Imperial Cancer Research UK Centre (C42671/A12196). SB was supported by Ovarian Cancer Action. We would like to thank Professor Nahum Sonenberg, Dr Bruno Fonseca and Professor Michael Seckl for their contributions and advice in the preparation of this manuscript. We would also like to thank Jenny Steel, Naina Patel and Joel Abrahams for their technical support.	Aoki K, 2013, FEBS LETT, V587, P2173, DOI 10.1016/j.febslet.2013.05.035; BERNSTEIN P, 1989, MOL CELL BIOL, V9, P659, DOI 10.1128/MCB.9.2.659; Biewenga P, 2008, GYNECOL ONCOL, V108, P520, DOI 10.1016/j.ygyno.2007.11.024; Blagden SP, 2011, NAT REV CLIN ONCOL, V8, P280, DOI 10.1038/nrclinonc.2011.16; Blagden SP, 2009, DEV BIOL, V334, P186, DOI 10.1016/j.ydbio.2009.07.016; Burrows C, 2010, NUCLEIC ACIDS RES, V38, P5542, DOI 10.1093/nar/gkq294; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chang N, 2010, MOL CELL BIOL, V30, P3875, DOI 10.1128/MCB.00169-10; CHEN CYA, 1995, MOL CELL BIOL, V15, P5777; Cheng YL, 2012, LAB INVEST, V92, P1013, DOI 10.1038/labinvest.2012.59; Dhillon T, 2010, J THORAC ONCOL, V5, P314, DOI 10.1097/JTO.0b013e3181ce6604; Eswaran J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01689; Graham JR, 2010, MOL CELL BIOL, V30, P5295, DOI 10.1128/MCB.00303-10; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Iwakawa M, 2007, CANCER BIOL THER, V6, P905, DOI 10.4161/cbt.6.6.4098; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Keene JD, 2005, CHROMOSOME RES, V13, P327, DOI 10.1007/s10577-005-0848-1; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Liu D, 2011, CANCER-AM CANCER SOC, V117, P3763, DOI 10.1002/cncr.25959; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Matoulkova E, 2012, RNA BIOL, V9, P563, DOI 10.4161/rna.20231; Merret R, 2013, CELL REP, V5, P1279, DOI 10.1016/j.celrep.2013.11.019; Molinolo AA, 2012, CLIN CANCER RES, V18, P2558, DOI 10.1158/1078-0432.CCR-11-2824; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sommer G, 2011, ONCOGENE, V30, P434, DOI 10.1038/onc.2010.425; Staudacher AH, 2014, EJNMMI RES, V4, DOI 10.1186/2191-219X-4-2; Sugiura R, 2011, J SIGNAL TRANSDUCT, V2011; Tcherkezian J, 2014, GENE DEV, V28, P357, DOI 10.1101/gad.231407.113; Thapar R, 2013, CELL SIGNAL, V25, P1699, DOI 10.1016/j.cellsig.2013.03.026; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Umayahara K, 2002, GENE CHROMOSOME CANC, V33, P98, DOI 10.1002/gcc.1215; Wang MJ, 2011, TUMOR BIOL, V32, P905, DOI 10.1007/s13277-011-0191-4; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Wurth L, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/178525; Xie C, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-272; Xu CL, 2013, MOL CANCER THER, V12, P207, DOI 10.1158/1535-7163.MCT-12-0273; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005	46	74	74	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2015	34	39					5025	5036		10.1038/onc.2014.428	http://dx.doi.org/10.1038/onc.2014.428			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9RC	25531318	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000361693300003
J	Weber, CE; Kothari, AN; Wai, PY; Li, NY; Driver, J; Zapf, MAC; Franzen, CA; Gupta, GN; Osipo, C; Zlobin, A; Syn, WK; Zhang, J; Kuo, PC; Mi, Z				Weber, C. E.; Kothari, A. N.; Wai, P. Y.; Li, N. Y.; Driver, J.; Zapf, M. A. C.; Franzen, C. A.; Gupta, G. N.; Osipo, C.; Zlobin, A.; Syn, W. K.; Zhang, J.; Kuo, P. C.; Mi, Z.			Osteopontin mediates an MZF1-TGF-beta 1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer	ONCOGENE			English	Article							GENE-EXPRESSION; STROMAL FIBROBLASTS; PLASMA OSTEOPONTIN; PROMOTES FIBROSIS; TUMOR-GROWTH; TGF-BETA; METASTASIS; ACTIVATION; CARCINOMA; INVASION	Interactions between tumor cells and cancer-associated fibroblasts (CAFs) in the tumor microenvironment significantly influence cancer growth and metastasis. Transforming growth factor-beta (TGF-beta) is known to be a critical mediator of the CAF phenotype, and osteopontin (OPN) expression in tumors is associated with more aggressive phenotypes and poor patient outcomes. The potential link between these two pathways has not been previously addressed. Utilizing in vitro studies using human mesenchymal stem cells (MSCs) and MDA-MB231 (OPN+) and MCF7 (OPN-) human breast cancer cell lines, we demonstrate that OPN induces integrin-dependent MSC expression of TGF-beta 1 to mediate adoption of the CAF phenotype. This OPN-TGF-beta 1 pathway requires the transcription factor, myeloid zinc finger 1 (MZF1). In vivo studies with xenotransplant models in NOD-scid mice showed that OPN expression increases cancer growth and metastasis by mediating MSC-to-CAF transformation in a process that is MZF1 and TGF-beta 1 dependent. We conclude that tumor-derived OPN engenders MSC-to-CAF transformation in the microenvironment to promote tumor growth and metastasis via the OPN-MZF1-TGF-beta 1 pathway.	[Weber, C. E.; Kothari, A. N.; Wai, P. Y.; Li, N. Y.; Driver, J.; Zapf, M. A. C.; Gupta, G. N.; Syn, W. K.; Kuo, P. C.; Mi, Z.] Loyola Univ Chicago, Loyola Univ, Dept Surg, Med Ctr, Maywood, IL USA; [Weber, C. E.; Kothari, A. N.; Wai, P. Y.; Li, N. Y.; Driver, J.; Zapf, M. A. C.; Franzen, C. A.; Gupta, G. N.; Osipo, C.; Zlobin, A.; Zhang, J.; Kuo, P. C.; Mi, Z.] Loyola Univ Chicago, Inst Oncol, Cardinal Bernardin Canc Ctr, Maywood, IL USA; [Franzen, C. A.; Gupta, G. N.] Loyola Univ Chicago, Dept Urol, Cardinal Bernardin Canc Ctr, Med Ctr,Loyola Univ, Maywood, IL USA; [Syn, W. K.] Barts Hlth NHS Trust, Liver Unit, London, England; [Syn, W. K.] Inst Hepatol, Regenerat & Repair, London, England	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Barts Health NHS Trust; University of London; University College London	Kuo, PC (corresponding author), Loyola Univ, Med Ctr, Dept Surg, EMS Bldg,Room 3244,2160 S First Ave, Maywood, IL 60153 USA.	pkuo@lumc.edu	Syn, Wing-Kin/AAB-8406-2020	Li, Neill/0000-0001-9149-4859; Franzen, Carrie/0000-0002-1127-8599; Zapf, Matthew/0000-0001-5544-8900	NIH [GM65113, CA155306, UL1 RR024128]; NATIONAL CANCER INSTITUTE [R21CA155306] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065113, R56GM065113, T32GM008750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grants: GM65113, CA155306 and UL1 RR024128. We thank Andy Hall, Research Histology Manager, at the University of Illinois at Chicago Research Resources Center who performed all immunohistochemical staining and mounting. We also thank Dr Dariusz Borys, of the Loyola Department of Pathology, for assistance with the imaging of slides.	Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bhattacharya SD, 2012, ANN SURG, V255, P319, DOI 10.1097/SLA.0b013e31823e3a1c; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Bramwell VHC, 2006, CLIN CANCER RES, V12, P3337, DOI 10.1158/1078-0432.CCR-05-2354; Brauer HA, 2013, CLIN CANCER RES, V19, P571, DOI 10.1158/1078-0432.CCR-12-2123; BROWN LF, 1994, AM J PATHOL, V145, P610; Casey TM, 2008, BREAST CANCER RES TR, V110, P39, DOI 10.1007/s10549-007-9684-7; Cook AC, 2005, MOL CARCINOGEN, V43, P225, DOI 10.1002/mc.20105; Davis C, 2011, MICROSC MICROANAL, V17, P528, DOI 10.1017/S1431927611000043; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Dumont N, 2013, NEOPLASIA, V15, P249, DOI 10.1593/neo.121950; Elkabets M, 2011, J CLIN INVEST, V121, P784, DOI 10.1172/JCI43757; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Fedarko NS, 2001, CLIN CANCER RES, V7, P4060; Gaboli M, 2001, GENE DEV, V15, P1625, DOI 10.1101/gad.902301; Gao MQ, 2010, J CELL SCI, V123, P3507, DOI 10.1242/jcs.072900; Hawinkels LJ, 2012, ONCOGENE, V33, P97, DOI [DOI 10.1038/ONC.2012.536, DOI 10.1038/onc.2012.536]; Helluin O, 2000, J BIOL CHEM, V275, P18337, DOI 10.1074/jbc.M001529200; HROMAS R, 1995, CANCER RES, V55, P3610; Hsieh YH, 2006, BIOCHEM BIOPH RES CO, V339, P217, DOI 10.1016/j.bbrc.2005.11.015; Hsieh YH, 2007, CHINESE J PHYSIOL, V50, P9; Huang WH, 2013, ONCOGENE, V32, P4343, DOI 10.1038/onc.2012.458; Ireson CR, 2006, MOL CANCER THER, V5, P2957, DOI 10.1158/1535-7163.MCT-06-0172; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; KENG PC, 1990, INT J RADIAT ONCOL, V18, P1061, DOI 10.1016/0360-3016(90)90441-L; Kidd S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030563; KIM SJ, 1989, J BIOL CHEM, V264, P402; Kohan M, 2009, AM J RESP CELL MOL, V41, P290, DOI 10.1165/rcmb.2008-0307OC; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Korpal M, 2009, NAT MED, V15, P960, DOI 10.1038/nm.1943; Lenga Y, 2008, CIRC RES, V102, P319, DOI 10.1161/CIRCRESAHA.107.160408; Mak GWY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042210; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Matsuzaki H, 2007, J ORAL PATHOL MED, V36, P30; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Mi ZY, 2011, CARCINOGENESIS, V32, P477, DOI 10.1093/carcin/bgr009; Mi Zhiyong, 2009, BMC Res Notes, V2, P119, DOI 10.1186/1756-0500-2-119; Mi ZY, 2009, MOL THER, V17, P153, DOI 10.1038/mt.2008.235; Mi ZY, 2004, J BIOL CHEM, V279, P46659, DOI 10.1074/jbc.M407952200; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Mishra PJ, 2011, METHODS MOL BIOL, V717, P245, DOI 10.1007/978-1-61779-024-9_14; Miyazaki KI, 2008, INVEST OPHTH VIS SCI, V49, P1367, DOI 10.1167/iovs.07-1007; MORRIS JF, 1994, MOL CELL BIOL, V14, P1786, DOI 10.1128/MCB.14.3.1786; Mudduluru G, 2010, MOL CANCER RES, V8, P159, DOI 10.1158/1541-7786.MCR-09-0326; Nicholas SB, 2010, KIDNEY INT, V77, P588, DOI 10.1038/ki.2009.518; O'Regan A, 2000, INT J EXP PATHOL, V81, P373, DOI 10.1046/j.1365-2613.2000.00163.x; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Otto WR, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-20; Pang H, 2013, CANCER EPIDEMIOL, V37, P985, DOI 10.1016/j.canep.2013.08.005; Patani N, 2008, ANTICANCER RES, V28, P4105; Qi W, 2008, BIOCHEM J, V416, P453, DOI 10.1042/BJ20080651; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Que-Gewirth NS, 2007, GENE THER, V14, P283, DOI 10.1038/sj.gt.3302900; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; Rodrigues LR, 2007, CANCER EPIDEM BIOMAR, V16, P1087, DOI 10.1158/1055-9965.EPI-06-1008; Shevde LA, 2006, CLIN EXP METASTAS, V23, P123, DOI 10.1007/s10585-006-9013-2; Singhal H, 1997, CLIN CANCER RES, V3, P605; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Su G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046685; Syn WK, 2011, HEPATOLOGY, V53, P106, DOI 10.1002/hep.23998; Szalay G, 2009, CIRC RES, V104, P851, DOI 10.1161/CIRCRESAHA.109.193805; Tsai SJ, 2012, BIOCHEM BIOPH RES CO, V425, P462, DOI 10.1016/j.bbrc.2012.07.125; Tuck AB, 1998, INT J CANCER, V79, P502, DOI 10.1002/(SICI)1097-0215(19981023)79:5<502::AID-IJC10>3.0.CO;2-3; Tuck AB, 2001, J MAMMARY GLAND BIOL, V6, P419, DOI 10.1023/A:1014734930781; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Udagawa T, 2006, FASEB J, V20, P95, DOI 10.1096/fj.04-3669com; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Wang H, 2009, STEM CELLS, V27, P1548, DOI 10.1002/stem.81; Wang L, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt96; Wolak T, 2009, KIDNEY INT, V76, P32, DOI 10.1038/ki.2009.90; Wong TY, 2007, LANCET, V370, P204, DOI 10.1016/S0140-6736(07)61104-0; Worthington JJ, 2011, TRENDS BIOCHEM SCI, V36, P47, DOI 10.1016/j.tibs.2010.08.002; Xu LN, 2013, GENET MOL RES, V12, P5863, DOI 10.4238/2013.November.22.14; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Yu KN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015623	80	123	132	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2015	34	37					4821	4833		10.1038/onc.2014.410	http://dx.doi.org/10.1038/onc.2014.410			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR0YP	25531323	Green Accepted			2022-12-26	WOS:000361050000003
J	Kunze, M; Malkani, N; Maurer-Stroh, S; Wiesinger, C; Schmid, JA; Berger, J				Kunze, Markus; Malkani, Naila; Maurer-Stroh, Sebastian; Wiesinger, Christoph; Schmid, Johannes A.; Berger, Johannes			Mechanistic Insights into PTS2-mediated Peroxisomal Protein Import THE CO-RECEPTOR PEX5L DRASTICALLY INCREASES THE INTERACTION STRENGTH BETWEEN THE CARGO PROTEIN AND THE RECEPTOR PEX7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING SIGNAL TYPE-2; RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; SACCHAROMYCES-CEREVISIAE; RECEPTOR PEX5P; YARROWIA-LIPOLYTICA; IN-VIVO; MEMBRANE; THIOLASE; YEAST; REQUIREMENTS	The destination of peroxisomal matrix proteins is encoded by short peptide sequences, which have been characterized as peroxisomal targeting signals (PTS) residing either at the C terminus (PTS1) or close to the N terminus (PTS2). PTS2-carrying proteins interact with their cognate receptor protein PEX7 that mediates their transport to peroxisomes by a concerted action with a co-receptor protein, which in mammals is the PTS1 receptor PEX5L. Using a modified version of the mammalian two-hybrid assay, we demonstrate that the interaction strength between cargo and PEX7 is drastically increased in the presence of the co-receptor PEX5L. In addition, cargo binding is a prerequisite for the interaction between PEX7 and PEX5L and ectopic overexpression of PTS2-carrying cargo protein drastically increases the formation of PEX7-PEX5L complexes in this assay. Consistently, we find that the peroxisomal transfer of PEX7 depends on cargo binding and that ectopic overexpression of cargo protein stimulates this process. Thus, the sequential formation of a highly stable trimeric complex involving cargo protein, PEX7 and PEX5L stabilizes cargo binding and is a prerequisite for PTS2-mediated peroxisomal import.	[Kunze, Markus; Wiesinger, Christoph; Berger, Johannes] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria; [Malkani, Naila; Schmid, Johannes A.] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria; [Maurer-Stroh, Sebastian] ASTAR, Bioinformat Inst BII, Singapore 138671, Singapore; [Maurer-Stroh, Sebastian] Nanyang Technol Univ, Sch Biol Sci, Singapore 117597, Singapore	Medical University of Vienna; Medical University of Vienna; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kunze, M (corresponding author), Med Univ Vienna, Ctr Brain Res, Spitalgasse 4, A-1090 Vienna, Austria.	markus.kunze@meduniwien.ac.at	Maurer-Stroh, Sebastian/Q-9476-2019; Schmid, Johannes A./C-7659-2009; Malkani, Naila/AAA-9224-2022; Berger, Johannes/A-9122-2014	Maurer-Stroh, Sebastian/0000-0003-0813-9640; Schmid, Johannes A./0000-0002-6586-3507; Malkani, Naila/0000-0001-6454-1525; Berger, Johannes/0000-0003-0182-2658; Wiesinger, Christoph/0000-0003-1257-4522	European Union [LSHG-C/2004-512018]; Austrian Science Fund (FWF) [P15510-B14, P21950-B20]; Austrian Science Fund (FWF) [P 21950] Funding Source: researchfish	European Union(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by the European Union Project "Peroxisomes" LSHG-C/2004-512018 and Austrian Science Fund (FWF) Projects P15510-B14 and P21950-B20.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Braverman N, 2002, HUM MUTAT, V20, P284, DOI 10.1002/humu.10124; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Dodt G, 2001, J BIOL CHEM, V276, P41769, DOI 10.1074/jbc.M106932200; Einwachter H, 2001, EMBO REP, V2, P1035, DOI 10.1093/embo-reports/kve228; Ghys K, 2002, BIOCHEM J, V365, P41, DOI 10.1042/BJ20011432; Girzalsky W, 2010, BBA-MOL CELL RES, V1803, P724, DOI 10.1016/j.bbamcr.2010.01.002; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; GLOVER JR, 1994, J BIOL CHEM, V269, P7558; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grunau S, 2009, TRAFFIC, V10, P451, DOI [10.1111/j.1600-0854.2009.00876.x, 10.1111/j.1600-0854.2008.00876.x]; Islinger M, 2009, TRAFFIC, V10, P1711, DOI 10.1111/j.1600-0854.2009.00966.x; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; Kunze M, 2011, J BIOL CHEM, V286, P45048, DOI 10.1074/jbc.M111.301853; Lee JR, 2006, PLANT J, V47, P457, DOI 10.1111/j.1365-313X.2006.02797.x; Liu XQ, 2013, J BIOL CHEM, V288, P7230, DOI 10.1074/jbc.M112.424911; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Pan DQ, 2013, NAT STRUCT MOL BIOL, V20, P987, DOI 10.1038/nsmb.2618; Petriv OI, 2004, J MOL BIOL, V341, P119, DOI 10.1016/j.jmb.2004.05.064; Purdue PE, 1998, J CELL BIOL, V143, P1859; Reumann S, 2004, PLANT PHYSIOL, V135, P783, DOI 10.1104/pp.103.035584; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Stanley WA, 2007, FEBS LETT, V581, P4795, DOI 10.1016/j.febslet.2007.09.001; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Sughra K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012683; Titorenko VI, 1998, J CELL BIOL, V142, P403, DOI 10.1083/jcb.142.2.403; VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wiesinger C, 2013, J BIOL CHEM, V288, P19269, DOI 10.1074/jbc.M112.445445; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422	38	26	26	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4928	4940		10.1074/jbc.M114.601575	http://dx.doi.org/10.1074/jbc.M114.601575			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25538232	Green Published, hybrid			2022-12-26	WOS:000350042000036
J	Shahi, P; Slorach, EM; Wang, CY; Chou, J; Lu, A; Ruderisch, A; Werb, Z				Shahi, Payam; Slorach, Euan M.; Wang, Chih-Yang; Chou, Jonathan; Lu, Angela; Ruderisch, Aline; Werb, Zena			The Transcriptional Repressor ZNF503/Zeppo2 Promotes Mammary Epithelial Cell Proliferation and Enhances Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; E-CADHERIN; ADHERENS JUNCTIONS; RAC1 ACTIVATION; FAMILY; EXPRESSION; CANCER; GENE; PROTEINS; SITES	The NET (nocA, Nlz, elB, TLP-1) subfamily of zinc finger proteins is an important mediator during developmental processes. The evolutionary conserved zinc finger protein ZNF503/Zeppo2 (zinc finger elbow-related proline domain protein 2, Zpo2) plays critical roles during embryogenesis. We found that Zpo2 is expressed in adult tissue and examined its function. We found that ZPO2 is a nuclearly targeted transcriptional repressor that is expressed in mammary epithelial cells. Elevated Zpo2 levels increase mammary epithelial cell proliferation. Zpo2 promotes cellular invasion through down-regulation of E-cadherin and regulates the invasive phenotype in a RAC1-dependent manner. We detect elevated Zpo2 expression during breast cancer progression in a MMTV-PyMT transgenic mouse model. Tumor transplant experiments indicated that overexpression of Zpo2 in MMTV-PyMT mammary tumor cell lines enhances lung metastasis. Our findings suggest that Zpo2 plays a significant role in mammary gland homeostasis and that deregulation of Zpo2 may promote breast cancer development.	[Shahi, Payam; Slorach, Euan M.; Chou, Jonathan; Lu, Angela; Ruderisch, Aline; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Wang, Chih-Yang] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 70101, Taiwan	University of California System; University of California San Francisco; National Cheng Kung University	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Anat, Box 0452,513 Parnassus Ave, San Francisco, CA 94143 USA.	zena.werb@ucsf.edu		Lu, Angela/0000-0003-2128-1369; Wang, Chih-Yang/0000-0002-4137-5074	NCI/National Institutes of Health [R01 CA129523, R01 CA057621]; National Research Service Award [T32 CA108462]; NATIONAL CANCER INSTITUTE [T32CA108462, R01CA129523, R01CA057621] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by NCI/National Institutes of Health Grants R01 CA129523 and R01 CA057621 and National Research Service Award T32 CA108462.	Akhtar N, 2001, MOL BIOL CELL, V12, P847, DOI 10.1091/mbc.12.4.847; [Anonymous], 2007, MOL CELL BIOL, V27, P678; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; CROSS JC, 1995, DEVELOPMENT, V121, P2513; Dorfman R, 2002, DEVELOPMENT, V129, P3585; Hage B, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-23; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Holland DG, 2011, EMBO MOL MED, V3, P167, DOI 10.1002/emmm.201100122; Hoyle J, 2004, DEV DYNAM, V229, P835, DOI 10.1002/dvdy.20001; Kitt KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017841; Ko HA, 2013, NEUROSCI LETT, V548, P44, DOI 10.1016/j.neulet.2013.05.020; Lee HH, 2010, J CELL SCI, V123, P3368, DOI 10.1242/jcs.071555; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nakagawa M, 2001, J CELL SCI, V114, P1829; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Reynisdottir I, 2013, CANCER MED-US, V2, P437, DOI 10.1002/cam4.88; Runko AP, 2004, J BIOL CHEM, V279, P11917, DOI 10.1074/jbc.M310076200; Sircoulomb F, 2011, EMBO MOL MED, V3, P153, DOI 10.1002/emmm.201100121; Slorach EM, 2011, GENE DEV, V25, P471, DOI 10.1101/gad.1998111; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; Sundberg LJ, 2003, J BIOL CHEM, V278, P29783, DOI 10.1074/jbc.M303771200; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072053; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	27	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3803	3813		10.1074/jbc.M114.611202	http://dx.doi.org/10.1074/jbc.M114.611202			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25538248	hybrid, Green Published			2022-12-26	WOS:000349456000051
J	Li, CJ; Dong, Y; Li, HG; Shen, JB; Zhang, FS				Li, Chunjie; Dong, Yan; Li, Haigang; Shen, Jianbo; Zhang, Fusuo			The Dynamic Process of Interspecific Interactions of Competitive Nitrogen Capture between Intercropped Wheat (Triticum aestivum L.) and Faba Bean (Vicia faba L.)	PLOS ONE			English	Article							GROWTH; PRODUCTIVITY; RHIZOSPHERE; DIVERSITY; FIXATION; BARLEY; YIELD	Wheat (Triticum aestivum L.)/faba bean (Vicia faba L.) intercropping shows significant overyielding and high nitrogen (N)-use efficiency, but the dynamics of plant interactions have rarely been estimated. The objective of the present study was to investigate the temporal dynamics of competitive N acquisition between intercropped wheat and faba bean with the logistic model. Wheat and faba bean were grown together or alone with limited N supply in pots. Data of shoot and root biomass and N content measured from 14 samplings were fitted to logistic models to determine instantaneous rates of growth and N uptake. The superiority of instantaneous biomass production and N uptake shifted from faba bean to wheat with their growth. Moreover, the shift of superiority on N uptake occurred 7-12 days earlier than that of biomass production. Interspecific competition stimulated intercropped wheat to have a much earlier and stronger superiority on instantaneous N uptake compared with isolated wheat. The modeling methodology characterized the temporal dynamics of biomass production and N uptake of intercropped wheat and faba bean in different planting systems, which helps to understand the underlying process of plant interaction for intercropping plants.	[Li, Chunjie; Li, Haigang; Shen, Jianbo; Zhang, Fusuo] China Agr Univ, CREFS, Beijing 100193, Peoples R China; [Dong, Yan] Yunnan Agr Univ, Coll Resources & Environm, Kunming 650201, Peoples R China	China Agricultural University; Yunnan Agricultural University	Li, HG (corresponding author), China Agr Univ, CREFS, Beijing 100193, Peoples R China.	haigangli@cau.edu.cn	Shen, Jianbo/Y-3591-2019; Zhang, Fusuo/AAV-4517-2021; Li, Chunjie/AAG-6790-2020	Shen, Jianbo/0000-0001-8943-948X; Li, Chunjie/0000-0002-2761-1085	Projects of International Cooperation and Exchanges NSFC [31210103906]; Innovative Group Grant of the National Natural Science Foundation of China [31121062]; National Natural Science Foundation of China [31201691, 30925024, 31330070]	Projects of International Cooperation and Exchanges NSFC; Innovative Group Grant of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Projects of International Cooperation and Exchanges NSFC (31210103906), the Innovative Group Grant of the National Natural Science Foundation of China (31121062) and the National Natural Science Foundation of China (31201691, 30925024, 31330070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandacoomaraswamy A, 2002, PLANT SOIL, V238, P1, DOI 10.1023/A:1014251714435; Bedoussac L, 2010, PLANT SOIL, V330, P37, DOI 10.1007/s11104-010-0303-8; Bretagnolle F, 1996, J ECOL, V84, P343, DOI 10.2307/2261197; Brown AM, 2001, COMPUT METH PROG BIO, V65, P191, DOI 10.1016/S0169-2607(00)00124-3; Cahill JF, 2011, ANNU REV ECOL EVOL S, V42, P289, DOI 10.1146/annurev-ecolsys-102710-145006; Fan FL, 2006, PLANT SOIL, V283, P275, DOI 10.1007/s11104-006-0019-y; Hortensteiner S, 2002, J EXP BOT, V53, P927, DOI 10.1093/jexbot/53.370.927; Jensen ES, 1996, PLANT SOIL, V182, P25, DOI 10.1007/BF00010992; Li H, 2008, PLANT SOIL, V312, P139, DOI 10.1007/s11104-007-9512-1; Li HG, 2010, BIOL FERT SOILS, V46, P79, DOI 10.1007/s00374-009-0411-x; Li HG, 2013, CROP PASTURE SCI, V64, P976, DOI 10.1071/CP13268; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Li QZ, 2011, PLANT SOIL, V339, P147, DOI 10.1007/s11104-010-0561-5; Li SM, 2004, ANN BOT-LONDON, V94, P297, DOI 10.1093/aob/mch140; Lithourgidis A, 2007, AGRON SUSTAIN DEV, V27, P95, DOI 10.1051/agro:2006033; Mariotti M, 2012, GRASS FORAGE SCI, V67, P243, DOI 10.1111/j.1365-2494.2011.00839.x; Mariotti M, 2009, GRASS FORAGE SCI, V64, P401, DOI 10.1111/j.1365-2494.2009.00705.x; Novoplansky A, 2009, PLANT CELL ENVIRON, V32, P726, DOI 10.1111/j.1365-3040.2009.01979.x; Peng YF, 2013, PLANT SOIL, V372, P41, DOI 10.1007/s11104-013-1678-0; PUCKRIDG.DW, 1967, AUST J AGR RES, V18, P193, DOI 10.1071/AR9670193; Robinson D, 2010, ANN BOT-LONDON, V106, P921, DOI 10.1093/aob/mcq186; Sanginga N, 1996, PLANT SOIL, V179, P119, DOI 10.1007/BF00011649; Shi JC, 2013, PLANT SOIL, V363, P139, DOI 10.1007/s11104-012-1299-z; TRENBATH BR, 1993, FIELD CROP RES, V34, P381, DOI 10.1016/0378-4290(93)90123-5; Trinder C, 2012, NEW PHYTOL, V193, P948, DOI 10.1111/j.1469-8137.2011.04020.x; Trinder CJ, 2013, FUNCT ECOL, V27, P918, DOI 10.1111/1365-2435.12078; Vandermeer J.H., 1992, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; WILLEY RW, 1990, AGR WATER MANAGE, V17, P215, DOI 10.1016/0378-3774(90)90069-B; Xiao YB, 2004, PLANT SOIL, V262, P45, DOI 10.1023/B:PLSO.0000037019.34719.0d; Yin XY, 2003, ANN BOT-LONDON, V91, P361, DOI 10.1093/aob/mcg029; Zhang FS, 2003, PLANT SOIL, V248, P305, DOI 10.1023/A:1022352229863; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	32	18	19	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115804	10.1371/journal.pone.0115804	http://dx.doi.org/10.1371/journal.pone.0115804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541699	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900091
J	Liu, GM; Xiao, L; Fang, TT; Cai, YM; Jia, G; Zhao, H; Wang, J; Chen, XL; Wu, CM				Liu, Guangmang; Xiao, Liang; Fang, Tingting; Cai, Yimin; Jia, Gang; Zhao, Hua; Wang, Jing; Chen, Xiaoling; Wu, Caimei			Pea Fiber and Wheat Bran Fiber Show Distinct Metabolic Profiles in Rats as Investigated by a H-1 NMR-Based Metabolomic Approach	PLOS ONE			English	Article							DIETARY FIBER; INTESTINAL-TRACT; FATTY-ACIDS; BILE-ACID; PLASMA; FERMENTATION; URINE; CHOLESTEROL; EXCRETION; RESPONSES	This study aimed to examine the effect of pea fiber (PF) and wheat bran fiber (WF) supplementation in rat metabolism. Rats were assigned randomly to one of three dietary groups and were given a basal diet containing 15% PF, 15% WF, or no supplemental fiber. Urine and plasma samples were analyzed by NMR-based metabolomics. PF significantly increased the plasma levels of 3-hydroxybutyrate, and myo-inositol as well as the urine levels of alanine, hydroxyphenylacetate, phenylacetyglycine, and a-ketoglutarate. However, PF significantly decreased the plasma levels of isoleucine, leucine, lactate, and pyruvate as well as the urine levels of allantoin, bile acids, and trigonelline. WF significantly increased the plasma levels of acetone, isobutyrate, lactate, myo-inositol, and lipids as well as the urine levels of alanine, lactate, dimethylglycine, N-methylniconamide, and alpha-ketoglutarate. However, WF significantly decreased the plasma levels of amino acids, and glucose as well as the urine levels of acetate, allantoin, citrate, creatine, hippurate, hydroxyphenylacetate, and trigonelline. Results suggest that PF and WF exposure can promote antioxidant activity and can exhibit common systemic metabolic changes, including lipid metabolism, energy metabolism, glycogenolysis and glycolysis metabolism, protein biosynthesis, and gut microbiota metabolism. PF can also decrease bile acid metabolism. These findings indicate that different fiber diet may cause differences in the biofluid profile in rats.	[Liu, Guangmang; Xiao, Liang; Fang, Tingting; Jia, Gang; Zhao, Hua; Chen, Xiaoling; Wu, Caimei] Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China; [Liu, Guangmang; Xiao, Liang; Fang, Tingting; Jia, Gang; Zhao, Hua; Chen, Xiaoling; Wu, Caimei] China Minist Educ, Key Lab Anim Dis Resistance Nutr, Chengdu 611130, Sichuan, Peoples R China; [Cai, Yimin] Japan Int Res Ctr Agr Sci, Ohwashi, Tibaragi 3058686, Japan; [Wang, Jing] Sichuan Agr Univ, Maize Res Inst, Chengdu 611130, Sichuan, Peoples R China	Sichuan Agricultural University; Japan International Research Center for Agricultural Sciences; Sichuan Agricultural University	Liu, GM (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China.	liugm@sicau.edu.cn			National Natural Science Foundation of China [31301986]; Research Foundation of Education Bureau of Sichuan Province [00924901]; Ministry of Education Chunhui Project of China [Z2010092]; Specific Research Supporting Program for Discipline Construction in Sichuan Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of Education Bureau of Sichuan Province; Ministry of Education Chunhui Project of China; Specific Research Supporting Program for Discipline Construction in Sichuan Agricultural University	Funding: This work was supported by the National Natural Science Foundation of China (No: 31301986), Research Foundation of Education Bureau of Sichuan Province (No:00924901), Ministry of Education Chunhui Project of China (No:Z2010092) and Specific Research Supporting Program for Discipline Construction in Sichuan Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts DS, 1996, JNCI-J NATL CANCER I, V88, P81, DOI 10.1093/jnci/88.2.81; Almar M, 2002, FREE RADICAL RES, V36, P247, DOI 10.1080/10715760290019255; Bohus E, 2008, J PROTEOME RES, V7, P4435, DOI 10.1021/pr800407j; CASSIDY MM, 1981, AM J CLIN NUTR, V34, P218, DOI 10.1093/ajcn/34.2.218; Chen H, 2013, BRIT J NUTR, V110, P1837, DOI 10.1017/S0007114513001293; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; CUMMINGS JH, 1987, AM J CLIN NUTR, V45, P1243, DOI 10.1093/ajcn/45.5.1243; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fardet A, 2007, J NUTR, V137, P923, DOI 10.1093/jn/137.4.923; HAMBERG O, 1989, AM J CLIN NUTR, V50, P324, DOI 10.1093/ajcn/50.2.324; Hill MJ, 1997, EUR J CANCER PREV, V6, pS43, DOI 10.1097/00008469-199703001-00009; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Huang CY, 2013, J PROTEOME RES, V12, P537, DOI 10.1021/pr301033a; Huang YL, 2008, J SCI FOOD AGR, V88, P435, DOI 10.1002/jsfa.3104; Jenkins DJA, 2002, DIABETES CARE, V25, P1522, DOI 10.2337/diacare.25.9.1522; Johansson-Persson A, 2013, ANAL BIOANAL CHEM, V405, P4799, DOI 10.1007/s00216-013-6874-5; Kasuya F, 1996, BIOCHEM PHARMACOL, V51, P805, DOI 10.1016/0006-2952(95)02399-2; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Lambo-Fodje AM, 2006, BRIT J NUTR, V96, P47, DOI 10.1079/BJN20061797; Lee JY, 1997, BIOCHEM ARCH, V13, P285; Li WD, 2005, J AGR FOOD CHEM, V53, P8533, DOI 10.1021/jf051634y; Lindgren F, 1996, J CHEMOMETR, V10, P521; Liu GM, 2014, RSC ADV, V4, P23749, DOI 10.1039/c4ra02421d; Liu GM, 2013, J AGR FOOD CHEM, V61, P11212, DOI 10.1021/jf403401v; Liu GM, 2011, J AGR FOOD CHEM, V59, P5572, DOI 10.1021/jf104129k; Maes C, 2002, J CEREAL SCI, V35, P315, DOI 10.1006/jcrs.2001.0439; Martins JM, 2004, J NUTR, V134, P3305, DOI 10.1093/jn/134.12.3305; MEIJER AJ, 1984, BIOCHEM J, V223, P559, DOI 10.1042/bj2230559; Monteith DK, 2006, EXPERT OPIN DRUG MET, V2, P687, DOI 10.1517/17425255.2.5.687; Norskov NP, 2013, J PROTEOME RES, V12, P2818, DOI 10.1021/pr400164b; NYMAN M, 1990, J NUTR, V120, P459, DOI 10.1093/jn/120.5.459; NYMAN M, 1986, BRIT J NUTR, V55, P487, DOI 10.1079/BJN19860056; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Pylkas AM, 2005, J MED FOOD, V8, P113, DOI 10.1089/jmf.2005.8.113; Rechner AR, 2002, FREE RADICAL RES, V36, P1229, DOI 10.1080/246-1071576021000016472; REDDY BS, 1980, J NUTR, V110, P1247, DOI 10.1093/jn/110.6.1247; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; SHAH N, 1982, J NUTR, V112, P658, DOI 10.1093/jn/112.4.658; Siddiqui RA, 2008, J NUTR BIOCHEM, V19, P417, DOI 10.1016/j.jnutbio.2007.07.001; Slavin JL, 1999, AM J CLIN NUTR, V70, p459S, DOI 10.1093/ajcn/70.3.459s; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; WU G, 1991, AM J PHYSIOL, V261, pE221, DOI 10.1152/ajpendo.1991.261.2.E221; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yde CC, 2012, BRIT J NUTR, V107, P1603, DOI 10.1017/S0007114511004909; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413	47	4	4	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115561	10.1371/journal.pone.0115561	http://dx.doi.org/10.1371/journal.pone.0115561			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541729	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900052
J	Rosenberg, C; Jahn, A; Pickartz, T; Wahnschaffe, U; Patrzyk, M; Hosten, N				Rosenberg, Christian; Jahn, Andrea; Pickartz, Tilman; Wahnschaffe, Ulrich; Patrzyk, Maciej; Hosten, Norbert			Gd-EOB-DTPA-Enhanced MR Guidance in Thermal Ablation of Liver Malignancies	PLOS ONE			English	Article							LASER-INDUCED THERMOTHERAPY; GADOXETIC ACID; RADIOFREQUENCY ABLATION; CLINICAL-EVALUATION; CONTRAST AGENTS; HEPATOCELLULAR-CARCINOMA; TUMOR ABLATION; THERMOMETRY; METASTASES; LESIONS	Objective: To evaluate the potency of Gd-EOB-DTPA to support hepatic catheter placement in laser ablation procedures by quantifying time-dependent delineation effects for instrumentation and target tumor within liver parenchyma. Monitoring potential influence on online MR thermometry during the ablation procedure is a secondary aim. Materials and Methods: 30 cases of MR-guided laser ablation were performed after i.v. bolus injection of gadoxetic acid (0.025 mmol/Kg Gd-EOB-DTPA; Bayer Healthcare, Berlin, Germany). T1-weighted GRE sequences were used for applicator guidance (FLASH 3D) in the catheter placement phase and for therapy monitoring (FLASH 2D) in the therapy phase. SNR and consecutive CNR values were measured for elements of interest plotted over time both for catheter placement and therapy phase and compared with a non-contrast control group of 19 earlier cases. Statistical analysis was realized using the paired Wilcoxon test. Results: Sustainable signal elevation of liver parenchyma in the contrast-enhanced group was sufficient to silhouette both target tumor and applicator against the liver. Differences in time dependent CNR alteration were highly significant between contrast-enhanced and non-contrast interventions for parenchyma and target on the one hand (p=0.020) and parenchyma and instrument on the other hand (p=0.002). Effects lasted for the whole procedure (monitoring up to 60 min) and were specific for the contrast-enhanced group. Contrasting maxima were seen after median 30 (applicator) and 38 (tumor) minutes, in the potential core time of a multineedle procedure. Contrast influence on T1 thermometry for real-time monitoring of thermal impact was not significant (p=0.068-0.715). Conclusion: Results strongly support anticipated promotive effects of Gd-EOB-DTPA for MR-guided percutaneous liver interventions by proving and quantifying the delineating effects for therapy-relevant elements in the procedure. Time benefit, cost effectiveness and oncologic outcome of the described beneficiary effects will have to be part of further investigations.	[Rosenberg, Christian; Jahn, Andrea; Hosten, Norbert] Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Mecklenburg Vor, Germany; [Pickartz, Tilman; Wahnschaffe, Ulrich] Univ Med Greifswald, Div Gastroenterol Endocrinol & Nutr Med, Clin Internal Med, Greifswald, Mecklenburg Vor, Germany; [Patrzyk, Maciej] Univ Med Greifswald, Clin Gen Surg Visceral Thorac & Vasc Surg, Greifswald, Mecklenburg Vor, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School	Rosenberg, C (corresponding author), Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Mecklenburg Vor, Germany.	rosenberg@uni-greifswald.de						Ba-Ssalamah A, 2009, EUR RADIOL, V19, P342, DOI 10.1007/s00330-008-1172-x; Bathe OF, 2007, J SURG ONCOL, V95, P670, DOI 10.1002/jso.20768; Bluemke DA, 2005, RADIOLOGY, V237, P89, DOI 10.1148/radiol.2371031842; Bruderl J., 2010, HDB SOZIALWISSENSCHA, P963; Crocetti L, 2010, CARDIOVASC INTER RAD, V33, P11, DOI 10.1007/s00270-009-9736-y; de Senneville BD, 2007, EUR RADIOL, V17, P2401, DOI 10.1007/s00330-007-0646-6; Elst LV, 1997, MAGNET RESON MED, V38, P604, DOI 10.1002/mrm.1910380415; Fahrmeir  L., 1996, MULTIVARIATE STAT VE; Filippone A, 2010, J MAGN RESON IMAGING, V31, P356, DOI 10.1002/jmri.22054; Fischbach F, 2011, J MAGN RESON IMAGING, V34, P874, DOI 10.1002/jmri.22691; Frericks BB, 2009, AM J ROENTGENOL, V193, P1053, DOI 10.2214/AJR.08.1946; Gillams AR, 2005, ABDOM IMAGING, V30, P419, DOI 10.1007/s00261-004-0256-6; Goldberg SN, 2009, J VASC INTERV RADIOL, V20, pS377, DOI 10.1016/j.jvir.2009.04.011; Halavaara J, 2006, J COMPUT ASSIST TOMO, V30, P345, DOI 10.1097/00004728-200605000-00001; HAMM B, 1995, RADIOLOGY, V195, P785, DOI 10.1148/radiology.195.3.7754011; Hammerstingl R, 2008, EUR RADIOL, V18, P457, DOI 10.1007/s00330-007-0716-9; Kickhefel A, 2011, J MAGN RESON IMAGING, V33, P704, DOI 10.1002/jmri.22499; Kuhn FP, 2013, EUR J NUCL MED MOL I, V40, P44, DOI 10.1007/s00259-012-2236-3; Lencioni Riccardo, 2013, Recent Results Cancer Res, V190, P181, DOI 10.1007/978-3-642-16037-0_12; Lencioni Riccardo, 2008, Expert Rev Gastroenterol Hepatol, V2, P697, DOI 10.1586/17474124.2.5.697; Lepetit-Coiffe M, 2010, EUR RADIOL, V20, P193, DOI 10.1007/s00330-009-1532-1; Mahnken AH, 2013, RADIOLOGY, V266, P407, DOI 10.1148/radiol.12112544; McDermott S, 2013, SEMIN INTERVENT RAD, V30, P49, DOI 10.1055/s-0033-1333653; Meister D, 2007, ROFO-FORTSCHR RONTG, V179, P497, DOI 10.1055/s-2007-962979; Nour Sherif Gamal, 2005, Magn Reson Imaging Clin N Am, V13, P561, DOI 10.1016/j.mric.2005.04.007; PARKER DL, 1984, IEEE T BIO-MED ENG, V31, P161, DOI 10.1109/TBME.1984.325382; Puls R, 2007, J MAGN RESON IMAGING, V25, P1174, DOI 10.1002/jmri.20936; Puls R, 2009, J VASC INTERV RADIOL, V20, P225, DOI 10.1016/j.jvir.2008.10.018; Raman SS, 2010, J COMPUT ASSIST TOMO, V34, P163, DOI 10.1097/RCT.0b013e3181c89d87; Reimer P, 1997, EUR RADIOL, V7, P275, DOI 10.1007/s003300050150; Reimer P, 1996, RADIOLOGY, V199, P177, DOI 10.1148/radiology.199.1.8633143; Rempp H, 2009, J MAGN RESON IMAGING, V30, P631, DOI 10.1002/jmri.21863; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Rosenberg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078559; Schmiegel W, 2010, Z GASTROENTEROL, V48, P65, DOI 10.1055/s-0028-1109936; Seale MK, 2009, RADIOGRAPHICS, V29, P1725, DOI 10.1148/rg.296095515; Sieber MA, 2009, J MAGN RESON IMAGING, V30, P1268, DOI 10.1002/jmri.21971; Stafford R. Jason, 2010, Critical Reviews in Biomedical Engineering, V38, P79, DOI 10.1615/CritRevBiomedEng.v38.i1.70; Vogl TJ, 1998, ROFO-FORTSCHR RONTG, V169, P182, DOI 10.1055/s-2007-1015071; Vogl TJ, 2004, INT J HYPERTHER, V20, P713, DOI 10.1080/02656730400007212	40	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e109217	10.1371/journal.pone.0109217	http://dx.doi.org/10.1371/journal.pone.0109217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541950	gold, Green Published, Green Submitted			2022-12-26	WOS:000347239900002
J	Marthandan, S; Priebe, S; Hemmerich, P; Klement, K; Diekmann, S				Marthandan, Shiva; Priebe, Steffen; Hemmerich, Peter; Klement, Karolin; Diekmann, Stephan			Long-Term Quiescent Fibroblast Cells Transit into Senescence	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; TELOMERE SHORTENING TRIGGERS; HUMAN-DIPLOID FIBROBLASTS; CYTOCHROME-C RELEASE; DNA-DAMAGE RESPONSE; CELLULAR SENESCENCE; REPLICATIVE SENESCENCE; PREMATURE SENESCENCE; LIFE-SPAN; MOLECULAR-MECHANISMS	Cellular senescence is described to be a consequence of telomere erosion during the replicative life span of primary human cells. Quiescence should therefore not contribute to cellular aging but rather extend lifespan. Here we tested this hypothesis and demonstrate that cultured long-term quiescent human fibroblasts transit into senescence due to similar cellular mechanisms with similar dynamics and with a similar maximum life span as proliferating controls, even under physiological oxygen conditions. Both, long-term quiescent and senescent fibroblasts almost completely fail to undergo apoptosis. The transition of long-term quiescent fibroblasts into senescence is also independent of HES1 which protects short-term quiescent cells from becoming senescent. Most significantly, DNA damage accumulates during senescence as well as during long-term quiescence at physiological oxygen levels. We suggest that telomere-independent, potentially maintenance driven gradual induction of cellular senescence during quiescence is a counterbalance to tumor development.	[Marthandan, Shiva; Hemmerich, Peter; Klement, Karolin; Diekmann, Stephan] JenAge Jena Ctr Syst Biol Aging, Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Priebe, Steffen] Hans Knoll Inst eV HKI, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Hans Knoll Institute (HKI)	Diekmann, S (corresponding author), JenAge Jena Ctr Syst Biol Aging, Fritz Lipmann Inst, Leibniz Inst Age Res, Beutenbergstr 11, Jena, Germany.	diekmann@fli-leibniz.de			Bundesministerium fur Bildung und Forschung (BMBF) [0315581]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by Bundesministerium fur Bildung und Forschung (BMBF), Grant code: 0315581.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Asai T, 2011, J CELL PHYSIOL, V226, P2215, DOI 10.1002/jcp.22561; Ashrafi K, 1999, P NATL ACAD SCI USA, V96, P9100, DOI 10.1073/pnas.96.16.9100; ATADJA P, 1995, EXP CELL RES, V217, P205, DOI 10.1006/excr.1995.1080; Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741; AUGENLICHT LH, 1974, EXP CELL RES, V89, P255, DOI 10.1016/0014-4827(74)90789-7; Bauer DE, 2004, FASEB J, V18, P1303, DOI 10.1096/fj.03-1001fje; BEAUSEJOUR CM, 2003, REVERSAL HUMAN CELLU, V22, P4212; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bladier C, 1997, CELL GROWTH DIFFER, V8, P589; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Campisi J, 2008, AGING CELL, V7, P281, DOI 10.1111/j.1474-9726.2008.00383.x; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chassot AA, 2008, CELL CYCLE, V7, P2038, DOI 10.4161/cc.7.13.6233; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Cho S, 2012, MOL CELLS, V33, P597, DOI 10.1007/s10059-012-0042-1; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Crescenzi E, 2003, BIOCHEM J, V375, P263, DOI 10.1042/BJ20030868; Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010; CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617; Cristofalo VJ, 2005, EXP GERONTOL, V40, P836, DOI 10.1016/j.exger.2005.08.005; Dai CY, 2000, ONCOGENE, V19, P1613, DOI 10.1038/sj.onc.1203438; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651; DeJesus V, 2002, EXP CELL RES, V274, P92, DOI 10.1006/excr.2001.5425; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dulic V, 2011, AGING-US, V3, P3, DOI 10.18632/aging.100257; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Evertts AG, 2013, MOL BIOL CELL, V24, P3025, DOI 10.1091/mbc.E12-07-0529; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; Gire V, 1998, MOL CELL BIOL, V18, P1611, DOI 10.1128/MCB.18.3.1611; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Grigoryev SA, 2004, J CELL SCI, V117, P6153, DOI 10.1242/cs.01537; Hara E, 1996, MOL CELL BIOL, V16, P859; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HAYFLICK L, 1985, EXP GERONTOL, V20, P145, DOI 10.1016/0531-5565(85)90032-4; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Holliday R, 2014, INTERD T GERONT GERI, V39, P1, DOI 10.1159/000358896; Hornsby PJ, 2002, J GERONTOL A-BIOL, V57, pB251, DOI 10.1093/gerona/57.7.B251; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang ES, 2002, MECH AGEING DEV, V123, P1681, DOI 10.1016/S0047-6374(02)00102-1; Imai Y, 2014, CELL REP, V7, P194, DOI 10.1016/j.celrep.2014.03.006; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; JIANG HP, 1994, ONCOGENE, V9, P3397; Johansson AC, 2003, CELL DEATH DIFFER, V10, P1253, DOI 10.1038/sj.cdd.4401290; Jones CJ, 2000, MOL CELL BIOL, V20, P5690, DOI 10.1128/MCB.20.15.5690-5699.2000; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SY, 2011, APOPTOSIS, V16, P795, DOI 10.1007/s10495-011-0612-2; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krtolica A, 2002, INT J BIOCHEM CELL B, V34, P1401, DOI 10.1016/S1357-2725(02)00053-5; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lackner DH, 2014, AGING CELL, V13, P946, DOI 10.1111/acel.12234; Ladha MH, 1998, MOL CELL BIOL, V18, P6605, DOI 10.1128/MCB.18.11.6605; Lane AA, 2010, CELL, V142, P360, DOI 10.1016/j.cell.2010.07.030; Laporte D, 2013, J CELL BIOL, V203, P585, DOI 10.1083/jcb.201306075; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lorenzini A, 2009, MECH AGEING DEV, V130, P784, DOI 10.1016/j.mad.2009.10.004; Lowndes NF, 2005, CURR BIOL, V15, pR99, DOI 10.1016/j.cub.2005.01.029; LUCIBELLO FC, 1993, J CELL SCI, V105, P123; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Manns J, 2011, FASEB J, V25, P3250, DOI 10.1096/fj.10-177527; Mazars GR, 1997, P NATL ACAD SCI USA, V94, P151, DOI 10.1073/pnas.94.1.151; Mazzini G, 2003, EUR J HISTOCHEM, V47, P289; Meyyappan M, 1998, MOL CELL BIOL, V18, P3163, DOI 10.1128/MCB.18.6.3163; Munro J, 2001, ONCOGENE, V20, P3541, DOI 10.1038/sj.onc.1204460; Naderi J, 2003, APOPTOSIS, V8, P91, DOI 10.1023/A:1021657220843; OKAMOTO A, 1994, P NATL ACAD SCI USA, V91, P11045, DOI 10.1073/pnas.91.23.11045; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Passos JF, 2009, AGE, V31, P353, DOI 10.1007/s11357-009-9108-1; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pawlowski J, 2000, P NATL ACAD SCI USA, V97, P529, DOI 10.1073/pnas.97.2.529; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Perucca P, 2009, CELL CYCLE, V8, P105, DOI 10.4161/cc.8.1.7507; Pignolo RJ, 1998, EXP GERONTOL, V33, P67, DOI 10.1016/S0531-5565(97)00090-9; Pitiyage GN, 2011, J PATHOL, V223, P604, DOI 10.1002/path.2839; Rivard N, 1996, J BIOL CHEM, V271, P18337, DOI 10.1074/jbc.271.31.18337; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SAGER R, 1991, ENVIRON HEALTH PERSP, V93, P59, DOI 10.2307/3431170; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Saretzki G, 1999, ONCOGENE, V18, P5148, DOI 10.1038/sj.onc.1202898; Schauble S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042150; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Seluanov A, 2001, MOL CELL BIOL, V21, P1552, DOI 10.1128/MCB.21.5.1552-1564.2001; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875; Sgambato A, 2000, J CELL PHYSIOL, V183, P18, DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Sitte N, 1998, FREE RADICAL BIO MED, V24, P885, DOI 10.1016/S0891-5849(97)00363-8; SMITH JR, 1980, SCIENCE, V207, P82; Soldani C, 2001, EUR J HISTOCHEM, V45, P389; SOPRANO KJ, 1994, J CELL BIOCHEM, V54, P405, DOI 10.1002/jcb.240540407; Steinert S, 2000, BIOCHEM BIOPH RES CO, V273, P1095, DOI 10.1006/bbrc.2000.3080; Suram A, 2014, AGING CELL, V13, P780, DOI 10.1111/acel.12246; Thuret G, 2003, BRIT J OPHTHALMOL, V87, P346, DOI 10.1136/bjo.87.3.346; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; TRLIFAJO.J, 1968, J HYG EPID MICROB IM, V12, P212; Uhrbom L, 1997, ONCOGENE, V15, P505, DOI 10.1038/sj.onc.1201227; van Os R, 2009, CELL STEM CELL, V4, P7, DOI 10.1016/j.stem.2008.12.007; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; WANG E, 1995, CANCER RES, V55, P2284; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wolstein JM, 2010, AM J PHYSIOL-RENAL, V299, pF1486, DOI 10.1152/ajprenal.00378.2010; Wright WE, 2001, CURR OPIN GENET DEV, V11, P98, DOI 10.1016/S0959-437X(00)00163-5; Yang NC, 2005, EXP GERONTOL, V40, P813, DOI 10.1016/j.exger.2005.07.011; Yusuf I, 2003, TRENDS IMMUNOL, V24, P380, DOI 10.1016/S1471-4906(03)00141-8; Zezula J, 2001, EMBO REP, V2, P27, DOI 10.1093/embo-reports/kve008; Zhang JL, 2002, MECH AGEING DEV, V123, P613, DOI 10.1016/S0047-6374(01)00412-2; Zhang XF, 2012, INT J MOL SCI, V13, P5866, DOI 10.3390/ijms13055866	135	31	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115597	10.1371/journal.pone.0115597	http://dx.doi.org/10.1371/journal.pone.0115597			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531649	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100081
J	Gumbo, H; Chasekwa, B; Church, JA; Ntozini, R; Mutasa, K; Humphrey, JH; Prendergast, AJ				Gumbo, Hlanai; Chasekwa, Bernard; Church, James A.; Ntozini, Robert; Mutasa, Kuda; Humphrey, Jean H.; Prendergast, Andrew J.			Congenital and Postnatal CMV and EBV Acquisition in HIV-Infected Zimbabwean Infants	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; CYTOMEGALOVIRUS-INFECTION; DISEASE PROGRESSION; VIRAL LOAD; CHILDREN; BORN; PREVALENCE; TYPE-1; REPLICATION; COINFECTION	Background: HIV-infected infants in sub-Saharan Africa have rapid disease progression. We hypothesized that co-infection with cytomegalovirus (CMV) or Epstein Barr virus (EBV) increases mortality in HIV-infected infants. Methods: 257 antiretroviral therapy-naive HIV-infected Zimbabwean infants were tested for CMV and EBV at 6 weeks of age by real-time PCR; if positive, birth samples were retrieved where available to distinguish congenital and postnatal infection. The impact of co-infection on mortality through 6 months was estimated using Kaplan-Meier and Cox proportional hazards methods. Results: At 6 weeks, 203/257 (79%) HIV-infected infants were CMV-positive; 27 (11%) had congenital CMV, 108 (42%) postnatal CMV and 68 (26%) indeterminate timing of infection. By 6 months, 37/108 (34%) infants with postnatal CMV versus 16/54 (30%) CMV-negative infants died (adjusted hazard ratio (aHR) 1.1 [95%CI 0.6, 2.2]). At 6 weeks, 33/257 (13%) HIV-infected infants had EBV co-infection; 6 (2%) had congenital EBV, 18 (7%) postnatal EBV and 9 (4%) indeterminate timing of infection. By 6 months, 5/18 (28%) infants with postnatal EBV versus 72/224 (32%) EBV-negative infants died (aHR 0.8 [95%CI 0.3, 2.3]). Conclusions: The vast majority of HIV-infants had acquired CMV by 6 weeks, and EBV co-infection occurred earlier than expected, with one in eight HIV-infected infants positive for EBV by 6 weeks. There was a high prevalence of congenital CMV infection and we identified 6 infants with congenital EBV infection, which has not previously been reported in Africa or in the context of HIV infection. Neither CMV nor EBV co-infection was associated with increased mortality.	[Gumbo, Hlanai; Chasekwa, Bernard; Church, James A.; Ntozini, Robert; Mutasa, Kuda; Humphrey, Jean H.; Prendergast, Andrew J.] Zvitambo Inst Maternal & Child Hlth Res, Harare, Zimbabwe; [Church, James A.; Prendergast, Andrew J.] Queen Mary Univ London, Blizard Inst, Ctr Paediat, London, England; [Humphrey, Jean H.; Prendergast, Andrew J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	University of London; Queen Mary University London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Prendergast, AJ (corresponding author), Zvitambo Inst Maternal & Child Hlth Res, Harare, Zimbabwe.	a.prendergast@qmul.ac.uk	Ntozini, Robert/AAD-8403-2020; Ntozini, Robert/AFU-4878-2022	Ntozini, Robert/0000-0002-8543-2835; Prendergast, Andrew/0000-0001-7904-7992; Chasekwa, Bernard/0000-0001-8080-7573	Wellcome Trust [093768/Z/10/Z]; National Institute for Health Research [ACF-2012-19-003] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Wellcome Trust (www.wellcome.ac.uk); grant 093768/Z/10/Z. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lafuente R, 2008, FORENSIC SCI INT, V178, P106, DOI 10.1016/j.forsciint.2008.02.007; Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321; Bates M, 2008, VIROLOGY, V382, P28, DOI 10.1016/j.virol.2008.09.001; BELLO C, 1991, J CLIN PATHOL, V44, P366, DOI 10.1136/jcp.44.5.366; Bowser CS, 2006, FETAL PEDIATR PATHOL, V25, P321, DOI 10.1080/15513810701209553; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Chan KH, 2001, J CLIN VIROL, V21, P57, DOI 10.1016/S1386-6532(01)00149-4; Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; Dickover RE, 1998, J INFECT DIS, V178, P375, DOI 10.1086/515637; Doyle M, 1996, PEDIATR INFECT DIS J, V15, P1102, DOI 10.1097/00006454-199612000-00010; Gibson RS, 1990, Q REV BIOL; GOLDBERG GN, 1981, JAMA-J AM MED ASSOC, V246, P1579, DOI 10.1001/jama.246.14.1579; Gompels UA, 2012, CLIN INFECT DIS, V54, P434, DOI 10.1093/cid/cir837; Guibert G, 2009, CLIN INFECT DIS, V48, P1516, DOI 10.1086/598934; Holder B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014013; Humphrey JH, 2006, J INFECT DIS, V193, P960; Ito Y, 2009, J MED VIROL, V81, P1399, DOI 10.1002/jmv.21527; JONCAS J, 1974, CAN MED ASSOC J, V110, P33; JONCAS JH, 1977, CAN MED ASSOC J, V117, P1417; KAFUKO GW, 1972, LANCET, V1, P706; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; KOVAL V, 1991, J VIROL, V65, P6969, DOI 10.1128/JVI.65.12.6969-6978.1991; Kraft CS, 2012, CLIN INFECT DIS, V54, P1793, DOI 10.1093/cid/cis212; Lanzieri TM, 2014, INT J INFECT DIS, V22, P44, DOI 10.1016/j.ijid.2013.12.010; Long SS, 2009, DNA VIRUSES HERPESVI, P1029; Gabriel MAM, 2007, MED SCI MONITOR, V13, pCR177; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; McMichael G, 2012, J MATERN-FETAL NEO M, V25, P2078, DOI 10.3109/14767058.2012.666587; Miller CS, 2006, J CLIN MICROBIOL, V44, P2409, DOI 10.1128/JCM.00256-06; Mutasa K, 2012, PEDIATR INFECT DIS J, V31, P948, DOI 10.1097/INF.0b013e318266aac2; Mwaanza N, 2014, CLIN INFECT DIS, V58, P728, DOI 10.1093/cid/cit766; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nilsson C, 2005, J ALLERGY CLIN IMMUN, V116, P438, DOI 10.1016/j.jaci.2005.04.027; Pedneault L, 1998, J INFECT DIS, V177, P1087, DOI 10.1086/517401; PETERSON PK, 1992, J CLIN INVEST, V89, P574, DOI 10.1172/JCI115623; Petrara MR, 2014, J INFECT DIS, V210, P392, DOI 10.1093/infdis/jiu099; Piriou E, 2012, J INFECT DIS, V205, P906, DOI 10.1093/infdis/jir872; RODIER MH, 1995, ACTA TROP, V59, P271, DOI 10.1016/0001-706X(95)00087-U; Rouet F, 2003, PEDIATRICS, V112, pE289, DOI 10.1542/peds.112.4.e289; Saghafian-Hedengren S, 2009, J IMMUNOL, V182, P2511, DOI 10.4049/jimmunol.0801699; Schaftenaar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099243; SCHOUB BD, 1993, S AFR MED J, V83, P108; SCHUSTER V, 1993, MONATSSCHR KINDERH, V141, P401; SEVER JL, 1995, PEDIATR AIDS HIV INF, V6, P75; Shearer WT, 1997, NEW ENGL J MED, V336, P1337, DOI 10.1056/NEJM199705083361901; Slyker J, 2014, CLIN INFECT DIS, V58, P564, DOI 10.1093/cid/cit727; Slyker JA, 2014, CLIN INFECT DIS, V58, P1333, DOI 10.1093/cid/ciu088; Slyker JA, 2013, J INFECT DIS, V207, P1798, DOI 10.1093/infdis/jit093; Slyker JA, 2009, AIDS, V23, P2173, DOI 10.1097/QAD.0b013e32833016e8; Spector SA, 1999, J VIROL, V73, P7027, DOI 10.1128/JVI.73.8.7027-7030.1999; TOTH FD, 1995, J VIROL, V69, P2223; UNAIDS, GLOB REP UNAIDS REP; Wang X, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-247	53	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114870	10.1371/journal.pone.0114870	http://dx.doi.org/10.1371/journal.pone.0114870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522217	Green Submitted, gold, Green Published			2022-12-26	WOS:000348845600010
J	Rosa, G; Huaylinos, ML; Gil, A; Lanata, C; Clasen, T				Rosa, Ghislaine; Huaylinos, Maria L.; Gil, Ana; Lanata, Claudio; Clasen, Thomas			Assessing the Consistency and Microbiological Effectiveness of Household Water Treatment Practices by Urban and Rural Populations Claiming to Treat Their Water at Home: A Case Study in Peru	PLOS ONE			English	Article							DRINKING-WATER; DEVELOPING-COUNTRIES; DISINFECTING WATER; HYGIENE PRACTICES; DIARRHEA; COST; QUESTIONNAIRES; INTERVENTIONS; METAANALYSIS; GUATEMALA	Background: Household water treatment (HWT) can improve drinking water quality and prevent disease if used correctly and consistently by vulnerable populations. Over 1.1 billion people report treating their water prior to drinking it. These estimates, however, are based on responses to household surveys that may exaggerate the consistency and microbiological performance of the practice-key factors for reducing pathogen exposure and achieving health benefits. The objective of this study was to examine how HWT practices are actually performed by households identified as HWT users, according to international monitoring standards. Methods and Findings: We conducted a 6-month case study in urban (n=117 households) and rural (n=115 households) Peru, a country in which 82.8% of households report treating their water at home. We used direct observation, in-depth interviews, surveys, spot-checks, and water sampling to assess water treatment practices among households that claimed to treat their drinking water at home. While consistency of reported practices was high in both urban (94.8%) and rural (85.3%) settings, availability of treated water (based on self-report) at time of collection was low, with 67.1% and 23.0% of urban and rural households having treated water at all three sampling visits. Self-reported consumption of untreated water in the home among adults and children <5 was common and this was corroborated during home observations. Drinking water of self-reported users was significantly better than source water in the urban setting and negligible but significantly better in the rural setting. However, only 46.3% and 31.6% of households had drinking water,1 CFU/100 mL at all follow-up visits. Conclusions: Our results raise questions about the usefulness of current international monitoring of HWT practices and their usefulness as a proxy indicator for drinking water quality. The lack of consistency and sub-optimal microbiological effectiveness also raises questions about the potential of HWT to prevent waterborne diseases.	[Rosa, Ghislaine; Clasen, Thomas] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Huaylinos, Maria L.; Gil, Ana; Lanata, Claudio] Inst Invest Nutr, Lima, Peru; [Clasen, Thomas] Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	University of London; London School of Hygiene & Tropical Medicine; Emory University; Rollins School Public Health	Rosa, G (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.	ghislaine.rosa@lshtm.ac.uk			Unicef and Hindustan Unilever Ltd.	Unicef and Hindustan Unilever Ltd.	This study was funded by Unicef and Hindustan Unilever Ltd. Unilever manufactures and sells point-of-use water treatment products. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander N, 2012, TROP MED INT HEALTH, V17, P684, DOI 10.1111/j.1365-3156.2012.02987.x; [Anonymous], 2009, DIARRH WHY CHILDR AR; APHA, 2001, STANDARD METHODS EXA; Arnold B, 2009, INT J EPIDEMIOL, V38, P1651, DOI 10.1093/ije/dyp241; Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Boerma J T, 1993, World Health Stat Q, V46, P222; Boisson S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012613; Brown J, 2012, AM J TROP MED HYG; Brown JC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030955, 10.1371/journal.pone.0036735]; Clasen T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004794.pub2; Clasen T, 2008, AM J TROP MED HYG, V79, P407, DOI 10.4269/ajtmh.2008.79.407; Clasen TF, 2008, ENVIRON SCI TECHNOL, V42, P4255, DOI 10.1021/es7024802; Colindres RE, 2007, J WATER HEALTH, V5, P367, DOI 10.2166/wh.2007.032; CURTIS V, 1993, B WORLD HEALTH ORGAN, V71, P23; Curtis V, 1997, HEALTH POLICY PLANN, V12, P122, DOI 10.1093/heapol/12.2.122; ENDES, 2004, END CONT 2004 2006; ENDES, 2009, PER DHS 2009 FIN REP; Enger KS, 2013, WATER RES, V47, P1181, DOI 10.1016/j.watres.2012.11.034; Enger KS, 2012, ENVIRON SCI TECHNOL, V46, P5160, DOI 10.1021/es204381e; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; GILMAN RH, 1993, AM J PUBLIC HEALTH, V83, P1554, DOI 10.2105/AJPH.83.11.1554; Kayser GL, 2013, INT J ENV RES PUB HE, V10, P4812, DOI 10.3390/ijerph10104812; Mausezahl D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000125; ManunEbo M, 1997, TROP MED INT HEALTH, V2, P1015, DOI 10.1046/j.1365-3156.1997.d01-180.x; Moser S., 2005, DETERMINANTS DIFFUSI; Pruss-Ustun A, 2014, TROP MED INT HLTH; Psutka R, 2011, ENVIRON SCI TECHNOL, V45, P6095, DOI 10.1021/es2004045; Rosa G, 2010, AM J TROP MED HYG, V82, P473, DOI 10.4269/ajtmh.2010.09-0320; Rosa G, 2010, AM J TROP MED HYG, V82, P289, DOI 10.4269/ajtmh.2010.09-0382; Ruel MT, 2002, J HEALTH POPUL NUTR, V20, P65; Sodha SV, 2011, J WATER HEALTH, V9, P577, DOI 10.2166/wh.2011.255; STANTON BF, 1987, B WORLD HEALTH ORGAN, V65, P217; STONE L, 1984, HUM ORGAN, V43, P27, DOI 10.17730/humo.43.1.6wl5k01724878166; WHO, 2011, GUID DRINK WAT QUAL; *WHO UNICEF, 2005, WAT LIF MAK IT HAPP; WHO/UNICEF, 2006, COR QUEST DRINK WAT; WHO & UNICEF, 2014, PROGR SAN DRINK WAT; Yang H, 2012, AM J TROP MED HYG, V86, P554, DOI 10.4269/ajtmh.2012.11-0730a; Zwane AP, 2011, P NATL ACAD SCI US	39	30	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114997	10.1371/journal.pone.0114997	http://dx.doi.org/10.1371/journal.pone.0114997			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA4AC	25522371	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000348845600013
J	Park, Y; Kim, W; Lee, JM; Park, J; Cho, JK; Pang, K; Lee, J; Kim, D; Park, SW; Yang, KM; Kim, SJ				Park, Y.; Kim, W.; Lee, J-M; Park, J.; Cho, J. K.; Pang, K.; Lee, J.; Kim, D.; Park, S-W; Yang, K-M; Kim, S-J			Cytoplasmic DRAK1 overexpressed in head and neck cancers inhibits TGF-beta 1 tumor suppressor activity by binding to Smad3 to interrupt its complex formation with Smad4	ONCOGENE			English	Article							SQUAMOUS-CELL CARCINOMA; TGF-BETA; DAP-KINASE; DOWN-REGULATION; APOPTOSIS; PROTEIN; GENE; PATHWAYS; RECEPTOR	Head and neck squamous cell carcinoma (HNSCC) is an extremely aggressive cancer with a poor prognosis and low patient survival. Because chemotherapy for advanced HNSCC is often ineffective, discovering new therapeutic targets that are important for HNSCC development and progression and elucidating their molecular mechanisms are required. In the present study, we describe the role of DRAK1 (death-associated protein kinase-related apoptosis-inducing kinase 1) as a novel negative regulator of the transforming growth factor-beta (TGF-beta) tumor suppressor signaling pathway for the first time in human HNSCC cells. DRAK1 was significantly overexpressed in primary human HNSCCs and in HNSCC cell lines. Through gain-and loss-of-function experiments, we demonstrated that the DRAK1 expression level regulated TGF-beta 1-induced transcriptional activity and expression of the tumor suppressor gene p21Waf1/Cip1. DRAK1 depletion enhanced TGF-beta 1-induced growth inhibition in vitro and suppressed tumorigenicity in xenograft models in vivo. Mechanistically, DRAK1 was predominantly localized in the cytoplasm and bound to Smad3, thereby interrupting Smad3/Smad4 complex formation, which is the core process for the induction of tumor suppressor genes by TGF-beta 1. Thus, our findings suggest that cytoplasmic DRAK1 increases tumorigenic potential through inhibition of TGF-beta 1-mediated tumor suppressor activity in HNSCC cells and may be a potential therapeutic target for HNSCCs.	[Park, Y.; Kim, W.; Lee, J-M; Park, J.; Cho, J. K.; Pang, K.; Lee, J.; Kim, D.; Yang, K-M; Kim, S-J] CHA Univ, CHA Canc Inst, Seoul 135081, South Korea; [Kim, W.] CHA Univ, Coll Med, Seoul 135081, South Korea; [Lee, J-M; Park, J.] CHA Univ, Coll Pharm, Seoul 135081, South Korea; [Cho, J. K.; Pang, K.; Lee, J.; Kim, S-J] CHA Univ, Dept Biomed Sci, Seoul 135081, South Korea; [Park, S-W] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University; Pochon Cha University; Seoul National University (SNU)	Yang, KM (corresponding author), CHA Univ, CHA Canc Inst, Dept Biomed Sci, 605 Yeoksam 1 Dong, Seoul 135081, South Korea.	kmyang@cha.ac.kr; kimsj@cha.ac.kr			National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning [NRF-2012M3A9C4048735, NRF-2009-0081756, NRF-2014R1A1A1005186]	National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning	This research was supported by the Bio-Synergy Research Project (NRF-2012M3A9C4048735 to S-JK), Bio & Medical Technology Development Program (NRF-2009-0081756 to S-JK) and Basic Science Research Program (NRF-2014R1A1A1005186 to K-MY), through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning.	Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Bornstein S, 2009, J CLIN INVEST, V119, P3408, DOI 10.1172/JCI38854; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Kang JM, 2012, ONCOGENE, V31, P5123, DOI 10.1038/onc.2012.18; Kim SJ, 2000, CYTOKINE GROWTH F R, V11, P159, DOI 10.1016/S1359-6101(99)00039-8; Kogel D, 2001, BIOESSAYS, V23, P352, DOI 10.1002/bies.1050; Koukourakis MI, 2006, J CLIN ONCOL, V24, P727, DOI 10.1200/JCO.2005.02.7474; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Mao P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081803; Mao P, 2011, J BIOL CHEM, V286, P19381, DOI 10.1074/jbc.M111.218040; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Qiu W, 2007, CANCER LETT, V245, P163, DOI 10.1016/j.canlet.2006.01.003; Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066; Wang D, 1997, CARCINOGENESIS, V18, P2285, DOI 10.1093/carcin/18.11.2285; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Weber F, 2007, JAMA-J AM MED ASSOC, V297, P187, DOI 10.1001/jama.297.2.187; White RA, 2010, ONCOGENE, V29, P5437, DOI 10.1038/onc.2010.306; Worsham MJ, 2006, ARCH OTOLARYNGOL, V132, P409, DOI 10.1001/archotol.132.4.409; Worsham MJ, 2003, ARCH OTOLARYNGOL, V129; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yang KM, 2013, CANCER RES, V73, P6679, DOI 10.1158/0008-5472.CAN-13-0891; Yang KM, 2012, CELL REP, V2, P1286, DOI 10.1016/j.celrep.2012.09.028; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69	33	26	27	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2015	34	39					5037	5045		10.1038/onc.2014.423	http://dx.doi.org/10.1038/onc.2014.423			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9RC	25531329				2022-12-26	WOS:000361693300004
J	Kumar, S; Das, S; Rachagani, S; Kaur, S; Joshi, S; Johansson, SL; Ponnusamy, MP; Jain, M; Batra, SK				Kumar, S.; Das, S.; Rachagani, S.; Kaur, S.; Joshi, S.; Johansson, S. L.; Ponnusamy, M. P.; Jain, M.; Batra, S. K.			NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer	ONCOGENE			English	Article							NUCLEAR RECEPTOR COACTIVATOR; GENE-EXPRESSION; RETINOIC ACID; BREAST-CANCER; POTENTIAL ROLE; GROWTH; ACTIVATION; SRC-3; AIB1; PROGRESSION	Pancreatic cancer (PC) is characterized by aberrant overexpression of mucins that contribute to its pathogenesis. Although the inflammatory cytokines contribute to mucin overexpression, the mucin profile of PC is markedly distinct from that of normal or inflamed pancreas. We postulated that de novo expression of various mucins in PC involves chromatin modifications. Analysis of chromatin modifying enzymes by PCR array identified differential expression of NCOA3 in MUC4-expressing PC cell lines. Immunohistochemistry analysis in tumor tissues from patients and spontaneous mouse models, and microarray analysis following the knockdown of NCOA3 were performed to elucidate its role in mucin regulation and overall impact on PC. Silencing of NCOA3 in PC cell lines resulted in significant downregulation of two most differentially expressed mucins in PC, MUC4 and MUC1 (P<0.01). Immunohistochemistry analysis in PC tissues and metastatic lesions established an association between NCOA3 and mucin (MUC1 and MUC4) expression. Spontaneous mouse model of PC (K-rasG12D; Pdx-1cre) showed early expression of Ncoa3 during preneoplastic lesions. Mechanistically, NCOA3 knockdown abrogated retinoic acid-mediated MUC4 upregulation by restricting MUC4 promoter accessibility as demonstrated by micrococcus nuclease digestion (P<0.05) and chromatin immuno-precipitation analysis. NCOA3 also created pro-inflammatory conditions by upregulating chemokines like CXCL1, 2, 5 and CCL20 (P<0.001). AKT, ubiquitin C, ERK1/2 and NF-kappa B occupied dominant nodes in the networks significantly modulated after NCOA3 silencing. In addition, NCOA3 stabilized mucins post translationally through fucosylation by FUT8, as the knockdown of FUT8 resulted in the downregulation of MUC4 and MUC1 at protein levels.	[Kumar, S.; Das, S.; Rachagani, S.; Kaur, S.; Joshi, S.; Ponnusamy, M. P.; Jain, M.; Batra, S. K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Johansson, S. L.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Jain, M.; Batra, S. K.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Batra, S. K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Batra, SK (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	sbatra@unmc.edu	Das, Srustidhar/GVU-1044-2022	Palanimuthu Ponnusamy, Moorthy/0000-0001-5744-193X	NIH [TMEN U54 CA163120, RO1 CA183459, EDRN UO1, CA111294, SPORE P50 CA127297, RO3 CA167342]; NATIONAL CANCER INSTITUTE [U54CA163120, U01CA111294, R03CA167342, R01CA183459, P50CA127297] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Lynette Smith, Dr Joshua Souchek, Ms Kavita Mallya, Dr Neeru Sharma and Dr Parama Dey for help in statistical analysis and technical support. Microarray analysis was performed using BRB-Array Tools developed by Dr. Richard Simon and BRB-Array Development Team. The work was supported, in parts, by grants from the NIH (TMEN U54 CA163120, RO1 CA183459, EDRN UO1, CA111294, SPORE P50 CA127297 and RO3 CA167342).	Al-Otaiby M, 2012, AM J PATHOL, V180, P1474, DOI 10.1016/j.ajpath.2011.12.032; Andrianifahanana M, 2005, ONCOGENE, V24, P6143, DOI 10.1038/sj.onc.1208756; Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bautista S, 1998, CLIN CANCER RES, V4, P2925; Borchers MT, 1999, AM J PHYSIOL-LUNG C, V276, pL549, DOI 10.1152/ajplung.1999.276.4.L549; Braat H, 2012, CANCER LETT, V318, P1, DOI 10.1016/j.canlet.2011.11.034; Brown K, 2003, J BIOL CHEM, V278, P39402, DOI 10.1074/jbc.M307832200; Carson DD, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127pe35; Chakraborty S, 2010, J CLIN PATHOL, V63, P579, DOI 10.1136/jcp.2010.076125; Chaturvedi P, 2008, CANCER RES, V68, P2065, DOI 10.1158/0008-5472.CAN-07-6041; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Dey P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026926; Dharmaraj N, 2010, MOL ENDOCRINOL, V24, P2253, DOI 10.1210/me.2009-0448; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Ghadimi BM, 1999, AM J PATHOL, V154, P525, DOI 10.1016/S0002-9440(10)65298-4; Grzesiak JJ, 2007, PANCREAS, V35, P293, DOI 10.1097/mpa.0b013e31811f4526; Haridas D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026839; Harigopal M, 2009, BREAST CANCER RES TR, V115, P77, DOI 10.1007/s10549-008-0063-9; Hawker NP, 2007, J INVEST DERMATOL, V127, P874, DOI 10.1038/sj.jid.5700624; Henke RT, 2004, CLIN CANCER RES, V10, P6134, DOI 10.1158/1078-0432.CCR-04-0561; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; HOLLINGSWORTH MA, 1994, INT J CANCER, V57, P198, DOI 10.1002/ijc.2910570212; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kawano T, 2008, INT J ONCOL, V33, P153; Koo JS, 2002, EXP LUNG RES, V28, P315, DOI 10.1080/01902140252964393; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Lahusen T, 2007, CANCER RES, V67, P7256, DOI 10.1158/0008-5472.CAN-07-1013; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Li J, 2012, MOL CELL BIOCHEM, V364, P29, DOI 10.1007/s11010-011-1201-y; Li X, 2003, J DENT RES, V82, P883, DOI 10.1177/154405910308201107; Li Z, 2012, WORLD J GASTROENTERO, V18, P855, DOI 10.3748/wjg.v18.i8.855; Lin HL, 2011, AM J PHYSIOL-RENAL, V300, pF1017, DOI 10.1152/ajprenal.00426.2010; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McAllister F, 2014, CANCER CELL, V25, P621, DOI 10.1016/j.ccr.2014.03.014; McCarroll JA, 2006, GUT, V55, P79, DOI 10.1136/gut.2005.064543; Mejias-Luque R, 2010, ONCOGENE, V29, P1753, DOI 10.1038/onc.2009.467; Moniaux N, 2008, BRIT J CANCER, V98, P1540, DOI 10.1038/sj.bjc.6604329; Nakles RE, 2011, MOL ENDOCRINOL, V25, P549, DOI 10.1210/me.2010-0114; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Okuyama N, 2006, INT J CANCER, V118, P2803, DOI 10.1002/ijc.21728; Percharde M, 2013, CELL CYCLE, V12, P195, DOI 10.4161/cc.23377; Rachagani S, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-68; Reid G, 2009, INT J BIOCHEM CELL B, V41, P155, DOI 10.1016/j.biocel.2008.08.028; Rieder S, 2011, ANTI-CANCER AGENT ME, V11, P427, DOI 10.2174/187152011795677454; Saitou M, 2005, J CLIN PATHOL, V58, P845, DOI 10.1136/jcp.2004.023572; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791; Wang Y, 2014, CANCER RES, V74, P1506, DOI 10.1158/0008-5472.CAN-13-2939; Wang Y, 2011, MOL ENDOCRINOL, V25, P2041, DOI 10.1210/me.2011-1222; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; York B, 2010, P NATL ACAD SCI USA, V107, P11122, DOI 10.1073/pnas.1005262107; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025; Zhao C, 2003, CANCER, V98, P18, DOI 10.1002/cncr.11482	57	23	24	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2015	34	37					4879	4889		10.1038/onc.2014.409	http://dx.doi.org/10.1038/onc.2014.409			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR0YP	25531332	Green Accepted			2022-12-26	WOS:000361050000008
J	Adhikari, S; Chetram, MA; Woodrick, J; Mitra, PS; Manthena, PV; Khatkar, P; Dakshanamurthy, S; Dixon, M; Karmahapatra, SK; Nuthalapati, NK; Gupta, S; Narasimhan, G; Mazumder, R; Loffredo, CA; Uren, A; Roy, R				Adhikari, Sanjay; Chetram, Mahandranauth A.; Woodrick, Jordan; Mitra, Partha S.; Manthena, Praveen V.; Khatkar, Pooja; Dakshanamurthy, Sivanesan; Dixon, Monica; Karmahapatra, Soumendra K.; Nuthalapati, Nikhil K.; Gupta, Suhani; Narasimhan, Ganga; Mazumder, Raja; Loffredo, Christopher A.; Ueren, Aykut; Roy, Rabindra			Germ Line Variants of Human N-Methylpurine DNA Glycosylase Show Impaired DNA Repair Activity and Facilitate 1,N-6-Ethenoadenine-induced Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; 3-METHYLADENINE-DNA GLYCOSYLASE; ESCHERICHIA-COLI; HUMAN-POPULATION; CANCER RISK; HUMAN-CELLS; DAMAGE; MOUSE; SUBSTRATE; POLYMORPHISMS	Human N-methylpurine DNA glycosylase (hMPG) initiates base excision repair of a number of structurally diverse purine bases including 1,N-6-ethenoadenine, hypoxanthine, and alkylation adducts in DNA. Genetic studies discovered at least eight validated non-synonymous single nucleotide polymorphisms (nsSNPs) of the hMPG gene in human populations that result in specific single amino acid substitutions. In this study, we tested the functional consequences of these nsSNPs of hMPG. Our results showed that two specific arginine residues, Arg-141 and Arg-120, are important for the activity of hMPG as the germ line variants R120C and R141Q had reduced enzymatic activity in vitro as well as in mammalian cells. Expression of these two variants in mammalian cells lacking endogenous MPG also showed an increase in mutations and sensitivity to an alkylating agent compared with the WT hMPG. Real time binding experiments by surface plasmon resonance spectroscopy suggested that these variants have substantial reduction in the equilibrium dissociation constant of binding( K-D) of hMPG toward 1,N-6-ethenoadenine- containing oligonucleotide (epsilon A-DNA). Pre-steady-state kinetic studies showed that the substitutions at arginine residues affected the turnover of the enzyme significantly under multiple turnover condition. Surface plasmon resonance spectroscopy further showed that both variants had significantly decreased nonspecific (undamaged) DNA binding. Molecular modeling suggested that R141Q substitution may have resulted in a direct loss of the salt bridge between epsilon A-DNA and hMPG, whereas R120C substitution redistributed, at a distance, the interactions among residues in the catalytic pocket. Together our results suggest that individuals carrying R120C and R141Q MPG variants may be at risk for genomic instability and associated diseases as a consequence.	[Adhikari, Sanjay; Chetram, Mahandranauth A.; Woodrick, Jordan; Mitra, Partha S.; Manthena, Praveen V.; Khatkar, Pooja; Dakshanamurthy, Sivanesan; Dixon, Monica; Karmahapatra, Soumendra K.; Nuthalapati, Nikhil K.; Gupta, Suhani; Narasimhan, Ganga; Loffredo, Christopher A.; Ueren, Aykut; Roy, Rabindra] Georgetown Univ, Mol Oncol Program, Lombardi Comprehens Canc Ctr, Med Ctr, Washington, DC 20057 USA; [Adhikari, Sanjay] Houston Methodist Hosp Res Inst, Canc Res Program, Houston, TX 77030 USA; [Mazumder, Raja] George Washington Univ, Dept Biochem & Mol Med, Washington, DC 20037 USA	Georgetown University; The Methodist Hospital System; The Methodist Hospital - Houston; George Washington University	Roy, R (corresponding author), Georgetown Univ, Mol Oncol Program, Lombardi Comprehens Canc Ctr, Med Ctr, Washington, DC 20057 USA.	rr228@georgetown.edu	Khatkar, Pooja/GVT-3706-2022; Dakshanamurthy, Sivanesan/CAF-4258-2022	Dakshanamurthy, Sivanesan/0000-0003-3681-4121; khatkar, pooja/0000-0003-3842-5146; Mazumder, Raja/0000-0001-8823-9945	National Institutes of Health [P30CA51008]; NATIONAL CANCER INSTITUTE [R01CA113447, P30CA051008, T32CA009686, R01CA108641, R01CA092306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Veronica Rodriguez for technical help in surface plasmon resonance experiments performed at the Biacore Molecular Interaction Shared Resource of the Lombardi Comprehensive Cancer Center. The Biacore Molecular Interaction Shared Resource of the Lombardi Comprehensive Cancer Center is supported by National Institutes of Health Grant P30CA51008.	Adhikari S, 2008, ANTI-CANCER AGENT ME, V8, P351, DOI 10.2174/187152008784220366; Adhikari S, 2008, PROTEIN EXPRES PURIF, V58, P257, DOI 10.1016/j.pep.2007.12.001; Adhikari S, 2008, DNA REPAIR, V7, P31, DOI 10.1016/j.dnarep.2007.07.012; Adhikari S, 2007, J BIOL CHEM, V282, P30078, DOI 10.1074/jbc.M704051200; Adhikari S, 2006, J BIOL CHEM, V281, P29525, DOI 10.1074/jbc.M602673200; Adhikari Sanjay, 2009, DNA Repair (Amst), V8, P1201, DOI 10.1016/j.dnarep.2009.06.005; Barbin A, 2000, MUTAT RES-REV MUTAT, V462, P55, DOI 10.1016/S1383-5742(00)00014-4; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Choudhury S, 2008, MOL CELL BIOCHEM, V313, P19, DOI 10.1007/s11010-008-9737-1; DARDEN TA, 1993, ENVIRON HEALTH PERSP, V101, P410, DOI 10.2307/3431897; Dey S, 2012, DNA REPAIR, V11, P570, DOI 10.1016/j.dnarep.2012.03.005; Engelward BP, 1996, EMBO J, V15, P945, DOI 10.1002/j.1460-2075.1996.tb00429.x; Galick HA, 2013, P NATL ACAD SCI USA, V110, P14314, DOI 10.1073/pnas.1306752110; Godschalk R, 2002, CARCINOGENESIS, V23, P2081, DOI 10.1093/carcin/23.12.2081; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Hadi MZ, 2000, NUCLEIC ACIDS RES, V28, P3871, DOI 10.1093/nar/28.20.3871; Hanson RN, 2003, J MED CHEM, V46, P2865, DOI 10.1021/jm0205806; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; Leitner-Dagan Y, 2012, JNCI-J NATL CANCER I, V104, P1765, DOI 10.1093/jnci/djs445; Levine RL, 2000, CANCER RES, V60, P4098; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Lunn RM, 2000, CARCINOGENESIS, V21, P551, DOI 10.1093/carcin/21.4.551; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Meira LB, 2009, P NATL ACAD SCI USA, V106, P888, DOI 10.1073/pnas.0807030106; Miao F, 2000, J BIOL CHEM, V275, P28433, DOI 10.1074/jbc.M001064200; Nair J, 2006, ANTIOXID REDOX SIGN, V8, P1003, DOI 10.1089/ars.2006.8.1003; Nyaga SG, 1997, BIOCHEMISTRY-US, V36, P4080, DOI 10.1021/bi962218x; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; Paik J, 2005, CANCER RES, V65, P10472, DOI 10.1158/0008-5472.CAN-05-1495; Ringvoll J, 2008, CANCER RES, V68, P4142, DOI 10.1158/0008-5472.CAN-08-0796; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; ROY R, 1994, BIOCHEMISTRY-US, V33, P15131, DOI 10.1021/bi00254a024; Roy R, 1998, BIOCHEMISTRY-US, V37, P580, DOI 10.1021/bi972313l; Roy R, 1996, CARCINOGENESIS, V17, P2177, DOI 10.1093/carcin/17.10.2177; Sambrook J., 2001, MOL CLONING LAB MANU; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Speina E, 2003, CANCER RES, V63, P4351; Tolentino JH, 2008, NUCLEIC ACIDS RES, V36, P1300, DOI 10.1093/nar/gkm1157; von Hippel PH, 2007, ANNU REV BIOPH BIOM, V36, P79, DOI 10.1146/annurev.biophys.34.040204.144521; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106	43	8	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4966	4980		10.1074/jbc.M114.627000	http://dx.doi.org/10.1074/jbc.M114.627000			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25538240	hybrid, Green Published			2022-12-26	WOS:000350042000039
J	Blancas-Mejia, LM; Hammernik, J; Marin-Argany, M; Ramirez-Alvarado, M				Blancas-Mejia, Luis M.; Hammernik, Jared; Marin-Argany, Marta; Ramirez-Alvarado, Marina			Differential Effects on Light Chain Amyloid Formation Depend on Mutations and Type of Glycosaminoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRIL FORMATION; DIMER INTERFACE; CONFORMATIONAL STABILITY; STRUCTURAL FEATURES; PROTEIN STABILITY; AL AMYLOIDOSIS; IMMUNOGLOBULIN; AGGREGATION; SULFATE; AMYLOIDOGENICITY	Amyloid light chain (AL) amyloidosis is a protein misfolding disease where immunoglobulin light chains sample partially folded states that lead to misfolding and amyloid formation, resulting in organ dysfunction and death. In vivo, amyloid deposits are found in the extracellular space and involve a variety of accessory molecules, such as glycosaminoglycans, one of the main components of the extracellular matrix. Glycosaminoglycans are a group of negatively charged heteropolysaccharides composed of repeating disaccharide units. In this study, we investigated the effect of glycosaminoglycans on the kinetics of amyloid fibril formation of three AL cardiac amyloidosis light chains. These proteins have similar thermodynamic stability but exhibit different kinetics of fibril formation. We also studied single restorative and reciprocal mutants and wild type germ line control protein. We found that the type of glycosaminoglycan has a different effect on the kinetics of fibril formation, and this effect seems to be associated with the natural propensity of each AL protein to form fibrils. Heparan sulfate accelerated AL-12, AL-09, kappa I Y87H, and AL-103 H92D fibril formation; delayed fibril formation for AL-103; and did not promote any fibril formation for AL-12 R65S, AL-103 delP95aIns, or kappa I O18/O8. Chondroitin sulfate A, on the other hand, showed a strong fibril formation inhibition for all proteins. We propose that heparan sulfate facilitates the formation of transient amyloidogenic conformations of AL light chains, thereby promoting amyloid formation, whereas chondroitin sulfate A kinetically traps partially unfolded intermediates, and further fibril elongation into fibrils is inhibited, resulting in formation/accumulation of oligomeric/protofibrillar aggregates.	[Blancas-Mejia, Luis M.; Marin-Argany, Marta; Ramirez-Alvarado, Marina] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Ramirez-Alvarado, Marina] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Hammernik, Jared] Univ Illinois, Sch Mol & Cellular Biol, Urbana, IL 61801 USA	Mayo Clinic; Mayo Clinic; University of Illinois System; University of Illinois Urbana-Champaign	Ramirez-Alvarado, M (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	ramirezalvarado.marina@mayo.edu		Ramirez-Alvarado, Marina/0000-0003-2325-6773; Argany, Meysam/0000-0001-6577-4443	National Institutes of Health [R01 GM 071514]; Mayo Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM 071514. This work was also supported by the Mayo Foundation.	Abraham RS, 2003, BLOOD, V101, P3801, DOI 10.1182/blood-2002-09-2707; Aguilera JJ, 2014, BIOCHIMIE, V104, P70, DOI 10.1016/j.biochi.2014.05.007; ALBINSSON B, 1992, J PHYS CHEM-US, V96, P6204, DOI 10.1021/j100194a023; Baden EM, 2008, J BIOL CHEM, V283, P30950, DOI 10.1074/jbc.M804822200; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blancas-Mejia LM, 2014, J MOL BIOL, V426, P347, DOI 10.1016/j.jmb.2013.10.016; Blancas-Mejia LM, 2013, ANNU REV BIOCHEM, V82, P745, DOI 10.1146/annurev-biochem-072611-130030; Blancas-Mejia LM, 2009, J MOL BIOL, V386, P1153, DOI 10.1016/j.jmb.2008.12.069; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Buxbaum JN, 2012, J MOL BIOL, V421, P142, DOI 10.1016/j.jmb.2012.01.024; DiCostanzo AC, 2012, J BIOL CHEM, V287, P27997, DOI 10.1074/jbc.M112.362921; Dispenzieri A, 2012, BLOOD REV, V26, P137, DOI 10.1016/j.blre.2012.03.001; Dubrey SW, 1998, QJM-MON J ASSOC PHYS, V91, P141, DOI 10.1093/qjmed/91.2.141; Falk RH, 2005, CIRCULATION, V112, P2047, DOI 10.1161/CIRCULATIONAHA.104.489187; Fauerbach JA, 2012, BIOPHYS J, V102, P1127, DOI 10.1016/j.bpj.2012.01.051; Guerrero-Munoz MJ, 2014, BIOCHEM PHARMACOL, V88, P468, DOI 10.1016/j.bcp.2013.12.023; Hernandez-Santoyo A, 2010, J MOL BIOL, V396, P280, DOI 10.1016/j.jmb.2009.11.038; Hu DM, 2008, BIOCHEMISTRY-US, V47, P8665, DOI 10.1021/bi800806d; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; Jiang XL, 1997, BIOCHEMISTRY-US, V36, P13187, DOI 10.1021/bi970408h; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Kumar SK, 2011, AM J HEMATOL, V86, P251, DOI 10.1002/ajh.21948; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; Martin DJ, 2011, BIOPHYS CHEM, V158, P81, DOI 10.1016/j.bpc.2011.05.011; Martin DJ, 2010, AMYLOID, V17, P129, DOI 10.3109/13506129.2010.530081; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Merlini G, 2006, BLOOD, V108, P2520, DOI 10.1182/blood-2006-03-001164; NELSON SR, 1991, BIOCHEM J, V275, P67, DOI 10.1042/bj2750067; OHISHI H, 1990, CLIN CHEM, V36, P88; Peterson FC, 2010, STRUCTURE, V18, P563, DOI 10.1016/j.str.2010.02.012; Pokkuluri PR, 2002, PROTEIN SCI, V11, P1687, DOI 10.1110/ps.4920102; Poshusta TL, 2013, INT J MOL SCI, V14, P22604, DOI 10.3390/ijms141122604; Randles EG, 2009, J MOL BIOL, V389, P199, DOI 10.1016/j.jmb.2009.04.010; Ren RY, 2010, J BIOL CHEM, V285, P37672, DOI 10.1074/jbc.M110.149575; SCHORMANN N, 1995, P NATL ACAD SCI USA, V92, P9490, DOI 10.1073/pnas.92.21.9490; Seyrek E, 2010, ADV COLLOID INTERFAC, V158, P119, DOI 10.1016/j.cis.2010.03.001; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Sikkink LA, 2008, BIOPHYS CHEM, V135, P25, DOI 10.1016/j.bpc.2008.02.019; Souillac PO, 2003, BIOCHEMISTRY-US, V42, P8094, DOI 10.1021/bi034652m; Souillac PO, 2002, J BIOL CHEM, V277, P12657, DOI 10.1074/jbc.M109230200; Souillac PO, 2002, J BIOL CHEM, V277, P12666, DOI 10.1074/jbc.M109229200; Sreerama N, 1999, BIOCHEMISTRY-US, V38, P10814, DOI 10.1021/bi990516z; Stevens FJ, 2000, CELL MOL LIFE SCI, V57, P441, DOI 10.1007/PL00000706; Trinkaus-Randall V, 2005, AM J PATHOL, V166, P197, DOI 10.1016/S0002-9440(10)62244-4; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall JS, 2004, J MOL RECOGNIT, V17, P323, DOI 10.1002/jmr.681; Wetzel R, 1997, ADV PROTEIN CHEM, V50, P183, DOI 10.1016/S0065-3233(08)60322-8	50	32	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4953	4965		10.1074/jbc.M114.615401	http://dx.doi.org/10.1074/jbc.M114.615401			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25538238	Green Published, hybrid			2022-12-26	WOS:000350042000038
J	Shalygin, A; Skopin, A; Kalinina, V; Zimina, O; Glushankova, L; Mozhayeva, GN; Kaznacheyeva, E				Shalygin, Alexey; Skopin, Anton; Kalinina, Vera; Zimina, Olga; Glushankova, Lyuba; Mozhayeva, Galina N.; Kaznacheyeva, Elena			STIM1 and STIM2 Proteins Differently Regulate Endogenous Store-operated Channels in HEK293 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA A431 CELLS; CALCIUM SENSORS STIM1; CA2+ ENTRY; PLASMA-MEMBRANE; FUNCTIONAL-PROPERTIES; TRPC CHANNELS; I-CRAC; ORAI1; ACTIVATION; INFLUX	The endoplasmic reticulum calcium sensors stromal interaction molecules 1 and 2 (STIM1 and STIM2) are key modulators of store-operated calcium entry. Both these sensors play a major role in physiological functions in normal tissue and in pathology, but available data on native STIM2-regulated plasma membrane channels are scarce. Only a few studies have recorded STIM2-induced CRAC (calcium release-activated calcium) currents. On the other hand, many cell types display store-operated currents different from CRAC. The STIM1 protein regulates not only CRAC but also transient receptor potential canonical (TRPC) channels, but it has remained unclear whether STIM2 is capable of regulating store-operated non-CRAC channels. Here we present for the first time experimental evidence for the existence of endogenous non-CRAC STIM2-regulated channels. As shown in single-channel patch clamp experiments on HEK293 cells, selective activation of native STIM2 proteins or STIM2 overexpression results in store-operated activation of I-min channels, whereas STIM1 activation blocks this process. Changes in the ratio between active STIM2 and STIM1 proteins can switch the regulation of I-min channels between store-operated and store-independent modes. We have previously characterized electrophysiological properties of different Ca2+ influx channels coexisting in HEK293 cells. The results of this study show that STIM1 and STIM2 differ in the ability to activate these store-operated channels; I-min channels are regulated by STIM2, TRPC3-containing I-NS channels are induced by STIM1, and TRPC1-composed I-max channels are activated by both STIM1 and STIM2. These new data about cross-talk between STIM1 and STIM2 and their different roles in store-operated channel activation are indicative of an additional level in the regulation of store-operated calcium entry pathways.	[Shalygin, Alexey; Skopin, Anton; Kalinina, Vera; Zimina, Olga; Glushankova, Lyuba; Mozhayeva, Galina N.; Kaznacheyeva, Elena] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Shalygin, A (corresponding author), Russian Acad Sci, Inst Cytol, 4 Tikhoretsky Ave, St Petersburg 194064, Russia.	a_shalygin@mail.ru; evkazn@incras.ru	Shalygin, Alexey V/Q-1361-2017; Kalinina, Vera/V-2408-2018; Glushankova, Lyubov/AAE-9361-2021; Kaznacheyeva, Elena V/I-7260-2017; Skopin, Anton Y/G-5457-2017	Shalygin, Alexey V/0000-0002-9896-1832; Kalinina, Vera/0000-0003-2053-5101; Glushankova, Lyubov/0000-0002-9995-1214; Kaznacheyeva, Elena V/0000-0003-1273-1188; Skopin, Anton/0000-0002-9693-0098	Russian Scientific Foundation [14-14-00720]; Russian Academy of Sciences; Scientific School Support Program [SS-1721.2014.4]; Dynasty Foundation; Russian Foundation for Basic Research; Russian Science Foundation [14-14-00720] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Academy of Sciences(Russian Academy of Sciences); Scientific School Support Program; Dynasty Foundation; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the Russian Scientific Foundation, Project 14-14-00720 (to E. K. and A. S.); the program "Molecular and Cellular Biology" of the Russian Academy of Sciences (to G. N. M. and L. G.); the Scientific School Support Program, Project SS-1721.2014.4 (to G. N. M.); the Dynasty Foundation; and the Russian Foundation for Basic Research.	Alicia S, 2008, CELL CALCIUM, V44, P479, DOI 10.1016/j.ceca.2008.03.001; Antigny F, 2013, J CELL SCI, V126, P2525, DOI 10.1242/jcs.122911; Aytes A, 2012, MOL CARCINOGEN, V51, P746, DOI 10.1002/mc.20843; Bandyopadhyay BC, 2011, J LEUKOCYTE BIOL, V89, P57, DOI 10.1189/jlb.0610381; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; Bojarski L, 2009, BBA-MOL CELL RES, V1793, P1050, DOI 10.1016/j.bbamcr.2008.11.008; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Bugaj V, 2005, J BIOL CHEM, V280, P16790, DOI 10.1074/jbc.M500192200; Cheng KT, 2012, P NATL ACAD SCI USA, V109, P14544, DOI 10.1073/pnas.1207354109; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Darbellay B, 2010, J BIOL CHEM, V285, P22437, DOI 10.1074/jbc.M110.118984; Ercan E, 2009, TRAFFIC, V10, P1802, DOI 10.1111/j.1600-0854.2009.00995.x; Gruszczynska-Biegala J, 2013, J NEUROCHEM, V126, P727, DOI 10.1111/jnc.12320; Gruszczynska-Biegala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019285; Gusev K, 2003, J GEN PHYSIOL, V122, P81, DOI 10.1085/jgp.200308815; Hooper JS, 2013, BRAIN RES, V1503, P7, DOI 10.1016/j.brainres.2013.02.002; Horinouchi T, 2012, BIOCHEM BIOPH RES CO, V428, P252, DOI 10.1016/j.bbrc.2012.10.034; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jardin I, 2009, BIOCHEM J, V420, P267, DOI 10.1042/BJ20082179; Kar P, 2012, P NATL ACAD SCI USA, V109, P6969, DOI 10.1073/pnas.1201204109; Kaznacheyeva E, 2000, J BIOL CHEM, V275, P4561, DOI 10.1074/jbc.275.7.4561; Kaznacheyeva E, 2001, P NATL ACAD SCI USA, V98, P148, DOI 10.1073/pnas.98.1.148; Kaznacheyeva E, 2007, J BIOL CHEM, V282, P23655, DOI 10.1074/jbc.M608378200; Kiselyov KI, 1999, PFLUG ARCH EUR J PHY, V437, P305, DOI 10.1007/s004240050784; Kiselyov KI, 1997, FEBS LETT, V407, P309, DOI 10.1016/S0014-5793(97)00366-9; Lee KP, 2014, J BIOL CHEM, V289, P6372, DOI 10.1074/jbc.M113.546556; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Ma HT, 2008, J IMMUNOL, V180, P2233, DOI 10.4049/jimmunol.180.4.2233; Matsumoto M, 2011, IMMUNITY, V34, P703, DOI 10.1016/j.immuni.2011.03.016; McAndrew D, 2011, MOL CANCER THER, V10, P448, DOI 10.1158/1535-7163.MCT-10-0923; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Pani B, 2013, J CELL SCI, V126, P667, DOI 10.1242/jcs.118943; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Rao JN, 2012, AM J PHYSIOL-CELL PH, V303, pC308, DOI 10.1152/ajpcell.00120.2012; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Ryazantseva M, 2013, BIOCHIMIE, V95, P1506, DOI 10.1016/j.biochi.2013.04.009; Saul S, 2014, EUR J PHARMACOL, V739, P49, DOI 10.1016/j.ejphar.2013.10.071; Schuhmann MK, 2010, J IMMUNOL, V184, P1536, DOI 10.4049/jimmunol.0902161; Selvaraj S, 2012, J CLIN INVEST, V122, P1354, DOI 10.1172/JCI61332; Shalygin A, 2010, CELL CALCIUM, V48, P209, DOI 10.1016/j.ceca.2010.09.002; Skopin A, 2013, BIOCHIMIE, V95, P347, DOI 10.1016/j.biochi.2012.10.004; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Stanisz H, 2014, PIGM CELL MELANOMA R, V27, P442, DOI 10.1111/pcmr.12222; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Sun SY, 2014, NEURON, V82, P79, DOI 10.1016/j.neuron.2014.02.019; Sundivakkam PC, 2012, MOL PHARMACOL, V81, P510, DOI 10.1124/mol.111.074658; Thiel M, 2013, J PHYSIOL-LONDON, V591, P1433, DOI 10.1113/jphysiol.2012.245399; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Weidinger C, 2013, EMBO MOL MED, V5, P1311, DOI 10.1002/emmm.201302989; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2; Zubov AI, 1999, J BIOL CHEM, V274, P25983, DOI 10.1074/jbc.274.37.25983	67	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4717	4727		10.1074/jbc.M114.601856	http://dx.doi.org/10.1074/jbc.M114.601856			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25533457	Green Published, hybrid			2022-12-26	WOS:000350042000015
J	Li, YT; Schmidt-Edelkraut, U; Poetz, F; Oliva, I; Mandl, C; Holzl-Wenig, G; Schonig, K; Bartsch, D; Ciccolini, F				Li, Yuting; Schmidt-Edelkraut, Udo; Poetz, Fabian; Oliva, Ilaria; Mandl, Claudia; Hoelzl-Wenig, Gabriele; Schoenig, Kai; Bartsch, Dusan; Ciccolini, Francesca			gamma-Aminobutyric A Receptor (GABA(A)R) Regulates Aquaporin 4 Expression in the Subependymal Zone RELEVANCE TO NEURAL PRECURSORS AND WATER EXCHANGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; BRAIN; AQP4; PHOSPHORYLATION; ASTROCYTES; ACTIVATION; MIGRATION; DIFFERENTIATION; PROLIFERATION; TRAFFICKING	Activation of gamma-aminobutyric A receptors (GABA(A)Rs) in the subependymal zone (SEZ) induces hyperpolarization and osmotic swelling in precursors, thereby promoting surface expression of the epidermal growth factor receptor (EGFR) and cell cycle entry. However, the mechanisms underlying the GABAergic modulation of cell swelling are unclear. Here, we show that GABA(A)Rs colocalize with the water channel aquaporin (AQP) 4 in prominin-1 immunopositive (P+) precursors in the postnatal SEZ, which include neural stem cells. GABA(A)R signaling promotes AQP4 expression by decreasing serine phosphorylation associated with the water channel. The modulation of AQP4 expression by GABA(A)R signaling is key to its effect on cell swelling and EGFR expression. In addition, GABA(A)R function also affects the ability of neural precursors to swell in response to an osmotic challenge in vitro and in vivo. Thus, the regulation of AQP4 by GABA(A)Rs is involved in controlling activation of neural stem cells and water exchange dynamics in the SEZ.	[Ciccolini, Francesca] Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci, D-69120 Heidelberg, Germany; [Schoenig, Kai; Bartsch, Dusan] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Mol Biol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Ciccolini, F (corresponding author), Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	Ciccolini@nbio.uni-heidelberg.de		Ciccolini, Francesca/0000-0002-7276-7361; Poetz, Fabian/0000-0002-5278-8931	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft.	Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Aprea J, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/816049; Benfenati V, 2010, NEUROSCIENCE, V168, P926, DOI 10.1016/j.neuroscience.2009.12.017; Binder DK, 2012, GLIA, V60, P1203, DOI 10.1002/glia.22317; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Bragg AD, 2006, GLIA, V53, P879, DOI 10.1002/glia.20347; Carmosino M, 2007, BIOL CELL, V99, P25, DOI 10.1042/BC200600068; Carrillo-Garcia C, 2010, MOL CELL NEUROSCI, V44, P318, DOI 10.1016/j.mcn.2010.04.003; Cavazzin C, 2006, GLIA, V53, P167, DOI 10.1002/glia.20256; Cesetti T, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00003; Cesetti T, 2011, STEM CELLS, V29, P307, DOI 10.1002/stem.573; Cesetti T, 2009, STEM CELLS, V27, P1443, DOI 10.1002/stem.74; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Gunnarson E, 2004, NEUROSCIENCE, V129, P947, DOI 10.1016/j.neuroscience.2004.08.022; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Johnstone SR, 2012, CIRC RES, V111, P201, DOI 10.1161/CIRCRESAHA.112.272302; Kadohira I, 2008, BIOCHEM BIOPH RES CO, V377, P463, DOI 10.1016/j.bbrc.2008.09.155; Khatri P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03803; Kong H, 2008, J CELL SCI, V121, P4029, DOI 10.1242/jcs.035758; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Mccoy ES, 2010, NEUROSCIENCE, V168, P971, DOI 10.1016/j.neuroscience.2009.09.020; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Nase G, 2008, GLIA, V56, P895, DOI 10.1002/glia.20664; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nguyen L, 2003, J NEUROSCI, V23, P3278; Nicchia GP, 2008, GLIA, V56, P869, DOI 10.1002/glia.20661; Obernier K, 2011, STEM CELLS, V29, P1415, DOI 10.1002/stem.682; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Venero JL, 2001, PROG NEUROBIOL, V63, P321, DOI 10.1016/S0301-0082(00)00035-6; Vicini S, 2008, J PHYSIOL-LONDON, V586, P3737, DOI 10.1113/jphysiol.2008.159046; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246; Zelenina M, 2002, AM J PHYSIOL-RENAL, V283, pF309, DOI 10.1152/ajprenal.00260.2001	43	7	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4343	4355		10.1074/jbc.M114.618686	http://dx.doi.org/10.1074/jbc.M114.618686			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25540202	Green Published, hybrid			2022-12-26	WOS:000349458400043
J	Higo, S; Shimizu, A; Masuda, Y; Nagasaka, S; Kajimoto, Y; Kanzaki, G; Fukui, M; Nagahama, K; Mii, A; Kaneko, T; Tsuruoka, S				Higo, Seiichiro; Shimizu, Akira; Masuda, Yukinari; Nagasaka, Shinya; Kajimoto, Yusuke; Kanzaki, Go; Fukui, Megumi; Nagahama, Kiyotaka; Mii, Akiko; Kaneko, Tomohiro; Tsuruoka, Shuichi			Acute Graft-Versus-Host Disease of the Kidney in Allogeneic Rat Bone Marrow Transplantation	PLOS ONE			English	Article							HEMATOPOIETIC-CELL TRANSPLANTATION; ACUTE-RENAL-FAILURE; NEPHROTIC SYNDROME; LETHAL GRAFT; ACUTE GVHD; T-CELLS; INJURY; RECIPIENTS; REJECTION; SURVIVAL	Allogeneic hematopoietic cell or bone marrow transplantation (BMT) causes graft-versus- host-disease (GVHD). However, the involvement of the kidney in acute GVHD is not well-understood. Acute GVHD was induced in Lewis rats (RT1(l)) by transplantation of Dark Agouti (DA) rat (RT1(a)) bone marrow cells (6.0x10(7) cells) without immunosuppression after lethal irradiation (10 Gy). We examined the impact of acute GVHD on the kidney in allogeneic BMT rats and compared them with those in Lewis-to-Lewis syngeneic BMT control and non-BMT control rats. In syngeneic BMT and non-BMT control rats, acute GVHD did not develop by day 28. In allogeneic BMT rats, severe acute GVHD developed at 21-28 days after BMT in the skin, intestine, and liver with decreased body weight (> 20%), skin rush, diarrhea, and liver dysfunction. In the kidney, infiltration of donor-type leukocytes was by day 28. Mild inflammation characterized by infiltration of CD3+ T-cells, including CD8+ T-cells and CD4+ T-cells, and CD68+ macrophages to the interstitium around the small arteries was noted. During moderate to severe inflammation, these infiltrating cells expanded into the peritubular interstitium with peritubular capillaritis, tubulitis, acute glomerulitis, and endarteritis. Renal dysfunction also developed, and the serum blood urea nitrogen (33.9 +/- 4.7 mg/dL) and urinary N-acetyl-beta-D-glucosaminidase (NAG: 31.5 +/- 15.5 U/L) levels increased. No immunoglobulin and complement deposition was detected in the kidney. In conclusion, the kidney was a primary target organ of acute GVHD after BMT. Acute GVHD of the kidney was characterized by increased levels of urinary NAG and cell-mediated injury to the renal microvasculature and renal tubules.	[Higo, Seiichiro; Fukui, Megumi; Mii, Akiko; Kaneko, Tomohiro; Tsuruoka, Shuichi] Nippon Med Sch, Dept Nephrol, Tokyo 113, Japan; [Higo, Seiichiro; Shimizu, Akira; Masuda, Yukinari; Nagasaka, Shinya; Kajimoto, Yusuke; Kanzaki, Go; Nagahama, Kiyotaka] Nippon Med Sch, Dept Analyt Human Pathol, Tokyo 113, Japan	Nippon Medical School; Nippon Medical School	Shimizu, A (corresponding author), Nippon Med Sch, Dept Analyt Human Pathol, 1-1-5 Sendagi, Tokyo 113, Japan.	ashimizu@nms.ac.jp	Tsuruoka, Shuichi/ABF-8453-2020; Kanzaki, Go/GLR-4254-2022; Kanzaki, Go/AAI-1150-2019; Tsuruoka, Shuichi/W-3322-2019	Kanzaki, Go/0000-0002-7795-369X; Mii, Akiko/0000-0003-0326-8267				ALMARAZ R, 1983, J SURG RES, V34, P133, DOI 10.1016/0022-4804(83)90052-5; Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251; Biedermann BC, 2003, BONE MARROW TRANSPL, V32, P1077, DOI 10.1038/sj.bmt.1704258; Choi SW, 2008, BLOOD, V112, P1539, DOI 10.1182/blood-2008-02-138867; Coghill JM, 2011, BLOOD, V117, P3268, DOI 10.1182/blood-2010-12-290403; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Heung M, 2012, CURR OPIN NEPHROL HY, V21, P628, DOI 10.1097/MNH.0b013e3283588f24; Ho VT, 2008, BEST PRACT RES CL HA, V21, P223, DOI 10.1016/j.beha.2008.02.009; HOLLER E, 1990, BLOOD, V75, P1011; Humphreys BD, 2005, J AM SOC NEPHROL, V16, P151, DOI 10.1681/ASN.2004100843; Ichiki Y, 2006, AUTOIMMUN REV, V5, P1, DOI 10.1016/j.autrev.2005.02.006; Kogon A, 2010, SEMIN NEPHROL, V30, P615, DOI 10.1016/j.semnephrol.2010.09.009; KORNGOLD R, 1985, J IMMUNOL, V135, P3004; Kusumi E, 2008, INT J HEMATOL, V87, P225, DOI 10.1007/s12185-008-0026-2; Lee SJ, 2005, BLOOD, V105, P4200, DOI 10.1182/blood-2004-10-4023; Liu AB, 2013, J CLIN VIROL, V58, P427, DOI 10.1016/j.jcv.2013.07.006; Lopes JA, 2011, BONE MARROW TRANSPL, V46, P1399, DOI 10.1038/bmt.2011.46; Mori J, 2012, INTERNAL MED, V51, P2105, DOI 10.2169/internalmedicine.51.7418; Paczesny S, 2010, BONE MARROW TRANSPL, V45, P1, DOI 10.1038/bmt.2009.328; Panoskaltsis-Mortari A, 2004, BLOOD, V103, P3590, DOI 10.1182/blood-2003-08-2827; Parikh CR, 2006, KIDNEY INT, V69, P430, DOI 10.1038/sj.ki.5000055; Parikh CR, 2005, AM J KIDNEY DIS, V45, P502, DOI 10.1053/j.ajkd.2004.11.013; Patzer L, 2003, PEDIATR NEPHROL, V18, P623, DOI 10.1007/s00467-003-1146-9; Reddy P, 2006, BONE MARROW TRANSPL, V38, P351, DOI 10.1038/sj.bmt.1705446; Reddy P, 2003, BLOOD REV, V17, P187, DOI 10.1016/S0268-960X(03)00009-2; ROOSNEK E, 1993, TRANSPLANTATION, V56, P691, DOI 10.1097/00007890-199309000-00036; Saba N, 2002, J HEMATOTH STEM CELL, V11, P377, DOI 10.1089/152581602753658565; Sale George E., 1995, P435; Shimabukuro-Vornhagen A, 2009, BLOOD, V114, P4919, DOI 10.1182/blood-2008-10-161638; Shimizu A, 2000, KIDNEY INT, V58, P2546, DOI 10.1046/j.1523-1755.2000.00440.x; Shimizu A, 2002, KIDNEY INT, V61, P1867, DOI 10.1046/j.1523-1755.2002.00309.x; Socie G, 2009, BLOOD, V114, P4327, DOI 10.1182/blood-2009-06-204669; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Srinivasan R, 2005, BRIT J HAEMATOL, V131, P74, DOI 10.1111/j.1365-2141.2005.05728.x; Uchiyama M, 2013, MOL VIS, V19, P2135; VOGELSANG GB, 1986, TRANSPLANTATION, V41, P644, DOI 10.1097/00007890-198605000-00018; ZAGER RA, 1994, KIDNEY INT, V46, P1443, DOI 10.1038/ki.1994.417; Zinocker S, 2011, J LEUKOCYTE BIOL, V90, P177, DOI 10.1189/jlb.0211067	39	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115399	10.1371/journal.pone.0115399	http://dx.doi.org/10.1371/journal.pone.0115399			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541735	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900040
J	Pan, HS; Liu, B; Lu, YH; Desneux, N				Pan, Hongsheng; Liu, Bing; Lu, Yanhui; Desneux, Nicolas			Life Table Parameters of Three Mirid Bug (Adelphocoris) Species (Hemiptera: Miridae) under Contrasted Relative Humidity Regimes	PLOS ONE			English	Article							BT COTTON; SEASONAL ABUNDANCE; MULTIPLE CROPS; NORTHERN CHINA; ADOPTION; LUCORUM; HISTORY	The genus Adelphocoris (Hemiptera: Miridae) is a group of important insect pests of Bt cotton in China. The three dominant species are A. lineolatus, A. suturalis, and A. fasciaticollis, and these species have different population dynamics. The causal factors for the differences in population dynamics have not been determined; one hypothesis is that humidity may be important for the growth of Adelphocoris populations. In the laboratory, the demographic parameters of the three Adelphocoris species were compared when the mirid bugs were subjected to various levels of relative humidity (40, 50, 60, 70 and 80% RH). Middle to high levels of RH (60, 70 and 80%) were associated with higher egg and nymph survival rates and increased adult longevity and female fecundity. Lower humidity levels (40 and 50% RH) had negative effects on the survival of nymphs, adult longevity and fecundity. The intrinsic rate of increase (r(m)), the net reproductive rate (R-0) and the finite rate of increase (lambda) for each Adelphocoris species increased with increasing RH. Significant positive relationships were found between RH and the life table parameters, r(m), R-0 and lambda for the three Adelphocoris species. These results will help to better understand the phenology of the three Adelphocoris species, and the information can be used in population growth models to optimize pest forecasting and management strategies for these key pests.	[Pan, Hongsheng; Liu, Bing; Lu, Yanhui] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Desneux, Nicolas] INRA, French Natl Inst Agr Res, Sophia Antipolis, France	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; INRAE	Lu, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yhlu@ippcaas.cn	Desneux, Nicolas/J-6262-2013	Lu, Yanhui/0000-0002-6552-0248	National Natural Science Foundation [31321004]; Special Fund for Agro-scientific Research in the Public Interest [201103011]; CMS [2014ZL047]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; CMS	This study was financially supported by the National Natural Science Foundation (No. 31321004), the Special Fund for Agro-scientific Research in the Public Interest (No. 201103011), and funds from CMS (2014ZL047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broufas GD, 2009, ANN ENTOMOL SOC AM, V102, P70, DOI 10.1603/008.102.0107; CHU H. F., 1958, ACTA ENT SINICA, V8, P97; Guarneri AA, 2002, PHYSIOL ENTOMOL, V27, P142, DOI 10.1046/j.1365-3032.2002.00279.x; Han RD, 2008, INSECT SCI, V15, P147, DOI 10.1111/j.1744-7917.2008.00195.x; Holmes LA, 2012, ENVIRON ENTOMOL, V41, P971, DOI 10.1603/EN12054; Li Qiaosi, 1994, Acta Ecologica Sinica, V14, P312; Liu HM, 1991, ACTA PHYTOPHYL SIN, V18, P147; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Lu YH, 2009, B ENTOMOL RES, V99, P543, DOI 10.1017/S000748530800655X; Lu Y H, 2008, ACTA PHYTOPHYLACICA, V35, P251, DOI [DOI 10.3866/PKU.WHXB201803163, DOI 10.1016/S1673-8527(08)60035-1]; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lu YanHui, 2011, Outlooks on Pest Management, V22, P248, DOI 10.1564/22dec02; Lu YH, 2011, CROP PROT, V30, P1455, DOI 10.1016/j.cropro.2011.07.010; Lu YH, 2011, APPL ENTOMOL ZOOL, V46, P421, DOI 10.1007/s13355-011-0058-6; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Lu YH, 2009, PHYSIOL ENTOMOL, V34, P318, DOI 10.1111/j.1365-3032.2009.00692.x; SAS Institute, 2005, SAS STAT US GUID; SMITH L, 1993, ENVIRON ENTOMOL, V22, P618, DOI 10.1093/ee/22.3.618; TING Yen-chin, 1963, Acta Phytophylacica Sinica, Peking, V2, P365; TING Yen-chin, 1963, Acta Phytophylacica Sinica, Peking, V2, P285; Ting YQ, 1964, ACTA ENTOMOL SINICA, V13, P298; WILLMER PG, 1982, ADV INSECT PHYSIOL, V16, P1, DOI 10.1016/S0065-2806(08)60151-4; Wu K, 2002, CROP PROT, V21, P997, DOI 10.1016/S0261-2194(02)00080-7; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Zhang SM., 1996, GEOGRAPHICAL DISTRIB	27	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115878	10.1371/journal.pone.0115878	http://dx.doi.org/10.1371/journal.pone.0115878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541705	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900103
J	Rafei, R; Dabboussi, F; Hamze, M; Eveillard, M; Lemarie, C; Gaultier, MP; Mallat, H; Moghnieh, R; Husni-Samaha, R; Joly-Guillou, ML; Kempf, M				Rafei, Rayane; Dabboussi, Fouad; Hamze, Monzer; Eveillard, Matthieu; Lemarie, Carole; Gaultier, Marie-Pierre; Mallat, Hassan; Moghnieh, Rima; Husni-Samaha, Rola; Joly-Guillou, Marie-Laure; Kempf, Marie			Molecular Analysis of Acinetobacter baumannii Strains Isolated in Lebanon Using Four Different Typing Methods	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; METALLO-BETA-LACTAMASE; REP-PCR; INTERLABORATORY REPRODUCIBILITY; EPIDEMIOLOGY; IDENTIFICATION; OUTBREAK; GENES; STANDARDIZATION; PREVALENCE	This study analyzed 42 Acinetobacter baumannii strains collected between 2009-2012 from different hospitals in Beyrouth and North Lebanon to better understand the epidemiology and carbapenem resistance mechanisms in our collection and to compare the robustness of pulsed field gel electrophoresis (PFGE), multilocus sequence typing (MLST), repetitive sequence-based PCR (rep-PCR) and bla(OXA-51) sequence-based typing (SBT). Among 31 carbapenem resistant strains, we have detected three carbapenem resistance genes: 28 carried the bla(OXA-23) gene, 1 the bla(OXA-24) gene and 2 strains the bla(OXA-58) gene. This is the first detection of bla(OXA-23) and bla(OXA-24) in Lebanon. PFGE identified 11 types and was the most discriminating technique followed by rep-PCR (9 types), bla(OXA-51) SBT (8 types) and MLST (7 types). The PFGE type A'/ST2 was the dominant genotype in our collection present in Beyrouth and North Lebanon. The clustering agreement between all techniques was measured by adjust Wallace coefficient. An overall agreement has been demonstrated. High values of adjust Wallace coefficient were found with followed combinations: PFGE to predict MLST types =100%, PFGE to predict bla(OXA-51) SBT=100%, bla(OXA-51) SBT to predict MLST=100%, MLST to predict bla(OXA-51) SBT=84.7%, rep-PCR to predict MLST=81.5%, PFGE to predict rep-PCR=69% and rep-PCR to predict bla(OXA-51) SBT=67.2%. PFGE and MLST are gold standard methods for outbreaks investigation and population structure studies respectively. Otherwise, these two techniques are technically, time and cost demanding. We recommend the use of bla(OXA-51) SBT as first typing method to screen isolates and assign them to their corresponding clonal lineages. Repetitive sequence-based PCR is a rapid tool to access outbreaks but careful interpretation of results must be always performed.	[Rafei, Rayane; Eveillard, Matthieu; Joly-Guillou, Marie-Laure; Kempf, Marie] Univ Angers, LUNAM Univ, Grp Etud Interact Hote Pathogene, CHU,Inst Biol Sante IRIS,UPRES EA3142, Angers, France; [Rafei, Rayane; Dabboussi, Fouad; Hamze, Monzer; Mallat, Hassan] Univ Libanaise, Ctr AZM Rech Biotechnol & Ses Applicat, Lab Sante & Environm, Tripoli, Libya; [Eveillard, Matthieu; Lemarie, Carole; Gaultier, Marie-Pierre; Joly-Guillou, Marie-Laure; Kempf, Marie] CHU, Inst Biol Sante PBH, Bacteriol Lab, Angers, France; [Moghnieh, Rima] Ain Wa Zein Hosp, Shouf, Lebanon; [Husni-Samaha, Rola] Lebanese Amer Univ, Rizk Hosp, Med Ctr, Dept Internal Med,Div Infect Dis, Beirut, Lebanon	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; University of Benghazi; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; American University of Beirut; Lebanese American University	Kempf, M (corresponding author), Univ Angers, LUNAM Univ, Grp Etud Interact Hote Pathogene, CHU,Inst Biol Sante IRIS,UPRES EA3142, Angers, France.	makempf@chu-angers.fr	Joly-Guillou, Marie-Laure/E-8206-2014; RAFEI, Rayane/AAI-3619-2020	Joly-Guillou, Marie-Laure/0000-0003-2593-6684; RAFEI, Rayane/0000-0001-9633-1290; Husni, Rola/0000-0002-6893-5027; KEMPF, Marie/0000-0002-2943-7500				Adams-Haduch JM, 2011, J CLIN MICROBIOL, V49, P3849, DOI 10.1128/JCM.00619-11; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bonnin RA, 2012, J CLIN MICROBIOL, V50, P1419, DOI 10.1128/JCM.06276-11; Chang KM, 2013, J MICROBIOL IMMUNOL, V46, P195, DOI 10.1016/j.jmii.2012.05.011; Di Popolo A, 2011, CLIN MICROBIOL INFEC, V17, P197, DOI 10.1111/j.1469-0691.2010.03254.x; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Giannouli M, 2009, J ANTIMICROB CHEMOTH, V63, P828, DOI 10.1093/jac/dkp032; Grisold AJ, 2010, J INFECTION, V60, P44, DOI 10.1016/j.jinf.2009.10.045; Grosso F, 2011, CLIN MICROBIOL INFEC, V17, P1275, DOI 10.1111/j.1469-0691.2011.03469.x; Grosso F, 2011, J ANTIMICROB CHEMOTH, V66, P62, DOI 10.1093/jac/dkq406; Gundi VAKB, 2009, MICROBIOL-SGM, V155, P2333, DOI 10.1099/mic.0.026054-0; Hamouda A, 2010, J CLIN MICROBIOL, V48, P2476, DOI 10.1128/JCM.02431-09; Higgins PG, 2012, J CLIN MICROBIOL, V50, P3493, DOI 10.1128/JCM.01759-12; Higgins PG, 2012, J MED MICROBIOL, V61, P137, DOI 10.1099/jmm.0.036046-0; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Higgins PG, 2010, INT J ANTIMICROB AG, V35, P305, DOI 10.1016/j.ijantimicag.2009.10.014; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Kempf M, 2013, APMIS, V121, P64, DOI 10.1111/j.1600-0463.2012.02935.x; Kempf M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039495; Kempf M, 2012, INT J ANTIMICROB AG, V39, P105, DOI 10.1016/j.ijantimicag.2011.10.004; Li WJ, 2009, FEMS MICROBIOL REV, V33, P892, DOI 10.1111/j.1574-6976.2009.00182.x; Maatallah M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082069; Mesli E, 2013, INT J INFECT DIS, V17, pE739, DOI 10.1016/j.ijid.2013.02.024; Minandri F, 2012, J CLIN MICROBIOL, V50, P590, DOI 10.1128/JCM.05555-11; Nemec A, 2004, J MED MICROBIOL, V53, P147, DOI 10.1099/jmm.0.05445-0; Pourcel C, 2011, J CLIN MICROBIOL, V49, P539, DOI 10.1128/JCM.02003-10; Pournaras S, 2014, J CLIN MICROBIOL, V52, P1653, DOI 10.1128/JCM.03565-13; Rafei R, 2014, INT J INFECT DIS, V21, P21, DOI 10.1016/j.ijid.2014.01.004; Ruiz M, 2007, CLIN MICROBIOL INFEC, V13, P1192, DOI 10.1111/j.1469-0691.2007.01825.x; Runnegar N, 2010, J CLIN MICROBIOL, V48, P4051, DOI 10.1128/JCM.01208-10; Schleicher X, 2013, CLIN MICROBIOL INFEC, V19, P737, DOI 10.1111/1469-0691.12026; Schuetz AN, 2012, DIAGN MICR INFEC DIS, V72, P14, DOI 10.1016/j.diagmicrobio.2011.09.012; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Turton JF, 2007, CLIN MICROBIOL INFEC, V13, P807, DOI 10.1111/j.1469-0691.2007.01759.x; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Zander E, 2012, J CLIN MICROBIOL, V50, P1900, DOI 10.1128/JCM.06462-11; Zarrilli R, 2008, ANTIMICROB AGENTS CH, V52, P4115, DOI 10.1128/AAC.00366-08; Zarrilli R, 2013, INT J ANTIMICROB AG, V41, P11, DOI 10.1016/j.ijantimicag.2012.09.008	42	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115969	10.1371/journal.pone.0115969	http://dx.doi.org/10.1371/journal.pone.0115969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541711	Green Published, gold			2022-12-26	WOS:000347239900121
J	Wei, QY; Chen, YL; Zeng, Z; Shu, C; Long, L; Lu, JH; Huang, YX; Yin, P				Wei, Qinyu; Chen, Yuanli; Zeng, Zheng; Shu, Chang; Long, Lu; Lu, Jianhua; Huang, Yangxin; Yin, Ping			Transmission/Disequilibrium Tests Incorporating Unaffected Offspring	PLOS ONE			English	Article							TRANSMISSION DISEQUILIBRIUM TEST; FAMILY-BASED TESTS; LINKAGE; ASSOCIATION; TDT	We propose a new method for family-based tests of association and linkage called transmission/disequilibrium tests incorporating unaffected offspring (TDTU). This new approach, constructed based on transmission/disequilibrium tests for quantitative traits (QTDT), provides a natural extension of the transmission/disequilibrium test (TDT) to utilize transmission information from heterozygous parents to their unaffected offspring as well as the affected offspring from ascertained nuclear families. TDTU can be used in various study designs and can accommodate all types of independent nuclear families with at least one affected offspring. When the study sample contains only case-parent trios, the TDTU is equivalent to TDT. Informative-transmission disequilibrium test (i-TDT) and generalized disequilibrium test(GDT) are another two methods that can use information of both unaffected offspring and affected offspring. In contract to i-TDT and GDT, the test statistic of TDTU is simpler and more explicit, and can be implemented more easily. Through computer simulations, we demonstrate that power of the TDTU is slightly higher compared to i-TDT and GDT. All the three methods are more powerful than method that uses affected offspring only, suggesting that unaffected siblings also provide information about linkage and association.	[Wei, Qinyu; Chen, Yuanli; Zeng, Zheng; Shu, Chang; Long, Lu; Lu, Jianhua; Yin, Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Huang, Yangxin] Univ S Florida, Coll Publ Hlth, Dept Biostat & Epidemiol, Tampa, FL USA	Huazhong University of Science & Technology; State University System of Florida; University of South Florida	Yin, P (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	pingyin2000@126.com						Chen WM, 2009, AM J HUM GENET, V85, P364, DOI 10.1016/j.ajhg.2009.08.003; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Guo CY, 2007, GENET EPIDEMIOL, V31, P115, DOI 10.1002/gepi.20195; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Lunetta KL, 2000, AM J HUM GENET, V66, P605, DOI 10.1086/302782; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sun FZ, 1999, AM J EPIDEMIOL, V150, P97; Sun FZ, 2000, ANN HUM GENET, V64, P555, DOI 10.1017/S000348000000840X	10	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114892	10.1371/journal.pone.0114892	http://dx.doi.org/10.1371/journal.pone.0114892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535968	Green Submitted, Green Published, gold			2022-12-26	WOS:000348563300024
J	Kuranov, AB; Vavilov, MN; Abildinova, GZ; Akilzhanova, AR; Iskakova, AN; Zholdybayeva, EV; Boldyreva, MN; Muller, CA; Momynaliev, KT				Kuranov, Alexandr B.; Vavilov, Mikhail N.; Abildinova, Gulshara Zh.; Akilzhanova, Ainur R.; Iskakova, Aisha N.; Zholdybayeva, Elena V.; Boldyreva, Margarita N.; Mueller, Claudia A.; Momynaliev, Kuvat T.			Polymorphisms of HLA-DRB1,-DQA1 and-DQB1 in Inhabitants of Astana, the Capital City of Kazakhstan	PLOS ONE			English	Article							CLASS-II ALLELE; HLA CLASS-I; HAPLOTYPE FREQUENCIES; MOLECULAR ANALYSIS; ETHNIC-GROUPS; POPULATION; GENES; DIVERSITY; ORIGIN; RUSSIA	Background: Kazakhstan has been inhabited by different populations, such as the Kazakh, Kyrgyz, Uzbek and others. Here we investigate allelic and haplotypic polymorphisms of human leukocyte antigen (HLA) genes at DRB1, DQA1 and DQB1 loci in the Kazakh ethnic group, and their genetic relationship between world populations. Methodology/Principal Findings: A total of 157 unrelated Kazakh ethnic individuals from Astana were genotyped using sequence based typing (SBTMethod) for HLA-DRB1, -DQA1 and -DQB1 loci. Allele frequencies, neighborjoining method, and multidimensional scaling analysis have been obtained for comparison with other world populations. Statistical analyses were performed using Arlequin v3.11. Applying the software PAST v. 2.17 the resulting genetic distance matrix was used for a multidimensional scaling analysis (MDS). Respectively 37, 17 and 19 alleles were observed at HLA-DRB1, -DQA1 and -DQB1 loci. The most frequent alleles were HLA-DRB1*07: 01 (13.1%), HLA-DQA1*03:01 (13.1%) and HLA-DQB1*03:01 (17.6%). In the observed group of Kazakhs DRB1*07:01DQA1* 02: 01-DQB1*02: 01 (8.0%) was the most common three loci haplotype. DRB1*10:01-DQB1*05:01 showed the strongest linkage disequilibrium. The Kazakh population shows genetic kinship with the Kazakhs from China, Uyghurs, Mongolians, Todzhinians, Tuvinians and as well as with other Siberians and Asians. Conclusions/Significance: The HLA-DRB1, -DQA1and -DQB1 loci are highly polymorphic in the Kazakh population, and this population has the closest relationship with other Asian and Siberian populations.	[Kuranov, Alexandr B.; Mueller, Claudia A.] Med Univ Clin, Tubingen, Germany; [Vavilov, Mikhail N.] Chelyabinsk Reg Blood Ctr, Chelyabinsk, Russia; [Abildinova, Gulshara Zh.] Natl Res Ctr Maternal & Child Hlth, Astana, Kazakhstan; [Akilzhanova, Ainur R.; Iskakova, Aisha N.; Zholdybayeva, Elena V.; Momynaliev, Kuvat T.] Natl Biotechnol Ctr, Astana, Kazakhstan; [Boldyreva, Margarita N.] NRC Inst Immunol FMBA Russia, Moscow, Russia	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; National Center for Biotechnology (NCB); NRC Institute of Immunology FMBA of Russia	Kuranov, AB (corresponding author), Med Univ Clin, Tubingen, Germany.	iskander.kuranov@gmail.com	Momynaliev, Kuvat/ADR-6456-2022; Akilzhanova, Ainur R/N-6931-2015; Zholdybayeva, Elena/AAB-1509-2020; Iskakova, Aisha N/C-7136-2015	Akilzhanova, Ainur R/0000-0001-6161-8355; Zholdybayeva, Elena/0000-0002-9677-008X; Iskakova, Aisha N/0000-0002-0631-062X; Momynaliev, Kuvat/0000-0003-4656-1025	Ministry of Education and Science of the Republic of Kazakhstan [N01.04.01]; German Academic Exchange Service (DAAD); Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University	Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University	This research was supported by funding from the Ministry of Education and Science of the Republic of Kazakhstan N01.04.01, German Academic Exchange Service (DAAD) for Alexandr B. Kuranov, Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University. This work was also supported in part by an intramural funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland A, 2014, DATABASE NATL CTR BI; Alexeev LP, 1991, P 11 INT HIST WORKSH, V1, P666; Amar A, 1999, HUM IMMUNOL, V60, P723, DOI 10.1016/S0198-8859(99)00043-9; Arnaiz-Villena A, 1999, TISSUE ANTIGENS, V53, P213, DOI 10.1034/j.1399-0039.1999.530301.x; Arnaiz-Villena A, 2003, HUM BIOL, V75, P375, DOI 10.1353/hub.2003.0040; Arnaiz-Villena A, 2001, TISSUE ANTIGENS, V57, P308, DOI 10.1034/j.1399-0039.2001.057004308.x; Arnaiz-Villena A, 2001, TISSUE ANTIGENS, V57, P118, DOI 10.1034/j.1399-0039.2001.057002118.x; Arnaiz-Villena A, 2001, HUM IMMUNOL, V62, P869, DOI 10.1016/S0198-8859(01)00285-3; Arnaiz-Villena A, 2000, TISSUE ANTIGENS, V56, P405, DOI 10.1034/j.1399-0039.2000.560503.x; Bera O, 2001, TISSUE ANTIGENS, V57, P200, DOI 10.1034/j.1399-0039.2001.057003200.x; Boldyreva M. N., 2006, Immunologiya, V27, P198; Boldyreva MN, 2007, THESIS NRC I IMMUNOL; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; Cechova E, 1998, TISSUE ANTIGENS, V51, P574, DOI 10.1111/j.1399-0039.1998.tb02996.x; Chen RB, 1992, HLA 1991, V1, P676; Derenko MV, 2007, RUSS J GENET+, V43, P334, DOI 10.1134/S1022795407030179; Derenko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015214; DOHERTY DG, 1992, HUM IMMUNOL, V34, P53, DOI 10.1016/0198-8859(92)90085-2; Dulik MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017548; Dunn PPJ, 2005, TISSUE ANTIGENS, V66, P99, DOI 10.1111/j.1399-0039.2005.00445.x; Dunn PPJ, 2003, METH MOLEC MED, V91, P233; Evseeva I, 2002, TISSUE ANTIGENS, V59, P38, DOI 10.1034/j.1399-0039.2002.590107.x; Farjadian S, 2007, INT J IMMUNOGENET, V34, P457, DOI 10.1111/j.1744-313X.2007.00723.x; Felsenstein J, 2005, DATABASE PHYLIP PHYL; Gonzalez-Galarza FF, 2011, DATABASE ALLELE FREQ; Grahovac B, 1998, HUM GENET, V102, P27, DOI 10.1007/s004390050650; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Helmberg W, 2004, DATABASE DBMHC SBT I; Hoppe Berthold, 2007, Methods Mol Med, V134, P71; Ivanova M, 2002, TISSUE ANTIGENS, V60, P496, DOI 10.1034/j.1399-0039.2002.600605.x; Jinam TA, 2010, TISSUE ANTIGENS, V75, P151, DOI 10.1111/j.1399-0039.2009.01417.x; Johansson A, 2008, EUR J HUM GENET, V16, P1341, DOI 10.1038/ejhg.2008.88; Kapustin S, 1999, TISSUE ANTIGENS, V54, P517, DOI 10.1034/j.1399-0039.1999.540509.x; Khidiyatova I. M., 2004, Genetika, V40, P267; Kotsch K, 1999, TISSUE ANTIGENS, V53, P486, DOI 10.1034/j.1399-0039.1999.530505.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kuranov AB, 2014, TISSUE ANTIGENS, V83, P106, DOI 10.1111/tan.12279; Kuranov AB, 2011, TISSUE ANTIGENS, V77, P263, DOI 10.1111/j.1399-0039.2010.01611.x; Leffell MS, 2002, HUM IMMUNOL, V63, P614, DOI 10.1016/S0198-8859(02)00415-9; Mack SJ, 2000, TISSUE ANTIGENS, V55, P383, DOI 10.1034/j.1399-0039.2000.550501.x; Marsh SGE, 2010, BONE MARROW TRANSPL, V45, P846, DOI 10.1038/bmt.2010.79; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Martinez-Laso J, 2001, ANN HUM GENET, V65, P245, DOI 10.1017/S0003480001008624; MartinezLaso J, 1996, TISSUE ANTIGENS, V47, P63, DOI 10.1111/j.1399-0039.1996.tb02515.x; Mas A, 2005, HUM IMMUNOL, V66, P1062, DOI 10.1016/j.humimm.2005.10.001; Matevosyan L, 2011, TISSUE ANTIGENS, V78, P21, DOI 10.1111/j.1399-0039.2011.01668.x; Matsumura Y, 2008, TISSUE ANTIGENS, V71, P447, DOI 10.1111/j.1399-0039.2008.01031.x; Mizuki N, 1997, TISSUE ANTIGENS, V50, P527, DOI 10.1111/j.1399-0039.1997.tb02909.x; Mizuki N, 1998, TISSUE ANTIGENS, V51, P287; Moscoso J, 2008, MOL IMMUNOL, V45, P1018, DOI 10.1016/j.molimm.2007.07.024; Nowak J, 2008, TISSUE ANTIGENS, V71, P193, DOI 10.1111/j.1399-0039.2007.00991.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pascual M, 2001, ARTHRITIS RHEUM, V44, P307, DOI 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K; Rajalingam R, 2004, HUM IMMUNOL, V65, P373, DOI 10.1016/j.humimm.2004.01.012; Robinson J, 2003, DATABASE IMGT HLA; RONNINGEN KS, 1990, HUM IMMUNOL, V29, P275, DOI 10.1016/0198-8859(90)90041-M; Samaha H, 2003, MOL IMMUNOL, V39, P1079, DOI 10.1016/S0161-5890(03)00073-7; Sanchez-Velasco P, 2001, TISSUE ANTIGENS, V58, P223, DOI 10.1034/j.1399-0039.2001.580402.x; Sayer D, 2001, TISSUE ANTIGENS, V57, P46, DOI 10.1034/j.1399-0039.2001.057001046.x; Shen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013458; Shen CM, 2010, HUM IMMUNOL, V71, P627, DOI 10.1016/j.humimm.2010.02.012; Song EY, 2002, TISSUE ANTIGENS, V59, P475, DOI 10.1034/j.1399-0039.2002.590604.x; Sulcebe G, 2009, INT J IMMUNOGENET, V36, P337, DOI 10.1111/j.1744-313X.2009.00868.x; Suslova TA, 2012, INT J IMMUNOGENET, V39, P394, DOI 10.1111/j.1744-313X.2012.01117.x; Tolstov SP, 1963, PEOPLES CENTRAL AS 2, P777; Tsuneto LT, 2003, TISSUE ANTIGENS, V62, P512, DOI 10.1046/j.1399-0039.2003.00139.x; Uinuk-ool TS, 2004, EUR J IMMUNOGENET, V31, P43, DOI 10.1111/j.1365-2370.2004.00443.x; Uinuk-ool TS, 2002, HUM GENET, V110, P209, DOI 10.1007/s00439-001-0668-0; Voorter CEM, 2006, HUM IMMUNOL, V67, P756, DOI 10.1016/j.humimm.2006.01.002; Vu-Trieu A, 1997, EUR J IMMUNOGENET, V24, P345, DOI 10.1046/j.1365-2370.1997.d01-107.x; Welinder L, 2000, EUR J IMMUNOGENET, V27, P93, DOI 10.1046/j.1365-2370.2000.00209.x; Zuniga J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074442	72	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115265	10.1371/journal.pone.0115265	http://dx.doi.org/10.1371/journal.pone.0115265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531278	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100047
J	Magalhaes, GF; Santos, GBND; Rosa, MB; Noblat, LDCB				Magalhaes, Gabriella Fernandes; Noblat de Carvalho Santos, Glaucia Beisl; Rosa, Mario Borges; Costa Beisl Noblat, Lucia de Araujo			Medication Reconciliation in Patients Hospitalized in a Cardiology Unit	PLOS ONE			English	Article							ADMISSION; DISCREPANCIES; ERRORS; IMPACT; TRANSITIONS; ORDERS	Objectives: To compare drugs prescribed on hospital admission with the list of drugs taken prior to admission for adult patients admitted to a cardiology unit and to identify the role of a pharmacist in identifying and resolving medication discrepancies. Method: This study was conducted in a 300 bed university hospital in Brazil. Clinical pharmacists taking medication histories and reconciling medications prescribed on admission with a list of drugs used prior to admission. Discrepancies were classified as justified (e.g., based on the pharmacotherapeutic guidelines of the hospital studied) or unintentional. Treatments were reviewed within 48 hours following hospitalization. Unintentional discrepancies were further classified according to the categorization of medication error severity. Pharmacists verbally contacted the prescriber to recommend actions to resolve the discrepancies. Results: A total of 181 discrepancies were found in 50 patients (86%). Of these discrepancies, 149 (82.3%) were justified changes to the patient's home medication regimen; however, 32 (17.7%) discrepancies found in 24 patients were unintentional. Pharmacists made 31 interventions and 23 (74.2%) were accepted. Among unintentional discrepancies, the most common was a different medication dose on admission (42%). Of the unintentional discrepancies 13 (40.6%) were classified as error without harm, 11 (34.4%) were classified as error without harm but which could affect the patient and require monitoring, 3 (9.4%) as errors could have resulted in harm and 5 (15.6%) were classified as circumstances or events that have the capacity to cause harm. Conclusion: The results revealed a high number of unintentional discrepancies and the pharmacist can play an important role by intervening and correcting medication errors at a hospital cardiology unit.	[Magalhaes, Gabriella Fernandes] Fed Univ Bahia State UFBA, Prof Edgard Santos Univ Hosp, Salvador, BA, Brazil; [Noblat de Carvalho Santos, Glaucia Beisl; Costa Beisl Noblat, Lucia de Araujo] Fed Univ Bahia State UFBA, Prof Edgard Santos Univ Hosp, Salvador, BA, Brazil; [Rosa, Mario Borges] Hosp Fdn Minas Gerais State FHEMIG, Inst Safe Medicat Practices Brazil, Belo Horizonte, MG, Brazil; [Costa Beisl Noblat, Lucia de Araujo] Fed Univ Bahia UFBA, Fac Pharm, Salvador, BA, Brazil	Universidade Federal da Bahia	Magalhaes, GF (corresponding author), Fed Univ Bahia State UFBA, Prof Edgard Santos Univ Hosp, Salvador, BA, Brazil.	gabimagalhaes@yahoo.com.br	Rosa, Mario B/I-8640-2012					ALFAROLARA ER, 2013, ATEN PRIMARIA; Aljadhey H, 2013, INT J QUAL HEALTH C, V25, P648, DOI 10.1093/intqhc/mzt075; BARNSTEINER JH, 2008, PATIENT SAFETY AND Q; BRAGA JF, 2011, REVISTA BRASILEIRA D, V2, P12; Buckley MS, 2013, ANN PHARMACOTHER, V47, P1599, DOI 10.1177/1060028013507428; Coffey Maitreya, 2009, Healthc Q, V12 Spec No Patient, P102; Cornish PL, 2005, ARCH INTERN MED, V165, P424, DOI 10.1001/archinte.165.4.424; Delgado SO, 2007, MED CLIN, V129, P343, DOI DOI 10.1157/13109550; Galvin M, 2013, INT J CLIN PHARM-NET, V35, P14, DOI 10.1007/s11096-012-9696-1; Gleason KM, 2004, AM J HEALTH-SYST PH, V61, P1689, DOI 10.1093/ajhp/61.16.1689; Gleason KM, 2010, J GEN INTERN MED, V25, P441, DOI 10.1007/s11606-010-1256-6; Hellstrom Lina M, 2012, BMC Clin Pharmacol, V12, P9, DOI 10.1186/1472-6904-12-9; *JOINT COMM INT, 2006, USING MEDICATION REC; *JOINT COMM INT, 2013, NATIONAL PATIENT SAF; Ketchum K, 2005, AM J NURS, V105, P78, DOI 10.1097/00000446-200511000-00033; KLIETHERMES MA, 2008, MEDICATION RECONCILI; LEGUELINELBLACH.G, 2014, EUR J INTERN MED, V48, P1298; Lehnbom EC, 2014, ANN PHARMACOTHER, V48, P1298, DOI 10.1177/1060028014543485; Lessard S, 2006, AM J HEALTH-SYST PH, V63, P740, DOI 10.2146/ajhp050291; Messeder AM, 2007, CAD SAUDE PUBLICA, V23, P835, DOI 10.1590/S0102-311X2007000400011; Moriel M C, 2008, Farm Hosp, V32, P65; Morimoto T, 2011, J GEN INTERN MED, V26, P148, DOI 10.1007/s11606-010-1518-3; Mueller SK, 2012, ARCH INTERN MED, V172, P1057, DOI 10.1001/archinternmed.2012.2246; *NICE, 2007, TECHNICAL PATIENT SA; Paez VF., 2010, REV CALID ASIST, V25, P308, DOI DOI 10.1016/J.CALI.2010.03.002; QUAGLIA TP, 2011, REVISTA BRASILEIRA D, V2, P40; Quelennec B, 2013, EUR J INTERN MED, V24, P530, DOI 10.1016/j.ejim.2013.02.007; Reeder TA, 2008, AM J HEALTH-SYST PH, V65, P857, DOI 10.2146/ajhp070292; RIBEIRO AF, 2011, REVISTA BRASILEIRA D, V2, P34; Rogers G, 2006, JT COMM J QUAL PATIE, V32, P37, DOI 10.1016/S1553-7250(06)32006-5; Rozich J., 2001, J CLIN OUTCOMES MANA, V8, P27; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Sinvani LD, 2013, J AM MED DIR ASSOC, V14, P668, DOI 10.1016/j.jamda.2013.02.021; *SOC CAT FARM CLIN, 2009, GUIA PARA LA IMPLANT; Tam VC, 2005, CAN MED ASSOC J, V173, P510, DOI 10.1503/cmaj.045311; UNROE KT, 2010, THE AMERICAN JOURNAL, V8, P115, DOI DOI 10.1016/J.AMJOPHARM.2010.04.002; Vira T, 2006, QUAL SAF HEALTH CARE, V15, P122, DOI 10.1136/qshc.2005.015347; *WHO, 2012, PATIENT SAFETY ACTIO	38	22	24	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115491	10.1371/journal.pone.0115491	http://dx.doi.org/10.1371/journal.pone.0115491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531902	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100073
J	Naue, J; Hansmann, T; Schmidt, U				Naue, Jana; Hansmann, Tobias; Schmidt, Ulrike			High-Resolution Melting of 12S rRNA and Cytochrome b DNA Sequences for Discrimination of Species within Distinct European Animal Families	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; IDENTIFICATION; GENE; HRM; ASSAY; FOOD	The cheap and easy identification of species is necessary within multiple fields of molecular biology. The use of high-resolution melting (HRM) of DNA provides a fast closed-tube method for analysis of the sequence composition of the mitochondrial genes 12S rRNA and cytochrome b. We investigated the potential use of HRM for species identification within eleven different animal groups commonly found in Europe by animal-group-specific DNA amplification followed by DNA melting. Influence factors as DNA amount, additional single base alterations, and the existence of mixed samples were taken into consideration. Visual inspection combined with mathematical evaluation of the curve shapes did resolve nearly all species within an animal group. The assay can therefore not only be used for identification of animal groups and mixture analysis but also for species identification within the respective groups. The use of a universal 12S rRNA system additionally revealed a possible approach for species discrimination, mostly by exclusion. The use of the HRM assay showed to be a reliable, fast, and cheap method for species discrimination within a broad range of different animal species and can be used in a flexible "modular" manner depending on the question to be solved.	[Naue, Jana; Hansmann, Tobias; Schmidt, Ulrike] Univ Freiburg, Med Ctr, Inst Legal Med, D-79104 Freiburg, Germany; [Naue, Jana] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Naue, J (corresponding author), Univ Freiburg, Med Ctr, Inst Legal Med, Albertstr 9, D-79104 Freiburg, Germany.	jana.naue@uniklinik-freiburg.de			German Research Foundation (DFG); Albert Ludwigs University Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alacs EA, 2010, FORENSIC SCI MED PAT, V6, P180, DOI 10.1007/s12024-009-9131-7; Alonso A, 2006, ELECTROPHORESIS, V27, P5101, DOI 10.1002/elps.200600331; Balitzki-Korte B, 2005, INT J LEGAL MED, V119, P291, DOI 10.1007/s00414-005-0537-9; Cousins MM, 2012, J CLIN MICROBIOL, V50, P3054, DOI 10.1128/JCM.01460-12; Dobrowolski SF, 2007, MOL GENET METAB, V91, P218, DOI 10.1016/j.ymgme.2007.03.010; Druml B, 2014, FOOD CHEM, V158, P245, DOI 10.1016/j.foodchem.2014.02.111; Er TK, 2012, CLIN CHIM ACTA, V414, P197, DOI 10.1016/j.cca.2012.09.012; Karlsson AO, 2007, FORENSIC SCI INT, V173, P16, DOI 10.1016/j.forsciint.2007.01.019; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Linacre Adrian, 2011, Investig Genet, V2, P2, DOI 10.1186/2041-2223-2-2; Martin-Nunez GM, 2012, CLIN CHIM ACTA, V413, P331, DOI 10.1016/j.cca.2011.09.014; Melton T, 2007, J FORENSIC SCI, V52, P1305, DOI 10.1111/j.1556-4029.2007.00553.x; Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10; Naue J, 2014, INT J LEGAL MED, V128, P11, DOI 10.1007/s00414-013-0857-0; Parson W, 2000, INT J LEGAL MED, V114, P23, DOI 10.1007/s004140000134; Pena VH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001530; Ramon-Laca A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092043; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Schutz E, 2009, ANAL BIOCHEM, V385, P143, DOI 10.1016/j.ab.2008.10.045; Teletchea F, 2005, TRENDS BIOTECHNOL, V23, P359, DOI 10.1016/j.tibtech.2005.05.006; Tobe SS, 2008, FORENSIC SCI INT-GEN, V2, P249, DOI 10.1016/j.fsigen.2008.03.002; Vietina M, 2013, FOOD CHEM, V141, P3820, DOI 10.1016/j.foodchem.2013.06.075; Yu L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-92; Zhou LM, 2005, CLIN CHEM, V51, P1770, DOI 10.1373/clinchem.2005.054924	25	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115575	10.1371/journal.pone.0115575	http://dx.doi.org/10.1371/journal.pone.0115575			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531439	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100079
J	Petrie, MA; Suneja, M; Faidley, E; Shields, RK				Petrie, Michael A.; Suneja, Manish; Faidley, Elizabeth; Shields, Richard K.			A Minimal Dose of Electrically Induced Muscle Activity Regulates Distinct Gene Signaling Pathways in Humans with Spinal Cord Injury	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; TYPE-2 DIABETES-MELLITUS; PARALYZED SOLEUS MUSCLE; MESSENGER-RNA EXPRESSION; INSULIN-RESISTANCE; DEHYDROGENASE-DEFICIENCY; COMPRESSIVE LOADS; EXERCISE; STIMULATION; INDIVIDUALS	Paralysis after a spinal cord injury (SCI) induces physiological adaptations that compromise the musculoskeletal and metabolic systems. Unlike non-SCI individuals, people with spinal cord injury experience minimal muscle activity which compromises optimal glucose utilization and metabolic control. Acute or chronic muscle activity, induced through electrical stimulation, may regulate key genes that enhance oxidative metabolism in paralyzed muscle. We investigated the short and long term effects of electrically induced exercise on mRNA expression of human paralyzed muscle. We developed an exercise dose that activated the muscle for only 0.6% of the day. The short term effects were assessed 3 hours after a single dose of exercise, while the long term effects were assessed after training 5 days per week for at least one year (adherence 81%). We found a single dose of exercise regulated 117 biological pathways as compared to 35 pathways after one year of training. A single dose of electrical stimulation increased the mRNA expression of transcriptional, translational, and enzyme regulators of metabolism important to shift muscle toward an oxidative phenotype (PGC-1 alpha, NR4A3, IFRD1, ABRA, PDK4). However, chronic training increased the mRNA expression of specific metabolic pathway genes (BRP44, BRP44L, SDHB, ACADVL), mitochondrial fission and fusion genes (MFF, MFN1, MFN2), and slow muscle fiber genes (MYH6, MYH7, MYL3, MYL2). These findings support that a dose of electrical stimulation (similar to 10 minutes/day) regulates metabolic gene signaling pathways in human paralyzed muscle. Regulating these pathways early after SCI may contribute to reducing diabetes in people with longstanding paralysis from SCI.	[Petrie, Michael A.; Faidley, Elizabeth; Shields, Richard K.] Univ Iowa, Carver Coll Med, Dept Phys Therapy & Rehabil Sci, Iowa City, IA 52242 USA; [Suneja, Manish] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA USA; [Shields, Richard K.] VA Med Ctr, Dept Vet Affairs, Iowa City, IA USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Shields, RK (corresponding author), Univ Iowa, Carver Coll Med, Dept Phys Therapy & Rehabil Sci, Iowa City, IA 52242 USA.	richard-shields@uiowa.edu		Petrie, Michael/0000-0002-5212-0907; Suneja, Manish/0000-0002-1613-8456; Shields, Richard/0000-0002-5838-9317	National Institute of Child Health and Human Development from National Institue of Health [R01HD062507]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development [1I01RXOOO149-01]; Craig H. Neilsen Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062507] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000149] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development from National Institue of Health; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); Craig H. Neilsen Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported in part by awards to RKS from the National Institute of Child Health and Human Development Grant R01HD062507 from National Institue of Health and Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development Grant 1I01RXOOO149-01, and the Craig H. Neilsen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CM, 2011, MUSCLE NERVE, V43, P65, DOI 10.1002/mus.21831; Andresen BS, 1996, HUM MOL GENET, V5, P461, DOI 10.1093/hmg/5.4.461; Arai A, 2002, J BIOL CHEM, V277, P24453, DOI 10.1074/jbc.M202216200; Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3; Barbour Jayne Alexandra, 2014, Int J Cell Biol, V2014, P156020, DOI 10.1155/2014/156020; Bauman WA, 1999, SPINAL CORD, V37, P765, DOI 10.1038/sj.sc.3100893; BIGLANDRITCHIE B, 1983, J PHYSIOL-LONDON, V340, P335, DOI 10.1113/jphysiol.1983.sp014765; Bjornholm M, 2005, BIOCHEM SOC T, V33, P354; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Brown RM, 2004, HUM GENET, V115, P123, DOI 10.1007/s00439-004-1124-8; Chu V, 2006, SPIE; Cragg JJ, 2013, NEUROLOGY, V81, P1864, DOI 10.1212/01.wnl.0000436074.98534.6e; Crameri RM, 2002, SCAND J MED SCI SPOR, V12, P316, DOI 10.1034/j.1600-0838.2002.20106.x; DUCKWORTH WC, 1980, DIABETES, V29, P906, DOI 10.2337/diabetes.29.11.906; Dudley-Javoroski S, 2012, OSTEOPOROSIS INT, V23, P2335, DOI 10.1007/s00198-011-1879-4; Dudley-Javoroski S, 2011, ARCH PHYS MED REHAB, V92, P242, DOI 10.1016/j.apmr.2010.10.031; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Fritz T, 2011, DIABETIC MED, V28, P1362, DOI 10.1111/j.1464-5491.2011.03348.x; Gaignard P, 2013, AM J HUM GENET, V93, P384, DOI 10.1016/j.ajhg.2013.06.015; Giger JM, 2009, J APPL PHYSIOL, V107, P1204, DOI 10.1152/japplphysiol.00344.2009; GRIMBY G, 1976, SCAND J REHABIL MED, V8, P37; HENNEMAN E, 1985, J EXP BIOL, V115, P105; Holmstrom MH, 2012, AM J PHYSIOL-ENDOC M, V302, pE731, DOI 10.1152/ajpendo.00159.2011; Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838; Jensen MP, 2012, SPINAL CORD, V50, P373, DOI 10.1038/sc.2011.150; Jin WZ, 2011, J CLIN INVEST, V121, P918, DOI 10.1172/JCI41940; Kawasaki E, 2009, J APPL PHYSIOL, V106, P1826, DOI 10.1152/japplphysiol.90923.2008; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kulkarni SS, 2012, METABOLISM, V61, P175, DOI 10.1016/j.metabol.2011.06.014; Lamon S, 2009, J PHYSIOL-LONDON, V587, P1795, DOI 10.1113/jphysiol.2009.168674; LaVela SL, 2006, J SPINAL CORD MED, V29, P387, DOI 10.1080/10790268.2006.11753887; Le WP, 2000, BBA-MOL CELL BIOL L, V1485, P121, DOI 10.1016/S1388-1981(00)00034-2; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Micheli L, 2011, J BIOL CHEM, V286, P5691, DOI 10.1074/jbc.M110.162842; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Palikaras K., 2014, EXP GERONTOL; Pearen MA, 2012, MOL ENDOCRINOL, V26, P372, DOI 10.1210/me.2011-1274; Petrie MA, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.248; Pilegaard H, 2006, DIABETES, V55, P3020, DOI 10.2337/db06-0152; Pruitt K., 2002, NCBI HDB, P307; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shields RK, 2007, NEUROREHAB NEURAL RE, V21, P169, DOI 10.1177/1545968306293447; Shields RK, 2006, J APPL PHYSIOL, V101, P556, DOI 10.1152/japplphysiol.00099.2006; Shields RK, 2006, MUSCLE NERVE, V34, P84, DOI 10.1002/mus.20564; Shields RK, 2006, J NEUROPHYSIOL, V95, P2380, DOI 10.1152/jn.01181.2005; Shields RK, 2006, SPINE, V31, P548, DOI 10.1097/01.brs.0000201303.49308.a8; Shields RK, 1997, J APPL PHYSIOL, V82, P1499, DOI 10.1152/jappl.1997.82.5.1499; SHIELDS RK, 1995, J NEUROPHYSIOL, V73, P2195, DOI 10.1152/jn.1995.73.6.2195; Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003; Spriet LL, 2002, EXERC SPORT SCI REV, V30, P91, DOI 10.1097/00003677-200204000-00009; STRAUSS AW, 1995, P NATL ACAD SCI USA, V92, P10496, DOI 10.1073/pnas.92.23.10496; Stuart CA, 2013, J CLIN ENDOCR METAB, V98, P2027, DOI 10.1210/jc.2012-3876; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Wallace MA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00469; Wallace MA, 2011, J PHYSIOL-LONDON, V589, P2027, DOI 10.1113/jphysiol.2011.205468; Winnick JJ, 2008, J CLIN ENDOCR METAB, V93, P771, DOI 10.1210/jc.2007-1524; Zijdewind I, 2012, J PHYSIOL-LONDON, V590, P1683, DOI 10.1113/jphysiol.2011.220103	61	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115791	10.1371/journal.pone.0115791	http://dx.doi.org/10.1371/journal.pone.0115791			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531450	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100109
J	deAlmeida, CE; Ochoa, R; de Lima, MC; David, MG; Pires, EJ; Peixoto, JG; Salata, C; Bernal, MA				deAlmeida, Carlos Eduardo; Ochoa, Ricardo; de Lima, Marilene Coelho; David, Mariano Gazineu; Pires, Evandro Jesus; Peixoto, Jose Guilherme; Salata, Camila; Bernal, Mario Antonio			A Feasibility Study of Fricke Dosimetry as an Absorbed Dose to Water Standard for Ir-192 HDR Sources	PLOS ONE			English	Article							MONTE-CARLO CALCULATIONS; FERROUS SULFATE DOSIMETER; WALL CORRECTION FACTORS; CO-60 GAMMA-RAYS; BRACHYTHERAPY SOURCES; CALORIMETRIC METHODS; IONIZATION-CHAMBER; X-RAYS; CALIBRATION; ENERGY	High dose rate brachytherapy (HDR) using Ir-192 sources is well accepted as an important treatment option and thus requires an accurate dosimetry standard. However, a dosimetry standard for the direct measurement of the absolute dose to water for this particular source type is currently not available. An improved standard for the absorbed dose to water based on Fricke dosimetry of HDR Ir-192 brachytherapy sources is presented in this study. The main goal of this paper is to demonstrate the potential usefulness of the Fricke dosimetry technique for the standardization of the quantity absorbed dose to water for Ir-192 sources. A molded, double-walled, spherical vessel for water containing the Fricke solution was constructed based on the Fricke system. The authors measured the absorbed dose to water and compared it with the doses calculated using the AAPM TG-43 report. The overall combined uncertainty associated with the measurements using Fricke dosimetry was 1.4% for k=1, which is better than the uncertainties reported in previous studies. These results are promising; hence, the use of Fricke dosimetry to measure the absorbed dose to water as a standard for HDR Ir-192 may be possible in the future.	[deAlmeida, Carlos Eduardo; Ochoa, Ricardo; de Lima, Marilene Coelho; David, Mariano Gazineu; Pires, Evandro Jesus; Salata, Camila] Univ Estado Rio De Janeiro, IBRAG, LCR, Rio De Janeiro, RJ, Brazil; [Peixoto, Jose Guilherme] Inst Radioprotecao & Dosimetria, LNMRI, Rio de Janeiro, RJ, Brazil; [Bernal, Mario Antonio] Univ Estadual Campinas, Inst Fis Gleb Wataghin, Campinas, SP, Brazil	Universidade do Estado do Rio de Janeiro; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Radioprotecao e Dosimetria; Universidade Estadual de Campinas	Salata, C (corresponding author), Univ Estado Rio De Janeiro, IBRAG, LCR, Rio De Janeiro, RJ, Brazil.	mila.salata@gmail.com	Bernal, Mario A/F-2251-2010	Bernal, Mario A/0000-0002-8305-5298; David, Mariano/0000-0002-0254-519X; Salata, Camila/0000-0001-7328-1200	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br/) - (CS, CEA), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) - (MGD, CEA), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/) - (MAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austerlitz C, 2008, MED PHYS, V35, P5360, DOI 10.1118/1.2996178; Borg J, 1999, MED PHYS, V26, P2441, DOI 10.1118/1.598763; Daskalov GM, 1998, MED PHYS, V25, P2200, DOI 10.1118/1.598418; Ferreira IH, 1999, PHYS MED BIOL, V44, P1897, DOI 10.1088/0031-9155/44/8/304; Franco L, 2011, INIS, V50, P111; FREGENE AO, 1967, RADIAT RES, V31, P256, DOI 10.2307/3572325; FREGENE AO, 1966, NATURE, V212, P818, DOI 10.1038/212818a0; IAEA, 1999, TECDOC1079 IAEA; ICRU, 1970, 16 ICRU, DOI [10.1093/jicru/os9.1.Report16, DOI 10.1093/JICRU/OS9.1.REPORT16]; Klassen NV, 1999, PHYS MED BIOL, V44, P1609, DOI 10.1088/0031-9155/44/7/303; MA CM, 1993, PHYS MED BIOL, V38, P93, DOI 10.1088/0031-9155/38/1/007; MA CM, 1993, MED PHYS, V20, P283, DOI 10.1118/1.597128; Marechal MH, 2003, PHYS MEDICA, V19, P131; Meesungnoen J, 2001, RADIAT RES, V155, P269, DOI 10.1667/0033-7587(2001)155[0269:MCCOTP]2.0.CO;2; Melhus CS, 2006, MED PHYS, V33, P1729, DOI 10.1118/1.2199987; Morrison R T., 1992, ORGANIC CHEM; NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458; Ochoa R, 2007, RADIOTHER ONCOL, V82, P222, DOI 10.1016/j.radonc.2007.01.005; Olszanski A, 2002, PIRS0815 I NAT MEAS; Rivard MJ, 2004, MED PHYS, V31, P633, DOI 10.1118/1.1646040; Salvat F., 2019, WORK P; Sarfehnia A, 2007, MED PHYS, V34, P4957, DOI 10.1118/1.2815941; Sarfehnia A, 2010, MED PHYS, V37, P1924, DOI 10.1118/1.3352685; Sarfehnia A, 2010, MED PHYS, V37, P1914, DOI 10.1118/1.3366254; Shalek R J, 1969, Ann N Y Acad Sci, V161, P44; Stump KE, 2002, MED PHYS, V29, P1483, DOI 10.1118/1.1487860; Wulff J, 2010, PHYS MED BIOL, V55, P4481, DOI 10.1088/0031-9155/55/16/S04	27	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115155	10.1371/journal.pone.0115155	http://dx.doi.org/10.1371/journal.pone.0115155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521914	Green Submitted, gold, Green Published			2022-12-26	WOS:000348845600020
J	Santhakumar, R; Vidyasekar, P; Verma, RS				Santhakumar, Rajalakshmi; Vidyasekar, Prasanna; Verma, Rama Shanker			Cardiogel: A Nano-Matrix Scaffold with Potential Application in Cardiac Regeneration Using Mesenchymal Stem Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; TISSUE-REPAIR; DIFFERENTIATION; GENE; FIBRONECTIN; INTEGRIN; PROTEIN; VEGF; MECHANISMS; PROSAPOSIN	3-Dimensional conditions for the culture of Bone Marrow-derived Stromal/Stem Cells (BMSCs) can be generated with scaffolds of biological origin. Cardiogel, a cardiac fibroblast-derived Extracellular Matrix (ECM) has been previously shown to promote cardiomyogenic differentiation of BMSCs and provide protection against oxidative stress. To determine the matrix composition and identify significant proteins in cardiogel, we investigated the differences in the composition of this nanomatrix and a BMSC-derived ECM scaffold, termed as 'mesogel'. An optimized protocol was developed that resulted in efficient decellularization while providing the maximum yield of ECM. The proteins were sequentially solubilized using acetic acid, Sodium Dodecyl Sulfate (SDS) and Dithiothreitol (DTT). These proteins were then analyzed using surfactant-assisted in-solution digestion followed by nano-liquid chromatography and tandem mass spectrometry (nLC-MS/MS). The results of these analyses revealed significant differences in their respective compositions and 17 significant ECM/matricellular proteins were differentially identified between cardiogel and mesogel. We observed that cardiogel also promoted cell proliferation, adhesion and migration while enhancing cardiomyogenic differentiation and angiogenesis. In conclusion, we developed a reproducible method for efficient extraction and solubilization of in vitro cultured cell-derived extracellular matrix. We report several important proteins differentially identified between cardiogel and mesogel, which can explain the biological properties of cardiogel. We also demonstrated the cardiomyogenic differentiation and angiogenic potential of cardiogel even in the absence of any external growth factors. The transplantation of Bone Marrow derived Stromal/Stem Cells (BMSCs) cultured on such a nanomatrix has potential applications in regenerative therapy for Myocardial Infarction (MI).	[Santhakumar, Rajalakshmi; Vidyasekar, Prasanna; Verma, Rama Shanker] Indian Inst Technol, Stem Cell & Mol Biol Lab, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Verma, RS (corresponding author), Indian Inst Technol, Stem Cell & Mol Biol Lab, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	vermars@iitm.ac.in		Verma, Rama/0000-0001-7287-7803	MHRD, India; CSIR, India	MHRD, India; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	The authors thank Dr. Madhulika Dixit, Vascular Biology Lab, Department of Biotechnology, Indian Institute of Technology Madras (IITM), India for providing EA. hy926 cells and Dr. Abdul Jaleel, Rajiv Gandhi Centre for Biotechnology, Trivandrum, India for his assistance in nLC-MS/MS analysis. The authors also would like to thank MHRD, India (RS) and CSIR, India (PV) for their fellowships.	Baharvand H, 2005, J MOL CELL CARDIOL, V38, P495, DOI 10.1016/j.yjmcc.2004.12.011; Banerjee I, 2012, CIRC RES, V110, P456, DOI 10.1161/CIRCRESAHA.111.258616; Bick RJ, 1998, CELL ADHES COMMUN, V6, P301, DOI 10.3109/15419069809010789; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Boudoulas KD, 2009, DIS MODEL MECH, V2, P344, DOI 10.1242/dmm.000240; Bramfeldt H, 2010, CURR MED CHEM, V17, P3944, DOI 10.2174/092986710793205327; Byron A, 2013, INT J EXP PATHOL, V94, P75, DOI 10.1111/iep.12011; Chang W, 2007, TISSUE ENG REGEN MED, V4, P370; Cohen T, 2005, MOL CELL BIOL, V25, P2431, DOI 10.1128/MCB.25.6.2431-2440.2005; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Feng Yong-qiang, 2013, Zhonghua Yi Xue Za Zhi, V93, P939; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gillette JM, 2004, J CELL SCI, V117, P441, DOI 10.1242/jcs.00909; Gronthos S, 2009, STEM CELLS DEV, V18, P1253, DOI 10.1089/scd.2008.0400; Heng BC, 2009, BIOL PROCED ONLINE, V11, P161, DOI 10.1007/s12575-009-9001-4; HILENSKI LL, 1991, CELL TISSUE RES, V264, P577, DOI 10.1007/BF00319047; HILENSKI LL, 1992, CELL MOTIL CYTOSKEL, V21, P87, DOI 10.1002/cm.970210202; Ho JH, 2010, J ORTHOP RES, V28, P131, DOI 10.1002/jor.20956; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jo JO, 2010, BBA-MOL CELL RES, V1803, P1244, DOI 10.1016/j.bbamcr.2010.07.005; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Konttinen YT, 2011, REGENERATIVE MEDICINE: FROM PROTOCOL TO PATIENT, P21, DOI 10.1007/978-90-481-9075-1_2; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026912; Lam MT, 2012, EXPERT REV CARDIOVAS, V10, P1039, DOI [10.1586/ERC.12.99, 10.1586/erc.12.99]; Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003; Li JP, 2007, AM J PHYSIOL-HEART C, V293, pH3415, DOI 10.1152/ajpheart.00532.2007; Li N, 2010, J NEUROCHEM, V112, P1527, DOI 10.1111/j.1471-4159.2009.06565.x; Liu LY, 2007, LANGMUIR, V23, P11168, DOI 10.1021/la701435x; Lockhart M, 2011, BIRTH DEFECTS RES A, V91, P535, DOI 10.1002/bdra.20810; LOHLER J, 1984, CELL, V38, P597, DOI 10.1016/0092-8674(84)90514-2; Pino AM, 2012, BIOL RES, V45, P279, DOI 10.4067/S0716-97602012000300009; Masago Y, 2012, J CELL SCI, V125, P1118, DOI 10.1242/jcs.089748; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0; Padmasekar M, 2007, CARDIOVASC RES, V75, P118, DOI 10.1016/j.cardiores.2007.03.003; Palumbo S, 2013, TISSUE ENG PT A, V19, P2176, DOI [10.1089/ten.tea.2012.0550, 10.1089/ten.TEA.2012.0550]; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Reinecke H, 2000, J CELL BIOL, V149, P731, DOI 10.1083/jcb.149.3.731; Rienks M, 2014, CIRC RES, V114, P872, DOI 10.1161/CIRCRESAHA.114.302533; Sauer H, 2013, STEM CELLS DEV, V22, P1443, DOI 10.1089/scd.2012.0640; Schmuck EG, 2014, CARDIOVASC ENG TECHN, V5, P119, DOI 10.1007/s13239-013-0167-1; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052; Segers VFM, 2010, J CARDIOVASC TRANSL, V3, P469, DOI 10.1007/s12265-010-9207-5; Shyamsunder P, 2013, GENE, V531, P444, DOI 10.1016/j.gene.2013.08.082; Shyamsunder P, 2013, GENE, V527, P521, DOI 10.1016/j.gene.2013.06.051; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Song H, 2007, STEM CELLS, V25, P1431, DOI 10.1634/stemcells.2006-0467; Sreejit P, 2013, CELL TISSUE RES, V353, P443, DOI 10.1007/s00441-013-1661-3; Sreejit P, 2011, EUR CELLS MATER, V21, P107, DOI 10.22203/eCM.v021a09; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Tekkatte C, 2012, CELL TISSUE RES, V347, P383, DOI 10.1007/s00441-012-1328-5; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; VanWinkle WB, 1996, IN VITRO CELL DEV-AN, V32, P478; Villegas SN, 2013, ELIFE, V2, DOI 10.7554/eLife.00806; VITADELLO M, 1990, J CELL SCI, V97, P11; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Wen ZZ, 2011, J CELL MOL MED, V15, P1032, DOI 10.1111/j.1582-4934.2010.01255.x; Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042; Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79; Yan BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075580; Ye L, 2013, CIRCULATION, V128, pS32, DOI 10.1161/CIRCULATIONAHA.112.000025; Zhang FB, 2005, BIOCHEM BIOPH RES CO, V336, P784, DOI 10.1016/j.bbrc.2005.08.177; Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0	68	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114697	10.1371/journal.pone.0114697	http://dx.doi.org/10.1371/journal.pone.0114697			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521816	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845600007
J	Kubic, JD; Little, EC; Lui, JW; Iizuka, T; Lang, D				Kubic, J. D.; Little, E. C.; Lui, J. W.; Iizuka, T.; Lang, D.			PAX3 and ETS1 synergistically activate MET expression in melanoma cells	ONCOGENE			English	Article							HEPATOCYTE GROWTH-FACTOR; DNA-BINDING MOTIF; C-MET; TRANSCRIPTION FACTOR; UP-REGULATION; RECEPTOR EXPRESSION; MELANOCYTIC LESIONS; MALIGNANT-MELANOMA; TERNARY COMPLEXES; TUMOR PROGRESSION	Melanoma is a highly aggressive disease that is difficult to treat owing to rapid tumor growth, apoptotic resistance and high metastatic potential. The MET proto-oncogene (MET) tyrosine kinase receptor promotes many of these cellular processes, but while MET is often overexpressed in melanoma, the mechanism driving this overexpression is unknown. As the MET gene is rarely mutated or amplified in melanoma, MET overexpression may be driven to increased activation through promoter elements. In this report, we find that transcription factors PAX3 and ETS1 directly interact to synergistically activate MET expression. Inhibition of PAX3 and ETS1 expression in melanoma cells leads to a significant reduction of MET receptor levels. The 300-bp 5' proximal MET promoter contains a PAX3 response element and two ETS1 consensus motifs. Although ETS1 can moderately activate both of these sites without cofactors, robust MET promoter activation of the first site is PAX dependent and requires the presence of PAX3, whereas the second site is PAX independent. The induction of MET by ETS1 via this second site is enhanced by hepatocyte growth factor-dependent ETS1 activation, thereby MET indirectly promotes its own expression. We further find that expression of a dominant-negative ETS1 reduces the ability of melanoma cells to grow both in culture and in vivo. Thus, we discover a pathway where ETS1 advances melanoma through the expression of MET via PAX-dependent and -independent mechanisms.	[Kubic, J. D.; Little, E. C.; Lui, J. W.; Iizuka, T.; Lang, D.] Univ Chicago, Dept Med, Dermatol Sect, Chicago, IL 60637 USA	University of Chicago	Lang, D (corresponding author), Univ Chicago, Dept Med, Dermatol Sect, 5841 South Maryland Ave,MC 5067,Room L536, Chicago, IL 60637 USA.	dlang@medicine.bsd.uchicago.edu		Lang, Deborah/0000-0003-1057-0923	University of Chicago Cancer Center Pilot program [P30-CA014599]; American Cancer Society [RSG-CSM-121505]; Friends of Dermatology-University of Chicago; Wendy Will Chase Foundation; National Institutes of Health [R01CA130202, R01AR062547]; NATIONAL CANCER INSTITUTE [P30CA014599, R01CA130202, R01CA184001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062547] Funding Source: NIH RePORTER	University of Chicago Cancer Center Pilot program(University of Chicago); American Cancer Society(American Cancer Society); Friends of Dermatology-University of Chicago; Wendy Will Chase Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Drs Ravi Salgia, Eric Svensson and Jonathan Epstein for providing material and/or intellectual support for this project. This work was supported by grants and financial support from the University of Chicago Cancer Center Pilot program (P30-CA014599), American Cancer Society (RSG-CSM-121505), Friends of Dermatology-University of Chicago, The Wendy Will Chase Foundation and the National Institutes of Health (R01CA130202 and R01AR062547).	Beuret L, 2007, J BIOL CHEM, V282, P14140, DOI 10.1074/jbc.M611563200; Bonvin E, 2012, MOL CELL BIOL, V32, P4674, DOI 10.1128/MCB.01067-12; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; FISHER RJ, 1991, ONCOGENE, V6, P2249; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; Fitzsimmons D, 2009, J MOL BIOL, V392, P452, DOI 10.1016/j.jmb.2009.07.028; GAMBAROTTA G, 1994, J BIOL CHEM, V269, P12852; Gambarotta G, 1996, ONCOGENE, V13, P1911; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; He SJ, 2005, MOL CANCER THER, V4, P996, DOI 10.1158/1535-7163.MCT-04-0252; Holterman CE, 2010, CANCER RES, V70, P730, DOI 10.1158/0008-5472.CAN-09-2090; Horikawa T, 2001, AM J PATHOL, V159, P27, DOI 10.1016/S0002-9440(10)61669-0; Jiang Y, 2001, BIOCHEM BIOPH RES CO, V286, P1123, DOI 10.1006/bbrc.2001.5521; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; Keehn CA, 2003, MODERN PATHOL, V16, P772, DOI 10.1097/01.MP.0000082395.59356.4F; Kubic JD, 2008, PIGM CELL MELANOMA R, V21, P627, DOI 10.1111/j.1755-148X.2008.00514.x; Lang D, 2003, HUM MOL GENET, V12, P937, DOI 10.1093/hmg/ddg107; Liu F, 2013, J INVEST DERMATOL, V133, P2041, DOI 10.1038/jid.2013.32; Maier H, 2003, NUCLEIC ACIDS RES, V31, P5483, DOI 10.1093/nar/gkg785; Mascarenhas JB, 2010, PIGM CELL MELANOMA R, V23, P225, DOI 10.1111/j.1755-148X.2010.00667.x; Mattia G, 2011, PIGM CELL MELANOMA R, V24, P953, DOI 10.1111/j.1755-148X.2011.00881.x; McGill GG, 2006, J BIOL CHEM, V281, P10365, DOI 10.1074/jbc.M513094200; Medic S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009977; Nakano T, 2000, J CELL PHYSIOL, V184, P255, DOI 10.1002/1097-4652(200008)184:2<255::AID-JCP14>3.0.CO;2-J; NATALI PG, 1993, BRIT J CANCER, V68, P746, DOI 10.1038/bjc.1993.422; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Paumelle R, 2002, ONCOGENE, V21, P2309, DOI 10.1038/sj.onc.1205297; Pinner S, 2009, CANCER RES, V69, P7679; Plummer RS, 2008, MODERN PATHOL, V21, P525, DOI 10.1038/modpathol.3801019; Puri N, 2007, CLIN CANCER RES, V13, P2246, DOI 10.1158/1078-0432.CCR-06-0776; Rothhammer T, 2004, CELL MOL LIFE SCI, V61, P118, DOI 10.1007/s00018-003-3337-8; Saeki H, 2000, CANCER, V89, P1670, DOI 10.1002/1097-0142(20001015)89:8<1670::AID-CNCR4>3.0.CO;2-J; Sahin A, 2009, INT J ONCOL, V34, P377, DOI 10.3892/ijo_00000161; SAITOH K, 1994, J PATHOL, V174, P191, DOI 10.1002/path.1711740308; Sato T, 2007, J BIOL CHEM, V282, P27702, DOI 10.1074/jbc.M611862200; Scholl FA, 2001, CANCER RES, V61, P823; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Stella MC, 2005, MOL CELL BIOL, V25, P3982, DOI 10.1128/MCB.25.10.3982-3996.2005; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Tajima A, 2000, BBA-GENE STRUCT EXPR, V1492, P377, DOI 10.1016/S0167-4781(00)00121-4; Tomita N, 2003, CIRCULATION, V107, P1411, DOI 10.1161/01.CIR.0000055331.41937.AA; Wasylyk C, 1997, ONCOGENE, V14, P899, DOI 10.1038/sj.onc.1200914; Wheat W, 1999, MOL CELL BIOL, V19, P2231; WOODS DB, 1992, NUCLEIC ACIDS RES, V20, P699, DOI 10.1093/nar/20.4.699; Yang BS, 1996, MOL CELL BIOL, V16, P538; Zhang XH, 2005, AM J PHYSIOL-RENAL, V288, pF16, DOI 10.1152/ajprenal.00318.2003	49	27	27	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 17	2015	34	38					4964	4974		10.1038/onc.2014.420	http://dx.doi.org/10.1038/onc.2014.420			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9QZ	25531327	Green Accepted			2022-12-26	WOS:000361693000006
J	Zhang, Z; Liu, X; Feng, B; Liu, N; Wu, Q; Han, Y; Nie, Y; Wu, K; Shi, Y; Fan, D				Zhang, Z.; Liu, X.; Feng, B.; Liu, N.; Wu, Q.; Han, Y.; Nie, Y.; Wu, K.; Shi, Y.; Fan, D.			STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer	ONCOGENE			English	Article							STROMAL INTERACTION MOLECULE-1; ACTIVATES CRAC CHANNELS; CA2+ INFLUX; MESENCHYMAL TRANSITION; CALCIUM; GROWTH; MIR-185; STORE; MIGRATION; SENSOR	STIM1 (stromal interaction molecule 1), an endoplasmic reticulum Ca2+ sensor that triggers the store-operated Ca2+ entry activation, has recently been implicated in cancer progression. However, the role of STIM1 in the progression and metastasis of colorectal cancer (CRC) has not been addressed. In this study, we confirmed increased expression of STIM1 in highly invasive CRC cell lines. Enhanced expression of STIM1 promoted CRC cell metastasis in vitro and in vivo, whereas silencing of STIM1 with small interfering RNA resulted in reduced metastasis. Ectopic expression of STIM1 in CRC cells induced epithelial-to-mesenchymal transition (EMT), whereas silencing of STIM1 had the opposite effect. Furthermore, STIM1 expression was markedly higher in CRC tissues than in adjacent noncancerous tissues. STIM1 overexpression correlated with poor differentiation and higher tumor node metastasis stage. CRC patients with positive STIM1 expression had poorer prognoses than those with negative STIM1 expression. Moreover, STIM1 was found to be a direct target of miR-185, a microRNA (miRNA) that has not previously been reported to be involved in EMT, in both CRC tissues and cell lines. Taken together, these findings demonstrate for the first time that STIM1 promotes metastasis and is associated with cancer progression and poor prognosis in patients with CRC. In addition, we show that expression of STIM1 is regulated by a posttranscriptional regulatory mechanism mediated by a new EMT-related miRNA. This novel miR-185-STIM1 axis promotes CRC metastasis and may be a candidate biomarker for prognosis and a target for new therapies.	[Zhang, Z.; Liu, X.; Feng, B.; Liu, N.; Wu, Q.; Han, Y.; Nie, Y.; Wu, K.; Shi, Y.; Fan, D.] Fourth Mil Med Univ, State Key Lab Canc Biol, 127 Chang Le West Rd, Xian 710032, Shaanxi, Peoples R China; [Zhang, Z.; Liu, X.; Feng, B.; Liu, N.; Wu, Q.; Han, Y.; Nie, Y.; Wu, K.; Shi, Y.; Fan, D.] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Shi, Y (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, 127 Chang Le West Rd, Xian 710032, Shaanxi, Peoples R China.; Shi, Y (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Shaanxi, Peoples R China.	shiyquan@fmmu.edu.cn; daimingfan@fmmu.edu.cn	Shi, Yongquan/AAE-3954-2020		National Basic Research Program of China [2010CB732405, 2010CB529300]; National Natural Science Foundation of China [81030044, 81272343, 81070326, 81172096, 81472300, 81472301, 81201632, 30900675]; National Science and Technology Projects of China [2014ZX09508002]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Projects of China	This work was supported by National Basic Research Program of China (Grant nos: 2010CB732405 and 2010CB529300), National Natural Science Foundation of China (Grant nos: 81030044, 81272343, 81070326, 81172096, 81472300, 81472301, 81201632 and 30900675) and National Science and Technology Projects of China (Grant no.: 2014ZX09508002).	Akcakaya P, 2011, INT J ONCOL, V39, P311, DOI 10.3892/ijo.2011.1043; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Duranton B, 2003, AMINO ACIDS, V24, P63, DOI 10.1007/s00726-002-0333-5; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Guo RW, 2009, CARDIOVASC RES, V81, P660, DOI 10.1093/cvr/cvn338; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu JJ, 2011, BIOCHEM BIOPH RES CO, V411, P786, DOI 10.1016/j.bbrc.2011.07.025; Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kraljevic Pavelic S., 2011, MOL CANCER, V10, P22, DOI DOI 10.1186/1476-4598-10-22; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Liu M, 2011, CANCER LETT, V301, P151, DOI 10.1016/j.canlet.2010.11.009; Liu XQ, 2011, CARCINOGENESIS, V32, P1798, DOI 10.1093/carcin/bgr213; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Lu WJ, 2009, AM J PHYSIOL-LUNG C, V297, pL17, DOI 10.1152/ajplung.00063.2009; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Okabe H, 1999, INT J IMPOT RES, V11, P133, DOI 10.1038/sj.ijir.3900394; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Ritchie MF, 2011, FRONT BIOSCI-LANDMRK, V16, P2402, DOI 10.2741/3862; Roberts-Thomson SJ, 2010, PHARMACOL THERAPEUT, V127, P121, DOI 10.1016/j.pharmthera.2010.04.016; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Stanisz H, 2014, PIGM CELL MELANOMA R, V27, P442, DOI 10.1111/pcmr.12222; Suyama E, 2004, J BIOL CHEM, V279, P38083, DOI 10.1074/jbc.C400313200; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Tan ZQ, 2014, MOL CELL BIOCHEM, V386, P223, DOI 10.1007/s11010-013-1860-y; Tang HL, 2012, CURR CANCER DRUG TAR, V12, P1032, DOI 10.2174/156800912803251180; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Wang ZW, 2010, DRUG RESIST UPDATE, V13, P109, DOI 10.1016/j.drup.2010.07.001; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Yoon JH, 2013, CLIN CANCER RES, V19, P4599, DOI 10.1158/1078-0432.CCR-12-3675; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhao LA, 2010, GUT, V59, P1226, DOI 10.1136/gut.2009.202739; Zhi QM, 2013, BIOMED PHARMACOTHER, V67, P393, DOI 10.1016/j.biopha.2013.03.022; Zhuang R, 2013, NUCLEIC ACIDS RES, V41, P7905, DOI 10.1093/nar/gkt565	51	84	88	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2015	34	37					4808	4820		10.1038/onc.2014.404	http://dx.doi.org/10.1038/onc.2014.404			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR0YP	25531324	hybrid, Green Published			2022-12-26	WOS:000361050000002
J	Ma, WJ; Ma, HQ; Fogerty, FJ; Mosher, DF				Ma, Wenjiang; Ma, Hanqing; Fogerty, Frances J.; Mosher, Deane F.			Bivalent Ligation of the Collagen-binding Modules of Fibronectin by SFS, a Non-anchored Bacterial Protein of Streptococcus equi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL UPSTREAM DOMAIN; LANCEFIELD GROUP-C; COOPERATIVE BINDING; STRUCTURAL-ANALYSIS; GENOME SEQUENCE; I COLLAGEN; SITES; PYOGENES; CLEAVAGE; IDENTIFICATION	SFS is a non-anchored protein of Streptococcus equi subspecies equi that causes upper respiratory infection in horses. SFS has been shown to bind to fibronectin (FN) and block interaction of FN with type I collagen. We have characterized interactions of a recombinant 60-mer polypeptide, R1R2, with FN. R1R2 contains two copies of collagen-like 19-residue repeats. Experiments utilizing various FN fragments and epitope-mapped anti-FN monoclonal antibodies located the binding site to 8-9FNI modules of the gelatin-binding domain. Fluorescence polarization and competitive enzyme-linked assays demonstrated that R1R2 binds preferentially to compact dimeric FN rather than monomeric constructs containing 8-9FNI or a large dimeric FN construct that is constitutively in an extended conformation. In contrast to bacterial peptides that bind 2-5FNI in addition to 8-9FNI, R1R2 did not cause conformational extension of FN as assessed by a conformationally sensitive antibody. Equilibrium and stopped-flow binding assays and size exclusion chromatography were compatible with a two-step binding reaction in which each of the repeats of R1R2 interacts with one of the subunits of dimeric FN, resulting in a stable complex with a slow k(off). In addition to not binding to type I collagen, the R1R2.FN complex incorporated less efficiently into extracellular matrix than free FN. Thus, R1R2 binds to FN utilizing features of compact soluble FN and in doing so interferes with the organization of the extracellular matrix. Asimilar bivalent binding strategy may underlie the collagen-FN interaction.	[Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Biomol Chem, 420 Henry Mall, Madison, WI 53706 USA.	dfmosher@wisc.edu			National Institutes of Health [P01 HL088594, R01 HL021644]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594, R01HL021644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL088594. Reagents and ideas for these studies were developed with National Institutes of Health Grant R01 HL021644.	An B, 2014, J BIOL CHEM, V289, P4941, DOI 10.1074/jbc.M113.530808; Atkin KE, 2010, J BIOL CHEM, V285, P36977, DOI 10.1074/jbc.M110.156935; BARNHAM M, 1987, EPIDEMIOL INFECT, V98, P183, DOI 10.1017/S0950268800061896; Beres SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003026; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; da Piedade I, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00683-13; Ensenberger MG, 2004, BIOPHYS CHEM, V112, P201, DOI 10.1016/j.bpc.2004.07.020; Erat MC, 2013, J BIOL CHEM, V288, P17441, DOI 10.1074/jbc.M113.469841; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0; FURCHT LT, 1980, J HISTOCHEM CYTOCHEM, V28, P1319, DOI 10.1177/28.12.7014712; Goodrich J. A., 2007, BINDING KINETICS MOL, P166; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; Harris G, 2014, J BIOL CHEM, V289, P22490, DOI 10.1074/jbc.M114.578419; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Karlstrom A, 2006, VET MICROBIOL, V114, P72, DOI 10.1016/j.vetmic.2005.10.036; Lannergard J, 2005, INFECT IMMUN, V73, P7243, DOI 10.1128/IAI.73.11.7243-7251.2005; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Lindmark H, 1999, INFECT IMMUN, V67, P2383, DOI 10.1128/IAI.67.5.2383-2388.1999; Lindmark H, 1996, INFECT IMMUN, V64, P3993, DOI 10.1128/IAI.64.10.3993-3999.1996; Ma Z, 2011, J BACTERIOL, V193, P5583, DOI 10.1128/JB.05700-11; Matthews JM, 2013, FEBS LETT, V587, P1164, DOI 10.1016/j.febslet.2013.01.002; Maurer LM, 2012, J BIOL CHEM, V287, P13303, DOI 10.1074/jbc.M111.294041; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MENZEL J, 1983, COLLAGEN REL RES, V3, P217; Moriya K, 2011, GASTROENTEROLOGY, V140, P1653, DOI 10.1053/j.gastro.2011.02.005; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; MOSHER DF, 1979, J CLIN INVEST, V64, P781, DOI 10.1172/JCI109524; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; ROCCO M, 1987, EMBO J, V6, P2343, DOI 10.1002/j.1460-2075.1987.tb02510.x; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Sevilla CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077316; Shi F, 2010, AM J PHYSIOL-CELL PH, V298, pC1265, DOI 10.1152/ajpcell.00341.2009; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; Timoney JF, 2008, EQUINE VET J, V40, P637, DOI 10.2746/042516408X322120; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2012, MATRIX BIOL, V31, P360, DOI 10.1016/j.matbio.2012.07.003; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; UGAROVA T, 1995, THROMB HAEMOSTASIS, V74, P253; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200	55	8	8	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4866	4876		10.1074/jbc.M114.612259	http://dx.doi.org/10.1074/jbc.M114.612259			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25525266	hybrid, Green Published			2022-12-26	WOS:000350042000031
J	Steeland, S; Puimege, L; Vandenbroucke, RE; Van Hauwermeiren, F; Haustraete, J; Devoogdt, N; Hulpiau, P; Leroux-Roels, G; Laukens, D; Meuleman, P; De Vos, M; Libert, C				Steeland, Sophie; Puimege, Leen; Vandenbroucke, Roosmarijn E.; Van Hauwermeiren, Filip; Haustraete, Jurgen; Devoogdt, Nick; Hulpiau, Paco; Leroux-Roels, Geert; Laukens, Debby; Meuleman, Philip; De Vos, Martine; Libert, Claude			Generation and Characterization of Small Single Domain Antibodies Inhibiting Human Tumor Necrosis Factor Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; ANTI-TNF THERAPY; FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; LYMPHOTOXIN-ALPHA; MURINE MODEL; CRYSTAL-STRUCTURE; ADVERSE EVENTS; IN-VIVO; AGENTS	The cytokine TNF is a well known drug target for several inflammatory diseases such as Crohn disease. Despite the great success of TNF blockers, therapy could be improved because of high costs and side effects. Selective inhibition of TNF receptor (TNFR) 1 signaling holds the potential to greatly reduce the pro-inflammatory activity of TNF, thereby preserving the advantageous immunomodulatory signals mediated by TNFR2. We generated a selective human TNFR1 inhibitor based on Nano-body (Nb) technology. Two anti-human TNFR1 Nbs were linked with an anti-albumin Nb to generate Nb Alb-70-96 named "TNF Receptor-One Silencer" (TROS). TROS selectively binds and inhibits TNF/TNFR1 and lymphotoxin-alpha/TNFR1 signaling with good affinity and IC50 values, both of which are in the nano-molar range. Surface plasmon resonance analysis reveals that TROS competes with TNF for binding to human TNFR1. In HEK293T cells, TROS strongly reduces TNF-induced gene expression, like IL8 and TNF, in a dose-dependent manner; and in ex vivo cultured colon biopsies of CD patients, TROS inhibits inflammation. Finally, in liver chimeric humanized mice, TROS antagonizes inflammation in a model of acute TNF-induced liver inflammation, reflected in reduced human IL8 expression in liver and reduced IL6 levels in serum. These results demonstrate the considerable potential of TROS and justify the evaluation of TROS in relevant disease animal models of both acute and chronic inflammation and eventually in patients.	[Steeland, Sophie; Puimege, Leen; Vandenbroucke, Roosmarijn E.; Van Hauwermeiren, Filip; Hulpiau, Paco; Libert, Claude] Univ Ghent VIB, Inflammat Res Ctr, B-9052 Ghent, Belgium; [Steeland, Sophie; Puimege, Leen; Vandenbroucke, Roosmarijn E.; Van Hauwermeiren, Filip; Hulpiau, Paco; Libert, Claude] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Haustraete, Jurgen] Univ Ghent VIB, Inflammat Res Ctr, Prot Serv Facil, B-9052 Ghent, Zwijnaarde, Belgium; [Devoogdt, Nick] Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, B-1000 Brussels, Belgium; [Devoogdt, Nick] Vrije Univ Brussel, Cellular & Mol Immunol Lab, B-1000 Brussels, Belgium; [Leroux-Roels, Geert; Meuleman, Philip] Ghent Univ Hosp, Ctr Vaccinol, Dept Clin Chem, B-9000 Ghent, Belgium; [Laukens, Debby; De Vos, Martine] Ghent Univ Hosp, Ctr Vaccinol, Dept Gastroenterol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Libert, C (corresponding author), Univ Ghent VIB, Inflammat Res Ctr, Dept Biomed Mol Biol, Technol Pk 927, B-9052 Ghent, Zwijnaarde, Belgium.	Claude.Libert@irc.VIB-UGent.be	Steeland, Sophie/Q-6061-2017; Vandenbroucke, Roosmarijn E/B-9419-2009; Hulpiau, Paco/C-3215-2009; Vandenbroucke, Roosmarijn/AAC-2757-2019; Devoogdt, Nick/H-5156-2013; Meuleman, Philip/H-2899-2013	Steeland, Sophie/0000-0002-8989-130X; Vandenbroucke, Roosmarijn E/0000-0002-8327-620X; Hulpiau, Paco/0000-0002-6692-2150; Devoogdt, Nick/0000-0001-9220-4833; Meuleman, Philip/0000-0001-6821-234X; Laukens, Debby/0000-0002-1984-5850	Agency for Innovation by Science and Technology in Flanders; Research Council of Ghent University; Research Foundation Flanders (FWO Vlaanderen); Interuniversity Attraction Poles Program of the Belgian Science Policy [IAP-VI-18, IAP-VII-47]	Agency for Innovation by Science and Technology in Flanders; Research Council of Ghent University(Ghent University); Research Foundation Flanders (FWO Vlaanderen)(FWO); Interuniversity Attraction Poles Program of the Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by the Agency for Innovation by Science and Technology in Flanders, the Research Council of Ghent University, the Research Foundation Flanders (FWO Vlaanderen), and Interuniversity Attraction Poles Program of the Belgian Science Policy Grants IAP-VI-18 and IAP-VII-47.	Ablynx, 2007, WO Patent, Patent No. [2008/028977 A2, 2008028977]; Ablynx, 2013, FAV IMM PROF ALX0171; Abu-Amer Y, 2000, J BIOL CHEM, V275, P27307; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal BB, 2014, ARTHRITIS RHEUMATOL, V66, P2657, DOI 10.1002/art.38753; Aikawa NE, 2010, CLIN REV ALLERG IMMU, V38, P82, DOI 10.1007/s12016-009-8140-3; Almoallim Hani, 2012, Open Rheumatol J, V6, P315, DOI 10.2174/1874312901206010315; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atzeni F, 2013, AUTOIMMUN REV, V12, P703, DOI 10.1016/j.autrev.2012.10.021; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Ben-Horin S, 2011, ALIMENT PHARM THER, V33, P987, DOI 10.1111/j.1365-2036.2011.04612.x; Ben-Horin S, 2014, NAT REV GASTRO HEPAT, V11, P243, DOI 10.1038/nrgastro.2013.253; Bluml S, 2010, ARTHRITIS RHEUM-US, V62, P1608, DOI 10.1002/art.27399; Boden EK, 2008, CURR OPIN GASTROEN, V24, P733, DOI 10.1097/MOG.0b013e328311f26e; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; Calmon-Hamaty F, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3376; Chen X, 2013, J IMMUNOL, V190, P1076, DOI 10.4049/jimmunol.1202659; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Chuang VTG, 2009, DRUG METAB PHARMACOK, V24, P358, DOI 10.2133/dmpk.24.358; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Cleynen I, 2012, NAT REV GASTRO HEPAT, V9, P496, DOI 10.1038/nrgastro.2012.125; Cohen M, 2012, REV NEUROL-FRANCE, V168, P33, DOI 10.1016/j.neurol.2011.06.005; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Cortez-Retamozo V, 2002, INT J CANCER, V98, P456, DOI 10.1002/ijc.10212; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; Deffar K, 2009, AFR J BIOTECHNOL, V8, P2645; Deng GM, 2010, J IMMUNOL, V184, P7154, DOI 10.4049/jimmunol.0902514; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; DIXON FJ, 1953, P SOC EXP BIOL MED, V83, P287; Emery P, 2012, RHEUMATOLOGY, V51, pV22, DOI 10.1093/rheumatology/kes115; Esters N, 2002, AM J GASTROENTEROL, V97, P1458; Eugster HP, 1999, EUR J IMMUNOL, V29, P626, DOI 10.1002/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.3.CO;2-1; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Fellermann K, 2013, DIGEST DIS, V31, P374, DOI 10.1159/000354703; Fischer R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027621; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Heyninck K, 2003, BIOCHEM PHARMACOL, V66, P1409, DOI 10.1016/S0006-2952(03)00491-X; Housley WJ, 2011, J IMMUNOL, V186, P6779, DOI 10.4049/jimmunol.1003868; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; Ishikawa D, 2013, MUCOSAL IMMUNOL, V6, P267, DOI 10.1038/mi.2012.67; Kagi D, 1999, J IMMUNOL, V162, P4598; Kary S, 2006, ANN RHEUM DIS, V65, P405, DOI 10.1136/ard.2005.037424; Katikireddi VS, 2010, INT J RHEUM DIS, V13, P12, DOI 10.1111/j.1756-185X.2009.01457.x; Kim SY, 2010, NAT REV RHEUMATOL, V6, P165, DOI 10.1038/nrrheum.2009.279; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Larsson P, 2008, PROTEIN SCI, V17, P990, DOI 10.1110/ps.073344908; Liu MY, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-68; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; McCann FE, 2014, ARTHRITIS RHEUMATOL, V66, P2728, DOI 10.1002/art.38755; Meuleman P, 2008, ANTIVIR RES, V80, P231, DOI 10.1016/j.antiviral.2008.07.006; MILATOVICH A, 1991, SOMAT CELL MOLEC GEN, V17, P519, DOI 10.1007/BF01233176; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Neregard P, 2014, SCAND J RHEUMATOL, V43, P85, DOI 10.3109/03009742.2013.834964; Nielsen OH, 2000, AM J GASTROENTEROL, V95, P359; Panaccione Remo, 2010, Therap Adv Gastroenterol, V3, P179, DOI 10.1177/1756283X09357579; Panes J, 2007, GUT, V56, P1184, DOI 10.1136/gut.2007.121830; Reinisch W, 2010, CURR DRUG TARGETS, V11, P152, DOI 10.2174/138945010790309894; Ricciardelli I, 2008, IMMUNOLOGY, V125, P178, DOI 10.1111/j.1365-2567.2008.02839.x; Rosenblum H, 2011, AUTOIMMUN REV, V10, P563, DOI 10.1016/j.autrev.2011.04.010; Saerens D, 2004, J BIOL CHEM, V279, P51965, DOI 10.1074/jbc.M409292200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schabert VF, 2013, J MANAGE CARE PHARM, V19, P621, DOI 10.18553/jmcp.2013.19.8.621; Schoonooghe Steve, 2012, Methods Mol Biol, V907, P325, DOI 10.1007/978-1-61779-974-7_19; Siontorou CG, 2013, INT J NANOMED, V8, P4215, DOI 10.2147/IJN.S39428; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; Suvannavejh GC, 2000, CELL IMMUNOL, V205, P24, DOI 10.1006/cimm.2000.1706; Tada Y, 2001, CLIN IMMUNOL, V99, P325, DOI 10.1006/clim.2001.5027; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Van Hauwermeiren F, 2011, CYTOKINE GROWTH F R, V22, P311, DOI 10.1016/j.cytogfr.2011.09.004; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeire S, 2003, GASTROENTEROLOGY, V125, P32, DOI 10.1016/S0016-5085(03)00701-7; Verweij CL, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2724; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Wunder A, 2003, J IMMUNOL, V170, P4793, DOI 10.4049/jimmunol.170.9.4793; Yarur AJ, 2014, WORLD J GASTROENTERO, V20, P3475, DOI 10.3748/wjg.v20.i13.3475	82	52	56	3	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4022	4037		10.1074/jbc.M114.617787	http://dx.doi.org/10.1074/jbc.M114.617787			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25538244	Green Published, hybrid			2022-12-26	WOS:000349458400015
J	Mehmedbasic, A; Christensen, SK; Nilsson, J; Rutschi, U; Gustafsen, C; Poulsen, ASA; Rasmussen, RW; Fjorback, AN; Larson, G; Andersen, OM				Mehmedbasic, Arnela; Christensen, Sofie K.; Nilsson, Jonas; Ruetschi, Ulla; Gustafsen, Camilla; Poulsen, Annemarie Svane Aavild; Rasmussen, Rikke W.; Fjorback, Anja N.; Larson, Goran; Andersen, Olav M.			SorLA Complement-type Repeat Domains Protect the Amyloid Precursor Protein against Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; SORTILIN-RELATED RECEPTOR; APOLIPOPROTEIN-E RECEPTOR; CELL-SURFACE; ALZHEIMERS-DISEASE; BETA-SECRETASE; LDL RECEPTOR; LR11/SORLA EXPRESSION; MOSAIC RECEPTOR; O-GLYCOSYLATION	SorLA is a neuronal sorting receptor that is genetically associated with Alzheimer disease. SorLA interacts directly with the amyloid precursor protein (APP) and affects the processing of the precursor, leading to a decreased generation of the amyloid-beta peptide. The SorLA complement-type repeat (CR) domains associate in vitro with APP, but the precise molecular determinants of SorLA.APP complex formation and the mechanisms responsible for the effect of binding on APP processing have not yet been elucidated. Here, we have generated protein expression constructs for SorLA devoid of the 11 CR-domains and for two SorLA mutants harboring substitutions of the fingerprint residues in the central CR-domains. We generated SH-SY5Y cell lines that stably express these SorLA variants to study the binding and processing of APP using co-immunoprecipitation and Western blotting/ELISAs, respectively. We found that the SorLA CR-cluster is essential for interaction with APP and that deletion of the CR-cluster abolishes the protection against APP processing. Mutation of identified fingerprint residues in the SorLA CR-domains leads to changes in the O-linked glycosylation of APP when expressed in SH-SY5Y cells. Our results provide novel information on the mechanisms behind the influence of SorLA activity on APP metabolism by controlling post-translational glycosylation in the Golgi, suggesting new strategies against amyloidogenesis in Alzheimer disease.	[Mehmedbasic, Arnela; Christensen, Sofie K.; Gustafsen, Camilla; Poulsen, Annemarie Svane Aavild; Rasmussen, Rikke W.; Fjorback, Anja N.; Andersen, Olav M.] Aarhus Univ, Dept Biomed, Danish Res Inst Translat Neurosci Nord EMBL Partn, Lundbeck Fdn Res Ctr MIND, DK-8000 Aarhus C, Denmark; [Nilsson, Jonas; Ruetschi, Ulla; Larson, Goran] Univ Gothenburg, Inst Biomed, Dept Clin Chem & Transfus Med, SE-41345 Gothenburg, Sweden	Aarhus University; Lundbeckfonden; University of Gothenburg	Andersen, OM (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 3,Bldg 1170, DK-8000 Aarhus C, Denmark.	o.andersen@biomed.au.dk	Larson, Göran/AAF-3404-2019; Andersen, Olav/N-2777-2017	Nilsson, Jonas/0000-0001-5263-2454; Gustafsen, Camilla/0000-0002-3349-4639; Andersen, Olav/0000-0003-4226-3354; Christensen, Sofie Kjellerup/0000-0003-2375-254X	Lundbeck Foundation; Novo Nordisk Foundation; Augustinus Foundation; Danish Alzheimer Research Foundation; Aase and Einar Danielsen Foundation; Hartman Foundation; Horslev Foundation; Lundbeck Foundation [R62-2010-5361] Funding Source: researchfish; Novo Nordisk Fonden [NNF11OC1015311] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Augustinus Foundation; Danish Alzheimer Research Foundation; Aase and Einar Danielsen Foundation; Hartman Foundation; Horslev Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Lundbeck Foundation, the Novo Nordisk Foundation, the Augustinus Foundation, the Danish Alzheimer Research Foundation, the Aase and Einar Danielsen Foundation, the Hartman Foundation, and the Horslev Foundation.	Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Andersen OM, 2003, BIOCHEMISTRY-US, V42, P9355, DOI 10.1021/bi034475p; Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; Andersen OM, 2001, BIOCHEMISTRY-US, V40, P15408, DOI 10.1021/bi0110692; Beglov D, 2009, PROTEINS, V77, P940, DOI 10.1002/prot.22519; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Bhalla A, 2012, NEUROBIOL DIS, V47, P126, DOI 10.1016/j.nbd.2012.03.030; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bohm C, 2006, J BIOL CHEM, V281, P14547, DOI 10.1074/jbc.M601660200; Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Cam JA, 2004, J BIOL CHEM, V279, P29639, DOI 10.1074/jbc.M313893200; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Dodson SE, 2008, J NEUROSCI, V28, P12877, DOI 10.1523/JNEUROSCI.4582-08.2008; DUNPHY WG, 1985, CELL, V42, P13, DOI 10.1016/S0092-8674(85)80097-0; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Fjorback AW, 2012, J NEUROSCI, V32, P1467, DOI 10.1523/JNEUROSCI.2272-11.2012; Fuentealba RA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-14; Georgopoulou N, 2001, BIOCHEM SOC SYMP, V67, P23; GRAEBERT KS, 1995, EUR J CELL BIOL, V66, P39; Gustafsen C, 2013, J NEUROSCI, V33, P64, DOI 10.1523/JNEUROSCI.2371-12.2013; Guttman M, 2010, J MOL BIOL, V398, P306, DOI 10.1016/j.jmb.2010.03.022; Guttman M, 2010, BIOCHEMISTRY-US, V49, P1207, DOI 10.1021/bi9017208; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Halim A, 2011, P NATL ACAD SCI USA, V108, P11848, DOI 10.1073/pnas.1102664108; Hampe W, 2000, J CELL SCI, V113, P4475; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Hermans-Borgmeyer I, 1998, MECH DEVELOP, V70, P65, DOI 10.1016/S0925-4773(97)00177-9; Hermey G, 2006, BIOCHEM J, V395, P285, DOI 10.1042/BJ20051364; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Huang S, 2010, J LIPID RES, V51, P297, DOI 10.1194/jlr.M000422; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Knauer MF, 1996, BRAIN RES, V740, P6, DOI 10.1016/S0006-8993(96)00711-1; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Lane RF, 2013, J NEUROSCI, V33, P7099, DOI 10.1523/JNEUROSCI.5270-12.2013; Lane RF, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-62; Lane RF, 2010, J NEUROSCI, V30, P13110, DOI 10.1523/JNEUROSCI.3872-10.2010; Lee CJ, 2010, STRUCTURE, V18, P366, DOI 10.1016/j.str.2009.12.013; McFarlane I, 1999, NEUROSCIENCE, V90, P15, DOI 10.1016/S0306-4522(98)00361-3; Morwald S, 1997, ARTERIOSCL THROM VAS, V17, P996, DOI 10.1161/01.ATV.17.5.996; Motoi Y, 1999, BRAIN RES, V833, P209, DOI 10.1016/S0006-8993(99)01542-5; Nyborg AC, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-3; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; PAHLSSON P, 1992, BIOCHEM BIOPH RES CO, V189, P1667, DOI 10.1016/0006-291X(92)90269-Q; Perdivara I, 2009, J PROTEOME RES, V8, P631, DOI 10.1021/pr800758g; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Portelius E, 2006, J PROTEOME RES, V5, P1010, DOI 10.1021/pr050475v; Pottier C, 2012, MOL PSYCHIATR, V17, P875, DOI 10.1038/mp.2012.15; Reitz C, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.13; Reitz C, 2011, ANN NEUROL, V69, P47, DOI 10.1002/ana.22308; Reitz C, 2011, ARCH NEUROL-CHICAGO, V68, P99, DOI 10.1001/archneurol.2010.346; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rohe M, 2008, J BIOL CHEM, V283, P14826, DOI 10.1074/jbc.M710574200; Sager KL, 2007, ANN NEUROL, V62, P640, DOI 10.1002/ana.21190; Sannerud R, 2009, SEMIN CELL DEV BIOL, V20, P183, DOI 10.1016/j.semcdb.2008.11.004; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Ullrich S, 2010, J BIOL CHEM, V285, P20664, DOI 10.1074/jbc.M109.055608; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Willnow TE, 2013, J CELL SCI, V126, P2751, DOI 10.1242/jcs.125393; Xue Y, 2011, J BIOL CHEM, V286, P29748, DOI 10.1074/jbc.M111.219659; Yamazaki H, 1996, J BIOL CHEM, V271, P24761, DOI 10.1074/jbc.271.40.24761; Yasui N, 2007, P NATL ACAD SCI USA, V104, P9988, DOI 10.1073/pnas.0700438104; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010	75	26	27	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3359	3376		10.1074/jbc.M114.619940	http://dx.doi.org/10.1074/jbc.M114.619940			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525276	hybrid, Green Published			2022-12-26	WOS:000349456000014
J	Meng, SM; Cao, J; He, QY; Xiong, LS; Chang, E; Radovick, S; Wondisford, FE; He, L				Meng, Shumei; Cao, Jia; He, Qiyi; Xiong, Lishou; Chang, Evan; Radovick, Sally; Wondisford, Fredric E.; He, Ling			Metformin Activates AMP-activated Protein Kinase by Promoting Formation of the alpha beta gamma Heterotrimeric Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; HEPATIC GLUCONEOGENESIS; GLUCOSE-PRODUCTION; GENE-EXPRESSION; PHOSPHORYLATION; MECHANISM; LKB1; INHIBITION; BINDING	Metformin is the most widely prescribed oral anti-diabetic agent. Recently, we have shown that low metformin concentrations found in the portal vein suppress glucose production in hepatocytes through activation of AMPK. Moreover, low concentrations of metformin were found to activate AMPK by increasing the phosphorylation of AMPK alpha at Thr-172. However, the mechanism underlying the increase in AMPK alpha phosphorylation at Thr-172 and activation by metformin remains unknown. In the current study, we find that low concentrations of metformin promote the formation of the AMPK alpha beta gamma complex, resulting in an increase in net phosphorylation of the AMPK alpha catalytic subunit at Thr-172 by augmenting phosphorylation by LKB1 and antagonizing dephosphorylation by PP2C.	[Meng, Shumei; Cao, Jia; He, Qiyi; Xiong, Lishou; Chang, Evan; Wondisford, Fredric E.; He, Ling] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Metab, Baltimore, MD 21287 USA; [Meng, Shumei; Cao, Jia; He, Qiyi; Xiong, Lishou; Chang, Evan; Wondisford, Fredric E.; He, Ling] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Metab, Baltimore, MD 21287 USA; [Meng, Shumei; Cao, Jia; He, Qiyi; Xiong, Lishou; Chang, Evan; Wondisford, Fredric E.; He, Ling] Johns Hopkins Univ, Sch Med, Dept Med, Div Metab, Baltimore, MD 21287 USA; [Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Endocrinol, Baltimore, MD 21287 USA; [Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Endocrinol, Baltimore, MD 21287 USA; [Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	He, L (corresponding author), Div Metab, 600 N Wolfe St, Baltimore, MD 21287 USA.	heling@jhmi.edu		Cao, Jia/0000-0002-9508-1397	NIDDK, National Institutes of Health [R00DK085142, R01DK63349]; JHU-UMD Diabetes Research Center [P60DK079637]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK085142, P30DK079637, P60DK079637, R01DK063349] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JHU-UMD Diabetes Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Grants from the NIDDK, National Institutes of Health: R00DK085142 (to L. H.), R01DK63349 (to F. E. W.), and the JHU-UMD Diabetes Research Center, P60DK079637.	Aatsinki SM, 2014, BRIT J PHARMACOL, V171, P2351, DOI 10.1111/bph.12585; Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271; Cheng JT, 2006, DIABETES, V55, P819, DOI 10.2337/diabetes.55.03.06.db05-0934; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DAVIES SP, 1994, EUR J BIOCHEM, V223, P351, DOI 10.1111/j.1432-1033.1994.tb19001.x; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Dyck JRB, 1999, EUR J BIOCHEM, V262, P184, DOI 10.1046/j.1432-1327.1999.00371.x; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, TRENDS BIOCHEM SCI, V36, P470, DOI 10.1016/j.tibs.2011.06.004; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; He L, 2014, J ENDOCRINOL, V221, P363, DOI 10.1530/JOE-14-0084; He L, 2013, MOL ENDOCRINOL, V27, P1322, DOI 10.1210/me.2012-1413; He L, 2012, J BIOL CHEM, V287, P32069, DOI 10.1074/jbc.M112.385864; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Heishi M, 2008, J TOXICOL SCI, V33, P339, DOI 10.2131/jts.33.339; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kim YD, 2012, J BIOL CHEM, V287, P37098, DOI 10.1074/jbc.M112.339887; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; STAPLETON D, 1994, J BIOL CHEM, V269, P29343; Takashima M, 2010, DIABETES, V59, P1608, DOI 10.2337/db09-1679; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178; Wondisford AR, 2014, J BIOL CHEM, V289, P4326, DOI 10.1074/jbc.M113.540500; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	38	83	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3793	3802		10.1074/jbc.M114.604421	http://dx.doi.org/10.1074/jbc.M114.604421			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25538235	hybrid, Green Published			2022-12-26	WOS:000349456000050
J	Li, K; Xue, YM; Chen, AJ; Jiang, YF; Xie, HF; Shi, QX; Zhang, SY; Ni, Y				Li, Kun; Xue, Yamei; Chen, Aijun; Jiang, Youfang; Xie, Haifeng; Shi, Qixian; Zhang, Songying; Ni, Ya			Heat Shock Protein 90 Has Roles in Intracellular Calcium Homeostasis, Protein Tyrosine Phosphorylation Regulation, and Progesterone-Responsive Sperm Function in Human Sperm	PLOS ONE			English	Article							MITOCHONDRIAL-TYPE RIBOSOMES; HUMAN SPERMATOZOA; MAMMALIAN SPERM; ACROSOME REACTION; FERTILIZING-CAPACITY; BOAR SPERMATOZOA; HSP90; GELDANAMYCIN; EXPRESSION; KINASE	Heat shock protein 90 plays critical roles in client protein maturation, signal transduction, protein folding and degradation, and morphological evolution; however, its function in human sperm is not fully understood. Therefore, our objective in this study was to elucidate the mechanism by which heat shock protein 90 exerts its effects on human sperm function. By performing indirect immunofluorescence staining, we found that heat shock protein 90 was localized primarily in the neck, midpiece, and tail regions of human sperm, and that its expression increased with increasing incubation time under capacitation conditions. Geldanamycin, a specific inhibitor of heat shock protein 90, was shown to inhibit this increase in heat shock protein 90 expression in western blotting analyses. Using a multifunctional microplate reader to examine Fluo-3 AM-loaded sperm, we observed for the first time that inhibition of heat shock protein 90 by using geldanamycin significantly decreased intracellular calcium concentrations during capacitation. Moreover, western blot analysis showed that geldanamycin enhanced tyrosine phosphorylation of several proteins, including heat shock protein 90, in a dose-dependent manner. The effects of geldanamycin on human sperm function in the absence or presence of progesterone was evaluated by performing chlortetracycline staining and by using a computer-assisted sperm analyzer. We found that geldanamycin alone did not affect sperm capacitation, hyperactivation, and motility, but did so in the presence of progesterone. Taken together, these data suggest that heat shock protein 90, which increases in expression in human sperm during capacitation, has roles in intracellular calcium homeostasis, protein tyrosine phosphorylation regulation, and progesterone-stimulated sperm function. In this study, we provide new insights into the roles of heat shock protein 90 in sperm function.	[Li, Kun; Chen, Aijun; Jiang, Youfang; Xie, Haifeng; Shi, Qixian; Ni, Ya] Zhejiang Acad Med Sci, Dept Reprod Physiol, Hangzhou 310013, Zhejiang, Peoples R China; [Xue, Yamei; Zhang, Songying] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Reprod Med Ctr,Dept Obstet & Gynecol, Hangzhou 310016, Zhejiang, Peoples R China	Zhejiang Academy of Medical Sciences; Zhejiang University	Zhang, SY (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Reprod Med Ctr,Dept Obstet & Gynecol, Hangzhou 310016, Zhejiang, Peoples R China.	zhangsongying@126.com; niya99@126.com	Li, Kun/I-1992-2014	Li, Kun/0000-0002-0678-1122; Xue, Yamei/0000-0001-5019-1587	Natural Science Foundation of China [81170554, 81000244]; Zhejiang Provincial Natural Science Foundation [Y2100058, LY14H040012]; Science and Technology Plan Project of Zhejiang Province [2013C31066, 2012F10004]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Science and Technology Plan Project of Zhejiang Province	This work was supported by the Natural Science Foundation of China (Nos. 81170554 and 81000244), Zhejiang Provincial Natural Science Foundation (Nos. Y2100058 and LY14H040012) and the Science and Technology Plan Project of Zhejiang Province (Nos. 2013C31066 and 2012F10004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	aE Calogero, 1996, MOL HUM REPROD, V2, P733; AITKEN J, 1994, BIOESSAYS, V16, P259, DOI 10.1002/bies.950160409; Alekseev OM, 2005, J BIOL CHEM, V280, P2904, DOI 10.1074/jbc.M410397200; Audouard C, 2011, FERTIL STERIL, V95, P1475, DOI 10.1016/j.fertnstert.2010.12.006; Baker MA, 2004, J CELL SCI, V117, P211, DOI 10.1242/jcs.00842; Baldi E, 2009, MOL CELL ENDOCRINOL, V308, P39, DOI 10.1016/j.mce.2009.02.006; Biggiogera M, 1996, EXP CELL RES, V229, P77, DOI 10.1006/excr.1996.0345; Cao WL, 2003, ASIAN J ANDROL, V5, P43; Casas I, 2010, THERIOGENOLOGY, V74, P940, DOI 10.1016/j.theriogenology.2010.04.021; Cole JA, 2011, J ANDROL, V32, P402, DOI 10.2164/jandrol.110.010702; Dai BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045109; De Amicis F, 2011, INT J ANDROL, V34, P430, DOI 10.1111/j.1365-2605.2010.01111.x; de Lamirande E, 1998, J ANDROL, V19, P215; Dun MD, 2012, HUM REPROD UPDATE, V18, P420, DOI 10.1093/humupd/dms009; Ecroyd H, 2003, BIOL REPROD, V69, P1801, DOI 10.1095/biolreprod.103.017350; Ferlin A, 2010, J UROLOGY, V183, P1248, DOI 10.1016/j.juro.2009.11.009; Gomendio M, 2006, P NATL ACAD SCI USA, V103, P15113, DOI 10.1073/pnas.0605795103; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; GRUPPI CM, 1993, DEV GENET, V14, P119, DOI 10.1002/dvg.1020140206; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; Gur Y, 2008, MOL CELL ENDOCRINOL, V282, P45, DOI 10.1016/j.mce.2007.11.015; Harper CV, 2005, HUM REPROD, V20, P2675, DOI 10.1093/humrep/dei158; Hou ML, 2008, ANIM REPROD SCI, V104, P56, DOI 10.1016/j.anireprosci.2007.01.006; Huang SY, 1999, THERIOGENOLOGY, V51, P1007, DOI 10.1016/S0093-691X(99)00046-1; Huang SY, 2000, THERIOGENOLOGY, V53, P1177, DOI 10.1016/S0093-691X(00)00262-4; ITOH H, 1991, FEBS LETT, V289, P110, DOI 10.1016/0014-5793(91)80920-X; Jaiswal BS, 1999, BIOL REPROD, V60, P1314, DOI 10.1095/biolreprod60.6.1314; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Kiang JG, 2006, AM J PHYSIOL-GASTR L, V291, pG117, DOI 10.1152/ajpgi.00397.2005; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Leach MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032467; Li CY, 2010, HUM REPROD, V25, P317, DOI 10.1093/humrep/dep406; Li K, 2012, J ANDROL, P937; Li K, 2013, HUM REPROD, V28, P47, DOI 10.1093/humrep/des384; Meizel S, 1997, BIOL REPROD, V56, P569, DOI 10.1095/biolreprod56.3.569; Mitchell LA, 2007, MOL HUM REPROD, V13, P605, DOI 10.1093/molehr/gam043; Mortimer ST, 1998, HUM REPROD, V13, P2139, DOI 10.1093/humrep/13.8.2139; Ni Y, 2007, J ANDROL, V28, P381, DOI 10.2164/jandrol.106.001289; Olson SD, 2011, MOL HUM REPROD, V17, P500, DOI 10.1093/molehr/gar040; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; ROLDAN ERS, 1994, SCIENCE, V266, P1578, DOI 10.1126/science.7985030; Sagare-Patil V, 2013, MOL CELL ENDOCRINOL, V374, P82, DOI 10.1016/j.mce.2013.04.005; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; UEHARA Y, 1988, VIROLOGY, V164, P294, DOI 10.1016/0042-6822(88)90649-6; Usachev YM, 2002, NEURON, V33, P113, DOI 10.1016/S0896-6273(01)00557-8; Visconti PE, 2011, ASIAN J ANDROL, V13, P395, DOI 10.1038/aja.2010.69; Volpe S, 2008, REPROD DOMEST ANIM, V43, P385, DOI 10.1111/j.1439-0531.2007.00918.x; Wertheimer EV, 2008, J BIOL CHEM, V283, P35539, DOI 10.1074/jbc.M804586200; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Wu YJ, 2011, CELL TISSUE RES, V344, P355, DOI 10.1007/s00441-011-1151-4; Xie HF, 2014, J MED RES, V43, P59; Zhang J, 2010, HUM REPROD, V25, P29, DOI 10.1093/humrep/dep356; Zhao C, 2009, PROTEOMICS, V9, P1385, DOI 10.1002/pmic.200800353; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	57	39	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115841	10.1371/journal.pone.0115841	http://dx.doi.org/10.1371/journal.pone.0115841			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541943	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900095
J	Lliros, M; Inceoglu, O; Garcia-Armisen, T; Anzil, A; Leporcq, B; Pigneur, LM; Viroux, L; Darchambeau, F; Descy, JP; Servais, P				Lliros, Marc; Inceoglu, Ozgul; Garcia-Armisen, Tamara; Anzil, Adriana; Leporcq, Bruno; Pigneur, Lise-Marie; Viroux, Laurent; Darchambeau, Francois; Descy, Jean-Pierre; Servais, Pierre			Bacterial Community Composition in Three Freshwater Reservoirs of Different Alkalinity and Trophic Status	PLOS ONE			English	Article							BACTERIOPLANKTON PRODUCTION; MICROBIAL DIVERSITY; SEASONAL DYNAMICS; LONGITUDINAL AXIS; ABUNDANT GROUP; HUMIC LAKE; BOTTOM-UP; TOP-DOWN; ACTINOBACTERIA; RATES	In order to investigate the factors controlling the bacterial community composition (BCC) in reservoirs, we sampled three freshwater reservoirs with contrasted physical and chemical characteristics and trophic status. The BCC was analysed by 16S rRNA gene amplicon 454 pyrosequencing. In parallel, a complete dataset of environmental parameters and phytoplankton community composition was also collected. BCC in the analysed reservoirs resembled that of epilimnetic waters of natural freshwater lakes with presence of Actinobacteria, Alpha-and Betaproteobacteria, Cytophaga-Flavobacteria-Bacteroidetes (CFB) and Verrucomicrobia groups. Our results evidenced that the retrieved BCC in the analysed reservoirs was strongly influenced by pH, alkalinity and organic carbon content, whereas comparatively little change was observed among layers in stratified conditions.	[Lliros, Marc; Leporcq, Bruno; Pigneur, Lise-Marie; Viroux, Laurent; Descy, Jean-Pierre] Univ Namur, Lab Freshwater Ecol, Namur, Belgium; [Inceoglu, Ozgul; Garcia-Armisen, Tamara; Anzil, Adriana; Servais, Pierre] Univ Libre Bruxelles, Brussels, Belgium; [Darchambeau, Francois] Univ Liege, Chem Oceanog Unit, Liege, Belgium	University of Namur; Universite Libre de Bruxelles; University of Liege	Servais, P (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	pservais@ulb.ac.be	Darchambeau, Francois/AAX-1206-2021; Llirós, Marc/R-5241-2016	Llirós, Marc/0000-0001-8456-4230; Descy, Jean-Pierre/0000-0003-1649-7800	Fonds National de la Recherche Scientifique (FNRS, Belgium) [2.4.547.09]; postdoctoral CERUNA grant from the Universite de Namur (Belgium); FNRS	Fonds National de la Recherche Scientifique (FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); postdoctoral CERUNA grant from the Universite de Namur (Belgium); FNRS(Fonds de la Recherche Scientifique - FNRS)	The Fonds National de la Recherche Scientifique (FNRS, Belgium; project 2.4.547.09) funded this work. MLI was recipient of a postdoctoral CERUNA grant from the Universite de Namur (Belgium). OI benefits from a FNRS postdoctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2006, APPL ENVIRON MICROB, V72, P3489, DOI 10.1128/AEM.72.5.3489-3497.2006; Amado AM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00167; American Public Health Association, 2005, STANDARD METHODS FOR; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Berdjeb L, 2011, APPL ENVIRON MICROB, V77, P3591, DOI 10.1128/AEM.02739-10; Berdjeb L, 2011, MICROB ECOL, V61, P941, DOI 10.1007/s00248-010-9767-6; Berg KA, 2009, ISME J, V3, P314, DOI 10.1038/ismej.2008.110; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 2001, CHANGES IN MARINE CO; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; Crump BC, 2007, ECOLOGY, V88, P1365, DOI 10.1890/06-0387; de Figueiredo DR, 2007, FEMS MICROBIOL ECOL, V59, P638, DOI 10.1111/j.1574-6941.2006.00241.x; Descy JP, 2000, J PHYCOL, V36, P274, DOI 10.1046/j.1529-8817.2000.99063.x; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dumestre JF, 2002, AQUAT MICROB ECOL, V26, P209, DOI 10.3354/ame026209; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Eiler A, 2007, APPL ENVIRON MICROB, V73, P3511, DOI 10.1128/AEM.02534-06; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fortunato CS, 2011, MICROB ECOL, V62, P374, DOI 10.1007/s00248-011-9805-z; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Garcia-Armisen T, 2010, APPL MICROBIOL BIOT, V87, P2281, DOI 10.1007/s00253-010-2698-9; Gasol JM, 2002, LIMNOL OCEANOGR, V47, P62, DOI 10.4319/lo.2002.47.1.0062; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Gorley C.K., 2006, GETTING STARTED PRIM; Hahn MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032772; Hahn MW, 2003, APPL ENVIRON MICROB, V69, P1442, DOI 10.1128/AEM.69.3.1442-1451.2003; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Hutalle-Schmelzer KML, 2010, FEMS MICROBIOL ECOL, V72, P58, DOI 10.1111/j.1574-6941.2009.00831.x; Jezbera J, 2012, FEMS MICROBIOL ECOL, V81, P467, DOI 10.1111/j.1574-6941.2012.01372.x; Jones SE, 2009, ENVIRON MICROBIOL, V11, P2463, DOI 10.1111/j.1462-2920.2009.01977.x; Katsiapi M, 2011, ENVIRON MONIT ASSESS, V181, P563, DOI 10.1007/s10661-010-1851-3; Kent AD, 2007, ISME J, V1, P38, DOI 10.1038/ismej.2007.6; Kent AD, 2006, ENVIRON MICROBIOL, V8, P1448, DOI 10.1111/j.1462-2920.2006.01039.x; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kritzberg ES, 2006, FEMS MICROBIOL ECOL, V56, P406, DOI 10.1111/j.1574-6941.2006.00084.x; Lemarchand C, 2006, FEMS MICROBIOL ECOL, V57, P442, DOI 10.1111/j.1574-6941.2006.00131.x; Lenchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066588; Lindstrom ES, 2000, MICROBIAL ECOL, V40, P104; Lindstrom ES, 2005, AQUAT SCI, V67, P210, DOI 10.1007/s00027-005-0769-2; Lindstrom ES, 2004, J PLANKTON RES, V26, P241, DOI 10.1093/plankt/fbh010; Lindstrom ES, 2001, MICROBIAL ECOL, V42, P598, DOI 10.1007/s00248-001-0031-y; Lindstrom ES, 2010, LIMNOL OCEANOGR, V55, P2052, DOI 10.4319/lo.2010.55.5.2052; Logue JB, 2012, ISME J, V6, P1127, DOI 10.1038/ismej.2011.184; Lymperopoulou DS, 2012, MICROBES ENVIRON, V27, P1, DOI 10.1264/jsme2.ME11253; Masin M, 2003, HYDROBIOLOGIA, V504, P99, DOI 10.1023/B:HYDR.0000008512.04563.0b; Naselli-Flores L, 2005, HYDROBIOLOGIA, V548, P85, DOI 10.1007/s10750-005-1149-6; Newton RJ, 2007, APPL ENVIRON MICROB, V73, P7169, DOI 10.1128/AEM.00794-07; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Pedros-Alio C, 2007, SCIENCE, V315, P192, DOI 10.1126/science.1135933; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pernthaler J, 2001, APPL ENVIRON MICROB, V67, P2145, DOI 10.1128/AEM.67.5.2145-2155.2001; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Peura S, 2012, ISME J, V6, P1640, DOI 10.1038/ismej.2012.21; Poikane S., 2009, WATER FRAMEWORK DIRE, P1; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Posch T, 2009, AQUAT MICROB ECOL, V54, P113, DOI 10.3354/ame01269; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Ruiz-Gonzalez C, 2013, FEMS MICROBIOL ECOL, V84, P316, DOI 10.1111/1574-6941.12063; Salcher MM, 2008, ENVIRON MICROBIOL, V10, P2074, DOI 10.1111/j.1462-2920.2008.01628.x; Sarmento H, 2008, J APPL PHYCOL, V20, P1001, DOI 10.1007/s10811-007-9294-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SERVAIS P, 1989, HYDROBIOLOGIA, V174, P99, DOI 10.1007/BF00014058; Shah V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026263; Simek K, 2005, APPL ENVIRON MICROB, V71, P2381, DOI 10.1128/AEM.71.5.2381-2390.2005; Simek K, 2001, MICROB ECOL, V42, P359, DOI 10.1007/s00248-001-0014-z; Simek K, 2001, APPL ENVIRON MICROB, V67, P2723, DOI 10.1128/AEM.67.6.2723-2733.2001; Simek K, 2008, AQUAT MICROB ECOL, V51, P249, DOI 10.3354/ame01193; Simek K, 2006, ENVIRON MICROBIOL, V8, P1613, DOI 10.1111/j.1462-2920.2006.01053.x; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Taipale S, 2009, AQUAT MICROB ECOL, V55, P1, DOI 10.3354/ame01277; Tarao M, 2009, APPL ENVIRON MICROB, V75, P4720, DOI 10.1128/AEM.00251-09; Trusova MY, 2002, MICROBIAL ECOL, V44, P252, DOI 10.1007/s00248-002-2020-1; Van der Gucht K, 2005, FEMS MICROBIOL ECOL, V53, P205, DOI 10.1016/j.femsec.2004.12.006; Watanabe K, 2009, FEMS MICROBIOL ECOL, V67, P57, DOI 10.1111/j.1574-6941.2008.00606.x; Weiss P, 1996, APPL ENVIRON MICROB, V62, P1998, DOI 10.1128/AEM.62.6.1998-2005.1996; Weyhenmeyer GA, 2013, FRESHWATER BIOL, V58, P612, DOI 10.1111/j.1365-2427.2012.02779.x; Yannarell AC, 2005, APPL ENVIRON MICROB, V71, P227, DOI 10.1128/AEM.71.1.227-239.2005; Yannarell AC, 2004, APPL ENVIRON MICROB, V70, P214, DOI 10.1128/AEM.70.1.214-223.2004; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9; Youngblut ND, 2013, APPL ENVIRON MICROB, V79, P39, DOI 10.1128/AEM.02226-12; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	92	65	68	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116145	10.1371/journal.pone.0116145	http://dx.doi.org/10.1371/journal.pone.0116145			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541975	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900149
J	Sparkes, J; Kortner, G; Ballard, G; Fleming, PJS; Brown, WY				Sparkes, Jessica; Koertner, Gerhard; Ballard, Guy; Fleming, Peter J. S.; Brown, Wendy Y.			Effects of Sex and Reproductive State on Interactions between Free-Roaming Domestic Dogs	PLOS ONE			English	Article							BEHAVIOR; DOMINANCE; TRANSMISSION; AGGRESSION; DINGOES; ECOLOGY	Free-roaming dogs (Canis familiaris) are common worldwide, often maintaining diseases of domestic pets and wildlife. Management of these dogs is difficult and often involves capture, treatment, neutering and release. Information on the effects of sex and reproductive state on intraspecific contacts and disease transmission is currently lacking, but is vital to improving strategic management of their populations. We assessed the effects of sex and reproductive state on short-term activity patterns and contact rates of free-roaming dogs living in an Australian Indigenous community. Population, social group sizes and rates of contact were estimated from structured observations along walked transects. Simultaneously, GPS telemetry collars were used to track dogs' movements and to quantify the frequency of contacts between individual animals. We estimated that the community's dog population was 326 +/- 52, with only 9.8 +/- 2.5% confined to a house yard. Short-term activity ranges of dogs varied from 9.2 to 133.7 ha, with males ranging over significantly larger areas than females. Contacts between two or more dogs occurred frequently, with entire females and neutered males accumulating significantly more contacts than spayed females or entire males. This indicates that sex and reproductive status are potentially important to epidemiology, but the effect of these differential contact rates on disease transmission requires further investigation. The observed combination of unrestrained dogs and high contact rates suggest that contagious disease would likely spread rapidly through the population. Pro-active management of dog populations and targeted education programs could help reduce the risks associated with disease spread.	[Sparkes, Jessica; Koertner, Gerhard; Ballard, Guy; Fleming, Peter J. S.; Brown, Wendy Y.] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Sparkes, Jessica; Koertner, Gerhard; Ballard, Guy] Biosecur New South Wales, Vertebrate Pest Res Unit, Armidale, NSW, Australia; [Fleming, Peter J. S.] Biosecur New South Wales, Vertebrate Pest Res Unit, Orange, Australia; [Sparkes, Jessica; Koertner, Gerhard; Ballard, Guy; Fleming, Peter J. S.] Invas Anim Cooperat Res Ctr, Armidale, NSW, Australia	University of New England	Sparkes, J (corresponding author), Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia.	jsparke4@une.edu.au		Ballard, Guy/0000-0002-0287-9720; Brown, Wendy/0000-0002-5309-3381; Sparkes, Jessica/0000-0001-9924-1143; Koertner, Gerhard/0000-0001-8230-0709; Fleming, Peter/0000-0002-3490-6148	Australian Postgraduate Award; UNE Apted scholar; Wildlife and Exotic Disease Preparedness Program	Australian Postgraduate Award(Australian Government); UNE Apted scholar; Wildlife and Exotic Disease Preparedness Program	Jessica Sparkes is an Australian Postgraduate Award and UNE Apted scholar recipient. The authors acknowledge the financial support of the Wildlife and Exotic Disease Preparedness Program (www.daff.gov.au/animalplant-health/emergency/wedpp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2013, 2011 CENS QUICKSTATS; Australian Companion Animal Council, 2010, CONTR PET CAR IND AU; BERMAN M, 1983, APPL ANIM ETHOL, V10, P5, DOI 10.1016/0304-3762(83)90107-4; Boitani L, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P147, DOI 10.1079/9781845931872.0147; Bourke S, 2009, DOGS REMOTE COMMUNIT; Bradbury L, 2006, AUST VET J, V84, P317, DOI 10.1111/j.1751-0813.2006.00028.x; Bradshaw JWS, 2009, J VET BEHAV, V4, P135, DOI 10.1016/j.jveb.2008.08.004; Bureau of Meteorology, 2014, CLIM STAT AUSTR LOC; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Cafazzo S, 2010, BEHAV ECOL, V21, P443, DOI 10.1093/beheco/arq001; Chapman DG, 1951, SOME PROPERTIES HYPE; Constable S, 2010, ANTHROZOOS, V23, P337, DOI 10.2752/175303710X12750451259336; Currie B., 1998, World Health, V51, P26; Durr S, 2014, PREV VET MED, V117, P340, DOI 10.1016/j.prevetmed.2014.07.008; Fox M. W., 1975, Applied Animal Ethology, V1, P119, DOI 10.1016/0304-3762(75)90082-6; Gompper ME, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P1; Gunata IK, 2011, THESIS UDAYANA U BAL; Hardaker J., 2012, P AUSTR I AN MAN ANN, P48; HARDEN RH, 1985, AUST WILDLIFE RES, V12, P25; Jackman J., 2007, STATE ANIMALS, P55; Kenward R., 1987, WILDLIFE RADIO TAGGI; Lisberg AE, 2011, ANIM BEHAV, V81, P757, DOI 10.1016/j.anbehav.2011.01.006; Majumder SS, 2014, ACTA ETHOL, V17, P1, DOI 10.1007/s10211-013-0158-0; Meek PD, 1999, WILDLIFE RES, V26, P847, DOI 10.1071/WR97101; Newsome TM, 2014, J MAMMAL, V95, P392, DOI 10.1644/13-MAMM-A-145.1; Newsome TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063931; Newsome TM, 2013, ECOGRAPHY, V36, P914, DOI 10.1111/j.1600-0587.2013.00056.x; Pal S.K., 2011, International Journal of Zoology, V2011, P1, DOI 10.1155/2011/314216; Perez-Guisado J, 2009, J ANIM VET ADV, V8, P336; Perez-Guisado J, 2009, J ANIM VET ADV, V8, P1412; R Core Team, 2021, R LANGUAGE ENV STAT; RUBIN HD, 1982, APPL ANIM ETHOL, V8, P161, DOI 10.1016/0304-3762(82)90141-9; SALMERI KR, 1991, J AM VET MED ASSOC, V198, P1193; Slater MR, 2001, PREV VET MED, V48, P273, DOI 10.1016/S0167-5877(00)00201-4; Sparkes J, 2014, CANINE RABIES AUSTR; Thomson P.C., 1992, Department of Primary Industries and Energy Bureau of Rural Resources Proceedings, V11, P125; THOMSON PC, 1992, WILDLIFE RES, V19, P543, DOI 10.1071/WR9920543; Totton SC, 2010, PREV VET MED, V97, P51, DOI 10.1016/j.prevetmed.2010.07.009; Van Kesteren F, 2013, PARASITOLOGY, V140, P1674, DOI 10.1017/S0031182013001182; Vaniscotte A, 2011, PARASITOLOGY, V138, P1316, DOI 10.1017/S0031182011000874; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510	41	37	38	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116053	10.1371/journal.pone.0116053	http://dx.doi.org/10.1371/journal.pone.0116053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541983	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900134
J	Taylor, JL; Zimet, GD; Donahue, KL; Alexander, AB; Shew, ML; Stupiansky, NW				Taylor, Jaime L.; Zimet, Greg D.; Donahue, Kelly L.; Alexander, Andreia B.; Shew, Marcia L.; Stupiansky, Nathan W.			Vaccinating Sons against HPV: Results from a US National Survey of Parents	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; INFLUENZA VACCINATION; ADOLESCENT GIRLS; ACCEPTABILITY; WOMEN; PREDICTORS; SAMPLE; MALES; BOYS; CARE	Purpose: The quadrivalent HPV vaccination was approved for use in males ages 9 to 26 in 2009 and recommended for routine administration in 2011. The purpose of this study was to uncover predictable commonalities amongst parents who chose to vaccinate their 11-17 year old sons against HPV. Methods: We compiled data from a U.S. national sample of 779 parents with sons 11-17 years old using a web-based survey to gather information about behavioral and sociodemographic factors which predicted receipt of 1 or more HPV vaccine doses based on parental report. Predictors were first modeled individually for univariable associations. Significant predictors (p<0.10) were combined in a multivariable model. Results: In the adjusted model, independent predictors included receipt of flu vaccination, health insurance coverage and sexual health topic discussions with sons. Sons who had received a flu shot in the last two years more frequently received at least one dose of the vaccine (OR 1.82; 95% CI 1.45-2.26). Sons covered by private health insurance had decreased odds of HPV vaccination (OR 0.56 95% CI 0.37-0.83). Lastly, parents who had discussed sexual health topics with their sons were more likely to vaccinate (OR 1.61; 95% CI 1.37-1.89). Conclusions: Male vaccination rates in the U.S. have increased, but males continue to be under-immunized. Utilization of health care is an important factor in HPV vaccine uptake; therefore, health care providers should use every contact as an opportunity to vaccinate. Communication about sexual health topics may provide a forum for parents and health care providers to have conversations about HPV vaccination as those more comfortable discussing these topics may also be more comfortable discussing HPV vaccination.	[Taylor, Jaime L.; Zimet, Greg D.; Donahue, Kelly L.; Alexander, Andreia B.; Shew, Marcia L.; Stupiansky, Nathan W.] Indiana Univ, Sch Med, Dept Pediat, Sect Adolescent Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Taylor, JL (corresponding author), Indiana Univ, Sch Med, Dept Pediat, Sect Adolescent Med, Indianapolis, IN 46202 USA.	jletaylo@iu.edu		Donahue, Kelly/0000-0002-2143-4612; Alexander, Andreia/0000-0001-8483-1124; Stupiansky, Nathan/0000-0003-1682-973X; Zimet, Gregory/0000-0003-3835-937X	Merck MISP [38094]	Merck MISP	Funding: Support was provided by Merck MISP #38094 (Zimet, PI) [http://engagezone.merck.com/misp.html]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AB, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-192; Barnack JL, 2010, WOMEN HEALTH ISS, V20, P28, DOI 10.1016/j.whi.2009.08.007; Centers for Disease Control and Prevention, 2014, HUM PAP; Centers for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, V60, P1705; Centers for Disease Control and Prevetnion, 2013, FLU VACC COV; Chao C, 2010, AM J EPIDEMIOL, V171, P357, DOI 10.1093/aje/kwp365; Chaturvedi AK, 2010, J ADOLESCENT HEALTH, V46, pS20, DOI 10.1016/j.jadohealth.2010.01.016; Crawford M, 2003, J SEX RES, V40, P13, DOI 10.1080/00224490309552163; Curtis CR, 2013, MMWR-MORBID MORTAL W, V62, P685; Daley MF, 2007, CLIN PEDIATR, V46, P408, DOI 10.1177/0009922806298647; Dempsey A, 2010, VACCINE, V28, P989, DOI 10.1016/j.vaccine.2009.10.133; Donahue KL, 2014, VACCINE, V32, P3883, DOI 10.1016/j.vaccine.2014.05.035; Etter DJ, 2012, CURR OPIN OBSTET GYN, V24, P305, DOI 10.1097/GCO.0b013e3283567005; Gilkey MB, 2012, VACCINE, V30, P5928, DOI 10.1016/j.vaccine.2012.07.045; Hagan JF, 2008, BRIGHT FUTURES GUIDE; Hechter RC, 2013, AM J PUBLIC HEALTH, V103, pE63, DOI 10.2105/AJPH.2013.301495; Hendry M, 2013, VACCINE, V31, P5152, DOI 10.1016/j.vaccine.2013.08.091; Holman DM, 2014, JAMA PEDIATR, V168, P76, DOI 10.1001/jamapediatrics.2013.2752; Humiston SG, 2005, ARCH PEDIAT ADOL MED, V159, P108, DOI 10.1001/archpedi.159.2.108; IBM Corp, 2012, SPSS STAT WIND; Kester LM, 2013, MATERN CHILD HLTH J, V17, P879, DOI 10.1007/s10995-012-1066-z; Laz TH, 2013, HUM VACC IMMUNOTHER, V9, P874, DOI 10.4161/hv.23190; Middleman AB, 2006, J ADOLESCENT HEALTH, V38, P321, DOI 10.1016/j.jadohealth.2006.01.002; Reiter PL, 2013, AM J PUBLIC HEALTH, V103, P1419, DOI 10.2105/AJPH.2012.301189; Reiter PL, 2011, SEX TRANSM DIS, V38, P235, DOI 10.1097/OLQ.0b013e3181f422bb; Reiter PL, 2010, VACCINE, V28, P6292, DOI 10.1016/j.vaccine.2010.06.114; Reiter PL, 2009, SOC SCI MED, V69, P475, DOI 10.1016/j.socscimed.2009.05.024; Stupiansky NW, 2013, SEXUALLY TRANSMITTED DISEASES: VACCINES, PREVENTION, AND CONTROL, 2ND EDITION, P251, DOI 10.1016/B978-0-12-391059-2.00011-5; Stupiansky NW, 2012, J ADOLESCENT HEALTH, V50, P103, DOI 10.1016/j.jadohealth.2011.04.010; Stupiansky NW, 2010, SEX HEALTH, V7, P304, DOI 10.1071/SH09127; Vadaparampil ST, 2011, VACCINE, V29, P8634, DOI 10.1016/j.vaccine.2011.09.006	31	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115154	10.1371/journal.pone.0115154	http://dx.doi.org/10.1371/journal.pone.0115154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25541726	Green Published, gold			2022-12-26	WOS:000347239900025
J	Wong, DM; Shen, ZY; Owyang, KE; Martinez-Agosto, JA				Wong, Daniel M.; Shen, Zhouyang; Owyang, Kristin E.; Martinez-Agosto, Julian A.			Insulin- and Warts-Dependent Regulation of Tracheal Plasticity Modulates Systemic Larval Growth during Hypoxia in Drosophila melanogaster	PLOS ONE			English	Article							BODY-SIZE; TUMOR-SUPPRESSOR; SIGNAL-TRANSDUCTION; CRITICAL WEIGHT; FAT-CELLS; OXYGEN; METAMORPHOSIS; HOMEOSTASIS; METABOLISM; PATHWAY	Adaptation to dynamic environmental cues during organismal development requires coordination of tissue growth with available resources. More specifically, the effects of oxygen availability on body size have been well-documented, but the mechanisms through which hypoxia restricts systemic growth have not been fully elucidated. Here, we characterize the larval growth and metabolic defects in Drosophila that result from hypoxia. Hypoxic conditions reduced fat body opacity and increased lipid droplet accumulation in this tissue, without eliciting lipid aggregation in hepatocyte-like cells called oenocytes. Additionally, hypoxia increased the retention of Dilp2 in the insulin-producing cells of the larval brain, associated with a reduction of insulin signaling in peripheral tissues. Overexpression of the wildtype form of the insulin receptor ubiquitously and in the larval trachea rendered larvae resistant to hypoxia-induced growth restriction. Furthermore, Warts downregulation in the trachea was similar to increased insulin receptor signaling during oxygen deprivation, which both rescued hypoxia-induced growth restriction, inhibition of tracheal molting, and developmental delay. Insulin signaling and loss of Warts function increased tracheal growth and augmented tracheal plasticity under hypoxic conditions, enhancing oxygen delivery during periods of oxygen deprivation. Our findings demonstrate a mechanism that coordinates oxygen availability with systemic growth in which hypoxia-induced reduction of insulin receptor signaling decreases plasticity of the larval trachea that is required for the maintenance of systemic growth during times of limiting oxygen availability.	[Wong, Daniel M.; Shen, Zhouyang; Owyang, Kristin E.; Martinez-Agosto, Julian A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Martinez-Agosto, Julian A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Martinez-Agosto, Julian A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Martinez-Agosto, Julian A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Martinez-Agosto, JA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	julianmartinez@mednet.ucla.edu	Martinez-Agosto, Julian A/I-9435-2019	Martinez-Agosto, Julian A/0000-0001-6776-6949; Shen, Zhouyang/0000-0002-6524-8993	David Geffen School of Medicine at UCLA; Irving and Jean Stone Stipend Award; URC/CARE Undergraduate Research Scholars Program; UCLA from Amgen Foundation; Howard Hughes Medical Institute through Precollege and Undergraduate Science Education Program	David Geffen School of Medicine at UCLA(University of California System); Irving and Jean Stone Stipend Award; URC/CARE Undergraduate Research Scholars Program; UCLA from Amgen Foundation; Howard Hughes Medical Institute through Precollege and Undergraduate Science Education Program	Funding: This work was supported by the David Geffen School of Medicine at UCLA, the Irving and Jean Stone Stipend Award and URC/CARE Undergraduate Research Scholars Program to KEO, and UCLA grants from the Amgen Foundation and Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program to DMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhouayri I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002319; Alic N, 2011, AGING CELL, V10, P137, DOI 10.1111/j.1474-9726.2010.00653.x; Andersen DS, 2013, TRENDS CELL BIOL, V23, P336, DOI 10.1016/j.tcb.2013.03.005; Arquier N, 2008, CELL METAB, V7, P333, DOI 10.1016/j.cmet.2008.02.003; Azad P, 2012, G3-GENES GENOM GENET, V2, P1169, DOI 10.1534/g3.112.003681; Ballard SL, 2010, DEV BIOL, V337, P375, DOI 10.1016/j.ydbio.2009.11.011; Bauer R, 2009, EMBO J, V28, P3706, DOI 10.1038/emboj.2009.305; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Boulan L, 2013, CURR BIOL, V23, P473, DOI 10.1016/j.cub.2013.01.072; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Callier V, 2013, J EXP BIOL, V216, P4334, DOI 10.1242/jeb.093120; Callier V, 2011, P NATL ACAD SCI USA, V108, P14664, DOI 10.1073/pnas.1106556108; Centanin L, 2005, EMBO REP, V6, P1070, DOI 10.1038/sj.embor.7400528; Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; Dekanty A, 2005, J CELL SCI, V118, P5431, DOI 10.1242/jcs.02648; Delanoue R, 2010, DEV CELL, V18, P1012, DOI 10.1016/j.devcel.2010.05.007; Demontis F, 2009, DEVELOPMENT, V136, P983, DOI 10.1242/dev.027466; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Evdokimova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003184; Frazier MR, 2001, PHYSIOL BIOCHEM ZOOL, V74, P641, DOI 10.1086/322172; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Ghabrial AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002087; Gleixner E, 2008, FEBS J, V275, P5108, DOI 10.1111/j.1742-4658.2008.06642.x; Gorr TA, 2004, J BIOL CHEM, V279, P36048, DOI 10.1074/jbc.M405077200; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Harrison JF, 2011, ANNU REV PHYSIOL, V73, P95, DOI 10.1146/annurev-physiol-012110-142155; Heinrich EC, 2011, J EXP BIOL, V214, P1419, DOI 10.1242/jeb.051904; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Hyun S, 2013, CELL MOL LIFE SCI, V70, P2351, DOI 10.1007/s00018-013-1313-5; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Jaspers MHJ, 2014, DEV BIOL, V385, P23, DOI 10.1016/j.ydbio.2013.10.022; Jiang CT, 2013, J BIOL CHEM, V288, P3844, DOI 10.1074/jbc.M112.426338; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Li Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003230; Li ZH, 2013, DEV CELL, V24, P133, DOI 10.1016/j.devcel.2012.12.010; Linneweber GA, 2014, CELL, V156, P69, DOI 10.1016/j.cell.2013.12.008; Low P, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-29; Makki R, 2014, ANNU REV ENTOMOL, V59, P405, DOI 10.1146/annurev-ento-011613-162056; Manning Gerards, 1993, P609; Mazure NM, 2010, CURR OPIN CELL BIOL, V22, P177, DOI 10.1016/j.ceb.2009.11.015; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mirth Christen Kerry, 2012, Front Endocrinol (Lausanne), V3, P49, DOI 10.3389/fendo.2012.00049; Mirth CK, 2014, P NATL ACAD SCI US; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Okamoto N, 2013, GENE DEV, V27, P87, DOI 10.1101/gad.204479.112; Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021; Parvy JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002925; Peck LS, 2005, J EXP ZOOL PART A, V303A, P968, DOI 10.1002/jez.a.211; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Riddiford L, 1985, DEV DROSOPHILA MELAN, P899; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sato-Miyata Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00147; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Strassburger K, 2012, DEV BIOL, V367, P187, DOI 10.1016/j.ydbio.2012.05.008; Tennessen JM, 2011, CURR BIOL, V21, pR750, DOI 10.1016/j.cub.2011.06.033; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; Walkiewicz MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005072; WIGGLESWORTH VB, 1988, TISSUE CELL, V20, P919, DOI 10.1016/0040-8166(88)90033-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229; Yu JN, 2011, EUR J CELL BIOL, V90, P1000, DOI 10.1016/j.ejcb.2011.06.004; Zhou D, 2013, ANNU REV GENOM HUM G, V14, P25, DOI 10.1146/annurev-genom-091212-153439; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221	79	31	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115297	10.1371/journal.pone.0115297	http://dx.doi.org/10.1371/journal.pone.0115297			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541690	gold, Green Published			2022-12-26	WOS:000347239900034
J	Xiang, K; Cheng, L; Luo, ZL; Ren, JD; Tian, FZ; Tang, LJ; Chen, T; Dai, RW				Xiang, Ke; Cheng, Long; Luo, Zhulin; Ren, Jiandong; Tian, Fuzhou; Tang, Lijun; Chen, Tao; Dai, Ruiwu			Glycyrrhizin Suppresses the Expressions of HMGB1 and Relieves the Severity of Traumatic Pancreatitis in Rats	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; IMPROVES SURVIVAL; ORGAN INJURY; CYTOKINE; PROTEIN; INFLAMMATION; RELEASE	Background: High mobility group box 1 (HMGB1) plays important roles in a large variety of diseases; glycyrrhizin (GL) is recognized as an HMGB1 inhibitor. However, few studies have focused on whether glycyrrhizin can potentially improve the outcome of traumatic pancreatitis (TP) by inhibiting HMGB1. Methods: A total of 60 male Wistar rats were randomly divided into three groups (n=20 in each): Control group, TP group and TP-GL group. Pancreatic trauma was established with a custom-made biological impact machine-III, and GL was administered at 15 minutes after the accomplishment of operation. To determine survival rates during the first 7 days after injury, another 60 rats (n=20 in each) were grouped and treated as mentioned above. At 24 hours of induction of TP, the histopathological changes in pancreas were evaluated and serum amylase levels were tested. Serum tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), and HMGB1 were measured using enzyme linked immunosorbent assay. HMGB1 expressions in pancreas were measured using immunohistochemical staining, Western blot and Real-Time PCR analysis. Results: Serum levels of HMGB1, TNF-alpha and IL-6 were increased dramatically in TP group at 24 hours after induction of TP. However, these indicators were reduced significantly by GL administration in TP-GL group comparing with TP group (P<0.05). Meanwhile, survival analysis showed that the seven-day survival rate in TP-GL group was significantly higher than that in TP group (85% versus 65%, P<0.05). GL treatment significantly decreased the pancreatic protein and mRNA expressions of HMGB1 and ameliorated the pancreatic injury in rats with TP. Conclusions: Glycyrrhizin might play an important role in improving survival rates and ameliorating pancreatic injury of TP by suppression of the expressions of HMGB1 and other proinflammatory cytokine.	[Xiang, Ke] Third Mil Med Univ, Chongqing, Peoples R China; [Xiang, Ke; Cheng, Long; Luo, Zhulin; Tian, Fuzhou; Tang, Lijun; Chen, Tao; Dai, Ruiwu] Chengdu Mil Gen Hosp, Dept Gen Surg, Chengdu, Peoples R China; [Ren, Jiandong] Chengdu Mil Gen Hosp, Dept Pharm, Chengdu, Peoples R China	Army Medical University	Tian, FZ (corresponding author), Chengdu Mil Gen Hosp, Dept Gen Surg, Chengdu, Peoples R China.	tfz3006101@163.com			PLA Medicine Key Project [BWS12J020]	PLA Medicine Key Project	This work was supported by Grant from the PLA Medicine Key Project (to F. T. No. BWS12J020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Cheng BQ, 2007, PANCREAS, V35, P256, DOI 10.1097/MPA.0b013e318064678a; Dai RW, 2012, J TRAUMA ACUTE CARE, V73, P648, DOI 10.1097/TA.0b013e318250ad07; Delany HM, 1996, J SURG RES, V60, P41, DOI 10.1006/jsre.1996.0008; Felderbauer P, 2005, BASIC CLIN PHARMACOL, V97, P342, DOI 10.1111/j.1742-7843.2005.pto_274.x; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Gwak GY, 2012, WORLD J GASTROENTERO, V18, P679, DOI 10.3748/wjg.v18.i7.679; Huang WC, 2010, CYTOKINE, V51, P119, DOI 10.1016/j.cyto.2010.02.021; Lantos J, 2010, SHOCK, V33, P562, DOI 10.1097/SHK.0b013e3181cd8c88; Laveda R, 2005, WORLD J GASTROENTERO, V11, P5309, DOI 10.3748/wjg.v11.i34.5309; Lesina M, 2014, SEMIN IMMUNOL, V26, P80, DOI 10.1016/j.smim.2014.01.002; Levine RA, 2011, J PANCREAS, V12, P47; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; MODLIN IM, 1989, ARCH SURG-CHICAGO, V124, P574; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Ren JD, 2012, J TRAUMA ACUTE CARE, V72, P1555, DOI 10.1097/TA.0b013e31824a7913; Rongione AJ, 1997, GASTROENTEROLOGY, V112, P960, DOI 10.1053/gast.1997.v112.pm9041259; Sawa H, 2006, WORLD J GASTROENTERO, V12, P7666, DOI 10.3748/wjg.v12.i47.7666; Subramanian A, 2007, SURG CLIN N AM, V87, P1515, DOI 10.1016/j.suc.2007.08.007; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Ulloa L, 2003, ANN NY ACAD SCI, V987, P319, DOI 10.1111/j.1749-6632.2003.tb06075.x; van Rossum TGJ, 2001, AM J GASTROENTEROL, V96, P2432, DOI 10.1111/j.1572-0241.2001.04049.x; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang W, 2013, CRIT CARE, V17, DOI 10.1186/cc12558; Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang; Yasuda T, 2006, PANCREAS, V33, P359, DOI 10.1097/01.mpa.0000236741.15477.8b; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Yuan H, 2009, PANCREAS, V38, P143, DOI 10.1097/MPA.0b013e31818166b4; Zhang ZW, 2010, DIGEST DIS SCI, V55, P2529, DOI 10.1007/s10620-009-1073-0	33	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115982	10.1371/journal.pone.0115982	http://dx.doi.org/10.1371/journal.pone.0115982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541713	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900124
J	Anbalagan, D; Yap, G; Yuan, Y; Pandey, VK; Lau, WH; Arora, S; Bist, P; Wong, JSB; Sethi, G; Nissom, PM; Lobie, PE; Lim, LHK				Anbalagan, Durkeshwari; Yap, Gracemary; Yuan, Yi; Pandey, Vijay K.; Lau, Wai Hoe; Arora, Suruchi; Bist, Pradeep; Wong, Justin S. B.; Sethi, Gautam; Nissom, Peter M.; Lobie, Peter E.; Lim, Lina H. K.			Annexin-A1 Regulates MicroRNA-26b*and MicroRNA-562 to Directly Target NF-kappa B and Angiogenesis in Breast Cancer Cells	PLOS ONE			English	Article							A1 EXPRESSION; PROGRESSION; METASTASIS; ACTIVATION; GROWTH; PHOSPHORYLATION; INHIBITION; ESOPHAGEAL; MECHANISM; LEUKEMIA	Annexin 1 (ANXA1) is an endogenous anti-inflammatory protein implicated in cancer. ANXA1 was previously shown to be regulated by hsa-miR-196a. However, whether ANXA1 itself regulates microRNA (miR) expression is unknown. Therefore, we investigated the regulation of miR by ANXA1 in MCF7 breast cancer cells. MCF7-EV (Empty vector) and MCF7-V5 (ANXA1-V5 expressing cells) were subjected to a miR microarray. Microarray analysis revealed a number of miRNAs which were dysregulated in MCF7-V5 cells. 2 novel miRNAs (miR562 and miR26b*) were validated, cloned and functionally characterized. As ANXA1 constitutively activates NF-kappa B activity to modulate breast cancer metastasis, we found that miR26b* and miR562 directly targeted the canonical NF-kappa B pathway by targeting the 3' UTR and inhibiting expression of Rel A (p65) and NF-kappa B1 (p105) respectively. MiR562 inhibited wound healing, which was reversed when ANXA1 was overexpressed. Overexpression of either miR562 or miR26b* in MCF-7 cells enhanced endothelial tube formation when cocultured with human umbilical cord endothelial cells while conversely, treatment of MCF7 cells with either anti-miR562 or anti-miR26b* inhibited endothelial tube formation after co-culture. Further analysis of miR562 revealed that miR562-transfected cell conditioned media enhances endothelial cell tube formation, indicating that miR562 increased angiogenic secreted factors from MCF-7 breast tumor cells. TNF alpha was increased upon overexpression of miR562, which was reversed when ANXA1 was co-transfected In conclusion, this data suggests that ANXA1-regulated miR26b* and miR562 may play a role in wound healing and tumor-induced endothelial cell tube formation by targeting NF-kappa B expression and point towards a potential therapeutic target for breast cancer.	[Anbalagan, Durkeshwari; Yap, Gracemary; Yuan, Yi; Arora, Suruchi; Bist, Pradeep; Lim, Lina H. K.] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Life Sci, Dept Physiol, Singapore 117456, Singapore; [Pandey, Vijay K.; Lau, Wai Hoe; Lobie, Peter E.] Canc Sci Inst, Singapore 117599, Singapore; [Wong, Justin S. B.] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Life Sci, Dept Microbiol, Singapore 117456, Singapore; [Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Nissom, Peter M.; Lim, Lina H. K.] Astar Bioproc Technol Inst, Singapore 138668, Singapore; [Anbalagan, Durkeshwari; Yap, Gracemary; Yuan, Yi; Arora, Suruchi; Bist, Pradeep; Wong, Justin S. B.] Ctr Life Sci, Inst Life Sci, NUS Immunol Program, Singapore 117456, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore	Lim, LHK (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Life Sci, Dept Physiol, 28 Med Dr, Singapore 117456, Singapore.	lina_lim@nuhs.edu.sg	Pandey, Vijay/P-2767-2016; Sethi, Gautam/F-2372-2011; BIST, PRADEEP/AAG-7986-2019; Nissom, Peter/F-6619-2017	Sethi, Gautam/0000-0002-8677-8475; Lim, Lina/0000-0002-2935-2275; Nissom, Peter/0000-0002-6514-3921	A-Star (SIGN) [07-11]; Biomedical Research Council [BMRC 07/1/21/19/507]; Singapore National Kidney Foundation [NKFRC-2011/01/05]	A-Star (SIGN)(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore National Kidney Foundation	This grant was funded by A-Star (SIGN grant 07-11), Biomedical Research Council (BMRC 07/1/21/19/507) and Singapore National Kidney Foundation (NKFRC-2011/01/05) to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 1997, CLIN EXP METASTAS, V15, P151, DOI 10.1023/A:1018452810915; Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bist P, 2011, ONCOGENE, V30, P3174, DOI 10.1038/onc.2011.28; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Borralho PM, 2009, FEBS J, V276, P6689, DOI 10.1111/j.1742-4658.2009.07383.x; Cao Y, 2008, APPL IMMUNOHISTO M M, V16, P530, DOI 10.1097/PAI.0b013e31817432c3; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Falini B, 2004, LANCET, V363, P1869, DOI 10.1016/S0140-6736(04)16356-3; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hammer DA, 2005, CURR BIOL, V15, pR96, DOI 10.1016/j.cub.2005.01.028; Hongsrichan N, 2013, WORLD J GASTROENTERO, V19, P2456, DOI 10.3748/wjg.v19.i16.2456; Hou SH, 2003, J BIOL CHEM, V278, P45994, DOI 10.1074/jbc.M307971200; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kisseleva T, 2006, J CLIN INVEST, V116, P2955, DOI 10.1172/JCI27392; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lin L, 2000, EMBO J, V19, P4712, DOI 10.1093/emboj/19.17.4712; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Tran N, 2013, ESSAYS BIOCHEM, V54, P17, DOI [10.1042/BSE0540017, 10.1042/bse0540017]; Patton KT, 2005, HISTOPATHOLOGY, V47, P597, DOI 10.1111/j.1365-2559.2005.02300.x; Paweletz CP, 2000, CANCER RES, V60, P6293; Pratt MAC, 2003, MOL CELL BIOL, V23, P6887, DOI 10.1128/MCB.23.19.6887-6900.2003; Sato Y, 2011, EXP THER MED, V2, P239, DOI 10.3892/etm.2011.210; Shen DJ, 2006, HUM PATHOL, V37, P1583, DOI 10.1016/j.humpath.2006.06.001; Shibata A, 2002, BREAST CANCER RES TR, V73, P237, DOI 10.1023/A:1015872531675; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Tabruyn SP, 2007, CELL DEATH DIFFER, V14, P1393, DOI 10.1038/sj.cdd.4402156; Wilczynska KM, 2006, J BIOL CHEM, V281, P34955, DOI 10.1074/jbc.M604616200; Xia SH, 2002, ONCOGENE, V21, P6641, DOI 10.1038/sj.onc.1205818; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008	38	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114507	10.1371/journal.pone.0114507	http://dx.doi.org/10.1371/journal.pone.0114507			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536365	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300013
J	Ulbrich, F; Schallner, N; Coburn, M; Loop, T; Lagreze, WA; Biermann, J; Goebel, U				Ulbrich, Felix; Schallner, Nils; Coburn, Mark; Loop, Torsten; Lagreze, Wolf Alexander; Biermann, Julia; Goebel, Ulrich			Argon Inhalation Attenuates Retinal Apoptosis after Ischemia/Reperfusion Injury in a Time- and Dose-Dependent Manner in Rats	PLOS ONE			English	Article							GANGLION-CELL DEATH; NF-KAPPA-B; BCL-2 PROTEIN FAMILY; NOBLE-GASES; BRAIN-INJURY; IN-VITRO; GENE-EXPRESSION; ISCHEMIA; NEUROPROTECTION; TRANSCRIPTION	Purpose: Retinal ischemia and reperfusion injuries (IRI) permanently affect neuronal tissue and function by apoptosis and inflammation due to the limited regenerative potential of neurons. Recently, evidence emerged that the noble gas Argon exerts protective properties, while lacking any detrimental or adverse effects. We hypothesized that Argon inhalation after IRI would exert antiapoptotic effects in the retina, thereby protecting retinal ganglion cells (RGC) of the rat's eye. Methods: IRI was performed on the left eyes of rats (n=8) with or without inhaled Argon postconditioning (25, 50 and 75 Vol%) for 1 hour immediately or delayed after ischemia (i.e. 1.5 and 3 hours). Retinal tissue was harvested after 24 hours to analyze mRNA and protein expression of Bcl-2, Bax and Caspase-3, NF-kappa B. Densities of fluorogold-prelabeled RGCs were analyzed 7 days after injury in whole-mounts. Histological tissue samples were prepared for immunohistochemistry and blood was analyzed regarding systemic effects of Argon or IRI. Statistics were performed using One-Way ANOVA. Results: IRI induced RGC loss was reduced by Argon 75 Vol% inhalation and was dose-dependently attenuated by lower concentrations, or by delayed Argon inhalation (1504 +/- 300 vs. 2761 +/- 257; p<0.001). Moreover, Argon inhibited Bax and Bcl- 2 mRNA expression significantly ( Bax: 1.64 +/- 0.30 vs. 0.78 +/- 0.29 and Bcl2: 2.07 +/- 0.29 vs. 0.99 +/- 0.22; both p<0.01), as well as caspase-3 cleavage (1.91 +/- 0.46 vs. 1.05 +/- 0.36; p<0.001). Expression of NF-kappa B was attenuated significantly. Immunohistochemistry revealed an affection of Muller cells and astrocytes. In addition, IRI induced leukocytosis was reduced significantly after Argon inhalation at 75 Vol%. Conclusion: Immediate and delayed Argon postconditioning protects IRI induced apoptotic loss of RGC in a time- and dose-dependent manner, possibly mediated by the inhibition of NF-kappa B. Further studies need to evaluate Argon's possible role as a therapeutic option.	[Ulbrich, Felix; Schallner, Nils; Loop, Torsten; Goebel, Ulrich] Univ Med Ctr, Dept Anesthesiol & Intens Care Med, Freiburg, Germany; [Coburn, Mark] Univ Hosp RWTH Aachen, Dept Anesthesiol, Aachen, Germany; [Lagreze, Wolf Alexander; Biermann, Julia] Univ Med Ctr, Ctr Eye, Freiburg, Germany	University of Freiburg; RWTH Aachen University; RWTH Aachen University Hospital; University of Freiburg	Goebel, U (corresponding author), Univ Med Ctr, Dept Anesthesiol & Intens Care Med, Freiburg, Germany.	ulrich.goebel@uniklinik-freiburg.de	Goebel, Ulrich M./AGG-1495-2022; Göbel, Ulrich/Q-7613-2016	Göbel, Ulrich/0000-0002-9991-3226; Coburn, Mark/0000-0002-7930-0270	Department of Anesthesiology and Intensive Care Medicine; Eye Center, University Medical Center Freiburg, Germany; Albert Ludwigs University Freiburg	Department of Anesthesiology and Intensive Care Medicine; Eye Center, University Medical Center Freiburg, Germany; Albert Ludwigs University Freiburg	This work was funded by departmental funding of the Department of Anesthesiology and Intensive Care Medicine and the Eye Center, University Medical Center Freiburg, Germany. The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraini JH, 2003, ANESTH ANALG, V96, P746, DOI 10.1213/01.ANE.0000050282.14291.38; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Agnihotri S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-160; Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; ARCHER DB, 1976, DOC OPHTHALMOL, V40, P339, DOI 10.1007/BF00155046; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Biermann J, 2011, MOL VIS, V17, P1275; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P526, DOI 10.1167/iovs.09-3903; Burda J, 2006, CELL MOL NEUROBIOL, V26, P1141, DOI 10.1007/s10571-006-9036-x; Chiarugi A, 2002, MOL BRAIN RES, V109, P179, DOI 10.1016/S0169-328X(02)00558-2; Coburn M, 2012, CRIT CARE MED, V40, P1965, DOI 10.1097/CCM.0b013e3182474cf5; David HN, 2013, N-S ARCH PHARMACOL, V386, P91, DOI 10.1007/s00210-012-0809-0; David HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030934; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Fischer D, 2000, INVEST OPHTH VIS SCI, V41, P3943; Hayreh S S, 1978, Int Ophthalmol, V1, P9, DOI 10.1007/BF00133273; Hayreh SS, 2004, EXP EYE RES, V78, P723, DOI 10.1016/S0014-4835(03)00214-8; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Irani Y, 2011, NEPHRON EXTRA, V1, P272, DOI 10.1159/000335197; Jawad N, 2009, NEUROSCI LETT, V460, P232, DOI 10.1016/j.neulet.2009.05.069; Jehle T, 2008, GRAEF ARCH CLIN EXP, V246, P1255, DOI 10.1007/s00417-007-0746-7; Joo CK, 1999, INVEST OPHTH VIS SCI, V40, P713; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; Kamphuis W, 2007, MOL VIS, V13, P1020; Koblin DD, 1998, ANESTH ANALG, V87, P419, DOI 10.1097/00000539-199808000-00035; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Meberg PJ, 1996, MOL BRAIN RES, V38, P179, DOI 10.1016/0169-328X(95)00229-L; Mukaida Y, 2004, CURR EYE RES, V28, P381, DOI 10.1080/02713680490503679; Nickells RW, 1996, J GLAUCOMA, V5, P345; Pagel PS, 2007, ANESTH ANALG, V105, P562, DOI 10.1213/01.ane.0000278083.31991.36; Peng T, 2013, CNS NEUROSCI THER, V19, P773, DOI 10.1111/cns.12159; Preckel B, 2006, ANESTHESIOLOGY, V105, P187, DOI 10.1097/00000542-200607000-00029; Rizvi M, 2010, EXP BIOL MED, V235, P886, DOI 10.1258/ebm.2010.009366; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Schallner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060672; Schallner N, 2011, EUR J PHARMACOL, V670, P58, DOI 10.1016/j.ejphar.2011.08.028; Schmidt KG, 2004, OPHTHALMOLOGE, V101, P1071, DOI 10.1007/s00347-004-1131-0; Soldatov P E, 1998, Aviakosm Ekolog Med, V32, P33; VERMA D, 1993, MED HYPOTHESES, V41, P205, DOI 10.1016/0306-9877(93)90231-E; Wang LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023194; Yi JH, 2007, NEUROCHEM INT, V50, P1014, DOI 10.1016/j.neuint.2007.04.019; Zhang C, 2002, INVEST OPHTH VIS SCI, V43, P3059; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	47	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115984	10.1371/journal.pone.0115984	http://dx.doi.org/10.1371/journal.pone.0115984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535961	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300096
J	Berman, MG; Hout, MC; Kardan, O; Hunter, MR; Yourganov, G; Henderson, JM; Hanayik, T; Karimi, H; Jonides, J				Berman, Marc G.; Hout, Michael C.; Kardan, Omid; Hunter, MaryCarol R.; Yourganov, Grigori; Henderson, John M.; Hanayik, Taylor; Karimi, Hossein; Jonides, John			The Perception of Naturalness Correlates with Low-Level Visual Features of Environmental Scenes	PLOS ONE			English	Article							INNER-CITY; STATISTICS; ATTENTION; IMAGES; EFFICIENT; COGNITION; BENEFITS; EXPOSURE	Previous research has shown that interacting with natural environments vs. more urban or built environments can have salubrious psychological effects, such as improvements in attention and memory. Even viewing pictures of nature vs. pictures of built environments can produce similar effects. A major question is: What is it about natural environments that produces these benefits? Problematically, there are many differing qualities between natural and urban environments, making it difficult to narrow down the dimensions of nature that may lead to these benefits. In this study, we set out to uncover visual features that related to individuals' perceptions of naturalness in images. We quantified naturalness in two ways: first, implicitly using a multidimensional scaling analysis and second, explicitly with direct naturalness ratings. Features that seemed most related to perceptions of naturalness were related to the density of contrast changes in the scene, the density of straight lines in the scene, the average color saturation in the scene and the average hue diversity in the scene. We then trained a machine-learning algorithm to predict whether a scene was perceived as being natural or not based on these low-level visual features and we could do so with 81% accuracy. As such we were able to reliably predict subjective perceptions of naturalness with objective low-level visual features. Our results can be used in future studies to determine if these features, which are related to naturalness, may also lead to the benefits attained from interacting with nature.	[Berman, Marc G.; Kardan, Omid] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Hout, Michael C.] New Mexico State Univ, Dept Psychol, Las Cruces, NM 88003 USA; [Hunter, MaryCarol R.] Univ Michigan, Dept Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Yourganov, Grigori; Henderson, John M.; Hanayik, Taylor; Karimi, Hossein] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA; [Jonides, John] Univ Michigan, Dept Psychol, Ann Arbor, MI USA	University of Chicago; New Mexico State University; University of Michigan System; University of Michigan; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Michigan System; University of Michigan	Berman, MG (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	bermanm@uchicago.edu	Karimi, Hossein/N-7151-2019	Hanayik, Taylor/0000-0003-0751-9844	Tom and Kitty Stoner Foundation (TKF); University of South Carolina; Division Of Behavioral and Cognitive Sci [1151358] Funding Source: National Science Foundation	Tom and Kitty Stoner Foundation (TKF); University of South Carolina; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was partially funded by the The Tom and Kitty Stoner Foundation (TKF) and the University of South Carolina to MGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADDELEY RJ, 1991, P ROY SOC B-BIOL SCI, V246, P219, DOI 10.1098/rspb.1991.0147; Berman MG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2374; Berman MG, 2012, J AFFECT DISORDERS, V140, P300, DOI 10.1016/j.jad.2012.03.012; Berman MG, 2008, PSYCHOL SCI, V19, P1207, DOI 10.1111/j.1467-9280.2008.02225.x; Berto R, 2005, J ENVIRON PSYCHOL, V25, P249, DOI 10.1016/j.jenvp.2005.07.001; Busing F. M. T. A., 1997, SoftStat '97. Advances in Statistical Software 6. 9th Conference on the Scientific Use of Statistical Software, P67; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chandler DM, 2007, J OPT SOC AM A, V24, P922, DOI 10.1364/JOSAA.24.000922; Cimprich B, 2003, CANCER NURS, V26, P284, DOI 10.1097/00002820-200308000-00005; CRAIK KH, 1973, ANNU REV PSYCHOL, V24, P403, DOI 10.1146/annurev.ps.24.020173.002155; DOYEN J, 1978, MATH Z, V163, P251, DOI 10.1007/BF01174898; Fei-Fei L, 2005, PROC CVPR IEEE, P524; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Field DJ, 1999, PHILOS T R SOC A, V357, P2527, DOI 10.1098/rsta.1999.0446; GOLDSTONE R, 1994, BEHAV RES METH INS C, V26, P381, DOI 10.3758/BF03204653; HANCOCK PJB, 1992, NETWORK-COMP NEURAL, V3, P61, DOI 10.1088/0954-898X/3/1/008; Hout MC, 2013, J EXP PSYCHOL GEN, V142, P256, DOI 10.1037/a0028860; Hout MC, 2013, WIRES COGN SCI, V4, P93, DOI 10.1002/wcs.1203; Huang J, 1999, STAT NATURAL IMAGES; Jaworska N, 2009, TUTOR QUANT METHODS, V5, P1, DOI 10.20982/tqmp.05.1.p001; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Kaplan S, 2010, PERSPECT PSYCHOL SCI, V5, P43, DOI 10.1177/1745691609356784; Kellert S.R., 1993, BIOPHILIA HYPOTHESIS, P42; KERSTEN D, 1987, J OPT SOC AM A, V4, P2395, DOI 10.1364/JOSAA.4.002395; Klette R, 1996, HDB IMAGE PROCESSING, V1996, P1; Kriegeskorte N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00245; Kuo FE, 2001, ENVIRON BEHAV, V33, P343, DOI 10.1177/00139160121973025; Kuo FE, 2001, ENVIRON BEHAV, V33, P543, DOI 10.1177/00139160121973124; Leykin A, 2003, DIFFERENCES EDGE PRO, V542; Mayer FS, 2009, ENVIRON BEHAV, V41, P607, DOI 10.1177/0013916508319745; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; SHEPARD RN, 1980, SCIENCE, V210, P390, DOI 10.1126/science.210.4468.390; Taylor AF, 2009, J ATTEN DISORD, V12, P402, DOI 10.1177/1087054708323000; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; WARD LM, 1980, CAN J BEHAV SCI, V12, P329, DOI 10.1037/h0081077; WARD LM, 1977, MULTIVAR BEHAV RES, V12, P23, DOI 10.1207/s15327906mbr1201_2; WARD LM, 1981, ENVIRON BEHAV, V13, P610, DOI 10.1177/0013916581135005; Wilson E. O., 1984, HARV U PRESS, DOI DOI 10.2307/J.CTVK12S6H; Yourganov G, 2010, ARCH ITAL BIOL, V148, P259; Yourganov G, 2014, NEUROIMAGE, V96, P117, DOI 10.1016/j.neuroimage.2014.03.074	45	76	76	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114572	10.1371/journal.pone.0114572	http://dx.doi.org/10.1371/journal.pone.0114572			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531411	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100018
J	Kumar, S; Zheng, H; Deng, BB; Mahajan, B; Grabias, B; Kozakai, Y; Morin, MJ; Locke, E; Birkett, A; Miura, K; Long, C				Kumar, Sanjai; Zheng, Hong; Deng, Bingbing; Mahajan, Babita; Grabias, Bryan; Kozakai, Yukiko; Morin, Merribeth J.; Locke, Emily; Birkett, Ashley; Miura, Kazutoyo; Long, Carole			A Slot Blot Immunoassay for Quantitative Detection of Plasmodium falciparum Circumsporozoite Protein in Mosquito Midgut Oocyst	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; MALARIA TRANSMISSION; FALSE POSITIVITY; SPOROZOITES; VIVAX; ANTIBODIES; PFS48/45; ANTIGEN; VACCINE; VECTOR	There is still a need for sensitive and reproducible immunoassays for quantitative detection of malarial antigens in preclinical and clinical phases of vaccine development and in epidemiology and surveillance studies, particularly in the vector host. Here we report the results of sensitivity and reproducibility studies for a research-grade, quantitative enhanced chemiluminescent-based slot blot assay (ECL-SB) for detection of both recombinant Plasmodium falciparum circumsporozoite protein (rPfCSP) and native PfCSP from Oocysts (Pf Oocyst) developing in the midguts of Anopheles stephensi mosquitoes. The ECL-SB detects as little as 1.25 pg of rPfCSP (linear range of quantitation 2.5-20 pg; R-2 = 0.9505). We also find the earliest detectable expression of native PfCSP in Pf Oocyst by ECL-SB occurs on day 7 post feeding with infected blood meal. The ECL-SB was able to detect approximately as few as 0.5 day 8 Pf Oocysts (linear quantitation range 1-4, R-2 = 0.9795) and determined that one Pf Oocyst expressed approximately 2.0 pg (0.5-3 pg) of native PfCSP, suggesting a similar range of detection for recombinant and native forms of PfCSP. The ECL-SB is highly reproducible; the Coefficient of Variation (CV) for inter-assay variability for rPfCSP and native PfCSP were 1.74% and 1.32%, respectively. The CVs for intra-assay variability performed on three days for rPfCSP were 2.41%, 0.82% and 2% and for native PfCSP 1.52%, 0.57%, and 1.86%, respectively. In addition, the ECL-SB was comparable to microscopy in determining the P. falciparum prevalence in mosquito populations that distinctly contained either high and low midgut Pf Oocyst burden. In whole mosquito samples, estimations of positivity for P. falciparum in the high and low burden groups were 83.3% and 23.3% by ECL-SB and 85.7% and 27.6% by microscopy. Based on its performance characteristics, ECL-SB could be valuable in vaccine development and to measure the parasite prevalence in mosquitoes and transmission-blocking interventions in endemic areas.	[Kumar, Sanjai; Zheng, Hong; Mahajan, Babita; Grabias, Bryan; Kozakai, Yukiko] Ctr Biol Evaluat & Res Food & Drug Adm, Div Emerging & Transfus Transmitted Dis, Lab Emerging Pathogens, Silver Spring, MD 20993 USA; [Deng, Bingbing; Miura, Kazutoyo; Long, Carole] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Morin, Merribeth J.; Locke, Emily; Birkett, Ashley] PATH Malaria Vaccine Initiat, Washington, DC 20001 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kumar, S (corresponding author), Ctr Biol Evaluat & Res Food & Drug Adm, Div Emerging & Transfus Transmitted Dis, Lab Emerging Pathogens, Silver Spring, MD 20993 USA.	Sanjai.kumar@fda.hhs.gov	Miura, Kazutoyo/AAY-9751-2020	Miura, Kazutoyo/0000-0003-4455-2432	PATH Malaria Vaccine Initiative; US Food and Drug Administration [CRADA 145-08]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020] Funding Source: NIH RePORTER	PATH Malaria Vaccine Initiative; US Food and Drug Administration; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded, in part, through financial support from the PATH Malaria Vaccine Initiative (http://www.malariavaccine.org, SK) and intramural funding from the US Food and Drug Administration (http://www.FDA.gov, SK, CRADA 145-08) and the National Institute of Allergy and Infectious Diseases (http://www.NIAID.NIH.gov, CL). The Path Malaria Vaccine initiative was extensively involved in the design of the study, data collection and analysis, decision to publish, and the preparation of the manuscript. All other funders had no such involvement.	Bashar K, 2013, ACTA TROP, V125, P220, DOI 10.1016/j.actatropica.2012.10.004; Bell AS, 2004, INT J PARASITOL, V34, P795, DOI 10.1016/j.ijpara.2004.03.008; Bowman NM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01990; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Churcher TS, 2012, INT J PARASITOL, V42, P1037, DOI 10.1016/j.ijpara.2012.09.002; Durnez L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-195; Healer J, 1997, INFECT IMMUN, V65, P3017, DOI 10.1128/IAI.65.8.3017-3023.1997; KASLOW DC, 1994, INFECT IMMUN, V62, P5576, DOI 10.1128/IAI.62.12.5576-5580.1994; Kumar R, 2013, VACCINE, V31, P3140, DOI 10.1016/j.vaccine.2013.05.006; Kumar S, 2013, J IMMUNOL METHODS, V390, P99, DOI 10.1016/j.jim.2013.02.001; Michaelis L, 2013, FEBS LETT, V587, P2712, DOI 10.1016/j.febslet.2013.07.015; Miura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057909; NAGASAWA H, 1988, EXP PARASITOL, V66, P27, DOI 10.1016/0014-4894(88)90047-1; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; Ouedraogo AL, 2011, INFECT IMMUN, V79, P4957, DOI 10.1128/IAI.05288-11; Rathore D, 2003, J BIOL CHEM, V278, P40905, DOI 10.1074/jbc.M306250200; Roeffen W, 1996, PARASITE IMMUNOL, V18, P103, DOI 10.1046/j.1365-3024.1996.d01-54.x; Rosenberg R, 2008, TRENDS PARASITOL, V24, P487, DOI 10.1016/j.pt.2008.07.009; SOMBOON P, 1993, T ROY SOC TROP MED H, V87, P322, DOI 10.1016/0035-9203(93)90148-J; Stone WJ, 2014, J INFECT DI IN PRESS; WEBER JL, 1985, MOL BIOCHEM PARASIT, V15, P305, DOI 10.1016/0166-6851(85)90092-1; WIRTZ RA, 1992, J MED ENTOMOL, V29, P854, DOI 10.1093/jmedent/29.5.854; WIRTZ RA, 1985, AM J TROP MED HYG, V34, P1048, DOI 10.4269/ajtmh.1985.34.1048; YOSHIDA N, 1981, J EXP MED, V154, P1225, DOI 10.1084/jem.154.4.1225; Zeeshan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043430	25	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115807	10.1371/journal.pone.0115807	http://dx.doi.org/10.1371/journal.pone.0115807			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531543	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100110
J	Wolff-Hughes, DL; Bassett, DR; Fitzhugh, EC				Wolff-Hughes, Dana L.; Bassett, David R.; Fitzhugh, Eugene C.			Population-Referenced Percentiles for Waist-Worn Accelerometer-Derived Total Activity Counts in US Youth: 2003-2006 NHANES	PLOS ONE			English	Article							PHYSICAL-ACTIVITY ASSESSMENT; ACTIVITY MONITORS; EPOCH LENGTH; CALIBRATION; VALIDATION; CHILDREN; AGE	Background: The total activity volume performed is an overall measure that takes into account the frequency, intensity, and duration of activities performed. The importance of considering total activity volume is shown by recent studies indicating that light physical activity (LPA) and intermittent moderate-to-vigorous physical activity (MVPA) have health benefits. Accelerometer-derived total activity counts (TAC) per day from a waist-worn accelerometer can serve as a proxy for an individual's total activity volume. The purpose of this study was to develop age- and gender-specific percentiles for daily TAC, minutes of MVPA, and minutes of LPA in U.S. youth ages 6 - 19 y. Methods: Data from the 2003 - 2006 NHANES waist-worn accelerometer component were used in this analysis. The sample was composed of youth aged 6 - 19 years with at least 4 d of >= 10 hours of accelerometer wear time (N=3698). MVPA was defined using age specific cutpoints as the total number of minutes at >= 4 metabolic equivalents (METs) for youth 6 - 17 y or minutes with >= 2020 counts for youth 18 - 19 y. LPA was defined as the total number of minutes between 100 counts and the MVPA threshold. TAC/d, MVPA, and LPA were averaged across all valid days. Results: For males in the 50th percentile, the median activity level was 441,431 TAC/d, with 53 min/d of MVPA and 368 min/d of LPA. The median level of activity for females was 234,322 TAC/d, with 32 min/d of MVPA and 355 min/d of LPA. Conclusion: Population referenced TAC/d percentiles for U.S. youth ages 6- 19 y provide a novel means of characterizing the total activity volume performed by children and adolescents.	[Wolff-Hughes, Dana L.; Bassett, David R.; Fitzhugh, Eugene C.] Univ Tennessee, Dept Kinesiol Recreat & Sports Studies, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Wolff-Hughes, DL (corresponding author), Univ Tennessee, Dept Kinesiol Recreat & Sports Studies, Knoxville, TN 37996 USA.	dwolff@utk.edu	Fitzhugh, Eugene/AAI-2489-2019	Wolff-Hughes, Dana/0000-0003-3280-9771				Ayabe Makoto, 2013, BMC Res Notes, V6, P20, DOI 10.1186/1756-0500-6-20; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; Baquet G, 2007, PREV MED, V44, P143, DOI 10.1016/j.ypmed.2006.10.004; Bassett DR, 2014, MED SCI SPORTS EXERC; Bischoff AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056700, 10.1371/journal.pone.0071417]; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Edwardson CL, 2010, MED SCI SPORT EXER, V42, P928, DOI 10.1249/MSS.0b013e3181c301f5; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Glazer NL, 2013, MED SCI SPORT EXER, V45, P109, DOI 10.1249/MSS.0b013e31826beae5; Holman RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025733; John D, 2010, MED SCI SPORT EXER, V42, P368, DOI 10.1249/MSS.0b013e3181b3af49; Kim J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-30; Lee IM, 2014, BRIT J SPORT MED, V48, P197, DOI 10.1136/bjsports-2013-093154; Loprinzi PD, 2012, RES Q EXERCISE SPORT, V83, P422; Maher C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086403; Mark AE, 2009, AM J PREV MED, V36, P416, DOI 10.1016/j.amepre.2009.01.027; Mattocks C, 2007, INT J PEDIATR OBES, V2, P218, DOI 10.1080/17477160701408809; Mcclain JJ, 2008, MED SCI SPORT EXER, V40, P2080, DOI 10.1249/MSS.0b013e3181824d98; National Cancer Institute, SAS PROGR AN NHANES; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Rothney MP, 2008, J APPL PHYSIOL, V105, P1091, DOI 10.1152/japplphysiol.90641.2008; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Swartz AM, 2000, MED SCI SPORT EXER, V32, pS450, DOI 10.1097/00005768-200009001-00003; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Tudor-Locke C, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110332; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; Welch WA, 2014, MED SCI SPORT EXER, V46, P1825, DOI 10.1249/MSS.0000000000000283; Welch WA, 2013, MED SCI SPORT EXER, V45, P2012, DOI 10.1249/MSS.0b013e3182965249; Welk GJ, 2004, MED SCI SPORT EXER, V36, P1637, DOI 10.1249/01.MSS.0000074670.03001.98; Westerterp KR, 1999, INT J OBESITY, V23, pS45, DOI 10.1038/sj.ijo.0800883	42	36	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115915	10.1371/journal.pone.0115915	http://dx.doi.org/10.1371/journal.pone.0115915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531290	gold, Green Submitted, Green Published			2022-12-26	WOS:000348845100117
J	Jacobsen, AV; Yemaneab, BT; Jass, J; Scherbak, N				Jacobsen, Annette V.; Yemaneab, Bisrat T.; Jass, Jana; Scherbak, Nikolai			Reference Gene Selection for qPCR Is Dependent on Cell Type Rather than Treatment in Colonic and Vaginal Human Epithelial Cell Lines	PLOS ONE			English	Article							RNA EXPRESSION; NORMALIZATION; TOOL; IDENTIFICATION; MODULATION; PROBIOTICS; MICROBIOTA; BLADDER; DESIGN	The ability of commensal bacteria to influence gene expression in host cells under the influence of pathogenic bacteria has previously been demonstrated, however the extent of this interaction is important for understanding how bacteria can be used as probiotics. Real-time quantitative polymerase chain reaction is the most sensitive tool for evaluating relative changes to gene expression levels. However as a result of its sensitivity an appropriate method of normalisation should be used to account for any variation incurred in preparatory experimental procedures. These variations may result from differences in the amount of starting material, quality of extracted RNA, or in the efficiency of the reverse transcriptase or polymerase enzymes. Selection of an endogenous control gene is the preferred method of normalisation, and ideally a proper validation of the gene's appropriateness for the study in question should be performed. In this study we used quantitative polymerase chain reaction data and applied four different algorithms (geNorm, BestKeeper, NormFinder, and comparative Delta C-q) to evaluate eleven different genes as to their suitability as endogenous controls for use in studies involving colonic (HT-29) and vaginal (VK2/E6E7) human mucosal epithelial cells treated with probiotic and pathogenic bacteria. We found phosphoglycerate kinase 1 to be most appropriate for HT-29 cells, and ribosomal protein large P0 to be the best choice for VK2/E6E7 cells. We also showed that use of less stable reference genes can lead to less accurate quantification of expression levels of gene of interest (GOI) and also can result in decreased statistical significance for GOI expression levels when compared to control. Additionally, we found the cell type being analysed had greater influence on reference gene selection than the treatment performed. This study provides recommendations for stable endogenous control genes for use in further studies involving colonic and vaginal cell lines after bacterial challenge.	[Jacobsen, Annette V.; Yemaneab, Bisrat T.; Jass, Jana; Scherbak, Nikolai] Univ Orebro, Sch Sci & Technol, SE-70182 Orebro, Sweden; [Jacobsen, Annette V.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia	Orebro University; Charles Sturt University	Scherbak, N (corresponding author), Univ Orebro, Sch Sci & Technol, SE-70182 Orebro, Sweden.	nikolai.scherbak@oru.se	Jass, Jana/D-1617-2013; Jacobsen, Annette/G-5594-2016	Jass, Jana/0000-0001-7957-0310; Jacobsen, Annette/0000-0003-0252-7685; Scherbak, Nikolai/0000-0001-9713-2365	Knowledge Foundation; Carl Tryggers Foundation, Sweden	Knowledge Foundation; Carl Tryggers Foundation, Sweden	The work was supported by the Knowledge Foundation, www.kks.se (JJ), and Carl Tryggers Foundation, www.carltryggersstiftelse.se/ (NS), Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Bahrami B, 2011, J APPL MICROBIOL, V110, P353, DOI 10.1111/j.1365-2672.2010.04889.x; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bourgine J, 2012, DRUG METAB DISPOS, V40, P694, DOI 10.1124/dmd.111.042465; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Coudeyras Sophie, 2008, Infect Dis Obstet Gynecol, V2008, P549640, DOI 10.1155/2008/549640; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Howarth GS, 2013, NUTRIENTS, V5, P58, DOI 10.3390/nu5010058; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Karlsson M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-15; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pinto MGV, 2009, INT J FOOD MICROBIOL, V133, P86, DOI 10.1016/j.ijfoodmicro.2009.05.013; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rastall RA, 2005, FEMS MICROBIOL ECOL, V52, P145, DOI 10.1016/j.femsec.2005.01.003; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Schmitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039632; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; Wagner RD, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-58; Wagner RD, 2012, OPEN J MED MICROBIOL, V02, P54, DOI [10.4236/ojmm.2012.23008, DOI 10.4236/OJMM.2012.23008]; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	36	12	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115592	10.1371/journal.pone.0115592	http://dx.doi.org/10.1371/journal.pone.0115592			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526394	Green Submitted, Green Published, gold			2022-12-26	WOS:000347186200038
J	Liu, XL; Zhang, J; Li, J; Volk, A; Breslin, P; Zhang, JW; Zhang, Z				Liu, Xinli; Zhang, Jun; Li, Jing; Volk, Andrew; Breslin, Peter; Zhang, Jiwang; Zhang, Zhou			The Synergistic Repressive Effect of NF-kappa B and JNK Inhibitor on the Clonogenic Capacity of Jurkat Leukemia Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TNF-ALPHA; INFLAMMATION; ACTIVATION; APOPTOSIS; LYMPHOMA; KINASE; TUMORIGENESIS; RESISTANCE; DEFICIENT	Deregulation of Nuclear Transcription Factor-kappa B (NF-kappa B) and Jun N-terminal kinase (JNK) signaling is commonly detected in leukemia, suggesting an important role for these two signaling pathways in the pathogenesis of leukemia. In this study, using Jurkat cells, an acute T-lymphoblastic leukemia (T-ALL) cell line, we evaluated the effects of an NF-kB inhibitor and a JNK inhibitor individually and in combination on the proliferation, survival and clonogenic capacity of leukemic cells. We found that leukemic stem/progenitor cells (LSPCs) were more sensitive to NF-kappa B inhibitor treatment than were healthy hematopoietic stem/progenitor cells (HSPCs), as shown by a reduction in the clonogenic capacity of the former. Inactivation of NF-kappa B leads to the activation of JNK signaling in both leukemic cells and healthy HSPCs. Interestingly, JNK inhibitor treatment enhanced the repressive effects of NF-kappa B inhibitor on LSPCs but prevented such repression in HSPCs. Our data suggest that JNK signaling stimulates proliferation/survival in LSPCs but is a death signal in HSPCs. The combination of NF-kappa B inhibitor and JNK inhibitor might provide a better treatment for T-ALL leukemia by synergistically killing LSPCs while simultaneously preventing the death of normal HPCs.	[Liu, Xinli; Zhang, Jun; Li, Jing] Shanghai Normal Univ, Coll Life & Environm Sci, Dept Biol, Shanghai, Peoples R China; [Zhang, Zhou] Shenyang Pharmaceut Univ, Coll Life Sci & Biopharm, Shenyang, Peoples R China; [Volk, Andrew; Breslin, Peter; Zhang, Jiwang] Loyola Univ Chicago, Cardinal Bernardin Canc Ctr, Inst Oncol, Maywood, IL 60153 USA; [Volk, Andrew; Breslin, Peter; Zhang, Jiwang] Loyola Univ Chicago, Dept Pathol, Maywood, IL 60153 USA; [Volk, Andrew; Breslin, Peter; Zhang, Jiwang] Loyola Univ Chicago, Dept Mol Cellular Physiol, Maywood, IL 60153 USA	Shanghai Normal University; Shenyang Pharmaceutical University; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Zhang, Z (corresponding author), Shenyang Pharmaceut Univ, Coll Life Sci & Biopharm, Shenyang, Peoples R China.	zhouzhang@hotmail.com	Zhang, Jiwang/AAG-2706-2021		State Key Development Program for Basic Research of China [2013CB966800]; Major Key Projects for the Fundamental Research of the Science and Technology Commission of Shanghai [13JC1406403]; Innovation Program of Shanghai Municipal Education Commission [13ZZ103]; National Natural Science Foundation of China [31270883]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Major Key Projects for the Fundamental Research of the Science and Technology Commission of Shanghai; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the State Key Development Program for Basic Research of China (Grant No. 2013CB966800) and Major Key Projects for the Fundamental Research of the Science and Technology Commission of Shanghai (Grant No. 13JC1406403) to JWZ; the Innovation Program of Shanghai Municipal Education Commission (Grant No. 13ZZ103) and the National Natural Science Foundation of China (Grant No. 31270883) to ZZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Ferrando Adolfo A, 2009, Hematology Am Soc Hematol Educ Program, P353, DOI 10.1182/asheducation-2009.1.353; Fuchs O, 2004, CURR PHARM, V3, P98; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hernandez-Ilizaliturri FJ, 2011, CANCER-AM CANCER SOC, V117, P5058, DOI 10.1002/cncr.26135; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Javelaud D, 2001, ONCOGENE, V20, P4365, DOI 10.1038/sj.onc.1204570; Jiang XJ, 2012, CANCER LETT, V326, P135, DOI 10.1016/j.canlet.2012.07.030; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Katsman A, 2009, CURR PHARM DESIGN, V15, P792, DOI 10.2174/138161209787582156; Knight B, 2000, J EXP MED, V192, P1809, DOI 10.1084/jem.192.12.1809; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Mori N, 2002, BLOOD, V100, P1828, DOI 10.1182/blood-2002-01-0151; Munzert G, 2004, LEUKEMIA LYMPHOMA, V45, P1181, DOI 10.1080/10428190310001657326; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Oguma K, 2010, FUTURE ONCOL, V6, P515, DOI [10.2217/fon.10.13, 10.2217/FON.10.13]; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Salem K, 2013, EXP HEMATOL, V41, P209, DOI 10.1016/j.exphem.2012.10.002; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schioppa T, 2011, P NATL ACAD SCI USA, V108, P10662, DOI 10.1073/pnas.1100994108; Volk A, 2014, J EXP MED, V211, P1093, DOI 10.1084/jem.20130990; Walsby E, 2012, ONCOTARGET, V3, P525; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746	39	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115490	10.1371/journal.pone.0115490	http://dx.doi.org/10.1371/journal.pone.0115490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526629	Green Submitted, Green Published, gold			2022-12-26	WOS:000347186200030
J	Sint, D; Niederklapfer, B; Kaufmann, R; Traugott, M				Sint, Daniela; Niederklapfer, Bettina; Kaufmann, Ruediger; Traugott, Michael			Group-Specific Multiplex PCR Detection Systems for the Identification of Flying Insect Prey	PLOS ONE			English	Article							GUT-CONTENT-ANALYSIS; MOLECULAR-IDENTIFICATION; INVERTEBRATE PREDATORS; GENERALIST PREDATORS; DIET ANALYSIS; DNA; PRIMERS; GENE; AMPLIFICATION; COLLEMBOLA	The applicability of species-specific primers to study feeding interactions is restricted to those ecosystems where the targeted prey species occur. Therefore, group-specific primer pairs, targeting higher taxonomic levels, are often desired to investigate interactions in a range of habitats that do not share the same species but the same groups of prey. Such primers are also valuable to study the diet of generalist predators when next generation sequencing approaches cannot be applied beneficially. Moreover, due to the large range of prey consumed by generalists, it is impossible to investigate the breadth of their diet with species-specific primers, even if multiplexing them. However, only few group-specific primers are available to date and important groups of prey such as flying insects have rarely been targeted. Our aim was to fill this gap and develop group-specific primers suitable to detect and identify the DNA of common taxa of flying insects. The primers were combined in two multiplex PCR systems, which allow a time- and cost-effective screening of samples for DNA of the dipteran subsection Calyptratae (including Anthomyiidae, Calliphoridae, Muscidae), other common dipteran families (Phoridae, Syrphidae, Bibionidae, Chironomidae, Sciaridae, Tipulidae), three orders of flying insects (Hymenoptera, Lepidoptera, Plecoptera) and coniferous aphids within the genus Cinara. The two PCR assays were highly specific and sensitive and their suitability to detect prey was confirmed by testing field-collected dietary samples from arthropods and vertebrates. The PCR assays presented here allow targeting prey at higher taxonomic levels such as family or order and therefore improve our ability to assess (trophic) interactions with flying insects in terrestrial and aquatic habitats.	[Sint, Daniela; Niederklapfer, Bettina; Kaufmann, Ruediger; Traugott, Michael] Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria	University of Innsbruck	Sint, D (corresponding author), Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria.	Daniela.Sint@uibk.ac.at	Sint, Daniela/HCI-8508-2022	Sint, Daniela/0000-0003-3387-4284; Traugott, Michael/0000-0001-9719-5059	Austrian Science Fund FWF [P20859-B17]; Alpine Research Centre Obergurgl of the University of Innsbruck; University of Innsbruck; Austrian Science Fund (FWF) [P 20859] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Alpine Research Centre Obergurgl of the University of Innsbruck; University of Innsbruck; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was financed and supported by the Austrian Science Fund FWF ("Invertebrate food webs in recently deglaciated alpine areas", project number P20859-B17), the Alpine Research Centre Obergurgl of the University of Innsbruck and an 'Excellentia fellowship' of the University of Innsbruck awarded to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admassu B, 2006, SOIL BIOL BIOCHEM, V38, P1308, DOI 10.1016/j.soilbio.2005.08.019; Agusti N, 2003, MOL ECOL, V12, P3467, DOI 10.1046/j.1365-294X.2003.02014.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Caballero S, 2012, MOL ECOL RESOUR, V12, P233, DOI 10.1111/j.1755-0998.2011.03089.x; CHEVET E, 1995, NUCLEIC ACIDS RES, V23, P3343, DOI 10.1093/nar/23.16.3343; Clarke LJ, 2014, MOL ECOL RESOUR, V14, P1160, DOI 10.1111/1755-0998.12265; Clarke LJ, 2014, MOL ECOL RESOUR, V14, P117, DOI 10.1111/1755-0998.12162; Corse E, 2010, MOL ECOL RESOUR, V10, P96, DOI 10.1111/j.1755-0998.2009.02795.x; Davey JS, 2013, J APPL ECOL, V50, P271, DOI 10.1111/1365-2664.12008; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; DIEFFENBACH CW, 2003, PCR PRIMER LAB MANUA, P13102; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harper GL, 2005, MOL ECOL, V14, P819, DOI [10.1111/j.1365-294X.2005.02442.x, 10.1111/j.1365-294x.2005.02442.x]; Jarman SN, 2004, MOL ECOL, V13, P1313, DOI 10.1111/j.1365-294X.2004.02109.x; Juen A, 2007, MOL ECOL, V16, P1545, DOI 10.1111/j.1365-294X.2007.03238.x; Juen A, 2005, OECOLOGIA, V142, P344, DOI 10.1007/s00442-004-1736-7; Juen A, 2006, SOIL BIOL BIOCHEM, V38, P1872, DOI 10.1016/j.soilbio.2005.11.034; Juen A, 2012, J PEST SCI, V85, P89, DOI 10.1007/s10340-011-0406-x; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; King RA, 2011, MOL ECOL RESOUR, V11, P370, DOI 10.1111/j.1755-0998.2010.02913.x; Koester M, 2013, CONSERV GENET RESOUR, V5, P1091, DOI 10.1007/s12686-013-9998-1; Kuusk AK, 2008, MOL ECOL RESOUR, V8, P678, DOI 10.1111/j.1471-8286.2007.02046.x; Kuusk AK, 2012, J PEST SCI, V85, P253, DOI 10.1007/s10340-012-0431-4; Luan YX, 2003, SCI CHINA SER C, V46, P67, DOI 10.1007/BF03182686; Ma J, 2005, J APPL ENTOMOL, V129, P330, DOI 10.1111/j.1439-0418.2005.00977.x; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Morales SE, 2009, APPL ENVIRON MICROB, V75, P2677, DOI 10.1128/AEM.02166-08; O'Rorke R, 2012, MOL ECOL RESOUR, V12, P5, DOI 10.1111/j.1755-0998.2011.03091.x; Pinol J, 2014, MOL ECOL RESOUR, V14, P18, DOI 10.1111/1755-0998.12156; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quemere E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058971; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; Romeu-Dalmau C, 2012, B ENTOMOL RES, V102, P566, DOI 10.1017/S0007485312000132; SCHOENLY K, 1990, ECOL ENTOMOL, V15, P333, DOI 10.1111/j.1365-2311.1990.tb00815.x; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Sint D, 2012, METHODS ECOL EVOL, V3, P898, DOI 10.1111/j.2041-210X.2012.00215.x; Sint D, 2011, MOL ECOL RESOUR, V11, P795, DOI 10.1111/j.1755-0998.2011.03018.x; Symondson William O.C., 2012, P166; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Traugott M, 2012, B ENTOMOL RES, V102, P239, DOI 10.1017/S0007485311000551; Traugott M, 2013, ADV ECOL RES, V49, P177, DOI 10.1016/B978-0-12-420002-9.00003-2; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Wallinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029473; Westheide W, 1996, SPEZIELLE ZOOLOGIE 1; Zarzoso-Lacoste D, 2013, MOL ECOL RESOUR, V13, P117, DOI 10.1111/1755-0998.12029	49	15	15	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115501	10.1371/journal.pone.0115501	http://dx.doi.org/10.1371/journal.pone.0115501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525799	Green Submitted, gold, Green Published			2022-12-26	WOS:000347186200031
J	Stojowska, K; Krawczyk, B				Stojowska, Karolina; Krawczyk, Beata			A New Double Digestion Ligation Mediated Suppression PCR Method for Simultaneous Bacteria DNA-Typing and Confirmation of Species: An Acinetobacter sp Model	PLOS ONE			English	Article							MELTING PROFILE METHOD; RESISTANT ENTEROCOCCUS-FAECIUM; GENOTYPING ANALYSIS; BAUMANNII; IDENTIFICATION; AMPLIFICATION; FRAGMENTS; AFLP; DIFFERENTIATION; STRAINS	We have designed a new ddLMS PCR (double digestion Ligation Mediated Suppression PCR) method based on restriction site polymorphism upstream from the specific target sequence for the simultaneous identification and differentiation of bacterial strains. The ddLMS PCR combines a simple PCR used for species or genus identification and the LM PCR strategy for strain differentiation. The bacterial identification is confirmed in the form of the PCR product(s), while the length of the PCR product makes it possible to differentiate between bacterial strains. If there is a single copy of the target sequence within genomic DNA, one specific PCR product is created (simplex ddLMS PCR), whereas for multiple copies of the gene the fingerprinting patterns can be obtained (multiplex ddLMS PCR). The described ddLMS PCR method is designed for rapid and specific strain differentiation in medical and microbiological studies. In comparison to other LM PCR it has substantial advantages: enables specific species' DNA-typing without the need for pure bacterial culture selection, is not sensitive to contamination with other cells or genomic DNA, and gives univocal "band-based" results, which are easy to interpret. The utility of ddLMS PCR was shown for Acinetobacter calcoaceticus-baumannii (Acb) complex, the genetically closely related and phenotypically similar species and also important nosocomial pathogens, for which currently, there are no recommended methods for screening, typing and identification. In this article two models are proposed: 39 recA-ddLMS PCR-MaeII/RsaI for Acb complex interspecific typing and 59 rrn-ddLMS PCR-HindIII/ApaI for Acinetobacter baumannii intraspecific typing. ddLMS PCR allows not only for DNA-typing but also for confirmation of species in one reaction. Also, practical guidelines for designing a diagnostic test based on ddLMS PCR for genotyping different species of bacteria are provided.	[Stojowska, Karolina; Krawczyk, Beata] Gdansk Univ Technol, Dept Microbiol, Fac Chem, Gdansk, Poland	Fahrenheit Universities; Gdansk University of Technology	Krawczyk, B (corresponding author), Gdansk Univ Technol, Dept Microbiol, Fac Chem, Gdansk, Poland.	beakrawc@pg.gda.pl	Krawczyk, Beata/ABG-4358-2020	Krawczyk, Beata/0000-0001-5528-8898	State Committee for Scientific Research, Poland [N N401 101138]; Department of Microbiology, Gdansk University of Technology	State Committee for Scientific Research, Poland(Polish State Committee for Scientific Research); Department of Microbiology, Gdansk University of Technology	This work was supported by the State Committee for Scientific Research, Poland (grant no N N401 101138 to KS BK) and the Department of Microbiology, Gdansk University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Grosso F, 2011, CLIN MICROBIOL INFEC, V17, P1275, DOI 10.1111/j.1469-0691.2011.03469.x; Grosso F, 2010, J HOSP INFECT, V75, P82, DOI 10.1016/j.jhin.2010.01.007; Gundi VAKB, 2009, MICROBIOL-SGM, V155, P2333, DOI 10.1099/mic.0.026054-0; Jeung JU, 2005, J BIOCHEM BIOPH METH, V64, P110, DOI 10.1016/j.jbbm.2005.06.001; Krawczyk B, 2003, J MICROBIOL METH, V52, P341, DOI 10.1016/S0167-7012(02)00187-2; Krawczyk B, 2002, MOL CELL PROBE, V16, P1, DOI 10.1006/mcpr.2001.0388; Krawczyk B, 2007, J MICROBIOL METH, V71, P114, DOI 10.1016/j.mimet.2007.08.010; Krawczyk B, 2006, J CLIN MICROBIOL, V44, P2327, DOI 10.1128/JCM.00052-06; Krawczyk B, 2011, J MICROBIOL BIOTECHN, V21, P1336, DOI 10.4014/jmb.1104.04019; Krawczyk Beata, 2007, Polish Journal of Microbiology, V56, P65; Kulah C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-30; Lai CC, 2012, J CLIN MICROBIOL, V50, P2982, DOI 10.1128/JCM.01194-12; Leibner-Ciszak J, 2010, J MED MICROBIOL, V59, P185, DOI 10.1099/jmm.0.013458-0; Li WJ, 2009, FEMS MICROBIOL REV, V33, P892, DOI 10.1111/j.1574-6976.2009.00182.x; Lim YM, 2007, J CLIN MICROBIOL, V45, P902, DOI 10.1128/JCM.01573-06; Masny A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng116; Masny A, 2001, BIOTECHNIQUES, V31, P930, DOI 10.2144/01314rr04; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Nowak-Zaleska A, 2008, POL J MICROBIOL, V57, P11; Park KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065026; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Smith D R, 1992, PCR Methods Appl, V2, P21; Stojowska K, 2009, EUR J CLIN MICROBIOL, V28, P1263, DOI 10.1007/s10096-009-0768-7; Stojowska K, 2009, POL J MICROBIOL, V58, P247; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; van der Wurff AWG, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.24.e105; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WISE KA, 1990, J HOSP INFECT, V16, P319, DOI 10.1016/0195-6701(90)90004-8	31	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115181	10.1371/journal.pone.0115181	http://dx.doi.org/10.1371/journal.pone.0115181			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522278	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845600023
J	Gong, X; Yi, J; Carmon, KS; Crumbley, CA; Xiong, W; Thomas, A; Fan, X; Guo, S; An, Z; Chang, JT; Liu, QJ				Gong, X.; Yi, J.; Carmon, K. S.; Crumbley, C. A.; Xiong, W.; Thomas, A.; Fan, X.; Guo, S.; An, Z.; Chang, J. T.; Liu, Q. J.			Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness	ONCOGENE			English	Article							TRANSCRIPTION FACTOR NRF2; PROTEIN-COUPLED RECEPTOR; COLORECTAL-CANCER; WNT/BETA-CATENIN; FUSION TRANSCRIPTS; IDENTIFIES GENES; KNOCKOUT MICE; METASTASIS; KEAP1; LGR4	The four R-spondins (RSPO1-4) and their three related receptors LGR4, 5 and 6 (LGR4-6) have emerged as a major ligand-receptor system with critical roles in development and stem cell survival through modulation of Wnt signaling. Recurrent, gain-of-expression gene fusions of RSPO2 (to EIF3E) and RSPO3 (to PTPRK) occur in a subset of human colorectal cancer. However, the exact roles and mechanisms of the RSPO-LGR system in oncogenesis remain largely unknown. We found that RSPO3 is aberrantly expressed at high levels in approximately half of Keap1-mutated lung adenocarcinomas (ADs). This high RSPO3 expression is driven by a combination of demethylation of its own promoter region and deficiency in Keap1 instead of gene fusion as in colon cancer. Patients with RSPO3-high tumors (similar to 9%, 36/412) displayed much poorer survival than the rest of the cohort (median survival of 28 vs 163 months, log-rank test P<0.0001). Knockdown (KD) of RSPO3, LGR4 or their signaling mediator IQGAP1 in lung cancer cell lines with Keap1 deficiency and high RSPO3-LGR4 expression led to reduction in cell proliferation and migration in vitro, and KD of LGR4 or IQGAP1 resulted in decrease in tumor growth and metastasis in vivo. These findings suggest that aberrant RSPO3-LGR4 signaling potentially acts as a driving mechanism in the aggressiveness of Keap1-deficient lung ADs.	[Gong, X.; Yi, J.; Carmon, K. S.; Crumbley, C. A.; Xiong, W.; Thomas, A.; Fan, X.; An, Z.; Chang, J. T.; Liu, Q. J.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Gong, X.; Yi, J.; Carmon, K. S.; Crumbley, C. A.; Xiong, W.; Thomas, A.; Fan, X.; An, Z.; Liu, Q. J.] Univ Texas Hlth Sci Ctr Houston, Texas Therapeut Inst, Houston, TX 77030 USA; [Guo, S.] Univ Texas Hlth Sci Ctr Houston, Div Oncol, Houston, TX 77030 USA; [Chang, J. T.] Univ Texas Hlth Sci Ctr Houston, Ctr Clin & Translat Sci, Houston, TX 77030 USA; [Chang, J. T.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Chang, J. T.] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Liu, QJ (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, 1825 Pressler St,Suite 530A, Houston, TX 77030 USA.	Qingyun.liu@uth.tmc.edu	Yi, Jing/S-2586-2016	Yi, Jing/0000-0001-5037-1924; Carmon, Kendra/0000-0002-3244-6096; An, Zhiqiang/0000-0001-9309-2335	Cancer Prevention and Research Institute of Texas (CPRIT) [RP100678]; US National Institute of Health-NIH [R01GM102485]; Texas Emerging Technology Fund; Janice D. Gordon endowment for bowel cancer research; NIH [R00LM009837, TL1TR000371]; CPRIT [R1006]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102485] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R00LM009837] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT); US National Institute of Health-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Emerging Technology Fund; Janice D. Gordon endowment for bowel cancer research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank TCGA for generating the genomics data, collecting the clinical information and making them available for analysis. We also thank cBioportal for providing data analysis and visualization tools and downloading capability. We thank Dr B Fang at the University of Texas MD Anderson Cancer for the cell lines A549, H460 and H2009 cells. This work was supported in part by the Cancer Prevention and Research Institute of Texas (CPRIT, RP100678), the US National Institute of Health-NIH (R01GM102485), the Texas Emerging Technology Fund and the Janice D. Gordon endowment for bowel cancer research (to QJL), by NIH (R00LM009837, TL1TR000371) and CPRIT (R1006; to JTC) and by the Texas Emerging Technology Fund (to ZA).	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gattelli A, 2006, J VIROL, V80, P11409, DOI 10.1128/JVI.00234-06; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gugger M, 2008, DIS MARKERS, V24, P41, DOI 10.1155/2008/857474; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hayashi H, 2010, INT J CANCER, V126, P2563, DOI 10.1002/ijc.24987; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu Y, 2011, HISTOPATHOLOGY, V59, P882, DOI 10.1111/j.1365-2559.2011.04013.x; Lowther W, 2005, J VIROL, V79, P10093, DOI 10.1128/JVI.79.15.10093-10096.2005; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Mazieres J, 2005, CANCER LETT, V222, P1, DOI 10.1016/j.canlet.2004.08.040; McDonald T, 1998, BIOCHEM BIOPH RES CO, V247, P266, DOI 10.1006/bbrc.1998.8774; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Miyoshi T, 2005, PATHOL INT, V55, P419, DOI 10.1111/j.1440-1827.2005.01847.x; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nam JS, 2007, GENE EXPR PATTERNS, V7, P306, DOI 10.1016/j.modgep.2006.08.006; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shinmura K, 2014, MOL BIOL REP, V41, P5375, DOI 10.1007/s11033-014-3409-x; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Takahashi T, 2010, J SURG ONCOL, V101, P500, DOI 10.1002/jso.21520; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Yamada W, 2009, BIOCHEM BIOPH RES CO, V381, P453, DOI 10.1016/j.bbrc.2009.02.066; Yi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078144	54	45	48	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 3	2015	34	36					4692	4701		10.1038/onc.2014.417	http://dx.doi.org/10.1038/onc.2014.417			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CQ9JU	25531322	Green Accepted			2022-12-26	WOS:000360931500003
J	Matsuo, K; Akakabe, Y; Kitamura, Y; Shimoda, Y; Ono, K; Ueyama, T; Matoba, S; Yamada, H; Hatakeyama, K; Asada, Y; Emoto, N; Ikeda, K				Matsuo, Kiyonari; Akakabe, Yoshiki; Kitamura, Youhei; Shimoda, Yoshiaki; Ono, Kazunori; Ueyama, Tomomi; Matoba, Satoaki; Yamada, Hiroyuki; Hatakeyama, Kinta; Asada, Yujiro; Emoto, Noriaki; Ikeda, Koji			Loss of Apoptosis Regulator through Modulating IAP Expression (ARIA) Protects Blood Vessels from Atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITOR AVASIMIBE; MACROPHAGES; MICE; INFLAMMATION; DISEASE; LESIONS; CELLS	Atherosclerosis is the primary cause for cardiovascular disease. Here we identified a novel mechanism underlying atherosclerosis, which is provided by ARIA (apoptosis regulator through modulating IAP expression), the transmembrane protein that we recently identified. ARIA is expressed in macrophages present in human atherosclerotic plaque as well as in mouse peritoneal macrophages. When challenged with acetylated LDL, peritoneal macrophages isolated from ARIA-deficient mice showed substantially reduced foam cell formation, whereas the uptake did not differ from that in wild-type macrophages. Mechanistically, loss of ARIA enhanced PI3K/Akt signaling and consequently reduced the expression of acyl coenzyme A: cholesterol acyltransferase-1 (ACAT-1), an enzyme that esterifies cholesterol and promotes its storage, in macrophages. Inhibition of PI3K abolished the reduction in ACAT-1 expression and foam cell formation in ARIA-deficient macrophages. In contrast, overexpression of ARIA reduced Akt activity and enhanced foam cell formation in RAW264.7 macrophages, which was abrogated by treatment with ACAT inhibitor. Of note, genetic deletion of ARIA significantly reduced the atherosclerosis in ApoE-deficient mice. Oil red-O-positive lipid-rich lesion was reduced, which was accompanied by an increase of collagen fiber and decrease of necrotic core lesion in atherosclerotic plaque in ARIA/ApoE double-deficient mice. Analysis of bone marrow chimeric mice revealed that loss of ARIA in bone marrow cells was sufficient to reduce the atherosclerogenesis in ApoE-deficient mice. Together, we identified a unique role of ARIA in the pathogenesis of atherosclerosis at least partly by modulating macrophage foam cell formation. Our results indicate that ARIA could serve as a novel pharmacotherapeutic target for the treatment of atherosclerotic diseases.	[Matsuo, Kiyonari; Akakabe, Yoshiki; Kitamura, Youhei; Shimoda, Yoshiaki; Ono, Kazunori; Ueyama, Tomomi; Matoba, Satoaki; Yamada, Hiroyuki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiol, Kamigyo Ku, Kyoto 6028566, Japan; [Emoto, Noriaki; Ikeda, Koji] Kobe Pharmaceut Univ, Dept Clin Pharm, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Hatakeyama, Kinta; Asada, Yujiro] Miyazaki Univ, Dept Pathol, Fac Med, Miyazaki 8891692, Japan	Kyoto Prefectural University of Medicine; Kobe Pharmaceutical University; University of Miyazaki	Ikeda, K (corresponding author), Kobe Pharmaceut Univ, Dept Clin Pharm, Higashinada Ku, 4-19-1 Motoyama Kitamachi, Kobe, Hyogo 6588558, Japan.	ikedak-circ@umin.ac.jp		ikeda, Koji/0000-0002-9972-7255; Emoto, Noriaki/0000-0001-6673-2616	Takeda Science Foundation;  [C:KAKENHI-23591107];  [KAKENHI-23659423];  [KAKENHI-26670406]	Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; 	This work was supported by Grant-in-aid for Scientific Research C:KAKENHI-23591107 and Grants-in-aid for Challenging Exploratory Research KAKENHI-23659423 and -26670406, as well as a research grant from Takeda Science Foundation.	Akakabe Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3389; Bocan TMA, 2000, ARTERIOSCL THROM VAS, V20, P70, DOI 10.1161/01.ATV.20.1.70; Daugherty A, 2002, CIRC RES, V90, P1039, DOI 10.1161/01.RES.0000021397.28936.F9; Ding L, 2012, CELL METAB, V15, P861, DOI 10.1016/j.cmet.2012.04.020; Farese RV, 2006, ARTERIOSCL THROM VAS, V26, P1684, DOI 10.1161/01.ATV.0000227511.35456.90; Faxon DP, 2004, CIRCULATION, V109, P2595, DOI 10.1161/01.CIR.0000128517.52533.DB; Fazio S, 2001, J CLIN INVEST, V107, P163, DOI 10.1172/JCI10310; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Ikeda K, 2009, P NATL ACAD SCI USA, V106, P8227, DOI 10.1073/pnas.0806780106; Ikenoya M, 2007, ATHEROSCLEROSIS, V191, P290, DOI 10.1016/j.atherosclerosis.2006.05.048; Kharbanda RK, 2005, CIRCULATION, V111, P804, DOI 10.1161/01.CIR.0000155236.25081.9B; Kitamura Y, 2014, J BIOL CHEM, V289, P2788, DOI 10.1074/jbc.M113.508143; Koide M, 2011, P NATL ACAD SCI USA, V108, P9472, DOI 10.1073/pnas.1101296108; Linton MF, 2003, INT J OBESITY, V27, pS35, DOI 10.1038/sj.ijo.0802498; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nakagawa Y, 2010, ARTERIOSCL THROM VAS, V30, P1908, DOI 10.1161/ATVBAHA.110.206185; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; Perrey S, 2001, ATHEROSCLEROSIS, V155, P359, DOI 10.1016/S0021-9150(00)00599-2; Rodriguez A, 1999, ARTERIOSCL THROM VAS, V19, P2199, DOI 10.1161/01.ATV.19.9.2199; Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064; Shimoda Y, 2014, BIOCHEM BIOPH RES CO, V446, P1243, DOI 10.1016/j.bbrc.2014.03.098; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Thompson RC, 2013, LANCET, V381, P1211, DOI 10.1016/S0140-6736(13)60598-X; Xu SW, 2010, CYTOTECHNOLOGY, V62, P473, DOI 10.1007/s10616-010-9290-0; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; Yuan Y, 2012, PROTEIN CELL, V3, P173, DOI 10.1007/s13238-012-2025-6	27	5	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3784	3792		10.1074/jbc.M114.605287	http://dx.doi.org/10.1074/jbc.M114.605287			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533470	Green Published, hybrid			2022-12-26	WOS:000349456000049
J	Zhang, X; Meekins, DA; An, CJ; Zolkiewski, M; Battaile, KP; Kanost, MR; Lovell, S; Michel, K				Zhang, Xin; Meekins, David A.; An, Chunju; Zolkiewski, Michal; Battaile, Kevin P.; Kanost, Michael R.; Lovell, Scott; Michel, Kristin			Structural and Inhibitory Effects of Hinge Loop Mutagenesis in Serpin-2 from the Malaria Vector Anopheles gambiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Host-Pathogen Interaction; Insect Immunity; Malaria; Serpin; Structural Biology	SERINE PROTEINASE HOMOLOGS; MANDUCA-SEXTA; FACTOR-XA; PROPHENOLOXIDASE ACTIVATION; MACROMOLECULAR STRUCTURES; ALLOSTERIC MECHANISM; ANTITHROMBIN-HEPARIN; IMMUNE-RESPONSES; SPACE-GROUP; INSECT	Background: Serpin-2 (SRPN2) is a key regulator of mosquito immunity and contains an inserted hinge region linked to activation in other serpins. Results: Structure/function analyses of hinge mutations refute a hypothesized activation mechanism in SRPN2. Conclusion: SRPN2 hinge insertion provides a thermodynamically stable conformation without restricting inhibitory capability. Significance: To effectively utilize SRPN2 for vector control, its mode of action must be understood. Serpin-2 (SRPN2) is a key negative regulator of the melanization response in the malaria vector Anopheles gambiae. SRPN2 irreversibly inhibits clip domain serine proteinase 9 (CLIPB9), which functions in a serine proteinase cascade culminating in the activation of prophenoloxidase and melanization. Silencing of SRPN2 in A. gambiae results in spontaneous melanization and decreased life span and is therefore a promising target for vector control. The previously determined structure of SRPN2 revealed a partial insertion of the hinge region of the reactive center loop (RCL) into sheet A. This partial hinge insertion participates in heparin-linked activation in other serpins, notably antithrombin III. SRPN2 does not contain a heparin binding site, and any possible mechanistic function of the hinge insertion was previously unknown. To investigate the function of the SRPN2 hinge insertion, we developed three SRPN2 variants in which the hinge regions are either constitutively expelled or inserted and analyzed their structure, thermostability, and inhibitory activity. We determined that constitutive hinge expulsion resulted in a 2.7-fold increase in the rate of CLIPB9(Xa) inhibition, which is significantly lower than previous observations of allosteric serpin activation. Furthermore, we determined that stable insertion of the hinge region did not appreciably decrease the accessibility of the RCL to CLIPB9. Together, these results indicate that the partial hinge insertion in SRPN2 does not participate in the allosteric activation observed in other serpins and instead represents a molecular trade-off between RCL accessibility and efficient formation of an inhibitory complex with the cognate proteinase.	[Zhang, Xin; Meekins, David A.; An, Chunju; Michel, Kristin] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [An, Chunju] China Agr Univ, Coll Agr & Biotechnol, Dept Entomol, Beijing 100094, Peoples R China; [Zolkiewski, Michal; Kanost, Michael R.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Battaile, Kevin P.] Hauptman Woodward Med Res Inst, Adv Photon Source Argonne Natl Lab, Ind Macromolecular Crystallog Assoc Collaborat Ac, Argonne, IL 60439 USA; [Lovell, Scott] Univ Kansas, Prot Struct Lab, Del Shankel Struct Biol Ctr, Lawrence, KS 66407 USA	Kansas State University; China Agricultural University; Kansas State University; Hauptman Woodward Medical Research Institute; University of Kansas	Michel, K (corresponding author), Kansas State Univ, Div Biol, 267 Chalmers Hall, Manhattan, KS 66506 USA.	kmichel@ksu.edu		Kanost, Michael/0000-0002-6827-0061; Battaile, Kevin/0000-0003-0833-3259	National Institutes of Health [R01AI095842, 5P20RR017708-10, 8P20GM103420-10]; Industrial Macromolecular Crystallography Association through Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Industrial Macromolecular Crystallography Association through Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI095842 (to K. M.). Use of the University of Kansas Protein Structure Laboratory was supported by National Institutes of Health Grants 5P20RR017708-10 and 8P20GM103420-10. Use of the Industrial Macromolecular Crystallography Association Collaborative Access Team beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; An CJ, 2011, CELL MOL LIFE SCI, V68, P1929, DOI 10.1007/s00018-010-0543-z; An CJ, 2011, PROTEINS, V79, P1999, DOI 10.1002/prot.23002; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Crompton PD, 2014, ANNU REV IMMUNOL, V32, P157, DOI 10.1146/annurev-immunol-032713-120220; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dementiev A, 2013, J BIOL CHEM, V288, P33611, DOI 10.1074/jbc.M113.510727; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dunstone MA, 2011, METHOD ENZYMOL, V501, P63, DOI 10.1016/B978-0-12-385950-1.00005-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P, 2012, SCIENCE, V336, P986, DOI 10.1126/science.1222162; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Felfoldi G, 2011, J IMMUNOL, V186, P4828, DOI 10.4049/jimmunol.1003246; Futamura A, 2000, J BIOL CHEM, V275, P4092, DOI 10.1074/jbc.275.6.4092; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gulley MM, 2013, J INSECT PHYSIOL, V59, P138, DOI 10.1016/j.jinsphys.2012.08.015; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Hillyer JF, 2010, ADV EXP MED BIOL, V708, P218; HOOD DB, 1994, BIOCHEMISTRY-US, V33, P8538, DOI 10.1021/bi00194a020; Horvath AJ, 2005, J BIOL CHEM, V280, P43168, DOI 10.1074/jbc.M505598200; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington JA, 1998, BIOCHEMISTRY-US, V37, P3272, DOI 10.1021/bi972182o; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Jiang H, 1995, INSECT BIOCHEM MOLEC, V25, P1093, DOI 10.1016/0965-1748(95)00042-9; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Karunamoorthi K, 2014, INT J PREVENTIVE MED, V5, P529; Knox TB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-76; Koella JC, 2009, ADV PARASIT, V68, P315, DOI 10.1016/S0065-308X(08)00612-X; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langdown J, 2004, J BIOL CHEM, V279, P47288, DOI 10.1074/jbc.M408961200; Lebedev AA, 2014, ACTA CRYSTALLOGR D, V70, P2430, DOI 10.1107/S1399004714014795; Lu AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00252; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2003, J MOL BIOL, V326, P823, DOI 10.1016/S0022-2836(02)01382-7; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olson ST, 2011, PROG MOL BIOL TRANSL, V99, P185, DOI 10.1016/S1877-1173(11)99005-X; Olson ST, 2010, BIOCHIMIE, V92, P1587, DOI 10.1016/j.biochi.2010.05.011; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Park SH, 2011, J BIOL CHEM, V286, P1567, DOI 10.1074/jbc.M110.144006; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Povelones M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003623; RATCLIFFE NA, 1984, SCIENCE, V226, P557, DOI 10.1126/science.226.4674.557; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; Silva APB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-450; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Van Walderveen MC, 2010, J BIOCHEM, V148, P255, DOI 10.1093/jb/mvq060; Volz J, 2005, J BIOL CHEM, V280, P40161, DOI 10.1074/jbc.M506191200; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wang JM, 2005, ACTA CRYSTALLOGR D, V61, P67, DOI 10.1107/S0907444904026721; Weiss DJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-171; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Yassine H, 2010, CELL MICROBIOL, V12, P1, DOI 10.1111/j.1462-5822.2009.01388.x; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1	75	6	8	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2946	2956		10.1074/jbc.M114.625665	http://dx.doi.org/10.1074/jbc.M114.625665			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25525260	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000349310700033
J	Bayin, NS; Modrek, AS; Dietrich, A; Lebowitz, J; Abel, T; Song, HR; Schober, M; Zagzag, D; Buchholz, CJ; Chao, MV; Placantonakis, DG				Bayin, N. Sumru; Modrek, Aram S.; Dietrich, August; Lebowitz, Jonathan; Abel, Tobias; Song, Hae-Ri; Schober, Markus; Zagzag, David; Buchholz, Christian J.; Chao, Moses V.; Placantonakis, Dimitris G.			Selective Lentiviral Gene Delivery to CD133-Expressing Human Glioblastoma Stem Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; HEMATOPOIETIC STEM; CANCER; CD133; IDENTIFICATION; VECTORS; GROWTH; VIRUS; AC133; MICROENVIRONMENT	Glioblastoma multiforme (GBM) is a deadly primary brain malignancy. Glioblastoma stem cells (GSC), which have the ability to self-renew and differentiate into tumor lineages, are believed to cause tumor recurrence due to their resistance to current therapies. A subset of GSCs is marked by cell surface expression of CD133, a glycosylated pentaspan transmembrane protein. The study of CD133-expressing GSCs has been limited by the relative paucity of genetic tools that specifically target them. Here, we present CD133-LV, a lentiviral vector presenting a single chain antibody against CD133 on its envelope, as a vehicle for the selective transduction of CD133-expressing GSCs. We show that CD133-LV selectively transduces CD133+ human GSCs in dose-dependent manner and that transduced cells maintain their stem-like properties. The transduction efficiency of CD133-LV is reduced by an antibody that recognizes the same epitope on CD133 as the viral envelope and by shRNA-mediated knockdown of CD133. Conversely, the rate of transduction by CD133-LV is augmented by overexpression of CD133 in primary human GBM cultures. CD133-LV selectively transduces CD133-expressing cells in intracranial human GBM xenografts in NOD. SCID mice, but spares normal mouse brain tissue, neurons derived from human embryonic stem cells and primary human astrocytes. Our findings indicate that CD133-LV represents a novel tool for the selective genetic manipulation of CD133-expressing GSCs, and can be used to answer important questions about how these cells contribute to tumor biology and therapy resistance.	[Bayin, N. Sumru; Modrek, Aram S.; Dietrich, August; Lebowitz, Jonathan; Song, Hae-Ri; Placantonakis, Dimitris G.] NYU, Dept Neurosurg, Sch Med, New York, NY 10016 USA; [Bayin, N. Sumru; Schober, Markus; Placantonakis, Dimitris G.] NYU, Helen L & Martin S Kimmel Ctr Stem Cell Biol, Sch Med, New York, NY 10016 USA; [Modrek, Aram S.] NYU, Sch Med, Med Scientist Training Program, New York, NY 10016 USA; [Abel, Tobias; Buchholz, Christian J.] Paul Ehrlich Inst, Langen, Germany; [Schober, Markus] NYU, Dept Cell Biol, Sch Med, New York, NY 10016 USA; [Schober, Markus] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA; [Zagzag, David] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Buchholz, Christian J.] German Canc Consortium, Heidelberg, Germany; [Chao, Moses V.] NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; [Placantonakis, Dimitris G.] NYU, Sch Med, Brain Tumor Ctr, New York, NY 10016 USA	New York University; New York University; New York University; Paul Ehrlich Institute; New York University; New York University; New York University; Helmholtz Association; German Cancer Research Center (DKFZ); New York University; New York University	Placantonakis, DG (corresponding author), NYU, Dept Neurosurg, Sch Med, 550 1St Ave, New York, NY 10016 USA.	dimitris.placantonakis@nyumc.org		Chao, Moses/0000-0002-6969-3744; Bayin, Nermin Sumru/0000-0003-4371-855X; Modrek, Aram/0000-0001-7586-9833; Placantonakis, Dimitris/0000-0003-1950-2978	NYSTEM Institutional training grant [CO26880]; Medical Scientist Training Program at NYU School of Medicine; American Brain Tumor Association Medical Student Summer Fellowship; NIH/NINDS [K08N5064297, 1R21N5087241- 01, 1R21NS088775-01]; LOEWE Center for Cell and Gene Therapy Frankfurt - Hessische Ministerium fur Wissenschaft und Kunst (HMWK) [Ill L 4-518/17.004]; Deutsche Forschungsgemeinschaft [BU 1301/3-1]; NIH/NCI [2P30CA016087-33]; NIH/NCATS [UL1 TR000038]; B*Cured Foundation; NYU Cancer Institute; NYU Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS088775, K08NS064297, R21NS087241] Funding Source: NIH RePORTER	NYSTEM Institutional training grant; Medical Scientist Training Program at NYU School of Medicine; American Brain Tumor Association Medical Student Summer Fellowship; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); LOEWE Center for Cell and Gene Therapy Frankfurt - Hessische Ministerium fur Wissenschaft und Kunst (HMWK); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); B*Cured Foundation; NYU Cancer Institute; NYU Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	N. Sumru Bayin received support from NYSTEM Institutional training grant #CO26880. Aram S. Modrek received support from the Medical Scientist Training Program at NYU School of Medicine. August Dietrich received support from American Brain Tumor Association Medical Student Summer Fellowship in Honor of Audley Ciamporcero, Jr. Hae-Ri Song received support from NIH/NINDS K08N5064297. Christian J. Buchholz receives support from the LOEWE Center for Cell and Gene Therapy Frankfurt funded by the Hessische Ministerium fur Wissenschaft und Kunst (HMWK; funding reference number: Ill L 4-518/17.004 (2010)) and the Deutsche Forschungsgemeinschaft (BU 1301/3-1). Dimitris Placantonakis received support from NIH/NINDS 1R21N5087241- 01, NIH/NINDS 1R21NS088775-01, NIH/NCI 2P30CA016087-33, NIH/NCATS UL1 TR000038, B*Cured Foundation, NYU Cancer Institute, and NYU Clinical and Translational Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anliker B, 2010, NAT METHODS, V7, P929, DOI 10.1038/nmeth.1514; Bach P, 2013, CANCER RES, V73, P865, DOI 10.1158/0008-5472.CAN-12-2221; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bauer N, 2011, EMBO MOL MED, V3, P398, DOI 10.1002/emmm.201100147; Brescia P, 2013, STEM CELLS, V31, P857, DOI 10.1002/stem.1317; Campos B, 2011, GLIA, V59, P1974, DOI 10.1002/glia.21239; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Cockrell AS, 2007, MOL BIOTECHNOL, V36, P184, DOI 10.1007/s12033-007-0010-8; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; de Miera EVS, 2012, PIGM CELL MELANOMA R, V25, P395, DOI 10.1111/j.1755-148X.2012.00994.x; Dirks PB, 2008, J CLIN ONCOL, V26, P2916, DOI 10.1200/JCO.2008.17.6792; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fargeas CA, 2003, STEM CELLS, V21, P506, DOI 10.1634/stemcells.21-4-506; Finkelshtein D, 2013, P NATL ACAD SCI USA, V110, P7306, DOI 10.1073/pnas.1214441110; Funke S, 2008, MOL THER, V16, P1427, DOI 10.1038/mt.2008.128; Hardee ME, 2012, CANCER RES, V72, P4119, DOI 10.1158/0008-5472.CAN-12-0546; Jamal M, 2012, NEOPLASIA, V14, P150, DOI 10.1593/neo.111794; Kang MK, 2007, STEM CELLS DEV, V16, P837, DOI 10.1089/scd.2007.0006; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Placantonakis DG, 2009, STEM CELLS, V27, P521, DOI 10.1634/stemcells.2008-0884; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schnierle BS, 1997, P NATL ACAD SCI USA, V94, P8640, DOI 10.1073/pnas.94.16.8640; Shimozato O, 2014, ONCOGENE; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009	41	16	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116114	10.1371/journal.pone.0116114	http://dx.doi.org/10.1371/journal.pone.0116114			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541984	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900146
J	Fallahi, M; Amelio, AL; Cleveland, JL; Rounbehler, RJ				Fallahi, Mohammad; Amelio, Antonio L.; Cleveland, John L.; Rounbehler, Robert J.			CREB Targets Define the Gene Expression Signature of Malignancies Having Reduced Levels of the Tumor Suppressor Tristetraprolin	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; AU-RICH ELEMENT; MESSENGER-RNA; STABILITY; SUBTYPES; CANCER; ALPHA; P38; INFLAMMATION; REGULATOR	The RNA-binding protein Tristetraprolin (TTP, ZFP36) functions as a tumor suppressor that impairs the development and disables the maintenance of MYC-driven lymphoma. In addition, other human cancers expressed reduced levels of TTP, suggesting that it may function as a tumor suppressor in several malignancies. To identify genes that may be associated with TTP tumor suppressor functions in human cancer, we analyzed The Cancer Genome Atlas (TCGA) breast cancer, lung adenocarcinoma, lung squamous cell carcinoma, and colon adenocarcinoma datasets. These analyses defined a signature of 50 genes differentially regulated between high and low TTP-expressing tumors. Notably, patients with low TTP-expressing breast cancer and lung adenocarcinoma had decreased survival rates and more aggressive tumors with increased necrosis. In addition, analysis across non-TCGA tumor gene expression databases identified a broad spectrum of human cancers having similarities with the TTP-low tumor gene signature, including pancreatic, bladder, and prostate cancer. TTP has documented roles in regulating mRNAs encoding inflammatory proteins, and pathway analysis identified several inflammatory pathways that are altered in tumors with low TTP expression. Surprisingly, the TTP-low tumor gene signature includes a core component of 20 under-expressed CREB target genes, suggesting that the regulation of CREB activity may be related to the tumor suppressor function of TTP. Thus, reduced levels of TTP are a potential biomarker for human cancers with poor outcome, and targeting the CREB pathway may be a therapeutic route for treating aggressive TTP-low tumors.	[Fallahi, Mohammad] Scripps Florida, Scripps Res Inst, Informat Core, Jupiter, FL USA; [Amelio, Antonio L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Dent, Chapel Hill, NC 27599 USA; [Cleveland, John L.; Rounbehler, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA	Scripps Research Institute; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill; H Lee Moffitt Cancer Center & Research Institute	Rounbehler, RJ (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA.	Robert.Rounbehler@moffitt.org		Amelio, Antonio L./0000-0002-6295-2694	NIH [R01-CA167093, K99-CA157954]; ThinkPink Kids Foundation; State of Florida; UNC University Cancer Research Funds; NCI Comprehensive Cancer Center [P30-CA076292, P30-CA016086]; NATIONAL CANCER INSTITUTE [R00CA157954, R01CA167093, P30CA076292, K99CA157954, P30CA016086] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ThinkPink Kids Foundation; State of Florida; UNC University Cancer Research Funds; NCI Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work is supported by NIH grants (R01-CA167093 to J.L.C. and K99-CA157954 to ALA.), by monies from the ThinkPink Kids Foundation (J.L.C.), by monies from the State of Florida to TSRI (J.L.C.), and UNC University Cancer Research Funds (A.L.A.). This work was also supported in part by NCI Comprehensive Cancer Center Grants P30-CA076292 awarded to the H. Lee Moffitt Cancer Center & Research Institute and P30-CA016086 awarded to the Lineberger Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bourcier C, 2011, AM J PHYSIOL-CELL PH, V301, pC609, DOI 10.1152/ajpcell.00506.2010; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lai WS, 2005, J BIOL CHEM, V280, P34365, DOI 10.1074/jbc.M506757200; Lee HH, 2010, INT J CANCER, V126, P1817, DOI 10.1002/ijc.24847; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Mukherjee N, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r12; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Newton K., 2012, COLD SPRING HARB PER, V4; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Rounbehler RJ, 2012, CELL, V150, P563, DOI 10.1016/j.cell.2012.06.033; Sanduja S, 2012, FRONT BIOSCI-LANDMRK, V17, P174, DOI 10.2741/3920; Sanduja S, 2009, AGING-US, V1, P803, DOI 10.18632/aging.100086; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Suswam E, 2008, CANCER RES, V68, P674, DOI 10.1158/0008-5472.CAN-07-2751; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Van Tubergen E, 2011, CANCER-AM CANCER SOC, V117, P2677, DOI 10.1002/cncr.25859; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010	46	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115517	10.1371/journal.pone.0115517	http://dx.doi.org/10.1371/journal.pone.0115517			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541715	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900049
J	Filipiak, M; Weiner, J				Filipiak, Michal; Weiner, January			How to Make a Beetle Out of Wood: Multi-Elemental Stoichiometry of Wood Decay, Xylophagy and Fungivory	PLOS ONE			English	Article							NUTRITIONAL CONSTRAINTS; LITTER DECOMPOSITION; NITROGEN; FORESTS; DEBRIS; PHYTOPLANKTON; ACCUMULATION; TERRESTRIAL; ERGOSTEROL; NUTRIENTS	The majority of terrestrial biomass is wood, but the elemental composition of its potential consumers, xylophages, differs hugely from that of wood. This causes a severe nutritional imbalance. We studied the stoichiometric relationships of 11 elements (C, N, P, K, Ca, Mg, Fe, Zn, Mn, Cu, Na) in three species of pine-xylem-feeding insects, Stictoleptura rubra, Arhopalus rusticus (Coleoptera, Cerambycidae) and Chalcophora mariana (Coleoptera, Buprestidae), to elucidate their mechanisms of tissue growth and to match their life histories to their dietary constraints. These beetles do not differ from other Coleoptera in their absolute elemental compositions, which are approximately 1000 (N), 100 (P, Cu) and 50 (K, Na) times higher than in dead but undecayed pine wood. This discrepancy diminishes along the wood decay gradient, but the elemental concentrations remain higher by an order of magnitude in beetles than in highly decayed wood. Numerical simulation of the life history of S. rubra shows that feeding on nutrient-poor undecayed wood would extend its development time to implausible values, whereas feeding on highly decomposed wood (heavily infected with fungi) would barely balance its nutritional budget during the long development period of this species. The changes in stoichiometry indicate that the relative change in the nutrient levels in decaying wood cannot be attributed solely to carbon loss resulting from decomposer respiration: the action of fungi substantially enriches the decaying wood with nutritional elements imported from the outside of the system, making it a suitable food for wood-eating invertebrates.	[Filipiak, Michal; Weiner, January] Jagiellonian Univ, Inst Environm Sci, PL-30387 Krakow, Poland	Jagiellonian University	Filipiak, M (corresponding author), Jagiellonian Univ, Inst Environm Sci, Ul Gronostajowa 7, PL-30387 Krakow, Poland.	michal0filipiak@gmail.com	Filipiak, Michał/C-1907-2016	Filipiak, Michał/0000-0001-7438-4885	National Science Centre [2011/01/B/NZ8/00103]; Polish Ministry of Science and Higher Education [DS/WBiNoZ/INoS/DS 756, DS/MND/WBiNoZ/INoS/11/2013]	National Science Centre(National Science Centre, Poland); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The study was supported by the National Science Centre (Grant No. 2011/01/B/NZ8/00103) and Polish Ministry of Science and Higher Education (Grant No. DS/WBiNoZ/INoS/DS 756 and DS/MND/WBiNoZ/INoS/11/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres MP, 2000, ECOLOGY, V81, P2198, DOI 10.1890/0012-9658(2000)081[2198:NBOPFB]2.0.CO;2; BODDY L, 1995, CAN J BOT, V73, pS1377, DOI 10.1139/b95-400; Boddy L, 2009, MYCOSCIENCE, V50, P9, DOI 10.1007/s10267-008-0450-4; Cairney JWG, 2005, MYCOL RES, V109, P7, DOI 10.1017/S0953756204001753; Campos JA, 2011, BIOL TRACE ELEM RES, V144, P1370, DOI 10.1007/s12011-011-9134-6; Clinton PW, 2009, CAN J FOREST RES, V39, P2193, DOI 10.1139/X09-134; Cohen AC, 2005, INSECT DIETS SCI TEC; Denno RF, 2003, ECOLOGY, V84, P2522, DOI 10.1890/02-0370; Dighton J., 2007, P287; DOMINIK J., 2004, OWADY USZKADZAJACE D; Douglas A.E., 2009, FUNCT ECOL, V23, P38; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Fukasawa Y, 2014, ECOL RES, V29, P257, DOI 10.1007/s11284-013-1120-3; Garrett LG, 2008, FOREST ECOL MANAG, V255, P3839, DOI 10.1016/j.foreco.2008.03.031; Gonzalez AL, 2011, OIKOS, V120, P1247, DOI 10.1111/j.1600-0706.2010.19151.x; Haack R.A., 1987, P449; Hessen DO, 2013, LIMNOL OCEANOGR, V58, P2219, DOI 10.4319/lo.2013.58.6.2219; Joern A, 2012, ECOLOGY, V93, P1002, DOI 10.1890/11-1142.1; Karimi R, 2006, ECOL LETT, V9, P1273, DOI 10.1111/j.1461-0248.2006.00979.x; Klamer M, 2004, SOIL BIOL BIOCHEM, V36, P57, DOI 10.1016/j.soilbio.2003.08.019; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Lindahl BO, 2002, PLANT SOIL, V242, P123, DOI 10.1023/A:1019650226585; Meerts P, 2002, ANN FOR SCI, V59, P713, DOI 10.1051/forest:2002059; Mooshammer M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00022; Niemenmaa O, 2008, INT BIODETER BIODEGR, V62, P125, DOI 10.1016/j.ibiod.2007.12.009; Palviainen M, 2010, FOREST ECOL MANAG, V260, P1478, DOI 10.1016/j.foreco.2010.07.046; Palviainen M, 2010, FOREST ECOL MANAG, V259, P390, DOI 10.1016/j.foreco.2009.10.034; Quigg A, 2011, P ROY SOC B-BIOL SCI, V278, P526, DOI 10.1098/rspb.2010.1356; ROSKOSKI JP, 1980, PLANT SOIL, V54, P33, DOI 10.1007/BF02181997; Rudawska M, 2005, FOOD CHEM, V92, P499, DOI 10.1016/j.foodchem.2004.08.017; Rumpold BA, 2013, MOL NUTR FOOD RES, V57, P802, DOI 10.1002/mnfr.201200735; Russell MB, 2014, ECOSYSTEMS, V17, P765, DOI 10.1007/s10021-014-9757-5; Schneider K, 2010, ECOL RES, V25, P565, DOI 10.1007/s11284-009-0686-2; Schneider T, 2012, ISME J, V6, P1749, DOI 10.1038/ismej.2012.11; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sun X, 2013, J INSECT PHYSIOL, V59, P408, DOI 10.1016/j.jinsphys.2013.01.010; Tanahashi M, 2009, J INSECT PHYSIOL, V55, P983, DOI 10.1016/j.jinsphys.2009.07.002; Tobin B, 2007, FORESTRY, V80, P455, DOI 10.1093/forestry/cpm024; Twining BS, 2013, ANNU REV MAR SCI, V5, P191, DOI 10.1146/annurev-marine-121211-172322; Vetter J, 2005, MYCOL RES, V109, P746, DOI 10.1017/S0953756205002455; Walczynska A, 2012, B ENTOMOL RES, V102, P644, DOI 10.1017/S0007485312000296; Walczynska A, 2010, B ENTOMOL RES, V100, P461, DOI 10.1017/S0007485309990514; Walczynska A, 2007, EUR J ENTOMOL, V104, P181, DOI 10.14411/eje.2007.027; Watkinson S, 2006, FUNGI BIOGEOCHEMICAL, P151, DOI [10.1017/CBO9780511550522.008, DOI 10.1017/CBO9780511550522.008]	46	37	37	9	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115104	10.1371/journal.pone.0115104	http://dx.doi.org/10.1371/journal.pone.0115104			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536334	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300029
J	Jin, SJ; Sonobe, Y; Kawanokuchi, J; Horiuchi, H; Cheng, Y; Wang, Y; Mizuno, T; Takeuchi, H; Suzumura, A				Jin, Shijie; Sonobe, Yoshifumi; Kawanokuchi, Jun; Horiuchi, Hiroshi; Cheng, Yi; Wang, Yue; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio			Interleukin-34 Restores Blood-Brain Barrier Integrity by Upregulating Tight Junction Proteins in Endothelial Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA NEUROTOXICITY; LANGERHANS CELLS; RAT-BRAIN; IN-VITRO; RECEPTOR; MICROGLIA; IL-34; LYMPHOCYTES; DISRUPTION	Interleukin-34 (IL-34) is a newly discovered cytokine as an additional ligand for colony stimulating factor-1 receptor (CSF1R), and its functions are expected to overlap with colony stimulating factor-1/macrophage-colony stimulating factor. We have previously shown that the IL-34 is primarily produced by neurons in the central nervous system (CNS) and induces proliferation and neuroprotective properties of microglia which express CSF1R. However, the functions of IL-34 in the CNS are still elucidative. Here we show that CNS capillary endothelial cells also express CSF1R. IL-34 protected blood-brain barrier integrity by restored expression levels of tight junction proteins, which were downregulated by pro-inflammatory cytokines. The novel function of IL-34 on the blood-brain barrier may give us a clue for new therapeutic strategies in neuroinflammatory and neurodegenerative diseases such as multiple sclerosis and Alzheimer's disease.	[Jin, Shijie; Sonobe, Yoshifumi; Kawanokuchi, Jun; Horiuchi, Hiroshi; Cheng, Yi; Wang, Yue; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Takeuchi, H (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	htake@riem.nagoya-u.ac.jp		Takeuchi, Hideyuki/0000-0001-5912-7581; jin, shijie/0000-0001-5689-841X; Horiuchi, Hiroshi/0000-0001-9008-2027	Ministry of Education, Culture, Sports, Science and Technology of Japan; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant from the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; and grants from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 1996, MOL MED TODAY, V2, P106, DOI 10.1016/1357-4310(96)88720-X; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Afonso PV, 2007, J IMMUNOL, V179, P2576, DOI 10.4049/jimmunol.179.4.2576; Begley DJ, 2003, ACTA PAEDIATR, V92, P83, DOI 10.1080/08035320310020904; Blamire AM, 2000, J NEUROSCI, V20, P8153; Bostrom EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081665; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Conejo-Garcia JR, 2005, BLOOD, V105, P679, DOI 10.1182/blood-2004-05-1906; FABRY Z, 1995, J IMMUNOL, V155, P325; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; HAO C, 1990, J NEUROSCI RES, V27, P314, DOI 10.1002/jnr.490270310; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kook SY, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23993; Li ED, 2011, J NEUROIMMUNOL, V240, P58, DOI 10.1016/j.jneuroim.2011.09.012; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Ma D, 2012, NEUROSCI LETT, V529, P86, DOI 10.1016/j.neulet.2012.08.071; Minagar A, 2003, ENDOTHELIUM-J ENDOTH, V10, P299, DOI 10.1080/10623320390272299; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; Mitrasinovic OM, 2005, J NEUROSCI, V25, P4442, DOI 10.1523/JNEUROSCI.0514-05.2005; Mizuno T, 2008, FASEB J, V22, P1797, DOI 10.1096/fj.07-099499; Mizuno T, 2011, AM J PATHOL, V179, P2016, DOI 10.1016/j.ajpath.2011.06.011; Nakamichi Y, 2012, P NATL ACAD SCI USA, V109, P10006, DOI 10.1073/pnas.1207361109; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; RISAU W, 1990, J CELL BIOL, V110, P1757, DOI 10.1083/jcb.110.5.1757; Sonobe Y, 2009, J BIOL CHEM, V284, P31834, DOI 10.1074/jbc.M109.025940; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Tureci O, 2011, GENE, V481, P83, DOI 10.1016/j.gene.2011.04.007; Wang Y, 2014, EUROPEAN J IMMUNOLOG; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Zhong Y, 2012, J NEUROSCI, V32, P143, DOI 10.1523/JNEUROSCI.4266-11.2012; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073	35	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115981	10.1371/journal.pone.0115981	http://dx.doi.org/10.1371/journal.pone.0115981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535736	gold, Green Submitted, Green Published			2022-12-26	WOS:000348563300095
J	Teshome, W; Assefa, A				Teshome, Wondu; Assefa, Anteneh			Predictors of Immunological Failure of Antiretroviral Therapy among HIV Infected Patients in Ethiopia: A Matched Case-Control Study	PLOS ONE			English	Article							VIROLOGICAL RESPONSES; RECOVERY; ADHERENCE; NONADHERENCE; MORTALITY; AFRICA; ADULTS; SWITCH; HAART; CARE	Background: In resource constrained settings, immunological assessment through CD4 count is used to assess response to first line Highly Active Antiretroviral Therapy (HAART). In this study, we aim to investigate factors associated with immunological treatment failure. Methods: A matched case-control study design was used. Cases were subjects who already experienced immunological treatment failure and controls were those without immunological failure after an exactly or approximately equivalent duration of first line treatment with cases. Data were analyzed using SPSS v16.0. Conditional logistic regression was carried out. Results: A total of 134 cases and 134 controls were included in the study. At baseline, the mean age +/- 1 SD of cases was 37.5 +/- 9.7 years whereas it was 36.9 +/- 9.2 years among controls. The median baseline CD4 counts of cases and controls were 121.0 cells/ml (IQR: 47-183 cells/ml) and 122.0 cells/ml (IQR: 80.0189.8 cells/ml), respectively. The median rate of CD4 cells increase was comparable for the two groups in the first six months of commencing HAART (P50.442). However, the median rate of CD4 increase was significantly different for the two groups in the next 6 months period (M6 to M12). The rate of increment was 8.8 (IQR: 0.5, 14.6) and 1.8 (IQR: 8.8, 11.3) cells/ml/month for controls and cases, respectively (Mann-Whitney U test, P50.003). In conditional logistic regressions grouped baseline CD4 count (P50.028), old age group and higher educational status (P, 0.001) were significant predictors of immunological treatment failure. Conclusion: Subjects with immunological treatment failure have an optimal rate of immunological recovery in the first 6 months of treatment with first line HAART, but relative to the non-failing group the rate declines at a later period, notably between 6 and 12 months. Low baseline CD4 count, old age and higher educational status were associated with immunological treatment failure.	[Teshome, Wondu; Assefa, Anteneh] Hawassa Univ, Coll Med & Hlth Sci, Sch Publ & Environm Hlth, Hawassa, Ethiopia	Hawassa University	Teshome, W (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Publ & Environm Hlth, Hawassa, Ethiopia.	wondu_teshome@yahoo.com	Asefa, Anteneh/AAG-6341-2020	Asefa, Anteneh/0000-0003-4470-1848; Teshome, Wondu/0000-0001-8292-7026	Hawassa University	Hawassa University	The study was funded by Hawassa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrogoua DP, 2012, PATIENT PREFER ADHER, V6, P227, DOI 10.2147/PPA.S26507; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Chandy S, 2011, AIDS CARE, V23, P569, DOI 10.1080/09540121.2010.525607; Charles M, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17375; Esposito A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-341; Federal Ministry of Health (FMoH) website, GUID MAN OPP INF ANT; FHAPCO website, MONTHL HIV CAR ART U; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Gsponer T, 2012, AIDS, V26, P57, DOI 10.1097/QAD.0b013e32834e1b5f; Gutierrez F, 2008, CURR HIV RES, V6, P100, DOI 10.2174/157016208783885038; Hansana V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-617; Herrmann S, 2008, INTERN MED J, V38, P8, DOI [10.1111/j.1445-5994.2008.01767.x, 10.1111/j.1445-5994.2007.01477.x]; Johnston V, 2012, JAIDS-J ACQ IMM DEF, V61, P370, DOI 10.1097/QAI.0b013e318266ee3f; Kanapathipillai R, 2011, TROP MED INT HEALTH, V16, P1495, DOI 10.1111/j.1365-3156.2011.02874.x; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Koethe JR, 2011, CLIN INFECT DIS, V53, P952, DOI 10.1093/cid/cir606; Landier J, 2011, AIDS CARE, V23, P75, DOI 10.1080/09540121.2010.498867; Langford Simone E, 2007, AIDS Res Ther, V4, P11, DOI 10.1186/1742-6405-4-11; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Nicastri E, 2005, J MED VIROL, V76, P153, DOI 10.1002/jmv.20352; Palombi L, 2009, CLIN INFECT DIS, V48, P115, DOI 10.1086/593312; Peltzer K, 2013, J HEALTH POPUL NUTR, V31, P150; Rajasuriar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020713; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; UNAIDS, TOG WE WILL END AIDS; van Griensven J, 2011, T ROY SOC TROP MED H, V105, P694, DOI 10.1016/j.trstmh.2011.08.007; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; WHO, ANT THER HIV INF AD	30	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115125	10.1371/journal.pone.0115125	http://dx.doi.org/10.1371/journal.pone.0115125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536416	Green Submitted, gold, Green Published			2022-12-26	WOS:000348563300030
J	Patterson, VL; Zullo, AJ; Koenig, C; Stoessel, S; Jo, H; Liu, XR; Han, J; Choi, M; Dewan, AT; Thomas, JL; Kuan, CY; Hoh, J				Patterson, Victoria L.; Zullo, Alfred J.; Koenig, Claire; Stoessel, Sean; Jo, Hakryul; Liu, Xinran; Han, Jinah; Choi, Murim; Dewan, Andrew T.; Thomas, Jean-Leon; Kuan, Chia-Yi; Hoh, Josephine			Neural-Specific Deletion of Htra2 Causes Cerebellar Neurodegeneration and Defective Processing of Mitochondrial OPA1	PLOS ONE			English	Article							SERINE-PROTEASE HTRA2/OMI; CYTOCHROME-C RELEASE; M-AAA PROTEASE; AUTOPHAGY; FUSION; OMI/HTRA2; MOVEMENTS; BRAIN; MND2; DEGRADATION	HTRA2, a serine protease in the intermembrane space, has important functions in mitochondrial stress signaling while its abnormal activity may contribute to the development of Parkinson's disease. Mice with a missense or null mutation of Htra2 fail to thrive, suffer striatal neuronal loss, and a parkinsonian phenotype that leads to death at 30-40 days of age. While informative, these mouse models cannot separate neural contributions from systemic effects due to the complex phenotypes of HTRA2 deficiency. Hence, we developed mice carrying a Htra2-floxed allele to query the consequences of tissue-specific HTRA2 deficiency. We found that mice with neural-specific deletion of Htra2 exhibited atrophy of the thymus and spleen, cessation to gain weight past postnatal (P) day 18, neurological symptoms including ataxia and complete penetrance of premature death by P40. Histologically, increased apoptosis was detected in the cerebellum, and to a lesser degree in the striatum and the entorhinal cortex, from P25. Even earlier at P20, mitochondria in the cerebella already exhibited abnormal morphology, including swelling, vesiculation, and fragmentation of the cristae. Furthermore, the onset of these structural anomalies was accompanied by defective processing of OPA1, a key molecule for mitochondrial fusion and cristae remodeling, leading to depletion of the L-isoform. Together, these findings suggest that HTRA2 is essential for maintenance of the mitochondrial integrity in neurons. Without functional HTRA2, a lifespan as short as 40 days accumulates a large quantity of dysfunctional mitochondria that contributes to the demise of mutant mice.	[Patterson, Victoria L.; Zullo, Alfred J.; Koenig, Claire; Stoessel, Sean; Jo, Hakryul; Hoh, Josephine] Yale Univ, Sch Med, Dept Environm Hlth Sci, New Haven, CT 06520 USA; [Han, Jinah; Thomas, Jean-Leon] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Choi, Murim] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Dewan, Andrew T.] Yale Univ, Sch Med, Dept Chron Dis Epidemiol, New Haven, CT 06510 USA; [Liu, Xinran] Yale Univ, Sch Med, Ctr Cellular & Mol Imaging, New Haven, CT 06510 USA; [Kuan, Chia-Yi] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Kuan, Chia-Yi] Childrens Healthcare Atlanta, Atlanta, GA USA	Yale University; Yale University; Yale University; Yale University; Yale University; Emory University; Children's Healthcare of Atlanta (CHOA)	Hoh, J (corresponding author), Yale Univ, Sch Med, Dept Environm Hlth Sci, New Haven, CT 06520 USA.	josephine.hoh@yale.edu	Choi, Murim/AAP-9120-2021; Han, Jinah/Q-5392-2019; Thomas, Jean-Leon/F-1151-2016	DeWan, Andrew/0000-0002-7679-8704; Koenig, Claire/0000-0003-2546-4031	Rosebay Medical Foundation; Yale Medical School Dean's Research Fund	Rosebay Medical Foundation; Yale Medical School Dean's Research Fund	This work was funded by Rosebay Medical Foundation and Yale Medical School Dean's Research Fund to JHoh. No URL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akepati VR, 2008, J NEUROCHEM, V106, P372, DOI 10.1111/j.1471-4159.2008.05401.x; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Baker M.J., 2011, COLD SPRING HARB PER, V3; Benninger DH, 2009, J NEUROL, V256, P256, DOI 10.1007/s00415-009-0092-2; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bogaerts V, 2008, HUM MUTAT, V29, P832, DOI 10.1002/humu.20713; Borghammer P, 2010, EUR J NEUROL, V17, P314, DOI 10.1111/j.1468-1331.2009.02807.x; Camicioli R, 2009, PARKINSONISM RELAT D, V15, P187, DOI 10.1016/j.parkreldis.2008.05.002; Catalan MJ, 1999, BRAIN, V122, P483, DOI 10.1093/brain/122.3.483; Cerasa A, 2006, BRAIN RES BULL, V71, P259, DOI 10.1016/j.brainresbull.2006.09.014; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Desideri Enrico, 2012, Int J Cell Biol, V2012, P607929, DOI 10.1155/2012/607929; Duvezin-Caubet S, 2007, MOL BIOL CELL, V18, P3582, DOI 10.1091/mbc.E07-02-0164; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; El-Khodor BF, 2008, EXP NEUROL, V212, P29, DOI 10.1016/j.expneurol.2008.02.025; Faccio L, 2000, J BIOL CHEM, V275, P2581, DOI 10.1074/jbc.275.4.2581; Fitzgerald JC, 2012, CELL DEATH DIFFER, V19, P257, DOI 10.1038/cdd.2011.90; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gerhardt E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028855; Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010; Goo HG, 2013, BBA-MOL CELL RES, V1833, P1866, DOI 10.1016/j.bbamcr.2013.03.016; Gray CW, 2000, EUR J BIOCHEM, V267, P5699, DOI 10.1046/j.1432-1327.2000.01589.x; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Ideguchi K, 2010, BIOCHEM BIOPH RES CO, V393, P264, DOI 10.1016/j.bbrc.2010.01.117; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; JONES JM, 1993, GENOMICS, V16, P669, DOI 10.1006/geno.1993.1246; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang S, 2013, CELL DEATH DIFFER, V20, P259, DOI 10.1038/cdd.2012.117; Kieper N, 2010, EXP CELL RES, V316, P1213, DOI 10.1016/j.yexcr.2010.01.005; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kruger R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.11.021; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Landes T, 2010, SEMIN CELL DEV BIOL, V21, P593, DOI 10.1016/j.semcdb.2009.12.012; Li B, 2010, CELL DEATH DIFFER, V17, P1773, DOI 10.1038/cdd.2010.55; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200; Moisoi N, 2009, CELL DEATH DIFFER, V16, P449, DOI 10.1038/cdd.2008.166; Niemann S, 2000, J NEUROSCI, V20, P4120; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pereira JB, 2009, NEUROREPORT, V20, P741, DOI 10.1097/WNR.0b013e328329370b; Plun-Favreau H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.77; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Rascol O, 1997, BRAIN, V120, P103, DOI 10.1093/brain/120.1.103; Ross OA, 2008, PARKINSONISM RELAT D, V14, P539, DOI 10.1016/j.parkreldis.2008.08.003; Simon-Sanchez J, 2008, HUM MOL GENET, V17, P1988, DOI 10.1093/hmg/ddn096; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; TAKADA M, 1993, NEUROSCI LETT, V150, P49, DOI 10.1016/0304-3940(93)90105-T; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Wang CY, 2011, BRAIN RES, V1385, P293, DOI 10.1016/j.brainres.2011.02.037; Wu T, 2008, J NEUROL NEUROSUR PS, V79, P760, DOI 10.1136/jnnp.2007.126599; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047; Zhang KY, 2011, EUR J RADIOL, V77, P269, DOI 10.1016/j.ejrad.2009.07.032; Zullo AJ, 2012, J BIOL CHEM, V287, P12668, DOI 10.1074/jbc.M111.320135	73	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115789	10.1371/journal.pone.0115789	http://dx.doi.org/10.1371/journal.pone.0115789			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531304	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100107
J	Cheval, B; Sarrazin, P; Pelletier, L				Cheval, Boris; Sarrazin, Philippe; Pelletier, Luc			Impulsive Approach Tendencies towards Physical Activity and Sedentary Behaviors, but Not Reflective Intentions, Prospectively Predict Non-Exercise Activity Thermogenesis	PLOS ONE			English	Article							NONEXERCISE ACTIVITY THERMOGENESIS; IMPLICIT; ADULTS; HEALTH; EMG	Understanding the determinants of non-exercise activity thermogenesis (NEAT) is crucial, given its extensive health benefits. Some scholars have assumed that a proneness to react differently to environmental cues promoting sedentary versus active behaviors could be responsible for inter-individual differences in NEAT. In line with this reflection and grounded on the Reflective-Impulsive Model, we test the assumption that impulsive processes related to sedentary and physical activity behaviors can prospectively predict NEAT, operationalized as spontaneous effort exerted to maintain low intensity muscle contractions within the release phases of an intermittent maximal isometric contraction task. Participants (n=91) completed a questionnaire assessing their intentions to adopt physical activity behaviors and a manikin task to assess impulsive approach tendencies towards physical activity behaviors (IAPA) and sedentary behaviors (IASB). Participants were then instructed to perform a maximal handgrip strength task and an intermittent maximal isometric contraction task. As hypothesized, multilevel regression analyses revealed that spontaneous effort was (a) positively predicted by IAPA, (b) negatively predicted by IASB, and (c) was not predicted by physical activity intentions, after controlling for some confounding variables such as age, sex, usual PA level and average force provided during the maximal-contraction phases of the task. These effects remained constant throughout all the phases of the task. This study demonstrated that impulsive processes may play a unique role in predicting spontaneous physical activity behaviors. Theoretically, this finding reinforces the utility of a motivational approach based on dual-process models to explain inter-individual differences in NEAT. Implications for health behavior theories and behavior change interventions are outlined.	[Cheval, Boris; Sarrazin, Philippe] Univ Grenoble Alpes, Lab Sport & Environm Social SENS, F-38000 Grenoble, France; [Cheval, Boris; Pelletier, Luc] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada; [Cheval, Boris] Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Ottawa; University of Geneva	Sarrazin, P (corresponding author), Univ Grenoble Alpes, Lab Sport & Environm Social SENS, F-38000 Grenoble, France.	philippe.sarrazin@ujf-grenoble.fr	Cheval, Boris/H-4574-2019	Cheval, Boris/0000-0002-6236-4673; Sarrazin, Philippe/0000-0003-0598-7564				Aiken L. S., 1991, MULTIPLE REGRESSION; Cheval B, 2014, HLTH PSYCHO IN PRESS; Conroy DE, 2010, ANN BEHAV MED, V39, P112, DOI 10.1007/s12160-010-9161-0; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; De Houwer J, 2001, COGNITION EMOTION, V15, P189, DOI 10.1080/0269993004200051; DUQUE J, 1995, APPL ERGON, V26, P61, DOI 10.1016/0003-6870(94)00003-H; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Friese M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044130; Friese M, 2011, SELF IDENTITY, V10, P336, DOI 10.1080/15298868.2010.536417; Friese M, 2008, EUR REV SOC PSYCHOL, V19, P285, DOI 10.1080/10463280802556958; Gast A, 2012, LEARN MOTIV, V43, P79, DOI 10.1016/j.lmot.2012.06.004; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Hofmann W., 2008, HEALTH PSYCHOL REV, V2, P111, DOI [10.1080/17437190802617668, DOI 10.1080/17437190802617668]; Hoozemans MJM, 2005, J ELECTROMYOGR KINES, V15, P358, DOI 10.1016/j.jelekin.2004.09.001; Krieglmeyer R, 2010, COGNITION EMOTION, V24, P810, DOI 10.1080/02699930903047298; Levine J, 2001, AM J PHYSIOL-ENDOC M, V281, pE670, DOI 10.1152/ajpendo.2001.281.4.E670; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Levine JA, 2002, BEST PRACT RES CL EN, V16, P679, DOI 10.1053/beem.2002.0227; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088; Mogg K, 2003, ADDICTION, V98, P825, DOI 10.1046/j.1360-0443.2003.00392.x; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wiers RW, 2011, PSYCHOL SCI, V22, P490, DOI 10.1177/0956797611400615; Xu YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087881	29	27	28	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115238	10.1371/journal.pone.0115238	http://dx.doi.org/10.1371/journal.pone.0115238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8WK	25526596	Green Submitted, Green Published, gold			2022-12-26	WOS:000347186200019
J	Li, ZL; Liang, XL; Liu, SX; Ye, ZM; Chen, YH; Wang, WJ; Li, RZ; Xu, LX; Feng, ZL; Shi, W				Li, Zhilian; Liang, Xinling; Liu, Shuangxin; Ye, Zhiming; Chen, Yuanhan; Wang, Wenjian; Li, Ruizhao; Xu, Lixia; Feng, Zhonglin; Shi, Wei			Pulmonary Hypertension: Epidemiology in Different CKD Stages and Its Association with Cardiovascular Morbidity	PLOS ONE			English	Article							ECHOCARDIOGRAPHY RECOMMENDATIONS; INDEPENDENT PREDICTOR; EUROPEAN ASSOCIATION; KIDNEY-DISEASE; HEART-FAILURE; PREVALENCE; MORTALITY; EVENTS; PROGNOSIS; PRESSURE	Background: Pulmonary hypertension (PH) was recently recognized as a common complication of end-stage renal disease (ESRD) that causes an increased risk of mortality. Epidemiological data for this disorder in earlier stages of chronic kidney disease (CKD) and its association with cardiovascular (CV) morbidity are scarce. Methods: We retrospectively analyzed 2,351 Chinese CKD patients with complete clinical records and echocardiography data between Jan 2008 and May 2012. The patients were divided into the following 6 groups: CKD Stages 1-4; Stage 5 for those not on or initiated on hemodialysis for <3 months; and Stage 5D for the patients undergoing hemodialysis for >= 3 months. The prevalence of PH and CV morbidity was investigated, and their association was evaluated with a logistic regression model. Results: PH was detected in 426 patients (18.1%). Mild, moderate and severe PH was diagnosed in 12.1%, 4.9% and 1.1% of the patients, respectively. Severe PH was detected in CKD Stages 5 and 5D. CV morbidity was found in 645 patients (27.4%). Compared with the non-PH group, the PH group had a higher risk for cardiac disease but not for cerebrovascular disease risk. PH severity was associated with cardiac morbidity risk [odds ratio (95% CI) for mild PH: 1.79 (1.30-2.47); moderate PH: 2.75 (1.73-4.37); severe PH: 3.90 (1.46-10.42)]. Conclusions: Our study showed for the first time the epidemiology profile of PH across the spectrum of CKD. Mild-to-moderate PH occurs with more frequency in advanced CKD, and severe PH is scarce in non-ESRD CKD. PH in CKD is associated with cardiac but not cerebrovascular disease, with increasing cardiac morbidity seen with increasing PH severity. Evidence from prospective studies addressing PH in this population is needed to predict cardiac events.	[Li, Zhilian; Liang, Xinling] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Li, Zhilian; Liang, Xinling; Liu, Shuangxin; Ye, Zhiming; Chen, Yuanhan; Wang, Wenjian; Li, Ruizhao; Xu, Lixia; Feng, Zhonglin; Shi, Wei] Southern Med Univ, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China	Shi, W (corresponding author), Southern Med Univ, Guangzhou, Guangdong, Peoples R China.	shiw_ggh@163.com	liu, shuangxin/AAS-7429-2020		National Natural Science Foundation [81200544, 81170683]; National Key Technology RD Program [2011BAI10B08]; National Clinical Key Specialty Construction Preparatory Projects, China	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); National Clinical Key Specialty Construction Preparatory Projects, China	This study was supported by grants from the National Natural Science Foundation (81200544 and 81170683), National Key Technology R&D Program (2011BAI10B08), and the National Clinical Key Specialty Construction Preparatory Projects, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwhab S, 2008, AM J NEPHROL, V28, P990, DOI 10.1159/000146076; Acarturk G, 2008, INT UROL NEPHROL, V40, P509, DOI 10.1007/s11255-007-9269-8; Agarwal R, 2012, NEPHROL DIAL TRANSPL, V27, P3908, DOI 10.1093/ndt/gfr661; BERGER M, 1985, J AM COLL CARDIOL, V6, P359, DOI 10.1016/S0735-1097(85)80172-8; Bolignano D, 2013, AM J KIDNEY DIS, V61, P612, DOI 10.1053/j.ajkd.2012.07.029; Covic A, 2009, NEPHROL DIAL TRANSPL, V24, P1506, DOI 10.1093/ndt/gfn613; Dagli CE, 2009, RESPIRATION, V78, P411, DOI 10.1159/000247334; Di Lullo L, 2013, CARDIORENAL MED, V3, P96, DOI 10.1159/000350952; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fabbian F, 2010, INT J NEPHROL, V11, P463; Fenstad ER, 2013, CHEST, V144, P1530, DOI 10.1378/chest.12-3033; Havlucu Y, 2007, RESPIRATION, V74, P503, DOI 10.1159/000102953; Hinderliter AL, 1999, AM J CARDIOL, V84, P481, DOI 10.1016/S0002-9149(99)00342-2; Humbert M, 2012, EUR RESPIR REV, V21, P306, DOI 10.1183/09059180.00005112; Issa N, 2008, TRANSPLANTATION, V86, P1384, DOI 10.1097/TP.0b013e318188d640; Kawar B, 2013, AM J NEPHROL, V37, P281, DOI 10.1159/000348804; Kumbar Lalathaksha, 2007, Adv Perit Dial, V23, P127; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P307, DOI 10.1093/ejechocard/jeq031; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P223, DOI 10.1093/ejechocard/jeq030; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li ZL, 2014, INT UROL NEPHROL, V46, P141, DOI 10.1007/s11255-013-0486-z; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; McQuillan BM, 2001, CIRCULATION, V104, P2797, DOI 10.1161/hc4801.100076; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Navaneethan SD, 2014, CLIN J AM SOC NEPHRO, V9, P855, DOI 10.2215/CJN.10191013; Pabst S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035310; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sise ME, 2013, KIDNEY INT, V84, P682, DOI 10.1038/ki.2013.186; Unal A, 2009, PERITON DIALYSIS INT, V29, P191; Weisbord SD, 2005, J AM SOC NEPHROL, V16, P2487, DOI 10.1681/ASN.2005020157; Yigla M, 2003, CHEST, V123, P1577, DOI 10.1378/chest.123.5.1577; Yigla M, 2006, SEMIN DIALYSIS, V19, P353, DOI 10.1111/j.1525-139X.2006.00186.x; Yigla M, 2009, KIDNEY INT, V75, P969, DOI 10.1038/ki.2009.10; Zoccali C, 2013, J AM SOC NEPHROL, V24, P639, DOI 10.1681/ASN.2012100990	35	24	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114392	10.1371/journal.pone.0114392	http://dx.doi.org/10.1371/journal.pone.0114392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525807	gold, Green Published, Green Submitted			2022-12-26	WOS:000347186200005
J	Lindsey, JC; Kawauchi, D; Schwalbe, EC; Solecki, DJ; Selby, MP; McKinnon, PJ; Olson, JM; Hayden, JT; Grundy, RG; Ellison, DW; Williamson, D; Bailey, S; Roussel, MF; Clifford, SC				Lindsey, J. C.; Kawauchi, D.; Schwalbe, E. C.; Solecki, D. J.; Selby, M. P.; McKinnon, P. J.; Olson, J. M.; Hayden, J. T.; Grundy, R. G.; Ellison, D. W.; Williamson, D.; Bailey, S.; Roussel, M. F.; Clifford, S. C.			Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenance	ONCOGENE			English	Article							HEDGEHOG PATHWAY; METHYLATION; CANCER; MODEL; PROTOONCOGENE; TUMORIGENESIS; INACTIVATION; ORGANIZATION; CEREBELLUM; INHIBITION	The identification of key tumorigenic events in Sonic Hedgehog (SHH) subgroup medulloblastomas (MBSHH) will be essential for the development of individualized therapies and improved outcomes. However, beyond confirmation of characteristic SHH pathway mutations, recent genome-wide sequencing studies have not revealed commonly mutated genes with widespread relevance as potential therapeutic targets. We therefore examined any role for epigenetic DNA methylation events in MBSHH using a cross-species approach to candidate identification, prioritization and validation. MBSHH-associated DNA methylation events were first identified in 216 subgrouped human medulloblastomas (50 MBSHH, 28 Wnt/Wingless, 44 Group 3 and 94 Group 4) and their conservation then assessed in tumors arising from four independent murine models of Shh medulloblastoma, alongside any role in tumorigenesis using functional assessments in mouse and human models. This strategy identified widespread regional CpG hypomethylation of VAV1, leading to its elevated expression, as a conserved aberrant epigenetic event, which characterizes the majority of MBSHH tumors in both species, and is associated with a poor outcome in MBSHH patients. Moreover, direct modulation of VAV1 in mouse and human models revealed a critical role in tumor maintenance, and its abrogation markedly reduced medulloblastoma growth. Further, Vav1 activity regulated granule neuron precursor germinal zone exit and migration initiation in an ex vivo model of early postnatal cerebellar development. These findings establish VAV1 as a critical epigenetically regulated oncogene with a key role in MBSHH maintenance, and highlight its potential as a validated therapeutic target and prognostic biomarker for the improved therapy of medulloblastoma.	[Lindsey, J. C.; Schwalbe, E. C.; Selby, M. P.; Hayden, J. T.; Williamson, D.; Bailey, S.; Clifford, S. C.] Newcastle Univ, Royal Victoria Infirm, Northern Inst Canc Res, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Kawauchi, D.; Roussel, M. F.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; [Solecki, D. J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [McKinnon, P. J.] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA; [Olson, J. M.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Grundy, R. G.] Univ Nottingham, Childrens Brain Tumor Res Ctr, Nottingham NG7 2RD, England; [Ellison, D. W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	Newcastle University - UK; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Washington; University of Washington Seattle; University of Nottingham; St Jude Children's Research Hospital	Clifford, SC (corresponding author), Newcastle Univ, Royal Victoria Infirm, Northern Inst Canc Res, Sir James Spence Inst Level 5, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	steve.clifford@ncl.ac.uk	Roussel, Martine F/F-1469-2016; Solecki, David/N-8080-2018	Roussel, Martine F/0000-0002-1740-8139; Lindsey, Janet/0000-0002-5043-7513; Clifford, Steve/0000-0003-4893-2184; Schwalbe, Ed/0000-0002-1190-9469	Brain Tumour Charity [16/46, 16/92]; NIH [CA-096832, CA-02165-29]; American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital; Mochida Foundation; Anderson fellowship; LoveOliver; Cancer Research UK [C8464/A13457]; Cancer Research UK [13457] Funding Source: researchfish; The Brain Tumour Charity [16/164, 16/193] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA114567, P30CA021765, P01CA096832, P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956] Funding Source: NIH RePORTER	Brain Tumour Charity; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Mochida Foundation; Anderson fellowship; LoveOliver; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); The Brain Tumour Charity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Brain Tumour Charity (grants 16/46 (SCC and SB) and 16/92 (SCC, SB, DWE and JCL)), NIH CA-096832, CA-02165-29 (MFR), the American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital (MFR, DK), the Mochida Foundation (DK), the Anderson fellowship (DK), LoveOliver (SCC and DW) and Cancer Research UK (grant C8464/A13457; SCC, SB and DWE). Cell lines D425Med and MEB-Med8A were gifts from Dr D Bigner (Duke University, Durham, USA) and Professor T Pietsch (University of Bonn Medical Centre, Bonn, Germany), respectively. Four normal cerebellar DNAs were gifts from Dr M Fruhwald (University of Munster, Munster, Germany). Vav1CA cDNA was a gift from Dr S Katzav (Hebrew University, Jerusalem, Israel). DAOY and D283Med cell lines were from the ATCC (Manassas, VA, USA). Approval from the Newcastle and North Tyneside Research Ethics Committee (study reference 07/Q0905/71) was obtained for the collection, storage, and biological study of all material described. Medulloblastomas investigated in this study include samples provided by the UK Children's Cancer and Leukaemia Group (CCLG) as part of CCLG-approved biological study BS-2007-04.	Abe R, 1999, J BIOL CHEM, V274, P30410, DOI 10.1074/jbc.274.43.30410; Anderton JA, 2008, NEURO-ONCOLOGY, V10, P981, DOI 10.1215/15228517-2008-048; Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Denkinger DJ, 2000, BBA-GENE STRUCT EXPR, V1491, P253, DOI 10.1016/S0167-4781(00)00008-7; Ellison DW, 2011, J CLIN ONCOL, V29, P1400, DOI 10.1200/JCO.2010.30.2810; Famulski JK, 2010, SCIENCE, V330, P1834, DOI 10.1126/science.1198480; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Hatton BA, 2008, CANCER RES, V68, P1768, DOI 10.1158/0008-5472.CAN-07-5092; Hovestadt V, 2013, ACTA NEUROPATHOL, V125, P913, DOI 10.1007/s00401-013-1126-5; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; Katzav S, 2007, CANCER LETT, V255, P241, DOI 10.1016/j.canlet.2007.04.015; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Kimura H, 2008, CANCER CELL, V13, P249, DOI 10.1016/j.ccr.2008.01.027; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Langdon JA, 2006, GENE CHROMOSOME CANC, V45, P47, DOI 10.1002/gcc.20262; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Lee Y, 2007, ONCOGENE, V26, P6442, DOI 10.1038/sj.onc.1210467; Lindsey JC, 2014, ACTA NEUROPATHOL, V127, P307, DOI 10.1007/s00401-013-1225-3; Lusher ME, 2002, CANCER RES, V62, P5906; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Oberley MJ, 2012, AM J BLOOD RES, V2, P1; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Pizer BL, 2009, BRIT J NEUROSURG, V23, P364, DOI 10.1080/02688690903121807; Quevedo C, 2010, MOL BIOL CELL, V21, P1125, DOI 10.1091/mbc.E09-04-0292; RDevelopmentCoreTeam, 2011, R FDN STAT COMP; Remke M, 2013, ACTA NEUROPATHOL, V126, P917, DOI 10.1007/s00401-013-1198-2; Roussel MF, 2011, CURR TOP DEV BIOL, V94, P235, DOI 10.1016/B978-0-12-380916-2.00008-5; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Schwalbe EC, 2011, CLIN CANCER RES, V17, P1883, DOI 10.1158/1078-0432.CCR-10-2210; Schwalbe EC, 2013, ACTA NEUROPATHOL, V125, P359, DOI 10.1007/s00401-012-1077-2; Sebban S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054321; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Taylor RE, 2003, J CLIN ONCOL, V21, P1581, DOI 10.1200/JCO.2003.05.116; Uziel T, 2005, GENE DEV, V19, P2656, DOI 10.1101/gad.1368605; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wells CM, 2005, EXP CELL RES, V310, P303, DOI 10.1016/j.yexcr.2005.07.015; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408; Zindy F, 2007, CANCER RES, V67, P2676, DOI 10.1158/0008-5472.CAN-06-3418	48	9	9	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 3	2015	34	36					4746	4757		10.1038/onc.2014.405	http://dx.doi.org/10.1038/onc.2014.405			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CQ9JU	25531316	Green Accepted			2022-12-26	WOS:000360931500008
J	Sankhala, RS; Koksal, AC; Ho, L; Nitschke, F; Minassian, BA; Cingolani, G				Sankhala, Rajeshwer S.; Koksal, Adem C.; Ho, Lan; Nitschke, Felix; Minassian, Berge A.; Cingolani, Gino			Dimeric Quaternary Structure of Human Laforin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY PHOSPHATASE; PROGRESSIVE MYOCLONUS EPILEPSY; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; BINDING DOMAIN; EPM2A GENE; PROTEIN; MUTATIONS; GLYCOGEN; PHOSPHORYLATION	The phosphatase laforin removes phosphate groups from glycogen during biosynthetic activity. Loss-of-function mutations in the gene encoding laforin is the predominant cause of Lafora disease, a fatal form of progressive myoclonic epilepsy. Here, we used hybrid structural methods to determine the molecular architecture of human laforin. We found that laforin adopts a dimeric quaternary structure, topologically similar to the prototypical dual specificity phosphatase VH1. The interface between the laforin carbohydrate-binding module and the dual specificity phosphatase domain generates an intimate substrate-binding crevice that allows for recognition and dephosphorylation of phosphomonoesters of glucose. We identify novel molecular determinants in the laforin active site that help decipher the mechanism of glucan phosphatase activity.	[Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Koksal, Adem C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Nitschke, Felix; Minassian, Berge A.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Minassian, Berge A.] Univ Toronto, Inst Med Sci, Dept Pediat, Toronto, ON M5S 1A8, Canada	Jefferson University; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu	Nitschke, Felix/AAN-1155-2021	Nitschke, Felix/0000-0002-1118-2693; Koksal, Adem/0000-0002-3163-7421	NCI [P30 CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD017987] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to the staff at the National Synchrotron Light Source beamlines X6A, X29, and X9 for assistance in data collection. Research in this publication includes work carried out at the Sydney Kimmel Cancer Center X-ray Crystallography and Molecular Interaction Facility, which is supported in part by NCI Grant P30 CA56036.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AFONINE PV, 2013, COMPUT CRYSTALLOGR N, V0004; Bhardwaj A, 2007, J MOL BIOL, V371, P374, DOI 10.1016/j.jmb.2007.05.051; Birmanns S, 2011, J STRUCT BIOL, V173, P428, DOI 10.1016/j.jsb.2010.11.002; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Christiansen C, 2009, FEBS J, V276, P5006, DOI 10.1111/j.1742-4658.2009.07221.x; DePaoli-Roach AA, 2015, J BIOL CHEM, V290, P841, DOI 10.1074/jbc.M114.607796; Dubey D, 2008, HUM MOL GENET, V17, P3010, DOI 10.1093/hmg/ddn199; Dukhande VV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024040; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Gayarre J, 2014, BRAIN, V137, P806, DOI 10.1093/brain/awt353; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Hejazi M, 2010, PLANT PHYSIOL, V152, P711, DOI 10.1104/pp.109.149914; Jackson MD, 2001, CHEM REV, V101, P2313, DOI 10.1021/cr000247e; Koksal AC, 2011, J BIOL CHEM, V286, P14373, DOI 10.1074/jbc.M111.226357; Koksal AC, 2009, J BIOL CHEM, V284, P10129, DOI 10.1074/jbc.M808362200; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Liu Y, 2006, J BIOL CHEM, V281, P34768, DOI 10.1074/jbc.M607778200; Lokareddy RK, 2013, BIOCHEMISTRY-US, V52, P938, DOI 10.1021/bi301476m; Meekins DA, 2014, P NATL ACAD SCI USA, V111, P7272, DOI 10.1073/pnas.1400757111; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2002, ADV NEUROL, V89, P199; Minassian BA, 2001, ANN NEUROL, V49, P271, DOI 10.1002/1531-8249(20010201)49:2<271::AID-ANA52>3.3.CO;2-4; Nardozzi J, 2010, J MOL BIOL, V402, P83, DOI 10.1016/j.jmb.2010.07.013; Nitschke F, 2013, CELL METAB, V17, P756, DOI 10.1016/j.cmet.2013.04.006; Olia AS, 2007, BIOCHEMISTRY-US, V46, P8776, DOI 10.1021/bi700186e; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanchez-Martin P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069523; Sankhala RS, 2014, BIOCHEMISTRY-US, V53, P862, DOI 10.1021/bi401240x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Singh S, 2009, HUM MUTAT, V30, P715, DOI 10.1002/humu.20954; Sorimachi K, 1997, STRUCTURE, V5, P647, DOI 10.1016/S0969-2126(97)00220-7; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Terwilliger Thomas C., 2012, Journal of Structural and Functional Genomics, V13, P81, DOI 10.1007/s10969-012-9129-3; Turnbull J, 2010, ANN NEUROL, V68, P925, DOI 10.1002/ana.22156; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Xiao JY, 2011, P NATL ACAD SCI USA, V108, P11860, DOI 10.1073/pnas.1109290108	49	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4552	4559		10.1074/jbc.M114.627406	http://dx.doi.org/10.1074/jbc.M114.627406			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25538239	hybrid, Green Published			2022-12-26	WOS:000350042000003
J	Pallan, PS; Nagy, LD; Lei, L; Gonzalez, E; Kramlinger, VM; Azumaya, CM; Wawrzak, Z; Waterman, MR; Guengerich, FP; Egli, M				Pallan, Pradeep S.; Nagy, Leslie D.; Lei, Li; Gonzalez, Eric; Kramlinger, Valerie M.; Azumaya, Caleigh M.; Wawrzak, Zdzislaw; Waterman, Michael R.; Guengerich, F. Peter; Egli, Martin			Structural and Kinetic Basis of Steroid 17 alpha,20-Lyase Activity in Teleost Fish Cytochrome P450 17A1 and Its Absence in Cytochrome P450 17A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-SITU PROTEOLYSIS; 17,20-LYASE ACTIVITY; ORTERONEL TAK-700; ANDROGEN SYNTHESIS; LYASE ACTIVITY; HUMAN P450C17; OXIDATION; EXPRESSION; INHIBITOR; PHOSPHORYLATION	Cytochrome P450 (P450) 17A enzymes play a critical role in the oxidation of the steroids progesterone (Prog) and pregnenolone (Preg) to glucocorticoids and androgens. In mammals, a single enzyme, P450 17A1, catalyzes both 17 alpha-hydroxylation and a subsequent 17 alpha,20-lyase reaction with both Prog and Preg. Teleost fish contain two 17A P450s; zebrafish P450 17A1 catalyzes both 17 alpha-hydroxylation and lyase reactions with Prog and Preg, and P450 17A2 is more efficient in pregnenolone 17 alpha-hydroxylation but does not catalyze the lyase reaction, even in the presence of cytochrome b(5). P450 17A2 binds all substrates and products, although more loosely than P450 17A1. Pulse-chase and kinetic spectral experiments and modeling established that the two-step P450 17A1 Prog oxidation is more distributive than the Preg reaction, i.e. 17 alpha-OHproduct dissociates more prior to the lyase step. The drug orteronel selectively blocked the lyase reaction of P450 17A1 but only in the case of Prog. X-ray crystal structures of zebrafish P450 17A1 and 17A2 were obtained with the ligand abiraterone and with Prog for P450 17A2. Comparison of the two fish P450 17A-abiraterone structures with human P450 17A1 (DeVore, N. M., and Scott, E. E. (2013) Nature 482, 116-119) showed only a few differences near the active site, despite only similar to 50% identity among the three proteins. The P450 17A2 structure differed in four residues near the heme periphery. These residues may allow the proposed alternative ferric peroxide mechanism for the lyase reaction, or residues removed from the active site may allow conformations that lead to the lyase activity.	[Pallan, Pradeep S.; Nagy, Leslie D.; Lei, Li; Gonzalez, Eric; Kramlinger, Valerie M.; Azumaya, Caleigh M.; Waterman, Michael R.; Guengerich, F. Peter; Egli, Martin] Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Argonne Natl Lab, Adv Photon Source, Sect 21, Life Sci Collaborat Access Team, Argonne, IL 60439 USA	Vanderbilt University; United States Department of Energy (DOE); Argonne National Laboratory	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu; martin.egli@vanderbilt.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459, R01GM103937] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Millennium Pharmaceuticals for orteronel, J. A. Oates for use of the radio-TLC imaging scanner, and K. Trisler for assistance in preparation of the manuscript. Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team (LSCAT) at Sector 21 of the Advanced Photon Source (APS), Argonne, IL. Use of the APS at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKHTAR M, 1994, BIOCHEMISTRY-US, V33, P4410, DOI 10.1021/bi00180a039; AKHTAR M, 1994, J CHEM SOC PERK T 1, P263, DOI 10.1039/p19940000263; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell-Parikh LC, 1999, J BIOL CHEM, V274, P23833, DOI 10.1074/jbc.274.34.23833; Brock BJ, 1999, BIOCHEMISTRY-US, V38, P1598, DOI 10.1021/bi9821059; Chen CF, 2010, FISH PHYSIOL BIOCHEM, V36, P1001, DOI 10.1007/s10695-009-9378-7; Chowdhury G, 2012, BIOCHEMISTRY-US, V51, P9995, DOI 10.1021/bi301092c; Chowdhury G, 2010, J BIOL CHEM, V285, P8031, DOI 10.1074/jbc.M109.088039; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; Fluck CE, 2003, J CLIN ENDOCR METAB, V88, P3762, DOI 10.1210/jc.2003-030143; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Gregory M, 2013, ANGEW CHEM INT EDIT, V52, P5342, DOI 10.1002/anie.201300760; Gregory MC, 2013, J AM CHEM SOC, V135, P16245, DOI 10.1021/ja4086403; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich F. P., 2015, CYTOCHROME P450 STRU, V4th; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Guengerich FP, 2011, ARCH BIOCHEM BIOPHYS, V507, P126, DOI 10.1016/j.abb.2010.08.017; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Hanson KL, 2010, DRUG METAB DISPOS, V38, P963, DOI 10.1124/dmd.110.032391; Hara T, 2013, J STEROID BIOCHEM, V134, P80, DOI 10.1016/j.jsbmb.2012.10.020; He X, 2005, J BIOL CHEM, V280, P22697, DOI 10.1074/jbc.M502632200; HIGUCHI A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P240, DOI 10.1016/0005-2760(91)90064-O; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Johnson Kenneth A., 2003, P1; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kagawa Norio, 1995, P419; Kaku T, 2011, BIOORGAN MED CHEM, V19, P6383, DOI 10.1016/j.bmc.2011.08.066; KATAGIRI M, 1982, BIOCHEM BIOPH RES CO, V108, P379, DOI 10.1016/0006-291X(82)91877-0; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; KUHNVELTEN WN, 1991, J BIOL CHEM, V266, P6291; LEEROBICHAUD P, 1995, BIOCHEMISTRY-US, V34, P14104, DOI 10.1021/bi00043a015; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Miller WL, 1998, ENDOCR RES, V24, P817, DOI 10.3109/07435809809032692; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng HM, 2014, J BIOL CHEM, V289, P33838, DOI 10.1074/jbc.M114.608919; Petrunak EM, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.610998; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RICHARDSON TH, 1995, ARCH BIOCHEM BIOPHYS, V323, P87, DOI 10.1006/abbi.1995.0013; SANDHU P, 1993, ARCH BIOCHEM BIOPHYS, V306, P443, DOI 10.1006/abbi.1993.1536; SHIMADA T, 1986, J BIOL CHEM, V261, P909; Shimshoni JA, 2012, J BIOL CHEM, V287, P42223, DOI 10.1074/jbc.M112.404475; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soucy P, 2000, EUR J BIOCHEM, V267, P3243, DOI 10.1046/j.1432-1327.2000.01349.x; Strittmatter P, 1978, Methods Enzymol, V52, P97; SWINNEY DC, 1994, BIOCHEMISTRY-US, V33, P2185, DOI 10.1021/bi00174a027; TAGASHIRA H, 1995, BIOCHEMISTRY-US, V34, P10939, DOI 10.1021/bi00034a028; Tee MK, 2008, ENDOCRINOLOGY, V149, P2667, DOI 10.1210/en.2007-1527; Tee MK, 2013, J BIOL CHEM, V288, P23903, DOI 10.1074/jbc.M113.460048; Walsh C., 1979, ENZYMATIC REACTION M, P33; Wang YJ, 2004, GEN COMP ENDOCR, V135, P241, DOI 10.1016/j.ygcen.2003.09.015; Wernimont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005094; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yamaoka M, 2013, J STEROID BIOCHEM, V138, P298, DOI 10.1016/j.jsbmb.2013.07.002; Yamaoka M, 2012, J STEROID BIOCHEM, V129, P115, DOI 10.1016/j.jsbmb.2012.01.001; YAMAZAKI T, 1992, BIOCHIM BIOPHYS ACTA, V1134, P143, DOI 10.1016/0167-4889(92)90037-C; Yamazaki T, 1998, BIOCHEMISTRY-US, V37, P2800, DOI 10.1021/bi9715066; YAMAZAKI T, 1992, BIOCHIM BIOPHYS ACTA, V1125, P335; ZHANG LH, 1995, P NATL ACAD SCI USA, V92, P10619, DOI 10.1073/pnas.92.23.10619; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501; Zhou LY, 2007, ENDOCRINOLOGY, V148, P4282, DOI 10.1210/en.2007-0487; Zhu JG, 2012, ARCH BIOCHEM BIOPHYS, V523, P30, DOI 10.1016/j.abb.2012.01.013	77	45	46	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3248	3268		10.1074/jbc.M114.627265	http://dx.doi.org/10.1074/jbc.M114.627265			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533464	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000349456000006
J	Zacherl, S; La Venuta, G; Muller, HM; Wegehingel, S; Dimou, E; Sehr, P; Lewis, JD; Erfle, H; Pepperkok, R; Nickel, W				Zacherl, Sonja; La Venuta, Giuseppe; Mueller, Hans-Michael; Wegehingel, Sabine; Dimou, Eleni; Sehr, Peter; Lewis, Joe D.; Erfle, Holger; Pepperkok, Rainer; Nickel, Walter			A Direct Role for ATP1A1 in Unconventional Secretion of Fibroblast Growth Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; PROTEIN SECRETION; QUALITY-CONTROL; CELL-SURFACE; TEC FAMILY; EXPORT; TRANSLOCATION; TRANSPORT; FGF-2	Previous studies proposed a role for the Na/K-ATPase in unconventional secretion of fibroblast growth factor 2 (FGF2). This conclusion was based upon pharmacological inhibition of FGF2 secretion in the presence of ouabain. However, neither independent experimental evidence nor a potential mechanism was provided. Based upon an unbiased RNAi screen, we now report the identification of ATP1A1, the alpha 1-chain of the Na/K-ATPase, as a factor required for efficient secretion of FGF2. As opposed to ATP1A1, down-regulation of the beta 1- and beta 3-chains (ATP1B1 and ATP1B3) of the Na/K-ATPase did not affect FGF2 secretion, suggesting that they are dispensable for this process. These findings indicate that it is not the membrane potential-generating function of the Na/K-ATPase complex but rather a so far unidentified role of potentially unassembled alpha 1-chains that is critical for unconventional secretion of FGF2. Consistently, in the absence of beta-chains, we found a direct interaction between the cytoplasmic domain of ATP1A1 and FGF2 with submicromolar affinity. Based upon these observations, we propose that ATP1A1 is a recruitment factor for FGF2 at the inner leaflet of plasma membranes that may control phosphatidylinositol 4,5-bisphosphate-dependent membrane translocation as part of the unconventional secretory pathway of FGF2.	[Zacherl, Sonja; La Venuta, Giuseppe; Mueller, Hans-Michael; Wegehingel, Sabine; Dimou, Eleni; Nickel, Walter] Heidelberg Univ, Biochem Ctr BZH, D-69120 Heidelberg, Germany; [Sehr, Peter; Lewis, Joe D.; Pepperkok, Rainer] EMBL, D-69117 Heidelberg, Germany; [Erfle, Holger] Heidelberg Univ, BioQuant, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Nickel, W (corresponding author), Heidelberg Univ, Biochem Ctr BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	walter.nickel@bzh.uni-heidelberg.de		Muller, Hans-Michael/0000-0002-2384-7285; Lewis, Joe/0000-0002-9926-1328; Sehr, Peter/0000-0002-4348-5066; Dimou, Eleni/0000-0003-4885-135X	Deutsche Forschungsgemeinschaft (DFG) [SFB 638, SFB/TRR 83, GRK1188]; Federal Ministry for Education and Research of Germany; Boehringer Ingelheim Fonds; DFG cluster of excellence CellNetworks	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Federal Ministry for Education and Research of Germany; Boehringer Ingelheim Fonds(Boehringer Ingelheim); DFG cluster of excellence CellNetworks	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants SFB 638, SFB/TRR 83, and GRK1188; the AID-NET program of the Federal Ministry for Education and Research of Germany (to W. N.); the Boehringer Ingelheim Fonds (to S. Z.); and the DFG cluster of excellence CellNetworks.	Aftab O, 2014, APOPTOSIS, V19, P1411, DOI 10.1007/s10495-014-1009-9; Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Dahl JP, 2000, BIOCHEMISTRY-US, V39, P14877, DOI 10.1021/bi001073y; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Ebert AD, 2010, TRAFFIC, V11, P813, DOI 10.1111/j.1600-0854.2010.01059.x; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; Erfle H, 2008, J BIOMOL SCREEN, V13, P575, DOI 10.1177/1087057108320133; Florkiewicz RZ, 1998, J BIOL CHEM, V273, P544, DOI 10.1074/jbc.273.1.544; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Mano H, 1999, CYTOKINE GROWTH F R, V10, P267, DOI 10.1016/S1359-6101(99)00019-2; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; Nickel W, 2011, TRAFFIC, V12, P799, DOI 10.1111/j.1600-0854.2011.01187.x; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schaeffer EM, 2000, CURR OPIN IMMUNOL, V12, P282, DOI 10.1016/S0952-7915(00)00088-1; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Stegmayer C, 2005, J CELL SCI, V118, P517, DOI 10.1242/jcs.01645; Steringer JP, 2015, J MOL BIOL, V427, P1202, DOI 10.1016/j.jmb.2014.07.012; Steringer JP, 2012, J BIOL CHEM, V287, P27659, DOI 10.1074/jbc.M112.381939; Taouji S, 2009, CURR GENOMICS, V10, P93, DOI 10.2174/138920209787847041; Temmerman K, 2008, TRAFFIC, V9, P1204, DOI 10.1111/j.1600-0854.2008.00749.x; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Torrado LC, 2009, J CELL SCI, V122, P3322, DOI 10.1242/jcs.049791; Yoshimura SH, 2008, J CELL SCI, V121, P2159, DOI 10.1242/jcs.022905; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103	40	40	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3654	3665		10.1074/jbc.M114.590067	http://dx.doi.org/10.1074/jbc.M114.590067			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533462	Green Published, hybrid			2022-12-26	WOS:000349456000038
J	La Rocca, R; Tallerico, R; Hassan, AT; Das, G; Tadepally, L; Matteucci, M; Liberale, C; Mesuraca, M; Scumaci, D; Gentile, F; Cojoc, G; Perozziello, G; Ammendolia, A; Gallo, A; Karre, K; Cuda, G; Candeloro, P; Di Fabrizio, E; Carbone, E				La Rocca, Rosanna; Tallerico, Rossana; Hassan, Almosawy Talib; Das, Gobind; Tadepally, Lakshmikanth; Matteucci, Marco; Liberale, Carlo; Mesuraca, Maria; Scumaci, Domenica; Gentile, Francesco; Cojoc, Gheorghe; Perozziello, Gerardo; Ammendolia, Antonio; Gallo, Adriana; Karre, Klas; Cuda, Giovanni; Candeloro, Patrizio; Di Fabrizio, Enzo; Carbone, Ennio			Mechanical Stress Downregulates MHC Class I Expression on Human Cancer Cell Membrane	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ENERGY SHOCK-WAVES; T-CELLS; OPTICAL DEFORMABILITY; RAMAN-SPECTROSCOPY; PHYSICAL-ACTIVITY; NK CELLS; NKG2D; RECOGNITION; IMMUNITY	In our body, cells are continuously exposed to physical forces that can regulate different cell functions such as cell proliferation, differentiation and death. In this work, we employed two different strategies to mechanically stress cancer cells. The cancer and healthy cell populations were treated either with mechanical stress delivered by a micropump (fabricated by deep X-ray nanolithography) or by ultrasound wave stimuli. A specific down-regulation of Major Histocompatibility Complex (MHC) class I molecules expression on cancer cell membrane compared to different kinds of healthy cells (fibroblasts, macrophages, dendritic and lymphocyte cells) was observed, stimulating the cells with forces in the range of nano-newton, and pressures between 1 and 10 bar (1 bar=100.000 Pascal), depending on the devices used. Moreover, Raman spectroscopy analysis, after mechanical treatment, in the range between 700-1800 cm(-1), indicated a relative concentration variation of MHC class I. PCA analysis was also performed to distinguish control and stressed cells within different cell lines. These mechanical induced phenotypic changes increase the tumor immunogenicity, as revealed by the related increased susceptibility to Natural Killer (NK) cells cytotoxic recognition.	[La Rocca, Rosanna; Tallerico, Rossana; Hassan, Almosawy Talib; Das, Gobind; Liberale, Carlo; Mesuraca, Maria; Scumaci, Domenica; Gentile, Francesco; Cojoc, Gheorghe; Perozziello, Gerardo; Cuda, Giovanni; Candeloro, Patrizio; Di Fabrizio, Enzo; Carbone, Ennio] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [La Rocca, Rosanna] IIT, Genoa, Italy; [Hassan, Almosawy Talib] Univ Thi Qar, Coll Med, Dept Microbiol, Nasseriah, Iraq; [Das, Gobind; Liberale, Carlo; Di Fabrizio, Enzo] King Abdullah Univ Sci & Technol, Thuwal, Saudi Arabia; [Tadepally, Lakshmikanth] Karolinska Inst, Dept Med, Sci Life Lab, Stockholm, Sweden; [Matteucci, Marco] Tech Univ Denmark, Nanotech Dept Micro & Nanotechnol, Lyngby, Denmark; [Ammendolia, Antonio] Magna Graecia Univ Catanzaro, Dept Surg & Med Sci, Catanzaro, Italy; [Gallo, Adriana] CNR, Endocrinol & Expt Oncol Inst, I-80125 Naples, Italy; [Karre, Klas; Carbone, Ennio] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Magna Graecia University of Catanzaro; Istituto Italiano di Tecnologia - IIT; University of Thi-Qar; King Abdullah University of Science & Technology; Karolinska Institutet; Technical University of Denmark; Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); Karolinska Institutet	Di Fabrizio, E (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy.	enzo.difabrizio@kaust.edu.sa; ennio.carbone@ki.se	Cuda, Giovanni/F-5359-2012; Ammendolia, Antonio/K-2155-2016; Candeloro, Patrizio/K-8097-2016; Tadepally, Lakshmikanth/P-5154-2019; Das, Gobind/N-7405-2013; Scumaci, Domenica/AAH-1493-2019; Cuda, Giovanni/AAC-2821-2019; GENTILE, Francesco/K-8565-2016; Liberale, Carlo/F-8370-2011	Cuda, Giovanni/0000-0001-6313-1866; Ammendolia, Antonio/0000-0002-2828-2455; Candeloro, Patrizio/0000-0001-6156-887X; Tadepally, Lakshmikanth/0000-0001-7256-5770; Das, Gobind/0000-0003-0942-681X; Cuda, Giovanni/0000-0001-6313-1866; GENTILE, Francesco/0000-0002-1724-6301; Liberale, Carlo/0000-0002-5653-199X; carbone, ennio/0000-0002-2275-8803; MESURACA, Maria/0000-0002-5455-168X; Scumaci, Domenica/0000-0002-8117-834X	UICC International Cancer Technology Transfer Fellowship [AIRC-IG 10189, AIRC 15521]; Ministry of Education and Research [PON01_02834 Prometeo, PONa3_00435 Biomedpark@UMG]; triennial fellowships "Luciana Selce'' FIRC; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	UICC International Cancer Technology Transfer Fellowship; Ministry of Education and Research; triennial fellowships "Luciana Selce'' FIRC(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	Ennio Carbone's work has been supported by a UICC International Cancer Technology Transfer Fellowship, grant AIRC-IG 10189, and grant AIRC 15521. Rossana Tallerico is a Post Doc awarded by triennial fellowships "Luciana Selce'' FIRC. Giovanni Cuda has been supported by PON01_02834 Prometeo (Ministry of Education and Research) and PONa3_00435 Biomedpark@UMG (Ministry of Education and Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BISCHOFF F, 1964, PROG EXP TUMOR RES, V5, P85; Bonnier F, 2010, ANALYST, V135, P3169, DOI 10.1039/c0an00539h; Bussani R, 2007, J CLIN PATHOL, V60, P27, DOI 10.1136/jcp.2005.035105; Candeloro P, 2013, ANALYST, V138, P7331, DOI 10.1039/c3an01665j; Carbone E, 1999, EUR J IMMUNOL, V29, P4022, DOI 10.1002/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.3.CO;2-F; Carbone E, 2005, BLOOD, V105, P251, DOI 10.1182/blood-2004-04-1422; Chan JW, 2006, BIOPHYS J, V90, P648, DOI 10.1529/biophysj.105.066761; CLAYMAN RV, 1991, AM J KIDNEY DIS, V17, P436, DOI 10.1016/S0272-6386(12)80638-X; CONSTABLE A, 1993, OPT LETT, V18, P1867, DOI 10.1364/OL.18.001867; Das G, 2011, J MOL STRUCT, V993, P500, DOI 10.1016/j.molstruc.2010.12.044; Das G, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3368687; Das G, 2009, BIOSENS BIOELECTRON, V24, P1693, DOI 10.1016/j.bios.2008.08.050; De Gelder J, 2007, ANAL CHIM ACTA, V585, P234, DOI 10.1016/j.aca.2006.12.050; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fregni G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076928; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guck J, 2000, PHYS REV LETT, V84, P5451, DOI 10.1103/PhysRevLett.84.5451; Guck J, 2001, BIOPHYS J, V81, P767, DOI 10.1016/S0006-3495(01)75740-2; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Jewett A, 2013, J CANCER, V4, P12, DOI 10.7150/jca.5519; Khaled W, 2004, ST HEAL T, V98, P147; KLEIN D, 1995, BIOCHEM MOL BIOL INT, V36, P59; KOHRI K, 1990, UROL RES, V18, P101, DOI 10.1007/BF00302468; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Majzner K, 2013, ANALYST, V138, P603, DOI 10.1039/c2an36222h; Matteucci M, 2007, MICROELECTRON ENG, V84, P1729, DOI 10.1016/j.mee.2007.01.242; Matthaus C, 2007, BIOPHYS J, V93, P668, DOI 10.1529/biophysj.106.102061; MCGINNES K, 1986, J IMMUNOL METHODS, V86, P7, DOI 10.1016/0022-1759(86)90258-9; McTiernan A, 2008, NAT REV CANCER, V8, P205, DOI 10.1038/nrc2325; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Perozziello G, 2013, ELECTROPHORESIS, V34, P1845, DOI 10.1002/elps.201300106; Perozziello G, 2012, SMALL, V8, P2886, DOI 10.1002/smll.201200160; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U; Rathje LSZ, 2014, P NATL ACAD SCI USA, V111, P1515, DOI 10.1073/pnas.1300238111; Reynen K, 2004, ANN ONCOL, V15, P375, DOI 10.1093/annonc/mdh086; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Szachowicz-Petelska B, 2013, J MEMBRANE BIOL, V246, P421, DOI 10.1007/s00232-013-9554-7; THOMAS GJ, 1983, J MOL BIOL, V165, P321, DOI 10.1016/S0022-2836(83)80260-5; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Winzer BM, 2011, CANCER CAUSE CONTROL, V22, P811, DOI 10.1007/s10552-011-9761-4; Yang GG, 2004, J BIOMECH, V37, P1543, DOI 10.1016/j.jbiomech.2004.01.005	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e0111758	10.1371/journal.pone.0111758	http://dx.doi.org/10.1371/journal.pone.0111758			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541692	Green Published, gold			2022-12-26	WOS:000347239900004
J	Navarro, JY; Lahti, DC				Navarro, Johanna Y.; Lahti, David C.			Light Dulls and Darkens Bird Eggs	PLOS ONE			English	Article							FEMALE CONDITION; COLOR; POULTRY; INHERITANCE; MUSEUM; POPULATION; EVOLUTION; SPECIMENS	Although egg color is generally consistent within individual birds and robust to environmental variation, recent evidence suggests a degree of susceptibility to environmental perturbation or modulation of egg color. Most of this variation manifests via the physiology of the laying female, but some direct impacts of the environment on laid eggs have also been discovered. Here we test whether light changes bird egg color and we quantify its effect, by subjecting variable blue-green eggs of Ruppell's weaver (Ploceus galbula) to a broad-spectrum light source under laboratory conditions, and measuring egg reflectance every few hours. Eggshells gradually decreased in reflectance across the entire measured wavelength spectrum of 250-800 nm. Reflectance peaks were disproportionately affected, such that the height decreased of both the blue-green peak and the smaller UV peak typical of blue-green eggs. The reflectance of lighter eggs was affected slightly more than that of darker eggs. These changes are similar to previous results for changes over long periods of time in darkness, suggesting that light might hasten the same process of pigment degradation that proceeds even without light. Comparison between the experimental light source and both sunlight and typical artificial lighting situations raises the possibility that significant color change might occur during incubation in some birds, but indicates that eggshell illumination in museums for short periods of study is unlikely to affect their color to a detectable extent. Additional research should be performed on eggs of other species and in other light environments, with an eye to an eventual generalized model of the effect of light on eggshell color.	[Navarro, Johanna Y.; Lahti, David C.] CUNY, Queens Coll, Dept Biol, Flushing, NY 11367 USA	City University of New York (CUNY) System; Queens College NY (CUNY)	Lahti, DC (corresponding author), CUNY, Queens Coll, Dept Biol, Flushing, NY 11367 USA.	david.lahti@qc.cuny.edu						Arendt WJ, 2004, CARIBB J SCI, V40, P204; Aviles JM, 2007, BEHAV ECOL SOCIOBIOL, V61, P475, DOI 10.1007/s00265-006-0275-0; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Butcher GD, 1995, FACTORS CAUSING POOR; Butler MW, 2013, FUNCT ECOL, V27, P1176, DOI 10.1111/1365-2435.12123; Cassey P, 2012, METHODS ECOL EVOL, V3, P450, DOI 10.1111/j.2041-210X.2011.00152.x; Cassey P, 2011, AVIAN BIOL RES, V4, P185, DOI 10.3184/175815511X13207699868421; Cassey P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1711, DOI 10.1007/s00265-010-1027-8; Cato PS, 1986, GUIDELINES MANAGING, V7; Collias E.C., 1984, P461; COLLIAS EC, 1993, AUK, V110, P683, DOI 10.2307/4088624; Craig A.J.F.K., 2010, P74; Dearborn DC, 2012, FUNCT ECOL, V26, P912, DOI 10.1111/j.1365-2435.2012.02001.x; Doucet SM, 2009, J AVIAN BIOL, V40, P146, DOI 10.1111/j.1600-048X.2009.03763.x; Duval C, 2013, J EXP BIOL, V216, P700, DOI 10.1242/jeb.077370; Francesch A, 1997, POULTRY SCI, V76, P1627, DOI 10.1093/ps/76.12.1627; Gomez D., 2006, AVICOL PROGRAM ANAL; Gosler AG, 2005, ECOL LETT, V8, P1105, DOI 10.1111/j.1461-0248.2005.00816.x; Gosler AG, 2000, P ROY SOC B-BIOL SCI, V267, P2469, DOI 10.1098/rspb.2000.1307; Hanley D, 2013, AVIAN BIOL RES, V6, P147, DOI 10.3184/175815513X13617279883973; Hanley D, 2012, J APPL ECOL, V49, P1055, DOI 10.1111/j.1365-2664.2012.02184.x; Heirwegh KPM, 1982, BILIRUBIN; Hill G. E., 2006, BIRD COLORATION, V1; Honza M, 2012, FOLIA ZOOL, V61, P219, DOI 10.25225/fozo.v61.i3.a5.2012; Hutt F.B., 1949, GENETICS OF THE FOWL; Jagannath A, 2008, J APPL ECOL, V45, P133, DOI 10.1111/j.1365-2664.2007.01386.x; JUDD DB, 1964, J OPT SOC AM, V54, P1031, DOI 10.1364/JOSA.54.001031; Lahti DC, 2013, OSTRICH, V84, P235, DOI 10.2989/00306525.2013.867548; Lahti DC, 2008, AUK, V125, P796, DOI 10.1525/auk.2008.07033; Lahti DC, 2005, P NATL ACAD SCI USA, V102, P18057, DOI 10.1073/pnas.0508930102; McCormack JE, 2010, AUK, V127, P35, DOI 10.1525/auk.2009.09043; MOAN J, 1991, PHOTOCHEM PHOTOBIOL, V53, P549, DOI 10.1111/j.1751-1097.1991.tb03669.x; Morales J, 2011, BEHAV ECOL SOCIOBIOL, V65, P197, DOI 10.1007/s00265-010-1025-x; Moreno J, 2006, BEHAV ECOL, V17, P651, DOI 10.1093/beheco/ark014; Moreno J, 2011, ORNIS FENNICA, V88, P51; Paterson D, 1897, NATURE, V56, P11; Pohland G, 2006, J ORNITHOL, V147, P464, DOI 10.1007/s10336-005-0038-0; Punnett RC, 1933, J GENET, V27, P465, DOI 10.1007/BF02981757; Punnett RC, 1920, J GENET, V10, P277, DOI 10.1007/BF02984299; Romanoff A. L., 1949, AVIAN EGG; Siefferman L, 2006, BEHAV ECOL SOCIOBIOL, V59, P651, DOI 10.1007/s00265-005-0092-x; Walters M., 1994, BIRDS EGGS; Wang ZP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003183; Wheelwright NT, 2012, CONDOR, V114, P412, DOI 10.1525/cond.2012.110149; Yoshizumi K, 2003, DYES PIGMENTS, V58, P197, DOI 10.1016/S0143-7208(03)00065-2	45	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116112	10.1371/journal.pone.0116112	http://dx.doi.org/10.1371/journal.pone.0116112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541724	Green Published, gold			2022-12-26	WOS:000347239900145
J	Polavarapu, S; Mani, AM; Gundala, NKV; Hari, AD; Bathina, S; Das, UN				Polavarapu, Sailaja; Mani, Arul M.; Gundala, Naveen K. V.; Hari, Anasuya D.; Bathina, Siresha; Das, Undurti N.			Effect of Polyunsaturated Fatty Acids and Their Metabolites on Bleomycin-Induced Cytotoxic Action on Human Neuroblastoma Cells In Vitro	PLOS ONE			English	Article							GAMMA-LINOLENIC ACID; INDUCED DIABETES-MELLITUS; ARACHIDONIC-ACID; PROSTAGLANDIN E-2; EICOSAPENTAENOIC ACID; LIPID-PEROXIDATION; INVASIVE CAPACITY; ANALOG SUPPRESS; OXIDANT STRESS; CANCER GROWTH	In the present study, we noted that bleomycin induced growth inhibitory action was augmented by all the polyunsaturated fatty acids (PUFAs) tested on human neuroblastoma IMR-32 (0.5x10(4) cells/100 mu l of IMR) cells (EPA> DHA> ALA=GLA=AA> DGLA=LA: similar to 60, 40, 30, 10-20% respectively) at the maximum doses used. Of all the prostaglandins (PGE(1), PGE(2), PGF(2 alpha), and PGI2) and leukotrienes (LTD4 and LTE4) tested; PGE(1), PGE(2) and LTD4 inhibited the growth of IMR-32 cells to a significant degree at the highest doses used. Lipoxin A(4) (LXA(4)), 19,20-dihydroxydocosapentaenoate (19, 20 DiHDPA) and 10(S), 17(S)-dihydroxy-4Z, 7Z, 11E, 13Z, 15E, 19Z-docosahexaenoic acid (protectin: 10(S), 17(S) DiHDoHE), metabolites of DHA, significantly inhibited the growth of IMR-32 cells. Pre-treatment with AA, GLA, DGLA and EPA and simultaneous treatment with all PUFAs used in the study augmented growth inhibitory action of bleomycin. Surprisingly, both indomethacin and nordihydroguaiaretic acid (NDGA) at 60 and 20 mu g/ml respectively enhanced the growth of IMR-32 cells even in the presence of bleomycin. AA enhanced oxidant stress in IMR-32 cells as evidenced by an increase in lipid peroxides, superoxide dismutase levels and glutathione peroxidase activity. These results suggest that PUFAs suppress growth of human neuroblastoma cells, augment growth inhibitory action of bleomycin by enhancing formation of lipid peroxides and altering the status of anti-oxidants and, in all probability, increase the formation of lipoxins, resolvins and protectins from their respective precursors that possess growth inhibitory actions.	[Polavarapu, Sailaja; Mani, Arul M.; Gundala, Naveen K. V.; Hari, Anasuya D.; Bathina, Siresha] Biosci Res Ctr, Visakhapatnam 530048, Andhra Pradesh, India; [Das, Undurti N.] UND Life Sci, Federal Way, WA 98003 USA		Das, UN (corresponding author), UND Life Sci, 2020 S 360th St,K-202, Federal Way, WA 98003 USA.	Undurti@hotmail.com	Gundala, Venkata Naveen K/L-8395-2019; Bathina, Siresha/ABF-2315-2021	Bathina, Siresha/0000-0002-1092-5600; Mani, Arul Murugan/0000-0002-8943-7406; Polavarapu, Sailaja/0000-0001-8189-6969	Ramalingaswami Fellowship of the Department of Biotechnology; Department of Biotechnology (DBT) [BT/PR11627/MED/30/157/2010]; Department of Science and Technology under Intensification of Research in High Priority Areas (IRPHA) [IR/SO/LU/03/2008/1]; Defence Research and Development Organisation, New Delhi [TC/2519/INM 203/2011/CARS, INM-311]; Indian Council of Medical Research (ICMR), Government of India	Ramalingaswami Fellowship of the Department of Biotechnology; Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology under Intensification of Research in High Priority Areas (IRPHA); Defence Research and Development Organisation, New Delhi(Defence Research & Development Organisation (DRDO)); Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR))	UND is in receipt of Ramalingaswami Fellowship of the Department of Biotechnology during the tenure of this study. This work was supported, in part, by grants from the Department of Biotechnology (DBT No. BT/PR11627/MED/30/157/2010), Department of Science and Technology (No. IR/SO/LU/03/2008/1) under Intensification of Research in High Priority Areas (IRPHA), and Defence Research and Development Organisation, New Delhi ([TC/2519/INM 203/2011/CARS] under R & D Project INM-311) to UND. SB was recipient of a fellowship from Indian Council of Medical Research (ICMR), Government of India. Author UND is the President and CEO of UND Life Sciences without any financial compensation. UND Life Sciences did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avis I, 2005, CANCER RES, V65, P4181, DOI 10.1158/0008-5472.CAN-04-3441; BECKMAN BS, 1992, P SOC EXP BIOL MED, V201, P169; BEGIN ME, 1986, JNCI-J NATL CANCER I, V77, P1053; BEGIN ME, 1986, PROG LIPID RES, V25, P573, DOI 10.1016/0163-7827(86)90116-5; BHAT KS, 1967, AM J CLIN NUTR, V20, P386, DOI 10.1093/ajcn/20.5.386; BOTHA JH, 1989, PROSTAG LEUKOTR ESS, V35, P119, DOI 10.1016/0952-3278(89)90175-0; BOTHA JH, 1985, PROSTA LEUKOTR MED, V19, P63, DOI 10.1016/0262-1746(85)90161-1; Brock TG, 2008, LIPIDS, V43, P161, DOI 10.1007/s11745-007-3136-3; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen Y, 2010, MOL CANCER THER, V9, P2164, DOI 10.1158/1535-7163.MCT-10-0173; Claria J, 1996, MOL MED, V2, P583, DOI 10.1007/BF03401642; Dajani OF, 2008, J CELL PHYSIOL, V214, P371, DOI 10.1002/jcp.21205; Das UN, 2004, PROSTAG LEUKOTR ESS, V70, P539, DOI 10.1016/j.plefa.2003.12.001; DAS UN, 1991, CANCER LETT, V56, P235, DOI 10.1016/0304-3835(91)90008-6; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; Das UN, 2012, PROSTAG LEUKOTR ESS, V86, P3, DOI 10.1016/j.plefa.2011.09.008; Das UN, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-37; de Bittencourt PIH, 1998, BIOCHEM MOL BIOL INT, V45, P1255; De Carlo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069760; DEBYDUPONT G, 1983, BIOMED PHARMACOTHER, V37, P386; Devi MMS, 2000, J PINEAL RES, V29, P108; Fahrmann JF, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-36; Ge HT, 2009, CELL BIOL INT, V33, P402, DOI 10.1016/j.cellbi.2009.01.014; Germain E, 1998, INT J CANCER, V75, P578, DOI 10.1002/(SICI)1097-0215(19980209)75:4<578::AID-IJC14>3.3.CO;2-I; Gillis RC, 2002, J SURG RES, V107, P145, DOI 10.1006/jsre.2002.6496; GIRI SN, 1983, TOXICOL APPL PHARM, V71, P132, DOI 10.1016/0041-008X(83)90052-2; Hao H, 2011, CANCER LETT, V309, P85, DOI 10.1016/j.canlet.2011.05.020; Jiang WG, 1998, INT J ONCOL, V13, P611; Kenny FS, 2001, INT J CANCER, V92, P342, DOI 10.1002/ijc.1213; KHAN MA, 1993, LEUKEMIA RES, V17, P241; KIRKOVA M, 1992, GEN PHARMACOL, V23, P503, DOI 10.1016/0306-3623(92)90119-5; KOBAYASHI H, 1985, PROSTAGLANDINS, V29, P255, DOI 10.1016/0090-6980(85)90206-0; Krenzel ES, 2013, BIOCHEMISTRY-US, V52, P1559, DOI 10.1021/bi301458b; KUMAR GS, 1995, CANCER LETT, V92, P27, DOI 10.1016/0304-3835(95)03753-J; Li CG, 2014, J EXP MED, V211, P15, DOI 10.1084/jem.20131080; Lu XF, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-106; Lu JM, 2010, MED SCI MONITOR, V16, pRA93; MADHAVI N, 1994, CANCER LETT, V84, P31, DOI 10.1016/0304-3835(94)90355-7; Maheo K, 2005, FREE RADICAL BIO MED, V39, P742, DOI 10.1016/j.freeradbiomed.2005.04.023; Manjari V, 2001, PROSTAG LEUKOTR ESS, V64, P53, DOI 10.1054/plef.2000.0237; Menendez JA, 2005, JNCI-J NATL CANCER I, V97, P1611, DOI 10.1093/jnci/dji343; MENGEAUD V, 1992, PROSTAG LEUKOTR ESS, V47, P313, DOI 10.1016/0952-3278(92)90204-V; Morita I, 1983, Gan To Kagaku Ryoho, V10, P1919; Mouradian M, 2014, PROSTAG LEUKOTR ESS, V90, P105, DOI 10.1016/j.plefa.2013.12.001; Mun GI, 2008, AM J PHYSIOL-HEART C, V295, pH1966, DOI 10.1152/ajpheart.00727.2008; PHILLIPS GB, 1967, J LIPID RES, V8, P676; Pompeia C, 2002, BIOL CELL, V94, P251, DOI 10.1016/S0248-4900(02)01200-5; RAMESH G, 1992, NUTRITION, V8, P343; Ramesh G, 1998, CANCER LETT, V123, P207, DOI 10.1016/S0304-3835(97)00426-6; Rizzo MT, 1999, CANCER RES, V59, P5047; ROBINSON KM, 1985, PROSTA LEUKOTR MED, V20, P209, DOI 10.1016/0262-1746(85)90011-3; ROSE DP, 1993, CANCER RES, V53, P4686; ROSE DP, 1994, CANCER RES, V54, P6557; ROSE DP, 1995, NUTR CANCER, V24, P33, DOI 10.1080/01635589509514391; RUSSO A, 1984, INT J RADIAT ONCOL, V10, P1675, DOI 10.1016/0360-3016(84)90526-1; SAGAR PS, 1993, MED SCI RES, V21, P457; SANTORO MG, 1986, CANCER RES, V46, P6073; Scioscia KA, 2000, HEAD NECK-J SCI SPEC, V22, P149, DOI 10.1002/(SICI)1097-0347(200003)22:2<149::AID-HED6>3.0.CO;2-T; Sheng HM, 1998, CANCER RES, V58, P362; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; SMITH DL, 1984, PROSTA LEUKOTR MED, V16, P1, DOI 10.1016/0262-1746(84)90080-5; SNYDER DS, 1989, EXP HEMATOL, V17, P6; Suresh Y, 2000, ENVIRON POLLUT, V109, P321, DOI 10.1016/S0269-7491(99)00254-7; Suresh Y, 2003, NUTRITION, V19, P213, DOI 10.1016/S0899-9007(02)00855-9; Suresh Y, 2003, NUTRITION, V19, P93, DOI 10.1016/S0899-9007(02)00856-0; Suresh Y, 2001, PROSTAG LEUKOTR ESS, V64, P37, DOI 10.1054/plef.2000.0236; Vang K, 2005, PROSTAG LEUKOTR ESS, V72, P363, DOI 10.1016/j.plefa.2005.02.002; Vartak S, 1998, BRIT J CANCER, V77, P1612, DOI 10.1038/bjc.1998.264; Wirtitsch M, 2009, ONCOL RES, V18, P83, DOI 10.3727/096504009789954654; Yu L, 2009, INT J CANCER, V125, P2540, DOI 10.1002/ijc.24607; ZEIDLER RB, 1987, INT J IMMUNOPHARMACO, V9, P691, DOI 10.1016/0192-0561(87)90040-3; Zweifel BS, 2002, CANCER RES, V62, P6706	73	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114766	10.1371/journal.pone.0114766	http://dx.doi.org/10.1371/journal.pone.0114766			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536345	gold, Green Published, Green Submitted			2022-12-26	WOS:000348563300020
J	Wang, DY; Yu, YL; Li, YX; Wang, Y; Wang, DY				Wang, Daoyong; Yu, Yonglin; Li, Yinxia; Wang, Yang; Wang, Dayong			Dopamine Receptors Antagonistically Regulate Behavioral Choice between Conflicting Alternatives in C-elegans	PLOS ONE			English	Article							DECISION-MAKING; CAENORHABDITIS-ELEGANS; SENSORY INTEGRATION; PREFRONTAL CORTEX; MODULATION; SEROTONIN; INHIBIT; NEURONS; GENE; POLYMORPHISMS	Caenorhabditis elegans is a useful model to study the neuronal or molecular basis for behavioral choice, a specific form of decision-making. Although it has been implied that both D1-like and D2-like dopamine receptors may contribute to the control of decision-making in mammals, the genetic interactions between D1-like and D2-like dopamine receptors in regulating decision-making are still largely unclear. In the present study, we investigated the molecular control of behavioral choice between conflicting alternatives (diacetyl and Cu2+) by D1-like and D2-like dopamine receptors and their possible genetic interactions with C. elegans as the assay system. In the behavioral choice assay system, mutation of dop-1 gene encoding D1-like dopamine receptor resulted in the enhanced tendency to cross the Cu2+ barrier compared with wild-type. In contrast, mutations of dop-2 or dop-3 gene encoding D2-like dopamine receptor caused the weak tendency to cross the Cu2+ barrier compared with wild-type. During the control of behavioral choice, DOP-3 antagonistically regulated the function of DOP-1. The behavioral choice phenotype of dop-2; dop-1dop-3 triple mutant further confirmed the possible antagonistic function of D2-like dopamine receptor on D1-like dopamine receptor in regulating behavioral choice. The genetic assays further demonstrate that DOP-3 might act through G alpha(o) signaling pathway encoded by GOA-1 and EGL-10, and DOP-1 might act through G alpha(q) signaling pathway encoded by EGL-30 and EAT-16 to regulate the behavioral choice. DOP-1 might function in cholinergic neurons to regulate the behavioral choice, whereas DOP-3 might function in GABAergic neurons, RIC, and SIA neurons to regulate the behavioral choice. In this study, we provide the genetic evidence to indicate the antagonistic relationship between D1-like dopamine receptor and D2-like dopamine receptor in regulating the decision-making of animals. Our data will be useful for understanding the complex functions of dopamine receptors in regulating decision-making in animals.	[Wang, Daoyong; Yu, Yonglin; Li, Yinxia; Wang, Yang; Wang, Dayong] Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing 210009, Jiangsu, Peoples R China	Southeast University - China	Wang, DY (corresponding author), Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing 210009, Jiangsu, Peoples R China.	dayongw@seu.edu.cn	da, chen/AAA-2175-2020		National Natural Science Foundation of China [30870810]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant from the National Natural Science Foundation of China (No. 30870810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardgett ME, 2009, BEHAV NEUROSCI, V123, P242, DOI 10.1037/a0014625; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; BRENNER S, 1974, GENETICS, V77, P71; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; COMINGS DE, 1991, JAMA-J AM MED ASSOC, V266, P1793, DOI 10.1001/jama.266.13.1793; Correa P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003015; de Krom M, 2009, BIOL PSYCHIAT, V65, P625, DOI 10.1016/j.biopsych.2008.09.035; Esposito G, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-138; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Ezak MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009487; Faumont S, 2012, CURR OPIN NEUROBIOL, V22, P580, DOI 10.1016/j.conb.2012.05.005; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Gong W, 1999, NEUROSCIENCE, V93, P1349, DOI 10.1016/S0306-4522(99)00235-3; Ha RY, 2009, PROG NEURO-PSYCHOPH, V33, P1217, DOI 10.1016/j.pnpbp.2009.07.009; Harris G, 2010, J NEUROSCI, V30, P7889, DOI 10.1523/JNEUROSCI.0497-10.2010; Ishihara T, 2002, CELL, V109, P639, DOI 10.1016/S0092-8674(02)00748-1; Jiu YM, 2010, PROTEIN CELL, V1, P75, DOI 10.1007/s13238-010-0003-4; Kimura KD, 2010, J NEUROSCI, V30, P16365, DOI 10.1523/JNEUROSCI.6023-09.2010; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Knable MB, 1997, J PSYCHOPHARMACOL, V11, P123, DOI 10.1177/026988119701100205; Li YX, 2011, NEUROSCI BULL, V27, P69, DOI 10.1007/s12264-011-1152-z; Li ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1780; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mills H, 2012, EMBO J, V31, P667, DOI 10.1038/emboj.2011.422; Omura DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038649; Paine TA, 2013, BEHAV BRAIN RES, V243, P247, DOI 10.1016/j.bbr.2013.01.018; Pardo M, 2012, NEUROPHARMACOLOGY, V62, P2068, DOI 10.1016/j.neuropharm.2011.12.033; Reuter M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00242; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Shinkai Y, 2011, J NEUROSCI, V31, P3007, DOI 10.1523/JNEUROSCI.4691-10.2011; Simon NW, 2011, J NEUROSCI, V31, P17460, DOI 10.1523/JNEUROSCI.3772-11.2011; St Onge JR, 2011, J NEUROSCI, V31, P8625, DOI 10.1523/JNEUROSCI.1020-11.2011; St Onge JR, 2009, NEUROPSYCHOPHARMACOL, V34, P681, DOI 10.1038/npp.2008.121; Sugiura M, 2005, J NEUROCHEM, V94, P1146, DOI 10.1111/j.1471-4159.2005.03268.x; Suo S, 2009, EMBO J, V28, P2437, DOI 10.1038/emboj.2009.194; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; Ye Hua-Yue, 2006, Neurosci Bull, V22, P355	41	12	18	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115985	10.1371/journal.pone.0115985	http://dx.doi.org/10.1371/journal.pone.0115985			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536037	gold, Green Published, Green Submitted			2022-12-26	WOS:000348563300097
J	Kimura, Y; Akagi, T; Hangai, M; Takayama, K; Hasegawa, T; Suda, K; Yoshikawa, M; Yamada, H; Nakanishi, H; Unoki, N; Ikeda, HO; Yoshimura, N				Kimura, Yugo; Akagi, Tadamichi; Hangai, Masanori; Takayama, Kohei; Hasegawa, Tomoko; Suda, Kenji; Yoshikawa, Munemitsu; Yamada, Hiroshi; Nakanishi, Hideo; Unoki, Noriyuki; Ikeda, Hanako Ohashi; Yoshimura, Nagahisa			Lamina Cribrosa Defects and Optic Disc Morphology in Primary Open Angle Glaucoma with High Myopia	PLOS ONE			English	Article							PERIPAPILLARY INTRACHOROIDAL CAVITATION; ZONE PARAPAPILLARY ATROPHY; COHERENCE TOMOGRAPHY; SWEPT-SOURCE; NERVE; EYES; DAMAGE; PARAMETERS; LOCATION; PREDICTS	Purpose: To investigate whether lamina cribrosa (LC) defects are associated with optic disc morphology in primary open angle glaucoma (POAG) eyes with high myopia. Methods: A total of 129 POAG patients and 55 age-matched control subjects with high myopia were evaluated. Three-dimensional scan images obtained by swept source optical coherence tomography were used to detect LC defects. Radial B-scans and infrared images obtained by spectral domain optical coherence tomography were used to measure beta-peripapillary atrophy (PPA) lengths with and without Bruch's membrane (BM) (temporal, nasal, superior, and inferior), tilt angle (vertical and horizontal), and disc diameter (transverse and longitudinal). Peripapillary intrachoroidal cavitations (PICCs), disc area, ovality index, and cyclotorsion of the optic disc were analyzed as well. Results: LC defects were found in 70 of 129 (54.2%) POAG eyes and 1 of 55 (1.8%) control eyes (P < 0.001). Age, sex, spherical equivalent, axial length, intraocular pressure, and central corneal thickness were not significantly different among POAG eyes with LC defects, POAG eyes without LC defects, and control eyes. Temporal PPA lengths without BM in all three groups correlated significantly with vertical and horizontal tilt angles, although no PPA length with BM correlated significantly with any tilt angle. PICCs were detected more frequently in POAG eyes with LC defects than those without LC defects (P = 0.01) and control eyes (P = 0.02). POAG eyes with LC defects showed a smaller ovality index (P = 0.004), longer temporal PPA without BM (P < 0.001), and larger vertical/horizontal tilt angles (vertical, P < 0.001; horizontal, P = 0.01), and transverse diameter (P = 0.01). In multivariate analysis for the presence of LC defects, presence of POAG (P < 0.001) and vertical tilt angle (P < 0.001) were identified as significant. Conclusions: The presence of LC defects was associated with myopic optic disc morphology in POAG eyes with high myopia.	[Kimura, Yugo; Akagi, Tadamichi; Hangai, Masanori; Takayama, Kohei; Hasegawa, Tomoko; Suda, Kenji; Yoshikawa, Munemitsu; Yamada, Hiroshi; Nakanishi, Hideo; Unoki, Noriyuki; Ikeda, Hanako Ohashi; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyowa, Hokkaido 6068507, Japan	Kyoto University	Kimura, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, 54 Kawahara Cho, Kyowa, Hokkaido 6068507, Japan.	akagi@kuhp.kyoto-u.ac.jp	SUDA, Kenji/W-1979-2019	SUDA, Kenji/0000-0003-1636-0898; Ikeda, Hanako/0000-0001-9572-8659	Japan Society for the Promotion of Science (JSPS) [25462713]; Public Trust Suda Memorial fund for Glaucoma Research [203120700072]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Public Trust Suda Memorial fund for Glaucoma Research	This research was supported by a Grant-in-Aid for Scientific Research (25462713) from the Japan Society for the Promotion of Science (JSPS), and Public Trust Suda Memorial fund for Glaucoma Research (203120700072) (http://www.smtb.jp/personal/entrustment/management/public/example/list.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2013, AM J OPHTHALMOL, V155, P927, DOI 10.1016/j.ajo.2012.12.014; Bellezza AJ, 2000, INVEST OPHTH VIS SCI, V41, P2991; CASHWELL LF, 1995, OPHTHALMOLOGY, V102, P1270, DOI 10.1016/S0161-6420(95)30874-3; Chang L, 2013, AM J OPHTHALMOL, V155, P991, DOI 10.1016/j.ajo.2013.01.016; CHIHARA E, 1992, GRAEF ARCH CLIN EXP, V230, P511, DOI 10.1007/BF00181770; Cho BJ, 2013, OPHTHALMOLOGY, V120, P528, DOI 10.1016/j.ophtha.2012.09.004; Hosseini H, 2013, AM J OPHTHALMOL, V156, P737, DOI 10.1016/j.ajo.2013.05.036; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P587, DOI 10.1007/BF02169209; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Kim M, 2013, OPHTHALMOLOGY, V120, P1790, DOI 10.1016/j.ophtha.2013.02.011; Kim TW, 2012, OPHTHALMOLOGY, V119, P21, DOI 10.1016/j.ophtha.2011.07.051; Kimura Y, 2012, INVEST OPHTH VIS SCI, V53, P6472, DOI 10.1167/iovs.12-10319; Kiumehr S, 2012, ARCH OPHTHALMOL-CHIC, V130, P552, DOI 10.1001/archopthalmol.2011.1309; Lee EJ, 2012, INVEST OPHTH VIS SCI, V53, P198, DOI 10.1167/iovs.11-7848; Lin LLK, 1999, OPTOMETRY VISION SCI, V76, P275, DOI 10.1097/00006324-199905000-00013; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; Mayama C, 2002, OPHTHALMOLOGY, V109, P2072, DOI 10.1016/S0161-6420(02)01175-2; Ohno-Matsui K, 2012, OPHTHALMOLOGY, V119, P1685, DOI 10.1016/j.ophtha.2012.01.047; Ohno-Matsui K, 2011, AM J OPHTHALMOL, V152, P256, DOI 10.1016/j.ajo.2011.01.052; Park HYL, 2012, OPHTHALMOLOGY, V119, P1844, DOI 10.1016/j.ophtha.2012.03.006; Park HYL, 2014, AM J OPHTHALMOL, V157, P550, DOI 10.1016/j.ajo.2013.11.008; Park KH, 1996, OPHTHALMOLOGY, V103, P1899, DOI 10.1016/S0161-6420(96)30409-0; Park SC, 2013, INVEST OPHTH VIS SCI, V54, P8401, DOI 10.1167/iovs.13-13014; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; Shimada N, 2007, OPHTHALMOLOGY, V114, P2070, DOI 10.1016/j.ophtha.2007.01.016; Spaide RF, 2012, RETINA-J RET VIT DIS, V32, P1037, DOI 10.1097/IAE.0b013e318242b9c0; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P5103, DOI 10.1167/iovs.08-2127; Takayama K, 2013, INVEST OPHTH VIS SCI, V54, P4798, DOI 10.1167/iovs.13-11677; Tatham AJ, 2014, OPHTHALMOLOGY, V121, P110, DOI 10.1016/j.ophtha.2013.08.018; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Teng CC, 2011, OPHTHALMOLOGY, V118, P2409, DOI 10.1016/j.ophtha.2011.06.014; Teng CC, 2010, OPHTHALMOLOGY, V117, P909, DOI 10.1016/j.ophtha.2009.10.016; Tezel G, 2004, BRIT J OPHTHALMOL, V88, P251, DOI 10.1136/bjo.2003.019281; Toranzo J, 2005, AM J OPHTHALMOL, V140, P731, DOI 10.1016/j.ajo.2005.03.063; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, P2486; Wu RY, 2011, AM J OPHTHALMOL, V152, P81, DOI 10.1016/j.ajo.2011.01.018; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Yeh SI, 2013, OPHTHALMOLOGY, V120, P544, DOI 10.1016/j.ophtha.2012.08.028; You JY, 2013, JAMA OPHTHALMOL, V131, P314, DOI 10.1001/jamaophthalmol.2013.1926; You QS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078743	44	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115313	10.1371/journal.pone.0115313	http://dx.doi.org/10.1371/journal.pone.0115313			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531656	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000348845100051
J	Kuo, HC; Guo, MMH; Liu, SF; Chen, CC; Sheen, JM; Yu, HR; Tiao, MM; Tain, YL; Huang, LT				Kuo, Ho-Chang; Guo, Mindy Ming-Huey; Liu, Shih-Feng; Chen, Chih-Cheng; Sheen, Jiunn-Ming; Yu, Hong-Ren; Tiao, Mao-Meng; Tain, You-Lin; Huang, Li-Tung			Cross-Fostering Increases Th1/Th2 Expression in a Prenatal Dexamethasone Exposure Rat Model	PLOS ONE			English	Article							T-CELLS; GLUCOCORTICOIDS; ATOPY; ASSOCIATION; ASTHMA; FETAL	Background: Prenatal dexamethasone exposure has been reported to increase allergy potential in childhood possibly by interference with normal immunological development in utero. This study investigated the effects of prenatal dexamethasone on T helper cell immune responses in a rat model. Methods: Pregnant rats received either dexamethasone 0.1 mg/kg/day or normal saline from gestational day 14-21. Off-springs were cared for by their biological mother, or cross-fostered by the opposing group. Spleen and blood samples were collected at post-natal day 7 and 120 and tested for mRNA expression and plasma cytokine levels of Th1/Th2/Th17 immune response. Results: Both Th1 (T-bet) and Th2 (GATA-3) mRNA expression were shown to have a significant increase in the prenatal dexamethasone exposure group at day 120 (p<0.05). The plasma levels for Th1 (IFN gamma and IL-2) and Th2 (IL-4, IL-5, IL-13) were found to have no significant differences between the two group (p>0.05). The mRNA expression of Th17 (ROR gamma t) showed a significant decrease at post-natal day 120 as well as the plasma level of IL-17A at day 7 (11.21 +/- 1.67 vs. 6.23 +/- 1.06 pg/ml, p=0.02). Cross-fostering by a dexamethasone exposed mother resulted in a significant increase in Th1/Th2 mRNA expression (p<0.05) and decrease of Th17. Conclusions: Prenatal dexamethasone exposure increased Th1, Th2 and decreased Th17 expression. Cross-fostering by a dexamethasone exposed mother results in more prominent increase of Th1 and Th2 expression.	[Kuo, Ho-Chang; Guo, Mindy Ming-Huey; Chen, Chih-Cheng; Sheen, Jiunn-Ming; Yu, Hong-Ren; Tiao, Mao-Meng; Tain, You-Lin; Huang, Li-Tung] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Guo, Mindy Ming-Huey; Liu, Shih-Feng; Chen, Chih-Cheng; Sheen, Jiunn-Ming; Yu, Hong-Ren; Tiao, Mao-Meng; Tain, You-Lin] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Liu, Shih-Feng] Kaohsiung Chang Gung Mem Hosp, Dept Resp Therapy & Internal Med, Kaohsiung, Taiwan; [Huang, Li-Tung] Chang Gung Univ, Dept Tradit Chinese Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Huang, LT (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.	litung.huang@gmail.com	Tain, You-Lin/H-2827-2019; Kuo, Ho-Chang/AAQ-6644-2020; 于, 鴻仁/AAW-6827-2021	Tain, You-Lin/0000-0002-7059-6407; Kuo, Ho-Chang/0000-0002-3295-2984; 于, 鴻仁/0000-0003-1242-8760; Liu, Shih-Feng/0000-0003-1394-5401; Tiao, Mao-Meng/0000-0002-0338-3495	Chang Gung Memorial Hospital, Kaohsiung, Taiwan [CMRPG8B0151]; National Science Council, Taiwan [NSC 102-2314-B-182-053-MY3]	Chang Gung Memorial Hospital, Kaohsiung, Taiwan(Chang Gung Memorial Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grant CMRPG8B0151 from the Chang Gung Memorial Hospital, Kaohsiung, Taiwan and Grant NSC 102-2314-B-182-053-MY3 from the National Science Council, Taiwan. The authors' funding source had no involvement in the study design, collection, analysis or interpretation of data, in the writing of the manuscript or decisions regarding submission.	Bisgaard H, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050131; Brownfoot FC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006764.pub3; Bunn TL, 2001, TOXICOL SCI, V64, P57, DOI 10.1093/toxsci/64.1.57; Dalziel SR, 2006, THORAX, V61, P678, DOI 10.1136/thx.2005.051763; Dietert RR, 2003, TOXICOLOGY, V194, P163, DOI 10.1016/j.tox.2003.07.001; Dietert RR, 2002, HUM EXP TOXICOL, V21, P479, DOI 10.1191/0960327102ht285oa; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Fahey AJ, 2006, J LEUKOCYTE BIOL, V80, P133, DOI 10.1189/jlb.0605296; Flammer JR, 2011, MOL ENDOCRINOL, V25, P1075, DOI 10.1210/me.2011-0068; Hauser J, 2006, BEHAV BRAIN RES, V175, P51, DOI 10.1016/j.bbr.2006.07.026; Hauser J, 2009, HORM BEHAV, V56, P364, DOI 10.1016/j.yhbeh.2009.07.003; Henderson JJ, 2008, PEDIATRICS, V121, pE92, DOI 10.1542/peds.2007-1107; Huang YC, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-40; Kuo HC, 2009, PEDIAT ALLERG IMM-UK, V20, P266, DOI 10.1111/j.1399-3038.2008.00779.x; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S6; Lemanske RF, 2001, NEW ENGL J MED, V344, P1643; Liberman AC, 2007, FASEB J, V21, P1177, DOI 10.1096/fj.06-7452com; Liberman AC, 2009, FASEB J, V23, P1558, DOI 10.1096/fj.08-121236; Liu CA, 2003, J ALLERGY CLIN IMMUN, V112, P899, DOI 10.1016/j.jaci.2003.08.030; Martino DJ, 2010, ALLERGY, V65, P7, DOI 10.1111/j.1398-9995.2009.02186.x; Peden DB, 2000, ENVIRON HEALTH PERSP, V108, P475, DOI 10.2307/3454539; Plyusnina IZ, 2009, BEHAV GENET, V39, P202, DOI 10.1007/s10519-008-9248-6; Pole JD, 2010, J PREGNANCY, V2010, DOI 10.1155/2010/789748; Pole J, 2009, J ASTHMA, V46, P47, DOI 10.1080/02770900802262795; Prescott SL, 1998, J IMMUNOL, V160, P4730; Ramirez F, 1996, J IMMUNOL, V156, P2406; Ronmark E, 2009, J ALLERGY CLIN IMMUN, V124, P357, DOI 10.1016/j.jaci.2009.05.011; Tain YL, 2014, J AM SOC HYPERTENS, V8, P216, DOI 10.1016/j.jash.2014.01.009; Tang JI, 2011, J HYPERTENS, V29, P282, DOI 10.1097/HJH.0b013e328340aa18; Tiao MM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/942172; Wu CY, 1998, J IMMUNOL, V161, P2723; Yang KD, 2007, CLIN EXP ALLERGY, V37, P680, DOI 10.1111/j.1365-2222.2007.02698.x; Yu HR, 2014, IMMUNOLOGY	33	4	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115554	10.1371/journal.pone.0115554	http://dx.doi.org/10.1371/journal.pone.0115554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526616	gold, Green Submitted, Green Published			2022-12-26	WOS:000347186200034
J	Chen, YC; Chiou, C; Lin, MN; Lin, CL				Chen, Yen-Chun; Chiou, Chia; Lin, Ming-Nan; Lin, Chin-Lon			The Prevalence and Risk Factors for Gallstone Disease in Taiwanese Vegetarians	PLOS ONE			English	Article							GALLBLADDER-DISEASE; GENERAL-POPULATION; PHYSICAL-ACTIVITY; UNITED-STATES; CHOLELITHIASIS; PREGNANCY; WOMEN; DIET; CHOLECYSTECTOMY; CHOLESTEROL	Introduction: Gallstone disease (GSD) and its complications are major public health issues globally. Although many community-based studies had addressed the risk factors for GSD, little is known about GSD prevalence and risk factors among Taiwanese vegetarians. Methods: This study included 1721 vegetarians who completed a questionnaire detailing their demographics, medical history, and life-styles. GSD was ascertained by ultrasonography or surgical history of cholecystectomy for GSD. The predictive probability of GSD for male and female vegetarians was estimated from the fitted model. Results: The prevalence of GSD was 8.2% for both male and female vegetarians. The risk of GSD is similar in men and women across all age groups, and increases steadily with increasing age. For male vegetarians, age (OR: 1.04; 95% CI: 1.00-1.08) and serum total bilirubin level (OR: 2.35; 95% CI: 1.31-4.22) predict risk for GSD. For female vegetarians, age (OR: 1.03; 95% CI: 1.01-1.05), BMI (OR: 1.07; 95% CI: 1.01-1.13), and alcohol consumption (OR: 7.85; 95% CI: 1.83-33.73) are associated with GSD. GSD is not associated with type of vegetarian diet, duration of vegetarianism, low education level, physical inactivity, diabetes, coronary artery disease, cerebral vascular accident, chronic renal failure, hepatitis C virus infection, and lipid abnormalities. GSD is also not associated with age at menarche, postmenopausal status, and multiparity in female vegetarians. Conclusions: Risk factors useful for predicting GSD in vegetarians are (1) age and total bilirubin level in men, and (2) age, BMI, and alcohol consumption in women. Many previously identified risk factors for general population does not seem to apply to Taiwanese vegetarians.	[Chen, Yen-Chun] Dalin Tzu Chi Hosp, Dept Internal Med, Buddhist Tzu Chi Med Fdn, Dalin Township, Chiayi County, Taiwan; [Chiou, Chia; Lin, Ming-Nan] Dalin Tzu Chi Hosp, Dept Family Med, Buddhist Tzu Chi Med Fdn, Dalin Township, Chiayi County, Taiwan; [Lin, Ming-Nan] Tzu Chi Univ, Dept Family Med, Coll Med, Hualien, Taiwan; [Lin, Chin-Lon] Tzu Chi Fdn, Hualien, Taiwan; [Lin, Chin-Lon] Buddhist Hualien Tzu Chi Hosp, Dept Internal Med, Hualien, Taiwan; [Lin, Chin-Lon] Tzu Chi Univ, Dept Internal Med, Coll Med, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; Tzu Chi University; Tzu Chi University	Lin, MN (corresponding author), Dalin Tzu Chi Hosp, Dept Family Med, Buddhist Tzu Chi Med Fdn, Dalin Township, Chiayi County, Taiwan.	mingnan.lin@gmail.com						Abu-Eshy S. A., 2007, Eastern Mediterranean Health Journal, V13, P794; ATTILI AF, 1995, HEPATOLOGY, V21, P656, DOI 10.1002/hep.1840210309; BARBARA L, 1995, AM J EPIDEMIOL, V141, P158, DOI 10.1093/oxfordjournals.aje.a117403; BASSO L, 1992, SURG GYNECOL OBSTET, V175, P41; Bini EJ, 2005, HEPATOLOGY, V41, P1029, DOI 10.1002/hep.20647; Chen CH, 2006, J GASTROEN HEPATOL, V21, P1737, DOI 10.1111/j.1440-1746.2006.04381.x; Chen CY, 1998, AGE AGEING, V27, P437, DOI 10.1093/ageing/27.4.437; Chen CY, 1999, HEPATO-GASTROENTEROL, V46, P1607; Chiu TH, PUBLIC HLTH NUTR, V17, P1459; Chiu THT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088547; de Pancorbo CM, 1997, J CLIN EPIDEMIOL, V50, P1347, DOI 10.1016/S0895-4356(97)00198-4; DeSantis A, 1997, HEPATOLOGY, V25, P787, DOI 10.1002/hep.510250401; DWYER JT, 1988, AM J CLIN NUTR, V48, P712, DOI 10.1093/ajcn/48.3.712; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Festi D, 2008, WORLD J GASTROENTERO, V14, P5282, DOI 10.3748/wjg.14.5282; Gaby AR, 2009, ALTERN MED REV, V14, P258; Halldestam I, 2009, BRIT J SURG, V96, P1315, DOI 10.1002/bjs.6687; HEATON KW, 1991, GUT, V32, P316, DOI 10.1136/gut.32.3.316; Hung SC, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-111; HWANG WS, 1970, GUT, V11, P141, DOI 10.1136/gut.11.2.141; Kothari SN, 2013, J AM COLL SURGEONS, V216, P1057, DOI 10.1016/j.jamcollsurg.2013.02.009; Lee YC, 2014, SCAND J GASTROENTERO, V49, P1001, DOI 10.3109/00365521.2014.920912; Leitzmann MF, 1998, ANN INTERN MED, V128, P417, DOI 10.7326/0003-4819-128-6-199803150-00001; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM199909093411101; Liu B, 2009, INT J EPIDEMIOL, V38, P312, DOI 10.1093/ije/dyn174; MARINGHINI A, 1993, ANN INTERN MED, V119, P116, DOI 10.7326/0003-4819-119-2-199307150-00004; MARKS JW, 1984, DIGEST DIS SCI, V29, P1118, DOI 10.1007/BF01317086; Moerman Clara J., 1994, Annals of Epidemiology, V4, P248, DOI 10.1016/1047-2797(94)90104-X; NOMURA H, 1988, AM J EPIDEMIOL, V128, P598, DOI 10.1093/oxfordjournals.aje.a115007; Phillips F, 2005, NUTR BULL, V30, P132, DOI 10.1111/j.1467-3010.2005.00467.x; PIXLEY F, 1985, BRIT MED J, V291, P11, DOI 10.1136/bmj.291.6487.11; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; SMITH DA, 1979, AM J CLIN NUTR, V32, P1519, DOI 10.1093/ajcn/32.7.1519; Stender S, 2013, HEPATOLOGY, V58, P2133, DOI 10.1002/hep.26563; Stender S, 2013, JAMA INTERN MED, V173, P1222, DOI 10.1001/jamainternmed.2013.6465; Sun H, 2009, WORLD J GASTROENTERO, V15, P1886, DOI 10.3748/wjg.15.1886; THORNTON J, 1983, LANCET, V2, P819; Tonstad S, 2009, DIABETES CARE, V32, P791, DOI 10.2337/dc08-1886; Tsai CJ, 2006, AM J MED, V119, P760, DOI 10.1016/j.amjmed.2006.02.040; VALDIVIESO V, 1993, HEPATOLOGY, V17, P1; Walcher T, 2010, EUR J GASTROEN HEPAT, V22, P1345, DOI 10.1097/MEG.0b013e32833efdb2	41	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115145	10.1371/journal.pone.0115145	http://dx.doi.org/10.1371/journal.pone.0115145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521621	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845600018
J	Ray, AM; Arnold, RA; Swift, I; Schapker, PA; McCann, S; Marshall, CJ; McElfresh, JS; Millar, JG				Ray, Ann M.; Arnold, Richard A.; Swift, Ian; Schapker, Philip A.; McCann, Sean; Marshall, Christopher J.; McElfresh, J. Steven; Millar, Jocelyn G.			(R)-Desmolactone Is a Sex Pheromone or Sex Attractant for the Endangered Valley Elderberry Longhorn Beetle Desmocerus californicus dimorphus and Several Congeners (Cerambycidae: Lepturinae)	PLOS ONE			English	Article							PLANT VOLATILES; HOST-PLANT; COLEOPTERA; IDENTIFICATION; COMPONENTS; GENUS	We report here that (4R, 9Z)-hexadec-9-en-4-olide [(R)-desmolactone] is a sex attractant or sex pheromone for multiple species and subspecies in the cerambycid genus Desmocerus. This compound was previously identified as a female-produced sex attractant pheromone of Desmocerus californicus californicus. Headspace volatiles from female Desmocerus aureipennis aureipennis contained (R)-desmolactone, and the antennae of adult males of two species responded strongly to synthetic (R)-desmolactone in coupled gas chromatography-electroantennogram analyses. In field bioassays in California, Oregon, and British Columbia, traps baited with synthetic (R)-desmolactone captured males of several Desmocerus species and subspecies. Only male beetles were captured, indicating that this compound acts as a sex-specific attractant, rather than as a signal for aggregation. In targeted field bioassays, males of the US federally threatened subspecies Desmocerus californicus dimorphus responded to the synthetic attractant in a dose dependent manner. Our results represent the first example of a "generic'' sex pheromone used by multiple species in the subfamily Lepturinae, and demonstrate that pheromone-baited traps may be a sensitive and efficient method of monitoring the threatened species Desmocerus californicus dimorphus, commonly known as the valley elderberry longhorn beetle.	[Ray, Ann M.] Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA; [Arnold, Richard A.] Entomol Consulting Serv Ltd, Pleasant Hill, CA USA; [Swift, Ian] Calif State Collect Arthropods, Sacramento, CA USA; [Schapker, Philip A.; Marshall, Christopher J.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [McCann, Sean] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [McElfresh, J. Steven; Millar, Jocelyn G.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	Xavier University; Oregon State University; Simon Fraser University; University of California System; University of California Riverside	Ray, AM (corresponding author), Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA.	raya6@xavier.edu	Ray, Ann/GWC-1693-2022	Ray, Ann/0000-0002-5411-8974; Millar, Jocelyn/0000-0001-7639-9001; McCann, Sean/0000-0001-6030-6456	Robert Borcer Endowment; National Science Foundation Division of Biological Infrastructure [0847965]; National Research Initiative of the United States Department of Agriculture Cooperative State Research; Education and Extension Service [2009-3530205047]	Robert Borcer Endowment; National Science Foundation Division of Biological Infrastructure(National Science Foundation (NSF)); National Research Initiative of the United States Department of Agriculture Cooperative State Research(United States Department of Agriculture (USDA)); Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	Funding for this project was provided by the Robert Borcer Endowment (Xavier University, www.xavier.edu, to AMR), National Science Foundation Division of Biological Infrastructure (www.nsf.gov) grant number #0847965 (to CJM), and the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service (www.csrees.usda.gov), grant number #2009-3530205047 (to JGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Atkins North America, 2013, PEER REV SCI FIND PR; Barbour JD, 2011, ANN ENTOMOL SOC AM, V104, P588, DOI 10.1603/AN10182; Barr CB, 1991, DISTRIBUTION HABITAT; Bolli R., 1994, DISSERTATIONES BOT; Burke HE, 1921, J ECON ENTOMOL, V14, P450, DOI 10.1093/jee/14.5.450; CHEMSAK JA, 2005, ILLUSTRATED REVISION, V2; Collinge SK, 2001, BIOL CONSERV, V100, P103, DOI 10.1016/S0006-3207(00)00211-1; Davis A., 1924, Bulletin of the Southern California Academy of Sciences, V23, P179; Eliyahu D, 2012, P NATL ACAD SCI USA, V109, pE490, DOI 10.1073/pnas.1111748109; Fonseca MG, 2010, J CHEM ECOL, V36, P1132, DOI 10.1007/s10886-010-9850-y; Graham EE, 2010, J ECON ENTOMOL, V103, P641, DOI 10.1603/EC10013; Halstead JA, 2000, PAN-PAC ENTOMOL, V76, P74; Hanks LM, 2014, ANN ENTOMOL SOC AM, V107, P211, DOI 10.1603/AN13067; Hanks LM, 2013, CHEMOECOLOGY, V23, P21, DOI 10.1007/s00049-012-0116-8; Hardie J, 1999, PHEROMONES NONLEPIDO; Hart CJ, 2013, COLEOPTS BULL, V67, P133, DOI 10.1649/0010-065X-67.2.133; Holyoak M, 2008, ENVIRON MANAGE, V42, P444, DOI 10.1007/s00267-008-9113-7; Huxel Gary R., 2000, Biological Invasions, V2, P81, DOI 10.1023/A:1010015722996; LADD TL, 1981, J ECON ENTOMOL, V74, P665, DOI 10.1093/jee/74.6.665; LINSLEY EG, 1972, CERAMBYCIDAE N AM 6; Maurel N, 2013, OREINA           SEP, V23, P13; MICHELSEN AXEL, 1963, BEHAVIOUR, V22, P152, DOI 10.1163/156853963X00338; Millar JG, 2010, J CHEM ECOL, V36, P923, DOI 10.1007/s10886-010-9831-1; Mitchell RF, 2013, CHEMOECOLOGY, V23, P121, DOI 10.1007/s00049-012-0122-x; Morrison M. L., 2003, Ecological Restoration, V21, P95, DOI 10.3368/er.21.2.95; Nehme ME, 2010, ENVIRON ENTOMOL, V39, P169, DOI 10.1603/EN09177; Pajares JA, 2010, J CHEM ECOL, V36, P570, DOI 10.1007/s10886-010-9791-5; Partners River, 2007, VELB HAB COL REMN PL; Paschen MA, 2012, J INSECT BEHAV, V25, P569, DOI 10.1007/s10905-012-9321-0; Ray AM, 2012, J CHEM ECOL, V38, P1151, DOI 10.1007/s10886-012-0181-z; Ray AM, 2012, J CHEM ECOL, V38, P157, DOI 10.1007/s10886-012-0070-5; Ray AM, 2011, J CHEM ECOL, V37, P173, DOI 10.1007/s10886-011-9908-5; Rodstein J, 2011, J CHEM ECOL, V37, P114, DOI 10.1007/s10886-010-9890-3; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Silk PJ, 2007, NATURWISSENSCHAFTEN, V94, P697, DOI 10.1007/s00114-007-0244-0; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Suckling DM, 2012, J ECON ENTOMOL, V105, P1, DOI 10.1603/EC11293; SVACHA P, 1988, Acta Universitatis Carolinae-Biologica, V32, P1; Svensson GP, 2012, J INSECT CONSERV, V16, P549, DOI 10.1007/s10841-011-9440-5; Swaine JM, 1928, NATL MUSEUM CANADA B, V52, P1; Talley TS, 2007, BIOL CONSERV, V135, P21, DOI 10.1016/j.biocon.2006.09.022; Talley TS, 2006, ENVIRON MANAGE, V37, P647, DOI 10.1007/s00267-004-0320-6; Tavakilian G, 2013, BAS DONN TIT CER LON; USDA, 2012, GYPS MOTH PROGR MAN; USFWS, 2012, FED REGISTER, V77, P60237; USFWS, 1984, VALL ELD LONGH BEETL; USFWS, 2006, VALL ELD LONGH BEETL; *USFWS, 1999, CONS GUID VALL ELD L; USFWS, 2014, FED REGISTER, V79, P55874; Wickham JD, 2014, J ECON ENTOMOL, V107, P259, DOI 10.1603/EC13333; 1980, FED REG, V45, P52803	52	24	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115498	10.1371/journal.pone.0115498	http://dx.doi.org/10.1371/journal.pone.0115498			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521293	gold, Green Submitted, Green Published			2022-12-26	WOS:000348845600051
J	Wang, Q; Li, XF; Ji, XL; Wang, JF; Shen, N; Gao, YL; Qi, XL; Wang, YQ; Gao, HL; Zhang, SD; Wang, XM				Wang, Qi; Li, Xiaofei; Ji, Xiaolin; Wang, Jingfei; Shen, Nan; Gao, Yulong; Qi, Xiaole; Wang, Yongqiang; Gao, Honglei; Zhang, Shide; Wang, Xiaomei			A Recombinant Avian Leukosis Virus Subgroup J for Directly Monitoring Viral Infection and the Selection of Neutralizing Antibodies	PLOS ONE			English	Article							CONTRIBUTES; PARTICLES; CHICKENS; ELEMENT; CHINA; CELLS	Avian leukosis virus subgroup J (ALV-J) has induced serious clinical outbreaks and has become a serious infectious disease of chickens in China. We describe here the creation of a recombinant ALV-J tagged with the enhanced green fluorescent protein (named rHPRS-103EGFP). We successfully utilize the rHPRS-103EGFP to visualize viral infection and for development of a simplified serum-neutralization test.	[Wang, Qi; Li, Xiaofei; Ji, Xiaolin; Gao, Yulong; Qi, Xiaole; Wang, Yongqiang; Gao, Honglei; Wang, Xiaomei] Chinese Acad Agr Sci, Div Avian Infect Dis, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150001, Peoples R China; [Wang, Jingfei; Shen, Nan] Chinese Acad Agr Sci, Ctr Anim Infect Dis Diag & Tech Serv, Harbin 150001, Peoples R China; [Wang, Jingfei; Shen, Nan] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150001, Peoples R China; [Zhang, Shide] Harbin Med Univ, Dept Radiol, Affiliated Hosp 2, Harbin 150086, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Harbin Medical University	Zhang, SD (corresponding author), Harbin Med Univ, Dept Radiol, Affiliated Hosp 2, Harbin 150086, Peoples R China.	zhangshide65@126.com; xmw@hvri.ac.cn	Li, xiaofei/GXF-7187-2022		National Natural Science Foundation of China [31072146, 31201923]; earmarked fund for the Modern Agro-industry Technology Research System [nycytx-42-G3-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the Modern Agro-industry Technology Research System	This study was funded by the National Natural Science Foundation of China (31072146), the National Natural Science Foundation of China (31201923) and the earmarked fund for the Modern Agro-industry Technology Research System (no. nycytx-42-G3-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA TW, 1984, J VIROL, V51, P123, DOI 10.1128/JVI.51.1.123-130.1984; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; Chesters PM, 2006, J GEN VIROL, V87, P2685, DOI 10.1099/vir.0.81884-0; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566; Gao YL, 2010, EMERG INFECT DIS, V16, P1637, DOI 10.3201/eid1610.100780; Hussain AI, 2003, J VIROL, V77, P1105, DOI 10.1128/JVI.77.2.1105-1111.2003; Ji XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084797; Jin J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000163; Kucerova D, 2013, J VIROL, V87, P8399, DOI 10.1128/JVI.03180-12; Li Y, 2013, J CLIN MICROBIOL; Martin N, 2009, CURR OPIN HIV AIDS, V4, P143, DOI 10.1097/COH.0b013e328322f94a; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Meng QW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-556; NASIOULAS G, 1995, P NATL ACAD SCI USA, V92, P11940, DOI 10.1073/pnas.92.25.11940; ROBINSON HL, 1982, P NATL ACAD SCI-BIOL, V79, P1225, DOI 10.1073/pnas.79.4.1225; RUDDELL A, 1995, VIROLOGY, V206, P1, DOI 10.1016/S0042-6822(95)80013-1; STIERHOF YD, 1991, J ELECTRON MICR TECH, V17, P336, DOI 10.1002/jemt.1060170307; Venugopal K, 1998, J GEN VIROL, V79, P757, DOI 10.1099/0022-1317-79-4-757; Wang Q, 2012, J VIROL, V86, P12849, DOI 10.1128/JVI.01113-12; WELT S, 1979, IMMUNOLOGY, V37, P587	20	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115422	10.1371/journal.pone.0115422	http://dx.doi.org/10.1371/journal.pone.0115422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522008	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845600045
J	Zeng, L; Morinibu, A; Kobayashi, M; Zhu, Y; Wang, X; Goto, Y; Yeom, CJ; Zhao, T; Hirota, K; Shinomiya, K; Itasaka, S; Yoshimura, M; Guo, G; Hammond, EM; Hiraoka, M; Harada, H				Zeng, L.; Morinibu, A.; Kobayashi, M.; Zhu, Y.; Wang, X.; Goto, Y.; Yeom, C. J.; Zhao, T.; Hirota, K.; Shinomiya, K.; Itasaka, S.; Yoshimura, M.; Guo, G.; Hammond, E. M.; Hiraoka, M.; Harada, H.			Aberrant IDH3 alpha expression promotes malignant tumor growth by inducing HIF-1-mediated metabolic reprogramming and angiogenesis	ONCOGENE			English	Article							BREAST-CANCER PATIENTS; TRANSCRIPTIONAL ACTIVITY; RADIATION-THERAPY; GENE-EXPRESSION; HIF-1 ACTIVITY; FACTOR-I; HYPOXIA; CELLS; FACTOR-1; TRANSFORMATION	Cancer cells gain a growth advantage through the so-called Warburg effect by shifting glucose metabolism from oxidative phosphorylation to aerobic glycolysis. Hypoxia-inducible factor 1 (HIF-1) has been suggested to function in metabolic reprogramming; however, the underlying mechanism has not been fully elucidated. We found that the aberrant expression of wild-type isocitrate dehydrogenase 3 alpha (IDH3 alpha), a subunit of the IDH3 heterotetramer, decreased alpha-ketoglutarate levels and increased the stability and transactivation activity of HIF-1 alpha in cancer cells. The silencing of IDH3 alpha significantly delayed tumor growth by suppressing the HIF-1-mediated Warburg effect and angiogenesis. IDH3 alpha expression was associated with the poor postoperative overall survival of lung and breast cancer patients. These results justify the exploitation of IDH3 as a novel target for the diagnosis and treatment of cancers.	[Zeng, L.; Morinibu, A.; Kobayashi, M.; Zhu, Y.; Wang, X.; Goto, Y.; Zhao, T.; Shinomiya, K.; Itasaka, S.; Yoshimura, M.; Hiraoka, M.; Harada, H.] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto 6068507, Japan; [Zeng, L.; Morinibu, A.; Kobayashi, M.; Zhu, Y.; Wang, X.; Goto, Y.; Yeom, C. J.; Zhao, T.; Shinomiya, K.; Harada, H.] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Grp Radiat & Tumor Biol, Kyoto 6068507, Japan; [Zeng, L.; Wang, X.; Zhao, T.; Guo, G.] Fourth Mil Med Univ, Dept Radiat Med, Xian, Shaanxi, Peoples R China; [Zhu, Y.] Chongqing Med Univ, Affiliated Hosp 1, Dept Oncol, Chongqing, Peoples R China; [Hirota, K.] Kyoto Univ, Kyoto Univ Hosp, Dept Anesthesia, Kyoto 6068507, Japan; [Hammond, E. M.] Univ Oxford, Oxford Inst Radiat Oncol, Dept Oncol, Oxford, England; [Harada, H.] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan	Kyoto University; Kyoto University; Air Force Military Medical University; Chongqing Medical University; Kyoto University; University of Oxford; Japan Science & Technology Agency (JST)	Harada, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	hharada@kuhp.kyoto-u.ac.jp	; Hirota, Kiichi/E-9181-2010	Hammond, Ester/0000-0002-2335-3146; Kobayshi, Minoru/0000-0003-3843-3584; Hirota, Kiichi/0000-0003-1110-0827	Funding Program for NEXT Generation World-Leading Researchers (NEXT Program) Japan Society for the Promotion of Science (JSPS), Japan [LS071]; program for Precursory Research for Embryonic Science and Technology (PRESTO) Japan Science and Technology Agency (JST); Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT, Japan [26293276, 26461886, 26670558, 26670555, 25861088, 24791293, 24659563]; Sagawa Foundation; Kobayashi Foundation; Takeda Science Foundation; Mochida Memorial Foundation; International Science and Technology Cooperation Project of China and Japan [2010DFA31900]; Cancer Research UK [19276] Funding Source: researchfish; Grants-in-Aid for Scientific Research [26670693] Funding Source: KAKEN	Funding Program for NEXT Generation World-Leading Researchers (NEXT Program) Japan Society for the Promotion of Science (JSPS), Japan; program for Precursory Research for Embryonic Science and Technology (PRESTO) Japan Science and Technology Agency (JST); Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sagawa Foundation; Kobayashi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation; International Science and Technology Cooperation Project of China and Japan; Cancer Research UK(Cancer Research UK); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr M Suematsu, Dr YA Minamishima, and Dr N Hayakawa for critical discussion. This study was supported by the Funding Program for NEXT Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS), Japan to HH (No. LS071), by the program for Precursory Research for Embryonic Science and Technology (PRESTO) from Japan Science and Technology Agency (JST) to HH, by the Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to HH, and by Grants-in-Aids for Scientific Research (B) to HH (No. 26293276), for Scientific Research (C) to AM (No. 26461886), for challenging Exploratory Research to HH (No. 26670558) and to MH (No. 26670555), and for Young Scientists (B) to MK (No. 25861088), MY (No. 24791293) and SI (No. 24659563) from MEXT, Japan, by the Sagawa Foundation for the Promotion of Cancer Research to HH, by the Kobayashi Foundation for Cancer Research to HH, by the Takeda Science Foundation to HH, by the Mochida Memorial Foundation for Medical and Pharmaceutical Research to HH, and by the International Science and Technology Cooperation Project of China and Japan to ZL and HH (No. 2010DFA31900).	Adler E, 1939, BIOCHEM J, V33, P1028, DOI 10.1042/bj0331028; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Bao Y, 2013, MOL CANCER RES, V11, P973, DOI 10.1158/1541-7786.MCR-12-0669-T; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Harada H, 2007, ONCOGENE, V26, P7508, DOI 10.1038/sj.onc.1210556; Harada H, 2009, BRIT J CANCER, V100, P747, DOI 10.1038/sj.bjc.6604939; Harada H, 2007, BIOCHEM BIOPH RES CO, V360, P791, DOI 10.1016/j.bbrc.2007.06.149; Harada H, 2005, MOL IMAGING, V4, P182; Harada H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1786; Harada H, 2009, J BIOL CHEM, V284, P5332, DOI 10.1074/jbc.M806653200; Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McCarthy N, 2012, NAT REV CANCER, V12, P229, DOI 10.1038/nrc3248; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Shibata T, 1998, INT J RADIAT ONCOL, V42, P913, DOI 10.1016/S0360-3016(98)00298-3; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Wakamatsu T, 2009, EUR J PHARMACOL, V617, P17, DOI 10.1016/j.ejphar.2009.06.060; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Zeng LH, 2008, CANCER SCI, V99, P2327, DOI 10.1111/j.1349-7006.2008.00943.x	30	59	61	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 3	2015	34	36					4758	4766		10.1038/onc.2014.411	http://dx.doi.org/10.1038/onc.2014.411			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CQ9JU	25531325				2022-12-26	WOS:000360931500009
J	Kanazawa, I; Canaff, L; Rafeh, JA; Angrula, A; Li, JJ; Riddle, RC; Boraschi-Diaz, I; Komarova, SV; Clemens, TL; Murshed, M; Hendy, GN				Kanazawa, Ippei; Canaff, Lucie; Rafeh, Jad Abi; Angrula, Aarti; Li, Jingjing; Riddle, Ryan C.; Boraschi-Diaz, Iris; Komarova, Svetlana V.; Clemens, Thomas L.; Murshed, Monzur; Hendy, Geoffrey N.			Osteoblast Menin Regulates Bone Mass in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; MESENCHYMAL STEM-CELLS; TGF-BETA; MICE DEVELOP; GENE; TYPE-1; EXPRESSION; RECEPTOR; GROWTH; DIFFERENTIATION	Menin, the product of the multiple endocrine neoplasia type 1 (Men1) tumor suppressor gene, mediates the cell proliferation and differentiation actions of transforming growth factor-beta (TGF-beta) ligand family members. In vitro, menin modulates osteoblastogenesis and osteoblast differentiation promoted and sustained by bone morphogenetic protein-2 (BMP-2) and TGF-beta, respectively. To examine the in vivo function of menin in bone, we conditionally inactivated Men1 in mature osteoblasts by crossing osteocalcin (OC)-Cre mice with floxed Men1 (Men1(f/f)) mice to generate mice lacking menin in differentiating osteoblasts (OC-Cre; Men1(f/f) mice). These mice displayed significant reduction in bone mineral density, trabecular bone volume, and cortical bone thickness compared with control littermates. Osteoblast and osteoclast number as well as mineral apposition rate were significantly reduced, whereas osteocyte number was increased. Primary calvarial osteoblasts proliferated more quickly but had deficient mineral apposition and alkaline phosphatase activity. Although the mRNA expression of osteoblast marker and cyclin-dependent kinase inhibitor genes were all reduced, that of cyclin-dependent kinase, osteocyte marker, and pro-apoptotic genes were increased in isolated Men1 knock-out osteoblasts compared with controls. In contrast to the knock-out mice, transgenic mice overexpressing a human menin cDNA in osteoblasts driven by the 2.3-kb Col1a1 promoter, showed a gain of bone mass relative to control littermates. Osteoblast number and mineral apposition rate were significantly increased in the Col1a1-Menin-Tg mice. Therefore, osteoblast menin plays a key role in bone development, remodeling, and maintenance.	[Murshed, Monzur] McGill Univ, Royal Victoria Hosp, Dept Med, Montreal, PQ H3A 1A1, Canada; [Rafeh, Jad Abi; Hendy, Geoffrey N.] McGill Univ, Royal Victoria Hosp, Dept Physiol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Royal Victoria Hosp, Dept Human Genet, Montreal, PQ H3A 1A1, Canada; [Li, Jingjing; Boraschi-Diaz, Iris; Komarova, Svetlana V.; Murshed, Monzur] McGill Univ, Royal Victoria Hosp, Dept Dent, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.] McGill Univ, Royal Victoria Hosp, Calcium Res Lab, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.] McGill Univ, Royal Victoria Hosp, Hormones & Canc Res Unit, Montreal, PQ H3A 1A1, Canada; [Riddle, Ryan C.; Clemens, Thomas L.] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21205 USA; [Clemens, Thomas L.] Vet Adm Med Ctr, Baltimore, MD 21201 USA	McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Hendy, GN (corresponding author), Royal Victoria Hosp, Calcium Res Lab, Rm H4-67,687 Pine Ave West, Montreal, PQ H3A 1A1, Canada.	geoffrey.hendy@mcgill.ca	Kanazawa, Ippei/F-8609-2010	Abi-Rafeh, Jad/0000-0002-7483-1515	Department of Medicine, McGill University [5767]; McGill University Health Centre-Research Institute [5758]; Canadian Institutes of Health Research [MOP-9315, 123310, 776403]; Fonds de la Recherche en Sante Quebec; Canadian Bureau for International Education; Uehara Memorial Foundation; Kanae Foundation for the Promotion of Medical Science; Network for Oral and Bone Health Research (RSBO) Summer Student Scholarship; McGill University Faculty of Dentistry	Department of Medicine, McGill University; McGill University Health Centre-Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Bureau for International Education; Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; Network for Oral and Bone Health Research (RSBO) Summer Student Scholarship; McGill University Faculty of Dentistry	This work was supported in part by the Department of Medicine, McGill University Grant 5767 and McGill University Health Centre-Research Institute Grant 5758 (to G. N. H.) and Canadian Institutes of Health Research Grants MOP-9315 (to G. N. H.), 123310 (to M. M.), and 776403 (to S. V. K.).; Recipient of fellowships from Fonds de la Recherche en Sante Quebec, Canadian Bureau for International Education, Uehara Memorial Foundation, and Kanae Foundation for the Promotion of Medical Science. Present address: Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Shimane 693-8501, Japan.; Recipient of a Network for Oral and Bone Health Research (RSBO) Summer Student Scholarship.; Supported by the McGill University Faculty of Dentistry.	Aziz A, 2009, DEV BIOL, V332, P116, DOI 10.1016/j.ydbio.2009.05.555; Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Bertolino P, 2003, MECH DEVELOP, V120, P549, DOI 10.1016/S0925-4773(03)00039-X; Bertolino P, 2003, CANCER RES, V63, P4836; Biondi CA, 2004, MOL CELL BIOL, V24, P3125, DOI 10.1128/MCB.24.8.3125-3131.2004; Boraschi-Diaz I, 2016, CYTOTECHNOLOGY, V68, P105, DOI 10.1007/s10616-014-9759-3; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Canaff L, 2012, J CLIN ENDOCR METAB, V97, pE282, DOI 10.1210/jc.2011-0241; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen D, 2004, FRONT BIOSCI-LANDMRK, V9, P349, DOI 10.2741/1090; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Engleka KA, 2007, DEV BIOL, V311, P524, DOI 10.1016/j.ydbio.2007.08.057; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Harding B, 2009, ENDOCR-RELAT CANCER, V16, P1313, DOI 10.1677/ERC-09-0082; Hay E, 2001, J BIOL CHEM, V276, P29028, DOI 10.1074/jbc.M011265200; Hendy GN, 2009, ADV EXP MED BIOL, V668, P37; Kaji H, 1999, CANCER RES, V59, P5097; Kaji H, 2001, P NATL ACAD SCI USA, V98, P3837, DOI 10.1073/pnas.061358098; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; Lemos MC, 2009, J ENDOCRINOL, V203, P133, DOI 10.1677/JOE-09-0124; Libutti SK, 2003, CANCER RES, V63, P8022; Manolson MF, 2003, J BIOL CHEM, V278, P49271, DOI 10.1074/jbc.M309914200; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Marulanda J, 2013, BONE, V57, P499, DOI 10.1016/j.bone.2013.08.021; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Otto WR, 2004, CELL PROLIFERAT, V37, P97, DOI 10.1111/j.1365-2184.2004.00303.x; Rafiei S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-605; Richard C, 2010, J BONE MINER RES, V25, P1627, DOI 10.1002/jbmr.58; Riddle RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063323; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sowa H, 2004, J BIOL CHEM, V279, P40267, DOI 10.1074/jbc.M401312200; Sowa H, 2003, J BIOL CHEM, V278, P21058, DOI 10.1074/jbc.M302044200; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; ten Dijke P, 2000, TRENDS BIOCHEM SCI, V25, P64, DOI 10.1016/S0968-0004(99)01519-4; Trouvin AP, 2010, CLIN INTERV AGING, V5, P345, DOI 10.2147/CIA.S10153; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	41	25	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3910	3924		10.1074/jbc.M114.629899	http://dx.doi.org/10.1074/jbc.M114.629899			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25538250	hybrid, Green Published			2022-12-26	WOS:000349458400003
J	Aerts, L; Craessaerts, K; De Strooper, B; Morais, VA				Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.			PINK1 Kinase Catalytic Activity Is Regulated by Phosphorylation on Serines 228 and 402	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Neurodegenerative Disease; Parkinson Disease; Posttranslational Modification (PTM); Protein Phosphorylation; PTEN-induced Putative Kinase 1 (PINK1); Serine; Threonine Protein Kinase	COMPLEX I ACTIVITY; LOSS-OF-FUNCTION; PARKIN RECRUITMENT; PINK1-DEPENDENT PHOSPHORYLATION; MITOCHONDRIAL MORPHOLOGY; RECESSIVE PARKINSONISM; DAMAGED MITOCHONDRIA; OXIDATIVE STRESS; ACTIVATE PARKIN; PROTEASE PARL	Background: PINK1 mutations affect mitochondrial homeostasis and cause Parkinson disease. Results: PINK1 is phosphorylated on the outer mitochondrial membrane. We show here that phosphorylation of serines 228 and 402 increases the capacity of PINK1 to phosphorylate its substrates Parkin and Ubiquitin. Conclusion: PINK1 phosphorylation regulates its kinase activity. Significance: Understanding PINK1 regulation is pivotal to unravel its mitochondrial function. Mutations in the PINK1 gene cause early-onset recessive Parkinson disease. PINK1 is a mitochondrially targeted kinase that regulates multiple aspects of mitochondrial biology, from oxidative phosphorylation to mitochondrial clearance. PINK1 itself is also phosphorylated, and this might be linked to the regulation of its multiple activities. Here we systematically analyze four previously identified phosphorylation sites in PINK1 for their role in autophosphorylation, substrate phosphorylation, and mitophagy. Our data indicate that two of these sites, Ser-228 and Ser-402, are autophosphorylated on truncated PINK1 but not on full-length PINK1, suggesting that the N terminus has an inhibitory effect on phosphorylation. We furthermore establish that phosphorylation of these PINK1 residues regulates the phosphorylation of the substrates Parkin and Ubiquitin. Especially Ser-402 phosphorylation appears to be important for PINK1 function because it is involved in Parkin recruitment and the induction of mitophagy. Finally, we identify Thr-313 as a residue that is critical for PINK1 catalytic activity, but, in contrast to previous reports, we find no evidence that this activity is regulated by phosphorylation. These data clarify the regulation of PINK1 through multisite phosphorylation.	[Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.] Flemish Inst Biotechnol VIB, Ctr Biol Dis, B-3000 Leuven, Belgium; [Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.] Univ Leuven, Ctr Human Genet, Leuven Inst Neurodegenerat Disorders, B-3000 Leuven, Belgium; [Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.] Univ Leuven, Univ Hosp Leuven, B-3000 Leuven, Belgium; [De Strooper, Bart] UCL, Inst Neurol, London WC1N 3BG, England	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; University of London; University College London	Morais, VA (corresponding author), Flemish Inst Biotechnol VIB, Ctr Biol Dis, Herestr 49,Box 602, B-3000 Leuven, Belgium.	Vanessa.Morais@cme.vib-kuleuven.be	de+Strooper, Bart/Z-1638-2019; Aerts, Liesbeth/J-7946-2015	Morais, Vanessa/0000-0002-0830-0548; Aerts, Liesbeth/0000-0002-7981-8176	Flemish agency for Innovation by Science and Technology (IWT); Fund for Scientific Research Flanders (FWO); Research Fund KU Leuven; Hercules Foundation; Federal Office for Scientific Affairs [IAP P7/16]; Methusalem grant of the Flemish government; Flemish Institute for Biotechnology; IWT; Janssen Pharmaceutica; Envivo; Remynd NV	Flemish agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research Flanders (FWO)(FWO); Research Fund KU Leuven(KU Leuven); Hercules Foundation; Federal Office for Scientific Affairs; Methusalem grant of the Flemish government; Flemish Institute for Biotechnology; IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Envivo; Remynd NV	This work was supported by the Flemish agency for Innovation by Science and Technology (IWT), by the Fund for Scientific Research Flanders (FWO), by Research Fund KU Leuven, by the Hercules Foundation, by Federal Office for Scientific Affairs Grant IAP P7/16, by a Methusalem grant of the Flemish government, and by the Flemish Institute for Biotechnology. B. D. S. is a paid consultant for the Alzheimer disease research programs at Janssen Pharmaceutica, Envivo, and Remynd NV.; Supported by an IWT doctoral grant.	Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Luo Q, 2014, EXP THER MED, V8, P286, DOI 10.3892/etm.2014.1702; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Matenia D, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00037; Matenia D, 2012, J BIOL CHEM, V287, P8174, DOI 10.1074/jbc.M111.262287; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nishi H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00270; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Pogson JH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004815; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Woodroof HI, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110012; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	48	76	78	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2798	2811		10.1074/jbc.M114.620906	http://dx.doi.org/10.1074/jbc.M114.620906			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25527497	Green Published, hybrid			2022-12-26	WOS:000349310700021
J	Politano, G; Benso, A; Savino, A; Di Carlo, S				Politano, Gianfranco; Benso, Alfredo; Savino, Alessandro; Di Carlo, Stefano			ReNE: A Cytoscape Plugin for Regulatory Network Enhancement	PLOS ONE			English	Article							MICRORNA; GENES; EXPRESSION; PREDICTION; BRAIN; RNAS	One of the biggest challenges in the study of biological regulatory mechanisms is the integration, americanmodeling, and analysis of the complex interactions which take place in biological networks. Despite post transcriptional regulatory elements (i.e., miRNAs) are widely investigated in current research, their usage and visualization in biological networks is very limited. Regulatory networks are commonly limited to gene entities. To integrate networks with post transcriptional regulatory data, researchers are therefore forced to manually resort to specific third party databases. In this context, we introduce ReNE, a Cytoscape 3.x plugin designed to automatically enrich a standard gene-based regulatory network with more detailed transcriptional, post transcriptional, and translational data, resulting in an enhanced network that more precisely models the actual biological regulatory mechanisms. ReNE can automatically import a network layout from the Reactome or KEGG repositories, or work with custom pathways described using a standard OWL/XML data format that the Cytoscape import procedure accepts. Moreover, ReNE allows researchers to merge multiple pathways coming from different sources. The merged network structure is normalized to guarantee a consistent and uniform description of the network nodes and edges and to enrich all integrated data with additional annotations retrieved from genome-wide databases like NCBI, thus producing a pathway fully manageable through the Cytoscape environment. The normalized network is then analyzed to include missing transcription factors, miRNAs, and proteins. The resulting enhanced network is still a fully functional Cytoscape network where each regulatory element (transcription factor, miRNA, gene, protein) and regulatory mechanism (up-regulation/down-regulation) is clearly visually identifiable, thus enabling a better visual understanding of its role and the effect in the network behavior. The enhanced network produced by ReNE is exportable in multiple formats for further analysis via third party applications. ReNE can be freely installed from the Cytoscape App Store (http://apps.cytoscape.org/apps/rene) and the full source code is freely available for download through a SVN repository accessible at http://www.sysbio.polito.it/tools_svn/BioInformatics/Rene/releases/. ReNE enhances a network by only integrating data from public repositories, without any inference or prediction. The reliability of the introduced interactions only depends on the reliability of the source data, which is out of control of ReNe developers.	[Politano, Gianfranco; Benso, Alfredo; Savino, Alessandro; Di Carlo, Stefano] Politecn Torino, Dept Control & Comp Engn, Turin, Italy; [Benso, Alfredo] Consorzio Interuniv Nazl Informat, Verres, AO, Italy	Polytechnic University of Turin	Politano, G (corresponding author), Politecn Torino, Dept Control & Comp Engn, Turin, Italy.	gianfranco.politano@polito.it	Benso, Alfredo/ABC-5311-2020; Di Carlo, Stefano/I-8872-2012; Benso, Alfredo/GRO-2198-2022; Savino, Alessandro/I-6132-2016	Benso, Alfredo/0000-0003-3433-7739; Di Carlo, Stefano/0000-0002-7512-5356; Savino, Alessandro/0000-0003-0529-7950	Regione Valle dAosta for the project: "Open Health Care Network Analysis" [CUP B15G13000010006]; Italian Ministry of Education, University & Research (MIUR)	Regione Valle dAosta for the project: "Open Health Care Network Analysis"; Italian Ministry of Education, University & Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	Funding: This work has been partially supported by Grant No. CUP B15G13000010006 awarded by the Regione Valle dAosta for the project: "Open Health Care Network Analysis" and by the Italian Ministry of Education, University & Research (MIUR) (Project PRIN 2010, MIND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bader G, 2013, PATHGUIDE; Benso A, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-S1-S5; Benso A, 2013, PROCEEDINGS IWBBIO 2013: INTERNATIONAL WORK-CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING, P397; Bethesda (MD): National Center for Biotechnology Information (US), 2008, NCBI GEN FREQ ASK QU; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Cerami Ethan G, 2011, Nucleic Acids Res, V39, pD685, DOI 10.1093/nar/gkq1039; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; D'Amelio M, 2009, PARKINSONISM RELAT D, V15, P660, DOI 10.1016/j.parkreldis.2009.02.013; Demir E, 2010, NAT BIOTECHNOL, V28, P935, DOI 10.1038/nbt.1666; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fazekas D, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-7; Fusco S, 2012, P NATL ACAD SCI USA, V109, P621, DOI 10.1073/pnas.1109237109; Hinske L. C., 2013, MIRIAD INTRAGENIC MI; Hinske LCG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-533; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; IPA QRC, 2013, ING; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160; Lagana A, 2009, MIRO MIRNA KNOWLEDGE; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lepoivre C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-19; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LLC B, 2013, BIOC; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Manyam G., 2013, BIOINFORMATICS; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pearson ER, 2005, DIABETOLOGIA, V48, P878, DOI 10.1007/s00125-005-1738-y; Pesch R, 2012, OASICS OPENACCESS SE, V26, P69, DOI [10.4230/OASIcs.GCB.2012.69, DOI 10.4230/OASICS.GCB.2012.69]; Piao Y, 2012, BBA-GEN SUBJECTS, V1820, P577, DOI 10.1016/j.bbagen.2011.08.007; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Potashkin JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043595; Punin J, 2001, XGMML REFERENCE; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Sandyk R, 1993, Int J Neurosci, V69, P125; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Xu HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-499; Yu N, 2012, NUCLEIC ACIDS RES, V40, pD797, DOI 10.1093/nar/gkr1127; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	52	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115585	10.1371/journal.pone.0115585	http://dx.doi.org/10.1371/journal.pone.0115585			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541727	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900055
J	Xing, JH; Liu, HT; Yang, HB; Chen, R; Chen, YG; Xu, J				Xing, Junhui; Liu, Hongtao; Yang, Huabing; Chen, Rui; Chen, Yuguo; Xu, Jian			Upregulation of Unc-51-Like Kinase 1 by Nitric Oxide Stabilizes SIRT1, Independent of Autophagy	PLOS ONE			English	Article							HEPATIC STEATOSIS; DEPENDENT DEGRADATION; PROTEIN MODIFICATION; CALORIE RESTRICTION; PROTEASOME ACTIVITY; DIABETES-MELLITUS; OXIDATIVE STRESS; DOWN-REGULATION; UBIQUITIN; MICE	SIRT1 is central to the lifespan and vascular health, but undergoes degradation that contributes to several medical conditions, including diabetes. How SIRT1 turnover is regulated remains unclear. However, emerging evidence suggests that endothelial nitric oxide synthase (eNOS) positively regulates SIRT1 protein expression. We recently identified NO as an endogenous inhibitor of 26S proteasome functionality with a cellular reporter system. Here we extended this finding to a novel pathway that regulates SIRT1 protein breakdown. In cycloheximide (CHX)-treated endothelial cells, NONOate, an NO donor, and A23187, an eNOS activator, significantly stabilized SIRT1 protein. Similarly, NO enhanced SIRT1 protein, but not mRNA expression, in CHX-free cells. NO also stabilized an autophagy-related protein unc-51 like kinase (ULK1), but did not restore SIRT1 protein levels in ULK1-siRNA-treated cells or in mouse embryonic fibroblasts (MEF) from Ulk(-/-) mice. This suggests that ULK1 mediated the NO regulation of SIRT1. Furthermore, adenoviral overexpression of ULK1 increased SIRT1 protein expression, while ULK1 siRNA treatment decreased it. Rapamycin-induced autophagy did not mimic these effects, suggesting that the effects of ULK1 were autophagy-independent. Treatment with MG132, a proteasome inhibitor, or siRNA of beta-TrCP1, an E3 ligase, prevented SIRT1 reduction induced by ULK1-siRNA. Mechanistically, ULK1 negatively regulated 26S proteasome functionality, which was at least partly mediated by O-linked-GlcNAc transferase (OGT), probably by increased O-GlcNAc modification of proteasomal subunit Rpt2. The NO-ULK1-SIRT1 axis was likely operative in the whole animal: both ULK1 and SIRT1 protein levels were significantly reduced in tissue homogenates in eNOS-knockout mice (lung) and in db/db mice where eNOS is downregulated (lung and heart). Taken together, the results show that NO stabilizes SIRT1 by regulating 26S proteasome functionality through ULK1 and OGT, but not autophagy, in endothelial cells.	[Xing, Junhui; Chen, Yuguo] Shandong Univ, Qilu Hosp, Dept Emergency, Jinan 250100, Peoples R China; [Xing, Junhui; Liu, Hongtao; Yang, Huabing; Xu, Jian] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73106 USA; [Xing, Junhui; Liu, Hongtao; Yang, Huabing; Xu, Jian] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Oklahoma Diabet Ctr, Oklahoma City, OK USA; [Chen, Rui] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA	Shandong University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Xu, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73106 USA.	jian-xu@ouhsc.edu		Xu, Jian/0000-0002-9557-2671	National Institutes of Health Grant from the COBRE Program of the National Institute of General Medical Sciences [5P20GM104934-08]; American Heart Association [14BGIA20030027]; American Diabetes Association [1-12-JF-58]; Oklahoma Center for Advancement of Science and Technology [HR14-062]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104934] Funding Source: NIH RePORTER	National Institutes of Health Grant from the COBRE Program of the National Institute of General Medical Sciences; American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); Oklahoma Center for Advancement of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by an National Institutes of Health Grant from the COBRE Program of the National Institute of General Medical Sciences (5P20GM104934-08) (JX, Project 2). This work was also supported by a Beginning-Grant-in-Aid Award (14BGIA20030027) from the American Heart Association (JX), a Junior Faculty Award (1-12-JF-58) from the American Diabetes Association (JX), and a Research Award (HR14-062) from the Oklahoma Center for Advancement of Science and Technology (JX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Chan EY, 2009, AUTOPHAGY, V5, P758, DOI 10.4161/auto.8709; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003; de Kreutzenberg SV, 2010, DIABETES, V59, P1006, DOI 10.2337/db09-1187; Dodson M, 2013, FREE RADICAL BIO MED, V63, P207, DOI 10.1016/j.freeradbiomed.2013.05.014; Fekete MR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-114; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Heessen S, 2003, FEBS LETT, V555, P397, DOI 10.1016/S0014-5793(03)01296-1; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Hong EH, 2010, J BIOL CHEM, V285, P1283, DOI 10.1074/jbc.M109.058628; Jang SH, 2012, J CLIN PATHOL, V65, P735, DOI 10.1136/jclinpath-2012-200685; Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koka S, 2014, AM J PHYSIOL-HEART C, V306, pH1558, DOI 10.1152/ajpheart.00865.2013; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li Y, 2014, GASTROENTEROLOGY, V146, P539, DOI 10.1053/j.gastro.2013.10.059; Liu HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098486; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046720; Liu HT, 2012, ARTERIOSCL THROM VAS, V32, P2131, DOI 10.1161/ATVBAHA.112.253385; Liu XY, 2011, P NATL ACAD SCI USA, V108, P1925, DOI 10.1073/pnas.1019619108; Liu Y, 2014, DIABETES; Luu L, 2013, DIABETOLOGIA, V56, P2010, DOI 10.1007/s00125-013-2946-5; McAlpine F, 2013, AUTOPHAGY, V9, P361, DOI 10.4161/auto.23066; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Ooboshi H, 1997, AM J PHYSIOL-HEART C, V273, pH265, DOI 10.1152/ajpheart.1997.273.1.H265; Ota H, 2008, ARTERIOSCL THROM VAS, V28, P1634, DOI 10.1161/ATVBAHA.108.164368; Ota H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029598; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Potente M, 2008, ARTERIOSCL THROM VAS, V28, P1577, DOI 10.1161/ATVBAHA.108.173682; Purushotham A, 2012, MOL CELL BIOL, V32, P1226, DOI 10.1128/MCB.05988-11; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Revollo JR, 2013, TRENDS BIOCHEM SCI, V38, P160, DOI 10.1016/j.tibs.2012.12.004; Sarkar S, 2011, MOL CELL, V43, P19, DOI 10.1016/j.molcel.2011.04.029; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Schwartz AL, 1999, ANNU REV MED, V50, P57; Singh SK, 2013, J EXP MED, V210, P987, DOI 10.1084/jem.20121608; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Tomada I, 2013, AGE, V35, P35, DOI 10.1007/s11357-011-9328-z; Tripathi DN, 2013, P NATL ACAD SCI USA, V110, pE2950, DOI 10.1073/pnas.1307736110; Vasko R, 2014, J AM SOC NEPHROL, V25, P276, DOI 10.1681/ASN.2013010069; Woo SR, 2013, BIOCHEM BIOPH RES CO, V441, P831, DOI 10.1016/j.bbrc.2013.10.146; Xu J, 2007, CIRCULATION, V116, P944, DOI 10.1161/CIRCULATIONAHA.106.684795; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Zachara N. E., 2011, CURR PROTOC MOL BIOL; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	62	12	12	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116165	10.1371/journal.pone.0116165	http://dx.doi.org/10.1371/journal.pone.0116165			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541949	gold, Green Published, Green Submitted			2022-12-26	WOS:000347239900152
J	Dasgupta, K; Jarvandi, S; De Civita, M; Pillay, S; Hajna, S; Gougeon, R; Bader, A; Da Costa, D				Dasgupta, Kaberi; Jarvandi, Soghra; De Civita, Mirella; Pillay, Sabrina; Hajna, Samantha; Gougeon, Rejeanne; Bader, Abeer; Da Costa, Deborah			Participants' Perceptions of a Group Based Program Incorporating Hands-On Meal Preparation and Pedometer-Based Self-Monitoring in Type 2 Diabetes	PLOS ONE			English	Article							AWAY-FROM-HOME; OUT-OF-HOME; WEIGHT-LOSS; PHYSICAL-ACTIVITY; DIETARY-INTAKE; RISK-FACTORS; BODY-WEIGHT; FOOD; PREVENTION; ADULTS	Background: Nutrition education (portion sizes, balanced meals) is a cornerstone of diabetes management; however, moving from information to behavior change is challenging. Through a single arm intervention study, we recently demonstrated that combining education with group-based meal preparation training has measureable effects on weight, eating behaviour, and glycemic control in adults with type 2 diabetes. In the present study, we conducted an in-depth examination of participants' perceptions of this strategy, through focus group discussion, to delineate effective elements of the strategy from participants' perspectives. Methods: Participants who had completed the nutrition education/meal preparation training program were invited to attend one of four focus group discussions. These were led by experienced facilitators and guided by questions addressing experiences during the intervention and their perceived impact. Audiotapes were transcribed and qualitative content analysis of transcripts was performed. We report herein themes that achieved saturation across the four discussions. Results: Twenty-nine (80.6%, 29/36) attended a focus group discussion. The program elements perceived as effective by participants included the hands-on interactive learning approach to meal preparation, the grocery store tour, pedometer-based self-monitoring, experiencing the link between food consumption/physical activity and glucose changes during the program, and peer support. Discussants reported changes in eating and walking behaviour, greater confidence in ability to self-manage diabetes, reductions in glucose levels and/or need for glucose-lowering medications, and, in some cases, weight loss. Family members and friends were facilitators for some and barriers for others in terms of achieving health behavior changes. Conclusions: Among adults with type 2 diabetes, a group based program that included hands-on meal preparation and pedometer-based self-monitoring was perceived as effective in conveying information, developing skills, building confidence, and changing health behaviors.	[Dasgupta, Kaberi; De Civita, Mirella; Pillay, Sabrina; Hajna, Samantha; Gougeon, Rejeanne; Da Costa, Deborah] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada; [Jarvandi, Soghra] Washington Univ, Sch Med, Div Hlth Behav Res, St Louis, MO USA; [Bader, Abeer] Community Diabet Educ Program Ottawa, Ottawa, ON, Canada	McGill University; Washington University (WUSTL)	Dasgupta, K (corresponding author), McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada.	kaberi.dasgupta@mcgill.ca		Jepson, Ruth/0000-0002-9446-445X; Hajna, Samantha/0000-0002-0431-2787	McGill University Office of the Vice-Principal; Canadian Institutes of Health Research [CAI 117789]; Lawson Foundation; Fonds de recherche du Quebec - Sante (FRQS); FRQS; Canadian Institutes of Health Research	McGill University Office of the Vice-Principal; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Lawson Foundation; Fonds de recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); FRQS; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by operating grants from the McGill University Office of the Vice-Principal (Research), the Canadian Institutes of Health Research (CAI 117789), and The Lawson Foundation awarded to KD. KD holds a senior clinician scientist career award from the Fonds de recherche du Quebec - Sante (FRQS). DD also holds a career award from the FRQS and SH holds a doctoral award from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SD, 2011, J AM DIET ASSOC, V111, P583, DOI 10.1016/j.jada.2011.01.009; Baker MK, 2011, DIABETES RES CLIN PR, V91, P1, DOI 10.1016/j.diabres.2010.06.030; Bandura A., 1986, SOCIAL FDN THOUGHT A; Beydoun MA, 2009, PUBLIC HEALTH NUTR, V12, P369, DOI 10.1017/S1368980008002140; Bezerra IN, 2012, NUTR REV, V70, P65, DOI 10.1111/j.1753-4887.2011.00459.x; Binkley JK, 2006, J CONSUM AFF, V40, P372, DOI 10.1111/j.1745-6606.2006.00062.x; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Burke LE, 2011, OBESITY, V19, P338, DOI 10.1038/oby.2010.208; Casey D, 2010, DIABETIC MED, V27, P79, DOI 10.1111/j.1464-5491.2009.02873.x; Dasgupta K, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-125; De Civita M, 2007, J PUBLIC HEALTH-UK, V29, P263, DOI 10.1093/pubmed/fdm033; Duffey KJ, 2007, AM J CLIN NUTR, V85, P201, DOI 10.1093/ajcn/85.1.201; Greaves CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-119; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Johnson F, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-83; Kant AK, 2004, PREV MED, V38, P243, DOI 10.1016/j.ypmed.2003.10.004; Krishnan S, 2010, AM J CLIN NUTR, V91, P465, DOI 10.3945/ajcn.2009.28682; Krueger R. A., 1988, FOCUS GROUPS PRACTIC; Krukowski RA, 2008, TELEMED J E-HEALTH, V14, P775, DOI 10.1089/tmj.2007.0132; Lee C, 2012, DIABETES METAB, V38, P420, DOI 10.1016/j.diabet.2012.04.002; Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975; Manrique J, 1998, J AGR ECON, V49, P321, DOI 10.1111/j.1477-9552.1998.tb01275.x; McAndrew LM, 2008, BRIT J HEALTH PSYCH, V13, P195, DOI 10.1348/135910708X295604; Orfanos P, 2007, PUBLIC HEALTH NUTR, V10, P1515, DOI 10.1017/S1368980007000171; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Prentice A M, 2003, Obes Rev, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x; Thornton LE, 2011, PUBLIC HEALTH NUTR, V14, P523, DOI 10.1017/S1368980010003022; Tudor-Locke C, 2008, MED SCI SPORT EXER, V40, pS537, DOI 10.1249/MSS.0b013e31817c7133; Wadden TA, 2009, OBESITY, V17, P713, DOI 10.1038/oby.2008.637; *WHO, 2003, WHO TECH REP SER, V916; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	32	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114620	10.1371/journal.pone.0114620	http://dx.doi.org/10.1371/journal.pone.0114620			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536068	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300017
J	Iotti, M; Leonardi, M; Lancellotti, E; Salerni, E; Oddis, M; Leonardi, P; Perini, C; Pacioni, G; Zambonelli, A				Iotti, Mirco; Leonardi, Marco; Lancellotti, Enrico; Salerni, Elena; Oddis, Marilena; Leonardi, Pamela; Perini, Claudia; Pacioni, Giovanni; Zambonelli, Alessandra			Spatio-Temporal Dynamic of Tuber magnatum Mycelium in Natural Truffle Grounds	PLOS ONE			English	Article							REAL-TIME PCR; EXTRARADICAL SOIL MYCELIUM; SPATIAL-DISTRIBUTION; LACTARIUS-DELICIOSUS; FUNGAL COMMUNITIES; SEASONAL DYNAMICS; BOLETUS-EDULIS; ECTOMYCORRHIZAL COMMUNITIES; FOREST; QUANTIFICATION	Tuber magnatum produces the world's most expensive truffle. This fungus produces very rare ectomycorrhizas which are difficult or even impossible to detect in the field. A "real-time'' PCR assay was recently developed to quantify and to track T. magnatum mycelium in soil. Here, this technique was used to investigate the spatial distribution of T. magnatum extra-radical mycelium in soil productive patches and its dynamic across seasons. This study was carried out in four different natural T. magnatum truffle grounds located in different Italian regions. During the fruiting seasons, the amount of T. magnatum mycelium was significantly higher around the fruiting points and decreased going farther away from them. Moreover, T. magnatum mycelium inside the productive patches underwent seasonal fluctuations. In early spring, the amount of T. magnatum mycelium was significantly higher than in summer. In summer, probably due to the hot and dry season, T. magnatum mycelium significantly decreased, whereas in autumn it increased again and was concentrated at the putative fruiting points. These results give new insights on T. magnatum ecology and are useful to plan the most appropriate sampling strategy for evaluating the management of a truffle ground.	[Iotti, Mirco; Leonardi, Pamela; Zambonelli, Alessandra] Univ Bologna, Dept Agr Sci, Bologna, Italy; [Leonardi, Marco; Oddis, Marilena; Pacioni, Giovanni] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy; [Lancellotti, Enrico] Univ Sassari, Dipartimento Agr, I-07100 Sassari, Italy; [Salerni, Elena; Perini, Claudia] Univ Siena, Dept Life Sci, I-53100 Siena, Italy	University of Bologna; University of L'Aquila; University of Sassari; University of Siena	Zambonelli, A (corresponding author), Univ Bologna, Dept Agr Sci, Bologna, Italy.	alessandr.zambonelli@unibo.it	Iotti, Mirco/M-1750-2015; Pacioni, Giovanni/O-7646-2015; Leonardi, Marco/AAA-5112-2020; Zambonelli, Alessandra/AAF-3581-2019	Iotti, Mirco/0000-0003-2705-0385; Pacioni, Giovanni/0000-0002-0201-5789; Leonardi, Marco/0000-0003-3502-4232; Lancellotti, Enrico/0000-0001-9966-0479	Interregional Project MAGNATUM - Emilia Romagna Region, Tuscany Region, Abruzzo Region [321 - 25.9.2007]	Interregional Project MAGNATUM - Emilia Romagna Region, Tuscany Region, Abruzzo Region	This work was supported by Interregional Project MAGNATUM (Decree n. 321 - 25.9.2007 of ARSIA Tuscany) funded by Emilia Romagna Region ( http://www.regione.emilia-romagna.it/), Tuscany Region (http://www.regione.toscana.it/), Abruzzo Region (http://www.regione.abruzzo.it/portale/index.asp), and Molise Region (http://www3.regione.molise.it/flex/cm/pages/ServeBLOB.php/L/IT/IDPagina/1) to AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri E, 2010, FUNGAL BIOL-UK, V114, P936, DOI 10.1016/j.funbio.2010.09.001; Benucci GMN, 2014, MYCORRHIZA, V24, P281, DOI 10.1007/s00572-013-0538-3; Benucci GMN, 2011, FEMS MICROBIOL ECOL, V76, P170, DOI 10.1111/j.1574-6941.2010.01039.x; Benucci GMN, 2013, SOIL BIOLOGY, V34, P265, DOI [10.1007/978-3-642-33823-6_15, DOI 10.1007/978-3-642-33823-6_15]; Bertini L, 2006, MICROBIOL RES, V161, P59, DOI 10.1016/j.micres.2005.06.003; Bidartondo MI, 2005, FUNGAL COMMUNITY ITS, P215; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Buntgen U, 2012, NAT CLIM CHANGE, V2, P827, DOI 10.1038/nclimate1733; Coll L, 2012, ECOSCIENCE, V19, P238, DOI 10.2980/19-3-3488; De la Varga H, 2013, MYCORRHIZA, V23, P391, DOI 10.1007/s00572-013-0481-3; De la Varga H, 2012, MYCORRHIZA, V22, P59, DOI 10.1007/s00572-011-0382-2; Ekblad A, 2013, PLANT SOIL, V366, P1, DOI 10.1007/s11104-013-1630-3; Feinstein LM, 2009, APPL ENVIRON MICROB, V75, P5428, DOI 10.1128/AEM.00120-09; Garcia-Barreda S, 2012, MYCORRHIZA, V22, P361, DOI 10.1007/s00572-011-0410-2; Giomaro GM, 2005, SOIL BIOL, V4, P253; Gryndler M, 2013, MYCORRHIZA, V23, P341, DOI 10.1007/s00572-012-0475-6; Guidot A, 2002, FEMS MICROBIOL ECOL, V42, P477, DOI 10.1111/j.1574-6941.2002.tb01036.x; Guidot A, 2001, MOL ECOL, V10, P1121, DOI 10.1046/j.1365-294X.2001.01265.x; Hall I. R., 2012, EDIBLE ECTOMYCORRHIZ, P191; Hall IR, 1998, ECON BOT, V52, P192, DOI 10.1007/BF02861209; HALL IR, 2007, TAMING TRUFFLE HIST; Hortal S, 2008, MYCORRHIZA, V18, P69, DOI 10.1007/s00572-007-0160-3; Horton TR, 2001, MOL ECOL, V10, P1855, DOI 10.1046/j.0962-1083.2001.01333.x; Iotti M, 2012, SOIL BIOLOGY, V34, P145, DOI DOI 10.1007/978-3-642-33823-6_; Iotti M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-93; Iotti M, 2010, FEMS MICROBIOL ECOL, V72, P250, DOI 10.1111/j.1574-6941.2010.00844.x; Kennedy PG, 2007, MOL ECOL, V16, P881, DOI 10.1111/j.1365-294X.2006.03191.x; Landeweert R, 2003, FEMS MICROBIOL ECOL, V45, P283, DOI 10.1016/S0168-6496(03)00163-6; Le Tacon F, 2014, MYCORRHIZA, V24, pS115, DOI 10.1007/s00572-014-0568-5; Lefevre C, 2012, SOIL BIOLOGY, V34, P209, DOI DOI 10.1007/978-3-642-33823-6_; Leonardi M, 2013, MYCORRHIZA, V23, P349, DOI 10.1007/s00572-012-0474-7; Lian CL, 2006, NEW PHYTOL, V171, P825, DOI 10.1111/j.1469-8137.2006.01801.x; Mello A, 2006, FEMS MICROBIOL LETT, V260, P1, DOI 10.1111/j.1574-6968.2006.00252.x; Morris J., 2005, FUNGAL COMMUNITY, P13; Morte A, 2012, SOIL BIOLOGY, V34, P241; Murat C, 2005, FEMS MICROBIOL LETT, V245, P307, DOI 10.1016/j.femsle.2005.03.019; Neumann J, 2013, PLANT SOIL, V371, P435, DOI 10.1007/s11104-013-1701-5; Orgiazzi A., 2013, Diversity, V5, P73; Parlade J, 2007, J BIOTECHNOL, V128, P14, DOI 10.1016/j.jbiotec.2006.09.010; Parlade J, 2013, MYCORRHIZA, V23, P99, DOI 10.1007/s00572-012-0454-y; Peintner U, 2007, ENVIRON MICROBIOL, V9, P880, DOI 10.1111/j.1462-2920.2006.01208.x; R Core Team, 2020, R LANG ENV STAT COMP; Raidl S, 2005, PLANT BIOLOGY, V7, P713, DOI 10.1055/s-2005-873003; Rellini I, 2011, J MAPS, V7, P353, DOI 10.4113/jom.2011.1180; Salerni E, 2014, MYCORRHIZA, V24, pS79, DOI 10.1007/s00572-013-0543-6; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Smith CJ, 2006, ENVIRON MICROBIOL, V8, P804, DOI 10.1111/j.1462-2920.2005.00963.x; Suz LM, 2008, FEMS MICROBIOL LETT, V285, P72, DOI 10.1111/j.1574-6968.2008.01213.x; Taylor AFS, 2002, PLANT SOIL, V244, P19, DOI 10.1023/A:1020279815472; van der Linde S, 2009, FEMS MICROBIOL ECOL, V69, P344, DOI 10.1111/j.1574-6941.2009.00716.x; Voriskova J, 2014, NEW PHYTOL, V201, P269, DOI 10.1111/nph.12481; Wallander H, 2013, SOIL BIOL BIOCHEM, V57, P1034, DOI 10.1016/j.soilbio.2012.08.027; Wang X., 2012, EDIBLE ECTOMYCORRHIZ, P227, DOI [10.1007/978-3-642-33823-6_13, DOI 10.1007/978-3-642-33823-6_13]; Zambonelli A., 2012, SOIL BIOL, V34, P105, DOI [10.1007/978-3-642-33823-6, DOI 10.1007/978-3-642-33823-6, 10.1007/978-3-642, DOI 10.1007/978-3-642-33823-6_]; Zampieri E, 2010, FEMS MICROBIOL ECOL, V71, P43, DOI 10.1111/j.1574-6941.2009.00783.x; Zhou ZH, 2001, J PLANT RES, V114, P179, DOI 10.1007/PL00013981	57	22	25	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115921	10.1371/journal.pone.0115921	http://dx.doi.org/10.1371/journal.pone.0115921			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535741	gold, Green Published, Green Submitted			2022-12-26	WOS:000348563300086
J	Napoli, PE; Coronella, F; Satta, GM; Galantuomo, MS; Fossarello, M				Napoli, Pietro Emanuele; Coronella, Franco; Satta, Giovanni Maria; Galantuomo, Maria Silvana; Fossarello, Maurizio			Evaluation of the Adhesive Properties of the Cornea by Means of Optical Coherence Tomography in Patients with Meibomian Gland Dysfunction and Lacrimal Tear Deficiency	PLOS ONE			English	Article							OCULAR SURFACE EPITHELIUM; DRY EYE DISEASE; BREAK-UP TIME; CONJUNCTIVAL EPITHELIA; ARTIFICIAL TEARS; FILM STABILITY; FLUORESCEIN; THICKNESS; MUCIN; CARBOXYMETHYLCELLULOSE	Objective: The aim was to determine the influence of meibomian gland dysfunction (MGD) and aqueous tear deficiency dry eye (ADDE) on the adhesive properties of the central cornea by means of optical coherence tomography (OCT), and to investigate the relationship between corneal adhesiveness and classical tear tests, as well as the reliability of results, in these lacrimal functional unit disorders. Design: Prospective, case-control study. Methods: Twenty-eight patients with MGD and 27 patients with ADDE were studied. A group of 32 healthy subjects of similar age and gender distribution served as a control group. The adhesive properties of the anterior corneal surface were measured by OCT, based on the retention time of adhesion marker above it, in all participants. Results: An excellent (>= 5 minutes), borderline (within 3-5 minutes), fair (within 1-3 minutes) and poor (< 1 minute) values of corneal adhesiveness were found, respectively, in 0%, 7.1%, 64.3% and 28.6% of MGD, in 0%, 7.4%, 63% and 29.6% of ADDE, and in 31.3%, 65.6%, 3.1% and 0% of healthy patients. The differences in time of corneal adhesiveness between MGD and healthy patients, as well as between ADDE and healthy patients, were found to be statistically significant (p<0.001; p<0.001; respectively). Conversely, no statistical significant differences between MGD and ADDE were found (p=0.952). Data analysis revealed a statistically significant correlation between corneal adhesiveness and clinical tests of dry eye, as well as an excellent degree of inter-rater reliability and reproducibility for OCT measurements (p<0.001). Conclusion: ADDE and MGD share similar abnormalities on OCT imaging. Decreased adhesive properties of the anterior cornea were identified as a common feature of MGD and ADDE. This simple OCT approach may provide new clues into the mechanism and evaluation of dry eye syndrome.	[Napoli, Pietro Emanuele; Coronella, Franco; Satta, Giovanni Maria; Galantuomo, Maria Silvana; Fossarello, Maurizio] Univ Cagliari, Dept Surg Sci, Eye Clin, Cagliari, Italy	University of Cagliari	Napoli, PE (corresponding author), Univ Cagliari, Dept Surg Sci, Eye Clin, Cagliari, Italy.	pietronapoli@ymail.com	Fossarello, Maurizio/AAD-8235-2021; Napoli, Pietro/AAP-8423-2020; Fossarello, Maurizio/G-2032-2015	Napoli, Pietro Emanuele/0000-0001-7020-0823; Fossarello, Maurizio/0000-0003-1520-7760				Afonso AA, 1999, OPHTHALMOLOGY, V106, P803, DOI 10.1016/S0161-6420(99)90170-7; Amano S, 2010, J EYE ATARASHII GANK, V27, P627; [Anonymous], 2007, OCUL SURF, V52, P93; [Anonymous], 2007, OCUL SURF, V52, P108; Braun RJ, 2003, MATH MED BIOL, V20, P1; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Bron AJ, 2001, SURV OPHTHALMOL, V45, pS221, DOI 10.1016/S0039-6257(00)00201-0; Cho P, 1998, OPHTHAL PHYSL OPT, V18, P319, DOI 10.1046/j.1475-1313.1998.00385.x; Danjo Y, 1998, INVEST OPHTH VIS SCI, V39, P2602; de Paiva CS, 2003, OPHTHALMOLOGY, V110, P1102; Garrett Q, 2007, INVEST OPHTH VIS SCI, V48, P1559, DOI 10.1167/iovs.06-0848; Gipson IK, 1997, PROG RETIN EYE RES, V16, P81, DOI 10.1016/S1350-9462(96)00022-5; Goto E, 2003, ARCH OPHTHALMOL-CHIC, V121, P173; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; Goto T, 2003, AM J OPHTHALMOL, V135, P607, DOI 10.1016/S0002-9394(02)02221-3; INATOMI T, 1995, INVEST OPHTH VIS SCI, V36, P1818; Johnson ME, 2005, CORNEA, V24, P811, DOI 10.1097/01.ico.0000154378.67495.40; King-Smith PE, 1999, OPTOMETRY VISION SCI, V76, P19, DOI 10.1097/00006324-199901000-00025; Koh S, 2008, INVEST OPHTH VIS SCI, V49, P133, DOI 10.1167/iovs.07-0762; KORB DR, 1994, CORNEA, V13, P354, DOI 10.1097/00003226-199407000-00012; Lemp MA, 2008, AM J OPHTHALMOL, V146, P350, DOI 10.1016/j.ajo.2008.05.016; Lemp MA, 2007, OCUL SURF, V5, P75; McNamara NA, 1997, INVEST OPHTH VIS SCI, V38, P1830; MENGHER LS, 1986, ACTA OPHTHALMOL, V64, P441; Napoli PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109843; Napoli PE, 2014, INVEST OPHTH VIS SCI, V55, P4533, DOI 10.1167/iovs.14-14666; Napoli PE, 2014, INVEST OPHTH VIS SCI, V55, P3179, DOI 10.1167/iovs.13-13613; Napoli PE, 2014, CAN J OPHTHALMOL, V49, P210, DOI 10.1016/j.jcjo.2013.10.003; PATEL S, 1985, AM J OPTOM PHYS OPT, V62, P188; Pflugfelder SC, 2000, INVEST OPHTH VIS SCI, V41, P1316; Sommer A., 1982, NUTR BLINDNESS XEROP; Sweeney DF, 2013, EXP EYE RES, V117, P28, DOI 10.1016/j.exer.2013.08.010; Wang JH, 2006, INVEST OPHTH VIS SCI, V47, P4349, DOI 10.1167/iovs.05-1654; Wang JH, 2006, INVEST OPHTH VIS SCI, V47, P3325, DOI 10.1167/iovs.06-0055	34	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115762	10.1371/journal.pone.0115762	http://dx.doi.org/10.1371/journal.pone.0115762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536051	gold, Green Published, Green Submitted			2022-12-26	WOS:000348563300071
J	Ni, HM; Bhakta, A; Wang, SG; Li, ZR; Manley, S; Huang, HQ; Copple, B; Ding, WX				Ni, Hong-Min; Bhakta, Amar; Wang, Shaogui; Li, Zhenrui; Manley, Sharon; Huang, Heqing; Copple, Bryan; Ding, Wen-Xing			Role of Hypoxia Inducing Factor-1 beta in Alcohol-Induced Autophagy, Steatosis and Liver Injury in Mice	PLOS ONE			English	Article							IN-VIVO; THERAPEUTIC TARGETS; LIPID-METABOLISM; ADIPOSE-TISSUE; FATTY LIVER; ETHANOL; INDUCTION; HIF-1-ALPHA; ACTIVATION; DISEASE	Chronic alcohol causes liver hypoxia and steatosis, which eventually develops into alcoholic liver disease (ALD). While it has been known that alcohol consumption activates hepatic hypoxia inducing factor-1 alpha (HIF-1 alpha), conflicting results regarding the role of HIF-1 alpha in alcohol-induced liver injury and steatosis in mice have been reported. In the present study, we aimed to use hepatocyte-specific HIF-1 beta knockout mice to eliminate the possible compensatory effects of the single knockout of the 1 alpha subunit of HIF to study the role of HIFs in ALD. C57BL/6 wild type mice were treated with acute ethanol to mimic human binge drinking. Matched wild-type and hepatocyte specific HIF-1 beta knockout mice were also subjected to a recently established Gao-binge alcohol model to mimic chronic plus binge conditions, which is quite common in human alcoholics. We found that acute alcohol treatment increased BNIP3 and BNIP3L/NIX expression in primary cultured hepatocytes and in mouse livers, suggesting that HIF may be activated in these models. We further found that hepatocyte-specific HIF-1 beta knockout mice developed less steatosis and liver injury following the Gao-binge model or acute ethanol treatment compared with their matched wild type mice. Mechanistically, protection against Gao-binge treatment-induced steatosis and liver injury was likely associated with increased FoxO3a activation and subsequent induction of autophagy in hepatocyte-specific HIF-1 beta knockout mice.	[Ni, Hong-Min; Bhakta, Amar; Wang, Shaogui; Li, Zhenrui; Manley, Sharon; Copple, Bryan; Ding, Wen-Xing] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Wang, Shaogui; Huang, Heqing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Guangzhou 510275, Guangdong, Peoples R China	University of Kansas; University of Kansas Medical Center; Sun Yat Sen University	Ding, WX (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	wxding@kumc.edu		Li, Zhenrui/0000-0001-7172-7643; Manley, Sharon/0000-0002-2411-9706	National Instiute on Alcohol Abuse and Alcoholism [R01 AA020518]; National Center for Research Resources [5P20RR021940]; National Institute of General Medical Sciences [8P20 GM103549, T32 ES007079]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103418]; National Institutes of Health [DK073566]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103549, P20GM103418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA020518, R01AA020518] Funding Source: NIH RePORTER	National Instiute on Alcohol Abuse and Alcoholism; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grant R01 AA020518 (to WXD) from National Instiute on Alcohol Abuse and Alcoholism (http://www.niaaa.nih.gov/; 5P20RR021940 (to WXD) from National Center for Research Resources (http://dnrc.nih.gov/reports/programs/ncrr.asp); 8P20 GM103549 and T32 ES007079 (to WXD) from the National Institute of General Medical Sciences (http://www.nigms.nih.gov/Pages/default.aspx); P20 GM103418 (to WXD) from Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (http://www.nigms.nih.gov/Pages/default.aspx; DK073566 (to BC) National Institutes of Health http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteel GE, 1997, HEPATOLOGY, V25, P920, DOI 10.1002/hep.510250422; Band M, 2009, FASEB J, V23, P2327, DOI 10.1096/fj.08-122978; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Bohensky J, 2007, AUTOPHAGY, V3, P207, DOI 10.4161/auto.3708; Chacko BK, 2011, HEPATOLOGY, V54, P153, DOI 10.1002/hep.24377; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Ding WX, 2011, AUTOPHAGY, V7, P248, DOI 10.4161/auto.7.2.14347; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Dolganiuc A, 2012, ALCOHOL CLIN EXP RES, V36, P1301, DOI 10.1111/j.1530-0277.2012.01742.x; Fromenty B, 1997, J HEPATOL, V26, P43, DOI 10.1016/S0168-8278(97)80496-5; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Kang L, 2007, J BIOL CHEM, V282, P28465, DOI 10.1074/jbc.M705503200; Kang XQ, 2009, HEPATOLOGY, V50, P1241, DOI 10.1002/hep.23090; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Li J, 2004, EXP MOL PATHOL, V77, P184, DOI 10.1016/j.yexmp.2004.08.002; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mansouri A, 1997, J HEPATOL, V27, P96, DOI 10.1016/S0168-8278(97)80286-3; Mathews S, 2014, AM J PHYSIOL-GASTR L, V306, pG819, DOI 10.1152/ajpgi.00041.2014; Mazure NM, 2010, CURR OPIN CELL BIOL, V22, P177, DOI 10.1016/j.ceb.2009.11.015; Mazure NM, 2009, AUTOPHAGY, V5, P868, DOI 10.4161/auto.9042; Mehal WZ, 2012, J HEPATOL, V56, P311, DOI 10.1016/j.jhep.2011.09.009; Menrad H, 2010, HEPATOLOGY, V51, P2183, DOI 10.1002/hep.23597; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; Ni HM, 2014, J HEPATOL, V61, P617, DOI 10.1016/j.jhep.2014.04.043; Ni HM, 2013, AM J PATHOL, V183, P1815, DOI 10.1016/j.ajpath.2013.08.011; Ni HM, 2012, TOXICOL SCI, V127, P438, DOI 10.1093/toxsci/kfs133; Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Nishiyama Y, 2012, J HEPATOL, V56, P441, DOI 10.1016/j.jhep.2011.07.024; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Rouschop KMA, 2009, CURR MOL MED, V9, P417, DOI 10.2174/156652409788167131; Seo Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.260; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Thomes PG, 2013, AUTOPHAGY, V9, P63, DOI 10.4161/auto.22490; Tikhanovich I, 2013, HEPATOLOGY; Tikhanovich I, 2013, J GASTROEN HEPATOL, V28, P125, DOI 10.1111/jgh.12021; Tomita S, 2000, MOL ENDOCRINOL, V14, P1674, DOI 10.1210/me.14.10.1674; Tumurbaatar B, 2013, AM J PATHOL, V183, P1803, DOI 10.1016/j.ajpath.2013.08.013; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536; Walshe TE, 2008, ANNU REV PATHOL-MECH, V3, P615, DOI 10.1146/annurev.pathmechdis.3.121806.151501; Williams JA, 2014, WORLD J GASTROENTERO, V20, P12908, DOI 10.3748/wjg.v20.i36.12908; Yang LL, 2014, FREE RADICAL BIO MED, V68, P260, DOI 10.1016/j.freeradbiomed.2013.12.026; Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; Zelickson BR, 2011, BBA-BIOENERGETICS, V1807, P1573, DOI 10.1016/j.bbabio.2011.09.011; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhong W, 2012, AM J PATHOL, V180, P998, DOI 10.1016/j.ajpath.2011.11.017	51	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115849	10.1371/journal.pone.0115849	http://dx.doi.org/10.1371/journal.pone.0115849			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536043	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300079
J	Blanco, Y; Rivas, LA; Garcia-Moyano, A; Aguirre, J; Cruz-Gil, P; Palacin, A; van Heerden, E; Parro, V				Blanco, Yolanda; Rivas, Luis A.; Garcia-Moyano, Antonio; Aguirre, Jacobo; Cruz-Gil, Patricia; Palacin, Arantxa; van Heerden, Esta; Parro, Victor			Deciphering the Prokaryotic Community and Metabolisms in South African Deep-Mine Biofilms through Antibody Microarrays and Graph Theory	PLOS ONE			English	Article							SULFUR-OXIDIZING BACTERIUM; SP-NOV.; MICROBIAL COMMUNITY; WITWATERSRAND BASIN; GOLD MINE; GEN. NOV.; SUBSURFACE; WATER; DIVERSITY; SEQUENCE	In the South African deep mines, a variety of biofilms growing in mine corridor walls as water seeps from intersections or from fractures represents excellent proxies for deep-subsurface environments. However, they may be greatly affected by the oxygen inputs through the galleries of mining activities. As a consequence, the interaction between the anaerobic water coming out from the walls with the oxygen inputs creates new conditions that support rich microbial communities. The inherent difficulties for sampling these delicate habitats, together with transport and storage conditions may alter the community features and composition. Therefore, the development of in situ monitoring methods would be desirable for quick evaluation of the microbial community. In this work, we report the usefulness of an antibody-microarray (EMChip66) immunoassay for a quick check of the microbial diversity of biofilms located at 1.3 km below surface within the Beatrix deep gold mine (South Africa). In addition, a deconvolution method, previously described and used for environmental monitoring, based on graph theory and applied on antibody cross-reactivity was used to interpret the immunoassay results. The results were corroborated and further expanded by 16S rRNA gene sequencing analysis. Both culture-independent techniques coincided in detecting features related to aerobic sulfur-oxidizers, aerobic chemoorganotrophic Alphaproteobacteria and metanotrophic Gammaproteobacteria. 16S rRNA gene sequencing detected phylotypes related to nitrate-reducers and anaerobic sulfur-oxidizers, whereas the EMChip66 detected immunological features from methanogens and sulfate-reducers. The results reveal a diverse microbial community with syntrophic metabolisms both anaerobic (fermentation, methanogenesis, sulphate and nitrate reduction) and aerobic (methanotrophy, sulphur oxidation). The presence of oxygen-scavenging microbes might indicate that the system is modified by the artificial oxygen inputs from the mine galleries.	[Blanco, Yolanda; Rivas, Luis A.; Aguirre, Jacobo; Cruz-Gil, Patricia; Parro, Victor] INTA CSIC, Ctr Astrobiol, Dept Mol Evolut, Madrid 28850, Spain; [Garcia-Moyano, Antonio; van Heerden, Esta] Univ Free State, Dept Biotechnol, TIA UFS Metagen Platform, ZA-9300 Bloemfontein, South Africa; [Palacin, Arantxa] Ctr Biotecnol & Genom Plantas, Madrid 28223, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of the Free State	Parro, V (corresponding author), INTA CSIC, Ctr Astrobiol, Dept Mol Evolut, Carretera Ajalvir,Km 4, Madrid 28850, Spain.	parrogv@cab.inta-csic.es	Aguirre, Jacobo/K-5855-2014; Garcia-Moyano, Antonio/AAI-8647-2020; Parro, Victor/K-3788-2014	Aguirre, Jacobo/0000-0003-2196-5103; Garcia-Moyano, Antonio/0000-0003-1997-8589; Parro, Victor/0000-0003-3738-0724; Rivas, Luis Alfonso/0000-0001-8392-3000	Spanish Ministerio de Ciencia e Innovacion (MICINN) [AYA2008-04013, AYA2011-24803, FIS2011-27569]; Comunidad de Madrid (Spain) [MODELICO-CM S2009ESP-1691]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid (Spain)(Comunidad de Madrid)	This work has been funded by the Spanish Ministerio de Ciencia e Innovacion (MICINN), grant No. AYA2008-04013, AYA2011-24803 and FIS2011-27569, and Comunidad de Madrid (Spain) under project MODELICO-CM S2009ESP-1691. http://www.idi.mineco.gob.es/portal/site/MICINN/; http://www.madrimasd.org/.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baker BJ, 2003, ENVIRON MICROBIOL, V5, P267, DOI 10.1046/j.1462-2920.2003.00408.x; Blanco Y, 2012, ENVIRON MICROBIOL, V14, P2495, DOI 10.1111/j.1462-2920.2012.02767.x; Borgonie G, 2011, NATURE, V474, P79, DOI 10.1038/nature09974; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gihring TM, 2006, GEOMICROBIOL J, V23, P415, DOI 10.1080/01490450600875696; Gonzalez RM, 2008, J PROTEOME RES, V7, P2406, DOI 10.1021/pr700822t; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hirayama H, 2005, EXTREMOPHILES, V9, P169, DOI 10.1007/s00792-005-0433-8; Inagaki F, 2003, EXTREMOPHILES, V7, P307, DOI 10.1007/s00792-003-0324-9; Ito T, 2005, INT J SYST EVOL MICR, V55, P1059, DOI 10.1099/ijs.0.63467-0; Kelly DP, 2000, INT J SYST EVOL MICR, V50, P547, DOI 10.1099/00207713-50-2-547; Li HY, 2012, ANAL CHEM, V84, P4776, DOI 10.1021/ac3003177; Lin LH, 2006, GEOMICROBIOL J, V23, P475, DOI 10.1080/01490450600875829; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mori K, 2008, INT J SYST EVOL MICR, V58, P1885, DOI 10.1099/ijs.0.65754-0; Morris JJ, 2008, APPL ENVIRON MICROB, V74, P4530, DOI 10.1128/AEM.02479-07; Moser DP, 2005, APPL ENVIRON MICROB, V71, P8773, DOI 10.1128/AEM.71.12.8773-8783.2005; Moser DP, 2003, GEOMICROBIOL J, V20, P517, DOI 10.1080/713851170; Onstott TC, 2006, GEOMICROBIOL J, V23, P369, DOI 10.1080/01490450600875688; Onstott TC, 2003, ENVIRON MICROBIOL, V5, P1168, DOI 10.1046/j.1462-2920.2003.00512.x; Parro V, 2005, PLANET SPACE SCI, V53, P729, DOI 10.1016/j.pss.2005.02.003; Parro V, 2010, HDB HYDROCARBON LIPI, P2699; Parro V, 2011, ASTROBIOLOGY, V11, P969, DOI 10.1089/ast.2011.0654; Parro V, 2011, ASTROBIOLOGY, V11, P29, DOI 10.1089/ast.2010.0510; Pfiffner SM, 2006, GEOMICROBIOL J, V23, P431, DOI 10.1080/01490450600875712; Pla-Roca M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011460; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Puente-Sanchez F, 2014, GEOBIOLOGY, V12, P34, DOI 10.1111/gbi.12065; Rastogi G, 2009, J MICROBIOL, V47, P371, DOI 10.1007/s12275-008-0249-1; Rivas LA, 2008, ANAL CHEM, V80, P7970, DOI 10.1021/ac8008093; Rivas LA, 2011, ENVIRON MICROBIOL, V13, P1421, DOI 10.1111/j.1462-2920.2011.02442.x; Robb FT, 2001, METHOD ENZYMOL, V330, P134; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Slater GF, 2006, GEOMICROBIOL J, V23, P453, DOI 10.1080/01490450600875787; Southerland IW, 2009, MICROBIOLOGY, V147, P3; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Vannini C, 2008, SYST APPL MICROBIOL, V31, P461, DOI 10.1016/j.syapm.2008.07.003; Wang Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-453; Wanger G, 2008, GEOBIOLOGY, V6, P325, DOI 10.1111/j.1472-4669.2008.00163.x; Wanger G, 2006, GEOMICROBIOL J, V23, P443, DOI 10.1080/01490450600875746; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; Weiner RM, 2000, INT J SYST EVOL MICR, V50, P459, DOI 10.1099/00207713-50-2-459; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yurkov VV, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P562, DOI 10.1007/0-387-30745-1_23	48	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114180	10.1371/journal.pone.0114180	http://dx.doi.org/10.1371/journal.pone.0114180			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531640	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100011
J	Lee, KM; Kim, TW; Weinreb, RN; Lee, EJ; Girard, MJA; Mari, JM				Lee, Kyoung Min; Kim, Tae-Woo; Weinreb, Robert N.; Lee, Eun Ji; Girard, Michael J. A.; Mari, Jean Martial			Anterior Lamina Cribrosa Insertion in Primary Open-Angle Glaucoma Patients and Healthy Subjects	PLOS ONE			English	Article							OPTIC-NERVE HEAD; COHERENCE TOMOGRAPHY IMAGES; CEREBROSPINAL-FLUID SPACE; AGE-RELATED-CHANGES; BRUCHS MEMBRANE; EXTRACELLULAR-MATRIX; REGIONAL DIFFERENCES; CONNECTIVE-TISSUE; THICKNESS; DEPTH	Purpose: To determine using swept-source optical coherence tomography (SS-OCT) whether there are differences in the location of the anterior lamina cribrosa insertion (ALI) in primary open-angle glaucoma (POAG) patients and healthy subjects. Methods: Fifty three eyes from 53 patients with POAG, and 53 eyes from 53 age-matched healthy subjects were included prospectively in Seoul National University Bundang Hospital. Twelve radial line B-scans centered on the optic disc in every half-clock-hour meridian were acquired using SS-OCT. The ALI position was assessed by measuring two parameters: (1) ALI distance (ALID)-the distance from the anterior scleral canal opening (ASCO) to the ALI; and (2) marginal anterior lamina cribrosa surface depth (mALCSD)-the perpendicular distance from the ASCO plane to the anterior lamina cribrosa surface. These parameters were compared between the two groups for each meridian. Results: Both ALID (256 +/- 54 vs. 209 +/- 37 mm, mean +/- SD, p < 0.001) and mALCSD (232 +/- 63 vs. 187 +/- 40 mm, p < 0.001) were significantly greater in the POAG group than in the normal group. The largest difference was observed at the 6.5 o'clock and 11.5 o'clock meridians for both ALID and mALCSD. Multiple regression analysis revealed a negative correlation between age and both ALID and mALCSD in the control group, and a negative correlation between mean deviation of the visual field test and both ALID and mALCSD in the POAG group. Conclusions: The ALI was displaced posteriorly in eyes with POAG compared to those of healthy controls. This finding suggests that the posteriorly located lamina cribrosa insertion is an important component of glaucomatous optic nerve excavation.	[Lee, Kyoung Min; Kim, Tae-Woo; Lee, Eun Ji] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Weinreb, Robert N.] Univ Calif San Diego, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Girard, Michael J. A.] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Girard, Michael J. A.] Singapore Eye Res Inst, Singapore, Singapore; [Mari, Jean Martial] Univ Lyon, INSERM, U1032, Lyon, France	Seoul National University (SNU); University of California System; University of California San Diego; University of California System; University of California San Diego; National University of Singapore; National University of Singapore; Singapore National Eye Center; Institut National de la Sante et de la Recherche Medicale (Inserm)	Kim, TW (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	twkim7@snu.ac.kr	Girard, Michael/F-9323-2015; Bui, Bang/AAD-2679-2021	Girard, Michael/0000-0003-4408-5918; Bui, Bang/0000-0001-7298-1352; Mari, Jean Martial/0000-0002-1169-6547; Kim, Tae-Woo/0000-0002-5180-0978	National Research Foundation of Korea - Korean Government [2013R1A1A1A05004781]; Research to Prevent Blindness (New York, NY)	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government); Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB))	The work was supported by a grant from the National Research Foundation of Korea funded by the Korean Government (no. 2013R1A1A1A05004781) and an unrestricted grant from Research to Prevent Blindness (New York, NY). The funding organizations had no role in the design or conduct of this research.	Albon J, 2000, BRIT J OPHTHALMOL, V84, P311, DOI 10.1136/bjo.84.3.311; Albon J, 2000, BRIT J OPHTHALMOL, V84, P318, DOI 10.1136/bjo.84.3.318; ANDERSON DR, 1969, ARCH OPHTHALMOL-CHIC, V82, P800; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2004, INVEST OPHTH VIS SCI, V45, P4388, DOI 10.1167/iovs.04-0022; Burgoyne CF, 2001, J GLAUCOMA, V10, pS16, DOI 10.1097/00061198-200110001-00007; Burgoyne CF, 2008, J GLAUCOMA, V17, P318, DOI 10.1097/IJG.0b013e31815a343b; Chauhan BC, 2013, AM J OPHTHALMOL, V156, P218, DOI 10.1016/j.ajo.2013.04.016; Downs JC, 2011, EXP EYE RES, V93, P133, DOI 10.1016/j.exer.2010.08.004; Furlanetto RL, 2013, INVEST OPHTH VIS SCI, V54, P4836, DOI 10.1167/iovs.12-11530; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P7738, DOI 10.1167/iovs.10-6925; HAYREH SS, 1974, BRIT J OPHTHALMOL, V58, P863, DOI 10.1136/bjo.58.10.863; Hernandez MR, 2008, PROG BRAIN RES, V173, P353, DOI 10.1016/S0079-6123(08)01125-4; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; HERNANDEZ MR, 1989, AM J OPHTHALMOL, V107, P476, DOI 10.1016/0002-9394(89)90491-1; Hussain AA, 2014, INVEST OPHTH VIS SCI, V55, P2358, DOI 10.1167/iovs.13-12503; Johnstone J, 2014, INVEST OPHTH VIS SCI, V55, P2004, DOI 10.1167/iovs.13-12937; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2660, DOI 10.1167/iovs.03-1363; Jonas JB, 1997, OPHTHALMOLOGY, V104, P1934, DOI 10.1016/S0161-6420(97)30004-9; Jonas Jost B, 2013, J Ophthalmic Vis Res, V8, P257; Kotecha A, 2006, BRIT J OPHTHALMOL, V90, P1531, DOI 10.1136/bjo.2006.100388; Kumar A, 2010, INVEST OPHTH VIS SCI, V51, P2664, DOI 10.1167/iovs.09-4195; Lee EJ, 2014, INVEST OPHTHALMOL VI; Lee EJ, 2013, GRAEF ARCH CLIN EXP, V251, P847, DOI 10.1007/s00417-012-2145-y; Lee EJ, 2011, AM J OPHTHALMOL, V152, P87, DOI 10.1016/j.ajo.2011.01.024; Mari JM, 2013, INVEST OPHTH VIS SCI, V54, P2238, DOI 10.1167/iovs.12-11327; Miki A, 2013, CLIN OPHTHALMOL, V7, P1995, DOI 10.2147/OPTH.S50120; Morgan JE, 2004, EYE, V18, P1089, DOI 10.1038/sj.eye.6701574; Park HYL, 2014, AM J OPHTHALMOL, V157, P550, DOI 10.1016/j.ajo.2013.11.008; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Park SC, 2012, INVEST OPHTH VIS SCI, V53, P1610, DOI 10.1167/iovs.11-7577; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Pena JDO, 1998, EXP EYE RES, V67, P517, DOI 10.1006/exer.1998.0539; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Ren RJ, 2014, INVEST OPHTH VIS SCI, V55, P1531, DOI 10.1167/iovs.13-13382; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Takayama K, 2013, INVEST OPHTH VIS SCI, V54, P4798, DOI 10.1167/iovs.13-11677; Tatham AJ, 2014, OPHTHALMOLOGY, V121, P110, DOI 10.1016/j.ophtha.2013.08.018; Vongphanit J, 2002, AM J OPHTHALMOL, V133, P679, DOI 10.1016/S0002-9394(02)01339-9; Wang NL, 2012, OPHTHALMOLOGY, V119, P2065, DOI 10.1016/j.ophtha.2012.03.054; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; WILCZEK M, 1947, BRIT J OPHTHALMOL, V31, P551, DOI 10.1136/bjo.31.9.551; Witmer MT, 2010, SURV OPHTHALMOL, V55, P403, DOI 10.1016/j.survophthal.2010.01.002; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P5068, DOI 10.1167/iovs.07-0790; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P7109, DOI 10.1167/iovs.11-7448; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P345, DOI 10.1167/iovs.09-5122; Yoshikawa M, 2014, INVEST OPHTH VIS SCI, V55, P477, DOI 10.1167/iovs.13-11897; You JY, 2013, JAMA OPHTHALMOL, V131, P314, DOI 10.1001/jamaophthalmol.2013.1926	51	42	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114935	10.1371/journal.pone.0114935	http://dx.doi.org/10.1371/journal.pone.0114935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531761	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100032
J	Benn, A; Robinson, ESJ				Benn, Abigail; Robinson, Emma S. J.			Investigating Glutamatergic Mechanism in Attention and Impulse Control Using Rats in a Modified 5-Choice Serial Reaction Time Task	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; NMDA RECEPTOR; BEHAVIORAL PHARMACOLOGY; PERFORMANCE DEFICITS; PHENCYCLIDINE; ANTAGONIST; KETAMINE; BLOCKADE; ACTIVATION; INHIBITION	The 5-choice serial reaction time task (5CSRTT) has been widely used to study attention and impulse control in rodents. In order to mimic cognitive impairments in psychiatry, one approach has been to use acute administration of NMDA antagonists. This disruption in glutamatergic transmission leads to impairments in accuracy, omissions, and premature responses although findings have been inconsistent. In this study, we further investigated glutamatergic mechanisms using a novel version of the 5CSRTT, which we have previously shown to be more sensitive to cognitive enhancers. We first investigated the effects of systemic treatment with NMDA antagonists. We also carried out a preliminary investigation using targeted medial prefrontal cortex infusions of a NMDA antagonist (MK801), mGluR2/ 3 antagonist (LY341495), and mGluR7 negative allosteric modulator (MMPIP). Acute systemic administration of the different NMDA antagonists had no specific effects on accuracy. At higher doses PCP, ketamine, and memantine, increased omissions and affected other measures suggesting a general disruption in task performance. Only MK801 increased premature responses, and reduced omissions at lower doses suggesting stimulant like effects. None of the NMDA antagonists affected accuracy or any other measures when tested using a short stimulus challenge. Infusions of MK801 had no effect on accuracy but increased premature responses following infralimbic, but not prelimbic infusion. LY341495 had no effects in either brain region but a decrease in accuracy was observed following prelimbic infusion of MMPIP. Contrary to our hypothesis, disruptions to glutamate transmission using NMDA antagonists did not induce any clear deficits in accuracy in this modified version of the 5CSRTT. We also found that the profile of effects for MK801 differed from those observed with PCP, ketamine, and memantine. The effects of MK801 in the infralimbic cortex add to the literature indicating this brain region and glutamate play an important role in impulse control.	[Benn, Abigail; Robinson, Emma S. J.] Univ Bristol, Dept Physiol & Pharmacol, Sch Med & Vet Sci, Bristol, Avon, England	University of Bristol	Benn, A (corresponding author), Univ Bristol, Dept Physiol & Pharmacol, Sch Med & Vet Sci, Bristol, Avon, England.	a.benn@bristol.ac.uk			Wellcome Trust [084621/Z/08/Z]; RCUK academic fellowship; Medical Research Council [G0700980] Funding Source: researchfish; MRC [G0700980] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); RCUK academic fellowship(UK Research & Innovation (UKRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study was provided by the Wellcome Trust (www.wellcome.ac.uk, Reference no. 084621/Z/08/Z) with additional funding from an RCUK academic fellowship awarded to ESJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnoli L, 2011, NEUROSCIENCE, V185, P39, DOI 10.1016/j.neuroscience.2011.04.044; Agnoli L, 2013, NEUROPSYCHOPHARMACOL, V38, P701, DOI 10.1038/npp.2012.236; ALLEN RM, 1978, AM J PSYCHIAT, V135, P1081; Amitai N, 2007, PSYCHOPHARMACOLOGY, V193, P521, DOI 10.1007/s00213-007-0808-x; Amitai N, 2010, BIOL PSYCHIAT, V68, P5, DOI 10.1016/j.biopsych.2010.03.004; Amitai N, 2009, PSYCHOPHARMACOLOGY, V202, P275, DOI 10.1007/s00213-008-1246-0; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Barker GRI, 2008, J NEUROSCI, V28, P2837, DOI 10.1523/JNEUROSCI.4447-07.2008; Barnes SA, 2012, NEUROPHARMACOLOGY, V62, P1432, DOI 10.1016/j.neuropharm.2011.04.024; Baviera M, 2008, PSYCHOPHARMACOLOGY, V196, P269, DOI 10.1007/s00213-007-0959-9; BRESINK I, 1995, NEUROPHARMACOLOGY, V34, P533, DOI 10.1016/0028-3908(95)00017-Z; Campbell BM, 2006, NEUROSCIENCE, V137, P505, DOI 10.1016/j.neuroscience.2005.09.024; Carli M, 2006, NEUROPSYCHOPHARMACOL, V31, P757, DOI 10.1038/sj.npp.1300893; Carli M, 2011, PSYCHOPHARMACOLOGY, V214, P625, DOI 10.1007/s00213-010-2066-6; Carli M, 2011, PSYCHOPHARMACOLOGY, V214, P639, DOI 10.1007/s00213-010-2065-7; Chudasama Y, 2003, J NEUROSCI, V23, P5477; Chudasama Y, 2001, BEHAV NEUROSCI, V115, P417, DOI 10.1037/0735-7044.115.2.417; Dix S, 2010, PSYCHOPHARMACOLOGY, V212, P227, DOI 10.1007/s00213-010-1945-1; Fletcher PJ, 2011, NEUROPHARMACOLOGY, V61, P468, DOI 10.1016/j.neuropharm.2011.02.025; Gilmour G, 2009, PSYCHOPHARMACOLOGY, V205, P203, DOI 10.1007/s00213-009-1530-7; Hascup ER, 2010, J NEUROCHEM, V115, P1608, DOI 10.1111/j.1471-4159.2010.07066.x; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Higgins GA, 2005, PSYCHOPHARMACOLOGY, V179, P85, DOI 10.1007/s00213-005-2203-9; Higgins GA, 2003, NEUROPHARMACOLOGY, V44, P324, DOI 10.1016/S0028-3908(02)00402-1; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Imre G, 2006, BRAIN RES BULL, V69, P338, DOI 10.1016/j.brainresbull.2006.01.010; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Lahti AC, 2001, NEUROPSYCHOPHARMACOL, V25, P455, DOI 10.1016/S0893-133X(01)00243-3; Lustig C, 2013, NEUROSCI BIOBEHAV R, V37, P2099, DOI 10.1016/j.neubiorev.2012.05.009; McKenna BS, 2013, PSYCHIAT RES-NEUROIM, V212, P183, DOI 10.1016/j.pscychresns.2013.01.005; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Murphy ER, 2012, PSYCHOPHARMACOLOGY, V219, P401, DOI 10.1007/s00213-011-2572-1; Murphy ER, 2005, PSYCHOPHARMACOLOGY, V179, P99, DOI 10.1007/s00213-004-2068-3; NESTOR PG, 1990, SCHIZOPHR RES, V3, P329, DOI 10.1016/0920-9964(90)90018-3; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Paine TA, 2009, NEUROPSYCHOPHARMACOL, V34, P2143, DOI 10.1038/npp.2009.40; Paine TA, 2009, NEUROPHARMACOLOGY, V56, P788, DOI 10.1016/j.neuropharm.2009.01.004; Paine TA, 2007, BIOL PSYCHIAT, V62, P687, DOI 10.1016/j.biopsych.2006.11.017; Passetti F, 2002, CEREB CORTEX, V12, P1254, DOI 10.1093/cercor/12.12.1254; Pozzi L, 2011, NEUROSCIENCE, V176, P336, DOI 10.1016/j.neuroscience.2010.11.060; Quarta D, 2007, NEUROPHARMACOLOGY, V53, P421, DOI 10.1016/j.neuropharm.2007.05.023; Robbins TW, 2006, TRENDS PHARMACOL SCI, V27, P141, DOI 10.1016/j.tips.2006.01.009; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Robinson ESJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1028, DOI 10.1038/sj.npp.1301487; Robinson ESJ, 2012, PSYCHOPHARMACOLOGY, V219, P303, DOI 10.1007/s00213-011-2420-3; Sanchez-Roige S, 2012, PSYCHOPHARMACOLOGY, V219, P253, DOI 10.1007/s00213-011-2560-5; Smith JW, 2011, PSYCHOPHARMACOLOGY, V217, P255, DOI 10.1007/s00213-011-2277-5; Swanson CJ, 2005, NAT REV DRUG DISCOV, V4, P131, DOI 10.1038/nrd1630; Terry AV, 2012, BIOCHEM PHARMACOL, V83, P941, DOI 10.1016/j.bcp.2011.12.043; Thomson DM, 2011, PSYCHOPHARMACOLOGY, V213, P681, DOI 10.1007/s00213-010-2020-7; Tomlinson A, 2014, EUR NEUROPSYCHOPHARM, V24, P1371, DOI 10.1016/j.euroneuro.2014.04.008; van Enkhuizen J, 2014, BEHAV BRAIN RES, V261, P40, DOI 10.1016/j.bbr.2013.12.003; Young JW, 2013, BEHAV BRAIN RES, V240, P119, DOI 10.1016/j.bbr.2012.11.028; Young J, 2013, PHILOSOPHY OF TRAGEDY: FROM PLATO TO ZIZEK, P3	56	31	31	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115374	10.1371/journal.pone.0115374	http://dx.doi.org/10.1371/journal.pone.0115374			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526617	gold, Green Published, Green Submitted			2022-12-26	WOS:000347186200024
J	Frees, AE; Rajaram, N; McCachren, SS; Fontanella, AN; Dewhirst, MW; Ramanujam, N				Frees, Amy E.; Rajaram, Narasimhan; McCachren, Samuel S., III; Fontanella, Andrew N.; Dewhirst, Mark W.; Ramanujam, Nimmi			Delivery-Corrected Imaging of Fluorescently-Labeled Glucose Reveals Distinct Metabolic Phenotypes in Murine Breast Cancer	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET; HIGH LACTATE LEVELS; TUMOR HYPOXIA; BLOOD-FLOW; RAPAMYCIN INHIBITOR; NECK TUMORS; HEAD; OXYGEN; PET; VASCULATURE	When monitoring response to cancer therapy, it is important to differentiate changes in glucose tracer uptake caused by altered delivery versus a true metabolic shift. Here, we propose an optical imaging method to quantify glucose uptake and correct for in vivo delivery effects. Glucose uptake was measured using a fluorescent D-glucose derivative 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-deoxy-D-glucose (2-NBDG) in mice implanted with dorsal skin flap window chambers. Additionally, vascular oxygenation (SO2) was calculated using only endogenous hemoglobin contrast. Results showed that the delivery factor proposed for correction, "R-D", reported on red blood cell velocity and injected 2-NBDG dose. Delivery-corrected 2-NBDG uptake (2-NBDG(60)/R-D) inversely correlated with blood glucose in normal tissue, indicating sensitivity to glucose demand. We further applied our method in metastatic 4T1 and nonmetastatic 4T07 murine mammary adenocarcinomas. The ratio 2-NBDG(60)/R-D was increased in 4T1 tumors relative to 4T07 tumors yet average SO2 was comparable, suggesting a shift toward a "Warburgian" (aerobic glycolysis) metabolism in the metastatic 4T1 line. In heterogeneous regions of both 4T1 and 4T07, 2-NBDG(60)/R-D increased slightly but significantly as vascular oxygenation decreased, indicative of the Pasteur effect in both tumors. These data demonstrate the utility of delivery-corrected 2-NBDG and vascular oxygenation imaging for differentiating metabolic phenotypes in vivo.	[Frees, Amy E.; Rajaram, Narasimhan; McCachren, Samuel S., III; Fontanella, Andrew N.; Ramanujam, Nimmi] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Dewhirst, Mark W.] Duke Univ, Med Ctr, Durham, NC USA	Duke University; Duke University	Frees, AE (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	amy.frees@duke.edu	Rajaram, Narasimhan/A-2249-2010; Dewhirst, Mark/Q-1302-2019; Ramanujam, Nimmi/AAA-7575-2021	Rajaram, Narasimhan/0000-0003-1224-8567; Dewhirst, Mark/0000-0003-3459-6546; Ramanujam, Nimmi/0000-0001-7319-8415; Martinez, Amy/0000-0002-8088-7398	National Science Foundation Graduate Research Fellowship Program; Department of Defense Era of Hope Scholar Awards [W81XWH-09-1-0410, W81XWH-05-10363]	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Department of Defense Era of Hope Scholar Awards	This research was supported by generous funding from the National Science Foundation Graduate Research Fellowship Program (www.nsf.gov/grfp; AEF) and the Department of Defense Era of Hope Scholar Awards (http://cdmrp.army.mil/bcrp/era; W81XWH-09-1-0410; PI: N. Ramanujam and W81XWH-05-10363; PI: N. Ramanujam). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertuzzi A, 2010, J THEOR BIOL, V262, P142, DOI 10.1016/j.jtbi.2009.09.024; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Bollineni VR, 2013, J NUCL MED, V54, P1175, DOI 10.2967/jnumed.112.115014; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Busk M, 2008, INT J CANCER, V122, P2726, DOI 10.1002/ijc.23449; Castell F, 2008, BRIT J CANCER, V98, P1597, DOI 10.1038/sj.bjc.6604330; EITZMAN D, 1992, J AM COLL CARDIOL, V20, P559, DOI 10.1016/0735-1097(92)90008-B; Epelbaum R, 2013, J NUCL MED, V54, P12, DOI 10.2967/jnumed.112.107466; Fontanella AN, 2013, MICROCIRCULATION, V20, P724, DOI 10.1111/micc.12072; GAILLARD WD, 1995, NEUROLOGY, V45, P1841, DOI 10.1212/WNL.45.10.1841; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gill EM, 2003, PHOTOCHEM PHOTOBIOL, V77, P653, DOI 10.1562/0031-8655(2003)077<0653:RBCAOT>2.0.CO;2; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Guppy M, 2002, BIOCHEM BIOPH RES CO, V299, P676, DOI 10.1016/S0006-291X(02)02710-9; Heppner GH, 2000, BREAST CANCER RES, V2, P331; HLATKY L, 1988, J CELL PHYSIOL, V134, P167, DOI 10.1002/jcp.1041340202; Hoeben BAW, 2013, ACTA ONCOL, V52, P1257, DOI 10.3109/0284186X.2013.812799; Hudetz AG, 1997, MICROVASC RES, V54, P35, DOI 10.1006/mvre.1997.2023; Koolen BB, 2014, ACTA ONCOL, V53, P50, DOI 10.3109/0284186X.2013.783714; Maher JC, 2007, MOL CANCER THER, V6, P732, DOI 10.1158/1535-7163.MCT-06-0407; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Manka D, 2005, CANCER RES, V65, P11689, DOI 10.1158/0008-5472.CAN-05-3091; Mankoff DA, 2009, CLIN CANCER RES, V15, P5294, DOI 10.1158/1078-0432.CCR-09-1448; Mees G, 2013, MOL IMAGING, V12, P49, DOI 10.2310/7290.2012.00020; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Millon SR, 2011, BREAST CANCER RES TR, V126, P55, DOI 10.1007/s10549-010-0884-1; Nitin N, 2009, INT J CANCER, V124, P2634, DOI 10.1002/ijc.24222; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6; Ohwada J, 2011, BIOORG MED CHEM LETT, V21, P1767, DOI 10.1016/j.bmcl.2011.01.065; Ostergaard L, 2013, CANCER RES, V73, P5618, DOI 10.1158/0008-5472.CAN-13-0964; Palmer GM, 2011, NAT PROTOC, V6, P1355, DOI 10.1038/nprot.2011.349; Palmer GM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3523363; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; Rajaram N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076524; Rajendran JG, 2005, RADIOL CLIN N AM, V43, P169, DOI 10.1016/j.rcl.2004.08.004; Russell J, 2009, INT J RADIAT ONCOL, V73, P1177, DOI 10.1016/j.ijrobp.2008.12.004; Schnell CR, 2008, CANCER RES, V68, P6598, DOI 10.1158/0008-5472.CAN-08-1044; Secomb TW, 2004, INT J RADIAT ONCOL, V59, P572, DOI 10.1016/j.ijrobp.2004.01.039; Sheth RA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3259364; Smallbone K, 2007, J THEOR BIOL, V244, P703, DOI 10.1016/j.jtbi.2006.09.010; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369; Specht JM, 2010, CLIN CANCER RES, V16, P2803, DOI 10.1158/1078-0432.CCR-10-0026; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; VAUPEL P, 1989, CANCER RES, V49, P6449; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vaupel PW, 2010, INT J HYPERTHER, V26, P211, DOI 10.3109/02656731003596259; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Walenta S, 2000, CANCER RES, V60, P916; Walenta S, 1997, AM J PATHOL, V150, P409; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Yamamoto T, 2008, TETRAHEDRON LETT, V49, P6876, DOI 10.1016/j.tetlet.2008.09.089; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zasadny KR, 2003, EUR J NUCL MED MOL I, V30, P274, DOI 10.1007/s00259-002-1022-z	59	17	17	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115529	10.1371/journal.pone.0115529	http://dx.doi.org/10.1371/journal.pone.0115529			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526261	Green Published, gold, Green Submitted			2022-12-26	WOS:000347186200032
J	Greenbaum, G; Templeton, AR; Zarmi, Y; Bar-David, S				Greenbaum, Gili; Templeton, Alan R.; Zarmi, Yair; Bar-David, Shirli			Allelic Richness following Population Founding Events - A Stochastic Modeling Framework Incorporating Gene Flow and Genetic Drift	PLOS ONE			English	Article							PER-GENERATION RULE; ONE-MIGRANT; NONEQUILIBRIUM MODELS; CONSERVATION; DIVERSITY; BOTTLENECKS; MANAGEMENT; NUMBER; EXTINCTION; NUCLEOTIDE	Allelic richness (number of alleles) is a measure of genetic diversity indicative of a population's long-term potential for adaptability and persistence. It is used less commonly than heterozygosity as a genetic diversity measure, partially because it is more mathematically difficult to take into account the stochastic process of genetic drift for allelic richness. This paper presents a stochastic model for the allelic richness of a newly founded population experiencing genetic drift and gene flow. The model follows the dynamics of alleles lost during the founder event and simulates the effect of gene flow on maintenance and recovery of allelic richness. The probability of an allele's presence in the population was identified as the relevant statistical property for a meaningful interpretation of allelic richness. A method is discussed that combines the probability of allele presence with a population's allele frequency spectrum to provide predictions for allele recovery. The model's analysis provides insights into the dynamics of allelic richness following a founder event, taking into account gene flow and the allele frequency spectrum. Furthermore, the model indicates that the "One Migrant per Generation" rule, a commonly used conservation guideline related to heterozygosity, may be inadequate for addressing preservation of diversity at the allelic level. This highlights the importance of distinguishing between heterozygosity and allelic richness as measures of genetic diversity, since focusing merely on the preservation of heterozygosity might not be enough to adequately preserve allelic richness, which is crucial for species persistence and evolution.	[Greenbaum, Gili; Zarmi, Yair] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Dept Solar Energy & Environm Phys, Midreshet Ben Gurion, Israel; [Greenbaum, Gili; Bar-David, Shirli] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Templeton, Alan R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Templeton, Alan R.] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Templeton, Alan R.] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel	Ben Gurion University; Ben Gurion University; Washington University (WUSTL); University of Haifa; University of Haifa	Greenbaum, G (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Dept Solar Energy & Environm Phys, Midreshet Ben Gurion, Israel.	gili.greenbaum@gmail.com	Templeton, Alan R./F-5963-2011; BAR-DAVID, SHIRLI/F-1512-2012	BAR-DAVID, SHIRLI/0000-0001-8103-041X; Templeton, Alan/0000-0002-0167-845X; Greenbaum, Gili/0000-0002-1631-8203	SIDEER (Swiss Institute for Dryland Environmental and Energy Research) Fund	SIDEER (Swiss Institute for Dryland Environmental and Energy Research) Fund	GG fellowship was supported by the 2010 SIDEER (Swiss Institute for Dryland Environmental and Energy Research) Fund for interdisciplinary research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F. W., 2012, CONSERV GENET; ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Andras JP, 2011, MOL ECOL, V20, P2525, DOI 10.1111/j.1365-294X.2011.05115.x; [Anonymous], 2006, POPULATION GENETICS; Barker JSF, 2001, CAN J FOREST RES, V31, P588, DOI 10.1139/cjfr-31-4-588; Caballero A, 2010, CONSERV GENET, V11, P409, DOI 10.1007/s10592-009-0020-0; Caballero A, 2013, GENETICS, V195, P1373, DOI 10.1534/genetics.113.158410; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dewar RC, 2011, MOL ECOL, V20, P3156, DOI 10.1111/j.1365-294X.2011.05171.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; EWENS WJ, 1964, GENETICS, V50, P891; Fisher RA, 1930, GENETICAL THEORY NAT; Foulley JL, 2006, LIVEST SCI, V101, P150, DOI 10.1016/j.livprodsci.2005.10.021; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; HILL WG, 1986, GENET RES, V48, P41, DOI 10.1017/S0016672300024642; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; JAMES JW, 1970, GENET RES, V16, P241, DOI 10.1017/S0016672300002500; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; KIMURA M, 1969, GENETICS, V63, P701; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KIMURA M, 1964, GENETICS, V49, P561; Kimura M., 1971, THEORETICAL ASPECTS; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; LACY R C, 1987, Conservation Biology, V1, P143, DOI 10.1111/j.1523-1739.1987.tb00023.x; LEBERG PL, 1992, EVOLUTION, V46, P477, DOI 10.1111/j.1558-5646.1992.tb02053.x; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Marshall D. R., 1975, Crop genetic resources for today and tomorrow. Genetic variation in plant populations., P53; MARUYAMA T, 1985, GENETICS, V111, P675; MARUYAMA T, 1984, GENETICS, V108, P745; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; Nachman MW, 2000, GENETICS, V156, P297; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Newman D, 1997, EVOLUTION, V51, P354, DOI [10.2307/2411107, 10.1111/j.1558-5646.1997.tb02422.x]; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; ROBERTSON A., 1960, PROC ROY SOC SER B BIOL SCI, V153, P234, DOI 10.1098/rspb.1960.0099; SCHOEN DJ, 1993, P NATL ACAD SCI USA, V90, P10623, DOI 10.1073/pnas.90.22.10623; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Simianer H, 2005, J ANIM BREED GENET, V122, P177, DOI 10.1111/j.1439-0388.2005.00523.x; SPIETH PT, 1974, GENETICS, V78, P961; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; TEMPLETON AR, 1980, GENETICS, V94, P1011; Toro MA, 2009, LIVEST SCI, V120, P174, DOI 10.1016/j.livsci.2008.07.003; Tracy LN, 2011, ANIM CONSERV, V14, P439, DOI 10.1111/j.1469-1795.2011.00448.x; Vogel F., 1997, HUMAN GENETICS PROBL; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; Vucetich JA, 2000, ANIM CONSERV, V3, P261, DOI 10.1017/S1367943000000986; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wang JL, 2004, CONSERV BIOL, V18, P332, DOI 10.1111/j.1523-1739.2004.00440.x; WATTERSON GA, 1984, THEOR POPUL BIOL, V26, P387, DOI 10.1016/0040-5809(84)90042-X; Weiser EL, 2013, CONSERV BIOL, V27, P335, DOI 10.1111/cobi.12011; Willing EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042649; Wolfram S., 2003, MATH BOOK; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1921, GENETICS, V6, P111; ZENG ZB, 1990, THEOR POPUL BIOL, V37, P254, DOI 10.1016/0040-5809(90)90039-X	62	108	110	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115203	10.1371/journal.pone.0115203	http://dx.doi.org/10.1371/journal.pone.0115203			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526062	Green Submitted, Green Published, gold			2022-12-26	WOS:000347186200017
J	Kulangara, K; Yang, J; Chellappan, M; Yang, Y; Leong, KW				Kulangara, Karina; Yang, Jennifer; Chellappan, Malathi; Yang, Yong; Leong, Kam W.			Nanotopography Alters Nuclear Protein Expression, Proliferation and Differentiation of Human Mesenchymal Stem/Stromal Cells	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; A-TYPE LAMINS; RETINOBLASTOMA GENE; STROMAL CELLS; STEM-CELLS; IDENTIFICATION; MUTATIONS; LMNA; A/C	Mesenchymal stem/stromal cells respond to physical cues present in their microenvironment such as substrate elasticity, geometry, or topography with respect to morphology, proliferation, and differentiation. Although studies have demonstrated the role of focal adhesions in topography-mediated changes of gene expression, information linking substrate topography to the nucleus remains scarce. Here we show by two-dimensional gel electrophoresis and western blotting that A-type lamins and retinoblastoma protein are downregulated in mesenchymal stem/stromal cells cultured on 350 nm gratings compared to planar substrates; these changes lead to a decrease in proliferation and changes in differentiation potential.	[Kulangara, Karina; Yang, Jennifer; Chellappan, Malathi; Yang, Yong; Leong, Kam W.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University	Leong, KW (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	kam.leong@duke.edu	, Proteomics Core UNC/AFQ-7201-2022; , Proteomics Core UNC/AAH-3777-2022; Leong, Kam/O-9302-2019	Leong, Kam/0000-0002-8133-4955	National Institutes of Health (NIH) [UH3TR000505, HL109442, AI096305]; Swiss National Science Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000505] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096305] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (NIH) grants UH3TR000505, HL109442, and AI096305 (http//www.nih.gov/). KK received funding from the Swiss National Science Foundation (http//www.snf.ch/en/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Bao LR, 2002, J VAC SCI TECHNOL B, V20, P2881, DOI 10.1116/1.1526355; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Caux F, 2003, J CLIN ENDOCR METAB, V88, P1006, DOI 10.1210/jc.2002-021506; Chalut KJ, 2010, SOFT MATTER, V6, P1675, DOI 10.1039/b921206j; Chen LS, 2003, LANCET, V362, P440, DOI 10.1016/S0140-6736(03)14069-X; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Friedman DB, 2004, PROTEOMICS, V4, P793, DOI 10.1002/pmic.200300635; Galderisi U, 2006, ONCOGENE, V25, P5250, DOI 10.1038/sj.onc.1209736; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Jones BJ, 2008, EXP HEMATOL, V36, P733, DOI 10.1016/j.exphem.2008.03.006; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kulangara K, 2012, BIOMATERIALS, V33, P4998, DOI 10.1016/j.biomaterials.2012.03.053; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908; Osorio C, 2007, NEUROBIOL AGING, V28, P1853, DOI 10.1016/j.neurobiolaging.2006.08.011; OZAKI T, 1994, ONCOGENE, V9, P2649; Parker Carol E., 2005, V301, P117; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037; Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102	35	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114698	10.1371/journal.pone.0114698	http://dx.doi.org/10.1371/journal.pone.0114698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521962	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845600008
J	Siu, MK; Tsai, YC; Chang, YS; Yin, JJ; Suau, F; Chen, WY; Liu, YN				Siu, M. K.; Tsai, Y-C; Chang, Y-S; Yin, J. J.; Suau, F.; Chen, W-Y; Liu, Y-N			Transforming growth factor-beta promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway	ONCOGENE			English	Article							MESENCHYMAL TRANSITION; CANCER; INHIBITION; EXPRESSION; INVASION; RECEPTOR; GENE	Transforming growth factor-beta (TGF beta) is enriched in the bone matrix and serves as a key factor in promoting bone metastasis in cancer. In addition, TGF beta signaling activates mammalian target of rapamycin (mTOR) functions, which is important for the malignant progression. Here, we demonstrate that TGF beta regulates the level of microRNA-96 (miR-96) through Smad-dependent transcription and that miR-96 promotes the bone metastasis in prostate cancer. The enhanced effects in cellular growth and invasiveness suggest that miR-96 functions as an oncomir/and metastamir. Supporting this idea, we identified a downstream target of the TGF beta-miR-96 signaling pathway to be AKT1S1 mRNA, whose translated protein is a negative regulator of mTOR kinase. Our findings provide a novel mechanism accounting for the TGF beta signaling and bone metastasis.	[Siu, M. K.; Tsai, Y-C; Liu, Y-N] Taipei Med Univ, Coll Med Sci & Technol, Program Canc Biol & Drug Discovery, Taipei 11031, Taiwan; [Siu, M. K.; Tsai, Y-C; Liu, Y-N] Acad Sinica, Taipei 115, Taiwan; [Siu, M. K.] Taipei Med Univ, Wan Fang Hosp, Dept Anesthesiol, Taipei 11031, Taiwan; [Tsai, Y-C; Chang, Y-S; Liu, Y-N] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei 11031, Taiwan; [Yin, J. J.; Suau, F.] NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA; [Chen, W-Y] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei 11031, Taiwan	Taipei Medical University; Academia Sinica - Taiwan; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Taipei Medical University; Taipei Municipal WanFang Hospital	Liu, YN (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, 250 Wu Hsing St, Taipei 11031, Taiwan.	yuanchin@tmu.edu.tw; liuy@tmu.edu.tw	Liu, Yen-Nien/AAW-4698-2021		Taipei Medical University-Wan Fang Hospital [102TMU-WFH-05]; Taipei Medical University [TMU102-AE1-B30]; Ministry of Science and Technology [NSC102-2320-B-038-001, NSC103-2311-B-038-001]	Taipei Medical University-Wan Fang Hospital; Taipei Medical University; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was jointly supported by grants from the Taipei Medical University-Wan Fang Hospital (102TMU-WFH-05) to Y-N Liu, Taipei Medical University (TMU102-AE1-B30) to Y-C Tsai, the Ministry of Science and Technology (NSC102-2320-B-038-001) of Taiwan to Y-N Liu, and the Ministry of Science and Technology (NSC103-2311-B-038-001) of Taiwan to Y-C Tsai. We also thank Dr Ji-Hshiung Chen (Tzu Chi University) for reading the manuscript and for his comments and helpful suggestions. We also thank Dr Orla Casey for reviewing our manuscript and discussion.	Ao MF, 2006, CANCER RES, V66, P8007, DOI 10.1158/0008-5472.CAN-05-4451; Bedi A, 2012, MOL CANCER THER, V11, P2429, DOI 10.1158/1535-7163.MCT-12-0101-T; Bertoldo F, 2014, BBA-REV CANCER, V1845, P248, DOI 10.1016/j.bbcan.2014.01.009; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; BROWN K, 1986, CELL, V46, P447, DOI 10.1016/0092-8674(86)90665-3; Butz H, 2012, TRENDS PHARMACOL SCI, V33, P382, DOI 10.1016/j.tips.2012.04.003; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fendler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080807; Gogna R, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.15; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Haflidadottir BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072400; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Lee C, 1999, PROSTATE, V39, P285; Li X, 2008, ONCOGENE, V27, P7118, DOI 10.1038/onc.2008.293; Lin HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015797; Liu CF, 2013, PROSTATE, V73, P418, DOI 10.1002/pros.22583; Liu YN, 2013, ONCOGENE, V32, P296, DOI 10.1038/onc.2012.58; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Martin P, 2011, AM J PATHOL, V179, P422, DOI 10.1016/j.ajpath.2011.03.035; Mishra S, 2014, ONCOGENE, V33, P4097, DOI 10.1038/onc.2013.374; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tian M, 2009, FUTURE ONCOL, V5, P259, DOI 10.2217/14796694.5.2.259; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Yadav V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047796; Yin JJ, 2010, CANCER RES, V70, P8662, DOI 10.1158/0008-5472.CAN-10-1435; Yin JJ, 2007, MOL CELL BIOL, V27, P7538, DOI 10.1128/MCB.00955-07; Yu SN, 2010, CANCER RES, V70, P6015, DOI 10.1158/0008-5472.CAN-09-4531; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	36	67	71	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 3	2015	34	36					4767	4776		10.1038/onc.2014.414	http://dx.doi.org/10.1038/onc.2014.414			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CQ9JU	25531317				2022-12-26	WOS:000360931500010
J	Ghosh, S; Adhikary, A; Chakraborty, S; Bhattacharjee, P; Mazumder, M; Putatunda, S; Gorain, M; Chakraborty, A; Kundu, GC; Das, T; Sen, PC				Ghosh, Swatilekha; Adhikary, Arghya; Chakraborty, Supriya; Bhattacharjee, Pushpak; Mazumder, Minakshi; Putatunda, Salil; Gorain, Mahadeo; Chakraborty, Arijit; Kundu, Gopal C.; Das, Tanya; Sen, Parimal C.			Cross-talk between Endoplasmic Reticulum (ER) Stress and the MEK/ERK Pathway Potentiates Apoptosis in Human Triple Negative Breast Carcinoma Cells ROLE OF A DIHYDROPYRIMIDONE, NIFETEPIMINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; TFII-I; CANCER; GRP78; EXPRESSION; IDENTIFICATION; INVOLVEMENT; INDUCTION; PATTERNS; MELANOMA	Triple negative breast cancers (TNBC) are among the most aggressive and therapy-resistant breast tumors and currently possess almost no molecular targets for therapeutic options in this horizon. In the present study we discerned the molecular mechanisms of potential interaction between the endoplasmic reticulum (ER) stress response and the MEK/ERK pathway in inducing apoptosis in TNBC cells. Here we observed that induction of ER stress alone was not sufficient to trigger significant apoptosis but simultaneous inhibition of the MEK/ERK pathway enhanced ER stress-induced apoptosis via a caspase-dependent mechanism. Our study also demonstrated nifetepimine, a dihydropyrimidone derivative as a potent anti-cancer agent in TNBC cells. Nifetepimine down-regulated the MEK/ERK pathway in MDAMB-231 and MDAMB-468 cells and resulted in blockage of ER stress-mediated GRP78 up-regulation. Detailed mechanistic studies also revealed that nifetepimine by down-regulating pERK expression also declined the promoter binding activity of TFII-I to the GRP78 promoter and in turn regulated GRP78 transcription. Studies further extended to in vivo Swiss albino and SCID mice models also revalidated the anti-carcinogenic property of nifetepimine. Thus our findings cumulatively suggest that nifetepimine couples two distinct signaling pathways to induce the apoptotic death cascade in TNBC cells and raises the possibility for the use of nifetepimine as a potent anticancer agent with strong immune-restoring properties for therapeutic intervention for this group of cancer bearers.	[Ghosh, Swatilekha; Adhikary, Arghya; Chakraborty, Supriya; Bhattacharjee, Pushpak; Mazumder, Minakshi; Das, Tanya; Sen, Parimal C.] Calcutta Improvement Trust Scheme VII M, Bose Inst, Div Mol Med, Kolkata 700054, India; [Putatunda, Salil; Chakraborty, Arijit] Maulana Azad Coll, Dept Chem, Kolkata 700013, India; [Gorain, Mahadeo; Kundu, Gopal C.] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Das, T (corresponding author), Calcutta Improvement Trust Scheme VII M, Bose Inst, Div Mol Med, P-1-12, Kolkata 700054, India.	tanya@jcbose.ac.in; parimal@jcbose.ac.in	Putatunda, Salil/O-1172-2017; Kundu, Gopal C./ABA-9897-2020; Chakraborty, Supriya/GNP-4762-2022; Bhattacharjee, Pushpak/AFV-4590-2022; Chakraborty, Supriya/U-4306-2018	Putatunda, Salil/0000-0002-0244-3329; Chakraborty, Supriya/0000-0002-6517-0217; Chakraborty, Supriya/0000-0002-0800-5792	Department of Science and Technology; Council of Scientific and Industrial Research; Department of Atomic Energy; University Grants Commission, Government of India	Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Atomic Energy(Department of Atomic Energy (DAE)); University Grants Commission, Government of India(University Grants Commission, India)	This work was supported by the grants from Department of Science and Technology, Council of Scientific and Industrial Research, Department of Atomic Energy, and the University Grants Commission, Government of India.	Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Chaabane C, 2006, BIOCHEM BIOPH RES CO, V345, P1377, DOI 10.1016/j.bbrc.2006.05.054; Chacon RD, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2574; De Laurentiis M, 2010, CANCER TREAT REV, V36, pS80, DOI 10.1016/S0305-7372(10)70025-6; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Elias AD, 2010, AM J CLIN ONCOL-CANC, V33, P637, DOI 10.1097/COC.0b013e3181b8afcf; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Gazit G, 1999, BREAST CANCER RES TR, V54, P135, DOI 10.1023/A:1006102411439; Ghosh S, 2012, J BIOL CHEM, V287, P32881, DOI 10.1074/jbc.M112.357889; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hersey P, 2006, INT REV CYTOL, V251, P131, DOI 10.1016/S0074-7696(06)51004-6; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hong M, 2005, J BIOL CHEM, V280, P16821, DOI 10.1074/jbc.M413753200; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Kaufmann SH, 2003, ONCOGENE, V22, P7414, DOI 10.1038/sj.onc.1206945; Kim DW, 2000, MOL CELL BIOL, V20, P1140, DOI 10.1128/MCB.20.4.1140-1148.2000; Kim DW, 2001, MOL CELL BIOL, V21, P3387, DOI 10.1128/MCB.21.10.3387-3397.2000; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Mhaidat N., 2011, INT J BIOL BIOMED EN, V5, P41; Misra UK, 2009, J CELL BIOCHEM, V106, P381, DOI 10.1002/jcb.22016; Novina CD, 1998, J BIOL CHEM, V273, P33443, DOI 10.1074/jbc.273.50.33443; Parker R, 2001, MOL CELL BIOL, V21, P3220, DOI 10.1128/MCB.21.9.3220-3233.2001; Pootrakul L, 2006, CLIN CANCER RES, V12, P5987, DOI 10.1158/1078-0432.CCR-06-0133; Reed John C., 1999, Current Opinion in Oncology, V11, P68, DOI 10.1097/00001622-199901000-00014; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roy AL, 2001, GENE, V274, P1, DOI 10.1016/S0378-1119(01)00625-4; Roy AL, 2006, ACS CHEM BIOL, V1, P619, DOI 10.1021/cb6004323; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	42	23	24	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3936	3949		10.1074/jbc.M114.594028	http://dx.doi.org/10.1074/jbc.M114.594028			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25527500	Green Published, hybrid			2022-12-26	WOS:000349458400005
J	Wang, DL; Coco, MW; Rose, RB				Wang, Dongli; Coco, Matthew W.; Rose, Robert B.			Interactions with the Bifunctional Interface of the Transcriptional Coactivator DCoH1 Are Kinetically Regulated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE; PHENYLALANINE-HYDROXYLASE; PTERIN-4A-CARBINOLAMINE DEHYDRATASE; 4A-CARBINOLAMINE DEHYDRATASE; 3-DIMENSIONAL STRUCTURE; DIMERIZATION COFACTOR; STRUCTURAL BASIS; PCBD1 CAUSE; PROTEIN; GENE	Pterin-4a-carbinolamine dehydratase (PCD) is a highly conserved enzyme that evolved a second, unrelated function in mammals, as a transcriptional coactivator. As a coactivator, PCD is known as DCoH or dimerization cofactor of the transcription factor HNF-1. These two activities are associated with a change in oligomeric state: from two dimers interacting as an enzyme in the cytoplasm to a dimer interacting with a dimer of HNF-1 in the nucleus. The same interface of DCoH forms both complexes. To determine how DCoH partitions between its two functions, we studied the folding and stability of the DCoH homotetramer. We show that the DCoH1 homotetramer is kinetically trapped, meaning once it forms it will not dissociate to interact with HNF-1. In contrast, DCoH2, a paralog of DCoH1, unfolds within hours. A simple mutation in the interface of DCoH2 from Ser-51 to Thr, as found in DCoH1, increases the kinetic stability by 9 orders of magnitude, to tau(1/2) similar to 2 million years. This suggests that the DCoH1 similar to HNF-1 complex must co-fold to interact. We conclude that simple mutations can dramatically affect the dissociation kinetics of a complex. Residue 51 represents a "kinetic hot spot" instead of a "thermodynamic hot spot." Kinetic regulation allows PCD to adopt two distinct functions. Mutations in DCoH1 associated with diabetes affect both functions of DCoH1, perhaps by disrupting the balance between the two DCoH complexes.	[Wang, Dongli; Coco, Matthew W.; Rose, Robert B.] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Rose, RB (corresponding author), N Carolina State Univ, Dept Mol & Struct Biochem, 128 Polk Hall, Raleigh, NC 27695 USA.	bob_rose@ncsu.edu		Rose, Robert/0000-0001-9496-6671	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract Number W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY SW, 1993, ADV EXP MED BIOL, V338, P47; Bayle JH, 2002, J BIOL CHEM, V277, P28884, DOI 10.1074/jbc.M201983200; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; CITRON BA, 1992, P NATL ACAD SCI USA, V89, P11891, DOI 10.1073/pnas.89.24.11891; CITRON BA, 1993, AM J HUM GENET, V53, P768; CURTIUS HC, 1990, BIOCHEM BIOPH RES CO, V172, P1060, DOI 10.1016/0006-291X(90)91554-6; DAVIS MD, 1992, FEBS LETT, V302, P73, DOI 10.1016/0014-5793(92)80288-R; Depaepe V, 2000, MOL BRAIN RES, V75, P76, DOI 10.1016/S0169-328X(99)00297-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENDRIZZI JA, 1995, SCIENCE, V268, P556, DOI 10.1126/science.7725101; Ferre S, 2014, J AM SOC NEPHROL, V25, P574, DOI 10.1681/ASN.2013040337; FICNER R, 1995, EMBO J, V14, P2034, DOI 10.1002/j.1460-2075.1995.tb07195.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HAUER CR, 1993, J BIOL CHEM, V268, P4828; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; HUFTON SE, 1995, BIOCHEM J, V311, P353, DOI 10.1042/bj3110353; Johnen G, 1997, P NATL ACAD SCI USA, V94, P13469, DOI 10.1073/pnas.94.25.13469; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; KAUFMAN S, 1958, J BIOL CHEM, V230, P931; Kaufman S, 1995, Adv Enzymol Relat Areas Mol Biol, V70, P103; Kelch BA, 2007, J MOL BIOL, V370, P784, DOI 10.1016/j.jmb.2007.04.078; Lim S, 2002, J BIOL CHEM, V277, P25040, DOI 10.1074/jbc.M203257200; Longo N, 2009, J INHERIT METAB DIS, V32, P333, DOI 10.1007/s10545-009-1067-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; MILLA ME, 1994, BIOCHEMISTRY-US, V33, P1125, DOI 10.1021/bi00171a011; Mukaiyama A, 2009, INT J MOL SCI, V10, P1369, DOI 10.3390/ijms10031369; Naponelli V, 2008, PLANT PHYSIOL, V146, P1515, DOI 10.1104/pp.107.114090; REBRIN I, 1995, BIOCHEMISTRY-US, V34, P5801, DOI 10.1021/bi00017a011; Resibois A, 1999, HISTOCHEM CELL BIOL, V111, P381, DOI 10.1007/s004180050371; Rho H, 2010, BIOCHEMISTRY-US, V49, P10187, DOI 10.1021/bi1015056; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Rose RB, 2004, BIOCHEMISTRY-US, V43, P7345, DOI 10.1021/bi049620t; Rose RB, 2000, NAT STRUCT BIOL, V7, P744; Salimi NL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000689; Simaite D, 2014, DIABETES, V63, P3557, DOI 10.2337/db13-1784; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; Song J, 1999, J BACTERIOL, V181, P2789, DOI 10.1128/JB.181.9.2789-2796.1999; Strandmann EPV, 1998, INT J DEV BIOL, V42, P53; Tejero J, 2013, IUBMB LIFE, V65, P358, DOI 10.1002/iub.1136; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Thony B, 1998, AM J HUM GENET, V62, P1302, DOI 10.1086/301887; Truhlar SME, 2004, PROTEIN SCI, V13, P381, DOI 10.1110/ps.03336804; Walters J, 2009, METHOD ENZYMOL, V455, P1, DOI 10.1016/S0076-6879(08)04201-8; Wang L, 2002, BIOCHEMISTRY-US, V41, P12569, DOI 10.1021/bi026561f; Wang Q, 2006, MOL BIOCHEM PARASIT, V146, P109, DOI 10.1016/j.molbiopara.2005.11.002; Watschinger K, 2013, IUBMB LIFE, V65, P366, DOI 10.1002/iub.1143; Wheatley NM, 2014, J BIOL CHEM, V289, P7973, DOI 10.1074/jbc.M113.531236; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; ZHAO GS, 1994, P NATL ACAD SCI USA, V91, P1366, DOI 10.1073/pnas.91.4.1366	51	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4319	4329		10.1074/jbc.M114.616870	http://dx.doi.org/10.1074/jbc.M114.616870			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25538247	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000349458400041
J	Kalderon, B; Kogan, G; Bubis, E; Pines, O				Kalderon, Bella; Kogan, Gleb; Bubis, Ettel; Pines, Ophry			Cytosolic Hsp60 Can Modulate Proteasome Activity in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONIN PROTEIN HSP60; HEAT-SHOCK PROTEINS; BAX; EXPRESSION; SURVIVAL; CELLS; TUMOR; LOCALIZATION; CANCER; HEAT-SHOCK-PROTEIN-60	Hsp60, an essential oligomeric molecular mitochondrial chaperone, has been subject to rigorous basic and clinical research. With yeast as a model system, we provide evidence for the ability of cytosolic yHsp60 to inhibit the yeast proteasome. (i) Following biological turnover of murine Bax (a proteasome substrate), we show that co-expression of cytosolic yHsp60 stabilizes Bax, enhances its association with mitochondria, and enhances its killing capacity. (ii) Expression of yHsp60 in the yeast cytosol (yHsp60c) inhibits degradation of a cytosolic protein Delta MTS-Aco1 tagged with the degron SL17 (a ubiquitin-proteasome substrate). (iii) Conditions under which Hsp60 accumulates in the cytosol (elevated Hsp60c or growth at 37 degrees C) correlate with reduced 20 S peptidase activity in proteasomes purified from cell extracts. (iv) Elevated yHsp60 in the cytosol correlate with accumulation of polyubiquitinated proteins. (v) According to 20 S proteasome pulldown experiments, Hsp60 is physically associated with proteasomes in extracts of cells expressing Hsp60c or grown at 37 degrees C. Even mutant Hsp60 proteins, lacking chaperone activity, were still capable of proteasome inhibition. The results support the hypothesis that localization of Hsp60 to the cytosol may modulate proteasome activity according to cell need.	[Kalderon, Bella; Kogan, Gleb; Bubis, Ettel; Pines, Ophry] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Microbiol Mol Genet, IL-91120 Jerusalem, Israel; [Pines, Ophry] Natl Univ Singapore, CREATE NUS HUJ Program, Singapore 138602, Singapore	Hebrew University of Jerusalem; National University of Singapore	Pines, O (corresponding author), Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Microbiol Mol Genet, IL-91120 Jerusalem, Israel.	ophryp@ekmd.huji.ac.il	pines, ophry/C-4086-2011	pines, ophry/0000-0001-7126-2575	Israel Science Foundation (ISF); Morasha program of the ISF; USA-Israel Binational Science Foundation (BSF); CREATE project of the National Research Foundation of Singapore	Israel Science Foundation (ISF)(Israel Science Foundation); Morasha program of the ISF; USA-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); CREATE project of the National Research Foundation of Singapore(National Research Foundation, Singapore)	This work was supported by grants from the Israel Science Foundation (ISF), The Morasha program of the ISF and The USA-Israel Binational Science Foundation (BSF), and the CREATE project of the National Research Foundation of Singapore.	Ang K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001290; Arlow T, 2013, P NATL ACAD SCI USA, V110, P246, DOI 10.1073/pnas.1215510110; Ben-Menachem R, 2011, J MOL BIOL, V409, P113, DOI 10.1016/j.jmb.2011.03.045; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Cappello F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-139; Castagna A, 2004, PROTEOMICS, V4, P3246, DOI 10.1002/pmic.200400835; Castle PE, 2005, CANCER LETT, V229, P245, DOI 10.1016/j.canlet.2005.06.045; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chen D, 2010, CURR PROTEIN PEPT SC, V11, P459, DOI 10.2174/138920310791824057; Chun JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009422; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Cornford PA, 2000, CANCER RES, V60, P7099; DJABALLAH H, 1993, BIOCHEM J, V292, P857, DOI 10.1042/bj2920857; Emter R, 2002, FEBS LETT, V521, P57, DOI 10.1016/S0014-5793(02)02818-1; Faried A, 2004, EUR J CANCER, V40, P2804, DOI 10.1016/j.ejca.2004.08.013; Feng HP, 2002, BLOOD, V100, P4108, DOI 10.1182/blood-2002-05-1389; Ghosh JC, 2008, J BIOL CHEM, V283, P5188, DOI 10.1074/jbc.M705904200; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Gross A, 2000, MOL CELL BIOL, V20, P3125, DOI 10.1128/MCB.20.9.3125-3136.2000; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Gupta S, 2002, CIRCULATION, V106, P2727, DOI 10.1161/01.CIR.0000038112.64503.6E; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Hayoun D, 2012, FEBS J, V279, P2083, DOI 10.1111/j.1742-4658.2012.08594.x; Hsu PL, 1998, CANCER RES, V58, P5507; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Jurgensmeier JM, 1997, MOL BIOL CELL, V8, P325; Kalderon Bella, 2014, Front Mol Biosci, V1, P23, DOI 10.3389/fmolb.2014.00023; Karniely S, 2006, EXP CELL RES, V312, P3835, DOI 10.1016/j.yexcr.2006.08.021; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Ligr M, 1998, FEBS LETT, V438, P61, DOI 10.1016/S0014-5793(98)01227-7; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Piselli P, 2000, ANTICANCER RES, V20, P825; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Sass E, 2003, J BIOL CHEM, V278, P45109, DOI 10.1074/jbc.M302344200; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Schneider J, 1999, ANTICANCER RES, V19, P2141; Shamaei-Tousi A, 2007, CELL STRESS CHAPERON, V12, P384, DOI 10.1379/CSC-300.1; Shlevin L, 2007, TRAFFIC, V8, P169, DOI 10.1111/j.1600-0854.2006.00518.x; Soltys BJ, 1997, CELL BIOL INT, V21, P315, DOI 10.1006/cbir.1997.0144; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Tsai YP, 2009, CARCINOGENESIS, V30, P1049, DOI 10.1093/carcin/bgp087; WEISS C, 1995, J BIOL CHEM, V270, P13956, DOI 10.1074/jbc.270.23.13956; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Zha HB, 1996, MOL CELL BIOL, V16, P6494	47	18	18	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3542	3551		10.1074/jbc.M114.626622	http://dx.doi.org/10.1074/jbc.M114.626622			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525272	hybrid, Green Published			2022-12-26	WOS:000349456000028
J	Kara, I; Poggi, M; Bonardo, B; Govers, R; Landrier, JF; Tian, S; Leibiger, I; Day, R; Creemers, JWM; Peiretti, F				Kara, Imene; Poggi, Marjorie; Bonardo, Bernadette; Govers, Roland; Landrier, Jean-Francois; Tian, Sun; Leibiger, Ingo; Day, Robert; Creemers, John W. M.; Peiretti, Franck			The Paired Basic Amino Acid-cleaving Enzyme 4 (PACE4) Is Involved in the Maturation of Insulin Receptor Isoform B AN OPPORTUNITY TO REDUCE THE SPECIFIC INSULIN RECEPTOR-DEPENDENT EFFECTS OF INSULIN-LIKE GROWTH FACTOR 2 (IGF2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Furin; Insulin; Insulin Receptor; Insulin-like Growth Factor (IGF); Metabolic Signaling; Mitogenic Signaling; Proprotein Convertase	HAMSTER OVARY CELLS; PROPROTEIN CONVERTASES; CANCER-CELLS; FUNCTIONAL-PROPERTIES; LIGAND-BINDING; CLEAVAGE SITE; FURIN; PRORECEPTOR; ACTIVATION; INHIBITOR	Background: The insulin receptor exists as two isoforms: IRA and IRB. Results: IRA and IRB are similarly matured by furin, but when furin activity is reduced, IRB is matured by PACE4. Conclusion: Proprotein convertase inhibition can selectively reduce IRA maturation and its signaling. Significance: This can be considered as a new opportunity to target IRA signaling in cancer. Gaining the full activity of the insulin receptor (IR) requires the proteolytic cleavage of its proform by intra-Golgi furin-like activity. In mammalian cells, IR is expressed as two isoforms (IRB and IRA) that are responsible for insulin action. However, only IRA transmits the growth-promoting and mitogenic effects of insulin-like growth factor 2. Here we demonstrate that the two IR isoforms are similarly cleaved by furin, but when this furin-dependent maturation is inefficient, IR proforms move to the cell surface where the proprotein convertase PACE4 selectively supports IRB maturation. Therefore, in situations of impaired furin activity, the proteolytic maturation of IRB is greater than that of IRA, and accordingly, the amount of phosphorylated IRB is also greater than that of IRA. We highlight the ability of a particular proprotein convertase inhibitor to effectively reduce the maturation of IRA and its associated mitogenic signaling without altering the signals emanating from IRB. In conclusion, the selective PACE4-dependent maturation of IRB occurs when furin activity is reduced; accordingly, the pharmacological inhibition of furin reduces IRA maturation and its mitogenic potential without altering the insulin effects.	[Kara, Imene; Poggi, Marjorie; Bonardo, Bernadette; Govers, Roland; Landrier, Jean-Francois; Peiretti, Franck] Aix Marseille Univ, Fac Med, INSERM 1062, INRA 1260, F-13385 Marseille 05, France; [Tian, Sun] Nuolan Net 1098, Amsterdam, Netherlands; [Leibiger, Ingo] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17176 Stockholm, Sweden; [Day, Robert] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Dept Chirur Urol, Fac Med & Sci Sante, Sherbrooke, PQ J1H 5N4, Canada; [Creemers, John W. M.] Katholieke Univ Leuven, Biochem Neuroendocrinol Lab, Ctr Human Genet, B-3000 Leuven, Belgium	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Karolinska Institutet; University of Sherbrooke; KU Leuven	Peiretti, F (corresponding author), Aix Marseille Univ, Fac Med, INSERM 1062, INRA 1260, 27 Blvd Jean Moulin, F-13385 Marseille 05, France.	franck.peiretti@univ-amu.fr	Govers, Roland/O-5782-2016; Landrier, Jean-Francois/AAH-2757-2019; Peiretti, Franck/GLV-3378-2022; poggi, marjorie/ABG-6438-2021; peiretti, franck/L-2718-2017	Govers, Roland/0000-0003-1359-5333; Landrier, Jean-Francois/0000-0002-8690-8014; Peiretti, Franck/0000-0001-7198-0534; poggi, marjorie/0000-0001-6331-9682; peiretti, franck/0000-0001-7198-0534; Tian, Sun/0000-0002-0133-4454	INSERM; INRA; Aix-Marseille Universite; Ministere de la Recherche et de l'Enseignement Superieur; Prostate Cancer Canada [D2013-8, 2012-951, TAG2014-02]; Canadian Cancer Society Research Institute [701590]; Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; Aix-Marseille Universite; Ministere de la Recherche et de l'Enseignement Superieur; Prostate Cancer Canada; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen(FWO)	This work was supported by INSERM, INRA, and Aix-Marseille Universite.; Recipient of a grant from the Ministere de la Recherche et de l'Enseignement Superieur.; Supported by Prostate Cancer Canada Grants D2013-8, 2012-951, and TAG2014-02 and Canadian Cancer Society Research Institute Grant 701590.; Supported by Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen.	Auzan C, 1997, MOL CELL ENDOCRINOL, V128, P129, DOI 10.1016/S0303-7207(97)04024-0; Basak A, 2010, CURR MED CHEM, V17, P2214, DOI 10.2174/092986710791331040; Bass J, 2000, P NATL ACAD SCI USA, V97, P11905, DOI 10.1073/pnas.97.22.11905; Bassi DE, 2001, P NATL ACAD SCI USA, V98, P10326, DOI 10.1073/pnas.191199198; Becker GL, 2011, BIOORG MED CHEM LETT, V21, P4695, DOI 10.1016/j.bmcl.2011.06.091; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Bernot D, 2011, J CELL SCI, V124, P1224, DOI 10.1242/jcs.079889; Bernot D, 2010, J BIOL CHEM, V285, P6508, DOI 10.1074/jbc.M109.078444; BRAVO DA, 1994, J BIOL CHEM, V269, P25830; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; Creemers JWM, 2006, ENDOCRINOLOGY, V147, P1621, DOI 10.1210/en.2005-1373; DARDEVET D, 1991, AM J PHYSIOL, V261, pE562, DOI 10.1152/ajpendo.1991.261.5.E562; Dufour EK, 2005, PROTEIN SCI, V14, P303, DOI 10.1110/ps.04843305; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; Essalmani R, 2013, J BIOL CHEM, V288, P26410, DOI 10.1074/jbc.M113.501304; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Govers Roland, 2008, V440, P129, DOI 10.1007/978-1-59745-178-9_10; HEDO JA, 1983, J BIOL CHEM, V258, P20; Hubbard SR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008946; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; KOBAYASHI M, 1988, DIABETES, V37, P653, DOI 10.2337/diabetes.37.5.653; Lalou C, 2013, CURR MED CHEM, V20, P583; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Levesque C, 2012, J MED CHEM, V55, P10501, DOI 10.1021/jm3011178; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; PASHMFOROUSH M, 1994, J BIOL CHEM, V269, P32639; Peiretti F, 2003, EXP CELL RES, V285, P278, DOI 10.1016/S0014-4827(03)00052-1; ROBERTSON BJ, 1993, J BIOL CHEM, V268, P24274; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; SALZMAN A, 1984, BIOCHEMISTRY-US, V23, P6555, DOI 10.1021/bi00321a043; SASAOKA T, 1989, DIABETOLOGIA, V32, P371, DOI 10.1007/BF00277261; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; Sucic JF, 1999, BIOCHEM J, V339, P639, DOI 10.1042/0264-6021:3390639; Tian S, 2009, BIOCHEM INSIGHTS, V2, P9, DOI 10.4137/BCI.S2049; Tian S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00261; Tsuji A, 2003, BBA-PROTEINS PROTEOM, V1645, P95, DOI 10.1016/S1570-9639(02)00532-0; Uhles S, 2003, J CELL BIOL, V163, P1327, DOI 10.1083/jcb.200306093; Uhles S, 2007, FASEB J, V21, P1609, DOI 10.1096/fj.06-7589com; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Vidal N, 2012, BIOCHIMIE, V94, P2569, DOI 10.1016/j.biochi.2012.07.006; VOGT B, 1991, BIOCHEM BIOPH RES CO, V177, P1013, DOI 10.1016/0006-291X(91)90639-O; YAMAGUCHI Y, 1991, ENDOCRINOLOGY, V129, P2058, DOI 10.1210/endo-129-4-2058; YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132; YOSHIMASA Y, 1988, SCIENCE, V240, P784, DOI 10.1126/science.3283938; YOSHIMASA Y, 1990, J BIOL CHEM, V265, P17230	51	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2812	2821		10.1074/jbc.M114.592543	http://dx.doi.org/10.1074/jbc.M114.592543			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25527501	Green Published, hybrid			2022-12-26	WOS:000349310700022
J	Ao, MX; Li, XM; Huang, C; Hou, ZQ; Qiu, WQ; Wang, W				Ao, Mingxin; Li, Xuemin; Huang, Chen; Hou, Zhiqiang; Qiu, Weiqiang; Wang, Wei			Significant Improvement in Dynamic Visual Acuity after Cataract Surgery: A Promising Potential Parameter for Functional Vision	PLOS ONE			English	Article							CONTRAST SENSITIVITY; MOTION PERCEPTION; PERFORMANCE; SYSTEM; AGE; ORGANIZATION; PATHWAYS; GLAUCOMA; DRIVERS	Purpose: Dynamic visual acuity (DVA) is a relatively independent parameter for evaluating the ability to distinguish details of a moving target. The present study has been designed to discuss the extent to which age-related cataract impacts DVA in elderly individuals and to determine whether it could be restored after bilateral phacoemulsification combined with intraocular lens implantation surgery. Methods: Twenty-six elderly cataract patients scheduled for binocular cataract surgery and 30 elderly volunteers without cataract were enrolled in the study. DVA at 15, 30, 60 and 90 degree per second (dps) was assessed, and velocity-dependent visual acuity decreases between consecutive speed levels were calculated. Results: Compared with the control group, the patient group exhibited significantly worse DVA performance at all speed levels (p<0.001), and the decreases in velocity-dependent visual acuity were more serious in the patient group at the intervals of 0-15 dps (p<0.001), 15-30 dps (p=0.007) and 30-60 dps (p=0.008). Postoperatively, DVA performance at every speed level in the patient group clearly improved (p<0.001) and recovered to levels compatible to the control group. The decrease in visual acuity with increasing speed was less pronounced than during the preoperative phase (p(0-15 dps)=0.001, p(15-30) (dps) <0.001 and p(30-60) (dps)=0.001) and became similar to that of the control group. The postoperative visual benefit regarding DVA was more pronounced than the improvement in static visual acuity (p(15 dps)=0.001 and p<0.001 at 30 dps, 60 dps and 90 dps). Conclusions: The impact of age-related cataract on DVA was more severe than its effects on static visual acuity. After cataract surgery, not only static vision of the	[Ao, Mingxin; Li, Xuemin; Hou, Zhiqiang; Qiu, Weiqiang; Wang, Wei] Peking Univ, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China; [Ao, Mingxin; Li, Xuemin; Hou, Zhiqiang; Qiu, Weiqiang; Wang, Wei] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Huang, Chen] Peking Univ, Hosp 3, Med Res Ctr, Beijing 100871, Peoples R China	Peking University; Peking University	Wang, W (corresponding author), Peking Univ, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China.	puh3_ww@bjmu.edu.cn		Hou, Zhiqiang/0000-0001-5638-6553	Academic Award for Excellent Doctorial Candidates of the Ministry of Education of China	Academic Award for Excellent Doctorial Candidates of the Ministry of Education of China	The research has been supported by Academic Award for Excellent Doctorial Candidates of the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertone A, 2011, NEUROREPORT, V22, P951, DOI 10.1097/WNR.0b013e32834d2f49; BURG A, 1966, J APPL PSYCHOL, V50, P460, DOI 10.1037/h0023982; CAMPBELL FW, 1978, VISION RES, V18, P1297, DOI 10.1016/0042-6989(78)90219-5; Castelo-Branco M, 2004, INVEST OPHTH VIS SCI, V45, P499, DOI 10.1167/iovs.03-0815; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Committee on Vision of the National Research Council (US), 1985, EM TECHN ASS VIS PER; Erickson GB, 2011, OPTOMETRY, V82, P528, DOI 10.1016/j.optm.2011.01.012; GEER I, 1993, OPTOMETRY VISION SCI, V70, P552, DOI 10.1097/00006324-199307000-00006; GILMORE GC, 1992, PSYCHOL AGING, V7, P654, DOI 10.1037/0882-7974.7.4.654; Hendry SHC, 1998, TRENDS NEUROSCI, V21, P344, DOI 10.1016/S0166-2236(98)01245-4; HOFFMAN LG, 1981, J AM OPTOM ASSOC, V52, P883; ISHIGAKI H, 1994, PERCEPT MOTOR SKILL, V78, P363, DOI 10.2466/pms.1994.78.2.363; Lewis P, 2011, VISION RES, V51, P1829, DOI 10.1016/j.visres.2011.06.011; LONG GM, 1990, PSYCHOL AGING, V5, P138, DOI 10.1037/0882-7974.5.1.138; LONG GM, 1992, OPTOMETRY VISION SCI, V69, P915, DOI 10.1097/00006324-199212000-00001; Mateus C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055348; McGregor LN, 2005, HUM FACTORS, V47, P469, DOI 10.1518/001872005774859953; McKendrick AM, 2007, INVEST OPHTH VIS SCI, V48, P2115, DOI 10.1167/iovs.06-1208; Owsley C, 2011, VISION RES, V51, P1610, DOI 10.1016/j.visres.2010.10.020; Patel I, 2006, INVEST OPHTH VIS SCI, V47, P65, DOI 10.1167/iovs.05-0582; Pilz KS, 2010, VISION RES, V50, P211, DOI 10.1016/j.visres.2009.11.014; Rouse M W, 1988, J Am Optom Assoc, V59, P946; Schneck Marilyn E, 2003, Ophthalmol Clin North Am, V16, P269, DOI 10.1016/S0896-1549(03)00008-7; Schneiders AG, 2010, PHYS THER SPORT, V11, P47, DOI 10.1016/j.ptsp.2010.01.001; SHINAR D, 1991, HUM FACTORS, V33, P507, DOI 10.1177/001872089103300503; Smither JAA, 2010, APPL ERGON, V41, P266, DOI 10.1016/j.apergo.2009.07.008; Spering M, 2011, VISION RES, V51, P836, DOI 10.1016/j.visres.2010.10.017; THYLEFORS B, 1990, INT OPHTHALMOL, V14, P211, DOI 10.1007/BF00158321; Uchida Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031530; Watson TL, 2009, CURR BIOL, V19, P1040, DOI 10.1016/j.cub.2009.04.052; Wilkins L, 2013, INVEST OPHTH VIS SCI, V54, P8364, DOI 10.1167/iovs.13-12774; Wood JM, 2002, HUM FACTORS, V44, P482, DOI 10.1518/0018720024497664	32	13	14	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115812	10.1371/journal.pone.0115812	http://dx.doi.org/10.1371/journal.pone.0115812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541959	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900092
J	dos Santos, IC; de Almeida, AAF; Anhert, D; da Conceicao, AS; Pirovani, CP; Pires, JL; Valle, RR; Baligar, VC				dos Santos, Ivanildes C.; de Almeida, Alex-Alan Furtado; Anhert, Dario; da Conceicao, Alessandro S.; Pirovani, Carlos P.; Pires, Jose L.; Valle, Raul Rene; Baligar, Virupax C.			Molecular, Physiological and Biochemical Responses of Theobroma cacao L. Genotypes to Soil Water Deficit	PLOS ONE			English	Article							2 CONTRASTING POPULATIONS; OXIDATIVE STRESS; DROUGHT-STRESS; ADAPTIVE RESPONSES; GROWTH-RESPONSES; GENE-EXPRESSION; LEAF-AREA; PLANTS; CLONES; PHOTOSYNTHESIS	Six months-old seminal plants of 36 cacao genotypes grown under greenhouse conditions were subjected to two soil water regimes (control and drought) to assess, the effects of water deficit on growth, chemical composition and oxidative stress. In the control, soil moisture was maintained near field capacity with leaf water potentials (Psi WL) ranging from -0.1 to -0.5 MPa. In the drought treatment, the soil moisture was reduced gradually by withholding additional water until Psi WL reached values of between -2.0 to -2.5 MPa. The tolerant genotypes PS-1319, MO-20 and MA-15 recorded significant increases in guaiacol peroxidase activity reflecting a more efficient antioxidant metabolism. In relation to drought tolerance, the most important variables in the distinguishing contrasting groups were: total leaf area per plant; leaf, stem and total dry biomass; relative growth rate; plant shoot biomass and leaf content of N, Ca, and Mg. From the results of these analyses, six genotypes were selected with contrasting characteristics for tolerance to soil water deficit [CC-40, C. SUL-4 and SIC-2 (non-tolerant) and MA-15, MO-20, and PA-13 (tolerant)] for further assessment of the expression of genes NCED5, PP2C, psbA and psbO to water deficit. Increased expression of NCED5, PP2C, psbA and psbO genes were found for non-tolerant genotypes, while in the majority of tolerant genotypes there was repression of these genes, with the exception of PA-13 that showed an increased expression of psbA. Mutivariate analysis showed that growth variables, leaf and total dry biomass, relative growth rate as well as Mg content of the leaves were the most important factor in the classification of the genotypes as tolerant, moderately tolerant and sensitive to water deficit. Therefore these variables are reliable plant traits in the selection of plants tolerant to drought.	[dos Santos, Ivanildes C.; de Almeida, Alex-Alan Furtado; Anhert, Dario; da Conceicao, Alessandro S.; Pirovani, Carlos P.] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil; [Pires, Jose L.; Valle, Raul Rene] Comissao Execut Plano Lavoura Cacaueira CEPEC CEP, Ctr Pesquisas Cacau, BR-45650000 Ilheus, BA, Brazil; [Baligar, Virupax C.] ARS, USDA, Beltsville, MD 20705 USA	Universidade Estadual de Santa Cruz; United States Department of Agriculture (USDA)	de Almeida, AAF (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Campus Soane Nazare de Andrade,Rod Jorge Amado, Ilheus, BA, Brazil.	alexalan@uesc.br	Pirovani, Carlos P/J-3426-2017; Pirovani, Carlos Priminho/N-1153-2019	Pirovani, Carlos P/0000-0002-6176-4069; Pirovani, Carlos Priminho/0000-0002-6176-4069				Alvim P. D. T., 1977, ECOPHYSIOLOGY TROPIC, P279; Anjum SA, 2011, AFR J AGR RES, V6, P2026; [Anonymous], 1997, MAN MET AN SOL; Arend M, 2011, TREE PHYSIOL, V31, P287, DOI 10.1093/treephys/tpr004; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Bae H, 2008, PLANT PHYSIOL BIOCH, V46, P174, DOI 10.1016/j.plaphy.2007.10.014; Bagci SA, 2007, J AGRON CROP SCI, V193, P198, DOI 10.1111/j.1439-037X.2007.00256.x; BALASIMHA D, 1988, 10TH INTERNATIONAL COCOA RESEARCH CONFERENCE, P215; Bargali K, 2004, J ARID ENVIRON, V58, P505, DOI 10.1016/j.jaridenv.2004.01.002; Bartley BGD, 2005, GENETIC DIVERSITY OF CACAO AND ITS UTILIZATION: BOTANY, PRODUCTION AND USES, P1, DOI 10.1079/9780851996196.0000; Bruck H, 2000, CROP SCI, V40, P120, DOI 10.2135/cropsci2000.401120x; Burman U, 2009, J PLANT NUTR, V32, P668, DOI 10.1080/01904160802715620; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Chao YY, 2012, PLANT GROWTH REGUL, V66, P1, DOI 10.1007/s10725-011-9623-9; Cheesman E. E., 1944, TROP AGRIC [TRINIDAD], V21, P144; Christmann A, 2006, PLANT BIOLOGY, V8, P314, DOI 10.1055/s-2006-924120; CHRISTOPHER DA, 1994, PLANT PHYSIOL, V104, P1119, DOI 10.1104/pp.104.4.1119; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P83, DOI 10.1590/S1677-04202007000200001; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Ding Y, 2006, ANN APPL BIOL, V149, P111, DOI 10.1111/j.1744-7348.2006.00080.x; Frey A, 2012, PLANT J, V70, P501, DOI 10.1111/j.1365-313X.2011.04887.x; GASPAR T, 1985, PHYSIOL PLANTARUM, V64, P418, DOI 10.1111/j.1399-3054.1985.tb03362.x; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Giardi MT, 1996, PLANTA, V199, P118, DOI 10.1007/BF00196888; Gill SS, 2010, PLANT SIGNAL BEHAV, V5, P26, DOI 10.4161/psb.5.1.10291; Guo XY, 2010, J PLANT ECOL, V3, P79, DOI 10.1093/jpe/rtq007; Hansch R, 2009, CURR OPIN PLANT BIOL, V12, P259, DOI 10.1016/j.pbi.2009.05.006; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hermans C, 2010, NEW PHYTOL, V187, P132, DOI 10.1111/j.1469-8137.2010.03257.x; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; Hunt R., 1990, BASIC GROWTH ANAL, DOI [10.1007/978-94-010-9117-6, DOI 10.1007/978-94-010-9117-6]; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Jolly WM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023252; JOLY RJ, 1989, ANN BOT-LONDON, V64, P1; Jones J.B., 1991, PLANT ANAL HDB PRACT; Jouili H, 2003, CR BIOL, V326, P639, DOI 10.1016/S1631-0691(03)00157-4; Jubany-Mari T, 2010, PLANT PHYSIOL BIOCH, V48, P351, DOI 10.1016/j.plaphy.2010.01.021; Khanna-Chopra R, 2012, PROTOPLASMA, V249, P469, DOI 10.1007/s00709-011-0308-z; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; Landhausser SM, 1996, CAN J BOT, V74, P686, DOI 10.1139/b96-087; Lee BR, 2007, J EXP BOT, V58, P1271, DOI 10.1093/jxb/erl280; Lei YB, 2006, PHYSIOL PLANTARUM, V127, P182, DOI 10.1111/j.1399-3054.2006.00638.x; Li CY, 2003, FOREST ECOL MANAG, V179, P377, DOI 10.1016/S0378-1127(02)00552-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch JP, 2004, FIELD CROP RES, V90, P101, DOI 10.1016/j.fcr.2004.07.008; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; Marron N, 2003, TREE PHYSIOL, V23, P1225, DOI 10.1093/treephys/23.18.1225; MARTINS DV, 1976, THESIS U FEDERAL BAH; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Motamayor JC, 2002, HEREDITY, V89, P380, DOI 10.1038/sj.hdy.6800156; Munoz F, 2001, AGROFOREST SYST, V51, P119, DOI 10.1023/A:1010651203815; Murakami R, 2005, FEBS J, V272, P2165, DOI 10.1111/j.1742-4658.2005.04636.x; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Nepomuceno AL, 2000, PESQUI AGROPECU BRAS, V35, P1407, DOI 10.1590/S0100-204X2000000700015; Pawlowicz I, 2012, ACTA PHYSIOL PLANT, V34, P1915, DOI 10.1007/s11738-012-0992-0; Peuke AD, 2011, TREE PHYSIOL, V31, P196, DOI 10.1093/treephys/tpr007; Pirovani CP, 2008, ELECTROPHORESIS, V29, P2391, DOI 10.1002/elps.200700743; RADFORD PJ, 1967, CROP SCI, V7, P171, DOI 10.2135/cropsci1967.0011183X000700030001x; Rascher U, 2004, PLANT CELL ENVIRON, V27, P1239, DOI 10.1111/j.1365-3040.2004.01231.x; Regier N, 2009, PLANT CELL ENVIRON, V32, P1724, DOI 10.1111/j.1365-3040.2009.02030.x; Rehem BC, 2011, PHOTOSYNTHETICA, V49, P127, DOI 10.1007/s11099-011-0021-3; RICHARDS F. J, 1969, PLANT PHYSL TREATISE, V5A, P3; Rivero RM, 2001, PLANT SCI, V160, P315, DOI 10.1016/S0168-9452(00)00395-2; Rucker K. S., 1995, Peanut Science, V22, P14, DOI 10.3146/pnut.22.1.0003; Ruiz JM, 1998, PHYTOCHEMISTRY, V48, P269, DOI 10.1016/S0031-9422(97)01132-1; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Sanchez-Diaz M, 2007, TREE PHYSIOL, V27, P1415, DOI 10.1093/treephys/27.10.1415; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Seo M, 2004, PLANT CELL PHYSIOL, V45, P1694, DOI 10.1093/pcp/pch198; Silva W. S. da, 1998, Agrotropica, V10, P31; Souza Júnior José Olimpio de, 2008, Rev. Bras. Ciênc. Solo, V32, P2367; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Tschaplinski TJ, 1998, TREE PHYSIOL, V18, P653; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P525, DOI 10.4161/psb.3.8.6186; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Vanderauwera S, 2005, PLANT PHYSIOL, V139, P806, DOI 10.1104/pp.105.065896; Wang Y, 2010, MOL PLANT, V3, P280, DOI 10.1093/mp/ssq006; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Wilkinson S, 2002, PLANT CELL ENVIRON, V25, P195, DOI 10.1046/j.0016-8025.2001.00824.x; Xiao XW, 2008, SILVA FENN, V42, P705, DOI 10.14214/sf.224; Yang YQ, 2005, PHYSIOL PLANTARUM, V124, P431, DOI 10.1111/j.1399-3054.2005.00517.x; Yin CY, 2005, ENVIRON EXP BOT, V53, P315, DOI 10.1016/j.envexpbot.2004.04.007; Zobel RW, 2007, PLANT SOIL, V297, P243, DOI 10.1007/s11104-007-9341-2	88	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115746	10.1371/journal.pone.0115746	http://dx.doi.org/10.1371/journal.pone.0115746			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541723	gold, Green Submitted, Green Published			2022-12-26	WOS:000347239900076
J	Patel, P; Brooks, C; Seneviratne, A; Hess, DA; Seguin, CA				Patel, Priya; Brooks, Courtney; Seneviratne, Ayesh; Hess, David A.; Seguin, Cheryle A.			Investigating Microenvironmental Regulation of Human Chordoma Cell Behaviour	PLOS ONE			English	Article							TISSUE-GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; NUCLEUS PULPOSUS CELLS; CANCER STEM-CELLS; MOUSE IMPLICATIONS; PROGENITOR CELLS; HYPOXIA; EXPRESSION; HIF-1-ALPHA; MIGRATION	The tumour microenvironment is complex and composed of many different constituents, including matricellular proteins such as connective tissue growth factor (CCN2), and is characterized by gradients in oxygen levels. In various cancers, hypoxia and CCN2 promote stem and progenitor cell properties, and regulate the proliferation, migration and phenotype of cancer cells. Our study was aimed at investigating the effects of hypoxia and CCN2 on chordoma cells, using the human U-CH1 cell line. We demonstrate that under basal conditions, U-CH1 cells express multiple CCN family members including CCN1, CCN2, CCN3 and CCN5. Culture of U-CH1 cells in either hypoxia or in the presence of recombinant CCN2 peptide promoted progenitor cell-like characteristics specific to the notochordal tissue of origin. Specifically, hypoxia induced the most robust increase in progenitor-like characteristics in U-CH1 cells, including increased expression of the notochord-associated markers T, CD24, FOXA1, ACAN and CA12, increased cell growth and tumour-sphere formation, and a decrease in the percentage of vacuolated cells present in the heterogeneous population. Interestingly, the effects of recombinant CCN2 peptide on U-CH1 cells were more pronounced under normoxia than hypoxia, promoting increased expression of CCN1, CCN2, CCN3 and CCN5, the notochord-associated markers SOX5, SOX6, T, CD24, and FOXA1 as well as increased tumour-sphere formation. Overall, this study highlights the importance of multiple factors within the tumour microenvironment and how hypoxia and CCN2 may regulate human chordoma cell behaviour.	[Patel, Priya] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada; [Brooks, Courtney; Seneviratne, Ayesh; Hess, David A.; Seguin, Cheryle A.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada; [Seneviratne, Ayesh; Hess, David A.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Seguin, CA (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada.	cheryle.seguin@schulich.uwo.ca	Seguin, Cheryle A/G-4511-2013; Hess, David A/M-2828-2013	Seguin, Cheryle/0000-0001-6503-9107	seed grant from the Chordoma Foundation; Arthritis Society/Canadian Arthritis Network Scholar award; CIHR Banting and Best Canada MSc Scholarship; Ontario Graduate Scholarship	seed grant from the Chordoma Foundation; Arthritis Society/Canadian Arthritis Network Scholar award; CIHR Banting and Best Canada MSc Scholarship; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was funded by a seed grant from the Chordoma Foundation www.chordomafoundation.org (awarded to CAS). CAS was supported by The Arthritis Society/Canadian Arthritis Network Scholar award. PP was supported by CIHR Banting and Best Canada MSc Scholarship and Ontario Graduate Scholarship. AS was supported by an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2013, J SPINAL DISORD TECH, V26, pE86, DOI 10.1097/BSD.0b013e31826e0ca4; Aydemir E, 2012, J NEUROSURG, V116, P810, DOI 10.3171/2011.12.JNS11430; Barrionuevo F, 2006, DEV BIOL, V295, P128, DOI 10.1016/j.ydbio.2006.03.014; Bedore J, 2013, ARTHRITIS RHEUM-US, V65, P2634, DOI 10.1002/art.38075; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; BJORNSSON J, 1993, CANCER-AM CANCER SOC, V71, P735, DOI 10.1002/1097-0142(19930201)71:3<735::AID-CNCR2820710314>3.0.CO;2-8; Bruederlein Silke, 2010, Sarcoma, V2010, P630129, DOI 10.1155/2010/630129; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen PC, 2013, CARCINOGENESIS, V34, P1669, DOI 10.1093/carcin/bgt103; Cheng S, 2014, TUMOUR BIOL; Chien W, 2013, INT J ONCOL, V38, P1741; Chiou MJ, 2006, BIOCHEM BIOPH RES CO, V349, P750, DOI 10.1016/j.bbrc.2006.08.095; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Chong HC, 2012, J ONCOL, V2012, DOI 10.1155/2012/351089; Dhar G, 2007, CANCER LETT, V254, P63, DOI 10.1016/j.canlet.2007.02.012; El-Heliebi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087663; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Erwin WM, 2006, ARTHRITIS RHEUM-US, V54, P3859, DOI 10.1002/art.22258; Franzen CA, 2009, MOL CANCER RES, V7, P1045, DOI 10.1158/1541-7786.MCR-09-0017; Fritah A, 2008, MOL CELL BIOL, V28, P1114, DOI 10.1128/MCB.01335-07; Fujikuni N, 2014, CANC SCI; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004; Hirschfeld M, 2009, CANCER RES, V69, P2082, DOI 10.1158/0008-5472.CAN-08-1997; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hongo K, 2013, J SURG RES, V182, P75, DOI 10.1016/j.jss.2012.08.034; Ji ZG, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-158; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Li PC, 2013, INT J MED SCI, V10, P399, DOI 10.7150/ijms.5407; Li XX, 2012, ONCOL LETT, V3, P1268, DOI 10.3892/ol.2012.645; Liang DM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-201; Maier JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055528; Mamede A C, 2013, ISRN Oncol, V2013, P918207, DOI 10.1155/2013/918207; McCann MR, 2012, DIS MODEL MECH, V5, P73, DOI 10.1242/dmm.008128; McKeown SR, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130676; McMaster ML, 2001, CANCER CAUSE CONTROL, V12, P1, DOI 10.1023/A:1008947301735; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Nelson AC, 2012, J PATHOL, V228, P274, DOI 10.1002/path.4082; Nishida T, 2009, BONE, V44, P24, DOI 10.1016/j.bone.2008.08.125; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ostroumov E, 2007, SPINE, V32, P2957, DOI 10.1097/BRS.0b013e31815cde91; Park SA, 2008, CLIN NUCL MED, V33, P906, DOI 10.1097/RLU.0b013e31818c4e88; Planque N, 2006, J CELL BIOCHEM, V99, P105, DOI 10.1002/jcb.20887; Presneau N, 2011, J PATHOL, V223, P327, DOI 10.1002/path.2816; Putman DM, 2012, STEM CELLS, V30, P2248, DOI 10.1002/stem.1206; Quail DF, 2013, INT J BIOCHEM CELL B, V45, P885, DOI 10.1016/j.biocel.2012.12.021; Ren TT, 2014, J PATHOL, V234, P526, DOI 10.1002/path.4415; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Scheil S, 2001, GENE CHROMOSOME CANC, V32, P203, DOI 10.1002/gcc.1184; Scheil-Bertram S, 2014, INT J ONCOL, V44, P1041, DOI 10.3892/ijo.2014.2268; Sha W, 2011, J CELL COMMUN SIGNAL, V5, P219, DOI 10.1007/s12079-011-0128-0; Smits P, 2003, DEVELOPMENT, V130, P1135, DOI 10.1242/dev.00331; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Sounni NE, 2013, CLIN CHEM, V59, P85, DOI 10.1373/clinchem.2012.185363; Suzuki H, 2001, ONCOGENE, V20, P5779, DOI 10.1038/sj.onc.1204742; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tamplin OJ, 2011, DEV BIOL; Tran CM, 2013, MATRIX BIOL, V32, P298, DOI 10.1016/j.matbio.2013.03.006; Tran CM, 2013, J BIOL CHEM, V288, P12654, DOI 10.1074/jbc.M112.448860; Tran CM, 2010, ARTHRITIS RHEUM-US, V62, P1983, DOI 10.1002/art.27445; Urban JPG, 2002, BIOCHEM SOC T, V30, P858, DOI 10.1042/bst0300858; Wahab NA, 2001, BIOCHEM J, V359, P89, DOI 10.1042/0264-6021:3590089; Wang Yue J, 2013, Methods Mol Biol, V980, P281, DOI 10.1007/978-1-62703-287-2_15; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Wolf N, 2010, ENDOCRINOLOGY, V151, P2835, DOI 10.1210/en.2009-1195; Yakkioui Y, 2014, BIOCH BIOPHYS ACTA; Yang AT, 2013, INT J MOL MED, V32, P35, DOI 10.3892/ijmm.2013.1380; Yang C, 2010, SPINE, V35, P1257, DOI 10.1097/BRS.0b013e3181c2a8b0; Yang XHR, 2009, NAT GENET, V41, P1176, DOI 10.1038/ng.454; You JJ, 2010, EXP EYE RES, V91, P825, DOI 10.1016/j.exer.2010.10.006; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Zagzag D, 2003, J CELL PHYSIOL, V196, P394, DOI 10.1002/jcp.10306	76	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115909	10.1371/journal.pone.0115909	http://dx.doi.org/10.1371/journal.pone.0115909			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541962	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900107
J	Peterson, J; Gisslen, M; Zetterberg, H; Fuchs, D; Shacklett, BL; Hagberg, L; Yiannoutsos, CT; Spudich, SS; Price, RW				Peterson, Julia; Gisslen, Magnus; Zetterberg, Henrik; Fuchs, Dietmar; Shacklett, Barbara L.; Hagberg, Lars; Yiannoutsos, Constantin T.; Spudich, Serena S.; Price, Richard W.			Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection	PLOS ONE			English	Article							AIDS DEMENTIA COMPLEX; CENTRAL-NERVOUS-SYSTEM; ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS-INFECTION; NEUROFILAMENT PROTEIN NFL; AMYLOID PRECURSOR PROTEIN; NEUROCOGNITIVE DISORDERS; ALZHEIMERS-DISEASE; VIRAL LOAD; NEURODEGENERATIVE DISEASES	The character of central nervous system (CNS) HIV infection and its effects on neuronal integrity vary with evolving systemic infection. Using a cross-sectional design and archived samples, we compared concentrations of cerebrospinal fluid (CSF) neuronal biomarkers in 143 samples from 8 HIV-infected subject groups representing a spectrum of untreated systemic HIV progression and viral suppression: primary infection; four groups of chronic HIV infection neuroasymptomatic (NA) subjects defined by blood CD4+ T cells of >350, 200-349, 50-199, and <50 cells/mu L; HAD; treatment-induced viral suppression; and 'elite' controllers. Samples from 20 HIV-uninfected controls were also examined. The neuronal biomarkers included neurofilament light chain protein (NFL), total and phosphorylated tau (t-tau, p-tau), soluble amyloid precursor proteins alpha and beta (sAPP alpha, sAPP beta) and amyloid beta (A beta) fragments 1-42, 1-40 and 1-38. Comparison of the biomarker changes showed a hierarchy of sensitivity in detection and suggested evolving mechanisms with progressive injury. NFL was the most sensitive neuronal biomarker. Its CSF concentration exceeded ageadjusted norms in all HAD patients, 75% of NA CD4<50, 40% of NA CD4 50-199, and 42% of primary infection, indicating common neuronal injury with untreated systemic HIV disease progression as well as transiently during early infection. By contrast, only 75% of HAD subjects had abnormal CSF t-tau levels, and there were no significant differences in t-tau levels among the remaining groups. sAPP alpha and beta were also abnormal (decreased) in HAD, showed less marked change than NFL with CD4 decline in the absence of HAD, and were not decreased in PHI. The CSF Ab peptides and p-tau concentrations did not differ among the groups, distinguishing the HIV CNS injury profile from Alzheimer's disease. These CSF biomarkers can serve as useful tools in selected research and clinical settings for patient classification, pathogenetic analysis, diagnosis and management.	[Peterson, Julia; Price, Richard W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Gisslen, Magnus; Hagberg, Lars] Univ Gothenburg, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden; [Zetterberg, Henrik] Inst Neurol, London WC1N 3BG, England; [Fuchs, Dietmar] Med Univ Innsbruck, Div Biol Chem, A-6020 Innsbruck, Austria; [Shacklett, Barbara L.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Yiannoutsos, Constantin T.] Indiana Univ, RM Fairbanks Sch Publ Hlth, Dept Biostat, Indianapolis, IN 46204 USA; [Spudich, Serena S.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	University of California System; University of California San Francisco; University of Gothenburg; University of Gothenburg; University of London; University College London; Medical University of Innsbruck; University of California System; University of California Davis; Indiana University System; Indiana University-Purdue University Indianapolis; Yale University	Price, RW (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	rwprice@sfgh.ucsf.edu	Fuchs, Dietmar/AAL-8011-2021; Shacklett, Barbara/A-7288-2009; Gisslen, Magnus/D-7454-2015	Fuchs, Dietmar/0000-0003-1627-9563; Shacklett, Barbara/0000-0002-7067-732X; Gisslen, Magnus/0000-0002-2357-1020	National Institutes of Health [P01 DA026134, R01 MH62701, R21MH096619, R21 NS069219, P01 MH094177, R01MH081772, UL1 TR000004]; Sahlgrenska Academy at the University of Gothenburg [ALFGBG-11067]; Swedish Research Council [2007-7092]; Knut and Alice Wallenberg Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004, UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081772, R21MH096619, R01MH062701, P01MH094177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS069219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA026134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sahlgrenska Academy at the University of Gothenburg; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from National Institutes of Health: P01 DA026134, R01 MH62701, R21MH096619, R21 NS069219, P01 MH094177, R01MH081772, and UL1 TR000004 (the UCSF CTSI); and Sahlgrenska Academy at the University of Gothenburg (ALFGBG-11067) and the Swedish Research Council (2007-7092) and the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulle S, 2007, J NEUROL, V254, P1026, DOI 10.1007/s00415-006-0481-8; Ances BM, 2012, JAIDS-J ACQ IMM DEF, V59, P469, DOI 10.1097/QAI.0b013e318249db17; Andreasson U, 2007, BIOMARK MED, V1, P59, DOI 10.2217/17520363.1.1.59; Anthony IC, 2006, ACTA NEUROPATHOL, V111, P529, DOI 10.1007/s00401-006-0037-0; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Arrildt KT, 2012, CURR HIV-AIDS REP, V9, P52, DOI 10.1007/s11904-011-0107-3; Bhaskaran K, 2008, ANN NEUROL, V63, P213, DOI 10.1002/ana.21225; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bonnet F, 2013, AIDS, V27, P391, DOI 10.1097/QAD.0b013e32835b1019; Brew BJ, 2005, NEUROLOGY, V65, P1490, DOI 10.1212/01.wnl.0000183293.95787.b7; Budka H, 1991, BRAIN PATHOL, V1, P163, DOI 10.1111/j.1750-3639.1991.tb00656.x; Canestri A, 2010, CLIN INFECT DIS, V50, P773, DOI 10.1086/650538; Clifford DB, 2009, NEUROLOGY, V73, P1982, DOI 10.1212/WNL.0b013e3181c5b445; Constantinescu R, 2011, ACTA NEUROL SCAND, V124, P206, DOI 10.1111/j.1600-0404.2010.01451.x; Constantinescu R, 2010, PARKINSONISM RELAT D, V16, P142, DOI 10.1016/j.parkreldis.2009.07.007; Dahl V, 2014, AIDS; Dahl V, 2013, AIDS, V27, P1145, DOI 10.1097/QAD.0b013e32835cf235; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Dotevall L, 1999, EUR J NEUROL, V6, P169, DOI 10.1111/j.1468-1331.1999.tb00010.x; Eden A, 2007, J INFECT DIS, V196, P1779, DOI 10.1086/523648; Ellis RJ, 1997, ANN NEUROL, V42, P679, DOI 10.1002/ana.410420503; Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd; Ernst T, 2009, ANN NEUROL, V65, P316, DOI 10.1002/ana.21594; Gelman BB, 2004, J NEUROVIROL, V10, P98, DOI 10.1080/13550280490279816; Gelman BB, 2013, JAIDS-J ACQ IMM DEF, V62, P487, DOI 10.1097/QAI.0b013e31827f1bdb; Gisslen M, 1999, J ACQ IMMUN DEF SYND, V21, P271, DOI 10.1097/00126334-199908010-00003; Gisslen M, 2007, J NEUROIMMUNE PHARM, V2, P112, DOI 10.1007/s11481-006-9035-1; Gisslen M, 2007, J INFECT DIS, V195, P1774, DOI 10.1086/518043; Gisslen M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-356; Gisslen M, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-63; Grahn A, 2013, J NEUROL, V260, P1813, DOI 10.1007/s00415-013-6883-5; Gray F, 2001, CLIN NEUROPATHOL, V20, P146; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Ho EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066188; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; Hua X, 2013, NEUROIMAGE-CLIN, V3, P132, DOI 10.1016/j.nicl.2013.07.009; JANSSEN RS, 1991, NEUROLOGY, V41, P778; Jernigan TL, 2011, J NEUROVIROL, V17, P248, DOI 10.1007/s13365-011-0032-7; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Krut JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088591; Krut JJ, 2013, J NEUROL, V260, P620, DOI 10.1007/s00415-012-6688-y; Lescure FX, 2011, CLIN INFECT DIS, V52, P235, DOI 10.1093/cid/ciq041; Lewczuk P, 2010, MOL PSYCHIATR, V15, P138, DOI 10.1038/mp.2008.84; Mankowski JL, 2002, J NEUROPATH EXP NEUR, V61, P85, DOI 10.1093/jnen/61.1.85; Masliah E, 1996, J NeuroAIDS, V1, P161; Mattsson N, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-51; McArthur JC, 1997, ANN NEUROL, V42, P689, DOI 10.1002/ana.410420504; Mellgren A, 2007, NEUROLOGY, V69, P1536, DOI 10.1212/01.wnl.0000277635.05973.55; Meyer ACL, 2013, NEUROEPIDEMIOLOGY, V41, P208, DOI 10.1159/000354629; Monforte AD, 2004, ANN NEUROL, V55, P320, DOI 10.1002/ana.10827; Murray ME, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt231; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; Nebuloni M, 2001, AIDS, V15, P571, DOI 10.1097/00002030-200103300-00005; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Ortega M, 2014, J NEUROIMMUNE PHARM; Peluso MJ, 2013, J INFECT DIS, V207, P1703, DOI 10.1093/infdis/jit088; Peluso MJ, 2012, AIDS, V26, P1765, DOI 10.1097/QAD.0b013e328355e6b2; POST MJD, 1991, RADIOLOGY, V178, P131, DOI 10.1148/radiology.178.1.1984291; Price RW, 2008, J INFECT DIS, V197, pS294, DOI 10.1086/533419; Price RW, 2014, SEMIN NEUROL, V34, P7, DOI 10.1055/s-0034-1372337; Price RW, 2013, J NEUROIMMUNE PHARM, V8, P1147, DOI 10.1007/s11481-013-9491-3; PRICE RW, 1990, J ACQ IMMUN DEF SYND, V3, pS51; Price RW, 1999, AIDS, V13, P1677, DOI 10.1097/00002030-199909100-00011; Price RW, 2001, AIDS, V15, P1251, DOI 10.1097/00002030-200107060-00006; PRICE RW, 1988, J INFECT DIS, V158, P1079, DOI 10.1093/infdis/158.5.1079; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Probasco JC, 2010, AIDS, V24, P1001, DOI 10.1097/QAD.0b013e328331e15b; Quintanar JL, 2003, PARASITOL RES, V90, P261, DOI 10.1007/s00436-003-0850-5; Risacher SL, 2013, SEMIN NEUROL, V33, P386, DOI 10.1055/s-0033-1359312; ROSENBLUM MK, 1990, PATHOL ANNU, V25, P117; Rosengren LE, 1999, NEUROLOGY, V52, P1090, DOI 10.1212/WNL.52.5.1090; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Saag M, 2010, CLIN INFECT DIS, V51, P239, DOI 10.1086/653678; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; SIDTIS JJ, 1993, ANN NEUROL, V33, P343, DOI 10.1002/ana.410330403; SIDTIS JJ, 1994, RES P ARNMD, V72, P273; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Sjogren M, 2001, J NEUROL NEUROSUR PS, V70, P624, DOI 10.1136/jnnp.70.5.624; Spudich S, 2011, J INFECT DIS, V204, P753, DOI 10.1093/infdis/jir387; Spudich SS, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-98; Studahl M, 2000, J NEUROL, V247, P636, DOI 10.1007/s004150070134; Tozzi V, 1999, AIDS, V13, P1889, DOI 10.1097/00002030-199910010-00011; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; VAZEUX R, 1987, AM J PATHOL, V126, P403; Waldo ML, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-54; YARCHOAN R, 1987, LANCET, V1, P132, DOI 10.1016/S0140-6736(87)91968-4; Zetterberg H, 2008, ARCH NEUROL-CHICAGO, V65, P1102, DOI 10.1001/archneur.65.8.1102; Zetterberg H, 2014, EXPERT REV NEUROTHER, V14, P621, DOI 10.1586/14737175.2014.915740; Zhu T, 2013, J NEUROVIROL, V19, P10, DOI 10.1007/s13365-012-0135-9	92	66	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116081	10.1371/journal.pone.0116081	http://dx.doi.org/10.1371/journal.pone.0116081			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541953	Green Published, gold			2022-12-26	WOS:000347239900140
J	Zeppilli, D; Bongiorni, L; Santos, RS; Vanreusel, A				Zeppilli, Daniela; Bongiorni, Lucia; Santos, Ricardo Serrao; Vanreusel, Ann			Changes in Nematode Communities in Different Physiographic Sites of the Condor Seamount (North-East Atlantic Ocean) and Adjacent Sediments	PLOS ONE			English	Article							ECOLOGICAL QUALITY STATUS; DEEP-SEA BIODIVERSITY; BENTHIC BIODIVERSITY; SPATIAL VARIATION; MICROHABITAT TYPE; SPECIES RICHNESS; ORGANIC-MATTER; DIVERSITY; ASSEMBLAGES; MEIOFAUNA	Several seamounts are known as 'oases' of high abundances and biomass and hotspots of biodiversity in contrast to the surrounding deep-sea environments. Recent studies have indicated that each single seamount can exhibit a high intricate habitat turnover. Information on alpha and beta diversity of single seamount is needed in order to fully understand seamounts contribution to regional and global biodiversity. However, while most of the seamount research has been focused on summits, studies considering the whole seamount structure are still rather poor. In the present study we analysed abundance, biomass and diversity of nematodes collected in distinct physiographic sites and surrounding sediments of the Condor Seamount (Azores, North-East Atlantic Ocean). Our study revealed higher nematode biomass in the seamount bases and values 10 times higher in the Condor sediments than in the far-field site. Although biodiversity indices did not showed significant differences comparing seamount sites and far-field sites, significant differences were observed in term of nematode composition. The Condor summit harboured a completely different nematode community when compared to the other seamount sites, with a high number of exclusive species and important differences in term of nematode trophic diversity. The oceanographic conditions observed around the Condor Seamount and the associated sediment mixing, together with the high quality of food resources available in seamount base could explain the observed patterns. Our results support the hypothesis that seamounts maintain high biodiversity through heightened beta diversity and showed that not only summits but also seamount bases can support rich benthic community in terms of standing stocks and diversity. Furthermore functional diversity of nematodes strongly depends on environmental conditions link to the local setting and seamount structure. This finding should be considered in future studies on seamounts, especially in view of the potential impacts due to current and future anthropogenic threats.	[Zeppilli, Daniela; Bongiorni, Lucia; Santos, Ricardo Serrao] Univ Azores, Ctr IMAR, P-9901862 Horta, Azores, Portugal; [Zeppilli, Daniela; Bongiorni, Lucia; Santos, Ricardo Serrao] LARSyS Associated Lab, P-9901862 Horta, Azores, Portugal; [Zeppilli, Daniela] IFREMER, Ctr Brest, REM EEP LEP, Inst Carnot Ifremer EDROME, Plouzane, France; [Zeppilli, Daniela] Univ Brest, Inst Univ Europeen Mer, CNRS IRD UBO, Lab Sci Environm Marin, Plouzane, France; [Bongiorni, Lucia] Natl Res Council ISMAR CNR, Inst Marine Sci, Venice, Italy; [Santos, Ricardo Serrao] Univ Azores, Dept Ocenog & Fisheries, P-9901862 Horta, Azores, Portugal; [Vanreusel, Ann] Univ Ghent, Dept Biol, Marine Biol sect, B-9000 Ghent, Belgium	Universidade dos Acores; Ifremer; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Universidade dos Acores; Ghent University	Zeppilli, D (corresponding author), Univ Azores, Ctr IMAR, P-9901862 Horta, Azores, Portugal.	Daniela.Zeppilli@ifremer.fr	Santos, Ricardo/B-3960-2008; Zeppilli, Daniela/AAD-4608-2022; Bongiorni, Lucia/AAL-1488-2021; CNR, Ismar/P-1247-2014	Santos, Ricardo/0000-0002-2536-1369; Bongiorni, Lucia/0000-0001-9033-4992; CNR, Ismar/0000-0001-5351-1486; ZEPPILLI, DANIELA/0000-0002-0809-2566	CONDOR; EEA [PT0040/2008]; Fundacao para a Ciencia e Tecnologia, Portugal (FCT) [PTDC/MAR/105486/2008]; Portuguese Foundation for Science and Technology (FCT) through FCT [531, Pest/OE/EEI/LA0009/2011-2014]; Azores Fund for Science and Technology (FRCT) by OE; COMPETE; QREN; ProConvergencia; FCT [-Pest/OE/EEI/LA0009/2014]; "Laboratoire d'Excellence" LabexMER - French government under the program "Investissements d'Avenir" [ANR-10-LABX-19]; Regional Council of Brittany; project "Deep-sea hYdrothermal Vent nematodes as potential source of new Antibiotics" (DYVA) by Fondation Total and Ifremer; RITMARE flagship project - MIUR	CONDOR; EEA; Fundacao para a Ciencia e Tecnologia, Portugal (FCT)(Portuguese Foundation for Science and Technology); Portuguese Foundation for Science and Technology (FCT) through FCT; Azores Fund for Science and Technology (FRCT) by OE; COMPETE; QREN; ProConvergencia; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); "Laboratoire d'Excellence" LabexMER - French government under the program "Investissements d'Avenir"(French National Research Agency (ANR)); Regional Council of Brittany(Region Bretagne); project "Deep-sea hYdrothermal Vent nematodes as potential source of new Antibiotics" (DYVA) by Fondation Total and Ifremer; RITMARE flagship project - MIUR	Funding: This study was funded by the CONDOR project (Observatory for long term study and monitoring of Azorean ecosystem, EEA Grants PT0040/2008, (Iceland, Liechtenstein), the Fundacao para a Ciencia e Tecnologia, Portugal (FCT Project BIOMOUNT, PTDC/MAR/105486/2008, COMPETE/FEDERE funds). IMAR-DOP/UAz is Research and Development Unit no. 531 and LARSyS-Associated Laboratory no. 9 funded by the Portuguese Foundation for Science and Technology (FCT) through FCT - Pest/OE/EEI/LA0009/2011-2014 and by the Azores Fund for Science and Technology (FRCT), funded by OE, COMPETE, QREN and ProConvergencia. The Open Access of this paper is funded by FCT -Pest/OE/EEI/LA0009/2014 (OE, COMPETE and QREN). DZ was partly supported by the "Laboratoire d'Excellence" LabexMER (ANR-10-LABX-19), co-funded by a grant from the French government under the program "Investissements d'Avenir" by a grant from the Regional Council of Brittany (SAD programme), and by the project "Deep-sea hYdrothermal Vent nematodes as potential source of new Antibiotics" (DYVA) funded by Fondation Total and Ifremer. LB was supported by the RITMARE flagship project 2012-2016 funded by MIUR and coordinated by CNR, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves AS, 2013, ECOL INDIC, V24, P462, DOI 10.1016/j.ecolind.2012.07.013; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andrassy I., 1956, Archivum Zoologicum Budapest, V2, P1; Bashmachnikov I, 2013, DEEP-SEA RES PT II, V98, P38, DOI 10.1016/j.dsr2.2013.09.014; BONGERS T, 1991, MAR ECOL PROG SER, V76, P135, DOI 10.3354/meps076135; Bongiorni L, 2013, DEEP-SEA RES PT II, V98, P75, DOI 10.1016/j.dsr2.2013.08.006; Braga-Henriques A, 2013, BIOGEOSCIENCES, V10, P4009, DOI 10.5194/bg-10-4009-2013; Chivers AJ, 2013, BIOGEOSCIENCES, V10, P3535, DOI 10.5194/bg-10-3535-2013; Clark M. R., 2010, 46 NZ AQ ENV BIOD; Clark MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029232; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Danovaro R, 2009, MAR ECOL PROG SER, V396, P197, DOI 10.3354/meps08269; Danovaro R., 2010, METHODS STUDY DEEP S; Danovaro R, 2008, ECOGRAPHY, V31, P231, DOI 10.1111/j.0906-7590.2008.5484.x; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; FABIANO M, 1995, CONT SHELF RES, V15, P1453, DOI 10.1016/0278-4343(94)00088-5; Feller R.J., 1988, P181; Froese Rainer, 2004, University of British Columbia Fisheries Centre Research Reports, V12, P25; Gad G, 2004, ARCH FISH MAR RES, V51, P30; Gad Gunnar, 2009, Marine Biodiversity, V39, P57; Gambi C, 2003, DEEP-SEA RES PT I, V50, P103, DOI 10.1016/S0967-0637(02)00143-7; Gambi C, 2014, GLOBAL ECOL BIOGEOGR, V23, P24, DOI 10.1111/geb.12094; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; George Kai Horst, 2013, Meiofauna Marina, V20, P1; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Hein JR, 2010, OCEANOGRAPHY, V23, P184, DOI 10.5670/oceanog.2010.70; Heinz P, 2004, MAR BIOL, V144, P985, DOI 10.1007/s00227-003-1257-7; INGELS J, 2011, PLOS ONE, DOI DOI 10.1371/JOURNAL.PONE.0020094; Lambshead PJD, 2004, NEMATOLOGY: ADVANCES AND PERSPECTIVES, VOL 1: NEMATODE MORPHOLOGY, PHYSIOLOGY AND ECOLOGY, P438, DOI 10.1079/9780851996455.0438; Lambshead PJD, 2003, J BIOGEOGR, V30, P475, DOI 10.1046/j.1365-2699.2003.00843.x; Leduc D, 2012, MAR ECOL PROG SER, V454, P53, DOI 10.3354/meps09609; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Lundsten L, 2009, MAR ECOL PROG SER, V374, P23, DOI 10.3354/meps07745; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McClain CR, 2010, MAR ECOL, V31, P1; McClain CR, 2007, J BIOGEOGR, V34, P2001, DOI 10.1111/j.1365-2699.2007.01783.x; MIRTOS AC, 2014, AQUACULT ENV INTERAC, V5, P17; Moens T., 2013, NEMATODA, P109, DOI DOI 10.1515/9783110274257.109; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; Moreno M, 2011, ECOL INDIC, V11, P328, DOI 10.1016/j.ecolind.2010.05.011; Muinos SB, 2013, MAR GEORESOUR GEOTEC, V31, P40, DOI 10.1080/1064119X.2012.661215; Ndaro SGM, 1999, HYDROBIOLOGIA, V405, P133, DOI 10.1023/A:1003874122971; Pape E, 2013, BIOGEOSCIENCES, V10, P3127, DOI 10.5194/bg-10-3127-2013; PLATT HM, 1988, BRIT CHROMADORIDS 2; PLATT HM, 1983, BRIT ENOPLIDS 1; PROBERT PK, 2007, SEAMOUNTS ECOLOGY FI, P442, DOI DOI 10.1002/9780470691953.CH20; Pusceddu A, 2014, P NATL ACAD SCI USA, V111, P8861, DOI 10.1073/pnas.1405454111; Pusceddu A, 2009, DEEP-SEA RES PT II, V56, P755, DOI 10.1016/j.dsr2.2008.10.012; Raes M, 2006, DEEP-SEA RES PT I, V53, P1880, DOI 10.1016/j.dsr.2006.08.012; Raes M, 2007, CORAL REEFS, V26, P113, DOI 10.1007/s00338-006-0184-8; Raes M, 2008, J BIOGEOGR, V35, P2207, DOI 10.1111/j.1365-2699.2008.01945.x; Ramalho SP, 2014, DEEP-SEA RES PT I, V83, P102, DOI 10.1016/j.dsr.2013.09.010; Roberts S, 2004, FRONT ECOL ENVIRON, V2, P123, DOI 10.2307/3868237; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P95, DOI 10.1111/j.1439-0485.2010.00369.x; Samadi S, 2006, MAR BIOL, V149, P1463, DOI 10.1007/s00227-006-0306-4; SANDULLI R, 2014, ITAL J ZOOLOG; Schlacher TA, 2014, DIVERS DISTRIB, V20, P491, DOI 10.1111/ddi.12142; Semprucci F, 2015, J MAR BIOL ASSOC UK, V95, P247, DOI 10.1017/S0025315414001271; Semprucci F, 2013, MEDITERR MAR SCI, V14, P48, DOI 10.12681/mms.366; Soetaert K, 2009, MAR ECOL PROG SER, V392, P123, DOI 10.3354/meps08202; Steyaert M, 2003, ESTUAR COAST SHELF S, V58, P353, DOI 10.1016/S0272-7714(03)00086-6; Tempera F, 2012, ELSEV INSIGHT, P807, DOI 10.1016/B978-0-12-385140-6.00059-1; Thresher RE, 2011, SCI REP-UK, V1, DOI 10.1038/srep00119; TIETJEN JH, 1992, NATO ADV SCI I C-MAT, V360, P45; Vanreusel A, 2010, MAR ECOL-EVOL PERSP, V31, P6, DOI 10.1111/j.1439-0485.2009.00352.x; Wang SP, 2014, ECOL LETT, V17, P891, DOI 10.1111/ele.12292; Warwick R. M., 1998, SYNOPSIS FREELIVING; Weber ME, 2000, MAR GEOL, V163, P169, DOI 10.1016/S0025-3227(99)00103-6; WHITE M, 2007, SEAMOUNTS ECOLOGY FI, P65, DOI DOI 10.1002/9780470691953CH4; Wieser W., 1953, ARK ZOOL, V2, P439; WILLEMS KA, 1982, J MAR BIOL ASSOC UK, V62, P535, DOI 10.1017/S0025315400019731; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; Zeppilli D, 2013, DEEP-SEA RES PT II, V98, P87, DOI 10.1016/j.dsr2.2013.08.009; Zeppilli D, 2012, DIVERS DISTRIB, V18, P832, DOI 10.1111/j.1472-4642.2011.00859.x	78	20	20	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115601	10.1371/journal.pone.0115601	http://dx.doi.org/10.1371/journal.pone.0115601			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541988	Green Published, gold			2022-12-26	WOS:000347239900056
J	Fujiwara, S; Hoshikawa, S; Ueno, T; Hirata, M; Saito, T; Ikeda, T; Kawaguchi, H; Nakamura, K; Tanaka, S; Ogata, T				Fujiwara, Sayaka; Hoshikawa, Shinya; Ueno, Takaaki; Hirata, Makoto; Saito, Taku; Ikeda, Toshiyuki; Kawaguchi, Hiroshi; Nakamura, Kozo; Tanaka, Sakae; Ogata, Toru			SOX10 Transactivates S100B to Suppress Schwann Cell Proliferation and to Promote Myelination	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SOX10; GENE-EXPRESSION; WAARDENBURG-SYNDROME; GROWTH-FACTOR; PROTEINS; ACTIVATION; DIFFERENTIATION; DISEASE; IDENTITY; MUTATION	Schwann cells are an important cell source for regenerative therapy for neural disorders. We investigated the role of the transcription factor sex determining region Y (SRY)-box 10 (SOX10) in the proliferation and myelination of Schwann cells. SOX10 is predominantly expressed in rat sciatic nerve-derived Schwann cells and is induced shortly after birth. Among transcription factors known to be important for the differentiation of Schw ann cells, SOX10 potently transactivates the S100B promoter. In cultures of Schwann cells, overexpressing SOX10 dramatically induces S100B expression, while knocking down SOX10 with shRNA suppresses S100B expression. Here, we identify three core response elements of SOX10 in the S100B promoter and intron 1 with a putative SOX motif. Knockdown of either SOX10 or S100B enhances the proliferation of Schwann cells. In addition, using dissociated cultures of dorsal root ganglia, we demonstrate that suppressing S100B with shRNA impairs myelination of Schwann cells. These results suggest that the SOX10-S100B signaling axis critically regulates Schwann cell proliferation and myelination, and therefore is a putative therapeutic target for neuronal disorders.	[Fujiwara, Sayaka; Hoshikawa, Shinya; Ueno, Takaaki; Hirata, Makoto; Ikeda, Toshiyuki; Kawaguchi, Hiroshi; Nakamura, Kozo; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Sensory & Motor Syst Med, Tokyo 113, Japan; [Saito, Taku] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Ogata, Toru] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Saitama, Japan	University of Tokyo; University of Tokyo	Ogata, T (corresponding author), Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Saitama, Japan.	ogata-toru@rehab.go.jp	Ikeda, Toshiyuki/GVS-5588-2022; Tanaka, Sakae/Y-3061-2019; Ogata, Toru/ADC-3560-2022	Tanaka, Sakae/0000-0001-9210-9414; Ogata, Toru/0000-0001-9011-8640	Japanese Ministry of Education, Culture, Sports, Science, and Technology [23300204]; Grants-in-Aid for Scientific Research [24592254] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#23300204). http://www.jsps.go.jp/english/index.html. This grant has been received by TO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLORE R, 1988, SCIENCE, V239, P1311, DOI 10.1126/science.2964086; Arcuri C, 2005, J BIOL CHEM, V280, P4402, DOI 10.1074/jbc.M406440200; Atanasoski S, 2008, MOL CELL NEUROSCI, V37, P519, DOI 10.1016/j.mcn.2007.11.005; AZMITIA EC, 1990, BRAIN RES, V516, P354, DOI 10.1016/0006-8993(90)90942-5; Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; EINHEBER S, 1995, J CELL BIOL, V129, P443, DOI 10.1083/jcb.129.2.443; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Gonzalez-Martinez T, 2003, MICROSC RES TECHNIQ, V60, P633, DOI 10.1002/jemt.10304; Haldin CE, 2010, INT J BIOCHEM CELL B, V42, P441, DOI 10.1016/j.biocel.2009.11.014; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Inoue K, 2002, ANN NEUROL, V52, P836, DOI 10.1002/ana.10404; Ito Y, 2006, P NATL ACAD SCI USA, V103, P7871, DOI 10.1073/pnas.0602332103; Jessen KR, 2002, J ANAT, V200, P367, DOI 10.1046/j.1469-7580.2002.00046.x; Jessen Kristjan R, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-19; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Kioussi C, 1996, TRENDS GENET, V12, P84, DOI 10.1016/0168-9525(96)81411-9; Kitamura T, 1998, INT J HEMATOL, V67, P351; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lang D, 2003, HUM MOL GENET, V12, P937, DOI 10.1093/hmg/ddg107; Ludwig A, 2004, FEBS LETT, V556, P236, DOI 10.1016/S0014-5793(03)01446-7; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; Melnikova IN, 2000, EUR J PHARMACOL, V393, P75, DOI 10.1016/S0014-2999(99)00884-5; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; Nishiyama H, 2002, NEUROSCI LETT, V321, P49, DOI 10.1016/S0304-3940(01)02549-6; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Paratore C, 2001, DEVELOPMENT, V128, P3949; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; Reiprich S, 2010, J NEUROCHEM, V112, P744, DOI 10.1111/j.1471-4159.2009.06498.x; Roh J, 2006, DIFFERENTIATION, V74, P542, DOI 10.1111/j.1432-0436.2006.00084.x; Saito T, 2007, EMBO REP, V8, P504, DOI 10.1038/sj.embor.7400934; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Schepers GE, 2000, NUCLEIC ACIDS RES, V28, P1473, DOI 10.1093/nar/28.6.1473; Schlierf B, 2006, J MOL BIOL, V361, P11, DOI 10.1016/j.jmb.2006.05.072; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; Shimotake T, 2007, J PEDIATR SURG, V42, P725, DOI 10.1016/j.jpedsurg.2006.12.003; Sock E, 2001, MOL CELL BIOL, V21, P6951, DOI 10.1128/MCB.21.20.6951-6959.2001; Srinivasan R, 2012, NUCLEIC ACIDS RES, V40, P6449, DOI 10.1093/nar/gks313; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Tateishi Narito, 2006, JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, V26, P11; Verastegui C, 2000, J BIOL CHEM, V275, P30757, DOI 10.1074/jbc.C000445200; Verheij JBGM, 2006, EUR J PAEDIATR NEURO, V10, P11, DOI 10.1016/j.ejpn.2005.10.004; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wei Q, 2004, J NEUROSCI RES, V78, P796, DOI 10.1002/jnr.20342; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041	53	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115400	10.1371/journal.pone.0115400	http://dx.doi.org/10.1371/journal.pone.0115400			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536222	Green Submitted, Green Published, gold			2022-12-26	WOS:000348563300037
J	Olson, CR; Owen, DC; Ryabinin, AE; Mello, CV				Olson, Christopher R.; Owen, Devin C.; Ryabinin, Andrey E.; Mello, Claudio V.			Drinking Songs: Alcohol Effects on Learned Song of Zebra Finches	PLOS ONE			English	Article							SPEECH; INTOXICATION; BIRDSONG; LANGUAGE; ETHANOL; ADOLESCENTS; PERFORMANCE; METABOLISM; MODULATION; CIRCUIT	Speech impairment is one of the most intriguing and least understood effects of alcohol on cognitive function, largely due to the lack of data on alcohol effects on vocalizations in the context of an appropriate experimental model organism. Zebra finches, a representative songbird and a premier model for understanding the neurobiology of vocal production and learning, learn song in a manner analogous to how humans learn speech. Here we show that when allowed access, finches readily drink alcohol, increase their blood ethanol concentrations (BEC) significantly, and sing a song with altered acoustic structure. The most pronounced effects were decreased amplitude and increased entropy, the latter likely reflecting a disruption in the birds' ability to maintain the spectral structure of song under alcohol. Furthermore, specific syllables, which have distinct acoustic structures, were differentially influenced by alcohol, likely reflecting a diversity in the neural mechanisms required for their production. Remarkably, these effects on vocalizations occurred without overt effects on general behavioral measures, and importantly, they occurred within a range of BEC that can be considered risky for humans. Our results suggest that the variable effects of alcohol on finch song reflect differential alcohol sensitivity of the brain circuitry elements that control different aspects of song production. They also point to finches as an informative model for understanding how alcohol affects the neuronal circuits that control the production of learned motor behaviors.	[Olson, Christopher R.; Ryabinin, Andrey E.; Mello, Claudio V.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Owen, Devin C.] Lewis & Clark Coll, Dept Psychol, Portland, OR 97219 USA	Oregon Health & Science University	Mello, CV (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, 3181 SW Sam Jackson Pk Rd L470, Portland, OR 97201 USA.	melloc@ohsu.edu	olson, Christopher/ABC-3812-2020	olson, Christopher/0000-0002-8351-0633; Mello, Claudio/0000-0002-9826-8421	National Institutes of Health through Portland Alcohol Research Center (PARC) [R24-GM092842, F32-NS062609, P60-AA010760]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM092842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS062609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760] Funding Source: NIH RePORTER	National Institutes of Health through Portland Alcohol Research Center (PARC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by National Institutes of Health grants R24-GM092842 (CVM), F32-NS062609 (CRO) and P60-AA010760 through the Portland Alcohol Research Center (PARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-229; Bachtell RK, 1999, BRAIN RES, V847, P157, DOI 10.1016/S0006-8993(99)02019-3; Becker HC, 2013, CURR TOP BEHAV NEURO, V13, P355, DOI 10.1007/7854_2012_203; Bloom L, 2001, MONOGR SOC RES CHILD, V66, pVII, DOI 10.1111/1540-5834.00162; Brown SA, 2000, ALCOHOL CLIN EXP RES, V24, P164, DOI 10.1111/j.1530-0277.2000.tb04586.x; Brumm H, 2009, BEHAV ECOL SOCIOBIOL, V63, P1387, DOI 10.1007/s00265-009-0749-y; Cowan JM, 1996, J ANAL TOXICOL, V20, P287, DOI 10.1093/jat/20.5.287; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Glenberg AM, 2008, Q J EXP PSYCHOL, V61, P905, DOI 10.1080/17470210701625550; Grant KA, 2003, PHARMACOL THERAPEUT, V100, P235, DOI 10.1016/j.pharmthera.2003.08.004; Grisel JE, 2002, ALCOHOL CLIN EXP RES, V26, P610, DOI 10.1097/00000374-200205000-00004; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hollien H, 2001, J ACOUST SOC AM, V110, P3198, DOI 10.1121/1.1413751; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jesse F, 2012, BEHAV PROCESS, V91, P262, DOI 10.1016/j.beproc.2012.09.006; JOHNSON K, 1990, PHONETICA, V47, P215, DOI 10.1159/000261863; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; KLINGHOLZ F, 1988, J ACOUST SOC AM, V84, P929, DOI 10.1121/1.396661; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lombardino AJ, 2000, J NEUROSCI, V20, P5054; Mahrt EJ, 2013, J NEUROSCI, V33, P5573, DOI 10.1523/JNEUROSCI.5054-12.2013; Medina KL, 2008, ALCOHOL CLIN EXP RES, V32, P386, DOI 10.1111/j.1530-0277.2007.00602.x; Office of Research Translation and Communications N NIH DHHS, 2004, NIAAA NEWSL, P1; Petkov Christopher I, 2012, Front Evol Neurosci, V4, P12, DOI 10.3389/fnevo.2012.00012; PISONI DB, 1989, ALCOHOL CLIN EXP RES, V13, P577, DOI 10.1111/j.1530-0277.1989.tb00381.x; Porrino LJ, 1998, ALCOHOL CLIN EXP RES, V22, P176, DOI 10.1097/00000374-199802000-00024; Poulsen MB, 2007, EUR J APPL PHYSIOL, V101, P513, DOI 10.1007/s00421-007-0511-y; Pytte CL, 2007, DEV NEUROBIOL, V67, P1699, DOI 10.1002/dneu.20520; Reiner A, 2005, ANAT REC PART A, V287A, P1080, DOI 10.1002/ar.a.20253; Rochefort C, 2007, DEV NEUROBIOL, V67, P809, DOI 10.1002/dneu.20393; Sakata JT, 2008, J NEUROPHYSIOL, V99, P1700, DOI 10.1152/jn.01296.2007; Sakata JT, 2012, J EXP BIOL, V215, P201, DOI 10.1242/jeb.056911; Schweinsburg AD, 2010, ALCOHOL, V44, P111, DOI 10.1016/j.alcohol.2009.09.032; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Sturdy CB, 1999, J COMP PSYCHOL, V113, P194, DOI 10.1037/0735-7036.113.2.194; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tisljar-Szabo E, 2013, J PSYCHOLINGUIST RES; Williams H, 2004, ANN NY ACAD SCI, V1016, P1, DOI 10.1196/annals.1298.029; Zhang Y, 2011, DEVELOPMENTAL SCI, V14, P566, DOI 10.1111/j.1467-7687.2010.01004.x	43	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115427	10.1371/journal.pone.0115427	http://dx.doi.org/10.1371/journal.pone.0115427			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536524	gold, Green Published, Green Submitted			2022-12-26	WOS:000348563300040
J	Torres, TS; Luz, PM; Derrico, M; Velasque, L; Grinsztejn, E; Veloso, VG; Cardoso, SW; Santini-Oliveira, M; Grinsztejn, B; De Boni, RB				Torres, Thiago S.; Luz, Paula M.; Derrico, Monica; Velasque, Luciane; Grinsztejn, Eduarda; Veloso, Valdilea G.; Cardoso, Sandra W.; Santini-Oliveira, Marilia; Grinsztejn, Beatriz; De Boni, Raquel Brandini			Factors Associated with Tobacco Smoking and Cessation among HIV-Infected Individuals under Care in Rio de Janeiro, Brazil	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; CIGARETTE-SMOKING; RISK-FACTORS; POSITIVE PATIENTS; CLINICAL CARE; HEALTH-RISKS; USE PATTERNS; MORTALITY; SMOKERS	Worldwide the prevalence of smoking among people living with HIV/AIDS is elevated compared to the general population. This probably reflects the cluster of individual characteristics that have shared risk factors for HIV infection and smoking. A cross-sectional study, enrolling a convenience sample from a Brazilian HIV clinical cohort was conducted to evaluate the prevalence of tobacco smoking and the factors associated with current smoking and abstinence. A total of 2,775 HIV-infected individuals were interviewed: 46.2% have never smoked, 29.9% were current smokers and 23.9% were former smokers. Current smokers had a higher prevalence of alcohol and illicit drug use when compared to the other two groups. A higher proportion of heterosexual individuals were former smokers or never smokers while among men who have sex with men (MSM) a higher proportion were current smokers. Former smokers had been more frequently diagnosed with high blood pressure, diabetes mellitus, cardiovascular diseases and depression, while for current smokers lung diseases were more frequent. Former smokers and current smokers were more likely to have had any hospital admission (42.0% and 41.2%, respectively) than participants who never smoked (33.5%) (p<0.001). Multivariate model results showed that current smokers (versus never smokers) were more likely to be less educated, to report the use of alcohol, crack and cocaine and to present clinical comorbidities. Former smokers (versus current smokers) were more likely to be older, to have smoked for a shorter amount of time and to have smoked >31 cigarettes/day. MSM (compared to heterosexuals) and cocaine users (versus non-users) had lower odds of being former smokers. Considering our results, smoking cessation interventions should be tailored to younger individuals, MSM and substance users.	[Torres, Thiago S.; Luz, Paula M.; Derrico, Monica; Velasque, Luciane; Grinsztejn, Eduarda; Veloso, Valdilea G.; Cardoso, Sandra W.; Santini-Oliveira, Marilia; Grinsztejn, Beatriz; De Boni, Raquel Brandini] Fundacao Oswaldo Cruz, HIV AIDS Clin Res Ctr, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Velasque, Luciane] Univ Fed Estado Rio de Janeiro UniRio, Dept Matemat, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Estado do Rio de Janeiro	Torres, TS (corresponding author), Fundacao Oswaldo Cruz, HIV AIDS Clin Res Ctr, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.	thiago.torres@ipec.fiocruz.br	Cardoso, Sandra W/D-7965-2015; DE BONI, RAQUEL BRANDINI/D-4212-2013; TORRES, THIAGO SILVA/D-6548-2014	Cardoso, Sandra W/0000-0001-5230-0003; DE BONI, RAQUEL BRANDINI/0000-0002-2455-5997; TORRES, THIAGO SILVA/0000-0002-2557-601X; Luz, Paula/0000-0001-9746-719X				Alavi-Naini R, 2013, J RES MED SCI, V18, P52; Amiya RM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-677; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Batista Joanna d’Arc Lyra, 2013, Rev. bras. epidemiol., V16, P432, DOI 10.1590/S1415-790X2013000200018; Benard A, 2007, AIDS PATIENT CARE ST, V21, P458, DOI 10.1089/apc.2006.0142; Benard A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008896; Berhe Gebretsadik, 2013, Ethiop Med J, V51, P227; Collins RL, 2001, HEALTH PSYCHOL, V20, P351, DOI 10.1037//0278-6133.20.5.351; Crabtree-Ramirez B, 2014, JAIDS-J ACQ IMM DEF, V67, pS96, DOI 10.1097/QAI.0000000000000261; Cropsey KL, 2013, ADDICT BEHAV, V38, P2541, DOI 10.1016/j.addbeh.2013.05.003; Dale L C, 1997, Tob Control, V6, P181; Dube S. R., 2010, Morbidity and Mortality Weekly Report, V59, P1135; Duval X, 2008, ANTIVIR THER, V13, P389; Ehrlich RI, 2004, INT J TUBERC LUNG D, V8, P369; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Feldman DN, 2009, AIDS EDUC PREV, V21, P81, DOI 10.1521/aeap.2009.21.3_supp.81; Fuster M, 2009, HIV MED, V10, P614, DOI 10.1111/j.1468-1293.2009.00735.x; Goren A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093014; Grinsztejn B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059768; Grinsztejn B, 2009, AIDS, V23, P2107, DOI 10.1097/QAD.0b013e32832ec494; Gritz ER, 2013, CLIN INFECT DIS, V57, P608, DOI 10.1093/cid/cit349; Gritz ER, 2004, NICOTINE TOB RES, V6, P71, DOI 10.1080/14622200310001656885; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Humfleet GL, 2013, NICOTINE TOB RES, V15, P1436, DOI 10.1093/ntr/ntt005; Humfleet GL, 2009, AIDS EDUC PREV, V21, P54, DOI 10.1521/aeap.2009.21.3_supp.54; Jaquet A, 2009, INT J TUBERC LUNG D, V13, P1433; Kumar SR, 2009, INDIAN J MED RES, V130, P15; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Lifson AR, 2012, CURR HIV-AIDS REP, V9, P223, DOI 10.1007/s11904-012-0121-0; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Louwagie GMC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1031; Malta DC, 2013, CAD SAUDE PUBLICA, V29, P812, DOI [10.1590/S0102-311X2013000400018, 10.1590/S0102-311X2013000800018]; Mamary EM, 2002, AIDS PATIENT CARE ST, V16, P39, DOI 10.1089/108729102753429389; Matthews AK, 2013, AIDS PATIENT CARE ST, V27, P22, DOI 10.1089/apc.2012.0253; Mayer KH, 2012, LANCET, V380, P378, DOI 10.1016/S0140-6736(12)60835-6; Ministerio da Saude do Brasil, 2012, B EP ESP TUB; Munyati SS, 2006, INT J TUBERC LUNG D, V10, P1279; Nahvi S, 2009, AIDS EDUC PREV, V21, P14, DOI 10.1521/aeap.2009.21.3_supp.14; Naidoo P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-396; Nakhaee F, 2009, SEX HEALTH, V6, P129, DOI 10.1071/SH08007; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Niaura R, 2000, CLIN INFECT DIS, V31, P808, DOI 10.1086/314048; O'Cleirigh C, 2015, AIDS BEHAV, V19, P178, DOI 10.1007/s10461-014-0762-7; Oka F, 2013, J INFECT CHEMOTHER, V19, P542, DOI 10.1007/s10156-012-0489-1; Pacek LR, 2013, AIDS BEHAV; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Peretti-Watel P, 2006, DRUG ALCOHOL DEPEN, V82, pS71, DOI 10.1016/S0376-8716(06)80012-8; Pines H, 2011, AIDS BEHAV, V15, P243, DOI 10.1007/s10461-010-9682-3; Reynolds NR, 2009, AIDS EDUC PREV, V21, P106, DOI 10.1521/aeap.2009.21.3_supp.106; Ribeiro SR, 2014, ANTIVIR THER, V19, P387, DOI 10.3851/IMP2716; Robinson WT, 2014, AIDS BEHAV, V18, pS324, DOI 10.1007/s10461-013-0585-y; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Shirley DK, 2013, AIDS PATIENT CARE ST, V27, P604, DOI 10.1089/apc.2013.0128; Shirley DK, 2013, CLIN INFECT DIS, V57, P275, DOI 10.1093/cid/cit207; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Souza PRB, 2007, CLINICS, V62, P579, DOI 10.1590/S1807-59322007000500008; Tesoriero JM, 2010, AIDS BEHAV, V14, P824, DOI 10.1007/s10461-008-9449-2; Torres TS, 2013, BRAZ J INFECT DIS, V17, P324, DOI 10.1016/j.bjid.2012.10.024; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; van Wijk JPH, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/201027; Vidrine DJ, 2006, AIDS, V20, P253, DOI 10.1097/01.aids.0000198094.23691.58; Villanti A, 2012, AIDS EDUC PREV, V24, P132, DOI 10.1521/aeap.2012.24.2.132; Waweru P, 2013, SAMJ S AFR MED J, V103, P858, DOI [10.7196/SAMJ.7388, 10.7196/samj.7388]; Webb MS, 2007, J BEHAV MED, V30, P371, DOI 10.1007/s10865-007-9112-9; Webb MS, 2009, AIDS EDUC PREV, V21, P94, DOI 10.1521/aeap.2009.21.3_supp.94; World Health Organization, 2007, UN TUB LUNG DIS WHO	67	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115900	10.1371/journal.pone.0115900	http://dx.doi.org/10.1371/journal.pone.0115900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25536064	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300081
J	Bentler, SE; Morgan, RO; Virnig, BA; Wolinsky, FD				Bentler, Suzanne E.; Morgan, Robert O.; Virnig, Beth A.; Wolinsky, Fredric D.			The Association of Longitudinal and Interpersonal Continuity of Care with Emergency Department Use, Hospitalization, and Mortality among Medicare Beneficiaries	PLOS ONE			English	Article							HEALTH; PHYSICIAN; ACCESS; DIMENSION; OUTCOMES; MODEL	Background: Continuity of medical care is widely believed to lead to better health outcomes and service utilization patterns for patients. Most continuity studies, however, have only used administrative claims to assess longitudinal continuity with a provider. As a result, little is known about how interpersonal continuity (the patient's experience at the visit) relates to improved health outcomes and service use. Methods: We linked claims-based longitudinal continuity and survey-based self-reported interpersonal continuity indicators for 1,219 Medicare beneficiaries who completed the National Health and Health Services Use Questionnaire. With these linked data, we prospectively evaluated the effect of both types of continuity of care indicators on emergency department use, hospitalization, and mortality over a five-year period. Results: Patient-reported continuity was associated with reduced emergency department use, preventable hospitalization, and mortality. Most of the claims-based measures, including those most frequently used to assess continuity, were not associated with reduced utilization or mortality. Conclusion: Our results indicate that the patient-and claims-based indicators of continuity have very different effects on these important health outcomes, suggesting that reform efforts must include the patient-provider experience when evaluating health care quality.	[Bentler, Suzanne E.] Univ Iowa, Publ Policy Ctr, Iowa City, IA 52242 USA; [Morgan, Robert O.] Univ Texas Houston, Sch Publ Hlth, Div Management Policy & Community Hlth, Houston, TX 77030 USA; [Virnig, Beth A.] Univ Minnesota, Sch Publ Hlth, Div Hlth Serv Res & Policy, Minneapolis, MN 55455 USA; [Wolinsky, Fredric D.] Univ Iowa, Coll Publ Hlth, Dept Hlth Management & Policy, Iowa City, IA 52246 USA	University of Iowa; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa	Bentler, SE (corresponding author), Univ Iowa, Publ Policy Ctr, 217 South Quad, Iowa City, IA 52242 USA.	suzanne-bentler@uiowa.edu	Wolinsky, Fredric D/F-9231-2011	Wolinsky, Fredric/0000-0002-0916-4955	Alvin R. Tarlov & John E. Ware Jr. Doctoral Dissertation Award; University of Iowa John W. Colloton Chair awarded	Alvin R. Tarlov & John E. Ware Jr. Doctoral Dissertation Award; University of Iowa John W. Colloton Chair awarded	This work was supported by an Alvin R. Tarlov & John E. Ware Jr. Doctoral Dissertation Award (http://www.hal-health.org/awards.htm#tarlov) awarded to SB and funds from the University of Iowa John W. Colloton Chair awarded to FW. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG HEALTHC RES QU, 2011, AHRQ QUAL IND VERS 4; *AM MED ASS, 2003, CURR PROC TERM 2004; Andersen R., 1968, THESIS PURDUE U W LA; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; ASPER F, 2007, RESDAC PUB, V9; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P46, DOI 10.1016/j.jclinepi.2009.03.012; BENSIRA Z, 1980, J HEALTH SOC BEHAV, V21, P170, DOI 10.2307/2136736; Bentler SE, 2014, MED CARE RES REV, V71, P156, DOI 10.1177/1077558713505909; Bentler SE, 2014, QUAL LIFE RES, V23, P185, DOI 10.1007/s11136-013-0472-z; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Boyer CA, 2010, J HEALTH SOC BEHAV, V51, pS80, DOI 10.1177/0022146510383489; BRESLAU N, 1975, J MED EDUC, V50, P965; Cabana MD, 2004, J FAM PRACTICE, V53, P974; EJLERTSSON G, 1984, MED CARE, V22, P231, DOI 10.1097/00005650-198403000-00006; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; ERIKSSON EA, 1983, MED CARE, V21, P858, DOI 10.1097/00005650-198309000-00003; Freeman GK, 2003, FAM PRACT, V20, P623, DOI 10.1093/fampra/cmg601; GINSBURG PB, 2008, POLICY PERSPECTIVE, V1; Gruneir A, 2011, MED CARE RES REV, V68, P131, DOI 10.1177/1077558710379422; Gulliford MC, 2006, ANN FAM MED, V4, P548, DOI 10.1370/afm.578; Gupta R, 2013, JAMA INTERN MED, V173, P1885, DOI 10.1001/jamainternmed.2013.7341; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Institute of Medicine (IOM), 2003, PRIOR AR NAT ACT TRA; *IOM, 1996, PRIM CAR AM HLTH NEW; Jee SH, 2006, MED CARE RES REV, V63, P158, DOI 10.1177/1077558705285294; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Leleu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071669; MAGILL MK, 1987, J FAM PRACTICE, V24, P165; Mainous AG, 1998, AM J PUBLIC HEALTH, V88, P1539, DOI 10.2105/AJPH.88.10.1539; *MEDPAC, 2005, REPORT TO THE CONGRE, P83; Morgan RO, 2008, J AM GERIATR SOC, V56, P2053, DOI 10.1111/j.1532-5415.2008.01993.x; Nutting Paul A, 2003, Ann Fam Med, V1, P149, DOI 10.1370/afm.63; Nyweide DJ, 2013, JAMA INTERN MED, V173, P1879, DOI 10.1001/jamainternmed.2013.10059; Pandhi N, 2007, FAM MED, V39, P266; Parchman ML, 2002, MED CARE, V40, P137, DOI 10.1097/00005650-200202000-00008; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rodriguez HP, 2008, J GEN INTERN MED, V23, P1499, DOI 10.1007/s11606-008-0692-z; Saultz John W, 2003, Ann Fam Med, V1, P134, DOI 10.1370/afm.23; Saultz JW, 2005, ANN FAM MED, V3, P159, DOI 10.1370/afm.285; SMEDBY O, 1986, MED CARE, V24, P511; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; STEINWACHS DM, 1979, MED CARE, V17, P551, DOI 10.1097/00005650-197906000-00001; Sturmberg J P, 2001, Aust Fam Physician, V30, P513; Sturmberg JP, 2002, FAM PRACT, V19, P85, DOI 10.1093/fampra/19.1.85; Uijen AA, 2011, J CLIN EPIDEMIOL, V64, P1391, DOI 10.1016/j.jclinepi.2011.03.006; van Walraven C, 2010, J EVAL CLIN PRACT, V16, P947, DOI 10.1111/j.1365-2753.2009.01235.x; Ware JE Jr, 2001, SCORE INTERPRET SING; Wolinsky FD, 2007, J GERONTOL B-PSYCHOL, V62, pS160, DOI 10.1093/geronb/62.3.S160; Wolinsky FD, 2010, J GERONTOL A-BIOL, V65, P421, DOI 10.1093/gerona/glp188; [No title captured]; [No title captured]	53	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115088	10.1371/journal.pone.0115088	http://dx.doi.org/10.1371/journal.pone.0115088			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531108	gold, Green Published			2022-12-26	WOS:000348845100036
J	Demion, M; Thireau, J; Gueffier, M; Finan, A; Khoueiry, Z; Cassan, C; Serafini, N; Aimond, F; Granier, M; Pasquie, JL; Launay, P; Richard, S				Demion, Marie; Thireau, Jerome; Gueffier, Melanie; Finan, Amanda; Khoueiry, Ziad; Cassan, Cecile; Serafini, Nicolas; Aimond, Franck; Granier, Mathieu; Pasquie, Jean-Luc; Launay, Pierre; Richard, Sylvain			Trpm4 Gene Invalidation Leads to Cardiac Hypertrophy and Electrophysiological Alterations	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNEL; HEART-RATE-VARIABILITY; MYOCYTE HYPERPLASIA; ATRIAL; CONDUCTION; CARDIOMYOCYTES; MICE; OVEREXPRESSION; PROLIFERATION; HYPERTENSION	Rationale: TRPM4 is a non-selective Ca2+-activated cation channel expressed in the heart, particularly in the atria or conduction tissue. Mutations in the Trpm4 gene were recently associated with several human conduction disorders such as Brugada syndrome. TRPM4 channel has also been implicated at the ventricular level, in inotropism or in arrhythmia genesis due to stresses such as beta-adrenergic stimulation, ischemia-reperfusion, and hypoxia re-oxygenation. However, the physiological role of the TRPM4 channel in the healthy heart remains unclear. Objectives: We aimed to investigate the role of the TRPM4 channel on whole cardiac function with a Trpm4 gene knock-out mouse (Trpm4(-/-)) model. Methods and Results: Morpho-functional analysis revealed left ventricular (LV) eccentric hypertrophy in Trpm4(-/-)mice, with an increase in both wall thickness and chamber size in the adult mouse (aged 32 weeks) when compared to Trpm4(+/+) littermate controls. Immunofluorescence on frozen heart cryosections and qPCR analysis showed no fibrosis or cellular hypertrophy. Instead, cardiomyocytes in Trpm4(-/-) mice were smaller than Trpm4(+/+) with a higher density. Immunofluorescent labeling for phospho-histone H3, a mitosis marker, showed that the number of mitotic myocytes was increased 3-fold in the Trpm4(-/-) neonatal stage, suggesting hyperplasia. Adult Trpm4(-/-) mice presented multilevel conduction blocks, as attested by PR and QRS lengthening in surface ECGs and confirmed by intracardiac exploration. Trpm4(-/-) mice also exhibited Luciani-Wenckebach atrioventricular blocks, which were reduced following atropine infusion, suggesting paroxysmal parasympathetic overdrive. In addition, Trpm4(-/-) mice exhibited shorter action potentials in atrial cells. This shortening was unrelated to modifications of the voltage-gated Ca2+ or K+ currents involved in the repolarizing phase. Conclusions: TRPM4 has pleiotropic roles in the heart, including the regulation of conduction and cellular electrical activity which impact heart development.	[Demion, Marie; Thireau, Jerome; Gueffier, Melanie; Finan, Amanda; Khoueiry, Ziad; Cassan, Cecile; Aimond, Franck; Granier, Mathieu; Pasquie, Jean-Luc; Richard, Sylvain] Univ Montpellier 2, Univ Montpellier 1, INSERM U1046, Montpellier, France; [Serafini, Nicolas; Launay, Pierre] Univ Paris 07, INSERM U1149, Equipe Avenir, Paris, France; [Pasquie, Jean-Luc] CHRU Montpellier, Serv Cardiol, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier	Launay, P (corresponding author), Univ Paris 07, INSERM U1149, Equipe Avenir, Paris, France.	pierre.launay@inserm.fr; sylvain.richard@inserm.fr	AIMOND, Franck/B-6024-2017; Launay, Pierre/AAH-7076-2019; marie, Demion/Q-8215-2016; Richard, Sylvain/C-9695-2016; Thireau, Jerome/C-5579-2016; SERAFINI, nicolas/S-5675-2019; Pasquié, Jean Luc/O-2216-2018	AIMOND, Franck/0000-0001-9124-0066; Thireau, Jerome/0000-0002-1641-5142; SERAFINI, nicolas/0000-0002-7440-4353; Pasquié, Jean Luc/0000-0003-3773-5804; Demion, Marie/0000-0003-4777-0654; Richard, Sylvain/0000-0001-9460-6705; Cassan, Cecile/0000-0003-2205-8222	Universite Montpellier; Agence Nationale de la Recherche ("Target channel'') [RPV09046FSA]; Agence Nationale de la Recherche ("Beat-genesis") [1128 03]; Region Languedoc-Roussillon (GEPETOS)	Universite Montpellier; Agence Nationale de la Recherche ("Target channel'')(French National Research Agency (ANR)); Agence Nationale de la Recherche ("Beat-genesis")(French National Research Agency (ANR)); Region Languedoc-Roussillon (GEPETOS)(Region Occitanie)	MD SR, grant from Universite Montpellier 2; PL MD SR, grant from Agence Nationale de la Recherche ("Target channel''; RPV09046FSA); SR, grant from Agence Nationale de la Recherche ("Beat-genesis" 2010 blanc 1128 03"); SR, grant from Region Languedoc-Roussillon (GEPETOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have	Abriel H, 2012, BIOCHEM PHARMACOL, V84, P873, DOI 10.1016/j.bcp.2012.06.021; Bagwe S, 2005, CIRCULATION, V112, P2245, DOI 10.1161/CIRCULATIONAHA.104.527325; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Brodde OE, 1999, PHARMACOL REV, V51, P651; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Burt R, 2013, CELL CALCIUM, V54, P193, DOI 10.1016/j.ceca.2013.06.003; Chang KTE, 2010, HUM PATHOL, V41, P1002, DOI 10.1016/j.humpath.2009.12.008; COLQUHOUN D, 1981, NATURE, V294, P752, DOI 10.1038/294752a0; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; DESIMONE G, 1987, AM J CARDIOL, V60, P1317, DOI 10.1016/0002-9149(87)90614-X; Dhingra R, 2005, J AM COLL CARDIOL, V45, P685, DOI 10.1016/j.jacc.2004.11.046; Du Y, 2010, AM J PATHOL, V177, P1155, DOI 10.2353/ajpath.2010.090587; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Fauconnier J, 2010, PROG BIOPHYS MOL BIO, V103, P71, DOI 10.1016/j.pbiomolbio.2010.01.002; FERRANS VJ, 1987, Z KARDIOL, V76, P20; Gemel J, 2014, J MOL CELL CARDIOL, V76, P159, DOI 10.1016/j.yjmcc.2014.08.021; Guinamard R, 2004, J PHYSIOL-LONDON, V558, P75, DOI 10.1113/jphysiol.2004.063974; Guinamard R, 2002, J MEMBRANE BIOL, V188, P127, DOI 10.1007/s00232-001-0180-4; Guinamard R, 2007, BBA-MOL BASIS DIS, V1772, P885, DOI 10.1016/j.bbadis.2007.02.007; Guinamard R, 2006, HYPERTENSION, V48, P587, DOI 10.1161/01.HYP.0000237864.65019.a5; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Hof T, 2013, HEART RHYTHM, V10, P1683, DOI 10.1016/j.hrthm.2013.08.014; Just A, 2000, AM J PHYSIOL-REG I, V279, pR2214, DOI 10.1152/ajpregu.2000.279.6.R2214; Kreuzberg MM, 2006, TRENDS CARDIOVAS MED, V16, P266, DOI 10.1016/j.tcm.2006.05.002; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054131; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; LUTAS EM, 1985, HYPERTENSION, V7, P979, DOI 10.1161/01.HYP.7.6.979; Mansier P, 1996, CARDIOVASC RES, V31, P371; Mathar I, 2014, CIRC RES, V114, P283, DOI 10.1161/CIRCRESAHA.114.302835; Mathar I, 2010, J CLIN INVEST, V120, P3267, DOI 10.1172/JCI41348; Mironov SL, 2011, J NEUROCHEM, V117, P295, DOI 10.1111/j.1471-4159.2011.07202.x; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; Ng SY, 2010, AM J PHYSIOL-CELL PH, V299, pC1234, DOI 10.1152/ajpcell.00402.2009; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; OLIVETTI G, 1992, AM J PATHOL, V141, P227; Richard S, 2006, PROG BIOPHYS MOL BIO, V90, P118, DOI 10.1016/j.pbiomolbio.2005.05.005; Royuela M, 2003, EUR J HISTOCHEM, V47, P29; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sah R, 2013, CIRCULATION, V128, P101, DOI 10.1161/CIRCULATIONAHA.112.000768; Silverman ME, 2004, CIRCULATION, V110, P1162, DOI 10.1161/01.CIR.0000140669.35049.34; Simard C, 2013, J MOL CELL CARDIOL, V59, P11, DOI 10.1016/j.yjmcc.2013.01.019; Simard Christophe, 2012, Br J Pharmacol, V165, P2354, DOI 10.1111/j.1476-5381.2011.01715.x; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Stull LB, 2006, PFLUG ARCH EUR J PHY, V452, P140, DOI 10.1007/s00424-005-0020-y; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Thireau J, 2008, EXP PHYSIOL, V93, P83, DOI 10.1113/expphysiol.2007.040733; Thireau J, 2010, ENDOCRINOLOGY, V151, P1837, DOI 10.1210/en.2009-1184; Trivedi CM, 2008, J BIOL CHEM, V283, P26484, DOI 10.1074/jbc.M803686200; Tseng YT, 2001, FASEB J, V15, P1921, DOI 10.1096/fj.01-0151com; van den Borne SWM, 2009, CARDIOVASC RES, V84, P273, DOI 10.1093/cvr/cvp207; Vanderbrink BA, 2000, J CARDIOVASC ELECTR, V11, P1270, DOI 10.1046/j.1540-8167.2000.01270.x; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; WANG J, 2013, PLOS GENET, V9, P70587, DOI DOI 10.1371/JOURNAL.PONE.0070587; Waters SB, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00011; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9	59	53	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115256	10.1371/journal.pone.0115256	http://dx.doi.org/10.1371/journal.pone.0115256			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531103	Green Published, gold			2022-12-26	WOS:000348845100046
J	Dou, F; Wight, JP; Wilson, LT; Storlien, JO; Hons, FM				Dou, Fugen; Wight, Jason P.; Wilson, Lloyd T.; Storlien, Joseph O.; Hons, Frank M.			Simulation of Biomass Yield and Soil Organic Carbon under Bioenergy Sorghum Production	PLOS ONE			English	Article							CROP RESIDUE REMOVAL; LONG-TERM EXPERIMENTS; NITROGEN-FERTILIZATION; MATTER FRACTIONS; ROOT CARBON; DNDC MODEL; TILLAGE; SEQUESTRATION; SYSTEMS; MANAGEMENT	Developing sustainable management practices including appropriate residue removal and nitrogen (N) fertilization for bioenergy sorghum is critical. However, the effects of residue removal and N fertilization associated with bioenergy sorghum production on soil organic carbon (SOC) are less studied compared to other crops. The objective of our research was to assess the impacts of residue removal and N fertilization on biomass yield and SOC under biomass sorghum production. Field measurements were used to calibrate the DNDC model, then verified the model by comparing simulated results with measured results using the field management practices as agronomic inputs. Both residue removal and N fertilization affected bioenergy sorghum yields in some years. The average measured SOC at 0-50 cm across the treatments and the time-frame ranged from 47.5 to 78.7 Mg C ha(-1), while the simulated SOC was from 56.3 to 67.3 Mg C ha(-1). The high correlation coefficients (0.65 to 0.99) and low root mean square error (3 to 18) between measured and simulated values indicate the DNDC model accurately simulated the effects of residue removal with N fertilization on bioenergy sorghum production and SOC. The model predictions revealed that there is, in the long term, a trend for higher SOC under bioenergy sorghum production regardless of residue management.	[Dou, Fugen; Wilson, Lloyd T.] Texas A&M AgriLife Res & Extens Ctr Beaumont, Beaumont, TX 77713 USA; [Wight, Jason P.; Storlien, Joseph O.; Hons, Frank M.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Dou, F (corresponding author), Texas A&M AgriLife Res & Extens Ctr Beaumont, Beaumont, TX 77713 USA.	f-dou@aesrg.tamu.edu	Wilson, Lloyd T/E-9971-2011	Wight, Jason/0000-0002-3523-4101	Texas A&M AgriLife Research Cropping Systems Program and USDA/NIFA Agriculture and Food Research Initiative [2011-67009-30050]	Texas A&M AgriLife Research Cropping Systems Program and USDA/NIFA Agriculture and Food Research Initiative	This research was funded by the Texas A&M AgriLife Research Cropping Systems Program and USDA/NIFA Agriculture and Food Research Initiative (grant #2011-67009-30050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Balesdent J, 2000, SOIL TILL RES, V53, P215, DOI 10.1016/S0167-1987(99)00107-5; Blanco-Canqui H, 2013, BIOENERG RES, V6, P358, DOI 10.1007/s12155-012-9221-3; Blanco-Canqui H, 2009, CRIT REV PLANT SCI, V28, P139, DOI 10.1080/07352680902776507; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P123, DOI 10.2136/sssaj1994.03615995005800010017x; Chirinda N, 2012, PLANT SOIL, V359, P321, DOI 10.1007/s11104-012-1208-5; Cibin R, 2012, HYDROL PROCESS, V26, P1629, DOI 10.1002/hyp.8280; Dou FG, 2013, PEDOSPHERE, V23, P409, DOI 10.1016/S1002-0160(13)60033-8; Dou F, 2008, SOIL SCI SOC AM J, V72, P1445, DOI 10.2136/sssaj2007.0230; Dou F, 2008, COMMUN SOIL SCI PLAN, V39, P667, DOI 10.1080/00103620701879117; Dou FG, 2006, SOIL SCI SOC AM J, V70, P1896, DOI 10.2136/sssaj2005.0229; Duiker SW, 1999, SOIL TILL RES, V52, P73, DOI 10.1016/S0167-1987(99)00059-8; Erickson JE, 2012, BIOENERG RES, V5, P86, DOI 10.1007/s12155-011-9129-3; Follett RF, 2001, SOIL TILL RES, V61, P77, DOI 10.1016/S0167-1987(01)00180-5; Galdos MV, 2009, SOIL SCI SOC AM J, V73, P802, DOI 10.2136/sssaj2007.0285; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hammerbeck AL, 2012, SOIL SCI SOC AM J, V76, P1390, DOI 10.2136/sssaj2011.0421; Hobbie SE, 2005, ECOSYSTEMS, V8, P644, DOI 10.1007/s10021-003-0110-7; Kering MK, 2012, BIOENERG RES, V5, P61, DOI 10.1007/s12155-011-9167-x; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Leip A, 2008, BIOGEOSCIENCES, V5, P73, DOI 10.5194/bg-5-73-2008; Li C., 2012, STEPS CALIBRATION VA; Li CS, 2006, ECOL MODEL, V196, P116, DOI 10.1016/j.ecolmodel.2006.02.007; Li CS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002045; Li CS, 1997, GEODERMA, V81, P45, DOI 10.1016/S0016-7061(97)00080-3; Maughan M, 2012, AGRON J, V104, P1032, DOI 10.2134/agronj2011.0408; Moebius-Clune BN, 2008, SOIL SCI SOC AM J, V72, P960, DOI 10.2136/sssaj2007.0248; OADES JM, 1984, PLANT SOIL, V76, P319, DOI 10.1007/BF02205590; Ouyang W, 2013, ECOL MODEL, V252, P228, DOI 10.1016/j.ecolmodel.2012.05.009; Pedroli B, 2013, BIOMASS BIOENERG, V55, P73, DOI 10.1016/j.biombioe.2012.09.054; Peltoniemi M, 2007, SILVA FENN, V41, P575, DOI 10.14214/sf.290; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Reeves DW, 1997, SOIL TILL RES, V43, P131, DOI 10.1016/S0167-1987(97)00038-X; Rufino MC, 2011, AGR SYST, V104, P175, DOI 10.1016/j.agsy.2010.06.001; Segoli M, 2013, ECOL MODEL, V263, P1, DOI 10.1016/j.ecolmodel.2013.04.010; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Smith P, 1997, GEODERMA, V81, P153, DOI 10.1016/S0016-7061(97)00087-6; Smith WN, 2012, AGR ECOSYST ENVIRON, V161, P27, DOI 10.1016/j.agee.2012.07.024; Solberg ED, 1998, ADV SOIL S, P235; Stewart CE, 2007, BIOGEOCHEMISTRY, V86, P19, DOI 10.1007/s10533-007-9140-0; Tang HJ, 2006, GEODERMA, V134, P200, DOI 10.1016/j.geoderma.2005.10.005; Wang LG, 2008, GEODERMA, V147, P47, DOI 10.1016/j.geoderma.2008.07.009; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Wight JP, 2012, BIOMASS BIOENERG, V46, P593, DOI 10.1016/j.biombioe.2012.06.036; Wilhelm WW, 2004, AGRON J, V96, P1, DOI 10.2134/agronj2004.0001; Zhang F, 2006, BIOGEOSCIENCES, V3, P451, DOI 10.5194/bg-3-451-2006; Zhao G, 2013, GLOBAL CHANGE BIOL, V19, P1585, DOI 10.1111/gcb.12145	49	23	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115598	10.1371/journal.pone.0115598	http://dx.doi.org/10.1371/journal.pone.0115598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531758	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100082
J	Huang, QL; Duan, ZG; Yang, JF; Ma, XY; Zhan, RT; Xu, H; Chen, WW				Huang, Qionglin; Duan, Zhonggang; Yang, Jinfen; Ma, Xinye; Zhan, Ruoting; Xu, Hui; Chen, Weiwen			SNP Typing for Germplasm Identification of Amomum villosum Lour. Based on DNA Barcoding Markers	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MOLECULAR AUTHENTICATION; MEDICINAL-PLANTS; SEQUENCE; PHYLOGENY; RDNA; NUCLEAR; REGION	Amomum villosum Lour., produced from Yangchun, Guangdong Province, China, is a Daodi medicinal material of Amomi Fructus in traditional Chinese medicine. This herb germplasm should be accurately identified and collected to ensure its quality and safety in medication. In the present study, single nucleotide polymorphism typing method was evaluated on the basis of DNA barcoding markers to identify the germplasm of Amomi Fructus. Genomic DNA was extracted from the leaves of 29 landraces representing three Amomum species (A. villosum Lour., A. xanthioides Wall. ex Baker and A. longiligulare T. L. Wu) by using the CTAB method. Six barcoding markers (ITS, ITS2, LSU D1-D3, matK, rbcL and trnH-psbA) were PCR amplified and sequenced; SNP typing and phylogenetic analysis were performed to differentiate the landraces. Results showed that high-quality bidirectional sequences were acquired for five candidate regions (ITS, ITS2, LSU D1-D3, matK, and rbcL) except trnH-psbA. Three ribosomal regions, namely, ITS, ITS2, and LSU D1-D3, contained more SNP genotypes (STs) than the plastid genes rbcL and matK. In the 29 specimens, 19 STs were detected from the combination of four regions (ITS, LSU D1-D3, rbcL, and matK). Phylogenetic analysis results further revealed two clades. Minimum-spanning tree demonstrated the existence of two main groups: group I was consisting of 9 STs (ST1-8 and ST11) of A. villosum Lour., and group II was composed of 3 STs (ST16-18) of A. longiligulare T. L. Wu. Our results suggested that ITS and LSU D1-D3 should be incorporated with the core barcodes rbcL and matK. The four combined regions could be used as a multiregional DNA barcode to precisely differentiate the Amomi Fructus landraces in different producing areas.	[Huang, Qionglin; Yang, Jinfen; Ma, Xinye; Zhan, Ruoting; Xu, Hui; Chen, Weiwen] Guangzhou Univ Chinese Med, Res Ctr Chinese Med Resource Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Huang, Qionglin; Yang, Jinfen; Ma, Xinye; Zhan, Ruoting; Xu, Hui; Chen, Weiwen] Minist Educ, Key Lab Chinese Med Resource Lingnan, Guangzhou, Guangdong, Peoples R China; [Duan, Zhonggang] Huizhou Univ, Dept Life Sci, Huizhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Huizhou University	Chen, WW (corresponding author), Guangzhou Univ Chinese Med, Res Ctr Chinese Med Resource Sci & Engn, Guangzhou, Guangdong, Peoples R China.	gdmchql2013@163.com			Special fund project of college discipline and specialty construction in Guangdong province of China [2013CXZDA011]	Special fund project of college discipline and specialty construction in Guangdong province of China	Special fund project of college discipline and specialty construction in Guangdong province of China (2013CXZDA011).	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Asahina H, 2010, J NAT MED-TOKYO, V64, P133, DOI 10.1007/s11418-009-0379-8; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; CHATTERTON NJ, 1992, PLANT MOL BIOL, V20, P163, DOI 10.1007/BF00029161; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chen W, 2007, STUDIES DAODI MED MA, P33; Chinese Pharmacopoeia Commission, 2010, PHARMACOPOEIA PEOPLE, V1, P236; de Paula Careta Francisco, 2012, Recent Pat DNA Gene Seq, V6, P122; Duan ZG, 2008, DNA BARCODING CHINES, P60; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Germano J, 1999, THEOR APPL GENET, V99, P37, DOI 10.1007/s001220051206; Heubl G, 2010, PLANTA MED, V76, P1963, DOI 10.1055/s-0030-1250519; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Huang Q, 2010, J GUANGZHOU U TRAD C, V27, P151; Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Kuzoff RK, 1998, MOL BIOL EVOL, V15, P251, DOI 10.1093/oxfordjournals.molbev.a025922; Lee Ok Ran, 2012, Methods Mol Biol, V862, P135, DOI 10.1007/978-1-61779-609-8_11; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Lou SK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-402; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Song JY, 2009, J ETHNOPHARMACOL, V124, P434, DOI 10.1016/j.jep.2009.05.042; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tate JA, 2003, SYST BOT, V28, P723; Tripathi AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057934; Wang HT, 2012, GENE, V494, P92, DOI 10.1016/j.gene.2011.11.026; Wang H, 2011, J PHARMACEUT BIOMED, V55, P972, DOI 10.1016/j.jpba.2011.03.037; Xu GJ, 2013, GENOME, V56, P109, DOI 10.1139/gen-2012-0182; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yuan Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05395; Zhao ZZ, 2012, J ETHNOPHARMACOL, V140, P476, DOI 10.1016/j.jep.2012.01.048	38	23	27	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114940	10.1371/journal.pone.0114940	http://dx.doi.org/10.1371/journal.pone.0114940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531885	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100033
J	Nilsen, ET; Freeman, J; Grene, R; Tokuhisa, J				Nilsen, Erik T.; Freeman, Joshua; Grene, Ruth; Tokuhisa, James			A Rootstock Provides Water Conservation for a Grafted Commercial Tomato (Solanum lycopersicum L.) Line in Response to Mild-Drought Conditions: A Focus on Vegetative Growth and Photosynthetic Parameters	PLOS ONE			English	Article							TOLERANCE; STRESS; PLANTS; PRODUCTIVITY	The development of water stress resistant lines of commercial tomato by breeding or genetic engineering is possible, but will take considerable time before commercial varieties are available for production. However, grafting commercial tomato lines on drought resistant rootstock may produce drought tolerant commercial tomato lines much more rapidly. Due to changing climates and the need for commercial production of vegetables in low quality fields there is an urgent need for stress tolerant commercial lines of vegetables such as tomato. In previous observations we identified a scion root stock combination ('BHN 602' scion grafted onto 'Jjak Kkung' rootstock hereafter identified as 602/Jjak) that had a qualitative drought-tolerance phenotype when compared to the non-grafted line. Based on this initial observation, we studied photosynthesis and vegetative above-ground growth during mild-drought for the 602/Jjak compared with another scion-rootstock combination ('BHN 602' scion grafted onto 'Cheong Gang' rootstock hereafter identified as 602/Cheong) and a non-grafted control. Overall above ground vegetative growth was significantly lower for 602/Jjak in comparison to the other plant lines. Moreover, water potential reduction in response to mild drought was significantly less for 602/Jjak, yet stomatal conductance of all plant-lines were equally inhibited by mild-drought. Light saturated photosynthesis of 602/Jjak was less affected by low water potential than the other two lines as was the % reduction in mesophyll conductance. Therefore, the Jjak Kkung rootstock caused aboveground growth reduction, water conservation and increased photosynthetic tolerance of mild drought. These data show that different rootstocks can change the photosynthetic responses to drought of a high yielding, commercial tomato line. Also, this rapid discovery of one scion-rootstock combination that provided mild-drought tolerance suggests that screening more scion-rootstock combination for stress tolerance may rapidly yield commercially viable, stress tolerant lines of tomato.	[Nilsen, Erik T.; Tokuhisa, James] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Freeman, Joshua] Univ Florida, North Florida Res & Educ Ctr, Quincy, FL 32611 USA; [Grene, Ruth] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; State University System of Florida; University of Florida; Virginia Polytechnic Institute & State University	Nilsen, ET (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	enilsen@vt.edu	Tokuhisa, James G/B-5664-2008	Tokuhisa, James G/0000-0002-3834-5149	Integrated Internal Competitive Grants Program	Integrated Internal Competitive Grants Program	This project was funded through the Integrated Internal Competitive Grants Program managed by the Virginia Agricultural Experiment Station (http://www.vaes.vt.edu). All authors were PIs on this award (JHF RG JGT ETN). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albacete A, 2009, PLANT CELL ENVIRON, V32, P928, DOI 10.1111/j.1365-3040.2009.01973.x; Bargmann BOR, 2009, PLANT CELL PHYSIOL, V50, P78, DOI 10.1093/pcp/pcn173; Bausher MG, 2011, HORTSCIENCE, V46, P596, DOI 10.21273/HORTSCI.46.4.596; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Martinez-Ballesta MC, 2010, SCI HORTIC-AMSTERDAM, V127, P112, DOI 10.1016/j.scienta.2010.08.002; Choi JY, 2011, PLANT CELL REP, V30, P867, DOI 10.1007/s00299-010-0989-3; CORNIC G, 1992, PHOTOSYNTHETICA, V27, P295; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Erzin V, 2010, ELECT J ENV AGR FOOD, V9, P1641; Fischer I, 2011, NEW PHYTOL, V190, P1032, DOI 10.1111/j.1469-8137.2011.03648.x; Gong PJ, 2010, J EXP BOT, V61, P3563, DOI 10.1093/jxb/erq167; He Y, 2009, ENVIRON EXP BOT, V66, P270, DOI 10.1016/j.envexpbot.2009.02.007; Holbrook NM, 2002, J EXP BOT, V53, P1503, DOI 10.1093/jexbot/53.373.1503; Isaakidis A, 2004, NEW ZEAL J CROP HORT, V32, P355, DOI 10.1080/01140671.2004.9514316; Jensen CR, 2010, AGR WATER MANAGE, V98, P403, DOI 10.1016/j.agwat.2010.10.018; Krishnamurthy KS, 2008, INDIAN J HORTIC, V65, P204; Lee JungMyung, 2003, Chronica Horticulturae, V43, P13; Liu YB, 2007, SCI CHINA SER C, V50, P15, DOI 10.1007/s11427-007-0002-8; Pire R, 2010, J FOOD AGRIC ENVIRON, V8, P703; Rivard CL, 2008, PHYTOPATHOLOGY, V98, pS133; Rivard CL, 2008, HORTSCIENCE, V43, P2104, DOI 10.21273/HORTSCI.43.7.2104; Sanchez-Rodriguez E, 2011, J PLANT PHYSIOL, V168, P816, DOI 10.1016/j.jplph.2010.11.018; Schwarz D, 2010, SCI HORTIC-AMSTERDAM, V127, P162, DOI 10.1016/j.scienta.2010.09.016; Sharma S, 2008, J HORTIC SCI BIOTECH, V83, P658, DOI 10.1080/14620316.2008.11512439; Silva VA, 2010, PESQUI AGROPECU BRAS, V45, P457, DOI 10.1590/S0100-204X2010000500004; Sommer KJ, 2010, S AFR J ENOL VITIC, V31, P181; Tuwei G, 2008, EXP AGR, V44, P537, DOI 10.1017/S0014479708006947; Xie TT, 2010, PAK J BOT, V42, P3981; Ziaf K, 2011, PLANT CELL PHYSIOL, V52, P1055, DOI 10.1093/pcp/pcr057	29	25	29	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115380	10.1371/journal.pone.0115380	http://dx.doi.org/10.1371/journal.pone.0115380			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531435	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100059
J	Cagavi, E; Bartulos, O; Suh, CY; Sun, BN; Yue, ZC; Jiang, ZX; Yue, LX; Qyang, YB				Cagavi, Esra; Bartulos, Oscar; Suh, Carol Y.; Sun, Baonan; Yue, Zhichao; Jiang, Zhengxin; Yue, Lixia; Qyang, Yibing			Functional Cardiomyocytes Derived from Isl1 Cardiac Progenitors via Bmp4 Stimulation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SMOOTH-MUSCLE; CARDIOVASCULAR PROGENITORS; DEVELOPING HEART; DIFFERENTIATION; MULTIPOTENT; MOUSE; EXPRESSION; RENEWAL; PATHWAY	As heart failure due to myocardial infarction remains a leading cause of morbidity worldwide, cell-based cardiac regenerative therapy using cardiac progenitor cells (CPCs) could provide a potential treatment for the repair of injured myocardium. As adult CPCs may have limitations regarding tissue accessibility and proliferative ability, CPCs derived from embryonic stem cells (ESCs) could serve as an unlimited source of cells with high proliferative ability. As one of the CPCs that can be derived from embryonic stem cells, Isl1 expressing cardiac progenitor cells (Isl1-CPCs) may serve as a valuable source of cells for cardiac repair due to their high cardiac differentiation potential and authentic cardiac origin. In order to generate an unlimited number of Isl1-CPCs, we used a previously established an ESC line that allows for isolation of Isl1-CPCs by green fluorescent protein (GFP) expression that is directed by the mef2c gene, specifically expressed in the Isl1 domain of the anterior heart field. To improve the efficiency of cardiac differentiation of Isl1-CPCs, we studied the role of Bmp4 in cardiogenesis of Isl1-CPCs. We show an inductive role of Bmp directly on cardiac progenitors and its enhancement on early cardiac differentiation of CPCs. Upon induction of Bmp4 to Isl1-CPCs during differentiation, the cTnT+ cardiomyocyte population was enhanced 2.8 +/- 0.4 fold for Bmp4 treated CPC cultures compared to that detected for vehicle treated cultures. Both Bmp4 treated and untreated cardiomyocytes exhibit proper electrophysiological and calcium signaling properties. In addition, we observed a significant increase in Tbx5 and Tbx20 expression in differentiation cultures treated with Bmp4 compared to the untreated control, suggesting a link between Bmp4 and Tbx genes which may contribute to the enhanced cardiac differentiation in Bmp4 treated cultures. Collectively these findings suggest a cardiomyogenic role for Bmp4 directly on a pure population of Isl1 expressing cardiac progenitors, which could lead to enhancement of cardiac differentiation and engraftment, holding a significant therapeutic value for cardiac repair in the future.	[Cagavi, Esra; Bartulos, Oscar; Suh, Carol Y.; Jiang, Zhengxin; Qyang, Yibing] Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr,Yale Cell Ctr,Sect Cardio, New Haven, CT 06510 USA; [Cagavi, Esra] Istanbul Medipol Univ, Sch Med, Dept Med Biol, Istanbul, Turkey; [Suh, Carol Y.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Sun, Baonan; Yue, Zhichao; Yue, Lixia] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT USA; [Qyang, Yibing] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Qyang, Yibing] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06510 USA	Yale University; Istanbul Medipol University; Yale University; University of Connecticut; Yale University; Yale University	Qyang, YB (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr,Yale Cell Ctr,Sect Cardio, New Haven, CT 06510 USA.	yibing.qyang@yale.edu		Cagavi, Esra/0000-0002-7199-583X; Bartulos Encinas, Oscar/0000-0003-0790-8583; Jiang, Zhengxin/0000-0002-0338-1481	AHA [09SDG2080420]; Connecticut Stem Cell Program [09SCAYALE10, 10SCA35, 11SCB18]; NIH [1K02HL116705-01, UL1 RR024139, R01HL078960]; National Science Foundation [DGE-1122492]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116705, K02HL101990, R01HL078960] Funding Source: NIH RePORTER	AHA(American Heart Association); Connecticut Stem Cell Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by AHA 09SDG2080420 (http://www.heart.org/HEARTORG/), Connecticut Stem Cell Program 09SCAYALE10, 10SCA35, 11SCB18 (http://www.ct.gov/dph/cwp/view.asp?a=3142&q=389700), NIH 1K02HL116705-01 and NIH UL1 RR024139/CTSA Scholar Award (http://grants.nih.gov/grants/guide/index.html)(Y. Qyang), National Science Foundation Graduate Research Fellowship DGE-1122492 (http://www.nsfgrfp.org/)(C. Suh) and NIH R01HL078960 (http://grants.nih.gov/grants/guide/index.html)(L. Yue). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Ben-David U, 2013, CELL STEM CELL, V12, P167, DOI 10.1016/j.stem.2012.11.015; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Clement S, 2007, J CELL SCI, V120, P229, DOI 10.1242/jcs.03340; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Engleka KA, 2012, CIRC RES, V110, P922, DOI 10.1161/CIRCRESAHA.112.266510; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee MO, 2013, P NATL ACAD SCI USA, V110, pE3281, DOI 10.1073/pnas.1303669110; Lee MY, 2011, BIOCHEM BIOPH RES CO, V416, P51, DOI 10.1016/j.bbrc.2011.10.140; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Mejia-Luna L, 2004, J PHYSIOL-LONDON, V559, P41, DOI 10.1113/jphysiol.2004.066852; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moretti A, 2010, FASEB J, V24, P700, DOI 10.1096/fj.09-139477; Musunuru K, 2010, ANNU REV CELL DEV BI, V26, P667, DOI 10.1146/annurev-cellbio-100109-103948; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nsair A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045603; Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; RUZICKA DL, 1988, J CELL BIOL, V107, P2575, DOI 10.1083/jcb.107.6.2575; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shen T, 2011, J CLIN INVEST, V110, DOI [10.1172/JCI59472.4640, DOI 10.1172/JCI59472.4640]; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Swapna I, 2012, P NATL ACAD SCI USA, V109, P16336, DOI 10.1073/pnas.1202818109; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Wang J, 2010, DEV CELL, V19, P903, DOI 10.1016/j.devcel.2010.10.022; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093	43	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e110752	10.1371/journal.pone.0110752	http://dx.doi.org/10.1371/journal.pone.0110752			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522363	Green Submitted, gold, Green Published			2022-12-26	WOS:000348845600001
J	Loizides-Mangold, U; Clement, S; Alfonso-Garcia, A; Branche, E; Conzelmann, S; Parisot, C; Potma, EO; Riezman, H; Negro, F				Loizides-Mangold, Ursula; Clement, Sophie; Alfonso-Garcia, Alba; Branche, Emilie; Conzelmann, Stephanie; Parisot, Clotilde; Potma, Eric O.; Riezman, Howard; Negro, Francesco			HCV 3a Core Protein Increases Lipid Droplet Cholesteryl Ester Content via a Mechanism Dependent on Sphingolipid Biosynthesis	PLOS ONE			English	Article							C VIRUS-INFECTION; TRIGLYCERIDE TRANSFER PROTEIN; ACTIVATED-RECEPTOR-ALPHA; CHRONIC HEPATITIS-C; SIGNAL-TRANSDUCTION; INSULIN-RESISTANCE; MASS-SPECTROMETRY; TRANSGENIC MICE; IN-VITRO; STEATOSIS	Hepatitis C virus (HCV) infected patients often develop steatosis and the HCV core protein alone can induce this phenomenon. To gain new insights into the pathways leading to steatosis, we performed lipidomic profiling of HCV core protein expressing-Huh-7 cells and also assessed the lipid profile of purified lipid droplets isolated from HCV 3a core expressing cells. Cholesteryl esters, ceramides and glycosylceramides, but not triglycerides, increased specifically in cells expressing the steatogenic HCV 3a core protein. Accordingly, inhibitors of cholesteryl ester biosynthesis such as statins and acyl-CoA cholesterol acyl transferase inhibitors prevented the increase of cholesteryl ester production and the formation of large lipid droplets in HCV core 3a-expressing cells. Furthermore, inhibition of de novo sphingolipid biosynthesis by myriocin - but not of glycosphingolipid biosynthesis by miglustat - affected both lipid droplet size and cholesteryl ester level. The lipid profile of purified lipid droplets, isolated from HCV 3a core-expressing cells, confirmed the particular increase of cholesteryl ester. Thus, both sphingolipid and cholesteryl ester biosynthesis are affected by the steatogenic core protein of HCV genotype 3a. These results may explain the peculiar lipid profile of HCV-infected patients with steatosis.	[Clement, Sophie; Branche, Emilie; Conzelmann, Stephanie; Parisot, Clotilde; Negro, Francesco] Univ Geneva, Sch Med, Univ Hosp, Div Clin Pathol, CH-1211 Geneva, Switzerland; [Negro, Francesco] Univ Geneva, Sch Med, Univ Hosp, Div Gastroenterol, CH-1211 Geneva, Switzerland; [Negro, Francesco] Univ Geneva, Sch Med, Univ Hosp, Div Hepatol, CH-1211 Geneva, Switzerland; [Loizides-Mangold, Ursula; Riezman, Howard] Univ Geneva, Dept Biochem, NCCR Chem Biol, CH-1211 Geneva, Switzerland; [Alfonso-Garcia, Alba; Potma, Eric O.] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA USA	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of California System; University of California Irvine	Negro, F (corresponding author), Univ Geneva, Sch Med, Univ Hosp, Div Clin Pathol, CH-1211 Geneva, Switzerland.	francesco.negro@hcuge.ch	Loizides-Mangold, Ursula/I-9061-2014	Loizides-Mangold, Ursula/0000-0001-9233-2974; Riezman, Howard/0000-0003-4680-9422; Alfonso-Garcia, Alba/0000-0002-6748-3751	University of Geneva; Swiss National Science Foundation; NCCR Chemical Biology and SystemsX.ch; SNSF [314730-130498, 314730-146991]; FLAGS Foundation; Balsells Fellowship Program	University of Geneva; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Chemical Biology and SystemsX.ch; SNSF(Swiss National Science Foundation (SNSF)); FLAGS Foundation; Balsells Fellowship Program	This work was supported by the University of Geneva; by the Swiss National Science Foundation (SNSF, http://www.snf.ch); the NCCR Chemical Biology and SystemsX.ch (http://www.systemsx.ch) evaluated by the SNSF to HR; by the SNSF (grants 314730-130498 and 314730-146991) to FN; by the FLAGS Foundation to SC and FN; and by the Balsells Fellowship Program to EOP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Amemiya F, 2008, J INFECT DIS, V197, P361, DOI 10.1086/525287; [Anonymous], 2014, HEPATOLOGY; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Birnbaum Y, 2014, CARDIOVASC DRUG THER, V28, P447, DOI 10.1007/s10557-014-6546-5; Brasaemle DL, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0315S29; Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002; Clement S, 2008, HEPATOLOGY, V48, P799, DOI 10.1002/hep.22404; Clement S, 2011, HEPATOLOGY, V54, P38, DOI 10.1002/hep.24340; Clement S, 2010, J HEPATOL, V52, P635, DOI 10.1016/j.jhep.2009.10.035; Corey KE, 2009, HEPATOLOGY, V50, P1030, DOI 10.1002/hep.23219; De Gottardi A, 2006, ALIMENT PHARM THER, V23, P107, DOI 10.1111/j.1365-2036.2006.02729.x; Dharancy S, 2005, GASTROENTEROLOGY, V128, P334, DOI 10.1053/j.gastro.2004.11.016; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; Forde KA, 2009, WORLD J GASTROENTERO, V15, P5020, DOI 10.3748/wjg.15.5020; Goswami R, 2005, J NEUROSCI RES, V81, P541, DOI 10.1002/jnr.20550; Grebely J, 2011, SEMIN LIVER DIS, V31, P331, DOI 10.1055/s-0031-1297922; Guan XL, 2010, METHOD ENZYMOL, V470, P369, DOI 10.1016/S0076-6879(10)70015-X; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; Hirata Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002860; Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232; Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603; Kim SS, 2007, GASTROENTEROLOGY, V132, P311, DOI 10.1053/j.gastro.2006.10.032; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Loizides-Mangold U, 2012, J LIPID RES, V53, P1522, DOI 10.1194/jlr.M025692; Machado MV, 2011, J GASTROEN HEPATOL, V26, P1361, DOI 10.1111/j.1440-1746.2011.06801.x; McPherson S, 2008, J HEPATOL, V49, P1046, DOI 10.1016/j.jhep.2008.06.022; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Mirandola S, 2006, GASTROENTEROLOGY, V130, P1661, DOI 10.1053/j.gastro.2006.02.035; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Moriya K, 2001, BIOCHEM BIOPH RES CO, V281, P1207, DOI 10.1006/bbrc.2001.4523; MURATA T, 1973, ANAL CHEM, V45, P1816, DOI 10.1021/ac60333a032; Nakamuta M, 2009, INT J MOL MED, V24, P825, DOI 10.3892/ijmm_00000299; Naples M, 2008, ATHEROSCLEROSIS, V198, P94, DOI 10.1016/j.atherosclerosis.2007.11.003; Nelson A, 2009, J CLIN GASTROENTEROL, V43, P990, DOI 10.1097/MCG.0b013e31819c392e; O'Leary JG, 2007, HEPATOLOGY, V45, P895, DOI 10.1002/hep.21554; Oem JK, 2008, J GEN VIROL, V89, P1225, DOI 10.1099/vir.0.83491-0; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Peyrou M, 2013, J HEPATOL, V59, P420, DOI 10.1016/j.jhep.2013.04.012; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Qiang G, 2009, VIRUS RES, V139, P127, DOI 10.1016/j.virusres.2008.10.008; Rabionet M, 2013, J LIPID RES, V54, P3312, DOI 10.1194/jlr.M040097; Read SA, 2014, J GEN VIROL, V95, P1900, DOI 10.1099/vir.0.065300-0; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Schrader M, 2001, J HISTOCHEM CYTOCHEM, V49, P1421, DOI 10.1177/002215540104901110; Serfaty L, 2001, J HEPATOL, V34, P428, DOI 10.1016/S0168-8278(00)00036-2; Sezaki H, 2009, INTERVIROLOGY, V52, P43, DOI 10.1159/000213504; Sugiyama K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094460; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Umehara T, 2006, BIOCHEM BIOPH RES CO, V346, P67, DOI 10.1016/j.bbrc.2006.05.085; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Woodhouse SD, 2010, HEPATOLOGY, V52, P443, DOI 10.1002/hep.23733; Yamaguchi A, 2005, DIGEST DIS SCI, V50, P1361, DOI 10.1007/s10620-005-2788-1; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008	61	18	18	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115309	10.1371/journal.pone.0115309	http://dx.doi.org/10.1371/journal.pone.0115309			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522003	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845600033
J	Shalini, S; Puccini, J; Wilson, CH; Finnie, J; Dorstyn, L; Kumar, S				Shalini, S.; Puccini, J.; Wilson, C. H.; Finnie, J.; Dorstyn, L.; Kumar, S.			Caspase-2 protects against oxidative stress in vivo	ONCOGENE			English	Article							DNA-DAMAGE RESPONSE; CELL-DEATH; ANTIOXIDANT DEFENSE; APOPTOSIS; PARAQUAT; ACTIVATION; PATHWAY; PHOSPHORYLATION; AUTOPHAGY; LIVER	Caspase-2 belongs to the caspase family of cysteine proteases with established roles in apoptosis. Recently, caspase-2 has been implicated in nonapoptotic functions including maintenance of genomic stability and tumor suppression. Our previous studies demonstrated that caspase-2 also regulates cellular redox status and delays the onset of several ageing-related traits. In the current study, we tested stress tolerance ability in caspase-2-deficient (Casp2(-/-)) mice by challenging both young and old mice with a low dose of the potent reactive oxygen species (ROS) generator, PQ that primarily affects lungs. In both groups of mice, PQ induced pulmonary damage. However, the lesions in caspase-2 knockout mice were consistently and reproducibly more severe than those in wild-type (WT) mice. Furthermore, serum interleukin (IL)-1 beta and IL-6 levels were higher in PQ-exposed aged Casp2(-/-) mice indicating increased inflammation. Interestingly, livers from Casp2(-/-)mice displayed karyomegaly, a feature commonly associated with ageing and aneuploidy. Given that Casp2(-/-) mice show impaired antioxidant defense, we tested oxidative damage in these mice. Protein oxidation significantly increased in PQ-injected old Casp2(-/-) mice. Moreover, FoxO1, SOD2 and Nrf2 expression levels were reduced and induction of superoxide dismutase (SOD) and glutathione peroxidase activity was not observed in PQ-treated Casp2(-/-) mice. Strong c-Jun amino-terminal kinase (JNK) activation was observed in Casp2(-/-) mice, indicative of increased stress. Together, our data strongly suggest that caspase-2 deficiency leads to increased cellular stress largely because these mice fail to respond to oxidative stress by upregulating their antioxidant defense mechanism. This makes the mice more vulnerable to exogenous challenges and may partly explain the shorter lifespan of Casp2(-/-) mice.	[Shalini, S.; Puccini, J.; Wilson, C. H.; Dorstyn, L.; Kumar, S.] Univ S Australia, Ctr Canc Biol, Adelaide, SA 5001, Australia; [Finnie, J.] Univ Adelaide, SA Pathol, Adelaide, SA, Australia; [Finnie, J.] Univ Adelaide, Sch Med & Vet Sci, Adelaide, SA, Australia	Centre for Cancer Biology; University of South Australia; SA Pathology; University of Adelaide; University of Adelaide	Kumar, S (corresponding author), Univ S Australia, Ctr Canc Biol, Adelaide, SA 5001, Australia.	sharad.kumar@unisa.edu.au	Kumar, Sharad/AAX-7787-2020; Dorstyn, Loretta/F-3673-2013	Kumar, Sharad/0000-0001-7126-9814; Dorstyn, Loretta/0000-0001-9886-0989; Shah, Sonia Shalini/0000-0002-9106-2324	National Health and Medical Research Council (NHMRC) [1021456, 1002863]; Cancer Council Research Fellowship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Research Fellowship(Cancer Council Australia)	We thank Jim Manavis for TUNEL, the staff at the SA Pathology animal resource facility for maintaining the mouse strains, and Swati Dawar for help with some of the immunoblots in Figure 4. This work was supported by the National Health and Medical Research Council (NHMRC) project grant (1021456), a Cancer Council Research Fellowship to LD and a NHMRC Senior Principal Research Fellowship (1002863) to SK.	Braga M, 2008, APOPTOSIS, V13, P822, DOI 10.1007/s10495-008-0216-7; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; BUS JS, 1976, TOXICOL APPL PHARM, V35, P501, DOI 10.1016/0041-008X(76)90073-9; BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dorstyn L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.342; Dorstyn L, 2012, CELL DEATH DIFFER, V19, P1288, DOI 10.1038/cdd.2012.36; Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430; Gonzalez-Polo RA, 2009, J NEUROCHEM, V109, P889, DOI 10.1111/j.1471-4159.2009.06020.x; Gorla GR, 2001, J CELL SCI, V114, P2943; HASSAN HM, 1979, J BIOL CHEM, V254, P846; He XQ, 2012, J PHARMACOL EXP THER, V342, P81, DOI 10.1124/jpet.112.194142; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Ikeyama S, 2002, FASEB J, V16, pA1163, DOI 10.1096/fj.01-0409fje; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jang S, 2008, P NATL ACAD SCI USA, V105, P7534, DOI 10.1073/pnas.0802865105; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Kurz T, 2007, ARCH BIOCHEM BIOPHYS, V462, P220, DOI 10.1016/j.abb.2007.01.013; Li J, 2003, FREE RADICAL BIO MED, V35, P292, DOI 10.1016/S0891-5849(03)00308-3; Li N, 2011, MECH AGEING DEV, V132, P75, DOI 10.1016/j.mad.2010.12.004; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Meng FY, 2012, AM J PATHOL, V181, P804, DOI 10.1016/j.ajpath.2012.06.010; Mercado N, 2011, BIOCHEM BIOPH RES CO, V406, P292, DOI 10.1016/j.bbrc.2011.02.035; Nakatani T, 1997, EXP CELL RES, V236, P137, DOI 10.1006/excr.1997.3715; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; O'Reilly LA, 2002, CELL DEATH DIFFER, V9, P832, DOI 10.1038/sj.cdd.4401033; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Panaretakis T, 2005, MOL BIOL CELL, V16, P3821, DOI 10.1091/mbc.E04-10-0862; Paroni G, 2004, MOL BIOL CELL, V15, P2804, DOI 10.1091/mbc.E03-08-0624; Parsons MJ, 2013, CELL DEATH DIFFER, V20, P1174, DOI 10.1038/cdd.2013.38; Puccini J, 2013, CELL DEATH DIFFER, V20, P1133, DOI 10.1038/cdd.2013.87; Puccini J, 2013, P NATL ACAD SCI USA, V110, P19920, DOI 10.1073/pnas.1311947110; Res Lopez A., 2012, RESP SYSTEM MEDIASTI, V529; Sanz N, 1997, J HEPATOL, V27, P525, DOI 10.1016/S0168-8278(97)80358-3; Shalini S, 2012, CELL DEATH DIFFER, V19, P1370, DOI 10.1038/cdd.2012.13; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Smith P, 1975, J Clin Pathol Suppl (R Coll Pathol), V9, P81, DOI 10.1136/jcp.28.Suppl_9.81; Tan M, 2013, TOXICOL LETT, V223, P1, DOI 10.1016/j.toxlet.2013.08.011; Thiruchelvam M, 2000, BRAIN RES, V873, P225, DOI 10.1016/S0006-8993(00)02496-3; Tiwari M, 2014, AUTOPHAGY, V10, P1054, DOI 10.4161/auto.28528; Tiwari M, 2011, J BIOL CHEM, V286, P8493, DOI 10.1074/jbc.M110.163824; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Zhang YP, 2007, MECH AGEING DEV, V128, P213, DOI 10.1016/j.mad.2006.11.030	48	22	22	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 17	2015	34	38					4995	5002		10.1038/onc.2014.413	http://dx.doi.org/10.1038/onc.2014.413			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9QZ	25531319				2022-12-26	WOS:000361693000009
J	Rosseels, J; Van den Brande, J; Violet, M; Jacobs, D; Grognet, P; Lopez, J; Huvent, I; Caldara, M; Swinnen, E; Papegaey, A; Caillierez, R; Buee-Scherrer, V; Engelborghs, S; Lippens, G; Colin, M; Buee, L; Galas, MC; Vanmechelen, E; Winderickx, J				Rosseels, Joelle; Van den Brande, Jeff; Violet, Marie; Jacobs, Dirk; Grognet, Pierre; Lopez, Juan; Huvent, Isabelle; Caldara, Marina; Swinnen, Erwin; Papegaey, Anthony; Caillierez, Raphaelle; Buee-Scherrer, Valerie; Engelborghs, Sebastiaan; Lippens, Guy; Colin, Morvane; Buee, Luc; Galas, Marie-Christine; Vanmechelen, Eugeen; Winderickx, Joris			Tau Monoclonal Antibody Generation Based on Humanized Yeast Models IMPACT ON TAU OLIGOMERIZATION AND DIAGNOSTICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; DEPENDENT AXONAL-TRANSPORT; CEREBROSPINAL-FLUID LEVELS; HUMAN PROTEIN-TAU; ALZHEIMERS-DISEASE; TRANSGENIC MOUSE; IN-VITRO; PHOSPHORYLATION; AGGREGATION; IDENTIFICATION	A link between Tau phosphorylation and aggregation has been shown in different models for Alzheimer disease, including yeast. We used human Tau purified from yeast models to generate new monoclonal antibodies, of which three were further characterized. The first antibody, ADx201, binds the Tau proline-rich region independently of the phosphorylation status, whereas the second, ADx215, detects an epitope formed by the Tau N terminus when Tau is not phosphorylated at Tyr(18). For the third antibody, ADx210, the binding site could not be deter-mined because its epitope is probably conformational. All three antibodies stained tangle-like structures in different brain sections of THY-Tau22 transgenic mice and Alzheimer patients, and ADx201 and ADx210 also detected neuritic plaques in the cortex of the patient brains. In hippocampal homogenates from THY-Tau22 mice and cortex homogenates obtained from Alzheimer patients, ADx215 consistently stained specific low order Tau oligomers in diseased brain, which in size correspond to Tau dimers. ADx201 and ADx210 additionally reacted to higher order Tau oligomers and presumed prefibrillar structures in the patient samples. Our data further suggest that formation of the low order Tau oligomers marks an early disease stage that is initiated by Tau phosphorylation at N-terminal sites. Formation of higher order oligomers appears to require additional phosphorylation in the C terminus of Tau. When used to assess Tau levels in human cerebrospinal fluid, the antibodies permitted us to discriminate patients with Alzheimer disease or other dementia like vascular dementia, indicative that these antibodies hold promising diagnostic potential.	[Rosseels, Joelle; Van den Brande, Jeff; Caldara, Marina; Swinnen, Erwin; Winderickx, Joris] Katholieke Univ Leuven, B-3001 Heverlee, Belgium; [Van den Brande, Jeff; Jacobs, Dirk; Vanmechelen, Eugeen] ADx NeuroSci NV, Technol Pk Zwijnaarde 4, B-9052 Ghent, Belgium; [Van den Brande, Jeff; Grognet, Pierre] Fujirebio Europe, B-9052 Ghent, Belgium; [Violet, Marie; Papegaey, Anthony; Caillierez, Raphaelle; Buee-Scherrer, Valerie; Colin, Morvane; Buee, Luc; Galas, Marie-Christine] JPArc Alzheimer & Tauopathies, UMR1172, INSERM, F-59045 Lille, France; [Violet, Marie; Papegaey, Anthony; Caillierez, Raphaelle; Buee-Scherrer, Valerie; Colin, Morvane; Buee, Luc; Galas, Marie-Christine] Univ Lille, Fac Med, F-59045 Lille, France; [Violet, Marie; Papegaey, Anthony; Caillierez, Raphaelle; Buee-Scherrer, Valerie; Colin, Morvane; Buee, Luc; Galas, Marie-Christine] Ctr Hosp Reg Univ Lille, Memory Clin, F-59037 Lille, France; [Lopez, Juan; Huvent, Isabelle; Lippens, Guy] Univ Lille Nord France, F-59000 Lille, France; [Lopez, Juan; Huvent, Isabelle; Lippens, Guy] CNRS, Struct & Funct Glycobiol UMR8576, F-59650 Villeneuve Dascq, France; [Engelborghs, Sebastiaan] Univ Antwerp, Inst Born Bunge, Reference Ctr Biol Markers Dementia BIODEM, B-2610 Antwerp, Belgium; [Engelborghs, Sebastiaan] Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Dept Neurol, B-2660 Antwerp, Belgium; [Engelborghs, Sebastiaan] Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Memory Clin, B-2660 Antwerp, Belgium	KU Leuven; H.U. Group Holdings Inc; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Antwerp	Vanmechelen, E (corresponding author), ADx NeuroSci NV, Technol Pk Zwijnaarde 4, B-9052 Ghent, Belgium.	Eugeen.vanmechelen@adxneurosciences.com; joris.winderickx@bio.kuleuven.be	Galas, Marie-Christine/AAL-9812-2020; BUEE, Luc/B-3126-2010; Vanmechelen, Eugeen/AAA-8005-2019	BUEE, Luc/0000-0002-6261-4230; swinnen, erwin/0000-0002-6311-7260; Huvent, Isabelle/0000-0002-7241-0290; lopez, juan/0000-0002-5390-6610; Buee-Scherrer, Valerie/0000-0002-6107-1289; Colin, Morvane/0000-0003-0611-4167; Lippens, Guy/0000-0002-8236-0901; Galas, Marie-Christine/0000-0002-3766-7103; Vanmechelen, Eugeen/0000-0002-9466-5366	Research Foundation Flanders (FWO-Vlaanderen); KU Leuven Research Fund (KU Leuven-BOF); KU Leuven Research Fund (KU Leuven-IOF); KU Leuven RD; Agency for Innovation by Science and Technology (IWT); IWT Ph.D. fellowship; FWO-Vlaanderen postdoctoral fellowships; LabEx DISTALZ (Excellent Laboratory-Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease); CNRS Large Scale Facility NMR THC [Fr3050]; INSERM; CNRS; University of Lille 2; Lille Metropole Communaute Urbaine (LMCU); Region Nord/Pas-de-Calais; FEDER; University of Antwerp Research Fund; Alzheimer Research Foundation (SAO-FRA); central Biobank facility of the Institute Born-Bunge/University Antwerp; Belgian Science Policy Office Interuniversity Attraction Poles (IAP) program; Flemish Government	Research Foundation Flanders (FWO-Vlaanderen)(FWO); KU Leuven Research Fund (KU Leuven-BOF)(KU Leuven); KU Leuven Research Fund (KU Leuven-IOF); KU Leuven RD(KU Leuven); Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); IWT Ph.D. fellowship; FWO-Vlaanderen postdoctoral fellowships; LabEx DISTALZ (Excellent Laboratory-Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease); CNRS Large Scale Facility NMR THC; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lille 2; Lille Metropole Communaute Urbaine (LMCU); Region Nord/Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); FEDER(European Commission); University of Antwerp Research Fund; Alzheimer Research Foundation (SAO-FRA); central Biobank facility of the Institute Born-Bunge/University Antwerp(General Electric); Belgian Science Policy Office Interuniversity Attraction Poles (IAP) program; Flemish Government(European Commission)	This work was supported by grants from the Research Foundation Flanders (FWO-Vlaanderen) (to J. W. and S. E.), KU Leuven Research Fund (KU Leuven-BOF; KU Leuven-IOF), KU Leuven R&D (to J. W.), and the Agency for Innovation by Science and Technology (IWT) (to J. W., E. V., and S. E.). This work was also supported by an IWT Ph.D. fellowship (to J. V. d. B.) and FWO-Vlaanderen postdoctoral fellowships (to M. C. and E. S.). This work was also supported through the LabEx DISTALZ (Excellent Laboratory-Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease), the CNRS Large Scale Facility NMR THC Fr3050, INSERM, CNRS, University of Lille 2, Lille Metropole Communaute Urbaine (LMCU), Region Nord/Pas-de-Calais, FEDER, the University of Antwerp Research Fund, the Alzheimer Research Foundation (SAO-FRA), the central Biobank facility of the Institute Born-Bunge/University Antwerp, the Belgian Science Policy Office Interuniversity Attraction Poles (IAP) program, and the Flemish Government initiated Methusalem excellence grant. J. W. and E. V. are both co-founders of ADx NeuroSciences and co-inventors on the patent entitled Antibodies to Phosphorylated Tau Aggregates (WO2013007839 (A1)).	Amniai L, 2011, BIOCHEM BIOPH RES CO, V412, P743, DOI 10.1016/j.bbrc.2011.08.046; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Bhaskar K, 2010, NEUROPATH APPL NEURO, V36, P462, DOI 10.1111/j.1365-2990.2010.01103.x; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Buerger K, 2005, NEUROLOGY, V65, P1502, DOI 10.1212/01.wnl.0000183284.92920.f2; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Buttner S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013700; Caillierez R, 2013, MOL THER, V21, P1358, DOI 10.1038/mt.2013.66; Castillo-Carranza DL, 2014, J ALZHEIMERS DIS, V40, pS97, DOI 10.3233/JAD-132477; Cowan CM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00114; D'Angelo F, 2013, DIS MODEL MECH, V6, P206, DOI 10.1242/dmm.010108; De Vos Ann, 2011, Int J Alzheimers Dis, V2011, P428970, DOI 10.4061/2011/428970; DELACOURTE A, 1986, J NEUROL SCI, V76, P173, DOI 10.1016/0022-510X(86)90167-X; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; Dujardin S, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-14; Galvan M, 2001, J ALZHEIMERS DIS, V3, P417, DOI 10.3233/JAD-2001-3409; Gamblin TC, 2003, BIOCHEMISTRY-US, V42, P2252, DOI 10.1021/bi0272510; Gendreau KL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00160; Gerson JE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00093; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Gottschalk PG, 2005, ANAL BIOCHEM, V343, P54, DOI 10.1016/j.ab.2005.04.035; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Haroutunian V, 2007, NEUROBIOL AGING, V28, P1, DOI 10.1016/j.neurobiolaging.2005.11.001; Hertze J, 2010, J ALZHEIMERS DIS, V21, P1119, DOI 10.3233/JAD-2010-100207; Iqbal K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00112; Irwin DJ, 2012, ARCH NEUROL-CHICAGO, V69, P1018, DOI 10.1001/archneurol.2012.26; Irwin DJ, 2012, BRAIN, V135, P807, DOI 10.1093/brain/aws013; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Kanaan NM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.006; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kato Y, 2009, BIOCHEM BIOPH RES CO, V390, P547, DOI 10.1016/j.bbrc.2009.10.001; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kimura T, 1996, DEMENTIA, V7, P177, DOI 10.1159/000106875; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Le Bastard N, 2013, J ALZHEIMERS DIS, V33, P117, DOI 10.3233/JAD-2012-121246; Lin YT, 2007, J NEUROCHEM, V103, P802, DOI 10.1111/j.1471-4159.2007.04792.x; Lippens G, 2004, CHEMBIOCHEM, V5, P73, DOI 10.1002/cbic.200300763; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mondragon-Rodriguez S, 2014, NEUROPATH APPL NEURO, V40, P121, DOI 10.1111/nan.12084; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Paton D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067364; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROSNER H, 1994, NEUROREPORT, V5, P1164; Sahara N, 2002, J NEUROCHEM, V83, P1498, DOI 10.1046/j.1471-4159.2002.01241.x; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Sergeant N, 2008, EXPERT REV PROTEOMIC, V5, P207, DOI 10.1586/14789450.5.2.207; Sjogren M, 2001, DEMENT GERIATR COGN, V12, P257, DOI 10.1159/000051268; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Vandebroek T, 2005, BIOCHEMISTRY-US, V44, P11466, DOI 10.1021/bi0506775; Vandebroek T, 2006, J BIOL CHEM, V281, P25388, DOI 10.1074/jbc.M602792200; Vanhelmont T, 2010, FEMS YEAST RES, V10, P992, DOI 10.1111/j.1567-1364.2010.00662.x; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; Ward SM, 2013, J ALZHEIMERS DIS, V37, P593, DOI 10.3233/JAD-131235; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Winderickx J, 2008, BBA-MOL CELL RES, V1783, P1381, DOI 10.1016/j.bbamcr.2008.01.020; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046	66	16	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4059	4074		10.1074/jbc.M114.627919	http://dx.doi.org/10.1074/jbc.M114.627919			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25540200	hybrid, Green Published			2022-12-26	WOS:000349458400018
J	Ganai, RA; Osterman, P; Johansson, E				Ganai, Rais A.; Osterman, Pia; Johansson, Erik			Yeast DNA Polymerase epsilon Catalytic Core and Holoenzyme Have Comparable Catalytic Rates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC REPLICATION FORK; OKAZAKI FRAGMENT MATURATION; STATE KINETIC-ANALYSIS; SACCHAROMYCES-CEREVISIAE; HIGH-FIDELITY; S-PHASE; NUCLEOTIDE INCORPORATION; EXONUCLEASE ACTIVITY; ACTIVE-SITE; DELTA	The holoenzyme of yeast DNA polymerase epsilon (Pol epsilon) consists of four subunits: Pol2, Dpb2, Dpb3, and Dpb4. A protease-sensitive site results in an N-terminal proteolytic fragment of Pol2, called Pol2(core), that consists of the catalytic core of Pol epsilon and retains both polymerase and exonuclease activities. Pre-steady-state kinetics showed that the exonuclease rates on single-stranded, double-stranded, and mismatched DNA were comparable between Pol epsilon and Pol2(core). Single-turnover pre-steady- state kinetics also showed that the k(pol) of Pol epsilon and Pol2(core) were comparable when preloading the polymerase onto the primer-template before adding Mg2+ epsilon and dTTP. However, a global fit of the data over six sequential nucleotide incorporations revealed that the overall polymerization rate and processivity were higher for Pol epsilon than for Pol2(core). The largest difference between Pol epsilon and Pol2(core) was observed when challenged for the formation of a ternary complex and incorporation of the first nucleotide. Pol epsilon needed less than 1 s to incorporate a nucleotide, but several seconds passed before Pol2(core) incorporated detectable levels of the first nucleotide. We conclude that the accessory subunits and the C terminus of Pol2 do not influence the catalytic rate of Pol epsilon but facilitate the loading and incorporation of the first nucleotide by Pol epsilon.	[Ganai, Rais A.; Osterman, Pia; Johansson, Erik] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden	Umea University	Johansson, E (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	erik.johansson@medchem.umu.se		Johansson, Erik/0000-0002-8526-6224; Osterman, Pia/0000-0001-9360-0782	Swedish Research Council; Swedish Cancer Society; Kempe Foundations; Knut and Alice Wallenberg Foundation; Insamlingstiftelsen at the medical faculty of Umea Universitet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Kempe Foundations; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Insamlingstiftelsen at the medical faculty of Umea Universitet	This work was supported in part by grants from the Swedish Research Council, the Swedish Cancer Society, the Kempe Foundations, the Knut and Alice Wallenberg Foundation, and Insamlingstiftelsen at the medical faculty of Umea Universitet.	Aksenova A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001209; Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Aria V, 2013, J BIOL CHEM, V288, P12742, DOI 10.1074/jbc.M112.398073; Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; BLOOM LB, 1994, BIOCHEMISTRY-US, V33, P7576, DOI 10.1021/bi00190a010; Brown JA, 2009, BIOCHEMISTRY-US, V48, P7502, DOI 10.1021/bi9005336; BUDD ME, 1989, J BIOL CHEM, V264, P6557; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Cho WH, 2013, P NATL ACAD SCI USA, V110, P2523, DOI 10.1073/pnas.1222494110; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; Dieckman LM, 2010, BIOCHEMISTRY-US, V49, P7344, DOI 10.1021/bi100556m; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Dunlap CA, 2002, BIOCHEMISTRY-US, V41, P11226, DOI 10.1021/bi025837g; Feng WY, 2003, MOL BIOL CELL, V14, P3427, DOI 10.1091/mbc.E03-02-0088; Fortune JM, 2005, J BIOL CHEM, V280, P29980, DOI 10.1074/jbc.M505236200; Georgescu RE, 2014, NAT STRUCT MOL BIOL, V21, P664, DOI 10.1038/nsmb.2851; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Goksenin AY, 2012, J BIOL CHEM, V287, P42675, DOI 10.1074/jbc.M112.422733; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; HAMATAKE RK, 1990, J BIOL CHEM, V265, P4072; Hogg M, 2006, NUCLEIC ACIDS RES, V34, P2528, DOI 10.1093/nar/gkl300; Hogg M, 2014, NAT STRUCT MOL BIOL, V21, P49, DOI 10.1038/nsmb.2712; Hogg M, 2010, BIOCHEMISTRY-US, V49, P2317, DOI 10.1021/bi901488d; Jaszczur M, 2008, GENETICS, V178, P633, DOI 10.1534/genetics.107.082818; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; JOYCE CM, 1992, J BIOL CHEM, V267, P24485; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kane DP, 2014, CANCER RES, V74, P1895, DOI 10.1158/0008-5472.CAN-13-2892; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; MORRISON A, 1994, MOL GEN GENET, V242, P289, DOI 10.1007/BF00280418; MORRISON A, 1991, P NATL ACAD SCI USA, V88, P9473, DOI 10.1073/pnas.88.21.9473; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; NAVAS TA, 1995, CELL, V80, P29, DOI 10.1016/0092-8674(95)90448-4; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pursell ZF, 2007, NUCLEIC ACIDS RES, V35, P3076, DOI 10.1093/nar/gkm132; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; RIVIN CJ, 1980, J CELL BIOL, V85, P108, DOI 10.1083/jcb.85.1.108; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Sabouri N, 2008, NUCLEIC ACIDS RES, V36, P5660, DOI 10.1093/nar/gkn555; Sabouri N, 2009, J BIOL CHEM, V284, P31555, DOI 10.1074/jbc.M109.043927; Sengupta S, 2013, CURR BIOL, V23, P543, DOI 10.1016/j.cub.2013.02.011; Shcherbakova PV, 2003, J BIOL CHEM, V278, P43770, DOI 10.1074/jbc.M306893200; Shinbrot E, 2014, GENOME RES, V24, P1740, DOI 10.1101/gr.174789.114; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Tsubotao T, 2006, J BIOL CHEM, V281, P32898, DOI 10.1074/jbc.M606637200; Yao NY, 2013, P NATL ACAD SCI USA, V110, P12942, DOI 10.1073/pnas.1309506110; Zahurancik WJ, 2014, NUCLEIC ACIDS RES, V42, P13853, DOI 10.1093/nar/gku1184; Zahurancik WJ, 2013, BIOCHEMISTRY-US, V52, P7041, DOI 10.1021/bi400803v	59	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3825	3835		10.1074/jbc.M114.615278	http://dx.doi.org/10.1074/jbc.M114.615278			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25538242	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000349456000053
J	Corominas-Murtra, B; Fuchs, B; Thurner, S				Corominas-Murtra, Bernat; Fuchs, Benedikt; Thurner, Stefan			Detection of the Elite Structure in a Virtual Multiplex Social System by Means of a Generalised K-Core	PLOS ONE			English	Article							COMPLEX NETWORKS; COMMUNITY STRUCTURE; ORGANIZATION; EMERGENCE; SOCIETY	Elites are subgroups of individuals within a society that have the ability and means to influence, lead, govern, and shape societies. Members of elites are often well connected individuals, which enables them to impose their influence to many and to quickly gather, process, and spread information. Here we argue that elites are not only composed of highly connected individuals, but also of intermediaries connecting hubs to form a cohesive and structured elite-subgroup at the core of a social network. For this purpose we present a generalization of the K-core algorithm that allows to identify a social core that is composed of well-connected hubs together with their 'connectors'. We show the validity of the idea in the framework of a virtual world defined by a massive multiplayer online game, on which we have complete information of various social networks. Exploiting this multiplex structure, we find that the hubs of the generalised K-core identify those individuals that are high social performers in terms of a series of indicators that are available in the game. In addition, using a combined strategy which involves the generalised K-core and the recently introduced M-core, the elites of the different 'nations' present in the game are perfectly identified as modules of the generalised K-core. Interesting sudden shifts in the composition of the elite cores are observed at deep levels. We show that elite detection with the traditional K-core is not possible in a reliable way. The proposed method might be useful in a series of more general applications, such as community detection.	[Corominas-Murtra, Bernat; Fuchs, Benedikt; Thurner, Stefan] Med Univ Vienna, Sect Sci Complex Syst, A-1090 Vienna, Austria; [Thurner, Stefan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Thurner, Stefan] IIASA, A-2361 Laxenburg, Austria	Medical University of Vienna; The Santa Fe Institute; International Institute for Applied Systems Analysis (IIASA)	Thurner, S (corresponding author), Med Univ Vienna, Sect Sci Complex Syst, Spitalgasse 23, A-1090 Vienna, Austria.	stefan.thurner@meduniwien.ac.at		Corominas-Murtra, Bernat/0000-0001-9806-5643	Austrian Science Fund FWF [KPP23378FW]; EU LASAGNE project [318132]; MULTIPLEX project [318132]; EU; Austrian Science Fund (FWF) [P 23378] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); EU LASAGNE project; MULTIPLEX project; EU(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding provided by Austrian Science Fund FWF under KPP23378FW, http://www.fwf.ac.at/en/, EU LASAGNE project, no. 318132 and the EU http://lasagne-project.eu/ and MULTIPLEX project, no. 318132, http://www.multiplexproject.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bianconi G, 2006, EUROPHYS LETT, V74, P740, DOI 10.1209/epl/i2005-10574-3; Bianconi G, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062806; Bollobas B., 1984, GRAPH THEORY COMBINA, P35; Bottomore T, 1993, ELITES SOC; Castronova Edward, 2005, SYNTHETIC WORLDS BUS; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Colomer-de-Simon P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02517; Corominas-Murtra B, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/18004; Corominas-Murtra B, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/38/385003; Davidsen J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.128701; Dorogovtsev SN, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.040601; Freeman LC, 1978, SOC NETWORKS, P215; FRIEDKIN NE, 1984, SOCIOL METHOD RES, V12, P235, DOI 10.1177/0049124184012003001; Fuchs B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103503; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; HARARY F, 1957, SOCIOMETRY, V20, P205, DOI 10.2307/2785673; Keller Suzanne, 1963, RULING CLASS; Klimek P, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/063008; Mills C. Wright, 1956, POWER ELITE; MILLS CW, 1958, BRIT J SOCIOL, V9, P29, DOI 10.2307/587620; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Newman ME, 2001, PHYS REV E, V64; Nicosia V, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.058701; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pierce William, 1967, WHO RULES AM, P17; RAPOPORT ANATOL, 1953, BULL MATH BIOPHYS, V15, P523, DOI 10.1007/BF02476440; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X; Szell M, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500646; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Szell M, 2010, SOC NETWORKS, V32, P313, DOI 10.1016/j.socnet.2010.06.001; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	34	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e112606	10.1371/journal.pone.0112606	http://dx.doi.org/10.1371/journal.pone.0112606			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25541957	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000347239900005
J	Desta, AF; Assefa, F; Leta, S; Stomeo, F; Wamalwa, M; Njahira, M; Appolinaire, D				Desta, Adey Feleke; Assefa, Fassil; Leta, Seyoum; Stomeo, Francesca; Wamalwa, Mark; Njahira, Moses; Appolinaire, Djikeng			Microbial Community Structure and Diversity in an Integrated System of Anaerobic-Aerobic Reactors and a Constructed Wetland for the Treatment of Tannery Wastewater in Modjo, Ethiopia	PLOS ONE			English	Article							BACTERIAL COMMUNITY; BIOLOGICAL NITROGEN; PHOSPHORUS REMOVAL; CHROMIUM REMOVAL; DIFFERENT PLANTS; SP NOV.; DYNAMICS; EFFLUENT; PERFORMANCE	A culture-independent approach was used to elucidate the microbial diversity and structure in the anaerobic-aerobic reactors integrated with a constructed wetland for the treatment of tannery wastewater in Modjo town, Ethiopia. The system has been running with removal efficiencies ranging from 94%-96% for COD, 91%-100% for SO4(2-) and S2-, 92%-94% for BOD, 56%-82% for total Nitrogen and 2%-90% for NH3-N. 16S rRNA gene clone libraries were constructed and microbial community assemblies were determined by analysis of a total of 801 unique clone sequences from all the sites. Operational Taxonomic Unit (OTU) -based analysis of the sequences revealed highly diverse communities in each of the reactors and the constructed wetland. A total of 32 phylotypes were identified with the dominant members affiliated to Clostridia (33%), Betaproteobacteria (10%), Bacteroidia (10%), Deltaproteobacteria (9%) and Gammaproteobacteria (6%). Sequences affiliated to the class Clostridia were the most abundant across all sites. The 801 sequences were assigned to 255 OTUs, of which 3 OTUs were shared among the clone libraries from all sites. The shared OTUs comprised 80 sequences belonging to Clostridiales Family XIII Incertae Sedis, Bacteroidetes and unclassified bacterial group. Significantly different communities were harbored by the anaerobic, aerobic and rhizosphere sites of the constructed wetland. Numerous representative genera of the dominant bacterial classes obtained from the different sample sites of the integrated system have been implicated in the removal of various carbon-containing pollutants of natural and synthetic origins. To our knowledge, this is the first report of microbial community structure in tannery wastewater treatment plant from Ethiopia.	[Desta, Adey Feleke; Assefa, Fassil] Univ Addis Ababa, Inst Biotechnol, Addis Ababa, Ethiopia; [Leta, Seyoum] Univ Addis Ababa, Coll Nat Sci, Ctr Environm Sci, Addis Ababa, Ethiopia; [Stomeo, Francesca; Wamalwa, Mark; Njahira, Moses; Appolinaire, Djikeng] Biosci Eastern & Cent Africa Int Livestock Res Be, Nairobi, Kenya	Addis Ababa University; Addis Ababa University	Desta, AF (corresponding author), Univ Addis Ababa, Inst Biotechnol, Addis Ababa, Ethiopia.	adey.desta@gmail.com		Wamalwa, Mark/0000-0001-7714-2697; Djikeng, Appolinaire/0000-0001-9271-3419; Leta, Seyoum/0000-0003-3774-4663; Desta, Adey/0000-0001-6431-7363	Swedish International Development cooperation Agency (SIDA) via East African Regional Programme; Research Network for Biotechnology, Biosafety and Policy Development (BID-EARN); Syngenta Foundation for Sustainable Agriculture (SFSA) via biosciences Eastern and Central Africa (BecA)	Swedish International Development cooperation Agency (SIDA) via East African Regional Programme; Research Network for Biotechnology, Biosafety and Policy Development (BID-EARN); Syngenta Foundation for Sustainable Agriculture (SFSA) via biosciences Eastern and Central Africa (BecA)	Funding: Funding was provided by the Swedish International Development cooperation Agency (SIDA) via the East African Regional Programme and Research Network for Biotechnology, Biosafety and Policy Development (BID-EARN) and Syngenta Foundation for Sustainable Agriculture (SFSA) via the biosciences Eastern and Central Africa (BecA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KTW, 1992, J SOC LEATH TECH CH, V76, P17; Amann R, 1998, FEMS MICROBIOL ECOL, V25, P205, DOI 10.1111/j.1574-6941.1998.tb00473.x; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Blackall LL, 2002, ANTON LEEUW INT J G, V81, P681, DOI 10.1023/A:1020538429009; Bosnic M, 2000, USRAS92120 UN IND DE, P17; Bruser T, 2000, J BIOL CHEM, V275, P1691, DOI 10.1074/jbc.275.3.1691; Burns AS, 2012, BIODEGRADATION, V23, P415, DOI 10.1007/s10532-011-9520-y; Calheiros CSC, 2010, WATER RES, V44, P5032, DOI 10.1016/j.watres.2010.07.017; Calheiros CSC, 2009, BIORESOURCE TECHNOL, V100, P3228, DOI 10.1016/j.biortech.2009.02.033; Castello E, 2011, WATER SCI TECHNOL, V64, P2265, DOI 10.2166/wst.2011.706; Cheng L, 2013, FEMS MICROBIOL ECOL, V85, P568, DOI 10.1111/1574-6941.12141; Collins B, 2004, ECOL ENG, V23, P107, DOI 10.1016/j.ecoleng.2004.07.005; Contzen M, 2000, SYST APPL MICROBIOL, V23, P487, DOI 10.1016/S0723-2020(00)80022-3; Dabert P, 2001, WATER SCI TECHNOL, V43, P1; Domingo JWS, 2011, BIOFOULING, V27, P993, DOI 10.1080/08927014.2011.618637; Dong YR, 2011, BIODEGRADATION, V22, P431, DOI 10.1007/s10532-010-9416-2; Dubbels BL, 2009, INT J SYST EVOL MICR, V59, P1576, DOI 10.1099/ijs.0.000638-0; Durai G., 2011, Journal of Environmental Science and Technology, V4, P1; EPA (Federal Environmental Protection Authority of Ethiopia), 2003, STAND IND POLL CON 3; Espinoza-Quinones FR, 2009, CHEM ENG J, V151, P59, DOI 10.1016/j.cej.2009.01.043; Gunther S, 2012, ENVIRON SCI TECHNOL, V46, P84, DOI 10.1021/es2010682; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Ibekwe AM, 2003, APPL ENVIRON MICROB, V69, P5060, DOI 10.1128/AEM.69.9.5060-5069.2003; Khan R, 2013, REV ENVIRON SCI BIO, V12, P75, DOI 10.1007/s11157-012-9287-6; Kleinsteuber S, 2006, APPL ENVIRON MICROB, V72, P3531, DOI 10.1128/AEM.72.5.3531-3542.2006; Koch C, 2013, NAT PROTOC, V8, P190, DOI 10.1038/nprot.2012.149; Krause L, 2008, J BIOTECHNOL, V136, P91, DOI 10.1016/j.jbiotec.2008.06.003; Lefebvre O, 2006, EXTREMOPHILES, V10, P505, DOI 10.1007/s00792-006-0524-1; Leta S, 2005, WORLD J MICROB BIOT, V21, P545, DOI 10.1007/s11274-004-3272-3; Leta S, 2004, APPL MICROBIOL BIOT, V66, P333, DOI 10.1007/s00253-004-1715-2; Leta S., 2003, ETHIOP J BIOL SCI, V2, P157; Li H, 2013, BIORESOURCE TECHNOL, V137, P286, DOI 10.1016/j.biortech.2013.02.050; Liang YM, 2012, ENVIRON TECHNOL, V33, P937, DOI 10.1080/09593330.2011.603362; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Mbadinga SM, 2012, APPL MICROBIOL BIOT, V96, P531, DOI 10.1007/s00253-011-3828-8; Mekonnen Girma, 2003, P 10 ANN C ETH SOC A; Metcalf W, 1991, WASTEWATER ENG TREAT; Ministry of Trade and Industry (MoTI), 2008, EXP AGR PROD ETH; Paschoal FMM, 2009, J HAZARD MATER, V166, P531, DOI 10.1016/j.jhazmat.2008.11.058; Aguilar JRP, 2008, INT J PHYTOREMEDIAT, V10, P359, DOI 10.1080/15226510802100390; Paisio CE, 2012, ENVIRON SCI POLLUT R, V19, P3430, DOI 10.1007/s11356-012-0870-8; Preethi V, 2009, J HAZARD MATER, V166, P150, DOI 10.1016/j.jhazmat.2008.11.035; Rameshraja D, 2011, INT J ENVIRON RES, V5, P349; Ravenschlag K, 2001, APPL ENVIRON MICROB, V67, P387, DOI 10.1128/AEM.67.1.387-395.2001; Reemtsma T, 1997, WATER RES, V31, P1035, DOI 10.1016/S0043-1354(96)00382-X; Rittiruk U., 2011, International Journal of Agricultural Technology, V7, P215; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheik CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040059; Sivaprakasam S, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-15; Song Z, 2004, DESALINATION, V164, P249, DOI 10.1016/S0011-9164(04)00193-6; Song Z, 2000, WATER RES, V34, P2171, DOI 10.1016/S0043-1354(99)00358-9; Tadesse I, 2003, WATER SCI TECHNOL, V48, P307, DOI 10.2166/wst.2003.0135; Tiglyene S, 2008, ENVIRON TECHNOL, V29, P613, DOI 10.1080/09593330801983888; UNEP (United Nations Environment Program), 1991, UNEP IEO UN PUBL SER, VIII; Vyrides I, 2011, ENVIRON ENG SCI, V28, P661, DOI 10.1089/ees.2010.0431; WANG BZ, 1991, WATER SCI TECHNOL, V24, P9, DOI 10.2166/wst.1991.0107; Wang L, 2006, WATER SCI TECHNOL, V54, P429, DOI 10.2166/wst.2006.923; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang LL, 2012, AFR J MICROBIOL RES, V6, P6444, DOI 10.5897/AJMR12.718	60	33	34	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115576	10.1371/journal.pone.0115576	http://dx.doi.org/10.1371/journal.pone.0115576			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541981	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900053
J	Slattery, ML; Lundgreen, A				Slattery, Martha L.; Lundgreen, Abbie			The Influence of the CHIEF Pathway on Colorectal Cancer-Specific Mortality	PLOS ONE			English	Article							PROTEIN-KINASE CASCADE; INSULIN-RELATED GENES; HUMAN BREAST-CANCER; LIFE-STYLE FACTORS; RECTAL-CANCER; COLON-CANCER; TUMOR ANGIOGENESIS; ENERGY-BALANCE; MICROSATELLITE INSTABILITY; PHYSICAL-ACTIVITY	Many components of the CHIEF (Convergence of Hormones, Inflammation, and Energy Related Factors) pathway could influence survival given their involvement in cell growth, apoptosis, angiogenesis, and tumor invasion stimulation. We used ARTP (Adaptive Rank Truncation Product) to test if genes in the pathway were associated with colorectal cancer-specific mortality. Colon cancer (n=1555) and rectal cancer (n=754) cases were followed over five years. Age, center, stage at diagnosis, and tumor molecular phenotype were considered when calculating ARTP p values. A polygenic risk score was used to summarize the magnitude of risk associated with this pathway. The JAK/STAT/SOC was significant for colon cancer survival (P-ARTP=0.035). Fifteen genes (DUSP2, INFGR1, IL6, IRF2, JAK2, MAP3K10, MMP1, NFkB1A, NOS2A, PIK3CA, SEPX1, SMAD3, TLR2, TYK2, and VDR) were associated with colon cancer mortality (P-ARTP<0.05); JAK2 (P-ARTP =0.0086), PIK3CA (P-ARTP=0.0098), and SMAD3 (P-ARTP=0.0059) had the strongest associations. Over 40 SNPs were significantly associated with survival within the 15 significant genes (P-ARTP<0.05). SMAD3 had the strongest association with survival (HRGG 2.46 95% CI 1.44,4.21 P-Ttrnd=0.0002). Seven genes (IL2RA, IL8RA, IL8RB, IRF2, RAF1, RUNX3, and SEPX1) were significantly associated with rectal cancer (P-ARTP<0.05). The HR for colorectal cancer-specific mortality among colon cancer cases in the upper at-risk alleles group was 11.81 (95% CI 7.07, 19. 74) and was 10.99 (95% CI 5.30, 22.78) for rectal cancer. These results suggest that several genes in the CHIEF pathway are important for colorectal cancer survival; the risk associated with the pathway merits validation in other studies.	[Slattery, Martha L.; Lundgreen, Abbie] Univ Utah, Dept Internal Med, Hlth Sci Ctr, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Slattery, ML (corresponding author), Univ Utah, Dept Internal Med, Hlth Sci Ctr, 383 Colorow Bldg, Salt Lake City, UT 84112 USA.	marty.slattery@hsc.utah.edu			National Institute of Health [CA48998]; NATIONAL CANCER INSTITUTE [R01CA048998, U01CA048998] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the National Institute of Health (CA48998), which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; Guervsos MA, 2007, CELL ONCOL, V29, P327; Caan BJ, 1998, INT J OBESITY, V22, P178, DOI 10.1038/sj.ijo.0800561; Carling D, 2004, CURR BIOL, V14, pR220, DOI 10.1016/j.cub.2004.02.048; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Ditsch N, 2012, J HISTOCHEM CYTOCHEM, V60, P121, DOI 10.1369/0022155411429155; Fedirko V, 2012, CANCER EPIDEM BIOMAR, V21, P582, DOI 10.1158/1055-9965.EPI-11-1065; Forsti A, 2010, GENE CHROMOSOME CANC, V49, P270, DOI 10.1002/gcc.20738; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Gunter MJ, 2006, CANCER EPIDEM BIOMAR, V15, P1126, DOI 10.1158/1055-9965.EPI-06-0042; Habermann N, 2013, GENES NUTR, V8, P115, DOI 10.1007/s12263-012-0302-x; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hsieh FC, 2005, BIOCHEM BIOPH RES CO, V335, P292, DOI 10.1016/j.bbrc.2005.07.075; Isaksson-Mettavainio M, 2006, ANTICANCER RES, V26, P507; Jacobs EJ, 2005, JNCI-J NATL CANCER I, V97, P975, DOI 10.1093/jnci/dji173; Lee DF, 2007, CELL CYCLE, V6, P3011, DOI 10.4161/cc.6.24.5085; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee SJ, 2014, ANN SURG ONCOL; Miteva LD, 2014, TUMOUR BIOL; Murtaugh MA, 2006, NUTR CANCER, V55, P35, DOI 10.1207/s15327914nc5501_5; Nakanishi C, 2004, ONCOLOGY-BASEL, V67, P476, DOI 10.1159/000082933; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Park J, 2012, INVEST NEW DRUG, V30, P1404, DOI 10.1007/s10637-011-9710-9; Przybylowska K, 2006, BREAST CANCER RES TR, V95, P65, DOI 10.1007/s10549-005-9042-6; Puri MC, 2003, P NATL ACAD SCI USA, V100, P12753, DOI 10.1073/pnas.2133552100; Samowitz WS, 2001, CANCER EPIDEM BIOMAR, V10, P917; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Scharf PJ, 2004, PROTEIN SCI, V13, P2541, DOI 10.1110/ps.04884704; Slattery ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037312; Slattery ML, 2012, MUTAT RES-FUND MOL M, V734, P30, DOI 10.1016/j.mrfmmm.2012.04.002; Slattery ML, 2009, CANCER PREV RES, V2, P922, DOI 10.1158/1940-6207.CAPR-08-0191; Slattery ML, 2009, DIS COLON RECTUM, V52, P1304, DOI 10.1007/DCR.0b013e3181a0e5df; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Slattery ML, 1997, CANCER RES, V57, P75; Slattery ML, 2003, NUTR CANCER, V46, P166, DOI 10.1207/S15327914NC4602_09; Slattery ML, 2003, AM J EPIDEMIOL, V158, P214, DOI 10.1093/aje/kwg134; Slattery ML, 2006, CANCER CAUSE CONTROL, V17, P239, DOI 10.1007/s10552-005-0411-6; Slattery ML, 2005, INT J CANCER, V115, P148, DOI 10.1002/ijc.20843; Slattery ML, 2013, MOL CARCINOG; Slattery ML, 2014, CARCINOGENESIS; Tekautz TM, 2006, BBA-MOL CELL RES, V1763, P1000, DOI 10.1016/j.bbamcr.2006.06.014; Ting WC, 2013, J KOREAN MED SCI, V28, P1302, DOI 10.3346/jkms.2013.28.9.1302; Tsamandas AC, 2004, STRAHLENTHER ONKOL, V180, P201, DOI 10.1007/s00066-004-1149-x; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Waldner MJ, 2010, J EXP MED, V207, P2855, DOI 10.1084/jem.20100438; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692; Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711; Xie W, 2003, CANCER J, V9, P302, DOI 10.1097/00130404-200307000-00013; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Yang HA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-92; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zgaga L, 2014, J CLIN ONCOL	54	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116169	10.1371/journal.pone.0116169	http://dx.doi.org/10.1371/journal.pone.0116169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541970	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900155
J	Wong, CCL; Au, SLK; Tse, APW; Xu, IMJ; Lai, RKH; Chiu, DKC; Wei, LL; Fan, DNY; Tsang, FHC; Lo, RCL; Wong, CM; Ng, IOL				Wong, Carmen Chak-Lui; Au, Sandy Leung-Kuen; Tse, Aki Pui-Wah; Xu, Iris Ming-Jing; Lai, Robin Kit-Ho; Chiu, David Kung-Chun; Wei, Larry Lai; Fan, Dorothy Ngo-Yin; Tsang, Felice Ho-Ching; Lo, Regina Cheuk-Lam; Wong, Chun-Ming; Ng, Irene Oi-Lin			Switching of Pyruvate Kinase Isoform L to M2 Promotes Metabolic Reprogramming in Hepatocarcinogenesis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CANCER CELLS; TUMOR-GROWTH; MICRORNA-122; REGULATOR; HYPOXIA; MIRNAS; GENE	Hepatocellular carcinoma (HCC) is an aggressive tumor, with a high mortality rate due to late symptom presentation and frequent tumor recurrences and metastasis. It is also a rapidly growing tumor supported by different metabolic mechanisms; nevertheless, the biological and molecular mechanisms involved in the metabolic reprogramming in HCC are unclear. In this study, we found that pyruvate kinase M2 (PKM2) was frequently over-expressed in human HCCs and its over-expression was associated with aggressive clinicopathological features and poor prognosis of HCC patients. Furthermore, knockdown of PKM2 suppressed aerobic glycolysis and cell proliferation in HCC cell lines in vitro. Importantly, knockdown of PKM2 hampered HCC growth in both subcutaneous injection and orthotopic liver implantation models, and reduced lung metastasis in vivo. Of significance, PKM2 over-expression in human HCCs was associated with a down-regulation of a liver-specific microRNA, miR-122. We further showed that miR-122 interacted with the 3UTR of the PKM2 gene. Re-expression of miR-122 in HCC cell lines reduced PKM2 expression, decreased glucose uptake in vitro, and suppressed HCC tumor growth in vivo. Our clinical data and functional studies have revealed a novel biological mechanism involved in HCC metabolic reprogramming.	[Wong, Carmen Chak-Lui; Au, Sandy Leung-Kuen; Tse, Aki Pui-Wah; Xu, Iris Ming-Jing; Lai, Robin Kit-Ho; Chiu, David Kung-Chun; Wei, Larry Lai; Fan, Dorothy Ngo-Yin; Tsang, Felice Ho-Ching; Lo, Regina Cheuk-Lam; Wong, Chun-Ming; Ng, Irene Oi-Lin] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Wong, Carmen Chak-Lui; Lo, Regina Cheuk-Lam; Wong, Chun-Ming; Ng, Irene Oi-Lin] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wong, CCL (corresponding author), Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	carmencl@pathology.hku.hk; iolng@hku.hk	Fan, Dorothy Ngo-yin/AAQ-2998-2020; WONG, Chun-Ming/A-6739-2009; Wong, Carmen Chak Lui/C-4660-2009; Lo, Cheuk Lam Regina/E-9874-2010	WONG, Chun-Ming/0000-0002-2497-7858; Wong, Carmen Chak Lui/0000-0001-5866-4705; Xu, Mingjing/0000-0002-9128-1172; Ng, Irene Oi-lin/0000-0001-7532-2029; Lo, Cheuk Lam Regina/0000-0001-6213-0343; Chiu, David Kung-Chun/0000-0002-9700-4707	University of Hong Kong [20120159055]; Hong Kong Research Grants Council Collaborative Research Fund [HKU 7/CRG/09]; SK Yee Medical Research Fund	University of Hong Kong(University of Hong Kong); Hong Kong Research Grants Council Collaborative Research Fund(Hong Kong Research Grants Council); SK Yee Medical Research Fund	This work was partly funded by Seed Funding Program for Basic Research Project Funding of the University of Hong Kong (20120159055) and Hong Kong Research Grants Council Collaborative Research Fund (HKU 7/CRG/09)) and SK Yee Medical Research Fund 2011. I.O.L. Ng is Loke Yew Professor in Pathology.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Burchard J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.58; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chen YH, 2013, MIRNA 93 INHIBITS GL; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hatziapostolou M, 2013, TRENDS ENDOCRIN MET, V24, P361, DOI 10.1016/j.tem.2013.03.002; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Horie T, 2009, BIOCHEM BIOPH RES CO, V389, P315, DOI 10.1016/j.bbrc.2009.08.136; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jung CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027740; Kim N, 2011, HEPATOL RES, V41, P170, DOI 10.1111/j.1872-034X.2010.00752.x; Lim JY, 2012, WORLD J GASTROENTERO, V18, P4037, DOI 10.3748/wjg.v18.i30.4037; Liu AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086872; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; NG IOL, 1995, CANCER, V76, P2443, DOI 10.1002/1097-0142(19951215)76:12<2443::AID-CNCR2820761207>3.0.CO;2-F; NOGUCHI T, 1987, J BIOL CHEM, V262, P14366; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhou CF, 2012, IUBMB LIFE, V64, P775, DOI 10.1002/iub.1066	29	41	42	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115036	10.1371/journal.pone.0115036	http://dx.doi.org/10.1371/journal.pone.0115036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541689	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900019
J	Anzar, M; Grochulski, P; Bonnet, B				Anzar, Muhammad; Grochulski, Pawel; Bonnet, Brennan			Synchrotron X-Ray Diffraction to Detect Glass or Ice Formation in the Vitrified Bovine Cumulus-Oocyte Complexes and Morulae	PLOS ONE			English	Article							HIGH SURVIVAL RATE; EMBRYO CRYOPRESERVATION; OPS VITRIFICATION; FROZEN SYSTEMS; COOLING RATE; FERTILIZATION; MATURATION; CRYOPROTECTANTS; QUANTIFICATION; DIFFRACTOMETRY	Vitrification of bovine cumulus-oocyte complexes (COCs) is not as successful as bovine embryos, due to oocyte's complex structure and chilling sensitivity. Synchrotron X-ray diffraction (SXRD), a powerful method to study crystal structure and phase changes, was used to detect the glass or ice formation in water, tissue culture medium (TCM)-199, vitrification solution 2 (VS2), and vitrified bovine COCs and morulae. Data revealed Debye's rings and peaks associated with the hexagonal ice crystals at 3.897, 3.635, 3.427, 2.610, 2.241, 1.912 and 1.878 A in both water and TCM-199, whereas VS2 showed amorphous (glassy) appearance, at 102K (2171 degrees C). An additional peak of sodium phosphate monobasic hydrate (NaH2PO4. H2O) crystals was observed at 2.064 A degrees in TCM-199 only. All ice and NaH2PO4. H2O peaks were detected in the non-vitrified (control) and vitrified COCs, except two ice peaks (3.145 and 2.655 angstrom) were absent in the vitrified COCs. The intensities of majority of ice peaks did not differ between the non-vitrified and vitrified COCs. The non-vitrified bovine morulae in TCM-199 demonstrated all iceand NaH2PO4. H2O-associated Debye's rings and peaks, found in TCM-199 alone. There was no Debye's ring present in the vitrified morulae. In conclusion, SXRD is a powerful method to confirm the vitrifiability of a solution and to detect the glass or ice formation in vitrified cells and tissues. The vitrified bovine COCs exhibited the hexagonal ice crystals instead of glass formation whereas the bovine morulae underwent a typical vitrification.	[Anzar, Muhammad] Agr & Agri Food Canada, Saskatoon Res Ctr, Canadian Anim Genet Resource Program, Cryobiol Lab, Saskatoon, SK, Canada; [Anzar, Muhammad] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK, Canada; [Grochulski, Pawel; Bonnet, Brennan] Canadian Light Source, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Anzar, M (corresponding author), Agr & Agri Food Canada, Saskatoon Res Ctr, Canadian Anim Genet Resource Program, Cryobiol Lab, Saskatoon, SK, Canada.	Muhammad.Anzar@agr.gc.ca		Anzar, Muhammad/0000-0001-8379-8852	Canadian Animal Genetic Resource Program	Canadian Animal Genetic Resource Program	This study was financially supported by the Canadian Animal Genetic Resource Program, Agriculture and Agri-Food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2005, BIOL REPROD, V72, P1416, DOI 10.1095/biolreprod.104.037051; Albarracin JL, 2005, MOL REPROD DEV, V72, P239, DOI 10.1002/mrd.20326; Arav A, 2014, THERIOGENOLOGY, V81, P96, DOI 10.1016/j.theriogenology.2013.09.011; ARAV A, 1993, J REPROD FERTIL, V99, P353, DOI 10.1530/jrf.0.0990353; Arav A, 2014, REPROD FERT DEVELOP, V26, P83, DOI 10.1071/RD13295; BRACKETT BG, 1975, BIOL REPROD, V12, P260, DOI 10.1095/biolreprod12.2.260; Chian RC, 2004, J REPROD DEVELOP, V50, P685, DOI 10.1262/jrd.50.685; Diez C, 2005, THERIOGENOLOGY, V64, P317, DOI 10.1016/j.theriogenology.2004.11.023; DOWELL LG, 1960, NATURE, V188, P1144, DOI 10.1038/1881144a0; Fodje M, 2012, J SYNCHROTRON RADIAT, V19, P274, DOI 10.1107/S0909049511056305; FUKU E, 1992, CRYOBIOLOGY, V29, P485, DOI 10.1016/0011-2240(92)90051-3; Grochulski Pawel, 2012, Journal of Structural and Functional Genomics, V13, P49, DOI 10.1007/s10969-012-9123-9; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; HUNTER JE, 1995, HUM REPROD, V10, P1184, DOI 10.1093/oxfordjournals.humrep.a136115; Hyttel P, 2000, MOL REPROD DEV, V56, P80, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;80::AID-MRD10&gt;3.0.CO;2-U; Kasai M, 2002, HUM REPROD, V17, P1863, DOI 10.1093/humrep/17.7.1863; Kasai N, 2010, XRAY DIFFRACTION MAC; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Larman Mark G, 2014, Methods Mol Biol, V1092, P153, DOI 10.1007/978-1-60327-292-6_10; Leibo SP, 2008, THERIOGENOLOGY, V69, P37, DOI 10.1016/j.theriogenology.2007.10.006; LEIBO SP, 1975, CRYOBIOLOGY, V12, P579, DOI 10.1016/0011-2240(75)90123-6; Liebermann Juergen, 2003, Reprod Biomed Online, V7, P623; Martino A, 1996, BIOL REPROD, V54, P1059, DOI 10.1095/biolreprod54.5.1059; Massip A, 2003, REPROD NUTR DEV, V43, P325, DOI 10.1051/rnd:2003024; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; Men HS, 2002, THERIOGENOLOGY, V57, P1095, DOI 10.1016/S0093-691X(01)00679-3; Minasi MG, 2012, FERTIL STERIL, V97, P1220, DOI 10.1016/j.fertnstert.2012.02.022; Morato R, 2008, MOL REPROD DEV, V75, P1318, DOI 10.1002/mrd.20873; NAKAGATA N, 1989, J REPROD FERTIL, V87, P479, DOI 10.1530/jrf.0.0870479; Nunes C, 2005, PHARM RES-DORDR, V22, P1942, DOI 10.1007/s11095-005-7626-9; PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9; Pereira RM, 2008, CELL TISSUE BANK, V9, P267, DOI 10.1007/s10561-008-9075-2; Prentice JR, 2011, THERIOGENOLOGY, V75, P602, DOI 10.1016/j.theriogenology.2010.09.027; Prentice Jennifer R, 2010, Vet Med Int, V2011, DOI 10.4061/2011/146405; Prentice-Biensch JR, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-73; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Seki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036058; Shaw JM, 2000, THERIOGENOLOGY, V53, P59, DOI 10.1016/S0093-691X(99)00240-X; Snell EH, 2007, J SYNCHROTRON RADIAT, V14, P109, DOI 10.1107/S090904950604605X; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;53::AID-MRD6&gt;3.0.CO;2-V; Varshney DB, 2006, PHARM RES-DORDR, V23, P2368, DOI 10.1007/s11095-006-9051-0; Varshney DB, 2009, J PHYS CHEM B, V113, P6177, DOI 10.1021/jp900404m; Varshney DB, 2009, PHARM RES-DORDR, V26, P1596, DOI 10.1007/s11095-009-9868-4; Weiss ADH, 2010, CRYOBIOLOGY, V61, P123, DOI 10.1016/j.cryobiol.2010.05.008; Will G., 2006, POWDER DIFFRACTION R; Wu B, 1999, MOL REPROD DEV, V54, P388, DOI 10.1002/(SICI)1098-2795(199912)54:4&lt;388::AID-MRD9&gt;3.0.CO;2-7; Yang CY, 2013, CRYOBIOLOGY, V67, P7, DOI 10.1016/j.cryobiol.2013.04.003; Yavin S, 2007, THERIOGENOLOGY, V67, P81, DOI 10.1016/j.theriogenology.2006.09.029; Zhou XL, 2010, CRYOBIOLOGY, V61, P66, DOI 10.1016/j.cryobiol.2010.05.002	51	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114801	10.1371/journal.pone.0114801	http://dx.doi.org/10.1371/journal.pone.0114801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536435	gold, Green Published, Green Submitted			2022-12-26	WOS:000348563300021
J	Cuervo-Escobar, S; Losada-Barragan, M; Umana-Perez, A; Porrozzi, R; Saboia-Vahia, L; Miranda, LHM; Morgado, FN; Menezes, RC; Sanchez-Gomez, M; Cuervo, P				Cuervo-Escobar, Sergio; Losada-Barragan, Monica; Umana-Perez, Adriana; Porrozzi, Renato; Saboia-Vahia, Leonardo; Miranda, Luisa H. M.; Morgado, Fernanda N.; Menezes, Rodrigo C.; Sanchez-Gomez, Myriam; Cuervo, Patricia			T-Cell Populations and Cytokine Expression Are Impaired in Thymus and Spleen of Protein Malnourished BALB/c Mice Infected with Leishmania infantum	PLOS ONE			English	Article							EXPERIMENTAL VISCERAL LEISHMANIASIS; GROWTH-FACTOR-I; ENERGY MALNUTRITION; DONOVANI INFECTION; IMMUNE-RESPONSE; NORTHEASTERN BRAZIL; CHAGASI INFECTION; GAMMA-INTERFERON; MIGRATION; VACCINE	Visceral leishmaniasis (VL) is a parasitic infectious disease that causes significant morbidity and mortality in the tropical and subtropical regions of the world. Although infections with visceralizing Leishmania may be asymptomatic, factors such as undernutrition increase the likelihood of progressing to clinical disease. Protein malnutrition, the most deleterious cause of malnutrition in developing countries, has been considered as a primary risk factor for the development of clinical VL. However, data regarding the immunological basis of this association are scarce. With the aim to analyze the effects of protein malnutrition on Leishmania infantum infection, we used BALB/c mice subjected to control or low protein isocaloric diets. Each animal group was divided into two subgroups and one was infected with L. infantum resulting in four study groups: animals fed 14% protein diet (CP), animals fed 4% protein diet (LP), animals fed 14% protein diet and infected (CPi), and animals fed 4% protein diet and infected (LPi). The susceptibility to L. infantum infection and immune responses were assessed in terms of body and lymphoid organ weight, parasite load, lymphocyte subpopulations, and cytokine expression. LPi mice had a significant reduction of body and lymphoid organ weight and exhibited a severe decrease of lymphoid follicles in the spleen. Moreover, LPi animals showed a significant decrease in CD4(+)CD8(+) T cells in the thymus, whereas there was an increase of CD4(+) and CD8(+) T cells percentages in the spleen. Notably, the cytokine mRNA levels in the thymus and spleen of protein	[Cuervo-Escobar, Sergio; Umana-Perez, Adriana; Sanchez-Gomez, Myriam] Univ Nacl Colombia, Dept Quim, Lab Hormonas, Bogota, Colombia; [Losada-Barragan, Monica; Porrozzi, Renato; Saboia-Vahia, Leonardo; Morgado, Fernanda N.; Cuervo, Patricia] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Leishmaniose, BR-21045900 Rio De Janeiro, Brazil; [Miranda, Luisa H. M.; Menezes, Rodrigo C.] Fiocruz MS, IPEC, Inst Pesquisa Cliin Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil	Universidad Nacional de Colombia; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Sanchez-Gomez, M (corresponding author), Univ Nacl Colombia, Dept Quim, Lab Hormonas, Bogota, Colombia.	pcuervo@fiocruz.br; mysanchezd@unal.edu.co	Porrozzi, Renato/U-2166-2019; Porrozzi, Renato/U-2059-2019; Cuervo, Patricia/F-9896-2012; Saboia-Vahia, Leonardo/F-7240-2013; Morgado, Fernanda N/K-2527-2013; Morgado, Fernanda/O-3577-2017; Menezes, Rodrigo/I-5149-2012; Menezes, Rodrigo/O-8722-2019; Miranda, Luisa/ABB-7298-2020; Cuervo, Patricia/Y-6048-2019; Morgado, Fernanda/AAV-4435-2021	Porrozzi, Renato/0000-0003-2167-316X; Morgado, Fernanda N/0000-0002-7188-251X; Morgado, Fernanda/0000-0002-7188-251X; Menezes, Rodrigo/0000-0003-1853-3449; Cuervo, Patricia/0000-0002-6245-4185; Morgado, Fernanda/0000-0002-7188-251X; Losada Barragan, Monica/0000-0003-1141-1828; Sanchez-Gomez, Myriam/0000-0002-9481-7534; Umana-Perez, Adriana/0000-0001-9262-2699	Convenio bilateral Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias, Colombia) [490992/2008-0, 490560/2013-0, 11263-576-2009]; CNPq-TWAS (Third World Academy of Sciences) [190405/2011-2]; FIOCRUZ-CNPq [476727/2010-3]; National University of Colombia Research Council [14233, 16433]	Convenio bilateral Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias, Colombia)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); CNPq-TWAS (Third World Academy of Sciences); FIOCRUZ-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National University of Colombia Research Council	This work was supported by the following Brazilian and Colombian agencies: Convenio bilateral Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) and Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias, Colombia) [P.C. CNPq grant #490992/2008-0; P.C. CNPq grant #490560/2013-0; M.S.G. Colciencias grant #11263-576-2009], CNPq-TWAS (Third World Academy of Sciences) [M.L.B. grant #190405/2011-2], FIOCRUZ-CNPq [P.C., R.P., L.S.V. and M.L.B. PROEP grant #476727/2010-3] and the National University of Colombia Research Council [M.S.G., S.C.E. and A.U.P. DIB grant #14233, 16433].	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Anstead GM, 2009, PROSTAG LEUKOTR ESS, V81, P41, DOI 10.1016/j.plefa.2009.04.011; Anstead GM, 2003, J LEUKOCYTE BIOL, V74, P982, DOI 10.1189/jlb.0203064; Anstead GM, 2001, INFECT IMMUN, V69, P4709, DOI 10.1128/IAI.69.8.4709-4718.2001; Arias JR, 1996, EMERG INFECT DIS, V2, P145, DOI 10.3201/eid0202.960213; BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639; BARONE KS, 1993, CELL IMMUNOL, V148, P226, DOI 10.1006/cimm.1993.1105; Basu R, 2007, INFECT IMMUN, V75, P5956, DOI 10.1128/IAI.00944-07; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Borelli P, 2007, BRIT J NUTR, V97, P307, DOI 10.1017/S0007114507172731; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carrion J, 2006, PARASITE IMMUNOL, V28, P173, DOI 10.1111/j.1365-3024.2006.00817.x; CERF BJ, 1987, J INFECT DIS, V156, P1030, DOI 10.1093/infdis/156.6.1030; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Colmenares M, 2003, INFECT IMMUN, V71, P3172, DOI 10.1128/IAI.71.6.3172-3182.2003; Cunningham-Rundles S, 2008, NUTR PEDIAT, P262; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DYE C, 1993, P ROY SOC B-BIOL SCI, V254, P33, DOI 10.1098/rspb.1993.0123; Engwerda CR, 2004, TRENDS PARASITOL, V20, P524, DOI 10.1016/j.pt.2004.08.009; Evans D, 1989, HDB ISOLATION CULTIV; Golbert DCF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S6-S3; Franke CR, 2002, T ROY SOC TROP MED H, V96, P236, DOI 10.1016/S0035-9203(02)90087-8; GOMEZ F, 1956, LANCET, V271, P121; Gurunathan S, 1997, J EXP MED, V186, P1137, DOI 10.1084/jem.186.7.1137; Hodge DL, 2012, EUR J IMMUNOL, V42, P2644, DOI 10.1002/eji.201242408; Ibrahim MK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002329; Iyer SS, 2012, J IMMUNOL, V188, P77, DOI 10.4049/jimmunol.1004027; Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451; Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697; KAYE PM, 1992, INFECT IMMUN, V60, P4335, DOI 10.1128/IAI.60.10.4335-4342.1992; Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492; Maciel BLL, 2008, AM J TROP MED HYG, V79, P591, DOI 10.4269/ajtmh.2008.79.591; Malafaia G, 2009, PARASITE IMMUNOL, V31, P41, DOI 10.1111/j.1365-3024.2008.01069.x; Marlet MVL, 2003, T ROY SOC TROP MED H, V97, P515, DOI 10.1016/S0035-9203(03)80012-3; Mello AS, 2014, INFLAMMATION; Mendes-da-Cruz DA, 2012, FASEB J, V26, P4390, DOI 10.1096/fj.11-202952; Miranda LHM, 2011, VET J, V190, P408, DOI 10.1016/j.tvjl.2010.12.004; Morrot A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001268; Naranjo WM, 2002, ENDOCRINOLOGY, V143, P2233, DOI 10.1210/en.143.6.2233; Nieto A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-39; Cunha MCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058872; Rey Luís C., 2005, J. Pediatr. (Rio J.), V81, P73, DOI [10.2223/JPED.1286, 10.1590/S0021-75572005000100014]; Rodriguez-Galan MC, 2005, J IMMUNOL, V174, P2796, DOI 10.4049/jimmunol.174.5.2796; Perez AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034360; Sanchez-Gomez M, 1999, BRIT J NUTR, V81, P145, DOI 10.1017/S0007114599000288; Santana CC, 2008, PARASITE IMMUNOL, V30, P515, DOI 10.1111/j.1365-3024.2008.01051.x; Savino W, 2002, EUR J CLIN NUTR, V56, pS46, DOI 10.1038/sj.ejcn.1601485; Savino W, 2007, BRIT J NUTR, V98, pS11, DOI 10.1017/S0007114507832880; Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062; Savino W, 2012, ANN NY ACAD SCI, V1261, P49, DOI 10.1111/j.1749-6632.2012.06637.x; Savino W, 2010, P NUTR SOC, V69, P636, DOI 10.1017/S0029665110002545; Serafim TD, 2010, MEM I OSWALDO CRUZ, V105, P811, DOI 10.1590/S0074-02762010000600014; Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002; Stager S, 2003, NAT MED, V9, P1287, DOI 10.1038/nm933; STERN JJ, 1988, J IMMUNOL, V140, P3971; THISSEN JP, 1992, J ENDOCRINOL, V132, P141, DOI 10.1677/joe.0.1320141; United Nations Children's Fund; WHO; The World Bank, 2012, UNICEF WHO WORLD BAN; Wang X, 2008, CYTOKINE, V43, P15, DOI 10.1016/j.cyto.2008.04.009; Wiig H, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-12; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; World Health Organization, 2011, GLOB HLTH OBS DAT RE; World Health Organization, 2010, LAB MAN EX PROC HUM, P10; Xavier JG, 2007, HISTOL HISTOPATHOL, V22, P651, DOI 10.14670/HH-22.651; Yarilin AA, 2004, CURR MED CHEM, V11, P447, DOI 10.2174/0929867043455972	66	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114584	10.1371/journal.pone.0114584	http://dx.doi.org/10.1371/journal.pone.0114584			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535967	Green Submitted, Green Published, gold			2022-12-26	WOS:000348563300015
J	El-Ashmawy, M; Delgado, O; Cardentey, A; Wright, WE; Shay, JW				El-Ashmawy, Mariam; Delgado, Oliver; Cardentey, Agnelio; Wright, Woodring E.; Shay, Jerry W.			CDDO-Me Protects Normal Lung and Breast Epithelial Cells but Not Cancer Cells from Radiation	PLOS ONE			English	Article							SYNTHETIC TRITERPENOIDS; IONIZING-RADIATION; METHYL ESTER; BARDOXOLONE METHYL; ETHYL AMIDE; PREVENTION; IMMORTALIZATION; CARCINOGENESIS; AMIFOSTINE; RISK	Although radiation therapy is commonly used for treatment for many human diseases including cancer, ionizing radiation produces reactive oxygen species that can damage both cancer and healthy cells. Synthetic triterpenoids, including CDDO-Me, act as anti-inflammatory and antioxidant modulators primarily by inducing the transcription factor Nrf2 to activate downstream genes containing antioxidant response elements (AREs). In the present series of experiments, we determined if CDDO-Me can be used as a radioprotector in normal non-cancerous human lung and breast epithelial cells, in comparison to lung and breast cancer cell lines. A panel of normal non-cancerous, partially cancer progressed, and cancer cell lines from both lung and breast tissue was exposed to gamma radiation with and without pre-treatment with CDDO-Me. CDDO-Me was an effective radioprotector when given,18 hours before radiation in epithelial cells (average dose modifying factor (DMF) 51.3), and Nrf2 function was necessary for CDDO-Me to exert these radioprotective effects. CDDO-Me did not protect cancer lines tested from radiation-induced cytotoxicity, nor did it protect experimentally transformed human bronchial epithelial cells (HBECs) with progressive oncogenic manipulations. CDDO-Me also protected human lymphocytes against radiation-induced DNA damage. A therapeutic window exists in which CDDO-Me protects normal cells from radiation by activating the Nrf2 pathway, but does not protect experimentally transformed or cancer cell lines. This suggests that use of this oral available, non-toxic class of drug can protect non-cancerous healthy cells during radiotherapy, resulting in better outcomes and less toxicity for patients.	[El-Ashmawy, Mariam; Cardentey, Agnelio; Wright, Woodring E.; Shay, Jerry W.] UT Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Delgado, Oliver] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Shay, Jerry W.] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia	University of Texas System; UTMD Anderson Cancer Center; King Abdulaziz University	Shay, JW (corresponding author), UT Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	Jerry.Shay@UTSouthwestern.edu		El-Ashmawy, Mariam/0000-0002-2335-4827; Delgado, Oliver/0000-0003-2547-5857	National Aeronautics and Space Administration [NNJ05HD36GD, NNX09AU95G, NNX11AC1G]; National Cancer Institute [Lung SPORE P50CA70907]; Howard Hughes Medical Institute Gilliam Fellowship; National Institutes of Health [C06 RR30414]; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR030414] Funding Source: NIH RePORTER	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute Gilliam Fellowship(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the National Aeronautics and Space Administration (NNJ05HD36GD, NNX09AU95G, and NNX11AC1G); the National Cancer Institute (Lung SPORE P50CA70907) (JWS); Howard Hughes Medical Institute Gilliam Fellowship (ME). This work was performed in laboratories constructed with support from National Institutes of Health grant C06 RR30414 (JWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen CN, 2003, SEMIN RADIAT ONCOL, V13, P62, DOI 10.1053/srao.2003.50006; Bernier J, 2004, NAT REV CANCER, V4, P737, DOI 10.1038/nrc1451; Casas F, 2004, HEMATOL ONCOL CLIN N, V18, P461, DOI 10.1016/j.hoc.2003.12.007; Cucinotta FA, 2012, HEALTH PHYS, V103, P643, DOI 10.1097/HP.0b013e318267b3ad; Daroczi B, 2009, MOL CANCER THER, V8, P2625, DOI 10.1158/1535-7163.MCT-09-0198; Eskiocak U, 2010, RADIAT RES, V174, P27, DOI 10.1667/RR2155.1; Gyori BM, 2014, REDOX BIOL, V2, P457, DOI 10.1016/j.redox.2013.12.020; Honda T, 2011, J MED CHEM, V54, P1762, DOI 10.1021/jm101445p; Hong DS, 2012, CLIN CANCER RES, V18, P3396, DOI 10.1158/1078-0432.CCR-11-2703; Kim SB, 2012, P NATL ACAD SCI USA, V109, pE2949, DOI 10.1073/pnas.1207718109; Kim YH, 2014, CANCER LETT, V354, P132, DOI 10.1016/j.canlet.2014.07.048; Koukourakis MI, 2004, CANCER CHEMOTH PHARM, V53, P8, DOI 10.1007/s00280-003-0691-z; Levy S, 2010, IUBMB LIFE, V62, P237, DOI 10.1002/iub.314; Liby K, 2005, CANCER RES, V65, P4789, DOI 10.1158/0008-5472.CAN-04-4539; Liby K, 2008, CLIN CANCER RES, V14, P4556, DOI 10.1158/1078-0432.CCR-08-0040; Liby K, 2007, CANCER RES, V67, P2414, DOI 10.1158/0008-5472.CAN-06-4534; Liby K, 2009, CANCER PREV RES, V2, P1050, DOI 10.1158/1940-6207.CAPR-09-0085; Liby KT, 2014, DOSE-RESPONSE, V12, P136, DOI 10.2203/dose-response.13-018.Liby; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Liby KT, 2010, CANCER PREV RES, V3, P1427, DOI 10.1158/1940-6207.CAPR-10-0197; Mitsuishi Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00200; Newhauser WD, 2011, NAT REV CANCER, V11, P438, DOI 10.1038/nrc3069; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; PIKE MC, 1964, BRIT J RADIOL, V37, P458, DOI 10.1259/0007-1285-37-438-458; RADFORD EP, 1980, RADIAT RES, V84, P369, DOI 10.2307/3575478; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Shanmugam MK, 2014, CANCER LETT, V346, P206, DOI 10.1016/j.canlet.2014.01.016; SHAY JW, 1993, EXP CELL RES, V209, P45, DOI 10.1006/excr.1993.1283; SHAY JW, 1995, MOL CELL BIOL, V15, P425, DOI 10.1128/MCB.15.1.425; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Wang YY, 2014, MOL CANCER, V13, DOI [10.1186/1476-4598-13-30, 10.1186/s12934-014-0151-y]; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Wasserman TH, 2001, ONCOLOGY-NY, V15, P1349	38	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115600	10.1371/journal.pone.0115600	http://dx.doi.org/10.1371/journal.pone.0115600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536195	Green Submitted, Green Published, gold			2022-12-26	WOS:000348563300055
J	Nizami, SM; Zhang, YP; Sha, LQ; Wei, Z; Xiang, Z				Nizami, Syed Moazzam; Zhang Yiping; Sha Liqing; Wei Zhao; Xiang Zhang			Managing Carbon Sinks in Rubber (Hevea brasilensis) Plantation by Changing Rotation length in SW China	PLOS ONE			English	Article							OLD-GROWTH FORESTS; SOIL CARBON; SEQUESTRATION; MANAGEMENT; AGRICULTURE; BIOMASS; STORAGE; CLIMATE; STAND	Extension of the rotation length in forest management has been highlighted in Article 3.4 of the Kyoto Protocol to help the countries in their commitments for reduction in greenhouse gas emissions. CO2FIX Model Ver.3.2 was used to examine the dynamics of carbon stocks (C stocks) in a rubber plantation in South Western China with the changing rotation lengths. To estimate the efficiency of increasing the rotation length as an Article 3.4 activity, study predicted that the rubber production and C stocks of the ecosystem increased with the increasing rotation (25, 30, 35, 40 and 45 years). While comparing the pace of growth both in economical (rubber production) and ecological (C stocks) terms in each rotation, 40 years rotation length showed maximum production and C stocks. After elongation of 40 year rotation to four consecutive cycles, it was concluded that the total C stocks of the ecosystem were 186.65 Mg ha(-1). The longer rotation lengths showed comparatively increased C stocks in below ground C stock after consecutive four rotations. The pace of C input (Mg C ha(-1)yr(-1)) and rubber production indicated that 40years rotation is best suited for rubber plantation. The study has developed carbon mitigation based on four rotation scenarios. The possible stimulated increase in C stocks of the entire ecosystem after consecutive long rotations indicated that the emphasis must be paid on deciding the rotation of rubber plantation in SW China for reporting under article 3.4 of the Kyoto Protocol.	[Nizami, Syed Moazzam; Zhang Yiping; Sha Liqing; Wei Zhao; Xiang Zhang] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Menglun 666303, Yunnan, Peoples R China; [Wei Zhao; Xiang Zhang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Nizami, Syed Moazzam] Arid Agr Univ, Fac Forestry Range Management & Wildlife, Rawalpindi 46300, Pakistan	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Nizami, SM (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Menglun 666303, Yunnan, Peoples R China.	moazzam@xtbg.org.cn; yipingzh@xtbg.ac.cn	Nizami, Syed Moazzam/V-7754-2019; Zhang, Xiang/A-7030-2016	Zhang, Xiang/0000-0001-6952-8784	National Natural Science Foundation of China [41271056, U1202234, 31290221]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA05020303, XDA05050601, XDA05050206]; CAS 135 program [XTBG-T03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); CAS 135 program	This study was supported by the National Natural Science Foundation of China (41271056, U1202234, 31290221), the "Strategic Priority Research Program" of the Chinese Academy of Sciences, (XDA05020303, XDA05050601, XDA05050206) and the CAS 135 program (XTBG-T03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Min, 1996, Tropical Ecology, V37, P183; Castillo A, 2004, ABOVEGROUND CARBON S; COOPER CF, 1983, CAN J FOREST RES, V13, P155, DOI 10.1139/x83-022; Cotta M, 2005, THESIS U FEDERAL VIC; de Blecourt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069357; Deng X, 2010, FOREST ECOSYSTEM XIS; Egbe A. E., 2012, Journal of Ecology and the Natural Environment, V4, P154; Egbe EA, 2011, APPL ECOL ENV RES, V9, P369, DOI 10.15666/aeer/0904_369385; Gisel R., 1992, WOOD DENSITIES TROPI; Harmon ME, 2002, CAN J FOREST RES, V32, P863, DOI [10.1139/x01-216, 10.1139/X01-216]; Huber M., 2012, CARBON SEQUESTRATION; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; Jia Kaixin, 2006, Shengtaixue Zazhi, V25, P1028; Kaipainen T, 2004, ENVIRON SCI POLICY, V7, P205, DOI 10.1016/j.envsci.2004.03.001; Kaul M, 2010, MITIG ADAPT STRAT GL, V15, P489, DOI 10.1007/s11027-010-9230-5; Kirschbaum MUF, 2008, SOIL BIOL BIOCHEM, V40, P392, DOI 10.1016/j.soilbio.2007.09.003; Liao CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010867; Liski J, 2001, CAN J FOREST RES, V31, P2004, DOI 10.1139/cjfr-31-11-2004; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Masera OR, 2003, ECOL MODEL, V164, P177, DOI 10.1016/S0304-3800(02)00419-2; Murray B., 2000, LAND USE LAND USE CH, P53; Nabuurs GJ., 2002, ECOL INDIC, V1, P213, DOI [DOI 10.1016/S1470-160X(02)00007-9, 10.1016/S1470-160X(02)00007-9]; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Philip M.S., 1994, MEASURING TREES FORE, P324; Pretty JN, 2002, PHILOS T R SOC A, V360, P1741, DOI 10.1098/rsta.2002.1029; Priyadarshan PM, 2005, J CROP IMPROV, V14, P221, DOI 10.1300/J411v14n01_10; Pussinen A, 2002, FOREST ECOL MANAG, V158, P103, DOI 10.1016/S0378-1127(00)00675-7; Ren YH CM, 1999, ACTA PHYTOECOLOGICA, V23; Running SW, 2008, SCIENCE, V321, P652, DOI 10.1126/science.1159607; Salimon C.I., 2009, J APPL SCI, V4, P57; Schelhaas MJ, 2004, 1068 ALTERRA; SFA, 2008, SFA B FOR EC CONSTR, P49; Song QH, 2013, IFOREST, V7, P42, DOI 10.3832/ifor0891-007; Song Qing-hai, 2010, Shengtaixue Zazhi, V29, P1887; Sun Y, 2013, THESIS U CHINESE ACA; Tschakert P, 2007, ECOL ECON, V60, P807, DOI 10.1016/j.ecolecon.2006.02.001; UNFCCC, 2001, C PART 6 SESS 2; UNFCCC, 1997, FCCCCP19977ADD UNFCC; van Dijk AIJM, 2007, FOREST ECOL MANAG, V251, P1, DOI 10.1016/j.foreco.2007.06.010; Vieira S, 2005, P NATL ACAD SCI USA, V102, P18502, DOI 10.1073/pnas.0505966102; Wang QK, 2009, FOREST ECOL MANAG, V258, P1437, DOI 10.1016/j.foreco.2009.06.050; Watson R.T., 2000, IMPL DIFF DEF GEN IS, P375; Wauters JB, 2008, FOREST ECOL MANAG, V255, P2347, DOI 10.1016/j.foreco.2007.12.038; Winjum JK, 1997, AGR FOREST METEOROL, V84, P153, DOI 10.1016/S0168-1923(96)02383-0; [吴志祥 Wu Zhixiang], 2009, [热带作物学报, Chinese Journal of Tropical Crops], V30, P135; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; Zhou GY, 2006, SCIENCE, V314, P1417, DOI 10.1126/science.1130168	47	22	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115234	10.1371/journal.pone.0115234	http://dx.doi.org/10.1371/journal.pone.0115234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536041	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300034
J	Omondi, EC; Kniss, AR				Omondi, Emmanuel Chiwo; Kniss, Andrew R.			Interplanting Annual Ryegrass, Wheat, Oat, and Corn to Mitigate Iron Deficiency in Dry Beans	PLOS ONE			English	Article							FE DEFICIENCY; CHLOROSIS; SUNFLOWER; NITROGEN; PLANTS; CHLOROPHYLL; NUTRITION; MANGANESE; NITRATE; ZINC	This study evaluated whether grass intercropping can be used to alleviate Fe deficiency chlorosis in dry beans (Phaseolus vulgaris L.) grown in high pH, calcareous soils with low organic matter. Field studies were conducted at the University of Wyoming Sustainable Agriculture Research and Extension Center in 2009 and 2010. Black- and navy beans were grown alone or intercropped with annual ryegrass (Lolium multiflorum Lam.), oat (Avena sativa L.), corn (Zea mays L.), or spring wheat (Triticum aestivum L.) in a two-factor factorial strip-plot randomized complete block design. All four grass species increased chlorophyll intensity in dry beans. However, grass species did not increase iron (Fe) concentration in dry bean tissues suggesting inefficient utilization of Fe present in the dry bean tissues. In 2009, nitrate-nitrogen (NO3-N) and manganese (Mn) concentration in bean tissue were greater in bean monoculture than in grass intercropped beans. Bean monoculture also had greater soil NO3-N concentrations than grass intercropped treatments. In 2009, grass intercrops reduced dry bean yield >25% compared to bean monoculture. Annual ryegrass was the least competitive of the four annual grass species. This suggests that competition from grasses for nutrients, water, or light may have outweighed benefits accruing from grass intercropping. Additional studies are required to determine the appropriate grass and dry bean densities, as well as the optimum time of grass removal.	[Omondi, Emmanuel Chiwo] Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA; [Kniss, Andrew R.] Univ Wyoming, Dept Plant Sci, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming	Omondi, EC (corresponding author), Univ Wyoming, Dept Ecosyst Sci & Management, 1000 East Univ Ave, Laramie, WY 82071 USA.	chiwomondi@yahoo.com	; Kniss, Andrew/B-3247-2010	Omondi, Emmanuel/0000-0002-3870-0809; Kniss, Andrew/0000-0003-2551-4959	Western Sustainable Agriculture Research and Extension Graduate Student grant	Western Sustainable Agriculture Research and Extension Graduate Student grant	This study was supported in part by a grant from the Western Sustainable Agriculture Research and Extension Graduate Student grant. The authors are also grateful to the University of Wyoming, Department of Plant Sciences for providing additional funds required to complete the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABADIA J, 1992, J PLANT NUTR, V15, P1699, DOI 10.1080/01904169209364432; AGBOOLA AA, 1972, AGRON J, V64, P409, DOI 10.2134/agronj1972.00021962006400040001x; AGGARWAL PK, 1992, AGRON J, V84, P71, DOI 10.2134/agronj1992.00021962008400010015x; Agrios GN, 2005, PLANT PATHOLOGY; AKTAS M, 1979, PLANT SOIL, V51, P257, DOI 10.1007/BF02232888; Alcaniz S, 2005, ACTA HORTIC, P535, DOI 10.17660/ActaHortic.2005.697.70; AMBLER JE, 1970, PLANT PHYSIOL, V46, P320, DOI 10.1104/pp.46.2.320; Bierman PM, 2005, NUTR MANAGEMENT FRUI; Bloom PR, 2011, SOIL SCI SOC AM J, V75, P2233, DOI 10.2136/sssaj2010.0391; Campbell CR, 1991, SO COOPERATIVE SERIE, V368, P1; CAMPBELL RJ, 1990, HORTSCIENCE, V25, P330, DOI 10.21273/HORTSCI.25.3.330; Castelli F, 1996, J AGRON CROP SCI, V177, P275, DOI 10.1111/j.1439-037X.1996.tb00246.x; Celik H., 2008, American-Eurasian Journal of Agricultural and Environmental Science, V3, P169; Combs S.M., 1998, N CENTRAL REG RES PU, P57; Cornell R.M., 2003, IRON OXIDES, Vsecond; DEAN RB, 1951, ANAL CHEM, V23, P636, DOI 10.1021/ac60052a025; EPSTEIN E, 1972, P412; Evers G. W., 1997, Ecology, production, and management of Lolium for forage in the USA., P29; Fageria Nand K., 2008, P245, DOI 10.1007/978-1-4020-6860-7_10; Fageria NK, 2001, COMMUN SOIL SCI PLAN, V32, P1659, DOI 10.1081/CSS-100104220; Gonzalez-Vallejo EB, 2000, PLANT PHYSIOL, V122, P337, DOI 10.1104/pp.122.2.337; Hamrick D, 2003, CROP PRODUCTION, V2; INSKEEP WP, 1987, AGRON J, V79, P779, DOI 10.2134/agronj1987.00021962007900050005x; Jacobsen J, 2003, FERTILIZER GUIDELINE; JOHNSON CLARENCE M., 1959, BULL CALIFORNIA AGRIC EXPT STA, V766, P25; Kabata-Pendias A., 1992, Trace elements in soils and plants.; KASHIRAD A, 1974, PLANT SOIL, V41, P91, DOI 10.1007/BF00017947; Keeney D. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P643; KIM J, 1994, BIOCHEMISTRY-US, V33, P389, DOI 10.1021/bi00168a001; Kirkland KJ, 2000, WEED TECHNOL, V14, P692, DOI 10.1614/0890-037X(2000)014[0692:ACSRWH]2.0.CO;2; Kosegarten HU, 1999, PLANT PHYSIOL, V121, P1069, DOI 10.1104/pp.121.4.1069; Krouma A, 2008, SYMBIOSIS, V46, P137; Krouma A, 2006, J PLANT PHYSIOL, V163, P1094, DOI 10.1016/j.jplph.2005.08.013; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Ling QH, 2011, PHOTOSYNTH RES, V108, P89, DOI 10.1007/s11120-011-9648-y; Loh FCW, 2002, HORTTECHNOLOGY, V12, P682, DOI 10.21273/HORTTECH.12.4.682; Ludwick A.E., 2002, W FERTILIZER HDB; MARSCHNER H, 1994, PLANT SOIL, V165, P261, DOI 10.1007/BF00008069; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; MENGEL K, 1988, PHYSIOL PLANTARUM, V72, P460, DOI 10.1111/j.1399-3054.1988.tb09151.x; MENGEL K, 1994, PLANT SOIL, V165, P275, DOI 10.1007/BF00008070; Mengel K, 1982, Principles of plant nutrition.; MENGEL K, 1994, J PLANT NUTR, V17, P1053, DOI 10.1080/01904169409364787; Morales F, 1998, J PLANT NUTR, V21, P815, DOI 10.1080/01904169809365444; MORTVEDT JJ, 1991, PLANT SOIL, V130, P273, DOI 10.1007/BF00011883; OLSEN RA, 1981, AM SCI, V69, P378; Omondi EC, 2010, J SUSTAIN AGR, V34, P244, DOI 10.1080/10440041003613230; Paul E. A., 1989, Soil microbiology and biochemistry.; Pinkard L, 2006, PRUNING THINNING COO, P64; Raju K. V., 1972, Zeitschrift fur Pflanzenernahrung und Bodenkunde, V133, P227, DOI 10.1002/jpln.19731330305; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; ROMHELD V, 1984, PLANT PHYSIOL, V76, P603, DOI 10.1104/pp.76.3.603; SAS Institute Inc, 2008, SAS STAT VERS 9 2; SHAXSON L, 1992, EXP AGR, V28, P211, DOI 10.1017/S0014479700019657; SIDERIS CP, 1949, PLANT PHYSIOL, V24, P416, DOI 10.1104/pp.24.3.416; Stevens B, 2005, NUTR MANAGEMENT GUID; STORER DA, 1984, COMMUN SOIL SCI PLAN, V15, P759, DOI 10.1080/00103628409367515; Suzuki K, 1997, BIOMETALS, V10, P77, DOI 10.1023/A:1018323021721; Sylvia D., 2005, PRINCIPLES APPL SOIL, Vsecond; TWYMAN E. S., 1951, New Phytologist, V50, P210, DOI 10.1111/j.1469-8137.1951.tb05186.x; USDA National Agriculture Statistical Service, 2008, N DAK ANN STAT B; USEPA-United States Environmental Protection Agency, 1992, TEST METH EV SOL WAS; Vansuyt G, 2000, PLANT PHYSIOL BIOCH, V38, P499, DOI 10.1016/S0981-9428(00)00763-4; WALLACE A, 1976, Communications in Soil Science and Plant Analysis, V7, P37, DOI 10.1080/00103627609366609; WALLACE ARTHUR, 1960, PROC AMER SOC HORT SCI, V75, P819; WEIHING RM, 1963, AGRON J, V55, P519, DOI 10.2134/agronj1963.00021962005500060004x; Whitney DA, 1998, RECOMMENDED CHEM SOI, V221, P59	67	2	2	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115673	10.1371/journal.pone.0115673	http://dx.doi.org/10.1371/journal.pone.0115673			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536084	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300063
J	Koh, O; Lee, J; Tan, MLS; Tai, ES; Foo, CJ; Chong, KJ; Goh, SY; Bee, YM; Thumboo, J; Cheung, YB; Singh, A; Wee, HL				Koh, Odelia; Lee, Jeannette; Tan, Maudrene L. S.; Tai, E-Shyong; Foo, Ce Jin; Chong, Kok Joon; Goh, Su-Yen; Bee, Yong Mong; Thumboo, Julian; Cheung, Yin-Bun; Singh, Avjeet; Wee, Hwee-Lin			Establishing the Thematic Framework for a Diabetes-Specific Health-Related Quality of Life Item Bank for Use in an English-Speaking Asian Population	PLOS ONE			English	Article							PEOPLE; QUESTIONNAIRE; ADAPTATION; MELLITUS	Aims: To establish a thematic framework for a Diabetes Mellitus (DM)-specific health-related quality of life (HRQoL) item bank by identifying important HRQoL themes and content gaps in existing DM-specific HRQoL measures and determining whether Patient-Reported Outcomes Measurement Information System (PROMIS) item banks are useful as a starting point. Methodology: English-speaking Type 2 DM patients were recruited from an outpatient specialist clinic in Singapore. Thematic analysis was performed through open coding and axial coding. Items from four existing DM-specific measures and PROMIS Version 1.0 and 2.0 item banks were compared with identified themes and sub-themes. Results: 42 patients participated (25 men and 17 women; 28 Chinese, 4 Malay, 8 Indians, 2 other ethnicities). Median age was 53.70 years (IQR45.82-56.97) and the median disease duration was 11.13 (SD9.77) years. 10 subthemes (neutral emotions, coping emotions, empowered to help others, support from family, spend more time with family, relationships, financial burden on family, improved relationship, social support and religion/spirituality) were not covered by existing DM-specific measures. PROMIS covered 5 of 6 themes, 15 of 30 subthemes and 19 of 35 codes identified. Emotional distress (frustration, fear and anxiety) was most frequently mentioned (200 times). Conclusions: We had developed a thematic framework for assessing DM-specific HRQoL in a multi-ethnic Asian population, identified new items that needed to be written and confirmed that PROMIS was a useful starting point. We hope that better understanding and measurement of HRQoL of Asian DM patients will translate to better quality of care for them.	[Koh, Odelia] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Lee, Jeannette; Tan, Maudrene L. S.; Tai, E-Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Tai, E-Shyong] Natl Univ Singapore Hosp, Dept Med, Div Endocrinol, Singapore 117548, Singapore; [Tai, E-Shyong; Chong, Kok Joon; Thumboo, Julian] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Foo, Ce Jin] Natl Univ Singapore Hosp, Dept Corp Planning & Dev, Singapore 117548, Singapore; [Goh, Su-Yen; Bee, Yong Mong] Singapore Gen Hosp, Dept Endocrinol, Singapore, Singapore; [Thumboo, Julian; Wee, Hwee-Lin] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore; [Thumboo, Julian] Duke NUS Grad Med Sch Singapore, Off Clin Sci, Singapore, Singapore; [Cheung, Yin-Bun] Duke NUS Grad Med Sch Singapore, Ctr Quantitat Med, Singapore, Singapore; [Cheung, Yin-Bun] Univ Tampere, FIN-33101 Tampere, Finland; [Singh, Avjeet; Wee, Hwee-Lin] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital; Singapore General Hospital; National University of Singapore; National University of Singapore; National University of Singapore	Wee, HL (corresponding author), Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore.	phawhl@nus.edu.sg	Wee, Hwee Lin/D-4126-2012	Wee, Hwee Lin/0000-0002-7150-1801; Tai, E Shyong/0000-0003-2929-8966	National University of Singapore [R-148-000-103-133]; Duke-NUS Signature Research Program Block Fund; Singapore Ministry of Health's National Medical Research Council under its Clinician Scientist Award	National University of Singapore(National University of Singapore); Duke-NUS Signature Research Program Block Fund; Singapore Ministry of Health's National Medical Research Council under its Clinician Scientist Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore)	This study was funded by a start-up grant from the National University of Singapore (WBS: R-148-000-103-133) and in part by the Duke-NUS Signature Research Program Block Fund. YBC was supported by the Singapore Ministry of Health's National Medical Research Council under its Clinician Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoli S, 2008, INT NURS REV, V55, P447, DOI 10.1111/j.1466-7657.2008.00664.x; Boyer JG, 1997, MED CARE, V35, P440, DOI 10.1097/00005650-199705000-00003; Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100; Cheng AY, 1999, DIABETES RES CLIN PR, V46, P259, DOI 10.1016/S0168-8227(99)00091-1; DAVIS WK, 1988, DIABETES CARE, V11, P538, DOI 10.2337/diacare.11.7.538; Pena MMEY, 2010, DIABETES METAB, V36, P305, DOI 10.1016/j.diabet.2010.02.003; Gibbs G.R., 2007, ANAL QUALITATIVE DAT; International Diabetes Federation, 2006, DIABETES ATLAS; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Koch T, 2000, J CLIN NURS, V9, P247, DOI 10.1046/j.1365-2702.2000.00341.x; Kong DL, 2011, DIABETES RES CLIN PR, V94, P45, DOI 10.1016/j.diabres.2011.05.026; Lai JS, 2003, QUAL LIFE RES, V12, P485, DOI 10.1023/A:1025014509626; Lasch KE, 2010, QUAL LIFE RES, V19, P1087, DOI 10.1007/s11136-010-9677-6; Maddigan SL, 2006, AM J PUBLIC HEALTH, V96, P1649, DOI 10.2105/AJPH.2005.067728; Meadows KA, 2000, DIABETIC MED, V17, P572, DOI 10.1046/j.1464-5491.2000.00322.x; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Pope C, 2006, QUALITATIVE RES HLTH; Ryan G.W., 2003, FIELD METHOD, V15, P85, DOI DOI 10.1177/1525822X02239569; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shim YT, 2012, DIABETIC MED, V29, pE241, DOI 10.1111/j.1464-5491.2012.03689.x; Tang KC, 1995, FAM PRACT, V12, P474, DOI 10.1093/fampra/12.4.474; Unden AL, 2008, GENDER MED, V5, P162, DOI 10.1016/j.genm.2008.05.003; World Health Organization, 1946, PREAMBL CONST WHO AD	23	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115654	10.1371/journal.pone.0115654	http://dx.doi.org/10.1371/journal.pone.0115654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531429	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845100089
J	Cui, J; Yang, Y; Li, H; Leng, Y; Qian, K; Huang, Q; Zhang, C; Lu, Z; Chen, J; Sun, T; Wu, R; Sun, Y; Song, H; Wei, X; Jing, P; Yang, X; Zhang, C				Cui, J.; Yang, Y.; Li, H.; Leng, Y.; Qian, K.; Huang, Q.; Zhang, C.; Lu, Z.; Chen, J.; Sun, T.; Wu, R.; Sun, Y.; Song, H.; Wei, X.; Jing, P.; Yang, X.; Zhang, C.			MiR-873 regulates ER alpha transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; CROSS-TALK; PHOSPHORYLATION; MECHANISMS; ANTAGONISM; INHIBITORS; SERINE-118; EXPRESSION; MICRORNAS; SURVIVAL	miRNAs (microRNAs) are frequently and aberrantly expressed in many cancers. MiR-873 has been revealed to be downregulated in colorectal cancer and glioblastoma. However, its function remains unclear. Here we report that miR-873 is downregulated in breast tumor compared with normal tissue. Enforced expression of miR-873 decreases the transcriptional activity of ER (estrogen receptor)-alpha but not ER beta through the modulation of ER alpha phosphorylation in ER-positive breast cancer cells. We also found that miR-873 inhibits breast cancer cell proliferation and tumor growth in nude mice. Reporter gene assays revealed cyclin-dependent kinase 3 (CDK3) as a direct target of miR-873. CDK3 was shown to be overexpressed in breast cancer and phosphorylate ERa at Ser104/116 and Ser118. Furthermore, we found that Mir-873 inhibits ER activity and cell growth via targeting CDK3. Interestingly, miR-873 was observed to be downregulated in tamoxifen-resistant MCF-7/TamR cells, while CDK3 is overexpressed in these cells. More importantly, re-expression of miR-873 reversed tamoxifen resistance in MCF-7/TamR cells. Our data demonstrate that miR-873 is a novel tumor suppressor in ER-positive breast cancer and a potential therapeutic approach for treatment of tamoxifen-resistant breast cancer.	[Cui, J.; Lu, Z.; Wu, R.; Sun, Y.; Song, H.; Zhang, C.] Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China; [Yang, Y.] Capital Med Univ, Beijing Inst Neurosci, Beijing, Peoples R China; [Li, H.] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY USA; [Leng, Y.; Qian, K.] Jiujiang Univ, Affiliated Hosp, Jiujiang, Peoples R China; [Huang, Q.] Jilin Agr Univ, Dept Anim Sci & Technol, Changchun, Peoples R China; [Zhang, C.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Chen, J.; Sun, T.] Nanchang Univ, Hosp 1, Dept Urol, Nanchang, Peoples R China; [Wei, X.] Peking Univ, Coll Chem & Mol Engn, Dept Appl Chem, Beijing 100871, Peoples R China; [Jing, P.] Purdue Univ, Indiana Univ, Coll Arts & Sci, Dept Chem, Ft Wayne, IN USA; [Yang, X.] Anhui Univ, Inst Hlth Sci, Hefei 230039, Peoples R China	Academy of Military Medical Sciences - China; Capital Medical University; Chinese Academy of Sciences; University of Kentucky; Jiujiang University; Jilin Agricultural University; Cincinnati Children's Hospital Medical Center; Nanchang University; Peking University; Purdue University System; Indiana University Purdue University Fort Wayne; Anhui University	Yang, X (corresponding author), Anhui Univ, Inst Hlth Sci, Hefei 230039, Peoples R China.	Stanleyxingyuan@hotmail.com; zhangcfu@gmail.com		Zhang, Chunni/0000-0002-7329-7162	National Natural Science Foundation of China [81102005, 31271154]; National High Technology Research and Development Program of China [2014AA020516]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	We are grateful to Mingjun Bi, Anne-Marie Overstreet and Alex Meredith for their advice, discussion and editor assistance. We thank Dr. Guanxuan Tan and his lab members for reagents and advice. We also thank Bill Evans for editorial support and grammar correction. This study was supported by the National Natural Science Foundation of China (Nos. 81102005, 31271154) and the National High Technology Research and Development Program of China (No. 2014AA020516).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Bergamaschi A, 2012, ONCOGENE, V31, P39, DOI 10.1038/onc.2011.223; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; BULLRICH F, 1995, CANCER RES, V55, P1199; Cho YY, 2009, CANCER RES, V69, P272, DOI 10.1158/0008-5472.CAN-08-3125; Cicenas J, 2011, J CANCER RES CLIN, V137, P1409, DOI 10.1007/s00432-011-1039-4; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Cui JJ, 2012, CANCER RES, V72, P5625, DOI 10.1158/0008-5472.CAN-12-1305; Cui JJ, 2011, CELL MOL LIFE SCI, V68, P1091, DOI 10.1007/s00018-010-0511-7; de Leeuw R, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/232435; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Hoffman JT, 2014, ANN ONCOL         S1, V25, pi27; Keeton EK, 2005, MOL ENDOCRINOL, V19, P1543, DOI 10.1210/me.2004-0395; Kim K, 2003, MOL ENDOCRINOL, V17, P804, DOI 10.1210/me.2002-0406; Klinge CM, 2012, TRENDS ENDOCRIN MET, V23, P223, DOI 10.1016/j.tem.2012.03.002; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kok M, 2009, JNCI-J NATL CANCER I, V101, P1725, DOI 10.1093/jnci/djp412; Likhite VS, 2006, MOL ENDOCRINOL, V20, P3120, DOI 10.1210/me.2006-0068; Manavathi B, 2013, ENDOCR REV, V34, P1, DOI 10.1210/er.2011-1057; McCartan D, 2012, CANCER RES, V72, P220, DOI 10.1158/0008-5472.CAN-11-1976; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Mulrane L, 2013, CANCER RES, V73, P6554, DOI 10.1158/0008-5472.CAN-13-1841; Nana-Sinkam SP, 2013, CLIN PHARMACOL THER, V93, P98, DOI 10.1038/clpt.2012.192; Nilsson S, 2011, NAT REV DRUG DISCOV, V10, P778, DOI 10.1038/nrd3551; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Ren SJ, 2004, CELL, V117, P239, DOI 10.1016/S0092-8674(04)00300-9; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Sarwar N, 2006, ENDOCR-RELAT CANCER, V13, P851, DOI 10.1677/erc.1.01123; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Sun X, 2014, ONCOGENE, V33, P4967, DOI [10.1038/onc.2013.492, 10.1038/onc.2014.224]; Sutherland RL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2454; Suzuki H, 2011, CANCER RES, V71, P5646, DOI 10.1158/0008-5472.CAN-11-1076; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Tian W, 2013, CLIN TRANSL ONCOL, V15, P335, DOI 10.1007/s12094-012-0929-5; Trowbridge JM, 1997, P NATL ACAD SCI USA, V94, P10132, DOI 10.1073/pnas.94.19.10132; Tyson JJ, 2011, NAT REV CANCER, V11, P523, DOI 10.1038/nrc3081; Vendrell JA, 2005, ENDOCR-RELAT CANCER, V12, P75, DOI 10.1677/erc.1.00899; Wang L, 2014, MOL MED REP, V9, P2582, DOI 10.3892/mmr.2014.2095; Ward A, 2013, ONCOGENE, V32, P1173, DOI 10.1038/onc.2012.128; Wardell SE, 2013, CLIN CANCER RES, V19, P2420, DOI 10.1158/1078-0432.CCR-12-3771; Wesierska-Gadek J, 2011, J CELL BIOCHEM, V112, P761, DOI 10.1002/jcb.23004; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Ye X, 2001, P NATL ACAD SCI USA, V98, P1682, DOI 10.1073/pnas.041596198; Zhang DX, 2011, J BIOL CHEM, V286, P17746, DOI 10.1074/jbc.M110.206029; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zheng D, 2008, CANCER RES, V68, P7650, DOI 10.1158/0008-5472.CAN-08-1137	55	72	73	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	30					3895	3907		10.1038/onc.2014.430	http://dx.doi.org/10.1038/onc.2014.430			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CN6KR	25531331				2022-12-26	WOS:000358544200002
J	Podrini, C; Koffas, A; Chokshi, S; Vinciguerra, M; Lelliott, CJ; White, JK; Adissu, HA; Williams, R; Greco, A				Podrini, Christine; Koffas, Apostolos; Chokshi, Shilpa; Vinciguerra, Manlio; Lelliott, Christopher J.; White, Jacqueline K.; Adissu, Hibret A.; Williams, Roger; Greco, Azzura			MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat-induced steatosis	FASEB JOURNAL			English	Article						histone methylation; bivalent promoter; histone variants; lipid uptake	IMMORTALIZED HUMAN HEPATOCYTES; GENOME-WIDE; HEPATIC STEATOSIS; HISTONE VARIANTS; LIVER-DISEASE; KNOCKOUT MICE; ATP SYNTHASE; MOUSE; EXPRESSION; CHROMATIN	The importance of epigenetic changes in the development of hepatic steatosis is largely unknown. The histone variant macroH2A1 under alternative splicing gives rise to macroH2A1.1 and macroH2A1.2. In this study, we show that the macroH2A1 isoforms play an important role in the regulation of lipid accumulation in hepatocytes. Hepatoma cell line and immortalized human hepatocytes transiently transfected or knocked down with macroH2A1 isoforms were used as in vitro model of fat-induced steatosis. Gene expressions were analyzed by quantitative PCR array and Western blot. Chromatin immunoprecipitation analysis was performed to check the association of histone H3 lysine 27 trimethylation (H3K27me3) and histone H3 lysine 4 trimethylation (H3K4me3) with the promoter of lipogenic genes. Livers from knockout mice that are resistant to lipid deposition despite a high-fat diet were used for histopathology. We found that macroH2A1.2 is regulated by fat uptake and that its overexpression caused an increase in lipid uptake, triglycerides, and lipogenic genes compared with macroH2A1.1. This suggests that macroH2A1.2 is important for lipid uptake, whereas macroH2A1.1 was found to be protective. The result was supported by a high positivity for macroH2A1.1 in knockout mice for genes targeted by macroH2A1 (Atp5a1 and Fam73b), that under a high-fat diet presented minimal lipidosis. Moreover, macroH2A1 isoforms differentially regulate the expression of lipogenic genes by modulating the association of the active (H3K4me3) and repressive (H3K27me3) histone marks on their promoters. This study underlines the importance of the replacement of noncanonical histones in the regulation of genes involved in lipid metabolism in the progression of steatosis.-Podrini, C., Koffas, A., Chokshi, S., Vinciguerra, M., Lelliott, C. J., White, J. K., Adissu, H. A., Williams, R., Greco, A. MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat-induced steatosis.	[Podrini, Christine; Koffas, Apostolos; Chokshi, Shilpa; Williams, Roger; Greco, Azzura] Fdn Liver Res, Inst Hepatol, London WC1E 6HX, England; [Vinciguerra, Manlio] UCL, Sch Med, Inst Liver & Digest Hlth, London W1N 8AA, England; [Lelliott, Christopher J.; White, Jacqueline K.] Wellcome Trust Sanger Inst, Mouse Genet Project, Cambridge, England; [Adissu, Hibret A.] Univ Toronto, Hosp Sick Children, Physiol & Expt Med Res Program, Toronto, ON M5G 1X8, Canada	University of London; University College London; University of London; University College London; UCL Medical School; Wellcome Trust Sanger Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Greco, A (corresponding author), Fdn Liver Res, Inst Hepatol, Epigenet Fatty Liver Dis Res Grp, 69-75 Chenies Mews, London WC1E 6HX, England.	a.greco@researchinliver.org.uk	Podrini, Christine/K-8621-2016; koffas, Apostolos/AAU-6858-2020; Vinciguerra, Manlio/N-1309-2015; adissu, hibret a/R-3282-2018	Podrini, Christine/0000-0002-5391-3378; koffas, Apostolos/0000-0002-2637-3847; Vinciguerra, Manlio/0000-0002-1768-3894; adissu, hibret a/0000-0003-3365-7466	Wellcome Trust Sanger Institute Mouse Genetics Project, Research Support Facility,; Institute of Hepatology, Foundation for Liver Research, London, United Kingdom	Wellcome Trust Sanger Institute Mouse Genetics Project, Research Support Facility,; Institute of Hepatology, Foundation for Liver Research, London, United Kingdom	The authors thank the staff from the Wellcome Trust Sanger Institute Mouse Genetics Project, Research Support Facility, and Mouse Informatics Group for excellent technical support. The authors also thank the histology support of Dr. Susan Newbigging and Lily Morikawa from the CMHD Pathology Core (www.cmhd.ca). This work was supported by the Institute of Hepatology, Foundation for Liver Research, London, United Kingdom.	Adissu HA, 2014, DIS MODEL MECH, V7, P515, DOI 10.1242/dmm.015263; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Assem M, 2004, J BIOL CHEM, V279, P22250, DOI 10.1074/jbc.M314111200; Bassett JHD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002858; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Changolkar LN, 2007, MOL CELL BIOL, V27, P2758, DOI 10.1128/MCB.02334-06; Changolkar LN, 2010, MOL CELL BIOL, V30, P5473, DOI 10.1128/MCB.00518-10; Cui W, 2010, AM J TRANSL RES, V2, P95; De Gottardi A, 2007, LAB INVEST, V87, P792, DOI 10.1038/labinvest.3700590; Ehara T, 2012, DIABETES, V61, P2442, DOI 10.2337/db11-1834; Feldstein AE, 2010, SEMIN LIVER DIS, V30, P391, DOI 10.1055/s-0030-1267539; Gamble MJ, 2010, CELL CYCLE, V9, P2568, DOI 10.4161/cc.9.13.12144; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Ghoshal K, 2006, J NUTR, V136, P1522, DOI 10.1093/jn/136.6.1522; Halleck MS, 1999, PHYSIOL GENOMICS, V1, P139, DOI 10.1152/physiolgenomics.1999.1.3.139; KATAOKA H, 1991, BIOCHIM BIOPHYS ACTA, V1089, P393, DOI 10.1016/0167-4781(91)90183-M; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Lesch BJ, 2013, P NATL ACAD SCI USA, V110, P16061, DOI 10.1073/pnas.1315204110; Mach T, 2000, Med Sci Monit, V6, P209; McClain CJ, 2004, ALCOHOL, V34, P67, DOI 10.1016/j.alcohol.2004.07.007; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nguyen TH, 2005, J HEPATOL, V43, P1031, DOI 10.1016/j.jhep.2005.05.036; Novikov L, 2011, MOL CELL BIOL, V31, P4244, DOI 10.1128/MCB.05244-11; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pehrson JR, 1997, J CELL BIOCHEM, V65, P107, DOI 10.1002/(SICI)1097-4644(199704)65:1<107::AID-JCB11>3.0.CO;2-H; Pogribny IP, 2009, J HEPATOL, V51, P176, DOI 10.1016/j.jhep.2009.03.021; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Rappa F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054458; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Ryder E, 2013, MAMM GENOME, V24, P286, DOI 10.1007/s00335-013-9467-x; Sheedfar F, 2015, INT J OBESITY, V39, P331, DOI 10.1038/ijo.2014.91; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Tappenden DM, 2011, TOXICOL APPL PHARM, V254, P299, DOI 10.1016/j.taap.2011.05.004; Turner BM, 2012, TRENDS GENET, V28, P436, DOI 10.1016/j.tig.2012.04.003; Volle C, 2014, CURR OPIN GENET DEV, V25, P8, DOI 10.1016/j.gde.2013.11.006; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; WHO (World Health Organization), 1998, WORLD HLTH REP 1998	41	28	30	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1676	1687		10.1096/fj.14-262717	http://dx.doi.org/10.1096/fj.14-262717			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25526730	Green Submitted			2022-12-26	WOS:000354114600007
J	Zhang, W; Zhang, XX; Gonzalez-Cobos, JC; Stolwijk, JA; Matrougui, K; Trebak, M				Zhang, Wei; Zhang, Xuexin; Gonzalez-Cobos, Jose C.; Stolwijk, Judith A.; Matrougui, Khalid; Trebak, Mohamed			Leukotriene-C-4 Synthase, a Critical Enzyme in the Activation of Store-independent Orai1/Orai3 Channels, Is Required for Neointimal Hyperplasia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL PROLIFERATION; OPERATED CALCIUM-ENTRY; SMOOTH-MUSCLE; C-4 SYNTHASE; CYSTEINYL-LEUKOTRIENES; PROMOTER POLYMORPHISM; CRAC CURRENTS; I-CRAC; STIM1; ORAI1	Leukotriene-C-4 synthase (LTC4S) generates LTC4 from arachidonic acid metabolism. LTC4 is a proinflammatory factor that acts on plasma membrane cysteinyl leukotriene receptors. Recently, however, we showed that LTC4 was also a cytosolic second messenger that activated store-independent LTC4-regulated Ca2+ (LRC) channels encoded by Orai1/Orai3 heteromultimers in vascular smooth muscle cells (VSMCs). We showed that Orai3 and LRC currents were up-regulated in medial and neointimal VSMCs after vascular injury and that Orai3 knockdown inhibited LRC currents and neointimal hyperplasia. However, the role of LTC4S in neointima formation remains unknown. Here we show that LTC4S knockdown inhibited LRC currents in VSMCs. We performed in vivo experiments where rat left carotid arteries were injured using balloon angioplasty to cause neointimal hyperplasia. Neointima formation was associated with up-regulation of LTC4S protein expression in VSMCs. Inhibition of LTC4S expression in injured carotids by lentiviral particles encoding shRNA inhibited neointima formation and inward and outward vessel remodeling. LRC current activation did not cause nuclear factor for activated T cells (NFAT) nuclear translocation in VSMCs. Surprisingly, knockdown of either LTC4S or Orai3 yielded more robust and sustained Akt1 and Akt2 phosphorylation on Ser-473/Ser-474 upon serum stimulation. LTC4S and Orai3 knockdown inhibited VSMC migration in vitro with no effect on proliferation. Akt activity was suppressed in neointimal and medial VSMCs from injured vessels at 2 weeks postinjury but was restored when the up-regulation of either LTC4S or Orai3 was prevented by shRNA. We conclude that LTC4S and Orai3 altered Akt signaling to promote VSMC migration and neointima formation.	[Zhang, Wei; Zhang, Xuexin; Gonzalez-Cobos, Jose C.; Stolwijk, Judith A.; Trebak, Mohamed] SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12203 USA; [Zhang, Wei; Gonzalez-Cobos, Jose C.; Trebak, Mohamed] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Matrougui, Khalid] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute; Albany Medical College; Eastern Virginia Medical School	Trebak, M (corresponding author), SUNY Albany, Coll Nanoscale Sci & Engn, 257 Fuller Rd, Albany, NY 12203 USA.	mtrebak@albany.edu		ZHANG zhang xue xin, XUEXIN/0000-0001-8276-3885	National Institutes of Health [R01HL097111, R01HL123364, R01HL095566]; American Heart Association [14GRNT18880008]; Applied Biophysics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097111, R01HL095566, R01HL123364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Applied Biophysics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL097111 and R01HL123364 (to M. T.) and R01HL095566 (to K. M.). This work was also supported by American Heart Association Grant 14GRNT18880008 (to M. T.).; Partially supported by a fellowship from Applied Biophysics Inc.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Ago H, 2013, J BIOCHEM, V153, P421, DOI 10.1093/jb/mvt007; Aubart FC, 2009, MOL THER, V17, P455, DOI 10.1038/mt.2008.291; Austen KF, 2008, NAT IMMUNOL, V9, P113, DOI 10.1038/ni0208-113; Berna-Erro A, 2012, BBA-MOL CELL RES, V1823, P1242, DOI 10.1016/j.bbamcr.2012.05.023; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Bevan S, 2008, STROKE, V39, P1109, DOI 10.1161/STROKEAHA.107.491969; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Chung AWY, 2007, BRIT J PHARMACOL, V150, P1075, DOI 10.1038/sj.bjp.0707181; Cowburn AS, 1998, J CLIN INVEST, V101, P834, DOI 10.1172/JCI620; Di Gennaro A, 2010, P NATL ACAD SCI USA, V107, P21093, DOI 10.1073/pnas.1015166107; Freiberg JJ, 2008, ARTERIOSCL THROM VAS, V28, P990, DOI 10.1161/ATVBAHA.107.158873; Freiberg JJ, 2009, J MOL CELL CARDIOL, V46, P579, DOI 10.1016/j.yjmcc.2009.01.002; Gonzalez-Cobos JC, 2013, CIRC RES, V112, P1013, DOI 10.1161/CIRCRESAHA.111.300220; Guo RW, 2012, CARDIOVASC RES, V93, P360, DOI 10.1093/cvr/cvr307; Guo RW, 2009, CARDIOVASC RES, V81, P660, DOI 10.1093/cvr/cvn338; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Iovannisci DM, 2007, ARTERIOSCL THROM VAS, V27, P394, DOI 10.1161/01.ATV.0000252680.72734.10; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jonas M, 2005, CIRC RES, V97, P725, DOI 10.1161/01.RES.0000183730.52908.C6; Liu JY, 2011, J BIOL CHEM, V286, P6510, DOI 10.1074/jbc.M110.183087; Malik N, 1998, CIRCULATION, V98, P1657, DOI 10.1161/01.CIR.98.16.1657; Mancarella S, 2013, FASEB J, V27, P893, DOI 10.1096/fj.12-215293; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Motiani RK, 2013, CHANNELS, V7, P392, DOI 10.4161/chan.24960; Motiani RK, 2013, PFLUG ARCH EUR J PHY, V465, P1249, DOI 10.1007/s00424-013-1254-8; Motiani RK, 2013, FASEB J, V27, P63, DOI 10.1096/fj.12-213801; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Niegowski D, 2014, J BIOL CHEM, V289, P5199, DOI 10.1074/jbc.M113.534628; Osher E, 2006, MOL CELL ENDOCRINOL, V252, P201, DOI 10.1016/j.mce.2006.03.038; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Ruhle B, 2013, CURR TOP MEMBR, V71, P209, DOI 10.1016/B978-0-12-407870-3.00009-3; Sampaio WO, 2007, HYPERTENSION, V49, P185, DOI 10.1161/01.HYP.0000251865.35728.2f; Sanak M, 1997, LANCET, V350, P1599, DOI 10.1016/S0140-6736(05)64015-9; Shen YH, 2013, CIRC RES, V112, P618, DOI 10.1161/CIRCRESAHA.112.300735; Shigematsu K, 2000, ARTERIOSCL THROM VAS, V20, P2373, DOI 10.1161/01.ATV.20.11.2373; Shinde AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003425; Spinelli AM, 2012, PFLUG ARCH EUR J PHY, V464, P481, DOI 10.1007/s00424-012-1160-5; Stabile E, 2003, CIRC RES, V93, P1059, DOI 10.1161/01.RES.0000105086.31909.1B; Taccone-Gallucci M, 2008, NEW ENGL J MED, V358, P746, DOI 10.1056/NEJMc073333; Thompson JL, 2013, CHANNELS, V7, P364, DOI 10.4161/chan.26156; Wang CCL, 2003, DIABETES, V52, P2562, DOI 10.2337/diabetes.52.10.2562; Warfel NA, 2012, J BIOL CHEM, V287, P3610, DOI 10.1074/jbc.R111.318675; Warfel NA, 2011, J BIOL CHEM, V286, P19777, DOI 10.1074/jbc.M111.237081; Yang HM, 2004, CIRCULATION, V110, P301, DOI 10.1161/01.CIR.0000135467.43430.16; Yun SJ, 2014, BBA-MOL BASIS DIS, V1842, P2184, DOI 10.1016/j.bbadis.2014.08.014; Zhang W., 2012, T TRP CHANNELS DRUG, P101; Zhang W, 2014, JOVE-J VIS EXP, DOI 10.3791/52045; Zhang W, 2011, CIRC RES, V109, P534, DOI 10.1161/CIRCRESAHA.111.246777; Zhang XX, 2014, J GEN PHYSIOL, V143, P345, DOI 10.1085/jgp.201311084; Zhang XX, 2013, MOL CELL BIOL, V33, P3715, DOI 10.1128/MCB.00554-13	54	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5015	5027		10.1074/jbc.M114.625822	http://dx.doi.org/10.1074/jbc.M114.625822			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25540197	Green Published, hybrid			2022-12-26	WOS:000350042000043
J	Teitelman, G; Kedees, M				Teitelman, Gladys; Kedees, Mamdouh			Mouse Insulin Cells Expressing an Inducible RIPCre Transgene Are Functionally Impaired	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELLS; MICE; GLUCOSE; MASS; PROLIFERATION; PROGENITORS; SECRETION; EXENDIN-4; RECEPTOR; AGONIST	We used cre-lox technology to test whether the inducible expression of Cre minimize the deleterious effect of the enzyme on beta cell function. We studied mice in which Cre is linked to a modified estrogen receptor (ER), and its expression is controlled by the rat insulin promoter (RIP). Following the injection of tamoxifen (TM), CreER-migrates to the nucleus and promotes the appearance of a reporter protein, enhanced yellow fluorescent protein (EYFP), in cells. Immunocytochemical analysis indicated that 46.6 +/- 2.1% insulin cells of adult RIPCreER-EYFP expressed EYFP. RIPCreER-EYFP (+TM) mice were normoglycemic throughout the study, and their glucose tolerance test results were similar to control CD-1 mice. However, an extended exposure to reagents that stimulate insulin synthesis was detrimental to the survival of IN+EYFP+ cells. The administration of an inhibitor of the enzyme dipeptidyl-peptidase (DPP4i), which prevents the cleavage of glucagon-like peptide (GLP-1), to adult RIPCreER-EYFP mice lead to a decrease in the percentage of IN+EYFP+ to 17.5 +/- 1.73 and a significant increase in apoptotic cells in islets. Similarly, a 2-week administration of the GLP-1 analog exendin 4 (ex-4) induced an almost complete ablation of IN+ expressing a different reporter protein and a significant decrease in the beta cell mass and rate of beta cell proliferation. Since normal beta cells do not die when induced to increase insulin synthesis, our observations indicate that insulin cells expressing an inducible RIPCre transgene are functionally deficient. Studies employing these mice should carefully consider the pitfalls of the Cre-Lox technique.	[Teitelman, Gladys; Kedees, Mamdouh] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Teitelman, G (corresponding author), SUNY Hlth Sci Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.	gteitelman@downstate.edu		Teitelman, Gladys/0000-0003-0687-3032				Abouna S, 2010, ORGANOGENESIS, V6, P125, DOI 10.4161/org.6.2.10374; Beall C, 2010, BIOCHEM J, V429, P323, DOI 10.1042/BJ20100231; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Brereton MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5639; Carrington EM, 2009, DIABETES, V58, P2316, DOI 10.2337/db08-1602; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Ellenbroek JH, 2013, DIABETOLOGIA, V56, P1980, DOI 10.1007/s00125-013-2957-2; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; GOKE R, 1993, J BIOL CHEM, V268, P19650; Grigoryan M, 2012, ENDOCRINOLOGY, V153, P3076, DOI 10.1210/en.2012-1120; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Harno E, 2013, CELL METAB, V18, P21, DOI 10.1016/j.cmet.2013.05.019; Hellerstrom C, 1985, DIABETIC PANCREAS, P53; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Holst JJ, 2005, DIABETOLOGIA, V48, P612, DOI 10.1007/s00125-005-1705-7; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Liu H, 2010, ENDOCRINOLOGY, V151, P520, DOI 10.1210/en.2009-0992; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Rankin MM, 2013, DIABETES, V62, P1634, DOI 10.2337/db12-0848; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tamarina NA, 2014, ISLETS, V6, DOI 10.4161/isl.27685; Tang TY, 2013, CELL METAB, V18, P883, DOI 10.1016/j.cmet.2013.10.012; Weinberg N, 2007, FORBES, V179, P56; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Yang KT, 2014, DIABETOLOGIA, V57, P352, DOI 10.1007/s00125-013-3085-8; Young AA, 1999, DIABETES, V48, P1026, DOI 10.2337/diabetes.48.5.1026; Zeng N, 2013, AGING CELL, V12, P1000, DOI 10.1111/acel.12132	30	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3647	3653		10.1074/jbc.M114.615484	http://dx.doi.org/10.1074/jbc.M114.615484			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533471	hybrid, Green Published			2022-12-26	WOS:000349456000037
J	Diopere, E; Maes, GE; Komen, H; Volckaert, FAM; Groenen, MAM				Diopere, Eveline; Maes, Gregory E.; Komen, Hans; Volckaert, Filip A. M.; Groenen, Martien A. M.			A Genetic Linkage Map of Sole (Solea solea): A Tool for Evolutionary and Comparative Analyses of Exploited (Flat)Fishes	PLOS ONE			English	Article							TURBOT SCOPHTHALMUS-MAXIMUS; COMMON SOLE; MICROSATELLITE MARKERS; COMPARATIVE GENOMICS; MARINE FISHES; POPULATIONS; TIME; DIVERGENCE; PLEURONECTIFORMES; SENEGALENSIS	Linkage maps based on markers derived from genes are essential evolutionary tools for commercial marine fish to help identify genomic regions associated with complex traits and subject to selective forces at play during exploitation or selective breeding. Additionally, they allow the use of genomic information from other related species for which more detailed information is available. Sole (solea solea L.) is a commercially important flatfish species in the North Sea, subject to overexploitation and showing evidence of fisheries-induced evolutionary changes in growth- and maturation-related traits. Sole would definitely benefit from a linkage map to better understand how evolution has shaped its genome structure. This study presents a linkage map of sole based on 423 single nucleotide polymorphisms derived from expressed sequence tags and 8 neutral microsatellite markers. The total map length is 1233.8 cM and consists of 38 linkage groups with a size varying between 0 to 92.1 cM. Being derived from expressed sequence tags allowed us to align the map with the genome of four model fish species, namely medaka (Oryzias latipes), Nile tilapia (Oreochromis niloticus), three-spined stickleback (Gasterosteus aculeatus) and green spotted pufferfish (Tetraodon nigroviridis). This comparison revealed multiple conserved syntenic regions with all four species, and suggested that the linkage groups represent 21 putative sole chromosomes. The map was also compared to the linkage map of turbot (Scophthalmus maximus), another commercially important flatfish species and closely related to sole. For all putative sole chromosomes (except one) a turbot homolog was detected, confirming the even higher degree of synteny between these two flatfish species.	[Diopere, Eveline; Maes, Gregory E.; Volckaert, Filip A. M.] Univ Leuven, Lab Biodivers & Evolutionary Genom, B-3000 Leuven, Belgium; [Komen, Hans; Groenen, Martien A. M.] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6700 AH Wageningen, Netherlands; [Maes, Gregory E.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia	KU Leuven; Wageningen University & Research; James Cook University	Diopere, E (corresponding author), Univ Leuven, Lab Biodivers & Evolutionary Genom, Ch Deberiotstr 32, B-3000 Leuven, Belgium.	eveline.diopere@bio.kuleuven.be	Groenen, Martien/D-8408-2012; Maes, Gregory/C-5450-2008; Komen, Hans/D-8876-2012; Maes, Gregory/N-4983-2019; Volckaert, Filip/AAC-7691-2019	Groenen, Martien/0000-0003-0484-4545; Maes, Gregory/0000-0002-1531-7321; Maes, Gregory/0000-0002-1531-7321; Diopere, Eveline/0000-0001-5773-2294	European Science Foundation programme Advances in Farm Animal Genomic Resources (LESC) [EX/3285]; European Community seventh Framework Programme [KBBE-212399]; Research Foundation-Flanders (FWO-Vlaanderen)	European Science Foundation programme Advances in Farm Animal Genomic Resources (LESC); European Community seventh Framework Programme(European Commission); Research Foundation-Flanders (FWO-Vlaanderen)(FWO)	Research was funded by the European Science Foundation programme Advances in Farm Animal Genomic Resources (LESC) (grant no EX/3285). The development of the SNP markers was funded by the European Community seventh Framework Programme during the FishPopTrace project (grant agreement no KBBE-212399). E.D. acknowledges a PhD grant from the Research Foundation-Flanders (FWO-Vlaanderen). G.E.M. was a post-doctoral researcher funded by the Research Foundation-Flanders (FWO-Vlaanderen) during the writing of this article and is now lecturer at James Cook University (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Betancur-R R., 2013, PLOS CURR, V18; Betancur R, 2013, SYST BIOL, V62, P763, DOI 10.1093/sysbio/syt039; Blonk RJW, 2010, THESIS WAGENINGEN U; Blonk RJW, 2010, GENETICS, V184, P213, DOI 10.1534/genetics.109.110536; Blonk RJW, 2010, AQUACULTURE, V300, P43, DOI 10.1016/j.aquaculture.2009.12.028; Blonk RJW, 2009, AQUACULTURE, V289, P26, DOI 10.1016/j.aquaculture.2009.01.012; BOUZA C, 1994, MAR BIOL, V120, P609, DOI 10.1007/BF00350082; Bouza C, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-54; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Canario AVM, 2008, REV FISH SCI, V16, P3, DOI 10.1080/10641260802319479; Castano-Sanchez C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-554; Cerda J, 2010, J FISH BIOL, V77, P1045, DOI 10.1111/j.1095-8649.2010.02695.x; Cerda J, 2013, GENES NUTR, V8, P5, DOI 10.1007/s12263-012-0312-8; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Fishman L, 2001, GENETICS, V159, P1701; Garoia F, 2006, MOL ECOL NOTES, V6, P144, DOI 10.1111/j.1471-8286.2005.01169.x; Gibson N.R., 2005, FLATFISHES BIOL EXPL; Green P, 1990, DOCUMENTATION CRI MA; Guyon R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-222; Guyon R, 2010, GENOMICS, V96, P228, DOI 10.1016/j.ygeno.2010.07.007; Hermida M, 2014, AQUACULTURE, V420, pS111, DOI 10.1016/j.aquaculture.2013.02.041; Howell BR, 1997, AQUACULTURE, V155, P355, DOI 10.1016/S0044-8486(97)00103-8; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; ICES, 2012, REP ICES ADV COMM; Imsland AK, 2003, REV FISH BIOL FISHER, V13, P379, DOI 10.1007/s11160-004-1632-6; Iyengar A, 2000, MAR BIOTECHNOL, V2, P49; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kai W, 2011, GENOME BIOL EVOL, V3, P424, DOI 10.1093/gbe/evr041; Kang JH, 2008, INT J BIOL SCI, V4, P143, DOI 10.7150/ijbs.4.143; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kenchington E, 2003, ICES J MAR SCI, V60, P1172, DOI 10.1016/S1054-3139(03)00136-X; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Lee AP, 2011, MOL BIOL EVOL, V28, P1205, DOI 10.1093/molbev/msq304; Li Xin, 2009, Journal of Bioinformatics and Computational Biology, V7, P521, DOI 10.1142/S0219720009004217; Liao XL, 2009, MAR BIOTECHNOL, V11, P699, DOI 10.1007/s10126-009-9184-3; Mabuchi K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-10; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Meynard CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036443; Moen T, 2009, ANIM GENET, V40, P993, DOI 10.1111/j.1365-2052.2009.01938.x; Molina-Luzon MJ, 2012, MOL ECOL RESOUR, V12, P956, DOI 10.1111/j.1755-0998.2012.03163.x; Mollet FM, 2007, MAR ECOL PROG SER, V351, P189, DOI 10.3354/meps07138; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Nielsen EE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1845; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Pardo BG, 2001, HEREDITY, V86, P531, DOI 10.1046/j.1365-2540.2001.00802.x; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Reid DP, 2007, GENETICS, V177, P1193, DOI 10.1534/genetics.107.075374; Ruan XH, 2010, AQUACULTURE, V308, P89, DOI 10.1016/j.aquaculture.2010.08.010; Sarropoulou E, 2008, MAR BIOTECHNOL, V10, P227, DOI 10.1007/s10126-007-9066-5; Setiamarga DHE, 2009, BIOL LETTERS, V5, P812, DOI 10.1098/rsbl.2009.0419; Sharpe DMT, 2009, EVOL APPL, V2, P260, DOI 10.1111/j.1752-4571.2009.00080.x; Song WT, 2013, CURR ZOOL, V59, P99, DOI 10.1093/czoolo/59.1.99; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x; Wenne R, 2007, AQUAT LIVING RESOUR, V20, P241, DOI 10.1051/alr:2007037; Yu JK, 2004, MOL GENET GENOMICS, V271, P742, DOI 10.1007/s00438-004-1027-3	59	11	11	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115040	10.1371/journal.pone.0115040	http://dx.doi.org/10.1371/journal.pone.0115040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541971	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000347239900020
J	Jacquet, N; Navarre, C; Desmecht, D; Boutry, M				Jacquet, Nicolas; Navarre, Catherine; Desmecht, Daniel; Boutry, Marc			Hydrophobin Fusion of an Influenza Virus Hemagglutinin Allows High Transient Expression in Nicotiana benthamiana, Easy Purification and Immune Response with Neutralizing Activity	PLOS ONE			English	Article							RECOMBINANT PROTEINS; RAPID PRODUCTION; TABACUM; PLANTS; IMMUNOGENICITY; ANTIBODIES; CHALLENGE; PARTICLES; EFFICIENT; VACCINES	The expression of recombinant hemagglutinin in plants is a promising alternative to the current egg-based production system for the influenza vaccines. Protein-stabilizing fusion partners have been developed to overcome the low production yields and the high downstream process costs associated with the plant expression system. In this context, we tested the fusion of hydrophobin I to the hemagglutinin ectodomain of the influenza A (H1N1)pdm09 virus controlled by the hybrid En(2)PMA4 transcriptional promoter to rapidly produce high levels of recombinant antigen by transient expression in agro-infiltrated Nicotiana benthamiana leaves. The fusion increased the expression level by a factor of similar to 2.5 compared to the unfused protein allowing a high accumulation level of 8.6% of the total soluble proteins. Hemagglutinin was located in ER-derived protein bodies and was successfully purified by combining an aqueous-two phase partition system and a salting out step. Hydrophobin interactions allowed the formation of high molecular weight hemagglutinin structures, while unfused proteins were produced as monomers. Purified protein was shown to be biologically active and to induce neutralizing antibodies after mice immunization. Hydrophobin fusion to influenza hemagglutinin might therefore be a promising approach for rapid, easy, and low cost production of seasonal or pandemic influenza vaccines in plants.	[Jacquet, Nicolas; Navarre, Catherine; Boutry, Marc] Univ Louvain, Inst Life Sci, Louvain, Belgium; [Desmecht, Daniel] Univ Liege, Fac Vet Med, Dept Pathol, Liege, Belgium	University of Liege	Boutry, M (corresponding author), Univ Louvain, Inst Life Sci, Louvain, Belgium.			Boutry, Marc/0000-0002-2315-6900	Service public de Wallonie [Waleo3 08/1/6861]; Belgian Fund for Scientific Research; Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture (Belgium); STFC [ST/I001816/1, ST/K000853/1] Funding Source: UKRI	Service public de Wallonie; Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture (Belgium)(Fonds de la Recherche Scientifique - FNRS); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported in part by grants from the Service public de Wallonie (Waleo3 08/1/6861) and the Belgian Fund for Scientific Research. NJ is recipient of a fellowship from the Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNET F. M., 1941, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V19, P291, DOI 10.1038/icb.1941.44; Conley AJ, 2011, PLANT BIOTECHNOL J, V9, P419, DOI 10.1111/j.1467-7652.2011.00596.x; Crouzet J, 2013, PLANT MOL BIOL, V82, P181, DOI 10.1007/s11103-013-0053-0; Cummings JF, 2014, VACCINE, V32, P2251, DOI 10.1016/j.vaccine.2013.10.017; D'Aoust MA, 2008, PLANT BIOTECHNOL J, V6, P930, DOI 10.1111/j.1467-7652.2008.00384.x; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; De Muynck B, 2009, TRANSGENIC RES, V18, P467, DOI 10.1007/s11248-008-9240-1; Duby G, 2010, PROTEOMICS, V10, P2545, DOI 10.1002/pmic.200900527; Floss DM, 2010, TRENDS BIOTECHNOL, V28, P37, DOI 10.1016/j.tibtech.2009.10.004; Gutierrez SP, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-40; Phan HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099347; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Joensuu JJ, 2012, METHODS MOL BIOL, V824, P527, DOI 10.1007/978-1-61779-433-9_28; Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021; Kanagarajan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033010; Kershaw MJ, 1998, FUNGAL GENET BIOL, V23, P18, DOI 10.1006/fgbi.1997.1022; Khurana S, 2011, VACCINE, V29, P5657, DOI 10.1016/j.vaccine.2011.06.014; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Leuzinger K, 2013, JOVE-J VIS EXP, DOI 10.3791/50521; Linder MB, 2004, BIOCHEMISTRY-US, V43, P11873, DOI 10.1021/bi0488202; Moriau L, 1999, PLANT J, V19, P31, DOI 10.1046/j.1365-313X.1999.00495.x; Mortimer E, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-14; Musiychuk K, 2007, INFLUENZA OTHER RESP, V1, P19, DOI 10.1111/j.1750-2659.2006.00005.x; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; NakariSetala T, 1996, EUR J BIOCHEM, V235, P248, DOI 10.1111/j.1432-1033.1996.00248.x; Navarre C, 2006, TRANSGENIC RES, V15, P325, DOI 10.1007/s11248-006-0002-7; OIE - World Organization for Animal Health, 2005, MANUAL DIAGNOSTIC TE; Perez-Bueno ML, 2004, PROTEOMICS, V4, P418, DOI 10.1002/pmic.200300655; Phan HT, 2013, PLANT BIOTECHNOL J, V11, P582, DOI 10.1111/pbi.12049; Reuter LJ, 2014, PLANT BIOTECHNOL J, V12, P402, DOI 10.1111/pbi.12147; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Santiago FW, 2012, VACCINE, V30, P4606, DOI 10.1016/j.vaccine.2012.05.005; Shaw A, 2012, VACCINE, V30, P4927, DOI 10.1016/j.vaccine.2012.04.095; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Shoji Y, 2008, VACCINE, V26, P2930, DOI 10.1016/j.vaccine.2008.03.045; Shoji Y, 2012, INFLUENZA OTHER RESP, V6, P204, DOI 10.1111/j.1750-2659.2011.00295.x; Shoji Y, 2011, HUM VACCINES, V7, P41, DOI 10.4161/hv.7.0.14561; Szilvay GR, 2006, BIOCHEMISTRY-US, V45, P8590, DOI 10.1021/bi060620y; Tognotti E, 2009, J INFECT DEV COUNTR, V3, P331, DOI 10.3855/jidc.239; Torrent M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-5; van der Fits L, 2000, PLANT MOL BIOL, V43, P495, DOI 10.1023/A:1006440221718; Wang W, 2012, INT J PHARMACEUT, V431, P1, DOI 10.1016/j.ijpharm.2012.04.040; Weaver EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018314; Yusibov V., 2010, BIOL, V65, P195	47	11	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115944	10.1371/journal.pone.0115944	http://dx.doi.org/10.1371/journal.pone.0115944			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541987	Green Published, gold			2022-12-26	WOS:000347239900113
J	Lambinet, V; Hayden, ME; Bieri, M; Gries, G				Lambinet, Veronika; Hayden, Michael E.; Bieri, Marco; Gries, Gerhard			Does the Earth's Magnetic Field Serve as a Reference for Alignment of the Honeybee Waggle Dance?	PLOS ONE			English	Article							APIS-MELLIFERA; ORIENTATION; BEES; MAGNETORECEPTION; COMMUNICATION; INFORMATION; SENSITIVITY; INTENSITY; DIRECTION; PERCEIVE	The honeybee (Apis mellifera) waggle dance, which is performed inside the hive by forager bees, informs hive mates about a potent food source, and recruits them to its location. It consists of a repeated figure-8 pattern: two oppositely directed turns interspersed by a short straight segment, the "waggle run''. The waggle run consists of a single stride emphasized by lateral waggling motions of the abdomen. Directional information pointing to a food source relative to the sun's azimuth is encoded in the angle between the waggle run line and a reference line, which is generally thought to be established by gravity. Yet, there is tantalizing evidence that the local (ambient) geomagnetic field (LGMF) could play a role. We tested the effect of the LGMF on the recruitment success of forager bees by placing observation hives inside large Helmholtz coils, and then either reducing the LGMF to 2% or shifting its apparent declination. Neither of these treatments reduced the number of nest mates that waggle dancing forager bees recruited to a feeding station located 200 m north of the hive. These results indicate that the LGMF does not act as the reference for the alignment of waggle-dancing bees.	[Lambinet, Veronika; Gries, Gerhard] Simon Fraser Univ, Dept Biol, Burnaby, BC V5A 1S6, Canada; [Hayden, Michael E.; Bieri, Marco] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Gries, G (corresponding author), Simon Fraser Univ, Dept Biol, Burnaby, BC V5A 1S6, Canada.	gries@sfu.ca			Natural Sciences and Engineering Research Council of Canada; NSERC-IRC; Contech Enterprises Inc.; Global Forest Science	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC-IRC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Contech Enterprises Inc.; Global Forest Science	This work was supported by the Natural Sciences and Engineering Research Council of Canada; NSERC-IRC; http://www.nserc-crsng.gc.ca (GG); Contech Enterprises Inc. (industrial sponsor of NSERC IRC); http://www.contech-inc.com (GG); and Global Forest Science (not-for-profit sponsor of NSERC-IRC); globalforestscience.org (GG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; DEJONG D, 1982, J COMP PHYSIOL, V147, P495, DOI 10.1007/BF00612015; Desoil M, 2005, J PHYS CONF SER, V17, P45, DOI 10.1088/1742-6596/17/1/007; DRELLER C, 1993, NATURWISSENSCHAFTEN, V80, P319, DOI 10.1007/BF01141904; Finlay CC, 2010, GEOPHYS J INT, V183, P1216, DOI 10.1111/j.1365-246X.2010.04804.x; FRISCH K V, 1949, Experientia, V5, P142; GOULD JL, 1978, SCIENCE, V201, P1026, DOI 10.1126/science.201.4360.1026; Hsu CY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000395; HSU CY, 1994, SCIENCE, V265, P95, DOI 10.1126/science.265.5168.95; Kirschvink JL, 1997, J EXP BIOL, V200, P1363; KIRSCHVINK JL, 1991, AM ZOOL, V31, P169; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; KUTERBACH DA, 1986, J EXP BIOL, V126, P375; LINDAUER M, 1959, Z VERGL PHYSIOL, V42, P334, DOI 10.1007/BF00298125; LINDAUER M, 1968, Z VERGL PHYSIOL, V60, P219, DOI 10.1007/BF00298600; MARTIN H, 1977, J COMP PHYSIOL, V122, P145, DOI 10.1007/BF00611888; MICHELSEN A, 1992, BEHAV ECOL SOCIOBIOL, V30, P143, DOI 10.1007/BF00166696; MICHELSEN A, 1993, J COMP PHYSIOL A, V173, P135, DOI 10.1007/BF00192972; Nieh JC, 2000, J EXP BIOL, V203, P1573; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Rohrseitz K, 1999, J COMP PHYSIOL A, V184, P463, DOI 10.1007/s003590050346; Tanner D, 2009, APIDOLOGIE, V40, P55, DOI 10.1051/apido:2008074; Tanner DA, 2008, BEHAV ECOL SOCIOBIOL, V62, P1891, DOI 10.1007/s00265-008-0619-z; Thom C, 2007, PLOS BIOL, V5, P1862, DOI 10.1371/journal.pbio.0050228; Tsujiuchi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000234; Valkova T, 2012, B ENTOMOL RES, V102, P461, DOI 10.1017/S0007485311000824; Von Frisch K, 1968, DANCE LANGUAGE ORIEN; VONFRISCH K, 1948, NATURWISSENSCHAFTEN, V35, P38; Walker MM, 2008, J THEOR BIOL, V250, P85, DOI 10.1016/j.jtbi.2007.09.030; WALKER MM, 1989, J COMP PSYCHOL, V103, P62; WALKER MM, 1989, J EXP BIOL, V145, P489; WALKER MM, 1989, J EXP BIOL, V141, P447; WENNER ADRIAN M., 1962, ANIMAL BEHAVIOUR, V10, P79, DOI 10.1016/0003-3472(62)90135-5	33	3	3	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115665	10.1371/journal.pone.0115665	http://dx.doi.org/10.1371/journal.pone.0115665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541731	Green Submitted, gold, Green Published			2022-12-26	WOS:000347239900067
J	Moyen, N; Thiberville, SD; Pastorino, B; Nougairede, A; Thirion, L; Mombouli, JV; Dimi, Y; Leparc-Goffart, I; Capobianchi, MR; Lepfoundzou, AD; de Lamballerie, X				Moyen, Nanikaly; Thiberville, Simon-Djamel; Pastorino, Boris; Nougairede, Antoine; Thirion, Laurence; Mombouli, Jean-Vivien; Dimi, Yannick; Leparc-Goffart, Isabelle; Capobianchi, Maria Rosaria; Lepfoundzou, Amelia Dzia; de Lamballerie, Xavier			First Reported Chikungunya Fever Outbreak in the Republic of Congo, 2011	PLOS ONE			English	Article							VIRUS-INFECTION; ISLAND; GABON	Background: Chikungunya is an Aedes -borne disease characterised by febrile arthralgia and responsible for massive outbreaks. We present a prospective clinical cohort study and a retrospective serological study relating to a CHIK outbreak, in the Republic of Congo in 2011. Methodology and Findings: We analysed 317 suspected cases, of which 308 (97.2%) lived in the city of Brazzaville (66.6% in the South area). Amongst them, 37 (11.7%) were CHIKV+ve patients (i.e., biologically confirmed by a real-time RT-PCR assay), of whom 36 (97.3%) had fever, 22 (66.7%) myalgia and 32 (86.5%) arthralgia. All tested negative for dengue. The distribution of incident cases within Brazzaville districts was compared with CHIKV seroprevalence before the outbreak (34.4% in 517 blood donors), providing evidence for previous circulation of CHIKV. We applied a CHIK clinical score to 126 patients recruited within the two first day of illness (including 28 CHIKV+ves (22.2%)) with sensitivity (78.6%) and specificity (72.4%) values comparing with those of the referent study in Reunion Island. The negative predictive value was high (92%), but the positive predictive value (45%) indicate poor potential contribution to medical practice to identify CHIKV+ve patients in low prevalence outbreaks. However, the score allowed a slightly more accurate follow-up of the evolution of the outbreak than the criterion "fever+arthralgia". The complete sequencing of a Congolase isolate (Brazza_MRS1) demonstrated belonging to the East/Central/South African lineage and was further used for producing a robust genome-scale CHIKV phylogenetic analysis. Conclusions/Significance: We describe the first Chikungunya outbreak declared in the Republic of Congo. The seroprevalence study conducted amongst blood donors before outbreak provided evidence for previous CHIKV circulation. We suggest that a more systematic survey of the entomological situation and of arbovirus circulation is necessary in Central Africa for better understanding the environmental, microbiological and sociological determinants of emergence.	[Moyen, Nanikaly; Thiberville, Simon-Djamel; Pastorino, Boris; Nougairede, Antoine; Thirion, Laurence; de Lamballerie, Xavier] Aix Marseille Univ, EHESP French Sch Publ Hlth, IRD French Inst Res Dev, EPV UMR D 190 Emergence Pathol Virales, F-13005 Marseille, France; [Dimi, Yannick; Lepfoundzou, Amelia Dzia] Ctr Natl Transfus Sanguine, Brazzaville, Rep Congo; [Mombouli, Jean-Vivien] Lab Natl Sante Publ, Brazzaville, Rep Congo; [Leparc-Goffart, Isabelle] IRBA Armed Forces Biomed Res Inst, French Natl Reference Ctr Arboviruses, F-13013 Marseille, France; [Capobianchi, Maria Rosaria] Natl Inst Infect Dis L Spallanzani, Virol Lab, I-00149 Rome, Italy	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; IRCCS Lazzaro Spallanzani	Moyen, N (corresponding author), Aix Marseille Univ, EHESP French Sch Publ Hlth, IRD French Inst Res Dev, EPV UMR D 190 Emergence Pathol Virales, F-13005 Marseille, France.	moyenmimi@gmail.com		pastorino, boris/0000-0001-5233-5193; Laurence, THIRION/0000-0003-4301-2944; Capobianchi, Maria Rosaria/0000-0003-3465-0071	EPV UMR_D 190 "Emergence des Pathologies Virales", Marseille, France	EPV UMR_D 190 "Emergence des Pathologies Virales", Marseille, France	Funding provided by EPV UMR_D 190 "Emergence des Pathologies Virales"13005 Marseille, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boelle PY, 2008, VECTOR-BORNE ZOONOT, V8, P207, DOI 10.1089/vbz.2006.0620; Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144; Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Demanou Maurice, 2010, BMC Res Notes, V3, P128, DOI 10.1186/1756-0500-3-128; Gerardin P, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4137; Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99; IRIN, 2011, CONGO OUTBR DENG LIK; Kelvin AA, 2011, J INFECT DEV COUNTR, V5, P441, DOI 10.3855/jidc.2171; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010; Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664; Lokireddy S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-77; Mombouli JV, 2013, EMERG INFECT DIS, V19, P1542, DOI 10.3201/eid1909.130451; Moro ML, 2012, J INFECTION, V65, P165, DOI 10.1016/j.jinf.2012.04.005; Nkoghe D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001517; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Pistone T, 2009, TRAVEL MED INFECT DI, V7, P52, DOI 10.1016/j.tmaid.2008.10.001; ProMED-mail, 2011, CHIKUNGUNYA AFRICA R; Reinert JF, 2000, J AM MOSQUITO CONTR, V16, P175; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; ROSS R. W., 1956, JOUR HYG, V54, P177; Salez N, 2014, J INFECT; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004; Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; WHO, 2011, OUTBR B; Win MK, 2010, J CLIN VIROL, V49, P111, DOI 10.1016/j.jcv.2010.07.004; Wurtz N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-336	37	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115938	10.1371/journal.pone.0115938	http://dx.doi.org/10.1371/journal.pone.0115938			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541718	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900112
J	Pei, RG; Zhou, YF; Wang, GX; Wang, HP; Huang, XY; Yan, XX; Yang, XH				Pei, Renguang; Zhou, Yunfeng; Wang, Guoxiang; Wang, Heping; Huang, Xinyu; Yan, Xiaoxing; Yang, Xiaohua			Outcomes of Bronchial Artery Embolization for Life-Threatening Hemoptysis Secondary to Tuberculosis	PLOS ONE			English	Article							MASSIVE HEMOPTYSIS; PULMONARY TUBERCULOSIS; MANAGEMENT; IMMEDIATE	Objective: To appraise the immediate and long-term outcomes of bronchial arterial embolization for life-threatening hemoptysis secondary to tuberculosis. Methods: 112 patients with life-threatening hemoptysis due to tuberculosis underwent bronchial artery embolization from January 2004 to February 2014. Life-threatening hemoptysis was defined as expectoration of at least 400 ml of blood in 24 hour. The median follow-up is 20 months, ranging from 2 to 52 months. Results: The hemoptysis control rate was 86.6% at 14 days, 84.8% at 30 days, 78.6% at 240 days, 75.9% at 360 days, respectively. None of these characteristics, including gender, age and tuberculosis status, was significantly associated with immediate control of bleeding. Patients with active tuberculosis had a significantly longer recurrence-free duration than did patients with inactive tuberculosis (P=0.040), which was further confirmed by Cox regression hazards model (P=0.046). There was no spinal cord complication or mortality related to bronchial artery embolization. The most common complication was transient chest pain. Conclusion: Bronchial arterial embolization is an effective and safe technique in the management of life-threatening hemoptysis secondary to tuberculosis. Active tuberculosis may be associated with a lower rate of recurrence of hemoptysis.	[Pei, Renguang; Wang, Guoxiang; Wang, Heping; Huang, Xinyu; Yan, Xiaoxing; Yang, Xiaohua] Yijishan Hosp, Wannan Med Coll, Dept Intervent Therapy, Wuhu, Peoples R China; [Zhou, Yunfeng] Yijishan Hosp, Wannan Med Coll, Dept Radiol, Wuhu, Peoples R China	Wannan Medical College; Wannan Medical College	Pei, RG (corresponding author), Yijishan Hosp, Wannan Med Coll, Dept Intervent Therapy, Wuhu, Peoples R China.	mediprg@bjmu.edu.cn						Anuradha C, 2012, DIAGN INTERV RADIOL, V18, P96, DOI 10.4261/1305-3825.DIR.3876-11.2; Chan VL, 2009, INT J TUBERC LUNG D, V13, P1167; Chun JY, 2010, CARDIOVASC INTER RAD, V33, P240, DOI 10.1007/s00270-009-9788-z; Chun JY, 2010, EUR RADIOL, V20, P558, DOI 10.1007/s00330-009-1591-3; CROCCO JA, 1968, ARCH INTERN MED, V121, P495, DOI 10.1001/archinte.121.6.495; DICHIRO G, 1974, RADIOLOGY, V112, P231; FRASER RS, 1993, PATHOL ANNU, V28, P231; Haponik EF, 2000, CHEST, V118, P1431, DOI 10.1378/chest.118.5.1431; HAYAKAWA K, 1992, CARDIOVASC INTER RAD, V15, P154, DOI 10.1007/BF02735578; Hwang HG, 2013, TUBERC RESPIR DIS, V74, P111, DOI 10.4046/trd.2013.74.3.111; Ibrahim WH, 2008, EUR RESPIR J, V32, P1131, DOI 10.1183/09031936.00080108; IM JG, 1993, RADIOLOGY, V186, P653, DOI 10.1148/radiology.186.3.8430169; Jean-Baptiste E, 2000, CRIT CARE MED, V28, P1642, DOI 10.1097/00003246-200005000-00066; KARDJIEV V, 1974, RADIOLOGY, V112, P81, DOI 10.1148/112.1.81; Lee Samuel, 2008, Hong Kong Medical Journal, V14, P14; Mal H, 1999, CHEST, V115, P996, DOI 10.1378/chest.115.4.996; Mossi Francesca, 2003, Radiol Med, V105, P48; Najarian KE, 1998, J THORAC IMAG, V13, P93, DOI 10.1097/00005382-199804000-00004; Osaki S, 2000, RESPIRATION, V67, P412, DOI 10.1159/000029540; RABKIN JE, 1987, RADIOLOGY, V163, P361, DOI 10.1148/radiology.163.2.3562815; REMY J, 1977, RADIOLOGY, V122, P33, DOI 10.1148/122.1.33; REMY J, 1974, ANN RADIOL, V17, P5; Shin BS, 2011, INT J TUBERC LUNG D, V15, P1093, DOI 10.5588/ijtld.10.0659; Sopko David R, 2011, Semin Intervent Radiol, V28, P48, DOI 10.1055/s-0031-1273940; Swanson KL, 2002, CHEST, V121, P789, DOI 10.1378/chest.121.3.789; Tanaka N, 1997, J VASC INTERV RADIOL, V8, P65, DOI 10.1016/S1051-0443(97)70517-7; UFLACKER R, 1985, RADIOLOGY, V157, P637, DOI 10.1148/radiology.157.3.4059552; van den Heuvel MM, 2007, INT J TUBERC LUNG D, V11, P909; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2	29	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115956	10.1371/journal.pone.0115956	http://dx.doi.org/10.1371/journal.pone.0115956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541693	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900115
J	Zhang, ZH				Zhang, Zhihua			The Evolution of Heterogeneities Altered by Mutational Robustness, Gene Expression Noise and Bottlenecks in Gene Regulatory Networks	PLOS ONE			English	Article							NONGENETIC HETEROGENEITY; PLASTICITY	Intra-population heterogeneity is commonly observed in natural and cellular populations and has profound influence on their evolution. For example, intra-tumor heterogeneity is prevalent in most tumor types and can result in the failure of tumor therapy. However, the evolutionary process of heterogeneity remains poorly characterized at both genotypic and phenotypic level. Here we study the evolution of intra-population heterogeneities of gene regulatory networks (GRN), in particular mutational robustness and gene expression noise as contributors to the development of heterogeneities. By in silico simulations, it was found that the impact of these factors on GRN can, under certain conditions, promote phenotypic heterogeneity. We also studied the effect of population bottlenecks on the evolution of GRN. When the GRN population passes through such bottlenecks, neither mutational robustness nor population fitness was observed to be substantially altered. Interestingly, however, we did detect a significant increase in the number of potential "generator" genes which can substantially induce population fitness, when stimulated by mutational hits.	Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Zhang, ZH (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China.	zhangzhihua@big.ac.cn			National Nature Science Foundation of China (NSFC) [31271398, 91131012]; National Basic Research Program of China (the 973 Program) [2014CB542002]; 100 Talents Project	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (the 973 Program)(National Basic Research Program of China); 100 Talents Project(Chinese Academy of Sciences)	This work was supported by grants from the National Nature Science Foundation of China (NSFC, http://www.nsfc.cov.cn/. Grant No. 31271398, 91131012), National Basic Research Program of China (the 973 Program. http://www.973.gov.cn/English/index.aspx. Grant No. 2014CB542002), and the 100 Talents Project (http://www.cas.cn/ggzy/rcpy/brjh/) to ZZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktipis CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026100; Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; Attolini CSO, 2009, ANN NY ACAD SCI, V1168, P23, DOI 10.1111/j.1749-6632.2009.04880.x; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; de Krom M, 2002, MOL CELL, V9, P1319, DOI 10.1016/S1097-2765(02)00558-0; Drake JW, 1998, GENETICS, V148, P1667; Durrett R, 2011, GENETICS, V188, P461, DOI 10.1534/genetics.110.125724; Espinosa-Soto C, 2011, J EVOLUTION BIOL, V24, P1284, DOI 10.1111/j.1420-9101.2011.02261.x; Espinosa-Soto C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-5; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Harary F., 1969, GRAPH THEORY; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Imhof M, 2001, P NATL ACAD SCI USA, V98, P1113, DOI 10.1073/pnas.98.3.1113; Kaufmann BB, 2007, PLOS BIOL, V5, P1973, DOI 10.1371/journal.pbio.0050239; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pisco AO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3467; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Sun W, 2010, GENETICS, V185, P349, DOI 10.1534/genetics.110.114280; TEMPLETON AR, 1980, GENETICS, V94, P1011; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Waddington C H, 1957, STRATEGY GENES DISCU; WAGNER A, 1994, P NATL ACAD SCI USA, V91, P4387, DOI 10.1073/pnas.91.10.4387; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Weinberg RA, 2007, BIOL CANC; WILSON RE, 1984, CANCER, V53, P1420, DOI 10.1002/1097-0142(19840315)53:6<1420::AID-CNCR2820530634>3.0.CO;2-R; Zhang ZH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.58	34	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116167	10.1371/journal.pone.0116167	http://dx.doi.org/10.1371/journal.pone.0116167			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541720	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900154
J	Kienhofer, D; Hahn, J; Schubert, I; Reinwald, C; Ipseiz, N; Lang, SC; Borras, EB; Amann, K; Sjowall, C; Barron, AE; Hueber, AJ; Agerberth, B; Schett, G; Hoffmann, MH				Kienhofer, D.; Hahn, J.; Schubert, I.; Reinwald, C.; Ipseiz, N.; Lang, S. C.; Borras, E. Bosch; Amann, K.; Sjowall, C.; Barron, A. E.; Hueber, A. J.; Agerberth, B.; Schett, G.; Hoffmann, M. H.			No Evidence of Pathogenic Involvement of Cathelicidins in Patient Cohorts and Mouse Models of Lupus and Arthritis	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; PRISTANE-INDUCED LUPUS; ANTIMICROBIAL PEPTIDE; REVISED CRITERIA; INFLAMMATION; LL-37; SELF; INTERFERON; BLOOD; DNA	Apart from their role in the immune defence against pathogens evidence of a role of antimicrobial peptides (AMPs) in autoimmune diseases has accumulated in the past years. The aim of this project was to examine the functional impact of the human cathelicidin LL-37 and the mouse cathelicidin-related AMP (CRAMP) on the pathogenesis of lupus and arthritis. Serum LL-37 and anti-LL-37 levels were measured by ELISA in healthy donors and patients with Systemic Lupus Erythematosus (SLE) and Rheumatoid arthritis (RA). Pristane-induced lupus was induced in female wild type (WT) and cathelicidin-deficient (CRAMP(-/-)) mice. Serum levels of anti-Sm/RNP, anti-dsDNA, and anti-histone were determined via ELISA, cytokines in sera and peritoneal lavages were measured via Multiplex. Expression of Interferon I stimulated genes (ISG) was determined by real-time PCR. Collagen-induced arthritis (CIA) was induced in male WT and CRAMP(-/-) mice and arthritis severity was visually scored and analysed histomorphometrically by OsteoMeasure software. Serum levels of anti-LL-37 were higher in SLE-patients compared to healthy donors or patients with RA. However, no correlation to markers of disease activity or organ involvement was observed. No significant differences of autoantibody or cytokine/chemokine levels, or of expression of ISGs were observed between WT and CRAMP(-/-) mice after pristane-injection. Furthermore, lung and kidney pathology did not differ in the absence of CRAMP. Incidence and severity of CIA and histological parameters (inflammation, cartilage degradation, and bone erosion) were not different in WT and CRAMP(-/-) mice. Although cathelicidins are upregulated in mouse models of lupus and arthritis, cathelicidin-deficiency did not persistently affect the diseases. Also in patients with SLE, autoantibodies against cathelicidins did not correlate with disease manifestation. Reactivity against cathelicidins in lupus and arthritis could thus be an epiphenomenon caused by extensive overexpression in blood and affected tissues. In addition, other cationic AMPs could functionally compensate for the deficiency of cathelicidins.	[Kienhofer, D.; Hahn, J.; Schubert, I.; Reinwald, C.; Ipseiz, N.; Lang, S. C.; Hueber, A. J.; Schett, G.; Hoffmann, M. H.] Univ Klinikum Erlangen, Dept Internal Med 3, Erlangen, Germany; [Borras, E. Bosch] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Amann, K.] Univ Klinikum Erlangen, Dept Nephropathol, Erlangen, Germany; [Sjowall, C.] Linkoping Univ, Dept Clin & Expt Med, Rheumatol AIR, Linkoping, Sweden; [Barron, A. E.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Agerberth, B.] Karolinska Univ, Dept Lab Med, Div Clin Microbiol, Huddinge, Sweden	University of Erlangen Nuremberg; Autonomous University of Barcelona; University of Erlangen Nuremberg; Linkoping University; Stanford University; Karolinska Institutet; Karolinska University Hospital	Hoffmann, MH (corresponding author), Univ Klinikum Erlangen, Dept Internal Med 3, Erlangen, Germany.	markus.hoffmann@uk-erlangen.de	Sjöwall, Christopher/C-9678-2009; Ipseiz, Natacha/AAG-6390-2019	Sjöwall, Christopher/0000-0003-0900-2048; Ipseiz, Natacha/0000-0001-5008-8889; Barron, Annelise/0000-0002-0735-6873; Hahn, Jonas/0000-0003-3944-2108; Hueber, Axel/0000-0001-6454-1234; Hoffmann, Markus/0000-0001-9698-9922	ELAN program of the University Erlangen-Nuremberg [12-03-07-1-Hoffmann]; Austrian Science fund (FWF) [J3102-B13]; Swedish society for Medical research (SSMF); Swedish Medical council [58X-11217-14-3]; EU [HEALTH-F2-2008-223404]; IMI program BTCure; Austrian Science Fund (FWF) [J 3102] Funding Source: researchfish	ELAN program of the University Erlangen-Nuremberg; Austrian Science fund (FWF)(Austrian Science Fund (FWF)); Swedish society for Medical research (SSMF); Swedish Medical council(Swedish Medical Research Council (SMRC)); EU(European Commission); IMI program BTCure; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The research was funded by the ELAN program of the University Erlangen-Nuremberg (grant number 12-03-07-1-Hoffmann), the Austrian Science fund (FWF, project J3102-B13), the Swedish society for Medical research (SSMF), the Swedish Medical council (58X-11217-14-3), the EU project Masterswitch (HEALTH-F2-2008-223404), and the IMI program BTCure.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Calvani N, 2005, J IMMUNOL, V175, P4777, DOI 10.4049/jimmunol.175.7.4777; Chamilos G, 2012, BLOOD, V120, P3699, DOI 10.1182/blood-2012-01-401364; Dietz AB, 2006, TRANSFUSION, V46, P2083, DOI 10.1111/j.1537-2995.2006.01033.x; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Herman S, 2012, AUTOIMMUNITY; Hoffmann MH, 2013, ANN RHEUM DIS, V72, P1239, DOI 10.1136/annrheumdis-2012-202218; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Lande R, 2014, EUR J IMMUNOL; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lee PY, 2008, J IMMUNOL, V180, P5101, DOI 10.4049/jimmunol.180.7.5101; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Leiss H, 2013, LUPUS, V22, P778, DOI 10.1177/0961203313492869; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tewary P, 2013, J IMMUNOL, V191, P865, DOI 10.4049/jimmunol.1201648; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O	33	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115474	10.1371/journal.pone.0115474	http://dx.doi.org/10.1371/journal.pone.0115474			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535966	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000348563300042
J	Heiss, EH; Kramer, MP; Atanasov, AG; Beres, H; Schachner, D; Dirsch, VM				Heiss, Elke H.; Kramer, Matthias P.; Atanasov, Atanas G.; Beres, Hortenzia; Schachner, Daniel; Dirsch, Verena M.			Glycolytic Switch in Response to Betulinic Acid in Non-Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PERMEABILITY TRANSITION PORE; ENDOTHELIAL-CELLS; CANCER CELLS; GLUCOSE; AMPK; METABOLISM; PHOSPHORYLATION; MITOCHONDRIA; DERIVATIVES	The naturally occurring triterpenoid betulinic acid (BA) shows pronounced polypharmacology ranging from anti-inflammatory to anti-lipogenic activities. Recent evidence suggests that rather diverse cellular signaling events may be attributed to the same common upstream switch in cellular metabolism. In this study we therefore examined the metabolic changes induced by BA (10 mM) administration, with focus on cellular glucose metabolism. We demonstrate that BA elevates the rates of cellular glucose uptake and aerobic glycolysis in mouse embryonic fibroblasts with concomitant reduction of glucose oxidation. Without eliciting signs of obvious cell death BA leads to compromised mitochondrial function, increased expression of mitochondrial uncoupling proteins (UCP) 1 and 2, and liver kinase B1 (LKB1)-dependent activation AMP-activated protein kinase. AMPK activation accounts for the increased glucose uptake and glycolysis which in turn are indispensable for cell viability upon BA treatment. Overall, we show for the first time a significant impact of BA on cellular bioenergetics which may be a central mediator of the pleiotropic actions of BA.	[Heiss, Elke H.; Kramer, Matthias P.; Atanasov, Atanas G.; Beres, Hortenzia; Schachner, Daniel; Dirsch, Verena M.] Univ Vienna, Dept Pharmacognosy, A-1090 Vienna, Austria	University of Vienna	Heiss, EH (corresponding author), Univ Vienna, Dept Pharmacognosy, Althanstr 14, A-1090 Vienna, Austria.	elke.heiss@univie.ac.at	Kramer, Matthias/L-1782-2016; Atanasov, Atanas G./C-5535-2013; Heiss, Elke/B-6086-2015; Kramer, Matthias P/A-6224-2009	Kramer, Matthias/0000-0002-0289-5261; Atanasov, Atanas G./0000-0003-2545-0967; Heiss, Elke/0000-0001-7618-5505; Dirsch, Verena/0000-0002-9261-5293	Austrian Science Fund [23317]; Austrian Science Fund (FWF) [P 23317] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by Austrian Science Fund (grant number 23317) to EHH Herzfelder 'sche Familienstiftung to EHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bernardo TC, 2013, BIOORGAN MED CHEM, V21, P7239, DOI 10.1016/j.bmc.2013.09.066; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Choi JY, 2009, MOLECULES, V14, P266, DOI 10.3390/molecules14010266; Chung MY, 2006, PLANTA MED, V72, P267, DOI 10.1055/s-2005-916178; Dehelean CA, 2013, J BIOMED NANOTECHNOL, V9, P577, DOI 10.1166/jbn.2013.1563; Fakhrudin N, 2010, MOL PHARMACOL, V77, P559, DOI 10.1124/mol.109.062141; Fendt SM, 2013, CANCER RES, V73, P4429, DOI 10.1158/0008-5472.CAN-13-0080; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Florez-Duquet M, 1998, AM J PHYSIOL-REG I, V274, pR196, DOI 10.1152/ajpregu.1998.274.1.R196; Fulda S, 1998, J BIOL CHEM, V273, P33942, DOI 10.1074/jbc.273.51.33942; Fulda S, 2009, MOL NUTR FOOD RES, V53, P140, DOI 10.1002/mnfr.200700491; Gao MH, 2014, ARCH TOXICOL, V88, P755, DOI 10.1007/s00204-013-1162-x; Genet C, 2010, J MED CHEM, V53, P178, DOI 10.1021/jm900872z; Gongol B, 2013, P NATL ACAD SCI USA, V110, P3161, DOI 10.1073/pnas.1222051110; Hardie DG, 2004, REV ENDOCR METAB DIS, V5, P119, DOI 10.1023/B:REMD.0000021433.63915.bb; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Heiss EH, 2013, REDOX BIOL, V1, P359, DOI 10.1016/j.redox.2013.06.001; Heiss EH, 2012, PLANTA MED, V78, P678, DOI 10.1055/s-0031-1298242; Kim J, 2012, PHYTOTHER RES, V26, P1103, DOI 10.1002/ptr.3672; Kim SJ, 2014, J AGR FOOD CHEM, V62, P434, DOI 10.1021/jf4030739; Kropat C, 2013, MOL NUTR FOOD RES, V57, P545, DOI 10.1002/mnfr.201200504; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Ledesma A, 2002, GENOME BIOL, V3; Liobikas J, 2011, J NAT PROD, V74, P1640, DOI 10.1021/np200060p; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Metallo CM, 2010, GENE DEV, V24, P2717, DOI 10.1101/gad.2010510; Mullauer FB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005361; Mullauer FB, 2009, APOPTOSIS, V14, P191, DOI 10.1007/s10495-008-0290-x; PISHA E, 1995, NAT MED, V1, P1046, DOI 10.1038/nm1095-1046; Qian KD, 2009, J MED CHEM, V52, P3248, DOI 10.1021/jm900136j; Quan HY, 2013, BIOCHEM PHARMACOL, V85, P1330, DOI 10.1016/j.bcp.2013.02.007; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; Salt IP, 2012, EXPERT OPIN INV DRUG, V21, P1155, DOI 10.1517/13543784.2012.696609; Santos RC, 2011, BIOCHIMIE, V93, P1065, DOI 10.1016/j.biochi.2011.02.014; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Steinkamp-Fenske K, 2007, J PHARMACOL EXP THER, V322, P836, DOI 10.1124/jpet.107.123356; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Takada Y, 2003, J IMMUNOL, V171, P3278, DOI 10.4049/jimmunol.171.6.3278; Tsai JC, 2011, AM J CHINESE MED, V39, P943, DOI 10.1142/S0192415X11009329; Vadivelu RK, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/251362; Van Beersel G, 2013, BIOSCIENCE REP, V33, P243, DOI 10.1042/BSR20120104; Viji V, 2011, BRIT J PHARMACOL, V162, P1291, DOI 10.1111/j.1476-5381.2010.01112.x; WARBURG O, 1956, SCIENCE, V124, P269; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Wu CA, 2013, BBA-MOL CELL RES, V1833, P1147, DOI 10.1016/j.bbamcr.2013.01.025; Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014; Xu QA, 2010, J CELL MOL MED, V14, P2604, DOI 10.1111/j.1582-4934.2010.01179.x; Yoon JJ, 2010, BIOCHEM BIOPH RES CO, V391, P96, DOI 10.1016/j.bbrc.2009.11.009; Zhao GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074782; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	52	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115683	10.1371/journal.pone.0115683	http://dx.doi.org/10.1371/journal.pone.0115683			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531780	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100093
J	Milagres, LG; Costa, PR; Silva, GP; Carvalho, KI; Pereira-Manfro, WF; Ferreira, B; Barreto, DM; Frota, ACC; Hofer, CB; Kallas, EG				Milagres, Lucimar G.; Costa, Priscilla R.; Silva, Giselle P.; Carvalho, Karina I.; Pereira-Manfro, Wania F.; Ferreira, Bianca; Barreto, Daniella M.; Frota, Ana Cristina C.; Hofer, Cristina B.; Kallas, Esper G.			Subsets of Memory CD4(+) T Cell and Bactericidal Antibody Response to Neisseria meningitidis Serogroup C after Immunization of HIV-Infected Children and Adolescents	PLOS ONE			English	Article							VACCINE; ACTIVATION; DISEASE; MARKER	Meningococcal disease is endemic in Brazil, with periodic outbreaks and case fatality rates reach as high as 18 to 20% of cases. Conjugate vaccines against meningococci are immunogenic in healthy children. However, we have previously shown a poor bactericidal antibody response to a Men C conjugate vaccine in Brazilian HIV-infected children and adolescents after a single vaccine administration. The goal of the present work was to investigate associations between bactericidal antibody response induced by MenC vaccine and the frequency and activation profile (expression of CD38, HLA-DR and CCR5 molecules) of total CD4(+) memory T cell sub-populations in HIV-1-infected children and adolescents. Responders to vaccination against MenC had a predominance (about 44%) of CD4(+) T-INTERMEDIATE subset followed by T-TRANSITIONAL memory subset (23 to 26%). Importantly, CD4(+) T-INT frequency was positively associated with bactericidal antibody response induced by vaccination. The positive correlation persisted despite the observation that the frequency T-INT CD38(+)HLA-DR+ was higher in responders. In contrast, CD4(+) T-CENTRAL MEMORY (T-CM) subset negatively correlated with bactericidal antibodies. In conclusion, these data indicate that less differentiated CD+ T cells, like TCM may be constantly differentiating into intermediate and later differentiated CD4(+) T cell subsets. These include CD4 T-INT subset which showed a positive association with bactericidal antibodies.	[Milagres, Lucimar G.; Silva, Giselle P.; Pereira-Manfro, Wania F.] Univ Estado Rio De Janeiro, Dept Microbiol Immunol & Parasitol, Rio De Janeiro, RJ, Brazil; [Costa, Priscilla R.; Carvalho, Karina I.; Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Hofer, Cristina B.] Univ Fed Rio de Janeiro, Inst Puericultura & Pediat Martagao Gesteira, Rio De Janeiro, RJ, Brazil; [Ferreira, Bianca; Barreto, Daniella M.; Frota, Ana Cristina C.; Hofer, Cristina B.] Univ Fed Rio de Janeiro, Sch Med, Dept Prevent Med, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Milagres, LG (corresponding author), Univ Estado Rio De Janeiro, Dept Microbiol Immunol & Parasitol, Rio De Janeiro, RJ, Brazil.	lucimar@uerj.br	Carvalho, Karina IL/J-6789-2012; Manfro, Wania FP/M-5882-2013; frota, Ana Cristina Cisne/L-3644-2018; milagres, lucimar g/K-7072-2012	Carvalho, Karina IL/0000-0002-7763-8139; frota, Ana Cristina Cisne/0000-0002-2825-4374; milagres, lucimar g/0000-0002-0860-818X; Manfro, Wania/0000-0003-0166-8144; Kallas, Esper/0000-0003-2026-6925	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [573879/2008-7, 552497/2011-8]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/112.645/2012]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/54055-5]; Fogarty Institute of the National Institutes of Health [5R01TW008397]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; FOGARTY INTERNATIONAL CENTER [R01TW008397] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fogarty Institute of the National Institutes of Health; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grants (#573879/2008-7 to EGK and #552497/2011-8 (Edital Casadinho) to LGM and EGK); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (#E-26/112.645/2012 to LGM); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (#2009/54055-5 to EGK); Fogarty Institute of the National Institutes of Health under award number 5R01TW008397 to CBH. PRC received scholarship support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. GSP received scholarship support from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett LG, 2014, J IMMUNOL, V192, P3607, DOI 10.4049/jimmunol.1301284; Borrow R, 2013, VACCINE, V31, P4477, DOI 10.1016/j.vaccine.2013.07.083; Breton G, 2013, J IMMUNOL, V191, P2194, DOI 10.4049/jimmunol.1200646; Burgers WA, 2009, J IMMUNOL, V182, P4751, DOI 10.4049/jimmunol.0803801; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Frota AC, PED INFECT IN PRESS; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; Milagres LG, 2013, AIDS, V27, P2697, DOI 10.1097/QAD.0000000000000007; Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, MAN CTR REF IM ESP A; Safadi MAP, 2012, J PEDIAT-BRAZIL, V88, P195, DOI 10.2223/JPED.2167; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Rosignoli G, 2007, AIDS, V21, P1379, DOI 10.1097/QAD.0b013e3281de7296; Safadi MAP, 2013, EPIDEMIOL INFECT, V141, P447, DOI 10.1017/S0950268812001689; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Yue FY, 2004, J IMMUNOL, V172, P2476, DOI 10.4049/jimmunol.172.4.2476	17	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115887	10.1371/journal.pone.0115887	http://dx.doi.org/10.1371/journal.pone.0115887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532028	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845100114
J	Mohri, Z; Rowland, EM; Clarke, LA; De Luca, A; Peiffer, V; Krams, R; Sherwin, SJ; Weinberg, PD				Mohri, Zahra; Rowland, Ethan M.; Clarke, Lindsey A.; De Luca, Amalia; Peiffer, Veronique; Krams, Rob; Sherwin, Spencer J.; Weinberg, Peter D.			Elevated Uptake of Plasma Macromolecules by Regions of Arterial Wall Predisposed to Plaque Instability in a Mouse Model	PLOS ONE			English	Article							RABBIT AORTIC-WALL; LOW-DENSITY-LIPOPROTEIN; TERM ALBUMIN UPTAKE; SHEAR-STRESS; ENDOTHELIAL PERMEABILITY; NITRIC-OXIDE; ATHEROSCLEROTIC LESIONS; IN-VIVO; MICE; PATTERNS	Atherosclerosis may be triggered by an elevated net transport of lipid-carrying macromolecules from plasma into the arterial wall. We hypothesised that whether lesions are of the thin-cap fibroatheroma (TCFA) type or are less fatty and more fibrous depends on the degree of elevation of transport, with greater uptake leading to the former. We further hypothesised that the degree of elevation can depend on haemodynamic wall shear stress characteristics and nitric oxide synthesis. Placing a tapered cuff around the carotid artery of apolipoprotein E -/- mice modifies patterns of shear stress and eNOS expression, and triggers lesion development at the upstream and downstream cuff margins; upstream but not downstream lesions resemble the TCFA. We measured wall uptake of a macromolecular tracer in the carotid artery of C57bl/6 mice after cuff placement. Uptake was elevated in the regions that develop lesions in hyperlipidaemic mice and was significantly more elevated where plaques of the TCFA type develop. Computational simulations and effects of reversing the cuff orientation indicated a role for solid as well as fluid mechanical stresses. Inhibiting NO synthesis abolished the difference in uptake between the upstream and downstream sites. The data support the hypothesis that excessively elevated wall uptake of plasma macromolecules initiates the development of the TCFA, suggest that such uptake can result from solid and fluid mechanical stresses, and are consistent with a role for NO synthesis. Modification of wall transport properties might form the basis of novel methods for reducing plaque rupture.	[Mohri, Zahra; Rowland, Ethan M.; Clarke, Lindsey A.; Peiffer, Veronique; Krams, Rob; Weinberg, Peter D.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [De Luca, Amalia; Peiffer, Veronique; Sherwin, Spencer J.] Univ London Imperial Coll Sci Technol & Med, Dept Aeronaut, London, England	Imperial College London; Imperial College London	Weinberg, PD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	p.weinberg@imperial.ac.uk	Sherwin, Spencer/C-1167-2010	Sherwin, Spencer/0000-0001-7681-2820	British Heart Foundation [PG/08/053/25192]; Imperial College's British Heart Foundation Centre of Research Excellence; British Heart Foundation [PG/13/16/30040] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Imperial College's British Heart Foundation Centre of Research Excellence; British Heart Foundation(British Heart Foundation)	This study was funded by a British Heart Foundation (www.bhf.org.uk) project grant PG/08/053/25192. EMR, LAC, ADL and VP were supported by Imperial College's British Heart Foundation Centre of Research Excellence (http://www3.imperial.ac.uk/bhfcre). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes SE, 1998, ARTERIOSCL THROM VAS, V18, P300, DOI 10.1161/01.ATV.18.2.300; Barnes SE, 2001, EXP MOL PATHOL, V71, P161, DOI 10.1006/exmp.2001.2395; BELL FP, 1974, EXP MOL PATHOL, V20, P57, DOI 10.1016/0014-4800(74)90043-4; BRATZLER RL, 1977, ATHEROSCLEROSIS, V28, P289, DOI 10.1016/0021-9150(77)90177-0; Cancel LM, 2010, ATHEROSCLEROSIS, V208, P335, DOI 10.1016/j.atherosclerosis.2009.07.051; Cheng C, 2005, BLOOD, V106, P3691, DOI 10.1182/blood-2005-06-2326; Cheng C, 2007, J CLIN INVEST, V117, P616, DOI 10.1172/JCI28180; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; Clarke LA, 2012, ATHEROSCLEROSIS, V224, P417, DOI 10.1016/j.atherosclerosis.2012.08.001; CORNHILL JF, 1980, ATHEROSCLEROSIS, V35, P321, DOI 10.1016/0021-9150(80)90130-6; Courtman DW, 1998, AM J PATHOL, V153, P1723, DOI 10.1016/S0002-9440(10)65687-8; DRAIJER R, 1995, CIRC RES, V76, P199, DOI 10.1161/01.RES.76.2.199; Ewins BA, 2002, J BIOMECH ENG-T ASME, V124, P684, DOI 10.1115/1.1517063; Feintuch A, 2007, AM J PHYSIOL-HEART C, V292, pH884, DOI 10.1152/ajpheart.00796.2006; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Forster BA, 1997, ARTERIOSCL THROM VAS, V17, P1361, DOI 10.1161/01.ATV.17.7.1361; Fothergill JE, 1964, FLUORESCENT PROTEIN, P34; GALIS ZS, 1995, P NATL ACAD SCI USA, V92, P402, DOI 10.1073/pnas.92.2.402; Glasunow M, 1926, VIRCHOWS ARCH PATH A, V261, P837; Greve JM, 2006, AM J PHYSIOL-HEART C, V291, pH1700, DOI 10.1152/ajpheart.00274.2006; Grinberg L, 2009, CLIN EXP PHARMACOL P, V36, P194, DOI 10.1111/j.1440-1681.2008.05010.x; HARRISHOOKER S, 1992, CELL BIOL INT REP, V16, P433, DOI 10.1016/S0309-1651(06)80063-9; Harrison M, 2013, ARTERIOSCL THROM VAS, V33, P694, DOI 10.1161/ATVBAHA.112.300379; Hartley CJ, 2000, AM J PHYSIOL-HEART C, V279, pH2326, DOI 10.1152/ajpheart.2000.279.5.H2326; Huang H, 2001, CIRCULATION, V103, P1051, DOI 10.1161/01.CIR.103.8.1051; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; KARNIADAKIS G. E., 2005, SPECTRAL HP ELEMENT; Kubes Pal, 1995, Microcirculation (New York), V2, P235, DOI 10.3109/10739689509146769; Kuebler WM, 2010, CELL PHYSIOL BIOCHEM, V26, P29, DOI 10.1159/000315103; Levick JR, 2009, INTRO CARDIOVASCULAR, P157; Mynard JP, 2013, ATHEROSCLEROSIS, V227, P259, DOI 10.1016/j.atherosclerosis.2013.01.026; Najafi AH, 2013, DIS MODEL MECH, V6, P323, DOI 10.1242/dmm.009977; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nielsen LB, 1996, ATHEROSCLEROSIS, V123, P1, DOI 10.1016/0021-9150(96)05802-9; Sanchez FA, 2006, AM J PHYSIOL-HEART C, V291, pH1058, DOI 10.1152/ajpheart.00370.2006; Schwartz SM, 2007, ARTERIOSCL THROM VAS, V27, P705, DOI 10.1161/01.ATV.0000261709.34878.20; SCHWENKE DC, 1988, CIRC RES, V62, P699, DOI 10.1161/01.RES.62.4.699; Sebkhi A, 1996, ARTERIOSCL THROM VAS, V16, P317, DOI 10.1161/01.ATV.16.2.317; SEBKHI A, 1994, J PHYSIOL-LONDON, V479P, pP77; Somerville JN, 2004, CALCIFIED TISSUE INT, V74, P469, DOI 10.1007/s00223-003-0101-x; Staughton TJ, 2004, TRENDS IN ATHEROSCLEROSIS RESEARCH, P123; Staughton TJ, 2001, AM J PHYSIOL-HEART C, V281, pH53, DOI 10.1152/ajpheart.2001.281.1.H53; Vincent PE, 2009, BIOPHYS J, V96, P3102, DOI 10.1016/j.bpj.2009.01.022; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Warboys CM, 2012, CELL MOL BIOENG, V5, P184, DOI 10.1007/s12195-012-0220-4; Warboys CM, 2010, AM J PHYSIOL-HEART C, V298, pH1850, DOI 10.1152/ajpheart.00114.2010; Weinberg PD, 2004, J VASC RES, V41, P1, DOI 10.1159/000076124; Weinberg PD, 2007, J BIOMECH, V40, P1594, DOI 10.1016/j.jbiomech.2006.07.020; WIKLUND O, 1985, ARTERIOSCLEROSIS, V5, P135, DOI 10.1161/01.ATV.5.2.135; Zilberberg J, 2001, MICROVASC RES, V62, P410, DOI 10.1006/mvre.2001.2362	50	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115728	10.1371/journal.pone.0115728	http://dx.doi.org/10.1371/journal.pone.0115728			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531765	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100102
J	Zhang, DL; Liu, X; Chen, J; Liu, B				Zhang, Delong; Liu, Xian; Chen, Jun; Liu, Bo			Distinguishing Patients with Parkinson's Disease Subtypes from Normal Controls Based on Functional Network Regional Efficiencies	PLOS ONE			English	Article							RESTING-STATE; BRAIN NETWORKS; SUBTHALAMIC NUCLEUS; BASAL GANGLIA; GLOBAL SIGNAL; CONNECTIVITY; TREMOR; MOTOR; PATHOPHYSIOLOGY; OSCILLATIONS	Many studies have demonstrated that the pathophysiology and clinical symptoms of Parkinson's disease (PD) are inhomogeneous. However, the symptom-specific intrinsic neural activities underlying the PD subtypes are still not well understood. Here, 15 tremor-dominant PD patients, 10 non-tremor-dominant PD patients, and 20 matched normal controls (NCs) were recruited and underwent resting-state functional magnetic resonance imaging (fMRI). Functional brain networks were constructed based on randomly generated anatomical templates with and without the cerebellum. The regional network efficiencies (i.e., the local and global efficiencies) were further measured and used to distinguish subgroups of PD patients (i.e., with tremor-dominant PD and non-tremor-dominant PD) from the NCs using linear discriminant analysis. The results demonstrate that the subtypespecific functional networks were small-world-organized and that the network regional efficiency could discriminate among the individual PD subgroups and the NCs. Brain regions involved in distinguishing between the study groups included the basal ganglia (i.e., the caudate and putamen), limbic regions (i.e., the hippocampus and thalamus), the cerebellum, and other cerebral regions (e.g., the insula, cingulum, and calcarine sulcus). In particular, the performances of the regional local efficiency in the functional network were better than those of the global efficiency, and the performances of global efficiency were dependent on the inclusion of the cerebellum in the analysis. These findings provide new evidence for the neurological basis of differences between PD subtypes and suggest that the cerebellum may play different roles in the pathologies of different PD subtypes. The present study demonstrated the power of the combination of graph-based network analysis and discrimination analysis in elucidating the neural basis of different PD subtypes.	[Zhang, Delong; Liu, Xian; Chen, Jun; Liu, Bo] Guangdong Prov Hosp Chinese Med, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Zhang, Delong] Guangzhou Univ Chinese Med, Postdoctoral Mobile Res Stn, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Liu, B (corresponding author), Guangdong Prov Hosp Chinese Med, Dept Radiol, Guangzhou, Guangdong, Peoples R China.	lbgdhtcm@163.com	Chen, Jun/AAD-7667-2020	CHEN, JUN/0000-0001-5049-5759	Natural Science Foundation of China [31371049]; Guangdong Science and Technology Department [2008B080703041, 2010B080701025]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department	This work was supported by the Natural Science Foundation of China (Nos. 31371049), Guangdong Science and Technology Department (Nos. 2008B080703041 and 2010B080701025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131; Dai ZJ, 2012, NEUROIMAGE, V59, P2187, DOI 10.1016/j.neuroimage.2011.10.003; Dubbelink KTEO, 2014, BRAIN, V137, P197, DOI 10.1093/brain/awt316; Eckert Thomas, 2005, NeuroRx, V2, P361, DOI 10.1007/BF03206677; Finkbiner AP, 2008, MOVEMENT DISORD, V23, P1632; Fishman PS, 2008, MOVEMENT DISORD, V23, P168, DOI 10.1002/mds.21736; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gottlich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077336; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; He BJ, 2007, CURR OPIN NEUROL, V20, P655, DOI 10.1097/WCO.0b013e3282f1c720; Helmich RC, 2012, BRAIN, V135, P3206, DOI 10.1093/brain/aws023; Helmich RC, 2011, ANN NEUROL, V69, P269, DOI 10.1002/ana.22361; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jellinger KA, 1999, J NEURAL TRANSM-SUPP, P1; JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lewinger JP, 2005, GENET EPIDEMIOL, V29, P262; Liu H, 2013, PSYCHIAT RES-NEUROIM, V211, P64, DOI 10.1016/j.pscychresns.2012.10.007; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Moran A, 2008, BRAIN, V131, P3395, DOI 10.1093/brain/awn270; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; PAULUS W, 1991, J NEUROPATH EXP NEUR, V50, P743, DOI 10.1097/00005072-199111000-00006; Payoux P, 2004, ARCH NEUROL-CHICAGO, V61, P1307, DOI 10.1001/archneur.61.8.1307; Poston KL, 2012, NEUROIMAGE, V62, P2261, DOI 10.1016/j.neuroimage.2011.12.021; Rivlin-Etzion M, 2006, CURR OPIN NEUROBIOL, V16, P629, DOI 10.1016/j.conb.2006.10.002; Skidmore F, 2011, NEUROSCI LETT, V499, P47, DOI 10.1016/j.neulet.2011.05.030; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Weinberger M, 2009, J NEUROPHYSIOL, V101, P789, DOI 10.1152/jn.90837.2008; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Zaidel A, 2009, CURR OPIN NEUROL, V22, P387, DOI 10.1097/WCO.0b013e32832d9d67; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	38	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115131	10.1371/journal.pone.0115131	http://dx.doi.org/10.1371/journal.pone.0115131			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531436	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100039
J	Liu, F; Jiao, AX; Wu, XR; Zhao, W; Yin, QQ; Qi, H; Jiao, WW; Xiao, J; Sun, L; Shen, C; Tian, JL; Shen, D; Jacqz-Aigrain, E; Shen, AD				Liu, Fang; Jiao, An-xia; Wu, Xi-rong; Zhao, Wei; Yin, Qing-qin; Qi, Hui; Jiao, Wei-wei; Xiao, Jing; Sun, Lin; Shen, Chen; Tian, Jian-ling; Shen, Dan; Jacqz-Aigrain, Evelyne; Shen, A-dong			Impact of Glutathione S-Transferase M1 and T1 on Anti-Tuberculosis Drug-Induced Hepatotoxicity in Chinese Pediatric Patients	PLOS ONE			English	Article							GSTT1 GENETIC POLYMORPHISMS; CYP2E1 POLYMORPHISMS; ADVERSE-REACTIONS; NULL MUTATIONS; GSTM1; LIVER; RISK; NAT2; SUSCEPTIBILITY; HEPATITIS	Background: Anti-tuberculosis drug induced hepatotoxicity (ATDH) is a major adverse drug reaction associated for anti-tuberculosis therapy. The glutathione Stransferases (GST) plays a crucial role in the detoxification of hepatotoxic metabolites of anti-tuberculosis drugs. An association between GSTM1/GSTT1 null mutations and increased risk of ATDH has been demonstrated in adults. Given the ethnic differences and developmental changes, our study aims to investigate the potential impacts of GSTM1/GSTT1genotypes on the development of ATDH in Han Chinese children treated with anti-tuberculosis therapy. Methods: Children receiving anti-tuberculosis therapy with or without evidence of ATDH were considered as the cases or controls, respectively. The GSTM1 and GSTT1 genotyping were performed using the polymerase chain reaction. Results: One hundred sixty-three children (20 cases and 143 controls) with a mean age of 4.7 years (range: 2 months-14.1 years) were included. For the GSTM1, 14 (70.0%) cases and 96 (67.1%) controls had homozygous null mutations. For the GSTT1, 13 (65.0%) cases and 97 (67.8%) controls had homozygous null mutations. Neither the GSTM1, nor the GSTT1 polymorphism was significantly correlated with the occurrence of ATHD. Conclusion: Ourresults did not support the GSTM1 and GSTT1 polymorphisms as the predictors of ADTH in Chinese Han children treated with anti-tuberculosis drugs. An age-related association between pharmacogenetics and ATHD need to be confirmed in the further study.	[Liu, Fang; Jiao, An-xia; Wu, Xi-rong; Yin, Qing-qin; Qi, Hui; Jiao, Wei-wei; Xiao, Jing; Sun, Lin; Shen, Chen; Tian, Jian-ling; Shen, Dan; Shen, A-dong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children,Minist Educ, Beijing, Peoples R China; [Liu, Fang; Jiao, An-xia; Wu, Xi-rong; Yin, Qing-qin; Qi, Hui; Jiao, Wei-wei; Xiao, Jing; Sun, Lin; Shen, Chen; Tian, Jian-ling; Shen, Dan; Shen, A-dong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Natl Key Discipline Pediat,Minist Educ, Beijing, Peoples R China; [Zhao, Wei] Shandong Univ, Sch Pharmaceut Sci, Dept Clin Pharm, Jinan 250100, Shandong, Peoples R China; [Zhao, Wei; Jacqz-Aigrain, Evelyne] Hop Robert Debre, AP HP, Dept Pediat Pharmacol & Pharmacogenet, F-75019 Paris, France; [Zhao, Wei; Jacqz-Aigrain, Evelyne] INSERM, Clin Invest Ctr CIC1426, Paris, France; [Zhao, Wei; Jacqz-Aigrain, Evelyne] Univ Paris Diderot, EA7323, Paris, France	Capital Medical University; Capital Medical University; Shandong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Shen, AD (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children,Minist Educ, Beijing, Peoples R China.	shenad16@hotmail.com	孙, 琳/HGE-6966-2022; zhao, wei/D-3322-2011; shen, chen/AAC-2458-2020; Jacqz-Aigrain, Evelyne/AAW-7089-2021	zhao, wei/0000-0002-1830-338X; Jacqz-Aigrain, Evelyne/0000-0002-4285-7067	National Natural Science Foundation of China [81271889]; Beijing Natural Science Foundation [7121007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China (No. 81271889), and Beijing Natural Science Foundation (No. 7121007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker ML, 2010, PHARMACOGENOMICS, V11, P1591, DOI [10.2217/pgs.10.175, 10.2217/PGS.10.146]; BENICHOU C, 1990, J HEPATOL, V11, P272; Buchard A, 2007, J MOL DIAGN, V9, P612, DOI 10.2353/jmoldx.2007.070030; *CENT EUR J PUBL H, 2010, WHO GLOBAL TUBERCULO, V18, P237; Chatterjee S, 2010, J CLIN PHARM THER, V35, P465, DOI 10.1111/j.1365-2710.2009.01101.x; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; Teixeira RLD, 2011, MEM I OSWALDO CRUZ, V106, P716, DOI 10.1590/S0074-02762011000600011; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; GARIBALDI RA, 1972, AM REV RESPIR DIS, V106, P357, DOI 10.1164/arrd.1972.106.3.357; Gupta VH, 2013, ANN HEPATOL, V12, P959, DOI 10.1016/S1665-2681(19)31302-X; Huang YS, 2007, J HEPATOL, V47, P128, DOI 10.1016/j.jhep.2007.02.009; Huang YS, 2014, J CHIN MED ASSOC, V77, P169, DOI 10.1016/j.jcma.2014.01.010; Johnsrud EK, 2003, J PHARMACOL EXP THER, V307, P402, DOI 10.1124/jpet.102.053124; Kim SH, 2010, TUBERCULOSIS, V90, P39, DOI 10.1016/j.tube.2009.12.001; Lee SW, 2010, INT J TUBERC LUNG D, V14, P622; Leiro V, 2008, LIVER INT, V28, P835, DOI 10.1111/j.1478-3231.2008.01700.x; Li C, 2013, EUR J CLIN MICROBIOL, V32, P859, DOI 10.1007/s10096-013-1831-y; Maria VAJ, 1997, HEPATOLOGY, V26, P664, DOI 10.1053/jhep.1997.v26.pm0009303497; Monteiro TP, 2012, J CLIN PHARM THER, V37, P712, DOI 10.1111/j.1365-2710.2012.01368.x; Neville KA, 2011, PEDIATR ANESTH, V21, P255, DOI 10.1111/j.1460-9592.2011.03533.x; Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014; Ramachandran G, 2011, INDIAN J PEDIATR, V78, P435, DOI 10.1007/s12098-010-0304-x; Rana SV, 2014, J CLIN PHARM THER, V39, P91, DOI 10.1111/jcpt.12105; Roy B, 2001, J GASTROEN HEPATOL, V16, P1033, DOI 10.1046/j.1440-1746.2001.02585.x; Shang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021836; Sharifzadeh M, 2005, PHARMACOL RES, V51, P353, DOI 10.1016/j.phrs.2004.10.009; Sharma SK, 2004, INFECT GENET EVOL, V4, P167, DOI 10.1016/j.meegid.2003.01.001; SINGH J, 1995, POSTGRAD MED J, V71, P359, DOI 10.1136/pgmj.71.836.359; Singla N, 2014, TUBERCULOSIS, V94, P293, DOI 10.1016/j.tube.2014.02.003; Sun HY, 2009, J FORMOS MED ASSOC, V108, P102, DOI 10.1016/S0929-6646(09)60040-1; Tang SW, 2012, J CLIN PHARM THER, V37, P588, DOI 10.1111/j.1365-2710.2012.01334.x; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Uetrecht J, 2013, PHARMACOL REV, V65, P779, DOI 10.1124/pr.113.007450; Verhagen LM, 2014, PHARMACOGENOMICS, V15, P285, DOI 10.2217/pgs.13.230; Vieira I, 1996, EUR J BIOCHEM, V238, P476, DOI 10.1111/j.1432-1033.1996.0476z.x; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2; Wang T, 2010, J INT MED RES, V38, P977, DOI 10.1177/147323001003800324; Xiang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085905; Yimer G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001809	39	11	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115410	10.1371/journal.pone.0115410	http://dx.doi.org/10.1371/journal.pone.0115410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525805	gold, Green Submitted, Green Published			2022-12-26	WOS:000347186200026
J	Renwick, J; McNally, P; John, B; DeSantis, T; Linnane, B; Murphy, P				Renwick, Julie; McNally, Paul; John, Bettina; DeSantis, Todd; Linnane, Barry; Murphy, Philip		SHIELD CF	The Microbial Community of the Cystic Fibrosis Airway Is Disrupted in Early Life	PLOS ONE			English	Editorial Material							DIVERSITY; BACTERIA; INFECTIONS; GREENGENES; NOV.	Background: Molecular techniques have uncovered vast numbers of organisms in the cystic fibrosis (CF) airways, the clinical significance of which is yet to be determined. The aim of this study was to describe and compare the microbial communities of the lower airway of clinically stable children with CF and children without CF. Methods: Bronchoalveolar lavage (BAL) fluid and paired oropharyngeal swabs from clinically stable children with CF (n=13) and BAL from children without CF (n=9) were collected. DNA was isolated, the 16S rRNA regions amplified, fragmented, biotinylated and hybridised to a 16S rRNA microarray. Patient medical and demographic information was recorded and standard microbiological culture was performed. Results: A diverse bacterial community was detected in the lower airways of children with CF and children without CF. The airway microbiome of clinically stable children with CF and children without CF were significantly different as measured by Shannon's Diversity Indices (p=0.001; t test) and Principle coordinate analysis (p=0.01; Adonis test). Overall the CF airway microbial community was more variable and had a less even distribution than the microbial community in the airways of children without CF. We highlighted several bacteria of interest, particularly Prevotella veroralis, CW040 and a Corynebacterium, which were of significantly differential abundance between the CF and non-CF lower airways. Both Pseudomonas aeruginosa and Streptococcus pneumoniae culture abundance were found to be associated with CF airway microbial community structure. The CF upper and lower airways were found to have a broadly similar microbial milieu. Conclusion: The microbial communities in the lower airways of stable children with CF and children without CF show significant differences in overall diversity. These discrepancies indicate a disruption of the airway microflora occurring early in life in children with CF.	[Renwick, Julie; Murphy, Philip] Univ Dublin Trinity Coll, Dept Clin Microbiol, Dublin 2, Ireland; [Renwick, Julie; McNally, Paul; Linnane, Barry; Murphy, Philip] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Renwick, Julie; Murphy, Philip] Tallaght Hosp, Natl Childrens Hosp, Dublin, Ireland; [John, Bettina; DeSantis, Todd] Second Genome, San Francisco, CA USA; [Linnane, Barry] Hosp Limerick, Limerick, Ireland; [Linnane, Barry] Univ Limerick, Grad Entry Med Sch, Ctr Intervent Infect Inflammat & Immun 4i, Limerick, Ireland	Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; Trinity College Dublin; University of Limerick	Renwick, J (corresponding author), Univ Dublin Trinity Coll, Dept Clin Microbiol, Dublin 2, Ireland.	jsrenwick@gmail.com	Elnazir, Basil/N-8418-2019; McNally, Paul/I-3151-2013; McNally, Paul/AAL-4407-2021	McNally, Paul/0000-0001-7102-1712; McNally, Paul/0000-0001-7102-1712				Bittar F, 2010, EMERG INFECT DIS, V16, P1231, DOI 10.3201/eid1608.100193; Blainey PC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004458; Charlson ES, 2011, AM J RESP CRIT CARE, DOI 201104-06550Cv2; Coenye T, 2002, J CLIN MICROBIOL, V40, P2062, DOI 10.1128/JCM.40.6.2062-2069.2002; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Downes J, 2008, INT J SYST EVOL MICR, V58, P1788, DOI 10.1099/ijs.0.65656-0; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Field TR, 2010, ANAEROBE, V16, P337, DOI 10.1016/j.anaerobe.2010.04.002; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Klepac-Ceraj V, 2010, ENV MICROBIOL; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; O'Connell HA, 2006, APPL ENVIRON MICROB, V72, P5013, DOI 10.1128/AEM.02474-05; Rigsbee L, 2012, AM J GASTROENTEROL; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sibley CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022702; Stressmann FA, 2012, THORAX; Stressmann FA, 2012, THORAX, V67, P867, DOI 10.1136/thoraxjnl-2011-200932; Tunney MM, 2011, THORAX, V66, P579, DOI 10.1136/thx.2010.137281; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Weigel LM, 2007, ANTIMICROB AGENTS CH, V51, P231, DOI 10.1128/AAC.00576-06; Whiteson KL, 2014, AM J RESP CRIT CARE, V189, P1309, DOI 10.1164/rccm.201312-2129PP; Whiteson KL, 2014, AM J RESP CRIT CARE; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	35	48	48	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e109798	10.1371/journal.pone.0109798	http://dx.doi.org/10.1371/journal.pone.0109798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526264	Green Published, Green Submitted, gold			2022-12-26	WOS:000347186200065
J	Clark, B; Costa, VP; O'Brien, BJ; Guglielmo, LG; Paton, CD				Clark, Bradley; Costa, Vitor P.; O'Brien, Brendan J.; Guglielmo, Luiz G.; Paton, Carl D.			Effects of a Seven Day Overload-Period of High-Intensity Training on Performance and Physiology of Competitive Cyclists	PLOS ONE			English	Article							TIME-TRIAL PERFORMANCE; IMPROVES PERFORMANCE; POWER OUTPUT; INTERVAL; ADAPTATIONS; PERIODIZATION; EFFICIENCY; VOLUME; TOUR	Objectives: Competitive endurance athletes commonly undertake periods of overload training in the weeks prior to major competitions. This investigation examined the effects of two seven-day high-intensity overload training regimes (HIT) on performance and physiological characteristics of competitive cyclists. Design: The study was a matched groups, controlled trial. Methods: Twenty-eight male cyclists (mean +/- SD, Age: 33 +/- 10 years, Mass 74 +/- 7 kg, VO2 peak 4.7 +/- 0.5 L center dot min(-1)) were assigned to a control group or one of two training groups for seven consecutive days of HIT. Before and after training cyclists completed an ergometer based incremental exercise test and a 20-km time-trial. The HIT sessions were,120 minutes in duration and consisted of matched volumes of 5, 10 and 20 second (short) or 15, 30 and 45 second (long) maximal intensity efforts. Results: Both the short and long HIT regimes led to significant (p<0.05) gains in time trial performance compared to the control group. Relative to the control group, the mean changes (+/- 90% confidence limits) in time-trial power were 8.2% +/- 3.8% and 10.4% +/- 4.3% for the short and long HIT regimes respectively; corresponding increases in peak power in the incremental test were 5.5% +/- 2.7% and 9.5% +/- 2.5%. Both HIT (short vs long) interventions led to non-significant (p. 0.05) increases (mean +/- SD) in VO2 peak (2.3% +/- 4.7% vs 3.5% +/- 6.2%), lactate threshold power (3.6% +/- 3.5% vs 2.9% +/- 5.3%) and gross efficiency (3.2% +/- 2.4% vs 5.1% +/- 3.9%) with only small differences between HIT regimes. Conclusions: Seven days of overload HIT induces substantial enhancements in time-trial performance despite non-significant increases in physiological measures with competitive cyclists.	[Clark, Bradley; O'Brien, Brendan J.] Federat Univ, Sch Hlth Sci, Ballarat, Vic, Australia; [Costa, Vitor P.; Guglielmo, Luiz G.] Univ Fed Santa Catarina, Phys Effort Lab, Florianopolis, SC, Brazil; [Paton, Carl D.] Eastern Inst Technol, Fac Hlth & Sport Sci, Hawkes Bay, New Zealand	Federation University Australia; Universidade Federal de Santa Catarina (UFSC); Eastern Institute of Technology	Paton, CD (corresponding author), Eastern Inst Technol, Fac Hlth & Sport Sci, Hawkes Bay, New Zealand.	cpaton@eit.ac.nz	Guglielmo, Luiz Guilherme GA Antonacci/I-1160-2015; Costa, Vitor Pereira/ABG-1056-2021; Costa, Vitor Pereira/N-8419-2016; Paton, Carl/H-3332-2019	Guglielmo, Luiz Guilherme GA Antonacci/0000-0001-6757-5050; Costa, Vitor Pereira/0000-0001-9146-6858; Costa, Vitor Pereira/0000-0001-9146-6858; Paton, Carl/0000-0002-7418-7213; O'Brien, Brendan/0000-0002-6371-1796; Clark, Bradley/0000-0003-2277-0463	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Dr. Costa would like to acknowledge and thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the travel scholarship which enabled his participation in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breil FA, 2010, EUR J APPL PHYSIOL, V109, P1077, DOI 10.1007/s00421-010-1455-1; Cohen J., 1986, STAT POWER ANAL BEHA; Creer AR, 2004, INT J SPORTS MED, V25, P92; Ebert TR, 2006, INT J SPORT PHYSIOL, V1, P324, DOI 10.1123/ijspp.1.4.324; Gross M, 2007, MED SCI SPORT EXER, V39, P1666, DOI 10.1249/mss.0b013e3180cac209; Halson SL, 2002, J APPL PHYSIOL, V93, P947, DOI 10.1152/japplphysiol.01164.2001; Hamilton RJ, 2006, INTJ SPORT PHYSIOL, V1, P40, DOI 10.1123/ijspp.1.1.40; Hopker J, 2010, APPL PHYSIOL NUTR ME, V35, P17, DOI 10.1139/H09-124; Hopkins WG, 2006, SPORTSCIENCE, V10, P46; HOROWITZ JF, 1994, INT J SPORTS MED, V15, P152, DOI 10.1055/s-2007-1021038; JEUKENDRUP AE, 1992, INT J SPORTS MED, V13, P534, DOI 10.1055/s-2007-1021312; Laursen PB, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01184.x; Laursen PB, 2005, J STRENGTH COND RES, V19, P527; Laursen PB, 2002, CAN J APPL PHYSIOL, V27, P336, DOI 10.1139/h02-019; Laursen PB, 2002, MED SCI SPORT EXER, V34, P1801, DOI 10.1097/00005768-200211000-00017; Lindsay FH, 1996, MED SCI SPORT EXER, V28, P1427, DOI 10.1097/00005768-199611000-00013; Lucia A, 2004, BRIT J SPORT MED, V38, P636, DOI 10.1136/bjsm.2003.008490; Meeusen R, 2006, EUR J SPORT SCI, V6, P1, DOI 10.1080/17461390600617717; Paton CD, 2006, EUR J SPORT SCI, V6, P25, DOI 10.1080/17461390500422796; Paton CD, 2005, J STRENGTH COND RES, V19, P826; Paton CD, 2004, SPORTSCIENCE, V8, P25; Ronnestad BR, 2014, SCAND J MED SCI SPOR, V24, P327, DOI 10.1111/sms.12016; Ronnestad BR, 2014, SCAND J MED SCI SPOR, V24, P34, DOI 10.1111/j.1600-0838.2012.01485.x; Ross A, 2001, SPORTS MED, V31, P1063, DOI 10.2165/00007256-200131150-00003; Seiler KS, 2006, SCAND J MED SCI SPOR, V16, P49, DOI 10.1111/j.1600-0838.2004.00418.x; Seiler S, 2013, SCAND J MED SCI SPOR, V23, P74, DOI 10.1111/j.1600-0838.2011.01351.x; Stepto NK, 1999, MED SCI SPORT EXER, V31, P736, DOI 10.1097/00005768-199905000-00018; WestgarthTaylor C, 1997, EUR J APPL PHYSIOL O, V75, P298, DOI 10.1007/s004210050164; Weston AR, 1997, EUR J APPL PHYSIOL O, V75, P7	29	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115308	10.1371/journal.pone.0115308	http://dx.doi.org/10.1371/journal.pone.0115308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521824	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845600032
J	Noble, JM; Scarmeas, N; Celenti, RS; Elkind, MSV; Wright, CB; Schupf, N; Papapanou, PN				Noble, James M.; Scarmeas, Nikolaos; Celenti, Romanita S.; Elkind, Mitchell S. V.; Wright, Clinton B.; Schupf, Nicole; Papapanou, Panos N.			Serum IgG Antibody Levels to Periodontal Microbiota Are Associated with Incident Alzheimer Disease	PLOS ONE			English	Article							CEREBROVASCULAR REACTIVITY; ACTINOMYCES-NAESLUNDII; EUBACTERIUM-NODATUM; ORAL-HEALTH; RISK; INFECTIONS; BACTERIA; RESPONSES; DEMENTIA; MARKERS	Background: Periodontitis and Alzheimer disease (AD) are associated with systemic inflammation. This research studied serum IgG to periodontal microbiota as possible predictors of incident AD. Methods: Using a case-cohort study design, 219 subjects (110 incident AD cases and 109 controls without incident cognitive impairment at last follow-up), matched on race-ethnicity, were drawn from the Washington Heights-Inwood Columbia Aging Project (WHICAP), a cohort of longitudinally followed northern Manhattan residents aged >65 years. Mean follow-up was five years (SD 2.6). In baseline sera, serum IgG levels were determined for bacteria known to be positively or negatively associated with periodontitis (Porphyromonas gingivalis, Tannerella forsythia, Actinobacillus actinomycetemcomitans Y4, Treponema denticola, Campylobacter rectus, Eubacterium nodatum, and Actinomyces naeslundii genospecies-2). In all analyses, we used antibody threshold levels shown to correlate with presence of moderate-severe periodontitis. Results: Mean age was 72 years (SD 6.9) for controls, and 79 years (SD 4.6) for cases (p<0.001). Non-Hispanic Whites comprised 26%, non-Hispanic Blacks 27%, and Hispanics 48% of the sample. In a model adjusting for baseline age, sex, education, diabetes mellitus, hypertension, smoking, prior history of stroke, and apolipoprotein E genotype, high anti-A. naeslundii titer (>640 ng/ml, present in 10% of subjects) was associated with increased risk of AD (HR=2.0, 95% CI: 1.1-3.8). This association was stronger after adjusting for other significant titers (HR=3.1, 95% CI: 1.5-6.4). In this model, high anti-E. nodatum IgG (>1755 ng/ml; 19% of subjects) was associated with lower risk of AD (HR50.5, 95% CI: 0.2-0.9). Conclusions: Serum IgG levels to common periodontal microbiota are associated with risk for developing incident AD.	[Noble, James M.; Scarmeas, Nikolaos; Schupf, Nicole] Columbia Univ, Taub Inst Alzheimer Dis & Aging Brain, New York, NY 10027 USA; [Noble, James M.; Scarmeas, Nikolaos; Elkind, Mitchell S. V.] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA; [Scarmeas, Nikolaos] Univ Athens, Dept Social Med Psychiat & Neurol, Athens 11528, Greece; [Celenti, Romanita S.; Papapanou, Panos N.] Columbia Univ, Coll Dent Med, Div Periodont, Sect Oral & Diagnost Sci, New York, NY USA; [Elkind, Mitchell S. V.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Wright, Clinton B.] Univ Miami, Evelyn F McKnight Brain Inst, Dept Neurol, Miami, FL USA; [Wright, Clinton B.] Univ Miami, Evelyn F McKnight Brain Inst, Dept Epidemiol & Publ Hlth Sci, Miami, FL USA; [Wright, Clinton B.] Univ Miami, Leonard M Miller Sch Med, Neurosci Program, Miami, FL USA	Columbia University; Columbia University; National & Kapodistrian University of Athens; Columbia University; Columbia University; University of Miami; University of Miami; University of Miami	Noble, JM (corresponding author), Columbia Univ, Taub Inst Alzheimer Dis & Aging Brain, New York, NY 10027 USA.	jn2054@columbia.edu	Noble, James McCallum/AAA-4218-2020; Scarmeas, Nikolaos/AAD-2512-2020; Scarmeas, Nikolaos/AAD-2517-2020	Noble, James McCallum/0000-0003-0648-6702; Scarmeas, Nikolaos/0000-0001-6453-8908; Scarmeas, Nikolaos/0000-0001-6453-8908; Papapanou, Panos N./0000-0002-6538-3618	Taub Institute for Alzheimer Disease and the Aging Brain; National Institutes of Health [R56 DE022568, R01 AG037212, UL1 TR000040]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE022568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037212] Funding Source: NIH RePORTER	Taub Institute for Alzheimer Disease and the Aging Brain; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a pilot grant from the Taub Institute for Alzheimer Disease and the Aging Brain, and the National Institutes of Health (R56 DE022568, R01 AG037212, and UL1 TR000040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, J PERIODONTOL, V76, P1406, DOI 10.1902/jop.2005.76.8.1406; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Beck JD, 2006, COMMUNITY DENT ORAL, V34, P1, DOI 10.1111/j.1600-0528.2006.00252.x; Beck JD, 2005, J PERIODONTOL, V76, P2089, DOI 10.1902/jop.2005.76.11-S.2089; Brailsford SR, 1998, CARIES RES, V32, P100, DOI 10.1159/000016438; Bretz WA, 2005, J AM GERIATR SOC, V53, P1532, DOI 10.1111/j.1532-5415.2005.53468.x; Cheng D, 2011, DEMENT GERIATR COGN, V31, P424, DOI 10.1159/000324134; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Demmer RT, 2010, PERIODONTOL 2000, V53, P28, DOI 10.1111/j.1600-0757.2009.00326.x; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dye BA, 2012, PERIODONTOL 2000, V58, P10, DOI 10.1111/j.1600-0757.2011.00413.x; Dye BA, 2009, J PERIODONTOL, V80, P634, DOI 10.1902/jop.2009.080474; Eke PI, 2010, J DENT RES, V89, P1208, DOI 10.1177/0022034510377793; Elkind MSV, 2010, STROKE, V41, pE117, DOI 10.1161/STROKEAHA.109.571299; Ford PJ, 2007, J DENT RES, V86, P35, DOI 10.1177/154405910708600105; Grau AJ, 2010, NAT REV NEUROL, V6, P681, DOI 10.1038/nrneurol.2010.163; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.3.CO;2-X; Haffajee AD, 2006, ORAL MICROBIOL IMMUN, V21, P269, DOI 10.1111/j.1399-302X.2006.00287.x; Haffajee AD, 2009, J PERIODONTAL RES, V44, P511, DOI 10.1111/j.1600-0765.2008.01154.x; Heller D, 2012, ARCH ORAL BIOL, V57, P973, DOI 10.1016/j.archoralbio.2012.02.003; Helzner EP, 2008, NEUROLOGY, V71, P1489, DOI 10.1212/01.wnl.0000334278.11022.42; HILL GB, 1987, J CLIN MICROBIOL, V25, P1540, DOI 10.1128/JCM.25.8.1540-1545.1987; Honig LS, 2003, ARCH NEUROL-CHICAGO, V60, P1707, DOI 10.1001/archneur.60.12.1707; Hoth KF, 2007, STROKE, V38, P308, DOI 10.1161/01.STR.0000254517.04275.3f; Johansson A, 2005, CEREBROVASC DIS, V20, P226, DOI 10.1159/000087703; Kamer AR, 2009, J NEUROIMMUNOL, V216, P92, DOI 10.1016/j.jneuroim.2009.08.013; Kishi M, 2010, J MED MICROBIOL, V59, P1354, DOI 10.1099/jmm.0.020636-0; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kulekci G, 2007, ANAEROBE; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Langholz B, 2007, COMPUT STAT DATA AN, V51, P3737, DOI 10.1016/j.csda.2006.12.028; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Munzel T, 2008, ANN MED, V40, P180, DOI 10.1080/07853890701854702; Noble JM, 2009, J NEUROL NEUROSUR PS, V80, P1206, DOI 10.1136/jnnp.2009.174029; Noble JM, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0384-x; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Papapanou PN, 2004, J CLIN PERIODONTOL, V31, P985, DOI 10.1111/j.1600-051X.2004.00599.x; Papapanou PN, 2001, J CLIN PERIODONTOL, V28, P103, DOI 10.1034/j.1600-051x.2001.280116.x; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Peyyala R, 2013, J DENT RES, V92, P235, DOI 10.1177/0022034512472508; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pussinen PJ, 2007, ATHEROSCLEROSIS, V193, P222, DOI 10.1016/j.atherosclerosis.2006.06.027; Pussinen PJ, 2004, STROKE, V35, P2020, DOI 10.1161/01.STR.0000136148.29490.fe; Reitz C, 2007, ARCH NEUROL-CHICAGO, V64, P1734, DOI 10.1001/archneur.64.12.1734; Sakellari D, 1997, ORAL MICROBIOL IMMUN, V12, P303, DOI 10.1111/j.1399-302X.1997.tb00395.x; Sato T, 2012, ARCH ORAL BIOL, V57, P1522, DOI 10.1016/j.archoralbio.2012.07.012; Silvestrini M, 2006, STROKE, V37, P1010, DOI 10.1161/01.STR.0000206439.62025.97; Stein PS, 2012, ALZHEIMERS DEMENT, V8, P196, DOI 10.1016/j.jalz.2011.04.006; Stewart R, 2008, PSYCHOSOM MED, V70, P936, DOI 10.1097/PSY.0b013e3181870aec; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; Tanner A, 1998, J CLIN PERIODONTOL, V25, P85, DOI 10.1111/j.1600-051X.1998.tb02414.x; Thorstensson H, 2010, GERODONTOLOGY, V27, P19, DOI 10.1111/j.1741-2358.2009.00297.x; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; van Oijen M, 2007, ANN NEUROL, V61, P403, DOI 10.1002/ana.21073; Vicenzini E, 2007, EUR NEUROL, V58, P84, DOI 10.1159/000103642; Vlachojannis C, 2010, J CLIN PERIODONTOL, V37, P685, DOI 10.1111/j.1600-051X.2010.01592.x	58	114	120	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114959	10.1371/journal.pone.0114959	http://dx.doi.org/10.1371/journal.pone.0114959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522313	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845600011
J	Gros, C; Fleury, L; Nahoum, V; Faux, C; Valente, S; Labella, D; Cantagrel, F; Rilova, E; Bouhlel, MA; David-Cordonnier, MH; Dufau, I; Ausseil, F; Mai, A; Mourey, L; Lacroix, L; Arimondo, PB				Gros, Christina; Fleury, Laurence; Nahoum, Virginie; Faux, Celine; Valente, Sergio; Labella, Donatella; Cantagrel, Frederic; Rilova, Elodie; Bouhlel, Mohamed Amine; David-Cordonnier, Marie-Helene; Dufau, Isabelle; Ausseil, Frederic; Mai, Antonello; Mourey, Lionel; Lacroix, Laurent; Arimondo, Paola B.			New Insights on the Mechanism of Quinoline-based DNA Methyltransferase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIGENETIC THERAPY; CANCER; METHYLATION; BINDING; FUTURE; DNMT1	Among the epigenetic marks, DNA methylation is one of the most studied. It is highly deregulated in numerous diseases, including cancer. Indeed, it has been shown that hypermethylation of tumor suppressor genes promoters is a common feature of cancer cells. Because DNA methylation is reversible, the DNA methyltransferases (DNMTs), responsible for this epigenetic mark, are considered promising therapeutic targets. Several molecules have been identified as DNMT inhibitors and, among the non-nucleoside inhibitors, 4-aminoquinoline-based inhibitors, such as SGI-1027 and its analogs, showed potent inhibitory activity. Here we characterized the in vitro mechanism of action of SGI-1027 and two analogs. Enzymatic competition studies with the DNA substrate and the methyl donor cofactor, S-adenosyl-L-methionine (AdoMet), displayed AdoMet non-competitive and DNA competitive behavior. In addition, deviations from the Michaelis-Menten model in DNA competition experiments suggested an interaction with DNA. Thus their ability to interact with DNA was established; although SGI-1027 was a weak DNA ligand, analog 5, the most potent inhibitor, strongly interacted with DNA. Finally, as 5 interacted with DNMT only when the DNA duplex was present, we hypothesize that this class of chemical compounds inhibit DNMTs by interacting with the DNA substrate.	[Gros, Christina; Fleury, Laurence; Faux, Celine; Cantagrel, Frederic; Rilova, Elodie; Dufau, Isabelle; Ausseil, Frederic; Arimondo, Paola B.] ETaC, CRDPF, Unite Serv & Rech, CNRS Pierre Fabre 3388, F-31035 Toulouse 01, France; [Nahoum, Virginie; Mourey, Lionel] CNRS, Inst Pharmacol & Biol Struct IPBS, F-31077 Toulouse, France; [Nahoum, Virginie; Mourey, Lionel] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France; [Valente, Sergio; Labella, Donatella; Mai, Antonello] Univ Roma La Sapienza, Dept Chem & Technol Drug, I-00185 Rome, Italy; [Bouhlel, Mohamed Amine; David-Cordonnier, Marie-Helene] IRCL, INSERM, JPARC Jean Pierre Aubert Res Ctr, UMR837,Team 4, F-59045 Lille, France; [Mai, Antonello] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Inst Pasteur, I-00185 Rome, Italy; [Lacroix, Laurent] CNRS, LBME, UMR5099, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Sapienza University Rome; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Fondazione Cenci Bolognetti; Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Arimondo, PB (corresponding author), CNRS Pierre Fabre 3388 ETaC, CRDPF, Unite Serv & Rech, 3 Ave H Curien, F-31035 Toulouse 01, France.	paola.arimondo@etac.cnrs.fr	DAVID-CORDONNIER, Marie-Helene/P-9909-2019; Lacroix, Laurent/C-7024-2009; Mourey, Lionel/B-5662-2009; Mai, Antonello/AAC-2144-2019; David-Cordonnier, Marie-Helene/M-3725-2018; Valente, Sergio/K-2198-2016; Arimondo, Paola B/R-9095-2017	DAVID-CORDONNIER, Marie-Helene/0000-0001-9831-5577; Lacroix, Laurent/0000-0002-6382-9057; Mourey, Lionel/0000-0002-8259-1259; David-Cordonnier, Marie-Helene/0000-0001-9831-5577; Valente, Sergio/0000-0002-2241-607X; Arimondo, Paola B/0000-0001-5175-4396; Nahoum, Virginie/0000-0003-3125-6618; cantagrel, frederic/0000-0002-5354-0540; Jacob (Gros), Christina/0000-0001-8869-9028; Mai, Antonello/0000-0001-9176-2382	CNRS (Action Thematique et Incitative sur Programme); Region Midi Pyrenees (Equipe d'Excellence); Region Midi Pyrenees (FEDER CNRS/Region Midi Pyrenees); Fondation pour la Recherche Medicale [FDT20130928249]; Ligue Nationale contre le Cancer Comite du Nord; FIRB [RBFR10ZJQT]; IIT-Sapienza Project; FP7 Project [BLUEPRINT/282510]; Sapienza Ateneo Project; Institut pour la Recherche sur le Cancer de Lille	CNRS (Action Thematique et Incitative sur Programme); Region Midi Pyrenees (Equipe d'Excellence)(Region Occitanie); Region Midi Pyrenees (FEDER CNRS/Region Midi Pyrenees)(Region Occitanie); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue Nationale contre le Cancer Comite du Nord; FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); IIT-Sapienza Project; FP7 Project; Sapienza Ateneo Project; Institut pour la Recherche sur le Cancer de Lille	This work was supported by the CNRS (Action Thematique et Incitative sur Programme to P. B. A.) and Region Midi Pyrenees (Equipe d'Excellence and FEDER CNRS/Region Midi Pyrenees; to P. B. A.), by Grant FDT20130928249 from the Fondation pour la Recherche Medicale (to C. G.), by Ligue Nationale contre le Cancer Comite du Nord (to M.-H. D. C.), by FIRB RBFR10ZJQT, IIT-Sapienza Project and FP7 Project BLUEPRINT/282510 (to A. M.), by Sapienza Ateneo Project 2012 (by S. V.), and a post-doctoral fellowship from Institut pour la Recherche sur le Cancer de Lille (to M. A. B.).	Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Copeland RA, 1998, BIOCHEM PHARMACOL, V55, P1785, DOI 10.1016/S0006-2952(97)00663-1; Copeland RA, 2003, ANAL BIOCHEM, V320, P1, DOI 10.1016/S0003-2697(03)00346-4; Dervan PB, 1999, CURR OPIN CHEM BIOL, V3, P688, DOI 10.1016/S1367-5931(99)00027-7; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fagan RL, 2013, J BIOL CHEM, V288, P23858, DOI 10.1074/jbc.M113.480517; Fahy J, 2012, EXPERT OPIN THER PAT, V22, P1427, DOI 10.1517/13543776.2012.729579; FOX KR, 1990, BIOCHEM J, V269, P217, DOI 10.1042/bj2690217; Gamage SA, 2013, BIOORGAN MED CHEM, V21, P3147, DOI 10.1016/j.bmc.2013.03.033; Gros C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt753; Gros C, 2012, BIOCHIMIE, V94, P2280, DOI 10.1016/j.biochi.2012.07.025; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Lacroix L, 2000, ARCH BIOCHEM BIOPHYS, V381, P153, DOI 10.1006/abbi.2000.1934; Lee BH, 2005, J BIOL CHEM, V280, P40749, DOI 10.1074/jbc.M505593200; Lemster T, 2009, EUR J MED CHEM, V44, P3235, DOI 10.1016/j.ejmech.2009.03.026; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Racane L, 2013, EUR J MED CHEM, V63, P882, DOI 10.1016/j.ejmech.2013.02.026; Rilova E, 2014, CHEMMEDCHEM, V9, P590, DOI 10.1002/cmdc.201300420; Singh V, 2013, CURR CANCER DRUG TAR, V13, P379, DOI 10.2174/15680096113139990077; Song LX, 2012, ANN HEMATOL, V91, P1879, DOI 10.1007/s00277-012-1550-y; Syeda F, 2011, J BIOL CHEM, V286, P15344, DOI 10.1074/jbc.M110.209882; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Valente S, 2014, J MED CHEM, V57, P701, DOI 10.1021/jm4012627; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Yoo J, 2012, CURR COMPUT-AID DRUG, V8, P317, DOI 10.2174/157340912803519606	26	41	42	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6293	6302		10.1074/jbc.M114.594671	http://dx.doi.org/10.1074/jbc.M114.594671			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25525263	Green Published, hybrid			2022-12-26	WOS:000350732500035
J	Macdonald, SS; Blaukopf, M; Withers, SG				Macdonald, Spencer S.; Blaukopf, Markus; Withers, Stephen G.			N-Acetylglucosaminidases from CAZy Family GH3 Are Really Glycoside Phosphorylases, Thereby Explaining Their Use of Histidine as an Acid/Base Catalyst in Place of Glutamic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; BETA-LACTAMASE INDUCTION; ESCHERICHIA-COLI; KINETIC-ANALYSIS; HYDROLASE NAGZ; IDENTIFICATION; GLUCOSIDASE; MECHANISMS; NUCLEOPHILE; ENZYMES	CAZy glycoside hydrolase family GH3 consists primarily of stereochemistry-retaining beta-glucosidases but also contains a subfamily of beta-N-acetylglucosaminidases. Enzymes from this subfamily were recently shown to use a histidine residue within a His-Asp dyad contained in a signature sequence as their catalytic acid/base residue. Reasons for their use of His rather than the Glu or Asp found in other glycosidases were not apparent. Through studies on a representative member, the Nag3 beta-N-acetylglucosaminidase from Cellulomonas fimi, we now show that these enzymes act preferentially as glycoside phosphorylases. Their need to accommodate an anionic nucleophile within the enzyme active site explains why histidine is used as an acid/base catalyst in place of the anionic glutamate seen in other GH3 family members. Kinetic and mechanistic studies reveal that these enzymes also employ a double-displacement mechanism involving a covalent glycosyl-enzyme intermediate, which was directly detected by mass spectrometry. Phosphate has no effect on the rates of formation of the glycosyl-enzyme intermediate, but it accelerates turnover of the N-acetylgluco-saminyl-enzyme intermediate similar to 3-fold, while accelerating turnover of the glucosyl-enzyme intermediate several hundredfold. These represent the first reported examples of retaining beta-glycoside phosphorylases, and the first instance of free beta-GlcNAc-1-phosphate in a biological context.	[Withers, Stephen G.] Univ British Columbia, Dept Chem, Ctr High Throughput Biol, Vancouver, BC V6T 1Z1, Canada; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z1, Canada	University of British Columbia; University of British Columbia	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, Ctr High Throughput Biol, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca		Macdonald, Spencer/0000-0001-9879-5507	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes for Health Research; Canada Foundation for Innovation; B. C. Knowledge Development Fund; Schrodinger Fellowship from the Austrian Science Fund; Canada Research Chair	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); B. C. Knowledge Development Fund; Schrodinger Fellowship from the Austrian Science Fund(Austrian Science Fund (FWF)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by the Natural Sciences and Engineering Research Council of Canada, the Canadian Institutes for Health Research, the Canada Foundation for Innovation, and the B. C. Knowledge Development Fund.; Recipient of a Schrodinger Fellowship from the Austrian Science Fund.; Supported by a Tier 1 Canada Research Chair. To whom correspondence should be addressed. Tel.: 604-822-3402; Fax: 604-822-8869; E-mail: withers@chem.ubc.ca.	Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; Balcewich MD, 2009, PROTEIN SCI, V18, P1541, DOI 10.1002/pro.137; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Burmeister WP, 2000, J BIOL CHEM, V275, P39385, DOI 10.1074/jbc.M006796200; Busca P, 1998, TETRAHEDRON LETT, V39, P8101, DOI 10.1016/S0040-4039(98)01838-3; Chan PHW, 2009, BIOCHEMISTRY-US, V48, P11220, DOI 10.1021/bi901606n; Chir J, 2002, BIOCHEM J, V365, P857, DOI 10.1042/BJ20020186; Dan S, 2000, J BIOL CHEM, V275, P4973, DOI 10.1074/jbc.275.7.4973; Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Elbein AD, 2010, J BIOL CHEM, V285, P9803, DOI 10.1074/jbc.M109.033944; IWASAKI H, 1989, J BACTERIOL, V171, P424, DOI 10.1128/jb.171.1.424-429.1989; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; Luley-Goedl C, 2010, BIOTECHNOL J, V5, P1324, DOI 10.1002/biot.201000217; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Mark BL, 2011, FUTURE MICROBIOL, V6, P1415, DOI [10.2217/FMB.11.128, 10.2217/fmb.11.128]; Mayer C, 2006, FEBS J, V273, P2929, DOI 10.1111/j.1742-4658.2006.05308.x; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Reith J, 2011, APPL MICROBIOL BIOT, V92, P1, DOI 10.1007/s00253-011-3486-x; Stubbs KA, 2013, CHEMBIOCHEM, V14, P1973, DOI 10.1002/cbic.201300395; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Vocadlo DJ, 2005, BIOCHEMISTRY-US, V44, P12809, DOI 10.1021/bi051121k; Vocadlo DJ, 2000, METH MOL B, V146, P203, DOI 10.1385/1-59259-045-4:203; Vocadlo DJ, 2000, BIOCHEMISTRY-US, V39, P1554; Vocadlo DJ, 2000, BIOCHEMISTRY-US, V39, P117, DOI 10.1021/bi991958d; VOET JG, 1970, J BIOL CHEM, V245, P1020; Votsch W, 2000, J BIOL CHEM, V275, P39032, DOI 10.1074/jbc.M004797200; WANG Q, 1995, BIOCHEMISTRY-US, V34, P14554, DOI 10.1021/bi00044a034; WANG QP, 1995, J AM CHEM SOC, V117, P10137, DOI 10.1021/ja00145a035; Watts AG, 2003, J AM CHEM SOC, V125, P7532, DOI 10.1021/ja0344967; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zechel DL, 2001, CURR OPIN CHEM BIOL, V5, P643, DOI 10.1016/S1367-5931(01)00260-5	33	33	35	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4887	4895		10.1074/jbc.M114.621110	http://dx.doi.org/10.1074/jbc.M114.621110			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25533455	hybrid, Green Published			2022-12-26	WOS:000350042000033
J	Sarveswaran, S; Chakraborty, D; Chitale, D; Sears, R; Ghosh, J				Sarveswaran, Sivalokanathan; Chakraborty, Debrup; Chitale, Dhananjay; Sears, Rosalie; Ghosh, Jagadananda			Inhibition of 5-Lipoxygenase Selectively Triggers Disruption of c-Myc Signaling in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOTRIENE BIOSYNTHESIS INHIBITOR; ARACHIDONATE 5-LIPOXYGENASE; INFLAMMATORY DISEASES; GROWTH; PROTEIN; METASTASIS; EXPRESSION; APOPTOSIS; PROLIFERATION; TARGET	Myc is up-regulated in almost all cancer types and is the subject of intense investigation because of its pleiotropic effects controlling a broad spectrum of cell functions. However, despite its recognition as a stand-alone molecular target, development of suitable strategies to block its function is hindered because of its nonenzymatic nature. We reported earlier that arachidonate 5-lipoxygenase (5-Lox) plays an important role in the survival and growth of prostate cancer cells, although details of the underlying mechanisms have yet to be characterized. By whole genome gene expression array, we observed that inhibition of 5-Lox severely down-regulates the expression of c-Myc oncogene in prostate cancer cells. Moreover, inhibition of 5-Lox dramatically decreases the protein level, nuclear accumulation, DNA binding, and transcriptional activities of c-Myc. Both the 5-Lox inhibition-induced down-regulation of c-Myc and induction of apoptosis are mitigated when the cells are treated with 5-oxoeicosatetraenoic acid, a metabolite of 5-Lox, confirming a role of 5-Lox in these processes. c-Myc is a transforming oncogene widely expressed in prostate cancer cells and maintains their transformed phenotype. Interestingly, MK591, a specific 5-Lox inhibitor, strongly affects the viability of Myc-overactivated prostate cancer cells and completely blocks their invasive and soft agar colony-forming abilities, but it spares nontransformed cells where expression of 5-Lox is undetectable. These findings indicate that the oncogenic function of c-Myc in prostate cancer cells is regulated by 5-Lox activity, revealing a novel mechanism of 5-Lox action and suggesting that the oncogenic function of c-Myc can be suppressed by suitable inhibitors of 5-Lox.	[Sarveswaran, Sivalokanathan; Chakraborty, Debrup; Ghosh, Jagadananda] Henry Ford Hlth Syst, Dept Urol, Detroit, MI 48202 USA; [Chitale, Dhananjay] Henry Ford Hlth Syst, Dept Pathol, Detroit, MI 48202 USA; [Chitale, Dhananjay; Ghosh, Jagadananda] Henry Ford Hlth Syst, Josephine Ford Canc Ctr, Detroit, MI 48202 USA; [Sears, Rosalie] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oregon Health & Science University	Ghosh, J (corresponding author), Henry Ford Hlth Syst, Dept Urol, Vattikuti Urol Inst, 1 Ford Pl,2D, Detroit, MI 48202 USA.	jghosh1@hfhs.org		Chitale, Dhananjay/0000-0002-4421-6431	National Institutes of Health from NCI [RO1 CA152334]; Department of Defense Prostate Cancer Research Program [W81-XWH-05-1-0022]; Henry Ford Health System Internal Research Grant [A10203]; NATIONAL CANCER INSTITUTE [R01CA152334] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Prostate Cancer Research Program(United States Department of Defense); Henry Ford Health System Internal Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA152334 from NCI. This work was also supported by Department of Defense Prostate Cancer Research Program W81-XWH-05-1-0022 and the Henry Ford Health System Internal Research Grant A10203 (to J. G.).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Anderson KM, 1998, PROSTATE, V37, P161, DOI 10.1002/(SICI)1097-0045(19981101)37:3<161::AID-PROS5>3.0.CO;2-D; BRIDEAU C, 1992, CAN J PHYSIOL PHARM, V70, P799, DOI 10.1139/y92-107; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 1999, MOL CELL BIOL, V19, P1; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Evan G, 2012, SCIENCE, V335, P293, DOI 10.1126/science.1217819; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Fleshner Neil, 2004, Journal of Urology, V171, pS19, DOI 10.1097/01.ju.0000107838.33623.19; FORDHUTCHINSON AW, 1994, ANNU REV BIOCHEM, V63, P383, DOI 10.1146/annurev.bi.63.070194.002123; Funk CD, 1996, BBA-LIPID LIPID MET, V1304, P65, DOI 10.1016/S0005-2760(96)00107-5; Ghosh J, 1998, P NATL ACAD SCI USA, V95, P13182, DOI 10.1073/pnas.95.22.13182; Ghosh J, 1997, BIOCHEM BIOPH RES CO, V235, P418, DOI 10.1006/bbrc.1997.6799; Ghosh J, 1999, ADV EXP MED BIOL, V469, P577; Ghosh J., 2008, CURR ENZYME INHIB, V4, P18, DOI DOI 10.2174/157340808783502540; Gil J, 2005, CANCER RES, V65, P2179, DOI 10.1158/0008-5472.CAN-03-4030; Gupta S, 2001, CANCER-AM CANCER SOC, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; Iversen PL, 2003, CLIN CANCER RES, V9, P2510; Jenkins RB, 1997, CANCER RES, V57, P524; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; KIMURA S, 1995, CANCER RES, V55, P1379; Kolonel LN, 1999, JNCI-J NATL CANCER I, V91, P414, DOI 10.1093/jnci/91.5.414; Li XN, 2013, J BIOL CHEM, V288, P18121, DOI 10.1074/jbc.M113.478560; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Matsuyama M, 2004, INT J ONCOL, V24, P821; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Moretti RM, 2004, INT J CANCER, V112, P87, DOI 10.1002/ijc.20387; NAG A, 1989, PROSTATE, V15, P115, DOI 10.1002/pros.2990150205; Nie D, 2007, FRONT BIOSCI, V12, P1574, DOI 10.2741/2170; Ochoa JJ, 2004, CARCINOGENESIS, V25, P1185, DOI 10.1093/carcin/bgh116; Pham H, 2006, PROSTAG LEUKOTR ESS, V74, P271, DOI 10.1016/j.plefa.2006.01.004; Ponzielli R, 2005, EUR J CANCER, V41, P2485, DOI 10.1016/j.ejca.2005.08.017; PRASIT P, 1993, J LIPID MEDIATOR, V6, P239; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Radmark O, 2010, BIOCHEM BIOPH RES CO, V396, P105, DOI 10.1016/j.bbrc.2010.02.173; Radmark O, 2009, J LIPID RES, V50, pS40, DOI 10.1194/jlr.R800062-JLR200; Rapp UR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006029; Rohan JNP, 2009, ENDOCRINOLOGY, V150, P2046, DOI 10.1210/en.2008-1395; Sampson AP, 2009, CURR OPIN INVEST DR, V10, P1163; Sarveswaran S, 2013, CANCER LETT, V336, P185, DOI 10.1016/j.canlet.2013.04.027; Sarveswaran S, 2011, BBA-MOL CELL RES, V1813, P2108, DOI 10.1016/j.bbamcr.2011.07.015; Sarveswaran S, 2010, CANCER LETT, V291, P167, DOI 10.1016/j.canlet.2009.10.008; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; WANG Y, 1995, J NATL CANCER I, V87, P1456, DOI 10.1093/jnci/87.19.1456; Wang YH, 2005, BREAST CANCER RES, V7, pR220, DOI 10.1186/bcr975; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Werz Oliver, 2002, Current Drug Targets - Inflammation and Allergy, V1, P23, DOI 10.2174/1568010023344959; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Yang PY, 2003, PROSTATE, V55, P281, DOI 10.1002/pros.10243; Zhang XY, 2005, P NATL ACAD SCI USA, V102, P13968, DOI 10.1073/pnas.0502330102	66	35	37	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4994	5006		10.1074/jbc.M114.599035	http://dx.doi.org/10.1074/jbc.M114.599035			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25540201	Green Published, hybrid			2022-12-26	WOS:000350042000041
J	D' Andrea, EL; Ferravante, A; Scudiero, I; Zotti, T; Reale, C; Pizzulo, M; De La Motte, LR; De Maio, C; Mazzone, P; Telesio, G; Vito, P; Stilo, R				D' Andrea, Egildo Luca; Ferravante, Angela; Scudiero, Ivan; Zotti, Tiziana; Reale, Carla; Pizzulo, Maddalena; De La Motte, Luigi Regenburgh; De Maio, Chiara; Mazzone, Pellegrino; Telesio, Gianluca; Vito, Pasquale; Stilo, Romania			The Dishevelled, EGL-10 and Pleckstrin (DEP) Domain-Containing Protein DEPDC7 Binds to CARMA2 and CARMA3 Proteins, and Regulates NF-kappa B Activation	PLOS ONE			English	Article							ESSENTIAL MODULATOR; FAMILY MEMBER; LYMPHOCYTE; BCL10; PROLIFERATION; EXPRESSION; CELLS; CARD	The molecular complexes containing BCL10, MALT1 and CARMA proteins (CBM complex) have been recently identified as a key component in the signal transduction pathways that regulate activation of Nuclear Factor kappaB (NF-kappa B) transcription factor. Herein we identified the DEP domain-containing protein DEPDC7 as cellular binding partners of CARMA2 and CARMA3 proteins. DEPDC7 displays a cytosolic distribution and its expression induces NF-kappa B activation. Conversely, shRNA-mediated abrogation of DEPDC7 results in impaired NF-kappa B activation following G protein-coupled receptors stimulation, or stimuli that require CARMA2 and CARMA3, but not CARMA1. Thus, this study identifies DEPDC7 as a CARMA interacting molecule, and provides evidence that DEPDC7 may be required to specifically convey on the CBM complex signals coming from activated G protein-coupled receptors.	[D' Andrea, Egildo Luca; Zotti, Tiziana; De La Motte, Luigi Regenburgh; Vito, Pasquale; Stilo, Romania] Univ Sannio, Dipartimento Sci & Tecnol, I-82100 Benevento, Italy; [Ferravante, Angela; Scudiero, Ivan; Reale, Carla; Pizzulo, Maddalena; De La Motte, Luigi Regenburgh; De Maio, Chiara; Mazzone, Pellegrino; Telesio, Gianluca; Vito, Pasquale] Biogem Consortium, I-83031 Ariano Irpino, AV, Italy; [Stilo, Romania] SannioTech Consortium, Benevento, Italy	University of Sannio	Vito, P (corresponding author), Univ Sannio, Dipartimento Sci & Tecnol, Via Port'Arsa 11, I-82100 Benevento, Italy.	vito@unisannio.it	vito, pasquale/ABF-5505-2020; Zotti, Tiziana/AAV-6768-2021; Reale, Carla/AAB-7939-2020; Mazzone, Pellegrino/AAC-6576-2020	Zotti, Tiziana/0000-0003-4753-116X; Reale, Carla/0000-0001-7682-4784; Mazzone, Pellegrino/0000-0002-6217-1505; scudiero, ivan/0000-0001-5559-5548; ferravante, angela/0000-0002-4932-3877; vito, pasquale/0000-0002-5721-7716				Battaglia F, 2008, J LEUKOCYTE BIOL, V83, P648, DOI 10.1189/jlb.0607349; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Consonni SV, 2014, NAT REV MOL CELL BIO, V15, P357, DOI 10.1038/nrm3791; Delekta PC, 2010, J BIOL CHEM, V285, P41432, DOI 10.1074/jbc.M110.158949; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Lee JS, 2008, SCAND J IMMUNOL, V67, P77, DOI 10.1111/j.1365-3083.2007.02040.x; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Marasco D, 2009, BIOCHEM J, V422, P553, DOI 10.1042/BJ20090055; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Scudiero I, 2014, J CELL PHYSIOL, V229, P990, DOI 10.1002/jcp.24543; Scudiero I, 2011, J CELL PHYSIOL, V226, P3121, DOI 10.1002/jcp.22667; Stilo R, 2004, J BIOL CHEM, V279, P34323, DOI 10.1074/jbc.M402244200; Stilo R, 2002, FEBS LETT, V521, P165, DOI 10.1016/S0014-5793(02)02869-7; Stilo R, 2008, J CELL SCI, V121, P1165, DOI 10.1242/jcs.021105; Sun J, 2010, WORLD J BIOL CHEM, V1, P353; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vessichelli M, 2012, J BIOL CHEM, V287, P13722, DOI 10.1074/jbc.M111.304436; Vito P, 2014, IMMUNOL LETT, V160, P102, DOI 10.1016/j.imlet.2014.02.002; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Zotti T, 2011, J BIOL CHEM, V286, P22924, DOI 10.1074/jbc.M110.215426	26	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116062	10.1371/journal.pone.0116062	http://dx.doi.org/10.1371/journal.pone.0116062			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541973	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900137
J	Ismail, S; Stokes, CA; Prestwich, EC; Roberts, RL; Juss, JK; Sabroe, I; Parker, LC				Ismail, Saila; Stokes, Clare A.; Prestwich, Elizabeth C.; Roberts, Rebecca L.; Juss, Jatinder K.; Sabroe, Ian; Parker, Lisa C.			Phosphoinositide-3 Kinase Inhibition Modulates Responses to Rhinovirus by Mechanisms that Are Predominantly Independent of Autophagy	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; VIRAL RECOGNITION; MAMMALIAN TARGET; I INTERFERON; RAPAMYCIN; PATHWAY; LY294002; VIRUS; 3-METHYLADENINE	Human rhinoviruses (HRV) are a major cause of exacerbations of airways disease. Aspects of cell signalling responses to HRV infection remain unclear, particularly with regard to signalling via PI3K, and the PI3K-dependent pathway, autophagy. We investigated the roles of PI3K and autophagy in the responses of epithelial cells to major and minor group HRV infection. The PI3K inhibitor 3-MA, commonly used to inhibit autophagy, markedly reduced HRV-induced cytokine induction. Further investigation of potential targets of 3-MA and comparison of results using this inhibitor to a panel of general and class I-selective PI3K inhibitors showed that several PI3Ks cooperatively regulate responses to HRV. Targeting by siRNA of the autophagy proteins Beclin-1, Atg7, LC3, alone or in combination, or targeting of the autophagy-specific class III PI3K had at most only modest effects on HRV-induced cell signalling as judged by induction of proinflammatory cytokine production. Our data indicate that PI3K and mTOR are involved in induction of proinflammatory cytokines after HRV infection, and that autophagy has little role in the cytokine response to HRV or control of HRV replication.	[Ismail, Saila; Stokes, Clare A.; Prestwich, Elizabeth C.; Roberts, Rebecca L.; Sabroe, Ian; Parker, Lisa C.] Univ Sheffield, Fac Med Dent & Hlth, Dept Infect & Immun, Acad Unit Resp Med, Sheffield S10 2RX, S Yorkshire, England; [Juss, Jatinder K.] Univ Cambridge, Addenbrookes & Papworth Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England	University of Sheffield; Papworth Hospital; University of Cambridge	Parker, LC (corresponding author), Univ Sheffield, Fac Med Dent & Hlth, Dept Infect & Immun, Acad Unit Resp Med, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	l.c.parker@sheffield.ac.uk	Sabroe, Ian/AAE-5858-2019; Roberts, Rebecca/J-9535-2015; Sabroe, Ian/I-5981-2013	Roberts, Rebecca/0000-0001-8231-2611; Ismail, Saila/0000-0002-5676-9893; Sabroe, Ian/0000-0001-9750-8975; Stokes, Clare/0000-0002-4076-5361	University of Sheffield; Putra University, Malaysia (UPM); Medical Research Council [MR/J010154/1]; MRC [MR/J010154/1] Funding Source: UKRI	University of Sheffield; Putra University, Malaysia (UPM); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SI was supported by a PhD studentship funded by The University of Sheffield and Putra University, Malaysia (UPM). LCP is supported by a New Investigator Research Grant from the Medical Research Council, Reference MR/J010154/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett JA, 2012, J VIROL, V86, P6595, DOI 10.1128/JVI.06755-11; Brabec-Zaruba M, 2007, J VIROL, V81, P10815, DOI 10.1128/JVI.00143-07; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Deretic V, 2012, J IMMUNOL, V189, P15, DOI 10.4049/jimmunol.1102108; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Foster FM, 2003, J CELL SCI, V116, P3037, DOI 10.1242/jcs.00609; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Hrincius ER, 2011, CELL MICROBIOL, V13, P1907, DOI 10.1111/j.1462-5822.2011.01680.x; Iwasaki A, 2007, AUTOPHAGY, V3, P354, DOI 10.4161/auto.4114; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Johnston Sebastian L, 2005, Proc Am Thorac Soc, V2, P150, DOI 10.1513/pats.200502-018AW; Juss JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045933; Klein KA, 2011, J VIROL, V85, P9651, DOI 10.1128/JVI.00316-11; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kong DX, 2010, EUR J CANCER, V46, P1111, DOI 10.1016/j.ejca.2010.01.005; Lau C, 2008, J IMMUNOL, V180, P870, DOI 10.4049/jimmunol.180.2.870; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lin YC, 2012, J IMMUNOL, V189, P4154, DOI 10.4049/jimmunol.1102739; Lu XY, 2011, MOL IMMUNOL, V48, P1417, DOI 10.1016/j.molimm.2011.03.017; Morris GE, 2006, FASEB J, V20, P2153, DOI 10.1096/fj.06-5910fje; Newcomb DC, 2008, AM J RESP CRIT CARE, V177, P1111, DOI 10.1164/rccm.200708-1243OC; Newcomb DC, 2005, J BIOL CHEM, V280, P36952, DOI 10.1074/jbc.M502449200; NOAH TL, 1995, IN VITRO CELL DEV-AN, V31, P738; Piper SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063365; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; REDDEL RR, 1988, CANCER RES, V48, P1904; Sachs LA, 2011, J VIROL METHODS, V171, P212, DOI 10.1016/j.jviromet.2010.10.027; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Stokes CA, 2011, J VIROL, V85, P7912, DOI 10.1128/JVI.02649-10; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yordy B, 2013, INT IMMUNOL, V25, P1, DOI 10.1093/intimm/dxs101; Zhao JW, 2010, MOL IMMUNOL, V48, P294, DOI 10.1016/j.molimm.2010.07.014; Zhao W, 2012, FEBS LETT, V586, P705, DOI 10.1016/j.febslet.2012.01.016	39	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116055	10.1371/journal.pone.0116055	http://dx.doi.org/10.1371/journal.pone.0116055			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541728	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000347239900136
J	Pasam, RK; Sharma, R; Walther, A; Ozkan, H; Graner, A; Kilian, B				Pasam, Raj K.; Sharma, Rajiv; Walther, Alexander; Ozkan, Hakan; Graner, Andreas; Kilian, Benjamin			Genetic Diversity and Population Structure in a Legacy Collection of Spring Barley Landraces Adapted to a Wide Range of Climates	PLOS ONE			English	Article							HORDEUM-VULGARE L.; MULTILOCUS GENOTYPE DATA; LINKAGE DISEQUILIBRIUM; EVOLUTIONARY HISTORY; MOLECULAR DIVERSITY; CULTIVATED BARLEY; ETHIOPIAN BARLEYS; ALLELIC RICHNESS; RESISTANCE GENE; POWDERY MILDEW	Global environmental change and increasing human population emphasize the urgent need for higher yielding and better adapted crop plants. One strategy to achieve this aim is to exploit the wealth of so called landraces of crop species, representing diverse traditional domesticated populations of locally adapted genotypes. In this study, we investigated a comprehensive set of 1485 spring barley landraces (LRC1485) adapted to a wide range of climates, which were selected from one of the largest genebanks worldwide. The landraces originated from 5 degrees to 62.5 degrees N and 16 degrees to 71 degrees E. The whole collection was genotyped using 42 SSR markers to assess the genetic diversity and population structure. With an average allelic richness of 5.74 and 372 alleles, LRC1485 harbours considerably more genetic diversity than the most polymorphic current GWAS panel for barley. Ten major clusters defined most of the population structure based on geographical origin, row type of the ear and caryopsis type - and were assigned to specific climate zones. The legacy core reference set LRC648 established in this study will provide a long-lasting resource and a very valuable tool for the scientific community. LRC648 is best suited for multi-environmental field testing to identify candidate genes underlying quantitative traits but also for allele mining approaches.	[Pasam, Raj K.; Sharma, Rajiv; Graner, Andreas; Kilian, Benjamin] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Genebank, Corrensstr 3, D-06466 Gatersleben, Germany; [Walther, Alexander] Univ Gothenburg, Dept Earth Sci, SE-40530 Gothenburg, Sweden; [Ozkan, Hakan] Cukurova Univ, Fac Agr, Dept Field Crops, TR-01330 Adana, Turkey	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Gothenburg; Cukurova University	Sharma, R (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Genebank, Corrensstr 3, D-06466 Gatersleben, Germany.	rajiv.sharma@hutton.ac.uk; benjamin.kilian@bayer.com	ÖZKAN, Hakan/C-8510-2011; Sharma, Rajiv/W-9683-2019	ÖZKAN, Hakan/0000-0003-3530-2626; Sharma, Rajiv/0000-0003-3488-8688; Kilian, Benjamin/0000-0002-9145-6980; Pasam, Raj/0000-0003-0908-1882; Graner, Andreas/0000-0003-3246-6393	Federal Ministry of Education and Research (BMBF), project GABI-GENOBAR [FKZ 0315066C]	Federal Ministry of Education and Research (BMBF), project GABI-GENOBAR	This work has been funded by the Federal Ministry of Education and Research (BMBF) - funded project GABI-GENOBAR (FKZ 0315066C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghani AH, 2015, GENET RESOUR CROP EV, V62, P275, DOI 10.1007/s10722-014-0152-z; Acquaah G., 2012, PRINCIPLES PLANT GEN; Alderman PD., 2013, P WORKSH MOD WHEAT R; ALLARD RW, 1992, GENETICS, V131, P957; ALLARD RW, 1972, GENETICS, V72, P489; [Anonymous], 2008, GLOBAL STRATEGY EX S, P1; Backes G, 2009, GENET RESOUR CROP EV, V56, P85, DOI 10.1007/s10722-008-9347-5; Bailey-Serres J, 2010, RICE, V3, P138, DOI 10.1007/s12284-010-9048-5; Bellucci E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083891; Bhullar NK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-88; Bhullar NK, 2009, P NATL ACAD SCI USA, V106, P9519, DOI 10.1073/pnas.0904152106; Bjornstad A, 1997, THEOR APPL GENET, V94, P514, DOI 10.1007/s001220050445; Bjornstad A, 2010, CROP SCI, V50, P1579, DOI 10.2135/cropsci2009.12.0719; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Castillo A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-266; CHAKRABORTY R, 1993, HUM BIOL, V65, P875; Comadran J, 2011, THEOR APPL GENET, V122, P1363, DOI 10.1007/s00122-011-1537-4; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Cuesta-Marcos A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-707; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dubcovsky J, 2005, MOL BREEDING, V15, P395, DOI 10.1007/s11032-005-0084-6; Escudero A, 2003, BIOL CONSERV, V113, P351, DOI 10.1016/S0006-3207(03)00122-8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fischbeck G, 2003, DEV PL GEN, V7, P29, DOI 10.1016/S0168-7972(03)80005-1; Glaszmann JC, 2010, CURR OPIN PLANT BIOL, V13, P167, DOI 10.1016/j.pbi.2010.01.004; Gong X, 2009, GENOME, V52, P849, DOI [10.1139/G09-058, 10.1139/g09-058]; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; GRANER A, 1993, THEOR APPL GENET, V86, P689, DOI 10.1007/BF00222657; Graner A, 2003, DEV PL GEN, V7, P121, DOI 10.1016/S0168-7972(03)80009-9; Hadado TT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-121; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Hamblin MT, 2010, CROP SCI, V50, P556, DOI 10.2135/cropsci2009.04.0198; Hamilton NRS., 2002, ACCESSION MANAGEMENT; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haseneyer G, 2010, PLANT BREEDING, V129, P271, DOI 10.1111/j.1439-0523.2009.01725.x; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Igartua E, 2013, GENET RESOUR CROP EV, V60, P251, DOI 10.1007/s10722-012-9831-9; Jakob SS, 2014, GENOME BIOL EVOL, V6, P685, DOI 10.1093/gbe/evu047; Jilal A, 2008, GENET RESOUR CROP EV, V55, P1221, DOI 10.1007/s10722-008-9322-1; Jones H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-320; Keilwagen J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05231; Kihara H., 1983, P 6 INT WHEAT GEN S; Kilian B, 2006, MOL GENET GENOMICS, V276, P230, DOI 10.1007/s00438-006-0136-6; Kilian B, 2014, GENET RESOUR CROP EV, V61, P89, DOI 10.1007/s10722-013-0017-x; Kilian B, 2012, BRIEF FUNCT GENOMICS, V11, P38, DOI 10.1093/bfgp/elr046; Knupffer H, 2009, PLANT GENET GENOMICS, V7, P31, DOI 10.1007/978-0-387-77489-3_2; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Lehmann CO, 1957, KULTURPFLANZE, V5, P108, DOI [10.1007/BF02095492, DOI 10.1007/BF02095492]; Leino MW, 2010, MOL BIOL EVOL, V27, P964, DOI 10.1093/molbev/msp308; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Malysheva-Otto LV, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-6; Mansfeld R, 1950, HORDEUM VULGARE L ZU, V20, P8; MAROOF MAS, 1994, P NATL ACAD SCI USA, V91, P5466, DOI 10.1073/pnas.91.12.5466; Mascher M, 2013, PLANT J, V76, P494, DOI 10.1111/tpj.12294; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; MEZAKA I, 2013, ADV BARLEY SCI, P25; Munoz-Amatriain M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094688; NEVO E, 1992, THEOR APPL GENET, V84, P958, DOI 10.1007/BF00227410; Newton AC, 2010, AGRON SUSTAIN DEV, V30, P237, DOI 10.1051/agro/2009032; Long NV, 2013, THEOR APPL GENET, V126, P2335, DOI 10.1007/s00122-013-2139-0; Orabi J, 2007, THEOR APPL GENET, V114, P1117, DOI 10.1007/s00122-007-0505-5; Pandey M, 2006, THEOR APPL GENET, V113, P715, DOI 10.1007/s00122-006-0340-0; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Pourkheirandish M, 2007, ANN BOT-LONDON, V100, P999, DOI 10.1093/aob/mcm139; Prada D, 2009, J EXP BOT, V60, P2541, DOI 10.1093/jxb/erp130; Pritchard JK, 2000, GENETICS, V155, P945; Rodriguez M, 2012, THEOR APPL GENET, V125, P171, DOI 10.1007/s00122-012-1824-8; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Russell J, 2011, NEW PHYTOL, V191, P564, DOI 10.1111/j.1469-8137.2011.03704.x; Russell JR, 2003, THEOR APPL GENET, V107, P413, DOI 10.1007/s00122-003-1261-9; Schiemann E, 1939, NATURWISSENSCHAFTEN, V27, P394, DOI 10.1007/BF01489506; SCHIEMANN E., 1943, ERGEB BIOL, V19, P409; SCHIEMANN E, 1951, J HERED, V5, P305; SCHOEN DJ, 1993, P NATL ACAD SCI USA, V90, P10623, DOI 10.1073/pnas.90.22.10623; Semenov MA, 2013, FOOD ENERGY SECUR, V2, P185, DOI 10.1002/fes3.34; Stein N, 2007, THEOR APPL GENET, V114, P823, DOI 10.1007/s00122-006-0480-2; Stracke S, 2009, THEOR APPL GENET, V118, P259, DOI 10.1007/s00122-008-0896-y; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Szucs P, 2007, MOL GENET GENOMICS, V277, P249, DOI 10.1007/s00438-006-0195-8; Taketa S, 2004, THEOR APPL GENET, V108, P1236, DOI 10.1007/s00122-003-1560-1; Taketa S, 2008, P NATL ACAD SCI USA, V105, P4062, DOI 10.1073/pnas.0711034105; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tondelli A, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0007; Tsehaye Y, 2012, EUPHYTICA, V188, P309, DOI 10.1007/s10681-012-0764-3; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Varshney RK, 2010, MOL BREEDING, V26, P229, DOI 10.1007/s11032-009-9373-9; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Ward DJ, 1962, USDA TECHNICAL B, V1276; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS., 1996, GENETIC DATA ANAL; WELTZIEN E, 1988, PLANT BREEDING, V101, P95, DOI 10.1111/j.1439-0523.1988.tb00273.x; Yahiaoui S, 2008, THEOR APPL GENET, V116, P271, DOI 10.1007/s00122-007-0665-3; Yahiaoui S, 2014, PLANT BREEDING, V133, P218, DOI 10.1111/pbr.12148; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	109	30	31	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116164	10.1371/journal.pone.0116164	http://dx.doi.org/10.1371/journal.pone.0116164			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541702	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900151
J	Lamont, EA; Wang, P; Enomoto, S; Borewicz, K; Abdallah, A; Isaacson, RE; Sreevatsan, S				Lamont, Elise A.; Wang, Ping; Enomoto, Shinichiro; Borewicz, Klaudyna; Abdallah, Ahmed; Isaacson, Richard E.; Sreevatsan, Srinand			A Combined Enrichment and Aptamer Pulldown Assay for Francisella tularensis Detection in Food and Environmental Matrices	PLOS ONE			English	Article							DNA APTAMERS; PASTEURELLA TULARENSIS; MYCOBACTERIUM-TUBERCULOSIS; SMALL INOCULA; TULAREMIA; GROWTH; ANTIBODIES; SELECTION; CELLS; MULTIPLICATION	Francisella tularensis, a Gram-negative bacterium and causative agent of tularemia, is categorized as a Class A select agent by the Centers for Disease Control and Prevention due to its ease of dissemination and ability to cause disease. Oropharyngeal and gastrointestinal tularemia may occur due to ingestion of contaminated food and water. Despite the concern to public health, little research is focused on F. tularensis detection in food and environmental matrices. Current diagnostics rely on host responses and amplification of F. tularensis genetic elements via Polymerase Chain Reaction; however, both tools are limited by development of an antibody response and limit of detection, respectively. During our investigation to develop an improved culture medium to aid F. tularensis diagnostics, we found enhanced F. tularensis growth using the spent culture filtrate. Addition of the spent culture filtrate allowed for increased detection of F. tularensis in mixed cultures of food and environmental matrices. Ultraperformance liquid chromatography (UPLC)/MS analysis identified several unique chemicals within the spent culture supernatant of which carnosine had a matching m/z ratio. Addition of 0.625 mg/mL of carnosine to conventional F. tularensis medium increased the growth of F. tularensis at low inoculums. In order to further enrich F. tularensis cells, we developed a DNA aptamer cocktail to physically separate F. tularensis from other bacteria present in food and environmental matrices. The combined enrichment steps resulted in a detection range of 1-106 CFU/mL (starting inoculums) in both soil and lettuce backgrounds. We propose that the two-step enrichment process may be utilized for easy field diagnostics and subtyping of suspected F. tularensis contamination as well as a tool to aid in basic research of F. tularensis ecology.	[Lamont, Elise A.; Wang, Ping; Abdallah, Ahmed; Sreevatsan, Srinand] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Isaacson, Richard E.; Sreevatsan, Srinand] Univ Minnesota, Dept Vet Biomed Sci, St Paul, MN 55108 USA; [Enomoto, Shinichiro] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Borewicz, Klaudyna] Wageningen Univ, Mol Ecol Grp, NL-6703 HB Wageningen, Netherlands	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Utah System of Higher Education; University of Utah; Wageningen University & Research	Sreevatsan, S (corresponding author), Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA.	sreev001@umn.edu	Sreevatsan, Srinand/V-6808-2019	Sreevatsan, Srinand/0000-0002-5162-2403; Lamont, Elise/0000-0001-7085-9740	Department of Homeland Security's National Center for Food Protection and Defense [3002-11364-00022511]	Department of Homeland Security's National Center for Food Protection and Defense	This study was funded by the Department of Homeland Security's National Center for Food Protection and Defense (#3002-11364-00022511) awarded to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; Antwerpen MH, 2013, GENOME ANNOUNC, V1; BEVANGER L, 1988, J CLIN MICROBIOL, V26, P433, DOI 10.1128/JCM.26.3.433-437.1988; BEVANGER L, 1994, CLIN DIAGN LAB IMMUN, V1, P238, DOI 10.1128/CDLI.1.2.238-240.1994; Broekhuijsen M, 2003, J CLIN MICROBIOL, V41, P2924, DOI 10.1128/JCM.41.7.2924-2931.2003; Brombacher E, 2003, MICROBIOL-SGM, V149, P2847, DOI 10.1099/mic.0.26306-0; Chang YC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01863; Chaudhuri RR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000352; Day JB, 2009, FOOD MICROBIOL, V26, P932, DOI 10.1016/j.fm.2009.06.005; Day JB, 2009, J FOOD PROTECT, V72, P1156, DOI 10.4315/0362-028X-72.6.1156; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Duan N, 2013, J MICROBIOL METHODS; Egan JR, 2011, BIOSECUR BIOTERROR, V9, P331, DOI 10.1089/bsp.2011.0004; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Foley JE, 2010, VET MICROBIOL, V140, P332, DOI 10.1016/j.vetmic.2009.07.017; Fulop M, 1996, AM J TROP MED HYG, V54, P364, DOI 10.4269/ajtmh.1996.54.364; Gill V, 1997, Semin Respir Infect, V12, P61; Gold L, 1995, Harvey Lect, V91, P47; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; HALMANN M, 1967, J GEN MICROBIOL, V49, P461, DOI 10.1099/00221287-49-3-461; HALMANN M, 1967, J GEN MICROBIOL, V49, P451, DOI 10.1099/00221287-49-3-451; Hartnett E, 2009, RISK ANAL, V29, P1506, DOI 10.1111/j.1539-6924.2009.01286.x; Hennessy DA, 2008, BIOSECUR BIOTERROR, V6, P66, DOI 10.1089/bsp.2007.0016; Humrighouse BW, 2011, APPL ENVIRON MICROB, V77, P6729, DOI 10.1128/AEM.05226-11; Joshi R, 2009, MOL CELL PROBE, V23, P20, DOI 10.1016/j.mcp.2008.10.006; Lamont EA, 2011, ANALYST, V136, P3884, DOI 10.1039/c1an15352h; Martin-Serradilla JI, 2004, REV CLIN ESP, V204, P351, DOI 10.1157/13063525; MASSEY ED, 1974, APPL MICROBIOL, V27, P25, DOI 10.1128/AEM.27.1.25-27.1974; MERRIOTT J, 1961, J INFECT DIS, V108, P136, DOI 10.1093/infdis/108.2.136; Mukamolova GV, 1999, ARCH MICROBIOL, V172, P9, DOI 10.1007/s002030050733; Ojeda SS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-215; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Petersen JM, 2009, LETT APPL MICROBIOL, V48, P663, DOI 10.1111/j.1472-765X.2009.02589.x; Petrosino JF, 2006, J BACTERIOL, V188, P6977, DOI 10.1128/JB.00506-06; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; Sharma N, 2013, CLIN VACCINE IMMUNOL, V20, P9, DOI 10.1128/CVI.00516-12; Shleeva MO, 2002, MICROBIOL-SGM, V148, P1581, DOI 10.1099/00221287-148-5-1581; Sridhar S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-598; STORRS EE, 1974, SCIENCE, V183, P851, DOI 10.1126/science.183.4127.851; Sun ZH, 1999, J BACTERIOL, V181, P7626, DOI 10.1128/JB.181.24.7626-7628.1999; TIAN Y, 1995, RNA, V1, P317; Versage JL, 2003, J CLIN MICROBIOL, V41, P5492, DOI 10.1128/JCM.41.12.5492-5499.2003; Vivekananda J, 2006, LAB INVEST, V86, P610, DOI 10.1038/labinvest.3700417; Wang P, 2011, EXP BIOL MED, V236, P466, DOI 10.1258/ebm.2011.010323; Whitehouse CA, 2012, LETT APPL MICROBIOL, V54, P313, DOI 10.1111/j.1472-765X.2012.03214.x; Wilke A, 2009, J MED MICROBIOL, V58, P112, DOI 10.1099/jmm.0.002279-0; Wongphatcharachai M, 2013, J CLIN MICROBIOL, V51, P46, DOI 10.1128/JCM.02118-12; Zelada-Guillen GA, 2009, ANGEW CHEM INT EDIT, V48, P7334, DOI 10.1002/anie.200902090	50	14	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114622	10.1371/journal.pone.0114622	http://dx.doi.org/10.1371/journal.pone.0114622			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536105	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300018
J	Ono, YJ; Tanabe, A; Nakamura, Y; Yamamoto, H; Hayashi, A; Tanaka, T; Sasaki, H; Hayashi, M; Terai, Y; Ohmichi, M				Ono, Yoshihiro J.; Tanabe, Akiko; Nakamura, Yoko; Yamamoto, Hikaru; Hayashi, Atsushi; Tanaka, Tomohito; Sasaki, Hiroshi; Hayashi, Masami; Terai, Yoshito; Ohmichi, Masahide			A Low-Testosterone State Associated with Endometrioma Leads to the Apoptosis of Granulosa Cells	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; IN-VITRO FERTILIZATION; GROWTH-FACTOR-I; ANDROGEN RECEPTOR; OOCYTE MATURATION; TRANSCRIPTION FACTOR; OVARIAN RESERVE; POOR RESPONDERS; GENE-EXPRESSION; BIM	Although endometriosis is suspected to be a cause of premature ovarian insufficiency (POI), the mechanism(s) underlying this process have not been elucidated. Recently, androgens were shown to promote oocyte maturation and to play a role in folliculogenesis. In addition, several reports have documented low testosterone levels in the follicular fluid obtained from endometriosis patients. We therefore examined whether the low levels of serum that testosterone inhibited apoptosis induced by sex steroids depletion via the PI3K/Akt-FoxO3a pathway in the COV434 cells. In conclusion, we elucidated the mechanism underlying the anti- apoptotic effects of testosterone on granulosa cells, and found that a low- testosterone status is a potentially important step in the development of premature ovarian insufficiency in patients with endometriosis.	[Ono, Yoshihiro J.; Tanabe, Akiko; Nakamura, Yoko; Yamamoto, Hikaru; Hayashi, Atsushi; Tanaka, Tomohito; Sasaki, Hiroshi; Hayashi, Masami; Terai, Yoshito; Ohmichi, Masahide] Osaka Med Coll, Dept Obstet & Gynecol, Osaka, Japan	Osaka Medical College	Tanabe, A (corresponding author), Osaka Med Coll, Dept Obstet & Gynecol, Osaka, Japan.	gyn074@poh.osaka-med.ac.jp		tanaka, tomohito/0000-0003-4210-701X	JSPS KAKENHI [21592117]; Grants-in-Aid for Scientific Research [26861347] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (Grant Number 21592117 to AT; http://www.mhlw.go.jp/english/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERIESZ C, 1995, HUM REPROD, V10, P2377; Bono Y, 2012, BRIT J CANCER, V106, P1205, DOI 10.1038/bjc.2012.26; Bosdou JK, 2012, HUM REPROD UPDATE, V18, P127, DOI 10.1093/humupd/dmr051; Brosens I, 2004, FERTIL STERIL, V81, P1198, DOI 10.1016/j.fertnstert.2003.09.071; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardenas H, 2002, REPRODUCTION, V123, P527, DOI 10.1530/rep.0.1230527; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; EPPIG JJ, 1983, DEV BIOL, V100, P39, DOI 10.1016/0012-1606(83)90198-7; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Evsen MS, 2014, CLIN EXP OBSTET GYN, V41, P432; Fang ZJ, 2002, J CLIN ENDOCR METAB, V87, P3460, DOI 10.1210/jc.87.7.3460; Gill A, 2004, MOL ENDOCRINOL, V18, P97, DOI 10.1210/me.2003-0326; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007; Hammes SR, 2004, MOL ENDOCRINOL, V18, P769, DOI 10.1210/me.2003-0317; Hansen KR, 2012, MENOPAUSE, V19, P164, DOI 10.1097/gme.0b013e31823b0b2e; Havelock JC, 2004, MOL CELL ENDOCRINOL, V228, P67, DOI 10.1016/j.mce.2004.04.018; HIRAI M, 1994, J STEROID BIOCHEM, V49, P1, DOI 10.1016/0960-0760(94)90294-1; Hsu SY, 1996, ENDOCRINOLOGY, V137, P4837, DOI 10.1210/en.137.11.4837; Hu YC, 2004, P NATL ACAD SCI USA, V101, P11209, DOI 10.1073/pnas.0404372101; HUGHES EG, 1993, FERTIL STERIL, V59, P963; Hwu YM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-80; Jamnongjit M, 2005, SEMIN REPROD MED, V23, P234, DOI 10.1055/s-2005-872451; Jamnongjit M, 2005, P NATL ACAD SCI USA, V102, P16257, DOI 10.1073/pnas.0508521102; Johnson AL, 1999, ENDOCRINOLOGY, V140, P4521, DOI 10.1210/en.140.10.4521; Juengel JL, 2006, REPRODUCTION, V131, P81, DOI 10.1530/rep.1.00704; Kaipia A, 1997, ANNU REV PHYSIOL, V59, P349, DOI 10.1146/annurev.physiol.59.1.349; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; Kim CH, 2011, FERTIL STERIL, V95, P679, DOI 10.1016/j.fertnstert.2010.07.1077; Liu L, 2007, DEVELOPMENT, V134, P199, DOI 10.1242/dev.02667; Lu Q, 2014, J ASSIST REPROD GEN, V31, P485, DOI 10.1007/s10815-014-0186-3; Massin N, 2006, HUM REPROD, V21, P1204, DOI 10.1093/humrep/dei481; Nielsen ME, 2011, MOL HUM REPROD, V17, P63, DOI 10.1093/molehr/gaq073; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Olivennes F, 2003, J Gynecol Obstet Biol Reprod (Paris), V32, pS45; Pellicer A, 1998, FERTIL STERIL, V69, P1135, DOI 10.1016/S0015-0282(98)00085-5; RATTS VS, 1995, ENDOCRINOLOGY, V136, P3665, DOI 10.1210/en.136.8.3665; Sasson IE, 2008, ANN NY ACAD SCI, V1127, P106, DOI 10.1196/annals.1434.014; Shiina H, 2006, P NATL ACAD SCI USA, V103, P224, DOI 10.1073/pnas.0506736102; Soules Michael R., 2001, Fertility and Sterility, V76, P874, DOI 10.1016/S0015-0282(01)02909-0; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Steckler T, 2005, ENDOCRINOLOGY, V146, P3185, DOI 10.1210/en.2004-1444; Toya M, 2000, FERTIL STERIL, V73, P344, DOI 10.1016/S0015-0282(99)00507-5; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Vendola K, 1999, HUM REPROD, V14, P2328, DOI 10.1093/humrep/14.9.2328; Vendola K, 1999, BIOL REPROD, V61, P353, DOI 10.1095/biolreprod61.2.353; Wang XL, 2012, J BIOL CHEM, V287, P10166, DOI 10.1074/jbc.M111.293274; Zeitoun K, 1999, MOL ENDOCRINOL, V13, P239, DOI 10.1210/me.13.2.239; Zeitoun KM, 1999, FERTIL STERIL, V72, P961, DOI 10.1016/S0015-0282(99)00393-3; Zhang H, 2000, MOL HUM REPROD, V6, P146, DOI 10.1093/molehr/6.2.146	51	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115618	10.1371/journal.pone.0115618	http://dx.doi.org/10.1371/journal.pone.0115618			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536335	gold, Green Published, Green Submitted			2022-12-26	WOS:000348563300056
J	Hossain, GS; Li, JH; Shin, HD; Du, GC; Wang, M; Liu, L; Chen, J				Hossain, Gazi Sakir; Li, Jianghua; Shin, Hyun-dong; Du, Guocheng; Wang, Miao; Liu, Long; Chen, Jian			One-Step Biosynthesis of alpha-Keto-gamma-Methylthiobutyric Acid from L-Methionine by an Escherichia coli Whole-Cell Biocatalyst Expressing an Engineered L-Amino Acid Deaminase from Proteus vulgaris	PLOS ONE			English	Article							ANTIBACTERIAL PROTEIN; KETOGLUTARIC ACID; GLUTAMIC-ACID; PURIFICATION; APOPTOSIS; MEDIATOR	alpha-Keto-gamma-methylthiobutyric acid (KMTB), a keto derivative of L-methionine, has great potential for use as an alternative to L-methionine in the poultry industry and as an anti-cancer drug. This study developed an environment friendly process for KMTB production from L-methionine by an Escherichia coli whole-cell biocatalyst expressing an engineered L-amino acid deaminase (L-AAD) from Proteus vulgaris. We first overexpressed the P. vulgaris L-AAD in E. coli BL21 (DE3) and further optimized the whole-cell transformation process. The maximal molar conversion ratio of L-methionine to KMTB was 71.2% (mol/mol) under the optimal conditions (70 g/L L-methionine, 20 g/L whole-cell biocatalyst, 5 mM CaCl2, 40 degrees C, 50 mM Tris-HCl [pH 8.0]). Then, error-prone polymerase chain reaction was used to construct P. vulgaris L-AAD mutant libraries. Among approximately 10(4) mutants, two mutants bearing lysine 104 to arginine and alanine 337 to serine substitutions showed 82.2% and 80.8% molar conversion ratios, respectively. Furthermore, the combination of these mutations enhanced the catalytic activity and molar conversion ratio by 1.3-fold and up to 91.4% with a KMTB concentration of 63.6 g/L. Finally, the effect of immobilization on whole-cell transformation was examined, and the immobilized whole-cell biocatalyst with Ca2+ alginate increased reusability by 41.3% compared to that of free cell production. Compared with the traditional multi-step chemical synthesis, our one-step biocatalytic production of KMTB has an advantage in terms of environmental pollution and thus has great potential for industrial KMTB production.	[Hossain, Gazi Sakir; Li, Jianghua; Du, Guocheng; Liu, Long] Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Peoples R China; [Li, Jianghua; Du, Guocheng; Liu, Long; Chen, Jian] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China; [Li, Jianghua; Du, Guocheng; Liu, Long; Chen, Jian] Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China; [Shin, Hyun-dong] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Hossain, Gazi Sakir; Wang, Miao] Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; University System of Georgia; Georgia Institute of Technology; Jiangnan University	Wang, M (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Peoples R China.	mwang@jiangnan.edu.cn; longliu@jiangnan.edu.cn	li, jianghua/GXG-4735-2022; Hossain, Gazi Sakir/AAE-5391-2020		Ministry of Science and Technology [2012AA022202]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1135]; National High Technology Research and Development Program of China (863 Program) [2014AA021201]; Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 Project [111-2-06]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 Project(Ministry of Education, China - 111 Project)	This work was financially supported by the Ministry of Science and Technology (2012AA022202), the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT1135), the National High Technology Research and Development Program of China (863 Program, 2014AA021201), the Priority Academic Program Development of Jiangsu Higher Education Institutions, and the 111 Project (111-2-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dilger RN, 2007, J NUTR, V137, P1868, DOI 10.1093/jn/137.8.1868; DODEVSKI I, 2011, ENG INTEGRAL MEMBRAN, P277; Garcia-Garcia M, 2008, BIOTECHNOL PROGR, V24, P187, DOI 10.1021/bp0702424; Hossain GS, 2014, J BIOTECHNOL, V169, P112, DOI 10.1016/j.jbiotec.2013.10.026; James SG, 1996, APPL ENVIRON MICROB, V62, P2783, DOI 10.1128/AEM.62.8.2783-2788.1996; Liu L, 2013, J BIOTECHNOL, V164, P97, DOI 10.1016/j.jbiotec.2013.01.005; Lucas-Elio P, 2005, BBA-GEN SUBJECTS, V1721, P193, DOI 10.1016/j.bbagen.2004.11.002; NAM KC, 1995, J LABELLED COMPD RAD, V36, P431, DOI 10.1002/jlcr.2580360505; Pantaleone DP, 2001, J MOL CATAL B-ENZYM, V11, P795, DOI 10.1016/S1381-1177(00)00155-7; Quash G, 2009, CURR MED CHEM, V16, P3686, DOI 10.2174/092986709789104966; QUASH G, 1995, BIOCHEM J, V305, P1017, DOI 10.1042/bj3051017; Quash G, 2004, B CANC, V91, P61; Rey P, 2010, US Pat, Patent No. [US20100178380A1, 20100178380]; Subhi AL, 2003, J BIOL CHEM, V278, P49868, DOI 10.1074/jbc.M308451200; Takahashi E, 1999, BIOSCI BIOTECH BIOCH, V63, P2244, DOI 10.1271/bbb.63.2244	15	27	32	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114291	10.1371/journal.pone.0114291	http://dx.doi.org/10.1371/journal.pone.0114291			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531756	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845100012
J	Jiang, L; Li, JY; Shen, C; Yang, SC; Han, ZG				Jiang, Li; Li, Jingyu; Shen, Chao; Yang, Sicong; Han, Zhangang			Obstacle Optimization for Panic Flow - Reducing the Tangential Momentum Increases the Escape Speed	PLOS ONE			English	Article							DYNAMICS; CROWD; EVACUATION; SIMULATION; DESIGN; MODELS	A disastrous form of pedestrian behavior is a stampede occurring in an event involving a large crowd in a panic situation. To deal with such stampedes, the possibility to increase the outflow by suitably placing a pillar or some other shaped obstacles in front of the exit has been demonstrated. We present a social force based genetic algorithm to optimize the best design of architectural entities to deal with large crowds. Unlike existing literature, our simulation results indicate that appropriately placing two pillars on both sides but not in front of the door can maximize the escape efficiency. Human experiments using 80 participants correspond well with the simulations. We observed a peculiar property named tangential momentum, the escape speed and the tangential momentum are found to be negatively correlated. The idea to reduce the tangential momentum has practical implications in crowd architectural design.	[Jiang, Li; Li, Jingyu; Shen, Chao; Yang, Sicong; Han, Zhangang] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China; [Li, Jingyu] Chinese Acad Sci, Inst Policy & Management, Beijing 100190, Peoples R China; [Shen, Chao] Natl Univ Denfense Technol, Coll Informat Syst & Management, Changsha 410073, Hunan, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; CAS Institutes of Science & Development; National University of Defense Technology - China	Han, ZG (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	zhan@bnu.edu.cn	Li, Jingyu/GSD-1924-2022	Yang, Sicong/0000-0003-3339-1549	China National Natural Science Foundation [61074116, 61374165, 31261160495]; Fundamental Research Funds for the Central Universities of China; BNU State Key Laboratory of ESPRE [2012-TDZY-21]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); BNU State Key Laboratory of ESPRE	This research is supported by China National Natural Science Foundation grants 61074116, 61374165 and 31261160495, as well as the Fundamental Research Funds for the Central Universities of China. This work was also supported by BNU State Key Laboratory of ESPRE (2012-TDZY-21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Marroquin F, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.020301; Batty M, 2003, INT J GEOGR INF SCI, V17, P673, DOI 10.1080/1365881031000135474; Escobar R, 2003, LECT NOTES ARTIF INT, V2801, P97; Frank GA, 2011, PHYSICA A, V390, P2135, DOI 10.1016/j.physa.2011.01.015; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D., 1992, Complex Systems, V6, P391; Helbing D, 2002, PEDESTRIAN AND EVACUATION DYNAMICS, P21; Helbing D., 2009, PEDESTRIAN CROWD EVA; Helbing D, 2014, ARXIV14027011; Hoogendoorn SP, 2003, LECT NOTES COMPUTATI, V32, P275, DOI DOI 10.1007/978-3-662-07969-027; Hughes RL, 2003, ANNU REV FLUID MECH, V35, P169, DOI 10.1146/annurev.fluid.35.101101.161136; Hughes RL, 2002, TRANSPORT RES B-METH, V36, P507, DOI 10.1016/S0191-2615(01)00015-7; Johansson Anders, 2007, PEDESTRIAN EVACUATIO, P267, DOI DOI 10.1007/978-3-540-47064-9; Johanssons A, 2007, ADV COMPLEX SYST, p[10, 271], DOI DOI 10.1142/S0219525907001355; Kallus N, 2014, ARXIV14022308; Kirchner A, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/10/P10011; Kirkland JA, 2003, IEEE SYS MAN CYBERN, P4328; Klupfel H, 2003, TRAFFIC AND GRANULAR FLOW'01, P549; LOVAS GG, 1994, TRANSPORT RES B-METH, V28, P429, DOI 10.1016/0191-2615(94)90013-2; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Schadschneider A., 2001, CONDMAT0112117 ARXIV; Shiwakoti N, 2014, SAFETY SCI, V66, P1, DOI 10.1016/j.ssci.2014.01.010; Shiwakoti N, 2013, TRANSPORT RES C-EMER, V37, P260, DOI 10.1016/j.trc.2013.04.009; Shukla PK, 2009, LECT NOTES ARTIF INT, V5865, P22, DOI 10.1007/978-3-642-10427-5_3; SRINIVAS M, 1994, IEEE T SYST MAN CYB, V24, P656, DOI 10.1109/21.286385; Willis A, 2000, P SEM K EUR TRANSP C, V445; Wright A, 1990, F GENETIC ALGORITHMS, P205; Yanagisawa Daichi, 2010, SICE Journal of Control, Measurement, and System Integration, V3, P395, DOI 10.9746/jcmsi.3.395; Yang XL, 2011, PHYSICA A, V390, P2375, DOI 10.1016/j.physa.2010.10.019; Yu WJ, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026112; Zheng Y, 2011, PHYSICA A, V390, P3147, DOI 10.1016/j.physa.2011.04.011; Zhou D, 2012, THEOR COMPUT SCI, V436, P106, DOI 10.1016/j.tcs.2012.01.010; Zuriguel I, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.278001	34	36	37	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115463	10.1371/journal.pone.0115463	http://dx.doi.org/10.1371/journal.pone.0115463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531676	Green Submitted, gold, Green Published			2022-12-26	WOS:000348845100071
J	Silambarasan, T; Manivannan, J; Priya, MK; Suganya, N; Chatterjee, S; Raja, B				Silambarasan, Thangarasu; Manivannan, Jeganathan; Priya, Mani Krishna; Suganya, Natarajan; Chatterjee, Suvro; Raja, Boobalan			Sinapic Acid Prevents Hypertension and Cardiovascular Remodeling in Pharmacological Model of Nitric Oxide Inhibited Rats	PLOS ONE			English	Article							MYOCARDIAL INFARCTED RATS; OXIDATIVE STRESS; CARDIAC-HYPERTROPHY; GENE-EXPRESSION; DIASTOLIC DYSFUNCTION; CLINICAL-IMPLICATIONS; ENDOTHELIAL-CELLS; HYDROGEN-PEROXIDE; S-NITROSYLATION; ANGIOTENSIN-II	Objectives: Hypertensive heart disease is a constellation of abnormalities that includes cardiac fibrosis in response to elevated blood pressure, systolic and diastolic dysfunction. The present study was undertaken to examine the effect of sinapic acid on high blood pressure and cardiovascular remodeling. Methods: An experimental hypertensive animal model was induced by L-NAME intake on rats. Sinapic acid (SA) was orally administered at a dose of 10, 20 and 40 mg/kg body weight (b.w.). Blood pressure was measured by tail cuff plethysmography system. Cardiac and vascular function was evaluated by Langendorff isolated heart system and organ bath studies, respectively. Fibrotic remodeling of heart and aorta was assessed by histopathologic analyses. Oxidative stress was measured by biochemical assays. mRNA and protein expressions were assessed by RT-qPCR and western blot, respectively. In order to confirm the protective role of SA on endothelial cells through its antioxidant property, we have utilized the in vitro model of H2O2-induced oxidative stress in EA.hy926 endothelial cells. Results: Rats with hypertension showed elevated blood pressure, declined myocardial performance associated with myocardial hypertrophy and fibrosis, diminished vascular response, nitric oxide (NO) metabolites level, elevated markers of oxidative stress (TBARS, LOOH), ACE activity, depleted antioxidant system (SOD, CAT, GPx, reduced GSH), aberrant expression of TGF-beta, beta-MHC, eNOS mRNAs and eNOS protein. Remarkably, SA attenuated high blood pressure, myocardial, vascular dysfunction, cardiac fibrosis, oxidative stress and ACE activity. Level of NO metabolites, antioxidant system, and altered gene expression were also repaired by SA treatment. Results of in vitro study showed that, SA protects endothelial cells from oxidative stress and enhance the production of NO in a concentration dependent manner. Conclusions: Taken together, these results suggest that SA may have beneficial role in the treatment of hypertensive heart disease by attenuating fibrosis and oxidative stress through its antioxidant potential.	[Silambarasan, Thangarasu; Manivannan, Jeganathan; Raja, Boobalan] Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Cardiovasc Biol Lab, Annamalainagar 608002, Tamil Nadu, India; [Manivannan, Jeganathan; Priya, Mani Krishna; Suganya, Natarajan; Chatterjee, Suvro] Anna Univ, AU KBC Res Ctr, Vasc Biol Lab, Chennai 600025, Tamil Nadu, India; [Chatterjee, Suvro] Anna Univ, Dept Biotechnol, Chennai 600025, Tamil Nadu, India	Annamalai University; Anna University; Anna University Chennai; Anna University; Anna University Chennai	Raja, B (corresponding author), Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Cardiovasc Biol Lab, Annamalainagar 608002, Tamil Nadu, India.	drrajaau@gmail.com	Raja, B./Z-1358-2019; Natarajan, Suganya/CAH-2845-2022	Raja, B./0000-0003-0685-4931; Natarajan, Suganya/0000-0002-9976-5403; Jeganathan, Manivannan/0000-0003-3948-0155				Andreasen MF, 2001, J AGR FOOD CHEM, V49, P4090, DOI 10.1021/jf0101758; Attia DM, 2001, J AM SOC NEPHROL, V12, P2585, DOI 10.1681/ASN.V12122585; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; BOLUYT MO, 1994, CIRC RES, V75, P23, DOI 10.1161/01.RES.75.1.23; Cataliotti A, 2011, CIRCULATION, V123, P1297, DOI 10.1161/CIRCULATIONAHA.110.981720; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Colonna VD, 2002, EUR J PHARMACOL, V450, P61; Diez J, 2002, CIRCULATION, V105, P2512, DOI 10.1161/01.CIR.0000017264.66561.3D; Dikalov SI, 2013, AM J PHYSIOL-HEART C, V305, pH1417, DOI 10.1152/ajpheart.00089.2013; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fang WT, 2010, ACTA PHARMACOL SIN, V31, P485, DOI 10.1038/aps.2010.23; Fenning A, 2005, AM J PHYSIOL-HEART C, V289, pH1408, DOI 10.1152/ajpheart.00140.2005; Galderisi M, 2008, J CARDIOVASC PHARM, V51, P523, DOI 10.1097/FJC.0b013e31817751a7; Hiremath P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097424; Jia LQ, 2012, J ETHNOPHARMACOL, V143, P100, DOI 10.1016/j.jep.2012.06.007; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Juranek I, 2005, GEN PHYSIOL BIOPHYS, V24, P263; Kai H, 2006, HYPERTENS RES, V29, P711, DOI 10.1291/hypres.29.711; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kanchana G., 2011, GLOB J PHARM, V5, P33; Kazakov A, 2013, CARDIOVASC RES, V100, P211, DOI 10.1093/cvr/cvt181; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Kumar S., 2010, INT J RES PHARM SCI, V1, P300, DOI [10.1002/cbf.1331, DOI 10.1002/CBF.1331]; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048872; Li YQ, 2013, ACTA PHARMACOL SIN, V34, P352, DOI 10.1038/aps.2012.164; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Majithiya JB, 2005, CARDIOVASC RES, V66, P150, DOI 10.1016/j.cardiores.2004.12.025; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Mapanga RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047322; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Maytin M, 2004, CIRCULATION, V109, P1168, DOI 10.1161/01.CIR.0000117229.60628.2F; Morrell CN, 2005, P NATL ACAD SCI USA, V102, P3782, DOI 10.1073/pnas.0408310102; Murdoch CE, 2006, CARDIOVASC RES, V71, P208, DOI 10.1016/j.cardiores.2006.03.016; NIEHAUS WG, 1968, EUR J BIOCHEM, V6, P126, DOI 10.1111/j.1432-1033.1968.tb00428.x; Pandya K, 2011, CIRC RES, V109, P609, DOI 10.1161/CIRCRESAHA.111.252619; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Pari L, 2011, CHEM-BIOL INTERACT, V194, P40, DOI 10.1016/j.cbi.2011.08.004; Rodrigo R, 2013, DIS MARKERS, V2013, P773, DOI 10.1155/2013/974358; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Roy SJ, 2013, EUR J PHARMACOL, V699, P213, DOI 10.1016/j.ejphar.2012.11.012; Roy SJ, 2012, FOOD CHEM TOXICOL, V50, P3984, DOI 10.1016/j.fct.2012.08.017; Sabri A, 2003, ANTIOXID REDOX SIGN, V5, P731, DOI 10.1089/152308603770380034; Saravanakumar M, 2011, EUR J PHARMACOL, V671, P87, DOI 10.1016/j.ejphar.2011.08.052; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Senthil SS, 2004, CLIN CHIM ACTA, V348, P131, DOI 10.1016/j.cccn.2004.05.004; Seymour EM, 2008, J GERONTOL A-BIOL, V63, P1034, DOI 10.1093/gerona/63.10.1034; Sharma DK, 2012, EUR J PHARMACOL, V691, P198, DOI 10.1016/j.ejphar.2012.07.022; Siamwala JH, 2013, J NUTR BIOCHEM, V24, P595, DOI 10.1016/j.jnutbio.2012.02.016; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Sukumaran SV, 2013, PHARMACOL RES, V78, P18, DOI 10.1016/j.phrs.2013.09.005; Susic D, 2007, AM J PHYSIOL-HEART C, V292, pH175, DOI 10.1152/ajpheart.00660.2006; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Tawfik HE, 2008, AM J PHYSIOL-HEART C, V295, pH1736, DOI 10.1152/ajpheart.87.2008; Xu HB, 2007, VASC PHARMACOL, V47, P18, DOI 10.1016/j.vph.2007.03.002; Zhang Y, 2014, HYPERTENS RES, V37, P43, DOI 10.1038/hr.2013.119; Zhao WY, 2008, MOL CELL BIOCHEM, V317, P43, DOI 10.1007/s11010-008-9803-8; Zobali F, 2001, PHARMACOLOGY, V63, P58, DOI 10.1159/000056113; Zou YN, 2002, J AGR FOOD CHEM, V50, P5884, DOI 10.1021/jf020496z	61	64	66	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115682	10.1371/journal.pone.0115682	http://dx.doi.org/10.1371/journal.pone.0115682			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531679	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100092
J	Anderson, DEJ; Glynn, JJ; Song, HK; Hinds, MT				Anderson, Deirdre E. J.; Glynn, Jeremy J.; Song, Howard K.; Hinds, Monica T.			Engineering an Endothelialized Vascular Graft: A Rational Approach to Study Design in a Non-Human Primate Model	PLOS ONE			English	Article							IN-VITRO ENDOTHELIALIZATION; FLUID SHEAR-STRESS; PROGENITOR CELLS; NEOINTIMAL HYPERPLASIA; GROWTH-FACTOR; EPTFE GRAFTS; INTIMAL HYPERPLASIA; THROMBUS FORMATION; OUTGROWTH CELLS; MECHANISMS	After many years of research, small diameter, synthetic vascular grafts still lack the necessary biologic integration to perform ideally in clinical settings. Endothelialization of vascular grafts has the potential to improve synthetic graft function, and endothelial outgrowth cells (EOCs) are a promising autologous cell source. Yet no work has established the link between endothelial cell functions and outcomes of implanted endothelialized grafts. This work utilized steady flow, oscillatory flow, and tumor necrosis factor stimulation to alter EOC phenotype and enable the formulation of a model to predict endothelialized graft performance. To accomplish this, EOC in vitro expression of coagulation and inflammatory markers was quantified. In parallel, in non-human primate (baboon) models, the platelet and fibrinogen accumulation on endothelialized grafts were quantified in an ex vivo shunt, or the tissue ingrowth on implanted grafts were characterized after 1mth. Oscillatory flow stimulation of EOCs increased in vitro coagulation markers and ex vivo platelet accumulation. Steady flow preconditioning did not affect platelet accumulation or intimal hyperplasia relative to static samples. To determine whether in vitro markers predict implant performance, a linear regression model of the in vitro data was fit to platelet accumulation data-correlating the markers with the thromboprotective performance of the EOCs. The model was tested against implant intimal hyperplasia data and found to correlate strongly with the parallel in vitro analyses. This research defines the effects of flow preconditioning on EOC regulation of coagulation in clinical vascular grafts through parallel in vitro, ex vivo, and in vivo analyses, and contributes to the translatability of in vitro tests to in vivo clinical graft performance.	[Anderson, Deirdre E. J.; Glynn, Jeremy J.; Hinds, Monica T.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Song, Howard K.] Oregon Hlth & Sci Univ, Div Cardiothorac Surg, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Hinds, MT (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA.	hindsm@ohsu.edu		Glynn, Jeremy/0000-0003-1961-9121	National Institutes of Health (NIH) [R01HL095474, R01HL103728]; NIH grant for the operation of the Oregon National Primate Research Center [OD011092]; National Science Foundation [DGE-0925180]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095474, R01HL103728] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant for the operation of the Oregon National Primate Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by National Institutes of Health (NIH, http://www.nih.gov/) grants R01HL095474 and R01HL103728. It was also supported by NIH grant OD011092 for the operation of the Oregon National Primate Research Center and by National Science Foundation (www.nsf.gov) Graduate Research Fellowship DGE-0925180 for JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmann KA, 2011, TISSUE ENG PT A, V17, P2511, DOI [10.1089/ten.tea.2011.0055, 10.1089/ten.TEA.2011.0055]; Anderson DEJ, 2011, ANN BIOMED ENG, V39, P2329, DOI 10.1007/s10439-011-0352-z; Anderson DEJ, 2014, CELLS TISSU IN PRESS; Ankeny RF, 2013, TISSUE ENG PT A, V19, P1573, DOI [10.1089/ten.tea.2012.0300, 10.1089/ten.TEA.2012.0300]; BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brown MA, 2009, TISSUE ENG PT A, V15, P3575, DOI 10.1089/ten.TEA.2008.0444; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CADROY Y, 1989, J LAB CLIN MED, V113, P436; CADROY Y, 1990, BLOOD, V75, P2185; Chen CY, 1997, ANN VASC SURG, V11, P74, DOI 10.1007/s100169900013; Chien S, 2008, ANN BIOMED ENG, V36, P554, DOI 10.1007/s10439-007-9426-3; CLOWES AW, 1985, AM J PATHOL, V118, P43; Dahl SLM, 2011, TRENDS CARDIOVAS MED, V21, P83, DOI 10.1016/j.tcm.2012.03.004; Deutsch M, 2009, J VASC SURG, V49, P352, DOI 10.1016/j.jvs.2008.08.101; Ensley AE, 2012, TISSUE ENG PT A, V18, P127, DOI [10.1089/ten.tea.2010.0290, 10.1089/ten.TEA.2010.0290]; Glynn J. J., 2013, TISSUE ENG B; Glynn JJ, 2014, TISSUE ENG A; GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047; HANSON SR, 1985, ARTERIOSCLEROSIS, V5, P595, DOI 10.1161/01.ATV.5.6.595; Hinds MT, 2008, J BIOMED MATER RES A, V86A, P804, DOI 10.1002/jbm.a.31672; HOCH JR, 1995, J VASC SURG, V22, P51, DOI 10.1016/S0741-5214(95)70088-9; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035; KRUPSKI WC, 1993, J VASC SURG, V17, P294, DOI 10.1016/0741-5214(93)90415-I; Lin PH, 2004, J VASC SURG, V39, P1322, DOI 10.1016/j.jvs.2004.01.046; Lumsden AB, 1996, J VASC SURG, V24, P825, DOI 10.1016/S0741-5214(96)70019-8; Lund T, 2010, THROMB HAEMOSTASIS, V104, P582, DOI 10.1160/TH09-12-0854; Mazzolai L, 2011, J VASC RES, V48, P443, DOI 10.1159/000324844; McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039; Meier LA, 2014, J CARDIOVASC TRANSL; Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; OSBORN L, 1990, CELL, V62, P3, DOI 10.1016/0092-8674(90)90230-C; Pearson JD, 1999, BEST PRACT RES CL HA, V12, P329, DOI 10.1053/beha.1999.0028; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; SCHNEIDER PA, 1989, J VASC SURG, V10, P75, DOI 10.1067/mva.1989.vs0100075; Stroncek JD, 2012, ACTA BIOMATER, V8, P201, DOI 10.1016/j.actbio.2011.09.002; Stroncek JD, 2011, TISSUE ENG PT A, V17, P2091, DOI [10.1089/ten.TEA.2010.0631, 10.1089/ten.tea.2010.0631]; Thebaud NB, 2010, ACTA BIOMATER, V6, P1437, DOI 10.1016/j.actbio.2009.11.012; TOREM S, 1988, J VASC SURG, V7, P172, DOI 10.1067/mva.1988.avs0070172; Vartanian KB, 2009, ENDOTHELIAL CELL FUN; Vartanian KB, 2010, AM J PHYSIOL-CELL PH, V298, pC333, DOI 10.1152/ajpcell.00340.2009; Walpoth BH, 2007, J THORAC CARDIOV SUR, V133, P1163, DOI 10.1016/j.jtcvs.2007.01.029; Wu KK, 1996, ANNU REV MED, V47, P315; Yazdani SK, 2010, J VASC SURG, V51, P174, DOI 10.1016/j.jvs.2009.08.074; ZILLA P, 1994, J VASC SURG, V19, P540, DOI 10.1016/S0741-5214(94)70083-4; Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017	48	68	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115163	10.1371/journal.pone.0115163	http://dx.doi.org/10.1371/journal.pone.0115163			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526637	gold, Green Published, Green Submitted			2022-12-26	WOS:000347186200015
J	Krishnan, A; Pramanik, GK; Revadi, SV; Venkateswaran, V; Borges, RM				Krishnan, Anusha; Pramanik, Gautam Kumar; Revadi, Santosh V.; Venkateswaran, Vignesh; Borges, Renee M.			High Temperatures Result in Smaller Nurseries which Lower Reproduction of Pollinators and Parasites in a Brood Site Pollination Mutualism	PLOS ONE			English	Article							FIG WASP COMMUNITY; FLOWERING ASYNCHRONY; CLIMATE-CHANGE; SEASONAL FLUCTUATIONS; YUCCA MOTH; HOST-PLANT; TRADE-OFF; SEED; EVOLUTIONARY; PHENOLOGY	In a nursery pollination mutualism, we asked whether environmental factors affected reproduction of mutualistic pollinators, non-mutualistic parasites and seed production via seasonal changes in plant traits such as inflorescence size and within-tree reproductive phenology. We examined seasonal variation in reproduction in Ficus racemosa community members that utilise enclosed inflorescences called syconia as nurseries. Temperature, relative humidity and rainfall defined four seasons: winter; hot days, cold nights; summer and wet seasons. Syconium volumes were highest in winter and lowest in summer, and affected syconium contents positively across all seasons. Greater transpiration from the nurseries was possibly responsible for smaller syconia in summer. The 3-5 degrees C increase in mean temperatures between the cooler seasons and summer reduced fig wasp reproduction and increased seed production nearly two-fold. Yet, seed and pollinator progeny production were never negatively related in any season confirming the mutualistic fig-pollinator association across seasons. Non-pollinator parasites affected seed production negatively in some seasons, but had a surprisingly positive relationship with pollinators in most seasons. While within-tree reproductive phenology did not vary across seasons, its effect on syconium inhabitants varied with season. In all seasons, within-tree reproductive asynchrony affected parasite reproduction negatively, whereas it had a positive effect on pollinator reproduction in winter and a negative effect in summer. Seasonally variable syconium volumes probably caused the differential effect of within-tree reproductive phenology on pollinator reproduction. Within-tree reproductive asynchrony itself was positively affected by intra-tree variation in syconium contents and volume, creating a unique feedback loop which varied across seasons. Therefore, nursery size affected fig wasp reproduction, seed production and within-tree reproductive phenology via the feedback cycle in this system. Climatic factors affecting plant reproductive traits cause biotic relationships between plants, mutualists and parasites to vary seasonally and must be accorded greater attention, especially in the context of climate change.	[Krishnan, Anusha; Venkateswaran, Vignesh; Borges, Renee M.] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Pramanik, Gautam Kumar] Johannes Gutenberg Univ Med Mainz, Inst Microscopy Anat & Neurobiol, Mainz, Germany; [Revadi, Santosh V.] Swedish Univ Agr Sci, Dept Plant Protect & Biol, Unit Chem Ecol, Alnarp, Sweden	Indian Institute of Science (IISC) - Bangalore; Johannes Gutenberg University of Mainz; Swedish University of Agricultural Sciences	Borges, RM (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	renee@ces.iisc.ernet.in	Venkateswaran, Vignesh/L-6002-2019; revadi, santosh/AAX-4341-2021	revadi, santosh/0000-0001-5647-3454	Ministry of Environment and Forests, Government of India	Ministry of Environment and Forests, Government of India(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of India)	This research was funded by the Ministry of Environment and Forests, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKER CL, 1981, OECOLOGIA, V49, P96, DOI 10.1007/BF00376905; Al-Beidh Sarah, 2012, ISRN Zoology, P1; Al-Beidh S, 2012, OIKOS, V121, P1833, DOI 10.1111/j.1600-0706.2011.20179.x; Anstett MC, 1996, J EVOLUTION BIOL, V9, P417, DOI 10.1046/j.1420-9101.1996.9040417.x; AUGSPURGER CK, 1983, BIOTROPICA, V15, P257, DOI 10.2307/2387650; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; Barrett LG, 2012, FUNCT ECOL, V26, P457, DOI 10.1111/j.1365-2435.2011.01940.x; BEATLEY JC, 1974, ECOLOGY, V55, P856, DOI 10.2307/1934421; BENTLEY BL, 1976, ECOLOGY, V57, P815, DOI 10.2307/1936195; Blatrix R, 2013, CR GEOSCI, V345, P306, DOI 10.1016/j.crte.2013.03.006; BRONSTEIN JL, 1989, EXPERIENTIA, V45, P622, DOI 10.1007/BF01975679; BRONSTEIN JL, 1990, ECOLOGY, V71, P2145, DOI 10.2307/1938628; BRONSTEIN JL, 1988, BIOTROPICA, V20, P215, DOI 10.2307/2388236; Cardona W, 2013, BIOTROPICA, V45, P203, DOI 10.1111/j.1744-7429.2012.00901.x; Cook JM, 2010, ECOL ENTOMOL, V35, P54, DOI 10.1111/j.1365-2311.2009.01148.x; Cook JM, 1996, J BIOGEOGR, V23, P487, DOI 10.1111/j.1365-2699.1996.tb00010.x; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Dunn DW, 2008, J ANIM ECOL, V77, P927, DOI 10.1111/j.1365-2656.2008.01416.x; Dunn DW, 2008, PLOS BIOL, V6, P490, DOI 10.1371/journal.pbio.0060059; Dyer LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062528; Forrest JRK, 2015, OIKOS, V124, P4, DOI 10.1111/oik.01386; FRANK SA, 1989, EXPERIENTIA, V45, P674, DOI 10.1007/BF01975684; GADGIL S, 1983, J CLIMATOL, V3, P47, DOI 10.1002/joc.3370030105; GALIL J, 1968, ECOLOGY, V49, P259, DOI 10.2307/1934454; Gates DJ, 2012, AM J BOT, V99, P757, DOI 10.3732/ajb.1100472; Ghara M, 2014, ARTHROPOD-PLANT INTE, V8, P191, DOI 10.1007/s11829-014-9300-9; Ghara M, 2010, ECOL ENTOMOL, V35, P139, DOI 10.1111/j.1365-2311.2010.01176.x; Gorden NLS, 2013, AM J BOT, V100, P679, DOI 10.3732/ajb.1200460; Grison-Pige L, 2002, J CHEM ECOL, V28, P283, DOI 10.1023/A:1017930023741; Harvey JA, 2013, ANNU REV ENTOMOL, V58, P333, DOI 10.1146/annurev-ento-120811-153622; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Herre EA, 1997, P ROY SOC B-BIOL SCI, V264, P1501, DOI 10.1098/rspb.1997.0208; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Jevanandam N, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0041; Johansson J, 2013, GLOBAL CHANGE BIOL, V19, P197, DOI 10.1111/gcb.12006; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Joreskog KG, 2012, LISREL 9 1 WINDOWS; Kerdelhue C, 2000, ECOLOGY, V81, P2832, DOI 10.1890/0012-9658(2000)081[2832:CCESOO]2.0.CO;2; Kerdelhue C, 1996, OIKOS, V75, P3, DOI 10.2307/3546315; Kersch MF, 2005, ECOLOGY, V86, P2117, DOI 10.1890/04-1916; Krishnan A, 2014, J ECOL, V102, P1329, DOI 10.1111/1365-2745.12277; Kudo G, 2008, ECOLOGY, V89, P321, DOI 10.1890/06-2131.1; LAWRENCE PO, 1981, ANN ENTOMOL SOC AM, V74, P540, DOI 10.1093/aesa/74.6.540; Liu YZ, 2012, NEW PHYTOL, V195, P427, DOI 10.1111/j.1469-8137.2012.04178.x; Lombardero MJ, 2003, OIKOS, V102, P243, DOI 10.1034/j.1600-0706.2003.12599.x; Malizia LR, 2001, CONDOR, V103, P45, DOI 10.1650/0010-5422(2001)103[0045:SFOBFA]2.0.CO;2; Meindl GA, 2013, OECOLOGIA, V173, P1355, DOI 10.1007/s00442-013-2711-y; MITCHELL RJ, 1992, FUNCT ECOL, V6, P123, DOI 10.2307/2389745; Muniz DG, 2012, STUD NEOTROP FAUNA E, V47, P111, DOI 10.1080/01650521.2012.698932; Pagamas P, 2008, SCI HORTIC-AMSTERDAM, V117, P21, DOI 10.1016/j.scienta.2008.03.017; PATINO S, 1994, OECOLOGIA, V100, P13, DOI 10.1007/BF00317125; Pellmyr O, 1996, NATURE, V380, P155, DOI 10.1038/380155a0; PITELKA LF, 1985, AM J BOT, V72, P311, DOI 10.2307/2443558; Pringle EG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001705; Proffit M, 2007, J ANIM ECOL, V76, P296, DOI 10.1111/j.1365-2656.2007.01213.x; Proffit M, 2009, ENTOMOL EXP APPL, V131, P46, DOI 10.1111/j.1570-7458.2009.00823.x; Raja S, 2015, ENTOMOL SCI, V18, P230, DOI 10.1111/ens.12100; Ramirez B, 1970, Evolution, Lancaster, Pa., V24, P680, DOI 10.1111/j.1558-5646.1970.tb01804.x; Randlkofer B, 2010, BASIC APPL ECOL, V11, P383, DOI 10.1016/j.baae.2010.03.003; Ranganathan Y, 2010, ENTOMOL EXP APPL, V137, P50, DOI 10.1111/j.1570-7458.2010.01038.x; Rico-Gray V, 2012, ARTHROPOD-PLANT INTE, V6, P289, DOI 10.1007/s11829-011-9170-3; Scaven VL, 2013, CURR ZOOL, V59, P418, DOI 10.1093/czoolo/59.3.418; Segraves KA, 2003, ECOLOGY, V84, P2943, DOI 10.1890/02-0619; Sentis A, 2013, GLOBAL CHANGE BIOL, V19, P833, DOI 10.1111/gcb.12094; Suleman N, 2013, ECOL ENTOMOL, V38, P478, DOI 10.1111/een.12041; Suleman N, 2013, PLANT SYST EVOL, V299, P927, DOI 10.1007/s00606-013-0773-2; Ulian T, 2013, S AFR J BOT, V88, P278, DOI 10.1016/j.sajb.2013.08.006; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; VANALEBEEK FAN, 1993, ENTOMOL EXP APPL, V69, P21, DOI 10.1007/BF02380670; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Wang R-W, 2009, PLOS ONE, V4, P1; Wang RW, 2008, J ANIM ECOL, V77, P616, DOI 10.1111/j.1365-2656.2008.01359.x; Wang RW, 2008, SYMBIOSIS, V45, P113; Wang RW, 2011, J R SOC INTERFACE, V8, P1487, DOI 10.1098/rsif.2011.0063; Wang RW, 2010, ECOLOGY, V91, P1308, DOI 10.1890/09-1446.1; Wang RW, 2005, J INTEGR PLANT BIOL, V47, P144, DOI 10.1111/j.1744-7909.2005.00034.x; Warren RJ, 2014, GLOBAL CHANGE BIOL, V20, P466, DOI 10.1111/gcb.12407; WEST SA, 1994, P ROY SOC B-BIOL SCI, V258, P67, DOI 10.1098/rspb.1994.0143; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x; Young LW, 2004, J EXP BOT, V55, P485, DOI 10.1093/jxb/erh038	83	8	8	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115118	10.1371/journal.pone.0115118	http://dx.doi.org/10.1371/journal.pone.0115118			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521512	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845600017
J	Zhao, LL; Yang, GS; Zhao, X				Zhao, Lili; Yang, Gongshe; Zhao, Xin			Rho-Associated Protein Kinases Play an Important Role in the Differentiation of Rat Adipose-Derived Stromal Cells into Cardiomyocytes In Vitro	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; DEDIFFERENTIATED FAT-CELLS; STEM-CELLS; BEATING CARDIOMYOCYTES; CARDIAC-FUNCTION; TISSUE; DISEASE; ROCK	Adipose-derived stromal cells (ADSCs) represent a readily available abundant supply of mesenchymal stem cells and have the ability to differentiate into cardiomyocytes in mice and human, making ADSCs a promising source of cardiomyocytes for transplantation. However, there has been no report of differentiation of rat ADSCs into cardiomyocytes. In addition, signaling pathways in the differentiation process from ADSCs to cardiomyocytes are unknown. In this study, we first demonstrated that rat ADSCs spontaneously differentiated into cardiomyocytes in vitro, when cultured on a complete medium formulation MethoCult GF M3534. These differentiated cells possessed cardiomyocyte phenotype and expressed cardiac markers. Moreover, these cells showed open excitation-contracting coupling and Ca2+ transient and contracted spontaneously. The role of Rho-associated protein kinases (ROCKs) in the differentiation process was then studied by using ROCK-specific inhibitor Y-27632 and ROCK siRNAs. These agents changed the arrangement of cytoskeleton and diminished appearance of cardiomyocyte phenotype, accompanied by inhibition of c-Jun N-terminal kinase (JNK) phosphorylation and promotion of Akt phosphorylation. Collectively, this is the first study to demonstrate that rat ADSCs could spontaneously differentiate into cardiomyocytes in vitro and ROCKs play an important role in the differentiation of ADSCs into beating cardiomyocytes in conjunction of the PI3K/Akt pathway and the JNK pathway.	[Zhao, Lili; Yang, Gongshe; Zhao, Xin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Zhao, Xin] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada	Northwest A&F University - China; McGill University	Zhao, X (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	zhaoxin@nwsuaf.edu.cn	Zhao, Xin/M-4312-2015	Zhao, Xin/0000-0002-1078-7332; Yang, Gongshe/0000-0003-2003-979X	China QianRen program	China QianRen program	This work was supported by the China QianRen program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader M, 2010, METHODS MOL BIOL, V597, P403, DOI 10.1007/978-1-60327-389-3_27; Bai XW, 2010, EUR HEART J, V31, P489, DOI 10.1093/eurheartj/ehp568; Castellani L, 2006, J BIOL CHEM, V281, P15249, DOI 10.1074/jbc.M601390200; Chen L, 2009, ENVIRON HEALTH PERSP, V117, P1124, DOI 10.1289/ehp.0800157; Choi YS, 2010, J CELL MOL MED, V14, P878, DOI 10.1111/j.1582-4934.2010.01009.x; Danoviz ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012077; Feng TS, 2010, STEM CELL REV REP, V6, P74, DOI 10.1007/s12015-010-9115-8; Iannaccone PM, 2009, DIS MODEL MECH, V2, P206, DOI 10.1242/dmm.002733; Ishida H, 2011, AM J PHYSIOL-HEART C, V301, pH1531, DOI 10.1152/ajpheart.00216.2011; Jumabay M, 2010, CARDIOVASC RES, V85, P17, DOI 10.1093/cvr/cvp267; Jumabay M, 2009, J MOL CELL CARDIOL, V47, P565, DOI 10.1016/j.yjmcc.2009.08.004; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Leobon B, 2009, CARDIOVASC RES, V83, P757, DOI 10.1093/cvr/cvp167; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Nakagami H, 2006, J ATHEROSCLER THROMB, V13, P77, DOI 10.5551/jat.13.77; Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47; Rai M, 2012, STEM CELLS DEV, V21, P54, DOI 10.1089/scd.2011.0326; Rangappa S, 2003, ANN THORAC SURG, V75, P775, DOI 10.1016/S0003-4975(02)04568-X; Riazi AM, 2005, J BIOL CHEM, V280, P10716, DOI 10.1074/jbc.M500028200; Schenke-Layland K, 2009, J SURG RES, V153, P217, DOI 10.1016/j.jss.2008.03.019; Schofield AV, 2013, CRIT REV BIOCHEM MOL, V48, P301, DOI 10.3109/10409238.2013.786671; Shen JF, 2011, INT J ORAL SCI, V3, P117, DOI 10.4248/IJOS11044; Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426; VASILIEV JM, 1987, J CELL SCI, P1; Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008; Wei L, 2001, DEVELOPMENT, V128, P2953; Yamada Y, 2007, STEM CELLS, V25, P1326, DOI 10.1634/stemcells.2006-0588; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841; Zhao LL, 2012, MOL BIOL REP, V39, P2585, DOI 10.1007/s11033-011-1011-z; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	32	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115191	10.1371/journal.pone.0115191	http://dx.doi.org/10.1371/journal.pone.0115191			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522345	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845600024
J	Lawn, S; Krishna, N; Pisklakova, A; Qu, XT; Fenstermacher, DA; Fournier, M; Vrionis, FD; Tran, N; Chan, JA; Kenchappa, RS; Forsyth, PA				Lawn, Samuel; Krishna, Niveditha; Pisklakova, Alexandra; Qu, Xiaotao; Fenstermacher, David A.; Fournier, Michelle; Vrionis, Frank D.; Nam Tran; Chan, Jennifer A.; Kenchappa, Rajappa S.; Forsyth, Peter A.			Neurotrophin Signaling via TrkB and TrkC Receptors Promotes the Growth of Brain Tumor-initiating Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-LIKE CELLS; TYROSINE KINASES; PHASE-II; GLIOBLASTOMA; PATHWAY; INHIBITION; SURVIVAL; GLIOMA; IDENTIFICATION; PROLIFERATION	Neurotrophins and their receptors are frequently expressed in malignant gliomas, yet their functions are largely unknown. Previously, we have shown that p75 neurotrophin receptor is required for glioma invasion and proliferation. However, the role of Trk receptors has not been examined. In this study, we investigated the importance of TrkB and TrkC in survival of brain tumor-initiating cells (BTICs). Here, we show that human malignant glioma tissues and also tumor-initiating cells isolated from fresh human malignant gliomas express the neurotrophin receptors TrkB and TrkC, not TrkA, and they also express neurotrophins NGF, BDNF, and neurotrophin 3 (NT3). Specific activation of TrkB and TrkC receptors by ligands BDNF and NT3 enhances tumor-initiating cell viability through activation of ERK and Akt pathways. Conversely, TrkB and TrkC knockdown or pharmacologic inhibition of Trk signaling decreases neurotrophin-dependent ERK activation and BTIC growth. Further, pharmacological inhibition of both ERK and Akt pathways blocked BDNF, and NT3 stimulated BTIC survival. Importantly, attenuation of BTIC growth by EGFR inhibitors could be overcome by activation of neurotrophin signaling, and neurotrophin signaling is sufficient for long term BTIC growth as spheres in the absence of EGF and FGF. Our results highlight a novel role for neurotrophin signaling in brain tumor and suggest that Trks could be a target for combinatorial treatment of malignant glioma.	[Lawn, Samuel; Chan, Jennifer A.; Forsyth, Peter A.] Univ Calgary, Southern Alberta Canc Res Inst, Tom Baker Canc Ctr, Calgary, AB T2N 4N2, Canada; [Krishna, Niveditha; Pisklakova, Alexandra; Vrionis, Frank D.; Nam Tran; Kenchappa, Rajappa S.; Forsyth, Peter A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Neurooncol, Tampa, FL 33612 USA; [Qu, Xiaotao; Fenstermacher, David A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biomed Informat, Tampa, FL 33612 USA; [Fournier, Michelle] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tissue Core, Tampa, FL 33612 USA; [Vrionis, Frank D.; Nam Tran; Kenchappa, Rajappa S.; Forsyth, Peter A.] Univ S Florida, Dept Oncol Sci, Coll Med, Tampa, FL 33612 USA	Tom Baker Cancer Clinic; University of Calgary; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Kenchappa, RS (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Neurooncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	Rajappa.Kenchappa@Moffitt.org; Peter.Forsyth@Moffitt.org			Moffitt Foundation; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	Moffitt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Moffitt Foundation.	Assimakopoulou M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-202; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bertrand T, 2012, J MOL BIOL, V423, P439, DOI 10.1016/j.jmb.2012.08.002; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Forsyth PA, 2014, J BIOL CHEM, V289, P8067, DOI 10.1074/jbc.M113.513762; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Gallia GL, 2009, MOL CANCER THER, V8, P386, DOI 10.1158/1535-7163.MCT-08-0680; Hegi ME, 2011, MOL CANCER THER, V10, P1102, DOI 10.1158/1535-7163.MCT-11-0048; Johnston ALM, 2007, PLOS BIOL, V5, P1723, DOI 10.1371/journal.pbio.0050212; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Kelly JJP, 2009, STEM CELLS, V27, P1722, DOI 10.1002/stem.98; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Marchetti D, 2003, PATHOL ONCOL RES, V9, P147, DOI 10.1007/BF03033729; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Prados MD, 2009, J CLIN ONCOL, V27, P579, DOI 10.1200/JCO.2008.18.9639; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Sarangi A, 2009, ONCOGENE, V28, P3468, DOI 10.1038/onc.2009.208; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wadhwa S, 2003, J BIOSCIENCES, V28, P181, DOI 10.1007/BF02706217; Wang Jun, 2008, Curr Chem Genomics, V1, P27, DOI 10.2174/1875397300801010027; Wang LM, 2008, PLOS BIOL, V6, P2496, DOI 10.1371/journal.pbio.0060289; Wang Y, 1998, ACTA NEUROPATHOL, V96, P357, DOI 10.1007/s004010050906; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	39	96	99	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3814	3824		10.1074/jbc.M114.599373	http://dx.doi.org/10.1074/jbc.M114.599373			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25538243	Green Published, hybrid			2022-12-26	WOS:000349456000052
J	Sumida, GM; Yamada, S				Sumida, Grant M.; Yamada, Soichiro			Rho GTPases and the Downstream Effectors Actin-related Protein 2/3 (Arp2/3) Complex and Myosin II Induce Membrane Fusion at Self-contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL FUSION; MYOBLAST FUSION; FUSOGEN EFF-1; CATENIN; DYNAMICS; POLYMERIZATION; MORPHOGENESIS; PHAGOCYTOSIS; PROTRUSIONS; ENDOCYTOSIS	Actin regulation is required for membrane activities that drive cell adhesion and migration. The Rho GTPase family plays critical roles in actin and membrane dynamics; however, the roles of the Rho GTPase family are not limited to cell adhesion and migration. Using micron-sized obstacles to induce the formation of self-contacts in epithelial cells, we previously showed that self-adhesion is distinct from cell-to-cell adhesion in that self-contacts are eliminated by membrane fusion. In the current study, we identified Rho GTPases, RhoA, Rac1, and Cdc42, as potential upstream regulators of membrane fusion. The RhoA downstream effector myosin II is required for fusion as the expression of mutant myosin light chain reduced membrane fusion. Furthermore, an inhibitor of the Arp2/3 complex, a downstream effector of Rac1 and Cdc42, also reduced self-contact-induced membrane fusion. At self-contacts, while the concentration of E-cadherin diminished, the intensity of GFP-tagged Arp3 rapidly fluctuated then decreased and stabilized after membrane fusion. Taken together, these data suggest that the Arp2/3 complex-mediated actin polymerization brings two opposing membranes into close apposition by possibly excluding E-cadherin from contact sites, thus promoting membrane fusion at self-contacts.	[Sumida, Grant M.; Yamada, Soichiro] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Yamada, S (corresponding author), Univ Calif Davis, Dept Biomed Engn, 451 Hlth Sci Dr,GBSF 2317, Davis, CA 95616 USA.	syamada@ucdavis.edu	Yamada, Soichiro/B-7360-2019	Yamada, Soichiro/0000-0001-6413-0814	National Institutes of Health [EUREKA GM094798]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant EUREKA GM094798 (to S. Y.).	Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Bjerregaard B, 2006, CELL MOL LIFE SCI, V63, P1906, DOI 10.1007/s00018-006-6201-9; Bjerregaard B, 2014, J ASSIST REPROD GEN, V31, P533, DOI 10.1007/s10815-014-0224-1; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Duan R, 2009, DEV BIOL, V325, P374, DOI 10.1016/j.ydbio.2008.10.035; Gallop JL, 2013, P NATL ACAD SCI USA, V110, P7193, DOI 10.1073/pnas.1305286110; Gruenbaum-Cohen Y, 2012, P NATL ACAD SCI USA, V109, P11211, DOI 10.1073/pnas.1116065109; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hansen SD, 2013, MOL BIOL CELL, V24, P3710, DOI 10.1091/mbc.E13-07-0388; Haralalka S, 2011, DEVELOPMENT, V138, P1551, DOI 10.1242/dev.057653; Harrison OJ, 2010, NAT STRUCT MOL BIOL, V17, P348, DOI 10.1038/nsmb.1784; Lammert E, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006619; Lenard A, 2013, DEV CELL, V25, P492, DOI 10.1016/j.devcel.2013.05.010; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Neco P, 2008, J BIOL CHEM, V283, P10949, DOI 10.1074/jbc.M709058200; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Perez-Vargas J, 2014, CELL, V157, P407, DOI 10.1016/j.cell.2014.02.020; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Rasmussen JP, 2008, DEV CELL, V14, P559, DOI 10.1016/j.devcel.2008.01.019; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Rougerie P, 2013, IMMUNOL REV, V256, P222, DOI 10.1111/imr.12118; Sens KL, 2010, J CELL BIOL, V191, P1013, DOI 10.1083/jcb.201006006; Shih WT, 2010, BIOPHYS J, V98, pL29, DOI 10.1016/j.bpj.2010.02.028; Shilagardi K, 2013, SCIENCE, V340, P359, DOI 10.1126/science.1234781; Soe K, 2011, BONE, V48, P837, DOI 10.1016/j.bone.2010.11.011; Stone CE, 2009, DEV BIOL, V329, P201, DOI 10.1016/j.ydbio.2009.02.030; Sumida GM, 2013, P NATL ACAD SCI USA, V110, P18958, DOI 10.1073/pnas.1311135110; Vasyutina E, 2009, P NATL ACAD SCI USA, V106, P8935, DOI 10.1073/pnas.0902501106; Xu H, 2011, P NATL ACAD SCI USA, V108, P17325, DOI 10.1073/pnas.1113888108; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yao LH, 2013, J NEUROSCI, V33, P15793, DOI 10.1523/JNEUROSCI.2171-13.2013; Zeev-Ben-Mordehai T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4912	39	18	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3238	3247		10.1074/jbc.M114.612168	http://dx.doi.org/10.1074/jbc.M114.612168			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25527498	hybrid, Green Published			2022-12-26	WOS:000349456000005
J	Sato, S; Miyazono, S; Tachibanaki, S; Kawamura, S				Sato, Shinya; Miyazono, Sadaharu; Tachibanaki, Shuji; Kawamura, Satoru			RDH13L, an Enzyme Responsible for the Aldehyde-Alcohol Redox Coupling Reaction (AL-OL Coupling Reaction) to Supply 11-cis Retinal in the Carp Cone Retinoid Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Photoreceptor; Retinal Metabolism; Retinoid; Vision; Vitamin A; NADP; Retinal; Retinol; Visual Cycle	VISUAL PIGMENT KINASE; VITAMIN-A; SUBSTRATE-SPECIFICITY; VERTEBRATE RETINA; PROTEIN; PHOTORECEPTORS; METABOLISM; OXIDATION; RPE65; ISOMEROHYDROLASE	Background: In carp cones, 11-cis retinal is formed with the AL-OL coupling reaction. Results: We identified RDH13L which catalyzes both the AL-OL coupling reaction with tightly-bound NADP(+) and the conventional RDH activity with exogenous NADP(+). Mouse RDH14 showed similar activity. Conclusion: Cones have effective mechanisms to regenerate the pigment. Significance: Molecular bases of effective pigment regeneration in cones are uncovered. Cone photoreceptors require effective pigment regeneration mechanisms to maintain their sensitivity in the light. Our previous studies in carp cones suggested the presence of an unconventional and very effective mechanism to produce 11-cis retinal, the necessary component in pigment regeneration. In this reaction (aldehyde-alcohol redox coupling reaction, AL-OL coupling reaction), formation of 11-cis retinal, i.e. oxidation of 11-cis retinol is coupled to reduction of an aldehyde at a 1:1 molar ratio without exogenous NADP(H) which is usually required in this kind of reaction. Here, we identified carp retinol dehydrogenase 13-like (RDH13L) as an enzyme catalyzing the AL-OL coupling reaction. RDH13L was partially purified from purified carp cones, identified as a candidate protein, and its AL-OL coupling activity was confirmed using recombinant RDH13L. We further examined the substrate specificity, subcellular localization, and expression level of RDH13L. Based on these results, we concluded that RDH13L contributes to a significant part, but not all, of the AL-OL coupling activity in carp cones. RDH13L contained tightly bound NADP(+) which presumably functions as a cofactor in the reaction. Mouse RDH14, a mouse homolog of carp RDH13L, also showed the AL-OL coupling activity. Interestingly, although carp cone membranes, carp RDH13L and mouse RDH14 all showed the coupling activity at 15-37 degrees C, they also showed a conventional NADP(+)-dependent 11-cis retinol oxidation activity above 25 degrees C without addition of aldehydes. This dual mechanism of 11-cis retinal synthesis attained by carp RDH13L and mouse RDH14 probably contribute to effective pigment regeneration in cones that function in the light.	[Sato, Shinya; Miyazono, Sadaharu; Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Dept Biol Sci, Grad Sch Sci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Kawamura, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamada Oka 1-3, Suita, Osaka 5650871, Japan.	kawamura@fbs.osaka-u.ac.jp		Sato, Shinya/0000-0002-5978-0975	Japan Society for the Promotion of Science [23227002, 24570085]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science Grants 23227002 (to S. K.) and 24570085 (to S. T.).	Ala-Laurila P, 2009, J BIOL CHEM, V284, P16492, DOI 10.1074/jbc.M109.004697; Arinobu D, 2010, J NEUROCHEM, V115, P259, DOI 10.1111/j.1471-4159.2010.06925.x; Belyaeva OV, 2008, FEBS J, V275, P138, DOI 10.1111/j.1742-4658.2007.06184.x; Bisswanger H., 2008, MULTISUBSTRATE REACT, P124; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kanan Y, 2008, EXP EYE RES, V86, P344, DOI 10.1016/j.exer.2007.11.006; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Kolesnikov AV, 2011, J NEUROSCI, V31, P7900, DOI 10.1523/JNEUROSCI.0438-11.2011; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Miyazono S, 2008, P NATL ACAD SCI USA, V105, P16051, DOI 10.1073/pnas.0806593105; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Reinheckel T, 1998, FREE RADICAL RES, V29, P297, DOI 10.1080/10715769800300331; Saari JC, 2012, ANNU REV NUTR, V32, P125, DOI 10.1146/annurev-nutr-071811-150748; Sato S, 2013, J BIOL CHEM, V288, P36589, DOI 10.1074/jbc.M113.521153; Schenkels P, 2000, MICROBIOL-SGM, V146, P775, DOI 10.1099/00221287-146-4-775; Scott T., 1988, CONCISE ENCY BIOCH, P397; Shimauchi-Matsukawa Y, 2005, MOL VIS, V11, P1220; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200	29	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2983	2992		10.1074/jbc.M114.629162	http://dx.doi.org/10.1074/jbc.M114.629162			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25533474	Green Published, hybrid			2022-12-26	WOS:000349310700036
J	Kao, LT; Lee, CZ; Liu, SP; Tsai, MC; Lin, HC				Kao, Li-Ting; Lee, Cha-Ze; Liu, Shih-Ping; Tsai, Ming-Chieh; Lin, Herng-Ching			Psoriasis and the Risk of Pneumonia: A Population-Based Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; OBSTRUCTIVE PULMONARY-DISEASE; METABOLIC SYNDROME; IFN-GAMMA; COMORBIDITIES; HOSPITALIZATION; EPIDEMIOLOGY; SEVERITY; DATABASE; MODERATE	Background: Psoriasis is a prevalent autoimmune disorder. Various studies have reported on the relationship between psoriasis and chronic diseases but very few have explored the association between psoriasis and subsequent acute infection. This retrospective cohort study aimed to compare the risk of pneumonia between subjects with and those without psoriasis. Methods: The medical records of 14,022 patients with psoriasis and 14,022 without psoriasis were obtained from the Taiwan Longitudinal Health Insurance Database 2000. Each patient was followed-up for a three-year period. Cox proportional hazard regressions were performed to compare difference of subsequent pneumonia incidence between subjects with and those without psoriasis. Results: There were 206 (1.47%) subjects with psoriasis and 138 (0.98%) without psoriasis hospitalized for pneumonia. By Cox proportional hazard regressions analysis, the HR (hazard ratio) of pneumonia requiring hospitalization for patients with psoriasis was 1.50 (95% confidence interval [CI]: 1.21-1.86) compared to patients without psoriasis. The adjusted HR was 1.40 (95% CI: 1.12-1.73). The adjusted HR of pneumonia hospitalization for subjects with mild and severe psoriasis was 1.36 (95% CI: 1.09-1.70) and 1.68 (95% CI: 1.12-2.52), respectively, compared to those without psoriasis. Conclusions: Patients with psoriasis have significantly higher incidence of pneumonia compared to those without psoriasis.	[Kao, Li-Ting] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Kao, Li-Ting; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Lee, Cha-Ze] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei 100, Taiwan; [Liu, Shih-Ping] Coll Med, Taipei, Taiwan; [Tsai, Ming-Chieh] Cathay Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Tsai, Ming-Chieh; Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan	National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Cathay General Hospital; Taipei Medical University	Tsai, MC (corresponding author), Cathay Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan.	tsaimj106@yahool.com.tw	Kao, Li-Ting/W-9287-2018	Kao, Li-Ting/0000-0003-0692-7408; LIU, SHIH-PING/0000-0002-8015-0695				Almirall J, 2008, EUR RESPIR J, V31, P1274, DOI 10.1183/09031936.00095807; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Baik I, 2000, ARCH INTERN MED, V160, P3082, DOI 10.1001/archinte.160.20.3082; Barlow GD, 2003, LANCET INFECT DIS, V3, P476, DOI 10.1016/S1473-3099(03)00721-7; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Chandran V, 2010, J AUTOIMMUN, V34, pJ314, DOI 10.1016/j.jaut.2009.12.001; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; Dreiher J, 2008, BRIT J DERMATOL, V159, P956, DOI 10.1111/j.1365-2133.2008.08749.x; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010; Gottlieb AB, 2008, J DERMATOL TREAT, V19, P5, DOI 10.1080/09546630701364768; Gottlieb AB, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.06.021; Green MS, 1996, J AM ACAD DERMATOL, V34, P911, DOI 10.1016/S0190-9622(96)90078-X; Gutierrez F, 2008, DRUG AGING, V25, P585, DOI 10.2165/00002512-200825070-00005; Kalb RE, 2009, J AM ACAD DERMATOL, V60, P824, DOI 10.1016/j.jaad.2008.11.906; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kieseier BC, 2012, AUTOIMMUN REV, V11, P191, DOI 10.1016/j.autrev.2011.05.011; Langley RGB, 2005, ANN RHEUM DIS, V64, P18, DOI 10.1136/ard.2004.033217; LINDEGARD B, 1986, DERMATOLOGICA, V172, P298, DOI 10.1159/000249365; Polverino E, 2011, MINERVA ANESTESIOL, V77, P196; Raychaudhuri SK, 2014, AUTOIMMUN REV, V13, P490, DOI 10.1016/j.autrev.2014.01.008; Schmitt J, 2005, DERMATOLOGY, V210, P194, DOI 10.1159/000083509; Smith ECA, 2008, INT J DERMATOL, V47, P514, DOI 10.1111/j.1365-4632.2008.03470.x; Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; Szegedi A, 2003, IMMUNOL LETT, V86, P277, DOI 10.1016/S0165-2478(03)00025-7; Takahashi H, 2010, CLIN EXP DERMATOL, V35, P645, DOI 10.1111/j.1365-2230.2009.03704.x; Tsai TF, 2011, J DERMATOL SCI, V63, P40, DOI 10.1016/j.jdermsci.2011.03.002; Wakkee M, 2011, J AM ACAD DERMATOL, V65, P1135, DOI 10.1016/j.jaad.2010.08.036; Wakkee M, 2009, DERMATOL CLIN, V27, P137, DOI 10.1016/j.det.2008.11.013; Yende S, 2005, AM J RESP CRIT CARE, V172, P1440, DOI 10.1164/rccm.200506-888OC; Yu AP, 2009, CURR MED RES OPIN, V25, P2429, DOI 10.1185/03007990903185557	33	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116077	10.1371/journal.pone.0116077	http://dx.doi.org/10.1371/journal.pone.0116077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541712	Green Submitted, gold, Green Published			2022-12-26	WOS:000347239900139
J	Takagi, Y; Matsuda, H; Taniguchi, Y; Iwaisaki, H				Takagi, Yu; Matsuda, Hirokazu; Taniguchi, Yukio; Iwaisaki, Hiroaki			Predicting the Phenotypic Values of Physiological Traits Using SNP Genotype and Gene Expression Data in Mice	PLOS ONE			English	Article							HETEROGENEOUS STOCK MICE; COMPLEX TRAITS; MOLECULAR MARKERS; GENOME; SELECTION; PEDIGREE; LASSO	Predicting phenotypes using genome-wide genetic variation and gene expression data is useful in several fields, such as human biology and medicine, as well as in crop and livestock breeding. However, for phenotype prediction using gene expression data for mammals, studies remain scarce, as the available data on gene expression profiling are currently limited. By integrating a few sources of relevant data that are available in mice, this study investigated the accuracy of phenotype prediction for several physiological traits. Gene expression data from two tissues as well as single nucleotide polymorphisms (SNPs) were used. For the studied traits, the variance of the effects of the expression levels was more likely to differ among the genes than were the effects of SNPs. For the glucose concentration, the total cholesterol amount, and the total tidal volume, the accuracy by cross validation tended to be higher when the gene expression data rather than the SNP genotype data were used, and a statistically significant increase in the accuracy was obtained when the gene expression data from the liver were used alone or jointly with the SNP genotype data. For these traits, there were no additional gains in accuracy from using the gene expression data of both the liver and lung compared to that of individual use. The accuracy of prediction using genes that were selected differently was examined; the use of genes with a higher tissue specificity tended to result in an accuracy that was similar to or greater than that associated with the use of all of the available genes for traits such as the glucose concentration and total cholesterol amount. Although relatively few animals were evaluated, the current results suggest that gene expression levels could be used as explanatory variables. However, further studies are essential to confirm our findings using additional animal samples.	[Takagi, Yu; Matsuda, Hirokazu; Taniguchi, Yukio; Iwaisaki, Hiroaki] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan	Kyoto University	Matsuda, H (corresponding author), Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan.	hmatsuda@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS), Japan [25850185]; Grants-in-Aid for Scientific Research [25850185] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This research was supported by the Grant-in-Aid for Young Scientists B (25850185) of the Japan Society for the Promotion of Science (JSPS), Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Bhattacharjee M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026959; Chen BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.69; Chen Z, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002956; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Christensen OF, 2012, ANIMAL, V6, P1565, DOI 10.1017/S1751731112000742; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Donitz J, 2008, NUCLEIC ACIDS RES, V36, pD689, DOI 10.1093/nar/gkm940; DUNN OJ, 1971, J AM STAT ASSOC, V66, P904, DOI 10.2307/2284252; Ehsani A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-456; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Gilbert S.F., 2003, DEV BIOL, V7th Edn; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Huang GJ, 2009, GENOME RES, V19, P1133, DOI 10.1101/gr.088120.108; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Pedroso I, 2011, COLD SPRING HARBOR P, V2011; Perez P, 2010, PLANT GENOME-US, V3, P106, DOI 10.3835/plantgenome2010.04.0005; Ruderfer DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006907; Solberg LC, 2006, MAMM GENOME, V17, P129, DOI 10.1007/s00335-005-0112-1; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; van Wieringen WN, 2009, COMPUT STAT DATA AN, V53, P1590, DOI 10.1016/j.csda.2008.05.021; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Visscher PM, 2010, HFSP J, V4, P6, DOI 10.2976/1.3292182; Yanai I, 2006, TRENDS GENET, V22, P132, DOI 10.1016/j.tig.2006.01.006	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115532	10.1371/journal.pone.0115532	http://dx.doi.org/10.1371/journal.pone.0115532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541966	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900050
J	Choi, DH; Kim, JH; Seo, JH; Lee, J; Choi, WS; Kim, YS				Choi, Dong-Hee; Kim, Ji-Hye; Seo, Joo-Ha; Lee, Jongmin; Choi, Wahn Soo; Kim, Yoon-Seong			Matrix Metalloproteinase-3 Causes Dopaminergic Neuronal Death through Nox1-Regenerated Oxidative Stress	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CENTRAL-NERVOUS-SYSTEM; NADPH OXIDASE ACTIVITY; SMOOTH-MUSCLE-CELLS; PARKINSONS-DISEASE; REACTIVE OXYGEN; ALPHA-SYNUCLEIN; NOX ENZYMES; SUBSTANTIA-NIGRA; CROSS-TALK	In the present study we investigated the interplay between matrix metalloproteinase 3 (MMP3) and NADPH oxidase 1 (Nox1) in the process of dopamine (DA) neuronal death. We found that MMP3 activation causes the induction of Nox1 via mitochondrial reactive oxygen species (ROS) production and subsequently Rac1 activation, eventually leading to Nox1-derived superoxide generation in a rat DA neuronal N27 cells exposed to 6-OHDA. While a MMP3 inhibitor, NNGH, largely attenuated mitochondrial ROS and subsequent Nox1 induction, both apocynin, a putative Nox inhibitor and GKT137831, a Nox1 selective inhibitor failed to reduce 6-OHDA-induced mitochondrial ROS. However, both inhibitors for MMP3 and Nox1 similarly attenuated 6-OHDA-induced N27 cell death. RNAi-mediated selective inhibition of MMP3 or Nox1 showed that knockdown of either MMP3 or Nox1 significantly reduced 6-OHDA-induced ROS generation in N27 cells. While 6-OHDA-induced Nox1 was abolished by MMP3 knockdown, Nox1 knockdown did not alter MMP3 expression. Direct overexpression of autoactivated MMP3 (actMMP3) in N27 cells or in rat substantia nigra (SN) increased expression of Nox1. Selective knockdown of Nox1 in the SN achieved by adeno-associated virus-mediated overexpression of Nox1-specific shRNA largely attenuated the actMMP3-mediated dopaminergic neuronal loss. Furthermore, Nox1 expression was significantly attenuated in Mmp3 null mice treated with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Together we established novel molecular mechanisms underlying oxidative stress-mediated dopaminergic neuronal death in which MMP3 activation is a key upstream event that leads to mitochondrial ROS, Nox1 induction and eventual dopaminergic neuronal death. Our findings may lead to the development of novel therapeutic approach.	[Choi, Dong-Hee; Kim, Ji-Hye; Seo, Joo-Ha; Lee, Jongmin] Konkuk Univ, Inst Biomed Sci & Technol, Neurosci Res Ctr, Seoul 143701, South Korea; [Choi, Dong-Hee] Konkuk Univ, Sch Med, Dept Med Sci, Seoul 143701, South Korea; [Lee, Jongmin] Konkuk Univ, Sch Med, Dept Rehabil Med, Seoul 143701, South Korea; [Choi, Wahn Soo] Konkuk Univ, Coll Med, Funct Genom Inst, Dept Immunol & Physiol, Chungju 380701, South Korea; [Kim, Yoon-Seong] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; State University System of Florida; University of Central Florida	Choi, DH (corresponding author), Konkuk Univ, Inst Biomed Sci & Technol, Neurosci Res Ctr, Seoul 143701, South Korea.	dchoi@konkuk.ac.kr; yskim@mail.ucf.edu	Lee, Jongmin/Q-4909-2019	Lee, Jongmin/0000-0001-8718-0099	National Research Foundation of Korea (NRF) grant - Korea government (MEST) [2011-0017016]; Korean Health Technology R&F Project, Ministry of Health & Welfare, Republic of Korea [A090123]; National Institutes of Health [RO1 NS062827]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062827] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) grant - Korea government (MEST); Korean Health Technology R&F Project, Ministry of Health & Welfare, Republic of Korea; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) No. 2011-0017016 (DHC) and a grant of the Korean Health Technology R&F Project, Ministry of Health & Welfare, Republic of Korea No. A090123 (DHC) and the National Institutes of Health grant RO1 NS062827 (YSK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam ZI, 1997, J NEUROCHEM, V69, P1326; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Aoyama T, 2012, HEPATOLOGY, V56, P2316, DOI 10.1002/hep.25938; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Choi DH, 2008, J NEUROCHEM, V106, P405, DOI 10.1111/j.1471-4159.2008.05399.x; Choi DH, 2012, ANTIOXID REDOX SIGN, V16, P1033, DOI 10.1089/ars.2011.3960; Choi DH, 2011, ANTIOXID REDOX SIGN, V14, P2137, DOI 10.1089/ars.2009.3059; Choi DH, 2011, J BIOL CHEM, V286, P14168, DOI 10.1074/jbc.M111.222430; Chung YC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/370526; Cristovao AC, 2009, ANTIOXID REDOX SIGN, V11, P2105, DOI [10.1089/ars.2009.2459, 10.1089/ARS.2009.2459]; Cristovao AC, 2012, J NEUROSCI, V32, P14465, DOI 10.1523/JNEUROSCI.2246-12.2012; Debbabi M, 2013, FASEB J, V27, P1733, DOI 10.1096/fj.12-216432; Desouki MM, 2005, CANCER BIOL THER, V4, P1367, DOI 10.4161/cbt.4.12.2233; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Flex A, 2006, J GERONTOL A-BIOL, V61, P1065, DOI 10.1093/gerona/61.10.1065; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Guo SZ, 2006, BRAIN RES, V1111, P222, DOI 10.1016/j.brainres.2006.06.041; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Jellinger KA, 2002, J NEURAL TRANSM-SUPP, P347; Katsuyama M, 2005, BIOCHEM J, V386, P255, DOI 10.1042/BJ20041180; Kim EM, 2014, BIOCH BIOPHYS RES CO; Kim EM, 2010, J BIOL CHEM, V285, P16444, DOI 10.1074/jbc.M109.093799; Kim ST, 2010, NEUROCHEM INT, V56, P161, DOI 10.1016/j.neuint.2009.09.014; Kim YS, 2007, FASEB J, V21, P179, DOI 10.1096/fj.06-5865com; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee K, 2012, MOL BIOL CELL, V23, P4097, DOI 10.1091/mbc.E12-02-0166; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; Levin J, 2009, EXP NEUROL, V215, P201, DOI 10.1016/j.expneurol.2008.10.010; Lokkegaard A, 2001, HIPPOCAMPUS, V11, P726, DOI 10.1002/hipo.1088; Lorenzl S, 2002, EXP NEUROL, V178, P13, DOI 10.1006/exnr.2002.8019; Lu WQ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001326; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Nayernia Z, 2013, ANTIOXID REDOX SIGNA; Nelson CM, 2008, J CELL BIOCHEM, V105, P25, DOI 10.1002/jcb.21821; PRASAD KN, 1994, IN VITRO CELL DEV-AN, V30A, P596; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Sorce S, 2012, CELL MOL LIFE SCI, V69, P2387, DOI 10.1007/s00018-012-1014-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; Wojtera M, 2005, FOLIA NEUROPATHOL, V43, P311; Wosniak J, 2009, ANTIOXID REDOX SIGN, V11, P1265, DOI 10.1089/ars.2009.2392; Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5	47	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115954	10.1371/journal.pone.0115954	http://dx.doi.org/10.1371/journal.pone.0115954			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536219	Green Published, gold			2022-12-26	WOS:000348563300093
J	Liu, LF; Lai, YY; Cheng, JP; Wang, L; Du, WL; Wang, ZF; Zhang, HS				Liu, Liangfeng; Lai, Yanyan; Cheng, Jinping; Wang, Ling; Du, Wenli; Wang, Zhoufei; Zhang, Hongsheng			Dynamic Quantitative Trait Locus Analysis of Seed Vigor at Three Maturity Stages in Rice	PLOS ONE			English	Article							LOW-TEMPERATURE GERMINABILITY; DESICCATION-TOLERANCE; PHYSIOLOGICAL-CHANGES; MOLECULAR DISSECTION; GENETIC ARCHITECTURE; GRAIN; QTLS; GERMINATION; DORMANCY; GROWTH	Seed vigor is an important characteristic of seed quality. In this study, one rice population of recombinant inbred lines (RILs) was used to determine the genetic characteristics of seed vigor, including the germination potential, germination rate, germination index and time for 50% of germination, at 4 (early), 5 (middle) and 6 weeks (late) after heading in two years. A total of 24 additive and 9 epistatic quantitative trait loci (QTL) for seed vigor were identified using QTL Cartographer and QTLNetwork program respectively in 2012; while 32 simple sequence repeat (SSR) markers associated with seed vigor were detected using bulked segregant analysis (BSA) in 2013. The additive, epistatic and QTL x development interaction effects regulated the dry maturity developmental process to improve seed vigor in rice. The phenotypic variation explained by each additive, epistatic QTL and QTL x development interaction ranged from 5.86 to 40.67%, 4.64 to 11.28% and 0.01 to 1.17%, respectively. The QTLs were rarely co-localized among the different maturity stages; more QTLs were expressed at the early maturity stage followed by the late and middle stages. Twenty additive QTLs were stably expressed in two years which might play important roles in establishment of seed vigor in different environments. By comparing chromosomal positions of these stably expressed additive QTLs with those previously identified, the regions of QTL for seed vigor are likely to coincide with QTL for grain size, low temperature germinability and seed dormancy; while 5 additive QTL might represent novel genes. Using four selected RILs, three cross combinations of seed vigor for the development of RIL populations were predicted; 19 elite alleles could be pyramided by each combination.	[Liu, Liangfeng; Lai, Yanyan; Cheng, Jinping; Wang, Ling; Du, Wenli; Wang, Zhoufei; Zhang, Hongsheng] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Lab Seed Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, ZF (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Lab Seed Sci & Technol, Nanjing, Jiangsu, Peoples R China.	wzf@njau.edu.cn; hszhang@njau.edu.cn			National Natural Science Foundation of China [31271806, 31000748]; Fundamental Research Funds for the Central Universities [KYZ201402, KYZ201202-9]; Special Fund for Agro-scientific Research in the Public Interest [201203052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the National Natural Science Foundation of China (Grant No. 31271806; 31000748), the Fundamental Research Funds for the Central Universities (Grant No. KYZ201402; KYZ201202-9), and the Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201203052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-16; Bailey PC, 1999, THEOR APPL GENET, V98, P281, DOI 10.1007/s001220051069; Bewley D., 2013, SEEDS PHYSL DEV GERM, V3; Cheng JP, 2014, MOL BREEDING, V34, P501, DOI 10.1007/s11032-014-0053-z; Cheng XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080002; Cui KH, 2002, THEOR APPL GENET, V105, P745, DOI 10.1007/s00122-002-0908-2; Farrant JM, 2011, CURR OPIN PLANT BIOL, V14, P340, DOI 10.1016/j.pbi.2011.03.018; Foolad Majid R, 2007, Int J Plant Genomics, V2007, P97386, DOI [10.1155/2007/64358, 10.1155/2007/97386]; Fujino K, 2004, THEOR APPL GENET, V108, P794, DOI 10.1007/s00122-003-1509-4; Fujino K, 2008, P NATL ACAD SCI USA, V105, P12623, DOI 10.1073/pnas.0805303105; Gu XY, 2005, THEOR APPL GENET, V110, P1108, DOI 10.1007/s00122-005-1939-2; Guan YJ, 2013, SCI HORTIC-AMSTERDAM, V154, P25, DOI 10.1016/j.scienta.2013.02.016; Guan YJ, 2009, J ZHEJIANG UNIV-SC B, V10, P427, DOI 10.1631/jzus.B0820373; Gutierrez L, 2007, TRENDS PLANT SCI, V12, P294, DOI 10.1016/j.tplants.2007.06.003; HATTORI T, 1994, PLANT MOL BIOL, V24, P805, DOI 10.1007/BF00029862; Huang DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-140; Huang H, 2012, J PROTEOMICS, V75, P1247, DOI 10.1016/j.jprot.2011.10.036; Jiang L, 2006, FIELD CROP RES, V98, P68, DOI 10.1016/j.fcr.2005.12.015; Joosen RVL, 2010, PLANT J, V62, P148, DOI 10.1111/j.1365-313X.2009.04116.x; Ma CX, 2002, GENETICS, V161, P1751; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; McCouch SR, 2008, RICE, V1, P72, DOI 10.1007/s12284-008-9004-9; Miura K, 2002, THEOR APPL GENET, V104, P981, DOI 10.1007/s00122-002-0872-x; Niu Y, 2013, MOL BREEDING, V31, P785, DOI 10.1007/s11032-012-9833-5; Salunkhe AS, 2011, MOL BIOTECHNOL, V49, P90, DOI 10.1007/s12033-011-9382-x; Shao GN, 2010, J GENET GENOMICS, V37, P523, DOI 10.1016/S1673-8527(09)60072-2; Singh R, 2012, J PLANT BIOCHEM BIOT, V21, P157, DOI 10.1007/s13562-011-0080-3; Sugimoto K, 2010, P NATL ACAD SCI USA, V107, P5792, DOI 10.1073/pnas.0911965107; Sun Qun, 2007, Agricultural Sciences in China, V6, P1060, DOI 10.1016/S1671-2927(07)60147-3; Sun YP, 2010, MOL BREEDING, V26, P493, DOI 10.1007/s11032-010-9390-8; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Venuprasad R, 2009, THEOR APPL GENET, V120, P177, DOI 10.1007/s00122-009-1168-1; Wan XY, 2005, THEOR APPL GENET, V110, P1334, DOI 10.1007/s00122-005-1976-x; Wang L, 2014, PLANTA, V239, P411, DOI 10.1007/s00425-013-1991-0; Wang ZF, 2010, J ZHEJIANG UNIV-SC B, V11, P958, DOI 10.1631/jzus.B1000238; Wang ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051202; Wang ZF, 2012, THEOR APPL GENET, V125, P807, DOI 10.1007/s00122-012-1873-z; Wang ZF, 2011, EUPHYTICA, V178, P297, DOI 10.1007/s10681-010-0287-8; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804; Wu RL, 2004, GENETICS, V168, P2383, DOI 10.1534/genetics.104.034447; Wu RL, 2004, BIOMETRICS, V60, P729, DOI 10.1111/j.0006-341X.2004.00223.x; Wu RL, 2004, GENETICS, V166, P1541, DOI 10.1534/genetics.166.3.1541; Wu RL, 2003, BIOSCIENCE, V53, P1041, DOI 10.1641/0006-3568(2003)053[1041:MDOAOA]2.0.CO;2; Wu RL, 2003, PHYSIOL GENOMICS, V14, P241, DOI 10.1152/physiolgenomics.00013.2003; Wu RL, 2002, J THEOR BIOL, V217, P275; Wurschum T, 2011, THEOR APPL GENET, V123, P109, DOI 10.1007/s00122-011-1570-3; Yan JQ, 1998, THEOR APPL GENET, V97, P267, DOI 10.1007/s001220050895; Yang J, 2005, QTLNETWORK 2 0; Zhang MengYu, 2012, African Journal of Biotechnology, V11, P6305, DOI 10.5897/AJB11.3740; Zhang S, 2007, AUST J AGR RES, V58, P811, DOI 10.1071/AR06253; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110; Zhang ZH, 2005, FIELD CROP RES, V91, P161, DOI 10.1016/j.fcr.2004.06.004	52	20	21	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115732	10.1371/journal.pone.0115732	http://dx.doi.org/10.1371/journal.pone.0115732			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536503	gold, Green Published, Green Submitted			2022-12-26	WOS:000348563300067
J	Schmidt, A; Frensch, M; Schleheck, D; Schink, B; Muller, N				Schmidt, Alexander; Frensch, Marco; Schleheck, David; Schink, Bernhard; Mueller, Nicolai			Degradation of Acetaldehyde and Its Precursors by Pelobacter carbinolicus and P-acetylenicus	PLOS ONE			English	Article							ALDEHYDE-FERREDOXIN OXIDOREDUCTASE; SYNTROPHIC ETHANOL OXIDATION; DEFINED CHEMOSTAT COCULTURES; DEHYDROGENASE ENZYME-SYSTEM; CARBON-MONOXIDE OXIDATION; SP-NOV; FORMATE DEHYDROGENASE; METHANOGENIC BACTERIA; EUBACTERIUM-ACIDAMINOPHILUM; METHANOBACILLUS-OMELIANSKII	Pelobacter carbinolicus and P. acetylenicus oxidize ethanol in syntrophic cooperation with methanogens. Cocultures with Methanospirillum hungatei served as model systems for the elucidation of syntrophic ethanol oxidation previously done with the lost "`Methanobacillus omelianskii" coculture. During growth on ethanol, both Pelobacter species exhibited NAD(+)-dependent alcohol dehydrogenase activity. Two different acetaldehyde-oxidizing activities were found: a benzyl viologen-reducing enzyme forming acetate, and a NAD(+)-reducing enzyme forming acetyl-CoA. Both species synthesized ATP from acetyl-CoA via acetyl phosphate. Comparative 2D-PAGE of ethanol-grown P. carbinolicus revealed enhanced expression of tungsten-dependent acetaldehyde: ferredoxin oxidoreductases and formate dehydrogenase. Tungsten limitation resulted in slower growth and the expression of a molybdenum-dependent isoenzyme. Putative comproportionating hydrogenases and formate dehydrogenase were expressed constitutively and are probably involved in interspecies electron transfer. In ethanol-grown cocultures, the maximum hydrogen partial pressure was about 1,000 Pa (1 mM) while 2 mM formate was produced. The redox potentials of hydrogen and formate released during ethanol oxidation were calculated to be E-H2=-358 +/- 12 mV and E-HCOOH=-366 +/- 19 mV, respectively. Hydrogen and formate formation and degradation further proved that both carriers contributed to interspecies electron transfer. The maximum Gibbs free energy that the Pelobacter species could exploit during growth on ethanol was -35 to -28 kJ per mol ethanol. Both species could be cultivated axenically on acetaldehyde, yielding energy from its disproportionation to ethanol and acetate. Syntrophic cocultures grown on acetoin revealed a two-phase degradation: first acetoin degradation to acetate and ethanol without involvement of the methanogenic partner, and subsequent syntrophic ethanol oxidation. Protein expression and activity patterns of both Pelobacter spp. grown with the named substrates were highly similar suggesting that both share the same steps in ethanol and acetalydehyde metabolism. The early assumption that acetaldehyde is a central intermediate in Pelobacter metabolism was now proven biochemically.	[Schmidt, Alexander; Frensch, Marco; Schleheck, David; Schink, Bernhard; Mueller, Nicolai] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Konstanz	Muller, N (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.	nicolai.mueller@uni-konstanz.de		Frensch, Marco/0000-0002-7161-0928	Deutsche Forschungsgemeinschaft (DFG) [SCHI 180/10]; University of Konstanz	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Konstanz	This work was funded by the Deutsche Forschungsgemeinschaft (DFG grants SCHI 180/10) and by the University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklujkar M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-690; ASAKAWA S, 1993, INT J SYST BACTERIOL, V43, P683, DOI 10.1099/00207713-43-4-683; ASAKAWA S, 1994, INT J SYST BACTERIOL, V44, P185, DOI 10.1099/00207713-44-1-185; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Balows A., 1992, PROKARYOTES, P3352, DOI [10.1007/978-1-4757-2191-1_21, DOI 10.1007/978-1-4757-2191-1_]; BARKER H. A., 1940, ANTONIE VAN LEEUWENHOEK JOUR MICROBIOL SEROL, V6, P201; BERGMEYER HU, 1963, BIOCHEM Z, V338, P114; Bergmeyer HU, 1974, METHODEN ENZYMATISCH; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYANT MP, 1967, ARCH MIKROBIOL, V59, P20, DOI 10.1007/BF00406313; Butler JE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-471; Butler JE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-103; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; da Silva SM, 2011, J BACTERIOL, V193, P2909, DOI 10.1128/JB.00042-11; DANIELS L, 1977, J BACTERIOL, V132, P118, DOI 10.1128/JB.132.1.118-126.1977; DIEKERT GB, 1978, J BACTERIOL, V136, P597, DOI 10.1128/JB.136.2.597-606.1978; DUBOURGUIER HC, 1986, ARCH MICROBIOL, V145, P248, DOI 10.1007/BF00443653; EVERS S, 1993, SYST APPL MICROBIOL, V16, P216; FERRY JG, 1974, INT J SYST BACTERIOL, V24, P465, DOI 10.1099/00207713-24-4-465; FRIMMER U, 1989, ARCH MICROBIOL, V152, P479, DOI 10.1007/BF00446933; Hagedoorn PL, 2005, J BIOL INORG CHEM, V10, P259, DOI 10.1007/s00775-005-0637-5; Hauschild E, 1997, BIOCH ENERGETIK SYNT; Haveman SA, 2008, APPL ENVIRON MICROB, V74, P4277, DOI 10.1128/AEM.02901-07; Haveman SA, 2006, APPL ENVIRON MICROB, V72, P6980, DOI 10.1128/AEM.01128-06; HENSGENS CMH, 1995, J BACTERIOL, V177, P6195, DOI 10.1128/jb.177.21.6195-6200.1995; HOLZER H, 1957, BIOCHEM Z, V329, P192; Kaden J, 1998, WASSERSTOFFTRANSFER; Klebensberger J, 2006, ARCH MICROBIOL, V185, P417, DOI 10.1007/s00203-006-0111-y; KROTO HW, 1974, CHEM PHYS LETT, V29, P265, DOI 10.1016/0009-2614(74)85029-3; Kung JW, 2010, J AM CHEM SOC, V132, P9850, DOI 10.1021/ja103448u; KUYKENDALL JR, 1994, MUTAT RES-FUND MOL M, V311, P49, DOI 10.1016/0027-5107(94)90072-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laukel M, 2003, EUR J BIOCHEM, V270, P325, DOI 10.1046/j.1432-1033.2003.03391.x; LOVLEY DR, 1995, APPL ENVIRON MICROB, V61, P2132, DOI 10.1128/AEM.61.6.2132-2138.1995; Makdessi K, 2001, J BIOL CHEM, V276, P24557, DOI 10.1074/jbc.M101293200; MCKELLAR RC, 1979, J BACTERIOL, V139, P231, DOI 10.1128/JB.139.1.231-238.1979; Mota CS, 2011, J BACTERIOL, V193, P2917, DOI 10.1128/JB.01531-10; Muller E, 1927, ADV SYNTH CATAL, V116, P175; Muller N, 2008, ENVIRON MICROBIOL, V10, P1501, DOI 10.1111/j.1462-2920.2007.01565.x; Nishimura JS, 1981, METHOD ENZYMOL, V71, P311; Omeljanskij VL, 1916, ANN I PASTEUR PARIS, V30, P56; OPPERMANN FB, 1994, J BACTERIOL, V176, P469, DOI 10.1128/JB.176.2.469-485.1994; OPPERMANN FB, 1989, FEMS MICROBIOL LETT, V60, P113, DOI 10.1016/0378-1097(89)90087-6; OPPERMANN FB, 1988, FEMS MICROBIOL LETT, V55, P47; OPPERMANN FB, 1991, J BACTERIOL, V173, P757, DOI 10.1128/jb.173.2.757-767.1991; Pau RN, 2002, MET IONS BIOL SYST, V39, P31; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PRINCE RC, 1987, J BIOL CHEM, V262, P5125; Rauh D, 2004, EUR J BIOCHEM, V271, P212, DOI 10.1111/j.1432-1033.2004.03922.x; REDDY CA, 1972, J BACTERIOL, V110, P133, DOI 10.1128/JB.110.1.133-138.1972; REDDY CA, 1972, J BACTERIOL, V110, P126, DOI 10.1128/JB.110.1.126-132.1972; Roy R, 2002, MET IONS BIOL SYST, V39, P673; SCHINK B, 1985, ARCH MICROBIOL, V142, P295, DOI 10.1007/BF00693407; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; SCHINK B, 1984, ARCH MICROBIOL, V137, P33, DOI 10.1007/BF00425804; Schink B, 2006, PROKARYOTES, V3, P5, DOI DOI 10.1007/0-387-30747-8_1; Schlegel H. G., 1992, ALLGEMEINE MIKROBIOL; Schmidhofer A, 2013, IEEE EPE, P1; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Schwarz G, 2007, MOL BIOL HEAVY METAL, P423; SEITZ HJ, 1990, FEMS MICROBIOL LETT, V71, P83; SEITZ HJ, 1990, ARCH MICROBIOL, V155, P82, DOI 10.1007/BF00291279; SEITZ HJ, 1990, ARCH MICROBIOL, V155, P89, DOI 10.1007/BF00291280; Sieber JR, 2012, ANNU REV MICROBIOL, V66, P429, DOI 10.1146/annurev-micro-090110-102844; SIGEL A, 2002, MOLYBDENUM TUNGSTEN; STACKEBRANDT E, 1989, SYST APPL MICROBIOL, V11, P257; Strohm TO, 2002, SYNTROPHE ETHANOL OX; tenBrink F, 2011, J BACTERIOL, V193, P1229, DOI 10.1128/JB.01057-10; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Valentine DL, 2000, J MICROBIOL METH, V39, P243, DOI 10.1016/S0167-7012(99)00125-6; WALLRABENSTEIN C, 1994, ARCH MICROBIOL, V162, P136; Wang M, 2000, CHEM RES TOXICOL, V13, P1149, DOI 10.1021/tx000118t; Wang SN, 2013, J BACTERIOL, V195, P4373, DOI 10.1128/JB.00678-13; WIDDEL F, 1981, ARCH MICROBIOL, V129, P395, DOI 10.1007/BF00406470; Worral S, 2011, ADVERSE DRUG REACT T, V20, P133; Zeikus JG, 1975, A VANLEEUWENHOEK, V41; ZIEGENHORN J, 1976, CLIN CHEM, V22, P151	77	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115902	10.1371/journal.pone.0115902	http://dx.doi.org/10.1371/journal.pone.0115902			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536080	Green Submitted, Green Published, gold			2022-12-26	WOS:000348563300082
J	Takeda, A; Nakamura, M; Fujii, H; Uematsu, C; Minamino, T; Adlard, PA; Bush, AI; Tamano, H				Takeda, Atsushi; Nakamura, Masatoshi; Fujii, Hiroaki; Uematsu, Chihiro; Minamino, Tatsuya; Adlard, Paul A.; Bush, Ashley I.; Tamano, Haruna			Amyloid beta-Mediated Zn2+ Influx into Dentate Granule Cells Transiently Induces a Short-Term Cognitive Deficit	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; MOLECULAR-MECHANISMS; SYNAPTIC PLASTICITY; INTERSTITIAL FLUID; NATURAL OLIGOMERS; FREE ZINC; IN-VIVO; CALCIUM; NEURONS	We examined an idea that short-term cognition is transiently affected by a state of confusion in Zn2+ transport system due to a local increase in amyloid-beta (A beta) concentration. A single injection of A beta (25 pmol) into the dentate gyrus affected dentate gyrus long-term potentiation (LTP) 1 h after the injection, but not 4 h after the injection. Simultaneously, 1-h memory of object recognition was affected when the training was performed 1 h after the injection, but not 4 h after the injection. A beta-mediated impairments of LTP and memory were rescued in the presence of zinc chelators, suggesting that Zn2+ is involved in A beta action. When A beta was injected into the dentate gyrus, intracellular Zn2+ levels were increased only in the injected area in the dentate gyrus, suggesting that A beta induces the influx of Zn2+ into cells in the injected area. When A beta was added to hippocampal slices, A beta did not increase intracellular Zn2+ levels in the dentate granule cell layer in ACSF without Zn2+, but in ACSF containing Zn2+. The increase in intracellular Zn2+ levels was inhibited in the presence of CaEDTA, an extracellular zinc chelator, but not in the presence of CNQX, an AMPA receptor antagonist. The present study indicates that A beta-mediated Zn2+ influx into dentate granule cells, which may occur without AMPA receptor activation, transiently induces a short-term cognitive deficit. Extracellular Zn2+ may play a key role for transiently A beta-induced cognition deficits.	[Takeda, Atsushi; Minamino, Tatsuya; Tamano, Haruna] Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Shizuoka 4228526, Japan; [Takeda, Atsushi; Nakamura, Masatoshi; Fujii, Hiroaki; Uematsu, Chihiro; Tamano, Haruna] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Shizuoka 4228526, Japan; [Adlard, Paul A.; Bush, Ashley I.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Oxidat Biol Unit, Parkville, Vic 3052, Australia	University of Shizuoka; University of Shizuoka; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Takeda, A (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Shizuoka 4228526, Japan.	takedaa@u-shizuoka-ken.ac.jp	Perry, George/A-8611-2009; Coulson, Elizabeth J./C-8766-2009; Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019	Perry, George/0000-0002-6547-0172; Coulson, Elizabeth J./0000-0003-3783-6197; Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069				Abramov AY, 2003, J NEUROSCI, V23, P5088; Arispe N, 1996, P NATL ACAD SCI USA, V93, P1710, DOI 10.1073/pnas.93.4.1710; Brouillette J, 2012, J NEUROSCI, V32, P7852, DOI 10.1523/JNEUROSCI.5901-11.2012; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Bush AI, 2013, J ALZHEIMERS DIS, V33, pS277, DOI 10.3233/JAD-2012-129011; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; GomezIsla T, 1996, J NEUROSCI, V16, P4491; He F., 2011, BIO-PROTOCOL, V1, pe80, DOI [DOI 10.21769/BIOPROTOC.80, 10.21769/BioProtoc.80]; Hirano T, 2002, J AM CHEM SOC, V124, P6555, DOI 10.1021/ja025567p; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kametani F, 2008, CURR ALZHEIMER RES, V5, P165, DOI 10.2174/156720508783954776; Kayed R, 2013, J ALZHEIMERS DIS, V33, pS67, DOI 10.3233/JAD-2012-129001; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Mattson MP, 2001, J MOL NEUROSCI, V17, P205, DOI 10.1385/JMN:17:2:205; MCNAUGHTON BL, 1977, J COMP NEUROL, V175, P439, DOI 10.1002/cne.901750404; Minami A, 2006, J NEUROSCI RES, V83, P167, DOI 10.1002/jnr.20714; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sensi SL, 1997, J NEUROSCI, V17, P9554; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sindreu CB, 2003, CEREB CORTEX, V13, P823, DOI 10.1093/cercor/13.8.823; Takamura Y, 2014, NEUROBIOL AGING, V35, P532, DOI 10.1016/j.neurobiolaging.2013.08.037; Takeda A, 2014, FRONT AGING NEUROSCI, V6; Takeda A, 2007, J NEUROSCI RES, V85, P3666, DOI 10.1002/jnr.21449; Takeda A, 2007, J NEUROSCI RES, V85, P1310, DOI 10.1002/jnr.21233; Takeda A, 2014, HIPPOCAMPUS, V24, P1404, DOI 10.1002/hipo.22322; Takeda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028615; Takeda A, 2010, BRAIN RES, V1354, P188, DOI 10.1016/j.brainres.2010.07.039; Ueno S, 2002, J CELL BIOL, V158, P215, DOI 10.1083/jcb.200204066; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	55	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115923	10.1371/journal.pone.0115923	http://dx.doi.org/10.1371/journal.pone.0115923			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536033	gold, Green Published, Green Submitted			2022-12-26	WOS:000348563300088
J	Ateba-Ngoa, U; Mombo-Ngoma, G; Zettlmeissi, E; van der Vlugt, LEPM; de Jong, S; Matsiegui, PB; Ramharter, M; Kremsner, PG; Yazdanbakhsh, M; Adegnika, AA				Ateba-Ngoa, Ulysse; Mombo-Ngoma, Ghyslain; Zettlmeissi, Eva; van der Vlugt, Lucien E. P. M.; de Jong, Sanne; Matsiegui, Pierre-Blaise; Ramharter, Michael; Kremsner, Peter G.; Yazdanbakhsh, Maria; Adegnika, Ayola Akim			CD4(+)CD25(hi)FOXP3(+) Cells in Cord Blood of Neonates Born from Filaria Infected Mother Are Negatively Associated with CD(4+)Tbet(+) and CD4(+)ROR gamma t(+) T Cells	PLOS ONE			English	Article							PATENT LYMPHATIC FILARIASIS; IN-UTERO SENSITIZATION; WUCHERERIA-BANCROFTI; IMMUNE-RESPONSES; HELMINTH; MALARIA; EPIDEMIOLOGY; HOMEOSTASIS; PARASITES; NEWBORNS	Background: Children who have been exposed in utero to maternal filarial infection are immunologically less responsive to filarial antigens, have less pathology, and are more susceptible to acquire infection than offspring of uninfected mothers. Moreover children from filaria infected mothers have been shown to be less responsive to vaccination as a consequence of an impairment of their immune response. However, it is not well known how in utero exposure to parasite antigens affects cellular immune responses. Methodology: Here, 30 pregnant women were examined for the presence of microfilaria of Loa loa and Mansonella perstans in peripheral blood. At delivery, cord blood mononuclear cells (CBMC) were obtained and the CD4(+)T cells were phenotyped by expression of the transcription factors Tbet, ROR gamma t, and FOXP3. Results: No significant difference was observed between newborns from infected versus uninfected mothers in the frequencies of total CD4(+)T cells and CD4(+)T cells subsets including CD4(+)Tbet(+), CD4(+)ROR gamma t(+) T and CD4(+)CD25(hi)FOXP3(+) T cells. However, there was a negative association between CD4(+)CD25(hi)FOXP3(+)T cells and CD4(+)Tbet(+) as well as CD4(+)ROR gamma t(+) T cells in the infected group only (B=-0.242, P=0.002; B=-0.178, P=0.013 respectively). Conclusion: Our results suggest that filarial infection during pregnancy leads to an expansion of functionally active regulatory T cells that keep TH1 and TH17 in check.	[Ateba-Ngoa, Ulysse; Mombo-Ngoma, Ghyslain; Matsiegui, Pierre-Blaise; Ramharter, Michael; Kremsner, Peter G.; Yazdanbakhsh, Maria; Adegnika, Ayola Akim] Ctr Rech Med Lambarene, Lambarene, Gabon; [Ateba-Ngoa, Ulysse; Mombo-Ngoma, Ghyslain; van der Vlugt, Lucien E. P. M.; de Jong, Sanne; Yazdanbakhsh, Maria; Adegnika, Ayola Akim] Leiden Univ, Med Ctr, Dept Parasitol, NL-2333 ZA Leiden, Netherlands; [Ateba-Ngoa, Ulysse; Mombo-Ngoma, Ghyslain; Zettlmeissi, Eva; Ramharter, Michael; Kremsner, Peter G.; Adegnika, Ayola Akim] Univ Tubingen, Inst Tropenmed, D-72074 Tubingen, Germany; [Mombo-Ngoma, Ghyslain] Univ Sci Sante, Dept Parasitol Mycol, Libreville, Gabon; [Matsiegui, Pierre-Blaise] Ctr Rech Med Ngounie, Fougamou, Gabon; [Ramharter, Michael] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, A-1090 Vienna, Austria	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eberhard Karls University of Tubingen; Medical University of Vienna	Adegnika, AA (corresponding author), Ctr Rech Med Lambarene, BP 118, Lambarene, Gabon.	ayola-akim.adegnika@medizin.uni-tuebingen.de	Mombo-Ngoma, Ghyslain/I-4305-2019; Yazdanbakhsh, Maria/AAI-3996-2020; ADEGNIKA, Ayola Akim/AAK-7307-2020; de Jong, Sanne E./K-2242-2015; Ramharter, Michael/C-5273-2013	Mombo-Ngoma, Ghyslain/0000-0003-2658-8706; Yazdanbakhsh, Maria/0000-0002-7666-1441; de Jong, Sanne E./0000-0002-6696-7359; Ramharter, Michael/0000-0002-9259-1885	EU [HEALTH-F3-2009-241642]; Deutsche Forschungsgemeinschaft [1150/6-1]	EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the EU-funded project the Immunological Interplay between Poverty Related Diseases and Helminth infections: An African-European Research Initiative "IDEA" (HEALTH-F3-2009-241642) and the Deutsche Forschungsgemeinschaft-funded project Deutsch-Afrikanische Kooperationsprojekte in der Infektiologie (DFG-Projekt KR 1150/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegnika AA, 2008, J INFECT DIS, V198, P928, DOI 10.1086/591057; Adegnika AA, 2012, CURR OPIN HIV AIDS, V7, P221, DOI 10.1097/COH.0b013e3283524d90; Akue JP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001329; Anosike J. C., 1994, Applied Parasitology, V35, P294; Babu S, 2006, J IMMUNOL, V176, P3248, DOI 10.4049/jimmunol.176.5.3248; Babu S, 2005, INFECT IMMUN, V73, P3394, DOI 10.1128/IAI.73.6.3394-3401.2005; Bal MS, 2010, PARASITOLOGY, V137, P669, DOI 10.1017/S0031182009991478; Breitling LP, 2006, INFECT IMMUN, V74, P5725, DOI 10.1128/IAI.00682-06; Broen K, 2007, MOL BIOCHEM PARASIT, V151, P1, DOI 10.1016/j.molbiopara.2006.10.001; Bueno LL, 2012, ACTA TROP, V123, P53, DOI 10.1016/j.actatropica.2012.02.071; Chakir H, 2003, J IMMUNOL METHODS, V278, P157, DOI 10.1016/S0022-1759(03)00200-X; EBERHARD ML, 1993, J PARASITOL, V79, P62, DOI 10.2307/3283278; Gallagher M, 2005, AIDS, V19, P1849, DOI 10.1097/01.aids.0000189846.90946.5d; GOLDSMID JM, 1970, J CLIN PATHOL, V23, P632, DOI 10.1136/jcp.23.7.632; Grzanka J, 2013, INT IMMUNOPHARMACOL, V16, P343, DOI 10.1016/j.intimp.2013.02.004; Kurtis JD, 2011, INFECT IMMUN, V79, P1254, DOI 10.1128/IAI.01072-10; Lalor MK, 2009, J INFECT DIS, V199, P795, DOI 10.1086/597069; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Malhotra I, 2003, INFECT IMMUN, V71, P5231, DOI 10.1128/IAI.71.9.5231-5237.2003; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; Merlin M, 1990, Med Trop (Mars), V50, P39; Metenou S, 2010, J IMMUNOL, V184, P5375, DOI 10.4049/jimmunol.0904067; Nkoghe D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-33; Perlaza BL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-27; Peterson RA, 2012, TOXICOL PATHOL, V40, P186, DOI 10.1177/0192623311430693; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Seydel LS, 2012, AM J TROP MED HYG, V86, P613, DOI 10.4269/ajtmh.2012.11-0463; Soboslay PT, 1999, CLIN EXP IMMUNOL, V117, P130; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; Wammes LJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001655; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437	34	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114630	10.1371/journal.pone.0114630	http://dx.doi.org/10.1371/journal.pone.0114630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531674	Green Submitted, gold, Green Published			2022-12-26	WOS:000348845100021
J	Danielson, E; Lee, SH				Danielson, Eric; Lee, Sang H.			SynPAnal: Software for Rapid Quantification of the Density and Intensity of Protein Puncta from Fluorescence Microscopy Images of Neurons	PLOS ONE			English	Article							DENDRITIC SPINES; EXCITATORY SYNAPSES; PLASTICITY; DISORDERS	Continuous modification of the protein composition at synapses is a driving force for the plastic changes of synaptic strength, and provides the fundamental molecular mechanism of synaptic plasticity and information storage in the brain. Studying synaptic protein turnover is not only important for understanding learning and memory, but also has direct implication for understanding pathological conditions like aging, neurodegenerative diseases, and psychiatric disorders. Proteins involved in synaptic transmission and synaptic plasticity are typically concentrated at synapses of neurons and thus appear as puncta (clusters) in immunofluorescence microscopy images. Quantitative measurement of the changes in puncta density, intensity, and sizes of specific proteins provide valuable information on their function in synaptic transmission, circuit development, synaptic plasticity, and synaptopathy. Unfortunately, puncta quantification is very labor intensive and time consuming. In this article, we describe a software tool designed for the rapid semi-automatic detection and quantification of synaptic protein puncta from 2D immunofluorescence images generated by confocal laser scanning microscopy. The software, dubbed as SynPAnal (for Synaptic Puncta Analysis), streamlines data quantification for puncta density and average intensity, thereby increases data analysis throughput compared to a manual method. SynPAnal is stand-alone software written using the JAVA programming language, and thus is portable and platform-free.	[Danielson, Eric; Lee, Sang H.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Lee, Sang H.] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Lee, SH (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.	shlee@mcw.edu	Lee, Sang/R-7518-2019	Lee, Sang H./0000-0001-5467-0331; Danielson, Eric/0000-0002-5442-0460	NIH [MH078135]; Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078135] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the NIH grant MH078135 and by funding provided through the Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cheng J, 2007, J NEUROSCI METH, V165, P122, DOI 10.1016/j.jneumeth.2007.05.020; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Danielson E, 2012, J NEUROSCI, V32, P6967, DOI 10.1523/JNEUROSCI.0025-12.2012; El-Hussein AE, 2000, SCIENCE, V290, P1364; Hebb D.O., 2002, ORG BEHAV NEUROPSYCH; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Kandel E., 2000, PRINCIPLES NEURAL SC; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Koh IYY, 2002, NEURAL COMPUT, V14, P1283, DOI 10.1162/089976602753712945; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pozueta J, 2012, NEUROSCIENCE; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Schmitz SK, 2011, J NEUROSCI METH, V195, P185, DOI 10.1016/j.jneumeth.2010.12.011; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shin SM, 2012, NAT NEUROSCI, V15, P1655, DOI 10.1038/nn.3259; Ting JT, 2012, ANNU REV NEUROSCI, V35, P49, DOI 10.1146/annurev-neuro-062111-150442; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zhang Y, 2007, NEUROIMAGE, V36, P346, DOI 10.1016/j.neuroimage.2007.02.044	22	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115298	10.1371/journal.pone.0115298	http://dx.doi.org/10.1371/journal.pone.0115298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531531	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100050
J	Fujita, N; Ono, M; Tomioka, T; Deie, M				Fujita, Naoto; Ono, Miharu; Tomioka, Tomoka; Deie, Masataka			Effects of Hyperbaric Oxygen at 1.25 Atmospheres Absolute with Normal Air on Macrophage Number and Infiltration during Rat Skeletal Muscle Regeneration	PLOS ONE			English	Article							CONTRACTILE FUNCTION; CRUSH INJURY; EXERCISE; THERAPY; HYPOXIA; EXPRESSION; APOPTOSIS; SORENESS; GROWTH; BLOOD	Use of mild hyperbaric oxygen less than 2 atmospheres absolute (2026.54 hPa) with normal air is emerging as a common complementary treatment for severe muscle injury. Although hyperbaric oxygen at over 2 atmospheres absolute with 100% O2 promotes healing of skeletal muscle injury, it is not clear whether mild hyperbaric oxygen is equally effective. The purpose of the present study was to investigate the impact of hyperbaric oxygen at 1.25 atmospheres absolute (1266.59 hPa) with normal air on muscle regeneration. The tibialis anterior muscle of male Wistar rats was injured by injection of bupivacaine hydrochloride, and rats were randomly assigned to a hyperbaric oxygen experimental group or to a nonhyperbaric oxygen control group. Immediately after the injection, rats were exposed to hyperbaric oxygen, and the treatment was continued for 28 days. The cross-sectional area of centrally nucleated muscle fibers was significantly larger in rats exposed to hyperbaric oxygen than in controls 5 and 7 days after injury. The number of CD68- or CD68- and CD206-positive cells was significantly higher in rats exposed to hyperbaric oxygen than in controls 24 h after injury. Additionally, tumor necrosis factor-a and interleukin-10 mRNA expression levels were significantly higher in rats exposed to hyperbaric oxygen than in controls 24 h after injury. The number of Pax7- and MyoD- or MyoD- and myogenin-positive nuclei per mm(2) and the expression levels of these proteins were significantly higher in rats exposed to hyperbaric oxygen than in controls 5 days after injury. These results suggest that mild hyperbaric oxygen promotes skeletal muscle regeneration in the early phase after injury, possibly due to reduced hypoxic conditions leading to accelerated macrophage infiltration and phenotype transition. In conclusion, mild hyperbaric oxygen less than 2 atmospheres absolute with normal air is an appropriate support therapy for severe muscle injuries.	[Fujita, Naoto; Ono, Miharu; Tomioka, Tomoka; Deie, Masataka] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Hiroshima, Japan; [Fujita, Naoto; Deie, Masataka] Hiroshima Univ, Fac Med, Hiroshima, Hiroshima, Japan	Hiroshima University; Hiroshima University	Fujita, N (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Hiroshima, Japan.	fujitan@hiroshima-u.ac.jp		Fujita, Naoto/0000-0001-9416-3502	Japanese Ministry of Education, Culture, Sports, Science, and Technology [25750202]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (no. 25750202 to NF). The URL of the funder's website is http://www.mext.go.jp/english/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2007, CIRC J, V71, P405, DOI 10.1253/circj.71.405; Babul S, 2003, CLIN J SPORT MED, V13, P138, DOI 10.1097/00042752-200305000-00003; Bajek S, 2011, COLLEGIUM ANTROPOL, V35, P91; Best TM, 1998, AM J SPORT MED, V26, P367, DOI 10.1177/03635465980260030401; Bosco MC, 2004, J IMMUNOL, V172, P1681, DOI 10.4049/jimmunol.172.3.1681; Bozok S, 2012, EUR J MED RES, V17, DOI 10.1186/2047-783X-17-14; Chaillou T, 2014, PFLUG ARCH EUR J PHY, V466, P587, DOI 10.1007/s00424-013-1336-7; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Escribese MM, 2012, IMMUNOBIOLOGY, V217, P1233, DOI 10.1016/j.imbio.2012.07.002; Germain G, 2003, UNDERSEA HYPERBAR M, V30, P135; Gregorevic P, 2000, J APPL PHYSIOL, V89, P1477, DOI 10.1152/jappl.2000.89.4.1477; Gregorevic P, 2002, MED SCI SPORT EXER, V34, P630, DOI 10.1097/00005768-200204000-00011; Harrison BC, 2001, MED SCI SPORT EXER, V33, P36; Kawada S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072603; Kharraz Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/491497; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Lu PG, 2013, J NEUROSURG SCI, V57, P253; Malm C, 2000, J PHYSIOL-LONDON, V529, P243, DOI 10.1111/j.1469-7793.2000.00243.x; Mekjavic IB, 2000, MED SCI SPORT EXER, V32, P558, DOI 10.1097/00005768-200003000-00002; Novak ML, 2014, J PATHOL, V232, P344, DOI 10.1002/path.4301; Novak ML, 2013, AM J PATHOL, V183, P1352, DOI 10.1016/j.ajpath.2013.06.034; Otis JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092363; Rigamonti E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/560629; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Takagi R, 2011, J APPL PHYSIOL, V110, P382, DOI 10.1152/japplphysiol.01187.2010; Takeuchi K, 2014, ACTA HISTOCHEM, V116, P327, DOI 10.1016/j.acthis.2013.08.010; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Ueng SWN, 2013, J ORTHOP RES, V31, P376, DOI 10.1002/jor.22235; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Yu JG, 2002, HISTOCHEM CELL BIOL, V118, P29, DOI 10.1007/s00418-002-0423-1; Yu JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062056; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	33	15	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115685	10.1371/journal.pone.0115685	http://dx.doi.org/10.1371/journal.pone.0115685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531909	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100094
J	Lam, PK				Lam, Pui K.			Special Relativity at the Quantum Scale	PLOS ONE			English	Article							DIRAC-EQUATION; NET	It has been suggested that the space-time structure as described by the theory of special relativity is a macroscopic manifestation of a more fundamental quantum structure (pre-geometry). Efforts to quantify this idea have come mainly from the area of abstract quantum logic theory. Here we present a preliminary attempt to develop a quantum formulation of special relativity based on a model that retains some geometric attributes. Our model is Feynman's "checker-board'' trajectory for a 1-D relativistic free particle. We use this model to guide us in identifying (1) the quantum version of the postulates of special relativity and (2) the appropriate quantum "coordinates''. This model possesses a useful feature that it admits an interpretation both in terms of paths in space-time and in terms of quantum states. Based on the quantum version of the postulates, we derive a transformation rule for velocity. This rule reduces to the Einstein's velocity-addition formula in the macroscopic limit and reveals an interesting aspect of time. The 3-D case, timedilation effect, and invariant interval are also discussed in term of this new formulation. This is a preliminary investigation; some results are derived, while others are interesting observations at this point.	Univ Hawaii Manoa, Dept Phys & Astron, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Lam, PK (corresponding author), Univ Hawaii Manoa, Dept Phys & Astron, Honolulu, HI 96822 USA.	plam@hawaii.edu						Einstein A, 1905, ANN PHYS-BERLIN, V17, P891; Einstein A., 1945, MEANING RELATIVITY; Feynman R. P., 1985, QED STRANGE THEORY L; Feynman R. P., 1965, QUANTUM MECH PATH IN, P35; FINKELSTEIN D, 1969, PHYS REV, V184, P1261, DOI 10.1103/PhysRev.184.1261; FINKELSTEIN D, 1989, INT J THEOR PHYS, V28, P441, DOI 10.1007/BF00673296; FINKELSTEIN D, 1991, INT J THEOR PHYS, V30, P463, DOI 10.1007/BF00672892; GERSCH HA, 1981, INT J THEOR PHYS, V20, P491, DOI 10.1007/BF00669436; JACOBSON T, 1984, J PHYS A-MATH GEN, V17, P2433, DOI 10.1088/0305-4470/17/12/015; JACOBSON T, 1984, J PHYS A-MATH GEN, V17, P375, DOI 10.1088/0305-4470/17/2/023; Landau LD, 1996, CLASSICAL THEORY FIE, P2; Marlow JR, 1980, QUANTUM THEORY GRAVI, P36; Michelson AA, 1887, AM J SCI, V34, P333, DOI [DOI 10.2475/AJS.S3-34.203.333, 10.2475/ajs.s3-34.203.333]; ORD GN, 1993, PHYS LETT A, V173, P343, DOI 10.1016/0375-9601(93)90247-W; Penrose R., 1984, SPINORS SPACE TIME, V1; ROSEN G, 1983, PHYS REV A, V28, P1139, DOI 10.1103/PhysRevA.28.1139; Schwinger J., 1958, SELECTED PAPERS QUAN; SELESNICK SA, 1991, INT J THEOR PHYS, V30, P1273, DOI 10.1007/BF01026175; von Weizsacker C. F., 1975, Quantum theory and the structures of time and space, P213; Wheeler J. A., 1989, P WORKSH COMPL ENTR, P3; Wheeler J. A., 1980, QUANTUM THEORY GRAVI, P1	22	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115810	10.1371/journal.pone.0115810	http://dx.doi.org/10.1371/journal.pone.0115810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531675	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100111
J	Taylor, PN; Wang, Y; Goodfellow, M; Dauwels, J; Moeller, F; Stephani, U; Baier, G				Taylor, Peter Neal; Wang, Yujiang; Goodfellow, Marc; Dauwels, Justin; Moeller, Friederike; Stephani, Ulrich; Baier, Gerold			A Computational Study of Stimulus Driven Epileptic Seizure Abatement	PLOS ONE			English	Article							ABSENCE SEIZURES; DYNAMICS; SPIKE; MODEL; STIMULATION; INHIBITION; OSCILLATIONS; THALAMUS; DISEASES	Active brain stimulation to abate epileptic seizures has shown mixed success. In spike-wave (SW) seizures, where the seizure and background state were proposed to coexist, single-pulse stimulations have been suggested to be able to terminate the seizure prematurely. However, several factors can impact success in such a bistable setting. The factors contributing to this have not been fully investigated on a theoretical and mechanistic basis. Our aim is to elucidate mechanisms that influence the success of single-pulse stimulation in noise-induced SW seizures. In this work, we study a neural population model of SW seizures that allows the reconstruction of the basin of attraction of the background activity as a four dimensional geometric object. For the deterministic (noise-free) case, we show how the success of response to stimuli depends on the amplitude and phase of the SW cycle, in addition to the direction of the stimulus in state space. In the case of spontaneous noise-induced seizures, the basin becomes probabilistic introducing some degree of uncertainty to the stimulation outcome while maintaining qualitative features of the noise-free case. Additionally, due to the different time scales involved in SW generation, there is substantial variation between SW cycles, implying that there may not be a fixed set of optimal stimulation parameters for SW seizures. In contrast, the model suggests an adaptive approach to find optimal stimulation parameters patient-specifically, based on real-time estimation of the position in state space. We discuss how the modelling work can be exploited to rationally design a successful stimulation protocol for the abatement of SW seizures using real-time SW detection.	[Taylor, Peter Neal; Wang, Yujiang] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Goodfellow, Marc] Univ Exeter, Coll Engn, Exeter, Devon, England; [Dauwels, Justin] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Moeller, Friederike; Stephani, Ulrich] Univ Med Ctr Schleswig Holstein, Dept Neuropediat, Kiel, Germany; [Baier, Gerold] UCL, London, England	Newcastle University - UK; University of Exeter; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Kiel; Schleswig Holstein University Hospital; University of London; University College London	Baier, G (corresponding author), UCL, London, England.	g.baier@ucl.ac.uk	Stephani, Ulrich/D-1004-2010; Taylor, Peter/E-8927-2011	Wang, Yujiang/0000-0002-4847-6273; Baier, Gerold/0000-0002-2540-3100; Moeller, Friederike/0000-0003-2434-2825; Taylor, Peter/0000-0003-2144-9838	EPSRC [EP/K026992/1]; BBSRC; DTC for Systems Biology (University of Manchester); Nanyang Technological University Singapore; Engineering and Physical Sciences Research Council [EP/K026992/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DTC for Systems Biology (University of Manchester); Nanyang Technological University Singapore(Nanyang Technological University); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the EPSRC (EP/K026992/1), the BBSRC, the DTC for Systems Biology (University of Manchester), and the Nanyang Technological University Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Otaibi FA, 2011, NEUROSURGERY, V69, P957, DOI 10.1227/NEU.0b013e31822b30cd; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Anderson WS, 2007, BIOL CYBERN, V97, P173, DOI 10.1007/s00422-007-0166-0; Avoli M, 2012, EPILEPSIA, V53, P779, DOI 10.1111/j.1528-1167.2012.03421.x; Barnes GN, 2008, NAT CLIN PRACT NEURO, V4, P650, DOI 10.1038/ncpneuro0947; Berenyi A, 2012, SCIENCE, V337, P735, DOI 10.1126/science.1223154; Breakspear M, 2006, CEREB CORTEX, V16, P1296, DOI 10.1093/cercor/bhj072; Cagnan H, 2013, BRAIN, V136, P3062, DOI 10.1093/brain/awt239; Caplan R, 2008, EPILEPSIA, V49, P1838, DOI 10.1111/j.1528-1167.2008.01680.x; Chakravarthy N, 2009, ANN BIOMED ENG, V37, P565, DOI 10.1007/s10439-008-9625-6; Conte A, 2007, NEUROSCI RES, V57, P140, DOI 10.1016/j.neures.2006.09.015; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; Dedeurwaerdere S, 2004, EPILEPSY RES, V59, P191, DOI 10.1016/j.eplepsyres.2004.04.005; Destexhe A, 1998, J NEUROSCI, V18, P9099; Foss J, 2002, BIO MED PHY, P283; Frohlich F, 2010, J NEUROSCI, V30, P10734, DOI 10.1523/JNEUROSCI.1239-10.2010; Goodfellow M, 2011, NEUROIMAGE, V55, P920, DOI 10.1016/j.neuroimage.2010.12.074; Kramer MA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041928; Marten F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.021911; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; MILTON J, 1995, CHAOS, V5, P8, DOI 10.1063/1.166103; Moeller F, 2008, EPILEPSIA, V49, P1510, DOI 10.1111/j.1528-1167.2008.01626.x; Moeller F, 2013, HUM BRAIN MAPP, V34, P1896, DOI 10.1002/hbm.22026; Moeller F, 2010, EPILEPSIA, V51, P2000, DOI 10.1111/j.1528-1167.2010.02698.x; Motamedi GK, 2002, EPILEPSIA, V43, P1441, DOI 10.1111/j.0013-9580.2002.4311a29.x; Oprisan SA, 2003, BIOPHYS J, V84, P2919, DOI 10.1016/S0006-3495(03)70019-8; Osorio I, 2009, INT J NEURAL SYST, V19, P149, DOI 10.1142/S0129065709001926; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Pinault Didier, 2005, Thalamus & Related Systems, V3, P181, DOI 10.1017/S1472928807000209; RAJNA P, 1989, EPILEPSIA, V30, P168, DOI 10.1111/j.1528-1157.1989.tb05450.x; Robinson PA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041924; Rodrigues S, 2006, PHYS LETT A, V355, P352, DOI 10.1016/j.physleta.2006.03.003; Saillet S, 2013, BRAIN STIMUL, V6, P241, DOI 10.1016/j.brs.2012.05.009; Selai C, 2005, EPILEPSIA, V46, P50, DOI 10.1111/j.1528-1167.2005.463010.x; Sinha N, 2014, P IEEE SMC; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439, DOI 10.1152/jn.1998.80.3.1439; Suffczynski P, 2006, IEEE T BIO-MED ENG, V53, P524, DOI 10.1109/TBME.2005.869800; Suffczynski P, 2004, NEUROSCIENCE, V126, P467, DOI 10.1016/j.neuroscience.2004.03.014; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Taylor PN, 2013, 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE, COGNITIVE ALGORITHMS, MIND, AND BRAIN (CCMB), P53, DOI 10.1109/CCMB.2013.6609165; Taylor PN, 2014, J NEUROSCI METH, V236, P51, DOI 10.1016/j.jneumeth.2014.08.010; Taylor PN, 2013, BIOL CYBERN, V107, P83, DOI 10.1007/s00422-012-0534-2; Taylor PN, 2011, J COMPUT NEUROSCI, V31, P679, DOI 10.1007/s10827-011-0332-1; Terry JR, 2012, EPILEPSIA, V53, pe166, DOI 10.1111/j.1528-1167.2012.03560.x; THEILER J, 1995, PHYS LETT A, V196, P335, DOI 10.1016/0375-9601(94)00856-K; Wang YJ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061918; Yousif NAB, 2005, EUR J NEUROSCI, V22, P3179, DOI 10.1111/j.1460-9568.2005.04496.x	51	67	70	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114316	10.1371/journal.pone.0114316	http://dx.doi.org/10.1371/journal.pone.0114316			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531883	Green Published, gold			2022-12-26	WOS:000348845100013
J	van der Linden, A; Blokker, BM; Kap, M; Weustink, AC; Riegman, PHJ; Oosterhuis, JW				van der Linden, Anita; Blokker, Britt M.; Kap, Marcel; Weustink, Annick C.; Riegman, Peter H. J.; Oosterhuis, J. Wolter			Post-Mortem Tissue Biopsies Obtained at Minimally Invasive Autopsy: An RNA-Quality Analysis	PLOS ONE			English	Article							MESSENGER-RNA; HETEROGENEITY; PERCEPTIONS; INTEGRITY	Introduction: Bereaved relatives often refuse to give consent for post-mortem investigation of deceased cancer patients, mainly because of the mutilation due to conventional autopsy (CA). Minimally invasive autopsy (MIA) may be a more acceptable alternative and, if implemented in clinical practice, creates an opportunity to more often obtain post-mortem tissue samples of (recurred) primary tumors and metastases for molecular research. As a measure for tissue quality for molecular studies, we hereby present a feasibility study, comparing the RNA quality of MIA and CA samples, and fresh frozen samples as reference. Materials and methods: Tissue samples of heart, liver and kidney were prospectively collected from 24 MIAs followed by CA, and compared to corresponding archival fresh frozen tissue. After RNA isolation and RT-qPCR, RNA integrity numbers (RIN) and GAPDH expression (six amplicon sizes ranging from 71 to 530 base pairs) were measured. RIN values and GAPDH Cq values were analyzed and compared between all sample groups and post-mortem intervals (PMI). Results: RIN values in MIA samples were significantly higher than those in CA samples. GAPDH was expressed significantly higher in MIA samples than in CA samples and 530 bp PCR products could be measured in all cases. GAPDH expression was significantly lower in samples with PMI >15 hours. As expected, the samples of the fresh frozen reference standard performed best in all analyses. Conclusion: MIA samples showed better RNA quality than CA samples, probably due to shorter PMI. Both had lower RNA quality and expression levels than fresh frozen tissue, however, remaining GAPDH RNA was still sufficiently intact. Therefore, other highly expressed genes are most likely also detectable. Gene array analysis should be performed to gain insight into the quality of entire postmortem genomes. Reducing PMI will further improve the feasibility of demanding molecular research on post-mortem tissues, this is most likely more feasible with MIA than CA.	[van der Linden, Anita; Blokker, Britt M.; Kap, Marcel; Riegman, Peter H. J.; Oosterhuis, J. Wolter] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Weustink, Annick C.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Oosterhuis, JW (corresponding author), Erasmus MC, Dept Pathol, Rotterdam, Netherlands.	j.w.oosterhuis@erasmusmc.nl	Riegman, Peter/GLS-0041-2022; Cappello, Francesco/F-9153-2012	Cappello, Francesco/0000-0001-9288-1148	Muntendam Prize of the Dutch Cancer Society [md11.009]	Muntendam Prize of the Dutch Cancer Society	The work described in this article was funded by the Muntendam Prize of the Dutch Cancer Society 2011 (number md11.009, http://www.kwf.nl/english/pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Allison KH, 2014, ONCOLOGY WILLISTON P, V15, P28; Bauer Martin, 2003, Leg Med (Tokyo), V5, P220, DOI 10.1016/j.legalmed.2003.08.001; Beach TG, 2009, 2009 BRN S 27; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Birdsill AC, 2011, CELL TISSUE BANK, V12, P311, DOI 10.1007/s10561-010-9210-8; BROWN HG, 1990, HUM PATHOL, V21, P154, DOI 10.1016/0046-8177(90)90123-M; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Byard RW, 2012, FORENSIC SCI MED PAT, V8, P402, DOI 10.1007/s12024-012-9322-5; Finkbeiner WE, 2009, AUTOPSY PATHOLOGY MA, P93; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Gupta S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-26; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heinrich M, 2007, INT J LEGAL MED, V121, P136, DOI 10.1007/s00414-006-0131-9; Hoefnagel LDC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2645; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kim BJ, 2013, MOL VIS, V19, P1290; Koppelkamm A, 2011, INT J LEGAL MED, V125, P573, DOI 10.1007/s00414-011-0578-1; Kristensen T, 2011, APPL IMMUNOHISTO M M, V19, P460, DOI 10.1097/PAI.0b013e318214e523; Mager SR, 2007, EUR J CANCER, V43, P828, DOI 10.1016/j.ejca.2007.01.002; MCPHEE SJ, 1986, AM J MED, V80, P665, DOI 10.1016/0002-9343(86)90822-3; Oluwasola OA, 2009, ARCH PATHOL LAB MED, V133, P78, DOI 10.1043/1543-2165-133.1.78; Partemi S, 2010, FORENSIC SCI INT, V203, P99, DOI 10.1016/j.forsciint.2010.07.005; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Romero IG, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-42; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; Sampaio-Silva F, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056507, 10.1371/annotation/cb8b37ac-cbe2-45e3-b9fe-d62e7ced4b25]; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sieuwerts AM, 2009, BREAST CANCER RES TR, V118, P455, DOI 10.1007/s10549-008-0290-0; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Vennemann M, 2010, FORENSIC SCI INT, V203, P76, DOI 10.1016/j.forsciint.2010.07.007; Viertler C, 2012, J MOL DIAGN, V14, P458, DOI 10.1016/j.jmoldx.2012.05.002; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Weustink AC, 2009, RADIOLOGY, V250, P897, DOI 10.1148/radiol.2503080421	36	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115675	10.1371/journal.pone.0115675	http://dx.doi.org/10.1371/journal.pone.0115675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531551	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845100091
J	Ahmad, J; Mohyud-Din, ST				Ahmad, Jamshad; Mohyud-Din, Syed Tauseef			An Efficient Algorithm for Some Highly Nonlinear Fractional PDEs in Mathematical Physics	PLOS ONE			English	Editorial Material							VARIATIONAL ITERATION METHOD; DIFFERENTIAL-EQUATIONS; NUMERICAL-SOLUTION; TRANSFORM	In this paper, a fractional complex transform (FCT) is used to convert the given fractional partial differential equations (FPDEs) into corresponding partial differential equations (PDEs) and subsequently Reduced Differential Transform Method (RDTM) is applied on the transformed system of linear and nonlinear time-fractional PDEs. The results so obtained are re-stated by making use of inverse transformation which yields it in terms of original variables. It is observed that the proposed algorithm is highly efficient and appropriate for fractional PDEs and hence can be extended to other complex problems of diversified nonlinear nature.	[Ahmad, Jamshad; Mohyud-Din, Syed Tauseef] HITEC Univ, Fac Sci, Dept Math, Taxila, Pakistan	NITEC University	Ahmad, J (corresponding author), HITEC Univ, Fac Sci, Dept Math, Taxila, Pakistan.	jamshadahmadm@gmail.com						Abbasbandy S, 2007, J COMPUT APPL MATH, V207, P59, DOI 10.1016/j.cam.2006.07.012; Abbasbandy S, 2007, INT J NUMER METH ENG, V70, P876, DOI 10.1002/nme.1924; Arikoglu A, 2007, CHAOS SOLITON FRACT, V34, P1473, DOI 10.1016/j.chaos.2006.09.004; Bildik N, 2006, INT J NONLIN SCI NUM, V7, P65; FORNBERG B, 1978, PHILOS T R SOC A, V289, P373, DOI 10.1098/rsta.1978.0064; He B, 2010, APPL MATH COMPUT, V217, P1976, DOI 10.1016/j.amc.2010.06.055; Jang MJ, 2006, APPL MATH COMPUT, V181, P767; Jumarie G, 2006, COMPUT MATH APPL, V51, P1367, DOI 10.1016/j.camwa.2006.02.001; Kurnaz A, 2005, INT J COMPUT MATH, V82, P709, DOI 10.1080/00207160512331329050; Li ZB, 2010, MATH COMPUT APPL, V15, P970, DOI 10.3390/mca15050970; Matinfar M, 2010, APPL APPL MATH, V5, P70; Merdan Mehmet, 2011, Mathematical & Computational Applications, V16, P761; Mohyud-Din S., 2010, WORLD APPL SCI J, V11, P622; Mohyud-Din ST, 2009, COMMUN KOREAN MATH S, V24, P605, DOI 10.4134/CKMS.2009.24.4.605; Momani S, 2005, APPL MATH COMPUT, V162, P1351, DOI 10.1016/j.amc.2004.03.014; Noor MA, 2008, ACTA APPL MATH, V104, P257, DOI 10.1007/s10440-008-9255-x; Odibat Z, 2007, PHYS LETT A, V369, P349, DOI 10.1016/j.physleta.2007.05.002; OLVER PJ, 1977, J MATH PHYS, V18, P1212, DOI 10.1063/1.523393; Rawashdeh, 2013, J APPL MATH BIONORFO, V3, P1; Soliman AA, 2006, CHAOS SOLITON FRACT, V29, P294, DOI 10.1016/j.chaos.2005.08.054; Sweilam NH, 2007, CHAOS SOLITON FRACT, V32, P145, DOI 10.1016/j.chaos.2005.11.028; Wazwaz AM, 2007, COMMUN NONLINEAR SCI, V12, P1395, DOI 10.1016/j.cnsns.2005.11.007; WHITHAM GB, 1967, PROC R SOC LON SER-A, V299, P6, DOI 10.1098/rspa.1967.0119; Yildirim A, 2009, ADV WATER RESOUR, V32, P1711, DOI 10.1016/j.advwatres.2009.09.003; Zhou J.K., 1986, DIFFERENTIAL TRANSFO; 何吉欢, 1999, [科技通报, Bulletin of Science and Technology], V15, P86	26	9	9	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e109127	10.1371/journal.pone.0109127	http://dx.doi.org/10.1371/journal.pone.0109127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525804	Green Published, gold, Green Submitted			2022-12-26	WOS:000347186200064
J	Boivin, F; Simard, A; Peres-Neto, P				Boivin, Frederic; Simard, Anouk; Peres-Neto, Pedro			Can Wide Consultation Help with Setting Priorities for Large-Scale Biodiversity Monitoring Programs?	PLOS ONE			English	Editorial Material							CLIMATE-CHANGE; CONSERVATION; MANAGEMENT; SCIENCE; NEEDS	Climate and other global change phenomena affecting biodiversity require monitoring to track ecosystem changes and guide policy and management actions. Designing a biodiversity monitoring program is a difficult task that requires making decisions that often lack consensus due to budgetary constrains. As monitoring programs require long-term investment, they also require strong and continuing support from all interested parties. As such, stakeholder consultation is key to identify priorities and make sound design decisions that have as much support as possible. Here, we present the results of a consultation conducted to serve as an aid for designing a large-scale biodiversity monitoring program for the province of Quebec (Canada). The consultation took the form of a survey with 13 discrete choices involving tradeoffs in respect to design priorities and 10 demographic questions (e.g., age, profession). The survey was sent to thousands of individuals having expected interests and knowledge about biodiversity and was completed by 621 participants. Overall, consensuses were few and it appeared difficult to create a design fulfilling the priorities of the majority. Most participants wanted 1) a monitoring design covering the entire territory and focusing on natural habitats; 2) a focus on species related to ecosystem services, on threatened and on invasive species. The only demographic characteristic that was related to the type of prioritization was the declared level of knowledge in biodiversity (null to high), but even then the influence was quite small.	[Boivin, Frederic; Peres-Neto, Pedro] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Simard, Anouk] Minist Forets Faune & Parcs, Quebec City, PQ, Canada	University of Quebec; University of Quebec Montreal	Boivin, F (corresponding author), Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada.	fredboivin@gmail.com		Peres Neto, Pedro/0000-0002-5629-8067				Balmford A, 2005, PHILOS T ROY SOC B, V360, P221, DOI 10.1098/rstb.2004.1599; Bonardi A, 2011, BIOL CONSERV, V144, P2328, DOI 10.1016/j.biocon.2011.06.011; Boutin S, 2009, FOREST ECOL MANAG, V258, pS168, DOI 10.1016/j.foreco.2009.08.024; Brown G, 2004, APPL GEOGR, V24, P161, DOI 10.1016/j.apgeog.2004.03.006; Caughlan L., 2001, ECOL INDIC, V1, DOI [10.1016/S1470-160X(01)00015-2, DOI 10.1016/S1470-160X(01)00015-2]; Convention on Biological Diversity (CBD), 2010, GLOB BIOD OUTL; Couillard L, 1986, VEEGEETATION MILIEUX; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; De'ath G, 2012, MULTIVARIATE PARTITI; Duarte LDS, 2012, ECOGRAPHY, V35, P952, DOI 10.1111/j.1600-0587.2011.07193.x; Geupel GR, 2011, TRENDS ECOL EVOL, V26, P107, DOI 10.1016/j.tree.2010.11.007; Green RE, 2005, CONSERV BIOL, V19, P56, DOI 10.1111/j.1523-1739.2005.00289.x; Haughland DL, 2010, TRENDS ECOL EVOL, V25, P199, DOI 10.1016/j.tree.2009.11.005; Human BA, 2010, MAR POLICY, V34, P645, DOI 10.1016/j.marpol.2009.12.003; Jiguet F, 2012, ACTA OECOL, V44, P58, DOI 10.1016/j.actao.2011.05.003; Legg CJ, 2006, J ENVIRON MANAGE, V78, P194, DOI 10.1016/j.jenvman.2005.04.016; Lepetz V, 2009, BIODIVERS CONSERV, V18, P3185, DOI 10.1007/s10531-009-9636-0; Lindenmayer DB, 2013, FRONT ECOL ENVIRON, V11, P549, DOI 10.1890/120220; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P745, DOI 10.1111/j.1442-9993.2011.02351.x; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P285, DOI 10.1111/j.1442-9993.2011.02314.x; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Lindenmayer DB, 2010, TRENDS ECOL EVOL, V25, P200, DOI 10.1016/j.tree.2009.11.006; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Lovett GM, 2007, FRONT ECOL ENVIRON, V5, P253, DOI 10.1890/1540-9295(2007)5[253:WNEM]2.0.CO;2; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Maddock AH, 2000, BIODIVERS CONSERV, V9, P1153, DOI 10.1023/A:1008992602151; MDDEP, 2013, REG AIR PROT; Montoya JM, 2010, PHILOS T R SOC B, V365, P2013, DOI 10.1098/rstb.2010.0114; MRNF, 2012, RESS IND FOR; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; R Core Team, 2021, R LANGUAGE ENV STAT; Rudd MA, 2014, BIOSCIENCE, V64, P219, DOI 10.1093/biosci/bit035; Rudd MA, 2013, MAR POLICY, V39, P101, DOI 10.1016/j.marpol.2012.09.004; Rudd MA, 2011, CONSERV BIOL, V25, P1165, DOI 10.1111/j.1523-1739.2011.01772.x; Rudd MA, 2011, CONSERV BIOL, V25, P476, DOI 10.1111/j.1523-1739.2010.01625.x; Schindler DW, 2001, CAN J FISH AQUAT SCI, V58, P18, DOI 10.1139/cjfas-58-1-18; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Tardif B., 2005, ATLAS BIODIVERSITE Q; Watson I, 2004, AUSTRAL ECOL, V29, P16, DOI 10.1111/j.1442-9993.2004.01350.x; Xenopoulos MA, 2005, GLOBAL CHANGE BIOL, V11, P1557, DOI 10.1111/j.1365-2486.2005.001008.x; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Zarraga A, 2011, STUD CLASS DATA ANAL, P505, DOI 10.1007/978-3-642-11363-5_57	48	0	0	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e113905	10.1371/journal.pone.0113905	http://dx.doi.org/10.1371/journal.pone.0113905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525798	Green Published, gold, Green Submitted			2022-12-26	WOS:000347186200069
J	Rajashekar, R; Liebl, D; Chikkaballi, D; Liss, V; Hensel, M				Rajashekar, Roopa; Liebl, David; Chikkaballi, Deepak; Liss, Viktoria; Hensel, Michael			Live Cell Imaging Reveals Novel Functions of Salmonella enterica SPI2-T3SS Effector Proteins in Remodeling of the Host Cell Endosomal System	PLOS ONE			English	Article							III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; LYSOSOMAL MEMBRANE-GLYCOPROTEINS; EPITHELIAL-CELLS; INTRACELLULAR SALMONELLA; ESCHERICHIA-COLI; TRANSLOCATED EFFECTORS; FILAMENTOUS STRUCTURES; TYPHIMURIUM; TRAFFICKING	Intracellular Salmonella enterica induce a massive remodeling of the endosomal system in infected host cells. One dramatic consequence of this interference is the induction of various extensive tubular aggregations of membrane vesicles, and tubules positive for late endosomal/lysosomal markers are referred to as Salmonella-induced filaments or SIF. SIF are highly dynamic in nature with extension and collapse velocities of 0.4-0.5 mm x sec(-1). The induction of SIF depends on the function of the Salmonella Pathogenicity Island 2 (SPI2) encoded type III secretion system (T3SS) and a subset of effector proteins. In this study, we applied live cell imaging and electron microscopy to analyze the role of individual effector proteins in SIF morphology and dynamic properties of SIF. SIF in cells infected with sifB, sseJ, sseK1, sseK2, sseI, sseL, sspH1, sspH2, slrP, steC, gogB or pipB mutant strains showed a morphology and dynamics comparable to SIF induced by WT Salmonella. SIF were absent in cells infected with the sifA-deficient strain and live cell analyses allowed tracking of the loss of the SCV membrane of intracellular sifA Salmonella. In contrast to analyses in fixed cells, in living host cells SIF induced by sseF- or sseG-deficient strains were not discontinuous, but rather continuous and thinner in diameter. A very dramatic phenotype was observed for the pipB2-deficient strain that induced very bulky, non-dynamic aggregations of membrane vesicles. Our study underlines the requirement of the study of Salmonella-host interaction in living systems and reveals new phenotypes due to the intracellular activities of Salmonella.	[Rajashekar, Roopa; Liebl, David; Chikkaballi, Deepak; Hensel, Michael] Univ Klinikum Erlangen, Mikrobiol Inst, Erlangen, Germany; [Liebl, David] EMBL Heidelberg, Cell Biol & Biophys Unit, Heidelberg, Germany; [Chikkaballi, Deepak; Liss, Viktoria; Hensel, Michael] Univ Osnabruck, Abt Mikrobiol, Osnabruck, Germany	University of Erlangen Nuremberg; European Molecular Biology Laboratory (EMBL); University Osnabruck	Hensel, M (corresponding author), Univ Klinikum Erlangen, Mikrobiol Inst, Erlangen, Germany.	Michael.Hensel@biologie.uni-osnabrueck.de	Liebl, David/AFJ-1224-2022; Liebl, David/AAF-4479-2022; Chikkaballi, Deepak/AAB-2775-2021	Liss, Viktoria/0000-0002-1304-2512; C A, Deepak/0000-0001-7835-5790; Hensel, Michael/0000-0001-6604-6253; Liebl, David/0000-0002-1899-7713	Deutsche Forschungsgemeinschaft [HE1964/17-1, HE1964/18-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft as project grant HE1964/17-1 and continued by grant HE1964/18-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakowski MA, 2010, CELL HOST MICROBE, V7, P453, DOI 10.1016/j.chom.2010.05.011; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Compeer EB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00037; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Drecktrah D, 2008, TRAFFIC, V9, P2117, DOI 10.1111/j.1600-0854.2008.00830.x; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544; Guy RL, 2000, MOL MICROBIOL, V37, P1417, DOI 10.1046/j.1365-2958.2000.02092.x; Halici S, 2008, INFECT IMMUN, V76, P4924, DOI 10.1128/IAI.00531-08; Hansen-Wester I, 2002, INFECT IMMUN, V70, P1403, DOI 10.1128/IAI.70.3.1403-1409.2002; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Henry T, 2006, P NATL ACAD SCI USA, V103, P13497, DOI 10.1073/pnas.0605443103; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Knodler LA, 2005, INFECT IMMUN, V73, P7027, DOI 10.1128/IAI.73.10.7027-7031.2005; Knodler LA, 2005, MOL BIOL CELL, V16, P4108, DOI 10.1091/mbc.e05-04-0367; Knodler LA, 2003, MOL MICROBIOL, V49, P685, DOI 10.1046/j.1365-2958.2003.03598.x; Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z; Kuhle V, 2004, TRAFFIC, V5, P356, DOI 10.1111/j.1398-9219.2004.00179.x; Kuhle V, 2002, CELL MICROBIOL, V4, P813, DOI 10.1046/j.1462-5822.2002.00234.x; Malik-Kale P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038732; Medina E, 1999, INFECT IMMUN, V67, P1093, DOI 10.1128/IAI.67.3.1093-1099.1999; Mesquita FS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002743; Mota LJ, 2009, CELL MICROBIOL, V11, P1236, DOI 10.1111/j.1462-5822.2009.01329.x; Murk JLAN, 2003, J MICROSC-OXFORD, V212, P81, DOI 10.1046/j.1365-2818.2003.01238.x; Odendall C, 2012, CELL HOST MICROBE, V12, P657, DOI 10.1016/j.chom.2012.09.011; Ohlson MB, 2005, INFECT IMMUN, V73, P6249, DOI 10.1128/IAI.73.10.6249-6259.2005; Rajashekar R, 2008, TRAFFIC, V9, P2100, DOI 10.1111/j.1600-0854.2008.00821.x; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sambrook J, 1989, MOL CLONING LAB MANU; Schroeder N, 2011, TRENDS MICROBIOL, V19, P268, DOI 10.1016/j.tim.2011.01.006; Schroeder N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001002; Seitz A, 2006, EMBO J, V25, P267, DOI 10.1038/sj.emboj.7600937; Stein M, 1996, J BACTERIOL, V178, P6546, DOI 10.1128/jb.178.22.6546-6554.1996; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Valdivia RH, 1996, MOL MICROBIOL, V22, P367, DOI 10.1046/j.1365-2958.1996.00120.x; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wild Jadwiga, 2004, Methods Mol Biol, V267, P155; Zhang YY, 2013, NANOSCALE, V5, P9296, DOI 10.1039/c3nr01550e	44	27	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115423	10.1371/journal.pone.0115423	http://dx.doi.org/10.1371/journal.pone.0115423			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522146	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845600046
J	Li, J; Feng, ZK; Wu, JY; Huang, Y; Lu, G; Zhu, M; Wang, B; Mao, X; Tao, XR				Li, Jia; Feng, Zhike; Wu, Jianyan; Huang, Ying; Lu, Gang; Zhu, Min; Wang, Bi; Mao, Xiang; Tao, Xiaorong			Structure and Function Analysis of Nucleocapsid Protein of Tomato Spotted Wilt Virus Interacting with RNA Using Homology Modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROPERTIES; N PROTEIN; I-TASSER; TOSPOVIRUS; ARCHITECTURE; REVEALS; TSWV; IDENTIFICATION; SUPPRESSOR; EXPRESSION	The nucleocapsid (N) protein of tomato spotted wilt virus (TSWV) plays key roles in assembling genomic RNA into ribonucleoprotein (RNP), which serves as a template for both viral gene transcription and genome replication. However, little is known about the molecular mechanism of how TSWV N interacts with genomic RNA. In this study, we demonstrated that TSWVN protein forms a range of higher ordered oligomers. Analysis of the RNA binding behavior of N protein revealed that no specific oligomer binds to RNA preferentially, instead each type of N oligomer is able to bind RNA. To better characterize the structure and function of N protein interacting with RNA, we constructed homology models of TSWV N and N-RNA complexes. Based on these homology models, we demonstrated that the positively charged and polar amino acids in its predicted surface cleft of TSWV N are critical for RNA binding. Moreover, by N-RNA homology modeling, we found that the RNA component is deeply embedded in the predicted protein cleft; consistently, TSWV N-RNA complexes are relatively resistant to digestion by RNase. Collectively, using homology modeling, we determined the RNA binding sites on N and found a new protective feature for N protein. Our findings also provide novel insights into the molecular details of the interaction of TSWV N with RNA components.	[Li, Jia; Feng, Zhike; Wu, Jianyan; Huang, Ying; Lu, Gang; Zhu, Min; Tao, Xiaorong] Nanjing Agr Univ, Dept Plant Pathol, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Nanjing 210095, Jiangsu, Peoples R China; [Mao, Xiang] Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China; [Wang, Bi] Zhejiang Univ, Inst Biotechnol, Hangzhou 310029, Zhejiang, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Zhejiang University	Tao, XR (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Nanjing 210095, Jiangsu, Peoples R China.	taoxiaorong@njau.edu.cn			National Natural Science Foundation of China [31471746, 31222045]; Program for New Century Excellent Talents in the University [NCET-12-0888]; Special Fund for Agro-scientific Research in the Public Interest [201303028]; Doctoral Fund of Ministry of Education of China [20130097110004]; Fundamental Research Funds for the Central Universities [KYTZ201403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in the University(Program for New Century Excellent Talents in University (NCET)); Special Fund for Agro-scientific Research in the Public Interest; Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31471746 and 31222045, Program for New Century Excellent Talents in the University Grant NCET-12-0888, Special Fund for Agro-scientific Research in the Public Interest Grant 201303028, Doctoral Fund of Ministry of Education of China Grant 20130097110004, and Fundamental Research Funds for the Central Universities Grant KYTZ201403.	ADKINS S, 1995, VIROLOGY, V207, P308, DOI 10.1006/viro.1995.1083; Ariza A, 2013, NUCLEIC ACIDS RES, V41, P5912, DOI 10.1093/nar/gkt268; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brindley MA, 2010, J VIROL, V84, P12174, DOI 10.1128/JVI.01222-10; Bucher E, 2003, J VIROL, V77, P1329, DOI 10.1128/JVI.77.2.1329-1336.2003; Elliott R.M., 1996, BUNYAVIRIDAE; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Feng ZK, 2013, NEW PHYTOL, V200, P1212, DOI 10.1111/nph.12447; Ferron F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002030; GOLDBACH R, 1996, BUNYAVIRIDAE; Guo Y, 2012, P NATL ACAD SCI USA, V109, P5046, DOI 10.1073/pnas.1200808109; Hu ZZ, 2011, ARCH VIROL, V156, P1905, DOI 10.1007/s00705-011-1078-9; Kainz M, 2004, PHYTOPATHOLOGY, V94, P759, DOI 10.1094/PHYTO.2004.94.7.759; Komoda K, 2013, ACTA CRYSTALLOGR F, V69, P700, DOI 10.1107/S174430911301302X; KORMELINK R, 1994, VIROLOGY, V200, P56, DOI 10.1006/viro.1994.1162; KORMELINK R, 1993, J GEN VIROL, V74, P790; Kormelink R, 2011, VIRUS RES, V162, P184, DOI 10.1016/j.virusres.2011.09.028; Kormelink R, 2011, BUNYAVIRIDAE: MOLECULAR AND CELLULAR BIOLOGY, P163; Li BB, 2013, P NATL ACAD SCI USA, V110, P9048, DOI 10.1073/pnas.1222552110; Mine A, 2010, J VIROL, V84, P6070, DOI 10.1128/JVI.00054-10; Mohl BP, 2009, RNA, V15, P391, DOI 10.1261/rna.1367209; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Niu FF, 2013, P NATL ACAD SCI USA, V110, P9054, DOI 10.1073/pnas.1300035110; Osborne JC, 2000, J VIROL, V74, P9946, DOI 10.1128/JVI.74.21.9946-9952.2000; Plyusnin A., 2012, VIRUS TAXONOMY; Raymond DD, 2012, P NATL ACAD SCI USA, V109, P19208, DOI 10.1073/pnas.1213553109; Raymond DD, 2010, P NATL ACAD SCI USA, V107, P11769, DOI 10.1073/pnas.1001760107; Reguera J, 2013, P NATL ACAD SCI USA, V110, P7246, DOI 10.1073/pnas.1302298110; Ribeiro D, 2009, VIROLOGY, V383, P121, DOI 10.1016/j.virol.2008.09.028; Richmond KE, 1998, VIROLOGY, V248, P6, DOI 10.1006/viro.1998.9223; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Soellick TR, 2000, P NATL ACAD SCI USA, V97, P2373, DOI 10.1073/pnas.030548397; Uhrig JF, 1999, P NATL ACAD SCI USA, V96, P55, DOI 10.1073/pnas.96.1.55; van Knippenberg I, 2002, VIROLOGY, V303, P278, DOI 10.1006/viro.2002.1632; Wang Y, 2012, J VIROL, V86, P12294, DOI 10.1128/JVI.01627-12; Wu JY, 2013, J VIROL, V87, P12885, DOI 10.1128/JVI.02264-13; Yu Cui, 2008, Journal of Zhejiang University (Agriculture and Life Sciences), V34, P597; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	41	33	39	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3950	3961		10.1074/jbc.M114.604678	http://dx.doi.org/10.1074/jbc.M114.604678			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25540203	Green Published, hybrid			2022-12-26	WOS:000349458400006
J	Davydov, DR; Davydova, NY; Sineva, EV; Halpert, JR				Davydov, Dmitri R.; Davydova, Nadezhda Y.; Sineva, Elena V.; Halpert, James R.			Interactions among Cytochromes P450 in Microsomal Membranes OLIGOMERIZATION OF CYTOCHROMES P450 3A4, 3A5, AND 2E1 AND ITS FUNCTIONAL CONSEQUENCES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; HUMAN LIVER-MICROSOMES; SUBSTRATE-BINDING; CROSS-LINKING; FUNCTIONAL INTERACTIONS; ROTATIONAL DIFFUSION; SPIN EQUILIBRIUM; LIGAND-BINDING; P450-P450 INTERACTIONS; ENDOPLASMIC-RETICULUM	The body of evidence of physiologically relevant P450-P450 interactions in microsomal membranes continues to grow. Here we probe oligomerization of human CYP3A4, CYP3A5, and CYP2E1 in microsomal membranes. Using a technique based on luminescence resonance energy transfer, we demonstrate that all three proteins are subject to a concentration-dependent equilibrium between the monomeric and oligomeric states. We also observed the formation of mixed oligomers in CYP3A4/CYP3A5, CYP3A4/CYP2E1, and CYP3A5/CYP2E1 pairs and demonstrated that the association of either CYP3A4 or CYP3A5 with CYP2E1 causes activation of the latter enzyme. Earlier we hypothesized that the intersubunit interface in CYP3A4 oligomers is similar to that observed in the crystallographic dimers of some microsomal drug-metabolizing cytochromes P450 (Davydov, D. R., Davydova, N. Y., Sineva, E. V., Kufareva, I., and Halpert, J. R. (2013) Pivotal role of P450-P450 interactions in CYP3A4 allostery: the case of alpha-naphthoflavone. Biochem. J. 453, 219-230). Here we report the results of intermolecular cross-linking of CYP3A4 oligomers with thiol-reactive bifunctional reagents as well as the luminescence resonance energy transfer measurements of interprobe distances in the oligomers of labeled CYP3A4 single-cysteine mutants. The results provide compelling support for the physiological relevance of the dimer-specific peripheral ligand-binding site observed in certain CYP3A4 structures. According to our interpretation, these results reveal an important general mechanism that regulates the activity and substrate specificity of the cytochrome P450 ensemble through interactions between multiple P450 species. As a result of P450-P450 cross-talk, the catalytic properties of the cytochrome P450 ensemble cannot be predicted by simple summation of the properties of the individual P450 species.	[Davydov, Dmitri R.; Davydova, Nadezhda Y.; Sineva, Elena V.; Halpert, James R.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Davydov, Dmitri R.] Russian Acad Med Sci, VN Orekhovich Inst Biomed Chem, Moscow 119832, Russia	University of California System; University of California San Diego; Russian Academy of Medical Sciences; Institute of Biomedical Chemistry	Davydov, DR (corresponding author), Univ Calif San Diego, 9500 Gilman Dr,MC 0202, La Jolla, CA 92093 USA.	dmrdavyd@gmail.com	Davydov, Dmitri R/H-2736-2013; Sineva, Elena/A-5267-2008	Davydov, Dmitri R/0000-0001-8520-0033; Sineva, Elena/0000-0003-2307-0581	National Institutes of Health [GM054995]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054995, R01GM054995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM054995 (to J. R. H.).	ALSTON K, 1991, J BIOL CHEM, V266, P735; Backes WL, 1998, BIOCHEMISTRY-US, V37, P12852, DOI 10.1021/bi980674a; Backes WL, 2003, PHARMACOL THERAPEUT, V98, P221, DOI 10.1016/S0163-7258(03)00031-7; BACKES WL, 1985, BIOCHEMISTRY-US, V24, P5130, DOI 10.1021/bi00340a026; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; Berka K, 2013, J PHYS CHEM B, V117, P11556, DOI 10.1021/jp4059559; BERNDT P, 1989, Biokhimiya, V54, P338; Brenner S, 2007, J PHYS CHEM B, V111, P7879, DOI 10.1021/jp073036n; Bui SH, 2012, J BIOL CHEM, V287, P19699, DOI 10.1074/jbc.M111.319202; Cawley GF, 2001, DRUG METAB DISPOS, V29, P1529; CAWLEY GF, 1995, BIOCHEMISTRY-US, V34, P1244, DOI 10.1021/bi00004a018; Chen GF, 1999, XENOBIOTICA, V29, P437, DOI 10.1080/004982599238461; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; Davydov DR, 2008, ARCH BIOCHEM BIOPHYS, V471, P134, DOI 10.1016/j.abb.2008.01.001; Davydov DR, 2013, BIOCHEM J, V453, P219, DOI 10.1042/BJ20130398; Davydov DR, 2012, J BIOL CHEM, V287, P6797, DOI 10.1074/jbc.M111.325654; Davydov DR, 2011, EXPERT OPIN DRUG MET, V7, P543, DOI 10.1517/17425255.2011.562194; Davydov DR, 2010, BBA-BIOENERGETICS, V1797, P378, DOI 10.1016/j.bbabio.2009.12.008; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Davydov DR, 2000, BIOCHEM BIOPH RES CO, V276, P1005, DOI 10.1006/bbrc.2000.3596; Davydov DR, 2005, BIOCHEMISTRY-US, V44, P13902, DOI 10.1021/bi0509346; DAVYDOV DR, 1995, ARCH BIOCHEM BIOPHYS, V320, P330, DOI 10.1016/0003-9861(95)90017-9; Davydov DR, 2001, ADV EXP MED BIOL, V500, P335; Fernando H, 2008, ARCH BIOCHEM BIOPHYS, V471, P20, DOI 10.1016/j.abb.2007.11.020; Fernando H, 2007, ARCH BIOCHEM BIOPHYS, V460, P129, DOI 10.1016/j.abb.2006.12.025; FISHER MT, 1987, BIOCHEMISTRY-US, V26, P4797, DOI 10.1021/bi00389a029; Gomes AM, 2009, PHARMACOGENOMICS, V10, P579, DOI [10.2217/pgs.09.7, 10.2217/PGS.09.7]; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; GREINERT R, 1982, XENOBIOTICA, V12, P717, DOI 10.3109/00498258209038946; GREINERT R, 1982, BIOSCIENCE REP, V2, P991, DOI 10.1007/BF01122166; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; Hazai E, 2005, DRUG METAB DISPOS, V33, P157, DOI 10.1124/dmd.104.001578; HILDEBRANDT P, 1989, EUR J BIOCHEM, V186, P383, DOI 10.1111/j.1432-1033.1989.tb15220.x; Hu G, 2010, DRUG METAB DISPOS, V38, P1976, DOI 10.1124/dmd.110.034942; Jang HH, 2014, ARCH BIOCHEM BIOPHYS, V545, P100, DOI 10.1016/j.abb.2014.01.008; KAMINSKY LS, 1985, EUR J BIOCHEM, V149, P479, DOI 10.1111/j.1432-1033.1985.tb08950.x; Karyakin A. V., 1988, VESTN AKAD MED NAUK, V1988, P53; KAWATO S, 1982, J BIOL CHEM, V257, P7023; Kelley RW, 2006, BIOCHEMISTRY-US, V45, P15807, DOI 10.1021/bi061803n; Kelley RW, 2005, BIOCHEMISTRY-US, V44, P2632, DOI 10.1021/bi0477900; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081980; MCINTOSH PR, 1980, FEBS LETT, V122, P54, DOI 10.1016/0014-5793(80)80400-5; Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111; MYASOEDOVA KN, 1990, FEBS LETT, V275, P235, DOI 10.1016/0014-5793(90)81479-8; Myasoedova KN, 2001, BIOSCIENCE REP, V21, P63, DOI 10.1023/A:1010486118448; Nagy JK, 2000, BIOCHEMISTRY-US, V39, P4154, DOI 10.1021/bi991781n; Ozalp C, 2005, DRUG METAB DISPOS, V33, P1382, DOI 10.1124/dmd.105.005538; Paumard P, 2002, BIOCHEMISTRY-US, V41, P10390, DOI 10.1021/bi025923g; Prahlad J, 2014, J NEUROCHEM, V130, P839, DOI 10.1111/jnc.12763; Praporski S, 2009, J BIOL CHEM, V284, P33224, DOI 10.1074/jbc.M109.006064; Reed JR, 2012, BIOCHEM J, V446, P489, DOI 10.1042/BJ20120636; Reed JR, 2012, PHARMACOL THERAPEUT, V133, P299, DOI 10.1016/j.pharmthera.2011.11.009; Reed JR, 2010, J BIOL CHEM, V285, P8942, DOI 10.1074/jbc.M109.076885; Renaud JP, 1996, BIOCHEM J, V319, P675, DOI 10.1042/bj3190675; SCHWARZ D, 1990, BIOCHEM BIOPH RES CO, V171, P175, DOI 10.1016/0006-291X(90)91373-Z; Sineva EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083898; SONO M, 1982, J BIOL CHEM, V257, P8308; Spatzenegger M, 2003, J PHARMACOL EXP THER, V304, P477, DOI 10.1124/jpet.102.043323; Subramanian M, 2010, DRUG METAB DISPOS, V38, P1003, DOI 10.1124/dmd.109.030155; Subramanian M, 2009, DRUG METAB DISPOS, V37, P1682, DOI 10.1124/dmd.109.026500; Tan YZ, 1997, ARCH BIOCHEM BIOPHYS, V342, P82, DOI 10.1006/abbi.1997.9995; Tsalkova TN, 2007, BIOCHEMISTRY-US, V46, P106, DOI 10.1021/bi061944p; TSONG TY, 1978, P NATL ACAD SCI USA, V75, P5955, DOI 10.1073/pnas.75.12.5955; TSUPRUN VL, 1986, FEBS LETT, V205, P35, DOI 10.1016/0014-5793(86)80861-4; WATANABE J, 1992, J HISTOCHEM CYTOCHEM, V40, P353, DOI 10.1177/40.3.1552174; WIBO M, 1971, J CELL BIOL, V51, P52, DOI 10.1083/jcb.51.1.52; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Yamada M, 2001, J INORG BIOCHEM, V83, P261, DOI 10.1016/S0162-0134(00)00169-0; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125; Yamazaki H, 1996, BIOCHEM PHARMACOL, V51, P313, DOI 10.1016/0006-2952(95)02178-7; ZIEGLER M, 1982, FEBS LETT, V150, P219, DOI 10.1016/0014-5793(82)81338-0	72	52	53	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3850	3864		10.1074/jbc.M114.615443	http://dx.doi.org/10.1074/jbc.M114.615443			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533469	hybrid, Green Published			2022-12-26	WOS:000349456000055
J	de Moraes, GP; Vieira, AAH				de Moraes, Guilherme Pavan; Augusto Henriques Vieira, Armando			Fourier Transform Infrared with Attenuated Total Reflectance Applied to the Discrimination of Freshwater Planktonic Coccoid Green Microalgae	PLOS ONE			English	Article							SELENASTRACEAE CHLOROPHYCEAE; FTIR SPECTROSCOPY; IDENTIFICATION; CLASSIFICATION; PHYLOGENY; BACTERIA; ALGAE; TOOL; ACID	Despite the recent advances on fine taxonomic discrimination in microorganisms, namely using molecular biology tools, some groups remain particularly problematic. Fine taxonomy of green algae, a widely distributed group in freshwater ecosystems, remains a challenge, especially for coccoid forms. In this paper, we propose the use of the Fourier Transform Infrared (FTIR) spectroscopy as part of a polyphasic approach to identify and classify coccoid green microalgae (mainly order Sphaeropleales), using triplicated axenic cultures. The attenuated total reflectance (ATR) technique was tested to reproducibility of IR spectra of the biological material, a primary requirement to achieve good discrimination of microalgal strains. Spectral window selection was also tested, in conjunction with the first derivative treatment of spectra, to determine which regions of the spectrum provided better separation and clustering of strains. The non-metric multidimensional scaling (NMDS), analysis of similarities (ANOSIM) and hierarchical clusters (HCA), demonstrated a correct discrimination and classification of closely related strains of chlorophycean coccoid microalgae, with respect to currently accepted classifications. FTIR-ATR was highly reproducible, and provided an excellent discrimination at the strain level. The best separation was achieved by analyzing the spectral windows of 1500-1200 cm(-1) and 900-675 cm(-1), which differs from those used in previously studies for the discrimination of broad algal groups, and excluding spectral regions related to storage compounds, which were found to give poor discrimination. Furthermore, hierarchical cluster analyses have positioned the strains tested into clades correctly, reproducing their taxonomic orders and families. This study demonstrates that FTIR-ATR has great potential to complement classical approaches for fine taxonomy of coccoid green microalgae, though a careful spectrum region selection is needed.	[de Moraes, Guilherme Pavan; Augusto Henriques Vieira, Armando] Univ Fed Sao Carlos, Dept Bot, Lab Phycol, BR-13560 Sao Carlos, SP, Brazil	Universidade Federal de Sao Carlos	de Moraes, GP (corresponding author), Univ Fed Sao Carlos, Dept Bot, Lab Phycol, BR-13560 Sao Carlos, SP, Brazil.	gpdemoraes@gmail.com			Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/50054-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Msc Scolarship	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Msc Scolarship	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Grant Number 2011/50054-4, http://www.fapesp.br/ and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Msc Scolarship, http://www.capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R. A., 2005, ALGAL CULTURING TECH; Beardall J, 2001, AQUAT SCI, V63, P107, DOI 10.1007/PL00001342; Beebe K.R., 1998, CHEMOMETRICS PRACTIC, V1st; BROWN MR, 1991, J EXP MAR BIOL ECOL, V145, P79, DOI 10.1016/0022-0981(91)90007-J; Dean AP, 2010, BIORESOURCE TECHNOL, V101, P4499, DOI 10.1016/j.biortech.2010.01.065; Domenighini A, 2009, J PHYCOL, V45, P522, DOI 10.1111/j.1529-8817.2009.00662.x; Fawley MW, 2006, J PHYCOL, V42, P142, DOI 10.1111/j.1529-8817.2006.00169.x; Giordano M, 2001, J PHYCOL, V37, P271, DOI 10.1046/j.1529-8817.2001.037002271.x; Giordano M, 2009, PLANT ECOL DIVERS, V2, P155, DOI 10.1080/17550870903353088; Giroldo D, 2005, J PLANKTON RES, V27, P695, DOI 10.1093/plankt/fbi043; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Harwood JL, 2009, BIOCHIMIE, V91, P679, DOI 10.1016/j.biochi.2008.11.004; Hegewald E, 2010, PHYCOLOGIA, V49, P325, DOI 10.2216/09-61.1; HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69; HELM D, 1991, J MICROBIOL METH, V14, P127, DOI 10.1016/0167-7012(91)90042-O; Hirschmugl CJ, 2006, INFRARED PHYS TECHN, V49, P57, DOI 10.1016/j.infrared.2006.01.032; Huss VAR, 1999, J PHYCOL, V35, P587, DOI 10.1046/j.1529-8817.1999.3530587.x; Kansiz M, 1999, PHYTOCHEMISTRY, V52, P407, DOI 10.1016/S0031-9422(99)00212-5; Krienitz L, 2001, J PHYCOL, V37, P852, DOI 10.1046/j.1529-8817.2001.01004.x; Krienitz L, 2012, HYDROBIOLOGIA, P1; Lang IK, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-124; Mariey L, 2001, VIB SPECTROSC, V26, P151, DOI 10.1016/S0924-2031(01)00113-8; Montechiaro F, 2006, PLANT CELL ENVIRON, V29, P2198, DOI 10.1111/j.1365-3040.2006.01593.x; NAUMANN D, 1988, J MOL STRUCT, V174, P165, DOI 10.1016/0022-2860(88)80152-2; Naumann D., 1985, Proceedings of the SPIE - The International Society for Optical Engineering, V553, P268, DOI 10.1117/12.970803; Naumann D., 2000, ENCY ANAL CHEM; NORRIS K P, 1959, J Hyg (Lond), V57, P326; Pace NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09; Preisner O, 2007, ANAL BIOANAL CHEM, V387, P1739, DOI 10.1007/s00216-006-0851-1; R Development Core Team, 2012, R LANG ENV STAT COMP; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Sackett O, 2014, BIOGEOSCIENCES, V11, P5795, DOI 10.5194/bg-11-5795-2014; Stehfest K, 2005, PLANT PHYSIOL BIOCH, V43, P717, DOI 10.1016/j.plaphy.2005.07.001; Stuart B., 2004, INFRARED SPECTROSCOP, DOI DOI 10.1111/j.1750-3841.2008.00799.x; Thomas L. C, 1954, SPECTROCHIM ACTA, V6, P302, DOI DOI 10.1016/0371-1951(54)80013-0	36	2	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e114458	10.1371/journal.pone.0114458	http://dx.doi.org/10.1371/journal.pone.0114458			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541701	gold, Green Published, Green Submitted			2022-12-26	WOS:000347239900010
J	Herrnberger, L; Hennig, R; Kremer, W; Hellerbrand, C; Goepferich, A; Kalbitzer, HR; Tamm, ER				Herrnberger, Leonie; Hennig, Robert; Kremer, Werner; Hellerbrand, Claus; Goepferich, Achim; Kalbitzer, Hans Robert; Tamm, Ernst R.			Formation of Fenestrae in Murine Liver Sinusoids Depends on Plasmalemma Vesicle-Associated Protein and Is Required for Lipoprotein Passage	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; RAT-LIVER; PAL-E; PHENOTYPIC HETEROGENEITY; NMR-SPECTROSCOPY; PV-1; SIEVE; CAPILLARIES; METABOLISM; MECHANISMS	Liver sinusoidal endothelial cells (LSEC) are characterized by the presence of fenestrations that are not bridged by a diaphragm. The molecular mechanisms that control the formation of the fenestrations are largely unclear. Here we report that mice, which are deficient in plasmalemma vesicle-associated protein (PLVAP), develop a distinct phenotype that is caused by the lack of sinusoidal fenestrations. Fenestrations with a diaphragm were not observed in mouse LSEC at three weeks of age, but were present during embryonic life starting from embryonic day 12.5. PLVAP was expressed in LSEC of wild-type mice, but not in that of Plvap-deficient littermates. Plvap(-/)-LSEC showed a pronounced and highly significant reduction in the number of fenestrations, a finding, which was seen both by transmission and scanning electron microscopy. The lack of fenestrations was associated with an impaired passage of macromolecules such as FITC-dextran and quantum dot nanoparticles from the sinusoidal lumen into Disse's space. Plvap-deficient mice suffered from a pronounced hyperlipoproteinemia as evidenced by milky plasma and the presence of lipid granules that occluded kidney and liver capillaries. By NMR spectroscopy of plasma, the nature of hyperlipoproteinemia was identified as massive accumulation of chylomicron remnants. Plasma levels of low density lipoproteins (LDL) were also significantly increased as were those of cholesterol and triglycerides. In contrast, plasma levels of high density lipoproteins (HDL), albumin and total protein were reduced. At around three weeks of life, Plvap-deficient livers developed extensive multivesicular steatosis, steatohepatitis, and fibrosis. PLVAP is critically required for the formation of fenestrations in LSEC. Lack of fenestrations caused by PLVAP deficiency substantially impairs the passage of chylomicron remnants between liver sinusoids and hepatocytes, and finally leads to liver damage.	[Herrnberger, Leonie; Tamm, Ernst R.] Univ Regensburg, Dept Human Anat & Embryol, D-93053 Regensburg, Germany; [Hennig, Robert; Goepferich, Achim] Univ Regensburg, Dept Pharmaceut Technol, D-93053 Regensburg, Germany; [Kremer, Werner; Kalbitzer, Hans Robert] Univ Regensburg, Dept Biophys & Phys Biochem, D-93053 Regensburg, Germany; [Kremer, Werner; Kalbitzer, Hans Robert] Univ Regensburg, Ctr Magnet Resonance Chem & Biomed, D-93053 Regensburg, Germany; [Hellerbrand, Claus] Univ Regensburg, Dept Internal Med 1, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg	Tamm, ER (corresponding author), Univ Regensburg, Dept Human Anat & Embryol, D-93053 Regensburg, Germany.	ernst.tamm@vkl.uni-regensburg.de	Goepferich, Achim/G-1151-2016; Tamm, Ernst/AAB-9772-2019	Goepferich, Achim/0000-0002-7646-0252; Tamm, Ernst/0000-0002-6679-8743; Kalbitzer, Hans Robert/0000-0002-6514-2355	Deutsche Forschungsgemeinschaft [FOR 1075, TP5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (FOR 1075, TP5); www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; BANKSTON PW, 1980, AM J ANAT, V159, P1, DOI 10.1002/aja.1001590102; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Braet F, 1998, P NATL ACAD SCI USA, V95, P13635, DOI 10.1073/pnas.95.23.13635; Braet F, 1996, HEPATOLOGY, V24, P627; Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1; Carpenter B, 2005, DEVELOPMENT, V132, P3293, DOI 10.1242/dev.01902; Chung CH, 2013, CLIN MOL HEPATOL, V19, P99, DOI 10.3350/cmh.2013.19.2.99; Cogger VC, 2006, ATHEROSCLEROSIS, V189, P273, DOI 10.1016/j.atherosclerosis.2005.12.025; Cohen DE, 2013, SEMIN LIVER DIS, V33, P380, DOI 10.1055/s-0033-1358519; DeLeve LD, 2007, SEMIN LIVER DIS, V27, P390, DOI 10.1055/s-2007-991515; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1; FREUND J, 1995, J BIOMOL NMR, V5, P321, DOI 10.1007/BF00211760; Gerber HP, 1999, DEVELOPMENT, V126, P1149; GHITESCU L, 1984, J CELL BIOL, V99, P639, DOI 10.1083/jcb.99.2.639; Guo JS, 2007, SEMIN LIVER DIS, V27, P413, DOI 10.1055/s-2007-991517; Hellerbrand C, 2013, PFLUG ARCH EUR J PHY, V465, P775, DOI 10.1007/s00424-012-1209-5; Herrnberger L, 2012, EXP EYE RES, V105, P27, DOI 10.1016/j.exer.2012.09.011; Herrnberger L, 2012, HISTOCHEM CELL BIOL, V138, P709, DOI 10.1007/s00418-012-0987-3; Ioannidou S, 2006, P NATL ACAD SCI USA, V103, P16770, DOI 10.1073/pnas.0603501103; Jacobs F, 2011, CARDIOVASC PATHOL, V20, P44, DOI 10.1016/j.carpath.2009.09.002; Jacobs F, 2010, AM J PATHOL, V176, P14, DOI 10.2353/ajpath.2010.090136; Jonas A, 2008, N COMP BIOC, P485, DOI 10.1016/B978-044453219-0.50019-2; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Keuschnigg J, 2012, BLOOD, V120, P232, DOI 10.1182/blood-2012-01-406876; Keuschnigg J, 2009, BLOOD, V114, P478, DOI 10.1182/blood-2008-11-188763; Kremer W., 2005, Patents, Patent No. [US 7927878, 7927878]; Lee S, 2010, SEMIN THROMB HEMOST, V36, P352, DOI 10.1055/s-0030-1253457; Mansbach CM, 2010, ANNU REV PHYSIOL, V72, P315, DOI 10.1146/annurev-physiol-021909-135801; McCuskey RS, 2008, ANAT REC, V291, P661, DOI 10.1002/ar.20663; MCGUIRE RF, 1992, HEPATOLOGY, V15, P989, DOI 10.1002/hep.1840150603; NAITO M, 1978, CELL TISSUE RES, V190, P371; Niemela H, 2005, BLOOD, V106, P3405, DOI 10.1182/blood-2005-01-0254; Pelta MD, 2002, MAGN RESON CHEM, V40, pS147, DOI 10.1002/mrc.1107; Petersen AK, 2012, HUM MOL GENET, V21, P1433, DOI 10.1093/hmg/ddr580; Pollinger K, 2013, P NATL ACAD SCI USA, V110, P6115, DOI 10.1073/pnas.1220281110; Sarin H, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-14; SCHAFFNER F, 1963, GASTROENTEROLOGY, V44, P239; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Shearer GC, 2006, KIDNEY INT, V70, P647, DOI 10.1038/sj.ki.5000318; Stan RV, 2012, DEV CELL, V23, P1203, DOI 10.1016/j.devcel.2012.11.003; Stan RV, 1999, J CELL BIOL, V145, P1189, DOI 10.1083/jcb.145.6.1189; Stan RV, 2001, GENOMICS, V72, P304, DOI 10.1006/geno.2000.6489; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Svistounov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046134; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Willnow TE, 1997, DIABETIC MED, V14, pS75, DOI 10.1002/(SICI)1096-9136(199708)14:3+<S75::AID-DIA449>3.3.CO;2-0; Wisse E, 2008, GENE THER, V15, P1193, DOI 10.1038/gt.2008.60; WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427; Wisse E, 1996, TOXICOL PATHOL, V24, P100, DOI 10.1177/019262339602400114	54	40	44	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115005	10.1371/journal.pone.0115005	http://dx.doi.org/10.1371/journal.pone.0115005			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541982	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900017
J	Lee, A; Kanuri, N; Zhang, YH; Sayuk, GS; Li, E; Ciorba, MA				Lee, Alexander; Kanuri, Navya; Zhang, Yuanhao; Sayuk, Gregory S.; Li, Ellen; Ciorba, Matthew A.			IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INDOLEAMINE 2,3 DIOXYGENASE; TRYPTOPHAN; 2,3-DIOXYGENASE; EXPRESSION; CANCER	Background: Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract. Genetic polymorphisms can confer CD risk and influence disease phenotype. Indoleamine 2,3 dioxygenase-1 (IDO1) is one of the most over-expressed genes in CD and mediates potent anti-inflammatory effects via tryptophan metabolism along the kynurenine pathway. We aimed to determine whether non-synonymous polymorphisms in IDO1 or IDO2 (a gene paralog) are important either as CD risk alleles or as modifiers of CD phenotype. Methods: Utilizing a prospectively collected database, clinically phenotyped CD patients (n=734) and non-IBD controls (n=354) were genotyped for established IDO1 and IDO2 non-synonymous single nucleotide polymorphisms (SNPs) and novel genetic variants elucidated in the literature. Allelic frequencies between CD and non-IBD controls were compared. Genotype-phenotype analysis was conducted. IDO1 enzyme activity was assessed by calculating the serum kynurenine to tryptophan ratio (K/T). Results: IDO1 SNPs were rare (1.7% non-IBD vs 1.1% CD; p=NS) and not linked to Crohn's disease diagnosis in this population. IDO1 SNPs did however associate with a severe clinical course, presence of perianal disease, extraintestinal manifestations and a reduced serum K/T ratio during active disease suggesting lower IDO1 function. IDO2 minor allele variants were common and one of them, rs45003083, associated with reduced risk of Crohn's disease (p=0.025). No IDO2 SNPs associated with a particular Crohn's disease clinical phenotype. Conclusions: This work highlights the functional importance of IDO enzymes in human Crohn's disease and establishes relative rates of IDO genetic variants in a US population.	[Lee, Alexander; Kanuri, Navya; Sayuk, Gregory S.; Ciorba, Matthew A.] Washington Univ, Sch Med, Div Gastroenterol, St Louis, MO 63110 USA; [Zhang, Yuanhao] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Sayuk, Gregory S.] Vet Affairs Med Ctr, John Cochrane Div, Div Gastroenterol, St Louis, MO USA; [Li, Ellen] SUNY Stony Brook, Div Gastroenterol, Stony Brook, NY 11794 USA	Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ciorba, MA (corresponding author), Washington Univ, Sch Med, Div Gastroenterol, St Louis, MO 63110 USA.	mciorba@wustl.edu			National Institutes of Health [DK089016, DK100737, AI095776, P30 DK52574, DK084113]; Crohn's and Colitis Foundation of America Career Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R03DK100737, K23DK084113, K08DK089016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America Career Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK089016, DK100737 and AI095776 to MAC; P30 DK52574 to the Washington University Digestive Diseases Research Core Center; DK084113 to GSS; a Crohn's and Colitis Foundation of America Career Development Award to MAC. AL was a scholar of The Mentors in Medicine Program and the Clinical Science Training and Research Pathway in the Department of Medicine at Washington University in St Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefayene M, 2009, PHARMACOGENET GENOM, V19, P464, DOI 10.1097/FPC.0b013e32832c005a; Beatty GL, 2013, J CLIN ONCOL, V31; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cader MZ, 2013, GUT, V62, P1653, DOI 10.1136/gutjnl-2012-303955; Chen HY, 2011, DIS COLON RECTUM, V54, P1020, DOI 10.1007/DCR.0b013e31821b94b3; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Choi BK, 2006, CYTOKINE, V34, P233, DOI 10.1016/j.cyto.2006.04.008; Ciorba MA, 2013, CURR OPIN GASTROEN, V29, P146, DOI 10.1097/MOG.0b013e32835c9cb3; Ciorba MA, 2010, J IMMUNOL, V184, P3907, DOI 10.4049/jimmunol.0900291; Cutler JA, 2012, J PSYCHOPHARMACOL, V26, P360, DOI 10.1177/0269881111434622; Ferdinande L, 2008, INT J IMMUNOPATH PH, V21, P289, DOI 10.1177/039463200802100205; Fields KK, 2013, J CLIN ONCOL, V31, DOI 10.1200/jco.2013.31.31_suppl.96; Fowler EV, 2005, J MED GENET, V42, P523, DOI 10.1136/jmg.2004.027425; Fujigaki H, 2012, ANAL BIOANAL CHEM, V403, P1777, DOI 10.1007/s00216-012-5946-2; Fukunaga M, 2012, J HISTOCHEM CYTOCHEM; Gupta NK, 2012, INFLAMM BOWEL DIS, V18, P1214, DOI 10.1002/ibd.21849; Gurtner GJ, 2003, GASTROENTEROLOGY, V125, P1762, DOI 10.1053/j.gastro.2003.08.031; Iskandar HN, 2012, TRANSL RES, V159, P313, DOI 10.1016/j.trsl.2012.01.001; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Lob S, 2009, CANCER IMMUNOL IMMUN, V58, P153, DOI 10.1007/s00262-008-0513-6; Mahanonda R, 2007, J IMMUNOL, V178, P1151, DOI 10.4049/jimmunol.178.2.1151; Metz R, 2014, INT IMMUNOL; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Nishizawa H, 2010, AM J REPROD IMMUNOL, V64, P68, DOI 10.1111/j.1600-0897.2010.00820.x; Prendergast GC, 2011, CURR MED CHEM, V18, P2257, DOI 0929-8673/11 $58.00+.00; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Schroecksnadel K, 2006, CLIN RHEUMATOL, V25, P334, DOI 10.1007/s10067-005-0056-6; Tardito S, 2013, HUM IMMUNOL, V74, P166, DOI 10.1016/j.humimm.2012.11.008; Thaker AI, 2013, GASTROENTEROLOGY, V145, P416, DOI 10.1053/j.gastro.2013.05.002; Widner B, 1997, CLIN CHEM, V43, P2424; Witkiewicz AK, 2009, J AM COLL SURGEONS, V208, P781, DOI 10.1016/j.jamcollsurg.2008.12.018; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhang TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037139	36	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115848	10.1371/journal.pone.0115848	http://dx.doi.org/10.1371/journal.pone.0115848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541686	gold, Green Published, Green Submitted			2022-12-26	WOS:000347239900097
J	Kim, SH; Cho, BY; Choi, H; Shin, ES; Ye, YM; Lee, JE; Park, HS				Kim, Seung-Hyun; Cho, Bo-Young; Choi, Hyunna; Shin, Eun-Soon; Ye, Young-Min; Lee, Jong-Eun; Park, Hae-Sim			The SNP rs3128965 of HLA-DPB1 as a Genetic Marker of the AERD Phenotype	PLOS ONE			English	Article							EXACERBATED RESPIRATORY-DISEASE; TRIGGERED 15-HETE GENERATION; ASPIRIN-INTOLERANT ASTHMA; KOREAN POPULATION; HYPERSENSITIVITY; ASSOCIATION; SENSITIVITY; LEUKOCYTES; PREDICT	Background: Two common clinical syndromes of acetylsalicylic acid (aspirin) hypersensitivity, aspirin-exacerbated respiratory disease (AERD) and aspirin-exacerbated cutaneous disease (AECD), were subjected to a genome-wide association study to identify strong genetic markers for aspirin hypersensitivity in a Korean population. Methods: A comparison of SNP genotype frequencies on an Affymetrix Genome-Wide Human SNP array of 179 AERD patients and 1989 healthy normal control subjects (NC) revealed SNPs on chromosome 6 that were associated with AERD, but not AECD. To validate the association, we enrolled a second cohort comprising AERD (n=264), NC (n=238) and disease-control (aspirin tolerant asthma; ATA, n=387) groups. Results: The minor genotype frequency (AG or AA) of a particular SNP, rs3128965, in the HLA-DPB1 region was higher in the AERD group compared to the ATA or NC group (P=0.001, P=0.002, in a co-dominant analysis model, respectively). Comparison of rs3128965 alleles with the clinical features of asthmatics revealed that patients harboring the A allele had increased bronchial hyperresponsiveness to inhaled aspirin and methacholine, and higher 15-HETE levels, than those without the A allele (P=0.039, 0.037, and 0.004, respectively). Conclusions: This implies the potential of rs3128965 as a genetic marker for diagnosis and prediction of the AERD phenotype.	[Kim, Seung-Hyun; Cho, Bo-Young; Choi, Hyunna; Ye, Young-Min; Park, Hae-Sim] Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon 441749, South Korea; [Shin, Eun-Soon; Lee, Jong-Eun] DNA Link Inc, Seoul, South Korea	Ajou University; DNA Link, Inc.	Kim, SH (corresponding author), Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon 441749, South Korea.	kimsh@ajou.ac.kr; hspark@ajou.ac.kr	Park, Hae-Sim/S-7974-2019	Kim, Seung-Hyun/0000-0003-1789-8964; Park, Hae-Sim/0000-0003-2614-0303	Korea Health 21 R&D Project, the Ministry of Health and Welfare, Republic of Korea [HI14C0065]	Korea Health 21 R&D Project, the Ministry of Health and Welfare, Republic of Korea	This study was supported by the Korea Health 21 R&D Project, the Ministry of Health and Welfare, Republic of Korea (HI14C0065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayuso P, 2013, CLIN EXP ALLERGY, V43, P1097, DOI 10.1111/cea.12140; Choi JH, 2004, J ALLERGY CLIN IMMUN, V113, P562, DOI 10.1016/j.jaci.2003.12.012; Dekker JW, 1997, CLIN EXP ALLERGY, V27, P574, DOI 10.1046/j.1365-2222.1997.540848.x; Hopkins C, 2007, OTOLARYNG HEAD NECK, V137, P555, DOI 10.1016/j.otohns.2007.02.004; Kim JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013818; Kim SH, 2013, IMMUNOL ALLERGY CLIN, V33, P177, DOI 10.1016/j.iac.2012.10.003; Kim SH, 2010, RESP MED, V104, P626, DOI 10.1016/j.rmed.2009.11.024; Kim SH, 2005, CLIN EXP ALLERGY, V35, P339, DOI 10.1111/j.1365-2222.2004.02197.x; Korosec P, 2011, RESP MED, V105, pS81, DOI 10.1016/S0954-6111(11)70017-8; Kowalski ML, 2005, ALLERGY, V60, P1139, DOI 10.1111/j.1398-9995.2005.00836.x; Liu C, 2009, AM J PHYSIOL-LUNG C, V297, pL196, DOI 10.1152/ajplung.00036.2008; Mascia K, 2005, J ALLERGY CLIN IMMUN, V116, P970, DOI 10.1016/j.jaci.2005.08.035; Nizankowska-Mogilnicka E, 2007, ALLERGY, V62, P1111, DOI 10.1111/j.1398-9995.2007.01409.x; Park BL, 2013, HUM GENET, V132, P313, DOI 10.1007/s00439-012-1247-2; Park HS, 2004, J ALLERGY CLIN IMMUN, V114, P688, DOI 10.1016/j.jaci.2004.05.051; PARK HS, 1995, CLIN EXP ALLERGY, V25, P38, DOI 10.1111/j.1365-2222.1995.tb01000.x; Park SM, 2013, ALLERGY ASTHMA IMMUN, V5, P258, DOI 10.4168/aair.2013.5.5.258; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanchez-Borges M, 2013, IMMUNOL ALLERGY CLIN, V33, P251, DOI 10.1016/j.iac.2012.10.004; Wenzel S, 2012, CLIN EXP ALLERGY, V42, P650, DOI 10.1111/j.1365-2222.2011.03929.x	20	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e111220	10.1371/journal.pone.0111220	http://dx.doi.org/10.1371/journal.pone.0111220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536158	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300002
J	Troisi, R; Ganmaa, D; Silva, ID; Davaalkham, D; Rosenberg, PS; Rich-Edwards, J; Frasier, L; Houghton, L; Janes, C; Stanczyk, F; Hoover, RN				Troisi, Rebecca; Ganmaa, Daavasambuu; Silva, Isabel dos Santos; Davaalkham, Dambadarjaa; Rosenberg, Philip S.; Rich-Edwards, Janet; Frasier, Lindsay; Houghton, Lauren; Janes, Craig; Stanczyk, Frank; Hoover, Robert N.			The Role of Hormones in the Differences in the Incidence of Breast Cancer between Mongolia and the United Kingdom	PLOS ONE			English	Article							RISK; WOMEN	Background: There are striking differences in breast cancer incidence between Asian and western women. Rates vary substantially within Asia also, with Mongolia's even lower than China's. These profound differences have been speculated to be due in part to diet, mediated by circulating hormone concentrations. Methods: Sex steroid hormone concentrations were measured in women living in Ulaanbaatar, Mongolia and the United Kingdom (U.K.). Diet was obtained by interview and national survey data. Mean hormone differences were compared by country, and systematic variation by number of days since last menstrual period was modeled and adjusted for age and parity; difference in overall area under the curves was assessed. Findings: The diet in Mongolia was higher in meat and dairy than in the U.K. Mean testosterone concentrations were 18.5% lower (p<0.0001) while estradiol concentrations were 19.1% higher (p=0.02) in Mongolian than British women, adjusted for age and parity. Progesterone was almost 50% higher in Mongolian women (p=0.04), particularly during the follicular phase and early luteal surge. Hormone concentrations generally were similar in Mongolian women born in Ulaanbaatar compared with those born in rural areas, although there was a decreasing progesterone trend by degree of westernization (rural Mongolia; urban Mongolia; U.K.). Mean hormone differences were similar when restricted to parous women, and with further adjustment for body mass index, height, and smoking status. Interpretation: These data augment accumulating evidence that circulating estrogens are unlikely to explain reduced breast cancer rates in Asia compared with the west, and suggest casting a wider net with respect to biomarkers. Lower testosterone and higher progesterone in Mongolian women raise the possibility that these hormones may be important to consider. In addition, the almost exclusive dietary reliance of Mongolians on meat and dairy argues against beneficial effects of a low-fat diet on circulating hormones explaining international breast cancer differences.	[Troisi, Rebecca; Rosenberg, Philip S.; Houghton, Lauren; Hoover, Robert N.] NCI, Epidemiol & Biostat Program, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Rockville, MD 20850 USA; [Ganmaa, Daavasambuu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ganmaa, Daavasambuu] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ganmaa, Daavasambuu; Davaalkham, Dambadarjaa] Hlth Sci Univ Mongolia, Ulaanbaatar, Mongolia; [Silva, Isabel dos Santos] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Rich-Edwards, Janet] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA; [Rich-Edwards, Janet] Harvard Univ, Brigham & Womens Hosp, Sch Med, Connors Ctr Womens Hlth & Gender Biol, Boston, MA 02115 USA; [Frasier, Lindsay] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Janes, Craig] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Stanczyk, Frank] Univ So Calif, Keck Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA; [Stanczyk, Frank] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Mongolian National University of Medical Sciences; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Simon Fraser University; University of Southern California; University of Southern California	Troisi, R (corresponding author), NCI, Epidemiol & Biostat Program, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Rockville, MD 20850 USA.	troisir@mail.nih.gov	Houghton, Lauren C./ABC-8638-2021	Houghton, Lauren C./0000-0002-1432-1580; Stanczyk, Frank/0000-0002-3607-121X; Davaalkham, Dambadarjaa/0000-0001-6999-9367; Rosenberg, Philip/0000-0001-6349-9126	U.S. National Cancer Institute, National Institutes of Health, Department of Health and Human Services	U.S. National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS))	All funding for this study was provided by the U.S. National Cancer Institute, National Institutes of Health, Department of Health and Human Services. Drs. Troisi and Hoover represented the NCI and had a role in the study design, data collection and analysis, decision to publish and preparation of the ms.	Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Ganmaa D, 2013, INT HEALTH, V5, P244, DOI 10.1093/inthealth/iht020; GOEBELSMANN U, 1973, J CLIN ENDOCR METAB, V36, P867, DOI 10.1210/jcem-36-5-867; Goebelsmann U, 1979, VASECTOMY IMMUNOLOGI, P165; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hoover RN, 2012, BRIT J CANCER, V107, P408, DOI 10.1038/bjc.2012.134; James RE, 2011, CANCER PREV RES, V4, P1626, DOI 10.1158/1940-6207.CAPR-11-0090; Johnson N, 2012, JNCI-J NATL CANCER I, V104, P657, DOI 10.1093/jnci/djs156; Kaaks R, 2014, INT J CANCER, V134, P1947, DOI 10.1002/ijc.28528; Key TJ, 2013, LANCET ONCOL, V14, P1009, DOI 10.1016/S1470-2045(13)70301-2; Matsuno RK, 2007, CANCER EPIDEM BIOMAR, V16, P1437, DOI 10.1158/1055-9965.EPI-07-0108; Probst-Hensch NM, 1999, ENDOCR-RELAT CANCER, V6, P165, DOI 10.1677/erc.0.0060165; SASAKI S, 1993, PREV MED, V22, P187, DOI 10.1006/pmed.1993.1016; Troisi R, 2012, CANCER CAUSE CONTROL, V23, P1047, DOI 10.1007/s10552-012-9973-2; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Zhai FY, 2009, NUTR REV, V67, pS56, DOI 10.1111/j.1753-4887.2009.00160.x; ZIEGLER RG, 1993, JNCI-J NATL CANCER I, V85, P1819, DOI 10.1093/jnci/85.22.1819	18	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114455	10.1371/journal.pone.0114455	http://dx.doi.org/10.1371/journal.pone.0114455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536229	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000348563300012
J	Bao, YP; Wang, W; Zhou, ZG; Sun, CH				Bao, Yongping; Wang, Wei; Zhou, Zhigang; Sun, Changhao			Benefits and Risks of the Hormetic Effects of Dietary Isothiocyanates on Cancer Prevention	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; CELL-LINES; PHENETHYL ISOTHIOCYANATE; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; STRESS-RESPONSE; BLADDER-CANCER; HUMAN PLASMA; DUAL ROLES; NRF2	The isothiocyanate (ITC) sulforaphane (SFN) was shown at low levels (1-5 mu M) to promote cell proliferation to 120-143% of the controls in a number of human cell lines, whilst at high levels (10-40 mM) it inhibited such cell proliferation. Similar dose responses were observed for cell migration, i. e. SFN at 2.5 mu M increased cell migration in bladder cancer T24 cells to 128% whilst high levels inhibited cell migration. This hormetic action was also found in an angiogenesis assay where SFN at 2.5 mu M promoted endothelial tube formation (118% of the control), whereas at 10-20 mu M it caused significant inhibition. The precise mechanism by which SFN influences promotion of cell growth and migration is not known, but probably involves activation of autophagy since an autophagy inhibitor, 3-methyladenine, abolished the effect of SFN on cell migration. Moreover, low doses of SFN offered a protective effect against free-radical mediated cell death, an effect that was enhanced by co-treatment with selenium. These results suggest that SFN may either prevent or promote tumour cell growth depending on the dose and the nature of the target cells. In normal cells, the promotion of cell growth may be of benefit, but in transformed or cancer cells it may be an undesirable risk factor. In summary, ITCs have a biphasic effect on cell growth and migration. The benefits and risks of ITCs are not only determined by the doses, but are affected by interactions with Se and the measured endpoint.	[Bao, Yongping; Wang, Wei; Zhou, Zhigang] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Zhou, Zhigang] Nantong Univ, Dept Cardiovasc Med, Affiliated Hosp, Nantong, Jiangsu, Peoples R China; [Sun, Changhao] Harbin Med Univ, Sch Publ Hlth, Harbin, Heilongjiang, Peoples R China	University of East Anglia; Nantong University; Harbin Medical University	Bao, YP (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	y.bao@uea.ac.uk	Bao, Yongping/A-6951-2010; SUN, CHANG/GXM-3680-2022	Bao, Yongping/0000-0002-6425-0370; 	National Natural Science Foundation of China (NSFC) [81128011]; Cancer Prevention Research Trust, United Kingdom	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Cancer Prevention Research Trust, United Kingdom	This study was supported in part by a grant from the National Natural Science Foundation of China (NSFC No. 81128011) and an award from the Cancer Prevention Research Trust, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfadda AA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/936486; Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Barrera LN, 2012, BBA-MOL CELL RES, V1823, P1914, DOI 10.1016/j.bbamcr.2012.07.007; Brigelius-Flohe Regina, 2012, Int J Cell Biol, V2012, P486147, DOI 10.1155/2012/486147; Calabrese EJ, 2013, HUM EXP TOXICOL, V32, P120, DOI 10.1177/0960327112455069; Calabrese EJ, 2013, CRIT REV TOXICOL, V43, P580, DOI 10.3109/10408444.2013.808172; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P980, DOI 10.1177/0960327110383625; Calabrese EJ, 2005, CRIT REV TOXICOL, V35, P463, DOI 10.1080/10408440591034502; Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P729, DOI 10.1016/j.bbadis.2011.12.003; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Clarke JD, 2011, PHARMACOL RES, V64, P456, DOI 10.1016/j.phrs.2011.07.005; Clayton RF, 2005, LIVER INT, V25, P389, DOI 10.1111/j.1478-3231.2005.01017.x; Cooley LS, 2010, J CELL SCI, V123, P3808, DOI 10.1242/jcs.064279; Cornelius C, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-15; Cramer JM, 2011, NUTR CANCER, V63, P196, DOI 10.1080/01635581.2011.523495; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Dinkova-Kostova AT, 2012, TRENDS MOL MED, V18, P337, DOI 10.1016/j.molmed.2012.04.003; Ekiz F, 2010, EUR J GASTROEN HEPAT, V22, P898, DOI 10.1097/MEG.0b013e32832fa632; FENWICK GR, 1983, CRC CR REV FOOD SCI, V18, P123, DOI 10.1080/10408398209527361; Fimognari C, 2007, MUTAT RES-REV MUTAT, V635, P90, DOI 10.1016/j.mrrev.2006.10.004; Fimognari C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035267; Galgano F, 2007, J FOOD SCI, V72, pS130, DOI 10.1111/j.1750-3841.2006.00258.x; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Giudice A, 2006, BIOESSAYS, V28, P169, DOI 10.1002/bies.20359; Gupta P, 2014, MOL NUTR FOOD RES; Hahm ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044957; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Hendrickx W, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00239; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Jackson SJT, 2004, J NUTR, V134, P2229, DOI 10.1093/jn/134.9.2229; Jakubikova J, 2005, INT J ONCOL, V27, P1449; Ji Y, 2003, ANAL BIOCHEM, V323, P39, DOI 10.1016/j.ab.2003.08.011; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Keum YS, 2005, DRUG NEWS PERSPECT, V18, P445, DOI 10.1358/dnp.2005.18.7.939350; Kuang LH, 2013, INT J BIOL SCI, V9, P656, DOI 10.7150/ijbs.5887; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Li D, 2012, FOOD CHEM, V133, P300, DOI 10.1016/j.foodchem.2012.01.026; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035122; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Ma XD, 2012, CANCER CHEMOTH PHARM, V69, P485, DOI 10.1007/s00280-011-1722-9; Mattson MP, 2008, AGEING RES REV, V7, P43, DOI 10.1016/j.arr.2007.08.004; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McNaughton SA, 2003, BRIT J NUTR, V90, P687, DOI 10.1079/BJN2003917; Melchini A, 2012, J MED CHEM, V55, P9682, DOI 10.1021/jm300929v; Michaud DS, 1999, JNCI-J NATL CANCER I, V91, P605, DOI 10.1093/jnci/91.7.605; Miller PE, 2012, NUTR CLIN PRACT, V27, P599, DOI 10.1177/0884533612456043; Misiewicz I, 2004, ACTA BIOCHIM POL, V51, P711; Mitsuishi Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00200; Moy KA, 2009, INT J CANCER, V125, P2652, DOI 10.1002/ijc.24583; Na HK, 2014, FREE RADICAL BIO MED, V67, P353, DOI 10.1016/j.freeradbiomed.2013.10.819; Navarro SL, 2009, CANCER EPIDEM BIOMAR, V18, P2974, DOI 10.1158/1055-9965.EPI-09-0701; Nishikawa T, 2010, ANGIOGENESIS, V13, P227, DOI 10.1007/s10456-010-9180-2; Oehme I, 2013, P NATL ACAD SCI USA, V110, pE2592, DOI 10.1073/pnas.1300113110; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Pietsch K, 2011, BIOGERONTOLOGY, V12, P329, DOI 10.1007/s10522-011-9334-7; Rand D, 2011, NANO LETT, V11, P2678, DOI 10.1021/nl200858y; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Rungapamestry V, 2007, BRIT J NUTR, V97, P644, DOI 10.1017/S0007114507381403; Santos IS, 2013, BIOTECHNOL ADV, V31, P514, DOI 10.1016/j.biotechadv.2012.08.005; Sestili P, 2010, MUTAT RES-FUND MOL M, V689, P65, DOI 10.1016/j.mrfmmm.2010.05.003; Shan YJ, 2013, J NUTR BIOCHEM, V24, P1062, DOI 10.1016/j.jnutbio.2012.08.004; Shelton P, 2013, FASEB J, V27, P414, DOI 10.1096/fj.12-217257; Son TG, 2008, NEUROMOL MED, V10, P236, DOI 10.1007/s12017-008-8037-y; Speciale A, 2011, CURR MOL MED, V11, P770, DOI 10.2174/156652411798062395; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Suppipat K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051251; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Vargas AJ, 2010, NUTR REV, V68, P418, DOI 10.1111/j.1753-4887.2010.00301.x; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Warwick E, 2012, BRIT J NUTR, V108, P2158, DOI 10.1017/S0007114512000554; Watson JD, 2014, LANCET, V383, P841, DOI 10.1016/S0140-6736(13)62365-X; Watson J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120144; Xu TZ, 2012, ANTI-CANCER AGENT ME, V12, P1132, DOI 10.2174/187152012803529691; Ye LX, 2002, CLIN CHIM ACTA, V316, P43, DOI 10.1016/S0009-8981(01)00727-6; Yu X, 2005, MUTAT RES-FUND MOL M, V591, P93, DOI 10.1016/j.mrfmmm.2005.04.017; Zanichelli F, 2012, AGE, V34, P281, DOI 10.1007/s11357-011-9231-7; Zhang DD, 2010, ANTIOXID REDOX SIGN, V13, P1623, DOI 10.1089/ars.2010.3301; Zhang YS, 2004, MUTAT RES-FUND MOL M, V555, P173, DOI 10.1016/j.mrfmmm.2004.04.017; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang YS, 2005, FREE RADICAL BIO MED, V38, P70, DOI 10.1016/j.freeradbiomed.2004.09.033; Zhang Y, 2007, ACTA PHARMACOL SIN, V28, P1343, DOI 10.1111/j.1745-7254.2007.00679.x; Zhao CR, 2010, CANCER EPIDEMIOL, V34, P523, DOI 10.1016/j.canep.2010.06.012	87	54	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114764	10.1371/journal.pone.0114764	http://dx.doi.org/10.1371/journal.pone.0114764			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532034	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000348845100024
J	Starr, ME; Steele, AM; Saito, M; Hacker, BJ; Evers, BM; Saito, H				Starr, Marlene E.; Steele, Allison M.; Saito, Mizuki; Hacker, Bill J.; Evers, B. Mark; Saito, Hiroshi			A New Cecal Slurry Preparation Protocol with Improved Long-Term Reproducibility for Animal Models of Sepsis	PLOS ONE			English	Article							AGE-DEPENDENT VULNERABILITY; SYSTEMIC INFLAMMATION; GUT MICROBIOTA; ADIPOSE-TISSUE; MORTALITY; LIGATION; MICE; ENDOTOXEMIA; IMMUNITY	Sepsis, a life-threatening systemic inflammatory response syndrome induced by infection, is widely studied using laboratory animal models. While cecal-ligation and puncture (CLP) is considered the gold standard model for sepsis research, it may not be preferable for experiments comparing animals of different size or under different dietary regimens. By comparing cecum size, shape, and cecal content characteristics in mice under different experimental conditions (aging, diabetes, pancreatitis), we show that cecum variability could be problematic for some CLP experiments. The cecal slurry (CS) injection model, in which the cecal contents of a laboratory animal are injected intraperitoneally to other animals, is an alternative method for inducing polymicrobial sepsis; however, the CS must be freshly prepared under conventional protocols, which is a major disadvantage with respect to reproducibility and convenience. The objective of this study was to develop an improved CS preparation protocol that allows for long-term storage of CS with reproducible results. Using our new CS preparation protocol we found that bacterial viability is maintained for at least 6 months when the CS is prepared in 15% glycerol-PBS and stored at -80 degrees C. To test sepsis-inducing efficacy of stored CS stocks, various amounts of CS were injected to young (4-6 months old), middle-aged (12-14 months old), and aged (24-26 months old) male C57BL/6 mice. Dose- and age-dependent mortality was observed with high reproducibility. Circulating bacteria levels strongly correlated with mortality suggesting an infection-mediated death. Further, injection with heat-inactivated CS resulted in acute hypothermia without mortality, indicating that CS-mediated death is not due to endotoxic shock. This new CS preparation protocol results in CS stocks which are durable for freezing preservation without loss of bacterial viability, allowing experiments to be performed more conveniently and with higher reproducibility than before.	[Starr, Marlene E.; Steele, Allison M.; Saito, Mizuki; Saito, Hiroshi] Univ Kentucky, Aging & Crit Care Res Lab, Lexington, KY 40536 USA; [Starr, Marlene E.; Hacker, Bill J.; Evers, B. Mark; Saito, Hiroshi] Univ Kentucky, Dept Surg, Lexington, KY 40536 USA; [Steele, Allison M.; Saito, Hiroshi] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Saito, Mizuki; Evers, B. Mark; Saito, Hiroshi] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Saito, H (corresponding author), Univ Kentucky, Aging & Crit Care Res Lab, Lexington, KY 40536 USA.	hiroshi.saito@uky.edu		Owen, Allison M./0000-0001-5623-4891; Raju, Raghavan/0000-0002-4516-8654	National Institutes of Health [R01 AG039732]; NATIONAL INSTITUTE ON AGING [R01AG039732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institutes of Health grants (R01 AG039732). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROZE WL, 1991, DIS COLON RECTUM, V34, P563, DOI 10.1007/BF02049895; Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; CROSS AS, 1993, INFECT IMMUN, V61, P2741, DOI 10.1128/IAI.61.7.2741-2747.1993; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Gentile LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094404; Gentile LF, 2014, J IMMUNOL, V192, P3156, DOI 10.4049/jimmunol.1301726; Hamilton MJ, 2012, AM J GASTROENTEROL, V107, P761, DOI 10.1038/ajg.2011.482; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; LANG CH, 1983, J SURG RES, V35, P201, DOI 10.1016/S0022-4804(83)80005-5; Maniatis T., 1982, MOL CLONING; Miller RA, 2000, J GERONTOL A-BIOL, V55, pB117, DOI 10.1093/gerona/55.3.B117; Okamura D, 2012, AGING CELL, V11, P760, DOI 10.1111/j.1474-9726.2012.00841.x; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004; Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002; Sam Albert D. Ii, 1997, Frontiers in Bioscience, V2, pE72; Shrum Bradly, 2014, BMC Res Notes, V7, P233, DOI 10.1186/1756-0500-7-233; Starr ME, 2014, AGING DIS, V5, P126, DOI 10.14336/AD.2014.0500126; Starr ME, 2013, AGING CELL, V12, P194, DOI 10.1111/acel.12040; Starr ME, 2011, FREE RADICAL BIO MED, V50, P371, DOI 10.1016/j.freeradbiomed.2010.11.013; Starr ME, 2010, BLOOD, V115, P4886, DOI 10.1182/blood-2009-10-246678; Starr ME, 2009, J GERONTOL A-BIOL, V64, P723, DOI 10.1093/gerona/glp046; Turnbull IR, 2003, SHOCK, V19, P310, DOI 10.1097/00024382-200304000-00003; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; WOOD W, 1993, J CLIN PATHOL, V46, P769, DOI 10.1136/jcp.46.8.769; Wynn JL, 2007, SHOCK, V28, P675, DOI 10.1097/shk.0b013e3180556d09; Zanotti-Cavazzoni SL, 2009, CRIT CARE CLIN, V25, P703, DOI 10.1016/j.ccc.2009.08.005	31	81	82	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115705	10.1371/journal.pone.0115705	http://dx.doi.org/10.1371/journal.pone.0115705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531402	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100098
J	Wang, TF; Chen, H				Wang, Tengfei; Chen, Hao			Carbon Disulfide Mediates Socially-Acquired Nicotine Self-Administration	PLOS ONE			English	Article							CIGARETTE-SMOKING; TOBACCO; ADOLESCENTS; AMYGDALA; BREATH; CUES; 1ST	The social environment plays a critical role in smoking initiation as well as relapse. We previously reported that rats acquired nicotine self-administration with an olfactogustatory cue only when another rat consuming the same cue was present during self-administration. Because carbon disulfide (CS2) mediates social learning of food preference in rodents, we hypothesized that socially acquired nicotine self-administration is also mediated by CS2. We tested this hypothesis by placing female adolescent Sprague-Dawley rats in operant chambers equipped with two lickometers. Licking on the active spout meeting a fixed-ratio 10 schedule triggered the concurrent delivery of an i.v. infusion (saline, or 30 mu g/kg nicotine, free base) and an appetitive olfactogustatory cue containing CS2 (0-500 ppm). Rats that self-administered nicotine with the olfactogustatory cue alone licked less on the active spout than on the inactive spout. Adding CS2 to the olfactogustatory cue reversed the preference for the spouts. The group that received 500 ppm CS2 and the olfactogustatory cue obtained a significantly greater number of nicotine infusions than other groups. After extinction training, the original self-administration context reinstated nicotine-seeking behavior in all nicotine groups. In addition, in rats that received the olfactogustatory cue and 500 ppm CS2 during SA, a social environment where the nicotine-associated olfactory cue is present, induced much stronger drug-seeking behavior compared to a social environment lacking the olfactogustatory cue. These data established that CS2 is a critical signal that mediates social learning of nicotine self-administration with olfactogustatory cues in rodents. Additionally, these data showed that the social context can further enhance the drug-seeking behavior induced by the drug-taking environment.	[Wang, Tengfei; Chen, Hao] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Chen, H (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA.	hchen@uthsc.edu	Chen, Hao/AAX-5849-2020	Chen, Hao/0000-0002-2680-6921				Chen H, 2007, NEUROPSYCHOPHARMACOL, V32, P700, DOI 10.1038/sj.npp.1301135; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044234; Chen H, 2011, NEUROPSYCHOPHARMACOL, V36, P2629, DOI 10.1038/npp.2011.149; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Conklin CA, 2008, EXP CLIN PSYCHOPHARM, V16, P207, DOI 10.1037/1064-1297.16.3.207; DAVIS JD, 1992, BEHAV NEUROSCI, V106, P217, DOI 10.1037/0735-7044.106.1.217; Eissenberg T, 2000, DRUG ALCOHOL DEPEN, V59, pS41; Galef BG, 2012, BEHAV BRAIN RES, V231, P266, DOI 10.1016/j.bbr.2011.07.021; GALEF BG, 1988, PHYSIOL BEHAV, V42, P119, DOI 10.1016/0031-9384(88)90285-5; Greenlund KJ, 1997, AM J PUBLIC HEALTH, V87, P1345, DOI 10.2105/AJPH.87.8.1345; HAHN G, 1990, ADDICT BEHAV, V15, P439, DOI 10.1016/0306-4603(90)90030-2; Hofstetter CR, 2007, NICOTINE TOB RES, V9, P1277, DOI 10.1080/14622200701704863; Hu MC, 2006, AM J PUBLIC HEALTH, V96, P299, DOI 10.2105/AJPH.2004.057232; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Jones-Price C, 1984, PB84192343 NITS; Kamboures MA, 2005, P NATL ACAD SCI USA, V102, P15762, DOI 10.1073/pnas.0507263102; Munger SD, 2010, CURR BIOL, V20, P1438, DOI 10.1016/j.cub.2010.06.021; PHILLIPS M, 1993, J CLIN PATHOL, V46, P861, DOI 10.1136/jcp.46.9.861; POPIK P, 1993, BEHAV NEURAL BIOL, V59, P63, DOI 10.1016/0163-1047(93)91173-K; Powell LM, 2005, J HEALTH ECON, V24, P950, DOI 10.1016/j.jhealeco.2005.02.002; Racicot S, 2013, DRUG ALCOHOL DEPEN, V130, P38, DOI 10.1016/j.drugalcdep.2012.10.006; Schepis TS, 2005, CURR OPIN PEDIATR, V17, P607, DOI 10.1097/01.mop.0000176442.49743.31; Spear L, 2000, ALCOHOL RES HEALTH, V24, P115; Stoffelmayr B, 2003, ADDICT BEHAV, V28, P1351, DOI 10.1016/S0306-4603(02)00250-2; Thiel KJ, 2009, PSYCHOPHARMACOLOGY, V204, P391, DOI 10.1007/s00213-009-1470-2; Umber BJ, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-13; Urberg KA, 1997, DEV PSYCHOL, V33, P834, DOI 10.1037/0012-1649.33.5.834; Wang T, 2014, GENES BRAIN BEHAV, V13, P202, DOI 10.1111/gbb.12112; Wells AM, 2011, LEARN MEMORY, V18, P693, DOI 10.1101/lm.2273111; White VM, 2008, BRIT J CANCER, V98, P1475, DOI 10.1038/sj.bjc.6604250; Zentall TR, 2012, J COMP PSYCHOL, V126, P114, DOI 10.1037/a0025381; Zhou XL, 2009, ADDICT BEHAV, V34, P365, DOI 10.1016/j.addbeh.2008.11.013	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115222	10.1371/journal.pone.0115222	http://dx.doi.org/10.1371/journal.pone.0115222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532105	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100045
J	Wee, S; Niklasson, M; Marinescu, VD; Segerman, A; Schmidt, L; Hermansson, A; Dirks, P; Forsberg-Nilsson, K; Westermark, B; Uhrbom, L; Linnarsson, S; Nelander, S; Andang, M				Wee, Shimei; Niklasson, Maria; Marinescu, Voichita Dana; Segerman, Anna; Schmidt, Linnea; Hermansson, Annika; Dirks, Peter; Forsberg-Nilsson, Karin; Westermark, Bengt; Uhrbom, Lene; Linnarsson, Sten; Nelander, Sven; Andang, Michael			Selective Calcium Sensitivity in Immature Glioma Cancer Stem Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; BRAIN-TUMORS; RNA-SEQ; GLIOBLASTOMA; IDENTIFICATION; CHEMOTHERAPY	Tumor-initiating cells are a subpopulation in aggressive cancers that exhibit traits shared with stem cells, including the ability to self-renew and differentiate, commonly referred to as stemness. In addition, such cells are resistant to chemo- and radiation therapy posing a therapeutic challenge. To uncover stemness-associated functions in glioma-initiating cells (GICs), transcriptome profiles were compared to neural stem cells (NSCs) and gene ontology analysis identified an enrichment of Ca2+ signaling genes in NSCs and the more stem-like (NSC-proximal) GICs. Functional analysis in a set of different GIC lines regarding sensitivity to disturbed homeostasis using A23187 and Thapsigargin, revealed that NSC-proximal GICs were more sensitive, corroborating the transcriptome data. Furthermore, Ca2+ drug sensitivity was reduced in GICs after differentiation, with most potent effect in the NSC-proximal GIC, supporting a stemness-associated Ca2+ sensitivity. NSCs and the NSC-proximal GIC line expressed a larger number of ion channels permeable to potassium, sodium and Ca2+. Conversely, a higher number of and higher expression levels of Ca2+ binding genes that may buffer Ca2+, were expressed in NSC-distal GICs. In particular, expression of the AMPA glutamate receptor subunit GRIA1, was found to associate with Ca2+ sensitive NSC-proximal GICs, and decreased as GICs differentiated along with reduced Ca2+ drug sensitivity. The correlation between high expression of Ca2+ channels (such as GRIA1) and sensitivity to Ca2+ drugs was confirmed in an additional nine novel GIC lines. Calcium drug sensitivity also correlated with expression of the NSC markers nestin (NES) and FABP7 (BLBP, brain lipid-binding protein) in this extended analysis. In summary, NSC-associated NES+/FABP7(+)/GRIA1(+) GICs were selectively sensitive to disturbances in Ca2+ homeostasis, providing a potential target mechanism for eradication of an immature population of malignant cells.	[Wee, Shimei; Andang, Michael] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Niklasson, Maria; Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Marinescu, Voichita Dana; Segerman, Anna; Schmidt, Linnea; Hermansson, Annika; Forsberg-Nilsson, Karin; Westermark, Bengt; Uhrbom, Lene; Nelander, Sven] Uppsala Univ, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden; [Dirks, Peter] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Karolinska Institutet; Karolinska Institutet; Uppsala University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Andang, M (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	Michael.Andang@ki.se	Forsberg-Nilsson, Karin/D-9604-2019; Segerman, Anna/ABH-2607-2021; Andäng, Michael/GRE-9898-2022; Linnarsson, Sten/HCH-3909-2022	Forsberg-Nilsson, Karin/0000-0003-0692-6245; Segerman, Anna/0000-0002-5070-7587; Nelander, Sven/0000-0003-1758-1262; Westermark, Bengt/0000-0001-7153-5545; Andang, Michael/0000-0002-2886-7891	Swedish Childhood Cancer foundation [PR2013-0084]; Swedish Cancer Foundation [CAN 2011/783]; Swedish Research Council [2011-4567]; Karolinska Institutet; Linnaeus center in Developmental Biology for Regenerative Medicine; Swedish Cancer Foundation	Swedish Childhood Cancer foundation(European Commission); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Linnaeus center in Developmental Biology for Regenerative Medicine; Swedish Cancer Foundation	Swedish Childhood Cancer foundation PR2013-0084 (www.barncancerfonden.se), Swedish Cancer Foundation CAN 2011/783 (www.cancerfonden.se), Swedish Research Council 2011-4567 (vr.se), Karolinska Institutet (www.ki.se), Linnaeus center in Developmental Biology for Regenerative Medicine (www.dbrm.se). SW was partially funded by the Karolinska Institutet PhD scholarship program. MN was funded by a postdoc scholarship from the Swedish Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; CHOUCAIR AK, 1986, J NEUROSURG, V65, P654, DOI 10.3171/jns.1986.65.5.0654; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Haas BR, 2010, CANCER RES, V70, P5597, DOI 10.1158/0008-5472.CAN-09-4666; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Huang Z, 2010, PROTEIN CELL, V1, P638, DOI 10.1007/s13238-010-0078-y; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Kapur N, 2007, AM J PHYSIOL-CELL PH, V292, pC1510, DOI 10.1152/ajpcell.00181.2006; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Kitambi SS, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.021; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mogami H, 1998, EMBO J, V17, P435, DOI 10.1093/emboj/17.2.435; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; Oh MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047846; Park DM, 2009, MOL CELLS, V28, P7, DOI 10.1007/s10059-009-0111-2; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Ramskold D, 2012, METHODS MOL BIOL, V802, P259, DOI 10.1007/978-1-61779-400-1_17; Resende RR, 2010, BBA-MOL CELL RES, V1803, P246, DOI 10.1016/j.bbamcr.2009.11.008; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Singh SK, 2003, CANCER RES, V63, P5821; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhao W, 2013, CANCER CELL, V23, P541, DOI 10.1016/j.ccr.2013.02.025	32	21	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115698	10.1371/journal.pone.0115698	http://dx.doi.org/10.1371/journal.pone.0115698			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531110	gold, Green Submitted, Green Published			2022-12-26	WOS:000348845100096
J	Zhang, ZM; Shi, Y; Zhao, SH; Li, JJ; Li, CC; Mao, BY				Zhang, Zuming; Shi, Yu; Zhao, Shuhua; Li, Jiejing; Li, Chaocui; Mao, Bingyu			Xenopus Nkx6.3 Is a Neural Plate Border Specifier Required for Neural Crest Development	PLOS ONE			English	Article							CRANIAL PLACODES; PARAXIAL MESODERM; FACTOR NKX6.1; BMP GRADIENT; BETA-CATENIN; CELL FATES; INDUCTION; GENES; SPECIFICATION; EXPRESSION	In vertebrates, the neural plate border (NPB) is established by a group of transcription factors including Dlx3, Msx1 and Zic1. The crosstalk between these NPB specifiers governs the separation of the NPB region into placode and neural crest (NC) territories and also their further differentiation. Understanding the mechanisms of NPB formation and NC development is critical for our knowledge of related human diseases. Here we identified Nkx6.3, a transcription factor of the Nkx family, as a new NPB specifier required for neural crest development in Xenopus embryos. XNkx6.3 is expressed in the ectoderm of the neural plate border region at neurula stages, covering the epidermis, placode and neural crest territories, but not the neural plate. Inhibition of Nkx6.3 by dominant negative construct or specific morpholino leads to neural crest defects, while overexpression of Nkx6.3 induces ectopic neural crest in the anterior neural fold. In animal caps, Nkx6.3 alone is able to initiate the whole neural crest regulatory network and induces neural crest fate robustly. We showed that overexpression of Nkx6.3 affects multiple signaling pathways, creating a high-Wnt, low-BMP environment required for neural crest development. Gain-and loss-of-function of Nkx6.3 have compound effects on the expression of known NPB genes, which is largely opposite to that of Dlx3. Overexpression of Dlx3 blocks the NC inducing activity of Nkx6.3. The crosstalk between Nkx6.3, Dlx3 and Msx1 is likely crucial for proper NPB formation and neural crest development in Xenopus.	[Zhang, Zuming; Zhao, Shuhua; Li, Jiejing; Li, Chaocui; Mao, Bingyu] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Shi, Yu] Chongqing Med Univ, Childrens Hosp, Dept Clin Lab, Chongqing, Peoples R China; [Shi, Yu] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Shi, Yu] Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Shi, Yu] Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China; [Zhang, Zuming] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chongqing Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Mao, BY (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	mao@mail.kiz.ac.cn		Mao, Bingyu/0000-0002-7993-3158	CAS Key Project [KSCX2-EW-R-05]; National Natural Science Foundation of China [81102519]; Chongqing Science and Technology Committee [cstc2012jjA0147]	CAS Key Project(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Committee	This work was supported by grants from the CAS Key Project (KSCX2-EW-R-05) to BM, National Natural Science Foundation of China (81102519) and the Chongqing Science and Technology Committee (cstc2012jjA0147) to YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2005, DEV BIOL, V288, P40, DOI 10.1016/j.ydbio.2005.07.022; Aybar MJ, 2003, DEVELOPMENT, V130, P483, DOI 10.1242/dev.00238; Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156; Beanan MJ, 2000, MECH DEVELOP, V91, P227, DOI 10.1016/S0925-4773(99)00303-2; Binot AC, 2010, DEV BIOL, V340, P397, DOI 10.1016/j.ydbio.2010.01.025; Brugmann SA, 2004, DEVELOPMENT, V131, P5871, DOI 10.1242/dev.01516; David R, 2001, MECH DEVELOP, V103, P189, DOI 10.1016/S0925-4773(01)00355-0; Deardorff MA, 2001, DEVELOPMENT, V128, P3655; Dichmann DS, 2011, DEV BIOL, V349, P378, DOI 10.1016/j.ydbio.2010.10.030; Feledy JA, 1999, NUCLEIC ACIDS RES, V27, P764, DOI 10.1093/nar/27.3.764; Feledy JA, 1999, DEV BIOL, V212, P455, DOI 10.1006/dbio.1999.9374; Groves AK, 2014, DEV BIOL, V389, P2, DOI 10.1016/j.ydbio.2013.11.027; Hong CS, 2008, DEVELOPMENT, V135, P3903, DOI 10.1242/dev.026229; Hong CS, 2007, MOL BIOL CELL, V18, P2192, DOI 10.1091/mbc.E06-11-1047; Jorgensen MC, 1999, FEBS LETT, V461, P287, DOI 10.1016/S0014-5793(99)01436-2; Li JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027198; Luo T, 2001, MOL REPROD DEV, V60, P331, DOI 10.1002/mrd.1095; Ma PC, 2013, DEV GENES EVOL, V223, P253, DOI 10.1007/s00427-013-0437-9; Marchant L, 1998, DEV BIOL, V198, P319, DOI 10.1006/dbio.1998.8902; McLarren KW, 2003, DEV BIOL, V259, P34, DOI 10.1016/S0012-1606(03)00177-5; Meulemans D, 2004, DEV CELL, V7, P291, DOI 10.1016/j.devcel.2004.08.007; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Mirmira RG, 2000, J BIOL CHEM, V275, P14743, DOI 10.1074/jbc.275.19.14743; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; Monsoro-Burq AH, 2003, DEVELOPMENT, V130, P3111, DOI 10.1242/dev.00531; Nakagawa T, 2012, J STEROID BIOCHEM, V132, P247, DOI 10.1016/j.jsbmb.2012.05.007; Nakata K, 1998, MECH DEVELOP, V75, P43, DOI 10.1016/S0925-4773(98)00073-2; Nichane M, 2008, DEV BIOL, V322, P355, DOI 10.1016/j.ydbio.2008.08.003; Pandur PD, 2000, MECH DEVELOP, V96, P253, DOI 10.1016/S0925-4773(00)00396-8; Patthey C, 2009, DEVELOPMENT, V136, P73, DOI 10.1242/dev.025890; Phillips BT, 2006, DEV BIOL, V294, P376, DOI 10.1016/j.ydbio.2006.03.001; Pieper M, 2012, DEVELOPMENT, V139, P1175, DOI 10.1242/dev.074468; Sasai N, 2001, DEVELOPMENT, V128, P2525; Sato S, 2010, DEV BIOL, V344, P158, DOI 10.1016/j.ydbio.2010.04.029; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schohl A, 2003, EMBO J, V22, P3303, DOI 10.1093/emboj/cdg328; Smith ST, 1996, DEVELOPMENT, V122, P3141; St-Jeannet JP, 2014, DEV BIOL, V389, P13, DOI 10.1016/j.ydbio.2014.02.011; Stuhlmiller TJ, 2012, CELL MOL LIFE SCI, V69, P3715, DOI 10.1007/s00018-012-0991-8; Suri C, 2004, DEV BIOL, V265, P90, DOI 10.1016/j.ydbio.2003.09.017; Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Tribulo C, 2003, DEVELOPMENT, V130, P6441, DOI 10.1242/dev.00878; Tucker JA, 2008, DEV CELL, V14, P108, DOI 10.1016/j.devcel.2007.11.004; Woda JM, 2003, DEVELOPMENT, V130, P331, DOI 10.1242/dev.00212; Zeng WL, 2010, BIOCHEM BIOPH RES CO, V394, P1024, DOI 10.1016/j.bbrc.2010.03.115; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920; Zhao SH, 2007, DEV GENES EVOL, V217, P477, DOI 10.1007/s00427-007-0155-2	49	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115165	10.1371/journal.pone.0115165	http://dx.doi.org/10.1371/journal.pone.0115165			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531524	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100040
J	Hayer, SN; Bading, H				Hayer, Stefanie N.; Bading, Hilmar			Nuclear Calcium Signaling Induces Expression of the Synaptic Organizers Lrrtm1 and Lrrtm2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEAT TRANSMEMBRANE PROTEINS; GENE-EXPRESSION; NMDA RECEPTORS; REVERSIBLE INHIBITION; TRANSCRIPTION FACTORS; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; CELL-DEATH; CREB; FAMILY	Calcium transients in the cell nucleus evoked by synaptic activity in hippocampal neurons function as a signaling end point in synapse-to-nucleus communication. As an important regulator of neuronal gene expression, nuclear calcium is involved in the conversion of synaptic stimuli into functional and structural changes of neurons. Here we identify two synaptic organizers, Lrrtm1 and Lrrtm2, as targets of nuclear calcium signaling. Expression of both Lrrtm1 and Lrrtm2 increased in a synaptic NMDA receptor- and nuclear calcium-dependent manner in hippocampal neurons within 2-4 h after the induction of action potential bursting. Induction of Lrrtm1 and Lrrtm2 occurred independently of the need for new protein synthesis and required calcium/calmodulin-dependent protein kinases and the nuclear calcium signaling target CREB-binding protein. Analysis of reporter gene constructs revealed a functional cAMP response element in the proximal promoter of Lrrtm2, indicating that at least Lrrtm2 is regulated by the classical nuclear Ca2+ /calmodulin-dependent protein kinase IV-CREB/CREB-binding protein pathway. These results suggest that one mechanism by which nuclear calcium signaling controls neuronal network function is by regulating the expression of Lrrtm1 and Lrrtm2.	[Hayer, Stefanie N.; Bading, Hilmar] Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bading, H (corresponding author), Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci, INF 364, D-69120 Heidelberg, Germany.	Hilmar.Bading@uni-hd.de						ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Bengtson CP, 2010, BIOPHYS J, V99, P4066, DOI 10.1016/j.bpj.2010.10.044; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Buchthal B, 2012, J BIOL CHEM, V287, P30967, DOI 10.1074/jbc.M112.382507; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Coutellier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046604; CURRAN T, 1995, J NEUROBIOL, V26, P403, DOI 10.1002/neu.480260312; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dick O, 2010, J BIOL CHEM, V285, P19354, DOI 10.1074/jbc.M110.127654; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hagenston AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004564; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Jaubert PJ, 2007, GENES BRAIN BEHAV, V6, P141, DOI 10.1111/j.1601-183X.2006.00240.x; Kleffmann W, 2012, MOL SYNDROMOL, V3, P68, DOI 10.1159/000341252; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Ludwig KU, 2009, MOL PSYCHIATR, V14, P743, DOI 10.1038/mp.2009.28; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mauceri D, 2011, NEURON, V71, P117, DOI 10.1016/j.neuron.2011.04.022; McNulty SE, 2012, LEARN MEMORY, V19, P588, DOI 10.1101/lm.026385.112; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; OFIR R, 1991, GENE EXPRESSION, V1, P55; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; RUBINSTEIN JH, 1963, AM J DIS CHILD, V105, P588, DOI 10.1001/archpedi.1963.02080040590010; Schlumm F, 2013, J BIOL CHEM, V288, P8074, DOI 10.1074/jbc.M112.432773; Sepp M, 2012, HUM MOL GENET, V21, P2873, DOI 10.1093/hmg/dds112; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; SIHRA TS, 1995, NEUROPHARMACOLOGY, V34, P731, DOI 10.1016/0028-3908(95)00051-7; Simonetti M, 2013, NEURON, V77, P43, DOI 10.1016/j.neuron.2012.10.037; Soler-Llavina GJ, 2013, NEURON, V79, P439, DOI 10.1016/j.neuron.2013.06.007; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; Weislogel JM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003598; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhu DY, 2004, P NATL ACAD SCI USA, V101, P9453, DOI 10.1073/pnas.0401063101	71	3	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5523	5532		10.1074/jbc.M113.532010	http://dx.doi.org/10.1074/jbc.M113.532010			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25527504	Green Published, hybrid			2022-12-26	WOS:000350044200024
J	Deshmukh, NP; Kang, HJ; Billings, SD; Taylor, RH; Hager, GD; Boctor, EM				Deshmukh, Nishikant P.; Kang, Hyun Jae; Billings, Seth D.; Taylor, Russell H.; Hager, Gregory D.; Boctor, Emad M.			Elastography Using Multi-Stream GPU: An Application to Online Tracked Ultrasound Elastography, In-Vivo and the da Vinci Surgical System	PLOS ONE			English	Article							REAL-TIME ELASTOGRAPHY; TRANSIENT ELASTOGRAPHY; MALIGNANCY; TISSUE; PERFORMANCE; ELASTICITY; FIBROSIS; CANCER; TOOL	A system for real-time ultrasound (US) elastography will advance interventions for the diagnosis and treatment of cancer by advancing methods such as thermal monitoring of tissue ablation. A multi-stream graphics processing unit (GPU) based accelerated normalized cross-correlation (NCC) elastography, with a maximum frame rate of 78 frames per second, is presented in this paper. A study of NCC window size is undertaken to determine the effect on frame rate and the quality of output elastography images. This paper also presents a novel system for Online Tracked Ultrasound Elastography (O-TRuE), which extends prior work on an offline method. By tracking the US probe with an electromagnetic (EM) tracker, the system selects in-plane radio frequency (RF) data frames for generating high quality elastograms. A novel method for evaluating the quality of an elastography output stream is presented, suggesting that O-TRuE generates more stable elastograms than generated by untracked, free-hand palpation. Since EM tracking cannot be used in all systems, an integration of real-time elastography and the da Vinci Surgical System is presented and evaluated for elastography stream quality based on our metric. The da Vinci surgical robot is outfitted with a laparoscopic US probe, and palpation motions are autonomously generated by customized software. It is found that a stable output stream can be achieved, which is affected by both the frequency and amplitude of palpation. The GPU framework is validated using data from in-vivo pig liver ablation; the generated elastography images identify the ablated region, outlined more clearly than in the corresponding B-mode US images.	[Deshmukh, Nishikant P.; Kang, Hyun Jae; Billings, Seth D.; Taylor, Russell H.; Hager, Gregory D.; Boctor, Emad M.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Boctor, Emad M.] Johns Hopkins Med Inst, Dept Radiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Deshmukh, NP (corresponding author), Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA.	nishikant@cs.jhu.edu			NIH SBIR Grant [CA134169, CA112852]; Johns Hopkins University; Intuitive Surgical Inc.; NATIONAL CANCER INSTITUTE [R44CA112852, R43CA112852, R44CA134169] Funding Source: NIH RePORTER	NIH SBIR Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University(Johns Hopkins University); Intuitive Surgical Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH SBIR Grant (PI: Dr. Everett Burdette) CA134169 and CA112852, and The Johns Hopkins University internal funds supported this work. Intuitive Surgical Inc. provided partial funding and equipment loan of the da Vinci Surgical System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Billings S, 2012, MED IMAGING 2012 IMA; Boctor EM, 2009, SPIE MED IMAGING, p72650R; Boni E, 2012, IEEE T ULTRASON FERR, V59, P1378, DOI 10.1109/TUFFC.2012.2338; Brock M, 2012, J UROLOGY, V187, P2039, DOI 10.1016/j.juro.2012.01.063; Cappelli C, 2012, J ULTRAS MED, V31, P1777; Deshmukh N, 2009, P INT C MED IM COMP; Ferraioli G, 2012, AM J ROENTGENOL, V199, P19, DOI 10.2214/AJR.11.7517; Foroughi P, 2013, ULTRASOUND MED BIOL, V39, P211, DOI 10.1016/j.ultrasmedbio.2012.09.006; Hinz T, 2013, DERMATOLOGY, V226, P81, DOI 10.1159/000346942; Kang H- J, 2012, SPIE MED IMAGING; Kang HJ, 2012, MIDAS J; Mak TM, 2013, ULTRASOUND MED BIOL, V39, P956, DOI 10.1016/j.ultrasmedbio.2013.01.009; Nair SP, 2011, IEEE T MED IMAGING, V30, P497, DOI 10.1109/TMI.2010.2087344; Nakashima K, 2013, J MED ULTRASON, V40, P359, DOI 10.1007/s10396-013-0457-0; NVIDIA, 2011, NVIDIA CUDA C PROGR; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Parkin DM, 2006, BREAST J, V12, pS70, DOI 10.1111/j.1075-122X.2006.00205.x; Popescu A, 2011, MED ULTRASON, V13, P33; Raj JJR, 2012, INT J ENG SCI TECHNO, V4; Rivaz H, 2008, LECT NOTES COMPUT SC, V5242, P458, DOI 10.1007/978-3-540-85990-1_55; Schneider FK, 2010, IEEE T INF TECHNOL B, V14, P538, DOI 10.1109/TITB.2009.2025653; Sen HT, 2012, SPIE MED IMAGING; Sumura M, 2007, INT J UROL, V14, P811, DOI 10.1111/j.1442-2042.2007.01829.x; Thomas A, 2006, ULTRASOUND OBST GYN, V28, P335, DOI 10.1002/uog.2823; Trimboli P, 2012, J CLIN ENDOCR METAB, V97, P4524, DOI 10.1210/jc.2012-2951; Turgay E, 2006, ULTRASOUND MED BIOL, V32, P221, DOI 10.1016/j.ultrasmedbio.2005.09.015; Wojcinski S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-159; Xiao X, 2012, AIP CONF PROC, V1503, P135, DOI 10.1063/1.4769931; Xie M, 2013, J ULTRAS MED, V32, P257, DOI 10.7863/jum.2013.32.2.257; Yang X, 2011, IEEE T ULTRASON FERR, V58, P2631, DOI 10.1109/TUFFC.2011.2126; Yoo JC, 2009, CIRC SYST SIGNAL PR, V28, P819, DOI [10.1007/s00034-009-9130-7, 10.1007/S00034-009-9130-7]	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115881	10.1371/journal.pone.0115881	http://dx.doi.org/10.1371/journal.pone.0115881			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541954	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900104
J	Challacombe, JF; Stubben, CJ; Klimko, CP; Welkos, SL; Kern, SJ; Bozue, JA; Worsham, PL; Cote, CK; Wolfe, DN				Challacombe, Jean F.; Stubben, Chris J.; Klimko, Christopher P.; Welkos, Susan L.; Kern, Steven J.; Bozue, Joel A.; Worsham, Patricia L.; Cote, Christopher K.; Wolfe, Daniel N.			Interrogation of the Burkholderia pseudomallei Genome to Address Differential Virulence among Isolates	PLOS ONE			English	Article							ANTIBIOTIC SUSCEPTIBILITY; NORTHERN AUSTRALIA; CARBON METABOLISM; CAUSATIVE AGENT; GENE-EXPRESSION; MELIOIDOSIS; RPOS; ADAPTATION; SURVIVAL; EPIDEMIOLOGY	Infection by the Gram-negative pathogen Burkholderia pseudomallei results in the disease melioidosis, acquired from the environment in parts of southeast Asia and northern Australia. Clinical symptoms of melioidosis range from acute (fever, pneumonia, septicemia, and localized infection) to chronic (abscesses in various organs and tissues, most commonly occurring in the lungs, liver, spleen, kidney, prostate and skeletal muscle), and persistent infections in humans are difficult to cure. Understanding the basic biology and genomics of B. pseudomallei is imperative for the development of new vaccines and therapeutic interventions. This formidable task is becoming more tractable due to the increasing number of B. pseudomallei genomes that are being sequenced and compared. Here, we compared three B. pseudomallei genomes, from strains MSHR668, K96243 and 1106a, to identify features that might explain why MSHR668 is more virulent than K96243 and 1106a in a mouse model of B. pseudomallei infection. Our analyses focused on metabolic, virulence and regulatory genes that were present in MSHR668 but absent from both K96243 and 1106a. We also noted features present in K96243 and 1106a but absent from MSHR668, and identified genomic differences that may contribute to variations in virulence noted among the three B. pseudomallei isolates. While this work contributes to our understanding of B. pseudomallei genomics, more detailed experiments are necessary to characterize the relevance of specific genomic features to B. pseudomallei metabolism and virulence. Functional analyses of metabolic networks, virulence and regulation shows promise for examining the effects of B. pseudomallei on host cell metabolism and will lay a foundation for future prediction of the virulence of emerging strains. Continued emphasis in this area will be critical for protection against melioidosis, as a better understanding of what constitutes a fully virulent Burkholderia isolate may provide for better diagnostic and medical countermeasure strategies.	[Challacombe, Jean F.; Stubben, Chris J.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Klimko, Christopher P.; Welkos, Susan L.; Bozue, Joel A.; Worsham, Patricia L.; Cote, Christopher K.] US Army Med Res Inst Infect Dis, Bacteriol Div, Ft Detrick, MD USA; [Kern, Steven J.] US Army Med Res Inst Infect Dis, Div Biostat, Ft Detrick, MD USA; [Wolfe, Daniel N.] Def Threat Reduct Agcy, Chem & Biol Technol Dept, Ft Belvoir, VA USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army	Challacombe, JF (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA.	jchalla@lanl.gov	Bozue, Joel/AAE-4363-2022; Bozue, Joel/AAE-4357-2022	Bozue, Joel/0000-0001-6959-8176; Bozue, Joel/0000-0001-6959-8176; Stubben, Chris/0000-0002-3390-4888	Defense Threat Reduction Agency (CCAR) [CB3846 PPE-1, CBS119924543-7049-BASIC]	Defense Threat Reduction Agency (CCAR)(United States Department of DefenseDefense Threat Reduction Agency)	This project was funded by the Defense Threat Reduction Agency (CCAR# CB3846 PPE-1 Burkholderia and CBS119924543-7049-BASIC). The funder had no role in study design, data collection and analysis, or decision to publish the manuscript. DNW contributed to the writing of the manuscript.	Abu Kwaik Y, 2013, CELL MICROBIOL, V15, P882, DOI 10.1111/cmi.12138; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; ATKINSON MR, 1990, J BACTERIOL, V172, P4758, DOI 10.1128/jb.172.9.4758-4765.1990; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Aziz RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048053; Barbier T, 2011, FEBS LETT, V585, P2929, DOI 10.1016/j.febslet.2011.08.011; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Brinkac LM, 2010, NUCLEIC ACIDS RES, V38, pD408, DOI 10.1093/nar/gkp850; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Cheng AC, 2004, J CLIN MICROBIOL, V42, P5477, DOI 10.1128/JCM.42.12.5477-5483.2004; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chieng S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-328; Chin CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-672; Choy JL, 2000, ACTA TROP, V74, P153, DOI 10.1016/S0001-706X(99)00065-0; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Currie BJ, 2003, EUR RESPIR J, V22, P542, DOI 10.1183/09031936.03.00006203; Currie BJ, 2001, AM J TROP MED HYG, V65, P177, DOI 10.4269/ajtmh.2001.65.177; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DEJSIRILERT S, 1991, JPN J MED SCI BIOL, V44, P63, DOI 10.7883/yoken1952.44.63; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; Fisher SH, 1999, MOL MICROBIOL, V32, P223, DOI 10.1046/j.1365-2958.1999.01333.x; Fuchs TM, 2012, FEMS MICROBIOL REV, V36, P435, DOI 10.1111/j.1574-6976.2011.00301.x; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Gal D, 2004, AM J TROP MED HYG, V71, P360, DOI 10.4269/ajtmh.2004.71.360; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Inglis TJJ, 2009, BRAZ J INFECT DIS, V13, P59, DOI 10.1590/S1413-86702009000100013; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Kaestli M, 2012, ENVIRON MICROBIOL, V14, P2058, DOI 10.1111/j.1462-2920.2011.02671.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Lengwehasatit I, 2008, MICROB PATHOGENESIS, V44, P238, DOI 10.1016/j.micpath.2007.08.017; Lerat E, 2005, NUCLEIC ACIDS RES, V33, P3125, DOI 10.1093/nar/gki631; Lerat E, 2004, GENOME RES, V14, P2273, DOI 10.1101/gr.2925604; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; Loprasert S, 2000, GENE, V254, P129, DOI 10.1016/S0378-1119(00)00279-1; Mao XJ, 2007, NUCLEIC ACIDS RES, V35, P1432, DOI 10.1093/nar/gkl1142; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; MAYS EE, 1975, CHEST, V68, P261, DOI 10.1378/chest.68.2.261; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Nandi T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000845; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; Ooi WF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003795; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Rattanavong S, 2011, APPL ENVIRON MICROB, V77, P532, DOI 10.1128/AEM.01822-10; REZNIKOFF WS, 1985, ANNU REV GENET, V19, P355, DOI 10.1146/annurev.ge.19.120185.002035; Robertson J, 2010, AM J TROP MED HYG, V82, P88, DOI 10.4269/ajtmh.2010.09-0226; Rodrigues F, 2006, J BACTERIOL, V188, P8178, DOI 10.1128/JB.01006-06; Sarovich DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091682; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; Suebrasri T., 2013, African Journal of Microbiology Research, V7, P1940; Thibault FM, 2004, J ANTIMICROB CHEMOTH, V54, P1134, DOI 10.1093/jac/dkh471; Trung TT, 2011, APPL ENVIRON MICROB, V77, P6486, DOI 10.1128/AEM.00735-11; Tuanyok A, 2007, J BACTERIOL, V189, P9044, DOI 10.1128/JB.01264-07; Tuanyok A, 2006, INFECT IMMUN, V74, P5465, DOI 10.1128/IAI.00737-06; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; Tumapa S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-190; Ulett GC, 2000, INFECT IMMUN, V68, P2034, DOI 10.1128/IAI.68.4.2034-2042.2000; Utaisincharoen P, 2006, MICROB PATHOGENESIS, V40, P184, DOI 10.1016/j.micpath.2006.01.002; Velapatino B, 2012, MICROBES INFECT, V14, P335, DOI 10.1016/j.micinf.2011.11.011; Walker DR, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P333; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wongtrakoongate P, 2012, MICROBIOL IMMUNOL, V56, P281, DOI 10.1111/j.1348-0421.2012.00447.x; Xiang ZS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r150; Yang J, 2011, TRENDS MICROBIOL, V19, P128, DOI 10.1016/j.tim.2010.12.001; Zhang YJJ, 2013, CELL MICROBIOL, V15, P1079, DOI 10.1111/cmi.12140	73	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115951	10.1371/journal.pone.0115951	http://dx.doi.org/10.1371/journal.pone.0115951			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536074	Green Submitted, gold, Green Published			2022-12-26	WOS:000348563300091
J	Churi, CR; Shroff, R; Wang, Y; Rashid, A; Kang, HC; Weatherly, J; Zuo, MX; Zinner, R; Hong, D; Meric-Bernstam, F; Janku, F; Crane, CH; Mishra, L; Vauthey, JN; Wolff, RA; Mills, G; Javle, M				Churi, Chaitanya R.; Shroff, Rachna; Wang, Ying; Rashid, Asif; Kang, HyunSeon C.; Weatherly, Jacqueline; Zuo, Mingxin; Zinner, Ralph; Hong, David; Meric-Bernstam, Funda; Janku, Filip; Crane, Christopher H.; Mishra, Lopa; Vauthey, Jean-Nicholas; Wolff, Robert A.; Mills, Gordon; Javle, Milind			Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications	PLOS ONE			English	Article							INTRAHEPATIC CHOLANGIOCARCINOMA; GALLBLADDER CANCER; FREQUENT MUTATION; BAP1; IDENTIFICATION; EPIDEMIOLOGY; EXPRESSION; MORTALITY; TRENDS; ERBB2	Background: Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic CCA have diverse clinical presentations. Next generation sequencing (NGS) technology may identify the genetic differences between these entities and identify molecular subgroups for targeted therapeutics. Methods: We describe successful NGS-based testing of 75 CCA patients along with the prognostic and therapeutic implications of findings. Mutation profiling was performed using either a) NGS panel of hotspot regions in 46 cancer-related genes using a 318-chip on Ion PGM Sequencer or b) Illumina HiSeq 2000 sequencing platform for 3,769 exons of 236 cancer-related genes plus 47 introns from 19 genes to an average depth of 1000X. Clinical data was abstracted and correlated with clinical outcome. Patients with targetable mutations were referred to appropriate clinical trials. Results: There were significant differences between intrahepatic (n = 55) and extrahepatic CCA (n = 20) in regard to the nature and frequency of the genetic aberrations (GAs). IDH1 and DNA repair gene alterations occurred more frequently in intrahepatic CCA, while ERBB2 GAs occurred in the extrahepatic group. Commonly occurring GAs in intrahepatic CCA were TP53 (35%), KRAS (24%), ARID1A (20%), IDH1 (18%), MCL1 (16%) and PBRM1 (11%). Most frequent GAs in extrahepatic CCA (n = 20) were TP53 (45%), KRAS (40%), ERBB2 (25%), SMAD4 (25%), FBXW7 (15%) and CDKN2A (15%). In intrahepatic CCA, KRAS, TP53 or MAPK/mTOR GAs were significantly associated with a worse prognosis while FGFR GAs correlated with a relatively indolent disease course. IDH1 GAs did not have any prognostic significance. GAs in the chromatin modulating genes, BAP1 and PBRM1 were associated with bone metastases and worse survival in extrahepatic CCA. Radiologic responses and clinical benefit was noted with EGFR, FGFR, C-met, B-RAF and MEK inhibitors. Conclusion: There are significant genetic differences between intra and extrahepatic CCA. NGS can potentially identify disease subsets with distinct prognostic and therapeutic implications.	[Churi, Chaitanya R.; Shroff, Rachna; Wang, Ying; Rashid, Asif; Kang, HyunSeon C.; Weatherly, Jacqueline; Zuo, Mingxin; Zinner, Ralph; Hong, David; Meric-Bernstam, Funda; Janku, Filip; Crane, Christopher H.; Mishra, Lopa; Vauthey, Jean-Nicholas; Wolff, Robert A.; Mills, Gordon; Javle, Milind] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Javle, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	mjavle@mdanderson.org	Janku, Filip/ABB-9136-2020; Shroff, Rachna/AAR-5802-2020; Zuo, Mingxin/E-1063-2015	Mishra, Lopa/0000-0002-6850-0808; Kang, Hyunseon/0000-0001-5313-3526	Cholangiocarcinoma Foundation;  [PO1 CA130821-01]; NATIONAL CANCER INSTITUTE [P01CA130821, P30CA016672] Funding Source: NIH RePORTER	Cholangiocarcinoma Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by funds from the Cholangiocarcinoma Foundation. PO1 CA130821-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, Acta Trop, V88, P169; Arai Toshiyuki, 2006, Nihon Rinsho, V64 Suppl 1, P476; Bertuccio P, 2013, ANN ONCOL, V24, P1667, DOI 10.1093/annonc/mds652; Borad MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004135; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Bose P, 2009, EXPERT OPIN INV DRUG, V18, P1735, DOI 10.1517/13543780903305428; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Chen TC, 2012, ANN SURG ONCOL, V19, pS675, DOI [10.1245/s10434-012-2224-7, 10.1245/s10434-012-2451-y]; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Chung JY, 2009, CLIN CANCER RES, V15, P660, DOI 10.1158/1078-0432.CCR-08-1084; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Goeppert B, 2014, MODERN PATHOL, V27, P1028, DOI 10.1038/modpathol.2013.206; Hamidi H, 2014, BR J CANC; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Herter-Sprie GS, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00086; Javle M, 2014, HUM PATHOL, V45, P701, DOI 10.1016/j.humpath.2013.11.001; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Kanagal-Shamanna R, 2014, MODERN PATHOL, V27, P314, DOI 10.1038/modpathol.2013.122; Khan SA, 2012, J HEPATOL, V56, P848, DOI 10.1016/j.jhep.2011.11.015; Kipp BR, 2012, HUM PATHOL, V43, P1552, DOI 10.1016/j.humpath.2011.12.007; Lee JW, 2006, CANCER LETT, V237, P89, DOI 10.1016/j.canlet.2005.05.026; Murali R, 2013, PATHOLOGY, V45, P116, DOI 10.1097/PAT.0b013e32835d0efb; Nakayama N, 2008, BRIT J CANCER, V99, P2020, DOI 10.1038/sj.bjc.6604783; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Parsi MA, 2013, WORLD J GASTROENTERO, V19, P457, DOI 10.3748/wjg.v19.i4.457; Patel T, 2001, HEPATOLOGY, V33, P1353, DOI 10.1053/jhep.2001.25087; Pirozzi CJ, 2013, CANCER CELL, V23, P570, DOI 10.1016/j.ccr.2013.04.024; Roa Ivan, 2014, Gastrointest Cancer Res, V7, P42; Ross JS, 2011, AM J CLIN PATHOL, V136, P527, DOI 10.1309/AJCPR1SVT1VHUGXW; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Shaib YH, 2004, J HEPATOL, V40, P472, DOI 10.1016/j.jhep.2003.11.030; Shin HR, 2010, J KOREAN MED SCI, V25, P1011, DOI 10.3346/jkms.2010.25.7.1011; Sia D, 2013, ONCOGENE, V32, P4861, DOI 10.1038/onc.2012.617; Subbiah IM, 2013, ONCOTARGET, V4, P156; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; van Essen TH, 2014, BR J OPHTHALMOL; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Yamasaki Susumu, 2003, J Hepatobiliary Pancreat Surg, V10, P288, DOI 10.1007/s00534-002-0732-8; Yoshikawa D, 2008, BRIT J CANCER, V98, P418, DOI 10.1038/sj.bjc.6604129	44	290	305	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115383	10.1371/journal.pone.0115383	http://dx.doi.org/10.1371/journal.pone.0115383			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536104	Green Submitted, Green Published, gold			2022-12-26	WOS:000348563300036
J	Goldstein, P; Korol, AB; Reiner-Benaim, A				Goldstein, Pavel; Korol, Abraham B.; Reiner-Benaim, Anat			Two-Stage Genome-Wide Search for Epistasis with Implementation to Recombinant Inbred Lines (RIL) Populations	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; FALSE DISCOVERY RATE; NETWORK ANALYSIS; MAPPING ANALYSIS; ASSOCIATION; PACKAGE; CROSSES; MARKERS; MODELS; QTL	Objective and Methods: This paper proposes an inegrative two-stage genome-wide search for pairwise epistasis on expression quantitative trait loci (eQTL). The traits are clustered into multi-trait complexes that account for correlations between them that may result from common epistasis effects. The search is done by first screening for epistatic regions and then using dense markers within the identified regions, resulting in substantial reduction in the number of tests for epistasis. The FDR is controlled using a hierarchical procedure that accounts for the search structure. Each combination of trait and marker-pair is tested using a model that accounts for both statistical and functional interpretations of epistasis and considers orthogonal effects, such that their contributions to heritability can be estimated individually. We examine the impact of using multi-trait complexes rather than single traits, and of using a hierarchical search for epistasis rather than skipping the initial screen for epistatic regions. We apply the proposed algorithm on Arabidopsis transcription data. Principal Findings: Both epistasis detection power and heritability contributed by epistasis increased when using multi-trait complexes rather than single traits. Epistatic effects common to the eQTLs included in the complexes have higher chance of being identified by analysis of multi-trait complexes, particularly when epistatic effects on individual traits are small. Compared to direct testing for all potential epistatic effects, the hierarchical search was substantially more powerful in detecting epistasis, while controlling the FDR at the desired level. Association in functional roles within genomic regions was observed, supporting an initial screen for epistatic QTLs.	[Goldstein, Pavel; Reiner-Benaim, Anat] Univ Haifa, Dept Stat, IL-3498838 Haifa, Israel; [Korol, Abraham B.] Univ Haifa, Dept Evolutionary & Environm Biol, IL-3498838 Haifa, Israel; [Korol, Abraham B.] Univ Haifa, Inst Evolut, IL-3498838 Haifa, Israel	University of Haifa; University of Haifa; University of Haifa	Reiner-Benaim, A (corresponding author), Univ Haifa, Dept Stat, IL-3498838 Haifa, Israel.	areiner@stat.haifa.ac.il	Reiner-Benaim, Anat/HGQ-1183-2022	Reiner-Benaim, Anat/0000-0001-8709-3112	Israeli Science Foundation [1303/10, 800-2010]	Israeli Science Foundation(Israel Science Foundation)	AR was supported by the Israeli Science Foundation (http://www.isf.org.il/) grant number 1303/10. Abraham B. Korol was supported by the Israeli Science Foundation grant number 800-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Castro JM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000062; Alvarez-Castro JM, 2007, GENETICS, V176, P1151, DOI 10.1534/genetics.106.067348; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carter GW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003010; deVisser JAGM, 1997, EVOLUTION, V51, P1499, DOI 10.1111/j.1558-5646.1997.tb01473.x; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Goeman JJ, 2014, STAT MED, V33, P1946, DOI 10.1002/sim.6082; Guo MY, 2010, BIOSTATISTICS, V11, P473, DOI 10.1093/biostatistics/kxq012; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Korol AB, 2001, GENETICS, V157, P1789; Lan H, 2003, GENETICS, V164, P1607; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee S, 2012, BIOINFORMATICS, V28, pI137, DOI 10.1093/bioinformatics/bts227; Mester DI, 2004, COMPUT BIOL CHEM, V28, P281, DOI 10.1016/j.compbiolchem.2004.08.003; Rau Christoph D., 2013, Frontiers in Genetics, V4, P28, DOI 10.3389/fgene.2013.00028; Reiner-Benaim A, 2007, BIOINFORMATICS, V23, P2239, DOI 10.1093/bioinformatics/btm300; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Ronin YI, 1999, GENETICS, V151, P387; Rouzic AL, 2012, NOIA IMPLEMENTATION; Schifano ED, 2013, AM J HUM GENET, V92, P744, DOI 10.1016/j.ajhg.2013.04.004; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Templeton AR, 2000, EPISTASIS EVOLUTIONA, P27; Voorman A, 2012, BIOINFORMATICS, V28, P1818, DOI 10.1093/bioinformatics/bts291; Wei WH, 2010, HEREDITY, V104, P401, DOI 10.1038/hdy.2009.129; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Yandell BS, 2007, BIOINFORMATICS, V23, P641, DOI 10.1093/bioinformatics/btm011; Yandell BS, 2013, QTLBIM QTL BAYESIAN; Yekutieli D, 2008, J AM STAT ASSOC, V103, P309, DOI 10.1198/016214507000001373; Yi NJ, 2007, GENETICS, V176, P1865, DOI 10.1534/genetics.107.071365; Zeng ZB, 2005, GENETICS, V169, P1711, DOI 10.1534/genetics.104.035857; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000642	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115680	10.1371/journal.pone.0115680	http://dx.doi.org/10.1371/journal.pone.0115680			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536193	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300064
J	Lin, YH; Huang, SM; Huang, CY; Tu, YN; Huang, TC				Lin, Yang-Hsien; Huang, Shih-Min; Huang, Chin-Yi; Tu, Yun-Niang; Huang, Tzung-Chi			Quantitative Analysis of Respiration-Related Movement for Abdominal Artery in Multiphase Hepatic CT	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; COMPUTED-TOMOGRAPHY; LIVER-TUMORS; MOTION; INJECTION; PERFUSION	Objectives: Respiration-induced motion in the liver causes potential errors on the measurement of contrast medium in abdominal artery from multiphase hepatic CT scans. In this study, we investigated the use of hepatic CT images to quantitatively estimate the abdominal artery motion due to respiration by optical flow method. Materials and Methods: A total of 132 consecutive patients were included in our patient cohort. We apply the optical flow method to compute the motion of the abdominal artery due to respiration. Results: The minimum and maximum displacement of the abdominal artery motion were 0.02 and 30.87 mm by manual delineation, 0.03 and 40.75 mm calculated by optical flow method, respectively. Both high consistency and correlation between the present method and the physicians' manual delineations were acquired with the regression equation of movement, y=0.81x+0.25, r=0.95, p<0.001. Conclusion: We estimated the motion of abdominal artery due to respiration using the optical flow method in multiphase hepatic CT scans and the motion estimations were validated with the visualization of physicians. The quantitative analysis of respiration-related movement of abdominal artery could be used for motion correction in the measurement of contrast medium passing though abdominal artery in multiphase CT liver scans.	[Lin, Yang-Hsien; Huang, Chin-Yi; Tu, Yun-Niang] Minist Hlth & Welf, Peng Hu Hosp, Dept Diagnost Radiol, Peng Hu City, Taiwan; [Huang, Shih-Min] China Med Univ Hosp, Dept Radiol, Taichung, Taiwan; [Huang, Tzung-Chi] ChinaMed Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Huang, Tzung-Chi] Asia Univ, Dept Biomed Informat, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Huang, TC (corresponding author), ChinaMed Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw	huang, tzungchi/O-4434-2015		school project of China Medical University, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	school project of China Medical University, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was financially supported by the school project of China Medical University, Taiwan, and by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beddar AS, 2007, INT J RADIAT ONCOL, V67, P630, DOI 10.1016/j.ijrobp.2006.10.007; Brandner ED, 2006, INT J RADIAT ONCOL, V65, P554, DOI 10.1016/j.ijrobp.2005.12.042; Clifford Mark A, 2002, Comput Aided Surg, V7, P291, DOI 10.3109/10929080209146038; Fleischmann D, 2010, RADIOL CLIN N AM, V48, P237, DOI 10.1016/j.rcl.2010.02.002; Ford EC, 2003, MED PHYS, V30, P88, DOI 10.1118/1.1531177; Guerrero T, 2004, PHYS MED BIOL, V49, P4147, DOI 10.1088/0031-9155/49/17/022; Hallman JL, 2012, INT J RADIAT ONCOL, V83, P435, DOI 10.1016/j.ijrobp.2011.06.1970; Horn B. K. P., 1981, DETERMINING OPTICAL, V17, P185, DOI DOI 10.1016/0004-3702(81)90024-2; Huang TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075903; Huang TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058886; Ippolito D, 2008, ACAD RADIOL, V15, P919, DOI 10.1016/j.acra.2008.02.005; Kandel S, 2012, INSIGHTS IMAGING, V3, P323, DOI 10.1007/s13244-012-0169-9; Kim T, 1999, ABDOM IMAGING, V24, P473, DOI 10.1007/s002619900543; Kubas A, 2008, CANCER RADIOTHER, V12, P768, DOI 10.1016/j.canrad.2008.04.011; Laghi A, 2003, RADIOLOGY, V226, P543, DOI 10.1148/radiol.2262012043; MERINE D, 1990, RADIOLOGY, V175, P707, DOI 10.1148/radiology.175.3.2160675; Mok GSP, 2013, IEEE T BIO-MED ENG, V60, P1927, DOI 10.1109/TBME.2013.2245132; Sahani DV, 2007, RADIOLOGY, V243, P736, DOI 10.1148/radiol.2433052020; Takemura A, 2008, RADIOL PHYS TECHNOL, V1, P178, DOI 10.1007/s12194-008-0025-2; Wagman R, 2003, INT J RADIAT ONCOL, V55, P659, DOI 10.1016/S0360-3016(02)03941-X; Wu CC, 2011, MICROVASC RES, V81, P252, DOI 10.1016/j.mvr.2011.01.003	21	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114222	10.1371/journal.pone.0114222	http://dx.doi.org/10.1371/journal.pone.0114222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536144	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300011
J	Mo, ST; Chiang, SJ; Lai, TY; Cheng, YL; Chung, CE; Kuo, SCH; Reece, KM; Chen, YC; Chang, NS; Wadzinski, BE; Chiang, CW				Mo, Shu-Ting; Chiang, Shang-Ju; Lai, Tai-Yu; Cheng, Yu-Ling; Chung, Cheng-En; Kuo, Spencer C. H.; Reece, Kelie M.; Chen, Yung-Cheng; Chang, Nan-Shan; Wadzinski, Brian E.; Chiang, Chi-Wu			Visualization of Subunit Interactions and Ternary Complexes of Protein Phosphatase 2A in Mammalian Cells	PLOS ONE			English	Article							REGULATORY SUBUNIT; CATALYTIC SUBUNIT; SUBCELLULAR-LOCALIZATION; B-SUBUNIT; PP2A; ALPHA-4; HOLOENZYME; EXPRESSION; BINDING; FAMILY	Protein phosphatase 2A (PP2A) is a ubiquitous phospho-serine/threonine phosphatase that controls many diverse cellular functions. The predominant form of PP2A is a heterotrimeric holoenzyme consisting of a scaffolding A subunit, a variable regulatory B subunit, and a catalytic C subunit. The C subunit also associates with other interacting partners, such as alpha 4, to form non-canonical PP2A complexes. We report visualization of PP2A complexes in mammalian cells. Bimolecular fluorescence complementation (BiFC) analysis of PP2A subunit interactions demonstrates that the B subunit plays a key role in directing the subcellular localization of PP2A, and confirms that the A subunit functions as a scaffold in recruiting the B and C subunits to form a heterotrimeric holoenzyme. BiFC analysis also reveals that alpha 4 promotes formation of the AC core dimer. Furthermore, we demonstrate visualization of specific ABC holoenzymes in cells by combining BiFC and fluorescence resonance energy transfer (BiFC-FRET). Our studies not only provide direct imaging data to support previous biochemical observations on PP2A complexes, but also offer a promising approach for studying the spatiotemporal distribution of individual PP2A complexes in cells.	[Mo, Shu-Ting; Chiang, Shang-Ju; Cheng, Yu-Ling; Chung, Cheng-En; Chen, Yung-Cheng; Chang, Nan-Shan; Chiang, Chi-Wu] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan; [Lai, Tai-Yu; Chang, Nan-Shan; Chiang, Chi-Wu] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Kuo, Spencer C. H.] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan 70101, Taiwan; [Chang, Nan-Shan; Chiang, Chi-Wu] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Reece, Kelie M.; Wadzinski, Brian E.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Vanderbilt University	Wadzinski, BE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.	brian.wadzinski@vanderbilt.edu; chiangcw@mail.ncku.edu.tw			Headquarters of University Advancement, National Cheng Kung University [D100-35B58]; National Science Council [NSC99-2320-B-006024-MY3]; National Institutes of Health [GM051366]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM051366, R01GM051366] Funding Source: NIH RePORTER	Headquarters of University Advancement, National Cheng Kung University; National Science Council(Ministry of Science and Technology, Taiwan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Headquarters of University Advancement, National Cheng Kung University (D100-35B58 to C.W.C.), National Science Council (NSC99-2320-B-006024-MY3 to C.W.C.) and National Institutes of Health (GM051366 to B.E.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Chung HY, 1999, BIOCHEMISTRY-US, V38, P10371, DOI 10.1021/bi990902g; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; FORSTER T, 1959, DISCUSS FARADAY SOC, P7; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Harper Jane V., 2004, V296, P157; HEALY AM, 1991, MOL CELL BIOL, V11, P5767, DOI 10.1128/MCB.11.11.5767; HENDRIX P, 1993, J BIOL CHEM, V268, P15267; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Ito A, 2003, AM J PATHOL, V162, P479, DOI 10.1016/S0002-9440(10)63842-4; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Jiang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2663; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lee TY, 2010, J BIOL CHEM, V285, P21567, DOI 10.1074/jbc.M109.094953; MAYER RE, 1991, BIOCHEMISTRY-US, V30, P3589, DOI 10.1021/bi00229a001; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; MUMBY M, 1995, SEMIN CANCER BIOL, V6, P229, DOI 10.1006/scbi.1995.0030; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shyu YJ, 2008, P NATL ACAD SCI USA, V105, P151, DOI 10.1073/pnas.0705181105; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Strack S, 1999, FEBS LETT, V460, P462, DOI 10.1016/S0014-5793(99)01377-0; Strack S, 1999, J COMP NEUROL, V413, P373; Strack S, 1998, J COMP NEUROL, V392, P515; TUNG HYL, 1985, EUR J BIOCHEM, V148, P253, DOI 10.1111/j.1432-1033.1985.tb08833.x; WADZINSKI BE, 1992, J BIOL CHEM, V267, P16883; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038569; Watkins GR, 2012, J BIOL CHEM, V287, P24207, DOI 10.1074/jbc.M112.368613; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yang J, 2007, BIOCHEMISTRY-US, V46, P8807, DOI 10.1021/bi7007118; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; ZOLNIEROWICZ S, 1994, BIOCHEMISTRY-US, V33, P11858, DOI 10.1021/bi00205a023	48	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e116074	10.1371/journal.pone.0116074	http://dx.doi.org/10.1371/journal.pone.0116074			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536081	Green Submitted, Green Published, gold			2022-12-26	WOS:000348563300099
J	Rolden, HJA; van Bodegom, D; Westendorp, RGJ				Rolden, Herbert J. A.; van Bodegom, David; Westendorp, Rudi G. J.			Changes in Health Care Expenditure after the Loss of a Spouse: Data on 6,487 Older Widows and Widowers in the Netherlands	PLOS ONE			English	Article							CONJUGAL BEREAVEMENT; INFORMAL CARE; FORMAL CARE; HOME-CARE; MORTALITY; DEATH; SUBSTITUTE; MARRIAGE; INSTITUTIONALIZATION; ADJUSTMENT	Background: In ageing populations, informal care holds great potential to limit rising health care expenditure. The majority of informal care is delivered by spouses. The loss of informal care due to the death of the spouse could therefore increase expenditure levels for formal care. Objective: To investigate the impact of the death of the spouse on health care expenditure by older people through time. Additionally, to examine whether the impact differs between socio-demographic groups, and what health services are affectedmost. Design: Longitudinal data on health care expenditure (from July 2007 through 2010) from a regional Dutch health care insurer was matched with data on marital status (2004-2011) from the Central Bureau of Statistics. Linear mixed models with log transformed health care expenditure, generalized linear models and two-part models were used to retrieve standardized levels of monthly health care expenditure of 6,487 older widowed subjects in the 42 months before and after the loss of the spouse. Results: Mean monthly health care expenditure in married subjects was (sic)502 in the 42 months before the death of the spouse, and expenditure levels rose by (sic)239 (48%) in the 42 months after the death of the spouse. The increase in expenditure after the death of the spouse was highest for men ((sic)319; 59%) and the oldest old ((sic)553; 82%). Expenditure levels showed the highest increase for hospital and home care services (together (sic)166). Conclusions: The loss of the spouse is associated with an increase in health care expenditure. The relatively high rise in long-term care expenses suggests that the loss of informal care is an important determinant of this rise.	[Rolden, Herbert J. A.; van Bodegom, David; Westendorp, Rudi G. J.] Leyden Acad Vital & Ageing, Leiden, Netherlands; [Rolden, Herbert J. A.; van Bodegom, David; Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rolden, HJA (corresponding author), Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Hlth Evidence, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	herbert.rolden@radboudumc.nl	Rolden, Herbert/E-2464-2016	van Bodegom, David/0000-0002-5691-8342				Arno PS, 1999, HEALTH AFFAIR, V18, P182, DOI 10.1377/hlthaff.18.2.182; Barendregt JJ, 1997, NEW ENGL J MED, V337, P1052, DOI 10.1056/NEJM199710093371506; Bolin K, 2008, HEALTH ECON, V17, P393, DOI 10.1002/hec.1275; Bonsang E, 2009, J HEALTH ECON, V28, P143, DOI 10.1016/j.jhealeco.2008.09.002; BUSS DM, 1985, AM SCI, V73, P47; Cartwright A, 1982, J R Coll Gen Pract, V32, P215; Charles KK, 2005, J HEALTH ECON, V24, P1174, DOI 10.1016/j.jhealeco.2005.05.001; Del Bono E, 2009, HEALTH SOC CARE COMM, V17, P267, DOI 10.1111/j.1365-2524.2008.00826.x; Elwert F, 2008, AM J PUBLIC HEALTH, V98, P2092, DOI 10.2105/AJPH.2007.114348; Espinosa J, 2008, J HEALTH ECON, V27, P1326, DOI 10.1016/j.jhealeco.2008.04.001; GARBACZ C, 1983, J HUM RESOUR, V18, P147, DOI 10.2307/145662; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Hoekstra J, 2008, KOSTEN ZIEKTEN NEDER; Iwashyna TJ, 2003, SOC SCI MED, V57, P2137, DOI 10.1016/S0277-9536(02)00546-4; KAPRIO J, 1987, AM J PUBLIC HEALTH, V77, P283, DOI 10.2105/AJPH.77.3.283; KEMPER P, 1992, HEALTH SERV RES, V27, P421; LEU RE, 1983, SOC SCI MED, V17, P1907, DOI 10.1016/0277-9536(83)90168-5; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; MASCIETAYLOR CGN, 1989, BEHAV GENET, V19, P223, DOI 10.1007/BF01065906; Miller EA, 2000, MED CARE RES REV, V57, P259, DOI 10.1177/107755870005700301; Mullahy J, 1998, J HEALTH ECON, V17, P247, DOI 10.1016/S0167-6296(98)00030-7; Nihtila E, 2008, AM J PUBLIC HEALTH, V98, P1228, DOI 10.2105/AJPH.2007.119271; Pezzin LE, 1996, J HUM RESOUR, V31, P650, DOI 10.2307/146270; Portrait F, 2000, HEALTH ECON, V9, P513, DOI 10.1002/1099-1050(200009)9:6<513::AID-HEC534>3.0.CO;2-R; Prigerson HG, 2000, GERONTOLOGIST, V40, P349, DOI 10.1093/geront/40.3.349; Raveis VH, 1999, SOC WORK HEALTH CARE, V29, P13; Rodrigues R., 2012, FACTS FIGURES HLTH A; SCHAEFER C, 1995, AM J EPIDEMIOL, V141, P1142, DOI 10.1093/oxfordjournals.aje.a117387; Schulz R, 2001, JAMA-J AM MED ASSOC, V285, P3123, DOI 10.1001/jama.285.24.3123; Simeonova E, 2013, J HEALTH ECON, V32, P33, DOI 10.1016/j.jhealeco.2012.10.010; Temple NJ, 2012, EUR J PUBLIC HEALTH, V22, P618, DOI 10.1093/eurpub/ckr139; van den Berg Bernard, 2004, Eur J Health Econ, V5, P36, DOI 10.1007/s10198-003-0189-y; van den Berg GJ, 2011, J HEALTH ECON, V30, P774, DOI 10.1016/j.jhealeco.2011.05.011; van Duin C, 2009, BEVOLKINGSPROGNOSE 2; Van Houtven CH, 2004, J HEALTH ECON, V23, P1159, DOI 10.1016/j.jhealeco.2004.04.008; WOLINSKY FD, 1992, J GERONTOL, V47, pS8, DOI 10.1093/geronj/47.1.S8; Wong A, 2011, HEALTH ECON, V20, P379, DOI 10.1002/hec.1597; Wong A, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-110	39	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115478	10.1371/journal.pone.0115478	http://dx.doi.org/10.1371/journal.pone.0115478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25536040	gold, Green Submitted, Green Published			2022-12-26	WOS:000348563300043
J	Sharma, A; Berga-Bolanos, R; Sen, JM				Sharma, Archna; Berga-Bolanos, Rosa; Sen, Jyoti Misra			T Cell Factor-1 Controls the Lifetime of CD4+CD8+Thymocytes In Vivo and Distal T Cell Receptor alpha-Chain Rearrangement Required for NKT Cell Development	PLOS ONE			English	Article							THYMOCYTE SURVIVAL; TCRA REARRANGEMENT; LINEAGE; DIFFERENTIATION; SPECIFICATION; PATHWAY; REPERTOIRE; SELECTION; WNT	Natural killer T (NKT) cells are a component of innate and adaptive immune systems implicated in immune, autoimmune responses and in the control of obesity and cancer. NKT cells develop from common CD4+ CD8+ double positive (DP) thymocyte precursors after the rearrangement and expression of T cell receptor (TCR) V alpha 14-J alpha 18 gene. Temporal regulation and late appearance of V alpha 14-J alpha 18 rearrangement in immature DP thymocytes has been demonstrated. However, the precise control of lifetime of DP thymocytes in vivo that enables distal rearrangements remains incompletely defined. Here we demonstrate that T cell factor (TCF)-1, encoded by the Tcf7 gene, is critical for the extended lifetime of DP thymocytes. TCF-1-deficient DP thymocytes fail to undergo TCR V alpha 14-J alpha 18 rearrangement and produce significantly fewer NKT cells. Ectopic expression of Bcl-x(L) permits V alpha 14-J alpha 18 rearrangement and rescues NKT cell development. We report that TCF-1 regulates expression of ROR gamma t, which regulates DP thymocyte survival by controlling expression of Bcl-x(L). We posit that TCF-1 along with its cofactors controls the lifetime of DP thymocytes in vivo.	[Sharma, Archna; Berga-Bolanos, Rosa; Sen, Jyoti Misra] NIA, Immune Cells & Inflammat Sect, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sen, JM (corresponding author), NIA, Immune Cells & Inflammat Sect, NIH, Baltimore, MD 21224 USA.	Jyoti-Sen@nih.gov	Sharma, Archna/R-9377-2016	Sharma, Archna/0000-0003-4745-0220	Intramural Research Program of the National Institute on Aging at the NIH; NATIONAL INSTITUTE ON AGING [ZIAAG000772] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging at the NIH; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institute on Aging at the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bezbradica JS, 2005, P NATL ACAD SCI USA, V102, P5114, DOI 10.1073/pnas.0408449102; D'Cruz LM, 2010, NAT IMMUNOL, V11, P240, DOI 10.1038/ni.1845; Dose M, 2009, P NATL ACAD SCI USA, V106, P8641, DOI 10.1073/pnas.0812255106; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Hager E, 2007, J IMMUNOL, V179, P2228, DOI 10.4049/jimmunol.179.4.2228; Hu TS, 2010, NAT IMMUNOL, V11, P435, DOI 10.1038/ni.1865; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Matsuda JL, 2005, CURR OPIN IMMUNOL, V17, P122, DOI 10.1016/j.coi.2005.01.002; Monticelli LA, 2009, P NATL ACAD SCI USA, V106, P19461, DOI 10.1073/pnas.0908249106; Sharma A, 2012, J IMMUNOL, V188, P3859, DOI 10.4049/jimmunol.1103729; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Stanic AK, 2004, J IMMUNOL, V172, P2265, DOI 10.4049/jimmunol.172.4.2265; Steinke FC, 2014, IMMUNOL RES, V59, P45, DOI 10.1007/s12026-014-8545-9; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wang RQ, 2011, J IMMUNOL, V187, P5964, DOI 10.4049/jimmunol.1101205; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yu Q, 2010, IMMUNOL RES, V47, P45, DOI 10.1007/s12026-009-8137-2	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115803	10.1371/journal.pone.0115803	http://dx.doi.org/10.1371/journal.pone.0115803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536344	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300076
J	Ng, SH; Lin, CY; Chan, SC; Lin, YC; Yen, TC; Liao, CT; Chang, JTC; Ko, SF; Wang, HM; Chang, CJ; Wang, JJ				Ng, Shu-Hang; Lin, Chien-Yu; Chan, Sheng-Chieh; Lin, Yu-Chun; Yen, Tzu-Chen; Liao, Chun-Ta; Chang, Joseph Tung-Chieh; Ko, Sheung-Fat; Wang, Hung-Ming; Chang, Chee-Jen; Wang, Jiun-Jie			Clinical Utility of Multimodality Imaging with Dynamic Contrast-Enhanced MRI, Diffusion-Weighted MRI, and F-18-FDG PET/CT for the Prediction of Neck Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiation	PLOS ONE			English	Article							METABOLIC TUMOR VOLUME; PROGNOSTIC-FACTOR; FDG-PET; ORGAN PRESERVATION; PEDIATRIC-PATIENTS; ORAL-CAVITY; HEAD; CANCER; SURVIVAL; PARAMETERS	The clinical usefulness of pretreatment imaging techniques for predicting neck control in patients with oropharyngeal or hypopharyngeal squamous cell carcinoma (OHSCC) treated with chemoradiation remains unclear. In this prospective study, we investigated the role of pretreatment dynamic contrast-enhanced perfusion MR imaging (DCE-PWI), diffusion-weighted MR imaging (DWI), and [F-18] fluorodeoxyglucose-positron emission tomography (F-18-FDG PET)/CT derived imaging markers for the prediction of neck control in OHSCC patients treated with chemoradiation. Patients with untreated OHSCC scheduled for chemoradiation between August, 2010 and July, 2012 were eligible for the study. Clinical variables and the following imaging parameters of metastatic neck lymph nodes were examined in relation to neck control: transfer constant, volume of blood plasma, and volume of extracellular extravascular space (V-e) on DCE-PWI; apparent diffusion coefficient (ADC) on DWI; maximum standardized uptake value, metabolic tumor volume, and total lesion glycolysis on F-18-FDG PET/CT. There were 69 patients (37 with oropharynx SCC and 32 with hypopharynx SCC) with successful pretreatment DCE-PWI and DWI available for analysis. After a median follow-up of 31 months, 25 (36.2%) participants had neck failure. Multivariate analysis identified hemoglobin level < 14.3 g/dL (P=0.019), V-e < 0.23 (P=0.040), and ADC>1.14x10(-3) mm(2)/s (P=0.003) as independent prognostic factors for 3-year neck control. A prognostic scoring system was formulated by summing up the three significant predictors of neck control. Patients with scores of 2-3 had significantly poorer neck control and overall survival rates than patients with scores of 0-1. We conclude that hemoglobin levels, V-e, and ADC are independent pretreatment prognostic factors for neck control in OHSCC treated with chemoradiation. Their combination may identify a subgroup of patients at high risk of developing neck failure.	[Ng, Shu-Hang; Chan, Sheng-Chieh; Yen, Tzu-Chen] Chang Gung Univ, Chang Gung Mem Hosp, Mol Imaging Ctr, Taoyuan, Taiwan; [Ng, Shu-Hang; Lin, Yu-Chun; Ko, Sheung-Fat] Chang Gung Univ, Chang Gung Mem Hosp, Dept Diagnost Radiol, Taoyuan, Taiwan; [Ng, Shu-Hang; Lin, Yu-Chun; Wang, Jiun-Jie] Chang Gung Univ, Chang Gung Mem Hosp, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Lin, Chien-Yu; Chang, Joseph Tung-Chieh] Chang Gung Univ, Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan, Taiwan; [Chan, Sheng-Chieh; Yen, Tzu-Chen] Chang Gung Univ, Chang Gung Mem Hosp, Dept Nucl Med, Taoyuan, Taiwan; [Liao, Chun-Ta] Chang Gung Univ, Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Wang, Hung-Ming] Chang Gung Univ, Chang Gung Mem Hosp, Dept Med Oncol, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Chang Gung Mem Hosp, Clin Informat, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Chang Gung Mem Hosp, Med Stat Res Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Wang, JJ (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan.	jwang@mail.cgu.edu.tw	Chan, Sheng Chieh/AAF-9127-2019	Chan, Sheng Chieh/0000-0003-3236-395X; Wang, Jiun-Jie/0000-0002-2422-9059; Chang, Chee Jen/0000-0002-7725-7555	National Science Council-Taiwan [99-2314-B-182A-095-MY3]	National Science Council-Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from the National Science Council-Taiwan (99-2314-B-182A-095-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allal AS, 2004, INT J RADIAT ONCOL, V59, P1295, DOI 10.1016/j.ijrobp.2003.12.039; Becker A, 2000, INT J RADIAT ONCOL, V46, P459, DOI 10.1016/S0360-3016(99)00384-3; Cao Y, 2008, INT J RADIAT ONCOL, V72, P1287, DOI 10.1016/j.ijrobp.2008.08.024; Chan SC, 2013, ORAL ONCOL, V49, P71, DOI 10.1016/j.oraloncology.2012.07.016; Chan SC, 2011, EUR J NUCL MED MOL I, V38, P1607, DOI 10.1007/s00259-011-1824-y; Chawla S, 2011, AM J NEURORADIOL, V32, P778, DOI 10.3174/ajnr.A2376; Chawla S, 2013, AM J ROENTGENOL, V200, P35, DOI 10.2214/AJR.12.9432; Chen SW, 2009, HEAD NECK-J SCI SPEC, V31, P709, DOI 10.1002/hed.21011; Choi HS, 2013, KOREAN J RADIOL, V14, P487, DOI 10.3348/kjr.2013.14.3.487; Cooper RA, 2000, RADIOTHER ONCOL, V57, P53, DOI 10.1016/S0167-8140(00)00259-0; Demirci U, 2011, ASIAN PAC J CANCER P, V12, P1817; Glaser CM, 2001, INT J RADIAT ONCOL, V50, P705, DOI 10.1016/S0360-3016(01)01488-2; Guo JY, 2012, CANCER-AM CANCER SOC, V118, P3776, DOI 10.1002/cncr.26701; Halfpenny W, 2002, BRIT J CANCER, V86, P512, DOI 10.1038/sj.bjc.6600114; Hatakenaka M, 2011, INT J RADIAT ONCOL, V81, P339, DOI 10.1016/j.ijrobp.2010.05.051; Hatakenaka Masamitsu, 2008, Magn Reson Med Sci, V7, P23, DOI 10.2463/mrms.7.23; Higgins KA, 2012, INT J RADIAT ONCOL, V82, P548, DOI 10.1016/j.ijrobp.2010.11.050; Humphries PD, 2007, RADIOLOGY, V245, P848, DOI 10.1148/radiol.2452061535; JAIN RK, 1987, CANCER RES, V47, P3039; Jansen JFA, 2012, INT J RADIAT ONCOL, V82, P299, DOI 10.1016/j.ijrobp.2010.11.022; Kamijo T, 2000, CLIN CANCER RES, V6, P3159; Kim S, 2010, AM J NEURORADIOL, V31, P262, DOI 10.3174/ajnr.A1817; Kim S, 2009, CLIN CANCER RES, V15, P986, DOI 10.1158/1078-0432.CCR-08-1287; King AD, 2010, EUR RADIOL, V20, P2213, DOI 10.1007/s00330-010-1769-8; Kubicek GJ, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-19; Liao CT, 2009, EUR J NUCL MED MOL I, V36, P1783, DOI 10.1007/s00259-009-1180-3; Lin YC, 2012, MAGN RESON MED; Ng SH, 2005, J NUCL MED, V46, P1136; Ng SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072230; Ohnishi K, 2011, J RADIAT RES, V52, P522, DOI 10.1269/jrr.10178; Pike MM, 2009, MAGN RESON MED, V61, P615, DOI 10.1002/mrm.21931; Schabel MC, 2008, PHYS MED BIOL, V53, P2345, DOI 10.1088/0031-9155/53/9/010; Schwartz DL, 2004, ARCH OTOLARYNGOL, V130, P1361, DOI 10.1001/archotol.130.12.1361; Seol YM, 2010, ACTA ONCOL, V49, P201, DOI 10.3109/02841860903440270; Stadler P, 1999, INT J RADIAT ONCOL, V44, P749, DOI 10.1016/S0360-3016(99)00115-7; Studer G, 2007, ACTA ONCOL, V46, P386, DOI 10.1080/02841860600815407; Tang C, 2012, INT J RADIAT ONCOL, V83, P1514, DOI 10.1016/j.ijrobp.2011.10.023; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Torizuka T, 2009, AM J ROENTGENOL, V192, pW156, DOI 10.2214/AJR.08.1429; Urba SG, 2005, J CLIN ONCOL, V23, P88, DOI 10.1200/JCO.2005.04.017; Vernon MR, 2008, INT J RADIAT ONCOL, V70, P678, DOI 10.1016/j.ijrobp.2007.10.044; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570; Worden FP, 2008, J CLIN ONCOL, V26, P3138, DOI 10.1200/JCO.2007.12.7597	44	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115933	10.1371/journal.pone.0115933	http://dx.doi.org/10.1371/journal.pone.0115933			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531391	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100118
J	Plumer, L; Davison, J; Saarma, U				Plumer, Liivi; Davison, John; Saarma, Urmas			Rapid Urbanization of Red Foxes in Estonia: Distribution, Behaviour, Attacks on Domestic Animals, and Health-Risks Related to Zoonotic Diseases	PLOS ONE			English	Article							VULPES-VULPES POPULATION; BADGERS MELES-MELES; ECHINOCOCCUS-MULTILOCULARIS; URBAN FOXES; SARCOPTIC MANGE; CITY; SWITZERLAND; GRANULOSUS; PATTERNS; WILDLIFE	Urban areas are becoming increasingly important for wildlife as diminishing natural habitats no longer represent a suitable environment for many species. Red foxes (Vulpes vulpes) are nowadays common in many cities worldwide, and in recent years they have colonized urban areas in Estonia. We used a public web-based questionnaire approach to evaluate the distribution and behaviour of Estonian urban foxes, to detect related problems and to assess health risks to humans and domestic animals. In total, 1205 responses were collected throughout the country. Foxes have colonized the majority of Estonian towns (33 out of 47) in a relatively short period of time, and have already established breeding dens in several towns. Despite their recent arrival, the behaviour of Estonian urban foxes is similar to that reported in longer-established urban fox populations: they are mostly active during night-time, often visit city centres and some also have dens in such locations. Certain characteristics of urban foxes serve as a basis for conflict with humans: foxes have entered houses and attacked domestic animals, killing cats and poultry. About 8% of reported foxes exhibited symptoms of sarcoptic mange, a disease that also infects domestic animals, especially dogs. The proportion of mange-infected foxes was higher in large urban areas. In addition to mange, a substantial fraction of red foxes in Estonia are known to be infected with the life-threatening tapeworm Echinococcus multilocularis, the causative agent of alveolar echinococcosis. Therefore, urban foxes may represent a source of serious infectious disease for pets and humans.	[Plumer, Liivi; Davison, John; Saarma, Urmas] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, EE-50090 Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Saarma, U (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia.	Urmas.Saarma@ut.ee	Saarma, Urmas/J-6448-2015; Saarma, Urmas/AAC-9813-2019; Cameron, Elissa/B-8053-2014	Saarma, Urmas/0000-0002-3222-571X; Saarma, Urmas/0000-0002-3222-571X; Cameron, Elissa/0000-0002-9243-0547	Estonian Research Council [IUT-2032, ESF-8793]; European Union through the European Regional Development Fund (Centre of Excellence FIBIR); Estonian Doctoral School of Ecology and Environmental Sciences	Estonian Research Council(Estonian Research Council); European Union through the European Regional Development Fund (Centre of Excellence FIBIR)(European Commission); Estonian Doctoral School of Ecology and Environmental Sciences	This work was supported by the Estonian Research Council (IUT-2032; ESF-8793), the European Union through the European Regional Development Fund (Centre of Excellence FIBIR) and the Estonian Doctoral School of Ecology and Environmental Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ZOONOOSIDE ARUANNE, P20; Baker PJ, 2007, MAMMAL REV, V37, P297, DOI 10.1111/j.1365-2907.2007.00102.x; Baker PJ, 2007, BEHAV ECOL, V18, P716, DOI 10.1093/beheco/arm035; Baker PJ, 2000, ANIM BEHAV, V59, P127, DOI 10.1006/anbe.1999.1285; Balestrieri A, 2011, CENT EUR J BIOL, V6, P283, DOI 10.2478/s11535-010-0106-1; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Bornstein S, 2006, VET DERMATOL, V17, P411, DOI 10.1111/j.1365-3164.2006.00548.x; Cassidy A, 2012, ENVIRON COMMUN, V6, P494, DOI 10.1080/17524032.2012.716370; Contesse P, 2004, MAMM BIOL, V69, P81, DOI 10.1078/1616-5047-00123; Davidson RK, 2008, VET PARASITOL, V156, P277, DOI 10.1016/j.vetpar.2008.05.019; Delahay RJ, 2009, MAMMAL REV, V39, P53, DOI 10.1111/j.1365-2907.2008.00135.x; Deplazes P, 2004, TRENDS PARASITOL, V20, P77, DOI 10.1016/j.pt.2003.11.011; DONCASTER CP, 1990, J MAMMAL, V71, P188, DOI 10.2307/1382166; Dudus L, 2014, MAMM BIOL, V79, P71, DOI 10.1016/j.mambio.2013.08.001; Eckert J., 2001, WHO OIE MANUAL ECHIN; Francis RA, 2012, APPL GEOGR, V32, P514, DOI 10.1016/j.apgeog.2011.06.013; Gloor S, 2001, MAMM BIOL, V66, P155; Haase D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066531; HARRIS S, 1986, J ANIM ECOL, V55, P575, DOI 10.2307/4740; Hegglin D, 2007, FUNCTIONAL ECOLOGY, V21, P55; Hegglin D, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-247; Hindrikson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046465; Janko C, 2012, ACTA THERIOL, V57, P245, DOI 10.1007/s13364-012-0074-0; Konig A, 2008, EUR J WILDLIFE RES, V54, P101, DOI 10.1007/s10344-007-0117-z; Konig A, 2012, WILDLIFE RES, V39, P488, DOI 10.1071/WR11077; Laurimaa L, 2015, EMERGING INFECT DIS; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Moks E, 2008, PARASITOLOGY, V135, P647, DOI 10.1017/S0031182008004198; Moks E, 2006, J WILDLIFE DIS, V42, P359, DOI 10.7589/0090-3558-42.2.359; Moks E, 2005, EMERG INFECT DIS, V11, P1973, DOI 10.3201/eid1112.050339; Niin E, 2008, VACCINE, V26, P3556, DOI 10.1016/j.vaccine.2008.04.056; Partel A, 2013, B OIE, V3, P58; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; Saarma U, 2009, PARASITOLOGY, V136, P317, DOI 10.1017/S0031182008005453; Sadlier LMJ, 2004, MAMMAL REV, V34, P75, DOI 10.1046/j.0305-1838.2003.00029.x; Scott DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099059; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Soulsbury CD, 2007, MAMMAL REV, V37, P278, DOI 10.1111/j.1365-2907.2007.00101.x; Soulsbury CD, 2011, J MAMMAL, V92, P190, DOI 10.1644/09-MAMM-A-187.1; Uraguchi K, 2009, POPULATION ECOLOGY, V51, P217; Vuorisalo T, 2014, LANDSCAPE URBAN PLAN, V124, P109, DOI 10.1016/j.landurbplan.2013.12.002; Whiteside HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022145	42	44	45	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115124	10.1371/journal.pone.0115124	http://dx.doi.org/10.1371/journal.pone.0115124			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531399	Green Submitted, gold, Green Published			2022-12-26	WOS:000348845100038
J	Xu, XB; Lan, WY; Jin, XX; Wang, B; Yan, HB; Chen, X; Lai, XW; Zhang, L; Zhang, XH; Li, ZS				Xu, Xiaobing; Lan, Wenya; Jin, Xinxin; Wang, Bin; Yan, Hongbo; Chen, Xi; Lai, Xiaowei; Zhang, Li; Zhang, Xiaohua; Li, Zhaoshen			Regulated Expression of PTPRJ by COX-2/PGE(2) Axis in Endothelial Cells	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; BREAST-CANCER CELLS; INDOMETHACIN THERAPY; TUMOR ANGIOGENESIS; RECEPTOR; DEP-1; PROGRESSION; GROWTH; MURINE; CD148	Background: This study was designed to examine a novel role of COX-2/PGE(2) signaling as a regulator of PTPRJ expression in endothelial cells. Methods: A bioinformatics analysis of a whole genome array was carried out to search for regulators of PTPRJ expression in endothelial cells. PTPRJ expression was also measured in endothelial cells derived from a balloon injury-induced neointimal hyperplasia model in male New Zealand Rabbits. Changes in PTPRJ expression in HUVEC cells was examined by RT-PCR and western blotting after transfection of COX-2 plasmids or treatment with varying concentrations of a COX-2 inhibitor. Results: A significant correlation was identified between COX-2 and PTPRJ in GSE39264 (Pearson correlation coefficient = -0.87; n = 22; P < 0.01, two-tailed). PTPRJ expression was reduced during the progression of neointimal hyperplasia after balloon injury, which correlated with an increase in COX-2 expression. In HUVECs, after transfection with 1 mu g/ml, 0.5 mu g/ml, or 0.25 mg/ml COX-2 plasmids, PTPRJ protein expression was reduced to 0.60- (+/- 0.08), 0.75- (+/- 0.09), and 0.88- (+/- 0.04) fold, respectively, while mRNA expression was reduced to 0.15- (+/- 0.03), 0.26- (+/- 0.05), and 0.47- (+/- 0.09) fold, respectively. After treatment of HUVECs with 10 mmol/L or 20 mmol/L celecoxib, the reduction in PTPRJ expression induced by COX-2 over-expression was not only rescued but in fact increased by 2.05-fold (+/- 0.28) and 3.34-fold (+/- 0.37), respectively, compared with control. Conclusions: Our results suggest that COX-2/PGE2 signaling may function as a negative regulator of PTPRJ expression in endothelial cells both in vivo and vitro.	[Xu, Xiaobing; Jin, Xinxin; Wang, Bin; Zhang, Xiaohua] Second Mil Med Univ, Clin Sch Nanjing, Jinling Hosp, Dept Gastroenterol & Hepatol, Nanjing, Jiangsu, Peoples R China; [Xu, Xiaobing; Lai, Xiaowei; Li, Zhaoshen] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Lan, Wenya; Zhang, Li] Nanjing Med Univ, Nanjing Brain Hosp, Dept Geriatr Neurol, Nanjing, Jiangsu, Peoples R China; [Yan, Hongbo; Chen, Xi] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China	Naval Medical University; Naval Medical University; Nanjing Medical University; Academy of Military Medical Sciences - China	Zhang, XH (corresponding author), Second Mil Med Univ, Clin Sch Nanjing, Jinling Hosp, Dept Gastroenterol & Hepatol, Nanjing, Jiangsu, Peoples R China.	jszhxh@sina.com; zhaoshenli@hotmail.com						Askarian-Amiri ME, 2011, RNA, V17, P878, DOI 10.1261/rna.2528811; Boivin B, 2008, P NATL ACAD SCI USA, V105, P9959, DOI 10.1073/pnas.0804336105; Borges LG, 1996, CIRC RES, V79, P570, DOI 10.1161/01.RES.79.3.570; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chang SH, 2004, P NATL ACAD SCI USA, V101, P591, DOI 10.1073/pnas.2535911100; Dave RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068306; Gaya A, 1999, LEUKEMIA LYMPHOMA, V35, P237, DOI 10.3109/10428199909145726; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris R.E, 2003, COX 2 BLOCKADE CANC; Iuliano R, 2003, CANCER RES, V63, P882; Keane MM, 1996, CANCER RES, V56, P4236; Kellie S, 2004, J CELL SCI, V117, P609, DOI 10.1242/jcs.00879; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Khan Z, 2011, CURR DRUG TARGETS, V12, P1082, DOI 10.2174/138945011795677764; Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Kumar BNP, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-273; Lala PK, 1997, INT J CANCER, V73, P371, DOI 10.1002/(SICI)1097-0215(19971104)73:3<371::AID-IJC12>3.0.CO;2-G; LALA PK, 1986, CELL IMMUNOL, V99, P108, DOI 10.1016/0008-8749(86)90220-0; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Le Pera I, 2005, ONCOGENE, V24, P3187, DOI 10.1038/sj.onc.1208510; Lin J, 2004, J IMMUNOL, V173, P2324, DOI 10.4049/jimmunol.173.4.2324; Izquierdo CL, 2011, AM J PATHOL, V178, P1361, DOI 10.1016/j.ajpath.2010.11.074; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Rozic JG, 2001, INT J CANCER, V93, P497, DOI 10.1002/ijc.1376; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Seno H, 2002, CANCER RES, V62, P506; Smart CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040742; Timoshenko AV, 2004, INT J CANCER, V108, P384, DOI 10.1002/ijc.11575; Timoshenko AV, 2003, EXP CELL RES, V289, P265, DOI 10.1016/S0014-4827(03)00269-6; Toomey DP, 2009, SURG-J R COLL SURG E, V7, P174, DOI 10.1016/S1479-666X(09)80042-5; Tsuboi N, 2008, BIOCHEM J, V413, P193, DOI 10.1042/BJ20071317; Wang DZ, 2004, P NATL ACAD SCI USA, V101, P415, DOI 10.1073/pnas.0307640100; Wang MT, 2007, CANCER METAST REV, V26, P525, DOI 10.1007/s10555-007-9096-5; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wu LY, 2011, CARDIOVASC DRUG THER, V25, P233, DOI 10.1007/s10557-011-6305-9; Yamashita A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/424929	39	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114996	10.1371/journal.pone.0114996	http://dx.doi.org/10.1371/journal.pone.0114996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532119	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845100035
J	Subburaj, Y; Ros, U; Hermann, E; Tong, R; Garcia-Saez, AJ				Subburaj, Yamunadevi; Ros, Uris; Hermann, Eduard; Tong, Rudi; Garcia-Saez, Ana J.			Toxicity of an alpha-Pore-forming Toxin Depends on the Assembly Mechanism on the Target Membrane as Revealed by Single Molecule Imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANEMONE STICHODACTYLA-HELIANTHUS; CELL PLASMA-MEMBRANE; EQUINATOXIN-II; SEA-ANEMONE; PARTICLE TRACKING; STICHOLYSIN-I; STRUCTURAL INSIGHTS; TRANSMEMBRANE PORE; LIVING CELLS; PROTEIN	alpha-Pore-forming toxins (alpha-PFTs) are ubiquitous defense tools that kill cells by opening pores in the target cell membrane. Despite their relevance in host/pathogen interactions, very little is known about the pore stoichiometry and assembly pathway leading to membrane permeabilization. Equinatoxin II (EqtII) is a model alpha-PFT from sea anemone that oligomerizes and forms pores in sphingomyelin-containing membranes. Here, we determined the spatiotemporal organization of EqtII in living cells by single molecule imaging. Surprisingly, we found that on the cell surface EqtII did not organize into a unique oligomeric form. Instead, it existed as a mixture of oligomeric species mostly including monomers, dimers, tetramers, and hexamers. Mathematical modeling based on our data supported a new model in which toxin clustering happened in seconds and proceeded via condensation of EqtII dimer units formed upon monomer association. Furthermore, altering the pathway of EqtII assembly strongly affected its toxic activity, which highlights the relevance of the assembly mechanism on toxicity.	[Subburaj, Yamunadevi; Hermann, Eduard; Tong, Rudi; Garcia-Saez, Ana J.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany; [Subburaj, Yamunadevi; Hermann, Eduard; Garcia-Saez, Ana J.] Bioquant, German Canc Res Ctr, D-69120 Heidelberg, Germany; [Ros, Uris] Fac Biol, Ctr Prot Studies, Havana, Cuba; [Hermann, Eduard; Garcia-Saez, Ana J.] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany	Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen	Garcia-Saez, AJ (corresponding author), Interfac Inst Biochem, D-72076 Tubingen, Germany.	ana.garcia@uni-tuebingen.de	Saez, Ana J. Garcia/U-1611-2019	Subburaj, Yamunadevi/0000-0003-2310-2889	Max Planck Society; German Cancer Research Center; Bundesministerium fur Bildung und Forschung [0312040]; EMBO; DAAD	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Cancer Research Center; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); EMBO(European Molecular Biology Organization (EMBO)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Max Planck Society, the German Cancer Research Center, and Bundesministerium fur Bildung und Forschung Grant 0312040 and grants from the EMBO and DAAD (to U. R.).	Anderluh A, 2014, J BIOL CHEM, V289, P4387, DOI 10.1074/jbc.M113.531632; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderluh G, 1998, BIOCHEM BIOPH RES CO, V242, P187, DOI 10.1006/bbrc.1997.7944; Antonini V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110824; Baker MAB, 2014, CHEMBIOCHEM, V15, P2139, DOI 10.1002/cbic.201300799; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Bayley H, 2009, NATURE, V459, P651, DOI 10.1038/459651a; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Bleicken S, 2013, J BIOL CHEM, V288, P33241, DOI 10.1074/jbc.M113.512087; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Chappie JS, 2013, J CELL SCI, V126, P2773, DOI 10.1242/jcs.108845; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Fuertes G, 2011, EUR BIOPHYS J BIOPHY, V40, P399, DOI 10.1007/s00249-011-0693-4; Garcia-Ortega L, 2011, BBA-BIOMEMBRANES, V1808, P2275, DOI 10.1016/j.bbamem.2011.05.012; Garcia-Saez AJ, 2011, J BIOL CHEM, V286, P37768, DOI 10.1074/jbc.M111.281592; Groulx N, 2011, J BIOL CHEM, V286, P42274, DOI 10.1074/jbc.M111.296103; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kristan K, 2004, J BIOL CHEM, V279, P46509, DOI 10.1074/jbc.M406193200; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Landeta O, 2011, J BIOL CHEM, V286, P8213, DOI 10.1074/jbc.M110.165852; LEE GM, 1991, P NATL ACAD SCI USA, V88, P6274, DOI 10.1073/pnas.88.14.6274; Malovrh P, 2003, J BIOL CHEM, V278, P22678, DOI 10.1074/jbc.M300622200; Mancheno JA, 2006, BIOPHYS CHEM, V119, P219, DOI 10.1016/j.bpc.2005.09.021; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; Meckel T, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600002; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Potrich C, 2005, BIOCONJUGATE CHEM, V16, P369, DOI 10.1021/bc049873z; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Sackmann E, 2014, ADV COLLOID INTERFAC, V208, P153, DOI 10.1016/j.cis.2014.02.006; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schmidt T, 1996, ANAL CHEM, V68, P4397, DOI 10.1021/ac960710g; Serge A, 2011, INTEGR BIOL-UK, V3, P675, DOI 10.1039/c0ib00121j; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Tejuca M, 2001, J MEMBRANE BIOL, V183, P125, DOI 10.1007/s00232-001-0060-y; Thompson JR, 2011, BIOPHYS J, V101, P2679, DOI 10.1016/j.bpj.2011.09.054; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; Valle A, 2011, TOXICON, V58, P8, DOI 10.1016/j.toxicon.2011.04.005; Wieser S, 2008, METHODS, V46, P131, DOI 10.1016/j.ymeth.2008.06.010; Xia T, 2013, ANNU REV PHYS CHEM, V64, P459, DOI 10.1146/annurev-physchem-040412-110127	45	40	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4856	4865		10.1074/jbc.M114.600676	http://dx.doi.org/10.1074/jbc.M114.600676			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25525270	Green Published, hybrid			2022-12-26	WOS:000350042000030
J	Ohshima, N; Kudo, T; Yamashita, Y; Mariggio, S; Araki, M; Honda, A; Nagano, T; Isaji, C; Kato, N; Corda, D; Izumi, T; Yanaka, N				Ohshima, Noriyasu; Kudo, Takahiro; Yamashita, Yosuke; Mariggio, Stefania; Araki, Mari; Honda, Ayako; Nagano, Tomomi; Isaji, Chiaki; Kato, Norihisa; Corda, Daniela; Izumi, Takashi; Yanaka, Noriyuki			New Members of the Mammalian Glycerophosphodiester Phosphodiesterase Family GDE4 AND GDE7 PRODUCE LYSOPHOSPHATIDIC ACID BY LYSOPHOSPHOLIPASE D ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; LYSOPHOSPHATIDIC ACID; FACTOR ACETYLHYDROLASE; MEMBRANE-PROTEIN; RECEPTOR; ENZYME; LPA; AUTOTAXIN; IDENTIFICATION; TRANSLOCATION	The known mammalian glycerophosphodiester phosphodiesterases (GP-PDEs) hydrolyze glycerophosphodiesters. In this study, two novel members of the mammalian GP-PDE family, GDE4 and GDE7, were isolated, and the molecular basis of mammalian GP-PDEs was further explored. The GDE4 and GDE7 sequences are highly homologous and evolutionarily close. GDE4 is expressed in intestinal epithelial cells, spermatids, and macrophages, whereas GDE7 is particularly expressed in gastro-esophageal epithelial cells. Unlike other mammalian GP-PDEs, GDE4 and GDE7 cannot hydrolyze either glycerophosphoinositol or glycerophosphocholine. Unexpectedly, both GDE4 and GDE7 show a lysophospholipase D activity toward lysophosphatidylcholine (lyso-PC). We purified the recombinant GDE4 and GDE7 proteins and show that these enzymes can hydrolyze lyso-PC to produce lysophosphatidic acid (LPA). Further characterization of purified recombinant GDE4 showed that it can also convert lyso-platelet-activating factor (1-O-alkyl-sn-glycero-3-phosphocholine; lyso-PAF) to alkyl-LPA. These data contribute to our current understanding of mammalian GP-PDEs and of their physiological roles via the control of lyso-PC and lyso-PAF metabolism in gastrointestinal epithelial cells and macrophages.	[Ohshima, Noriyasu; Araki, Mari; Isaji, Chiaki; Izumi, Takashi] Gunma Univ, Dept Biochem, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Kudo, Takahiro; Yamashita, Yosuke; Honda, Ayako; Nagano, Tomomi; Kato, Norihisa; Yanaka, Noriyuki] Hiroshima Univ, Grad Sch Biosphere Sci, Dept Mol & Appl Biosci, Higashi Hiroshima City 7398511, Japan; [Mariggio, Stefania; Corda, Daniela] CNR, Inst Prot Biochem, I-80131 Naples, Italy	Gunma University; Hiroshima University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Yanaka, N (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Dept Mol & Appl Biosci, Higashi Hiroshima City 7398511, Japan.	yanaka@hiroshima-u.ac.jp	Yanaka, Noriyuki/P-9096-2016; Corda, Daniela/K-6385-2016; Mariggio', Stefania/H-5467-2015	Corda, Daniela/0000-0002-3614-751X; Mariggio', Stefania/0000-0002-6397-3016	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Italian Association for Cancer Research; PRIN Project [2012CK5RPF_05]	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Italian Association for Cancer Research; PRIN Project	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. Y.) and from the Italian Association for Cancer Research (to D. C.) and PRIN Project 2012CK5RPF_05 (to S. M.).	Aaltonen N, 2010, J CHROMATOGR B, V878, P1145, DOI 10.1016/j.jchromb.2010.03.030; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BURG MB, 1995, AM J PHYSIOL-RENAL, V268, pF983, DOI 10.1152/ajprenal.1995.268.6.F983; Chang PA, 2008, MOL MEMBR BIOL, V25, P557, DOI 10.1080/09687680802537605; Chiang KP, 2006, CHEM BIOL, V13, P1041, DOI 10.1016/j.chembiol.2006.08.008; Corda D, 2014, FEBS J, V281, P998, DOI 10.1111/febs.12699; Corda D, 2009, CELL MOL LIFE SCI, V66, P3449, DOI 10.1007/s00018-009-0113-4; Corda D, 2009, J BIOL CHEM, V284, P24848, DOI 10.1074/jbc.M109.035444; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; Gallazzini M, 2008, P NATL ACAD SCI USA, V105, P11026, DOI 10.1073/pnas.0805496105; Gallazzini M, 2009, PHYSIOLOGY, V24, P245, DOI 10.1152/physiol.00009.2009; Gellett AM, 2012, BIOCHEM BIOPH RES CO, V422, P758, DOI 10.1016/j.bbrc.2012.05.077; Hirabayashi T, 1999, J BIOL CHEM, V274, P5163, DOI 10.1074/jbc.274.8.5163; Howard KM, 2000, J BIOL CHEM, V275, P19891, DOI 10.1074/jbc.M001462200; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Jonkers J, 2009, CANCER CELL, V15, P457, DOI 10.1016/j.ccr.2009.05.003; Mariggio S, 2006, FASEB J, V20, P2567, DOI 10.1096/fj.05-5397fje; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nogusa Y, 2004, GENE, V337, P173, DOI 10.1016/j.gene.2004.04.026; Ohshima N, 2002, J BIOL CHEM, V277, P9722, DOI 10.1074/jbc.M112406200; Ohshima N, 2008, J BACTERIOL, V190, P1219, DOI 10.1128/JB.01223-07; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Okazaki Y, 2010, J BIOL CHEM, V285, P27652, DOI 10.1074/jbc.M110.106708; Okudaira S, 2010, BIOCHIMIE, V92, P698, DOI 10.1016/j.biochi.2010.04.015; Park S, 2013, SCIENCE, V339, P324, DOI 10.1126/science.1231921; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; San Pietro E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000194; Sanada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061931; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Simon GM, 2008, J BIOL CHEM, V283, P9341, DOI 10.1074/jbc.M707807200; Simon GM, 2010, MOL BIOSYST, V6, P1411, DOI 10.1039/c000237b; Simon MF, 2005, J BIOL CHEM, V280, P14656, DOI 10.1074/jbc.M412585200; SIMON MF, 1982, BIOCHEM BIOPH RES CO, V108, P1743, DOI 10.1016/S0006-291X(82)80113-7; Tanaka T, 2013, DIGEST DIS SCI, V58, P950, DOI 10.1007/s10620-012-2475-y; Tanaka T, 2009, BIOSCI BIOTECH BIOCH, V73, P1293, DOI 10.1271/bbb.80813; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Tokumura A, 2002, BIOCHEM J, V365, P617, DOI 10.1042/BJ20020348; Topanurak S, 2013, P NATL ACAD SCI USA, V110, P7482, DOI 10.1073/pnas.1305220110; Tsukahara T, 2006, J BIOL CHEM, V281, P3398, DOI 10.1074/jbc.M510843200; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Williams JR, 2009, J BIOL CHEM, V284, P17304, DOI 10.1074/jbc.M109.003194; Wu XQ, 2004, J BIOL CHEM, V279, P36158, DOI 10.1074/jbc.M402454200; Yanaka N, 2003, J BIOL CHEM, V278, P43595, DOI 10.1074/jbc.M302867200; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100; Zheng B, 2000, P NATL ACAD SCI USA, V97, P3999, DOI 10.1073/pnas.97.8.3999	50	22	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4260	4271		10.1074/jbc.M114.614537	http://dx.doi.org/10.1074/jbc.M114.614537			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25528375	Green Published, hybrid			2022-12-26	WOS:000349458400036
J	Wegener, KM; Nagarajan, A; Pakrasi, HB				Wegener, Kimberly M.; Nagarajan, Aparna; Pakrasi, Himadri B.			An Atypical psbA Gene Encodes a Sentinel D1 Protein to Form a Physiologically Relevant Inactive Photosystem II Complex in Cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; GENOME; FIXATION; LIGHT; PHOTOACTIVATION; PHOTOSYNTHESIS; RECOMBINATION; RESOLUTION; ADAPTATION; EVOLUTION	Photosystem II, a large membrane-bound enzyme complex in cyanobacteria and chloroplasts, mediates light-induced oxidation of water to molecular oxygen. The D1 protein of PSII, encoded by the psbA gene, provides multiple ligands for cofactors crucial to this enzymatic reaction. Cyanobacteria contain multiple psbA genes that respond to various physiological cues and environmental factors. Certain unicellular cyanobacterial cells, such as Cyanothece sp. ATCC 51142, are capable of nitrogen fixation, a highly oxygen-sensitive process, by separating oxygen evolution from nitrogen fixation using a day-night cycle. We have shown that c-psbA4, one of the five psbA orthologs in this cyanobacterium, is exclusively expressed during nighttime. Remarkably, the corresponding D1 isoform has replacements of a number of amino acids that are essential ligands for the catalytic Mn4CaO5 metal center for water oxidation by PSII. At least 30 cyanobacterial strains, most of which are known to have nitrogen fixing abilities, have similar psbA orthologs. We expressed the c-psbA4 gene from Cyanothece 51142 in a 4E-3 mutant strain of the model non-nitrogen-fixing cyanobacterium Synechocystis sp. PCC 6803, which lacks any psbA gene. The resultant strain could not grow photoautotrophically. Moreover, these Synechocystis 6803 cells were incapable of PSII-mediated oxygen evolution. Based on our findings, we have named this physiologically relevant, unusual D1 isoform sentinel D1. Sentinel D1 represents a new class of D1 protein that, when incorporated in a PSII complex, ensures that PSII cannot mediate water oxidation, thus allowing oxygen-sensitive processes such as nitrogen fixation to occur in cyanobacterial cells.	[Wegener, Kimberly M.; Nagarajan, Aparna; Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, CB1137,1 Brookings Dr, St Louis, MO 63130 USA.	pakrasi@wustl.edu		Nagarajan, Aparna/0000-0003-4434-5601	National Science Foundation [MCB 0745611, MCB 1331194]; Div Of Molecular and Cellular Bioscience [1331194] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB 0745611 and MCB 1331194 (to H. B. P.).	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANBUDURAI PR, 1994, P NATL ACAD SCI USA, V91, P8082, DOI 10.1073/pnas.91.17.8082; Bandyopadhyay A, 2011, MBIO, V2, DOI 10.1128/mBio.00214-11; Bandyopadhyay A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1139; Bench SR, 2013, J PHYCOL, V49, P786, DOI 10.1111/jpy.12090; Berman-Frank I, 2003, RES MICROBIOL, V154, P157, DOI 10.1016/S0923-2508(03)00029-9; Burnap RL, 1996, BIOCHEMISTRY-US, V35, P874, DOI 10.1021/bi951964j; Campbell D, 1999, PHYSIOL PLANTARUM, V105, P746, DOI 10.1034/j.1399-3054.1999.105420.x; Cardona T, 2009, BBA-BIOENERGETICS, V1787, P252, DOI 10.1016/j.bbabio.2009.01.015; Dagan T, 2013, GENOME BIOL EVOL, V5, P31, DOI 10.1093/gbe/evs117; Debus R. J., 1990, CURRENT RES PHOTOSYN, V1, P829; DINER BA, 1988, J BIOL CHEM, V263, P8972; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; GALLON JR, 1992, NEW PHYTOL, V122, P571; Gan F, 2014, SCIENCE, V345, P1312, DOI 10.1126/science.1256963; Gorbunov MY, 2002, LIMNOL OCEANOGR, V47, P309, DOI 10.4319/lo.2002.47.1.0309; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Komenda J, 2012, CURR OPIN PLANT BIOL, V15, P245, DOI 10.1016/j.pbi.2012.01.017; Kos PB, 2008, BBA-BIOENERGETICS, V1777, P74, DOI 10.1016/j.bbabio.2007.10.015; KULKARNI RD, 1994, J BACTERIOL, V176, P959, DOI 10.1128/JB.176.4.959-965.1994; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MANNAN RM, 1993, PLANT PHYSIOL, V103, P971, DOI 10.1104/pp.103.3.971; Mate Z, 1998, J BIOL CHEM, V273, P17439, DOI 10.1074/jbc.273.28.17439; Meeks JC, 2001, PHOTOSYNTH RES, V70, P85, DOI 10.1023/A:1013840025518; Meunier PC, 1998, PLANT PHYSIOL, V116, P1551, DOI 10.1104/pp.116.4.1551; MOHAMED A, 1993, MOL GEN GENET, V238, P161, DOI 10.1007/BF00279543; Mohr R, 2010, ISME J, V4, P1456, DOI 10.1038/ismej.2010.67; MUNZ FW, 1973, VISION RES, V13, P1829, DOI 10.1016/0042-6989(73)90060-6; Murray JW, 2012, PHOTOSYNTH RES, V110, P177, DOI 10.1007/s11120-011-9714-5; Nagarajan A, 2014, BBA-BIOENERGETICS, V1837, P1417, DOI 10.1016/j.bbabio.2014.02.022; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P10859, DOI 10.1021/bi00159a029; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Overmann J., 2013, PROKARYOTES, P203, DOI DOI 10.1007/978-3-642-30123-0_51; Pfreundt U, 2012, ISME J, V6, P1367, DOI 10.1038/ismej.2011.199; Postgate J., 1998, NITROGEN FIXATION; Rakhimberdieva MG, 2007, BBA-BIOENERGETICS, V1767, P757, DOI 10.1016/j.bbabio.2006.12.007; Raven JA, 2006, ASTROBIOLOGY, V6, P668, DOI 10.1089/ast.2006.6.668; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Salih GF, 1997, PLANT CELL, V9, P869, DOI 10.1105/tpc.9.6.869; Satoh K, 2007, PHOTOSYNTH RES, V94, P203, DOI 10.1007/s11120-007-9191-z; Sherman LA, 1998, PHOTOSYNTH RES, V58, P25, DOI 10.1023/A:1006137605802; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Sicora C, 2004, PHYS CHEM CHEM PHYS, V6, P4832, DOI 10.1039/b406695b; Sicora CI, 2008, BBA-BIOENERGETICS, V1777, P130, DOI 10.1016/j.bbabio.2007.09.001; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; Stockel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016680; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; TAKAHASHI M, 1988, FEBS LETT, V240, P6, DOI 10.1016/0014-5793(88)80330-2; TAKAHASHI Y, 1990, PLANT CELL PHYSIOL, V31, P273; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiel T., 1990, CURRENT RES PHOTOSYN, V1, P291; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; Williams R. J. P., 1997, NATURAL SELECTION CH; Zhang XH, 2012, PHOTOSYNTH RES, V114, P133, DOI 10.1007/s11120-012-9783-0	60	19	20	0	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3764	3774		10.1074/jbc.M114.604124	http://dx.doi.org/10.1074/jbc.M114.604124			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525275	hybrid, Green Published			2022-12-26	WOS:000349456000047
J	Welbourn, S; Kao, S; Du Pont, KE; Andrew, AJ; Berndsen, CE; Strebel, K				Welbourn, Sarah; Kao, Sandra; Du Pont, Kelly E.; Andrew, Amy J.; Berndsen, Christopher E.; Strebel, Klaus			Positioning of Cysteine Residues within the N-terminal Portion of the BST-2/Tetherin Ectodomain Is Important for Functional Dimerization of BST-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 VIRUS RELEASE; CELL-SURFACE; MOLECULAR-CLONING; TETHERIN; VPU; PROTEIN; LOCALIZATION; RESTRICTION; INHIBITION; ANTAGONISM	BST-2/tetherin is a cellular host factor capable of restricting the release of a variety of enveloped viruses, including HIV-1. Structurally, BST-2 consists of an N-terminal cytoplasmic domain, a transmembrane domain, an ectodomain, and a C-terminal membrane anchor. The BST-2 ectodomain encodes three cysteine residues in its N-terminal half, each of which can contribute to the formation of cysteine-linked dimers. We previously reported that any one of the three cysteine residues is sufficient to produce functional BST-2 dimers. Here we investigated the importance of cysteine positioning on the ectodomain for functional dimerization of BST-2. Starting with a cysteine-free monomeric form of BST-2, individual cysteine residues were reintroduced at various locations throughout the ectodomain. The resulting BST-2 variants were tested for expression, dimerization, surface presentation, and inhibition of HIV-1 virus release. We found significant flexibility in the positioning of cysteine residues, although the propensity to form cysteine-linked dimers generally decreased with increasing distance from the N terminus. Interestingly, all BST-2 variants, including the one lacking all three ectodomain cysteines, retained the ability to form non-covalent dimers, and all of the BST-2 variants were efficiently expressed at the cell surface. Importantly, not all BST-2 variants capable of forming cysteine-linked dimers were functional, suggesting that cysteine-linked dimerization of BST-2 is necessary but not sufficient for inhibiting virus release. Our results expose new structural constraints governing the functional dimerization of BST-2, a property essential to its role as a restriction factor tethering viruses to the host cell.	[Welbourn, Sarah; Kao, Sandra; Andrew, Amy J.; Strebel, Klaus] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Du Pont, Kelly E.; Berndsen, Christopher E.] James Madison Univ, Dept Chem & Biochem, Harrisonburg, VA 22807 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); James Madison University	Strebel, K (corresponding author), NIAID, Viral Biochem Sect, Mol Microbiol Lab, NIH, Bldg 4,Rm 310,4 Ctr Dr MSC 0460, Bethesda, MD 20892 USA.	kstrebel@nih.gov	Welbourn, Sarah/AAU-5645-2020	Zuccaro, Kelly E/0000-0001-8904-5106; Berndsen, Christopher/0000-0002-4285-4341; Welbourn, Sarah/0000-0002-2932-1436	Intramural Research Program of the NIAID, National Institutes of Health [1 ZO1 AI000669]; Canadian Institutes of Health Research; Research Corporation Development Award [7957]; James Madison University Program of Grants for Faculty Assistance; 4-VA organization; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000669, ZIAAI000669] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Research Corporation Development Award; James Madison University Program of Grants for Faculty Assistance; 4-VA organization; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Intramural Research Program of the NIAID, National Institutes of Health Grant 1 ZO1 AI000669.; Supported by a postdoctoral fellowship from the Canadian Institutes of Health Research.; Supported by Research Corporation Development Award 7957, the James Madison University Program of Grants for Faculty Assistance, and the 4-VA organization.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alvarez RA, 2014, J VIROL, V88, P6031, DOI 10.1128/JVI.00449-14; Andrew A, 2011, J INTERF CYTOK RES, V31, P137, DOI 10.1089/jir.2010.0108; Andrew A, 2010, MOL ASPECTS MED, V31, P407, DOI 10.1016/j.mam.2010.08.002; Andrew AJ, 2012, J BIOL CHEM, V287, P44278, DOI 10.1074/jbc.M112.418822; Andrew AJ, 2011, J BIOL CHEM, V286, P39967, DOI 10.1074/jbc.M111.287011; Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; Arias JF, 2014, P NATL ACAD SCI USA, V111, P6425, DOI 10.1073/pnas.1321507111; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Hammonds J, 2012, J VIROL, V86, P2259, DOI 10.1128/JVI.05906-11; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; Hu ZQ, 2010, J COMPUT CHEM, V31, P371, DOI 10.1002/jcc.21330; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Sakuma T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006934; Schubert HL, 2010, P NATL ACAD SCI USA, V107, P17951, DOI 10.1073/pnas.1008206107; SUTHERLAND R, 1981, P NATL ACAD SCI-BIOL, V78, P4515, DOI 10.1073/pnas.78.7.4515; Swiecki M, 2013, MOL IMMUNOL, V54, P132, DOI 10.1016/j.molimm.2012.11.008; Swiecki M, 2011, J BIOL CHEM, V286, P2987, DOI 10.1074/jbc.M110.190538; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Venkatesh S., 2013, PLOS PATHOG, DOI [10.1371/journal.ppat.1003483, DOI 10.1371/J0URNAL.PPAT.1003483]; Xu FW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-198; Yang HT, 2010, P NATL ACAD SCI USA, V107, P18428, DOI 10.1073/pnas.1011485107	34	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3740	3751		10.1074/jbc.M114.617639	http://dx.doi.org/10.1074/jbc.M114.617639			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525265	Green Published, hybrid			2022-12-26	WOS:000349456000045
J	Bal, G; Rivot, E; Bagliniere, JL; White, J; Prevost, E				Bal, Guillaume; Rivot, Etienne; Bagliniere, Jean-Luc; White, Jonathan; Prevost, Etienne			A Hierarchical Bayesian Model to Quantify Uncertainty of Stream Water Temperature Forecasts	PLOS ONE			English	Article							SALMON SALMO-SALAR; CLIMATE-CHANGE IMPACTS; ATLANTIC SALMON; NEW-BRUNSWICK; BROWN TROUT; RIVER; GROWTH; L.; CONSERVATION; CALIBRATION	Providing generic and cost effective modelling approaches to reconstruct and forecast freshwater temperature using predictors as air temperature and water discharge is a prerequisite to understanding ecological processes underlying the impact of water temperature and of global warming on continental aquatic ecosystems. Using air temperature as a simple linear predictor of water temperature can lead to significant bias in forecasts as it does not disentangle seasonality and long term trends in the signal. Here, we develop an alternative approach based on hierarchical Bayesian statistical time series modelling of water temperature, air temperature and water discharge using seasonal sinusoidal periodic signals and time varying means and amplitudes. Fitting and forecasting performances of this approach are compared with that of simple linear regression between water and air temperatures using i) an emotive simulated example, ii) application to three French coastal streams with contrasting bio-geographical conditions and sizes. The time series modelling approach better fit data and does not exhibit forecasting bias in long term trends contrary to the linear regression. This new model also allows for more accurate forecasts of water temperature than linear regression together with a fair assessment of the uncertainty around forecasting. Warming of water temperature forecast by our hierarchical Bayesian model was slower and more uncertain than that expected with the classical regression approach. These new forecasts are in a form that is readily usable in further ecological analyses and will allow weighting of outcomes from different scenarios to manage climate change impacts on freshwater wildlife.	[Bal, Guillaume; Bagliniere, Jean-Luc] INRA, UMR ESE Ecol & Sante Ecosyst 0985, F-35042 Rennes, France; [Bal, Guillaume; White, Jonathan] Inst Marine, Oranmore, Ireland; [Rivot, Etienne] Agrocampus Ouest, UMR ESE Ecol & Sante Ecosyst 0985, Rennes, France; [Prevost, Etienne] INRA, UMR Ecobiop Ecol Comportementale & Biol Populat P, St Pee Sur Nivelle, France; [Prevost, Etienne] Univ Pau & Pays Adour, UMR Ecobiop Ecol Comportementale & Biol Populat P, Anglet, France	INRAE; Marine Institute Ireland; Institut Agro; Agrocampus Ouest; INRAE; Universite de Pau et des Pays de l'Adour; Universite de Pau et des Pays de l'Adour	Bal, G (corresponding author), INRA, UMR ESE Ecol & Sante Ecosyst 0985, F-35042 Rennes, France.	guillaume.bal.pro@gmail.com		Rivot, Etienne/0000-0002-5442-121X	French Ministry of Education and Research; French Ministry of Ecology and Sustainable Development 'Programme GICC2: Gestion et Impact du Changement Climatique'	French Ministry of Education and Research; French Ministry of Ecology and Sustainable Development 'Programme GICC2: Gestion et Impact du Changement Climatique'	This research was performed while Dr. Guillaume Bal was a Ph.D. student sponsored by the French Ministry of Education and Research. A grant from the French Ministry of Ecology and Sustainable Development 'Programme GICC2: Gestion et Impact du Changement Climatique' also supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Nedushan B, 2007, HYDROL PROCESS, V21, P21, DOI 10.1002/hyp.6353; Almodovar A, 2012, GLOBAL CHANGE BIOL, V18, P1549, DOI 10.1111/j.1365-2486.2011.02608.x; Bagliniere JL, 2005, ICES J MAR SCI, V62, P695, DOI 10.1016/j.icesjms.2005.02.008; Bagliniere JL, 2002, PROD ANIM, V15, P319; Bal G, 2011, J FISH BIOL, V78, P1002, DOI 10.1111/j.1095-8649.2011.02902.x; BENYAHYA L, 2007, CANADIAN WATER RESOU, V31, P179, DOI DOI 10.4296/CWRJ3203179; Benyahya L, 2007, J ENVIRON ENG SCI, V6, P437, DOI [10.1139/S06-067, 10.1139/s06-067]; Beschta RL, 1987, STREAMSIDE MANAGEMEN, P191; Betts RA, 2011, PHILOS T R SOC A, V369, P67, DOI 10.1098/rsta.2010.0292; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Buisson L, 2008, ECOL FRESHW FISH, V17, P244, DOI 10.1111/j.1600-0633.2007.00276.x; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Caissie D, 1998, CAN J CIVIL ENG, V25, P250, DOI 10.1139/cjce-25-2-250; Caissie D, 2007, J HYDROL, V336, P303, DOI 10.1016/j.jhydrol.2007.01.008; Chenard JF, 2008, HYDROL PROCESS, V22, P3361, DOI 10.1002/hyp.6928; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Cragg-Hine D, 2006, J FISH BIOL, V68, P1891, DOI 10.1111/j.0022-1112.2006.01062.x; Cunjak RA, 2005, OECOLOGIA, V144, P636, DOI 10.1007/s00442-005-0101-9; Daufresne M, 2007, GLOBAL CHANGE BIOL, V13, P2467, DOI 10.1111/j.1365-2486.2007.01449.x; Daufresne M, 2007, OECOLOGIA, V151, P544, DOI 10.1007/s00442-006-0655-1; Dumas J, 2007, BFPP-CONNAISS GEST P, P39, DOI 10.1051/kmae:2007009; Erickson TR, 2000, J HYDROL ENG, V5, P317, DOI 10.1061/(ASCE)1084-0699(2000)5:3(317); Forseth T, 2001, FRESHWATER BIOL, V46, P173, DOI 10.1046/j.1365-2427.2001.00631.x; GELMAN A, 2012, BAYESIAN DATA ANALYS; Gibelin AL, 2003, CLIM DYNAM, V20, P327, DOI 10.1007/s00382-002-0277-1; Graham CT, 2009, J FISH BIOL, V74, P1143, DOI 10.1111/j.1095-8649.2009.02180.x; Harwood J, 2003, TRENDS ECOL EVOL, V18, P617, DOI 10.1016/j.tree.2003.08.001; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; *INT PAN CLIM CHAN, 2007, SCIENCE BASIS INTERG; JANSSEN PHM, 1995, ECOL MODEL, V83, P55, DOI 10.1016/0304-3800(95)00084-9; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Jutila E, 2006, ECOL FRESHW FISH, V15, P321, DOI 10.1111/j.1600-0633.2006.00171.x; Kielbassa J, 2010, ECOL MODEL, V221, P2475, DOI 10.1016/j.ecolmodel.2010.07.001; Koch H, 2010, HYDROL PROCESS, V24, P3826, DOI 10.1002/hyp.7814; KOTHANDARAMAN V, 1971, J SANIT ENG DIV ASCE, V97, P19; Lassalle G, 2008, BIOL CONSERV, V141, P1105, DOI 10.1016/j.biocon.2008.02.010; Li F, 2014, CONSERV BIOL, V28, P498, DOI 10.1111/cobi.12219; Litchman E, 2010, ECOL LETT, V13, P1560, DOI 10.1111/j.1461-0248.2010.01544.x; Malcolm IA, 2008, HYDROL PROCESS, V22, P968, DOI 10.1002/hyp.6996; Marce R, 2008, HYDROL PROCESS, V22, P3418, DOI 10.1002/hyp.6955; Marschall EA, 1998, CAN J FISH AQUAT SCI, V55, P48, DOI 10.1139/cjfas-55-S1-48; Mearns LO, 2010, CLIMATIC CHANGE, V100, P77, DOI 10.1007/s10584-010-9841-6; Monk WA, 2009, AM FISH S S, V69, P215; Moradkhani H, 2008, WATER SCI TECHNOL LI, V63, P1; MORIN G, 1994, CAN J CIVIL ENG, V21, P63, DOI 10.1139/l94-006; Ormerod SJ, 2009, AQUAT CONSERV, V19, P609, DOI 10.1002/aqc.1062; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pedersen NL, 2007, HYDROL PROCESS, V21, P348, DOI 10.1002/hyp.6237; Perkins DM, 2010, HYDROBIOLOGIA, V657, P181, DOI 10.1007/s10750-009-0080-7; Piffady J, 2010, FRESHWATER BIOL, V55, P2359, DOI 10.1111/j.1365-2427.2010.02453.x; Pilgrim JM, 1998, J AM WATER RESOUR AS, V34, P1109, DOI 10.1111/j.1752-1688.1998.tb04158.x; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pont D, 2005, CAN J FISH AQUAT SCI, V62, P163, DOI 10.1139/F04-183; *R DEV COR TEAM, 2013, R A LANGUAGE ENVIRON; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Rivot E, 2004, ECOL MODEL, V179, P463, DOI 10.1016/j.ecolmodel.2004.05.011; Schindler DW, 2001, CAN J FISH AQUAT SCI, V58, P18, DOI 10.1139/cjfas-58-1-18; SINOKROT BA, 1993, WATER RESOUR RES, V29, P2299, DOI 10.1029/93WR00540; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; STEFAN HG, 1993, WATER RESOUR BULL, V29, P27; Sutton RJ, 2007, RIVER RES APPL, V23, P775, DOI 10.1002/rra.1026; Thorpe JE, 1998, EVOL ECOL, V12, P581, DOI 10.1023/A:1022351814644; Tixier G, 2009, HYDROBIOLOGIA, V624, P13, DOI 10.1007/s10750-008-9663-y; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Webb BW, 2008, HYDROL PROCESS, V22, P902, DOI 10.1002/hyp.6994; Webb BW, 2004, HYDROL PROCESS, V18, P2117, DOI 10.1002/hyp.1463; Webb BW, 2003, HYDROL PROCESS, V17, P3069, DOI 10.1002/hyp.1280; WEHRLY KE, 2004, AMERICAN FISHERIES S, V48, DOI DOI 10.1577/T09-153.1; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055	70	19	20	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115659	10.1371/journal.pone.0115659	http://dx.doi.org/10.1371/journal.pone.0115659			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541732	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900064
J	Khadaroo, RG; Fortis, S; Salim, SY; Streutker, C; Churchill, TA; Zhang, HB				Khadaroo, Rachel G.; Fortis, Spyridon; Salim, Saad Y.; Streutker, Catherine; Churchill, Thomas A.; Zhang, Haibo			I-FABP as Biomarker for the Early Diagnosis of Acute Mesenteric Ischemia and Resultant Lung Injury	PLOS ONE			English	Article							ACID-BINDING PROTEIN; MULTIPLE ORGAN DYSFUNCTION; INTESTINAL ISCHEMIA; PANETH CELLS; BACTERIAL TRANSLOCATION; REPERFUSION INJURY; XANTHINE-OXIDASE; CRITICALLY-ILL; HOST-DEFENSE; FAILURE	Acute mesenteric ischemia (AMI) is a life-threatening condition that can result in multiple organ injury and death. A timely diagnosis and treatment would have a significant impact on the morbidity and mortality in high-risk patient population. The purpose of this study was to investigate if intestinal fatty acid binding protein (IFABP) and alpha-defensins can be used as biomarkers for early AMI and resultant lung injury. C57BL/6 mice were subjected to intestinal ischemia by occlusion of the superior mesenteric artery. A time course of intestinal ischemia from 0.5 to 3 h was performed and followed by reperfusion for 2 h. Additional mice were treated with N-acetyl-cysteine (NAC) at 300 mg/kg given intraperitoneally prior to reperfusion. AMI resulted in severe intestinal injury characterized by neutrophil infiltrate, myeloperoxidase (MPO) levels, cytokine/chemokine levels, and tissue histopathology. Pathologic signs of ischemia were evident at 1 h, and by 3 h of ischemia, the full thickness of the intestine mucosa had areas of coagulative necrosis. It was noted that the levels of alpha-defensins in intestinal tissue peaked at 1 h and I-FABP in plasma peaked at 3 h after AMI. Intestinal ischemia also resulted in lung injury in a time-dependent manner. Pretreatment with NAC decreased the levels of intestinal alpha-defensins and plasma I-FABP, as well as lung MPO and cytokines. In summary, the concentrations of intestinal alpha-defensins and plasma I-FABP predicted intestinal ischemia prior to pathological evidence of ischemia and I-FABP directly correlated with resultant lung injury. The antioxidant NAC reduced intestinal and lung injury induced by AMI, suggesting a role for oxidants in the mechanism for distant organ injury. I-FABP and alpha-defensins are promising biomarkers, and may guide the treatment with antioxidant in early intestinal and distal organ injury.	[Khadaroo, Rachel G.; Salim, Saad Y.; Churchill, Thomas A.] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Khadaroo, Rachel G.] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada; [Fortis, Spyridon; Zhang, Haibo] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Dept Anesthesia, Dept Physiol & Med, Toronto, ON M5B 1W8, Canada; [Fortis, Spyridon; Zhang, Haibo] Univ Toronto, Toronto, ON, Canada; [Streutker, Catherine; Zhang, Haibo] St Michaels Hosp, Dept Pathol, Toronto, ON M5B 1W8, Canada	University of Alberta; University of Alberta; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Khadaroo, RG (corresponding author), Univ Alberta, Dept Surg, Edmonton, AB, Canada.	khadaroo@ualberta.ca	Fortis, Spyridon/Q-3295-2018; Fortis, Spyridon/AAK-3171-2020	Fortis, Spyridon/0000-0001-7807-6740; Fortis, Spyridon/0000-0001-7807-6740	Edmonton Civics Employees University of Alberta; Canadian Institutes of Health Research (CIHR)	Edmonton Civics Employees University of Alberta; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding: RGK was supported by Edmonton Civics Employees University of Alberta. HZ was supported by Canadian Institutes of Health Research (CIHR) Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta S, 2012, J THROMB THROMBOLYS, V33, P355, DOI 10.1007/s11239-011-0660-z; Adams JM, 2001, CRIT CARE MED, V29, P2194, DOI 10.1097/00003246-200111000-00023; Al-Khowaiter SS, 2014, CAN ASSOC RADIOL J, V65, P67, DOI 10.1016/j.carj.2012.01.002; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Machado MCC, 2012, CRIT CARE, V16, DOI 10.1186/cc11653; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Cronk Daniel R, 2006, Curr Surg, V63, P322, DOI 10.1016/j.cursur.2006.05.006; Cunliffe RN, 2001, GUT, V48, P176, DOI 10.1136/gut.48.2.176; Davreux CJ, 1997, SHOCK, V8, P432, DOI 10.1097/00024382-199712000-00007; Dayal SD, 2002, J TRAUMA, V52, P1048, DOI 10.1097/00005373-200206000-00005; de Groot H, 2007, TRANSPL P, V39, P481, DOI 10.1016/j.transproceed.2006.12.012; Deitch EA, 2002, SURGERY, V131, P241, DOI 10.1067/msy.2002.116408; DEITCH EA, 1994, SHOCK, V1, P141, DOI 10.1097/00024382-199402000-00010; Derikx JPM, 2007, SHOCK, V28, P544, DOI 10.1097/shk.0b013e3180644e32; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3556, DOI 10.1128/IAI.60.9.3556-3565.1992; Evennett NJ, 2009, WORLD J SURG, V33, P1374, DOI 10.1007/s00268-009-0074-7; Glenister KM, 2004, ANZ J SURG, V74, P260, DOI 10.1111/j.1445-2197.2004.02956.x; GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269, DOI 10.1152/ajpheart.1988.255.6.H1269; Grootjans J, 2010, AM J PATHOL, V176, P2283, DOI 10.2353/ajpath.2010.091069; HARWARD TRS, 1993, J VASC SURG, V18, P459, DOI 10.1016/0741-5214(93)90264-M; Howard TJ, 1996, AM J SURG, V171, P405, DOI 10.1016/S0002-9610(97)89619-5; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; KANDA T, 1995, GUT, V36, P788, DOI 10.1136/gut.36.5.788; Kanda T, 2011, J GASTROENTEROL, V46, P492, DOI 10.1007/s00535-011-0373-2; Kassahun WT, 2008, LANGENBECK ARCH SURG, V393, P163, DOI 10.1007/s00423-007-0263-5; Khadaroo RG, 2008, CRIT CARE, V12, DOI 10.1186/cc7001; Klempnauer J, 1997, SURGERY, V121, P239, DOI 10.1016/S0039-6060(97)90351-2; Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9; Maya ML, 2010, REV ESP ENFERM DIG, V102, P478, DOI 10.4321/s1130-01082010000800004; MARSHALL JC, 1993, ANN SURG, V218, P111, DOI 10.1097/00000658-199308000-00001; MCKELVEY TG, 1988, AM J PHYSIOL, V254, pG753, DOI 10.1152/ajpgi.1988.254.5.G753; OCKNER RK, 1974, J CLIN INVEST, V54, P326, DOI 10.1172/JCI107768; OUELLETTE AJ, 1990, J BIOL CHEM, V265, P9831; Pastores SM, 1996, AM J GASTROENTEROL, V91, P1697; Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC; SACCHETTINI JC, 1990, J BIOL CHEM, V265, P19199; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; SHENG ZY, 1991, CHINESE MED J-PEKING, V104, P897; Thuijls G, 2011, ANN SURG, V253, P303, DOI 10.1097/SLA.0b013e318207a767; Vincent JL, 2002, CHEST, V121, P1602, DOI 10.1378/chest.121.5.1602; Whyte AJ, 2010, J EMERG MED, V39, P607, DOI 10.1016/j.jemermed.2008.05.007; WILCOX MG, 1995, DIGEST DIS SCI, V40, P709, DOI 10.1007/BF02064966; WILSON C, 1987, BRIT J SURG, V74, P279, DOI 10.1002/bjs.1800740417	44	28	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115242	10.1371/journal.pone.0115242	http://dx.doi.org/10.1371/journal.pone.0115242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541714	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900028
J	Lourenco, L; Colley, G; Nosyk, B; Shopin, D; Montaner, JSG; Lima, VD				Lourenco, Lillian; Colley, Guillaume; Nosyk, Bohdan; Shopin, Dmitry; Montaner, Julio S. G.; Lima, Viviane D.		STOP HIV AIDS Study Grp	High Levels of Heterogeneity in the HIV Cascade of Care across Different Population Subgroups in British Columbia, Canada	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INJECTION-DRUG USERS; UNITED-STATES; HEALTH-CARE; MEDICATION ADHERENCE; DISEASE PROGRESSION; TREATMENT OUTCOMES; PROSPECTIVE COHORT; VIRAL LOAD; INFECTION	Background: The HIV cascade of care (cascade) is a comprehensive tool which identifies attrition along the HIV care continuum. We executed analyses to explicate heterogeneity in the cascade across key strata, as well as identify predictors of attrition across stages of the cascade. Methods: Using linked individual-level data for the population of HIV-positive individuals in BC, we considered the 2011 calendar year, including individuals diagnosed at least 6 months prior, and excluding individuals that died or were lost to follow-up before January 1st, 2011. We defined five stages in the cascade framework: HIV 'diagnosed', 'linked' to care, 'retained' in care, 'on HAART' and virologically 'suppressed'. We stratified the cascade by sex, age, risk category, and regional health authority. Finally, multiple logistic regression models were built to predict attrition across each stage of the cascade, adjusting for stratification variables. Results: We identified 7621 HIV diagnosed individuals during the study period; 80% were male and 5% were <30, 17% 30-39, 37% 40-49 and 40% were >= 50 years. Of these, 32% were MSM, 28% IDU, 8% MSM/IDU, 12% heterosexual, and 20% other. Overall, 85% of individuals 'on HAART' were 'suppressed'; however, this proportion ranged from 60%-93% in our various stratifications. Most individuals, in all subgroups, were lost between the stages: 'linked' to 'retained' and 'on HAART' to 'suppressed'. Subgroups with the highest attrition between these stages included females and individuals <30 years (regardless of transmission risk group). IDUs experienced the greatest attrition of all subgroups. Logistic regression results found extensive statistically significant heterogeneity in attrition across the cascade between subgroups and regional health authorities. Conclusions: We found that extensive heterogeneity in attrition existed across subgroups and regional health authorities along the HIV cascade of care in B.C., Canada. Our results provide critical information to optimize engagement in care and health service delivery.	[Lourenco, Lillian; Colley, Guillaume; Nosyk, Bohdan; Shopin, Dmitry; Montaner, Julio S. G.; Lima, Viviane D.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Nosyk, Bohdan] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Montaner, Julio S. G.; Lima, Viviane D.] Univ British Columbia, Fac Med, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; University of British Columbia	Lima, VD (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	vlima@cfenet.ubc.ca			British Columbia Ministry of Health; Michael Smith Foundation for Health Research; CIHR; Canadian Institutes of Health Research [MOP-125948]; US National Institute on Drug Abuse [R03DA033851-01]; US National Institutes of Health [R01DA036307]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036307, R03DA033851] Funding Source: NIH RePORTER	British Columbia Ministry of Health; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding: This study was funded by the British Columbia Ministry of Health-funded Seek and Treat for Optimal Prevention of HIV & AIDS pilot project. VDL is supported by a Scholar Award from the Michael Smith Foundation for Health Research, a New Investigator Award from CIHR and two grants from the Canadian Institutes of Health Research (MOP-125948) and the US National Institute on Drug Abuse (R03DA033851-01). JSGM is supported by the British Columbia Ministry of Health and by the US National Institutes of Health (R01DA036307). BN is supported by a Scholar Award from the Michael Smith Foundation for Health Research. The funders had no role in the design, data collection, data analysis, data interpretation, or writing of the report. The remaining authors report no disclosures.	Alvarez-Uria G., 2013, Interdisciplinary Perspectives on Infectious Diseases, V2013, P384805, DOI 10.1155/2013/384805; Aziz M, 2011, CLIN INFECT DIS, V52, pS231, DOI 10.1093/cid/ciq047; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; BCMJ, 2013, BRIT COLUMBIA MED J, V55; Benbow N SS, 2012, AIDS C WASH DC; Berg KM, 2004, J GEN INTERN MED, V19, P1111, DOI 10.1111/j.1525-1497.2004.30445.x; Boden D, 1999, JAMA-J AM MED ASSOC, V282, P1135, DOI 10.1001/jama.282.12.1135; British Columbia Centre for Excellence in HIV/AIDS, 2011, CHIN IMPL BC CFES TR; Carr RL, 2004, J ASSOC NURSE AIDS C, V15, P30, DOI 10.1177/1055329003261981; Carter A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092334; Cheever LW, 2007, CLIN INFECT DIS, V44, P1500, DOI 10.1086/517534; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cook JA, 2002, J ACQ IMMUN DEF SYND, V30, P401, DOI [10.1097/00042560-200208010-00005, 10.1097/01.QAI.0000018280.16783.FE]; Cunningham WE, 1999, MED CARE, V37, P1270, DOI 10.1097/00005650-199912000-00010; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Gardner EM, 2014, LANCET INFECT DIS, V14, P5, DOI 10.1016/S1473-3099(13)70272-X; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Group EAT, 2013, FRANC AD NEW NAT POL; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Heath K, 2014, INT J EPIDEMIOLOGY; Helleberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072257; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Hosek Sybil G, 2008, J HIV AIDS Prev Child Youth, V9, P192, DOI 10.1080/15538340902824118; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Joy R, 2008, JAIDS-J ACQ IMM DEF, V47, P500, DOI 10.1097/QAI.0b013e3181648dfd; Krusi A, 2010, INT J DRUG POLICY, V21, P4, DOI 10.1016/j.drugpo.2009.08.003; Lima VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010991; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; MacDonell KE, 2010, J PEDIATR PSYCHOL, V35, P593, DOI 10.1093/jpepsy/jsp080; Malta M, 2008, ADDICTION, V103, P1242, DOI 10.1111/j.1360-0443.2008.02269.x; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Merenstein D, 2009, AIDS PATIENT CARE ST, V23, P289, DOI 10.1089/apc.2008.0161; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Minniear TD, 2013, AIDS RES HUM RETROV, V29, P99, DOI [10.1089/aid.2012.0267, 10.1089/AID.2012.0267]; Moatti JP, 2000, AIDS, V14, P151, DOI 10.1097/00002030-200001280-00010; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Mugavero MJ, 2011, CLIN INFECT DIS, V52, pS238, DOI 10.1093/cid/ciq048; Muthulingam D, 2013, JAIDS-J ACQ IMM DEF, V63, P112, DOI 10.1097/QAI.0b013e3182894555; Nosyk B, 2014, LANCET INFECT DIS, V14, P40, DOI 10.1016/S1473-3099(13)70254-8; Nosyk B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054416; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; Palepu A, 2004, ANTIVIR THER, V9, P713; Palepua A, 2006, DRUG ALCOHOL DEPEN, V84, P188, DOI 10.1016/j.drugalcdep.2006.02.003; Poole WK, 2001, J EPIDEMIOL COMMUN H, V55, P66, DOI 10.1136/jech.55.1.66; Puskas Cathy M, 2011, Curr HIV/AIDS Rep, V8, P277, DOI 10.1007/s11904-011-0098-0; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Rodger A, 2014, 21 C RETR OPP INF BO; Rudy BJ, 2009, AIDS PATIENT CARE ST, V23, P185, DOI 10.1089/apc.2008.0162; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Shacham E, 2010, AIDS PATIENT CARE ST, V24, P229, DOI 10.1089/apc.2009.0275; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Tapp C, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-86; Taylor Barbara S, 2013, Top Antivir Med, V21, P75; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; Wood E, 2003, J INFECT DIS, V188, P1164, DOI 10.1086/378703; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649	62	52	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115277	10.1371/journal.pone.0115277	http://dx.doi.org/10.1371/journal.pone.0115277			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25541682	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900031
J	Ortega, CE; Seidner, Y; Dominguez, I				Ortega, Charina E.; Seidner, Yoshua; Dominguez, Isabel			Mining CK2 in Cancer	PLOS ONE			English	Article							PROTEIN-KINASE CK2; GENE-EXPRESSION PATTERNS; SQUAMOUS-CELL CARCINOMAS; HUMAN PROSTATE-CANCER; CASEIN KINASE-2; OVARIAN-CANCER; BREAST-CANCER; PANCREATIC ADENOCARCINOMA; DROSOPHILA-MELANOGASTER; COLORECTAL-CANCER	Cancer is a leading cause of death worldwide. Cancer cells proliferate uncontrollably and, many cases, spread to other parts of the body. A protein historically involved in cancer is protein kinase CK2. CK2 is a serine-threonine kinase that has been involved in cell growth, cell proliferation and cell apoptosis. CK2 functions as an oncogene when overexpressed in mouse tissues, and can synergize with known oncogenes, such as ras, to induce cell transformation in cells in culture. CK2, typically the CK2 alpha protein, is found elevated in a number of human tumors. However, we have little information on CK2 alpha' and CK2 beta proteins, and scarce information on CK2 gene transcript expression. Here, we explore the expression of CK2 transcripts in primary tumor tissues using the database Oncomine in the six cancers with the highest mortality in the U.S.A. In addition, we studied the correlation between CK2 expression and overall survival using the Kaplan-Meier Plotter database in breast, ovarian, and lung cancers. We found widespread upregulation in the expression of CK2 genes in primary tumor tissues. However, we found underexpression of CK2 alpha' transcripts in some tumors, increased CK2 beta transcripts in some invasive tumors, and deregulation of CK2 transcripts in some tumor precursors. There was also correlation between CK2 expression levels and patient survival. These data provides additional evidence for CK2 as a biomarker for cancer studies and as a target for cancer therapy.	[Ortega, Charina E.; Seidner, Yoshua; Dominguez, Isabel] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University	Dominguez, I (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	isdoming@bu.edu		Ortega, Charina/0000-0002-8814-8629; /0000-0001-9617-4141	National Institutes of General Medical Sciences [1R01GM098367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098367] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: The following resources that were used in this manuscript: buying of computers, maintenance of computers and software, and PI salary. These resource were acquired with funding from the National Institutes of General Medical Sciences; 1R01GM098367 (http://www.nigms.nih.gov/Pages/default.aspx). Therefore, indirectly, this R01 grant supported this work. There are no other sources of funding. The work was performed by two undergraduate students that had no funding, and volunteer their time and effort for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib TR, 2004, BRIT J CANCER, V90, P686, DOI 10.1038/sj.bjc.6601603; Ahmad KA, 2008, ADV ENZYME REGUL, V48, P179, DOI 10.1016/j.advenzreg.2008.04.002; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; AHMED K, 1974, RES COMMUN CHEM PATH, V9, P771; Ahmed K, 2000, J CELL BIOCHEM, P130; Allada R, 2005, MOL CELL BIOCHEM, V274, P141, DOI 10.1007/s11010-005-2943-1; Axtell RC, 2006, J IMMUNOL, V177, P8542, DOI 10.4049/jimmunol.177.12.8542; Battistutta R, 2009, CELL MOL LIFE SCI, V66, P1868, DOI 10.1007/s00018-009-9155-x; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bibby AC, 2005, INT J BIOL SCI, V1, P67; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Canton DA, 2006, CELL SIGNAL, V18, P267, DOI 10.1016/j.cellsig.2005.07.008; Costa R, 2014, BBA-PROTEINS PROTEOM, V1844, P722, DOI 10.1016/j.bbapap.2014.01.014; Cozza G, 2013, CURR MED CHEM, V20, P671, DOI 10.2174/092986713804999312; Currier N, 2005, TOXICOL PATHOL, V33, P726, DOI 10.1080/01926230500352226; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DAYAMAKIN M, 1994, CANCER RES, V54, P2262; Deplus R, 2014, CELL REP, V8, P743, DOI 10.1016/j.celrep.2014.06.048; Deshiere A, 2013, ONCOGENE, V32, P1373, DOI 10.1038/onc.2012.165; Di Maira G, 2007, ONCOGENE, V26, P6915, DOI 10.1038/sj.onc.1210495; Dominguez I, 2009, CELL MOL LIFE SCI, V66, P1850, DOI 10.1007/s00018-009-9153-z; Drygin D, 2013, CK2 LOGICAL TARGET C, P383; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Eom GH, 2011, CIRCULATION, V123, P2392, DOI 10.1161/CIRCULATIONAHA.110.003665; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gaedcke J, 2010, GENE CHROMOSOME CANC, V49, P1024, DOI 10.1002/gcc.20811; GAPANY M, 1995, MOL MED, V1, P659, DOI 10.1007/BF03401606; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Hauck L, 2008, NAT MED, V14, P315, DOI 10.1038/nm1729; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Howlader N, 2013, SEER CANC STAT REV 1; Hung MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011418; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Kramerov AA, 2008, MOL CELL BIOCHEM, V316, P177, DOI 10.1007/s11010-008-9831-4; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Logsdon CD, 2003, CANCER RES, V63, P2649; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Luo W, 2013, CANCER RES, V73, P2289, DOI 10.1158/0008-5472.CAN-12-4119; Lupp S, 2013, MOL CELL BIOCHEM, V384, P71, DOI 10.1007/s11010-013-1782-8; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Olenkina OM, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1285, DOI 10.1134/S0006297912110077; Olenkina OM, 2012, GENE, V499, P143, DOI 10.1016/j.gene.2012.03.023; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Ruzzene M, 2010, BBA-PROTEINS PROTEOM, V1804, P499, DOI 10.1016/j.bbapap.2009.07.018; Sabates-Bellver J, 2007, FALK SYMP, V158, P27; Salvi M, 2006, FEBS LETT, V580, P3948, DOI 10.1016/j.febslet.2006.06.031; Sarno S, 2008, MOL BIOSYST, V4, P889, DOI 10.1039/b805534c; SEITZ G, 1989, BIOCHEM BIOPH RES CO, V163, P635, DOI 10.1016/0006-291X(89)92184-0; Seldin DC, 2005, MOL CELL BIOCHEM, V274, P63, DOI 10.1007/s11010-005-3078-0; SELDIN DC, 1995, CURR OPIN IMMUNOL, V7, P665, DOI 10.1016/0952-7915(95)80075-1; Seldin DC, 2013, ONCOGENIC POTENTIAL, P293; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Singh NN, 2008, J MOL MED, V86, P887, DOI 10.1007/s00109-008-0352-0; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; STALTER G, 1994, BIOCHEM BIOPH RES CO, V202, P141, DOI 10.1006/bbrc.1994.1904; Talbot SG, 2005, CANCER RES, V65, P3063, DOI 10.1158/0008-5472.CAN-04-1985; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Trembley J.H., 2013, CK2 SUPPRESSION APOP, P219; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; US Cancer Statistics Working Group, 2014, US CANC STAT 1999 20; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Welsh JB, 2001, CANCER RES, V61, P5974; WHO, 2010, GLOB STAT REP NONC D; WIRKNER U, 1992, BIOCHIM BIOPHYS ACTA, V1131, P220, DOI 10.1016/0167-4781(92)90083-C; Xu X, 1999, MOL CELL BIOCHEM, V191, P65, DOI 10.1023/A:1006866412652; Yamagata N, 2003, CLIN CANCER RES, V9, P4695; Yaylim I, 2002, ANTICANCER RES, V22, P215; YENICE S, 1994, PROSTATE, V24, P11, DOI 10.1002/pros.2990240105; Yoshihara K, 2009, CANCER SCI, V100, P1421, DOI 10.1111/j.1349-7006.2009.01204.x; Zhang J., 2011, DATABASE J BIOL DATA; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786; Zou JJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-97	89	113	120	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115609	10.1371/journal.pone.0115609	http://dx.doi.org/10.1371/journal.pone.0115609			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541719	gold, Green Published, Green Submitted			2022-12-26	WOS:000347239900058
J	Schuldt, K; Ehmen, C; Evans, J; May, J; Ansong, D; Sievertsen, J; Muntau, B; Ruge, G; Agbenyega, T; Horstmann, RD				Schuldt, Kathrin; Ehmen, Christa; Evans, Jennifer; May, Juergen; Ansong, Daniel; Sievertsen, Juergen; Muntau, Birgit; Ruge, Gerd; Agbenyega, Tsiri; Horstmann, Rolf D.			Endothelial Protein C Receptor Gene Variants Not Associated with Severe Malaria in Ghanaian Children	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PLASMA-LEVELS; EPCR GENE; PROCR; RISK; DISEASE; LOCI; POLYMORPHISMS; ORGANIZATION; COAGULATION	Background: Two recent reports have identified the Endothelial Protein C Receptor (EPCR) as a key molecule implicated in severe malaria pathology. First, it was shown that EPCR in the human microvasculature mediates sequestration of Plasmodium falciparum-infected erythrocytes. Second, microvascular thrombosis, one of the major processes causing cerebral malaria, was linked to a reduction in EPCR expression in cerebral endothelial layers. It was speculated that genetic variation affecting EPCR functionality could influence susceptibility to severe malaria phenotypes, rendering PROCR, the gene encoding EPCR, a promising candidate for an association study. Methods: Here, we performed an association study including high-resolution variant discovery of rare and frequent genetic variants in the PROCR gene. The study group, which previously has proven to be a valuable tool for studying the genetics of malaria, comprised 1,905 severe malaria cases aged 1-156 months and 1,866 apparently healthy children aged 2-161 months from the Ashanti Region in Ghana, West Africa, where malaria is highly endemic. Association of genetic variation with severe malaria phenotypes was examined on the basis of single variants, reconstructed haplotypes, and rare variant analyses. Results: A total of 41 genetic variants were detected in regulatory and coding regions of PROCR, 17 of which were previously unknown genetic variants. In association tests, none of the single variants, haplotypes or rare variants showed evidence for an association with severe malaria, cerebral malaria, or severe malaria anemia. Conclusion: Here we present the first analysis of genetic variation in the PROCR gene in the context of severe malaria in African subjects and show that genetic variation in the PROCR gene in our study population does not influence susceptibility to major severe malaria phenotypes.	[Schuldt, Kathrin; Ehmen, Christa; Evans, Jennifer; Sievertsen, Juergen; Muntau, Birgit; Ruge, Gerd; Horstmann, Rolf D.] Bernhard Nocht Inst Trop Med, Dept Mol Med, D-20359 Hamburg, Germany; [May, Juergen] Bernhard Nocht Inst Trop Med, Infect Dis Epidemiol Grp, D-20359 Hamburg, Germany; [Ansong, Daniel; Agbenyega, Tsiri] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana	Bernhard Nocht Institut fur Tropenmedizin; Bernhard Nocht Institut fur Tropenmedizin; Kwame Nkrumah University Science & Technology	Schuldt, K (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	schuldt@bnitm.de		ANSONG, Daniel/0000-0003-1328-9117; May, Jurgen/0000-0001-7831-8420	Bernhard Nocht Institute for Tropical Medicine (BNITM)	Bernhard Nocht Institute for Tropical Medicine (BNITM)	The study was funded by the Bernhard Nocht Institute for Tropical Medicine (BNITM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2014, BLOOD, V123, P163, DOI 10.1182/blood-2013-09-521005; Bongfen SE, 2009, TRENDS PARASITOL, V25, P417, DOI 10.1016/j.pt.2009.05.012; Bush WS, 2010, BIOINFORMATICS, V26, P578, DOI 10.1093/bioinformatics/btp678; Dennis J, 2012, BLOOD, V119, P2392, DOI 10.1182/blood-2011-10-383448; Esser C, 2014, CELL MICROBIOL, V16, P701, DOI 10.1111/cmi.12270; Gleeson EM, 2012, CELL MOL LIFE SCI, V69, P717, DOI 10.1007/s00018-011-0825-0; Hayashi T, 1999, GENE, V238, P367, DOI 10.1016/S0378-1119(99)00360-1; Kallel C, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-103; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; Medina P, 2004, THROMB HAEMOSTASIS, V91, P905, DOI 10.1160/TH03-10-0657; Mollica LR, 2006, BLOOD, V108, P1251, DOI 10.1182/blood-2006-02-001461; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Moxon CA, 2013, BLOOD, V122, P842, DOI 10.1182/blood-2013-03-490219; Naka I, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-105; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Pintao MC, 2011, J THROMB HAEMOST, V9, P969, DOI 10.1111/j.1538-7836.2011.04256.x; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiner AP, 2008, J THROMB HAEMOST, V6, P1625, DOI 10.1111/j.1538-7836.2008.03118.x; San Lucas FA, 2012, BIOINFORMATICS, V28, P421, DOI 10.1093/bioinformatics/btr667; Saposnik B, 2004, BLOOD, V103, P1311, DOI 10.1182/blood-2003-07-2520; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schuldt K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002066; Simmonds RE, 1999, BLOOD, V94, P632, DOI 10.1182/blood.V94.2.632.414k24_632_641; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Tang WH, 2010, BLOOD, V116, P5032, DOI 10.1182/blood-2010-05-283739; Timmann C, 2012, NATURE, V489, P443, DOI 10.1038/nature11334; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216	34	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115770	10.1371/journal.pone.0115770	http://dx.doi.org/10.1371/journal.pone.0115770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541704	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900082
J	Soderlund, CA; Nelson, WM; Goff, SA				Soderlund, Carol A.; Nelson, William M.; Goff, Stephen A.			Allele Workbench: Transcriptome Pipeline and Interactive Graphics for Allele-Specific Expression	PLOS ONE			English	Article							RNA-SEQ DATA; GENE-EXPRESSION; SEQUENCING DATA; DIFFERENTIAL EXPRESSION; REFERENCE GENOME; VARIANTS; BIAS; ANNOTATION; GENERATION; FRAMEWORK	Sequencing the transcriptome can answer various questions such as determining the transcripts expressed in a given species for a specific tissue or condition, evaluating differential expression, discovering variants, and evaluating allele-specific expression. Differential expression evaluates the expression differences between different strains, tissues, and conditions. Allele-specific expression evaluates expression differences between parental alleles. Both differential expression and allele-specific expression have been studied for heterosis (hybrid vigor), where the hybrid has improved performance over the parents for one or more traits. The Allele Workbench software was developed for a heterosis study that evaluated allele-specific expression for a mouse F1 hybrid using libraries from multiple tissues with biological replicates. This software has been made into a distributable package, which includes a pipeline, a Java interface to build the database, and a Java interface for query and display of the results. The required input is a reference genome, annotation file, and one or more RNA-Seq libraries with optional replicates. It evaluates allelic imbalance at the SNP and transcript level and flags transcripts with significant opposite directional allele-specific expression. The Java interface allows the user to view data from libraries, replicates, genes, transcripts, exons, and variants, including queries on allele imbalance for selected libraries. To determine the impact of allele-specific SNPs on protein folding, variants are annotated with their effect (e.g., missense), and the parental protein sequences may be exported for protein folding analysis. The Allele Workbench processing results in transcript files and read counts that can be used as input to the previously published Transcriptome Computational Workbench, which has a new algorithm for determining a trimmed set of gene ontology terms. The software with demo files is available from https://code.google.com/p/alleleworkbench. Additionally, all software is ready for immediate use from an Atmosphere Virtual Machine Image available from the iPlant Collaborative (www.iplantcollaborative.org).	[Soderlund, Carol A.; Nelson, William M.] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA; [Goff, Stephen A.] Univ Arizona, iPlant Collaborat, Tucson, AZ USA	University of Arizona; University of Arizona	Soderlund, CA (corresponding author), Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA.	cari@agcol.arizona.edu			National Science Foundation [DBI-1265383, IOS-1248090]; Division Of Integrative Organismal Systems [1248090] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation (http://www.nsf.gov) grants DBI-1265383 (PI SAG) and IOS-1248090 (PI SAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2014, HTSEQ PYTHON FRAMEWO, DOI [10.1101/ 002824, DOI 10.1101/002824, 10.1101/002824]; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bell GDM, 2013, GENOME BIOL EVOL, V5, P1309, DOI 10.1093/gbe/evt072; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fontanillas P, 2010, MOL ECOL, V19, P212, DOI 10.1111/j.1365-294X.2010.04472.x; Goff SA, 2011, NEW PHYTOL, V189, P923, DOI 10.1111/j.1469-8137.2010.03574.x; Goncalves A, 2011, BIOINFORMATICS, V27, P867, DOI 10.1093/bioinformatics/btr012; Graze RM, 2012, MOL BIOL EVOL, V29, P1521, DOI 10.1093/molbev/msr318; Guo M, 2006, THEOR APPL GENET, V113, P831, DOI 10.1007/s00122-006-0335-x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090581; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks280; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Marth G, 2012, ARXIV12073907V2; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mooney S, 2005, BRIEF BIOINFORM, V6, P44, DOI 10.1093/bib/6.1.44; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pandey RV, 2013, MOL ECOL RESOUR, V13, P740, DOI 10.1111/1755-0998.12110; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Perumbakkam S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-64; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quinn A, 2014, BIOINFORMATICS, V30, P2603, DOI 10.1093/bioinformatics/btu342; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Satya RV, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks425; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shabalina SA, 2013, NUCLEIC ACIDS RES, V41, P2073, DOI 10.1093/nar/gks1205; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Soderlund C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069401; Stevenson KR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-536; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wei Xiaoxing, 2013, Genomics Proteomics & Bioinformatics, V11, P247, DOI 10.1016/j.gpb.2013.05.006; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yalcin B, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r18; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu XQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-274; Zhai RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060668	58	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115740	10.1371/journal.pone.0115740	http://dx.doi.org/10.1371/journal.pone.0115740			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541944	gold, Green Published, Green Submitted			2022-12-26	WOS:000347239900074
J	Xie, XY; Yang, YF; Chi, Q; Li, ZP; Zhang, H; Li, Y; Yang, Y				Xie, Xiangyang; Yang, Yanfang; Chi, Qiang; Li, ZhiPing; Zhang, Hui; Li, Ying; Yang, Yang			Controlled Release of Dutasteride from Biodegradable Microspheres: In Vitro and In Vivo Studies	PLOS ONE			English	Article							BENIGN PROSTATIC HYPERPLASIA; BURST RELEASE; DRUG; OPTIMIZATION; FABRICATION; EFFICIENCY; DELIVERY; MODEL	The aim of the present work was to study the in vitro/in vivo characteristics of dutasteride loaded biodegradable microspheres designed for sustained release of dutasteride over four weeks. An O/W emulsion-solvent evaporation method was used to incorporate dutasteride, which is of interest in the treatment of benign prostatic hyperplasia (BPH), into poly(lactide-co-glycolide) (PLGA). A response surface method (RSM) with central composite design (CCD) was employed to optimize the formulation variables. A prolonged in vitro drug release profile was observed, with a complete release of the entrapped drug within 28 days. The pharmacokinetics study showed sustained plasma drug concentration-time profile of dutasteride loaded microspheres after subcutaneous injection into rats. The in vitro drug release in rats correlated well with the in vivo pharmacokinetics profile. The pharmacodynamics evaluated by determination of the BPH inhibition in the rat models also showed a prolonged pharmacological response. These results suggest the potential use of dutasteride loaded biodegradable microspheres for the management of BPH over long periods.	[Xie, Xiangyang; Yang, Yang] Guangzhou Mil Command, Wuhan Gen Hosp, Dept Pharm, Wuhan, Peoples R China; [Yang, Yanfang] Chinese Acad Med Sci, Inst Mat Med, Beijing Key Lab Drug Delivery Technol & Novel For, Beijing 100050, Peoples R China; [Yang, Yanfang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chi, Qiang] 215th Clin 406th Hosp, Chinese Peoples Liberat Army, Dept Pharm, Dalian, Peoples R China; [Li, ZhiPing; Zhang, Hui; Li, Ying; Yang, Yang] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Academy of Military Medical Sciences - China	Yang, Y (corresponding author), Guangzhou Mil Command, Wuhan Gen Hosp, Dept Pharm, Wuhan, Peoples R China.	xxysypu@163.com						Beak IH, 2012, CHEM PHARM BULL, V60, P1468, DOI 10.1248/cpb.c12-00563; Clark RV, 2004, J CLIN ENDOCR METAB, V89, P2179, DOI 10.1210/jc.2003-030330; Coimbra PA, 2008, J MICROENCAPSUL, V25, P170, DOI [10.1080/02652040701814140, 10.1080/02652040701814140 ]; Emberton M, 2003, UROLOGY, V61, P267, DOI 10.1016/S0090-4295(02)02371-3; Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015; Govender S, 2005, INT J PHARMACEUT, V306, P24, DOI 10.1016/j.ijpharm.2005.07.026; Guo QL, 2004, BIOL PHARM BULL, V27, P333, DOI 10.1248/bpb.27.333; Hameed BH, 2008, J HAZARD MATER, V158, P324, DOI 10.1016/j.jhazmat.2008.01.088; Hassan AS, 2009, EUR J PHARM BIOPHARM, V73, P337, DOI 10.1016/j.ejpb.2009.07.009; Hickey T, 2002, BIOMATERIALS, V23, P1649, DOI 10.1016/S0142-9612(01)00291-5; Kim BK, 2002, J MICROENCAPSUL, V19, P811, DOI 10.1080/0265204021000022770; Mahmoudi M, 2009, J COLLOID INTERF SCI, V336, P510, DOI 10.1016/j.jcis.2009.04.046; NASLUND MJ, 1986, J UROLOGY, V136, P1136, DOI 10.1016/S0022-5347(17)45239-6; Qandil Amjad M., 2013, Journal of Pharmaceutical Investigation, V43, P171, DOI 10.1007/s40005-013-0065-4; Roehrborn CG, 2005, BJU INT, V96, P572, DOI 10.1111/j.1464-410X.2005.05686.x; Shi GX, 2002, POLYM ADVAN TECHNOL, V13, P227, DOI 10.1002/pat.178; Singh B, 2005, CRIT REV THER DRUG, V22, P215, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i3.10; Sun H, 2008, J ETHNOPHARMACOL, V115, P203, DOI 10.1016/j.jep.2007.09.026; Tatemichi S, 2006, J UROLOGY, V176, P1236, DOI 10.1016/j.juro.2006.04.029; Veloso AAS, 1997, INVEST OPHTH VIS SCI, V38, P665; Viswanathan NB, 1999, J CONTROL RELEASE, V58, P9, DOI 10.1016/S0168-3659(98)00140-0; WAGNER JG, 1963, J PHARM SCI, V52, P610, DOI 10.1002/jps.2600520629; Wang J, 2002, J CONTROL RELEASE, V82, P289, DOI 10.1016/S0168-3659(02)00137-2; Wu J, 2013, ACTA BIOMATER, V9, P7410, DOI 10.1016/j.actbio.2013.03.022; Wu XJ, 2014, UROLOGY, V83, P539, DOI 10.1016/j.urology.2013.10.007; Xie XY, 2015, PHARM DEV TECHNOL, V20, P633, DOI 10.3109/10837450.2014.892131; Yang Y, 2013, PHARM DEV TECHNOL, V18, P1169, DOI 10.3109/10837450.2011.618948; Yang Y, 2011, PHARMAZIE, V66, P694, DOI 10.1691/ph.2011.1007; Zolnik BS, 2008, J CONTROL RELEASE, V127, P137, DOI 10.1016/j.jconrel.2008.01.004	29	8	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e114835	10.1371/journal.pone.0114835	http://dx.doi.org/10.1371/journal.pone.0114835			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541985	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900014
J	Yadav, DK; Prasad, A; Kruk, J; Pospisil, P				Yadav, Deepak Kumar; Prasad, Ankush; Kruk, Jerzy; Pospisil, Pavel			Evidence for the Involvement of Loosely Bound Plastosemiquinones in Superoxide Anion Radical Production in Photosystem II	PLOS ONE			English	Article							PLASTOQUINONE-POOL; CYTOCHROME B(559); OXYGEN REDUCTION; ELECTRON-ACCEPTOR; MANGANESE COMPLEX; REDOX CHANGES; OXIDATION; QUINONE; EVOLUTION; CLUSTER	Recent evidence has indicated the presence of novel plastoquinone-binding sites, Q(C) and Q(D), in photosystem II (PSII). Here, we investigated the potential involvement of loosely bound plastosemiquinones in superoxide anion radical (O-2(-)) formation in spinach PSII membranes using electron paramagnetic resonance (EPR) spin-trapping spectroscopy. Illumination of PSII membranes in the presence of the spin trap EMPO (5-(ethoxycarbonyl)-5-methyl-1-pyrroline N-oxide) resulted in the formation of O-2(-), which was monitored by the appearance of EMPO-OOH adduct EPR signal. Addition of exogenous short-chain plastoquinone to PSII membranes markedly enhanced the EMPO-OOH adduct EPR signal. Both in the unsupplemented and plastoquinone-supplemented PSII membranes, the EMPO-OOH adduct EPR signal was suppressed by 50% when the urea-type herbicide DCMU (3-(3,4-dichlorophenyl)-1,1-dimethylurea) was bound at the Q(B) site. However, the EMPO-OOH adduct EPR signal was enhanced by binding of the phenolic-type herbicide dinoseb (2,4-dinitro-6-sec-butylphenol) at the Q(D) site. Both in the unsupplemented and plastoquinone-supplemented PSII membranes, DCMU and dinoseb inhibited photoreduction of the high-potential form of cytochrome b(559) (cyt b(559)). Based on these results, we propose that O-2(-) is formed via the reduction of molecular oxygen by plastosemiquinones formed through one-electron reduction of plastoquinone at the Q(B) site and one-electron oxidation of plastoquinol by cyt b(559) at the Q(C) site. On the contrary, the involvement of a plastosemiquinone formed via the one-electron oxidation of plastoquinol by cyt b(559) at the Q(D) site seems to be ambiguous. In spite of the fact that the existence of Q(C) and Q(D) sites is not generally accepted yet, the present study provided more spectroscopic data on the potential functional role of these new plastoquinone-binding sites.	[Yadav, Deepak Kumar; Prasad, Ankush; Pospisil, Pavel] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, CR-77147 Olomouc, Czech Republic; [Kruk, Jerzy] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Plant Physiol & Biochem, Krakow, Poland	Palacky University Olomouc; Jagiellonian University	Pospisil, P (corresponding author), Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, CR-77147 Olomouc, Czech Republic.	pavel.pospisil@upol.cz	POSPÍŠIL, Pavel/AAH-4451-2019; Prasad, Ankush/G-6690-2011	POSPÍŠIL, Pavel/0000-0001-9126-2011; Prasad, Ankush/0000-0002-2009-8987; Yadav, Deepak Kumar/0000-0002-4555-3851	Ministry of Education, Youth and Sports of the Czech Republic [LO1204, CZ.1.07/2.3.00/20.0057, CZ.1.07/2.3.00/30.0041]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Funding: This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic grants no. LO1204 (National Program of Sustainability I), no. CZ.1.07/2.3.00/20.0057 (Progress and Internationalization of Biophysical Research at the Faculty of Science, Palacky University) and no. CZ.1.07/2.3.00/30.0041 (Support for Building Excellent Research Teams and Intersectoral Mobility at Palacky University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANYEV G, 1994, PHOTOSYNTH RES, V41, P327, DOI 10.1007/BF00019410; Arato A, 2004, BBA-BIOENERGETICS, V1608, P171, DOI 10.1016/j.bbabio.2003.12.003; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bondarava N, 2010, PHYSIOL PLANTARUM, V138, P463, DOI 10.1111/j.1399-3054.2009.01312.x; Brudvig GW, 2008, PHILOS T R SOC B, V363, P1211, DOI 10.1098/rstb.2007.2217; Buchel C, 1999, P NATL ACAD SCI USA, V96, P14288, DOI 10.1073/pnas.96.25.14288; Cardona T, 2012, BBA-BIOENERGETICS, V1817, P26, DOI 10.1016/j.bbabio.2011.07.012; Cleland RE, 1999, FEBS LETT, V457, P348, DOI 10.1016/S0014-5793(99)01067-4; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FORD RC, 1983, FEBS LETT, V160, P159, DOI 10.1016/0014-5793(83)80957-0; Frankel LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058042; Frankel LK, 2012, BIOCHEMISTRY-US, V51, P6371, DOI 10.1021/bi300650n; Fufezan C, 2002, FEBS LETT, V532, P407, DOI 10.1016/S0014-5793(02)03724-9; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hasegawa K, 2014, PHOTOSYNTH RES, V120, P113, DOI 10.1007/s11120-012-9787-9; HAUSKA G, 1983, BIOCHIM BIOPHYS ACTA, V726, P97, DOI 10.1016/0304-4173(83)90002-2; Ivanov B, 2007, FEBS LETT, V581, P1342, DOI 10.1016/j.febslet.2007.02.044; Kaminskaya O, 2007, BBA-BIOENERGETICS, V1767, P550, DOI 10.1016/j.bbabio.2007.02.005; Kaminskaya O, 2007, BIOCHEMISTRY-US, V46, P1091, DOI 10.1021/bi0613022; Kaminskaya OP, 2013, BBA-BIOENERGETICS, V1827, P471, DOI 10.1016/j.bbabio.2013.01.007; Kato Y, 2009, P NATL ACAD SCI USA, V106, P17365, DOI 10.1073/pnas.0905388106; Khorobrykh S, 2004, BBA-BIOENERGETICS, V1657, P164, DOI 10.1016/j.bbabio.2004.04.009; KLIMOV VV, 1979, DOKL AKAD NAUK SSSR+, V249, P227; KRIEGER A, 1995, BBA-BIOENERGETICS, V1229, P193, DOI 10.1016/0005-2728(95)00002-Z; Kruk J, 2001, J BIOL CHEM, V276, P86, DOI 10.1074/jbc.M003602200; Kruk J, 2006, BBA-BIOENERGETICS, V1757, P1669, DOI 10.1016/j.bbabio.2006.08.004; Lambreva MD, 2014, CURR PROTEIN PEPT SC, V15, P285, DOI 10.2174/1389203715666140327104802; Mubarakshina M, 2006, BBA-BIOENERGETICS, V1757, P1496, DOI 10.1016/j.bbabio.2006.09.004; Mubarakshina MM, 2010, PHYSIOL PLANTARUM, V140, P103, DOI 10.1111/j.1399-3054.2010.01391.x; Muh F, 2012, BBA-BIOENERGETICS, V1817, P44, DOI 10.1016/j.bbabio.2011.05.021; Pospisil P, 2004, BIOCHEMISTRY-US, V43, P6783, DOI 10.1021/bi036219i; Pospisil P, 2006, BIOCHEM J, V397, P321, DOI 10.1042/BJ20060068; Pospisil P, 2012, BBA-BIOENERGETICS, V1817, P218, DOI 10.1016/j.bbabio.2011.05.017; Pospisil P, 2011, J PHOTOCH PHOTOBIO B, V104, P341, DOI 10.1016/j.jphotobiol.2011.02.013; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; Renger G, 2005, ADV PHOTO RESPIRAT, V22, P139; Shibamoto T, 2009, BIOCHEMISTRY-US, V48, P10682, DOI 10.1021/bi901691j; Sinha RK, 2010, J BIOENERG BIOMEMBR, V42, P337, DOI 10.1007/s10863-010-9299-2; Snyrychova I, 2006, PHOTOSYNTH RES, V88, P323, DOI 10.1007/s11120-006-9061-0; Tiwari A, 2009, BBA-BIOENERGETICS, V1787, P985, DOI 10.1016/j.bbabio.2009.03.017; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vass I, 2012, BBA-BIOENERGETICS, V1817, P209, DOI 10.1016/j.bbabio.2011.04.014; WOOD PM, 1987, TRENDS BIOCHEM SCI, V12, P250, DOI 10.1016/0968-0004(87)90123-X; WYDRZYNSKI T, 1987, BIOCHIM BIOPHYS ACTA, V893, P33, DOI 10.1016/0005-2728(87)90145-9; Zhang H, 2000, FEBS LETT, V473, P58, DOI 10.1016/S0014-5793(00)01498-8; Zhang SP, 2003, PHOTOSYNTH RES, V75, P41, DOI 10.1023/A:1022439009587	48	17	17	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115466	10.1371/journal.pone.0115466	http://dx.doi.org/10.1371/journal.pone.0115466			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541694	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900046
J	Lilly, JL; Sheldon, PR; Hoversten, LJ; Romero, G; Balasubramaniam, V; Berron, BJ				Lilly, Jacob L.; Sheldon, Phillip R.; Hoversten, Liv J.; Romero, Gabriela; Balasubramaniam, Vivek; Berron, Brad J.			Interfacial Polymerization for Colorimetric Labeling of Protein Expression in Cells	PLOS ONE			English	Article							SIGNAL AMPLIFICATION; FILMS; SENSITIVITY	Determining the location of rare proteins in cells typically requires the use of on-sample amplification. Antibody based recognition and enzymatic amplification is used to produce large amounts of visible label at the site of protein expression, but these techniques suffer from the presence of nonspecific reactivity in the biological sample and from poor spatial control over the label. Polymerization based amplification is a recently developed alternative means of creating an on-sample amplification for fluorescence applications, while not suffering from endogenous labels or loss of signal localization. This manuscript builds upon polymerization based amplification by developing a stable, archivable, and colorimetric mode of amplification termed Polymer Dye Labeling. The basic concept involves an interfacial polymer grown at the site of protein expression and subsequent staining of this polymer with an appropriate dye. The dyes Evans Blue and eosin were initially investigated for colorimetric response in a microarray setting, where both specifically stained polymer films on glass. The process was translated to the staining of protein expression in human dermal fibroblast cells, and Polymer Dye Labeling was specific to regions consistent with desired protein expression. The labeling is stable for over 200 days in ambient conditions and is also compatible with modern mounting medium.	[Lilly, Jacob L.; Sheldon, Phillip R.; Romero, Gabriela; Berron, Brad J.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA; [Hoversten, Liv J.; Balasubramaniam, Vivek] Univ Colorado, Dept Pediat, Denver, CO 80202 USA	University of Kentucky; University of Colorado System; University of Colorado Denver	Berron, BJ (corresponding author), Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA.	brad.berron@uky.edu		Romero, Gabriela/0000-0001-8081-2946; Hoversten, Liv J./0000-0002-7732-6055	National Institute of Biomedical Imaging and Bioengineering [R21 EB012188]; National Science Foundation [CBET-1351531]; National Cancer Institute [R25CA153954]; NATIONAL CANCER INSTITUTE [R25CA153954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB012188] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institute of Biomedical Imaging and Bioengineering (R21 EB012188), the National Science Foundation (CBET-1351531), and the National Cancer Institute (R25CA153954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457, DOI 10.1177/40.10.1527370; Avens HJ, 2009, ABSTR PAP AM CHEM S, V237; Avens HJ, 2011, J HISTOCHEM CYTOCHEM, V59, P76, DOI 10.1369/jhc.2010.955948; Avens HJ, 2011, J NANOPART RES, V13, P331, DOI 10.1007/s11051-010-0034-z; Berron BJ, 2012, LAB CHIP, V12, P708, DOI 10.1039/c2lc21101g; Berron BJ, 2011, BIOTECHNOL BIOENG, V108, P1521, DOI 10.1002/bit.23101; Cruise GM, 1998, BIOTECHNOL BIOENG, V57, P655, DOI 10.1002/(SICI)1097-0290(19980320)57:6<655::AID-BIT3>3.0.CO;2-K; de Matos LL, 2010, BIOMARK INSIGHTS, V5, P9; Rojo MG, 2009, FOLIA HISTOCHEM CYTO, V47, P349, DOI 10.2478/v10042-008-0114-4; Hansen RR, 2008, ANAL BIOANAL CHEM, V392, P167, DOI 10.1007/s00216-008-2259-6; Hansen RR, 2008, BIOMACROMOLECULES, V9, P355, DOI 10.1021/bm700672z; Hansen RR, 2009, ANAL BIOCHEM, V386, P285, DOI 10.1016/j.ab.2008.12.009; Johnson LM, 2009, AUST J CHEM, V62, P877, DOI 10.1071/CH09095; Kaastrup K, 2013, ANAL CHEM, V85, P8055, DOI 10.1021/ac4018988; Kaastrup K, 2012, LAB CHIP, V12, P4055, DOI 10.1039/c2lc40584a; Khire VS, 2006, MACROMOLECULES, V39, P5081, DOI 10.1021/ma060073o; Lakowicz JR, 1983, PRINCIPLES FLUORESCE, P187, DOI 10.1007/978-1-4615-7658-7_7; Lee JK, 2012, BIOMACROMOLECULES, V13, P1136, DOI 10.1021/bm300037t; Lou XH, 2005, ANAL CHEM, V77, P4698, DOI 10.1021/ac050706h; Moss L, 2002, J DENT RES, V81; Okelo GO, 2007, BIOSENS BIOELECTRON, V23, P588, DOI 10.1016/j.bios.2007.06.011; Qian H, 2009, ANAL CHEM, V81, P9824, DOI 10.1021/ac900959v; Qian H, 2009, ANAL CHEM, V81, P4536, DOI 10.1021/ac900401m; Sikes HD, 2008, NAT MATER, V7, P52, DOI 10.1038/nmat2042; Sikes HD, 2009, LAB CHIP, V9, P653, DOI 10.1039/b816198d; Singh I, 2011, TXB HUMAN HISTOLOGY; Woo HY, 2005, J AM CHEM SOC, V127, P14721, DOI 10.1021/ja052906g; Wu YF, 2009, ANAL CHEM, V81, P7015, DOI 10.1021/ac9011254	28	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115630	10.1371/journal.pone.0115630	http://dx.doi.org/10.1371/journal.pone.0115630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536421	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300057
J	Zhang, T; Yu, LX; McCord, P; Miller, D; Bhamidimarri, S; Johnson, D; Monteros, MJ; Ho, J; Reisen, P; Samac, DA				Zhang, Tiejun; Yu, Long-Xi; McCord, Per; Miller, David; Bhamidimarri, Suresh; Johnson, David; Monteros, Maria J.; Ho, Julie; Reisen, Peter; Samac, Deborah A.			Identification of Molecular Markers Associated with Verticillium Wilt Resistance in Alfalfa (Medicago Sativa L.) Using High-Resolution Melting	PLOS ONE			English	Article							LINKAGE MAPS; FORAGE YIELD; ALBO-ATRUM; GENETICS; MODEL; MICROSATELLITE; MECHANISMS; TRUNCATULA; CULTIVARS; QTL	Verticillium wilt, caused by the soilborne fungus, Verticillium alfalfae, is one of the most serious diseases of alfalfa (Medicago sativa L.) worldwide. To identify loci associated with resistance to Verticillium wilt, a bulk segregant analysis was conducted in susceptible or resistant pools constructed from 13 synthetic alfalfa populations, followed by association mapping in two F1 populations consisted of 352 individuals. Simple sequence repeat (SSR) and single nucleotide polymorphism (SNP) markers were used for genotyping. Phenotyping was done by manual inoculation of the pathogen to replicated cloned plants of each individual and disease severity was scored using a standard scale. Marker-trait association was analyzed by TASSEL. Seventeen SNP markers significantly associated with Verticillium wilt resistance were identified and they were located on chromosomes 1, 2, 4, 7 and 8. SNP markers identified on chromosomes 2, 4 and 7 co-locate with regions of Verticillium wilt resistance loci reported in M. truncatula. Additional markers identified on chromosomes 1 and 8 located the regions where no Verticillium resistance locus has been reported. This study highlights the value of SNP genotyping by high resolution melting to identify the disease resistance loci in tetraploid alfalfa. With further validation, the markers identified in this study could be used for improving resistance to Verticillium wilt in alfalfa breeding programs.	[Zhang, Tiejun; Yu, Long-Xi; McCord, Per] ARS, USDA, Prosser, WA 99350 USA; [Miller, David; Bhamidimarri, Suresh] DuPont Pioneer, Arlington, WI USA; [Johnson, David] Alforex Seeds, Salem, WI USA; [Monteros, Maria J.] Samuel Roberts Noble Fdn Inc, Forage Improvement Div, Ardmore, OK USA; [Ho, Julie; Reisen, Peter] Forage Genet Int Inc, Davis, CA USA; [Samac, Deborah A.] ARS, USDA, St Paul, MN USA	United States Department of Agriculture (USDA); Noble Research Institute; United States Department of Agriculture (USDA)	Yu, LX (corresponding author), ARS, USDA, 24106 N Bunn Rd, Prosser, WA 99350 USA.	Longxi.yu@ars.usda.gov	Samac, Deborah/ABC-8744-2021	Samac, Deborah/0000-0002-1847-0508; Monteros, Maria/0000-0002-6061-3883	USDA-ARS National Program [5354-21000-015-00D]; National Alfalfa and Forage Alliance	USDA-ARS National Program; National Alfalfa and Forage Alliance	This work was supported by USDA-ARS National Program Project No. 5354-21000-015-00D and by a grant from the National Alfalfa and Forage Alliance to L-X Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SN, 2003, ADVANCES IN PLANT DISEASE MANAGEMENT, P345; Ben C, 2013, J EXP BOT, V64, P317, DOI 10.1093/jxb/ers337; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brouwer DJ, 2000, CROP SCI, V40, P1387, DOI 10.2135/cropsci2000.4051387x; Cho MH, 2008, CLIN CHEM, V54, P2055, DOI 10.1373/clinchem.2008.109744; Croxford AE, 2008, NEW PHYTOL, V180, P594, DOI 10.1111/j.1469-8137.2008.02588.x; D'hoop BB, 2010, THEOR APPL GENET, V121, P1151, DOI 10.1007/s00122-010-1379-5; De Koeyer D, 2010, MOL BREEDING, V25, P67, DOI 10.1007/s11032-009-9309-4; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; GRAU CR, 1991, PLANT DIS, V75, P82, DOI 10.1094/PD-75-0082; Grau CR, 1991, STANDARD TESTS CHARA; Gupta PK, 1999, PLANT BREEDING, V118, P369, DOI 10.1046/j.1439-0523.1999.00401.x; Han Y., 2011, BMC GENOMICS, V12, P350, DOI DOI 10.1186/1471-2164-12-350; Han YH, 2012, MOL BREEDING, V29, P489, DOI 10.1007/s11032-011-9566-x; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Huang HC, 2003, CAN J PLANT PATHOL, V25, P328; HUANG HC, 1985, PHYTOPATHOLOGY, V75, P482, DOI 10.1094/Phyto-75-482; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028341; Julier Bernadette, 2003, BMC Plant Biology, V3, P9, DOI 10.1186/1471-2229-3-9; Knepper Caleb, 2010, Arabidopsis Book, V8, pe012, DOI 10.1199/tab.0124; Kwok Pui-Yan, 2003, Current Issues in Molecular Biology, V5, P43; Larsen RC, 2007, PHYTOPATHOLOGY, V97, P1519, DOI 10.1094/PHYTO-97-11-1519; Leath K. T., 1988, Alfalfa and alfalfa improvement., P621; Li XH, 2012, AGRONOMY-BASEL, V2, P40, DOI 10.3390/agronomy2010040; Mackie JM, 2007, THEOR APPL GENET, V114, P1417, DOI 10.1007/s00122-007-0527-z; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MILLER PR, 1991, CROP SCI, V31, P1492, DOI 10.2135/cropsci1991.0011183X003100060019x; Musial JM, 2007, THEOR APPL GENET, V114, P1427, DOI 10.1007/s00122-007-0528-y; Papadopoulos YA, 1987, THESIS U GUELPH GUEL; Pennypacker BW, 2000, PHYSIOL MOL PLANT P, V57, P87, DOI 10.1006/pmpp.2000.0284; Rampling LR, 2001, AUST J AGR RES, V52, P1131, DOI 10.1071/AR01027; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Robins JG, 2007, CROP SCI, V47, P11, DOI 10.2135/cropsci2006.07.0447; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Smith EG, 1995, AGRON J, V87, P1206, DOI 10.2134/agronj1995.00021962008700060028x; Studer B, 2009, MOL BREEDING, V24, P191, DOI 10.1007/s11032-009-9291-x; VIANDS DR, 1985, CROP SCI, V25, P1096, DOI 10.2135/cropsci1985.0011183X002500060047x; VIANDS DR, 1992, J PROD AGRIC, V5, P504, DOI 10.2134/jpa1992.0504; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yang SM, 2008, P NATL ACAD SCI USA, V105, P12164, DOI 10.1073/pnas.0802518105; Zhu HY, 2005, PLANT PHYSIOL, V137, P1189, DOI 10.1104/pp.104.058891	43	16	17	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115953	10.1371/journal.pone.0115953	http://dx.doi.org/10.1371/journal.pone.0115953			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536106	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300092
J	Huynh, FC; Jones, FE				Huynh, Felicia C.; Jones, Frank E.			MicroRNA-7 Inhibits Multiple Oncogenic Pathways to Suppress HER2 Delta 16 Mediated Breast Tumorigenesis and Reverse Trastuzumab Resistance	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; CANCER-CELLS; HER2; SRC; PROTEIN	The oncogenic isoform of HER2, HER2 Delta 16, is expressed with HER2 in nearly 50% of HER2 positive breast tumors where HER2 Delta 16 drives metastasis and resistance to multiple therapeutic interventions including tamoxifen and trastuzumab. In recent years microRNAs have been shown to influence multiple aspects of tumorigenesis and tumor cell response to therapy. Accordingly, the HER2 Delta 16 oncogene alters microRNA expression to promote endocrine resistance. With the goal of identifying microRNA suppressors of HER2 Delta 16 oncogenic activity we investigated the contribution of altered microRNA expression to HER2 Delta 16 mediated tumorigenesis and trastuzumab resistance. Using a gene array strategy comparing microRNA expression profiles of MCF-7 to MCF-7/HER2 Delta 16 cells, we found that expression of HER2 Delta 16 significantly altered expression of 16 microRNAs by 2-fold or more including a 4.8 fold suppression of the miR-7 tumor suppressor. Reestablished expression of miR-7 in the MCF-7/HER2 Delta 16 cell line caused a G1 cell cycle arrest and reduced both colony formation and cell migration activity to levels of parental MCF-7 cells. Suppression of miR-7 in the MCF-7 cell line resulted in enhanced colony formation activity but not cell migration, indicating that miR-7 suppression is sufficient to drive tumor cell proliferation but not migration. MiR-7 inhibited MCF-7/HER2 Delta 16 Delta cell migration through a mechanism involving suppression of the miR-7 target gene EGFR. In contrast, miR-7 inhibition of MCF-7/HER2 Delta 16 cell proliferation involved a pathway where miR-7 expression resulted in the inactivation of Src kinase independent of suppressed EGFR expression. Also independent of EGFR suppression, reestablished miR-7 expression sensitized refractory MCF-7/HER2 Delta 16 cells to trastuzumab. Our results demonstrate that reestablished miR-7 expression abolishes HER2 Delta 16 induced cell proliferation and migration while sensitizing HER2 Delta 16 expressing cells to trastuzumab therapy. We propose that miR-7 regulated pathways, including EGFR and Src kinase, represent targets for the therapeutic intervention of refractory and metastatic HER2 Delta 16 driven breast cancer.	[Huynh, Felicia C.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Jones, Frank E.] Tulane Univ, Tulane Canc Ctr, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	Tulane University; Tulane University	Jones, FE (corresponding author), Tulane Univ, Tulane Canc Ctr, Dept Cell & Mol Biol, New Orleans, LA 70118 USA.	fjones3@tulane.edu						Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Barrett A, 2002, INT J CANCER, V101, P581, DOI 10.1002/ijc.10644; Barrett A, 2007, INT J CANCER, V121, P265, DOI 10.1002/ijc.22673; Cittelly DM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-317; Cittelly DM, 2010, ONCOGENIC HER2DELTA1; DiGiovanna MP, 2005, J CLIN ONCOL, V23, P1152, DOI 10.1200/JCO.2005.09.055; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kong XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041523, 10.1371/journal.pone.0033381]; Mitra D., 2010, J BIOL CHEM, V286, P40531; Mitra D, 2009, MOL CANCER THER, V8, P2152, DOI 10.1158/1535-7163.MCT-09-0295; Naresh A, 2008, CANCER RES, V68, P6387, DOI 10.1158/0008-5472.CAN-08-0538; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Pencheva N, 2013, NAT CELL BIOL, V15, P546, DOI 10.1038/ncb2769; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sanchez N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065671; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sridhar J, 2014, BIOORG MED CHEM LETT, V24, P126, DOI 10.1016/j.bmcl.2013.11.064; Thor AD, 2000, J CLIN ONCOL, V18, P3230, DOI 10.1200/JCO.2000.18.18.3230; Verghese ET, 2008, J PATHOL, V215, P214, DOI 10.1002/path.2359; Wang H, 2012, PLOS ONE, V7, P34210, DOI DOI 10.1371/J0URNAL.P0NE.0034210; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Yamamoto S, 2014, CANCER CELL, V25, P762, DOI 10.1016/j.ccr.2014.04.024; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337	32	42	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114419	10.1371/journal.pone.0114419	http://dx.doi.org/10.1371/journal.pone.0114419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532106	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100015
J	Chaires, JB; Trent, JO; Gray, RD; Dean, WL; Buscaglia, R; Thomas, SD; Miller, DM				Chaires, Jonathan B.; Trent, John O.; Gray, Robert D.; Dean, William L.; Buscaglia, Robert; Thomas, Shelia D.; Miller, Donald M.			An Improved Model for the hTERT Promoter Quadruplex	PLOS ONE			English	Article							TELOMERIC DNA; CORE PROMOTER; MUTATIONS; CANCER; REGION; SEQUENCE; CELLS; ACID; TRANSCRIPTION; MELANOMA	Mutations occur at four specific sites in the hTERT promoter in >75% of glioblastomas and melanomas, but the mechanism by which the mutations affect gene expression remains unexplained. We report biophysical computational studies that show that the hTERT promoter sequence forms a novel G-quadruplex structure consisting of three contiguous, stacked parallel quadruplexes. The reported hTERT mutations map to the central quadruplex within this structure, and lead to an alteration of its hydrodynamic properties and stability.	[Chaires, Jonathan B.; Trent, John O.; Gray, Robert D.; Dean, William L.; Buscaglia, Robert; Thomas, Shelia D.; Miller, Donald M.] Univ Louisville, James Graham Brown Canc Ctr, Dept Med, Louisville, KY 40292 USA	University of Louisville	Chaires, JB (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Dept Med, Louisville, KY 40292 USA.	j.chaires@louisville.edu		Chaires, Jonathan/0000-0001-5477-945X; trent, John/0000-0002-7346-4231	NIH [CA35635, GM077422, 1P30GM106396-01]; James Graham Brown Foundation; NATIONAL CANCER INSTITUTE [R01CA035635] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077422, P30GM106396] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James Graham Brown Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants CA35635 (JBC), GM077422 (JBC & JOT) and 1P30GM106396-01 (DMM) and by the James Graham Brown Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Corey DR, 2009, CHEM BIOL, V16, P1219, DOI 10.1016/j.chembiol.2009.12.001; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; Dailey MM, 2010, NUCLEIC ACIDS RES, V38, P4877, DOI 10.1093/nar/gkq166; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Jameson D. M., 2014, INTRO FLUORESCENCE; Kan ZY, 2007, NUCL ACIDS RES; Karsisiotis AI, 2011, ANGEW CHEM INT EDIT, V50, P10645, DOI 10.1002/anie.201105193; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Le HT, 2013, TOP CURR CHEM, V330, P179, DOI 10.1007/128_2012_351; Lim KW, 2010, J AM CHEM SOC, V132, P12331, DOI 10.1021/ja101252n; Micheli E, 2010, BIOPHYS CHEM, V153, P43, DOI 10.1016/j.bpc.2010.10.003; Montanaro L, 1979, Methods Enzymol, V60, P712; MURCHIE AIH, 1992, NUCLEIC ACIDS RES, V20, P49, DOI 10.1093/nar/20.1.49; Neidle S, 2003, CURR OPIN STRUC BIOL, V13, P275, DOI 10.1016/S0959-440X(03)00072-1; Nygren J, 1998, BIOPOLYMERS, V46, P39, DOI 10.1002/(SICI)1097-0282(199807)46:1<39::AID-BIP4>3.0.CO;2-Z; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Palumbo SL, 2008, NUCL ACIDS RES; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Petraccone L, 2008, J AM CHEM SOC, V130, P16530, DOI 10.1021/ja8075567; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shay JW, 2008, BRIT J CANCER, V98, P677, DOI 10.1038/sj.bjc.6604209; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Xing MZ, 2014, J CLIN ONCOL, V32, P2718, DOI 10.1200/JCO.2014.55.5094; Xu Y, 2013, CHEMBIOCHEM, V14, P927, DOI 10.1002/cbic.201300157	40	41	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115580	10.1371/journal.pone.0115580	http://dx.doi.org/10.1371/journal.pone.0115580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526084	Green Submitted, gold, Green Published			2022-12-26	WOS:000347186200037
J	Rodriguez-Navarro, DN; Rodriguez-Carvajal, MA; Acosta-Jurado, S; Soto, MJ; Margaret, I; Crespo-Rivas, JC; Sanjuan, J; Temprano, F; Gil-Serrano, A; Ruiz-Sainz, JE; Vinardell, JM				Rodriguez-Navarro, Dulce N.; Rodriguez-Carvajal, Miguel A.; Acosta-Jurado, Sebastian; Soto, Maria J.; Margaret, Isabel; Crespo-Rivas, Juan C.; Sanjuan, Juan; Temprano, Francisco; Gil-Serrano, Antonio; Ruiz-Sainz, Jose E.; Vinardell, Jose M.			Structure and Biological Roles of Sinorhizobium fredii HH103 Exopolysaccharide	PLOS ONE			English	Article							FAST-GROWING RHIZOBIA; SP STRAIN NGR234; BRADYRHIZOBIUM-JAPONICUM; SYMBIOTIC PROPERTIES; BIOFILM FORMATION; EXOB MUTANTS; EXTRACELLULAR POLYSACCHARIDES; SURFACE POLYSACCHARIDE; LEUCAENA-LEUCOCEPHALA; ROOT-NODULES	Here we report that the structure of the Sinorhizobium fredii HH103 exopolysaccharide (EPS) is composed of glucose, galactose, glucuronic acid, pyruvic acid, in the ratios 5:2:2:1 and is partially acetylated. A S. fredii HH103 exoA mutant (SVQ530), unable to produce EPS, not only forms nitrogen fixing nodules with soybean but also shows increased competitive capacity for nodule occupancy. Mutant SVQ530 is, however, less competitive to nodulate Vigna unguiculata. Biofilm formation was reduced in mutant SVQ530 but increased in an EPS overproducing mutant. Mutant SVQ530 was impaired in surface motility and showed higher osmosensitivity compared to its wild type strain in media containing 50 mM NaCl or 5% (w/v) sucrose. Neither S. fredii HH103 nor 41 other S. fredii strains were recognized by soybean lectin (SBL). S. fredii HH103 mutants affected in exopolysaccharides (EPS), lipopolysaccharides (LPS), cyclic glucans (CG) or capsular polysaccharides (KPS) were not significantly impaired in their soybean-root attachment capacity, suggesting that these surface polysaccharides might not be relevant in early attachment to soybean roots. These results also indicate that the molecular mechanisms involved in S. fredii attachment to soybean roots might be different to those operating in Bradyrhizobium japonicum.	[Rodriguez-Navarro, Dulce N.; Temprano, Francisco] Ctr Torres Tomejil, IFAPA, Alcala Del Rio, Sevilla, Spain; [Rodriguez-Carvajal, Miguel A.; Gil-Serrano, Antonio] Univ Seville, Fac Quim, Dept Quim Organ, E-41012 Seville, Spain; [Acosta-Jurado, Sebastian; Margaret, Isabel; Crespo-Rivas, Juan C.; Ruiz-Sainz, Jose E.; Vinardell, Jose M.] Univ Seville, Dept Microbiol, Fac Biol, Seville, Spain; [Soto, Maria J.; Sanjuan, Juan] CSIC, Dept Microbiol Suelo & Sistemas Simbiot, Estn Expt Zaidin, Granada, Spain	University of Sevilla; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Vinardell, JM (corresponding author), Univ Seville, Dept Microbiol, Fac Biol, Seville, Spain.	jvinar@us.es	Gil-Serrano, Antonio M/L-2002-2014; Soto, Maria Jose/O-3406-2014; Vinardell, José M/H-5355-2013; Carvajal, Miguel Ángel Rodríguez/F-2577-2012; Jurado, Sebastián Acosta/ABH-3676-2020; Oliver, Isabel Maria Margaret/J-8663-2016	Gil-Serrano, Antonio M/0000-0001-9503-0891; Soto, Maria Jose/0000-0003-2045-7238; Vinardell, José M/0000-0002-7105-5389; Carvajal, Miguel Ángel Rodríguez/0000-0002-2131-6448; Sanjuan, Juan/0000-0002-6404-8754; Margaret Oliver, Isabel Maria/0000-0001-8770-1309; Acosta Jurado, Sebastian/0000-0002-5505-2508	Andalusia Government [P07-CVI-02506]; Spanish Ministry of Science and Innovation [BIO2010-18005, BIO2011-30229-C02-01, AGL2009-13487-C04-02]; European Regional Development Fund (FEDER)	Andalusia Government; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund (FEDER)(European Commission)	This work was supported by grants from the Andalusia Government (P07-CVI-02506) and the Spanish Ministry of Science and Innovation (BIO2010-18005, BIO2011-30229-C02-01, AGL2009-13487-C04-02). The authors also thank the European Regional Development Fund (FEDER) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca-Grau AM, 2012, APPL ENVIRON MICROB, V78, P1644, DOI 10.1128/AEM.07117-11; Albareda M, 2006, FEMS MICROBIOL LETT, V259, P67, DOI 10.1111/j.1574-6968.2006.00244.x; AN JH, 1995, CARBOHYD RES, V269, P303, DOI 10.1016/0008-6215(94)00361-I; BECKER A, 1998, RHIZOBIACEAE MOL BIO; Becker A, 2005, MOL PLANT MICROBE IN, V18, P899, DOI 10.1094/MPMI-18-0899; Becker BU, 1998, MOL GEN GENET, V259, P161, DOI 10.1007/s004380050801; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bianciotto V, 2001, MOL PLANT MICROBE IN, V14, P255, DOI 10.1094/MPMI.2001.14.2.255; BORTHAKUR D, 1988, MOL GEN GENET, V213, P155, DOI 10.1007/BF00333413; BORTHAKUR D, 1986, MOL GEN GENET, V203, P320, DOI 10.1007/BF00333974; BUENDIACLAVERIA AM, 1994, SYST APPL MICROBIOL, V17, P155, DOI 10.1016/S0723-2020(11)80001-9; CHAPLIN MF, 1982, ANAL BIOCHEM, V123, P336, DOI 10.1016/0003-2697(82)90455-9; Chataigne G, 2008, J CHROMATOGR A, V1185, P241, DOI 10.1016/j.chroma.2008.01.065; Ciucanu I, 2003, J AM CHEM SOC, V125, P16213, DOI 10.1021/ja035660t; Crespo-Rivas JC, 2009, MOL PLANT MICROBE IN, V22, P575, DOI 10.1094/MPMI-22-5-0575; D'Haeze W, 2004, MOL MICROBIOL, V52, P485, DOI 10.1111/j.1365-2958.2004.03989.x; de Cordoba FJF, 2008, BIOMACROMOLECULES, V9, P678, DOI 10.1021/bm701011d; Den Herder G, 2009, CURR OPIN PLANT BIOL, V12, P491, DOI 10.1016/j.pbi.2009.05.010; DIEBOLD R, 1989, J BACTERIOL, V171, P4821, DOI 10.1128/jb.171.9.4821-4830.1989; DJORDJEVIC SP, 1986, CARBOHYD RES, V148, P87, DOI 10.1016/0008-6215(86)80039-8; DJORDJEVIC SP, 1987, J BACTERIOL, V169, P53, DOI 10.1128/jb.169.1.53-60.1987; Dominguez-Ferreras A, 2006, J BACTERIOL, V188, P7617, DOI 10.1128/JB.00719-06; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; DYLAN T, 1990, J BACTERIOL, V172, P1409, DOI 10.1128/jb.172.3.1409-1417.1990; Faure R, 2006, J ORG CHEM, V71, P5151, DOI 10.1021/jo0525682; Ferguson GP, 2002, J BACTERIOL, V184, P5625, DOI 10.1128/JB.184.20.5625-5632.2002; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; FRIEDMAN AM, 1982, GENE, V18, P289, DOI 10.1016/0378-1119(82)90167-6; Fujishige NA, 2006, FEMS MICROBIOL ECOL, V56, P195, DOI 10.1111/j.1574-6941.2005.00044.x; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Gao MS, 2010, MOL PLANT MICROBE IN, V23, P355, DOI 10.1094/MPMI-23-4-0355; Gay-Fraret J, 2012, FEMS MICROBIOL LETT, V333, P28, DOI 10.1111/j.1574-6968.2012.02595.x; GERWIG GJ, 1978, CARBOHYD RES, V62, P349, DOI 10.1016/S0008-6215(00)80881-2; Gil-Serrano AM, 1999, BIOCHEM J, V342, P527, DOI 10.1042/0264-6021:3420527; Goddard TD, 1993, SPARKY 3; Gossmann JA, 2012, NEW PHYTOL, V196, P561, DOI 10.1111/j.1469-8137.2012.04281.x; GRAY JX, 1991, J BACTERIOL, V173, P3066, DOI 10.1128/JB.173.10.3066-3077.1991; Ramirez-Bahena MH, 2009, INT J SYST EVOL MICR, V59, P1929, DOI 10.1099/ijs.0.006320-0; HER GR, 1990, CARBOHYD RES, V198, P305, DOI 10.1016/0008-6215(90)84300-J; Hidalgo A, 2010, MICROBIOL-SGM, V156, P3398, DOI 10.1099/mic.0.042499-0; Hotter GS, 1997, ARCH MICROBIOL, V167, P182, DOI 10.1007/s002030050433; HOTTER GS, 1991, J BACTERIOL, V173, P851, DOI 10.1128/jb.173.2.851-859.1991; HUBER TA, 1984, J BACTERIOL, V158, P1168, DOI 10.1128/JB.158.3.1168-1171.1984; Quelas JI, 2010, MOL PLANT MICROBE IN, V23, P1592, DOI 10.1094/MPMI-05-10-0122; IVASHINA TV, 1994, GENE, V150, P111, DOI 10.1016/0378-1119(94)90868-0; Janczarek M, 2011, INT J MOL SCI, V12, P7898, DOI 10.3390/ijms12117898; Janczarek M, 2009, ANTON LEEUW INT J G, V96, P471, DOI 10.1007/s10482-009-9362-3; JANSSON PE, 1993, ACTA CHEM SCAND, V47, P711, DOI 10.3891/acta.chem.scand.47-0711; Jarabo-Lorenzo A, 2003, SYST APPL MICROBIOL, V26, P611, DOI 10.1078/072320203770865927; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Jones KM, 2012, J BACTERIOL, V194, P4322, DOI 10.1128/JB.00751-12; Kelly SJ, 2013, MOL PLANT MICROBE IN, V26, P319, DOI 10.1094/MPMI-09-12-0227-R; KEYSER HH, 1982, SCIENCE, V215, P1631, DOI 10.1126/science.215.4540.1631; Kim JS, 2006, CARBOHYD RES, V341, P1061, DOI 10.1016/j.carres.2006.03.008; Krol Elizaveta, 2009, P189; LAU JM, 1987, CARBOHYD RES, V168, P219, DOI 10.1016/0008-6215(87)80028-9; Laus MC, 2006, MOL MICROBIOL, V59, P1704, DOI 10.1111/j.1365-2958.2006.05057.x; LIANG R, 1987, ANAL BIOCHEM, V164, P488, DOI 10.1016/0003-2697(87)90523-9; Lindberg B., 1975, ADV CARBOHYD CHEM BI, V31, P185, DOI [10.1016/s0065-2318(08)60297-8, DOI 10.1016/S0065-2318(08)60297-8]; Madinabeitia N, 2002, MOL PLANT MICROBE IN, V15, P150, DOI 10.1094/MPMI.2002.15.2.150; Margaret I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074717; Margaret I, 2012, MOL PLANT MICROBE IN, V25, P825, DOI 10.1094/MPMI-10-11-0262; Margaret I, 2011, J BIOTECHNOL, V155, P11, DOI 10.1016/j.jbiotec.2011.03.016; Margaret-Oliver I, 2012, ARCH MICROBIOL, V194, P87, DOI 10.1007/s00203-011-0729-2; Nogales J, 2012, J BACTERIOL, V194, P2027, DOI 10.1128/JB.06524-11; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Parada M, 2006, MOL PLANT MICROBE IN, V19, P43, DOI 10.1094/MPMI-19-0043; Parella T, 2004, PULSE PROGRAM CATALO; PARNISKE M, 1994, MOL PLANT MICROBE IN, V7, P631, DOI 10.1094/MPMI-7-0631; PARNISKE M, 1993, MOL PLANT MICROBE IN, V6, P99, DOI 10.1094/MPMI-6-099; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; PUTNOKY P, 1990, J BACTERIOL, V172, P5450, DOI 10.1128/jb.172.9.5450-5458.1990; REINHOLD BB, 1994, J BACTERIOL, V176, P1997, DOI 10.1128/jb.176.7.1997-2002.1994; REUBER TL, 1993, CELL, V74, P269, DOI 10.1016/0092-8674(93)90418-P; REUHS BL, 1993, J BACTERIOL, V175, P3570, DOI 10.1128/jb.175.11.3570-3580.1993; REUHS BL, 1995, J BACTERIOL, V177, P4289, DOI 10.1128/jb.177.15.4289-4296.1995; RIGAUD J, 1975, J GEN MICROBIOL, V88, P223, DOI 10.1099/00221287-88-2-223; Rinaudi LV, 2010, FEMS MICROBIOL LETT, V304, P1, DOI 10.1111/j.1574-6968.2009.01840.x; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Rodriguez-Carvajal MA, 2008, CARBOHYD RES, V343, P3066, DOI 10.1016/j.carres.2008.08.028; Rodriguez-Navarro DN, 2007, FEMS MICROBIOL LETT, V272, P127, DOI 10.1111/j.1574-6968.2007.00761.x; Roslund MU, 2011, CARBOHYD RES, V346, P1311, DOI 10.1016/j.carres.2011.04.033; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sassaki GL, 2005, CARBOHYD RES, V340, P731, DOI 10.1016/j.carres.2005.01.020; SIMON R, 1984, MOL GEN GENET, V196, P413, DOI 10.1007/BF00436188; Skorupska A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-7; Soto MJ, 2006, MICROBIOL-SGM, V152, P3167, DOI 10.1099/mic.0.29112-0; Staehelin C, 2006, J BACTERIOL, V188, P6168, DOI 10.1128/JB.00365-06; Thomas-Oates J, 2003, SYST APPL MICROBIOL, V26, P453, DOI 10.1078/072320203322497491; TRINICK MJ, 1980, J APPL BACTERIOL, V49, P39, DOI 10.1111/j.1365-2672.1980.tb01042.x; Vanderlinde EM, 2010, FEMS MICROBIOL ECOL, V71, P327, DOI 10.1111/j.1574-6941.2009.00824.x; vanWorkum WAT, 1997, MOL PLANT MICROBE IN, V10, P290, DOI 10.1094/MPMI.1997.10.2.290; Vinardell JM, 2004, MOL PLANT MICROBE IN, V17, P676, DOI 10.1094/MPMI.2004.17.6.676; Vinardell JM, 2004, ARCH MICROBIOL, V181, P144, DOI 10.1007/s00203-003-0635-3; Vincent JM, 1970, MANUAL PRACTICAL STU, P144; Weidner S, 2012, J BACTERIOL, V194, P1617, DOI 10.1128/JB.06729-11; XU LM, 1995, INT J SYST BACTERIOL, V45, P706, DOI 10.1099/00207713-45-4-706; Yang SS, 2001, J BIOTECHNOL, V91, P243, DOI 10.1016/S0168-1656(01)00340-6	99	30	30	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115391	10.1371/journal.pone.0115391	http://dx.doi.org/10.1371/journal.pone.0115391			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521500	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845600041
J	Clifton, MC; Simon, MJ; Erramilli, SK; Zhang, HD; Zaitseva, J; Hermodson, MA; Stauffacher, CV				Clifton, Matthew C.; Simon, Michael J.; Erramilli, Satchal K.; Zhang, Huide; Zaitseva, Jelena; Hermodson, Mark A.; Stauffacher, Cynthia V.			In Vitro Reassembly of the Ribose ATP-binding Cassette Transporter Reveals a Distinct Set of Transport Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG ABC TRANSPORTER; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; INWARD-FACING CONFORMATION; COLI MALTOSE TRANSPORTER; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BTUCD-F; AMP-PNP; ALTERNATING ACCESS	Bacterial ATP-binding cassette (ABC) importers are primary active transporters that are critical for nutrient uptake. Based on structural and functional studies, ABC importers can be divided into two distinct classes, type I and type II. Type I importers follow a strict alternating access mechanism that is driven by the presence of the substrate. Type II importers accept substrates in a nucleotide-free state, with hydrolysis driving an inward facing conformation. The ribose transporter in Escherichia coli is a tripartite complex consisting of a cytoplasmic ATP-binding cassette protein, RbsA, with fused nucleotide binding domains; a transmembrane domain homodimer, RbsC,; and a periplasmic substrate binding protein, RbsB. To investigate the transport mechanism of the complex RbsABC(2) we probed intersubunit interactions by varying the presence of the substrate ribose and the hydrolysis cofactors, ATP/ADP and Mg2+ We were able to purify a full complex, RbsABC(2), in the presence of stable, transition state mimics (ATP, Mg2+, and VO4); a RbsAC complex in the presence of ADP and Mg2+; and a heretofore unobserved RbsBC complex in the absence of cofactors. The presence of excess ribose also destabilized complex formation between RbsB and RbsC. These observations suggest that RbsABC(2), shares functional traits with both type land type II importers, as well as possessing unique features, and employs a distinct mechanism relative to other ABC transporters.	[Clifton, Matthew C.; Simon, Michael J.; Erramilli, Satchal K.; Stauffacher, Cynthia V.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Clifton, Matthew C.; Simon, Michael J.; Erramilli, Satchal K.; Stauffacher, Cynthia V.] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; [Zhang, Huide; Zaitseva, Jelena; Hermodson, Mark A.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Stauffacher, CV (corresponding author), Purdue Univ, Dept Biol Sci, Hockmeyer Hall,240 S Martin Jischke Dr, W Lafayette, IN 47907 USA.	cstauffa@purdue.edu		Erramilli, Satchal/0000-0001-8694-7681	National Institutes of Health Cancer Center Core Grant [CA23168]; National Institutes of Health Biophysics Training Grant [T32-GM008296]; National Institutes of Health Public Health Service Grants [GM54993, GM64676]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008296, P01GM064676, R01GM054993] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Biophysics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Public Health Service Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Cancer Center Core Grant CA23168, Biophysics Training Grant T32-GM008296, and Public Health Service Grants GM54993 and GM64676.	Ames GFL, 2001, J BIOENERG BIOMEMBR, V33, P79, DOI 10.1023/A:1010797029183; [Anonymous], 1996, CIRCULAR DICHROISM C; Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200; Barroga CF, 1996, PROTEIN SCI, V5, P1093; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; BINNIE RA, 1992, PROTEIN SCI, V1, P1642, DOI 10.1002/pro.5560011212; Bjorkman AJ, 1998, J MOL BIOL, V279, P651, DOI 10.1006/jmbi.1998.1785; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; BUCKEL SD, 1986, J BIOL CHEM, V261, P7659; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Chen J, 2013, CURR OPIN STRUC BIOL, V23, P492, DOI 10.1016/j.sbi.2013.03.011; Chen SS, 2013, NATURE, V499, P364, DOI 10.1038/nature12232; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dietrich D, 2009, MOL BIOL CELL, V20, P530, DOI 10.1091/mbc.E08-07-0745; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Findley J. B. C., 1987, BIOL MEMBRANES PRACT, P219; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Greller G, 2001, EUR J BIOCHEM, V268, P4011, DOI 10.1046/j.1432-1327.2001.02313.x; Hohl M, 2014, P NATL ACAD SCI USA, V111, P11025, DOI 10.1073/pnas.1400485111; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Holland I. B., 2003, ABC PROTEINS BACTERI, P147; HOPE JN, 1986, J BIOL CHEM, V261, P7663; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Joseph B, 2011, J BIOL CHEM, V286, P41008, DOI 10.1074/jbc.M111.269472; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Korkhov VM, 2014, NAT STRUCT MOL BIOL, V21, P1097, DOI 10.1038/nsmb.2918; Korkhov VM, 2012, NATURE, V490, P367, DOI 10.1038/nature11442; Landmesser H, 2002, BBA-BIOMEMBRANES, V1565, P64, DOI 10.1016/S0005-2736(02)00506-0; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; Liu PQ, 1998, P NATL ACAD SCI USA, V95, P3495, DOI 10.1073/pnas.95.7.3495; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mishra S, 2014, ELIFE, V3, DOI 10.7554/eLife.02740; MOWBRAY SL, 1992, J MOL BIOL, V225, P155, DOI 10.1016/0022-2836(92)91033-L; Narayanan A, 2011, PROTEIN SCI, V20, P51, DOI 10.1002/pro.535; Newstead S, 2009, STRUCTURE, V17, P1213, DOI 10.1016/j.str.2009.07.009; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Park Y, 1999, J BACTERIOL, V181, P1039, DOI 10.1128/JB.181.3.1039-1042.1999; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rice AJ, 2014, CRIT REV BIOCHEM MOL, V49, P426, DOI 10.3109/10409238.2014.953626; Rice AJ, 2013, J BIOL CHEM, V288, P21228, DOI 10.1074/jbc.M113.483495; Scheffel F, 2004, BBA-BIOENERGETICS, V1656, P57, DOI 10.1016/j.bbabio.2004.01.005; Sharma S, 2005, J BACTERIOL, V187, P2908, DOI 10.1128/JB.187.8.2908-2911.2005; Slotboom DJ, 2014, NAT REV MICROBIOL, V12, P79, DOI 10.1038/nrmicro3175; Stewart JB, 2003, J BACTERIOL, V185, P5234, DOI 10.1128/JB.185.17.5234-5239.2003; TEETERS CL, 1987, BIOPHYS J, V51, P527, DOI 10.1016/S0006-3495(87)83378-7; Tirado-Lee L, 2011, STRUCTURE, V19, P1701, DOI 10.1016/j.str.2011.10.004; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vigonsky E, 2013, P NATL ACAD SCI USA, V110, P5440, DOI 10.1073/pnas.1213598110; WALLACE BA, 1987, BIOCHEMISTRY-US, V26, P65, DOI 10.1021/bi00375a010; WALLACE BA, 1984, ANAL BIOCHEM, V142, P317, DOI 10.1016/0003-2697(84)90471-8; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114; WILLIS RC, 1974, J BIOL CHEM, V249, P6926; Woo JS, 2012, NAT STRUCT MOL BIOL, V19, P1310, DOI 10.1038/nsmb.2417; Zaitseva J, 1996, PROTEIN SCI, V5, P1100; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622	77	8	12	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5555	5565		10.1074/jbc.M114.621573	http://dx.doi.org/10.1074/jbc.M114.621573			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25533465	Green Published, hybrid			2022-12-26	WOS:000350044200027
J	Jepsen, MR; Kloverpris, S; Mikkelsen, JH; Pedersen, JH; Fuchtbauer, EM; Laursen, LS; Oxvig, C				Jepsen, Malene R.; Kloverpris, Soren; Mikkelsen, Jakob H.; Pedersen, Josefine H.; Fuchtbauer, Ernst-Martin; Laursen, Lisbeth S.; Oxvig, Claus			Stanniocalcin-2 Inhibits Mammalian Growth by Proteolytic Inhibition of the Insulin-like Growth Factor Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-PROTEIN-A; IGF BINDING PROTEIN-4; PAPP-A; SUBSTRATE-SPECIFICITY; NEGATIVE REGULATOR; MICE DEFICIENT; EXPRESSION; GENE; OVEREXPRESSION; IDENTIFICATION	Mammalian stanniocalcin-2 (STC2) is a secreted polypeptide widely expressed in developing and adult tissues. However, although transgenic expression in mice is known to cause severe dwarfism, and targeted deletion of STC2 causes increased postnatal growth, its precise biological role is still unknown. We found that STC2 potently inhibits the proteolytic activity of the growth-promoting metalloproteinase, pregnancy-associated plasma protein-A (PAPP-A). Proteolytic inhibition requires covalent binding of STC2 to PAPP-A and is mediated by a disulfide bond, which involves Cys-120 of STC2. Binding of STC2 prevents PAPP-A cleavage of insulin-like growth factor-binding protein (IGFBP)-4 and hence release within tissues of bioactive IGF, required for normal growth. Concordantly, we show that STC2 efficiently inhibits PAPP-A-mediated IGF receptor signaling in vitro and that transgenic mice expressing a mutated variant of STC2, STC2(C120A), which is unable to inhibit PAPP-A, grow like wild-type mice. Our work identifies STC2 as a novel proteinase inhibitor and a previously unrecognized extracellular component of the IGF system.	[Jepsen, Malene R.; Kloverpris, Soren; Mikkelsen, Jakob H.; Pedersen, Josefine H.; Fuchtbauer, Ernst-Martin; Laursen, Lisbeth S.; Oxvig, Claus] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark	Aarhus University	Oxvig, C (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark.	co@mbg.au.dk		Laursen, Lisbeth Schmidt/0000-0002-8676-5869; Mikkelsen, Jakob Hauge/0000-0002-2914-3297; Jepsen, Malene/0000-0003-1959-5019; Oxvig, Claus/0000-0002-4715-9719	Lundbeck Foundation; Novo Nordisk Foundation; Danish Council for Independent Research (Medical Sciences); Danish Genetically Modified Animal Resource	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Danish Genetically Modified Animal Resource	This work was supported by grants from the Lundbeck Foundation, the Novo Nordisk Foundation, the Danish Council for Independent Research (Medical Sciences), and the Danish Genetically Modified Animal Resource.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Bale LK, 2005, J ENDOCRINOL, V186, P325, DOI 10.1677/joe.1.06259; Bayes-Genis A, 2001, NEW ENGL J MED, V345, P1022, DOI 10.1056/NEJMoa003147; Boldt HB, 2004, J BIOL CHEM, V279, P38525, DOI 10.1074/jbc.M405222200; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; Cerda-Costa N, 2014, PROTEIN SCI, V23, P123, DOI 10.1002/pro.2400; Chang ACM, 2005, MOL CELL BIOL, V25, P10604, DOI 10.1128/MCB.25.23.10604-10610.2005; Chang ACM, 2003, ENDOCR-RELAT CANCER, V10, P359, DOI 10.1677/erc.0.0100359; Chang ACM, 1998, MOL CELL ENDOCRINOL, V141, P95, DOI 10.1016/S0303-7207(98)00097-5; Chang ACM, 2008, ENDOCRINOLOGY, V149, P2403, DOI 10.1210/en.2007-1219; Conover CA, 2004, DEVELOPMENT, V131, P1187, DOI 10.1242/dev.00997; Conover CA, 2011, ENDOCRINOLOGY, V152, P2837, DOI 10.1210/en.2011-0036; Conover CA, 2010, J GERONTOL A-BIOL, V65, P590, DOI 10.1093/gerona/glq032; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; Gagliardi AD, 2005, AM J PHYSIOL-ENDOC M, V288, pE92, DOI 10.1152/ajpendo.00268.2004; Gerard N, 2004, J ENDOCRINOL, V182, P457, DOI 10.1677/joe.0.1820457; Gerritsen ME, 2005, VITAM HORM, V70, P105, DOI 10.1016/S0083-6729(05)70004-2; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gyrup C, 2007, BIOCHEMISTRY-US, V46, P1972, DOI 10.1021/bi062229i; Harrington SC, 2007, CIRC RES, V100, P1696, DOI 10.1161/CIRCRESAHA.106.146183; Joensuu K, 2008, CANCER LETT, V265, P76, DOI 10.1016/j.canlet.2008.02.022; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67; Laursen LS, 2007, MOL ENDOCRINOL, V21, P1246, DOI 10.1210/me.2006-0522; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Laursen LS, 2002, BIOCHEM J, V367, P31, DOI 10.1042/BJ20020831; Laursen LS, 2001, FEBS LETT, V504, P36, DOI 10.1016/S0014-5793(01)02760-0; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; Mader JR, 2013, J ENDOCRINOL, V219, P51, DOI 10.1530/JOE-13-0167; Mikkelsen JH, 2014, ONCOTARGET, V5, P1014, DOI 10.18632/oncotarget.1629; Mikkelsen JH, 2014, J IMMUNOL METHODS, V404, P33, DOI 10.1016/j.jim.2013.12.002; Ning Y, 2008, MOL ENDOCRINOL, V22, P1213, DOI 10.1210/me.2007-0536; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Olsen HS, 1996, P NATL ACAD SCI USA, V93, P1792, DOI 10.1073/pnas.93.5.1792; Overgaard MT, 2000, J BIOL CHEM, V275, P31128, DOI 10.1074/jbc.M001384200; Overgaard MT, 2001, J BIOL CHEM, V276, P21849, DOI 10.1074/jbc.M102191200; OXVIG C, 1994, BBA-GEN SUBJECTS, V1201, P415, DOI 10.1016/0304-4165(94)90071-X; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Qin XZ, 2006, ENDOCRINOLOGY, V147, P5653, DOI 10.1210/en.2006-1055; Rehage M, 2007, ENDOCRINOLOGY, V148, P6176, DOI 10.1210/en.2007-0274; Rimbault M, 2013, GENOME RES, V23, P1985, DOI 10.1101/gr.157339.113; Schoenebeck JJ, 2014, ANNU REV CELL DEV BI, V30, P535, DOI 10.1146/annurev-cellbio-100913-012927; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Smith GCS, 2002, NATURE, V417, P916, DOI 10.1038/417916a; Soe R, 2002, EUR J BIOCHEM, V269, P2247, DOI 10.1046/j.1432-1033.2002.02883.x; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Trindade DM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-57; Varghese R, 2002, ENDOCRINOLOGY, V143, P868, DOI 10.1210/en.143.3.868; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; Weyer K, 2007, J BIOL CHEM, V282, P10988, DOI 10.1074/jbc.M607903200; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yeung BHY, 2012, MOL CELL ENDOCRINOL, V349, P272, DOI 10.1016/j.mce.2011.11.007	55	85	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3430	3439		10.1074/jbc.M114.611665	http://dx.doi.org/10.1074/jbc.M114.611665			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533459	Green Published, hybrid			2022-12-26	WOS:000349456000019
J	May, T; Ozden, I; Brush, B; Borton, D; Wagner, F; Agha, N; Sheinberg, DL; Nurmikko, AV				May, Travis; Ozden, Ilker; Brush, Benjamin; Borton, David; Wagner, Fabien; Agha, Naubahar; Sheinberg, David L.; Nurmikko, Arto V.			Detection of Optogenetic Stimulation in Somatosensory Cortex by Non-Human Primates - Towards Artificial Tactile Sensation	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; CORTICAL-NEURONS; NEURAL CIRCUITS; MICROSTIMULATION; DISCRIMINATION; ACTIVATION; MOTOR; INFORMATION; POPULATIONS; BEHAVIOR	Neuroprosthesis research aims to enable communication between the brain and external assistive devices while restoring lost functionality such as occurs from stroke, spinal cord injury or neurodegenerative diseases. In future closed-loop sensorimotor prostheses, one approach is to use neuromodulation as direct stimulus to the brain to compensate for a lost sensory function and help the brain to integrate relevant information for commanding external devices via, e.g. movement intention. Current neuromodulation techniques rely mainly of electrical stimulation. Here we focus specifically on the question of eliciting a biomimetically relevant sense of touch by direct stimulus of the somatosensory cortex by introducing optogenetic techniques as an alternative to electrical stimulation. We demonstrate that light activated opsins can be introduced to target neurons in the somatosensory cortex of non-human primates and be optically activated to create a reliably detected sensation which the animal learns to interpret as a tactile sensation localized within the hand. The accomplishment highlighted here shows how optical stimulation of a relatively small group of mostly excitatory somatosensory neurons in the nonhuman primate brain is sufficient for eliciting a useful sensation from data acquired by simultaneous electrophysiology and from behavioral metrics. In this first report to date on optically neuromodulated behavior in the somatosensory cortex of nonhuman primates we do not yet dissect the details of the sensation the animals exerience or contrast it to those evoked by electrical stimulation, issues of considerable future interest.	[May, Travis; Ozden, Ilker; Brush, Benjamin; Borton, David; Agha, Naubahar; Nurmikko, Arto V.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Borton, David] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Ctr Neuroprosthet, CH-1015 Lausanne, Switzerland; [Wagner, Fabien; Sheinberg, David L.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Nurmikko, Arto V.] Brown Univ, Dept Phys, Providence, RI 02912 USA	Brown University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Brown University; Brown University	Nurmikko, AV (corresponding author), Brown Univ, Sch Engn, Providence, RI 02912 USA.	Arto_Nurmikko@brown.edu	Wagner, Fabien/ABC-4084-2020; Coish, Elizabeth/AAU-1245-2020; Ozden, Ilker/AAJ-3856-2020; Core, Vector/CAF-4832-2022	Wagner, Fabien/0000-0002-9582-6109; 	United States Defense Advanced Research Projects Agency [N66001-10-C-2010]; National Science Foundation [CBET-1402803, CBET-1264816]; United States National Science Foundation [0937848]	United States Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF)); United States National Science Foundation(National Science Foundation (NSF))	This work was supported by grants REPAIR Program (N66001-10-C-2010) from the United States Defense Advanced Research Projects Agency, from the National Science Foundation (CBET-1402803 and CBET-1264816), and Emerging Frontiers in Research and Innovation from the United States National Science Foundation (0937848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensmaia SJ, 2014, NAT REV NEUROSCI, V15, P313, DOI 10.1038/nrn3724; Berg J, 2013, IEEE T NEURAL SYSTEM; Bernstein JG, 2011, TRENDS COGN SCI, V15, P592, DOI 10.1016/j.tics.2011.10.003; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Butovas S, 2003, J NEUROPHYSIOL, V90, P3024, DOI 10.1152/jn.00245.2003; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Dai J, 2014, CURR BIOL, V24, P63, DOI 10.1016/j.cub.2013.11.011; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Doty R, 1969, ANN REV PSYCHOL; Ga Tabot, 2013, P NATL ACAD SCI US; Gerits A., 2012, CURR BIOL, P1; Ghazanfar AA, 2000, J NEUROSCI, V20, P3761, DOI 10.1523/JNEUROSCI.20-10-03761.2000; Goodwin AW, 2004, ANNU REV NEUROSCI, V27, P53, DOI 10.1146/annurev.neuro.26.041002.131032; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Han X, 2012, PROG BRAIN RES, V196, P215, DOI 10.1016/B978-0-444-59426-6.00011-2; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hernandez A, 1997, J NEUROSCI, V17, P6391; Histed M, 2014, P NAT 2013; Histed MH, 2013, PROG NEUROBIOL, V103, P115, DOI 10.1016/j.pneurobio.2012.01.006; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Jazayeri M, 2012, NAT NEUROSCI, V15, P1368, DOI 10.1038/nn.3210; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; London BM, 2008, IEEE T NEUR SYS REH, V16, P32, DOI 10.1109/TNSRE.2007.907544; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; Murphey DK, 2007, CURR BIOL, V17, P862, DOI 10.1016/j.cub.2007.03.066; Murphey DK, 2009, P NATL ACAD SCI USA, V106, P5389, DOI 10.1073/pnas.0804998106; Nevalainen P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00158; Ni AM, 2010, CURR BIOL, V20, P824, DOI 10.1016/j.cub.2010.02.065; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; O'Connor DH, 2013, NAT NEUROSCI, V16, P958, DOI 10.1038/nn.3419; O'Doherty JE, 2012, IEEE T NEUR SYS REH, V20, P85, DOI 10.1109/TNSRE.2011.2166807; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; O'Doherty JE, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.020.2009; Ochoa JL, 2010, NEUROSCI LETT, V470, P162, DOI 10.1016/j.neulet.2009.10.007; Ohayon S, 2013, J NEUROSCI, V33, P16684, DOI 10.1523/JNEUROSCI.2675-13.2013; Ozden I, 2013, J NEUROSCI METH, P1; Packer AM, 2013, NAT NEUROSCI, V16, P805, DOI 10.1038/nn.3427; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Rolston John D, 2009, Front Neuroeng, V2, P12, DOI 10.3389/neuro.16.012.2009; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 1996, NEUROREPORT, V7, P1273, DOI 10.1097/00001756-199605170-00011; Shaikhouni A, 2013, J NEUROPHYSIOL, V109, P2192, DOI 10.1152/jn.00368.2012; Stamatakis AM, 2013, NEURON, V80, P1039, DOI 10.1016/j.neuron.2013.08.023; Tabot GA, 2014, NEUROBIOL DIS; Tehovnik EJ, 2006, J NEUROPHYSIOL, V96, P512, DOI 10.1152/jn.00126.2006; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Venkatraman S, 2011, IEEE T NEUR SYS REH, V19, P317, DOI 10.1109/TNSRE.2011.2117441; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Weber DJ, 2012, J MOTOR BEHAV, V44, P403, DOI 10.1080/00222895.2012.735283; Wickens TD, 2001, ELEMENTARY SIGNAL DE, V1; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	62	30	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e114529	10.1371/journal.pone.0114529	http://dx.doi.org/10.1371/journal.pone.0114529			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541938	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900011
J	O'Neil, SF; Mac, A; Rhodes, G; Webster, MA				O'Neil, Sean F.; Mac, Amy; Rhodes, Gillian; Webster, Michael A.			Adding Years to Your Life (or at Least Looking Like It): A Simple Normalization Underlies Adaptation to Facial Age	PLOS ONE			English	Article							FACE RECOGNITION; PERCEPTION; SHAPE; IDENTITY; GENDER; REPRESENTATION; EXPRESSIONS; MECHANISMS; TEXTURE; SYSTEM	Adaptation has been widely used to probe how experience shapes the visual encoding of faces, but the pattern of perceptual changes produced by adaptation and the neural mechanisms these imply remain poorly characterized. We explored how adaptation alters the perceived age of faces, a fundamental facial attribute which can uniquely and reliably be scaled by observers. This allowed us to measure how adaptation to one age level affected the full continuum of perceived ages. Participants guessed the ages of faces ranging from 18-89, before or after adapting to a different set of faces composed of younger, older, or middle-aged adults. Adapting to young or old faces induced opposite linear shifts in perceived age that were independent of the model's age. Specifically, after adapting to younger or older faces, faces of all ages appeared 2 to 3 years older or younger, respectively. In contrast, middle-aged adaptors induced no aftereffects. This pattern suggests that adaptation leads to a simple and uniform renormalization of age perception, and is consistent with a norm-based neural code for the mechanisms mediating the perception of facial age.	[O'Neil, Sean F.; Mac, Amy; Webster, Michael A.] Univ Nevada, Dept Psychol, Reno, NV 89557 USA; [Rhodes, Gillian; Webster, Michael A.] Univ Western Australia, Sch Psychol, ARC Ctr Excellence Cognit & Its Disorders, Perth, WA 6009, Australia	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Western Australia	Webster, MA (corresponding author), Univ Nevada, Dept Psychol, Reno, NV 89557 USA.	mwebster@unr.edu		Rhodes, Gillian/0000-0002-3631-8518; Webster, Michael/0000-0001-8262-7525	National Institutes of Health [EY-10834]; Australian Research Council [ARC-CE110001021, ARC-DP08773791, ARC DP130102300]; NATIONAL EYE INSTITUTE [R29EY010834, R01EY010834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	MW, SO, and AM were supported by National Institutes of Health EY-10834. GR was supported by Australian Research Council ARC-CE110001021, ARC-DP08773791, and ARC DP130102300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; Calder AJ, 2008, J EXP PSYCHOL GEN, V137, P244, DOI 10.1037/0096-3445.137.2.244; Dickinson JE, 2010, J VISION, V10, DOI 10.1167/10.13.5; Durgin FH, 1996, SPATIAL VISION, V9, P423, DOI 10.1163/156856896X00204; Engell AD, 2010, PERCEPTION, V39, P931, DOI 10.1068/p6633; Enlow D.H., 1982, HDB FACIAL GROWTH; Fang F, 2005, NEURON, V45, P793, DOI 10.1016/j.neuron.2005.01.037; George PA, 2000, VIS COGN, V7, P485, DOI 10.1080/135062800394621; Lai M, 2013, CORTEX, V49, P252, DOI 10.1016/j.cortex.2011.09.010; Lai M, 2012, CORTEX, V48, P477, DOI 10.1016/j.cortex.2010.11.014; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; McKone E, 2014, VISION RES, V98, P1, DOI 10.1016/j.visres.2014.01.007; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; O'Neil SF, 2011, VIS COGN, V19, P534, DOI 10.1080/13506285.2011.561262; O'Toole AJ, 1999, VISION RES, V39, P3145, DOI 10.1016/S0042-6989(99)00034-6; Rhodes G, 2003, PSYCHOL SCI, V14, P558, DOI 10.1046/j.0956-7976.2003.psci_1465.x; Rhodes G., 2011, OXFORD HDB FACE PERC, P263, DOI DOI 10.1093/OXFORDHB/9780199559053.001.0001; Rhodes G, 2006, VISION RES, V46, P2977, DOI 10.1016/j.visres.2006.03.002; Robbins R, 2007, J EXP PSYCHOL HUMAN, V33, P570, DOI 10.1037/0096-1523.33.3.570; Ross DA, 2013, PSYCHON B REV; Russell R, 2006, PERCEPTION, V35, P749, DOI 10.1068/p5490; Schweinberger SR, 2010, VISION RES, V50, P2570, DOI 10.1016/j.visres.2010.08.017; Skinner AL, 2010, PSYCHOL SCI, V21, P1248, DOI 10.1177/0956797610380702; Storrs KR, 2012, VISION RES, V64, P7, DOI 10.1016/j.visres.2012.04.020; Susilo T, 2010, VISION RES, V50, P300, DOI 10.1016/j.visres.2009.11.016; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; WEBSTER MA, 1995, NATURE, V373, P694, DOI 10.1038/373694a0; Webster MA, 2011, PHILOS T R SOC B, V366, P1702, DOI 10.1098/rstb.2010.0360; Webster MA, 2008, J OPT SOC AM A, V25, P2817, DOI 10.1364/JOSAA.25.002817; Wright DB, 2003, ACTA PSYCHOL, V114, P101, DOI 10.1016/S0001-6918(03)00052-0; Wuerger SM, 1996, VISION RES, V36, P3107, DOI 10.1016/0042-6989(96)00057-0; Xu H, 2008, J NEUROSCI, V28, P3374, DOI 10.1523/JNEUROSCI.0182-08.2008; Yovel G, 2013, TRENDS COGN SCI, V17, P263, DOI 10.1016/j.tics.2013.04.004; Zaske R, 2013, ACTA PSYCHOL, V144, P583, DOI 10.1016/j.actpsy.2013.09.009; Zaidi Q, 1998, J OPT SOC AM A, V15, P1767, DOI 10.1364/JOSAA.15.001767; Zhao C, 2011, VISION RES, V51, P2021, DOI 10.1016/j.visres.2011.07.014	38	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116105	10.1371/journal.pone.0116105	http://dx.doi.org/10.1371/journal.pone.0116105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25541948	gold, Green Submitted, Green Published			2022-12-26	WOS:000347239900143
J	Wang, WW; Ye, CBH; Liu, JJ; Zhang, D; Kimata, JT; Zhou, P				Wang, Weiming; Ye, Chaobaihui; Liu, Jingjing; Zhang, Di; Kimata, Jason T.; Zhou, Paul			CCR5 Gene Disruption via Lentiviral Vectors Expressing Cas9 and Single Guided RNA Renders Cells Resistant to HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ONE-STEP GENERATION; T-CELLS; GENOME; NUCLEASE; CRISPR/CAS9; MICE; INDIVIDUALS; DISTINCT; ALLELES	CCR5, a coreceptor for HIV-1 entry, is a major target for drug and genetic intervention against HIV-1. Genetic intervention strategies have knocked down CCR5 expression levels by shRNA or disrupted the CCR5 gene using zinc finger nucleases (ZFN) or Transcription activator-like effector nuclease (TALEN). In the present study, we silenced CCR5 via CRISPR associated protein 9 (Cas9) and single guided RNAs (sgRNAs). We constructed lentiviral vectors expressing Cas9 and CCR5 sgRNAs. We show that a single round transduction of lentiviral vectors expressing Cas9 and CCR5 sgRNAs into HIV-1 susceptible human CD4(+) cells yields high frequencies of CCR5 gene disruption. CCR5 gene-disrupted cells are not only resistant to R5-tropic HIV-1, including transmitted/founder (T/F) HIV-1 isolates, but also have selective advantage over CCR5 gene-undisrupted cells during R5-tropic HIV-1 infection. Importantly, using T7 endonuclease I assay we did not detect genome mutations at potential off-target sites that are highly homologous to these CCR5 sgRNAs in stably transduced cells even at 84 days post transduction. Thus we conclude that silencing of CCR5 via Cas9 and CCR5-specific sgRNAs could be a viable alternative strategy for engineering resistance against HIV-1.	[Wang, Weiming; Ye, Chaobaihui; Liu, Jingjing; Zhou, Paul] Chinese Acad Sci, Inst Pasteur Shanghai, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China; [Zhang, Di] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Kimata, Jason T.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Shanghai Jiao Tong University; Baylor College of Medicine	Zhou, P (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China.	blzhou@sibs.ac.cn		Kimata, Jason/0000-0002-0504-0090	Chinese National Science Foundation [31170871, 81161160569]; National Science and Technology Major Projects [2012ZX10001-008, 2014ZX10001-001]; French Energy Company Areva; National Institutes of Health [AI106574]; Baylor-UTHouston CFAR [P30AI036211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211, R01AI106574] Funding Source: NIH RePORTER	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects; French Energy Company Areva; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor-UTHouston CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by research grants from the Chinese National Science Foundation (31170871 and 81161160569), National Science and Technology Major Projects (2012ZX10001-008 and 2014ZX10001-001) and French Energy Company Areva to P.Z. and by research grants from National Institutes of Health to J.T.K. (AI106574) and the Baylor-UTHouston CFAR (P30AI036211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina R, 2003, ANTICANCER RES, V23, P1997; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chelli M, 2001, J BIOL CHEM, V276, P46975, DOI 10.1074/jbc.M106432200; Cho S. W., 2013, GENOME RES; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; FREED EO, 1989, J VIROL, V63, P4670, DOI 10.1128/JVI.63.11.4670-4675.1989; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kothe DL, 2007, VIROLOGY, V360, P218, DOI 10.1016/j.virol.2006.10.017; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Liu LH, 2013, J VIROL, V87, P1899, DOI 10.1128/JVI.01038-12; Liu LH, 2011, J VIROL, V85, P8467, DOI 10.1128/JVI.00520-11; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Maggio I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05105; Maier DA, 2013, HUM GENE THER, V24, P245, DOI 10.1089/hum.2012.172; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller AD, 1996, J VIROL, V70, P5564, DOI 10.1128/JVI.70.8.5564-5571.1996; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Nazari R, 2008, CURR GENE THER, V8, P264, DOI 10.2174/156652308785160674; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Overbaugh J, 1996, AIDS RES HUM RETROV, V12, P107, DOI 10.1089/aid.1996.12.107; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Ray N, 2006, CURR TOP MICROBIOL, V303, P97, DOI 10.1007/978-3-540-33397-5_5; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527; Shaw GM, 2012, COLD SPRING HARB PER, V2; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Swan CH, 2006, GENE THER, V13, P1480, DOI 10.1038/sj.gt.3302801; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Theodore TS, 1996, AIDS RES HUM RETROV, V12, P191, DOI 10.1089/aid.1996.12.191; Tsai CJ, 2009, J NANOPART RES, V11, P1, DOI 10.1007/s11051-008-9474-0; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wen M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-79; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	56	35	45	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115987	10.1371/journal.pone.0115987	http://dx.doi.org/10.1371/journal.pone.0115987			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541967	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900125
J	Cleather, DJ; Southgate, DFL; Bull, AMJ				Cleather, Daniel J.; Southgate, Dominic F. L.; Bull, Anthony M. J.			On the Role of the Patella, ACL and Joint Contact Forces in the Extension of the Knee	PLOS ONE			English	Article							MOMENT ARM LENGTH; IN-VIVO; CRUCIATE LIGAMENT; PROVIDES INSIGHT; TENDON; MUSCLE; MODEL; PATELLECTOMY; FLEXION; CHAIN	Traditional descriptions of the knee suggest that the function of the patella is to facilitate knee extension by increasing the moment arm of the quadriceps muscles. Through modelling and evidence from the literature it is shown in this paper that the presence of the patella makes the ability of the quadriceps to rotate the thigh greater than their ability to rotate the tibia. Furthermore, this difference increases as the knee is flexed, thus demonstrating a pattern that is consistent with many human movements. This paper also shows that the anterior cruciate ligament plays a previously unheralded role in extending the shank and that translation at the tibiofemoral and patellofemoral joints is important in improving the capacity for thigh rotation when the knee is flexed. This study provides new insights as to how the structure of the knee is adapted to its purpose and illustrates how the functional anatomy of the knee contributes to its extension function.	[Cleather, Daniel J.] St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, England; [Southgate, Dominic F. L.; Bull, Anthony M. J.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	St Mary's University Twickenham London; Imperial College London	Cleather, DJ (corresponding author), St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, England.	daniel.cleather@smuc.ac.uk	Cleather, Daniel J/AAB-6053-2020; Bull, Anthony M J/C-2317-2008	Cleather, Daniel J/0000-0001-7852-3440; Bull, Anthony M J/0000-0002-4473-8264	Wellcome Trust; Engineering and Physical Sciences Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was partially supported by the Wellcome Trust and the Engineering and Physical Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amis AA., 1996, CURR ORTHOPAED, V10, P102; [Anonymous], 1945, LANCET, V246, P53, DOI 10.1016/S0140-6736(45)91805-8; BEYNNON BD, 1995, AM J SPORT MED, V23, P24, DOI 10.1177/036354659502300105; Beynnon BD, 1998, J BIOMECH, V31, P519, DOI 10.1016/S0021-9290(98)00044-X; Bishop R. E. D., 1977, Engineering in Medicine, V6, P53, DOI 10.1243/EMED_JOUR_1977_006_013_02; BUFF HU, 1988, J BIOMECH, V21, P17, DOI 10.1016/0021-9290(88)90187-X; BUTLER DL, 1980, J BONE JOINT SURG AM, V62, P259, DOI 10.2106/00004623-198062020-00013; Cleather DJ, 2015, J THEOR BIOL, V365, P217, DOI 10.1016/j.jtbi.2014.10.020; Cleather DJ, 2012, P I MECH ENG H, V226, P120, DOI 10.1177/0954411911432104; Cleather DJ, 2011, ANN BIOMED ENG, V39, P2476, DOI 10.1007/s10439-011-0340-3; Cleather DJ, 2011, ANN BIOMED ENG, V39, P1925, DOI 10.1007/s10439-011-0303-8; Cleather DJ, 2011, ANN BIOMED ENG, V39, P147, DOI 10.1007/s10439-010-0161-9; DeFrate LE, 2007, J BIOMECH, V40, P1716, DOI 10.1016/j.jbiomech.2006.08.009; Escamilla RF, 1998, MED SCI SPORT EXER, V30, P556, DOI 10.1097/00005768-199804000-00014; Gill HS, 1996, CLIN BIOMECH, V11, P81, DOI 10.1016/0268-0033(95)00021-6; HERZOG W, 1993, J ANAT, V182, P213; Horsman MDK, 2007, CLIN BIOMECH, V22, P239, DOI 10.1016/j.clinbiomech.2006.10.003; HUBERTI H H, 1984, Journal of Orthopaedic Research, V2, P49, DOI 10.1002/jor.1100020108; HUNGERFORD DS, 1979, CLIN ORTHOP RELAT R, P9; KAUFER H, 1971, J BONE JOINT SURG AM, VA 53, P1551, DOI 10.2106/00004623-197153080-00007; Komatsu T, 2005, J ORTHOP RES, V23, P334, DOI 10.1016/j.orthres.2004.08.001; Nha KW, 2008, J ORTHOP RES, V26, P1067, DOI 10.1002/jor.20554; NISELL R, 1986, ACTA ORTHOP SCAND, V57, P41, DOI 10.3109/17453678608993213; REILLY DT, 1972, ACTA ORTHOP SCAND, V43, P126, DOI 10.3109/17453677208991251; SHOEMAKER SC, 1986, J BONE JOINT SURG AM, V68A, P71, DOI 10.2106/00004623-198668010-00009; SHORBE HB, 1958, J BONE JOINT SURG AM, V40, P1281, DOI 10.2106/00004623-195840060-00008; SMIDT GL, 1973, J BIOMECH, V6, P79, DOI 10.1016/0021-9290(73)90040-7; SUTTON FS, 1976, J BONE JOINT SURG AM, V58, P537, DOI 10.2106/00004623-197658040-00017; Tsaopoulos DE, 2007, J BIOMECH, V40, P3325, DOI 10.1016/j.jbiomech.2007.05.005; Tsaopoulos DE, 2006, CLIN BIOMECH, V21, P657, DOI 10.1016/j.clinbiomech.2006.02.009; VANEIJDEN TMGJ, 1986, J BIOMECH, V19, P219, DOI 10.1016/0021-9290(86)90154-5; YAMAGUCHI GT, 1989, J BIOMECH, V22, P1, DOI 10.1016/0021-9290(89)90179-6	32	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115670	10.1371/journal.pone.0115670	http://dx.doi.org/10.1371/journal.pone.0115670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536067	Green Published, Green Accepted, gold			2022-12-26	WOS:000348563300062
J	Miao, SJ; Qiao, YF; Han, XZ; Franco, RB; Burger, M				Miao, Shujie; Qiao, Yunfa; Han, Xiaozeng; Franco, Roberta Brancher; Burger, Martin			Frozen Cropland Soil in Northeast China as Source of N2O and CO2 Emissions	PLOS ONE			English	Article							NITROUS-OXIDE; CARBON-DIOXIDE; AGRICULTURAL SOIL; FLUXES; FOREST; SEASON; DYNAMICS; FALLOW; CH4	Agricultural soils are important sources of atmospheric N2O and CO2. However, in boreal agro-ecosystems the contribution of the winter season to annual emissions of these gases has rarely been determined. In this study, soil N2O and CO2 fluxes were measured for 6 years in a corn-soybean-wheat rotation in northeast China to quantify the contribution of wintertime N2O and CO2 fluxes to annual emissions. The treatments were chemical fertilizer (NPK), chemical fertilizer plus composted pig manure (NPKOM), and control (Cont.). Mean soil N2O fluxes among all three treatments in the winter (November-March), when soil temperatures are below -7 degrees C for extended periods, were 0.89-3.01 mu g N m(-2) h(-1), and in between the growing season and winter (October and April), when freeze-thaw events occur, 1.73-5.48 mu g N m(-2) h(-1). The cumulative N2O emissions were on average 0.27-1.39, 0.03-0.08 and 0.03-0.11 kg N2O-N ha(-1) during the growing season, October and April, and winter, respectively. The average contributions of winter N2O efflux to annual emissions were 6.3-12.1%. In all three seasons, the highest N2O emissions occurred in NPKOM, while NPK and Cont. emissions were similar. Cumulative CO2 emissions were 2.73-4.94, 0.13-0.20 and 0.07-0.11 Mg CO2-C ha(-1) during growing season, October and April, and winter, respectively. The contribution of winter CO2 to total annual emissions was 2.0-2.4%. Our results indicate that in boreal agricultural systems in northeast China, CO2 and N2O emissions continue throughout the winter.	[Miao, Shujie; Qiao, Yunfa; Han, Xiaozeng] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Mollisols Agroecol, Harbin, Peoples R China; [Miao, Shujie; Qiao, Yunfa; Franco, Roberta Brancher; Burger, Martin] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; University of California System; University of California Davis	Burger, M (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	mburger@ucdavis.edu	Bond-Lamberty, Benjamin/C-6058-2008	Bond-Lamberty, Benjamin/0000-0001-9525-4633; Franco, Roberta/0000-0002-3323-444X	National Natural Science Foundation of China [41371297, 41101219]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (41371297, 41101219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm J, 1999, BIOGEOCHEMISTRY, V44, P163, DOI 10.1023/A:1006074606204; Benoit R.E., 1972, P 1972 TUNDR BIOM S, P111; Brooks PD, 1996, BIOGEOCHEMISTRY, V32, P93, DOI 10.1007/BF00000354; Ding WX, 2010, GEODERMA, V155, P381, DOI 10.1016/j.geoderma.2009.12.023; Fernandez-Luqueno F, 2009, SCI TOTAL ENVIRON, V407, P4289, DOI 10.1016/j.scitotenv.2009.04.016; Filippa G, 2009, BIOGEOCHEMISTRY, V95, P131, DOI 10.1007/s10533-009-9304-1; FIRESTONE MK, 1989, LIFE SCI R, V47, P7; Flanagan PW, 1972, P 1972 TUNDR BIOM S, P110; GOODROAD LL, 1984, J ENVIRON QUAL, V13, P448, DOI 10.2134/jeq1984.00472425001300030024x; Groffman PM, 2011, BIOGEOCHEMISTRY, V102, P223, DOI 10.1007/s10533-010-9436-3; Guo ZL, 2009, AGROFOREST SYST, V76, P67, DOI 10.1007/s10457-008-9170-1; Kariyapperuma KA, 2012, CAN J SOIL SCI, V92, P315, DOI 10.4141/CJSS2011-059; Kessavalou A, 1998, J ENVIRON QUAL, V27, P1094, DOI 10.2134/jeq1998.00472425002700050015x; Li HB, 2009, COMMUN SOIL SCI PLAN, V40, P1350, DOI 10.1080/00103620902761585; Li RP, 2010, CHINESE SCI BULL, V55, P2723, DOI 10.1007/s11434-010-3181-9; Maljanen M, 2007, TELLUS B; Maljanen M, 2010, CAN J FOREST RES, V40, P565, DOI 10.1139/X10-004; Merbold L, 2013, BIOGEOSCIENCES, V10, P3185, DOI 10.5194/bg-10-3185-2013; Metz B, 2007, MITIGATION CLIMATE C; Ohkubo S, 2012, AGR FOREST METEOROL, V165, P25, DOI 10.1016/j.agrformet.2012.06.012; Oquist MG, 2004, FEMS MICROBIOL ECOL, V49, P371, DOI 10.1016/j.femsec.2004.04.006; Panikov NS, 2007, FEMS MICROBIOL ECOL, V59, P500, DOI 10.1111/j.1574-6941.2006.00210.x; Pfab H, 2011, J PLANT NUTR SOIL SC, V174, P545, DOI 10.1002/jpln.201000123; Phillips RL, 2012, SOIL BIOL BIOCHEM, V45, P14, DOI 10.1016/j.soilbio.2011.09.012; Qiao YF, 2014, FIELD CROP RES, V161, P98, DOI 10.1016/j.fcr.2014.03.005; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Rochette P, 1998, CAN J SOIL SCI, V78, P283, DOI 10.4141/S97-066; Roehm CL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001889; Shi XH, 2012, GLOBAL BIOGEOCHEM CY, V26; SOIL SURVEY STAFF, 2014, KEYS SOIL TAXONOMY, V12th; Song Chuang-ye, 2009, Journal of Forestry Research (Harbin), V20, P117, DOI 10.1007/s11676-009-0021-3; Teepe R, 2000, SOIL BIOL BIOCHEM, V32, P1807, DOI 10.1016/S0038-0717(00)00078-X; van Bochove E, 2000, GLOBAL BIOGEOCHEM CY, V14, P113, DOI 10.1029/1999GB900101; Wagner-Riddle C, 2007, GLOBAL CHANGE BIOL, V13, P1722, DOI 10.1111/j.1365-2486.2007.01388.x; Wang W, 2010, SOIL BIOL BIOCHEM, V42, P451, DOI 10.1016/j.soilbio.2009.11.028; Wilson HM, 2008, APPL SOIL ECOL, V39, P264, DOI 10.1016/j.apsoil.2007.12.013; ZIMOV SA, 1993, J GEOPHYS RES-ATMOS, V98, P5017, DOI 10.1029/92JD02473; Zou JW, 2009, GLOBAL CHANGE BIOL, V15, P229, DOI 10.1111/j.1365-2486.2008.01775.x	38	10	11	7	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115761	10.1371/journal.pone.0115761	http://dx.doi.org/10.1371/journal.pone.0115761			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536036	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300070
J	Qiu, JH; Wang, XW; Meng, XD; Zheng, Y; Li, G; Ma, JY; Ye, G; Li, Y; Li, J				Qiu, Jianhong; Wang, Xiangwei; Meng, Xiaodong; Zheng, Yan; Li, Gang; Ma, Jiyao; Ye, Gang; Li, Yong; Li, Jie			Attenuated NER Expressions of XPF and XPC Associated with Smoking Are Involved in the Recurrence of Bladder Cancer	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-REPAIR; RESISTANCE; RISK; MECHANISM; GENES; CELLS	The varied NER genes and smoking are two important risk factors of bladder cancer, but the mechanism of the NER protein and smoking in cancer progression, however, remains unclear. In this report, we compared the expressions of NER genes in 79 bladder cancer tissues with or without any recurrence by real-time PCR and then analyzed the varied NER genes by immunochemistry in 219 bladder cancer tissue samples. Based on the clinical data, we analyzed the clinical value of varied NER genes and smoking in 219 bladder cancers by the Kaplan-Meier method and Cox proportional hazards regression. We found the expressions of the NER gene XPF and XPC were significantly lower in bladder cancer tissues with a recurrence compared with those without a recurrence at mRNA level. Also, the patients with the XPF and XPC defect had a statistically significant lower median recurrence-free survival time than those without the XPF and XPC defect, and smoking can make this difference more remarkable. Our results suggest that XPF and XPC expression may be a potential predictive factor for bladder cancer, and smoking can not only influence the recurrence of bladder cancer as a single factor but also aggravate the results of the XPF defect and XPC defect.	[Qiu, Jianhong; Meng, Xiaodong; Zheng, Yan; Li, Gang; Ma, Jiyao; Li, Yong; Li, Jie] Bethune Int Peace Hosp, Dept Urol, Shijiazhuang, Peoples R China; [Wang, Xiangwei; Ye, Gang] Third Mil Med Univ, Affiliated Hosp 2, Dept Urol, Chongqing, Peoples R China	Army Medical University	Li, J (corresponding author), Bethune Int Peace Hosp, Dept Urol, Shijiazhuang, Peoples R China.	li_jie8301@163.com	Wu, Yuqi/AAL-9861-2020		National Science & Technology Pillar Program of China [2011A322]	National Science & Technology Pillar Program of China	The study was supported by the National Science & Technology Pillar Program of China (No. 2011A322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barckhausen C, 2013, ONCOGENE; Boffetta P, 2008, SCAND J UROL NEPHROL, V42, P45, DOI 10.1080/03008880802283664; Chen ZW, 2007, CANCER RES, V67, P4578, DOI 10.1158/0008-5472.CAN-06-0877; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Ferreccio C, 2013, EPIDEMIOLOGY, V24, P898, DOI 10.1097/EDE.0b013e31829e3e03; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Han WN, 2012, CANCER PREV RES, V5, P1155, DOI 10.1158/1940-6207.CAPR-12-0185-T; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Katiyar SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021410; Kim WJ, 2008, CANCER SCI, V99, P646, DOI 10.1111/j.1349-7006.2008.00735.x; Kornguth DG, 2005, INT J RADIAT ONCOL, V62, P665, DOI 10.1016/j.ijrobp.2004.11.026; Li J, 2012, MED SCI MONITOR, V18, pBR156, DOI 10.12659/MSM.882618; Liu Y, 2012, ONCOL REP, V28, P337, DOI 10.3892/or.2012.1759; Martinez-Lacaci I, 2007, CLIN TRANSL ONCOL, V9, P13, DOI 10.1007/s12094-007-0004-9; Meijerman I, 2008, CANCER TREAT REV, V34, P505, DOI 10.1016/j.ctrv.2008.03.002; Melis JPM, 2013, DNA REPAIR, V12, P1081, DOI 10.1016/j.dnarep.2013.08.019; Melis JPM, 2013, TOXICOL APPL PHARM, V266, P289, DOI 10.1016/j.taap.2012.11.004; Meulenbroek EM, 2013, NUCLEIC ACIDS RES, V41, P1363, DOI 10.1093/nar/gks1127; Neumann AS, 2005, MOL CARCINOGEN, V42, P65, DOI 10.1002/mc.20069; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Nouspikel T, 2011, MECH AGEING DEV, V132, P355, DOI 10.1016/j.mad.2011.03.003; Ray A, 2013, DNA REPAIR, V12, P273, DOI 10.1016/j.dnarep.2013.01.003; Roelofzen JH, 2014, UROL ONCOL; Rouissi K, 2011, PATHOL ONCOL RES, V17, P879, DOI 10.1007/s12253-011-9398-3; Theodorescu D, 2003, HISTOL HISTOPATHOL, V18, P259, DOI 10.14670/HH-18.259; vanderSpek PJ, 1996, NUCLEIC ACIDS RES, V24, P2551, DOI 10.1093/nar/24.13.2551; Wang M, 2010, ONCOGENE, V29, P1920, DOI 10.1038/onc.2009.484; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wyszynski A, 2014, CANCER-AM CANCER SOC, V120, P408, DOI 10.1002/cncr.28394; Yeh KT, 2012, ANN SURG ONCOL, V19, P734, DOI 10.1245/s10434-011-1992-9	32	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115224	10.1371/journal.pone.0115224	http://dx.doi.org/10.1371/journal.pone.0115224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535740	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300032
J	Acker, J; Nguyen, NTT; Vandamme, M; Tavenet, A; Briand-Suleau, A; Conesa, C				Acker, Joel; Ngoc-Thuy-Trinh Nguyen; Vandamme, Marie; Tavenet, Arounie; Briand-Suleau, Audrey; Conesa, Christine			Sub1 and Maf1, Two Effectors of RNA Polymerase III, Are Involved in the Yeast Quiescence Cycle	PLOS ONE			English	Article							SENSITIVE PHOSPHOPROTEOME REVEALS; CHROMATIN-ASSOCIATED PROTEIN; MULTIPLE FUNCTIONS; LIFE-SPAN; TRANSCRIPTION; REPRESSION; NUTRIENT; STRESS; DNA; TOR	Sub1 and Maf1 exert an opposite effect on RNA polymerase III transcription interfering with different steps of the transcription cycle. In this study, we present evidence that Sub1 and Maf1 also exhibit an opposite role on yeast chronological life span. First, cells lacking Sub1 need more time than wild type to exit from resting and this lag in re-proliferation is correlated with a delay in transcriptional reactivation. Second, our data show that the capacity of the cells to properly establish a quiescent state is impaired in the absence of Sub1 resulting in a premature death that is dependent on the Ras/PKA and Tor1/Sch9 signalling pathways. On the other hand, we show that maf1D cells are long-lived mutant suggesting a connection between Pol III transcription and yeast longevity.	[Acker, Joel; Ngoc-Thuy-Trinh Nguyen; Vandamme, Marie; Tavenet, Arounie; Briand-Suleau, Audrey; Conesa, Christine] iBiTec S CEA, FRE3377, Gif Sur Yvette, France; [Acker, Joel; Ngoc-Thuy-Trinh Nguyen; Vandamme, Marie; Tavenet, Arounie; Briand-Suleau, Audrey; Conesa, Christine] CNRS, FRE3377, Gif Sur Yvette, France; [Acker, Joel; Ngoc-Thuy-Trinh Nguyen; Vandamme, Marie; Tavenet, Arounie; Briand-Suleau, Audrey; Conesa, Christine] Univ Paris 11, FRE3377, Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Acker, J (corresponding author), iBiTec S CEA, FRE3377, Gif Sur Yvette, France.	joel.acker@cea.fr; christine.conesa@cea.fr	Acker, Joël/F-5138-2010; Briand-Suleau, Audrey/O-8620-2017; BRIAND-SULEAU, Audrey/A-9956-2019	Acker, Joël/0000-0002-0855-875X; 	French National Research Agency [2010-BLAN-1605-01]; International PhD Program of the CEA	French National Research Agency(French National Research Agency (ANR)); International PhD Program of the CEA	This work was supported by the French National Research Agency (grant 2010-BLAN-1605-01) and the International PhD Program of the CEA to AT and NTTN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; Boguta M, 2013, BBA-GENE REGUL MECH, V1829, P376, DOI 10.1016/j.bbagrm.2012.11.004; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Cabart P, 2008, J BIOL CHEM, V283, P36108, DOI 10.1074/jbc.M807538200; Calvo O, 2005, EMBO J, V24, P1009, DOI 10.1038/sj.emboj.7600575; Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07; Conesa C, 2010, RNA BIOL, V7, P287, DOI 10.4161/rna.7.3.11491; Coute Y, 2006, MASS SPECTROM REV, V25, P215, DOI 10.1002/mas.20067; Das C, 2006, MOL CELL BIOL, V26, P8303, DOI 10.1128/MCB.00887-06; De Virgilio C, 2012, FEMS MICROBIOL REV, V36, P306, DOI 10.1111/j.1574-6976.2011.00287.x; Dechampesme AM, 1999, J CELL BIOL, V145, P1369, DOI 10.1083/jcb.145.7.1369; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Dieci G, 2013, BBA-GENE REGUL MECH, V1829, P331, DOI 10.1016/j.bbagrm.2012.10.009; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Duffy SK, 2012, CELL, V149, P936, DOI 10.1016/j.cell.2012.02.064; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Garcia A, 2012, MOL BIOL CELL, V23, P4297, DOI 10.1091/mbc.E12-04-0331; Ghavidel A, 2007, CELL, V131, P915, DOI 10.1016/j.cell.2007.09.042; Gomes P, 2007, MECH AGEING DEV, V128, P383, DOI 10.1016/j.mad.2007.04.003; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; JU QD, 1994, YEAST, V10, P151, DOI 10.1002/yea.320100203; Kajstura M, 2007, CYTOM PART A, V71A, P125, DOI 10.1002/cyto.a.20357; Karkusiewicz I, 2011, J BIOL CHEM, V286, P39478, DOI 10.1074/jbc.M111.253310; Koyama H, 2008, GENES CELLS, V13, P1113, DOI 10.1111/j.1365-2443.2008.01229.x; Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Moir RD, 2013, BBA-GENE REGUL MECH, V1829, P361, DOI 10.1016/j.bbagrm.2012.11.001; Morawiec E, 2013, GENE, V526, P16, DOI 10.1016/j.gene.2013.04.055; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Rosonina E, 2009, MOL CELL BIOL, V29, P2308, DOI 10.1128/MCB.01841-08; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Swinnen E, 2013, FEMS YEAST RES; Tavenet A, 2009, P NATL ACAD SCI USA, V106, P14265, DOI 10.1073/pnas.0900162106; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; Weinberger M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000748; Whitney ML, 2007, MOL BIOL CELL, V18, P2678, DOI 10.1091/mbc.E07-01-0006; Zheng JS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.77	48	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114587	10.1371/journal.pone.0114587	http://dx.doi.org/10.1371/journal.pone.0114587			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531541	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845100020
J	Kashi, VP; Jacob, RA; Shamanna, RA; Menon, M; Balasiddaiah, A; Varghese, RK; Bachu, M; Ranga, U				Kashi, Venkatesh P.; Jacob, Rajesh A.; Shamanna, Raghavendra A.; Menon, Malini; Balasiddaiah, Anangi; Varghese, Rebu K.; Bachu, Mahesh; Ranga, Udaykumar			The Grafting of Universal T-Helper Epitopes Enhances Immunogenicity of HIV-1 Tat Concurrently Improving Its Safety Profile	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CLADE-SPECIFIC DIFFERENCES; IMMUNE-RESPONSES; TYPE-1 TAT; NEUTRALIZING ANTIBODIES; CYNOMOLGUS MONKEYS; RHESUS MACAQUES; 89.6P CHALLENGE; PROTEIN; AIDS	Extracellular Tat (eTat) plays an important role in HIV-1 pathogenesis. The presence of anti-Tat antibodies is negatively correlated with disease progression, hence making Tat a potential vaccine candidate. The cytotoxicity and moderate immunogenicity of Tat however remain impediments for developing Tat-based vaccines. Here, we report a novel strategy to concurrently enhance the immunogenicity and safety profile of Tat. The grafting of universal helper T-lymphocyte (HTL) epitopes, Pan DR Epitope (PADRE) and Pol(711) into the cysteine rich domain (CRD) and the basic domain (BD) abolished the transactivation potential of the Tat protein. The HTL-Tat proteins elicited a significantly higher titer of antibodies as compared to the wild-type Tat in BALB/c mice. While the N-terminal epitope remained immunodominant in HTL-Tat immunizations, an additional epitope in exon-2 was recognized with comparable magnitude suggesting a broader immune recognition. Additionally, the HTL-Tat proteins induced cross-reactive antibodies of high avidity that efficiently neutralized exogenous Tat, thus blocking the activation of a Tat-defective provirus. With advantages such as presentation of multiple B-cell epitopes, enhanced antibody response and importantly, transactivation-deficient Tat protein, this approach has potential application for the generation of Tat-based HIV/AIDS vaccines.	[Kashi, Venkatesh P.; Jacob, Rajesh A.; Shamanna, Raghavendra A.; Menon, Malini; Balasiddaiah, Anangi; Varghese, Rebu K.; Bachu, Mahesh; Ranga, Udaykumar] Jawaharlal Nehru Ctr Adv Sci Res, HIV AIDS Lab, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India; [Jacob, Rajesh A.] Int Ctr Genet Engn & Biotechnol, Cellular Immunol Grp, Cape Town, South Africa; [Shamanna, Raghavendra A.] NIA, Lab Mol Gerontol, Baltimore, MD 21224 USA	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Ranga, U (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, HIV AIDS Lab, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India.	udaykumar@jncasr.ac.in	Bachu, Mahesh/I-4343-2015	Bachu, Mahesh/0000-0002-6494-6642	Indian Council of Medical Research, India [HIV/50/114/09-ECDII, 2008-06300]; Jawaharlal Nehru Center for Advanced Scientific Research to Udaykumar Ranga	Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); Jawaharlal Nehru Center for Advanced Scientific Research to Udaykumar Ranga(Department of Science & Technology (India))	This study was supported by grants from the Indian Council of Medical Research, India (HIV/50/114/09-ECDII, IRIS No. 2008-06300) and intramural grants from Jawaharlal Nehru Center for Advanced Scientific Research to Udaykumar Ranga. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2001, P NATL ACAD SCI USA, V98, P1781, DOI 10.1073/pnas.98.4.1781; Belliard G, 2005, VACCINE, V23, P1399, DOI 10.1016/j.vaccine.2004.08.037; Butto S, 2003, J INFECT DIS, V188, P1171, DOI 10.1086/378412; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; Campbell GR, 2005, J BIOL CHEM, V280, P38376, DOI 10.1074/jbc.M506630200; Caselli E, 1999, J IMMUNOL, V162, P5631; Cui ZR, 2004, VACCINE, V22, P2631, DOI 10.1016/j.vaccine.2003.12.013; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; Fayolle C, 2010, VACCINE, V28, P6930, DOI 10.1016/j.vaccine.2010.07.059; Ferrantelli F, 2011, VACCINE, V29, P2918, DOI 10.1016/j.vaccine.2011.02.006; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gandhi N, 2009, AIDS RES HUM RETROV, V25, P691, DOI 10.1089/aid.2008.0299; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Gavioli R, 2008, VACCINE, V26, P727, DOI 10.1016/j.vaccine.2007.11.040; Goldstein G, 2012, HUM VACC IMMUNOTHER, V8, P1425, DOI 10.4161/hv.21616; Goldstein G, 2010, VACCINE, V28, P1008, DOI 10.1016/j.vaccine.2009.10.129; Gupta S, 2008, J IMMUNOL, V180, P79, DOI 10.4049/jimmunol.180.1.79; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Kashi VP, 2009, VACCINE, V27, P6739, DOI 10.1016/j.vaccine.2009.08.078; Leifert JA, 2002, GENE THER, V9, P1422, DOI 10.1038/sj.gt.3301819; Liang XP, 2005, J VIROL, V79, P12321, DOI 10.1128/JVI.79.19.12321-12331.2005; Maggiorella MT, 2004, VACCINE, V22, P3258, DOI 10.1016/j.vaccine.2004.03.009; Mishra M, 2008, ANN NEUROL, V63, P366, DOI 10.1002/ana.21292; MODESTI N, 1991, NEW BIOL, V3, P759; Moreau E, 2004, J GEN VIROL, V85, P2893, DOI 10.1099/vir.0.80365-0; Nicoli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077746; Osterhaus ADME, 1999, VACCINE, V17, P2713, DOI 10.1016/S0264-410X(98)00498-8; Pauza CD, 2000, P NATL ACAD SCI USA, V97, P3515, DOI 10.1073/pnas.070049797; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Ramakrishna L, 2004, J VIROL, V78, P9174, DOI 10.1128/JVI.78.17.9174-9189.2004; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; Rao VR, 2008, J NEUROSCI, V28, P10010, DOI 10.1523/JNEUROSCI.2955-08.2008; Rayne F, 2010, CELL BIOL INT, V34, P409, DOI 10.1042/CBI20090376; Re MC, 2001, J CLIN VIROL, V21, P81, DOI 10.1016/S1386-6532(00)00189-X; Re MC, 1996, CLIN DIAGN LAB IMMUN, V3, P230, DOI 10.1128/CDLI.3.2.230-232.1996; Rezza G, 2005, J INFECT DIS, V191, P1321, DOI 10.1086/428909; Richardson MW, 2003, BIOMED PHARMACOTHER, V57, P4, DOI 10.1016/S0753-3322(02)00327-X; Romani B, 2010, J GEN VIROL, V91, P1, DOI 10.1099/vir.0.016303-0; Ruckwardt TJ, 2004, J VIROL, V78, P13190, DOI 10.1128/JVI.78.23.13190-13196.2004; Sforza F, 2014, AIDS, V28, P1729, DOI 10.1097/QAD.0000000000000315; Siddappa NB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-53; Silvera P, 2002, J VIROL, V76, P3800, DOI 10.1128/JVI.76.8.3800-3809.2002; Tikhonov I, 2003, J VIROL, V77, P3157, DOI 10.1128/JVI.77.5.3157-3166.2003; vanBaalen CA, 1997, J GEN VIROL, V78, P1913, DOI 10.1099/0022-1317-78-8-1913; Zagury J F, 1998, J Hum Virol, V1, P282	46	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114155	10.1371/journal.pone.0114155	http://dx.doi.org/10.1371/journal.pone.0114155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531437	Green Submitted, gold, Green Published			2022-12-26	WOS:000348845100009
J	Stratonovitch, P; Elias, J; Denholm, I; Slater, R; Semenov, MA				Stratonovitch, Pierre; Elias, Jan; Denholm, Ian; Slater, Russell; Semenov, Mikhail A.			An Individual-Based Model of the Evolution of Pesticide Resistance in Heterogeneous Environments: Control of Meligethes aeneus Population in Oilseed Rape Crops	PLOS ONE			English	Article							POLLEN BEETLE; INSECTICIDE RESISTANCE; SPATIAL DYNAMICS; MANAGEMENT; EXPOSURE; DISPERSAL; EFFICACY; LESSONS; ECOLOGY; SYSTEMS	Preventing a pest population from damaging an agricultural crop and, at the same time, preventing the development of pesticide resistance is a major challenge in crop protection. Understanding how farming practices and environmental factors interact with pest characteristics to influence the spread of resistance is a difficult and complex task. It is extremely challenging to investigate such interactions experimentally at realistic spatial and temporal scales. Mathematical modelling and computer simulation have, therefore, been used to analyse resistance evolution and to evaluate potential resistance management tactics. Of the many modelling approaches available, individual-based modelling of a pest population offers most flexibility to include and analyse numerous factors and their interactions. Here, a pollen beetle (Meligethes aeneus) population was modelled as an aggregate of individual insects inhabiting a spatially heterogeneous landscape. The development of the pest and host crop (oilseed rape) was driven by climatic variables. The agricultural land of the landscape was managed by farmers applying a specific rotation and crop protection strategy. The evolution of a single resistance allele to the pyrethroid lambda cyhalothrin was analysed for different combinations of crop management practices and for a recessive, intermediate and dominant resistance allele. While the spread of a recessive resistance allele was severely constrained, intermediate or dominant resistance alleles showed a similar response to the management regime imposed. Calendar treatments applied irrespective of pest density accelerated the development of resistance compared to ones applied in response to prescribed pest density thresholds. A greater proportion of spring-sown oilseed rape was also found to increase the speed of resistance as it increased the period of insecticide exposure. Our study demonstrates the flexibility and power of an individual-based model to simulate how farming practices affect pest population dynamics, and the consequent impact of different control strategies on the risk and speed of resistance development.	[Stratonovitch, Pierre; Semenov, Mikhail A.] Rothamsted Res, Computat & Syst Biol Dept, Harpenden, Herts, England; [Elias, Jan; Slater, Russell] Syngenta Crop Protect AG, Res Biol, Stein, Switzerland; [Denholm, Ian] Univ Hertfordshire, Human & Environm Sci Dept, Hatfield AL10 9AB, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Syngenta; University of Hertfordshire	Stratonovitch, P (corresponding author), Rothamsted Res, Computat & Syst Biol Dept, Harpenden, Herts, England.	pierre.stratonovitch@rothamsted.ac.uk	Semenov, Mikhail/HCI-8667-2022; Semenov, Mikhail/W-8060-2019; Stratonovitch, Pierre/H-4833-2019	Semenov, Mikhail/0000-0002-1561-7113; Stratonovitch, Pierre/0000-0002-5806-2066	Syngenta; Biotechnology and Biological Sciences Research Council of the UK	Syngenta(Syngenta); Biotechnology and Biological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research leading to these results has received funding from Syngenta. Rothamsted Research receives strategic funding from the Biotechnology and Biological Sciences Research Council of the UK. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. The funders collected insecticide efficacy data.	Bourguet D, 2013, TRENDS ECOL EVOL, V28, P110, DOI 10.1016/j.tree.2012.09.001; Buchi R, 2002, AGR ECOSYST ENVIRON, V90, P255, DOI 10.1016/S0167-8809(01)00213-4; Buechs Wolfgang, 2000, IOBC-WPRS Bulletin, V23, P151; Carriere Y, 2012, P NATL ACAD SCI USA, V109, P775, DOI 10.1073/pnas.1117851109; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cook SM, 2006, ENTOMOL EXP APPL, V119, P221, DOI 10.1111/j.1570-7458.2006.00419.x; De Angelis D., 1992, INDIVIDUAL BASED MOD, DOI 10.1201/9781351073462; Denholm I, 2002, SCIENCE, V297, P2222, DOI 10.1126/science.1077266; Ekbom B, 2003, AGRIC FOR ENTOMOL, V5, P247, DOI 10.1046/j.1461-9563.2003.00184.x; Evans MR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1452; Evans MR, 2012, PHILOS T R SOC B, V367, P163, DOI 10.1098/rstb.2011.0191; Frearson DJT, 2005, ENTOMOL EXP APPL, V116, P21, DOI 10.1111/j.1570-7458.2005.00299.x; Garthwaite D. G., 2008, PESTICIDE USAGE SURV; GEORGHIOU GP, 1977, J ECON ENTOMOL, V70, P319, DOI 10.1093/jee/70.3.319; GEORGHIOU GP, 1977, J ECON ENTOMOL, V70, P653, DOI 10.1093/jee/70.5.653; Gould F, 1997, P NATL ACAD SCI USA, V94, P3519, DOI 10.1073/pnas.94.8.3519; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V., 2005, INDIVIDUAL BASED MOD; Habekotte B, 1997, FIELD CROP RES, V54, P127, DOI 10.1016/S0378-4290(97)00043-9; Hansen LM, 2003, PEST MANAG SCI, V59, P1057, DOI 10.1002/ps.737; Jonsson M, 2007, PHYSIOL ENTOMOL, V32, P188, DOI 10.1111/j.1365-3032.2007.00562.x; Jorgensen SE, 2001, FUNDAMENTALS ECOLOGI; JUDSON OP, 1994, TRENDS ECOL EVOL, V9, P9, DOI 10.1016/0169-5347(94)90225-9; Kautz M, 2014, ECOL MODEL, V273, P264, DOI 10.1016/j.ecolmodel.2013.11.022; Liu C, 2014, ECOL MODEL, V280, P30, DOI 10.1016/j.ecolmodel.2013.09.007; Liu C, 2013, ECOL MODEL, V248, P92, DOI 10.1016/j.ecolmodel.2012.09.016; Miller FJ, 2000, TOXICOLOGY, V149, P21, DOI 10.1016/S0300-483X(00)00229-8; Nauen R, 2012, PESTIC BIOCHEM PHYS, V103, P173, DOI 10.1016/j.pestbp.2012.04.012; OSBORNE P, 1960, PARASITOLOGY, V50, P91, DOI 10.1017/S0031182000025233; Peck SL, 1999, J ECON ENTOMOL, V92, P1, DOI 10.1093/jee/92.1.1; Perez L, 2011, ECOL INFORM, V6, P62, DOI 10.1016/j.ecoinf.2010.09.003; Perez L, 2010, ENVIRON MODELL SOFTW, V25, P223, DOI 10.1016/j.envsoft.2009.08.004; Potting RPJ, 2005, ECOL MODEL, V182, P199, DOI 10.1016/j.ecolmodel.2004.07.017; ROUSH RT, 1989, PESTIC SCI, V26, P423, DOI 10.1002/ps.2780260409; Schuler TH, 2003, TRANSGENIC RES, V12, P351, DOI 10.1023/A:1023342027192; Semenov MA, 2010, CLIM RES, V44, P3, DOI 10.3354/cr00865; Shi MR, 2012, J STORED PROD RES, V51, P23, DOI 10.1016/j.jspr.2012.06.003; Slater R, 2011, PEST MANAG SCI, V67, P633, DOI 10.1002/ps.2101; Stratonovitch P., 2010, PROC SOCIAL BEHAV SC, V2, P7749, DOI [10.1016/j.sbspro.2010.05.210, DOI 10.1016/J.SBSPRO.2010.05.210]; Tabashnik B.E., 1990, PESTICIDE RESISTANCE, P153; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; TAYLOR CE, 1979, J ECON ENTOMOL, V72, P105, DOI 10.1093/jee/72.1.105; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Vinatier F, 2012, AGR ECOSYST ENVIRON, V146, P52, DOI 10.1016/j.agee.2011.10.005; Vinatier F, 2009, ECOL MODEL, V220, P2244, DOI 10.1016/j.ecolmodel.2009.06.023; White JW, 2014, OIKOS, V123, P385, DOI 10.1111/j.1600-0706.2013.01073.x; Williams IH, 2007, AGR FOREST ENTOMOL, V9, P279, DOI 10.1111/j.1461-9563.2007.00343.x	47	26	27	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115631	10.1371/journal.pone.0115631	http://dx.doi.org/10.1371/journal.pone.0115631			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531104	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100086
J	Yang, LZ; Zhang, W; Shi, B; Yang, ZY; Wei, ZD; Gu, F; Zhang, J; Cui, GB; Liu, Y; Zhou, YF; Zhang, XC; Rao, HY				Yang, Li-Zhuang; Zhang, Wei; Shi, Bin; Yang, Zhiyu; Wei, Zhengde; Gu, Feng; Zhang, Jing; Cui, Guanbao; Liu, Ying; Zhou, Yifeng; Zhang, Xiaochu; Rao, Hengyi			Electrical Stimulation over Bilateral Occipito-Temporal Regions Reduces N170 in the Right Hemisphere and the Composite Face Effect	PLOS ONE			English	Article							NONINVASIVE BRAIN-STIMULATION; ACQUIRED PROSOPAGNOSIA; PREFRONTAL CORTEX; INTERHEMISPHERIC CONNECTIVITY; EXTRASTRIATE CORTEX; RECOGNITION ABILITY; VISUAL-CORTEX; MOTOR CORTEX; PERCEPTION; TDCS	Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that can modulate cortical excitability. Although the clinical value of tDCS has been advocated, the potential of tDCS in cognitive rehabilitation of face processing deficits is less understood. Face processing has been associated with the occipito-temporal cortex (OT). The present study investigated whether face processing in healthy adults can be modulated by applying tDCS over the OT. Experiment 1 investigated whether tDCS can affect N170, a face-sensitive ERP component, with a face orientation judgment task. The N170 in the right hemisphere was reduced in active stimulation conditions compared with the sham stimulation condition for both upright faces and inverted faces. Experiment 2 further demonstrated that tDCS can modulate the composite face effect, a type of holistic processing that reflects the obligatory attention to all parts of a face. The composite face effect was reduced in active stimulation conditions compared with the sham stimulation condition. Additionally, the current polarity did not modulate the effect of tDCS in the two experiments. The present study demonstrates that N170 can be causally manipulated by stimulating the OT with weak currents. Furthermore, our study provides evidence that obligatory attention to all parts of a face can be affected by the commonly used tDCS parameter setting.	[Yang, Li-Zhuang; Zhang, Wei; Yang, Zhiyu; Wei, Zhengde; Gu, Feng; Cui, Guanbao; Zhou, Yifeng; Zhang, Xiaochu] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei, Anhui, Peoples R China; [Yang, Li-Zhuang; Zhang, Wei; Yang, Zhiyu; Wei, Zhengde; Gu, Feng; Cui, Guanbao; Zhou, Yifeng; Zhang, Xiaochu] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Shi, Bin; Liu, Ying] Anhui Med Univ, Prov Hosp, Hefei, Anhui, Peoples R China; [Zhang, Jing] Anhui Univ Chinese Med, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Zhang, Xiaochu] Chinese Acad Sci, Ctr Med Phys & Technol, Hefei Inst Phys Sci, Hefei, Anhui, Peoples R China; [Zhang, Xiaochu] Univ Sci & Technol China, Sch Humanities & Social Sci, Hefei, Anhui, Peoples R China; [Rao, Hengyi] Univ Penn, Ctr Funct Neuroimaging, Dept Neurol & Radiol, Philadelphia, PA 19104 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Anhui University of Chinese Medicine; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Pennsylvania; Pennsylvania Medicine	Yang, LZ (corresponding author), Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei, Anhui, Peoples R China.	lzyang@ustc.edu.cn; zxcustc@ustc.edu.cn	Rao, Hengyi/AAQ-4919-2020; Zhang, Xiaochu/AAG-8768-2022; Zhang, Xiaochu/AEW-0582-2022; Yang, Li-Zhuang/AAJ-3623-2020; Rao, Hengyi/A-7064-2009; Yang, Li-Zhuang/F-3648-2016; Rao, Hengyi/K-5152-2019; Zhang, Xiaochu/O-9592-2014	Rao, Hengyi/0000-0003-2735-2500; Yang, Li-Zhuang/0000-0002-0192-4323; Rao, Hengyi/0000-0003-2735-2500; Yang, Li-Zhuang/0000-0002-0192-4323; Zhang, Xiaochu/0000-0002-7541-0130; Wei, Zhengde/0000-0003-4586-0170; Gu, Feng/0000-0002-5954-5596	National Natural Science Foundation of China [31230032, 31171083, 31070984, 31471071]; Fundamental Research Funds for the Central Universities of China [WK2070000033]; 100 Talents Programme of The Chinese Academy of Sciences [BJ2070000047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); 100 Talents Programme of The Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Natural Science Foundation of China (31230032, 31171083, 31070984, 31471071) (http://www.nsfc.gov.cn/publish/portal0/default.htm), and the Fundamental Research Funds for the Central Universities of China (WK2070000033) (http://www.moe.edu.cn/), and 100 Talents Programme of The Chinese Academy of Sciences (BJ2070000047) (http://www.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan G, 2011, NEUROPSYCHOLOGIA, V49, P2541, DOI 10.1016/j.neuropsychologia.2011.05.002; Azabou E, 2013, RESP PHYSIOL NEUROBI, V189, P183, DOI 10.1016/j.resp.2013.07.024; Barton JJS, 2008, J NEUROPSYCHOL, V2, P197, DOI 10.1348/174866407X214172; Barton JJS, 2009, PERCEPTION, V38, P242, DOI 10.1068/p6099; Barton JJS, 2004, PERCEPTION, V33, P939, DOI 10.1068/p5243; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bikson M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00688; Boggio PS, 2008, DRUG ALCOHOL DEPEN, V92, P55, DOI 10.1016/j.drugalcdep.2007.06.011; Boggio PS, 2008, NEUROSCI LETT, V447, P101, DOI 10.1016/j.neulet.2008.10.009; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P4057, DOI 10.1016/j.neuropsychologia.2010.09.017; Busigny T, 2010, CORTEX, V46, P965, DOI 10.1016/j.cortex.2009.07.004; Cecere R, 2013, J NEUROSCI, V33, P6469, DOI 10.1523/JNEUROSCI.3431-12.2013; Dalrymple KA, 2011, NEUROPSYCHOLOGIA, V49, P2553, DOI 10.1016/j.neuropsychologia.2011.05.003; Davies-Thompson J, 2012, J NEUROPHYSIOL, V108, P3087, DOI 10.1152/jn.01171.2011; DeGutis J, 2013, COGNITION, V126, P87, DOI 10.1016/j.cognition.2012.09.004; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; DERENZI E, 1986, NEUROPSYCHOLOGIA, V24, P385; Dzhelyova MP, 2011, J COGNITIVE NEUROSCI, V23, P2782, DOI 10.1162/jocn.2011.21604; Eimer M, 2011, BRAIN RES, V1376, P76, DOI 10.1016/j.brainres.2010.12.046; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Floel A, 2014, NEUROIMAGE, V85, P934, DOI 10.1016/j.neuroimage.2013.05.098; Fregni F, 2008, J CLIN PSYCHIAT, V69, P32, DOI 10.4088/JCP.v69n0105; Gao L, 2009, PSYCHOPHYSIOLOGY, V46, P970, DOI 10.1111/j.1469-8986.2009.00853.x; Gao ZF, 2011, ATTEN PERCEPT PSYCHO, V73, P1477, DOI 10.3758/s13414-011-0109-7; Gauthier I, 2002, J EXP PSYCHOL HUMAN, V28, P431, DOI 10.1037//0096-1523.28.2.431; Gauthier I, 2007, COGNITION, V103, P322, DOI 10.1016/j.cognition.2006.05.003; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HOLE GJ, 1994, PERCEPTION, V23, P65, DOI 10.1068/p230065; Hsiao JH, 2009, PSYCHOL SCI, V20, P455, DOI 10.1111/j.1467-9280.2009.02315.x; Itier RJ, 2011, NEUROIMAGE, V54, P705, DOI 10.1016/j.neuroimage.2010.07.031; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kongthong N, 2013, NEUROSCI LETT, V544, P141, DOI 10.1016/j.neulet.2013.04.002; Kuo MF, 2014, NEUROIMAGE, V85, P948, DOI 10.1016/j.neuroimage.2013.05.117; Lafontaine MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081721; Le Grand R, 2004, PSYCHOL SCI, V15, P762, DOI 10.1111/j.0956-7976.2004.00753.x; Lindenberg R, 2013, J NEUROSCI, V33, P9176, DOI 10.1523/JNEUROSCI.0055-13.2013; Mattavelli G, 2013, NEUROIMAGE, V76, P24, DOI 10.1016/j.neuroimage.2013.03.020; Maurer D, 2007, NEUROPSYCHOLOGIA, V45, P1438, DOI 10.1016/j.neuropsychologia.2006.11.016; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Meinzer M, 2012, J NEUROSCI, V32, P1859, DOI 10.1523/JNEUROSCI.4812-11.2012; Mercure E, 2008, J COGNITIVE NEUROSCI, V20, P2070, DOI 10.1162/jocn.2008.20137; Moos K, 2012, J NEUROSCI, V32, P16360, DOI 10.1523/JNEUROSCI.6233-11.2012; Nasr S, 2009, J VISION, V9, DOI 10.1167/9.5.5; Nguyen V.T., 2013, NEUROIMAGE; Nitsche M A, 2012, Front Psychiatry, V3, P58, DOI 10.3389/fpsyt.2012.00058; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Park CH, 2013, NEUROSCI LETT, V539, P7, DOI 10.1016/j.neulet.2013.01.047; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; Pitcher D, 2011, EXP BRAIN RES, V209, P481, DOI 10.1007/s00221-011-2579-1; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; Ramon M, 2012, BRAIN COGNITION, V78, P7, DOI 10.1016/j.bandc.2011.10.009; Renzi C, 2013, NEUROIMAGE, V74, P45, DOI 10.1016/j.neuroimage.2013.02.015; Richler JJ, 2008, J EXP PSYCHOL LEARN, V34, P1356, DOI 10.1037/a0013080; Richler JJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00553; Richler JJ, 2011, J VISION, V11, DOI 10.1167/11.13.17; Richler JJ, 2011, PSYCHOL SCI, V22, P464, DOI 10.1177/0956797611401753; Richler JJ, 2009, ATTEN PERCEPT PSYCHO, V71, P530, DOI 10.3758/APP.71.3.530; Richler JJ, 2013, VIS COGN, V21; Riddoch MJ, 2008, COGN NEUROPSYCHOL, V25, P3, DOI 10.1080/02643290801920113; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Rossion B, 2013, VIS COGN, V21, P139, DOI 10.1080/13506285.2013.772929; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Sadeh B, 2010, NEUROIMAGE, V53, P782, DOI 10.1016/j.neuroimage.2010.06.029; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Tanaka JW, 2006, J COGNITIVE NEUROSCI, V18, P1488, DOI 10.1162/jocn.2006.18.9.1488; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Towler J, 2012, NEUROPSYCHOLOGIA, V50, P3588, DOI 10.1016/j.neuropsychologia.2012.10.017; Tseng P, 2012, J NEUROSCI, V32, P10554, DOI 10.1523/JNEUROSCI.0362-12.2012; Tso RVY, 2014, PSYCHOL SCI, V25, P1757, DOI 10.1177/0956797614541284; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Van Belle G, 2011, NEUROPSYCHOLOGIA, V49, P3145, DOI 10.1016/j.neuropsychologia.2011.07.010; Wang RS, 2012, PSYCHOL SCI, V23, P169, DOI 10.1177/0956797611420575; Watanabe S, 2003, NEUROSCIENCE, V116, P879, DOI 10.1016/S0306-4522(02)00752-2; Wong ACN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008405; Wong ACN, 2009, PSYCHOL SCI, V20, P1108, DOI 10.1111/j.1467-9280.2009.02430.x; Young A., 1987, PERCEPTION, V10, P747, DOI DOI 10.1068/P160747; Yovel G, 2008, NEUROPSYCHOLOGIA, V46, P3061, DOI 10.1016/j.neuropsychologia.2008.06.017; Zhou GM, 2012, PSYCHON B REV, V19, P157, DOI 10.3758/s13423-011-0174-x	88	10	10	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115772	10.1371/journal.pone.0115772	http://dx.doi.org/10.1371/journal.pone.0115772			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531112	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100106
J	Zhang, W; Shen, SX; Wang, W; Zhou, CL; Xu, LM; Qiu, JH; Wang, JQ; Meng, XX; Liang, YX; Niu, KJ; Guo, Q				Zhang, Wen; Shen, Suxing; Wang, Wei; Zhou, Chunling; Xu, Limin; Qiu, Jiahe; Wang, Jiaqi; Meng, Xiangxue; Liang, Yixiong; Niu, Kaijun; Guo, Qi			Poor Lower Extremity Function Was Associated with Pre-Diabetes and Diabetes in Older Chinese People	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; MUSCLE STRENGTH; GENDER-DIFFERENCES; HEALTH; ADULTS; FALLS; WOMEN; RISK; MASS; LIMITATIONS	Objective: To determine whether a relationship exists between performance-based physical assessments and pre-diabetes/diabetes in an older Chinese population. Methods: Our study population comprised 976 subjects (mean +/- SD age: 67.6 +/- 6.0 years; 44.5% men) from the Hangu area of Tianjin, China. Diabetes was defined by self-reporting of a physician's diagnosis, or a fasting plasma glucose level >= 126 mg/dL; and pre-diabetes was defined as a fasting plasma glucose level >= 100 mg/dL and <126 mg/dL. Results: When all other variables were adjusted for, men needing longer to finish a Timed Up and Go Test and a decreased usual walking speed had higher odds of pre-diabetes (P for trend=0.007 and 0.008, respectively) and diabetes (P for trend=0.012 and 0.014, respectively). However, women needing longer to finish the test and a decreased usual walking speed had a higher odds of diabetes (P for trend=0.020 and 0.034, respectively) but not of pre-diabetes. There was no apparent association between grip strength and pre-diabetes/diabetes in both sexes. Conclusions: In this study, poor lower extremity function was associated with prediabetes/diabetes in older people.	[Zhang, Wen; Shen, Suxing; Qiu, Jiahe; Wang, Jiaqi; Meng, Xiangxue; Liang, Yixiong; Guo, Qi] Tianjin Med Univ, Dept Rehabil & Sports Med, Tianjin, Peoples R China; [Wang, Wei; Xu, Limin] Tianjin Med Univ, Gen Hosp, Dept Rehabil, Tianjin, Peoples R China; [Zhou, Chunling] Community Serv Ctr, Tianjin, Peoples R China; [Niu, Kaijun] Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China; [Niu, Kaijun] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China; [Guo, Qi] Tianjin Med Univ, TEDA, TEDA Int Cardiovasc Hosp, Cardiovasc Clin Coll,Dept Rehabil Med, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Guo, Q (corresponding author), Tianjin Med Univ, Dept Rehabil & Sports Med, Tianjin, Peoples R China.	guoqijp@gmail.com	LIANG, YIXIONG/ABC-6068-2021; , Yixiong/AAQ-2023-2020	, Yixiong/0000-0002-2260-066X; Niu, Kaijun/0000-0002-8772-2481	National Natural Science Foundation of China [81372118]; Tianjin City High School Science & Technology Fund Planning Project [20120130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin City High School Science & Technology Fund Planning Project	This work was supported by grant (81372118) from the National Natural Science Foundation of China (QG), and grant (20120130) from the Tianjin City High School Science & Technology Fund Planning Project (QG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2010, OTOL NEUROTOL, V31, P1445, DOI 10.1097/MAO.0b013e3181f2f035; Allen MD, 2013, MUSCLE NERVE, V48, P298, DOI 10.1002/mus.23792; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Cesari M, 2004, J GERONTOL A-BIOL, V59, P242; Chau RMW, 2013, DISABIL REHABIL, V35, P1975, DOI 10.3109/09638288.2013.770079; Cigolle CT, 2011, J GEN INTERN MED, V26, P272, DOI 10.1007/s11606-010-1510-y; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Delbaere K, 2012, AGE AGEING, V41, P404, DOI 10.1093/ageing/afs004; Franch-Nadal J, 2014, FAM PRACT; [江朝强 JIANG Chao-qiang], 2009, [中华流行病学杂志, Chinese Journal of Epidemiology], V30, P462; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; IJzerman TH, 2012, DIABETES RES CLIN PR, V95, P345, DOI 10.1016/j.diabres.2011.10.026; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Lee CG, 2013, J AM GERIATR SOC, V61, P1872, DOI 10.1111/jgs.12502; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee PG, 2013, DIABETES CARE, V36, P3076, DOI 10.2337/dc13-0412; Lee PG, 2009, J AM GERIATR SOC, V57, P511, DOI 10.1111/j.1532-5415.2008.02150.x; Lin YC, 2010, J NURS RES, V18, P88, DOI 10.1097/JNR.0b013e3181dda6d8; McDermott MM, 2004, J AM GERIATR SOC, V52, P405, DOI 10.1111/j.1532-5415.2004.52113.x; McInnes L, 2005, WORLDV EVID-BASED NU, V2, P33, DOI 10.1111/j.1524-475X.2005.04094.x; Meigs JB, 2002, DIABETES CARE, V25, P977, DOI 10.2337/diacare.25.6.977; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Nathan DM, 2007, DIABETIC MED, V24, P137; Okumiya K, 1998, J AM GERIATR SOC, V46, P928, DOI 10.1111/j.1532-5415.1998.tb02737.x; Onder G, 2005, J GERONTOL A-BIOL, V60, P74, DOI 10.1093/gerona/60.1.74; Park SW, 2007, DIABETES CARE, V30, P1507, DOI 10.2337/dc06-2537; Perreault L, 2010, OBESITY, V18, P2093, DOI 10.1038/oby.2010.76; Phielix E, 2008, PHYSIOL BEHAV, V94, P252, DOI 10.1016/j.physbeh.2008.01.020; Roman de Mettelinge T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067055; SAID G, 1992, NEW ENGL J MED, V326, P1257, DOI 10.1056/NEJM199205073261905; Sayer AA, 2005, DIABETES CARE, V28, P2541, DOI 10.2337/diacare.28.10.2541; Shimada H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002424; Stenholm S, 2011, J GERONTOL A-BIOL, V66, P341, DOI 10.1093/gerona/glq226; Tsunoda K, 2013, GERIATR GERONTOL INT, V13, P919, DOI 10.1111/ggi.12032; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326; Volpato S, 2012, DIABETES CARE, V35, P1672, DOI 10.2337/dc11-2202; Wander PL, 2011, DIABETES RES CLIN PR, V92, P261, DOI 10.1016/j.diabres.2011.01.007; Wang J, 2011, DIABETES VASC DIS RE, V8, P29, DOI 10.1177/1479164110396743; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118	43	33	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115883	10.1371/journal.pone.0115883	http://dx.doi.org/10.1371/journal.pone.0115883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531769	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845100112
J	Zhao, L; Cao, XD; Zheng, W; Kan, Y				Zhao, Ling; Cao, Xinde; Zheng, Wei; Kan, Yue			Phosphorus-Assisted Biomass Thermal Conversion: Reducing Carbon Loss and Improving Biochar Stability	PLOS ONE			English	Article							BLACK CARBON; PYROLYSIS TEMPERATURE; CONTAMINATED SOILS; CARBON/CARBON COMPOSITES; OXIDATION RESISTANCE; GRAPHITE OXIDATION; INHIBITION; IMMOBILIZATION; IMPACT; PLANT	There is often over 50% carbon loss during the thermal conversion of biomass into biochar, leading to it controversy for the biochar formation as a carbon sequestration strategy. Sometimes the biochar also seems not to be stable enough due to physical, chemical, and biological reactions in soils. In this study, three phosphorus-bearing materials, H3PO4, phosphate rock tailing (PRT), and triple superphosphate (TSP), were used as additives to wheat straw with a ratio of 1: 0.4-0.8 for biochar production at 500 degrees C, aiming to alleviate carbon loss during pyrolysis and to increase biochar-C stabilization. All these additives remarkably increased the biochar yield from 31.7% (unmodified biochar) to 46.9%-56.9% (modified biochars). Carbon loss during pyrolysis was reduced from 51.7% to 35.5%-47.7%. Thermogravimetric analysis curves showed that the additives had no effect on thermal stability of biochar but did enhance its oxidative stability. Microbial mineralization was obviously reduced in the modified biochar, especially in the TSP-BC, in which the total CO2 emission during 60-d incubation was reduced by 67.8%, compared to the unmodified biochar. Enhancement of carbon retention and biochar stability was probably due to the formation of meta-phosphate or C-O-PO3, which could either form a physical layer to hinder the contact of C with O-2 and bacteria, or occupy the active sites of the C band. Our results indicate that pre-treating biomass with phosphors-bearing materials is effective for reducing carbon loss during pyrolysis and for increasing biochar stabilization, which provides a novel method by which biochar can be designed to improve the carbon sequestration capacity.	[Zhao, Ling; Cao, Xinde; Kan, Yue] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai 200240, Peoples R China; [Zhao, Ling; Zheng, Wei] Univ Illinois, Illinois Sustainable Technol Ctr, Champaign, IL 61820 USA	Shanghai Jiao Tong University; University of Illinois System; University of Illinois Urbana-Champaign	Cao, XD (corresponding author), Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai 200240, Peoples R China.	xdcao@sjtu.edu.cn			National Natural Science Foundation of China [21107070, 21377081]; Shanghai Science and Technology Commission [13231202502]; Shanghai Education Commission [14ZZ026]; State Key Laboratory of Pollution Control and Resource Reuse Foundation [PCRRF12009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Education Commission; State Key Laboratory of Pollution Control and Resource Reuse Foundation	This work was supported by the National Natural Science Foundation of China (No. 21107070, 21377081), Shanghai Science and Technology Commission (13231202502), and Shanghai Education Commission (14ZZ026). This work was also partially supported by State Key Laboratory of Pollution Control and Resource Reuse Foundation (NO. PCRRF12009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, D317207A ASTM; ANTAL MJ, 1990, ENERG FUEL, V4, P221, DOI 10.1021/ef00021a001; Bruun S, 2008, ORG GEOCHEM, V39, P839, DOI 10.1016/j.orggeochem.2008.04.020; Bruun S, 2008, ENVIRON SCI TECHNOL, V42, P1388; Cantrell KB, 2012, BIORESOURCE TECHNOL, V107, P419, DOI 10.1016/j.biortech.2011.11.084; Cao RX, 2003, ENVIRON POLLUT, V122, P19, DOI 10.1016/S0269-7491(02)00283-X; Cao XD, 2013, ENVIRON SCI POLLUT R, V20, P5913, DOI 10.1007/s11356-012-1349-3; Cao XD, 2011, ENVIRON SCI TECHNOL, V45, P4884, DOI 10.1021/es103752u; Cao XD, 2010, BIORESOURCE TECHNOL, V101, P5222, DOI 10.1016/j.biortech.2010.02.052; Cao XD, 2009, J HAZARD MATER, V164, P555, DOI 10.1016/j.jhazmat.2008.08.034; Cheng CH, 2006, ORG GEOCHEM, V37, P1477, DOI 10.1016/j.orggeochem.2006.06.022; Cross A, 2013, GCB BIOENERGY, V5, P215, DOI 10.1111/gcbb.12035; Fang YY, 2012, ENVIRON SCI POLLUT R, V19, P1659, DOI 10.1007/s11356-011-0674-2; Harvey OR, 2010, ENVIRON SCI TECHNOL, V46, P1415; Hossain MK, 2011, J ENVIRON MANAGE, V92, P223, DOI 10.1016/j.jenvman.2010.09.008; Kluepfel L, 2014, ENVIRON SCI TECHNOL, V48, P5601, DOI 10.1021/es500906d; Kuzyakov Y, 2009, SOIL BIOL BIOCHEM, V41, P210, DOI 10.1016/j.soilbio.2008.10.016; LeCroy C, 2013, SOIL BIOL BIOCHEM, V58, P248, DOI 10.1016/j.soilbio.2012.11.023; Lee YJ, 2003, CARBON, V41, P1987, DOI 10.1016/S0008-6223(03)00199-4; Lehmann J., 2009, SCI TECHNOL HUM VAL, DOI 10.4324/9781849770552; Li KZ, 2012, CORROS SCI, V60, P314, DOI 10.1016/j.corsci.2012.03.031; Lu WM, 2002, CARBON, V40, P1249, DOI 10.1016/S0008-6223(01)00297-4; Rosas JM, 2012, CARBON, V50, P1523, DOI 10.1016/j.carbon.2011.11.030; Mathews JA, 2008, ENERG POLICY, V36, P940, DOI 10.1016/j.enpol.2007.11.029; Matovic D, 2011, ENERGY, V36, P2011, DOI 10.1016/j.energy.2010.09.031; MCKEE DW, 1984, CARBON, V22, P285, DOI 10.1016/0008-6223(84)90172-6; Meyer S, 2012, ENVIRON SCI TECHNOL, V46, P12726, DOI 10.1021/es302302g; Meyer S, 2011, ENVIRON SCI TECHNOL, V45, P9473, DOI 10.1021/es201792c; Novak JM, 2010, GEODERMA, V154, P281, DOI 10.1016/j.geoderma.2009.10.014; OH SG, 1993, J MATER RES, V8, P2879, DOI 10.1557/JMR.1993.2879; Park JH, 2011, J HAZARD MATER, V185, P829, DOI 10.1016/j.jhazmat.2010.09.095; Peng L, 2014, ENVIRON SCI POLLUT R, V21, P7631, DOI 10.1007/s11356-014-2677-2; Qian TT, 2014, ENVIRON SCI TECHNOL, V48, P10734, DOI 10.1021/es502669s; RICHARDS GN, 1991, J ANAL APPL PYROL, V21, P133, DOI 10.1016/0165-2370(91)80021-Y; Spokas KA, 2009, CHEMOSPHERE, V77, P574, DOI 10.1016/j.chemosphere.2009.06.053; Trompowsky PM, 2005, ORG GEOCHEM, V36, P1480, DOI 10.1016/j.orggeochem.2005.08.001; Uchimiya M, 2014, J AGR FOOD CHEM, V62, P1802, DOI 10.1021/jf4053385; Wan YQ, 2009, J ANAL APPL PYROL, V86, P161, DOI 10.1016/j.jaap.2009.05.006; Whitman T, 2011, ENVIRON SCI TECHNOL, V45, P3687, DOI 10.1021/es103301k; Wu XX, 2006, CARBON, V44, P141, DOI 10.1016/j.carbon.2005.06.038; Yao FX, 2010, CHEMOSPHERE, V80, P724, DOI 10.1016/j.chemosphere.2010.05.026; Zhao L, 2013, J HAZARD MATER, V256, P1, DOI 10.1016/j.jhazmat.2013.04.015; Zimmerman AR, 2010, ENVIRON SCI TECHNOL, V44, P1295, DOI 10.1021/es903140c	43	47	53	16	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115373	10.1371/journal.pone.0115373	http://dx.doi.org/10.1371/journal.pone.0115373			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531111	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100056
J	Brindle, E; Stevens, D; Crudder, C; Levin, CE; Garrett, D; Lyman, C; Boyle, DS				Brindle, Eleanor; Stevens, Daniel; Crudder, Christopher; Levin, Carol E.; Garrett, Dean; Lyman, Chris; Boyle, David S.			A Multiplex Immunoassay Method for Simultaneous Quantification of Iron, Vitamin A and Inflammation Status Markers	PLOS ONE			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; RETINOL-BINDING-PROTEIN; C-REACTIVE PROTEIN; ENZYME-IMMUNOASSAY; SERUM RETINOL; CHILD UNDERNUTRITION; DEFICIENCY ANEMIA; FERRITIN; NUTRITION; DIAGNOSIS	Deficiencies of vitamin A and iron affect a significant portion of the world's population, and efforts to characterize patterns of these deficiencies are hampered by a lack of measurement tools appropriate for large-scale population-based surveys. Vitamin A and iron are not easily measured directly, so reliable proxy markers for deficiency status have been identified and adopted. Measurement of inflammatory markers is necessary to interpret vitamin A and iron status markers, because circulating levels are altered by inflammation. We developed a multiplex immunoassay method for simultaneous measurement of five markers relevant to assessing inflammation, vitamin A and iron status: alpha-1-acid glycoprotein, C-reactive protein, retinol binding protein 4, ferritin and soluble transferrin receptor. Serum and plasma specimens were used to optimize the assay protocol. To evaluate assay performance, plasma from 72 volunteers was assayed using the multiplex technique and compared to conventional immunoassay methods for each of the five markers. Results of the new and conventional assay methods were highly correlated (Pearson Correlations of 0.606 to 0.991, p<.0001). Inter-assay imprecision for the multiplex panel varied from 1% to 8%, and all samples fell within the limits of quantification for all assays at a single dilution. Absolute values given by the multiplex and conventional assays differed, indicating a need for further work to devise a new standard curve. This multiplexed micronutrient immunoassay technique has excellent potential as a cost effective tool for use in large-scale deficiency assessment efforts.	[Brindle, Eleanor] Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA; [Stevens, Daniel; Crudder, Christopher; Garrett, Dean; Boyle, David S.] PATH, Seattle, WA USA; [Levin, Carol E.] Univ Washington, Dis Control Prior Network, Seattle, WA 98195 USA; [Garrett, Dean] ICF Int, Rockville, MD 20850 USA; [Lyman, Chris] Quansys Biosci, Logan, UT 84321 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Brindle, E (corresponding author), Univ Washington, Ctr Studies Demog & Ecol, 218D Raitt Hall,Box 353412, Seattle, WA 98195 USA.	ebrindle@uw.edu	Brindle, Eleanor/AAK-5028-2021	Brindle, Eleanor/0000-0002-4272-0909	Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant [R24 HD042828]; Bill and Melinda Gates Foundation; United States Agency for International Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); United States Agency for International Development(United States Agency for International Development (USAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Partial support for this research came from a Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant, R24 HD042828, to the Center for Studies in Demography & Ecology at the University of Washington, from the Bill and Melinda Gates Foundation to PATH, and from the United States Agency for International Development to PATH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2012, ANN NUTR METAB, V61, P8, DOI 10.1159/000345165; Akesson A, 1999, SCAND J CLIN LAB INV, V59, P77, DOI 10.1080/00365519950185788; Baingana RK, 2008, FOOD NUTR BULL, V29, P297, DOI 10.1177/156482650802900406; Baingana RK, 2012, PUBLIC HEALTH NUTR, P1; Beguin Y, 2003, CLIN CHIM ACTA, V329, P9, DOI 10.1016/S0009-8981(03)00005-6; BENDER DA, 2003, NUTR BIOCH VITAMINS, P30; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brindle E, 2010, J IMMUNOL METHODS, V362, P112, DOI 10.1016/j.jim.2010.09.014; Cascella M, 2013, ARCH BIOCHEM BIOPHYS, V539, P187, DOI 10.1016/j.abb.2013.06.003; Cermak J, 1998, EUR J HAEMATOL, V61, P210; Chaimongkol L, 2011, CLIN BIOCHEM, V44, P1030, DOI 10.1016/j.clinbiochem.2011.05.023; Chang SY, 2013, PEDIATRICS, V131, pE755, DOI 10.1542/peds.2011-3513; Chiba A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3683; Cook JD, 1998, BLOOD, V92, P1807, DOI 10.1182/blood.V92.5.1807.417a03_1807_1813; Cook JD, 2005, BEST PRACT RES CL HA, V18, P319, DOI 10.1016/j.beha.2004.08.022; Courtright P, 2011, ARCH DIS CHILD, V96, P1129, DOI 10.1136/archdischild-2011-300093; Davies C., 2005, IMMUNOASSAY HDB, P3; de Pee S, 2002, J NUTR, V132, p2895S, DOI 10.1093/jn/132.9.2895S; DERUYTER MGM, 1976, CLIN CHEM, V22, P1593; Ellington AA, 2010, CLIN CHEM, V56, P186, DOI 10.1373/clinchem.2009.127514; Elmadfa I, 2012, INT J VITAM NUTR RES, V82, P342, DOI 10.1024/0300-9831/a000129; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Ervasti M, 2004, CLIN LAB HAEMATOL, V26, P205, DOI 10.1111/j.1365-2257.2004.00600.x; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Gamble MV, 2001, AM J CLIN NUTR, V73, P594; Garrett DA, 2011, AM J CLIN NUTR, V94, p685S, DOI 10.3945/ajcn.110.005751; Guagnozzi D, 2006, INFLAMM BOWEL DIS, V12, P150, DOI 10.1097/01.MIB.0000199223.27595.e3; Hikawa A, 1996, CLIN CHIM ACTA, V254, P159, DOI 10.1016/0009-8981(96)06375-9; Hix J, 2004, AM J CLIN NUTR, V79, P93; ISHIKAWA K, 1982, CLIN CHIM ACTA, V123, P73, DOI 10.1016/0009-8981(82)90115-2; Lattie EG, 2012, BRAIN BEHAV IMMUN, V26, P849, DOI 10.1016/j.bbi.2012.02.008; Malope BI, 2001, BRIT J HAEMATOL, V115, P84, DOI 10.1046/j.1365-2141.2001.03063.x; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Miller J., 2013, COLD SPRING HARB PER, V<bold>3</bold>; Mitka M, 2013, JAMA-J AM MED ASSOC, V309, P2428, DOI 10.1001/jama.2013.7239; Muthayya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067860; NG RH, 1983, CLIN CHEM, V29, P1109; Northrop-Clewes CA, 2008, ANN CLIN BIOCHEM, V45, P18, DOI 10.1258/acb.2007.007167; Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219; Rimon E, 2002, ARCH INTERN MED, V162, P445, DOI 10.1001/archinte.162.4.445; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; Tanumihardjo SA, 2011, AM J CLIN NUTR, V94, p658S, DOI 10.3945/ajcn.110.005777; Thurnham DI, 2014, P NUTR SOC, V73, P1, DOI 10.1017/S0029665113003662; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; WHO, 2009, GLOB PREV VIT A DEF, P55	47	11	11	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115164	10.1371/journal.pone.0115164	http://dx.doi.org/10.1371/journal.pone.0115164			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525806	Green Published, gold, Green Submitted			2022-12-26	WOS:000347186200016
J	Davila, A; Schouten, B; Verfaillie, K				Davila, Alex; Schouten, Ben; Verfaillie, Karl			Perceiving the Direction of Articulatory Motion in Point-Light Actions	PLOS ONE			English	Article							BIOLOGICAL-MOTION; STIMULUS SET; PERCEPTION; ORIENTATION; ATTENTION; FEATURES; OBJECT; DEPTH	Human observers are able to perceive the motion direction of actions (either forward or backward) on the basis of the articulatory, relative motion of the limbs, even when the actions are shown under point-light conditions. However, most studies have focused on the action of walking. The primary purpose of the present study is to further investigate the perception of articulatory motion in different point-light actions (walking, crawling, hand walking, and rowing). On each trial, participants were presented with a forward or backward moving person and they had to decide on the direction of articulatory motion of the person. We analyzed sensitivity (d') as well as response bias (c). In addition to the type of action, the diagnosticity of the available information was manipulated by varying the visibility of the body parts (full body, only upper limbs, or only lower limbs) and the viewpoint from which the action was seen (from frontal view to sagittal view). We observe that, depending on the specific action, perception of direction of motion is driven by different body parts. Implications for the possible existence of a life detector, i.e., an evolutionarily old and innate visual filter that is tuned to quickly and automatically detect the presence of a moving living organism and direct attention to it, are discussed.	[Davila, Alex; Schouten, Ben; Verfaillie, Karl] Univ Leuven, Expt Psychol Lab, Leuven, Belgium	KU Leuven	Verfaillie, K (corresponding author), Univ Leuven, Expt Psychol Lab, Leuven, Belgium.	Karl.Verfaillie@psy.kuleuven.be	Davila, Alex/AAJ-5086-2020		Fund for Scientific Research-Flanders [G.0810.13];  [3H090031]	Fund for Scientific Research-Flanders(FWO); 	The writing of this article was supported by project from the Fund for Scientific Research-Flanders G.0810.13. Alex Davila was supported by Phd Project 3H090031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autodesk Inc, 2011, AUT 3D STUD MAX REL; BARCIKOWSKI RS, 1984, AM STAT, V38, P148, DOI 10.2307/2683254; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Bulthoff I, 1998, NAT NEUROSCI, V1, P254, DOI 10.1038/699; Casile A, 2006, CURR BIOL, V16, P69, DOI 10.1016/j.cub.2005.10.071; Cavanagh P, 2001, COGNITION, V80, P47, DOI 10.1016/S0010-0277(00)00153-0; Chang DHF, 2008, J VISION, V8, DOI 10.1167/8.5.3; Chang DHF, 2009, J VISION, V9, DOI [10.1167/9.1.19, 10.1167/9.5.8]; Cutting James E, 1981, INTERSENSORY PERCEPT, P249, DOI DOI 10.1007/978-1-4615-9197-9_8; CUTTING JE, 1981, J EXP PSYCHOL HUMAN, V7, P71, DOI 10.1037/0096-1523.7.1.71; Dekeyser M, 2002, BEHAV RES METH INS C, V34, P375, DOI 10.3758/BF03195465; DITTRICH WH, 1993, PERCEPTION, V22, P15, DOI 10.1068/p220015; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Girden E.R., 1992, ANOVA REPEATED MEASU, V84; HOFFMAN DD, 1982, BIOL CYBERN, V42, P195; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kuhlmann S, 2009, J VISION, V9, DOI 10.1167/9.10.11; Lange Joachim, 2008, Adv Cogn Psychol, V3, P419, DOI 10.2478/v10053-008-0006-3; Lu HJ, 2006, J VISION, V6, P475, DOI 10.1167/6.4.12; MacLellan MJ, 2012, J NEUROPHYSIOL, V107, P114, DOI 10.1152/jn.00693.2011; Manera V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022650; Manera V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014594; Manera V, 2010, BEHAV RES METHODS, V42, P168, DOI 10.3758/BRM.42.1.168; MCBEATH MK, 1992, PSYCHOL SCI, V3, P362, DOI 10.1111/j.1467-9280.1992.tb00048.x; Michotte A, 1954, MICHOTTES EXPT PHENO, P24; Michotte A. E, 1946, PERCEPTION CAUSALITE; Patrick SK, 2009, J NEUROPHYSIOL, V101, P603, DOI 10.1152/jn.91125.2008; Red Eye Studio Inc, 2002, HANDWALK; Saunders DR, 2010, J VISION, V10, DOI 10.1167/10.11.9; Saunders DR, 2009, PERCEPTION, V38, P522, DOI 10.1068/p6140; Schouten B, 2011, ATTEN PERCEPT PSYCHO, V73, P130, DOI 10.3758/s13414-010-0018-1; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Shipley TF, 2003, PSYCHOL SCI, V14, P377, DOI 10.1111/1467-9280.24471; Sterzer P, 2008, CURR BIOL, V18, pR697, DOI 10.1016/j.cub.2008.06.021; Takahashi K, 2011, J VISION, V11, DOI 10.1167/11.14.8; Thompson J, 2012, NEUROIMAGE, V59, P4, DOI 10.1016/j.neuroimage.2011.05.044; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; van Boxtel JJA, 2011, J VISION, V11, DOI 10.1167/11.7.19; Vangeneugden J, 2010, J VISION, V10, DOI 10.1167/10.4.22; Vanrie J, 2004, BEHAV RES METH INS C, V36, P625, DOI 10.3758/BF03206542; Vanrie J, 2006, PERCEPT PSYCHOPHYS, V68, P601, DOI 10.3758/BF03208762; VERFAILLIE K, 1993, J EXP PSYCHOL HUMAN, V19, P992, DOI 10.1037/0096-1523.19.5.992; Verfaillie K, 2000, BRAIN COGNITION, V44, P192, DOI 10.1006/brcg.2000.1228; WEBB JA, 1982, ARTIF INTELL, V19, P107, DOI 10.1016/0004-3702(82)90023-6; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Withagen R, 2002, ECOL PSYCHOL, V14, P223, DOI 10.1207/S15326969ECO1404_2; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002	49	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115117	10.1371/journal.pone.0115117	http://dx.doi.org/10.1371/journal.pone.0115117			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8WK	25526397	Green Published, Green Submitted, gold			2022-12-26	WOS:000347186200013
J	Ng, DHJ; Humphries, JD; Byron, A; Millon-Fremillon, A; Humphries, MJ				Ng, Daniel H. J.; Humphries, Jonathan D.; Byron, Adam; Millon-Fremillon, Angelique; Humphries, Martin J.			Microtubule-Dependent Modulation of Adhesion Complex Composition	PLOS ONE			English	Article							CELL-MATRIX ADHESIONS; BINDING PROTEIN RHO; LARGE GENE LISTS; FOCAL ADHESIONS; MYOSIN-II; INTEGRIN ADHESOME; FIBRONECTIN FIBRILLOGENESIS; ACTIN CYTOSKELETON; VINCULIN-BINDING; STRESS FIBERS	The microtubule network regulates the turnover of integrin-containing adhesion complexes to stimulate cell migration. Disruption of the microtubule network results in an enlargement of adhesion complex size due to increased RhoA-stimulated actomyosin contractility, and inhibition of adhesion complex turnover; however, the microtubule-dependent changes in adhesion complex composition have not been studied in a global, unbiased manner. Here we used label-free quantitative mass spectrometry-based proteomics to determine adhesion complex changes that occur upon microtubule disruption with nocodazole. Nocodazole-treated cells displayed an increased abundance of the majority of known adhesion complex components, but no change in the levels of the fibronectin-binding alpha(5)beta(1) integrin. Immunofluorescence analyses confirmed these findings, but revealed a change in localisation of adhesion complex components. Specifically, in untreated cells, alpha(5)-integrin co-localised with vinculin at peripherally located focal adhesions and with tensin at centrally located fibrillar adhesions. In nocodazole-treated cells, however, alpha(5)-integrin was found in both peripherally located and centrally located adhesion complexes that contained both vinculin and tensin, suggesting a switch in the maturation state of adhesion complexes to favour focal adhesions. Moreover, the switch to focal adhesions was confirmed to be force-dependent as inhibition of cell contractility with the Rho-associated protein kinase inhibitor, Y-27632, prevented the nocodazole-induced conversion. These results highlight a complex interplay between the microtubule cytoskeleton, adhesion complex maturation state and intracellular contractile force, and provide a resource for future adhesion signaling studies. The proteomics data have been deposited in the ProteomeXchange with identifier PXD001183.	[Ng, Daniel H. J.; Humphries, Jonathan D.; Byron, Adam; Millon-Fremillon, Angelique; Humphries, Martin J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Humphries, MJ (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.	martin.humphries@manchester.ac.uk	Ng, Daniel/AAN-2799-2020; Byron, Adam/AID-5111-2022; Byron, Adam/C-4871-2008; Humphries, Jonathan D./AAE-7760-2022	Byron, Adam/0000-0002-5939-9883; Humphries, Jonathan D./0000-0002-8953-7079; Humphries, Martin/0000-0002-4331-6967	Wellcome Trust [092015]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (grant 092015 to M.J.H.). URL: http://www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Chautard E, 2009, BIOINFORMATICS, V25, P690, DOI 10.1093/bioinformatics/btp025; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; DANOWSKI BA, 1989, J CELL SCI, V93, P255; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Ghatak S, 2013, BIOCHEM SOC T, V41, P995, DOI 10.1042/BST20130062; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Hemmings L, 1996, J CELL SCI, V109, P2715; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Nalbant P, 2009, MOL BIOL CELL, V20, P4070, DOI 10.1091/mbc.E09-01-0041; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rooney C, 2010, EMBO REP, V11, P292, DOI 10.1038/embor.2010.10; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Stehbens SJ, 2014, NAT CELL BIOL, V16, P558, DOI 10.1038/ncb2975; van der Vaart B, 2013, DEV CELL, V27, P145, DOI 10.1016/j.devcel.2013.09.010; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Wu JM, 2009, NAT METHODS, V6, P75, DOI [10.1038/nmeth.1282, 10.1038/NMETH.1282]; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 1999, J CELL SCI, V112, P1655	55	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115213	10.1371/journal.pone.0115213	http://dx.doi.org/10.1371/journal.pone.0115213			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526367	gold, Green Published, Green Submitted			2022-12-26	WOS:000347186200018
J	Naess, S; Lie, BA; Melum, E; Olsson, M; Hov, JR; Croucher, PJP; Hampe, J; Thorsby, E; Bergquist, A; Traherne, JA; Schrumpf, E; Boberg, KM; Schreiber, S; Franke, A; Karlsen, TH				Naess, Sigrid; Lie, Benedicte A.; Melum, Espen; Olsson, Marita; Hov, Johannes R.; Croucher, Peter J. P.; Hampe, Jochen; Thorsby, Erik; Bergquist, Annika; Traherne, James A.; Schrumpf, Erik; Boberg, Kirsten Muri; Schreiber, Stefan; Franke, Andre; Karlsen, Tom H.			Refinement of the MHC Risk Map in a Scandinavian Primary Sclerosing Cholangitis Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; MULTIPLE-SCLEROSIS; HLA-B; SUSCEPTIBILITY; HAPLOTYPES; ANTIGEN; LOCI; ALLELES; DISEASE	Background: Genetic variants within the major histocompatibility complex (MHC) represent the strongest genetic susceptibility factors for primary sclerosing cholangitis (PSC). Identifying the causal variants within this genetic complex represents a major challenge due to strong linkage disequilibrium and an overall high physical density of candidate variants. We aimed to refine the MHC association in a geographically restricted PSC patient panel. Methodology/Principal Findings: A total of 365 PSC cases and 368 healthy controls of Scandinavian ancestry were included in the study. We incorporated data from HLA typing (HLA-A, -B, -C, -DRB3, -DRB1, -DQB1) and single nucleotide polymorphisms across the MHC (n = 18,644; genotyped and imputed) alongside previously suggested PSC risk determinants in the MHC, i.e. amino acid variation of DR beta, a MICA microsatellite polymorphism and HLA-C and HLA-B according to their ligand properties for killer immunoglobulin-like receptors. Breakdowns of the association signal by unconditional and conditional logistic regression analyses demarcated multiple PSC associated MHC haplotypes, and for eight of these classical HLA class I and II alleles represented the strongest association. A novel independent risk locus was detected near NOTCH4 in the HLA class III region, tagged by rs116212904 (odds ratio [95% confidence interval] = 2.32 [1.80, 3.00], P=1.35 x 10(-11)). Conclusions/Significance: Our study shows that classical HLA class I and II alleles, predominantly at HLA-B and HLA-DRB1, are the main risk factors for PSC in the MHC. In addition, the present assessments demonstrated for the first time an association near NOTCH4 in the HLA class III region.	[Naess, Sigrid; Melum, Espen; Hov, Johannes R.; Schrumpf, Erik; Boberg, Kirsten Muri; Karlsen, Tom H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Norwegian PSC Res Ctr,Dept Transplantat Med,Div C, N-0027 Oslo, Norway; [Naess, Sigrid; Hov, Johannes R.; Thorsby, Erik; Boberg, Kirsten Muri; Karlsen, Tom H.] Univ Oslo, Inst Clin Med, N-0027 Oslo, Norway; [Naess, Sigrid; Melum, Espen; Hov, Johannes R.; Karlsen, Tom H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Clin Med, N-0027 Oslo, Norway; [Lie, Benedicte A.; Thorsby, Erik] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Immunol, N-0027 Oslo, Norway; [Lie, Benedicte A.] Univ Oslo, Dept Med Genet, N-0027 Oslo, Norway; [Lie, Benedicte A.] Oslo Univ Hosp, Oslo, Norway; [Olsson, Marita] Chalmers Univ Technol, S-41296 Gothenburg, Sweden; [Croucher, Peter J. P.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Hampe, Jochen] Tech Univ Dresden, Univ Hosp Dresden, Dept Med 1, D-01062 Dresden, Germany; [Bergquist, Annika] Karolinska Univ Hosp, Karolinska Inst, Dept Gastroenterol & Hepatol, Stockholm, Sweden; [Traherne, James A.] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England; [Schrumpf, Erik] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 1QP, England; [Boberg, Kirsten Muri; Karlsen, Tom H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Transplantat Med,Gastroenterol Sect, N-0027 Oslo, Norway; [Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Schreiber, Stefan] Univ Kiel, Dept Gen Internal Med, Kiel, Germany	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Chalmers University of Technology; University of California System; University of California Berkeley; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Cambridge; University of Cambridge; University of Oslo; National Hospital Norway; University of Kiel; University of Kiel	Karlsen, TH (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Norwegian PSC Res Ctr,Dept Transplantat Med,Div C, N-0027 Oslo, Norway.	t.h.karlsen@medisin.uio.no	Franke, Andre/B-2151-2010; Hampe, Jochen/A-2555-2010; Hov, Johannes R/J-1480-2019	Franke, Andre/0000-0003-1530-5811; Hampe, Jochen/0000-0002-2421-6127; Hov, Johannes R/0000-0002-5900-8096; Bergquist, Annika/0000-0002-3858-6241	Norwegian PSC research center; Research Computing Services at the University of Oslo; DFG Excellence Cluster "Inflammation at Interfaces"; EU [262055]	Norwegian PSC research center; Research Computing Services at the University of Oslo; DFG Excellence Cluster "Inflammation at Interfaces"(German Research Foundation (DFG)); EU(European Commission)	The study received support from the Norwegian PSC research center, the Research Computing Services at the University of Oslo and the DFG Excellence Cluster "Inflammation at Interfaces". Grant support was also received from the EU Seventh Framework Programme (FP7/2007-2013, grant number 262055, ESGI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowlus CL, 2010, LIVER TRANSPLANT, V16, P1324, DOI 10.1002/lt.22161; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Donaldson PT, 2002, AUTOIMMUNITY, V35, P555, DOI 10.1080/0891693021000054093; DONALDSON PT, 1991, HEPATOLOGY, V13, P129, DOI 10.1016/0270-9139(91)90225-K; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Folseraas T, 2011, BEST PRACT RES CL GA, V25, P713, DOI 10.1016/j.bpg.2011.09.010; Fuchsberger C, 2014, BIOINFORMATICS; Gabriel C, 2014, TISSUE ANTIGENS, V83, P65, DOI 10.1111/tan.12298; Hirschfield GM, 2013, LANCET, V382, P1587, DOI 10.1016/S0140-6736(13)60096-3; Hov JR, 2011, HEPATOLOGY, V53, P1967, DOI 10.1002/hep.24299; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Karlsen T, 2007, GENES IMMUN, V8, P275, DOI 10.1038/sj.gene.6364377; Karlsen TH, 2007, J HEPATOL, V46, P899, DOI 10.1016/j.jhep.2007.01.032; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Rahman P, 2012, J RHEUMATOL, V39, P1726, DOI 10.3899/jrheum.111242; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Saarinen S, 2000, AM J GASTROENTEROL, V95, P3195; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sayer DC, 2004, TISSUE ANTIGENS, V64, P556, DOI 10.1111/j.1399-0039.2004.00283.x; Sayer DC, 2004, TISSUE ANTIGENS, V63, P412, DOI 10.1111/j.0001-2815.2004.00214.x; Shayevitz C, 2012, AM J MED GENET B, V159B, P477, DOI 10.1002/ajmg.b.32050; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Spurkland A, 1999, TISSUE ANTIGENS, V53, P459, DOI 10.1034/j.1399-0039.1999.530502.x; Tobler Andreas R, 2005, J Biomol Tech, V16, P398; Trowsdale J., 2013, ANN REV GENOMICS HUM; Valdes AM, 2009, DIABETES OBES METAB, V11, P46, DOI 10.1111/j.1463-1326.2008.01002.x; Wiencke K, 2007, TISSUE ANTIGENS, V69, P161, DOI 10.1111/j.1399-0039.2006.00738.x; Wiencke K, 2001, HEPATOLOGY, V34, P625, DOI 10.1053/jhep.2001.27543; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zachary AA, 2001, HUM IMMUNOL, V62, P1127, DOI 10.1016/S0198-8859(01)00305-6	39	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114486	10.1371/journal.pone.0114486	http://dx.doi.org/10.1371/journal.pone.0114486			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521205	Green Published, gold			2022-12-26	WOS:000348845600002
J	Shan, X; Fu, YS; Aziz, F; Wang, XQ; Yan, Q; Liu, JW				Shan, Xiu; Fu, Yuan-Shan; Aziz, Faisal; Wang, Xiao-Qi; Yan, Qiu; Liu, Ji-Wei			Ginsenoside Rg3 Inhibits Melanoma Cell Proliferation through Down-Regulation of Histone Deacetylase 3 (HDAC3) and Increase of p53 Acetylation	PLOS ONE			English	Article							CANCER-CELLS; BRAF INHIBITORS; EXPRESSION; APOPTOSIS; DIFFERENTIATION; TRICHOSTATIN; COMBINATION; DACARBAZINE; BELINOSTAT; STABILITY	Malignant melanoma is an aggressive and deadly form of skin cancer, and despite recent advances in available therapies, is still lacking in completely effective treatments. Rg3, a monomer extracted from ginseng roots, has been attempted for the treatment of many cancers. It is reported that the expressions of histone deacetylase 3 (HDAC3) and p53 acetylation correlate with tumor cell growth. However, the antitumor effect of Rg3 on melanoma and the mechanism by which it regulates HDAC3 expression and p53 acetylation remain unknown. We found high expression of HDAC3 in human melanoma tissues to be significantly correlated to lymph node metastasis and clinical stage of disease (p<0.05). In melanoma cells, Rg3 inhibited cell proliferation and induced G0/G1 cell cycle arrest. Rg3 also decreased the expression of HDAC3 and increased the acetylation of p53 on lysine (k373/k382). Moreover, suppression of HDAC3 by either siRNA or a potent HDAC3 inhibitor (MS-275) inhibited cell proliferation, increased p53 acetylation and transcription activity. In A375 melanoma xenograft studies, we demonstrated that Rg3 and HDAC3 short hairpin RNA (shHDAC3) inhibited the growth of xenograft tumors with down-regulation of HDAC3 expression and up-regulation of p53 acetylation. In conclusion, Rg3 has antiproliferative activity against melanoma by decreasing HDAC3 and increasing acetylation of p53 both in vitro and in vivo. Thus, Rg3 serves as a potential therapeutic agent for the treatment of melanoma.	[Shan, Xiu; Liu, Ji-Wei] Dalian Med Univ, Dept Oncol, Affiliated Hosp 1, Dalian, Liaoning Provin, Peoples R China; [Fu, Yuan-Shan] Dalian Med Univ, Dept Human Anat, Dalian, Liaoning Provin, Peoples R China; [Aziz, Faisal; Yan, Qiu] Dalian Med Univ, Dept Biochem & Mol Biol, Liaoning Prov Core Lab Glycobiol & Glycoengn, Dalian, Liaoning Provin, Peoples R China; [Wang, Xiao-Qi] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA	Dalian Medical University; Dalian Medical University; Dalian Medical University; Northwestern University; Feinberg School of Medicine	Yan, Q (corresponding author), Dalian Med Univ, Dept Biochem & Mol Biol, Liaoning Prov Core Lab Glycobiol & Glycoengn, Dalian, Liaoning Provin, Peoples R China.	yanqiu63@126.com; jiweiliudl@126.com	Aziz, Faisal/AAF-4666-2020	Aziz, Faisal/0000-0002-5802-5855	National Natural Science Foundation of China Research Grant [30672753]; Major State basic Research Development Program (973 program) of China [2012CB822103]	National Natural Science Foundation of China Research Grant(National Natural Science Foundation of China (NSFC)); Major State basic Research Development Program (973 program) of China(National Basic Research Program of China)	The project was supported by the National Natural Science Foundation of China Research Grant (No. 30672753) and the Major State basic Research Development Program (973 program) of China (2012CB822103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan LM, 2014, TARGET ONCOL, V9, P63, DOI 10.1007/s11523-013-0276-7; Avril MF, 2004, J CLIN ONCOL, V22, P1118, DOI 10.1200/JCO.2004.04.165; Bartling B, 2005, LUNG CANCER-J IASLC, V49, P145, DOI 10.1016/j.lungcan.2005.02.006; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boissinot M, 2012, LEUKEMIA RES, V36, P1304, DOI 10.1016/j.leukres.2012.07.002; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Chang J, 2012, BRIT J CANCER, V106, P116, DOI 10.1038/bjc.2011.532; Chen CQ, 2013, MOL CELL BIOCHEM, V383, P137, DOI 10.1007/s11010-013-1762-z; Diyabalanage HVK, 2013, CANCER LETT, V329, P1, DOI 10.1016/j.canlet.2012.09.018; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Feng LF, 2013, J MOL MED, V91, P49, DOI 10.1007/s00109-012-0932-x; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jazirehi AR, 2013, AM J CLIN EXP IMMUNO, V2, P55; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kim SM, 2009, ARCH PHARM RES, V32, P755, DOI 10.1007/s12272-009-1515-4; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lai F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.192; Lee CK, 2012, FOOD CHEM TOXICOL, V50, P2565, DOI 10.1016/j.fct.2012.01.005; Lee JY, 2013, MOL CANCER THER, V12, P274, DOI 10.1158/1535-7163.MCT-12-0054; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Li DW, 2014, PROTEIN CELL, V5, P214, DOI 10.1007/s13238-013-0010-3; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liu JW, 2009, CANCER RES, V69, P8662, DOI 10.1158/0008-5472.CAN-09-1099; Liu TG, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-250; Ma C, 2014, J DERMATOL TREAT, V25, P401, DOI 10.3109/09546634.2013.813897; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; McDermott J, 2014, DRUG TODAY, V50, P337, DOI 10.1358/dot.2014.50.5.2138703; Menzies AM, 2013, EUR J CANCER, V49, P3229, DOI 10.1016/j.ejca.2013.06.027; Minami J, 2014, LEUKEMIA, V28, P680, DOI 10.1038/leu.2013.231; Minamiya Y, 2010, TUMOR BIOL, V31, P533, DOI 10.1007/s13277-010-0066-0; Molife LR, 2011, EXPERT OPIN INV DRUG, V20, P1723, DOI 10.1517/13543784.2011.629604; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; Oie S, 2013, BIOCHEM BIOPH RES CO, V432, P236, DOI 10.1016/j.bbrc.2013.02.007; Pan XY, 2012, EUR J PHARMACOL, V683, P27, DOI 10.1016/j.ejphar.2012.02.040; Park EH, 2014, J GINSENG RES, V38, P22, DOI 10.1016/j.jgr.2013.11.007; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Shen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030815; Sibaud V, 2013, ANN DERMATOL VENER, V140, P510, DOI 10.1016/j.annder.2013.02.031; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Sun Yan, 2006, Zhongguo Fei Ai Za Zhi, V9, P254, DOI 10.3779/j.issn.1009-3419.2006.03.09; Thakur VS, 2012, INT J ONCOL, V41, P353, DOI 10.3892/ijo.2012.1449; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Yamamoto S, 2003, CANCER GENE THER, V10, P179, DOI 10.1038/sj.cgt.7700551; Yoo JH, 2010, CANCER LETT, V289, P99, DOI 10.1016/j.canlet.2009.08.008; Zhang ZH, 2004, CLIN CANCER RES, V10, P6962, DOI 10.1158/1078-0432.CCR-04-0455; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	49	71	75	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115401	10.1371/journal.pone.0115401	http://dx.doi.org/10.1371/journal.pone.0115401			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521755	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845600043
J	Yadav, GP; Shree, S; Maurya, R; Rai, N; Singh, DK; Srivastava, KK; Ramachandran, R				Yadav, Gaya Prasad; Shree, Sonal; Maurya, Ruchi; Rai, Niyati; Singh, Diwakar Kumar; Srivastava, Kishore Kumar; Ramachandran, Ravishankar			Characterization of M. tuberculosis SerB2, an Essential HAD-Family Phosphatase, Reveals Novel Properties	PLOS ONE			English	Article							HUMAN PHOSPHOSERINE PHOSPHATASE; MULTIPLE SEQUENCE ALIGNMENT; PORPHYROMONAS-GINGIVALIS; D-SERINE; DATABASE SEARCH; ACT DOMAIN; BINDING; INTERMEDIATE; INHIBITORS; RESOLUTION	M. tuberculosis harbors an essential phosphoserine phosphatase (MtSerB2, Rv3042c) that contains two small- molecule binding ACT-domains (Pfam 01842) at the N-terminus followed by the phosphoserine phosphatase (PSP) domain. We found that exogenously added MtSerB2 elicits microtubule rearrangements in THP-1 cells. Mutational analysis demonstrates that phosphatase activity is co-related to the elicited rearrangements, while addition of the ACT-domains alone elicits no rearrangements. The enzyme is dimeric, exhibits divalent metal-ion dependency, and is more specific for L-phosphoserine unlike other classical PSPases. Binding of a variety of amino acids to the ACT-domains influences MtSerB2 activity by either acting as activators/inhibitors/have no effects. Additionally, reduced activity of the PSP domain can be enhanced by equimolar addition of the ACT domains. Further, we identified that G18 and G108 of the respective ACT-domains are necessary for ligand-binding and their mutations to G18A and G108A abolish the binding of ligands like L-serine. A specific transition to higher order oligomers is observed upon the addition of L-serine at similar to 0.8 molar ratio as supported by Isothermal calorimetry and Size exclusion chromatography experiments. Mutational analysis shows that the transition is dependent on binding of L-serine to the ACT-domains. Furthermore, the higher-order oligomeric form of MtSerB2 is inactive, suggesting that its formation is a mechanism for feedback control of enzyme activity. Inhibition studies involving over eight inhibitors, MtSerB2, and the PSP domain respectively, suggests that targeting the ACT-domains can be an effective strategy for the development of inhibitors.	[Yadav, Gaya Prasad; Shree, Sonal; Maurya, Ruchi; Rai, Niyati; Ramachandran, Ravishankar] CSIR Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow 226031, Uttar Pradesh, India; [Singh, Diwakar Kumar; Srivastava, Kishore Kumar] CSIR Cent Drug Res Inst, Div Microbiol, Lucknow 226031, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ramachandran, R (corresponding author), CSIR Cent Drug Res Inst, Mol & Struct Biol Div, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.	r_ravishankar@cdri.res.in	Shree, Sonal/AAE-9442-2020; yadav, gaya/AAA-3576-2021; Yadav, Gaya P/F-3720-2019	Shree, Sonal/0000-0002-5665-8157; Yadav, Gaya P/0000-0002-4514-4679; Ramachandran, Ravishankar/0000-0002-0723-9861	Council of Scientific and Industrial Research -network grant SPLenDID [BSC0104]; Council of Scientific and Industrial Research -network grant GENESIS [BSC0121]; Department of Biotechnology project [SSP0025]	Council of Scientific and Industrial Research -network grant SPLenDID; Council of Scientific and Industrial Research -network grant GENESIS; Department of Biotechnology project	The work was funded by Council of Scientific and Industrial Research -network grants SPLenDID (BSC0104) and GENESIS (BSC0121) respectively. NR was supported by the Department of Biotechnology project SSP0025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth Jan, 2011, Journal of Structural and Functional Genomics, V12, P83, DOI 10.1007/s10969-011-9101-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 1997, FEBS LETT, V408, P281, DOI 10.1016/S0014-5793(97)00438-9; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dunlop DS, 1997, BIOCHEM BIOPH RES CO, V235, P26, DOI 10.1006/bbrc.1997.6724; Furuya S, 2000, P NATL ACAD SCI USA, V97, P11528, DOI 10.1073/pnas.200364497; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Hawkinson JE, 1997, EUR J PHARMACOL, V337, P315, DOI 10.1016/S0014-2999(97)01304-6; Jung SK, 2012, BIOORG MED CHEM LETT, V22, P2084, DOI 10.1016/j.bmcl.2012.01.011; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATSUI T, 1995, J NEUROCHEM, V65, P454; Moffatt CE, 2012, CELL MICROBIOL, V14, P577, DOI 10.1111/j.1462-5822.2011.01743.x; Nakano I, 2007, STEM CELLS, V25, P1975, DOI 10.1634/stemcells.2007-0046; O'Brien R., 2001, PROTEIN LIGAND INTER; Peeraer Y, 2004, EUR J BIOCHEM, V271, P3421, DOI 10.1111/j.0014-2956.2004.04277.x; Peeraer Y, 2003, ACTA CRYSTALLOGR D, V59, P971, DOI 10.1107/S0907444903005407; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SAVOCA R, 1995, J NEUROSCI METH, V61, P159, DOI 10.1016/0165-0270(95)00038-V; Takeuchi H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003326; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tribble GD, 2006, P NATL ACAD SCI USA, V103, P11027, DOI 10.1073/pnas.0509813103; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721	34	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115409	10.1371/journal.pone.0115409	http://dx.doi.org/10.1371/journal.pone.0115409			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521849	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845600044
J	Toyjanova, J; Flores-Cortez, E; Reichner, JS; Franck, C				Toyjanova, Jennet; Flores-Cortez, Estefany; Reichner, Jonathan S.; Franck, Christian			Matrix Confinement Plays a Pivotal Role in Regulating Neutrophil-generated Tractions, Speed, and Integrin Utilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPATIOTEMPORAL ORGANIZATION; MIGRATION; FORCES; MICROSCOPY; LOCOMOTION; MECHANISMS; STRESSES; VOLUME	Neutrophils are capable of switching from integrin-dependent motility on two-dimensional substrata to integrin-independent motion following entry into the confined three-dimensional matrix of an afflicted tissue. However, whether integrins still maintain a regulatory role for cell traction generation and cell locomotion under the physical confinement of the three-dimensional matrix is unknown, and this is challenging to deduce from motility studies alone. Using three-dimensional traction force microscopy and a double hydrogel sandwich system, we determined the three-dimensional spatiotemporal traction forces of motile neutrophils at unprecedented resolution and show, for the first time, that entry into a highly confined space (2.5D) is a sufficient trigger to convert to integrin-independent migration. We find that integrins exert a significant regulatory role in determining the magnitude and spatial distribution of tractions and cell speed on confined cells. We also find that 90% of neutrophil tractions are in the out-of-plane axis, and this may be a fundamental element of neutrophil traction force generation.	[Toyjanova, Jennet; Franck, Christian] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Flores-Cortez, Estefany; Reichner, Jonathan S.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Surg, Providence, RI 02903 USA	Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Franck, C (corresponding author), Brown Univ, Sch Engn, 182 Hope St,Box D, Providence, RI 02912 USA.	franck@brown.edu		Reichner, Jonathan/0000-0002-7349-6321	National Institutes of Health [GM066194, AI101469]; Brown University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066194, R56GM066194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM066194 (to J. S. R.) and AI101469 (to J. S. R. and C. F.). This work was also supported by a Brown University seed grant (to J. S. R. and C. F.).	Aubry D, 2015, BIOMECH MODEL MECHAN, V14, P143, DOI 10.1007/s10237-014-0595-3; Bar-Kochba E, 2015, EXP MECH, V55, P261, DOI 10.1007/s11340-014-9874-2; Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102; Bower A. F., 2010, APPL MECH SOLIDS, P100; BROWN AF, 1982, J CELL SCI, V58, P455; Butler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011921; Byrd AS, 2013, J IMMUNOL, V190, P4136, DOI 10.4049/jimmunol.1202671; Carey SP, 2012, BIOMATERIALS, V33, P4157, DOI 10.1016/j.biomaterials.2012.02.029; D'Errico J., 2020, MATLAB CENTRAL FILE; Delanoe-Ayari H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248103; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Farid H, 2004, IEEE T IMAGE PROCESS, V13, P496, DOI 10.1109/TIP.2004.823819; Franck C, 2007, EXP MECH, V47, P427, DOI 10.1007/s11340-007-9037-9; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Hawkins RJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058103; Hur SS, 2009, CELL MOL BIOENG, V2, P425, DOI 10.1007/s12195-009-0082-6; Jannat RA, 2011, BIOPHYS J, V101, P575, DOI 10.1016/j.bpj.2011.05.040; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2014, SEMIN IMMUNOPATHOL, V36, P227, DOI 10.1007/s00281-014-0418-8; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lin Y, 2010, J MECH PHYS SOLIDS, V58, P502, DOI 10.1016/j.jmps.2010.01.010; Long R, 2011, BIOPHYS J, V101, P643, DOI 10.1016/j.bpj.2011.06.049; Lopez-Fagundo C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0247; Maskarinec SA, 2009, P NATL ACAD SCI USA, V106, P22108, DOI 10.1073/pnas.0904565106; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; Meili R, 2010, MOL BIOL CELL, V21, P405, DOI 10.1091/mbc.E09-08-0703; Miron-Mendoza M, 2010, BIOMATERIALS, V31, P6425, DOI 10.1016/j.biomaterials.2010.04.064; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Oakes PW, 2009, BLOOD, V114, P1387, DOI 10.1182/blood-2008-11-191445; Pospieszalska MK, 2011, BIOPHYS J, V100, P1697, DOI 10.1016/j.bpj.2011.02.038; Qian J, 2009, BIOPHYS J, V97, P2438, DOI 10.1016/j.bpj.2009.08.027; Renkawitz J, 2010, EMBO REP, V11, P744, DOI 10.1038/embor.2010.147; Shin ME, 2010, BLOOD, V116, P3297, DOI 10.1182/blood-2009-12-260851; Smith LA, 2007, BIOPHYS J, V92, pL58, DOI 10.1529/biophysj.106.102822; Stroka KM, 2009, CELL MOTIL CYTOSKEL, V66, P328, DOI 10.1002/cm.20363; Sundd P, 2010, NAT METHODS, V7, P821, DOI [10.1038/NMETH.1508, 10.1038/nmeth.1508]; TINGBEALL HP, 1993, BLOOD, V81, P2774; Toyjanova J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090976; WARD MD, 1993, BIOPHYS J, V64, P936, DOI 10.1016/S0006-3495(93)81456-5	39	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3752	3763		10.1074/jbc.M114.619643	http://dx.doi.org/10.1074/jbc.M114.619643			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525264	Green Published, hybrid			2022-12-26	WOS:000349456000046
J	Dillahunt-Aspillaga, C; Finch, D; Massengale, J; Kretzmer, T; Luther, SL; McCart, JA				Dillahunt-Aspillaga, Christina; Finch, Dezon; Massengale, Jill; Kretzmer, Tracy; Luther, Stephen L.; McCart, James A.			Using Information from the Electronic Health Record to Improve Measurement of Unemployment in Service Members and Veterans with mTBI and Post-Deployment Stress	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; COMMUNITY INTEGRATION; MILITARY VETERANS; SELF-EFFICACY; US ARMY; RETURN; WORK; WAR; REHABILITATION; OUTCOMES	Objective: The purpose of this pilot study is 1) to develop an annotation schema and a training set of annotated notes to support the future development of a natural language processing (NLP) system to automatically extract employment information, and 2) to determine if information about employment status, goals and work-related challenges reported by service members and Veterans with mild traumatic brain injury (mTBI) and post-deployment stress can be identified in the Electronic Health Record (EHR). Design: Retrospective cohort study using data from selected progress notes stored in the EHR. Setting: Post-deployment Rehabilitation and Evaluation Program (PREP), an inpatient rehabilitation program for Veterans with TBI at the James A. Haley Veterans' Hospital in Tampa, Florida. Participants: Service members and Veterans with TBI who participated in the PREP program (N=60). Main Outcome Measures: Documentation of employment status, goals, and work-related challenges reported by service members and recorded in the EHR. Results: Two hundred notes were examined and unique vocational information was found indicating a variety of self-reported employment challenges. Current employment status and future vocational goals along with information about cognitive, physical, and behavioral symptoms that may affect return-to-work were extracted from the EHR. The annotation schema developed for this study provides an excellent tool upon which NLP studies can be developed. Conclusions: Information related to employment status and vocational history is stored in text notes in the EHR system. Information stored in text does not lend itself to easy extraction or summarization for research and rehabilitation planning purposes. Development of NLP systems to automatically extract text-based employment information provides data that may improve the understanding and measurement of employment in this important cohort.	[Dillahunt-Aspillaga, Christina; Finch, Dezon; Luther, Stephen L.; McCart, James A.] James A Haley Vet Hosp, Ctr Innovat Disabil & Rehabil Res CINDRR, Tampa, FL 33612 USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Dept Rehabil & Mental Hlth Counseling, Tampa, FL USA; [Massengale, Jill; Kretzmer, Tracy] James A Haley Vet Hosp, Tampa, FL 33612 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Dillahunt-Aspillaga, C (corresponding author), James A Haley Vet Hosp, Ctr Innovat Disabil & Rehabil Res CINDRR, Tampa, FL 33612 USA.	cdillahuntas@usf.edu		Dillahunt-Aspillaga, Christina/0000-0002-1231-2023	VHA QUERI RRP [12-450]	VHA QUERI RRP	Funding for this work was provided by VHA QUERI RRP 12-450. The views expressed in this work are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; [Anonymous], 2008, MILD TRAUM BRAIN INJ; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Benshoff J, 2008, REHABIL RES POLI ED, V22, P227; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carbonell JG, 1987, ENCY ARTIFICIAL INTE, P660; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; Cerrito P.B., 2006, DATA TEXT MINING ELE; Chiarini-Tremblay M, 2005, AMCIS 2005 P, P109; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Clemens EV, 2008, CAREER DEV Q, V56, P246, DOI 10.1002/j.2161-0045.2008.tb00039.x; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Defense and Veterans Brain Injury Center, 2013, DOD WORLDW TBI NUMB; DeJong G., 1982, STRATEGIES NATURAL L, P149; Department of Veterans Affairs, 2010, VET HLTH ADM HDB; Dillahunt-Aspillaga C., 2014, SGRJARC, V45, P25; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Ettenhofer ML, 2012, MIL MED, V177, P1272, DOI 10.7205/MILMED-D-12-00095; Frain MP, 2010, J REHABIL, V76, P13; Frain MP, 2011, VOC EVAL WORK ADJ AS, V38, P34; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Guillen R, 2009, P I2B2 WORKSH CHALL, P868; Hannold EM, 2013, J REHABIL RES DEV, V50, P1315, DOI 10.1682/JRRD.2013.04.0084; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Institute of Medicine, 2008, GULF WAR HLTH, V7; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kretzmer T, 2013, MILITARY TBI CASE MA, V4, P8; Kupersmith J, 2009, J REHABIL RES DEV, V46, pXVII, DOI 10.1682/JRRD.2009.06.0085; Lang KP, 2014, J HEAD TRAUMA REHAB, V29, P44, DOI 10.1097/HTR.0b013e31829c85d0; LEHNERT W, 1995, J EXP THEOR ARTIF IN, V7, P49, DOI 10.1080/09528139508953800; Lew HL, 2007, J REHABIL RES DEV, V44, pVII; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Madaus JW, 2009, J POSTSECOND EDUC DI, V22, P10; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; National Research Council, 2014, GULF WAR HLTH, V9; Ness BM, 2014, J HEAD TRAUMA REHAB, V29, P33, DOI 10.1097/HTR.0b013e3182a1cd4e; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; O'Neil M, 2014, J INT NEUROPSYCH SOC, V5, P1; Ogren PV, 2006, P 2006 C N AM CHAPT, P273, DOI [10.3115/1225785.1225791, DOI 10.3115/1225785.1225791], DOI 10.3115/1225785.1225791]; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pakhomov SVS, 2008, J AM MED INFORM ASSN, V15, P198, DOI 10.1197/jamia.M2585; Pakhomov Serguei, 2005, P ACL 2005 INT POST, P25, DOI 10.3115/1225753.1225760; Pogoda T, 2014, J HEAD TRAUMA REHABI; Ponsford J., 2014, J HEAD TRAUMA REHABI; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Prigerson HG, 2002, AM J PUBLIC HEALTH, V92, P59, DOI 10.2105/AJPH.92.1.59; Rao R.B., 2006, ACM SIGKDD EXPLOR NE, V8, P3, DOI [10.1145/1147234.1147236.1, DOI 10.1145/1147234.1147236.1]; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sayer N, 2012, STRATEGIC PLAN FY 20; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shigaki CL, 2009, DISABIL REHABIL, V31, P484, DOI 10.1080/09638280802240449; Spackman KA, 1997, J AM MED INFORM ASSN, P640; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Office of Patient Care Services, 2005, VHA HDB; THOMPSON K, 1968, COMMUN ACM, V11, P419, DOI 10.1145/363347.363387; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Turchin A, 2006, J AM MED INFORM ASSN, V13, P691, DOI 10.1197/jamia.M2078; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vocational Rehabilitation Institute, 2011, CAR V10; Waljas M, 2013, J HEAD TRAU IN PRESS; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Xu H, 2010, J AM MED INFORM ASSN, V17, P19, DOI 10.1197/jamia.M3378; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; Zeng Qing T, 2006, BMC Med Inform Decis Mak, V6, P30, DOI 10.1186/1472-6947-6-30	86	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115873	10.1371/journal.pone.0115873	http://dx.doi.org/10.1371/journal.pone.0115873			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25541956	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900101
J	Moens, SJB; Mooij, HL; Hassing, HC; Kruit, JK; Witjes, JJ; de Sande, MAJV; Nederveen, AJ; Xu, D; Dallinga-Thie, GM; Esko, JD; Stroes, ESG; Nieuwdorp, M				Moens, Sophie J. Bernelot; Mooij, Hans L.; Hassing, H. Carlijne; Kruit, Janine K.; Witjes, Julia J.; de Sande, Michiel A. J. van; Nederveen, Aart J.; Xu, Ding; Dallinga-Thie, Geesje M.; Esko, Jeffrey D.; Stroes, Erik S. G.; Nieuwdorp, Max			Carriers of Loss-of-Function Mutations in EXT Display Impaired Pancreatic Beta-Cell Reserve Due to Smaller Pancreas Volume	PLOS ONE			English	Article							HEREDITARY MULTIPLE EXOSTOSES; INDUCED INSULIN-SECRETION; GLUCAGON-LIKE PEPTIDE-1; HEPARAN-SULFATE; TUMOR SUPPRESSORS; BIOSYNTHESIS; ASSOCIATION; RISK; OSTEOCALCIN; GROWTH	Exotosin (EXT) proteins are involved in the chain elongation step of heparan sulfate (HS) biosynthesis, which is intricately involved in organ development. Loss of function mutations (LOF) in EXT1 and EXT2 result in hereditary exostoses (HME). Interestingly, HS plays a role in pancreas development and beta-cell function, and genetic variations in EXT2 are associated with an increased risk for type 2 diabetes mellitus. We hypothesized that loss of function of EXT1 or EXT2 in subjects with hereditary multiple exostoses (HME) affects pancreatic insulin secretion capacity and development. We performed an oral glucose tolerance test (OGTT) followed by hyperglycemic clamps to investigate first-phase glucose-stimulated insulin secretion (GSIS) in HME patients and age and gender matched non-affected relatives. Pancreas volume was assessed with magnetic resonance imaging (MRI). OGTT did not reveal significant differences in glucose disposal, but there was a markedly lower GSIS in HME subjects during hyperglycemic clamp (iAUC HME: 0.72 [0.46-1.16] vs. controls 1.53 [0.69-3.36] nmol.l(-1).min(-1), p<0.05). Maximal insulin response following arginine challenge was also significantly attenuated (iAUC HME: 7.14 [4.22-10.5] vs. controls 10.2 [7.91-12.70] nmol.l(-1).min(-1) p<0.05), indicative of an impaired beta-cell reserve. MRI revealed a significantly smaller pancreatic volume in HME subjects (HME: 72.0 +/- 15.8 vs. controls 96.5 +/- 26.0 cm(3) p=0.04). In conclusion, loss of function of EXT proteins may affect beta-cell mass and insulin secretion capacity in humans, and render subjects at a higher risk of developing type 2 diabetes when exposed to environmental risk factors.	[Moens, Sophie J. Bernelot; Mooij, Hans L.; Hassing, H. Carlijne; Witjes, Julia J.; Dallinga-Thie, Geesje M.; Stroes, Erik S. G.; Nieuwdorp, Max] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Kruit, Janine K.] Univ Groningen, Univ Med Ctr Groningen, Dept Paediat, Groningen, Netherlands; [de Sande, Michiel A. J. van] LUMC, Dept Orthopaed, Leiden, Netherlands; [Nederveen, Aart J.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Xu, Ding; Esko, Jeffrey D.; Nieuwdorp, Max] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92103 USA; [Dallinga-Thie, Geesje M.; Nieuwdorp, Max] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California San Diego; University of Amsterdam; Academic Medical Center Amsterdam	Nieuwdorp, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.nieuwdorp@amc.uva.nl	Xu, Ding/B-2493-2009; van de Sande, Michiel/N-9607-2019; Kruit, Janine/AGI-8582-2022	Xu, Ding/0000-0001-9380-2712; van de Sande, Michiel/0000-0002-9156-7656; Kruit, Janine/0000-0002-5414-0485; dallinga-thie, geesje/0000-0001-5412-5923; Nederveen, Aart/0000-0002-5477-973X	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(NWO)-VENI grant [016.096.044]; Dutch Diabetes foundation [2009.80.114]; National Institutes of Health [NIH GM33063]; CardioVasculair Onderzoek Nederland (CVON-GENIUS) [CVON2011-19]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063, R37GM033063] Funding Source: NIH RePORTER	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(NWO)-VENI grant; Dutch Diabetes foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CardioVasculair Onderzoek Nederland (CVON-GENIUS); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M. Nieuwdorp is supported by Nederlandse Organisatie voor Wetenschappelijk Onderzoek(NWO)-VENI grant 2008 (016.096.044); http://www.nwo.nl/. J.K. Kruit is supported by a grant from the Dutch Diabetes foundation (2009.80.114); http://www.diabetesfonds.nl. J.D. Esko is supported by National Institutes of Health (NIH GM33063); http://www.nih.gob/. S.J. Bernelot Moens and E.S.G. Stroes received a grant from CardioVasculair Onderzoek Nederland (CVON-GENIUS)number CVON2011-19; http://www.cvon.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anower-E-Khuda MF, 2013, GLYCOBIOLOGY, V23, P865, DOI 10.1093/glycob/cwt024; Bari MS, 2012, JCPSP-J COLL PHYSICI, V22, P797, DOI 12.2012/JCPSP.797799; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Booth SL, 2013, NAT REV ENDOCRINOL, V9, P43, DOI 10.1038/nrendo.2012.201; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Duncan G, 2001, J CLIN INVEST, V108, P511, DOI 10.1172/JCI200113737; FAJANS SS, 1967, J CLIN ENDOCR METAB, V27, P1600, DOI 10.1210/jcem-27-11-1600; Fridlyand LE, 2006, DIABETES OBES METAB, V8, P136, DOI 10.1111/j.1463-1326.2005.00496.x; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Hecht JT, 2002, BONE, V31, P199, DOI 10.1016/S8756-3282(02)00796-2; Heijboer AC, 2011, CLIN CHIM ACTA, V412, P1191, DOI 10.1016/j.cca.2011.03.010; Herder C, 2008, HORM METAB RES, V40, P722, DOI 10.1055/s-2008-1078730; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Jaerger M, 2007, J ORTHOP RES, V25, P1541, DOI 10.1002/jor.20479; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Kayed H, 2006, PANCREAS, V32, P119, DOI 10.1097/01.mpa.0000202937.55460.0c; Kifagi C, 2011, GENET TEST MOL BIOMA, V15, P399, DOI 10.1089/gtmb.2010.0199; Kuchuk NO, 2009, J CLIN ENDOCR METAB, V94, P1244, DOI 10.1210/jc.2008-1832; Lewis JP, 2008, DIABETES, V57, P2220, DOI 10.2337/db07-1319; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Liu L, 2013, HUM GENET, V132, P139, DOI 10.1007/s00439-012-1231-x; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; McCulloch LJ, 2011, MOL GENET METAB, V104, P648, DOI 10.1016/j.ymgme.2011.08.026; Mizokami A, 2014, BONE, V69, P68, DOI 10.1016/j.bone.2014.09.006; Mizokami A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057375; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Nadanaka S, 2008, J BIOCHEM, V144, P7, DOI 10.1093/jb/mvn040; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; Nijpels G, 2008, J CLIN ENDOCR METAB, V93, P2633, DOI 10.1210/jc.2007-2837; Nybakken K, 2002, BBA-GEN SUBJECTS, V1573, P280, DOI 10.1016/S0304-4165(02)00395-1; Okada M, 2010, BIOCHEM J, V428, P463, DOI 10.1042/BJ20100101; Osman NMS, 2003, ANAT EMBRYOL, V207, P333, DOI 10.1007/s00429-003-0348-z; Park JW, 2013, BRIT J SURG, V100, P1064, DOI 10.1002/bjs.9146; Pedrini E, 2011, J BONE JOINT SURG AM, V93A, P2294, DOI [10.2106/JBJS.J.00949, 10.2106/JBJSJ.00949]; Raats CJI, 1997, J BIOL CHEM, V272, P26734, DOI 10.1074/jbc.272.42.26734; Rong R, 2009, DIABETES, V58, P478, DOI 10.2337/db08-0877; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SOLOMON L, 1964, AM J HUM GENET, V16, P351; Straub SG, 2004, AM J PHYSIOL-CELL PH, V287, pC565, DOI 10.1152/ajpcell.00079.2004; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Thams P, 1999, EUR J ENDOCRINOL, V140, P87, DOI 10.1530/eje.0.1400087; Thomas MK, 2000, DIABETES, V49, P2039, DOI 10.2337/diabetes.49.12.2039; Tripathy D, 2004, DIABETES CARE, V27, P2204, DOI 10.2337/diacare.27.9.2204; Vergeer M, 2010, DIABETES CARE, V33, P869, DOI 10.2337/dc09-1562; Wei JW, 2014, J CLIN INVEST, V124, P1781, DOI 10.1172/JCI72323; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zertal-Zidani S, 2007, DIABETOLOGIA, V50, P585, DOI 10.1007/s00125-006-0571-2; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	52	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115662	10.1371/journal.pone.0115662	http://dx.doi.org/10.1371/journal.pone.0115662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541963	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900065
J	Durigan, M; Abreu, AG; Zucchi, MI; Franco, RMB; de Souza, AP				Durigan, Mauricio; Abreu, Aluana Goncalves; Zucchi, Maria Imaculada; Bueno Franco, Regina Maura; de Souza, Anete Pereira			Genetic Diversity of Giardia duodenalis: Multilocus Genotyping Reveals Zoonotic Potential between Clinical and Environmental Sources in a Metropolitan Region of Brazil	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; MOLECULAR CHARACTERIZATION; CRYPTOSPORIDIUM OOCYSTS; SEQUENCE-ANALYSIS; ASSEMBLAGE-B; INTESTINALIS; WATER; DOGS; IDENTIFICATION; PCR	Background: Giardia duodenalis is a flagellate protozoan that parasitizes humans and several other mammals. Protozoan contamination has been regularly documented at important environmental sites, although most of these studies were performed at the species level. There is a lack of studies that correlate environmental contamination and clinical infections in the same region. The aim of this study is to evaluate the genetic diversity of a set of clinical and environmental samples and to use the obtained data to characterize the genetic profile of the distribution of G. duodenalis and the potential for zoonotic transmission in a metropolitan region of Brazil. Methodology/Principal Findings: The genetic assemblages and subtypes of G. duodenalis isolates obtained from hospitals, a veterinary clinic, a day-care center and important environmental sites were determined via multilocus sequence-based genotyping using three unlinked gene loci. Cysts of Giardia were detected at all of the environmental sites. Mixed assemblages were detected in 25% of the total samples, and an elevated number of haplotypes was identified. The main haplotypes were shared among the groups, and new subtypes were identified at all loci. Ten multilocus genotypes were identified: 7 for assemblage A and 3 for assemblage B. Conclusions/Significance: There is persistent G. duodenalis contamination at important environmental sites in the city. The identified mixed assemblages likely represent mixed infections, suggesting high endemicity of Giardia in these hosts. Most Giardia isolates obtained in this study displayed zoonotic potential. The high degree of genetic diversity in the isolates obtained from both clinical and environmental samples suggests that multiple sources of infection are likely responsible for the detected contamination events. The finding that many multilocus genotypes (MLGs) and haplotypes are shared by different groups suggests that these sources of infection may be related and indicates that there is a notable risk of human infection caused by Giardia in this region.	[Durigan, Mauricio; de Souza, Anete Pereira] Univ Campinas UNICAMP, Mol Biol & Genet Engn Ctr CBMEG, Campinas, SP, Brazil; [Abreu, Aluana Goncalves; Zucchi, Maria Imaculada] APTA Sapaulo Agcy Agribusiness Technol, Piracicaba, SP, Brazil; [Bueno Franco, Regina Maura] Univ Campinas UNICAMP, Inst Biol, Dept Anim Biol, Campinas, SP, Brazil; [de Souza, Anete Pereira] Univ Campinas UNICAMP, Inst Biol, Dept Plant Biol, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	de Souza, AP (corresponding author), Univ Campinas UNICAMP, Mol Biol & Genet Engn Ctr CBMEG, Campinas, SP, Brazil.	anete@unicamp.br	DE SOUZA, ANETE PEREIRA/B-8663-2012; Abreu, Aluana/AGQ-4693-2022; Zucchi, Maria Imaculada/D-2637-2012; Abreu, Aluana G/L-7772-2013; Durigan, Mauricio/GLU-4564-2022; Zucchi, Maria Imaculada/AAC-8157-2019; Franco, Regina Bueno/N-5326-2015	DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Abreu, Aluana/0000-0003-2765-3741; Zucchi, Maria Imaculada/0000-0002-4863-1843; Abreu, Aluana G/0000-0003-2765-3741; Zucchi, Maria Imaculada/0000-0002-4863-1843; Franco, Regina Bueno/0000-0003-1920-6140	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq [577032/2008-9, 304914/2010-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [MS 2008/52197-4, DD 2011/50413-4]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through a research grant and a research fellowship awarded to APS (number 577032/2008-9 and 304914/2010-0), by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - BioComputacional Program) and by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) through a graduate fellowship to MD (MS 2008/52197-4 and DD 2011/50413-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2003, J VET MED SCI, V65, P29, DOI 10.1292/jvms.65.29; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Al-Mohammed HI, 2011, PARASITOL RES, V108, P1375, DOI 10.1007/s00436-010-2033-5; ANDREWS RH, 1989, INT J PARASITOL, V19, P183, DOI 10.1016/0020-7519(89)90006-4; Ankarklev J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001780; Bertrand I, 2007, WATER RES, V41, P3675, DOI 10.1016/j.watres.2007.02.043; Bowman DD, 2010, EXP PARASITOL, V124, P121, DOI 10.1016/j.exppara.2009.01.003; Caccio SM, 2008, INT J PARASITOL, V38, P1523, DOI 10.1016/j.ijpara.2008.04.008; Caccio SA, 2002, INT J PARASITOL, V32, P1023, DOI 10.1016/S0020-7519(02)00068-1; Caccio SM, 2008, MOL BIOCHEM PARASIT, V160, P75, DOI 10.1016/j.molbiopara.2008.04.006; Caccio SM, 2010, EXP PARASITOL, V124, P107, DOI 10.1016/j.exppara.2009.02.007; Neto RC, 2006, WATER SCI TECHNOL, V54, P89, DOI 10.2166/wst.2006.453; Neto RC, 2010, WATER SCI TECHNOL, V62, P217, DOI 10.2166/wst.2010.312; Cardoso F. M., 2005, Revista de Ciencias Medicas, V14, P337; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; CDC, 1994, ADDR EM INF DIS THRE; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dos Santos Luciana Urbano, 2013, ISRN Parasitol, V2013, P713958, DOI 10.5402/2013/713958; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faust E. C., 1938, American Journal of Tropical Medicine, V18, P169; Franco R M, 1996, Rev Soc Bras Med Trop, V29, P585, DOI 10.1590/S0037-86821996000600010; Franco Regina Maura Bueno, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P109, DOI 10.1590/S0036-46652001000200011; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; Geurden T, 2012, VET PARASITOL, V190, P383, DOI 10.1016/j.vetpar.2012.06.039; Geurden T, 2008, VET PARASITOL, V155, P142, DOI 10.1016/j.vetpar.2008.05.002; Geurden T, 2010, VET PARASITOL, V172, P337, DOI 10.1016/j.vetpar.2010.05.015; Gioia I, 1992, Rev Soc Bras Med Trop, V25, P177, DOI 10.1590/S0037-86821992000300005; Haramoto E, 2012, FOOD ENVIRON VIROL, V4, P93, DOI 10.1007/s12560-012-9082-0; HOMAN WL, 1992, PARASITOL RES, V78, P316, DOI 10.1007/BF00937090; Hopkins RM, 1997, J PARASITOL, V83, P44, DOI 10.2307/3284315; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kobayashi Jun, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P13, DOI 10.1590/S0036-46651995000100003; Kreader CA, 1996, APPL ENVIRON MICROB, V62, P1102, DOI 10.1128/AEM.62.3.1102-1106.1996; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Lebbad M, 2008, ACTA TROP, V106, P44, DOI 10.1016/j.actatropica.2008.01.004; Lebbad M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001262; Lebbad M, 2010, VET PARASITOL, V168, P231, DOI 10.1016/j.vetpar.2009.11.003; Levecke B, 2009, INT J PARASITOL, V39, P1595, DOI 10.1016/j.ijpara.2009.05.013; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Maddison DR, 1997, SYST BIOL, V46, P590, DOI 10.2307/2413497; MAHBUBANI MH, 1992, J CLIN MICROBIOL, V30, P74, DOI 10.1128/JCM.30.1.74-78.1992; Monis PT, 1996, PARASITOLOGY, V112, P1, DOI 10.1017/S0031182000065021; Monis PT, 1998, PARASITOLOGY, V116, P7, DOI 10.1017/S0031182097002011; Monis PT, 1999, INT J PARASITOL, V29, P381, DOI 10.1016/S0020-7519(98)00216-1; Moura E C, 1997, J Pediatr (Rio J), V73, P406; NASH TE, 1992, EXP PARASITOL, V75, P369, DOI 10.1016/0014-4894(92)90250-E; O'Handley RM, 2002, GIARDIA COSMOPOLITAN; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palmer CS, 2008, VET PARASITOL, V154, P142, DOI 10.1016/j.vetpar.2008.02.031; Paoletti B, 2010, RES VET SCI, P10; Silva FMPE, 2012, PARASITOL RES, V110, P325, DOI 10.1007/s00436-011-2492-3; Plutzer J, 2008, INT J HYG ENVIR HEAL, V211, P524, DOI 10.1016/j.ijheh.2008.04.004; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Santos Luciana Urbano, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P309, DOI 10.1590/S0036-46652004000600003; Sato MIZ, 2013, SCI TOTAL ENVIRON, V442, P389, DOI 10.1016/j.scitotenv.2012.09.077; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Shepherd KM, 1996, APPL ENVIRON MICROB, V62, P1317, DOI 10.1128/AEM.62.4.1317-1322.1996; SMITH AL, 1989, PARASITOLOGY, V99, P329, DOI 10.1017/S0031182000059035; Soliman RH, 2011, PARASITOL INT, V60, P507, DOI 10.1016/j.parint.2011.09.006; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Sulaiman IM, 2004, DISTRIBUTION GIARDIA; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Gomez-Munoz MT, 2012, RES VET SCI, V93, P836, DOI 10.1016/j.rvsc.2011.12.012; Thompson RCA, 2008, VET J, V177, P18, DOI 10.1016/j.tvjl.2007.09.022; Thompson RCA, 2000, PARASITOL TODAY, V16, P210, DOI 10.1016/S0169-4758(99)01624-5; Wang RJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04208; WHO, 2002, RED RISKS PROM HLTH; Wielinga CM, 2011, INT J PARASITOL, P1; World Health Organization, 2011, WORLD HLTH STAT 2011; Yoder Jonathan S., 2010, Morbidity and Mortality Weekly Report, V59, P15; Zhang WZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001826; Zhang WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031262	78	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115489	10.1371/journal.pone.0115489	http://dx.doi.org/10.1371/journal.pone.0115489			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536055	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300044
J	Fairthorne, J; Hammond, G; Bourke, J; Jacoby, P; Leonard, H				Fairthorne, Jenny; Hammond, Geoff; Bourke, Jenny; Jacoby, Peter; Leonard, Helen			Early Mortality and Primary Causes of Death in Mothers of Children with Intellectual Disability or Autism Spectrum Disorder: A Retrospective Cohort Study	PLOS ONE			English	Article							DOWN-SYNDROME; NEUROFIBROMATOSIS 1; SLEEP PROBLEMS; FRAGILE-X; STRESS; HEALTH; SMOKING; PARENTS; BEHAVIOR	Introduction: Mothers of children with intellectual disability or autism spectrum disorder (ASD) have poorer health than other mothers. Yet no research has explored whether this poorer health is reflected in mortality rates or whether certain causes of death are more likely. We aimed to calculate the hazard ratios for death and for the primary causes of death in mothers of children with intellectual disability or ASD compared to other mothers. Methods: The study population comprised all mothers of live-born children in Western Australia from 1983-2005. We accessed state-wide databases which enabled us to link socio-demographic details, birth dates, diagnoses of intellectual disability or ASD in the children and dates and causes of death for all mothers who had died prior to 2011. Using Cox Regression with death by any cause and death by each of the three primary causes as the event of interest, we calculated hazard ratios for death for mothers of children intellectual disability or ASD compared to other mothers. Results and Discussion: During the study period, mothers of children with intellectual disability or ASD had more than twice the risk of death. Mothers of children with intellectual disability were 40% more likely to die of cancer; 150% more likely to die of cardiovascular disease and nearly 200% more likely to die from misadventure than other mothers. Due to small numbers, only hazard ratios for cancer were calculated for mothers of children with ASD. These mothers were about 50% more likely to die from cancer than other mothers. Possible causes and implications of our results are discussed. Conclusion: Similar studies, pooling data from registries elsewhere, would improve our understanding of factors increasing the mortality of mothers of children with intellectual disability or ASD. This would allow the implementation of informed services and interventions to improve these mothers' longevity.	[Fairthorne, Jenny; Bourke, Jenny; Jacoby, Peter; Leonard, Helen] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Hammond, Geoff] Hlth Dept Western Australia, Perth, WA, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia	Fairthorne, J (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.	Jenny.Fairthorne@telethonkids.org.au	Fairthorne, Jenny/ABB-3901-2020; Leonard, Helen/A-1010-2013	Leonard, Helen/0000-0001-6405-5834	Australian Postgraduate Award; University of Western Australia Top-up Award	Australian Postgraduate Award(Australian Government); University of Western Australia Top-up Award	Funding provided by Australian Postgraduate Award and University of Western Australia Top-up Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbeduto L, 2004, AM J MENT RETARD, V109, P237, DOI 10.1352/0895-8017(2004)109<237:PWACIM>2.0.CO;2; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Australian Bureau of Statistics, 2012, SOC IND AR INTR US F; Baker BL, 2003, J INTELL DISABIL RES, V47, P217, DOI 10.1046/j.1365-2788.2003.00484.x; Baker-Ericzen MJ, 2005, RES PRACT PERS SEV D, V30, P194, DOI 10.2511/rpsd.30.4.194; Bigby C, 2006, DISABIL SOC, V21, P567, DOI 10.1080/09687590600918032; Bjartveit K, 2005, TOB CONTROL, V14, P315, DOI 10.1136/tc.2005.011932; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Bourke-Taylor H, 2012, J PAEDIATR CHILD H, V48, P153, DOI 10.1111/j.1440-1754.2011.02060.x; Caldwell J., 2008, J DISABIL POLICY STU, V19, P68, DOI [10.1177/1044207308316093, DOI 10.1177/1044207308316093]; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Centers for Disease Control and Prevention, 2012, PREV AUT SPECTR DIS; Centers for Disease Control and Prevention, 2002, ICD 10 CAUS DEATH LI; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Corrice AM, 2009, AJIDD-AM J INTELLECT, V114, P254, DOI 10.1352/1944-7558-114.4.254-268; Daniels JL, 2008, PEDIATRICS, V121, pE1357, DOI 10.1542/peds.2007-2296; Department of Health WA, 2011, WHAT WE COLL MAN; Dumas J.E., 1991, EXCEPTIONALITY SPEC, V2, P97, DOI [10.1080/09362839109524770, DOI 10.1080/09362839109524770]; Eoh HJ, 2005, INT J IND ERGONOM, V35, P307, DOI 10.1016/j.ergon.2004.09.006; Finsterer J, 2013, INT J GEN MED, V6, P743, DOI 10.2147/IJGM.S45825; Hagerman RJ, 2006, J DEV BEHAV PEDIATR, V27, P63, DOI 10.1097/00004703-200602000-00012; Hodapp RM, 2001, PARENT-SCI PRACT, V1, P317, DOI 10.1207/S15327922PAR0104_3; Institute for Digital Research and Education, 2014, SUPPL NOT APPL SURV; Kouvonen A, 2005, J EPIDEMIOL COMMUN H, V59, P63, DOI 10.1136/jech.2004.019752; Lawrence D, 2010, CAN J PSYCHIAT, V55, P752, DOI 10.1177/070674371005501202; Lawrence D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-285; Leonard H, 2006, ANN EPIDEMIOL, V16, P448, DOI 10.1016/j.annepidem.2005.05.002; Leonard H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017875; Norlin D, 2013, J INTELL DISABIL RES, V57, P552, DOI 10.1111/j.1365-2788.2012.01564.x; Olsson MB, 2001, J INTELL DISABIL RES, V45, P535, DOI 10.1046/j.1365-2788.2001.00372.x; Petterson B, 2005, ANN HUM BIOL, V32, P237, DOI 10.1080/03014460500075035; Polimeni MA, 2005, J INTELL DISABIL RES, V49, P260, DOI 10.1111/j.1365-2788.2005.00642.x; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Richdale A, 2000, J INTELLECT DEV DIS, V25, P147, DOI 10.1080/13269780050033562; Rizk S, 2011, OTJR-OCCUP PART HEAL, V31, P164, DOI 10.3928/15394492-20110415-01; Sanders JL, 1997, CHILD FAM BEHAV THER, V19, P15, DOI 10.1300/J019v19n04_02; Sawyer MG, 2010, J AUTISM DEV DISORD, V40, P620, DOI 10.1007/s10803-009-0912-3; Sen E, 2007, J SPEC PEDIATR NURS, V12, P238, DOI 10.1111/j.1744-6155.2007.00119.x; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; Takahashi Y, 2001, JAPAN MED ASS J, V44, P359; Thiel C, 2011, INT J SPORTS MED, V32, P142, DOI 10.1055/s-0030-1268436; Watt M, 2012, COMMUNITY WORK FAMIL, V16, P1; Webster RI, 2008, J CHILD NEUROL, V23, P32, DOI 10.1177/0883073807307977; Woodward M., 2013, EPIDEMIOLOGY STUDY D; YearginAllsopp M, 1997, DEV MED CHILD NEUROL, V39, P142	45	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e113430	10.1371/journal.pone.0113430	http://dx.doi.org/10.1371/journal.pone.0113430			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25535971	Green Accepted, Green Published, gold			2022-12-26	WOS:000348563300006
J	Mohsen, H; Haddad, P; Allam, A; Hassan, A				Mohsen, Hassan; Haddad, Pascale; Allam, Ayman; Hassan, Azza			Patterns in Place of Cancer Death in the State of Qatar: A Population-Based Study	PLOS ONE			English	Article							TERMINALLY-ILL PATIENTS; OF-LIFE CARE; UNITED-STATES; REGIONAL-VARIATIONS; PREFERRED PLACE; PALLIATIVE CARE; SOUTH-AUSTRALIA; PEOPLE DIE; HOME; END	Background: International studies show that most people prefer to die at home; however, hospitals remain the most common place of death (PoD). This study aims to investigate the patterns in PoD and the associated factors, which are crucial for end-of-life cancer care enhancement. Method: This retrospective, population-based study analyzed all registered cancer deaths in Qatar between January 1, 2006 and December 31, 2012 (n=1,224). The main outcome measures were patient characteristics: age, gender, nationality, cancer diagnosis, year of death, and PoD. Time trends for age-standardized proportions of death in individual PoDs were evaluated using chi-square analysis. Odds ratio (OR) were determined for variables associated with the most preferred (acute palliative care unit [APCU] and hematology/oncology ward) versus least preferred (ICU and general medicine ward) PoDs in Qatar, stratified by nationality. Results: The hematology/oncology ward was the most common PoD (32.4%; 95% CI 26.7-35.3%) followed by ICU (31.4%; 95% CI 28.7-34.3%), APCU (26.9%; 95% CI 24.3-29.6%), and general medicine ward (9.2%; 95% CI 7.6-11.1%). APCU trended upward (+0.057/year; p<0.001), while the hematology/oncology ward trended downward (-0.055/year; p<0.001). No statistically significant changes occurred in the other PoDs; home deaths remained low (0.4%; 95% Cl 0.38-0.42). Qataris who died from liver cancer (OR 0.23) and aged 65 or older (OR 0.64) were less likely to die in the APCU or hematology/oncology ward (p<0.05). Non-Qataris who died from pancreatic cancer (OR 3.12) and female (OR 2.05) were more likely to die in the APCU or hematology/oncology ward (p<0.05). Both Qataris and non-Qataris who died from hematologic malignancy (OR 0.18 and 0.41, respectively) were more likely to die in the ICU or general medicine ward (p<0.05). Conclusion: A high percentage of cancer deaths in Qatar occur in hospital. As home was the preferred PoD for most people, effective home care and hospice programs are needed to improve end-of-life cancer care.	[Mohsen, Hassan; Haddad, Pascale; Hassan, Azza] Weill Cornell Med Coll, Doha, Qatar; [Allam, Ayman; Hassan, Azza] Natl Ctr Canc Care & Res, Doha, Qatar; [Hassan, Azza] Univ Alexandria, Med Res Inst, Canc Management & Res, Alexandria, Egypt	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hamad Medical Corporation; Egyptian Knowledge Bank (EKB); Alexandria University	Hassan, A (corresponding author), Weill Cornell Med Coll, Doha, Qatar.	ahassan15@hmc.org.qa			Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medical College in Qatar	Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medical College in Qatar	Dr. Reyad H. Mohsen, Dr. Laith J. Abu Raddad, Dr. Mouyyad Zaza, and Dr. Naveed Anwar for their invaluable support, encouragement, and clinical acumen. Additional support was provided by the Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medical College in Qatar. The statements made herein are solely the responsibility of the authors.	Ahlner-Elmqvist M, 2004, PALLIATIVE MED, V18, P585, DOI 10.1191/0269216304pm924oa; Al-Kindi SG, 2013, AM J HOSP PALLIAT ME, V30, P25, DOI 10.1177/1049909112439931; American Cancer Society, 2014, CANCER FACTS FIGURES; Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Barnato AE, 2010, MED CARE, V48, P125, DOI 10.1097/MLR.0b013e3181c161e4; Beccaro M, 2006, J EPIDEMIOL COMMUN H, V60, P412, DOI 10.1136/jech.2005.043646; Bruera E, 1999, CAN MED ASSOC J, V161, P290; Castillo-Guzman S, 2013, AM J HOSP PALLIAT ME, V30, P249, DOI 10.1177/1049909112448228; Centers for Disease Control and Prevention National Center for Health Statistics (CDC NCHS), 2012, UNDERLYING CAUSE OF; Cohen J, 2010, J CLIN ONCOL, V28, P2267, DOI 10.1200/JCO.2009.23.2850; Conlon KC, 1996, ANN SURG, V223, P273, DOI 10.1097/00000658-199603000-00007; Cress RD, 2006, CANCER CAUSE CONTROL, V17, P403, DOI 10.1007/s10552-005-0539-4; European Association for Palliative Care, 2010, EAPC TASK FORCE ON T; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2004, HEALTH AFFAIR, V23, pVAR19, DOI 10.1377/hlthaff.var.19; Fisher ES, 2003, PERSPECT BIOL MED, V46, P69, DOI 10.1353/pbm.2003.0004; Foreman LM, 2006, PALLIATIVE MED, V20, P447, DOI 10.1191/0269216306pm1149oa; Gao W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001410; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Gott M, 2004, PALLIATIVE MED, V18, P460, DOI 10.1191/0269216304pm889oa; Gruneir A, 2007, MED CARE RES REV, V64, P351, DOI 10.1177/1077558707301810; Howell DA, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-42; Hunt R, 1996, PALLIATIVE MED, V10, P5, DOI 10.1177/026921639601000103; HUNT RW, 1991, MED J AUSTRALIA, V155, P549, DOI 10.5694/j.1326-5377.1991.tb93893.x; IMF, 2013, WOR ECON OUTLOOK, P1; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Lin HC, 2007, SUPPORT CARE CANCER, V15, P1333, DOI 10.1007/s00520-006-0204-9; Lindqvist O, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001173; MACADAM M, 2004, HOME HLTH CARE MANAG, V16, P393; Marie Curie Cancer Care, 2012, UNDERSTANDING THE CO; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Menec V., 2004, PATTERNS OF HEALTH C; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Murray MA, 2003, J PALLIATIVE CARE, V19, P176, DOI 10.1177/082585970301900305; Mystakidou K, 2009, J PAIN SYMPTOM MANAG, V38, P309, DOI 10.1016/j.jpainsymman.2008.09.007; National Center for Health Statistics, 2011, HEALTH UNITED STATES; National Health Strategy, 2011, QATAR NATIONAL CANCE; O'Brien M, 2010, HEALTH SOC CARE COMM, V18, P337, DOI 10.1111/j.1365-2524.2009.00897.x; PINZON LCE, 2011, J PAIN SYMPTOM MANAG, V41, P893, DOI DOI 10.1016/J.JPAINSYMMAN.2010.07.016; Qatar Statistics Authority, 2013, POPULATION STRUCTURE; Richards M, 2008, END OF LIFE CARE STR; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Schmidt CM, 2004, ARCH SURG-CHICAGO, V139, P718, DOI 10.1001/archsurg.139.7.718; Tang ST, 2003, CANCER NURS, V26, P245, DOI 10.1097/00002820-200306000-00012; United Nations. Department of Economic and Social Affairs Population Division, 2013, WORLD POPULATION PRO; Warren JL, 2011, J NATL CANCER I, V103, P853, DOI 10.1093/jnci/djr145; Wilson DM, 2009, SOC SCI MED, V68, P1752, DOI 10.1016/j.socscimed.2009.03.006; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; World Health Organization, 2012, LOBAL HEALTH OBSERVA; World Health Organization, 2004, BETTER PALLIATIVE CA; World Health Organization Division of Control of Tropical Diseases Schistosomiasis and Intestinal Parasites Unit., 2004, THE SOLID FACTS PALL, P28; World Heath Organization, 2004, THE SOLID FACTS PALL, P28; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863	57	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e109615	10.1371/journal.pone.0109615	http://dx.doi.org/10.1371/journal.pone.0109615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25536076	gold, Green Submitted, Green Published			2022-12-26	WOS:000348563300001
J	Qin, ZP; Robichaud, P; He, TY; Fisher, GJ; Voorhees, JJ; Quan, TH				Qin, Zhaoping; Robichaud, Patrick; He, Tianyuan; Fisher, Gary J.; Voorhees, John J.; Quan, Taihao			Oxidant Exposure Induces Cysteine-Rich Protein 61 (CCN1) via c-Jun/AP-1 to Reduce Collagen Expression in Human Dermal Fibroblasts	PLOS ONE			English	Article							TRANSCRIPTION FACTOR AP-1; GROWTH-FACTOR-BETA; HUMAN SKIN; ULTRAVIOLET-IRRADIATION; C-JUN; MATRIX METALLOPROTEINASE-1; EXTRACELLULAR-MATRIX; CONNECTIVE-TISSUE; NEGATIVE REGULATOR; OXIDATIVE STRESS	Human skin is a primary target of oxidative stress from reactive oxygen species (ROS) generated from both extrinsic and intrinsic sources. Oxidative stress inhibits the production of collagen, the most abundant protein in skin, and thus contributes to connective tissue aging. Here we report that cysteine-rich protein 61 (CCN1), a negative regulator of collagen production, is markedly induced by ROS and mediates loss of type I collagen in human dermal fibroblasts. Conversely, antioxidant N-acetyl-L-cysteine significantly reduced CCN1 expression and prevented ROS-induced loss of type I collagen in both human dermal fibroblasts and human skin in vivo. ROS increased c-Jun, a critical member of transcription factor AP-1 complex, and increased c-Jun binding to the AP-1 site of the CCN1 promoter. Functional blocking of c-Jun significantly reduced CCN1 promoter and gene expression and thus prevented ROS-induced loss of type I collagen. Targeting the c-Jun/CCN1 axis may provide clinical benefit for connective tissue aging in human skin.	[Qin, Zhaoping; Robichaud, Patrick; He, Tianyuan; Fisher, Gary J.; Voorhees, John J.; Quan, Taihao] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Quan, TH (corresponding author), Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA.	thquan@umich.edu	Voorhees, John/AAM-9966-2020; Zhou, Zhongjun/C-4476-2009	Voorhees, John/0000-0003-1856-785X; Quan, Taihao/0000-0002-0954-5109; Zhou, Zhongjun/0000-0001-7092-8128	National Institutes of Health [RO1-ES014697, RO1-ES014697-S1, RO1-AG019364]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants RO1-ES014697; NIH RO1-ES014697-S1; and NIH RO1-AG019364. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; BROWN PH, 1994, ONCOGENE, V9, P791; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chung JH, 2000, J INVEST DERMATOL, V115, P177, DOI 10.1046/j.1523-1747.2000.00009.x; Dasgupta J, 2010, J CELL PHYSIOL, V225, P52, DOI 10.1002/jcp.22193; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Firuzi O, 2011, CURR MED CHEM, V18, P3871, DOI 10.2174/092986711803414368; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Fisher GJ, 2000, J CLIN INVEST, V106, P663, DOI 10.1172/JCI9362; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; FISHER LJ, 1991, NEURON, V6, P371, DOI 10.1016/0896-6273(91)90246-V; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; Han JS, 2003, EUR J BIOCHEM, V270, P3408, DOI 10.1046/j.1432-1033.2003.03723.x; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Juric V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031303; Kang S, 2003, J INVEST DERMATOL, V120, P835, DOI 10.1046/j.1523-1747.2003.12122.x; Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13; Kunz M, 2003, J BIOL CHEM, V278, P45651, DOI 10.1074/jbc.M301373200; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; LAVKER RM, 1979, J INVEST DERMATOL, V73, P59, DOI 10.1111/1523-1747.ep12532763; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lee HY, 2007, CIRC RES, V100, P372, DOI 10.1161/01.RES.0000257945.97958.77; Lo YYC, 1996, J BIOL CHEM, V271, P15703, DOI 10.1074/jbc.271.26.15703; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Malnou CE, 2010, J BIOL CHEM, V285, P6552, DOI 10.1074/jbc.M109.032680; Pashkow FJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/514623; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Qin ZP, 2014, AGE, V36, P353, DOI 10.1007/s11357-013-9565-4; Qin ZP, 2013, J BIOL CHEM, V288, P12386, DOI 10.1074/jbc.M112.424358; Quan TH, 2006, AM J PATHOL, V169, P482, DOI 10.2353/ajpath.2006.060128; Quan TH, 2012, J CELL BIOCHEM, V113, P3011, DOI 10.1002/jcb.24179; Quan TH, 2011, J CELL COMMUN SIGNAL, V5, P201, DOI 10.1007/s12079-011-0144-0; Quan TH, 2011, EXP DERMATOL, V20, P572, DOI 10.1111/j.1600-0625.2011.01278.x; Quan TH, 2009, J CELL COMMUN SIGNAL, V3, P19, DOI 10.1007/s12079-009-0044-8; Quan TH, 2010, J INVEST DERMATOL, V130, P1697, DOI 10.1038/jid.2010.29; Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224; Quan TH, 2005, J BIOL CHEM, V280, P8079, DOI 10.1074/jbc.M409647200; Quan TH, 2004, AM J PATHOL, V165, P741, DOI 10.1016/S0002-9440(10)63337-8; Quan TH, 2001, J BIOL CHEM, V276, P26349, DOI 10.1074/jbc.M010835200; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Scharffetter-Kochanek K, 2000, EXP GERONTOL, V35, P307, DOI 10.1016/S0531-5565(00)00098-X; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SMITH JG, 1962, J INVEST DERMATOL, V39, P347, DOI 10.1038/jid.1962.122; UITTO J, 1986, DERMATOL CLIN, V4, P433, DOI 10.1016/S0733-8635(18)30806-4; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x	53	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115402	10.1371/journal.pone.0115402	http://dx.doi.org/10.1371/journal.pone.0115402			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536346	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300038
J	Raleigh, MD; Pentel, PR; LeSage, MG				Raleigh, Michael D.; Pentel, Paul R.; LeSage, Mark G.			Pharmacokinetic Correlates of the Effects of a Heroin Vaccine on Heroin Self-Administration in Rats	PLOS ONE			English	Article							MORPHINE CONJUGATE VACCINE; 6-MONOACETYLMORPHINE; METABOLITES; OXYCODONE; RELAPSE; BRAIN; ANTIBODIES; BINDING; POLICY; MODEL	The purpose of this study was to evaluate the effects of a morphine-conjugate vaccine (M-KLH) on the acquisition, maintenance, and reinstatement of heroin self-administration (HSA) in rats, and on heroin and metabolite distribution during heroin administration that approximated the self-administered dosing rate. Vaccination with M-KLH blocked heroin-primed reinstatement of heroin responding. Vaccination also decreased HSA at low heroin unit doses but produced a compensatory increase in heroin self-administration at high unit doses. Vaccination shifted the heroin dose-response curve to the right, indicating reduced heroin potency, and behavioral economic demand curve analysis further confirmed this effect. In a separate experiment heroin was administered at rates simulating heroin exposure during HSA. Heroin and its active metabolites, 6-acetylmorphine (6-AM) and morphine, were retained in plasma and metabolite concentrations were reduced in brain in vaccinated rats compared to controls. Reductions in 6-AM concentrations in brain after vaccination were consistent with the changes in HSA rates accompanying vaccination. These data provide evidence that 6-AM is the principal mediator of heroin reinforcement, and the principal target of the M-KLH vaccine, in this model. While heroin vaccines may have potential as therapies for heroin addiction, high antibody to drug ratios appear to be important for obtaining maximal efficacy.	[Raleigh, Michael D.; Pentel, Paul R.; LeSage, Mark G.] Minneapolis Med Res Fdn Inc, Minneapolis, MN 55417 USA; [Raleigh, Michael D.; Pentel, Paul R.; LeSage, Mark G.] Hennepin Healthcare Syst, Minneapolis, MN USA; [Pentel, Paul R.; LeSage, Mark G.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Pentel, Paul R.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [LeSage, Mark G.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Raleigh, MD (corresponding author), Minneapolis Med Res Fdn Inc, Minneapolis, MN 55417 USA.	rale0011@umn.edu	LeSage, Mark G./AAS-8628-2020		National Institute of Health National Institute on Drug Abuse [DA026300, DA030715]; Minneapolis Medical Research Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026300, R01DA030715] Funding Source: NIH RePORTER	National Institute of Health National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Minneapolis Medical Research Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Health National Institute on Drug Abuse (grants DA026300, DA030715) (PRP) and a Postdoctoral fellowship award from the Minneapolis Medical Research Foundation (MDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JM, 2009, J PHARMACOL EXP THER, V331, P153, DOI 10.1124/jpet.109.152462; [Anonymous], RES 2012 NAT SURV DR; [Anonymous], 2012, WORLD DRUG REP 2012; Anton B, 2006, VACCINE, V24, P3232, DOI 10.1016/j.vaccine.2006.01.047; Antonilli L, 2005, PSYCHOPHARMACOLOGY, V182, P58, DOI 10.1007/s00213-005-0030-7; BazinRedureau MI, 1997, J PHARM PHARMACOL, V49, P277, DOI 10.1111/j.2042-7158.1997.tb06795.x; Beardsley PM, 2004, EXP CLIN PSYCHOPHARM, V12, P163, DOI 10.1037/1064-1297.12.3.163; Bogen IL, 2014, J PHARMACOL EXP THER, V349, P568, DOI 10.1124/jpet.113.212035; BONESE KF, 1974, NATURE, V252, P708, DOI 10.1038/252708a0; Carrera MRA, 2000, P NATL ACAD SCI USA, V97, P6202, DOI 10.1073/pnas.97.11.6202; Comer SD, 1999, PSYCHOPHARMACOLOGY, V143, P327, DOI 10.1007/s002130050956; CORRIGALL WA, 1988, PHARMACOL BIOCHEM BE, V30, P443, DOI 10.1016/0091-3057(88)90478-9; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Girardin F, 2003, CLIN PHARMACOL THER, V74, P341, DOI 10.1016/S0009-9236(03)00199-1; Gottas A, 2013, BRIT J PHARMACOL, V170, P546, DOI 10.1111/bph.12305; Grebenstein P, 2013, PHARMACOL BIOCHEM BE, V114, P70, DOI 10.1016/j.pbb.2013.10.020; Hursh SR, 2008, PSYCHOL REV, V115, P186, DOI 10.1037/0033-295X.115.1.186; Hursh SR, 2013, J EXP ANAL BEHAV, V99, P98, DOI 10.1002/jeab.7; INTURRISI CE, 1983, LIFE SCI, V33, P773, DOI 10.1016/0024-3205(83)90616-1; Jones JM, 2013, J PHARMACEUT BIOMED, V74, P291, DOI 10.1016/j.jpba.2012.10.033; Kosten TA, 2013, PROG NEURO-PSYCHOPH, V45, P223, DOI 10.1016/j.pnpbp.2013.05.012; Li QQ, 2011, J NEUROCHEM, V119, P1271, DOI 10.1111/j.1471-4159.2011.07502.x; Ma Li-xia, 2006, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V22, P368; Moreno AY, 2010, MOL PHARMACEUT, V7, P431, DOI 10.1021/mp900213u; Pravetoni M, 2012, VACCINE, V30, P4617, DOI 10.1016/j.vaccine.2012.04.101; Pravetoni M, 2012, J PHARMACOL EXP THER, V341, P225, DOI 10.1124/jpet.111.189506; Raleigh MD, 2013, J PHARMACOL EXP THER, V344, P397, DOI 10.1124/jpet.112.201194; Rentsch KM, 2001, CLIN PHARMACOL THER, V70, P237, DOI 10.1067/mcp.2001.117981; Schlosburg JE, 2013, P NATL ACAD SCI USA, V110, P9036, DOI 10.1073/pnas.1219159110; Selley DE, 2001, BIOCHEM PHARMACOL, V62, P447, DOI 10.1016/S0006-2952(01)00689-X; Stowe GN, 2011, J MED CHEM, V54, P5195, DOI 10.1021/jm200461m; WAINER BH, 1973, J IMMUNOL, V110, P667	32	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115696	10.1371/journal.pone.0115696	http://dx.doi.org/10.1371/journal.pone.0115696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536404	gold, Green Published, Green Submitted			2022-12-26	WOS:000348563300066
J	Sample, SJ; Heaton, CM; Behan, M; Bleedorn, JA; Racette, MA; Hao, ZL; Muir, P				Sample, Susannah J.; Heaton, Caitlin M.; Behan, Mary; Bleedorn, Jason A.; Racette, Molly A.; Hao, Zhengling; Muir, Peter			Role of Calcitonin Gene-Related Peptide in Functional Adaptation of the Skeleton	PLOS ONE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; IN-VIVO; STRESS-FRACTURES; BONE-RESORPTION; CGRP; RAT; EXPRESSION; MICE; INNERVATION; MICRODAMAGE	Peptidergic sensory nerve fibers innervating bone and periosteum are rich in calcitonin gene-related peptide (CGRP), an osteoanabolic neurotransmitter. There are two CGRP isoforms, CGRP alpha and CGRP beta. Sensory fibers are a potential means by which the nervous system may detect and respond to loading events within the skeleton. However, the functional role of the nervous system in the response of bone to mechanical loading is unclear. We used the ulna end-loading model to induce an adaptive modeling response in CGRP alpha and CGRP beta knockout mouse lines and their respective wildtype controls. For each knockout mouse line, groups of mice were treated with cyclic loading or sham-loading of the right ulna. A third group of mice received brachial plexus anesthesia (BPA) of the loaded limb before mechanical loading. Fluorochrome labels were administered at the time of loading and 7 days later. Ten days after loading, bone responses were quantified morphometrically. We hypothesized that CGRP signaling is required for normal mechanosensing and associated load-induced bone formation. We found that mechanically-induced activation of periosteal mineralizing surface in mice and associated blocking with BPA were eliminated by knockout of CGRP alpha signaling. This effect was not evident in CGRP beta knockout mice. We also found that mineral apposition responses to mechanical loading and associated BPA blocking were retained with CGRP alpha deletion. We conclude that activation of periosteal mineralizing surfaces in response to mechanical loading of bone is CGRP alpha-dependent in vivo. This suggests that release of CGRP from sensory peptidergic fibers in periosteum and bone has a functional role in load-induced bone formation.	[Sample, Susannah J.; Heaton, Caitlin M.; Bleedorn, Jason A.; Racette, Molly A.; Hao, Zhengling; Muir, Peter] Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Behan, Mary] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Muir, P (corresponding author), Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	muirp@vetmed.wisc.edu	Muir, Peter/AAH-8057-2021	Muir, Peter/0000-0003-0028-6005	AO Research Fund of the AO Foundation Switzerland [S-08-22M]; National Institutes of Health [T32 RR023916]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR023916] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD011078, T32OD010423] Funding Source: NIH RePORTER	AO Research Fund of the AO Foundation Switzerland; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by a grant from the AO Research Fund of the AO Foundation Switzerland (Project S-08-22M). Susannah J. Sample also received support from National Institutes of Health (T32 RR023916). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARA SG, 1985, SCIENCE, V229, P1094, DOI 10.1126/science.2994212; Ballica R, 1999, J BONE MINER RES, V14, P1067, DOI 10.1359/jbmr.1999.14.7.1067; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; de Souza RL, 2005, J BONE MINER RES, V20, P2159, DOI 10.1359/JBMR.050812; Drissi H, 1997, J BONE MINER RES, V12, P1805, DOI 10.1359/jbmr.1997.12.11.1805; Drissi H, 1999, CYTOKINE, V11, P200, DOI 10.1006/cyto.1998.0415; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; HERT J, 1971, Folia Morphologica (Prague), V19, P290; HILL EL, 1991, CELL TISSUE RES, V264, P469, DOI 10.1007/BF00319037; Hirt D, 1997, PEPTIDES, V18, P1461, DOI 10.1016/S0196-9781(97)00199-X; Imai S, 1997, J BONE MINER RES, V12, P1018, DOI 10.1359/jbmr.1997.12.7.1018; Irie K, 2002, MICROSC RES TECHNIQ, V58, P85, DOI 10.1002/jemt.10122; Jimenez-Andrade JM, 2010, BONE, V46, P306, DOI 10.1016/j.bone.2009.09.013; LANYON LE, 1984, J BIOMECH, V17, P897, DOI 10.1016/0021-9290(84)90003-4; Lappe J, 2005, J BONE MINER RES, V20, P571, DOI 10.1359/JBMR.041208; Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6; Li L, 2007, J ORTHOP RES, V25, P1204, DOI 10.1002/jor.20406; Li JA, 2010, J ORTHOP RES, V28, P1643, DOI 10.1002/jor.21169; Long H, 2010, ACTA ORTHOP, V81, P639, DOI 10.3109/17453674.2010.504609; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Martin CD, 2007, NEUROSCI LETT, V427, P148, DOI 10.1016/j.neulet.2007.08.055; MCBRYDE AM, 1976, AM J SPORTS MED, V5, P212; Mrak E, 2010, J CELL PHYSIOL, V225, P701, DOI 10.1002/jcp.22266; Muir P, 2006, BONE, V38, P342, DOI 10.1016/j.bone.2005.08.020; Muir P, 1999, BONE, V25, P571, DOI 10.1016/S8756-3282(99)00205-7; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Sample SJ, 2008, J BONE MINER RES, V23, P1372, DOI [10.1359/jbmr.080407, 10.1359/JBMR.080407]; Sample SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020386; Sample SJ, 2010, J BONE MINER RES, V25, P2016, DOI 10.1002/jbmr.101; Saxon LK, 2005, BONE, V36, P454, DOI 10.1016/j.bone.2004.12.001; Schinke T, 2004, J BONE MINER RES, V19, P2049, DOI 10.1359/JBMR.040915; Schutz B, 2004, J COMP NEUROL, V476, P32, DOI 10.1002/cne.20211; Serre CM, 1999, BONE, V25, P623, DOI 10.1016/S8756-3282(99)00215-X; Silberstein SD, 2013, NEUROLOGY, V81, P1184, DOI 10.1212/WNL.0b013e3182a6cc33; TORRANCE AG, 1994, CALCIFIED TISSUE INT, V54, P241, DOI 10.1007/BF00301686; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Villa I, 2003, AM J PHYSIOL-ENDOC M, V284, pE627, DOI 10.1152/ajpendo.00307.2002; Villa I, 2000, EUR J PHARMACOL, V409, P273, DOI 10.1016/S0014-2999(00)00872-4; Wang LP, 2010, BONE, V46, P1369, DOI 10.1016/j.bone.2009.11.029; Wu Q, 2009, NEUROSCI LETT, V463, P254, DOI 10.1016/j.neulet.2009.07.078	44	19	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e113959	10.1371/journal.pone.0113959	http://dx.doi.org/10.1371/journal.pone.0113959			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536054	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300008
J	Tan, L; Pu, YQ; Pattathil, S; Avci, U; Qian, J; Arter, A; Chen, LW; Hahn, MG; Ragauskas, AJ; Kieliszewski, MJ				Tan, Li; Pu, Yunqiao; Pattathil, Sivakumar; Avci, Utku; Qian, Jin; Arter, Allison; Chen, Liwei; Hahn, Michael G.; Ragauskas, Arthur J.; Kieliszewski, Marcia J.			Changes in Cell Wall Properties Coincide with Overexpression of Extensin Fusion Proteins in Suspension Cultured Tobacco Cells	PLOS ONE			English	Article							INTERMOLECULAR CROSS-LINK; O-GLYCOSYLATION CODES; ARABINOGALACTAN-PROTEINS; DI-ISODITYROSINE; EXPRESSION; GLYCOPROTEIN; CELLULASE; IMPROVES; TYROSINE; GROWTH	Extensins are one subfamily of the cell wall hydroxyproline-rich glycoproteins, containing characteristic SerHyp(4) glycosylation motifs and intermolecular cross-linking motifs such as the TyrXaaTyr sequence. Extensins are believed to form a cross-linked network in the plant cell wall through the tyrosine-derivatives isodityrosine, pulcherosine, and di-isodityrosine. Overexpression of three synthetic genes encoding different elastin-arabinogalactan protein-extensin hybrids in tobacco suspension cultured cells yielded novel cross-linking glycoproteins that shared features of the extensins, arabinogalactan proteins and elastin. The cell wall properties of the three transgenic cell lines were all changed, but in different ways. One transgenic cell line showed decreased cellulose crystallinity and increased wall xyloglucan content; the second transgenic cell line contained dramatically increased hydration capacity and notably increased cell wall biomass, increased di-isodityrosine, and increased protein content; the third transgenic cell line displayed wall phenotypes similar to wild type cells, except changed xyloglucan epitope extractability. These data indicate that overexpression of modified extensins may be a route to engineer plants for bioenergy and biomaterial production.	[Tan, Li; Pattathil, Sivakumar; Avci, Utku; Qian, Jin; Hahn, Michael G.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Tan, Li; Pattathil, Sivakumar; Avci, Utku; Qian, Jin; Hahn, Michael G.] Univ Georgia, BioEnergy Sci Ctr, Athens, GA 30602 USA; [Hahn, Michael G.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Pu, Yunqiao; Ragauskas, Arthur J.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Arter, Allison; Chen, Liwei; Kieliszewski, Marcia J.] Ohio Univ, Dept Chem & Biochem, Athens, OH 45701 USA; [Chen, Liwei] Suzhou Inst Nanotech & Nanobion SINANO, Suzhou, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; United States Department of Energy (DOE); Oak Ridge National Laboratory; University System of Ohio; Ohio University	Tan, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	tan@ccrc.uga.edu	Hahn, Michael/AHC-5847-2022; Ragauskas, Art/J-7486-2016; AVCI, UTKU/AAC-5794-2020; Pu, Yunqiao/H-3206-2016	Ragauskas, Art/0000-0002-3536-554X; AVCI, UTKU/0000-0001-5355-9906; , Sivakumar Pattathil/0000-0003-3870-4137; Pu, Yunqiao/0000-0003-2554-1447	National Science Foundation [MCB9874744]; Herman Frasch Foundation [526-HF02]; Department of Energy Bioenergy Research Center Award DOE [DE-PS02-06ER64304]; Office of Biological and Environmental Research in the Department of Energy Office of Science	National Science Foundation(National Science Foundation (NSF)); Herman Frasch Foundation; Department of Energy Bioenergy Research Center Award DOE(United States Department of Energy (DOE)); Office of Biological and Environmental Research in the Department of Energy Office of Science	This research was funded by grants to MK from the National Science Foundation (MCB9874744) and the Herman Frasch Foundation (526-HF02); and to LT, MGH, and AJR by the Department of Energy Bioenergy Research Center Award DOE DE-PS02-06ER64304. The BioEnergy Science Center is a United States Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson M, 2010, PLANT SCI, V178, P61, DOI 10.1016/j.plantsci.2009.11.003; An G, 1988, PLANT MOL BIOL MAN A, V3, P1; Bergman T., 1986, ADV METHODS PROTEIN, P45; Blemenkrantz N, 1973, ANAL BIOCHEM, V54, P484; Brady JD, 1996, BIOCHEM J, V315, P323, DOI 10.1042/bj3150323; Brady JD, 1998, PHYTOCHEMISTRY, V47, P349, DOI 10.1016/S0031-9422(97)00592-X; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Dai ZY, 2000, TRANSGENIC RES, V9, P43, DOI 10.1023/A:1008922404834; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Held MA, 2004, J BIOL CHEM, V279, P55474, DOI 10.1074/jbc.M408396200; HERBERS K, 1995, NAT BIOTECHNOL, V13, P63, DOI DOI 10.1038/NBT0195-63; Jung HJG, 2012, PLANT SCI, V185, P65, DOI 10.1016/j.plantsci.2011.10.014; Kieliszewski MJ, 2001, PHYTOCHEMISTRY, V57, P319, DOI 10.1016/S0031-9422(01)00029-2; Kieliszewski MJ, 2014, USA patent, Patent No. [US 08623812, 08623812]; KOMALAVILAS P, 1989, CARBOHYD RES, V189, P261, DOI 10.1016/0008-6215(89)84102-3; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; Park YW, 2003, PLANT J, V33, P1099, DOI 10.1046/j.1365-313X.2003.01696.x; Pattathil Sivakumar, 2012, Methods Mol Biol, V908, P61, DOI 10.1007/978-1-61779-956-3_6; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; Pechar M, 2007, MACROMOL BIOSCI, V7, P56, DOI 10.1002/mabi.200600196; POPE DG, 1977, PLANT PHYSIOL, V59, P894, DOI 10.1104/pp.59.5.894; Pu YQ, 2006, CARBOHYD RES, V341, P591, DOI 10.1016/j.carres.2005.12.012; Reiersen H, 1998, J MOL BIOL, V283, P255, DOI 10.1006/jmbi.1998.2067; Sage E H, 1977, Adv Exp Med Biol, V79, P291; Schnabelrauch LS, 1996, PLANT J, V9, P477, DOI 10.1046/j.1365-313X.1996.09040477.x; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; Shpak E, 1999, P NATL ACAD SCI USA, V96, P14736, DOI 10.1073/pnas.96.26.14736; Shpak E, 2001, J BIOL CHEM, V276, P11272, DOI 10.1074/jbc.M011323200; Tan L, 2003, PLANT PHYSIOL, V132, P1362, DOI 10.1104/pp.103.021766; URRY DW, 1993, ANGEW CHEM INT EDIT, V32, P819, DOI 10.1002/anie.199308191; Wang HZ, 2012, IND CROP PROD, V37, P170, DOI 10.1016/j.indcrop.2011.12.014; Wang HZ, 2012, MOL PLANT, V5, P297, DOI 10.1093/mp/ssr098; Xu JF, 2007, BIOTECHNOL BIOENG, V97, P997, DOI 10.1002/bit.21407; Xu JF, 2010, TRANSGENIC RES, V19, P849, DOI 10.1007/s11248-010-9367-8; Zhang D, 2011, BIOENERG RES, V4, P276, DOI 10.1007/s12155-011-9138-2	35	8	10	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115906	10.1371/journal.pone.0115906	http://dx.doi.org/10.1371/journal.pone.0115906			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536327	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300084
J	Mirone, A; Brun, E; Coan, P				Mirone, Alessandro; Brun, Emmanuel; Coan, Paola			A Dictionary Learning Approach with Overlap for the Low Dose Computed Tomography Reconstruction and Its Vectorial Application to Differential Phase Tomography	PLOS ONE			English	Article							ITERATIVE IMAGE-RECONSTRUCTION; ALGORITHM; SPARSE; INDEX	X-ray based Phase-Contrast Imaging (PCI) techniques have been demonstrated to enhance the visualization of soft tissues in comparison to conventional imaging methods. Nevertheless the delivered dose as reported in the literature of biomedical PCI applications often equals or exceeds the limits prescribed in clinical diagnostics. The optimization of new computed tomography strategies which include the development and implementation of advanced image reconstruction procedures is thus a key aspect. In this scenario, we implemented a dictionary learning method with a new form of convex functional. This functional contains in addition to the usual sparsity inducing and fidelity terms, a new term which forces similarity between overlapping patches in the superimposed regions. The functional depends on two free regularization parameters: a coefficient multiplying the sparsity-inducing L-1 norm of the patch basis functions coefficients, and a coefficient multiplying the L-2 norm of the differences between patches in the overlapping regions. The solution is found by applying the iterative proximal gradient descent method with FISTA acceleration. The gradient is computed by calculating projection of the solution and its error backprojection at each iterative step. We study the quality of the solution, as a function of the regularization parameters and noise, on synthetic data for which the solution is a-priori known. We apply the method on experimental data in the case of Differential Phase Tomography. For this case we use an original approach which consists in using vectorial patches, each patch having two components: one per each gradient component. The resulting algorithm, implemented in the European Synchrotron Radiation Facility tomography reconstruction code PyHST, has proven to be efficient and well-adapted to strongly reduce the required dose and the number of projections in medical tomography.	[Mirone, Alessandro; Brun, Emmanuel] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Brun, Emmanuel; Coan, Paola] Univ Munich, Dept Phys, D-85748 Garching, Germany; [Coan, Paola] Ludwig Maximilians Univ Hosp Munich, Inst Clin Radiol, Munich, Germany	European Synchrotron Radiation Facility (ESRF); University of Munich; University of Munich	Brun, E (corresponding author), European Synchrotron Radiat Facil, BP 220, F-38043 Grenoble, France.	emmanuel.brun@esrf.fr	Brun, emmanuel/J-7942-2018; Coan, Paola/L-8804-2013; Coan, Paola/GPC-5718-2022; brun, emmanuel/U-8780-2019	Brun, emmanuel/0000-0002-0332-4903; Coan, Paola/0000-0003-1399-2398; Coan, Paola/0000-0003-1399-2398; brun, emmanuel/0000-0002-0332-4903	DFG-Cluster of Excellence Munich-Centre for Advanced Photonics [EXE158]; internal ESRF funding	DFG-Cluster of Excellence Munich-Centre for Advanced Photonics(German Research Foundation (DFG)); internal ESRF funding	This work was partially supported by the DFG-Cluster of Excellence Munich-Centre for Advanced Photonics EXE158. Other funding is internal ESRF funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001; Combettes PL, 2011, SPRINGER SER OPTIM A, V49, P185, DOI 10.1007/978-1-4419-9569-8_10; Diemoz PC, 2012, OPT EXPRESS, V20, P2789, DOI 10.1364/OE.20.002789; Dilmanian FA, 2000, PHYS MED BIOL, V45, P933, DOI 10.1088/0031-9155/45/4/309; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Fahimian BP, 2013, MED PHYS, V40, DOI 10.1118/1.4791644; Gasilov S, 2014, OPT EXPRESS, V22, P5216, DOI 10.1364/OE.22.005216; Liao HY, 2009, J OPT SOC AM A, V26, P2311, DOI 10.1364/JOSAA.26.002311; Mirone A, 2013, GPL RELEASE PY UNPUB; Mirone A, 2014, NUCL INSTRUM METH B, V324, P41, DOI 10.1016/j.nimb.2013.09.030; Olivo A, 2008, PHYS MED BIOL, V53, P6461, DOI 10.1088/0031-9155/53/22/012; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Sunaguchi N, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824075; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Wen YW, 2012, IEEE T IMAGE PROCESS, V21, P1770, DOI 10.1109/TIP.2011.2181401; Xu QF, 2012, OPT EXPRESS, V20, P10724, DOI 10.1364/OE.20.010724; Xu Q, 2012, IEEE T MED IMAGING, V31, P1682, DOI 10.1109/TMI.2012.2195669; Zhao B, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/24/8217; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109	25	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114325	10.1371/journal.pone.0114325	http://dx.doi.org/10.1371/journal.pone.0114325			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531987	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100014
J	Zalewski, W; Gasparis, S; Boczkowska, M; Rajchel, IK; Kala, M; Orczyk, W; Nadolska-Orczyk, A				Zalewski, Wojciech; Gasparis, Sebastian; Boczkowska, Maja; Rajchel, Izabela K.; Kala, Maciej; Orczyk, Waclaw; Nadolska-Orczyk, Anna			Expression Patterns of HvCKX Genes Indicate Their Role in Growth and Reproductive Development of Barley	PLOS ONE			English	Article							CYTOKININ OXIDASE/DEHYDROGENASE GENES; TRANSGENIC BARLEY; ARABIDOPSIS; RICE; IDENTIFICATION; WEIGHT; FAMILY; MAIZE; AUXIN; WHEAT	Cytokinin oxidase/dehydrogenase proteins (CKX) are encoded by a multigene family of CKX genes with a varying number of members depending on species. For some of the genes, spectacular effects on grain production in selected cereals have been observed. Despite the fact that partial or full length sequences of most HvCKX genes in barley (Hordeum vulgare) have already been published, in most cases their specific biological functions have not been reported. Detailed expression patterns for five HvCKX genes in different organs/tissues of developing barley plants coupled with analysis of RNAi silent for two genes are presented to test the hypothesis that these expression profiles might indicate their function. Elevated expression for four of them - HvCKX1, HvCKX9, HvCKX4, and HvCKX11 - was found in developing kernels of wild-type plants compared to other tissues. HvCKX5 was mainly expressed in leaf tissue. Lower expression was noted for HvCKX1 in seedling roots and for HvCKX9 in leaves. The documented effect of RNAi silencing of HvCKX1 and a trend for HvCKX9 was higher plant productivity, and the trait was inherited through four generations. Higher plant yield was determined by higher numbers of seeds and spikes. Increased productivity was significantly greater in HvCKX1 silenced plants showing higher relative expression of HvCKX1 in developing kernels of wild-type plants compared to the expression of HvCKX9. Both HvCKX1 silenced T-1 seedlings of cv. Golden Promise and the newly transformed breeding line STH7308 showed greater root mass, but this trait was not inherited in the next generation. Similarly HvCKX9 silenced T-1 seedlings exhibited greater plant height without inheritance in the next generation. It is suggested that these effects were not inherited because of compensation by other genes co-ordinately regulating reproductive development. One line with untypically changed, inherited phenotype, which was selected from several dozen silenced lines showing stable and common phenotypes is presented.	[Zalewski, Wojciech; Gasparis, Sebastian; Boczkowska, Maja; Rajchel, Izabela K.; Kala, Maciej; Nadolska-Orczyk, Anna] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Funct Gen, Blonie, Poland; [Orczyk, Waclaw] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Genet Engn, Blonie, Poland	Institute of Plant Breeding & Acclimatization; Institute of Plant Breeding & Acclimatization	Nadolska-Orczyk, A (corresponding author), Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Funct Gen, Blonie, Poland.	a.orczyk@ihar.edu.pl	Gasparis, Sebastian/ABF-3685-2020; Boczkowska, Maja/J-3654-2019	Gasparis, Sebastian/0000-0003-0521-086X; Boczkowska, Maja/0000-0001-8691-410X; Nadolska-Orczyk, Anna/0000-0001-6127-3860	Polish Ministry of Science and Higher Education [620/N-COST/09/2010/0]; Polish Ministry of Agriculture and Rural Development [1-1-01-4-04]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish Ministry of Agriculture and Rural Development	This research was supported by grant 620/N-COST/09/2010/0 from the Polish Ministry of Science and Higher Education, statutory grant 1-1-01-4-04 and PB No. 5 from the Polish Ministry of Agriculture and Rural Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bartlett JG, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-22; Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brugiere N, 2003, PLANT PHYSIOL, V132, P1228, DOI 10.1104/pp.102.017707; Frebort I, 2002, ANAL BIOCHEM, V306, P1, DOI 10.1006/abio.2002.5670; Galuszka P, 2004, EUR J BIOCHEM, V271, P3990, DOI 10.1111/j.1432-1033.2004.04334.x; Galuszka P, 2002, NCBI GENBANK; Gao SP, 2014, PLANT PHYSIOL, V165, P1035, DOI 10.1104/pp.114.238584; Gimenez MJ, 2011, PLANTA, V233, P163, DOI 10.1007/s00425-010-1290-y; Hensel G, 2008, J PLANT PHYSIOL, V165, P71, DOI 10.1016/j.jplph.2007.06.015; Horvath H, 2000, P NATL ACAD SCI USA, V97, P1914, DOI 10.1073/pnas.030527497; Hou BK, 2004, J BIOL CHEM, V279, P47822, DOI 10.1074/jbc.M409569200; Kakimoto T, 2001, PLANT CELL PHYSIOL, V42, P677, DOI 10.1093/pcp/pce112; Mameaux S, 2012, PLANT BIOTECHNOL J, V10, P67, DOI 10.1111/j.1467-7652.2011.00645.x; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Przetakiewicz A, 2003, PLANT CELL TISS ORG, V73, P245, DOI 10.1023/A:1023030511800; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmulling T, 2003, J PLANT RES, V116, P241, DOI 10.1007/s10265-003-0096-4; Song JC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-78; Takei K, 2002, J EXP BOT, V53, P971, DOI 10.1093/jexbot/53.370.971; Waterhouse PM, 2003, NAT REV GENET, V4, P29, DOI 10.1038/nrg982; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; Zalewski W, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-206; Zalewski W, 2010, J EXP BOT, V61, P1839, DOI 10.1093/jxb/erq052; Zhang L, 2012, NEW PHYTOL, V195, P574, DOI 10.1111/j.1469-8137.2012.04194.x	35	32	32	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115729	10.1371/journal.pone.0115729	http://dx.doi.org/10.1371/journal.pone.0115729			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531889	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100103
J	Zhao, YQ; Zhao, M; Li, XM; Ma, XC; Zheng, QH; Chen, XS; Lin, YW; Cai, YF				Zhao, Yuanqi; Zhao, Min; Li, Xiaomin; Ma, Xiancong; Zheng, Qinghao; Chen, Xiaosheng; Lin, Yinwing; Cai, Yefeng			The Predictive Value of the Boston Acute Stroke Imaging Scale (BASIS) in Acute Ischemic Stroke Patients among Chinese Population	PLOS ONE			English	Article							MODIFIED-RANKIN-SCALE; OF-HEALTH STROKE; INTRACRANIAL ATHEROSCLEROSIS; ALBERTA STROKE; GLOBAL BURDEN; SCORE; OUTCOMES; REHABILITATION; PREVALENCE; OCCLUSION	Objective: Evaluate the predictive value of Boston Acute Stroke Imaging Scale (BASIS) in acute ischemic stroke in Chinese population. Methods: This was a retrospective study. 566 patients of acute ischemic stroke were classified as having a major stroke or minor stroke based on BASIS. We compared short-term outcome (death, occurrence of complications, admission to intensive care unit [ICU] or neurological intensive care unit [NICU]), long-term outcome (death, recurrence of stroke, myocardial infarction, modified Rankin scale) and economic index including in-hospital cost and length of hospitalization. Continuous variables were compared by using the Student t test or Kruskal-Wallis test. Categorical variables were tested with the Chisquare test. Cox regression analysis was applied to identify whether BASIS was the independent predictive variable of death. Results: During hospitalization, 9 patients (4.6%) died in major stroke group while no patients died in minor stroke group (p < 0.001), 12 patients in the major stroke group and 5 patients in minor stroke group were admitted to ICU/NICU (p=0.001). There were more complications (cerebral hernia, pneumonia, urinary tract infection) in major stroke group than minor stroke group (p < 0.05). Meanwhile, the average cost of hospitalization in major stroke group was 3,100 US$ and 1,740 US$ in minor stroke group (p < 0.001); the average length of stay in major and minor stroke group was 21.3 days and 17.3 days respectively (p < 0.001). Results of the follow-up showed that 52 patients (26.7%) died in major stroke group while 56 patients (15.1%) died in minor stroke group (P < 0.001). 62.2% of the patients in major stroke group and 80.4% of the patients in minor stroke group were able to live independently (P=0.002). The survival analysis showed that patients with major stroke had 80% higher of risk of death than patients with minor stroke even after adjusting traditional atherosclerotic factors and NIHSS at baseline (HR=1.8, 95% CI: 1.1-3.1). Conclusion: BASIS can predict in-hospital mortality, occurrence of complication, length of stay and hospitalization cost of the acute ischemic stroke patients and can also estimate the long term outcome (death and the dependency). BASIS could and should be used as a dichotomous stroke classification system in the daily practice.	[Zhao, Yuanqi; Cai, Yefeng] Guangdong Prov Hosp Chinese Med, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Zhao, Min] Southern Med Univ, Natl Clin Res Ctr Kidney Dis, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Li, Xiaomin] JiangmenWuyi Tradit Chinese Med Hosp, Dept Neurol, Jiangmen, Guangdong, Peoples R China; [Ma, Xiancong] Yue Bei Peoples Hosp, Dept Neurol, Shaoguan, Guangdong, Peoples R China; [Zheng, Qinghao] Meizhou Municipal Hosp Tradit Chinese Med, Dept Internal Med, Meizhou, Guangdong, Peoples R China; [Chen, Xiaosheng] Kang Mei Hosp, Dept Neurol, Jieyang, Guangdong, Peoples R China; [Lin, Yinwing] Chinese Univ Hong Kong, Kwong Wah Hosp, Chinese Med Clin Res & Serv Ctr, Dept Chinese Med, Hong Kong, Hong Kong, Peoples R China	Guangzhou University of Chinese Medicine; Southern Medical University - China; Chinese University of Hong Kong; Kwong Wah Hospital	Cai, YF (corresponding author), Guangdong Prov Hosp Chinese Med, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	caiyefeng@126.com		zhao, yuanqi/0000-0003-1254-6732	Scientific Research Project of Public Welfare Industry, State Administration of Traditional Chinese Medicine of P. R. of China [200707004]; Finance Department of Guangdong Province [[2006] 143]	Scientific Research Project of Public Welfare Industry, State Administration of Traditional Chinese Medicine of P. R. of China; Finance Department of Guangdong Province	This work was supported by the Scientific Research Project of Public Welfare Industry, State Administration of Traditional Chinese Medicine of P. R. of China (No. 200707004); and the Finance Department of Guangdong Province (No. [2006] 143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird AE, 2001, LANCET, V357, P2095, DOI 10.1016/S0140-6736(00)05183-7; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Caplan LR, 2004, JAMA-J AM MED ASSOC, V292, P1883, DOI 10.1001/jama.292.15.1883; Chang KC, 2002, STROKE, V33, P2670, DOI 10.1161/01.STR.0000034396.68980.39; Cipriano LE, 2009, AM J NEURORADIOL, V30, P703, DOI 10.3174/ajnr.A1441; Elwood D, 2009, PM&R, V1, P147, DOI 10.1016/j.pmrj.2008.10.010; Ghandehari K, 2013, J RES MED SCI, V18, P906; Gonzalez RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030352; Heldner MR, 2013, STROKE, V44, P1153, DOI 10.1161/STROKEAHA.111.000604; Hill MD, 2014, STROKE, V45, P444, DOI 10.1161/STROKEAHA.113.003580; Huybrechts KF, 2008, CEREBROVASC DIS, V26, P381, DOI 10.1159/000151678; Huybrechts KF, 2007, CURR MED RES OPIN, V23, P1627, DOI 10.1185/030079907X210444; Linfante I, 2001, ARCH NEUROL-CHICAGO, V58, P621, DOI 10.1001/archneur.58.4.621; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Liu XD, 2007, CLIN NEUROL NEUROSUR, V109, P571, DOI 10.1016/j.clineuro.2007.05.008; Maas MB, 2009, STROKE, V40, P2988, DOI 10.1161/STROKEAHA.109.555664; Mahoney FI, 1965, MD STATE MED J; Merino JG, 2008, NAT CLIN PRACT NEURO, V4, P592, DOI 10.1038/ncpneuro0919; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Puetz V, 2008, INT J STROKE, V3, P230, DOI 10.1111/j.1747-4949.2008.00221.x; Quinn TJ, 2009, INT J STROKE, V4, P200, DOI 10.1111/j.1747-4949.2009.00271.x; Rockman CB, 2013, J VASC SURG, V57, P327, DOI 10.1016/j.jvs.2012.08.118; Sato S, 2008, NEUROLOGY, V70, P2371, DOI 10.1212/01.wnl.0000304346.14354.0b; Sillanpaa N, 2012, NEURORADIOLOGY, V54, P663, DOI 10.1007/s00234-011-0954-z; Torres-Mozqueda F, 2008, AM J NEURORADIOL, V29, P1111, DOI 10.3174/ajnr.A1000; Vora NA, 2011, STROKE, V42, P645, DOI 10.1161/STROKEAHA.110.596312; Wade D T, 1988, Int Disabil Stud, V10, P64; WADE DT, 1992, CURR OPIN NEUROL NEU, V5, P682; Wang YJ, 2014, STROKE, V45, P663, DOI 10.1161/STROKEAHA.113.003508; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Xu GL, 2007, CEREBROVASC DIS, V23, P117, DOI 10.1159/000097047; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	32	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e113967	10.1371/journal.pone.0113967	http://dx.doi.org/10.1371/journal.pone.0113967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531102	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845100006
J	Flower, A; Gavin, DG; Heyerdahl, EK; Parsons, RA; Cohn, GM				Flower, Aquila; Gavin, Daniel G.; Heyerdahl, Emily K.; Parsons, Russell A.; Cohn, Gregory M.			Western Spruce Budworm Outbreaks Did Not Increase Fire Risk over the Last Three Centuries: A Dendrochronological Analysis of Inter-Disturbance Synergism	PLOS ONE			English	Article							PINE-BEETLE OUTBREAKS; TREE-RING RECONSTRUCTION; ACTIVE CROWN FIRE; SUB-ALPINE FOREST; MOUNTAIN PINE; STAND DYNAMICS; CLIMATE; WILDFIRE; MORTALITY; HISTORY	Insect outbreaks are often assumed to increase the severity or probability of fire occurrence through increased fuel availability, while fires may in turn alter susceptibility of forests to subsequent insect outbreaks through changes in the spatial distribution of suitable host trees. However, little is actually known about the potential synergisms between these natural disturbances. Assessing inter-disturbance synergism is challenging due to the short length of historical records and the confounding influences of land use and climate changes on natural disturbance dynamics. We used dendrochronological methods to reconstruct defoliator outbreaks and fire occurrence at ten sites along a longitudinal transect running from central Oregon to western Montana. We assessed synergism between disturbance types, analyzed long-term changes in disturbance dynamics, and compared these disturbance histories with dendroclimatological moisture availability records to quantify the influence of moisture availability on disturbances. After approximately 1890, fires were largely absent and defoliator outbreaks became longer-lasting, more frequent, and more synchronous at our sites. Fires were more likely to occur during warm-dry years, while outbreaks were most likely to begin near the end of warm-dry periods. Our results show no discernible impact of defoliation events on subsequent fire risk. Any effect from the addition of fuels during defoliation events appears to be too small to detect given the overriding influence of climatic variability. We therefore propose that if there is any relationship between the two disturbances, it is a subtle synergistic relationship wherein climate determines the probability of occurrence of each disturbance type, and each disturbance type damps the severity, but does not alter the probability of occurrence, of the other disturbance type over long time scales. Although both disturbance types may increase in frequency or extent in response to future warming, our records show no precedent that western spruce budworm outbreaks will increase future fire risk.	[Flower, Aquila; Gavin, Daniel G.] Univ Oregon, Dept Geog, Eugene, OR 97403 USA; [Heyerdahl, Emily K.; Parsons, Russell A.; Cohn, Gregory M.] US Forest Serv, Rocky Mt Res Stn, USDA, Missoula, MT 59808 USA	University of Oregon; United States Department of Agriculture (USDA); United States Forest Service	Flower, A (corresponding author), Univ Oregon, Dept Geog, 1251 Univ Oregon, Eugene, OR 97403 USA.	Aquila.Flower@wwu.edu	Gavin, Daniel G/C-9214-2009	Gavin, Daniel G/0000-0001-8743-3949	United States Department of Agriculture Joint Fire Science Program [09-1-06-5]; Mazamas Foundation; Doctoral Dissertation Research Improvement grant from the National Science Foundation [1233278]; Rocky Mountain Research Station (Forest Service, U.S. Department of Agriculture) [09-JV-11221637]; University of Oregon	United States Department of Agriculture Joint Fire Science Program; Mazamas Foundation; Doctoral Dissertation Research Improvement grant from the National Science Foundation; Rocky Mountain Research Station (Forest Service, U.S. Department of Agriculture)(United States Department of Agriculture (USDA)United States Forest Service); University of Oregon	This research was supported in part by funds provided by the United States Department of Agriculture Joint Fire Science Program as Project 09-1-06-5 (firescience.gov); funding for AF, DG, EH, RP, and GC. AF was also funded through a Graduate Student Research Grant from the Mazamas Foundation (mazamasfoundation.org) and a Doctoral Dissertation Research Improvement grant (#1233278) from the National Science Foundation (nsf.gov). This research was undertaken with support from the Rocky Mountain Research Station (Forest Service, U.S. Department of Agriculture) under Research Joint Venture Agreement 09-JV-11221637 and the University of Oregon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee J. K., 1993, FIRE ECOLOGY PACIFIC; ALFARO RI, 1982, CAN J FOREST RES, V12, P780, DOI 10.1139/x82-117; ANDERSON L, 1987, FOREST ECOL MANAG, V22, P251, DOI 10.1016/0378-1127(87)90109-5; Andrews P.L., 2008, BEHAVEPLUS FIRE MODE; [Anonymous], 1968, TREE RING DATING; Arno S.F., 1976, INT187 USDA FOR SERV; Arno SF, 2000, US FOR SERV RMRS-P, P97; Bebi P, 2003, ECOLOGY, V84, P362, DOI 10.1890/0012-9658(2003)084[0362:IBFASB]2.0.CO;2; Belsky AJ, 1997, CONSERV BIOL, V11, P315, DOI 10.1046/j.1523-1739.1997.95405.x; Bigler C, 2007, OIKOS, V116, P1983, DOI 10.1111/j.2007.0030-1299.16034.x; Black SH, 2013, NAT AREA J, V33, P59, DOI 10.3375/043.033.0107; Borman MM, 2005, CONSERV BIOL, V19, P1658, DOI 10.1111/j.1523-1739.2005.00115.x; Bulaon B, 2006, 0607 USDA FOR SERV; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Campbell R, 2006, CAN J FOREST RES, V36, P1758, DOI 10.1139/X06-069; Carolin VM, 1987, FOREST SERVICE TECHN, V1694, P29; Cohn GM, 2014, INT J WILDLAND FIRE, V23, P709, DOI 10.1071/WF13074; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Covington W. W., 1994, Journal of Sustainable Forestry, V2, P13, DOI 10.1300/J091v02n01_02; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Dyer T.G.J., 2006, TREE RINGS CLIMATE, DOI 10.2307/2402947; Falk DA, 2011, FRONT ECOL ENVIRON, V9, P446, DOI 10.1890/100052; Fellin D.G., 1982, W SPRUCE BUDWORM, V53; Ferrell G. T., 1982, PSW164 USDA FOR SERV; Fleming RA, 2002, CLIMATIC CHANGE, V55, P251, DOI 10.1023/A:1020299422491; Flower A, 2014, FOREST ECOL MANAG, V324, P16, DOI 10.1016/j.foreco.2014.03.042; Furyaev V.V., 1983, BARK BEETLES FUELS F, V116; Gavin DG, 2006, ECOLOGY, V87, P1722, DOI 10.1890/0012-9658(2006)87[1722:WCCOSF]2.0.CO;2; Grissino-Mayer H.D., 2001, TREE RES, V57, P115; Heppner D., 2006, BC Journal of Ecosystems and Management, V7, P45; Hessburg P. F., 1994, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; Hessburg PF, 2007, LANDSCAPE ECOL, V22, P5, DOI 10.1007/s10980-007-9098-2; Heyerdahl E. K., 1997, THESIS U WASHINGTON; Heyerdahl EK, 2001, ECOLOGY, V82, P660, DOI 10.1890/0012-9658(2001)082[0660:SCOHFR]2.0.CO;2; Heyerdahl EK, 2008, ECOLOGY, V89, P705, DOI 10.1890/06-2047.1; Heyerdahl EK, 2008, INT J WILDLAND FIRE, V17, P40, DOI 10.1071/WF07024; Heyerdahl EK, 2006, FOREST ECOL MANAG, V230, P107, DOI 10.1016/j.foreco.2006.04.024; Hicke JA, 2012, FOREST ECOL MANAG, V271, P81, DOI 10.1016/j.foreco.2012.02.005; Hoffman C, 2012, FOREST SCI, V58, P178, DOI 10.5849/forsci.10-137; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Hummel S, 2003, NORTHWEST SCI, V77, P159; Jenkins MJ, 2008, FOREST ECOL MANAG, V254, P16, DOI 10.1016/j.foreco.2007.09.045; Jenkins MJ, 2012, FOREST ECOL MANAG, V275, P23, DOI 10.1016/j.foreco.2012.02.036; Jolly WM, 2012, ECOLOGY, V93, P941; Jolly WM, 2012, FOREST ECOL MANAG, V269, P52, DOI 10.1016/j.foreco.2011.12.022; Keane R., 2002, ROCKY MOUNTAIN RES S, P24; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Kulakowski D, 2003, J BIOGEOGR, V30, P1445, DOI 10.1046/j.1365-2699.2003.00912.x; Kulakowski D, 2011, FOREST ECOL MANAG, V262, P1686, DOI 10.1016/j.foreco.2011.07.016; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; Little E.L, 1971, ATLAS US TREES VOLUM, V1, P1146, DOI DOI 10.5962/BHL.TITLE.130546; Lynch HJ, 2008, CAN J FOREST RES, V38, P3112, DOI 10.1139/X08-143; Maclauchlan Lorraine E., 2009, British Columbia Journal of Ecosystems and Management, V10, P37; Marlon JR, 2012, P NATL ACAD SCI USA, V109, pE535, DOI 10.1073/pnas.1112839109; Maruoka KR, 1994, THESIS U WASHINGTON; McCullough DG, 1998, ANNU REV ENTOMOL, V43, P107, DOI 10.1146/annurev.ento.43.1.107; McKenzie D, 2011, ECOL STUD-ANAL SYNTH, V213, P3, DOI 10.1007/978-94-007-0301-8_1; Mote PW, 2010, CLIMATIC CHANGE, V102, P29, DOI 10.1007/s10584-010-9848-z; Mote PW, 2003, TRENDS TEMPERATURE P; Murdock TQ, 2013, ENVIRON SCI POLICY, V26, P75, DOI 10.1016/j.envsci.2012.07.026; Page W, 2007, FOREST SCI, V53, P662; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Parker TJ, 2006, AGR FOREST ENTOMOL, V8, P167, DOI 10.1111/j.1461-9563.2006.00305.x; Perry DA, 2011, FOREST ECOL MANAG, V262, P703, DOI 10.1016/j.foreco.2011.05.004; Pickett S.T.A., 1985, SCIENCE, DOI DOI 10.1126/SCIENCE.230.4724.434; Powell D, 1994, EFFECTS 1980S W SPRU; Powell EN, 2012, ECOL MONOGR, V82, P69, DOI 10.1890/11-0607.1; Preisler Haiganoush K., 2010, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P371; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Rothermel R. C., 1972, USDA Forests Service Research Paper, Intermountain Forest and Range Experiment Station; Ryerson DE, 2003, CAN J FOREST RES, V33, P1010, DOI 10.1139/X03-026; Simard M, 2011, ECOL MONOGR, V81, P3, DOI 10.1890/10-1176.1; Sokal R.R., 1994, BIOMETRY PRINCIPLES; STOCKS BJ, 1987, FOREST CHRON, V63, P8, DOI 10.5558/tfc63008-1; Sturtevant BR, 2012, ECOL APPL, V22, P1278, DOI 10.1890/11-0590.1; Swetnam T.W., 1995, PNWRP484 USDA FOR SE, DOI DOI 10.2737/PNW-RP-484; Swetnam TW, 1999, ECOL APPL, V9, P1189, DOI 10.1890/1051-0761(1999)009[1189:AHEUTP]2.0.CO;2; SWETNAM TW, 1993, ECOL MONOGR, V63, P399, DOI 10.2307/2937153; Swetnam TW, 1998, J CLIMATE, V11, P3128, DOI 10.1175/1520-0442(1998)011<3128:MDAERT>2.0.CO;2; SWETNAM TW, 1989, FOREST SCI, V35, P962; Van Sickle G., 1987, W SPRUCE BUDWORM, P57; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Westerling AL, 2003, B AM METEOROL SOC, V84, P595, DOI 10.1175/BAMS-84-5-595; Williams CJ, 1971, PSWRP072 USDA FOR SE; ZOBEL DB, 1973, BOT GAZ, V134, P209, DOI 10.1086/336706	86	19	20	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114282	10.1371/journal.pone.0114282	http://dx.doi.org/10.1371/journal.pone.0114282			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526633	Green Published, gold			2022-12-26	WOS:000347186200004
J	Li, Q; Hua, SR; Wang, C; Cai, SY; Zhang, J				Li, Qiang; Hua, Surong; Wang, Chu; Cai, Siyi; Zhang, Jia			The Value of Routine Biopsy during Percutaneous Kyphoplasty for Vertebral Compression Fractures	PLOS ONE			English	Article							BALLOON KYPHOPLASTY; HISTOLOGICAL-EVALUATION; BONE-BIOPSY; OSTEOPOROSIS; VERTEBROPLASTY; EPIDEMIOLOGY; MYELOMA	Objective: Percutaneous kyphoplasty (PKP) is now widely performed to treat VCF, which is usually caused by osteoporosis. Previous researches have reported unsuspected malignancies found by biopsy. However, the safety and cost-effective profiles of routine biopsy during PKP are unclear. The purpose of this study was to evaluate the feasibility of routine biopsy during PKP in treatment of VCF. Methods: Ninety-three patients (September 2007-November 2010) undergoing PKP without biopsy were reviewed as the control group. One hundred and three consecutive patients (November 2010-September 2013) undergoing PKP with biopsy of every operated vertebral level were prospectively enrolled as the biopsy group. The rate of unsuspected lesions was reported, and the severe adverse events, surgical duration, cement leakage rate and pain control were compared between the two groups. Results: No statistically significant differences were found between the two groups, regarding the severe adverse events, surgical duration, cement leakage rate and pain control. Four unsuspected lesions were found in the biopsy group, three of which were malignancies with a 2.9% (3/103) unsuspected malignancy rate. The economic analysis showed that routine biopsy was cost-effective in finding new malignancies comparing with a routine cancer screening campaign. Conclusions: Routine biopsy during PKP was safe and cost-effective in finding unsuspected malignancies. We advocate routine biopsy in every operated vertebral level during PKP for VCF patients.	[Li, Qiang; Wang, Chu; Cai, Siyi; Zhang, Jia] Beijing Union Med Coll Hosp, Dept Orthoped, Beijing, Peoples R China; [Hua, Surong] Beijing Union Med Coll Hosp, Dept Surg, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Zhang, J (corresponding author), Beijing Union Med Coll Hosp, Dept Orthoped, Beijing, Peoples R China.	zhangjia3661@163.com	Cai, Siyi/AAL-6676-2020	Hua, Surong/0000-0003-3630-3954				Berenson J, 2011, LANCET ONCOL, V12, P225, DOI 10.1016/S1470-2045(11)70008-0; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; Edidin AA, 2012, APPL HEALTH ECON HEA, V10, P273, DOI 10.2165/11633220-000000000-00000; Felsenberg D, 2002, J BONE MINER RES, V17, P716; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Ledlie JT, 2003, J NEUROSURG, V98, P36, DOI 10.3171/spi.2003.98.1.0036; Leslie WD, 2014, CURR OPIN RHEUMATOL, V26, P440, DOI 10.1097/BOR.0000000000000064; Li ZF, 2012, ASIAN PAC J CANCER P, V13, P3529, DOI 10.7314/APJCP.2012.13.7.3529; Ma XL, 2012, EUR SPINE J, V21, P1844, DOI 10.1007/s00586-012-2441-6; Muijs SPJ, 2009, SPINE, V34, P2395, DOI 10.1097/BRS.0b013e3181b8707e; Phekoo KJ, 2004, BRIT J HAEMATOL, V127, P299, DOI 10.1111/j.1365-2141.2004.05207.x; Phillips FM, 2003, SPINE, V28, P2260, DOI 10.1097/01.BRS.0000085092.84097.7B; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; Schoenfeld AJ, 2008, INJURY, V39, P327, DOI 10.1016/j.injury.2007.06.019; Shindle MK, 2006, J BONE JOINT SURG AM, V88A, P2721, DOI 10.2106/JBJS.F.00100; Svedbom A, 2013, OSTEOPOROSIS INT, V24, P355, DOI 10.1007/s00198-012-2102-y; Togawa D, 2005, SPINE, V30, P781, DOI 10.1097/01.brs.0000157478.03349.57; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6; Zhang L, 2013, ONCOL LETT, V5, P135, DOI 10.3892/ol.2012.944	19	5	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115417	10.1371/journal.pone.0115417	http://dx.doi.org/10.1371/journal.pone.0115417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526360	Green Submitted, gold, Green Published			2022-12-26	WOS:000347186200028
J	Raz, N; Danin-Poleg, Y; Hayman, RB; Bar-On, Y; Linetsky, A; Shmoish, M; Sanjuan, E; Amaro, C; Walt, DR; Kashi, Y				Raz, Nili; Danin-Poleg, Yael; Hayman, Ryan B.; Bar-On, Yudi; Linetsky, Alex; Shmoish, Michael; Sanjuan, Eva; Amaro, Carmen; Walt, David R.; Kashi, Yechezkel			Genome-Wide SNP-Genotyping Array to Study the Evolution of the Human Pathogen Vibrio vulnificus Biotype 3	PLOS ONE			English	Article							IDENTIFICATION; DIVERSITY; PCR; EPIDEMIOLOGY; POLYMORPHISM; INFECTIONS; STRAINS; PLASMID; GENE	Vibrio vulnificus is an aquatic bacterium and an important human pathogen. Strains of V. vulnificus are classified into three different biotypes. The newly emerged biotype 3 has been found to be clonal and restricted to Israel. In the family Vibrionaceae, horizontal gene transfer is the main mechanism responsible for the emergence of new pathogen groups. To better understand the evolution of the bacterium, and in particular to trace the evolution of biotype 3, we performed genome-wide SNP genotyping of 254 clinical and environmental V. vulnificus isolates with worldwide distribution recovered over a 30-year period, representing all phylogeny groups. A custom single-nucleotide polymorphism (SNP) array implemented on the Illumina GoldenGate platform was developed based on 570 SNPs randomly distributed throughout the genome. In general, the genotyping results divided the V. vulnificus species into three main phylogenetic lineages and an additional subgroup, clade B, consisting of environmental and clinical isolates from Israel. Data analysis suggested that 69% of biotype 3 SNPs are similar to SNPs from clade B, indicating that biotype 3 and clade B have a common ancestor. The rest of the biotype 3 SNPs were scattered along the biotype 3 genome, probably representing multiple chromosomal segments that may have been horizontally inserted into the clade B recipient core genome from other phylogroups or bacterial species sharing the same ecological niche. Results emphasize the continuous evolution of V. vulnificus and support the emergence of new pathogenic groups within this species as a recurrent phenomenon. Our findings contribute to a broader understanding of the evolution of this human pathogen.	[Raz, Nili; Danin-Poleg, Yael; Bar-On, Yudi; Linetsky, Alex; Kashi, Yechezkel] Technion Israel Inst Technol, Fac Biotechnol & Food Engn, IL-32000 Haifa, Israel; [Hayman, Ryan B.; Walt, David R.] Tufts Univ, Dept Chem, Medford, MA USA; [Shmoish, Michael] Technion Israel Inst Technol, Bioinformat Knowledge Unit, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, IL-32000 Haifa, Israel; [Sanjuan, Eva; Amaro, Carmen] Univ Valencia, Fac Biol, Dept Microbiol, Valencia, Spain	Technion Israel Institute of Technology; Tufts University; Technion Israel Institute of Technology; University of Valencia	Kashi, Y (corresponding author), Technion Israel Inst Technol, Fac Biotechnol & Food Engn, IL-32000 Haifa, Israel.	kashi@techunix.technion.ac.il	Amaro, Carmen/K-7873-2014; Kashi, Yechezkel/GWC-2425-2022; sanjuan, Eva/B-1433-2014	Amaro, Carmen/0000-0003-1323-6330; sanjuan, Eva/0000-0001-7671-0779	NATO [CBD.MD.SFP 981456]; Environment and Health Fund's Interdisciplinary Research Fund (Israel) [RGA0804]; FEDER funds; Programa Consolider-Ingenio from MICINN (Spain) [CSD2009-00006];  [AGL2011-29639]	NATO(NATO (North Atlantic Treaty Organisation)); Environment and Health Fund's Interdisciplinary Research Fund (Israel); FEDER funds(European Commission); Programa Consolider-Ingenio from MICINN (Spain); 	This research was supported by NATO, Project CBD.MD.SFP 981456, by the Environment and Health Fund's Interdisciplinary Research Fund RGA0804 (Israel), by grants AGL2011-29639 (co-funded with FEDER funds) and Programa Consolider-Ingenio 2010 CSD2009-00006 from MICINN (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; AKHUNOV E, 2009, THEOR APPL GENET, V119, P507, DOI DOI 10.1007/s00122-009-1059-5; Amaro C, 1996, APPL ENVIRON MICROB, V62, P1454, DOI 10.1128/AEM.62.4.1454-1457.1996; Arias CR, 1998, APPL ENVIRON MICROB, V64, P3403; Baker S, 2008, J CLIN MICROBIOL, V46, P1741, DOI 10.1128/JCM.02249-07; Baker-Austin C, 2012, FOOD MICROBIOL, V30, P17, DOI 10.1016/j.fm.2011.09.002; Bier N, 2013, APPL ENVIRON MICROB, V79, P3570, DOI 10.1128/AEM.00477-13; Bisharat N, 2005, EMERG INFECT DIS, V11, P30, DOI 10.3201/eid1101.040440; Bisharat N, 1999, LANCET, V354, P1421, DOI 10.1016/S0140-6736(99)02471-X; Bisharat N, 2007, INFECT GENET EVOL, V7, P685, DOI 10.1016/j.meegid.2007.07.007; Bisharat N, 2007, MICROBIOL-SGM, V153, P847, DOI 10.1099/mic.0.2006/003723-0; Broza YY, 2007, J CLIN MICROBIOL, V45, P2951, DOI 10.1128/JCM.00236-07; Broza YY, 2012, INT J FOOD MICROBIOL, V153, P436, DOI 10.1016/j.ijfoodmicro.2011.12.011; Broza YY, 2009, EMERG INFECT DIS, V15, P1282, DOI 10.3201/eid1508.080839; Butler H, 2012, METHODS MOL BIOL; Chatzidaki-Livanis M, 2006, APPL ENVIRON MICROB, V72, P6136, DOI 10.1128/AEM.00341-06; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Cohen ALV, 2007, APPL ENVIRON MICROB, V73, P5553, DOI 10.1128/AEM.00635-07; Dalsgaard A, 1996, EUR J CLIN MICROBIOL, V15, P227, DOI 10.1007/BF01591359; Danin-Poleg Y, 2013, GENOME ANNOUNC, V1; Davis J.C., 1986, STAT DATA ANAL GEOLO; Efimov V, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00393; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Fitzgerald JR, 2001, TRENDS MICROBIOL, V9, P547, DOI 10.1016/S0966-842X(01)02228-4; Fouz B, 2010, J FISH DIS, V33, P383, DOI 10.1111/j.1365-2761.2009.01130.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gulig PA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-512; Gutacker M, 2003, APPL ENVIRON MICROB, V69, P3203, DOI 10.1128/AEM.69.6.3203-3212.2003; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harper D.A., 1999, NUMERICAL PALAEOBIOL, DOI [10.5772/intechopen.73573, DOI 10.5772/INTECHOPEN.73573]; Hoi L, 1997, APPL ENVIRON MICROB, V63, P1674; HOLLIS DG, 1976, J CLIN MICROBIOL, V3, P425; Holt KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001490; Holt KE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-144; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Hyten DL, 2008, THEOR APPL GENET, V116, P945, DOI 10.1007/s00122-008-0726-2; Janda J. M., 2003, MANUAL CLIN MICROBIO, P706; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Kim IH, 2011, J MICROBIOL BIOTECHN, V21, P1228, DOI 10.4014/jmb.1111.11016; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; Lee CT, 2008, J BACTERIOL, V190, P1638, DOI 10.1128/JB.01484-07; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LUDWIG W, 1992, SYST APPL MICROBIOL, V15, P487, DOI 10.1016/S0723-2020(11)80107-4; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Morrison SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037553; Nilsson WB, 2003, J CLIN MICROBIOL, V41, P442, DOI 10.1128/JCM.41.1.442-446.2003; Oliver JD, 2006, BIOLOGY OF VIBRIOS, P349; Patnala R, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-39; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Quirke AM, 2006, BIOINFORMATICS, V22, P905, DOI 10.1093/bioinformatics/btl015; Roltgen K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000751; Roig FJ, 2009, MICROBIOL-SGM, V155, P489, DOI 10.1099/mic.0.023424-0; Rosche TM, 2005, MICROBIOL IMMUNOL, V49, P381, DOI 10.1111/j.1348-0421.2005.tb03731.x; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Sanjuan E, 2011, APPL ENVIRON MICROB, V77, P688, DOI 10.1128/AEM.01263-10; Sanjuan E, 2009, APPL ENVIRON MICROB, V75, P1604, DOI 10.1128/AEM.01594-08; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Shiu SH, 2008, HEREDITY, V100, P141, DOI 10.1038/sj.hdy.6800916; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; Tamura K, 2011, MOLBIOLEVOL; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; TISON DL, 1982, APPL ENVIRON MICROB, V44, P640, DOI 10.1128/AEM.44.3.640-646.1982; Urbanczyk H, 2008, J BACTERIOL, V190, P3494, DOI 10.1128/JB.00101-08; Warner JM, 1999, APPL ENVIRON MICROB, V65, P1141; Zaidenstein R, 2008, EMERG INFECT DIS, V14, P1875, DOI 10.3201/eid1412.080499	70	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114576	10.1371/journal.pone.0114576	http://dx.doi.org/10.1371/journal.pone.0114576			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526263	Green Published, Green Submitted, gold			2022-12-26	WOS:000347186200006
J	Vieira, FG; LaDow, E; Moreno, A; Kidd, JD; Levine, B; Thompson, K; Gill, A; Finkbeiner, S; Perrin, S				Vieira, Fernando G.; LaDow, Eva; Moreno, Andy; Kidd, Joshua D.; Levine, Beth; Thompson, Kenneth; Gill, Alan; Finkbeiner, Steven; Perrin, Steven			Dexpramipexole Is Ineffective in Two Models of ALS Related Neurodegeneration	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; QUALITY STANDARDS SUBCOMMITTEE; PRACTICE PARAMETER UPDATE; AMERICAN ACADEMY; MOUSE MODEL; PRAMIPEXOLE; TDP-43; KNS-760704; MANAGEMENT; NEUROLOGY	Treatment options for people living with amyotrophic lateral sclerosis (ALS) are limited and ineffective. Recently, dexpramipexole (RPPX) was advanced into human ALS clinical trials. In the current studies, we investigated RPPX in two parallel screening systems: 1) appropriately powered, sibling-matched, gender-balanced survival efficacy screening in high-copy B6-SJL-SOD1(G93A)/Gur1 mice, and 2) high-content neuronal survival screening in primary rat cortical neurons transfected with wild-type human TDP43 or mutant human TDP43. In both cases, we exposed the test systems to RPPX levels approximating those achieved in human Phase II clinical investigations. In SOD1(G93A) mice, no effect was observed on neuromotor disease progression or survival. In primary cortical neurons transfected with either mutant or wild-type human TDP43, a marginally significant improvement in a single indicator of neuronal survival was observed, and only at the 10 mu M RPPX treatment. These systems reflect both mutant SOD1- and TDP43-mediated forms of neurodegeneration. The systems also reflect both complex non-cell autonomous and neuronal cell autonomous disease mechanisms. The results of these experiments, taken in context with results produced by other molecules tested in both screening systems, do not argue positively for further study of RPPX in ALS.	[Vieira, Fernando G.; Moreno, Andy; Kidd, Joshua D.; Levine, Beth; Thompson, Kenneth; Gill, Alan; Perrin, Steven] ALS Therapy Dev Inst, Cambridge, MA 02139 USA; [LaDow, Eva; Finkbeiner, Steven] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Finkbeiner, Steven] Taube Koret Ctr Neurodegenerat Dis Res, San Francisco, CA USA; [Finkbeiner, Steven] Hellman Family Fdn Alzheimers Dis Res Program, San Francisco, CA USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vieira, FG (corresponding author), ALS Therapy Dev Inst, Cambridge, MA 02139 USA.	fvieira@als.net; sfinkbeiner@gladstone.ucsf.edu	Vieira, Fernando/L-6246-2013; Vieira, Fernando/ABG-9082-2020	Vieira, Fernando/0000-0003-2996-6418; Vieira, Fernando/0000-0003-2996-6418	Taube-Koret Center for Neurodegenerative Disease Research [NS R01 NS083390]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039074, R01NS083390] Funding Source: NIH RePORTER	Taube-Koret Center for Neurodegenerative Disease Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded primarily by way of the grass roots fundraising efforts of people living with ALS and their families and friends. The funds which they raised were donated directly to the ALS Therapy Development Institute, a 501c3 not-for-profit research organization. Additionally, the cell-based research work was funded by the Taube-Koret Center for Neurodegenerative Disease Research (S. F.) and NS R01 NS083390. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian KN, 2012, BRAIN RES, V1446, P1, DOI 10.1016/j.brainres.2012.01.046; Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Bozik ME, 2011, J CLIN PHARMACOL, V51, P1177, DOI 10.1177/0091270010379412; Cassarino DS, 1998, J NEUROCHEM, V71, P295; Chang WL, 2012, BRAIN RES, V1437, P69, DOI 10.1016/j.brainres.2011.12.007; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Cudkowicz M, 2011, NAT MED, V17, P1652, DOI 10.1038/nm.2579; Cudkowicz ME, 2013, LANCET NEUROL, V12, P1059, DOI 10.1016/S1474-4422(13)70221-7; Danzeisen R, 2006, J PHARMACOL EXP THER, V316, P189, DOI 10.1124/jpet.105.092312; Daub A, 2009, CURR OPIN NEUROBIOL, V19, P537, DOI 10.1016/j.conb.2009.10.002; Ferrari-Toninelli Giulia, 2010, BMC Pharmacology, V10, P2, DOI 10.1186/1471-2210-10-2; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; Gordon P, 2012, TCRM, V359, DOI [10.2147/TCRM.S21981, DOI 10.2147/TCRM.S21981]; Gordon PH, 2013, AGING DIS, V4, P295, DOI 10.14336/AD.2013.0400295; Hatzipetros T, 2014, BRAIN RES, V1584, P59, DOI 10.1016/j.brainres.2013.10.013; Lincecum JM, 2010, NAT GENET, V42, P392, DOI 10.1038/ng.557; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Miller RG, 2009, NEUROLOGY, V73, P1227, DOI 10.1212/WNL.0b013e3181bc01a4; Miller RG, 2009, NEUROLOGY, V73, P1218, DOI 10.1212/WNL.0b013e3181bc0141; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Serio A, 2013, P NATL ACAD SCI USA, P1, DOI [10.1073/pnas.1300398110/-/DCSupplemental, DOI 10.1073/PNAS.1300398110/-/DCSUPPLEMENTAL]	28	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e91608	10.1371/journal.pone.0091608	http://dx.doi.org/10.1371/journal.pone.0091608			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526593	Green Published, Green Submitted, gold			2022-12-26	WOS:000347186200062
J	Miyata, H; Watanabe, S; Minagawa, Y				Miyata, Hiromitsu; Watanabe, Shigeru; Minagawa, Yasuyo			Performance of Young Children on "Traveling Salesperson'' Navigation Tasks Presented on a Touch Screen	PLOS ONE			English	Article							PIGEONS COLUMBA-LIVIA; SALESMAN PROBLEM; ROUTE SELECTION; SPATIAL MEMORY; MAZE PROBLEMS; HEURISTICS; PATHS	Background: The traveling salesperson problem (TSP) refers to a task in which one finds the shortest path when traveling through multiple spatially distributed points. Little is known about the developmental course of the strategies used to solve TSPs. The present study examined young children's performance and route selection strategies in one-way TSPs using a city-block metric. A touch screen-based navigation task was applied. Methodology/Principal Findings: Children (39-70 months) and adults (21-35 years) made serial responses on a touch screen to move a picture of a dog (the target) to two or three identical pictures of a bone (the goals). For all the versions of the tasks, significant improvement in measures of performance was observed from younger to older participants. In TSPs in which a specific route selection strategy such as the nearest-neighbor strategy minimized the total traveling distance, older participants used that strategy more frequently than younger ones. By contrast, in TSPs in which multiple strategies equally led to the minimal traveling distance, children tended to use strategies different from those used by adults, such as traveling straight to the farthest goal first. Conclusions/Significance: The results primarily suggest development of efficient route selection strategies that can optimize total numbers of movements and/or solution time. Unlike adults, children sometimes prioritized other strategies such as traveling straight ahead until being forced to change directions. This may reflect the fact that children were either less attentive to the task or less efficient at perceiving the overall shape of the problem and/or the relative distance from the starting location to each goal.	[Miyata, Hiromitsu] Japan Soc Promot Sci, Tokyo, Japan; [Miyata, Hiromitsu; Minagawa, Yasuyo] Keio Univ, Grad Sch Human Relat, Tokyo, Japan; [Watanabe, Shigeru] Keio Univ, Fac Letters, Tokyo, Japan	Japan Society for the Promotion of Science; Keio University; Keio University	Miyata, H (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	miyata@he.u-tokyo.ac.jp			Research Fellowship of the Japan Society for the Promotion of Science (JSPS) for Young Scientists to Hiromitsu Miyata; Japan Ministry of Education, Culture, Sports, Science and Technology Global COE Program [D-09]	Research Fellowship of the Japan Society for the Promotion of Science (JSPS) for Young Scientists to Hiromitsu Miyata; Japan Ministry of Education, Culture, Sports, Science and Technology Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Research Fellowship of the Japan Society for the Promotion of Science (JSPS) for Young Scientists to Hiromitsu Miyata, and by the Japan Ministry of Education, Culture, Sports, Science and Technology Global COE Program, D-09, to Keio University, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applegate DL, 2007, TRAVELING SALESMAN P; Burns NR, 2006, J PROBL SOLVING, V1, P5, DOI 10.7771/1932-6246.1003; Davidse NJ, 2014, COGN NEUROPSYCHOL, V31, P221, DOI 10.1080/02643294.2013.876980; Dry M, 2006, J PROBL SOLVING, V1, P20, DOI 10.7771/1932-6246.1004; Ferguson B, 2014, COGNITION, V131, P139, DOI 10.1016/j.cognition.2013.12.014; Gallistel CR, 1996, J EXP BIOL, V199, P211; GARLING T, 1988, ENVIRON PLANN A, V20, P547, DOI 10.1068/a200547; Gibson B, 2012, ANIM COGN, V15, P379, DOI 10.1007/s10071-011-0463-9; Gibson BM, 2007, J EXP PSYCHOL ANIM B, V33, P244, DOI 10.1037/0097-7403.33.3.244; Graham SM, 2000, MEM COGNITION, V28, P1191, DOI 10.3758/BF03211820; Helsgaun K, 2000, EUR J OPER RES, V126, P106, DOI 10.1016/S0377-2217(99)00284-2; HIRTLE SC, 1992, GEOFORUM, V23, P227, DOI 10.1016/0016-7185(92)90019-Z; HUDSON JA, 1995, CHILD DEV, V66, P984, DOI 10.1111/j.1467-8624.1995.tb00917.x; Hui SK, 2009, MARKET SCI, V28, P566, DOI 10.1287/mksc.1080.0402; Janson CH, 1998, ANIM BEHAV, V55, P1229, DOI 10.1006/anbe.1997.0688; Keen R, 2011, ANNU REV PSYCHOL, V62, P1, DOI 10.1146/annurev.psych.031809.130730; MacGregor JN, 2006, J PROBL SOLVING, V1, P33, DOI 10.7771/1932-6246.1005; MacGregor JN, 1996, PERCEPT PSYCHOPHYS, V58, P527, DOI 10.3758/BF03213088; MacGregor JN, 1999, PERCEPTION, V28, P1417, DOI 10.1068/p2863; MENZEL EW, 1973, SCIENCE, V182, P943, DOI 10.1126/science.182.4115.943; Miyata H, 2008, ANIM COGN, V11, P505, DOI 10.1007/s10071-008-0141-8; Miyata H, 2006, J COMP PSYCHOL, V120, P358, DOI 10.1037/0735-7036.120.4.358; Miyata H, 2012, PERCEPT MOTOR SKILL, V115, P27, DOI 10.2466/23.04.22.PMS.115.4.27-42; Miyata H, 2011, J COMP PSYCHOL, V125, P431, DOI 10.1037/a0024240; Miyata H, 2010, J COMP PSYCHOL, V124, P433, DOI 10.1037/a0019931; Miyata H, 2009, J COMP PSYCHOL, V123, P69, DOI 10.1037/a0012890; Miyata H, 2011, BRAIN RES, V1374, P90, DOI 10.1016/j.brainres.2010.12.047; Ormerod TC, 1999, PERCEPT PSYCHOPHYS, V61, P1227, DOI 10.3758/BF03207625; Pellicano E, 2011, P NATL ACAD SCI USA, V108, P421, DOI 10.1073/pnas.1014076108; Polivanova N.I., 1974, VOPROSY PSYCHOL, V4, P41; Rego C, 2011, EUR J OPER RES, V211, P427, DOI 10.1016/j.ejor.2010.09.010; Roderer T, 2014, METACOGN LEARN, V9, P1, DOI 10.1007/s11409-013-9109-4; van Rooij I, 2006, J PROBL SOLVING, V1, P44, DOI 10.7771/1932-6246.1006; Vickers D, 2001, PSYCHOL RES-PSYCH FO, V65, P34, DOI 10.1007/s004260000031; Walwyn AL, 2014, J PROBLEM SOLVING, V3, P93; Wiener JM, 2009, PSYCHOL RES-PSYCH FO, V73, P644, DOI 10.1007/s00426-008-0181-3; YAMAMOTO Y, 1997, JUNKAI SALESMAN MOND	37	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115292	10.1371/journal.pone.0115292	http://dx.doi.org/10.1371/journal.pone.0115292			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA4AC	25521714	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845600031
J	Mahmmoud, YA; Kopec, W; Khandelia, H				Mahmmoud, Yasser A.; Kopec, Wojciech; Khandelia, Himanshu			K+ Congeners That Do Not Compromise Na+ Activation of the Na+, K+-ATPase HYDRATION OF THE ION BINDING CAVITY LIKELY CONTROLS ION SELECTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; OSMOTIC-STRESS; ALPHA-SUBUNIT; FORCE-FIELD; SITES; WATER; NA,K-ATPASE; MECHANISM	The Na+, K+-ATPase is essential for ionic homeostasis in animal cells. The dephosphoenzyme contains Na+ selective inward facing sites, whereas the phosphoenzyme contains K+ selective outward facing sites. Under normal physiological conditions, K+ inhibits cytoplasmic Na+ activation of the enzyme. Acetamidinium (Acet(+)) and formamidinium (Form(+)) have been shown to permeate the pump through the outward facing sites. Here, we show that these cations, unlike K+, are unable to enter the inward facing sites in the dephosphorylated enzyme. Consistently, the organic cations exhibited little to no antagonism to cytoplasmic Na+ activation. Na+, K+-ATPase structures revealed a previously undescribed rotamer transition of the hydroxymethyl side chain of the absolutely conserved Thr(772) of the alpha-subunit. The side chain contributes its hydroxyl to Na+ in site I in the E-1 form and rotates to contribute its methyl group toward K+ in the E-2 form. Molecular dynamics simulations to the E-1 center dot AlF4-center dot ADP center dot 3Na(+) structure indicated that 1) bound organic cations differentially distorted the ion binding sites, 2) the hydroxymethyl of Thr(772) rotates to stabilize bound Form(+) through water molecules, and 3) the rotamer transition is mediated by water traffic into the ion binding cavity. Accordingly, dehydration induced by osmotic stress enhanced the interaction of the congeners with the outward facing sites and profoundly modified the organization of membrane domains of the alpha-subunit. These results assign a catalytic role for water in pump function, and shed light on a backbone-independent but a conformation-dependent switch between H-bond and dispersion contact as part of the catalytic mechanism of the Na+, K+-ATPase.	[Mahmmoud, Yasser A.] Univ Aarhus, Dept Biomed, DK-8000 Aarhus C, Denmark; [Kopec, Wojciech; Khandelia, Himanshu] Univ Southern Denmark, Ctr Biomembrane Phys, MEMPHYS, DK-5230 Odense M, Denmark	Aarhus University; University of Southern Denmark	Mahmmoud, YA (corresponding author), Univ Aarhus, Ole Worms 6,Bld 1180, DK-8000 Aarhus C, Denmark.	yasser@privat.dk		Khandelia, Himanshu/0000-0001-9913-6394	Novo Nordic Foundation; Lundbeck Foundation; Lundbeck Foundation [R82-2011-7280] Funding Source: researchfish	Novo Nordic Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by a grant from the Novo Nordic Foundation (to Y. A. M.) and the Lundbeck Foundation (to H. K. and W. K.).	BAGINSKI ES, 1967, CLIN CHEM, V13, P326; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Damjanovic A, 2009, PROTEINS, V76, P1007, DOI 10.1002/prot.22439; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DRAPEAU P, 1980, J BIOL CHEM, V255, P7827; Dudev T, 2010, J AM CHEM SOC, V132, P2321, DOI 10.1021/ja909280g; Dudev T, 2009, J AM CHEM SOC, V131, P8092, DOI 10.1021/ja900168k; Esmann M, 2008, BIOPHYS J, V94, P2767, DOI 10.1529/biophysj.106.101774; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FORBUSH B, 1988, J BIOL CHEM, V263, P7979; GARAY RP, 1973, J PHYSIOL-LONDON, V231, P297, DOI 10.1113/jphysiol.1973.sp010234; Gatto C, 2007, J MEMBRANE BIOL, V216, P49, DOI 10.1007/s00232-007-9028-x; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Gonzalez-Lebrero RM, 2002, J BIOL CHEM, V277, P5910, DOI 10.1074/jbc.M105886200; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; HILLE B, 1971, P NATL ACAD SCI USA, V68, P280, DOI 10.1073/pnas.68.2.280; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Jorgensen PL, 2001, BBA-BIOENERGETICS, V1505, P57, DOI 10.1016/S0005-2728(00)00277-2; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KARLISH SJD, 1990, P NATL ACAD SCI USA, V87, P4566, DOI 10.1073/pnas.87.12.4566; Kirschner KN, 2001, P NATL ACAD SCI USA, V98, P10541, DOI 10.1073/pnas.191362798; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Klodos I, 2002, KIDNEY INT, V62, P2097, DOI 10.1046/j.1523-1755.2002.00654.x; Kopec W, 2014, BIOCHEMISTRY-US, V53, P746, DOI 10.1021/bi401425g; KROONBATENBURG LMJ, 1990, BIOPOLYMERS, V29, P1243, DOI 10.1002/bip.360290813; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Li J, 2013, P NATL ACAD SCI USA, V110, P7696, DOI 10.1073/pnas.1218986110; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahmmoud YA, 2003, J BIOL CHEM, V278, P37427, DOI 10.1074/jbc.M305126200; Mahmmoud YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096909; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Noskov SY, 2007, J GEN PHYSIOL, V129, P135, DOI 10.1085/jgp.200609633; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; Ostmeyer J, 2013, NATURE, V501, DOI 10.1038/nature12395; Panman MR, 2013, NAT CHEM, V5, P929, DOI [10.1038/NCHEM.1744, 10.1038/nchem.1744]; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PARSEGIAN VA, 1986, METHOD ENZYMOL, V127, P400; Pedersen PA, 1998, BIOCHEMISTRY-US, V37, P17818, DOI 10.1021/bi981898w; Peluffo RD, 2009, BIOCHEMISTRY-US, V48, P8105, DOI 10.1021/bi900687u; Pitsawong W, 2010, J BIOL CHEM, V285, P9697, DOI 10.1074/jbc.M109.073247; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Ratheal IM, 2010, P NATL ACAD SCI USA, V107, P18718, DOI 10.1073/pnas.1004214107; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sugita Y, 2010, P NATL ACAD SCI USA, V107, P21465, DOI 10.1073/pnas.1015819107; Therien AG, 1999, AM J PHYSIOL-CELL PH, V277, pC891, DOI 10.1152/ajpcell.1999.277.5.C891; Therien AG, 1996, J BIOL CHEM, V271, P7104, DOI 10.1074/jbc.271.12.7104; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106; Yohannan S, 2007, J MOL BIOL, V366, P806, DOI 10.1016/j.jmb.2006.11.081; Yu HB, 2011, NAT STRUCT MOL BIOL, V18, P1159, DOI 10.1038/nsmb.2113; Zeuthen T, 2010, J MEMBRANE BIOL, V234, P57, DOI 10.1007/s00232-009-9216-y	61	6	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3720	3731		10.1074/jbc.M114.577486	http://dx.doi.org/10.1074/jbc.M114.577486			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533461	Green Published, hybrid			2022-12-26	WOS:000349456000043
J	Lin, WY				Lin, Wan-Yu			Adaptive Combination of P-Values for Family-Based Association Testing with Sequence Data	PLOS ONE			English	Article							UNCOMMON CAUSAL VARIANTS; RARE DISEASE VARIANTS; COMPLEX DISEASES; PRINCIPAL-COMPONENTS; GENETIC ASSOCIATION; COMMON DISEASES; HAPLOTYPE; DISEQUILIBRIUM; GENOME; MODEL	Family-based study design will play a key role in identifying rare causal variants, because rare causal variants can be enriched in families with multiple affected subjects. Furthermore, different from population-based studies, family studies are robust to bias induced by population substructure. It is well known that rare causal variants are difficult to detect from single-locus tests. Therefore, burden tests and non-burden tests have been developed, by combining signals of multiple variants in a chromosomal region or a functional unit. This inevitably incorporates some neutral variants into the test statistics, which can dilute the power of statistical methods. To guard against the noise caused by neutral variants, we here propose an 'adaptive combination of P-values method' (abbreviated as 'ADA'). This method combines per-site P-values of variants that are more likely to be causal. Variants with large P-values (which are more likely to be neutral variants) are discarded from the combined statistic. In addition to performing extensive simulation studies, we applied these tests to the Genetic Analysis Workshop 17 data sets, where real sequence data were generated according to the 1000 Genomes Project. Compared with some existing methods, ADA is more robust to the inclusion of neutral variants. This is a merit especially when dichotomous traits are analyzed. However, there are some limitations for ADA. First, it is more computationally intensive. Second, pedigree structures and founders' sequence data are required for the permutation procedure. Third, unrelated controls cannot be included. We here show that, for family-based studies, the application of ADA is limited to dichotomous trait analyses with full pedigree information.	Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	National Taiwan University	Lin, WY (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	linwy@ntu.edu.tw		LIN, WAN-YU/0000-0002-3385-4702	Ministry of Science and Technology of Taiwan [102-2628-B-002-039-MY3]; National Taiwan University [NTU-CESRP-103R7622-8, NTU-CDP-102R7769]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This work was supported by grants 102-2628-B-002-039-MY3 from the Ministry of Science and Technology of Taiwan, NTU-CESRP-103R7622-8, and NTU-CDP-102R7769 from National Taiwan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 2011, BMC P S9, V5, pS2; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; BESAG J, 1991, BIOMETRIKA, V78, P301; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chen H, 2013, GENET EPIDEMIOL, V37, P196, DOI 10.1002/gepi.21703; Cheng KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074310; Cheung YH, 2012, GENET EPIDEMIOL, V36, P675, DOI 10.1002/gepi.21662; Chung RH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-199; Chung RH, 2014, GENET EPIDEMIOL; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; De G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048495; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Fan RZ, 2005, ANN HUM GENET, V69, P187, DOI 10.1046/j.1529-8817.2004.00151.x; Fier H, 2012, BIOINFORMATICS, V28, P3027, DOI 10.1093/bioinformatics/bts568; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; He ZX, 2014, AM J HUM GENET, V94, P33, DOI 10.1016/j.ajhg.2013.11.021; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Ionita-Laza I, 2013, STAT BIOSCI, V5, P54, DOI 10.1007/s12561-012-9062-9; Ionita-Laza I, 2013, EUR J HUM GENET, V21, P1158, DOI 10.1038/ejhg.2012.308; Ionita-Laza I, 2012, AM J HUM GENET, V90, P1002, DOI 10.1016/j.ajhg.2012.04.010; Ionita-Laza I, 2011, GENETICS, V189, P1061, DOI 10.1534/genetics.111.131813; Jiang Y, 2014, AM J HUM GENET, V94, P845, DOI 10.1016/j.ajhg.2014.04.014; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li Y, 2010, AM J HUM GENET, V87, P728, DOI 10.1016/j.ajhg.2010.10.014; Liang LM, 2007, BIOINFORMATICS, V23, P1565, DOI 10.1093/bioinformatics/btm138; Lin WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094337; Lin WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085728; Lin WY, 2013, GENET EPIDEMIOL, V37, P560, DOI 10.1002/gepi.21740; Lin WY, 2012, GENET EPIDEMIOL, V36, P572, DOI 10.1002/gepi.21650; Lin WY, 2011, BMC P S9, V5, pS118; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Oualkacha K, 2013, GENET EPIDEMIOL, V37, P366, DOI 10.1002/gepi.21725; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Saad M, 2011, BMC P S9, V5, pS33; Saad M, 2014, GENET EPIDEMIOL, V38, P1, DOI 10.1002/gepi.21776; Schaid DJ, 2013, HUM GENET, V132, P1301, DOI 10.1007/s00439-013-1335-y; Schaid DJ, 2013, GENET EPIDEMIOL, V37, P409, DOI 10.1002/gepi.21727; Schifano ED, 2012, GENET EPIDEMIOL, V36, P797, DOI 10.1002/gepi.21676; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Svishcheva GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099407; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Therneau T, 2012, R PACKAGE VERSION 2; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yi NJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002382; Yi NJ, 2011, GENET EPIDEMIOL, V35, P57, DOI 10.1002/gepi.20554; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zawistowski M, 2010, AM J HUM GENET, V87, P604, DOI 10.1016/j.ajhg.2010.10.012; Zhang YW, 2013, GENET EPIDEMIOL, V37, P99, DOI 10.1002/gepi.21691	66	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115971	10.1371/journal.pone.0115971	http://dx.doi.org/10.1371/journal.pone.0115971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541952	gold, Green Submitted, Green Published			2022-12-26	WOS:000347239900122
J	Kinouchi, M; Uchida, D; Kuribayashi, N; Tamatani, T; Nagai, H; Miyamoto, Y				Kinouchi, Makoto; Uchida, Daisuke; Kuribayashi, Nobuyuki; Tamatani, Tetsuya; Nagai, Hirokazu; Miyamoto, Youji			Involvement of miR-518c-5p to Growth and Metastasis in Oral Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CHEMOKINE RECEPTOR CXCR4; LYMPH-NODE METASTASIS; MICRORNA EXPRESSION; STEM-CELLS; IDENTIFICATION; TUMORIGENESIS; NICHES	We have previously demonstrated that a stromal cell-derived factor-1 (SDF-1; CXCL12)/CXCR4 system is involved in the establishment of metastasis in oral cancer. Recently, small non coding RNAs, microRNAs (miRNAs) have been shown to be involved in the metastatic process of several types of cancers. However, the miRNAs that contribute to metastases induced by the SDF-1/CXCR4 system in oral cancer are largely unknown. In this study, we examined the metastasis-related miRNAs induced by the SDF-1/CXCR4 system using B88-SDF-1 oral cancer cells, which exhibit functional CXCR4 and distant metastatic potential in vivo. Through miRNA microarray analysis, we identified the upregulation of miR-518c-5p in B88-SDF-1 cells, and confirmed the induction by real-time PCR analysis. Although an LNA-based miR-518c-5p inhibitor did not affect cell growth of B88-SDF-1 cells, it did significantly inhibit the migration of the cells. Next, we transfected a miR-518c expression vector into parental B88 cells and CAL27 oral cancer cells and isolated stable transfectants, B88-518c and CAL27-518c cells, respectively. The anchorage-dependent and -independent growth of miR-518c transfectants was significantly enhanced compared with the growth of mock cells. Moreover, we detected the enhanced migration of these cells. The LNA-based miR-518c-5p inhibitor significantly impaired the enhanced cell growth and migration of miR-518c transfectants, indicating that these phenomena were mainly dependent on the expression of miR-518c-5p. Next, we examined the function of miR-518c-5p in vivo. miR-518c transfectants or mock transfectants were inoculated into the masseter muscle or the blood vessels of nude mice. Tumor volume, lymph nodes metastasis, and lung metastasis were significantly increased in the mice inoculated with the miR-518c transfectants. These results indicated that miR-518c-5p regulates the growth and metastasis of oral cancer as a downstream target of the SDF-1/CXCR4 system.	[Kinouchi, Makoto; Uchida, Daisuke; Kuribayashi, Nobuyuki; Tamatani, Tetsuya; Nagai, Hirokazu; Miyamoto, Youji] Univ Tokushima, Grad Sch, Inst Hlth Biosciences, Dept Oral Surg Subdiv Mol Oral Med,Div Integrated, Tokushima 770, Japan		Uchida, D (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosciences, Dept Oral Surg Subdiv Mol Oral Med,Div Integrated, Tokushima 770, Japan.	daisuke@tokushima-u.ac.jp		Hoque, Mohammad Obaidul/0000-0001-6701-9978	 [25293411];  [26463046]; Grants-in-Aid for Scientific Research [26463046] Funding Source: KAKEN	; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (B; 25293411 and C; 26463046; http://www.jsps.go.jp/english/e-grants/grants01.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almofti A, 2004, INT J ONCOL, V25, P65; Bouyssou JMC, 2014, BBA-REV CANCER, V1845, P255, DOI 10.1016/j.bbcan.2014.02.002; Chen ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069134; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Flor I, 2012, J PATHOL, V227, P270, DOI 10.1002/path.4014; Fornari F, 2012, J PATHOL, V227, P275, DOI 10.1002/path.3995; Fukunaga S, 2006, ONCOLOGY-BASEL, V71, P204, DOI 10.1159/000106070; Gellmini S, 2008, J ENDOCRINOL INVEST, V31, P809, DOI 10.1007/BF03349262; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Kasamatsu A, 2005, INT J BIOCHEM CELL B, V37, P1869, DOI 10.1016/j.biocel.2005.04.004; Khan MZ, 2011, J NEUROIMMUNE PHARM, V6, P163, DOI 10.1007/s11481-010-9228-5; Korshunov A, 2010, ACTA NEUROPATHOL, V120, P253, DOI 10.1007/s00401-010-0688-8; Kuribayashi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080773; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Rhodes LV, 2011, EXP CELL RES, V317, P2573, DOI 10.1016/j.yexcr.2011.08.016; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Scotton CJ, 2002, CANCER RES, V62, P5930; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; Uchida D, 2007, MOL CANCER RES, V5, P1, DOI DOI 10.1158/1541-7786.MCR-06-0208.PUBMED:17259342; Uchida D, 2013, CLIN EXP METASTAS, V30, P133, DOI 10.1007/s10585-012-9518-9; Uchida D, 2011, EUR J CANCER, V47, P452, DOI 10.1016/j.ejca.2010.09.028; Uchida DE, 2004, LAB INVEST, V84, P1538, DOI 10.1038/labinvest.3700190; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	28	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115936	10.1371/journal.pone.0115936	http://dx.doi.org/10.1371/journal.pone.0115936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536052	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300089
J	Nagaraj, VH; Mukhopadhyay, S; Dayarian, A; Sengupta, AM				Nagaraj, Vijayalakshmi H.; Mukhopadhyay, Swagatam; Dayarian, Adel; Sengupta, Anirvan M.			Breaking an Epigenetic Chromatin Switch: Curious Features of Hysteresis in Saccharomyces cerevisiae Telomeric Silencing	PLOS ONE			English	Article							GENE-EXPRESSION; PAF1 COMPLEX; METHYLATION; SIR2; MECHANISM; PROTEIN; HETEROCHROMATIN; IDENTIFICATION; INHERITANCE; DYNAMICS	In addition to gene network switches, local epigenetic modifications to DNA and histones play an important role in all-or-none cellular decision-making. Here, we study the dynamical design of a well-characterized epigenetic chromatin switch: the yeast SIR system, in order to understand the origin of the stability of epigenetic states. We study hysteresis in this system by perturbing it with a histone deacetylase inhibitor. We find that SIR silencing has many characteristics of a nonlinear bistable system, as observed in conventional genetic switches, which are based on activities of a few promoters affecting each other through the abundance of their gene products. Quite remarkably, our experiments in yeast telomeric silencing show a very distinctive pattern when it comes to the transition from bistability to monostability. In particular, the loss of the stable silenced state, upon increasing the inhibitor concentration, does not seem to show the expected saddle node behavior, instead looking like a supercritical pitchfork bifurcation. In other words, the 'off' state merges with the 'on' state at a threshold concentration leading to a single state, as opposed to the two states remaining distinct up to the threshold and exhibiting a discontinuous jump from the 'off' to the 'on' state. We argue that this is an inevitable consequence of silenced and active regions coexisting with dynamic domain boundaries. The experimental observations in our study therefore have broad implications for the understanding of chromatin silencing in yeast and beyond.	[Nagaraj, Vijayalakshmi H.; Sengupta, Anirvan M.] Rutgers State Univ, BioMaPS Inst, Piscataway, NJ 08854 USA; [Mukhopadhyay, Swagatam] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Dayarian, Adel] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Sengupta, Anirvan M.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ USA	Rutgers State University New Brunswick; Cold Spring Harbor Laboratory; University of California System; University of California Santa Barbara; Rutgers State University New Brunswick	Sengupta, AM (corresponding author), Rutgers State Univ, BioMaPS Inst, Piscataway, NJ 08854 USA.	anirvans@physics.rutgers.edu			NHGRI [R01 HG003470]; NSF [PHY11-25915]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003470] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was partially supported by a NHGRI grant R01 HG003470 to AMS. AD acknowledges support of NSF PHY11-25915. AMS also thanks KITP, UCSB (supported in part by NSF Phy11-25915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2008, MOL BIOL CELL, Vxxxiii, P1601; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Arkin A, 1998, GENETICS, V149, P1633; Aurell E, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051914; Aurell E, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.048101; Batenchuk C, 2011, BIOPHYS J, V100, pL56, DOI 10.1016/j.bpj.2011.04.021; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Burke D, 2000, METHODS YEAST GENETI, Vxvii; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen LY, 2005, CELL, V120, P37, DOI 10.1016/j.cell.2004.11.030; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; David-Rus D, 2009, J THEOR BIOL, V258, P112, DOI 10.1016/j.jtbi.2008.12.021; Dayarian A, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/3/036005; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Frederiks F, 2008, NAT STRUCT MOL BIOL, V15, P550, DOI 10.1038/nsmb.1432; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Kaufman PD, 2010, CURR OPIN CELL BIOL, V22, P284, DOI 10.1016/j.ceb.2010.02.002; Kelemen JZ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000332; Kitada T, 2012, GENE DEV, V26, P2443, DOI 10.1101/gad.201095.112; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Micheelsen MA, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/026010; Mukhopadhyay S, ROLE MULTIPLE UNPUB; Mukhopadhyay S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003121; Mukhopadhyaya S, 2010, BIOSYSTEMS, V102, P49, DOI 10.1016/j.biosystems.2010.07.012; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; Poon Betty P. K., 2012, Frontiers in Genetics, V3, P144, DOI 10.3389/fgene.2012.00144; Posakony J, 2004, COMB CHEM HIGH T SCR, V7, P661; Prohaska SJ, 2010, J THEOR BIOL, V265, P27, DOI 10.1016/j.jtbi.2010.03.011; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Ptashne M, 2004, GENETIC SWITCH PHAGE, Vxiv; Ptashne M, 1992, GENETIC SWITCH PHAGE, Vix; Radman-Livaja M, 2011, EMBO J, V30, P1012, DOI 10.1038/emboj.2011.30; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Riggs AD, 2004, P NATL ACAD SCI USA, V101, P4, DOI 10.1073/pnas.0307781100; Riggs AD, 1998, CIBA F SYMP, V214, P214; Rohlf T, 2012, EPIGENOMICS-UK, V4, P205, DOI [10.2217/epi.11.117, 10.2217/EPI.11.117]; Roma DM, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011902; Rossmann MP, 2011, MOL CELL, V42, P127, DOI 10.1016/j.molcel.2011.03.007; Ruault M, 2011, J CELL BIOL, V192, P417, DOI 10.1083/jcb.201008007; Sears FW, 1975, THERMODYNAMICS KINET, Vviii; Sedighi M, 2007, PHYS BIOL, V4, P246, DOI 10.1088/1478-3975/4/4/002; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sneppen K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002643; Song J, 2012, J CELL SCI, V125, P3723, DOI 10.1242/jcs.084764; Steffen PA, 2012, BIOESSAYS, V34, P901, DOI 10.1002/bies.201200076; Strogatz SH, 1994, NONLINEAR DYNAMICS C, Vxi; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962; Ugolini S, 1996, CURR GENET, V30, P485, DOI 10.1007/s002940050160; Van Leeuwen F, 2002, METHOD ENZYMOL, V350, P165, DOI 10.1016/S0076-6879(02)50962-9; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	71	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e113516	10.1371/journal.pone.0113516	http://dx.doi.org/10.1371/journal.pone.0113516			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536038	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000348563300007
J	Windolf, CD; Loegters, T; Scholz, M; Windolf, J; Flohe, S				Windolf, Ceylan D.; Loegters, Tim; Scholz, Martin; Windolf, Joachim; Flohe, Sascha			Lysostaphin-Coated Titan-Implants Preventing Localized Osteitis by Staphylococcus aureus in a Mouse Model	PLOS ONE			English	Article							POSTTRAUMATIC OSTEOMYELITIS; ANTIBIOTIC-RESISTANCE; ORTHOPEDIC IMPLANTS; BACTERIOLYTIC AGENT; BIOFILM FORMATION; INFECTIONS; MECHANISMS; SURFACES; PROTEIN; BONE	The increasing incidence of implant-associated infections induced by Staphylococcus aureus (SA) in combination with growing resistance to conventional antibiotics requires novel therapeutic strategies. In the current study we present the first application of the biofilm-penetrating antimicrobial peptide lysostaphin in the context of bone infections. In a standardized implant-associated bone infection model in mice beta-irradiated lysostaphin-coated titanium plates were compared with uncoated plates. Coating of the implant was established with a poly(D, L)-lactide matrix (PDLLA) comprising lysostaphin formulated in a stabilizing and protecting solution (SPS). All mice were osteotomized and infected with a defined count of SA. Fractures were fixed with lysostaphin-coated locking plates. Plates uncoated or PDLLA-coated served as controls. All mice underwent debridement and lavage on Days 7, 14, 28 to determine the bacterial load and local immune reaction. Fracture healing was quantified by conventional radiography. On Day 7 bacterial growth in the lavages of mice with lysostaphin-coated plates showed a significantly lower count to the control groups. Moreover, in the lysostaphin-coated plate groups complete fracture healing were observed on Day 28. The fracture consolidation was accompanied by a diminished local immune reaction. However, control groups developed an osteitis with lysis or destruction of the bone and an evident local immune response. The presented approach of terminally sterilized lysostaphin-coated implants appears to be a promising therapeutic approach for low grade infection or as prophylactic strategy in high risk fracture care e. g. after severe open fractures.	[Windolf, Ceylan D.; Loegters, Tim; Scholz, Martin; Windolf, Joachim; Flohe, Sascha] Univ Dusseldorf, Dept Trauma & Hand Surg, D-40225 Dusseldorf, Germany; [Scholz, Martin] LEUKOCARE AG, D-82152 Martinsried, Germany	Heinrich Heine University Dusseldorf	Windolf, CD (corresponding author), Univ Dusseldorf, Dept Trauma & Hand Surg, Moorenstr 5, D-40225 Dusseldorf, Germany.	ceylan.windolf@uni-duesseldorf.de		Flohe, Sascha/0000-0002-8033-1242	"Zentrales Innnovationsprogramm Mittelstand'' of the German ministry of economics and Technology [KF2790101MK0]; AO-Research foundation (AO Start-Up) [S-11-34F]	"Zentrales Innnovationsprogramm Mittelstand'' of the German ministry of economics and Technology; AO-Research foundation (AO Start-Up)	The work was financially supported by the "Zentrales Innnovationsprogramm Mittelstand'' of the German ministry of economics and Technology; www.zim-bmwi.de; (KF2790101MK0); SF and the AO-Research foundation; https://www.aofoundation.org; (AO Start-Up grant S-11-34F); SF. They were not involved in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B; Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031; Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044; Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089; Climo MW, 1998, ANTIMICROB AGENTS CH, V42, P1355, DOI 10.1128/AAC.42.6.1355; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Dajcs JJ, 2002, INVEST OPHTH VIS SCI, V43, P3712; Dajcs JJ, 2001, CURR EYE RES, V22, P451, DOI 10.1076/ceyr.22.6.451.5486; Dajcs JJ, 2000, INVEST OPHTH VIS SCI, V41, P1432; Bastos MDD, 2010, PHARMACEUTICALS, V3, P1139, DOI 10.3390/ph3041139; Diener T., 2003, PROGR BIOMEDICAL RES, V8, P82; Fei J, 2010, ORTHOPEDICS, V33, P310, DOI DOI 10.HTTP://DX.D0I.0RG/10; Garcia LG, 2013, J ANTIMICROB CHEMOTH, V68, P1455, DOI 10.1093/jac/dkt072; Gargis SR, 2010, APPL ENVIRON MICROB, V76, P6944, DOI 10.1128/AEM.01066-10; Gollwitzer H, 2005, J ORTHOP RES, V23, P802, DOI 10.1016/j.orthres.2005.02.003; Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Greiner SH, 2008, ACTA ORTHOP, V79, P717, DOI 10.1080/17453670810016768; Grundmann S, 2007, J AM COLL CARDIOL, V50, P351, DOI 10.1016/j.jacc.2007.03.046; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hudson MC, 1999, FEMS MICROBIOL LETT, V173, P279, DOI 10.1016/S0378-1097(99)00079-8; Kaplan SL, 2014, J INFECTION, V68, pS51, DOI 10.1016/j.jinf.2013.09.014; Kempf B, 2006, PRACTICE INTRAMEDULL, P283, DOI 10.1007/3-540-32345-7_29; Kokai-Kun JF, 2003, ANTIMICROB AGENTS CH, V47, P1589, DOI 10.1128/AAC.47.5.1589-1597.2003; Kokai-Kun JF, 2007, J ANTIMICROB CHEMOTH, V60, P1051, DOI 10.1093/jac/dkm347; Kokai-Kun JF, 2009, J ANTIMICROB CHEMOTH, V64, P94, DOI 10.1093/jac/dkp145; Kumar JK, 2008, APPL MICROBIOL BIOT, V80, P555, DOI 10.1007/s00253-008-1579-y; Lakdawala M., 2013, INT J SCI NATURE, V4, P522; Meghji S, 1998, BRIT J RHEUMATOL, V37, P1095; Montanaro L, 2011, INT J ARTIF ORGANS, V34, P781, DOI 10.5301/ijao.5000052; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Pulverer G, 1968, Z Med Mikrobiol Immunol, V154, P49, DOI 10.1007/BF02123078; Sabala I, 2014, FEBS J, V281, P4112, DOI 10.1111/febs.12929; Sadowska B, 2013, ARCH IMMUNOL THER EX, V61, P413, DOI 10.1007/s00005-013-0240-3; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; Schmidmaier G, 2001, J BIOMED MATER RES, V58, P449; Stefansdottir A, 2009, SCAND J INFECT DIS, V41, P831, DOI 10.3109/00365540903186207; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; TRAYER HR, 1970, J BIOL CHEM, V245, P4842; Vester H, 2010, INJURY, V41, P1053, DOI 10.1016/j.injury.2010.05.010; Wagner C, 2005, INT J ARTIF ORGANS, V28, P1172, DOI 10.1177/039139880502801115; Wagner C, 2003, SHOCK, V20, P503, DOI 10.1097/01.shk.0000093542.78705.e3; Walencka Elzbieta, 2005, Polish Journal of Microbiology, V54, P191; Windolf CD, 2013, J ORTHOP RES, V31, P2013, DOI 10.1002/jor.22446; Wu JA, 2003, ANTIMICROB AGENTS CH, V47, P3407, DOI 10.1128/AAC.47.11.3407-3414.2003; Xiao L, 2012, BIOMEDICAL SCI ENG T, P471; Yarwood JM, 2003, J CLIN INVEST, V112, P1620, DOI 10.1172/JCI200320442	50	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115940	10.1371/journal.pone.0115940	http://dx.doi.org/10.1371/journal.pone.0115940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536060	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300090
J	de Araujo, RF; Reinaldo, MPOD; Brito, GAD; Cavalcanti, PD; Freire, MAD; de Medeiros, CAX; de Araujo, AA				de Araujo Junior, Raimundo Fernandes; Oliveira da Silva Reinaldo, Maria Patricia; de Castro Brito, Gerly Anne; Cavalcanti, Pedro de Franca; de Moura Freire, Marco Aurelio; Xavier de Medeiros, Caroline Addison; de Araujo, Aurigena Antunes			Olmesartan Decreased Levels of IL-1 beta and TNF-alpha, Down-Regulated MMP-2, MMP-9, COX-2, RANK/RANKL and Up-Regulated SOCs-1 in an Intestinal Mucositis Model	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; THERAPY; PATHOGENESIS; NEUTROPENIA; TELMISARTAN; ACTIVATION; LOSARTAN; STRESS; DAMAGE; RANKL	Methotrexate (MTX) is a pro-oxidant compound that depletes dihydrofolate pools and is widely used in the treatment of leukaemia and other malignancies. The efficacy of methotrexate is often limited by mucositis and intestinal injury, which are major causes of morbidity in children and adults. The aim of this study was to evaluate the effect of olmesartan (OLM), an angiotensin II receptor antagonist, on an Intestinal Mucositis Model (IMM) induced by MTX in Wistar rats. IMM was induced via intraperitoneal (i.p.) administration of MTX (7 mg/kg) for three consecutive days. The animals were pre-treated with oral OLM at 0.5, 1 or 5 mg/kg or with vehicle 30 min prior to exposure to MTX. Small intestinal homogenates were assayed for levels of the IL-1 beta, IL-10 and TNF-alpha cytokines, malondialdehyde and myeloperoxidase activity. Additionally, immunohistochemical analyses of MMP-2, MMP-9, COX-2, RANK/RANKL and SOCS-1 and confocal microscopy analysis of SOCS-1 expression were performed. Treatment with MTX + OLM (5 mg/kg) resulted in a reduction of mucosal inflammatory infiltration, ulcerations, vasodilatation and haemorrhagic areas (p < 0.05) as well as reduced concentrations of MPO (p < 0.001) and the pro-inflammatory cytokines IL-1 beta (p < 0.001) and TNF-alpha (p < 0.01), and increase anti-inflammatory cytocine IL-10 (p < 0.05). Additionally, the combined treatment reduced expression of MMP-2, MMP-9, COX-2, RANK and RANKL(p < 0.05) and increased cytoplasmic expression of SOCS-1 (p < 0.05). Our findings confirm the involvement of OLM in reducing the inflammatory response through increased immunosuppressive signalling in an IMM. We also suggest that the beneficial effect of olmesartan treatment is specifically exerted during the damage through blocking inflammatory cytocines.	[de Araujo Junior, Raimundo Fernandes] Univ Fed Rio Grande do Norte, Dept Morphol, Post Grad Program Hlth Sci, Natal, RN, Brazil; [de Araujo Junior, Raimundo Fernandes; Oliveira da Silva Reinaldo, Maria Patricia] Univ Fed Rio Grande do Norte, Post Grad Program Funct & Struct Biol, Natal, RN, Brazil; [de Castro Brito, Gerly Anne] Univ Fed Ceara, Dept Morphol, Post Grad Program Pharmacol, Fortaleza, Ceara, Brazil; [de Araujo Junior, Raimundo Fernandes; Oliveira da Silva Reinaldo, Maria Patricia; Cavalcanti, Pedro de Franca] Univ Fed Rio Grande do Norte, Dept Morphol, Natal, RN, Brazil; [Cavalcanti, Pedro de Franca; de Moura Freire, Marco Aurelio] Edmond & Lily Safra Int Inst Neurosci Natal, Natal, RN, Brazil; [Xavier de Medeiros, Caroline Addison; de Araujo, Aurigena Antunes] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Natal, RN, Brazil; [de Araujo, Aurigena Antunes] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Post Grad Program Publ Hlth, Natal, RN, Brazil; [de Araujo, Aurigena Antunes] Univ Fed Rio Grande do Norte, Post Grad Program Pharmaceut Sci, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Ceara; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	de Araujo, RF (corresponding author), Univ Fed Rio Grande do Norte, Dept Morphol, Post Grad Program Hlth Sci, Natal, RN, Brazil.	araujojr@cb.ufrn.br	Freire, Marco/A-1450-2010; de Araujo, Aurigena/ABI-8455-2020; de Castro Brito, Gerly Anne/C-8597-2013; Brito, Gerly/AHB-3965-2022; Araújo Júnior, Raimundo Fernandes/D-2354-2014	Freire, Marco/0000-0002-6483-0498; de Castro Brito, Gerly Anne/0000-0002-8214-4379; Brito, Gerly/0000-0002-8214-4379; Araújo Júnior, Raimundo Fernandes/0000-0003-2349-2354; Araujo, Aurigena/0000-0001-9264-4695	CNPq [47.6996/2013]; Alberto Santos Dumont Association for Research Support (AASDAP); Financier of Studies and Projects (FINEP); National Institute Brain Machine Interface (INCEMAQ) (INCTs Program CNPq/MCT)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Alberto Santos Dumont Association for Research Support (AASDAP); Financier of Studies and Projects (FINEP); National Institute Brain Machine Interface (INCEMAQ) (INCTs Program CNPq/MCT)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CNPq Universal Notice n. 47.6996/2013. MAMF and PFC wish to thank Alberto Santos Dumont Association for Research Support (AASDAP), Financier of Studies and Projects (FINEP), and National Institute Brain Machine Interface (INCEMAQ) (INCTs Program CNPq/MCT) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dasooqi N, 2010, EXP BIOL MED, V235, P1244, DOI 10.1258/ebm.2010.010082; Araujo AA, 2013, J CLIN PERIODONTOL, V40, P1104, DOI 10.1111/jcpe.12160; Araujo AA, 2013, N-S ARCH PHARMACOL, V386, P875, DOI 10.1007/s00210-013-0886-8; Avritscher Elenir B C, 2004, Semin Oncol Nurs, V20, P3; Boukhettala N, 2009, AM J PHYSIOL-ENDOC M, V296, pE182, DOI 10.1152/ajpendo.90459.2008; Chan ESL, 2013, BULL HOSP JT DIS, V71, pS5; DESOUZA GEP, 1985, AGENTS ACTIONS, V17, P97; Drucker DJ, 2002, GASTROENTEROLOGY, V122, P531, DOI 10.1053/gast.2002.31068; Duncan M, 2003, ALIMENT PHARM THER, V18, P853, DOI 10.1046/j.1365-2036.2003.01784.x; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Freire MAM, 2007, NEUROTOXICOLOGY, V28, P175, DOI 10.1016/j.neuro.2006.06.007; Fujimoto M, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/470468; Gulgun M, 2010, EXP TOXICOL PATHOL, V62, P109, DOI 10.1016/j.etp.2009.02.120; He Y, 2006, J BIOL CHEM, V281, P5559, DOI 10.1074/jbc.M512338200; Hovsepian E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079445; KENDALL C, 1983, J IMMUNOL METHODS, V56, P329, DOI 10.1016/S0022-1759(83)80022-2; Kolli VK, 2013, CANCER CHEMOTH PHARM, V71, P1209, DOI 10.1007/s00280-013-2115-z; Kong YY, 2000, IMMUNOL TODAY, V21, P495, DOI 10.1016/S0167-5699(00)01718-7; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Leitao RFC, 2007, CANCER CHEMOTH PHARM, V59, P603, DOI 10.1007/s00280-006-0301-y; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; MCKENDRY RJR, 1993, J RHEUMATOL, V20, P1850; Medina C, 2006, J PHARMACOL EXP THER, V318, P933, DOI 10.1124/jpet.106.103465; Miyazono Y, 2004, SCAND J GASTROENTERO, V39, P1119, DOI 10.1080/00365520410003605; Naito Y, 2004, INFLAMM RES, V53, P462, DOI 10.1007/s00011-004-1281-1; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nakano A, 2009, HYPERTENS RES, V32, P765, DOI 10.1038/hr.2009.95; Purcell W Thomas, 2003, Curr Oncol Rep, V5, P114, DOI 10.1007/s11912-003-0098-3; Rahimtoola Shahbudin H, 2008, Curr Probl Cardiol, V33, P159, DOI 10.1016/j.cpcardiol.2008.01.003; Refaat R, 2013, EUR J PHARMACOL, V698, P421, DOI 10.1016/j.ejphar.2012.10.024; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Sandmann S, 2006, BLOOD PRESSURE, V15, P116, DOI 10.1080/08037050600586593; Sonis ST, 2004, ORAL ONCOL, V40, P170, DOI 10.1016/S1368-8375(03)00148-9; Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Souza MHLP, 2003, BRAZ J MED BIOL RES, V36, P1383, DOI 10.1590/S0100-879X2003001000015; Tewari KS, 2014, GYNECOL ONCOL, V133, P439, DOI 10.1016/j.ygyno.2014.03.013; Totsuka T, 2009, J IMMUNOL, V182, P6079, DOI 10.4049/jimmunol.0711823; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang D, 2013, J CELL MOL MED, V17, P1577, DOI 10.1111/jcmm.12128; Yasufuku T, 2013, J INFECT CHEMOTHER, V19, P211, DOI 10.1007/s10156-012-0478-4	41	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114923	10.1371/journal.pone.0114923	http://dx.doi.org/10.1371/journal.pone.0114923			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531650	Green Published, gold			2022-12-26	WOS:000348845100031
J	Dorj, G; Sunderland, B; Hendrie, D; Parsons, R				Dorj, Gereltuya; Sunderland, Bruce; Hendrie, Delia; Parsons, Richard			Parenteral Medication Prescriptions, Dispensing and Administration Habits in Mongolia	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INJECTION PRACTICES; UNSAFE INJECTIONS; RAPID ASSESSMENT; CARE; INFECTION; COMMUNITY; TRANSMISSION; POPULATION; SETTINGS	High levels of injection prescribing were reported in Mongolia. Understanding the factors influencing the injection prescribing is essential to reduce their inappropriate use. The study evaluated the views, experiences and attitudes of community members associated with the prescribing of injections in Mongolia. A structured questionnaire focusing on respondents' characteristics, experiences and views about injections was developed and administered face-to-face to community members in Ulaanbaatar, Mongolia. Standard descriptive statistics were used to summarize demographic data and responses to the questionnaires. Dependant variables were compared using Kruskal-Wallis Tests for independence. Statistical analyses were performed using SPSS Version 21.0. Six hundred participants were approached and the response rate was 79% (n=474). Almost half of the respondents were aged between 31 and 50 (n=228, 48.1%) and 40.9% of respondents were male (n=194). Most respondents were from Ulaanbaatar city (n=407, 85.7%). All respondents had received injections in the past and 268 (56.5%) had received injection in the past year. The most common reason for having an injection in the past year was reported as treatment of a disease (n=163, 60.8%), or for administration of vitamins (n=70, 26.1%). Injections were prescribed by a doctor (n=353, 74.9%), dispensed by a pharmacist (n=283, 59.7%) and administered by a nurse (n=277, 54.9%). Only 16% of all respondents had the expectation of receiving injections when they visited a doctor (n=77). An important perception regarding injections was that they hastened the recovery process (n=269, 56.8%). When asked their opinion about therapeutic injections, 40% of all respondents agreed that injections were a better medicine (n=190) than oral medications, with older respondents strongly agreeing (p<0.001). Based on this total sample, approximately 1891 injections per 1000 patients were administered.The excessive injection use seems to be promoted by inappropriate prescribing, dispensing and administration of medication by doctors and others.	[Dorj, Gereltuya; Sunderland, Bruce; Parsons, Richard] Curtin Univ, Sch Pharm, Perth, WA 6845, Australia; [Hendrie, Delia] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia	Curtin University; Curtin University	Dorj, G (corresponding author), Curtin Univ, Sch Pharm, Perth, WA 6845, Australia.	gereltuya.dorj@postgrad.curtin.edu.au	Dorj, Gereltuya/K-4714-2019; Dorj, Gereltuya/AAE-6796-2019; Dorj, Gereltuya/AAH-6080-2020	Dorj, Gereltuya/0000-0001-9489-6829; Hendrie, Delia/0000-0001-5022-5281				Altaf A, 2001, PILOT TESTING WHO TO, P42; Altaf Arshad, 2004, J Ayub Med Coll Abbottabad, V16, P35; Ariuntuya S, 2011, HLTH INDICATORS MONG; Berild D, 2002, INT J ANTIMICROB AG, V20, P333, DOI 10.1016/S0924-8579(02)00203-0; Bolormaa TS, 2007, MONG HLTH SYST REV H; Cheraghali A. M., 2006, Journal of Pharmacology and Toxicology, V1, P33; Chowdhury A, 2003, HEPATOLOGY, V37, P802, DOI 10.1053/jhep.2003.50157; Chowdhury AKA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-779; Cobey M, 2011, KNOWLEDGE ATTITUDES; Dashdelger A, 1998, WHO COLLABORAT UNPUB; Davaasuren D, 2006, REPORT ASSESSMENT IN, P20; Dorj G, 2014, EVALUATION PRESCRIBI, P318; DUA V, 1994, SOC SCI MED, V38, P717, DOI 10.1016/0277-9536(94)90462-6; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Gumodoka B, 1996, TROP MED INT HEALTH, V1, P874; Hadiyono JEP, 1996, SOC SCI MED, V42, P1177, DOI 10.1016/0277-9536(95)00391-6; HARKNESS JA, 1998, ZUMA NACHRICHTEN SPE, V0003; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; Hutin YJF, 2003, BMJ-BRIT MED J, V327, P1075, DOI 10.1136/bmj.327.7423.1075; Hutin YVF, 2001, PILOT TESTING WHO TO, P10; Janjua NZ, 2005, INT J QUAL HEALTH C, V17, P401, DOI 10.1093/intqhc/mzi048; Jiang Q, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-324; Kermode M, 2004, HEALTH PROMOT INT, V19, P95, DOI 10.1093/heapro/dah110; Khan AJ, 2000, B WORLD HEALTH ORGAN, V78, P956; Lakshman M, 2000, SOC SCI MED, V51, P11, DOI 10.1016/S0277-9536(99)00426-8; Langsten RL, 2005, J HEALTH POPUL NUTR, V23, P282; Logez S, 2004, AM J INFECT CONTROL, V32, P31, DOI 10.1016/j.ajic.2003.06.006; Marx MA, 2003, AM J TROP MED HYG, V68, P258, DOI 10.4269/ajtmh.2003.68.258; Ministry of Health Mongolia, 2009, 6 ESS DRUG LIST MONG; Ministry of Health Mongolia, 2010, GUID AMB CAR; Raglow GJ, 2001, TROP MED INT HEALTH, V6, P69, DOI 10.1046/j.1365-3156.2001.00653.x; Rajasekaran M, 2003, PUBLIC HEALTH, V117, P208, DOI 10.1016/S0033-3506(03)00065-9; Reeler AV, 2000, B WORLD HEALTH ORGAN, V78, P135; REELER AV, 1990, SOC SCI MED, V31, P1119, DOI 10.1016/0277-9536(90)90233-I; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; Singh S, 2000, SCAND J INFECT DIS, V32, P3, DOI 10.1080/00365540050164137; SURVIVAL II C. H. I. L. D., 2002, INJ PRACT RAP ASS RE; Talaat M, 2003, TROP MED INT HEALTH, V8, P234, DOI 10.1046/j.1365-3156.2003.01015.x; van Staa A, 1996, DAP RES SERIES, P127; Vong S, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-56; World Health Organization and The SIGN alliance, 2001, INJ SAF; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115384	10.1371/journal.pone.0115384	http://dx.doi.org/10.1371/journal.pone.0115384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531766	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000348845100062
J	Salim, LZA; Othman, R; Abdulla, MA; Al-Jashamy, K; Ali, HM; Hassandarvish, P; Dehghan, F; Ibrahim, MY; Omer, FAA; Mohan, S				Salim, Landa Zeenelabdin Ali; Othman, Rozana; Abdulla, Mahmood Ameen; Al-Jashamy, Karim; Ali, Hapipah Mohd; Hassandarvish, Pouya; Dehghan, Firouzeh; Ibrahim, Mohamed Yousif; Omer, Fatima Abd Elmutaal Ahmed; Mohan, Syam			Thymoquinone Inhibits Murine Leukemia WEHI-3 Cells In Vivo and In Vitro	PLOS ONE			English	Article							NIGELLA-SATIVA; CYCLE ARREST; BCR-ABL; APOPTOSIS; EXPRESSION; PROLIFERATION; ACTIVATION; INDUCTION; PATHWAY; GROWTH	Background: Thymoquinone is an active ingredient isolated from Nigella sativa (Black Seed). This study aimed to evaluate the in vitro and in vivo anti-leukemic effects of thymoquinone on WEHI-3 cells. Methodology/Principal Findings: The cytotoxic effect of thymoquinone was assessed using an MTT assay, while the inhibitory effect of thymoquinone on murine WEHI-3 cell growth was due to the induction of apoptosis, as evidenced by chromatin condensation dye, Hoechst 33342 and acridine orange/propidium iodide fluorescent staining. In addition, Annexin V staining for early apoptosis was performed using flowcytometric analysis. Apoptosis was found to be associated with the cell cycle arrest at the S phase. Expression of Bax, Bcl2 and HSP 70 proteins were observed by western blotting. The effects of thymoquinone on BALB/c mice injected with WEHI-3 cells were indicated by the decrease in the body, spleen and liver weights of the animal, as compared to the control. Conclusion: Thymoquinone promoted natural killer cell activities. This compound showed high toxicity against WEHI-3 cell line which was confirmed by an increase of the early apoptosis, followed by up-regulation of the anti-apoptotic protein, Bcl2, and down-regulation of the apoptotic protein, Bax. On the other hand, high reduction of the spleen and liver weight, and significant histopathology study of spleen and liver confirmed that thymoquinone inhibited WEHI-3 growth in the BALB/c mice. Results from this study highlight the potential of thymoquinone to be developed as an anti-leukemic agent.	[Salim, Landa Zeenelabdin Ali; Othman, Rozana; Ibrahim, Mohamed Yousif; Omer, Fatima Abd Elmutaal Ahmed] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Al-Jashamy, Karim] SEGi Univ, Fac Med, Dept Pathol, Petaling Jaya, Malaysia; [Ali, Hapipah Mohd] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur, Malaysia; [Hassandarvish, Pouya] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Dehghan, Firouzeh] Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia; [Mohan, Syam] Jazan Univ, Med Res Ctr, Jazan, Saudi Arabia; [Othman, Rozana; Abdulla, Mahmood Ameen; Ali, Hapipah Mohd] Univ Malaya, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; SEGi University; Universiti Malaya; Universiti Malaya; Universiti Malaya; Jazan University; Universiti Malaya	Othman, R (corresponding author), Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia.	rozanaothman@um.edu.my	Mohan, Syam/A-1231-2011; Ibrahim, Mohamed Yousif/I-4603-2016; OTHMAN, ROZANA/B-9628-2010; Al-Jashamy, Karim Alwan/D-1609-2010; Hassandarvish, Pouya/K-8112-2012	Ibrahim, Mohamed Yousif/0000-0003-3752-9154; OTHMAN, ROZANA/0000-0002-8260-9252; Al-Jashamy, Karim Alwan/0000-0003-3421-6451; Hassandarvish, Pouya/0000-0003-0364-5587	High Impact Research Grant (HIR) from the Ministry of Higher Education Malaysia [UM.C/HIR/MOHE/SC/09, F000009-21001]; PPP from the University of Malaya [PG141-2012B]; UMRG from the University of Malaya [RP002/2012B]	High Impact Research Grant (HIR) from the Ministry of Higher Education Malaysia; PPP from the University of Malaya; UMRG from the University of Malaya	This research is supported by High Impact Research Grant UM.C/HIR/MOHE/SC/09 (HIR grant F000009-21001) from the Ministry of Higher Education Malaysia, and PPP grant (PG141-2012B) and UMRG grant (RP002/2012B) from the University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Ghafar SA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/549705; Aggarwal BB, 2008, PLANTA MED, V74, P1560, DOI 10.1055/s-2008-1074578; Ahmad Aftab, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P337, DOI 10.1016/S2221-1691(13)60075-1; Alabsi AM, 2012, LEUKEMIA RES, V36, P634, DOI 10.1016/j.leukres.2011.11.001; Anasamy T, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/939810; Arbab IA, 2013, J ETHNOPHARMACOL, V145, P343, DOI 10.1016/j.jep.2012.11.020; Arslan SO, 2005, NUTR RES, V25, P673, DOI 10.1016/j.nutres.2005.06.004; Attoub S, 2013, FUND CLIN PHARMACOL, V27, P557, DOI 10.1111/j.1472-8206.2012.01056.x; Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Banerjee S, 2010, NUTR CANCER, V62, P938, DOI 10.1080/01635581.2010.509832; BEDI A, 1994, BLOOD, V83, P2038; Chang Y-C, 2011, EVID-BASED COMPL ALT, V2011; Chang YH, 2009, BIOSCI BIOTECH BIOCH, V73, P2589, DOI 10.1271/bbb.90357; da Rocha Adriana B., 2001, Current Opinion in Pharmacology, V1, P364; El Mezayen R, 2006, IMMUNOL LETT, V106, P72, DOI 10.1016/j.imlet.2006.04.012; El-Mahdy MA, 2005, INT J CANCER, V117, P409, DOI 10.1002/ijc.21205; El-Najjar N, 2010, APOPTOSIS, V15, P183, DOI 10.1007/s10495-009-0421-z; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fu WY, 2005, TOXICON, V46, P171, DOI 10.1016/j.toxicon.2005.03.021; Garber JC, 2011, RES IFLA; Guo F, 2005, BLOOD, V105, P1246, DOI 10.1182/blood-2004-05-2041; Harzallah HJ, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/854065; Hosseini M, 2012, J PHARM BIOALLIED SC, V4, P219, DOI 10.4103/0975-7406.99052; Huang LH, 2010, EUR J PHARMACOL, V645, P9, DOI 10.1016/j.ejphar.2010.06.070; Ismail M, 2010, FREE RADICAL BIO MED, V48, P664, DOI 10.1016/j.freeradbiomed.2009.12.002; Ivankovic S., 2006, Experimental Oncology, V28, P220; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lin CC, 2006, ANTICANCER RES, V26, P1097; Lin JP, 2009, LEUKEMIA RES, V33, P823, DOI 10.1016/j.leukres.2008.09.032; Lu CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036831; Lu HF, 2007, IN VIVO, V21, P285; Lutterodt H, 2010, LWT-FOOD SCI TECHNOL, V43, P1409, DOI 10.1016/j.lwt.2010.04.009; Mohan S, 2010, LEUKEMIA RES, V34, P1483, DOI 10.1016/j.leukres.2010.04.023; Ng KB, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-41; Nigjeh SE, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/783690; Nobili S, 2009, PHARMACOL RES, V59, P365, DOI 10.1016/j.phrs.2009.01.017; Olfert ED, 1993, GUIDE CARE USE EXPT, V1; Paarakh P. M., 2010, Indian Journal of Natural Products and Resources, V1, P409; Salim LZA, 2013, MOLECULES, V18, P11219, DOI 10.3390/molecules180911219; Salminen S, 1998, INT J FOOD MICROBIOL, V44, P93, DOI 10.1016/S0168-1605(98)00128-7; Schneider-Stock R, 2014, DRUG DISCOV TODAY, V19, P18, DOI 10.1016/j.drudis.2013.08.021; Shoieb AM, 2003, INT J ONCOL, V22, P107; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Torres MP, 2010, MOL CANCER THER, V9, P1419, DOI 10.1158/1535-7163.MCT-10-0075; Tsou MF, 2009, LEUKEMIA RES, V33, P1505, DOI 10.1016/j.leukres.2009.01.030; Woo CC, 2012, BIOCHEM PHARMACOL, V83, P443, DOI 10.1016/j.bcp.2011.09.029; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Yang JS, 2006, ANTICANCER RES, V26, P219; Yeh RD, 2011, ANTICANCER RES, V31, P2821; Yu CS, 2010, PHYTOTHER RES, V24, P163, DOI 10.1002/ptr.2841; Yu FS, 2007, IN VIVO, V21, P407; Zhang B, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/781516	52	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115340	10.1371/journal.pone.0115340	http://dx.doi.org/10.1371/journal.pone.0115340			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531768	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100052
J	Cho, I; Park, H; Choi, YJ; Hwang, MH; Bates, DW				Cho, Insook; Park, Hyeok; Choi, Youn Jeong; Hwang, Mi Heui; Bates, David W.			Understanding the Nature of Medication Errors in an ICU with a Computerized Physician Order Entry System	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ADVERSE DRUG EVENTS; ADMINISTRATION ERRORS; FACILITIES; SAFETY; IMPACT; RECORD	Objectives: We investigated incidence rates to understand the nature of medication errors potentially introduced by utilizing a computerized physician order entry (CPOE) system in the three clinical phases of the medication process: prescription, administration, and documentation. Methods: Overt observations and chart reviews were employed at two surgical intensive care units of a 950-bed tertiary teaching hospital. Ten categories of high-risk drugs prescribed over a four-month period were noted and reviewed. Error definition and classifications were adapted from previous studies for use in the present research. Incidences of medication errors in the three phases of the medication process were analyzed. In addition, nurses' responses to prescription errors were also assessed. Results: Of the 534 prescriptions issued, 286 (53.6%) included at least one error. The proportion of errors was 19.0% (58) of the 306 drug administrations, of which two-thirds were verbal orders classified as errors due to incorrectly entered prescriptions. Documentation errors occurred in 205 (82.7%) of 248 correctly performed administrations. When tracking incorrectly entered prescriptions, 93% of the errors were intercepted by nurses, but two-thirds of them were recorded as prescribed rather than administered. Conclusion: The number of errors occurring at each phase of the medication process was relatively high, despite long experience with a CPOE system. The main causes of administration errors and documentation errors were prescription errors and verbal order processes. To reduce these errors, hospital-level and unit-level efforts toward a better system are needed.	[Cho, Insook; Choi, Youn Jeong; Hwang, Mi Heui] Inha Univ, Dept Nursing, Inchon, South Korea; [Cho, Insook; Bates, David W.] Harvard Univ, Sch Med, Boston, MA USA; [Cho, Insook; Bates, David W.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Park, Hyeok; Choi, Youn Jeong; Hwang, Mi Heui] Inha Univ Hosp, Dept Nursing, Inchon, South Korea; [Bates, David W.] Partners Healthcare Syst Inc, Wellesley, MA USA	Inha University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Inha University; Inha University Hospital; Partners Healthcare System	Cho, I (corresponding author), Inha Univ, Dept Nursing, Inchon, South Korea.	Insook.cho@inha.ac.kr	Bates, David/AAE-7283-2019	Cho, Insook/0000-0002-5152-9567	Korea Research Foundation Grant - Korean Government (MOEHRD) [331-2007-1-E00273, KRF-2013R1A1A2006387]; Centers for Education and Research on Therapeutics (CERT) [U19HS021094]; Agency for Healthcare Research and Quality, Rockville, MD, USA; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS021094] Funding Source: NIH RePORTER	Korea Research Foundation Grant - Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaNational Research Foundation of KoreaKorean Government); Centers for Education and Research on Therapeutics (CERT); Agency for Healthcare Research and Quality, Rockville, MD, USA(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD, 331-2007-1-E00273). D.W.B was sponsored by the Centers for Education and Research on Therapeutics (CERT Grant # U19HS021094), Agency for Healthcare Research and Quality, Rockville, MD, USA. I.C. was also supported by a Korea Research Foundation Grant, which was funded by the Korean Government (MOEHRD, No. KRF-2013R1A1A2006387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali J, 2010, ANAESTHESIA, V65, P119, DOI 10.1111/j.1365-2044.2009.06134.x; Aspden P., 2006, I MED, P26; Barker KN, 2002, ARCH INTERN MED, V162, P1897, DOI 10.1001/archinte.162.16.1897; Bradley Victoria M, 2006, J Healthc Inf Manag, V20, P46; Calabrese AD, 2001, INTENS CARE MED, V27, P1592, DOI 10.1007/s001340101065; Cho I, 2009, STUD HEALTH TECHNOL, V146, P445, DOI 10.3233/978-1-60750-024-7-445; Colpaert K, 2006, CRIT CARE, V10, DOI 10.1186/cc3983; DeYoung JL, 2009, AM J HEALTH-SYST PH, V66, P1110, DOI 10.2146/ajhp080355; Flynn EA, 2002, AM J HEALTH-SYST PH, V59, P436, DOI 10.1093/ajhp/59.5.436; Heo JH, 2013, INT J MED INFORM, V82, P987, DOI 10.1016/j.ijmedinf.2013.07.001; Institute for Safe Medication Practices, 2008, I SAF MED PRACT HIGH; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Lee KO, 2000, J KOREAN ACAD NURS, V30, P1243; Magrabi F, 2010, J AM MED INFORM ASSN, V17, P575, DOI 10.1136/jamia.2009.001719; Metzger J, 2010, HEALTH AFFAIR, V29, P655, DOI 10.1377/hlthaff.2010.0160; Middleton B, 2013, J AM MED INFORM ASSN, V20, pE2, DOI 10.1136/amiajnl-2012-001458; Moreland PJ, 2012, CIN-COMPUT INFORM NU, V30, P97, DOI 10.1097/NCN.0b013e318224b54e; Nanji KC, 2011, J AM MED INFORM ASSN, V18, P767, DOI 10.1136/amiajnl-2011-000205; Page A., 2004, KEEPING PATIENTS SAF; Tissot E, 1999, INTENS CARE MED, V25, P353, DOI 10.1007/s001340050857; van den Bemt PMLA, 2002, CRIT CARE MED, V30, P846, DOI 10.1097/00003246-200204000-00022; Walsh KE, 2006, PEDIATRICS, V118, P1872, DOI 10.1542/peds.2006-0810; Warrick C, 2011, INTENS CARE MED, V37, P691, DOI 10.1007/s00134-010-2126-8; Wilmer A, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2008.030783	25	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114243	10.1371/journal.pone.0114243	http://dx.doi.org/10.1371/journal.pone.0114243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8WK	25526059	Green Published, Green Submitted, gold			2022-12-26	WOS:000347186200001
J	Du, ZY; Wang, QF				Du, Zhi-Yuan; Wang, Qing-Feng			Correlations of Life Form, Pollination Mode and Sexual System in Aquatic Angiosperms	PLOS ONE			English	Article							EVOLUTION; BIOLOGY; POLLEN; CALLITRICHACEAE; REPRODUCTION; POTAMOGETON; SEAGRASSES; PLANTS	Aquatic plants are phylogenetically well dispersed across the angiosperms. Reproductive and other life-history traits of aquatic angiosperms are closely associated with specific growth forms. Hydrophilous pollination exhibits notable examples of convergent evolution in angiosperm reproductive structures, and hydrophiles exhibit great diversity in sexual system. In this study, we reconstructed ancestral characters of aquatic lineages based on the phylogeny of aquatic angiosperms. Our aim is to find the correlations of life form, pollination mode and sexual system in aquatic angiosperms. Hydrophily is the adaptive evolution of completely submersed angiosperms to aquatic habitats. Hydroautogamy and maleflower-ephydrophily are the transitional stages from anemophily and entomophily to hydrophily. True hydrophily occurs in 18 submersed angiosperm genera, which is associated with an unusually high incidence of unisexual flowers. All marine angiosperms are submersed, hydrophilous species. This study would help us understand the evolution of hydrophilous pollination and its correlations with life form and sexual system.	[Du, Zhi-Yuan; Wang, Qing-Feng] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Wang, QF (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China.	qfwang@wbgcas.cn			National Natural Science Foundation of China [31100175]; Chinese Academy of Sciences [XDAO5090305]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the National Natural Science Foundation of China (Grant No. 31100175) to ZYD and the strategic pilot science and technology projects of the Chinese Academy of Sciences (Grant No. XDAO5090305) to QFW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN JD, 1995, EVOL ECOL, V9, P139, DOI 10.1007/BF01237753; Ackerman JD, 1998, FUNCT ECOL, V12, P979; Ackerman JD, 2000, PLANT SYST EVOL, V222, P167, DOI 10.1007/BF00984101; Arber A., 1920, WATER PLANTS STUDY A; Barrett Spencer C. H., 1997, P225; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj.hdy.6800016; Cook C.D.K., 1990, AQUATIC PLANT BOOK; COOK CDK, 1988, ANN MO BOT GARD, V75, P768, DOI 10.2307/2399365; Cook Christopher D.K., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P79, DOI 10.1078/1433-8319-00066; COX PA, 1988, ANNU REV ECOL SYST, V19, P261, DOI 10.1146/annurev.es.19.110188.001401; Crisp MD, 2005, TRENDS ECOL EVOL, V20, P122, DOI 10.1016/j.tree.2004.11.010; Endress PK, 2004, AUST SYST BOT, V17, P343, DOI 10.1071/SB04004; GRACE JB, 1993, AQUAT BOT, V44, P159, DOI 10.1016/0304-3770(93)90070-D; GUO YH, 1989, AQUAT BOT, V34, P381; GUO YH, 1990, AQUAT BOT, V38, P283, DOI 10.1016/0304-3770(90)90011-9; Iles WJD, 2012, AM J BOT, V99, P663, DOI 10.3732/ajb.1100524; Lansdown R.V., 2012, STATUS DISTRIBUTION, P117; LES DH, 1988, ANN MO BOT GARD, V75, P819, DOI 10.2307/2399370; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Maddison W., 2018, MESQUITE MODULAR SYS; Philbrick CT, 1996, BIOSCIENCE, V46, P813, DOI 10.2307/1312967; PHILBRICK CT, 1992, SYST BOT, V17, P282, DOI 10.2307/2419523; PHILBRICK CT, 1993, AM J BOT, V80, P391, DOI 10.2307/2445385; PHILBRICK CT, 1988, ANN MO BOT GARD, V75, P836, DOI 10.2307/2399371; PHILBRICK CT, 1987, SYST BOT, V12, P98, DOI 10.2307/2419218; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA	27	12	13	3	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115653	10.1371/journal.pone.0115653	http://dx.doi.org/10.1371/journal.pone.0115653			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525810	gold, Green Submitted, Green Published			2022-12-26	WOS:000347186200041
J	Dziaman, T; Ludwiczak, H; Ciesla, JM; Banaszkiewicz, Z; Winczura, A; Chmielarczyk, M; Wisniewska, E; Marszalek, A; Tudek, B; Olinski, R				Dziaman, Tomasz; Ludwiczak, Hubert; Ciesla, Jaroslaw M.; Banaszkiewicz, Zbigniew; Winczura, Alicja; Chmielarczyk, Mateusz; Wisniewska, Ewa; Marszalek, Andrzej; Tudek, Barbara; Olinski, Ryszard			PARP-1 Expression is Increased in Colon Adenoma and Carcinoma and Correlates with OGG1	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; POLY(ADP-RIBOSE) POLYMERASE-1; SER326CYS POLYMORPHISM; REPAIR PATHWAY; LUNG-CANCER; GENE; STRESS; RISK; CARCINOGENESIS; CANCERIZATION	The ethiology of colon cancer is largely dependent on inflammation driven oxidative stress. The analysis of 8-oxodeoxyguanosine (8-oxodGuo) level in leukocyte DNA of healthy controls (138 individuals), patients with benign adenomas (AD, 137 individuals) and with malignant carcinomas (CRC, 169 individuals) revealed a significant increase in the level of 8-oxodGuo in leukocyte DNA of AD and CRC patients in comparison to controls. The counteracting mechanism is base excision repair, in which OGG1 and PARP-1 play a key role. We investigated the level of PARP-1 and OGG1 mRNA and protein in diseased and marginal, normal tissues taken from AD and CRC patients and in leukocytes taken from the patients as well as from healthy subjects. In colon tumors the PARP-1 mRNA level was higher than in unaffected colon tissue and in polyp tissues. A high positive correlation was found between PARP-1 and OGG1 mRNA levels in all investigated tissues. This suggests reciprocal influence of PARP-1 and OGG1 on their expression and stability, and may contribute to progression of colon cancer. PARP-1 and OGG1 proteins level was several fold higher in polyps and CRC in comparison to normal colon tissues. Individuals bearing the Cys326Cys genotype of OGG1 were characterized by higher PARP-1 protein level in diseased tissues than the Ser326Cys and Ser326Ser genotypes. Aforementioned result may suggest that the diseased cells with polymorphic OGG1 recruit more PARP protein, which is necessary to remove 8-oxodGuo. Thus, patients with decreased activity of OGG1/polymorphism of the OGG1 gene and higher 8-oxodGuo level may be more susceptible to treatment with PARP-1 inhibitors.	[Dziaman, Tomasz; Olinski, Ryszard] Nicolaus Copernicus Univ, Dept Clin Biochem, Coll Med, PO-85092 Bydgoszcz, Poland; [Ludwiczak, Hubert; Ciesla, Jaroslaw M.; Winczura, Alicja; Tudek, Barbara] Polish Acad Sci, Inst Biochem & Biophys, PO-02106 Warsaw, Poland; [Banaszkiewicz, Zbigniew] Nicolaus Copernicus Univ, Dept Surg, Coll Med, PO-85092 Bydgoszcz, Poland; [Chmielarczyk, Mateusz; Tudek, Barbara] Univ Warsaw, Inst Genet & Biotechnol, Fac Biol, PO-02106 Warsaw, Poland; [Wisniewska, Ewa; Marszalek, Andrzej] Nicolaus Copernicus Univ, Dept Clin Pathomorphol, Coll Med, PO-85092 Bydgoszcz, Poland; [Marszalek, Andrzej] Univ Med Sci, Dept Oncol Pathol, PO-61868 Poznan, Poland; [Marszalek, Andrzej] Wielkopolskie Oncol Ctr, PO-61868 Poznan, Poland	Nicolaus Copernicus University; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Nicolaus Copernicus University; University of Warsaw; Nicolaus Copernicus University; Wielkopolskie Centrum Onkologii	Tudek, B (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5a, PO-02106 Warsaw, Poland.	tudek@ibb.waw.pl; ryszardo@cm.umk.pl	Dziaman, Tomasz/E-5240-2014; Dziaman, Tomasz/P-6426-2019; Olinski, Ryszard/E-9607-2014	Dziaman, Tomasz/0000-0001-6802-4832; Ciesla, Jaroslaw/0000-0003-0695-7201; Chmielarczyk, Mateusz/0000-0003-2067-1031; Olinski, Ryszard/0000-0001-9927-8755	Polish Ministry of Science and Higher Education [N N401 280039]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was financed by the Polish Ministry of Science and Higher Education grant N N401 280039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Quesada R, 2007, CURR MED CHEM, V14, P1179, DOI 10.2174/092986707780597998; Amente S, 2010, CELL CYCLE, V9, P3002, DOI 10.4161/cc.9.15.12499; Bai P, 2012, FEBS LETT, V586, P3771, DOI 10.1016/j.febslet.2012.09.026; Bieche I, 1996, CLIN CANCER RES, V2, P1163; Blake DJ, 2007, TOXICOL SCI, V99, P277, DOI 10.1093/toxsci/kfm166; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Chen L, 2003, J UROLOGY, V170, P2471, DOI 10.1097/01.ju.0000087498.23008.bb; Cho EY, 2003, CANCER EPIDEM BIOMAR, V12, P1100; Colussi C, 2002, CURR BIOL, V12, P912, DOI 10.1016/S0960-9822(02)00863-1; Cooke MS, 2006, CLIN CHIM ACTA, V365, P30, DOI 10.1016/j.cca.2005.09.009; Curtin N, 2014, BIOCHEM SOC T, V42, P82, DOI 10.1042/BST20130187; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Fekete A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042690; Flohr C, 2003, NUCLEIC ACIDS RES, V31, P5332, DOI 10.1093/nar/gkg715; Gackowski D, 2002, INT J CANCER, V101, P395, DOI 10.1002/ijc.10610; Ghabreau L, 2004, INT J CANCER, V109, P317, DOI 10.1002/ijc.11731; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Goodman M, 2008, CANCER CAUSE CONTROL, V19, P1051, DOI 10.1007/s10552-008-9169-y; Hatt L, 2008, MUTAT RES-FUND MOL M, V639, P45, DOI 10.1016/j.mrfmmm.2007.11.002; Hawthorn L, 2014, GENOMICS, V103, P211, DOI 10.1016/j.ygeno.2013.11.003; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; HIRAI K, 1983, CANCER RES, V43, P3441; Idogawa M, 2005, GASTROENTEROLOGY, V128, P1919, DOI 10.1053/j.gastro.2005.03.007; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Janik J, 2011, MUTAT RES-FUND MOL M, V709-10, P21, DOI 10.1016/j.mrfmmm.2011.02.009; JARUGA P, 1994, FEBS LETT, V341, P59, DOI 10.1016/0014-5793(94)80240-8; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Leung EYL, 2008, INT J CANCER, V123, P2460, DOI 10.1002/ijc.23811; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lu H, 2011, J BIOL CHEM, V286, P20335, DOI 10.1074/jbc.M110.215632; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Noren Hooten N, 2011, J BIOL CHEM, V286, P44679, DOI 10.1074/jbc.M111.255869; Nosho K, 2006, EUR J CANCER, V42, P2374, DOI 10.1016/j.ejca.2006.01.061; Obtulowicz T, 2010, MUTAGENESIS, V25, P463, DOI 10.1093/mutage/geq028; Obtulowicz T, 2010, FREE RADICAL BIO MED, V49, P1064, DOI 10.1016/j.freeradbiomed.2010.06.027; Olinski R, 2003, MUTAT RES-FUND MOL M, V531, P177, DOI 10.1016/j.mrfmmm.2003.07.005; Olinski R, 2002, FREE RADICAL BIO MED, V33, P192, DOI 10.1016/S0891-5849(02)00878-X; Paz-Elizur T, 2007, DNA REPAIR, V6, P45, DOI 10.1016/j.dnarep.2006.08.003; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; REMMELE W, 1987, PATHOLOGE, V8, P138; Rodriguez-Hernandez A, 2006, APOPTOSIS, V11, P131, DOI 10.1007/s10495-005-3276-y; Saebo M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-208; Shimizu S, 2004, ONCOL REP, V12, P821; Shinmura K, 2001, ANTIOXID REDOX SIGN, V3, P597, DOI 10.1089/15230860152542952; Storr S J, 2012, Curr Mol Pharmacol, V5, P88; TOMODA T, 1991, AM J HEMATOL, V37, P223, DOI 10.1002/ajh.2830370402; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Xu ZG, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-144	51	40	41	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115558	10.1371/journal.pone.0115558	http://dx.doi.org/10.1371/journal.pone.0115558			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526641	Green Submitted, Green Published, gold			2022-12-26	WOS:000347186200035
J	Fujimoto, N; Ohnuma, K; Aoe, K; Hosono, O; Yamada, T; Kishimoto, T; Morimoto, C				Fujimoto, Nobukazu; Ohnuma, Kei; Aoe, Keisuke; Hosono, Osamu; Yamada, Taketo; Kishimoto, Takumi; Morimoto, Chikao			Clinical Significance of Soluble CD26 in Malignant Pleural Mesothelioma	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; ANTI-CD26 MONOCLONAL-ANTIBODY; PROLONGED SURVIVAL; ASBESTOS EXPOSURE; EXPRESSION; OVEREXPRESSION; ASSOCIATION; METASTASIS; DIAGNOSIS; EFFUSION	There is no established single diagnostic marker for malignant pleural mesothelioma (MPM). CD26 is a 110 kDa, multifunctional, membrane-bound glycoprotein that has dipeptidyl peptidase IV (DPPIV) enzyme activity. The aim of this study was to evaluate the clinical significance of soluble CD26 (sCD26) in patients with MPM. The study included 80 MPM patients, 79 subjects with past asbestos exposure (SPE), and 134 patients with other benign pleural diseases (OPD) that were included as a control group. sCD26 levels and DPPIV activity in serum and/or pleural fluid were determined using an ELISA kit. Serum sCD26 levels and DPPIV enzyme activity in patients with MPM were significantly decreased compared with those in the SPE group (P=0.000). The level of serum sCD26 was significantly decreased in patients with advanced stages of MPM compared with those with earlier stages (P=0.047). The median OS of patients with MPM who had higher DPPIV enzyme activity was significantly longer than that of those with lower DPPIV enzyme activity (P=0.032). The sCD26 levels in the pleural fluid of MPM patients with an epithelioid subtype were significantly increased compared with the OPD cohort (P=0.012). Moreover, DPPIV enzyme activity in the pleural fluid of patients with MPM with an epithelioid subtype were significantly increased compared with those in the OPD cohort (P=0.009). Patients with MPM who had lower specific DPPIV activity, determined as DPPIV/sCD26, showed significantly prolonged survival compared with those with higher specific DPPIV activity (P=0.028). Serum sCD26 and DPPIV enzyme activity appear to be useful biomarkers for differentiating patients with MPM from SPE. The sCD26 levels or DPPIV enzyme activity in pleural fluid appear to be biomarkers in patients with an epithelioid subtype of MPM. DPPIV activity in serum or pleural fluid appears to be predictive for the prognosis of patients with MPM.	[Fujimoto, Nobukazu] Okayama Rosai Hosp, Dept Med Oncol, Okayama, Japan; [Ohnuma, Kei; Hosono, Osamu; Morimoto, Chikao] Juntendo Univ, Grad Sch Med, Dept Therapy Dev & Innovat Immune Disorders & Can, Bunkyo Ku, Tokyo, Japan; [Aoe, Keisuke] Natl Hosp Org Yamaguchi Ube Med Ctr, Dept Med Oncol & Clin Res, Ube, Yamaguchi, Japan; [Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Kishimoto, Takumi] Okayama Rosai Hosp, Dept Internal Med, Okayama, Japan	Juntendo University; Keio University	Fujimoto, N (corresponding author), Okayama Rosai Hosp, Dept Med Oncol, Okayama, Japan.	nobufujimot@gmail.com	Fujimoto, Nobukazu/U-8488-2019	Fujimoto, Nobukazu/0000-0002-4516-0433	Ministry of Education, Science, Sports and Culture; Ministry of Health, Labor and Welfare, Japan; National Institute of Biomedical Innovation; Foundation of Strategic Research Projects in Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan [S1311011]	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Foundation of Strategic Research Projects in Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported by grants-in-aid from the Ministry of Education, Science, Sports and Culture, and Ministry of Health, Labor and Welfare, Japan; by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; and a Grant-in-Aid (S1311011) from the Foundation of Strategic Research Projects in Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (http://www.nibio.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2008, FRONT HORM RES, V36, P182, DOI 10.1159/000115365; AISNER J, 1995, CHEST, V108, P1122; Andrieu T, 2003, J CLIN VIROL, V27, P59, DOI 10.1016/S1386-6532(02)00128-2; Aoe K, 2012, CLIN CANCER RES, V18, P1447, DOI 10.1158/1078-0432.CCR-11-1990; Britton M, 2002, SEMIN ONCOL, V29, P18, DOI 10.1053/sonc.2002.30237; CARBONE A, 1995, BLOOD, V86, P4617, DOI 10.1182/blood.V86.12.4617.bloodjournal86124617; Churg A, 2004, TUMOURS PLEURA; Cordero OJ, 2000, BRIT J CANCER, V83, P1139, DOI 10.1054/bjoc.2000.1410; DROZ D, 1990, AM J PATHOL, V137, P895; Fujimoto N, 2013, RESPIR INVESTIG, V51, P92, DOI 10.1016/j.resinv.2013.02.002; Fujimoto N, 2010, EXP THER MED, V1, P313, DOI 10.3892/etm_00000048; Gemba K, 2013, ACTA ONCOL, V52, P803, DOI 10.3109/0284186X.2012.709948; Gemba K, 2012, CANCER SCI, V103, P483, DOI 10.1111/j.1349-7006.2011.02165.x; Ghani FI, 2011, BIOCHEM BIOPH RES CO, V404, P735, DOI 10.1016/j.bbrc.2010.12.054; Hammar SP, 2011, ASBESTOS INDUCED PLE; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Hirai K, 1999, PATHOL INT, V49, P264, DOI 10.1046/j.1440-1827.1999.00859.x; Ho L, 2001, CLIN CANCER RES, V7, P2031; Inamoto T, 2007, CLIN CANCER RES, V13, P4191, DOI 10.1158/1078-0432.CCR-07-0110; Inamoto T, 2006, CLIN CANCER RES, V12, P3470, DOI 10.1158/1078-0432.CCR-06-0361; Ishii T, 2001, P NATL ACAD SCI USA, V98, P12138, DOI 10.1073/pnas.211439098; Ismail-Khan Roohi, 2006, Cancer Control, V13, P255; Kajiyama H, 2002, CANCER RES, V62, P2753; KAMEOKA J, 1993, SCIENCE, V261, P466, DOI 10.1126/science.8101391; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; Ohnuma K, 2004, P NATL ACAD SCI USA, V101, P14186, DOI 10.1073/pnas.0405266101; Ohnuma K, 2015, J CLIN LAB ANAL, V29, P106, DOI 10.1002/jcla.21736; Pass HI, 2012, NEW ENGL J MED, V367, P1417, DOI 10.1056/NEJMoa1115050; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Robinson BWS, 2003, LANCET, V362, P1612, DOI 10.1016/S0140-6736(03)14794-0; Scherpereel A, 2006, AM J RESP CRIT CARE, V173, P1155, DOI 10.1164/rccm.200511-1789OC; Shiomi K, 2008, CLIN CANCER RES, V14, P1431, DOI 10.1158/1078-0432.CCR-07-1613; Stange T, 2000, EUR J HISTOCHEM, V44, P157; Sun YX, 2008, CLIN EXP METASTAS, V25, P765, DOI 10.1007/s10585-008-9188-9; Yamaguchi U, 2008, J CLIN ONCOL, V26, P4100, DOI 10.1200/JCO.2007.14.2331	38	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115647	10.1371/journal.pone.0115647	http://dx.doi.org/10.1371/journal.pone.0115647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526639	gold, Green Published, Green Submitted			2022-12-26	WOS:000347186200040
J	Hirsch, PE; Schillinger, S; Weigt, H; Burkhardt-Holm, P				Hirsch, Philipp Emanuel; Schillinger, Sebastian; Weigt, Hannes; Burkhardt-Holm, Patricia			A Hydro-Economic Model for Water Level Fluctuations: Combining Limnology with Economics for Sustainable Development of Hydropower	PLOS ONE			English	Article							LAKE-LEVEL; RESERVOIR OPERATION; ECOLOGICAL IMPACTS; CLASS STRENGTH; CLIMATE-CHANGE; OPTIMIZATION; COMMUNITIES; INCREASE; RUNOFF; RIVERS	Water level fluctuations in lakes lead to shoreline displacement. The seasonality of flooding or beaching of the littoral area affects nutrient cycling, redox gradients in sediments, and life cycles of aquatic organisms. Despite the ecological importance of water level fluctuations, we still lack a method that assesses water levels in the context of hydropower operations. Water levels in reservoirs are influenced by the operator of a hydropower plant, who discharges water through the turbines or stores water in the reservoir, in a fashion that maximizes profit. This rationale governs the seasonal operation scheme and hence determines the water levels within the boundaries of the reservoir's water balance. For progress towards a sustainable development of hydropower, the benefits of this form of electricity generation have to be weighed against the possible detrimental effects of the anthropogenic water level fluctuations. We developed a hydro-economic model that combines an economic optimization function with hydrological estimators of the water balance of a reservoir. Applying this model allowed us to accurately predict water level fluctuations in a reservoir. The hydro-economic model also allowed for scenario calculation of how water levels change with climate change scenarios and with a change in operating scheme of the reservoir (increase in turbine capacity). Further model development will enable the consideration of a variety of additional parameters, such as water withdrawal for irrigation, drinking water supply, or altered energy policies. This advances our ability to sustainably manage water resources that must meet both economic and environmental demands.	[Hirsch, Philipp Emanuel; Schillinger, Sebastian; Weigt, Hannes] Univ Basel, Res Ctr Sustainable Energy & Water Supply, Basel, Switzerland; [Hirsch, Philipp Emanuel; Schillinger, Sebastian; Burkhardt-Holm, Patricia] Univ Basel, Dept Environm Sci, Program Man Soc Environm, Basel, Switzerland; [Burkhardt-Holm, Patricia] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Basel; University of Basel; University of Alberta	Hirsch, PE (corresponding author), Univ Basel, Res Ctr Sustainable Energy & Water Supply, Basel, Switzerland.	philipp.hirsch@unibas.ch		Weigt, Hannes/0000-0002-2036-9177; Hirsch, Philipp Emanuel/0000-0002-6927-2368	University of Basel; Amt fur Umwelt und Energie AUE, Basel; EBL: Genossenschaft Elektra Baselland; EBM: Genossenschaft Elektra Birseck; IWB: Industrielle Werke Basel	University of Basel; Amt fur Umwelt und Energie AUE, Basel; EBL: Genossenschaft Elektra Baselland; EBM: Genossenschaft Elektra Birseck; IWB: Industrielle Werke Basel	The study was funded by grants from the University of Basel to the Program Man-Society-Environment and conducted within the Research Centre for Sustainable Energy and Water Supply (FoNEW) which is funded by local sponsors (Amt fur Umwelt und Energie AUE, Basel; EBL: Genossenschaft Elektra Baselland; EBM: Genossenschaft Elektra Birseck; IWB: Industrielle Werke Basel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgottspon H, 2012, STOCHASTIC DYNAMIC P, P5; Alfieri L, 2006, WATER RESOUR MANAG, V20, P761, DOI 10.1007/s11269-005-9006-y; Arthington AH, 2006, ECOL APPL, V16, P1311, DOI 10.1890/1051-0761(2006)016[1311:TCOPEF]2.0.CO;2; Bates B.C., 2008, TECHNICAL PAPER INTE, DOI DOI 10.1016/J.JMB.2010.08.039; Bednarek AT, 2001, ENVIRON MANAGE, V27, P803, DOI 10.1007/s002670010189; Cott PA, 2008, J AM WATER RESOUR AS, V44, P343, DOI 10.1111/j.1752-1688.2007.00166.x; Dienst M, 2004, LIMNOLOGICA, V34, P29, DOI 10.1016/S0075-9511(04)80019-7; Filippini M, 2001, PERSPEKTIVEN WASSERK; Finger D, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010733; Geraldes Ana Maria, 2005, Lakes & Reservoirs Research and Management, V10, P59, DOI 10.1111/j.1440-1770.2005.00257.x; Grumbine RE, 2013, SCIENCE, V339, P36, DOI 10.1126/science.1227211; Hampton SE, 2011, MAR FRESHWATER RES, V62, P350, DOI 10.1071/MF10229; Helland IP, 2010, STANDARDIZED BROWN T, P23; Hill T., 2006, STAT METHODS APPL; Jager HI, 2008, RIVER RES APPL, V24, P340, DOI 10.1002/rra.1069; Kadioglu M, 1997, ANN GEOPHYS-ATM HYDR, V15, P1489, DOI 10.1007/s00585-997-1489-9; Kahl U, 2008, LIMNOLOGICA, V38, P258, DOI 10.1016/j.limno.2008.06.006; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Kimaite FM, 2011, THESIS; Kiviat E, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt008; Kobierska F, 2013, ADV WATER RESOUR, V55, P204, DOI 10.1016/j.advwatres.2012.07.024; Koboltschnig GR, 2008, HYDROL PROCESS, V22, P3950, DOI 10.1002/hyp.7112; Krause P., 2005, ADV GEOSCI, V5, P89, DOI [10.5194/adgeo-5-89-2005, DOI 10.5194/ADGEO-5-89-2005, DOI 10.5194/ADGE0-5-89-2005]; Kuhne A, 1978, GEOGR HELV, V33, P191; Larry W, 2009, WATER RESOURCES ENG; Liebe J, 2005, PHYS CHEM EARTH, V30, P448, DOI 10.1016/j.pce.2005.06.011; Luwesi CN, 2013, J AGR FOOD APPL SCI, V1, P46; Martorella M, 2006, EURASIP J APPL SIG P, DOI 10.1155/ASP/2006/87298; Meyer JL, 1999, J AM WATER RESOUR AS, V35, P1373, DOI 10.1111/j.1752-1688.1999.tb04222.x; Milbrink G, 2011, CAN J FISH AQUAT SCI, V68, P2167, DOI 10.1139/F2011-131; Mortsch LD, 1998, CLIMATIC CHANGE, V40, P391, DOI 10.1023/A:1005445709728; Moss Brian, 2008, Freshwater Reviews, V1, P29, DOI 10.1608/FRJ-1.1.2; Nechwatal J, 2008, HYDROBIOLOGIA, V613, P109, DOI 10.1007/s10750-008-9476-z; Noury M, 2014, WATER RESOUR+, V41, P261, DOI 10.1134/S0097807814030129; Pandit MK, 2012, CONSERV BIOL, V26, P1061, DOI 10.1111/j.1523-1739.2012.01918.x; Perez-Diaz JI, 2010, ENERG CONVERS MANAGE, V51, P2955, DOI 10.1016/j.enconman.2010.06.038; Peter A, 2010, HANDB ENVIRON CHEM, V6, P247, DOI 10.1007/978-3-540-88275-6_13; Pfaundler M., 2013, DATENSATZ MQ GWN CH; Poff NL, 2013, CURR OPIN ENV SUST, V5, P667, DOI 10.1016/j.cosust.2013.11.006; Rodrigues LN, 2013, WATER RESOUR IRRIG M, V2, P1; Schindler DW, 2001, CAN J FISH AQUAT SCI, V58, P18, DOI 10.1139/cjfas-58-1-18; Shang SH, 2013, J ARID LAND, V5, P133, DOI 10.1007/s40333-013-0153-3; SOARES S, 1995, IEE P-GENER TRANSM D, V142, P569, DOI 10.1049/ip-gtd:19952156; Sreenivasan KR, 1996, SADHANA-ACAD P ENG S, V21, P503, DOI 10.1007/BF02745572; Stahli M, 2011, KLIMAWANDEL WASSERKR, P18; Stoll S, 2013, J APPL ICHTHYOL, V29, P617, DOI 10.1111/jai.12144; Swiss Federal Office of Energy SFOE, 2014, WAT LEV RES EL STAT; Swiss Federal Office of Energy SFOE, 2013, BEW PUMPSP SCHW RAHM; Swiss Federal Office of Energy SFOE, 2013, EINZ SCHW EZGG CH, P27; Swiss Federal Office of Energy SFOE, 2013, HYDR DAT LAK ZUER SC; Thornton KW., 1990, RESERVOIR LIMNOLOGY; Turner MA, 2005, CAN J FISH AQUAT SCI, V62, P991, DOI 10.1139/F05-003; van der Linden P., 2009, ENSEMBLES CLIMATE CH; Wantzen KM, 2008, HYDROBIOLOGIA, V613, P1, DOI 10.1007/s10750-008-9466-1; White MS, 2008, HYDROBIOLOGIA, V613, P21, DOI 10.1007/s10750-008-9469-y; White MS, 2010, LIMNOL OCEANOGR, V55, P2275, DOI 10.4319/lo.2010.55.6.2275; Windels SK, 2013, J WILDLIFE MANAGE, V77, P1626, DOI 10.1002/jwmg.608; Yang L, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017362; Zohary T, 2011, INLAND WATERS, V1, P47, DOI 10.5268/IW-1.1.406	59	19	19	0	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114889	10.1371/journal.pone.0114889	http://dx.doi.org/10.1371/journal.pone.0114889			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526619	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000347186200008
J	Ye, CL; Yan, WW; Xiang, H; He, HX; Yang, MS; Ijaz, M; Useh, N; Hsieh, CL; McDonough, PL; McDonough, SP; Mohamed, H; Yang, ZB; Chang, YF				Ye, Cuilian; Yan, Weiwei; Xiang, Hua; He, Hongxuan; Yang, Maosheng; Ijaz, Muhammad; Useh, Nicodemus; Hsieh, Ching-Lin; McDonough, Patrick L.; McDonough, Sean P.; Mohamed, Hussni; Yang, Zhibang; Chang, Yung-Fu			Recombinant Antigens rLipL21, rLoa22, rLipL32 and rLigACon4-8 for Serological Diagnosis of Leptospirosis by Enzyme-Linked Immunosorbent Assays in Dogs	PLOS ONE			English	Editorial Material							IMMUNOGLOBULIN-LIKE PROTEIN; CANINE LEPTOSPIROSIS; UNITED-STATES; SEROVARS; SERODIAGNOSIS; INTERROGANS; ANTIBODIES; INFECTION; LIPL32; LIGA	Animal leptospirosis is one of the most common zoonotic diseases in the United States and around the world. In a previous study, we applied four recombinant antigens, rLipL21, rLoa22, rLipL32 and rLigACon4-8 of Leptospira interrogans (L. interrogans) for the serological diagnosis of equine leptospirosis (Ye et al, Serodiagnosis of equine leptospirosis by ELISA using four recombinant protein markers, Clin. Vaccine. Immunol. 21:478-483). In this study, the same four recombinant antigens were evaluated for their potential to diagnose canine leptospirosis by ELISA. A total of 305 canine sera that were Leptospira microscopic agglutination test (MAT)-negative (n=102) and MAT-positive (n=203) to 5 serovars (Pomona, Grippotyphosa, Icterohaemorrhagiae, Canicola and Hardjo) were tested. When individual recombinant antigens were used, the sensitivity and specificity of ELISA were 97.5% and 84.3% for rLigACon4-8; 89.7% and 81.4% for rLoa22; 92.6% and 84.3% for rLipL32 and 99.5% and 84.3% for rLipL21, respectively compared to the MAT. The sensitivity and specificity of ELISA were, 92.6% and 91.2% for rLigACon4-8 and rLipL32, 97.5% and 84.3% for rLigACon4-8 and rLipL21, 89.7% and 87.3% for rLigACon4-8 and rLoa22, 89.7% and 87.3% to rLipL21 and rLoa22, 92.6% and 91.2% for rLipL21 and rLipL32 and 89.2% and 94.1% for rLoa22 and rLipL32 when one of the two antigens was test positive. The use of all four antigens in the ELISA assay was found to be sensitive and specific, easy to perform, and agreed with the results of the standard Leptospira Microscopic Agglutination test (MAT) for the diagnosis of canine leptospirosis.	[Ye, Cuilian; Yan, Weiwei; Xiang, Hua; He, Hongxuan; Yang, Maosheng; Ijaz, Muhammad; Useh, Nicodemus; Hsieh, Ching-Lin; McDonough, Patrick L.; Mohamed, Hussni; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [McDonough, Sean P.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Ye, Cuilian] Chongqing Univ Technol, Sch Pharm & Bioengn, Chongqing, Peoples R China; [Ye, Cuilian; Yang, Zhibang] Chongqing Med Univ, Sch Basic Med Sci, Dept Pathogen Biol, Chongqing, Peoples R China; [Xiang, Hua] Guangdong Acad Agr Sci, Vet Inst, Guangzhou, Guangdong, Peoples R China; [He, Hongxuan] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Yang, Maosheng] Guizhou Acad Agr Sci, Guizhou Inst Anim Husb & Vet Med, Guiyang, Peoples R China	Cornell University; Cornell University; Chongqing University of Technology; Chongqing Medical University; Guangdong Academy of Agricultural Sciences; Chinese Academy of Sciences; Institute of Zoology, CAS; Guizhou Academy of Agricultural Sciences	Chang, YF (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	yc42@cornell.edu; yc42@cornell.edu	Hsieh, Ching-Lin/ABA-6461-2021; Ijaz, Muhammad/AAX-9864-2020; Hsieh, Ching-Lin/K-4139-2018; HSIEH, CHING-LIN/G-6057-2011	HSIEH, CHING-LIN/0000-0001-9468-9969; Hsieh, Ching-Lin/0000-0002-3665-5717				Andre-Fontaine G, 2013, VET REC, V172, P502, DOI 10.1136/vr.101333; Barmettler R, 2011, JAVMA-J AM VET MED A, V238, P183, DOI 10.2460/javma.238.2.183; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Birnbaum N, 1998, J SMALL ANIM PRACT, V39, P231, DOI 10.1111/j.1748-5827.1998.tb03640.x; Bomfim MRQ, 2005, VET MICROBIOL, V109, P89, DOI 10.1016/j.vetmic.2005.05.002; Bourhy P, 2013, J MED MICROBIOL, V62, P822, DOI 10.1099/jmm.0.054304-0; Budihal SV, 2014, J CLIN DIAGN RES, V8, P199, DOI 10.7860/JCDR/2014/6593.3950; Cann KF, 2013, EPIDEMIOL INFECT, V141, P671, DOI 10.1017/S0950268812001653; Chalayon P, 2011, T ROY SOC TROP MED H, V105, P289, DOI 10.1016/j.trstmh.2011.01.008; Chen HW, 2013, AM J TROP MED HYG, V89, P1088, DOI 10.4269/ajtmh.13-0041; Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06; Cullen PA, 2003, INFECT IMMUN, V71, P2414, DOI 10.1128/IAI.71.5.2414-2421.2003; Donskey CJ, 2014, J CLIN MICROBIOL, V52, P315, DOI 10.1128/JCM.01852-13; Ellis WA, 2010, VET REC, V167, P602, DOI 10.1136/vr.c4965; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001; Fraune CK, 2013, JAVMA-J AM VET MED A, V242, P1373, DOI 10.2460/javma.242.10.1373; Gautam R, 2010, JAVMA-J AM VET MED A, V237, P293, DOI 10.2460/javma.237.3.293; Gautam R, 2010, PREV VET MED, V96, P122, DOI 10.1016/j.prevetmed.2010.05.017; Greenlee JJ, 2005, AM J VET RES, V66, P1816, DOI 10.2460/ajvr.2005.66.1816; Greenlee JJ, 2004, AM J VET RES, V65, P1100, DOI 10.2460/ajvr.2004.65.1100; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Hartleben CP, 2013, CURR MICROBIOL, V66, P106, DOI 10.1007/s00284-012-0237-x; Hennebelle JH, 2013, JAVMA-J AM VET MED A, V242, P941, DOI 10.2460/javma.242.7.941; Joseph S, 2012, J VET SCI, V13, P99, DOI 10.4142/jvs.2012.13.1.99; Klaasen HLBM, 2013, VET REC, V172, P181, DOI 10.1136/vr.101100; Klopfleisch R, 2010, VET MED INT, V2010; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Mayer-Scholl A, 2013, VECTOR-BORNE ZOONOT, V13, P200, DOI 10.1089/vbz.2012.1121; Midence JN, 2012, J VET INTERN MED, V26, P149, DOI 10.1111/j.1939-1676.2011.00852.x; Nabity SA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001878; Oliveira TR, 2008, CLIN VACCINE IMMUNOL, V15, P1715, DOI 10.1128/CVI.00214-08; Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729; Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0; Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002; Phraisuwan P, 2002, EMERG INFECT DIS, V8, P1455, DOI 10.3201/eid0812.020180; Pinne M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051025; Public Health Surveillance and Informatics Program Office CfDCaP, 2013, LEPT LEPT INT; Raghavan R, 2011, PREV VET MED, V101, P241, DOI 10.1016/j.prevetmed.2011.05.010; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Sankar S, 2010, RES VET SCI, V88, P375, DOI 10.1016/j.rvsc.2009.11.004; Schreier S, 2013, EXPERT REV CLIN IMMU, V9, P263, DOI [10.1586/eci.12.110, 10.1586/ECI.12.110]; Srimanote P, 2008, J MICROBIOL METH, V72, P73, DOI 10.1016/j.mimet.2007.10.012; Stokes JE, 2007, JAVMA-J AM VET MED A, V230, P1657, DOI 10.2460/javma.230.11.1657; Suepaul SM, 2010, EPIDEMIOL INFECT, V138, P1059, DOI 10.1017/S0950268809990902; Sykes JE, 2011, J VET INTERN MED, V25, P1, DOI 10.1111/j.1939-1676.2010.0654.x; Tangeman LE, 2013, JAVMA-J AM VET MED A, V243, P1316, DOI 10.2460/javma.243.9.1316; Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056; Thaipadungpanit J, 2013, AM J TROP MED HYG, V89, P794, DOI 10.4269/ajtmh.13-0124; VANDENBROEK AHM, 1991, J SMALL ANIM PRACT, V32, P118, DOI 10.1111/j.1748-5827.1991.tb00526.x; Yan WW, 2013, CLIN VACCINE IMMUNOL, V20, P1143, DOI 10.1128/CVI.00245-13; Ye CL, 2014, CLIN VACCINE IMMUNOL, V21, P478, DOI 10.1128/CVI.00649-13	54	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e111367	10.1371/journal.pone.0111367	http://dx.doi.org/10.1371/journal.pone.0111367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526513	gold, Green Published, Green Submitted			2022-12-26	WOS:000347186200066
J	Cobbin, JCA; Zeng, WG; Jackson, DC; Brown, LE				Cobbin, Joanna C. A.; Zeng, Weiguang; Jackson, David C.; Brown, Lorena E.			Different Arms of the Adaptive Immune System Induced by a Combination Vaccine Work in Concert to Provide Enhanced Clearance of Influenza	PLOS ONE			English	Article							CD8(+) T-CELLS; VIRUS HEMAGGLUTININ; SYNTHETIC PEPTIDE; M2 PROTEIN; ANTIBODY; PROTECTION; RESPONSES; MICE; INDUCTION; NUCLEOPROTEIN	Current split influenza virus vaccines that induce strain-specific neutralising antibodies provide some degree of protection against influenza infection but there is a clear need to improve their effectiveness. The constant antigenic drift of influenza viruses means that vaccines are often not an exact match to the circulating strain and so levels of relevant antibodies may not be sufficiently high to afford protection. In the situation where the emergent influenza virus is completely novel, as is the case with pandemic strains, existing vaccines may provide no benefit. In this study we tested the concept of a combination vaccine consisting of sub-optimal doses of split influenza virus vaccine mixed with a cross-protective T-cell inducing lipopeptide containing the TLR2 ligand Pam2Cys. Mice immunised with combination vaccines showed superior levels of lung viral clearance after challenge compared to either split virus or lipopeptide alone, mediated through activation of enhanced humoral and/or additional cellular responses. The mechanism of action of these vaccines was dependent on the route of administration, with intranasal administration being superior to subcutaneous and intramuscular routes, potentially through the induction of memory CD8(+) T cells in the lungs. This immunisation strategy not only provides a mechanism for minimising the dose of split virus antigen but also, through the induction of cross-protective CD8(+) T cells, proves a breadth of immunity to provide potential benefit upon encounter with serologically diverse influenza isolates.	[Cobbin, Joanna C. A.; Zeng, Weiguang; Jackson, David C.; Brown, Lorena E.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3052, Australia	University of Melbourne	Brown, LE (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3052, Australia.	lorena@unimelb.edu.au		Jackson, David/0000-0001-7255-270X; Brown, Lorena/0000-0001-9342-909X	National Health and Medical Research Council of Australia [567122]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Program Grant 567122 from the National Health and Medical Research Council of Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COMPELLING NEED GAME; Baz M, 2012, CLIN VACCINE IMMUNOL, V19, P209, DOI 10.1128/CVI.05441-11; BODMER HC, 1988, CELL, V52, P253, DOI 10.1016/0092-8674(88)90514-4; Brown Lorena E., 2005, Current Drug Delivery, V2, P383, DOI 10.2174/156720105774370258; Chua BY, 2011, J IMMUNOL, V187, P1692, DOI 10.4049/jimmunol.1100486; Deliyannis G, 2006, EUR J IMMUNOL, V36, P770, DOI 10.1002/eji.200535217; Deliyannis G, 2002, J VIROL, V76, P4212, DOI 10.1128/JVI.76.9.4212-4221.2002; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Harling-McNabb L, 1999, INT IMMUNOL, V11, P1431, DOI 10.1093/intimm/11.9.1431; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; JACKSON DC, 1986, VIROLOGY, V155, P625, DOI 10.1016/0042-6822(86)90222-9; JACKSON DC, 1994, VIROLOGY, V198, P613, DOI 10.1006/viro.1994.1073; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Kendal AP, 1982, CONCEPTS PROCEDURES; Lau YF, 2006, INT IMMUNOL, V18, P1801, DOI 10.1093/intimm/dxl114; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; MCMICHAEL AJ, 1981, CLIN EXP IMMUNOL, V43, P276; Middleton D, 2009, J VIROL, V83, P7770, DOI 10.1128/JVI.00241-09; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Ng WC, 2009, INFLUENZA OTHER RESP, V3, P177, DOI 10.1111/j.1750-2659.2009.00087.x; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Osterholm MT, 2013, JAMA-J AM MED ASSOC, P1; Pejoski D, 2010, IMMUNOL CELL BIOL, V88, P605, DOI 10.1038/icb.2010.15; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; SHERMAN LA, 1992, J EXP MED, V175, P1221, DOI 10.1084/jem.175.5.1221; SLEPUSHKIN VA, 1995, VACCINE, V13, P1399, DOI 10.1016/0264-410X(95)92777-Y; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Tan ACL, 2012, ANTIVIR RES, V94, P168, DOI 10.1016/j.antiviral.2012.03.009; TANNOCK GA, 1984, INFECT IMMUN, V43, P457, DOI 10.1128/IAI.43.2.457-462.1984; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Zeng WG, 2011, MOL IMMUNOL, V48, P490, DOI 10.1016/j.molimm.2010.10.003; Zeng WG, 2002, J IMMUNOL, V169, P4905, DOI 10.4049/jimmunol.169.9.4905	38	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115356	10.1371/journal.pone.0115356	http://dx.doi.org/10.1371/journal.pone.0115356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522323	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845600036
J	Kalkat, M; Chan, PK; Wasylishen, AR; Srikumar, T; Kim, SS; Ponzielli, R; Bazett-Jones, DP; Raught, B; Penn, LZ				Kalkat, Manpreet; Chan, Pak-Kei; Wasylishen, Amanda R.; Srikumar, Tharan; Kim, Sam S.; Ponzielli, Romina; Bazett-Jones, David P.; Raught, Brian; Penn, Linda Z.			Identification of c-MYC SUMOylation by Mass Spectrometry	PLOS ONE			English	Article							SUMO MODIFICATION; GENE-EXPRESSION; BREAST-CANCER; PROTEIN; PHOSPHORYLATION; UBIQUITIN; SITES; APOPTOSIS; P300; P53	The c-MYC transcription factor is a master regulator of many cellular processes and deregulation of this oncogene has been linked to more than 50% of all cancers. This deregulation can take many forms, including altered post-translational regulation. Here, using immunoprecipitation combined with mass spectrometry, we identified a MYC SUMOylation site (K326). Abrogation of signaling through this residue by substitution with arginine (K326R) has no obvious effects on MYC half-life, intracellular localization, transcriptional targets, nor on the biological effects of MYC overexpression in two different cell systems assessed for soft agar colony formation, proliferation, and apoptosis. While we have definitively demonstrated that MYC SUMOylation can occur on K326, future work will be needed to elucidate the mechanisms and biological significance of MYC regulation by SUMOylation.	[Kalkat, Manpreet; Chan, Pak-Kei; Wasylishen, Amanda R.; Srikumar, Tharan; Kim, Sam S.; Ponzielli, Romina; Raught, Brian; Penn, Linda Z.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Kalkat, Manpreet; Wasylishen, Amanda R.; Kim, Sam S.; Raught, Brian; Penn, Linda Z.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Bazett-Jones, David P.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Penn, LZ (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.	lpenn@uhnresearch.ca	Srikumar, Tharan/Q-5642-2016	Penn, Linda/0000-0001-8133-5459; Wasylishen, Amanda/0000-0002-1940-5169; Kalkat, Manpreet/0000-0002-4843-9755	Canadian Breast Cancer Research Ontario Region Doctoral Fellowship; Canadian Institutes of Health Research [MOP-130340, MOP-27578]	Canadian Breast Cancer Research Ontario Region Doctoral Fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	MK is supported by a Canadian Breast Cancer Research Ontario Region Doctoral Fellowship (http://www.cbcf.org/ontario/Pages/default.aspx). Work in the BR lab is funded by a Canadian Institutes of Health Research operating grant MOP-130340 (http://www.cihr-irsc.gc.ca/e/193.html). Work in the LZP and BR lab is funded by a Canadian Institutes of Health Research operating grant MOP-27578 (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshareeda AT, 2014, BREAST CANCER RES TR, V144, P519, DOI 10.1007/s10549-014-2897-7; Amente S, 2012, AM J CANCER RES, V2, P330; ASKEW DS, 1991, ONCOGENE, V6, P1915; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Bogachek MV, 2014, CANCER CELL, V25, P748, DOI 10.1016/j.ccr.2014.04.008; Cairo S, 2005, ONCOGENE, V24, P2195, DOI 10.1038/sj.onc.1208338; Dahle O, 2003, EUR J BIOCHEM, V270, P1338, DOI 10.1046/j.1432-1033.2003.03504.x; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Goard CA, 2010, INT J CANCER, V127, P2936, DOI 10.1002/ijc.25295; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; HENRIKSSON M, 1993, ONCOGENE, V8, P3199; Jeram SM, 2010, PROTEOMICS, V10, P254, DOI 10.1002/pmic.200900648; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Liu HW, 2012, NUCLEIC ACIDS RES, V40, P10172, DOI 10.1093/nar/gks819; Lutz W, 1996, ONCOGENE, V13, P803; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; PULVERER BJ, 1994, ONCOGENE, V9, P59; Raman N, 2013, CHROMOSOMA, V122, P475, DOI 10.1007/s00412-013-0429-6; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Sabo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091072; Sahin U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5187; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Srikumar T, 2013, J CELL BIOL, V201, P145, DOI 10.1083/jcb.201210019; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wasylishen AR, 2014, ONCOGENE, V33, P1066, DOI 10.1038/onc.2013.36; Wasylishen AR, 2011, ONCOGENE, V30, P3727, DOI 10.1038/onc.2011.88; Wasylishen AR, 2013, CANCER RES, V73, P6504, DOI 10.1158/0008-5472.CAN-12-4063; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Zhang HJ, 2013, CELL BIOCHEM BIOPHYS, V67, P1081, DOI 10.1007/s12013-013-9612-x; Zhang KL, 2005, BIOCHEM BIOPH RES CO, V336, P274, DOI 10.1016/j.bbrc.2005.08.075	44	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115337	10.1371/journal.pone.0115337	http://dx.doi.org/10.1371/journal.pone.0115337			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522242	Green Submitted, gold, Green Published			2022-12-26	WOS:000348845600035
J	Serrano-Sanchez, JA; Bello-Lujan, LM; Auyanet-Batista, JM; Fernandez-Rodriguez, MJ; Gonzalez-Henriquez, JJ				Serrano-Sanchez, Jose A.; Bello-Lujan, Luis M.; Auyanet-Batista, Juan M.; Fernandez-Rodriguez, Maria J.; Gonzalez-Henriquez, Juan J.			Lack of Exercise of "Moderate to Vigorous" Intensity in People with Low Levels of Physical Activity Is a Major Discriminant for Sociodemographic Factors and Morbidity	PLOS ONE			English	Article							SEDENTARY LIFE-STYLE; LEISURE-TIME; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; PRESCRIBING EXERCISE; JOINT ASSOCIATIONS; SKELETAL-MUSCLE; TRENDS; HEALTH; RISK	Introduction: The aim is to examine the differences between participation at low and zero moderate to vigorous physical activity (MVPA) in relation to their trends and associations with known socio-demographic and health factors. We hypothesised that the number of people at zero MVPA level could be rising despite a parallel increase in the population meeting the recommended MVPA level. We also hypothesised that graded associations of socio-demographic and health factors exist across MVPA levels. Methods: Two independent population-based samples (n=4320 [2004] and n=2176 [1997]), were recruited with a stratified and random sampling procedure and interviewed at home by professional interviewers. The MVPA was assessed by validated questionnaire. The participants were classified into three MVPA levels: zero, low and recommended MVPA. The trend of each MVPA level was analysed with the standardized prevalence ratios. Correlates of low and zero MVPA levels were examined using multinomial logistic regression. Results: The population at zero and recommended MVPA levels rose between 1997-2004 by 12% (95% CI, 5-20%) and 7% (95% CI, 24-19%) respectively, while the population at low MVPA level decreased. At zero MVPA level, associativepatterns were observed with sociodemographic and health factors which were different when compared to the population at low MVPA level. Conclusions: Despite the slight increase of population meeting the recommended MVPA level, a higher trend of increase was observed at zero MVPA level. Both recommended and low MPVA levels increased their participation by absorbing participants from the low MVPA level. The sociodemographic profile of those with low MVPA was more similar to the population at recommended MVPA than at zero MVPA level. Methodological implications about the combination of light and moderate-intensity PA could be derived. The prevention of decline in actual low MVPA could change the trend of increase in the population at zero MVPA level, particularly among young adults.	[Serrano-Sanchez, Jose A.] Univ Las Palmas Gran Canaria, Dept Phys Educ & Sport Sci, Las Palmas Gran Canaria, Spain; [Serrano-Sanchez, Jose A.] Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci IUIBS, Las Palmas Gran Canaria, Spain; [Bello-Lujan, Luis M.] Canary Isl Hlth Serv, Directorate Gen Publ Hlth, Las Palmas Gran Canaria, Spain; [Auyanet-Batista, Juan M.] Canary Isl Hlth Serv, Dept Primary Hlth Care, Las Palmas Gran Canaria, Spain; [Fernandez-Rodriguez, Maria J.] Univ Hosp Dr Negrin, Dept Clin Pathobiol, Las Palmas Gran Canaria, Spain; [Gonzalez-Henriquez, Juan J.] Univ Las Palmas Gran Canaria, Dept Matemath, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Serrano-Sanchez, JA (corresponding author), Univ Las Palmas Gran Canaria, Dept Phys Educ & Sport Sci, Las Palmas Gran Canaria, Spain.	jose.serrano@ulpgc.es	Serrano-Sanchez, Jose A/L-3691-2014; Henríquez, Juan José González/AAZ-7810-2020	Serrano-Sanchez, Jose A/0000-0002-4868-8751; Henríquez, Juan José González/0000-0002-0622-5580	Canary Health Services	Canary Health Services	The grants were managed directly by Canary Health Services. Technical work was performed by the authors. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Serrano-Sanchez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038693; Ara I, 2011, INT J OBESITY, V35, P99, DOI 10.1038/ijo.2010.123; Barengo NC, 2002, MED SCI SPORT EXER, V34, P1302, DOI 10.1097/00005768-200208000-00011; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Bernstein MS, 1999, AM J PUBLIC HEALTH, V89, P862, DOI 10.2105/AJPH.89.6.862; Boon RM, 2010, BRIT J SPORT MED, V44, P741, DOI 10.1136/bjsm.2008.052167; Brownson RC, 2001, AM J PUBLIC HEALTH, V91, P1995, DOI 10.2105/AJPH.91.12.1995; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Cabrera de Leon A, 2008, REV ESP SALUD PUBLIC, V82, P1; de Leon AC, 2007, REV ESP CARDIOL, V60, P244, DOI 10.1157/13100275; Carlson SA, 2010, AM J PREV MED, V39, P305, DOI 10.1016/j.amepre.2010.06.006; Chan CB, 2009, INT J ENV RES PUB HE, V6, P2639, DOI 10.3390/ijerph6102639; Chau J, 2007, TRENDS POPULATION LE; Chen YJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-427; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Churilla JR, 2012, METAB SYNDR RELAT D, V10, P70, DOI 10.1089/met.2011.0057; Cleland V, 2010, SOC SCI MED, V70, P2011, DOI 10.1016/j.socscimed.2010.02.028; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Duncan GE, 2005, ARCH INTERN MED, V165, P2362, DOI 10.1001/archinte.165.20.2362; Duncan GE, 2001, PREV MED, V33, P18, DOI 10.1006/pmed.2001.0847; Elosua R, 2005, J GERONTOL A-BIOL, V60, P760, DOI 10.1093/gerona/60.6.760; Fernandez-Berges D, 2012, REV ESP CARDIOL, V65, P241, DOI [10.1016/j.rec.2011.10.017, 10.1016/j.recesp.2011.10.015]; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; George ES, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-20; Goldstein H., 1999, MULTILEVEL STAT MODE; Gordon-Larsen P, 2004, AM J PREV MED, V27, P277, DOI 10.1016/j.amepre.2004.07.006; Hallal PC, 2003, MED SCI SPORT EXER, V35, P1894, DOI 10.1249/01.MSS.0000093615.33774.0E; Hallal Pedro C, 2011, Rev. bras. epidemiol., V14, P53, DOI 10.1590/S1415-790X2011000500006; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Hayes DK, 2011, PREV CHRONIC DIS, V8; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Brodersen NH, 2007, BRIT J SPORT MED, V41, P140, DOI 10.1136/bjsm.2006.031138; Hu G, 2007, AM J HYPERTENS, V20, P1242, DOI 10.1016/j.amjhyper.2007.07.015; IBM Corp, 2010, REL 2010 IBM SPSS ST; Instituto de Evaluacion, 2009, SIST EST IND ED; ISTAC, 2004, HLTH SURV CAN 2004 M; Juneau CE, 2010, PREV MED, V51, P384, DOI 10.1016/j.ypmed.2010.09.002; Katzmarzyk Peter T, 2007, Appl Physiol Nutr Metab, V32 Suppl 2F, pS206, DOI 10.1139/H07-167; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; King AC, 2000, HEALTH PSYCHOL, V19, P354, DOI 10.1037//0278-6133.19.4.354; Kruger J., 2005, Morbidity and Mortality Weekly Report, V54, P991; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Li FZ, 2005, J AGING PHYS ACTIV, V13, P87, DOI 10.1123/japa.13.1.87; Liao Y, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-131; Lynch BM, 2011, BREAST CANCER RES TR, V130, P183, DOI 10.1007/s10549-011-1559-2; Lynch BM, 2010, ANN BEHAV MED, V40, P265, DOI 10.1007/s12160-010-9209-1; Marshall SJ, 2011, AM J LIFESTYLE MED, V5, P518, DOI 10.1177/1559827610395487; Meseguer CM, 2011, REV ESP CARDIOL, V64, P21, DOI [10.1016/j.recesp.2010.07.007, 10.1016/j.rec.2010.06.010]; Muthen BO, 1995, SOCIOL METHODOL, V25, P267, DOI 10.2307/271070; Nelson MC, 2005, AM J PREV MED, V28, P259, DOI 10.1016/j.amepre.2004.12.006; NEWMAN S. C., 2001, WILEY S PRO STAT BIO; Ng N, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.6347; Nokes N, 2009, J SPORT MED PHYS FIT, V49, P136; Organization WH, 2009, GLOB HLTH RISKS MORT; Pate RR, 2006, CIRCULATION, V114, P1214, DOI 10.1161/CIRCULATIONAHA.106.177052; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Petersen CB, 2010, SCAND J PUBLIC HEALT, V38, P121, DOI 10.1177/1403494809357098; Phillips AC, 2010, BRIT J HEALTH PSYCH, V15, P337, DOI 10.1348/135910709X466180; Pols MA, 1998, EUR J EPIDEMIOL, V14, P63, DOI 10.1023/A:1007427831179; R Core Team, 2012, R LANG ENV STAT COMP; Reddigan JI, 2011, AM J CARDIOL, V108, P1426, DOI 10.1016/j.amjcard.2011.07.005; Redondo A, 2011, REV ESP CARDIOL, V64, P997, DOI [10.1016/j.recesp.2011.06.020, 10.1016/j.rec.2011.06.020]; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Rutten A, 2001, J EPIDEMIOL COMMUN H, V55, P139, DOI 10.1136/jech.55.2.139; Schoenborn CA, 2011, AM J PREV MED, V40, P514, DOI 10.1016/j.amepre.2010.12.029; Seefeldt V, 2002, SPORTS MED, V32, P143, DOI 10.2165/00007256-200232030-00001; Serrano-Sanchez JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024453; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Sjostrom M, 2006, J PUBLIC HEALTH-HEID, V14, P291, DOI 10.1007/s10389-006-0031-y; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Stamatakis E, 2007, PREV MED, V45, P416, DOI 10.1016/j.ypmed.2006.12.014; Steinberg GR, 2006, J CLIN ENDOCR METAB, V91, P3592, DOI 10.1210/jc.2006-0638; Sugiyama T, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-35; TABATCHNICK BG, 2007, USING MULTIVARIATE S; Tanasescu N, 2002, JAMA-J AM MED ASSOC, V288, P1994, DOI 10.1001/jama.288.16.1994; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Tudor-Locke C, 2013, APPL PHYSIOL NUTR ME, V38, P100, DOI 10.1139/apnm-2012-0235; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Vandelanotte C, 2010, AUST NZ J PUBL HEAL, V34, P248, DOI 10.1111/j.1753-6405.2010.00521.x; Varo JJ, 2003, INT J EPIDEMIOL, V32, P138, DOI 10.1093/ije/dyg116; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; World Health Organization, 1995, PROT GUID COUNTR INT; World Health Organization, 2004, GLOB STRAT DIET PHYS; Yu S, 2003, HEART, V89, P502, DOI 10.1136/heart.89.5.502; Zabina E. Y., 1995, EXPERIENCE VALIDATIO	90	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115321	10.1371/journal.pone.0115321	http://dx.doi.org/10.1371/journal.pone.0115321			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA4AC	25522144	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845600034
J	Vulfius, CA; Kasheverov, IE; Starkov, VG; Osipov, AV; Andreeva, TV; Filkin, SY; Gorbacheva, EV; Astashev, ME; Tsetlin, VI; Utkin, YN				Vulfius, Catherine A.; Kasheverov, Igor E.; Starkov, Vladislav G.; Osipov, Alexey V.; Andreeva, Tatyana V.; Filkin, Sergey Yu.; Gorbacheva, Elena V.; Astashev, Maxim E.; Tsetlin, Victor I.; Utkin, Yuri N.			Inhibition of Nicotinic Acetylcholine Receptors, a Novel Facet in the Pleiotropic Activities of Snake Venom Phospholipases A(2)	PLOS ONE			English	Article							LYMNAEA-STAGNALIS NEURONS; NAJA-NAJA-ATRA; ALPHA-BUNGAROTOXIN; PHARMACOLOGICAL-PROPERTIES; ENZYMATIC-ACTIVITY; BINDING-PROTEIN; SKELETAL-MUSCLE; NEUROTOXINS; MECHANISM; AFFINITY	Phospholipases A(2) represent the most abundant family of snake venom proteins. They manifest an array of biological activities, which is constantly expanding. We have recently shown that a protein bitanarin, isolated from the venom of the puff adder Bitis arietans and possessing high phospholipolytic activity, interacts with different types of nicotinic acetylcholine receptors and with the acetylcholine-binding protein. To check if this property is characteristic to all venom phospholipases A(2), we have studied the capability of these enzymes from other snakes to block the responses of Lymnaea stagnalis neurons to acetylcholine or cytisine and to inhibit alpha-bungarotoxin binding to nicotinic acetylcholine receptors and acetylcholine-binding proteins. Here we present the evidence that phospholipases A(2) from venoms of vipers Vipera ursinii and V. nikolskii, cobra Naja kaouthia, and krait Bungarus fasciatus from different snake families suppress the acetylcholine- or cytisine-elicited currents in L. stagnalis neurons and compete with alpha-bungarotoxin for binding to muscle- and neuronal alpha 7-types of nicotinic acetylcholine receptor, as well as to acetylcholine- binding proteins. As the phospholipase A(2) content in venoms is quite high, under some conditions the activity found may contribute to the deleterious venom effects. The results obtained suggest that the ability to interact with nicotinic acetylcholine receptors may be a general property of snake venom phospholipases A(2), which add a new target to the numerous activities of these enzymes.	[Vulfius, Catherine A.; Gorbacheva, Elena V.; Astashev, Maxim E.] Russian Acad Sci, Inst Cell Biophys, Pushchino 142290, Moscow Region, Russia; [Kasheverov, Igor E.; Starkov, Vladislav G.; Osipov, Alexey V.; Andreeva, Tatyana V.; Filkin, Sergey Yu.; Tsetlin, Victor I.; Utkin, Yuri N.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Utkin, YN (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	utkin@mx.ibch.ru	Tsetlin, Victor/X-2491-2018; Astashev, Maksim E./A-9122-2015; Utkin, Yuri/L-2952-2019; Alexey, Osipov/AAQ-1422-2021; Utkin, Yuri N./F-1958-2014; Filkin, Sergey/B-9991-2016	Astashev, Maksim E./0000-0002-6591-0748; Utkin, Yuri/0000-0002-4609-970X; Utkin, Yuri N./0000-0002-4609-970X; Filkin, Sergey/0000-0002-4710-6051; Vulfius, Catherine/0000-0002-2904-0976; Osipov, Aleksei/0000-0001-7665-4711	Russian Foundation for Basic Research [12-04-01523, 13-04-01897, 13-04-40377-CoMfi]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The reported study was partially supported by Russian Foundation for Basic Research, research projects Nos. 12-04-01523, 13-04-01897, and 13-04-40377-CoMfi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augert A, 2009, EMBO REP, V10, P271, DOI 10.1038/embor.2008.255; BENJAMIN PR, 1972, Z ZELLFORSCH MIK ANA, V128, P564, DOI 10.1007/BF00306989; Bernard D, 2014, BBA-REV CANCER, V1846, P40, DOI 10.1016/j.bbcan.2014.03.003; BON C, 1979, EUR J BIOCHEM, V99, P471, DOI 10.1111/j.1432-1033.1979.tb13278.x; BON C, 1977, EUR J BIOCHEM, V74, P43, DOI 10.1111/j.1432-1033.1977.tb11364.x; Brazil OV, 2000, J NAT TOXINS, V9, P33; Buisson B, 1996, J NEUROSCI, V16, P7880; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; CHEMERIS NK, 1982, J PHYSIOL-LONDON, V323, P1; Coenen MJH, 2013, J AM SOC NEPHROL, V24, P677, DOI 10.1681/ASN.2012070730; CONDREA E, 1981, TOXICON, V19, P705, DOI 10.1016/0041-0101(81)90108-2; Copic A, 1999, J BIOL CHEM, V274, P26315, DOI 10.1074/jbc.274.37.26315; Cupillard L, 1999, J BIOL CHEM, V274, P7043, DOI 10.1074/jbc.274.11.7043; DARVENIZA P, 1979, BIOCHEM J, V181, P545, DOI 10.1042/bj1810545; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Heus F, 2013, TOXICON, V61, P112, DOI 10.1016/j.toxicon.2012.11.002; Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x; KASTURI S, 1990, IMMUNOLOGY, V70, P175; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5; KOSTYUK PG, 1981, J NEUROSCI METH, V4, P201, DOI 10.1016/0165-0270(81)90032-7; KRIZAJ I, 1989, BIOCHIM BIOPHYS ACTA, V999, P198, DOI 10.1016/0167-4838(89)90218-5; Kukhtina VV, 2000, EUR J BIOCHEM, V267, P6784, DOI 10.1046/j.1432-1033.2000.01775.x; LAMBEAU G, 1990, J BIOL CHEM, V265, P9526; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; Makarova YaV, 2006, BIOCHEMISTRY-MOSCOW, V71, P838; MEZNA M, 1994, BIOCHEM J, V301, P503, DOI 10.1042/bj3010503; Montecucco C, 2008, CELL MOL LIFE SCI, V65, P2897, DOI 10.1007/s00018-008-8113-3; Mordvintsev DY, 2005, COMPUT BIOL CHEM, V29, P398, DOI 10.1016/j.compbiolchem.2005.08.007; ONO JK, 1981, J NEUROSCI, V1, P259; Osipov AV, 2010, TOXICON, V55, P186, DOI 10.1016/j.toxicon.2009.07.011; PAPKE RL, 1994, MOL PHARMACOL, V45, P142; Prijatelj P, 2008, TOXICON, V51, P1520, DOI 10.1016/j.toxicon.2008.03.031; Pungercar J, 2007, TOXICON, V50, P871, DOI 10.1016/j.toxicon.2007.07.025; Purohit P, 2013, J GEN PHYSIOL, V141, P467, DOI 10.1085/jgp.201210946; Quik M, 1996, J NEUROCHEM, V67, P145; RADVANYI F, 1989, ANAL BIOCHEM, V177, P103, DOI 10.1016/0003-2697(89)90022-5; Ramazanova AS, 2008, TOXICON, V51, P524, DOI 10.1016/j.toxicon.2007.11.001; Rossetto O, 2006, J NEUROCHEM, V97, P1534, DOI 10.1111/j.1471-4159.2006.03965.x; Rouault M, 2006, BIOCHEMISTRY-US, V45, P5800, DOI 10.1021/bi060217r; RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Sine SM, 2013, BIOCHEM J, V454, P311, DOI 10.1042/BJ20130638; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Tsai IH, 2007, FEBS J, V274, P512, DOI 10.1111/j.1742-4658.2006.05598.x; Tsai IH, 2011, TOXICON, V57, P332, DOI 10.1016/j.toxicon.2010.12.012; Vardjan Nina, 2013, Commun Integr Biol, V6, pe23600, DOI 10.4161/cib.23600; VILLAR MT, 1988, BIOCHIM BIOPHYS ACTA, V938, P35, DOI 10.1016/0005-2736(88)90119-8; Vulfius CA, 2013, BIOCHEM MOSC SUPPL S, V7, P203, DOI 10.1134/S1990747813040077; Vulfius CA, 2005, NEUROSCI LETT, V373, P232, DOI 10.1016/j.neulet.2004.10.010; Vulfius CA, 2001, NEUROSCI LETT, V309, P189, DOI 10.1016/S0304-3940(01)02081-X; Vulfius CA, 2011, TOXICON, V57, P787, DOI 10.1016/j.toxicon.2011.02.013; WARRELL DA, 1989, T ROY SOC TROP MED H, V83, P732, DOI 10.1016/0035-9203(89)90311-8; Wu J, 2006, J PHYSIOL-LONDON, V576, P103, DOI 10.1113/jphysiol.2006.114645	56	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115428	10.1371/journal.pone.0115428	http://dx.doi.org/10.1371/journal.pone.0115428			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522251	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845600047
J	Wang, Z; Xu, D; Ding, HF; Kim, J; Zhang, J; Hai, T; Yan, C				Wang, Z.; Xu, D.; Ding, H-F; Kim, J.; Zhang, J.; Hai, T.; Yan, C.			Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model	ONCOGENE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR-3; GENE-EXPRESSION; ADAPTIVE-RESPONSE; TUMOR-SUPPRESSOR; METASTASIS; KINASE; TRANSACTIVATION; ADENOCARCINOMA; REPRESSION	Activating transcription factor 3 (ATF3) responds to diverse cellular stresses, and regulates oncogenic activities (for example, proliferation, survival and migration) through direct transcriptional regulation or protein-protein interactions. Although aberrant ATF3 expression is frequently found in human cancers, the role of ATF3 in tumorigenesis is poorly understood. Here, we demonstrate that ATF3 suppresses the development of prostate cancer induced by knockout of the tumor suppressor Pten in mouse prostates. Whereas the oncogenic stress elicited by Pten loss induced ATF3 expression in prostate epithelium, we found that ATF3 deficiency increased cell proliferation and promoted cell survival, leading to early onset of mouse prostatic intraepithelial neoplasia and the progression of prostate lesions to invasive adenocarcinoma. Importantly, the loss of ATF3 promoted activation of the oncogenic AKT signaling evidenced by high levels of phosphorylated AKT and S6 proteins in ATF3-null prostate lesions. In line with these in vivo results, knockdown of ATF3 expression in human prostate cancer cells by single guided RNA-mediated targeting activated AKT and increased matrix metalloproteinase-9 expression. Our results thus link ATF3 to the AKT signaling, and suggest that ATF3 is a tumor suppressor for the major subset of prostate cancers harboring dysfunctional Pten.	[Wang, Z.; Ding, H-F; Yan, C.] Georgia Regents Univ, GRU Canc Ctr, Augusta, GA 30912 USA; [Wang, Z.; Xu, D.; Yan, C.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Ding, H-F] Georgia Regents Unviers, Dept Pathol, Augusta, GA 30912 USA; [Kim, J.] Georgia Regents Unviers, Dept Biostat & Epidemiol, Augusta, GA 30912 USA; [Zhang, J.] Case Western Reserve Univ, Sch Med, Dept Radiat Oncol, Cleveland, OH USA; [Hai, T.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Yan, C.] Georgia Regents Unviers, Dept Biochem & Mol Biol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; Albany Medical College; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Case Western Reserve University; University System of Ohio; Ohio State University; University System of Georgia; Augusta University	Yan, C (corresponding author), Georgia Regents Univ, GRU Canc Ctr, 1410 Laney Walker Blvd,CN2134, Augusta, GA 30912 USA.	cyan@gru.edu	Hai, Tsonwin/E-3185-2011	Hai, Tsonwin/0000-0003-4510-0315; Yan, Chunhong/0000-0002-3974-7991; Ding, Han-Fei/0000-0001-5702-3439	NIH [R01CA139107, R01CA164006]; Department of Defense [W81XWH-07-1-0095]; NATIONAL CANCER INSTITUTE [R01CA164006, R01CA154625, R01CA139107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants R01CA139107, R01CA164006 and a Department of Defense award W81XWH-07-1-0095 to CY. We thank Dr George Church for providing sgRNA targeting reagents and Dr Honglin Li for providing NF-kappa B reagents.	Agarwal A, 2005, ONCOGENE, V24, P1021, DOI 10.1038/sj.onc.1208296; Bandyopadhyay S, 2006, CANCER RES, V66, P11983, DOI 10.1158/0008-5472.CAN-06-0943; Blando J, 2009, AM J PATHOL, V174, P1869, DOI 10.2353/ajpath.2009.080055; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Chen HH, 2004, MOL PHARMACOL, V65, P1130, DOI 10.1124/mol.65.5.1130; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2010, BLOOD, V115, P4734, DOI 10.1182/blood-2009-03-213512; Hackl C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-668; Hai T, 1999, GENE EXPRESSION, V7, P321; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Huang CY, 2015, MOL NEUROBIOL, V51, P543, DOI 10.1007/s12035-014-8710-0; Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200; Ishiguro T, 1996, CANCER RES, V56, P875; Jan YH, 2012, CANCER RES, V72, P5119, DOI 10.1158/0008-5472.CAN-12-1842; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Liu W, 2011, J BIOL CHEM, V286, P18949, DOI 10.1074/jbc.M111.232637; Liu YQ, 2013, CANCER LETT, V337, P66, DOI 10.1016/j.canlet.2013.05.022; Liu YP, 2013, CANCER RES, V73, P6194, DOI 10.1158/0008-5472.CAN-13-0518; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stearns ME, 2004, MOL CANCER RES, V2, P403; Svensson RU, 2011, AM J PATHOL, V179, P502, DOI 10.1016/j.ajpath.2011.03.014; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Varambally S, 2012, CANCER CELL, V8, P393; Wang HB, 2012, MOL CELL BIOL, V32, P3190, DOI 10.1128/MCB.00159-12; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wei SS, 2014, J BIOL CHEM, V289, P8947, DOI 10.1074/jbc.M113.503755; Wolford CC, 2013, J CLIN INVEST, V123, P2893, DOI 10.1172/JCI64410; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yan CH, 2002, J BIOL CHEM, V277, P10804, DOI 10.1074/jbc.M112069200; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879; Zhang QY, 2012, CANCER RES, V72, P2589, DOI 10.1158/0008-5472.CAN-11-3795	51	49	50	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 17	2015	34	38					4975	4984		10.1038/onc.2014.426	http://dx.doi.org/10.1038/onc.2014.426			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9QZ	25531328	Green Accepted			2022-12-26	WOS:000361693000007
J	Shibata, H; Kanadome, T; Sugiura, H; Yokoyama, T; Yamamuro, M; Moss, SE; Maki, M				Shibata, Hideki; Kanadome, Takashi; Sugiura, Hirofumi; Yokoyama, Takeru; Yamamuro, Minami; Moss, Stephen E.; Maki, Masatoshi			A New Role for Annexin A11 in the Early Secretory Pathway via Stabilizing Sec31A Protein at the Endoplasmic Reticulum Exit Sites (ERES)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY SPLICED ISOFORM; ALG-2; CALCIUM; COPII; TRANSPORT; LOCALIZATION; ORGANIZATION; EXPORT; ALIX; BINDING	Exit of cargo molecules from the endoplasmic reticulum (ER) for transport to the Golgi is the initial step in intracellular vesicular trafficking. The coat protein complex II (COPII) machinery is recruited to specialized regions of the ER, called ER exit sites (ERES), where it plays a central role in the early secretory pathway. It has been known for more than two decades that calcium is an essential factor in vesicle trafficking from the ER to Golgi apparatus. However, the role of calcium in the early secretory pathway is complicated and poorly understood. We and others previously identified Sec31A, an outer cage component of COPII, as an interacting protein for the penta-EF-hand calcium-binding protein ALG-2. In this study, we show that another calcium-binding protein, annexin A11 (AnxA11), physically associates with Sec31A by the adaptor function of ALG-2. Depletion of AnxA11 or ALG-2 decreases the population of Sec31A that is stably associated with the ERES and causes scattering of juxta-nuclear ERES to the cell periphery. The synchronous ER-to-Golgi transport of transmembrane cargoes is accelerated in AnxA11- or ALG-2-knockdown cells. These findings suggest that AnxA11 maintains architectural and functional features of the ERES by coordinating with ALG-2 to stabilize Sec31A at the ERES.	[Shibata, Hideki; Kanadome, Takashi; Sugiura, Hirofumi; Yokoyama, Takeru; Yamamuro, Minami; Maki, Masatoshi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Moss, Stephen E.] UCL, Dept Cell Biol, UCL Inst Ophthalmol, London EC1V 9EL, England	Nagoya University; University of London; University College London	Shibata, H (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	shibabou@agr.nagoya-u.ac.jp	Maki, Masatoshi/AAM-6839-2021	Maki, Masatoshi/0000-0001-9144-5491; Kanadome, Takashi/0000-0002-8851-4780	Uehara Memorial Foundation; Toyoaki Scholarship Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24580138, 23380056]; Japan Society for the Promotion of Science	Uehara Memorial Foundation(Uehara Memorial Foundation); Toyoaki Scholarship Foundation(Toyoaki Scholarship Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Uehara Memorial Foundation (to H. S.), the Toyoaki Scholarship Foundation (to H. S.), Grant-in-aid for Scientific Research (C) 24580138 (to H. S.), and Grant-in aid for Scientific Research (B) 23380056 (to M. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.; Recipient of Japan Society for the Promotion of Science Research Fellowship for Young Scientists (DC1).	ALI SM, 1989, NATURE, V340, P313, DOI 10.1038/340313a0; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Arasaki K, 2006, MOL BIOL CELL, V17, P2780, DOI 10.1091/mbc.E05-10-0973; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; BECKERS CJM, 1990, J BIOL CHEM, V265, P18298; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhattacharyya D, 2007, MOL BIOL CELL, V18, P839, DOI 10.1091/mbc.E06-08-0707; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Budnik A, 2009, FEBS LETT, V583, P3796, DOI 10.1016/j.febslet.2009.10.038; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; DOMS RW, 1987, J CELL BIOL, V105, P1957, DOI 10.1083/jcb.105.5.1957; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; GALLIONE CJ, 1985, J VIROL, V54, P374, DOI 10.1128/JVI.54.2.374-382.1985; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Helm JR, 2014, J BIOL CHEM, V289, P23609, DOI 10.1074/jbc.M114.561829; Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x; Hughes H, 2009, J CELL SCI, V122, P2924, DOI 10.1242/jcs.044032; Ichioka F, 2007, ARCH BIOCHEM BIOPHYS, V457, P142, DOI 10.1016/j.abb.2006.11.008; Iinuma T, 2007, J BIOL CHEM, V282, P17632, DOI 10.1074/jbc.M611237200; Inuzuka T, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-25; Kitaura Y, 2001, J BIOL CHEM, V276, P14053, DOI 10.1074/jbc.M008649200; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054382; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Miller EA, 2013, CURR OPIN CELL BIOL, V25, P420, DOI 10.1016/j.ceb.2013.04.005; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Okumura M, 2009, BIOCHEM BIOPH RES CO, V386, P237, DOI 10.1016/j.bbrc.2009.06.015; OSBORN M, 2006, CELL BIOL LAB HDB, P549; Osugi K, 2012, J BIOCHEM, V151, P657, DOI 10.1093/jb/mvs029; PIND SN, 1994, J CELL BIOL, V125, P239, DOI 10.1083/jcb.125.2.239; Satoh H, 2002, BIOCHEM BIOPH RES CO, V291, P1166, DOI 10.1006/bbrc.2002.6600; SCHWANINGER R, 1991, J BIOL CHEM, V266, P13055; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Shimoi W, 2005, J BIOL CHEM, V280, P10141, DOI 10.1074/jbc.M409673200; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Suzuki H, 2008, STRUCTURE, V16, P1562, DOI 10.1016/j.str.2008.07.012; Tarabykina S, 2000, J BIOL CHEM, V275, P10514, DOI 10.1074/jbc.275.14.10514; Tomas A, 2004, J CELL BIOL, V165, P813, DOI 10.1083/jcb.200311054; Tomas A, 2003, J BIOL CHEM, V278, P20210, DOI 10.1074/jbc.M212669200; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Watson P, 2006, TRAFFIC, V7, P1678, DOI 10.1111/j.1600-0854.2006.00493.x; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390	54	32	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4981	4993		10.1074/jbc.M114.592089	http://dx.doi.org/10.1074/jbc.M114.592089			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25540196	Green Published, hybrid			2022-12-26	WOS:000350042000040
J	Wang, XY; Li, M; Wang, ZQ; Han, SC; Tang, XH; Ge, YX; Zhou, LQ; Zhou, CC; Yuan, QP; Yang, M				Wang, Xinyu; Li, Meng; Wang, Zhiqiong; Han, Sichong; Tang, Xiaohu; Ge, Yunxia; Zhou, Liqing; Zhou, Changchun; Yuan, Qipeng; Yang, Ming			Silencing of Long Noncoding RNA MALAT1 by miR-101 and miR-217 Inhibits Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; HEPATOCELLULAR-CARCINOMA; GASTRIC-CANCER; RISK-FACTORS; LUNG-CANCER; ADENOCARCINOMA; MICRORNA-101; TARGET; METASTASIS	MALAT1, a highly conserved long noncoding RNA, is deregulated in several types of cancers. However, its role in esophageal squamous cell carcinoma (ESCC) and its posttranscriptional regulation remain poorly understood. In this study we provide first evidences that a posttranscriptional regulation mechanism of MALAT1 by miR-101 and miR-217 exists in ESCC cells. This posttranscriptional silencing of MALAT1 could significantly suppress the proliferation of ESCC cells through the arrest of G(2)/M cell cycle, which may be due to MALAT1-mediated up-regulation of p21 and p27 expression and the inhibition of B-MYB expression. Moreover, we also found the abilities of migration and invasion of ESCC cells were inhibited after overexpression of miR-101, miR-217, or MALAT1 siRNA. This might be attributed to the deregulation of downstream genes of MALAT1, such as MIA2, HNF4G, ROBO1, CCT4, and CTHRC1. A significant negative correlation exists between miR-101 or miR-217 and MALAT1 in 42 pairs of ESCC tissue samples and adjacent normal tissues. Mice xenograft data also support the tumor suppressor role of both miRNAs in ESCCs.	[Wang, Xinyu; Li, Meng; Wang, Zhiqiong; Han, Sichong; Tang, Xiaohu; Ge, Yunxia; Yuan, Qipeng; Yang, Ming] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Lab Biomed Mat, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China; [Zhou, Liqing] Huaian 2 Hosp, Dept Radiat Oncol, Huaian 223002, Jiangsu, Peoples R China; [Zhou, Changchun] Shandong Acad Med Sci, Shandong Canc Hosp, Clin Lab, Jinan 250117, Shandong, Peoples R China	Beijing University of Chemical Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Yang, M (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, POB 53, Beijing 100029, Peoples R China.	yangm@mail.buct.edu.cn	Yang, Ming/G-4705-2012; , CC. Zhou/AGI-1229-2022	Yang, Ming/0000-0002-7722-7487; 	National Natural Science Foundation of China [31271382, 91229126, 81201586]; National High-Tech Research and Development Program of China [SS2015AA020950]; Beijing Higher Education Young Elite Teacher Project [YETP0521]; Fundamental Research Funds for the Central Universities [YS1407]; open project of State Key Laboratory of Molecular Oncology [SKL-KF-2013-03]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Higher Education Young Elite Teacher Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); open project of State Key Laboratory of Molecular Oncology; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by National Natural Science Foundation of China Grants 31271382, 91229126, and 81201586, National High-Tech Research and Development Program of China Grant SS2015AA020950, Beijing Higher Education Young Elite Teacher Project YETP0521, the Fundamental Research Funds for the Central Universities (YS1407), the open project of State Key Laboratory of Molecular Oncology (SKL-KF-2013-03, and the Program for Changjiang Scholars and Innovative Research Team in University (IRT13045).	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; GAO YT, 1994, INT J CANCER, V58, P192, DOI 10.1002/ijc.2910580208; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Han YH, 2013, FEBS LETT, V587, P3875, DOI 10.1016/j.febslet.2013.10.023; HU JF, 1994, INT J CANCER, V57, P38, DOI 10.1002/ijc.2910570108; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jalali S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053823; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Lai MC, 2012, MED ONCOL, V29, P1810, DOI 10.1007/s12032-011-0004-z; Leucci E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02535; Li H, 2013, NEOPLASMA, V60, P511, DOI 10.4149/neo_2013_066; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Liu L, 2012, CARCINOGENESIS, V33, P119, DOI 10.1093/carcin/bgr250; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ren SC, 2013, J UROLOGY, V190, P2278, DOI 10.1016/j.juro.2013.07.001; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang HJ, 2010, EUR J CANCER, V46, P2295, DOI 10.1016/j.ejca.2010.05.012; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Xu CA, 2011, INT J ONCOL, V39, P169, DOI 10.3892/ijo.2011.1007; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Zhang XJ, 2013, CARCINOGENESIS, V34, P2309, DOI 10.1093/carcin/bgt213; Zhang Z, 2013, CELL DEATH DIFFER, V20, P1558, DOI 10.1038/cdd.2013.110; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160; Zhou CC, 2011, FEBS LETT, V585, P1828, DOI 10.1016/j.febslet.2011.04.040; Zhou LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064331	42	253	269	0	77	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3925	3935		10.1074/jbc.M114.596866	http://dx.doi.org/10.1074/jbc.M114.596866			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25538231	Green Published, hybrid			2022-12-26	WOS:000349458400004
J	Ednie, AR; Bennett, ES				Ednie, Andrew R.; Bennett, Eric S.			Reduced Sialylation Impacts Ventricular Repolarization by Modulating Specific K+ Channel Isoforms Distinctly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiomyocyte; Glycosylation; Patch Clamp; Potassium Channel; Sialic Acid; Sialyltransferase; Action Potential; Arrhythmia; Ion Channel Gating	POLYUNSATURATED FATTY-ACIDS; ADULT-MOUSE VENTRICLES; CARDIAC ION CHANNELS; SIALIC-ACID; LINKED GLYCOSYLATION; MOLECULAR PHYSIOLOGY; CONGENITAL DISORDERS; SURFACE EXPRESSION; TARGETED DELETION; MAMMALIAN BRAIN	Background: Glycosylation results from the coordinated activities of glycogene products that can modulate ion channel function. Results: Gene ablation of the sialyltransferase ST3Gal4 impacts sialylation and gating of specific cardiac voltage-gated K+ channel isoforms and thereby ventricular repolarization. Conclusion: Individual glycogene products serve unique roles in affecting cardiac voltage-gated K+ channel activity. Significance: Protein glycosylation significantly contributes to ventricular electrical signaling. Voltage-gated K+ channels (K-v) are responsible for repolarizing excitable cells and can be heavily glycosylated. Cardiac K-v activity is indispensable where even minimal reductions in function can extend action potential duration, prolong QT intervals, and ultimately contribute to life-threatening arrhythmias. Diseases such as congenital disorders of glycosylation often cause significant cardiac phenotypes that can include arrhythmias. Here we investigated the impact of reduced sialylation on ventricular repolarization through gene deletion of the sialyltransferase ST3Gal4. ST3Gal4-deficient mice (ST3Gal4(-/-)) had prolonged QT intervals with a concomitant increase in ventricular action potential duration. Ventricular apex myocytes isolated from ST3Gal4(-/-) mice demonstrated depolarizing shifts in activation gating of the transient outward (I-to) and delayed rectifier (I-Kslow) components of K+ current with no change in maximum current densities. Consistently, similar protein expression levels of the three K-v isoforms responsible for I-to and I-Kslow were measured for ST3Gal4(-/-)versus controls. However, novel non-enzymatic sialic acid labeling indicated a reduction in sialylation of ST3Gal4(-/-) ventricular K(v)4.2 and K(v)1.5, which contribute to I-to and I-Kslow, respectively. Thus, we describe here a novel form of regulating cardiac function through the activities of a specific glycogene product. Namely, reduced ST3Gal4 activity leads to a loss of isoform-specific K-v sialylation and function, thereby limiting K-v activity during the action potential and decreasing repolarization rate, which likely contributes to prolonged ventricular repolarization. These studies elucidate a novel role for individual glycogene products in contributing to a complex network of cardiac regulation under normal and pathologic conditions.	[Ednie, Andrew R.; Bennett, Eric S.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA	State University System of Florida; University of South Florida	Bennett, ES (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, MDC 8,12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	esbennet@health.usf.edu			National Institutes of Health from NHLBI [1R01HL102171]; National Science Foundation [IOS-1146882, CMMI-1266331]; James and Esther King Florida Biomedical Research Program [09KW-04]; American Heart Association, Greater Southeast Affiliate [14GRNT20450148]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102171] Funding Source: NIH RePORTER; Directorate For Engineering [1266331] Funding Source: National Science Foundation	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); James and Esther King Florida Biomedical Research Program; American Heart Association, Greater Southeast Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported in part by National Institutes of Health Grant 1R01HL102171 from NHLBI. This work was also supported in part by Research Grants IOS-1146882 and CMMI-1266331 from the National Science Foundation; Challenge Grant 09KW-04 from the James and Esther King Florida Biomedical Research Program; and Grant 14GRNT20450148 from the American Heart Association, Greater Southeast Affiliate.	Abbott GW, 2006, CURR PHARM DESIGN, V12, P3631, DOI 10.2174/138161206778522065; Aimond F, 2005, CIRC RES, V96, P451, DOI 10.1161/01.RES.0000156890.25876.63; Antzelevitch C, 2003, J CARDIOVASC ELECTR, V14, P1259, DOI 10.1046/j.1540-8167.2003.03316.x; Belanger MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024874; Bennett E, 1997, J GEN PHYSIOL, V109, P327, DOI 10.1085/jgp.109.3.327; Borjesson SI, 2008, BIOPHYS J, V95, P2242, DOI 10.1529/biophysj.108.130757; Borjesson SI, 2011, J GEN PHYSIOL, V137, P563, DOI 10.1085/jgp.201110599; Borjesson SI, 2010, BIOPHYS J, V98, P396, DOI 10.1016/j.bpj.2009.10.026; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Bustamante JM, 2005, INT J CARDIOL, V102, P211, DOI 10.1016/j.ijcard.2004.05.014; Calloe K, 2009, CARDIOVASC RES, V81, P686, DOI 10.1093/cvr/cvn339; Carchon HA, 2004, CLIN CHEM, V50, P101, DOI 10.1373/clinchem.2003.021568; Chandrasekhar KD, 2011, J PHYSIOL-LONDON, V589, P3721, DOI 10.1113/jphysiol.2011.211284; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; Cheng L, 2011, J BIOL CHEM, V286, P20478, DOI 10.1074/jbc.M111.218560; Clancy CE, 2002, J CLIN INVEST, V110, P1075, DOI 10.1172/JCI200216945; Ednie AR, 2013, J MOL CELL CARDIOL, V59, P117, DOI 10.1016/j.yjmcc.2013.02.013; Ednie AR, 2012, COMPR PHYSIOL, V2, P1269, DOI 10.1002/cphy.c110044; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; FERMINI B, 1991, AM J PHYSIOL, V260, pH735, DOI 10.1152/ajpheart.1991.260.3.H735; Freeman LC, 2000, J MEMBRANE BIOL, V177, P65, DOI 10.1007/s002320001100; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Gurney A, 2009, EUR BIOPHYS J BIOPHY, V38, P305, DOI 10.1007/s00249-008-0326-8; Hall MK, 2011, FEBS LETT, V585, P3322, DOI 10.1016/j.febslet.2011.09.021; HRYSHKO LV, 1993, BIOCHIM BIOPHYS ACTA, V1151, P35, DOI 10.1016/0005-2736(93)90068-B; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Johnson D, 2004, J BIOL CHEM, V279, P44303, DOI 10.1074/jbc.M408900200; Johnson D, 2006, J BIOL CHEM, V281, P25875, DOI 10.1074/jbc.M605060200; Jones DK, 2008, CHANNELS, V2, P70, DOI 10.4161/chan.2.2.6000; JOZIASSE DH, 1985, J BIOL CHEM, V260, P4941; Key JA, 2012, BIOCONJUGATE CHEM, V23, P363, DOI 10.1021/bc200276k; Kiarash A, 2004, CARDIOVASC RES, V63, P264, DOI 10.1016/j.cardiores.2004.04.001; Kodirov SA, 2004, AM J PHYSIOL-HEART C, V286, pH368, DOI 10.1152/ajpheart.00303.2003; Kohler JJ, 2009, CHEMBIOCHEM, V10, P2147, DOI 10.1002/cbic.200900401; Kranz C, 2007, AM J MED GENET A, V143A, P1371, DOI 10.1002/ajmg.a.31791; Kratz EM, 2014, ALCOHOL ALCOHOLISM, V49, P23, DOI 10.1093/alcalc/agt152; Laedermann CJ, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00137; LANGER GA, 1976, SCIENCE, V193, P1013, DOI 10.1126/science.948758; Li HL, 2004, AM J PHYSIOL-HEART C, V286, pH319, DOI 10.1152/ajpheart.00665.2003; Marengo FD, 1998, J MOL CELL CARDIOL, V30, P127, DOI 10.1006/jmcc.1997.0579; Martin PT, 2003, GLYCOBIOLOGY, V13, p67R, DOI 10.1093/glycob/cwg077; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Montpetit ML, 2009, P NATL ACAD SCI USA, V106, P16517, DOI 10.1073/pnas.0905414106; Nacher J, 2010, NEUROSCIENCE, V167, P825, DOI 10.1016/j.neuroscience.2010.02.067; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Niwa N, 2008, J MOL CELL CARDIOL, V44, P95, DOI 10.1016/j.yjmcc.2007.10.007; Norring SA, 2013, FASEB J, V27, P622, DOI 10.1096/fj.12-214387; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Oudit GY, 2001, J MOL CELL CARDIOL, V33, P851, DOI 10.1006/jmcc.2001.1376; Pearl PL, 2001, J CHILD NEUROL, V16, P409, DOI 10.1177/088307380101600604; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; Ravens U, 2008, EUROPACE, V10, P1133, DOI 10.1093/europace/eun193; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Schwalbe RA, 2008, BIOCHEM CELL BIOL, V86, P21, DOI 10.1139/o07-152; Schwetz TA, 2011, J BIOL CHEM, V286, P4123, DOI 10.1074/jbc.M110.171322; Schwetz TA, 2010, BBA-BIOMEMBRANES, V1798, P367, DOI 10.1016/j.bbamem.2009.11.018; Sheridan C, 2011, NAT BIOTECHNOL, V29, P121, DOI 10.1038/nbt.1769; Shi G, 1999, J MEMBRANE BIOL, V168, P265, DOI 10.1007/s002329900515; Stocker PJ, 2006, J GEN PHYSIOL, V127, P253, DOI 10.1085/jgp.200509423; Taha AY, 2010, EPILEPSIA, V51, P1348, DOI 10.1111/j.1528-1167.2010.02654.x; Takashima S, 2008, BIOSCI BIOTECH BIOCH, V72, P1155, DOI 10.1271/bbb.80025; Todorovic SM, 2014, PFLUG ARCH EUR J PHY, V466, P701, DOI 10.1007/s00424-014-1452-z; Tristani-Firouzi M, 2001, AM J MED, V110, P50, DOI 10.1016/S0002-9343(00)00623-9; Tyrrell L, 2001, J NEUROSCI, V21, P9629, DOI 10.1523/JNEUROSCI.21-24-09629.2001; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; Ufret-Vincenty CA, 2001, AM J PHYSIOL-CELL PH, V281, pC464, DOI 10.1152/ajpcell.2001.281.2.C464; VanWagoner DR, 1997, CIRC RES, V80, P772; Vijay IK, 1998, J MAMMARY GLAND BIOL, V3, P325, DOI 10.1023/A:1018771628925; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Watanabe I, 2007, BRAIN RES, V1144, P1, DOI 10.1016/j.brainres.2007.01.092; Xiao YF, 2005, J MEMBRANE BIOL, V206, P141, DOI 10.1007/S00232-005-0786-Z; Xu HD, 1996, J GEN PHYSIOL, V108, P405, DOI 10.1085/jgp.108.5.405; Yacoub S, 2008, HEART, V94, P244, DOI 10.1136/hrt.2007.132316; Yang KC, 2010, J PHYSIOL-LONDON, V588, P5015, DOI 10.1113/jphysiol.2010.197418; Zeng Y, 2009, NAT METHODS, V6, P207, DOI [10.1038/NMETH.1305, 10.1038/nmeth.1305]; Zhang L, 2007, AM J PHYSIOL-CELL PH, V293, pC152, DOI 10.1152/ajpcell.00480.2006	76	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2769	2783		10.1074/jbc.M114.605139	http://dx.doi.org/10.1074/jbc.M114.605139			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25525262	hybrid, Green Published			2022-12-26	WOS:000349310700019
J	Rybalka, E; Timpani, CA; Cooke, MB; Williams, AD; Hayes, A				Rybalka, Emma; Timpani, Cara A.; Cooke, Matthew B.; Williams, Andrew D.; Hayes, Alan			Defects in Mitochondrial ATP Synthesis in Dystrophin-Deficient Mdx Skeletal Muscles May Be Caused by Complex I Insufficiency	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; DMD BMD CARRIERS; ENERGY-METABOLISM; OXIDATIVE-PHOSPHORYLATION; INTRAMITOCHONDRIAL CA2+; MOUSE; CALCIUM; BIOENERGETICS; CALMITINE; CHANNELS	Duchenne Muscular Dystrophy is a chronic, progressive and ultimately fatal skeletal muscle wasting disease characterised by sarcolemmal fragility and intracellular Ca2+ dysregulation secondary to the absence of dystrophin. Mounting literature also suggests that the dysfunction of key energy systems within the muscle may contribute to pathological muscle wasting by reducing ATP availability to Ca2+ regulation and fibre regeneration. No study to date has biochemically quantified and contrasted mitochondrial ATP production capacity by dystrophic mitochondria isolated from their pathophysiological environment such to determine whether mitochondria are indeed capable of meeting this heightened cellular ATP demand, or examined the effects of an increasing extramitochondrial Ca2+ environment. Using isolated mitochondria from the diaphragm and tibialis anterior of 12 week-old dystrophin-deficient mdx and healthy control mice (C57BL10/ScSn) we have demonstrated severely depressed Complex I-mediated mitochondrial ATP production rate in mdx mitochondria that occurs irrespective of the macronutrient-derivative substrate combination fed into the Kreb's cycle, and, which is partially, but significantly, ameliorated by inhibition of Complex I with rotenone and stimulation of Complex II-mediated ATP-production with succinate. There was no difference in the MAPR response of mdx mitochondria to increasing extramitochondrial Ca2+ load in comparison to controls, and 400 nM extramitochondrial Ca2+ was generally shown to be inhibitory to MAPR in both groups. Our data suggests that DMD pathology is exacerbated by a Complex I deficiency, which may contribute in part to the severe reductions in ATP production previously observed in dystrophic skeletal muscle.	[Rybalka, Emma; Timpani, Cara A.; Cooke, Matthew B.; Hayes, Alan] Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis Prevent & Management, Melbourne, Vic 8001, Australia; [Rybalka, Emma; Cooke, Matthew B.; Hayes, Alan] Victoria Univ, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia; [Rybalka, Emma; Cooke, Matthew B.; Hayes, Alan] Western Hlth, Australian Inst Musculoskeletal Sci, Melbourne, Vic, Australia; [Williams, Andrew D.] Univ Tasmania, Sch Human Life Sci, Launceston, Tas 7250, Australia	Victoria University; Victoria University; University of Tasmania	Rybalka, E (corresponding author), Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis Prevent & Management, Melbourne, Vic 8001, Australia.	emma.rybalka@vu.edu.au	Hayes, Alan/M-4231-2014; Williams, Andrew D/J-4269-2013	Hayes, Alan/0000-0003-1398-3694; Williams, Andrew D/0000-0001-8863-3491; Timpani, Cara/0000-0003-4567-4319; Cooke, Matthew B/0000-0002-4978-4294; Rybalka, Emma/0000-0002-4854-0036				Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; AUSTIN L, 1992, NEUROMUSCULAR DISORD, V2, P27, DOI 10.1016/0960-8966(92)90023-Y; BARBIROLI B, 1992, J NEUROL SCI, V109, P188, DOI 10.1016/0022-510X(92)90167-J; BARBIROLI B, 1992, MUSCLE NERVE, V15, P344, DOI 10.1002/mus.880150313; BHATTACHARYA SK, 1993, J NEUROL SCI, V120, P180, DOI 10.1016/0022-510X(93)90271-Y; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; CHI MMY, 1987, METABOLISM, V36, P761, DOI 10.1016/0026-0495(87)90113-2; Cole MA, 2002, NEUROMUSCULAR DISORD, V12, P247, DOI 10.1016/S0960-8966(01)00278-4; DAS AM, 1990, BIOCHEM SOC T, V18, P554, DOI 10.1042/bst0180554; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P2098, DOI 10.1016/j.biocel.2008.02.007; DUNN JF, 1991, J NEUROL SCI, V103, P226, DOI 10.1016/0022-510X(91)90168-7; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; EVEN PC, 1994, BIOCHEM J, V304, P649, DOI 10.1042/bj3040649; FONG P, 1990, SCIENCE, V250, P673, DOI 10.1126/science.2173137; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; Gellerich FN, 2010, BBA-BIOENERGETICS, V1797, P1018, DOI 10.1016/j.bbabio.2010.02.005; Godin R, 2012, J PHYSL; Godin Richard, 2012, J Physiol, V590, P5487, DOI 10.1113/jphysiol.2012.240390; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; LUCASHERON B, 1990, NEUROSCI LETT, V115, P103, DOI 10.1016/0304-3940(90)90525-E; LUCASHERON B, 1990, J NEUROL SCI, V99, P349, DOI 10.1016/0022-510X(90)90169-N; MCCORMACK JG, 1993, DEV NEUROSCI-BASEL, V15, P165, DOI 10.1159/000111332; MCCORMACK JG, 1993, BIOCHEM SOC T, V21, P793, DOI 10.1042/bst0210793; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; MONGINI T, 1988, NEUROLOGY, V38, P476, DOI 10.1212/WNL.38.3.476; Onopiuk M, 2009, BIOCHEM BIOPH RES CO, V386, P463, DOI 10.1016/j.bbrc.2009.06.053; Passaquin AC, 2002, NEUROMUSCULAR DISORD, V12, P174, DOI 10.1016/S0960-8966(01)00273-5; Percival JM, 2013, HUM MOL GENET, V22, P153, DOI 10.1093/hmg/dds415; Reutenauer J, 2008, BRIT J PHARMACOL, V155, P574, DOI 10.1038/bjp.2008.285; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; SCHOLTE HR, 1980, J NEUROL SCI, V45, P217, DOI 10.1016/0022-510X(80)90167-7; Schuh RA, 2012, AM J PHYSIOL-REG I, V302, pR712, DOI 10.1152/ajpregu.00229.2011; Sperl W, 1997, MOL CELL BIOCHEM, V174, P71, DOI 10.1023/A:1006880529195; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Tseng BS, 2002, J APPL PHYSIOL, V93, P537, DOI 10.1152/japplphysiol.00202.2002; Tuon L, 2010, MUSCLE NERVE, V41, P257, DOI 10.1002/mus.21559; WERNETTE ME, 1981, J BIOL CHEM, V256, P2767; WIBOM R, 1990, SCAND J CLIN LAB INV, V50, P143, DOI 10.3109/00365519009089146; Wibom R, 2005, J BIOLUMINESCENCE CH, V6, P123; Williams AD, 2004, J CARD FAIL, V10, P141, DOI 10.1016/j.cardfail.2003.09.004; Williams AD, 2007, J CARD FAIL, V13, P79, DOI 10.1016/j.cardfail.2006.10.017	44	87	88	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115763	10.1371/journal.pone.0115763	http://dx.doi.org/10.1371/journal.pone.0115763			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541951	Green Accepted, Green Published, gold			2022-12-26	WOS:000347239900080
J	Djordjevic, MA; Bezos, A; Susanti; Marmuse, L; Driguez, H; Samain, E; Vauzeilles, B; Beau, JM; Kordbacheh, F; Rolfe, BG; Schworer, R; Daines, AM; Gresshoff, PM; Parish, CR				Djordjevic, Michael A.; Bezos, Anna; Susanti; Marmuse, Laurence; Driguez, Hugues; Samain, Eric; Vauzeilles, Boris; Beau, Jean-Marie; Kordbacheh, Farzaneh; Rolfe, Barry G.; Schworer, Ralf; Daines, Alison M.; Gresshoff, Peter M.; Parish, Christopher R.			Lipo-Chitin Oligosaccharides, Plant Symbiosis Signalling Molecules That Modulate Mammalian Angiogenesis In Vitro	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RECEPTOR-LIKE KINASE; ESCHERICHIA-COLI; NODULATION FACTORS; INNATE IMMUNITY; RHIZOBIUM-LEGUMINOSARUM; ARBUSCULAR MYCORRHIZA; HIGH-AFFINITY; BINDING; CHITOOLIGOSACCHARIDES	Lipochitin oligosaccharides (LCOs) are signaling molecules required by ecologically and agronomically important bacteria and fungi to establish symbioses with diverse land plants. In plants, oligo-chitins and LCOs can differentially interact with different lysin motif (LysM) receptors and affect innate immunity responses or symbiosis-related pathways. In animals, oligo-chitins also induce innate immunity and other physiological responses but LCO recognition has not been demonstrated. Here LCO and LCO-like compounds are shown to be biologically active in mammals in a structure dependent way through the modulation of angiogenesis, a tightly-regulated process involving the induction and growth of new blood vessels from existing vessels. The testing of 24 LCO, LCO-like or oligo-chitin compounds resulted in structure-dependent effects on angiogenesis in vitro leading to promotion, or inhibition or nil effects. Like plants, the mammalian LCO biological activity depended upon the presence and type of terminal substitutions. Un-substituted oligo-chitins of similar chain lengths were unable to modulate angiogenesis indicating that mammalian cells, like plant cells, can distinguish between LCOs and un-substituted oligo-chitins. The cellular mode-of-action of the biologically active LCOs in mammals was determined. The stimulation or inhibition of endothelial cell adhesion to vitronectin or fibronectin correlated with their pro- or anti-angiogenic activity. Importantly, novel and more easily synthesised LCO-like disaccharide molecules were also biologically active and de-acetylated chitobiose was shown to be the primary structural basis of recognition. Given this, simpler chitin disaccharides derivatives based on the structure of biologically active LCOs were synthesised and purified and these showed biological activity in mammalian cells. Since important chronic disease states are linked to either insufficient or excessive angiogenesis, LCO and LCO-like molecules may have the potential to be a new, carbohydrate-based class of therapeutics for modulating angiogenesis.	[Djordjevic, Michael A.; Kordbacheh, Farzaneh; Rolfe, Barry G.] Australian Natl Univ, Coll Med Biol & Environm, Res Sch Biol, Plant Sci Div, Canberra, ACT, Australia; [Bezos, Anna; Susanti; Parish, Christopher R.] Australian Natl Univ, John Curtin Sch Med Res, Coll Med Biol & Environm, Canberra, ACT 2601, Australia; [Marmuse, Laurence; Driguez, Hugues; Samain, Eric] Univ Grenoble Alpes, CERMAV, France CNRS, Grenoble, France; [Vauzeilles, Boris; Beau, Jean-Marie] Univ Paris 11, Inst Chim Mol & Mat Orsay, Orsay, France; [Vauzeilles, Boris; Beau, Jean-Marie] CNRS, Inst Chim Subst Nat, Ctr Rech Gif, Gif Sur Yvette, France; [Schworer, Ralf; Daines, Alison M.] Victoria Univ Wellington, Ferrier Res Inst, Lower Hutt Wellington, New Zealand; [Gresshoff, Peter M.] Univ Queensland, Ctr Integrat Legume Res, Brisbane, Qld, Australia	Australian National University; Australian National University; John Curtin School of Medical Research; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Queensland	Djordjevic, MA (corresponding author), Australian Natl Univ, Coll Med Biol & Environm, Res Sch Biol, Plant Sci Div, GPO Box 4, Canberra, ACT, Australia.	Michael.Djordjevic@anu.edu.au	Djordjevic, Michael/C-9945-2009; Schwörer, Ralf/F-7598-2014; Vauzeilles, Boris/G-2225-2017	Schwörer, Ralf/0000-0002-9352-6559; Djordjevic, Michael/0000-0002-9819-1372; Parish, Christopher/0000-0001-7740-0430	Australian Research Council [DP1096299]; ICMG FR [2607]; PolyNat Carnot Institute; LabEx ARCANE [ANR-11-LABX-0003-01]	Australian Research Council(Australian Research Council); ICMG FR; PolyNat Carnot Institute; LabEx ARCANE	Funding support from the Australian Research Council is acknowledged (DP1096299) to MAD and CRP. The authors acknowledge support from ICMG FR 2607, PolyNat Carnot Institute, and LabEx ARCANE (ANR-11-LABX-0003-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; ARDOUREL M, 1994, PLANT CELL, V6, P1357, DOI 10.1105/tpc.6.10.1357; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Bakkers J, 1997, P NATL ACAD SCI USA, V94, P7982, DOI 10.1073/pnas.94.15.7982; Brinchmann BC, 2011, ANN AGR ENV MED, V18, P7; Broghammer A, 2012, P NATL ACAD SCI USA, V109, P13859, DOI 10.1073/pnas.1205171109; BROWN KJ, 1995, EXP CELL RES, V217, P132, DOI 10.1006/excr.1995.1072; Brown KJ, 1996, LAB INVEST, V75, P539; Cottaz S, 2005, METAB ENG, V7, P311, DOI 10.1016/j.ymben.2005.05.004; Czaja LF, 2012, PLANT PHYSIOL, V159, P1671, DOI 10.1104/pp.112.195990; D'Haeze W, 2002, GLYCOBIOLOGY, V12, p79R, DOI 10.1093/glycob/12.6.79R; Demont-Caulet N, 1999, PLANT PHYSIOL, V120, P83, DOI 10.1104/pp.120.1.83; DJORDJEVIC MA, 1985, PLANT MOL BIOL, V4, P147, DOI 10.1007/BF02418762; Einarsson JM, 2013, BIOCHEM BIOPH RES CO, V434, P298, DOI 10.1016/j.bbrc.2013.02.122; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Funkhouser JD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-96; Grenouillat N, 2004, ANGEW CHEM INT EDIT, V43, P4644, DOI 10.1002/anie.200460275; Gressent F, 1999, P NATL ACAD SCI USA, V96, P4704, DOI 10.1073/pnas.96.8.4704; Gupta R, 2009, CIRC RES, V105, P724, DOI 10.1161/CIRCRESAHA.109.200386; Kaga S, 2005, J MOL CELL CARDIOL, V39, P813, DOI 10.1016/j.yjmcc.2005.08.003; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Kartha KPR, 1998, J CARBOHYD CHEM, V17, P693, DOI 10.1080/07328309808002346; Kawada M, 2012, ONCOGENE, V31, P3111, DOI 10.1038/onc.2011.498; Laroche RJF, 2013, GENE EXPR PATTERNS, V13, P212, DOI 10.1016/j.gep.2013.02.007; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lefebvre B, 2012, J BIOL CHEM, V287, P10812, DOI 10.1074/jbc.M111.281634; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Liang Y, 2013, SCIENCE, V10, P1126; Mac Gabhann F, 2010, WIRES SYST BIOL MED, V2, P694, DOI 10.1002/wsbm.92; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; MCKAY IA, 1993, APPL ENVIRON MICROB, V59, P3385, DOI 10.1128/AEM.59.10.3385-3392.1993; ONEILL HC, 1983, J IMMUNOL METHODS, V64, P257, DOI 10.1016/0022-1759(83)90433-7; Osborn HMI, 2004, J PHARM PHARMACOL, V56, P691, DOI 10.1211/0022357023619; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; Parish CR, 1999, CANCER RES, V59, P3433; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Pupo E, 2013, FEBS J, V280, P1095, DOI 10.1111/febs.12104; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Rasmussen MO, 2004, ORG BIOMOL CHEM, V2, P1908, DOI 10.1039/b403575e; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Samain E, 1999, J BIOTECHNOL, V72, P33, DOI 10.1016/S0168-1656(99)00048-6; Samain E, 1997, CARBOHYD RES, V302, P35, DOI 10.1016/S0008-6215(97)00107-9; Sane David C., 2004, Angiogenesis, V7, P193, DOI 10.1007/s10456-004-2699-3; Schimpl M, 2012, BIOCHEM J, V446, P149, DOI 10.1042/BJ20120377; Schworer R, 2013, CHEM-EUR J, V19, P6817, DOI 10.1002/chem.201204519; Semino CE, 2000, INT J DEV BIOL, V44, P183; SPAINK HP, 1994, MOL MICROBIOL, V13, P821, DOI 10.1111/j.1365-2958.1994.tb00474.x; STACEY G, 1994, J BACTERIOL, V176, P620, DOI 10.1128/jb.176.3.620-633.1994; Tang H, 2013, J IMMUNOL, V190, P438, DOI 10.4049/jimmunol.1201827; van Eijk M, 2005, INT IMMUNOL, V17, P1505, DOI 10.1093/intimm/dxh328; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wan JR, 2012, PLANT PHYSIOL, V160, P396, DOI 10.1104/pp.112.201699; Wang JN, 2011, ARTERIOSCL THROM VAS, V31, pE19, DOI 10.1161/ATVBAHA.111.230706; Xia GQ, 2001, EUR J BIOCHEM, V268, P4079, DOI 10.1046/j.1432-1327.2001.02323.x; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003	57	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e112635	10.1371/journal.pone.0112635	http://dx.doi.org/10.1371/journal.pone.0112635			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536397	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300004
J	Chen, X; Gu, Y; Singh, K; Shang, CW; Barzegar, M; Jiang, SX; Huang, SL				Chen, Xin; Gu, Ying; Singh, Karnika; Shang, Chaowei; Barzegar, Mansoureh; Jiang, Shanxiang; Huang, Shile			Maduramicin Inhibits Proliferation and Induces Apoptosis in Myoblast Cells	PLOS ONE			English	Article							MEDIATED GROWTH-INHIBITION; CYCLE ARREST; CANCER-CELLS; TOXICITY; SALINOMYCIN; DEATH; CARDIOMYOPATHY; LITTER; ANTIBIOTICS; PATHWAYS	Maduramicin, a polyether ionophore antibiotic derived from the bacterium Actinomadura yumaensis, is currently used as a feed additive against coccidiosis in poultry worldwide. It has been clinically observed that maduramicin can cause skeletal muscle and heart cell damage, resulting in skeletal muscle degeneration, heart failure, and even death in animals and humans, if improperly used. However, the mechanism of its toxic action in myoblasts is not well understood. Using mouse myoblasts (C2C12) and human rhabdomyosarcoma (RD and Rh30) cells as an experimental model for myoblasts, here we found that maduramicin inhibited cell proliferation and induced cell death in a concentration-dependent manner. Further studies revealed that maduramicin induced accumulation of the cells at G(0)/G(1) phase of the cell cycle, and induced apoptosis in the cells. Concurrently, maduramicin downregulated protein expression of cyclin D1, cyclin-dependent kinases (CDK4 and CDK6), and CDC25A, and upregulated expression of the CDK inhibitors (p21(Cip1) and p27(Kip1)), resulting in decreased phosphorylation of Rb. Maduramicin also induced expression of BAK, BAD, DR4, TRADD and TRAIL, leading to activation of caspases 8, 9 and 3 as well as cleavage of poly ADP ribose polymerase (PARP). Taken together, our results suggest that maduramicin executes its toxicity in myoblasts at least by inhibiting cell proliferation and inducing apoptotic cell death.	[Chen, Xin; Gu, Ying; Jiang, Shanxiang] Nanjing Agr Univ, Coll Vet Med, Lab Vet Pharmacol & Toxicol, Nanjing, Jiangsu, Peoples R China; [Chen, Xin; Gu, Ying; Singh, Karnika; Shang, Chaowei; Barzegar, Mansoureh; Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA; [Shang, Chaowei; Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA	Nanjing Agricultural University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Jiang, SX (corresponding author), Nanjing Agr Univ, Coll Vet Med, Lab Vet Pharmacol & Toxicol, Nanjing, Jiangsu, Peoples R China.	nauvy@sina.com; shuan1@lsuhsc.edu	Barzegar, Mansoureh/ABB-7572-2021; Huang, Shile/I-1632-2019	Huang, Shile/0000-0002-3239-1072	National Natural Science Foundation of China [090600253]; NIH [NCI CA115414]; American Cancer Society [RSG-08-135-01-CNE]; Nanjing Agricultural University; Feist-Weiller Cancer Center; Louisiana State University Health Sciences Center; NATIONAL CANCER INSTITUTE [R01CA115414] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Nanjing Agricultural University; Feist-Weiller Cancer Center; Louisiana State University Health Sciences Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the grants from National Natural Science Foundation of China (No. 090600253, S.J.), NIH (NCI CA115414; S.H.), American Cancer Society (RSG-08-135-01-CNE; S.H.), Nanjing Agricultural University, and the Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Additives E. P. o, 2011, EFSA J, V9, P1952; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; BASTIANELLO SS, 1995, ONDERSTEPOORT J VET, V62, P5; Boehmerle W, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.46; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Dorne JLCM, 2013, TOXICOL APPL PHARM, V270, P196, DOI 10.1016/j.taap.2010.12.014; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; FOURIE N, 1991, ONDERSTEPOORT J VET, V58, P291; Fuchs D, 2009, BIOCHEM BIOPH RES CO, V390, P743, DOI 10.1016/j.bbrc.2009.10.042; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Jayashree M, 2011, J TROP PEDIATRICS, V57, P340, DOI 10.1093/tropej/fmq099; Kant V, 2013, SCI INT, V1, P261, DOI DOI 10.17311/SCIINTL.2013.261.265; Kim JH, 2012, BIOCHEM BIOPH RES CO, V418, P98, DOI 10.1016/j.bbrc.2011.12.141; Kim WK, 2012, INVEST NEW DRUG, V30, P1311, DOI 10.1007/s10637-011-9685-6; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; LABEDA DP, 1985, INT J SYST BACTERIOL, V35, P333, DOI 10.1099/00207713-35-3-333; Lavine MD, 2011, ANTIMICROB AGENTS CH, V55, P745, DOI 10.1128/AAC.01092-10; Lieke T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-466; LIU CM, 1983, J ANTIBIOT, V36, P343, DOI 10.7164/antibiotics.36.343; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Odaka Y, 2014, CARCINOGENESIS, V35, P192, DOI 10.1093/carcin/bgt277; Oehme FW, 1999, VET HUM TOXICOL, V41, P251; Park WH, 2003, INT J ONCOL, V22, P855; Park WH, 2003, INT J ONCOL, V22, P377; Park WH, 2003, INT J ONCOL, V23, P197; Park WH, 2002, BRIT J HAEMATOL, V119, P400, DOI 10.1046/j.1365-2141.2002.03834.x; Pisani DF, 2004, CELL DEATH DIFFER, V11, P1157, DOI 10.1038/sj.cdd.4401479; Rosenwald IB, 2004, ONCOGENE, V23, P3230, DOI 10.1038/sj.onc.1207552; SANFORD SE, 1991, CAN VET J, V32, P567; Sharma N, 2005, EMERG MED J, V22, P880, DOI 10.1136/emj.2004.020883; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shimshoni JA, 2014, FOOD CHEM TOXICOL, V68, P283, DOI 10.1016/j.fct.2014.03.034; SHLOSBERG A, 1992, VET RES COMMUN, V16, P45, DOI 10.1007/BF01839204; Shlosberg A, 1997, VET REC, V140, P643, DOI 10.1136/vr.140.25.643; Singh T, 2003, VET PARASITOL, V116, P345, DOI 10.1016/j.vetpar.2003.07.009; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; TSOU HR, 1984, J ANTIBIOT, V37, P1651, DOI 10.7164/antibiotics.37.1651; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050638; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhou HY, 2010, INT J CANCER, V127, P2467, DOI 10.1002/ijc.25255; Zhou J, 2013, TOXICOL LETT, V222, P139, DOI 10.1016/j.toxlet.2013.07.022	45	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115652	10.1371/journal.pone.0115652	http://dx.doi.org/10.1371/journal.pone.0115652			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531367	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845100088
J	Karn, RC; Chung, AG; Laukaitis, CM				Karn, Robert C.; Chung, Amanda G.; Laukaitis, Christina M.			Did Androgen-Binding Protein Paralogs Undergo Neo-and/or Subfunctionalization as the Abp Gene Region Expanded in the Mouse Genome?	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; MUS-MUSCULUS; SEXUAL ISOLATION; EVOLUTIONARY RELATIONSHIPS; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; ADAPTIVE EVOLUTION; STATISTICAL-MODEL; DUPLICATE GENES; LACRIMAL GLAND	The Androgen-binding protein (Abp) region of the mouse genome contains 30 Abpa genes encoding alpha subunits and 34 Abpbg genes encoding betagamma subunits, their products forming dimers composed of an alpha and a betagamma subunit. We endeavored to determine how many Abp genes are expressed as proteins in tears and saliva, and as transcripts in the exocrine glands producing them. Using standard PCR, we amplified Abp transcripts from cDNA libraries of C57BL/6 mice and found fifteen Abp gene transcripts in the lacrimal gland and five in the submandibular gland. Proteomic analyses identified proteins corresponding to eleven of the lacrimal gland transcripts, all of them different from the three salivary ABPs reported previously. Our qPCR results showed that five of the six transcripts that lacked corresponding proteins are expressed at very low levels compared to those transcripts with proteins. We found 1) no overlap in the repertoires of expressed Abp paralogs in lacrimal gland/tears and salivary glands/saliva; 2) substantial sex-limited expression of lacrimal gland/tear expressed-paralogs in males but no sex-limited expression in females; and 3) that the lacrimal gland/tear expressed-paralogs are found exclusively in ancestral clades 1, 2 and 3 of the five clades described previously while the salivary glands/saliva expressed-paralogs are found only in clade 5. The number of instances of extremely low levels of transcription without corresponding protein production in paralogs specific to tears and saliva suggested the role of subfunctionalization, a derived condition wherein genes that may have been expressed highly in both glands ancestrally were down-regulated subsequent to duplication. Thus, evidence for subfunctionalization can be seen in our data and we argue that the partitioning of paralog expression between lacrimal and salivary glands that we report here occurred as the result of adaptive evolution.	[Karn, Robert C.; Chung, Amanda G.; Laukaitis, Christina M.] Univ Arizona, Coll Med, Tucson, AZ 85724 USA	University of Arizona	Karn, RC (corresponding author), Univ Arizona, Coll Med, Tucson, AZ 85724 USA.	rkarn@butler.edu	Laukaitis, Christina/AAW-2510-2020; Laukaitis, Christina M/AAL-5865-2021; Laukaitis, Christina/ABF-1739-2021	Laukaitis, Christina M/0000-0003-1466-7941; 	partnership for Native American Cancer Prevention [U54 CA143924]; University of Arizona by the Howard Hughes Medical Institute [52006942]; Cancer Center Support Grant [P30 CA23074]; NATIONAL CANCER INSTITUTE [P30CA023074, U54CA143924] Funding Source: NIH RePORTER	partnership for Native American Cancer Prevention; University of Arizona by the Howard Hughes Medical Institute; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	C.M.L. received salary support from the partnership for Native American Cancer Prevention (U54 CA143924, health.nih.gov). A.G.C. was supported in part by a grant to the University of Arizona by the Howard Hughes Medical Institute (52006942, http://www.hhmi.org). Laboratory space and core facilities were supported by a Cancer Center Support Grant (P30 CA23074, health. nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andon NL, 2002, PROTEOMICS, V2, P1156, DOI 10.1002/1615-9861(200209)2:9<1156::AID-PROT1156>3.0.CO;2-4; Bimova B, 2005, BIOL J LINN SOC, V84, P349, DOI 10.1111/j.1095-8312.2005.00439.x; Bimova BV, 2011, MOL ECOL, V20, P2403, DOI 10.1111/j.1365-294X.2011.05106.x; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Cancela ML, 2014, ARCH BIOCH BIOPHYS; Clark NL, 2005, PLOS GENET, V1, P335, DOI 10.1371/journal.pgen.0010035; Coyne JA, 1997, GENETICS, V145, P1015; Cusack BP, 2007, TRENDS GENET, V23, P270, DOI 10.1016/j.tig.2007.03.010; DLOUHY SR, 1986, BIOCHEM GENET, V24, P743, DOI 10.1007/BF00499007; DLOUHY SR, 1987, GENETICS, V115, P535; DOMINGUEZ P, 1995, FEBS LETT, V376, P257, DOI 10.1016/0014-5793(95)01294-4; Emes RD, 2004, GENOME RES, V14, P1516, DOI 10.1101/gr.2540304; Force A, 1999, GENETICS, V151, P1531; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Janousek V, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-107; Karn R, 2013, INT J BIOCH RES, V3, P328, DOI DOI 10.9734/IJBCRR/2013/5763; Karn RC, 1999, MOL BIOL EVOL, V16, P1192, DOI 10.1093/oxfordjournals.molbev.a026209; Karn RC, 1999, BIOCHEM GENET, V37, P187, DOI 10.1023/A:1018786622052; Karn RC, 2003, BIOCHEMISTRY-US, V42, P7162, DOI 10.1021/bi027424l; KARN RC, 1981, BIOCHEM GENET, V19, P355, DOI 10.1007/BF00504280; Karn RC, 2014, BIOCH SOC T IN PRESS, V42; Karn RC, 2013, PROTEOMES, V1, DOI 10.3390/proteomes1030275; Karn RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047697; Karn RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020979; Karn RC, 2009, GENOME BIOL EVOL, V1, P494, DOI 10.1093/gbe/evp049; Katju V, 2003, GENETICS, V165, P1793; Katju Vaishali, 2013, Frontiers in Genetics, V4, P273, DOI 10.3389/fgene.2013.00273; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-606; Kondrashov FA, 2006, J THEOR BIOL, V239, P141, DOI 10.1016/j.jtbi.2005.08.033; Laukaitis C., 2012, EVOLUTION HOUSE MOUS; Laukaitis CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-46; Laukaitis CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035898; Laukaitis CM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-40; Laukaitis CM, 2005, BIOL J LINN SOC, V84, P493, DOI 10.1111/j.1095-8312.2005.00450.x; Laukaitis CM, 2003, MAMM GENOME, V14, P679, DOI 10.1007/s00335-003-2291-y; Laukaitis CM, 1997, EVOLUTION, V51, P2000, DOI [10.2307/2411020, 10.1111/j.1558-5646.1997.tb05121.x]; Li KL, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-20; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Neme R, 2014, CURR BIOL, V24, pR238, DOI 10.1016/j.cub.2014.02.016; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ohno S., 1970, EVOLUTION GENE DUPLI; Ohno S., 1967, SEX CHROMOSOMES SEX; Ozyildirim AM, 2005, INVEST OPHTH VIS SCI, V46, P1572, DOI 10.1167/iovs.04-1380; Qian WJ, 2005, MOL CELL PROTEOMICS, V4, P700, DOI 10.1074/mcp.M500045-MCP200; Remington SG, 2005, INVEST OPHTH VIS SCI, V46, P31, DOI 10.1167/iovs.04-0216; Rutter MT, 2012, TRENDS PLANT SCI, V17, P204, DOI 10.1016/j.tplants.2012.01.006; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; SPOFFORD JB, 1969, GENETICS, V62, P555; Swanson WJ, 2004, GENETICS, V168, P1457, DOI 10.1534/genetics.104.030478; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Talley HM, 2001, EVOLUTION, V55, P631, DOI 10.1554/0014-3820(2001)055[0631:FPFMSI]2.0.CO;2; Wagner A, 1998, BIOESSAYS, V20, P785, DOI 10.1002/(SICI)1521-1878(199810)20:10<785::AID-BIES2>3.3.CO;2-D; Wang YP, 2012, ANN NY ACAD SCI, V1256, P1, DOI 10.1111/j.1749-6632.2011.06384.x; Yang ZF, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-147; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhao J, 2003, EXP EYE RES, V77, P297, DOI 10.1016/S0014-4835(03)00152-0	62	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115454	10.1371/journal.pone.0115454	http://dx.doi.org/10.1371/journal.pone.0115454			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531410	Green Submitted, gold, Green Published			2022-12-26	WOS:000348845100068
J	Hou, N; Han, J; Li, J; Liu, YX; Qin, YN; Ni, L; Song, TS; Huang, C				Hou, Ni; Han, Jia; Li, Jie; Liu, Yingxun; Qin, Yannan; Ni, Lei; Song, Tusheng; Huang, Chen			MicroRNA Profiling in Human Colon Cancer Cells during 5-Fluorouracil-Induced Autophagy	PLOS ONE			English	Article							PREDICTION; MECHANISMS; PROTEINS; TARGET	Autophagy modulation is now recognized as a potential therapeutic approach for cancer (including colorectal cancer), yet the molecular mechanisms regulating autophagy in response to cellular stress are still not well understood. MicroRNAs (miRNAs) have been found to play important roles in controlling many cellular functions, including growth, metabolism and stress response. The physiological importance of the miRNA-autophagy interconnection is only beginning to be elucidated. MiRNA microarray technology facilitates analysis of global miRNA expression in certain situations. In this study, we explored the expression profile of miRNAs during the response of human colon cancer cells (HT29s) to 5-FU treatment and nutrient starvation using miRNA microarray analysis. The alteration of miRNA expression showed the same pattern under both conditions was further testified by qRT-PCR in three human colon cancer cell lines. In addition, bioinformatic prediction of target genes, pathway analysis and gene network analysis were performed to better understand the roles of these miRNAs in the regulation of autophagy. We identified and selected four downregulated miRNAs including hsa-miR-302a-3p and 27 upregulated miRNAs under these two conditions as having the potential to target genes involved in the regulation of autophagy in human colon cancer cells. They have the potential to modulate autophagy in 5-FU-based chemotherapy in colorectal cancer.	[Hou, Ni; Han, Jia; Liu, Yingxun; Qin, Yannan; Ni, Lei; Song, Tusheng; Huang, Chen] Xi An Jiao Tong Univ, Dept Genet & Mol Biol, Sch Med, Xian 710049, Peoples R China; [Li, Jie] Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Gen Surg, Xian 710049, Peoples R China; [Huang, Chen] Xi An Jiao Tong Univ, Key Lab Environm & Genes Related Dis, Sch Med, Xian 710049, Peoples R China; [Huang, Chen] Xi An Jiao Tong Univ, Cardiovasc Res Ctr, Sch Med, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Huang, C (corresponding author), Xi An Jiao Tong Univ, Dept Genet & Mol Biol, Sch Med, Xian 710049, Peoples R China.	hchen@mail.xjtu.edu.cn			National Natural Science Foundation of China [31100969, 81172358]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [2013-09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by grants from the National Natural Science Foundation of China (grant No. 31100969) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (2013-09) to Dr. Hou. It was also supported by a grant from the National Natural Science Foundation of China (grant No. 81172358) to Dr. Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babar IA, 2008, FUTURE ONCOL, V4, P289, DOI 10.2217/14796694.4.2.289; Chen KL, 2012, CANCER LETT, V317, P89, DOI 10.1016/j.canlet.2011.11.015; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Frankel LB, 2011, EMBO J, V30, P4628, DOI 10.1038/emboj.2011.331; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; HE L, 2004, NAT REV GENET, V5, P522; Jegga AG, 2011, AUTOPHAGY, V7, P477, DOI 10.4161/auto.7.5.14811; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kubota C, 2010, J BIOL CHEM, V285, P667, DOI 10.1074/jbc.M109.053058; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li J, 2010, EUR J CANCER, V46, P1900, DOI 10.1016/j.ejca.2010.02.021; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Lorin S, 2013, SEMIN CANCER BIOL, V23, P361, DOI 10.1016/j.semcancer.2013.06.007; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Meschini S, 2011, CURR CANCER DRUG TAR, V11, P357, DOI 10.2174/156800911794519707; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; O'Connell MJ, 2009, J CLIN ONCOL, V27, P3082, DOI 10.1200/JCO.2009.22.2919; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Perez-Rivas LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091884; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Yin JQ, 2008, TRENDS BIOTECHNOL, V26, P70, DOI 10.1016/j.tibtech.2007.11.007; Yu Y, 2012, LEUKEMIA, V26, P1752, DOI 10.1038/leu.2012.65; Zhai HY, 2013, CELL CYCLE, V12, P246, DOI 10.4161/cc.23273; Zou ZY, 2012, J BIOL CHEM, V287, P4148, DOI 10.1074/jbc.M111.307405	30	19	20	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114779	10.1371/journal.pone.0114779	http://dx.doi.org/10.1371/journal.pone.0114779			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526515	Green Submitted, gold, Green Published			2022-12-26	WOS:000347186200007
J	Ibrahim, NI; Khamis, MF; Yunoh, MFM; Abdullah, S; Mohamed, N; Shuid, AN				Ibrahim, Nurul 'Izzah; Khamis, Mohd Fadhli; Yunoh, Mohd Faridz Mod; Abdullah, Shahrum; Mohamed, Norazlina; Shuid, Ahmad Nazrun			Targeted Delivery of Lovastatin and Tocotrienol to Fracture Site Promotes Fracture Healing in Osteoporosis Model: Micro-Computed Tomography and Biomechanical Evaluation	PLOS ONE			English	Article							IN-VITRO; BONE; ESTROGEN; RALOXIFENE; CALCIUM; ALENDRONATE; REPAIR; MICROSTRUCTURE; MICROSPHERES; SUPPRESSION	Osteoporosis is becoming a major health problem that is associated with increased fracture risk. Previous studies have shown that osteoporosis could delay fracture healing. Although there are potential agents available to promote fracture healing of osteoporotic bone such as statins and tocotrienol, studies on direct delivery of these agents to the fracture site are limited. This study was designed to investigate the effects of two potential agents, lovastatin and tocotrienol using targeted drug delivery system on fracture healing of postmenopausal osteoporosis rats. The fracture healing was evaluated using micro CT and biomechanical parameters. Forty-eight Sprague-Dawley female rats were divided into 6 groups. The first group was sham-operated (SO), while the others were ovariectomized (OVx). After two months, the right tibiae of all rats were fractured at metaphysis region using pulsed ultrasound and were fixed with plates and screws. The SO and OVxC groups were given two single injections of lovastatin and tocotrienol carriers. The estrogen group (OVx+EST) was given daily oral gavages of Premarin (64.5 mu g/kg). The Lovastatin treatment group (OVx+Lov) was given a single injection of 750 mu g/kg lovastatin particles. The tocotrienol group (OVx+TT) was given a single injection of 60 mg/kg tocotrienol particles. The combination treatment group (OVx+Lov+TT) was given two single injections of 750 mu g/kg lovastatin particles and 60 mg/kg tocotrienol particles. After 4 weeks of treatment, the fractured tibiae were dissected out for micro-CT and biomechanical assessments. The combined treatment group (OVx+Lov+TT) showed significantly higher callus volume and callus strength than the OVxC group (p<0.05). Both the OVx+Lov and OVx+TT groups showed significantly higher callus strength than the OVxC group (p<0.05), but not for callus volume. In conclusion, combined lovastatin and tocotrienol may promote better fracture healing of osteoporotic bone.	[Ibrahim, Nurul 'Izzah; Mohamed, Norazlina; Shuid, Ahmad Nazrun] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Pharmacol, Kuala Lumpur, Malaysia; [Khamis, Mohd Fadhli] Univ Sains Malaysia, Sch Dent Sci, Kubang Kerian, Kelantan, Malaysia; [Yunoh, Mohd Faridz Mod; Abdullah, Shahrum] Univ Kebangsaan Malaysia, Fac Engn, Dept Mech & Mat Engn, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Sains Malaysia; Universiti Kebangsaan Malaysia	Shuid, AN (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Pharmacol, Jalan Yaacob Latif, Kuala Lumpur, Malaysia.	anazrun@yahoo.com	Khamis, Mohd Fadhli/E-6917-2012; Mohamed, Norazlina/M-7306-2017; ABDULLAH, SHAHRUM/AAD-7938-2019; Ibrahim, Nurul 'Izzah/X-7167-2019; SHUID, AHMAD NAZRUN/AAS-7556-2020	Khamis, Mohd Fadhli/0000-0002-2418-7995; Mohamed, Norazlina/0000-0003-2480-0224; ABDULLAH, SHAHRUM/0000-0003-0345-5628; 	Ministry of Higher Education (Malaysia) [/1/2012/SKK03/UKM/02/1]	Ministry of Higher Education (Malaysia)(Ministry of Education, Malaysia)	This work was supported by ERGS (Exploratory Research Grant Scheme),/1/2012/SKK03/UKM/02/1, Ministry of Higher Education (Malaysia), to Ahmad Nazrun Shuid. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Majeed S, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/960742; Altundag O, 2004, MED HYPOTHESES, V63, P1010, DOI 10.1016/j.mehy.2004.04.022; Cao YP, 2002, J BONE MINER RES, V17, P2237, DOI 10.1359/jbmr.2002.17.12.2237; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; Chiste RC, 2011, FOOD CHEM, V127, P419, DOI 10.1016/j.foodchem.2010.12.139; Cruess RL, 1975, TXB SMALL ANIMAL ORT, P1; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Estai MA, 2011, IRAN J MED SCI, V36, P281; EVANS G, 1994, ENDOCRINOLOGY, V134, P2283, DOI 10.1210/en.134.5.2283; Garrett IR, 2007, J ORTHOP RES, V25, P1351, DOI 10.1002/jor.20391; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gerstenfeld LC, 2009, J BONE MINER RES, V24, P196, DOI 10.1359/JBMR.081113; Giannotti S, 2013, CLIN CASES MINER BON, V10, P116, DOI 10.11138/ccmbm/2013.10.2.116; Giannotti S, 2012, CLIN CASES MINER BON, V9, P56; GRUNDNES O, 1993, ACTA ORTHOP SCAND, V64, P340, DOI 10.3109/17453679308993640; Guyton JR, 2006, AM J CARDIOL, V97, p95C, DOI 10.1016/j.amjcard.2005.12.016; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Hagihara M, 2011, J BIOL CHEM, V286, P5157, DOI 10.1074/jbc.M110.180919; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; Hao YJ, 2007, BONE, V41, P631, DOI 10.1016/j.bone.2007.06.006; Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1; Jadhav SB, 2006, J PHARM PHARMACOL, V58, P3, DOI 10.1211/jpp.58.1.0002; Kubo T, 1999, J STEROID BIOCHEM, V68, P197, DOI 10.1016/S0960-0760(99)00032-1; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liu HQ, 2008, BONE, V43, pS54, DOI 10.1016/j.bone.2008.08.048; Maniam S, 2008, BASIC CLIN PHARMACOL, V103, P55, DOI 10.1111/j.1742-7843.2008.00241.x; McAnally JA, 2007, EXP BIOL MED, V232, P523; McCann RM, 2008, J ORTHOP RES, V26, P384, DOI 10.1002/jor.20505; Mehta M, 2013, EUR CELLS MATER, V25, P366, DOI 10.22203/eCM.v025a26; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2; Nelson HD, 2002, ANN INTERN MED, V137, P529, DOI 10.7326/0003-4819-137-6-200209170-00015; Nyman JS, 2009, J BIOMECH, V42, P891, DOI 10.1016/j.jbiomech.2009.01.016; Packer L, 2001, J NUTR, V131, p369S, DOI 10.1093/jn/131.2.369S; PARKER RA, 1993, J BIOL CHEM, V268, P11230; PECK WA, 1993, AM J MED, V94, P646; Rafi Shaik M, 2012, INT J PHARM SCI, V2, P112, DOI DOI 10.1016/j.jconrel.2004.04.023; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; Roland S, 2011, J ORTHOPAED RES, V29, P1245; Russell KRM, 2005, PHYTOTHER RES, V19, P433, DOI 10.1002/ptr.1650; SATO M, 1995, J PHARMACOL EXP THER, V272, P1252; Sato M, 1996, J PHARMACOL EXP THER, V279, P298; SERBINOVA E, 1991, FREE RADICAL BIO MED, V10, P263, DOI 10.1016/0891-5849(91)90033-Y; Sharlina M, 2012, EVID-BASED COMPL ALT, V2012; Sheweita SA, 2007, CURR DRUG METAB, V8, P519; Shuid AN, 2010, J ORTHOP RES, V28, P1651, DOI 10.1002/jor.21180; Song BL, 2006, J BIOL CHEM, V281, P25054, DOI 10.1074/jbc.M605575200; Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200; Stuermer EK, 2010, LANGENBECK ARCH SURG, V395, P163, DOI 10.1007/s00423-008-0436-x; Sturmer EK, 2006, J BONE MINER RES, V21, P89, DOI 10.1359/JBMR.050913; TAN B, 2010, TOCOTRIENOLS NEW VIT; Tann B, 2008, TOCOTRIENOLS VITAMIN; Torchilin VP, 2001, J CONTROL RELEASE, V73, P137, DOI 10.1016/S0168-3659(01)00299-1; Urata T, 1999, J CONTROL RELEASE, V58, P133, DOI 10.1016/S0168-3659(98)00146-1; WAKIYAMA N, 1981, CHEM PHARM BULL, V29, P3363; Wang WX, 2010, J BONE MINER RES, V25, P1658, DOI 10.1002/jbmr.42; Weis JA, 2010, J BIOMECH, V43, P557, DOI 10.1016/j.jbiomech.2009.09.051; World Health Organization (WHO), 2003, WHO TECHN REP SER, P919	59	34	40	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115595	10.1371/journal.pone.0115595	http://dx.doi.org/10.1371/journal.pone.0115595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526611	Green Submitted, Green Published, gold			2022-12-26	WOS:000347186200039
J	Toth, K; Wasserkort, R; Sipos, F; Kalmaar, A; Wichmann, B; Leiszter, K; Valcz, G; Juhasz, M; Miheller, P; Patai, AV; Tulassay, Z; Molnar, B				Toth, Kinga; Wasserkort, Reinhold; Sipos, Ferenc; Kalmar, Alexandra; Wichmann, Barnabas; Leiszter, Katalin; Valcz, Gabor; Juhasz, Mark; Miheller, Pal; Patai, Arpad V.; Tulassay, Zsolt; Molnar, Bela			Detection of Methylated Septin 9 in Tissue and Plasma of Colorectal Patients with Neoplasia and the Relationship to the Amount of Circulating Cell-Free DNA	PLOS ONE			English	Article							AMERICAN-CANCER-SOCIETY; TASK-FORCE; BLOOD-TEST; EXPRESSION; GENE; SERUM; LEUKEMIA; QUANTIFICATION; BIOMARKERS; POLYPS	Background: Determination of methylated Septin 9 (mSEPT9) in plasma has been shown to be a sensitive and specific biomarker for colorectal cancer (CRC). However, the relationship between methylated DNA in plasma and colon tissue of the same subjects has not been reported. Methods: Plasma and matching biopsy samples were collected from 24 patients with no evidence of disease (NED), 26 patients with adenoma and 34 patients with CRC. Following bisulfite conversion of DNA a commercial RT-PCR assay was used to determine the total amount of DNA in each sample and the fraction of mSEPT9 DNA. The Septin-9 protein was assessed using immunohistochemistry. Results: The percent of methylated reference (PMR) values for SEPT9 above a PMR threshold of 1% were detected in 4.2% (1/24) of NED, 100% (26/26) of adenoma and 97.1% (33/34) of CRC tissues. PMR differences between NED vs. adenoma and NED vs. CRC comparisons were significant (p<0.001). In matching plasma samples using a PMR cut-off level of 0.01%, SEPT9 methylation was 8.3% (2/24) of NED, 30.8% (8/26) of adenoma and 88.2% (30/34) of CRC. Significant PMR differences were observed between NED vs. CRC (p<0.01) and adenoma vs. CRC (p<0.01). Significant differences (p<0.01) were found in the amount of cfDNA (circulating cell-free DNA) between NED and CRC, and a modest correlation was observed between mSEPT9 concentration and cfDNA of cancer (R2 50.48). The level of Septin-9 protein in tissues was inversely correlated to mSEPT9 levels with abundant expression in normals, and diminished expression in adenomas and tumors. Conclusions: Methylated SEPT9 was detected in all tissue samples. In plasma samples, elevated mSEPT9 values were detected in CRC, but not in adenomas. Tissue levels of mSEPT9 alone are not sufficient to predict mSEPT9 levels in plasma. Additional parameters including the amount of cfDNA in plasma appear to also play a role.	[Toth, Kinga; Sipos, Ferenc; Kalmar, Alexandra; Leiszter, Katalin; Juhasz, Mark; Miheller, Pal; Patai, Arpad V.; Tulassay, Zsolt; Molnar, Bela] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Wasserkort, Reinhold] Epigenomics AG, Berlin, Germany; [Kalmar, Alexandra; Wichmann, Barnabas; Valcz, Gabor; Tulassay, Zsolt; Molnar, Bela] Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences	Toth, K (corresponding author), Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary.	drtothkinga@yahoo.com	Sipos, Ferenc/GYV-6182-2022	Miheller, Pal/0000-0002-7396-3145				Ahlquist DA, 2012, CLIN GASTROENTEROL H, V10, P272, DOI 10.1016/j.cgh.2011.10.008; Ahlquist DA, 2012, GASTROENTEROLOGY, V142, P248, DOI 10.1053/j.gastro.2011.10.031; Amir S, 2010, MOL CANCER RES, V8, P643, DOI 10.1158/1541-7786.MCR-09-0497; Atamaniuk J, 2008, EUR J APPL PHYSIOL, V104, P711, DOI 10.1007/s00421-008-0827-2; Bischoff FZ, 2005, HUM REPROD UPDATE, V11, P59, DOI 10.1093/humupd/dmh053; Boni L, 2007, SURG ONCOL, V16, pS29, DOI 10.1016/j.suronc.2007.10.004; Breitbach S, 2012, SPORTS MED, V42, P565, DOI 10.2165/11631380-000000000-00000; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; Connolly D, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2924; Danese E, 2013, BRIT J CANCER, V109, P807, DOI 10.1038/bjc.2013.351; Danese E, 2010, CLIN CHEM LAB MED, V48, P1665, DOI 10.1515/CCLM.2010.301; Denters MJ, 2012, GASTROENTEROLOGY, V142, P497, DOI 10.1053/j.gastro.2011.11.024; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Elshimali YI, 2013, INT J MOL SCI, V14, P18925, DOI 10.3390/ijms140918925; Estey MP, 2011, CURR BIOL, V21, pR384, DOI 10.1016/j.cub.2011.03.067; Federici A, 2005, J MED SCREEN, V12, P83, DOI 10.1258/0969141053908357; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; He QO, 2010, CANCER GENET CYTOGEN, V202, P1, DOI 10.1016/j.cancergencyto.2010.05.018; Jahr S, 2001, CANCER RES, V61, P1659; Johnson DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098238; Kim DS, 2004, NEOPLASIA, V6, P168, DOI 10.1593/neo.03310; Kim HJ, 2003, GENE CHROMOSOME CANC, V38, P8, DOI 10.1002/gcc.10235; Kojima K, 2004, LEUKEMIA, V18, P998, DOI 10.1038/sj.leu.2403334; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2009, NEW ENGL J MED, V361, P1179, DOI 10.1056/NEJMcp0902176; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Manderson AP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1936; McDade SS, 2007, HUM MOL GENET, V16, P742, DOI 10.1093/hmg/ddm003; Montagna C, 2003, CANCER RES, V63, P2179; Pignone M, 2002, ANN INTERN MED, V137, P96, DOI 10.7326/0003-4819-137-2-200207160-00007; Russell SEH, 2000, CANCER RES, V60, P4729; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith RA, 2010, CA-CANCER J CLIN, V60, P99, DOI 10.3322/caac.20063; Taback B, 2004, ANN NY ACAD SCI, V1022, P17, DOI 10.1196/annals.1318.004; Tanzer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009061; Tamkovich SN, 2008, B EXP BIOL MED+, V146, P89, DOI 10.1007/s10517-008-0213-4; Tamkovich SN, 2006, ANN NY ACAD SCI, V1075, P191, DOI 10.1196/annals.1368.026; Tanaka Manami, 2003, Med Sci Monit, V9, pMT61; Tatsumi K, 2001, GENE CHROMOSOME CANC, V30, P230, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1084>3.0.CO;2-J; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046000; Toth K, 2011, PATHOL ONCOL RES, V17, P503, DOI 10.1007/s12253-010-9338-7; van der Vaart M, 2007, CLIN CHEM, V53, P2215, DOI 10.1373/clinchem.2007.092734; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang JY, 2004, WORLD J SURG, V28, P721, DOI 10.1007/s00268-004-7366-8; Warren JD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-133; Wasserkort R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-398	50	73	78	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115415	10.1371/journal.pone.0115415	http://dx.doi.org/10.1371/journal.pone.0115415			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526039	Green Published, Green Submitted, gold			2022-12-26	WOS:000347186200027
J	Kim, JY; Lim, SC; Kim, G; Yun, HJ; Ahn, SG; Choi, HS				Kim, J. Y.; Lim, S-C; Kim, G.; Yun, H. J.; Ahn, S-G; Choi, H. S.			Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity	ONCOGENE			English	Article							NF-KAPPA-B; ACTIVATED SIGNAL TRANSDUCER; RECEPTOR ACCESSORY PROTEIN; IL-1 RECEPTOR; MAST-CELLS; NUCLEAR FACTOR; AP-1 ACTIVITY; CANCER CELLS; STAT3; GROWTH	Cytokines of the interleukin-1 (IL-1) family, such as IL-1 alpha/beta and IL-18, have pleiotropic activities in innate and adaptive immune responses in host defense and diseases. Insight into their biological functions helped develop novel therapeutic approaches to treat human inflammatory diseases. IL-33 is an important member of the IL-1 family of cytokines and is a ligand of the ST2 receptor, a member of the IL-1 receptor family. However, the role of the IL-33/ST2 axis in tumor growth and metastasis of breast cancer remains unclear. Here, we demonstrate that IL-33 is a critical tumor promoter during epithelial cell proliferation and tumorigenesis in the breast. IL-33 dose-and time-dependently increased Cancer Osaka Thyroid (COT) phosphorylation via ST2-COT interaction in normal epithelial and breast cancer cells. The IL-33/ST2/COT cascade induced the activation of the MEK-ERK (MEK-extracellular signal-regulated kinase), JNK-cJun (cJun N-terminal kinase-cJun) and STAT3 (signal transducer and activator of transcription 3) signaling pathways, followed by increased AP-1 and stat3 transcriptional activity. When small interfering RNAs of ST2 and COT were introduced into cells, IL-33-induced AP-1 and stat3 activity were significantly decreased, unlike that in the control cells. The inhibition of COT activity resulted in decreased IL-33-induced epithelial cell transformation, and knockdown of IL-33, ST2 and COT in breast cancer cells attenuated tumorigenicity of breast cancer cells. Consistent with these observations, ST2 levels were positively correlated with COT expression in human breast cancer. These findings provide a novel perspective on the role of the IL-33/ST2/COT signaling pathway in supporting cancer-associated inflammation in the tumor microenvironment. Therapeutic approaches that target this pathway may, therefore, effectively inhibit carcinogenesis in the breast.	[Kim, J. Y.; Kim, G.; Yun, H. J.; Choi, H. S.] Chosun Univ, Coll Pharm, Gwangju 501759, Jeollanamdo, South Korea; [Lim, S-C] Chosun Univ, Sch Med, Dept Pathol, Gwangju 501759, Jeollanamdo, South Korea; [Ahn, S-G] Chosun Univ, Sch Dent, Dept Pathol, Gwangju 501759, Jeollanamdo, South Korea	Chosun University; Chosun University; Chosun University	Choi, HS (corresponding author), Chosun Univ, Coll Pharm, Gwangju 501759, Jeollanamdo, South Korea.	chs@chosun.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST) [NRF-2013R1A1A2004714]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (NRF-2013R1A1A2004714).	Ali S, 2007, P NATL ACAD SCI USA, V104, P18660, DOI 10.1073/pnas.0705939104; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Alvarez JV, 2005, CANCER RES, V65, P5054, DOI 10.1158/0008-5472.CAN-04-4281; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Berclaz G, 2001, INT J ONCOL, V19, P1155; BERGERS G, 1994, EMBO J, V13, P1176, DOI 10.1002/j.1460-2075.1994.tb06367.x; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Choi HS, 2008, FASEB J, V22, P113, DOI 10.1096/fj.07-9078com; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Funakoshi-Tago M, 2008, CELL SIGNAL, V20, P1679, DOI 10.1016/j.cellsig.2008.05.013; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; GELIN J, 1991, CANCER RES, V51, P415; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Harmey JH, 2002, INT J CANCER, V101, P415, DOI 10.1002/ijc.10632; Hu WT, 2014, MOL HUM REPROD, V20, P358, DOI 10.1093/molehr/gat094; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Jovanovic I, 2011, EUR J IMMUNOL, V41, P1902, DOI 10.1002/eji.201141417; Jovanovic IP, 2014, INT J CANCER, V134, P1669, DOI 10.1002/ijc.28481; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Khanal P, 2011, MOL CARCINOGEN, V50, P961, DOI 10.1002/mc.20761; Kim G, 2013, CARCINOGENESIS, V34, P341, DOI 10.1093/carcin/bgs342; Kim K, 2014, CARCINOGENESIS, V35, P1352, DOI 10.1093/carcin/bgu044; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Li L, 2002, J BIOL CHEM, V277, P17397, DOI 10.1074/jbc.M109962200; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lin X, 1999, IMMUNITY, V10, P271, DOI 10.1016/S1074-7613(00)80027-8; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Onda H, 1999, J CEREBR BLOOD F MET, V19, P1279, DOI 10.1097/00004647-199911000-00013; Palmer G, 2008, CYTOKINE, V42, P358, DOI 10.1016/j.cyto.2008.03.008; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Radisky DC, 2004, SCIENCE, V303, P775, DOI 10.1126/science.1094412; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sugimoto K, 2004, J CLIN INVEST, V114, P857, DOI 10.1172/JCI200420014; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; TOMINAGA S, 1991, BIOCHIM BIOPHYS ACTA, V1090, P1, DOI 10.1016/0167-4781(91)90029-L; Tsatsanis C, 1998, P NATL ACAD SCI USA, V95, P3827, DOI 10.1073/pnas.95.7.3827	48	63	64	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 17	2015	34	38					4928	4938		10.1038/onc.2014.418	http://dx.doi.org/10.1038/onc.2014.418			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9QZ	25531326				2022-12-26	WOS:000361693000003
J	Stolting, G; de Oliveira, RC; Guzman, RE; Miranda-Laferte, E; Conrad, R; Jordan, N; Schmidt, S; Hendriks, J; Gensch, T; Hidalgo, P				Stoelting, Gabriel; de Oliveira, Regina Campos; Guzman, Raul E.; Miranda-Laferte, Erick; Conrad, Rachel; Jordan, Nadine; Schmidt, Silke; Hendriks, Johnny; Gensch, Thomas; Hidalgo, Patricia			Direct Interaction of Ca-V beta with Actin Up-regulates L-type Calcium Currents in HL-1 Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL SUBUNITS; HUMAN HEART; EXPRESSION; MODULATION; COMPLEX; DOMAIN; CELLS; MECHANISM; CANINE	Expression of the beta-subunit (Ca-V beta) is required for normal function of cardiac L-type calcium channels, and its up-regulation is associated with heart failure. Ca-V beta binds to the alpha(1) poreforming subunit of L-type channels and augments calcium current density by facilitating channel opening and increasing the number of channels in the plasma membrane, by a poorly understood mechanism. Actin, a key component of the intracellular trafficking machinery, interacts with Src homology 3 domains in different proteins. Although Ca-V beta encompasses a highly conserved Src homology 3 domain, association with actin has not yet been explored. Here, using co-sedimentation assays and FRET experiments, we uncover a direct interaction between Ca-V beta and actin filaments. Consistently, single-molecule localization analysis reveals streaklike structures composed by Ca-V beta(2) that distribute over several micrometers along actin filaments in HL-1 cardiomyocytes. Overexpression of Ca-V beta(2)-N3 in HL-1 cells induces an increase in L-type current without altering voltage-dependent activation, thus reflecting an increased number of channels in the plasma membrane. Ca-V beta mediated L-type up-regulation, and Ca-V beta-actin association is prevented by disruption of the actin cytoskeleton with cytochalasin D. Our study reveals for the first time an interacting partner of Ca-V beta that is directly involved in vesicular trafficking. We propose a model in which Ca-V beta promotes anterograde trafficking of the L-type channels by anchoring them to actin filaments in their itinerary to the plasma membrane.	[Stoelting, Gabriel; Guzman, Raul E.; Miranda-Laferte, Erick; Conrad, Rachel; Jordan, Nadine; Hendriks, Johnny; Gensch, Thomas; Hidalgo, Patricia] Forschungszentrum Julich, Inst Complex Syst 4, D-52425 Julich, Germany; [de Oliveira, Regina Campos; Schmidt, Silke] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany	Helmholtz Association; Research Center Julich; Hannover Medical School	Hidalgo, P (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophys ICS4, D-52425 Julich, Germany.	pa.hidalgo@fz-juelich.de	Hidalgo, Patricia/I-7506-2013; Stolting, Gabriel/G-3704-2014	Hidalgo, Patricia/0000-0002-4162-6590; Stolting, Gabriel/0000-0002-2339-0545	Deutsche Forschungsgemeinschaft [Hi 800/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Hi 800/3-1 (to P. H.).	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Barde I, 2010, CURR PROTOC NEUROSCI, V53, P4211; BEAN BP, 1985, J GEN PHYSIOL, V86, P1, DOI 10.1085/jgp.86.1.1; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Bourdin B, 2010, J BIOL CHEM, V285, P22851, DOI 10.1074/jbc.M110.111062; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Chien AJ, 1998, J BIOL CHEM, V273, P23590, DOI 10.1074/jbc.273.36.23590; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; Cribbs LL, 2001, CIRC RES, V88, P403; Dzhura I, 2003, BIOPHYS J, V85, P274, DOI 10.1016/S0006-3495(03)74473-7; Fang K, 2011, J PHYSIOL-LONDON, V589, P4437, DOI 10.1113/jphysiol.2011.214247; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; Gilbert D, 2007, INT J DEV NEUROSCI, V25, P479, DOI 10.1016/j.ijdevneu.2007.08.001; Gonzalez-Gutierrez G, 2008, P NATL ACAD SCI USA, V105, P14198, DOI 10.1073/pnas.0806558105; Gonzalez-Gutierrez G, 2007, J BIOL CHEM, V282, P2156, DOI 10.1074/jbc.M609071200; Haase H, 1996, J MOL MED-JMM, V74, P99; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013; Hong TT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000312; Hullin R, 2003, J BIOL CHEM, V278, P21623, DOI 10.1074/jbc.M211164200; Hullin R, 1999, CIRCULATION, V100, P155, DOI 10.1161/01.CIR.100.2.155; Hullin R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000292; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Larsen JK, 2002, J MOL CELL CARDIOL, V34, P519, DOI 10.1006/jmcc.2001.1534; Link S, 2009, J BIOL CHEM, V284, P30129, DOI 10.1074/jbc.M109.045583; Luvisetto S, 2004, J GEN PHYSIOL, V124, P445, DOI 10.1085/jgp.200409034; Meissner M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227819; Miranda-Laferte E, 2011, J BIOL CHEM, V286, P22203, DOI 10.1074/jbc.M110.201871; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; Obermair GJ, 2008, CURR OPIN PHARMACOL, V8, P311, DOI 10.1016/j.coph.2008.01.008; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Scholl UI, 2013, NAT GENET, V45, P1050, DOI 10.1038/ng.2695; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Simms BA, 2012, CELL MOL LIFE SCI, V69, P843, DOI 10.1007/s00018-011-0843-y; Sun YS, 2011, NAT PROTOC, V6, P1324, DOI 10.1038/nprot.2011.364; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Wei S, 2000, CIRC RES, V86, P175, DOI 10.1161/01.RES.86.2.175; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1; Wolter S, 2010, J MICROSC-OXFORD, V237, P12, DOI 10.1111/j.1365-2818.2009.03287.x; Xia M, 2004, J MOL CELL CARDIOL, V36, P111, DOI 10.1016/j.yjmcc.2003.10.007	49	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4561	4572		10.1074/jbc.M114.573956	http://dx.doi.org/10.1074/jbc.M114.573956			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25533460	Green Published, hybrid			2022-12-26	WOS:000350042000004
J	Courtemanche, N; Gifford, SM; Simpson, MA; Pollard, TD; Koleske, AJ				Courtemanche, Naomi; Gifford, Stacey M.; Simpson, Mark A.; Pollard, Thomas D.; Koleske, Anthony J.			Abl2/Abl-related Gene Stabilizes Actin Filaments, Stimulates Actin Branching by Actin-related Protein 2/3 Complex, and Promotes Actin Filament Severing by Cofilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL EDGE PROTRUSION; ABL-FAMILY KINASES; F-ACTIN; TYROSINE KINASE; ARP2/3 COMPLEX; N-WASP; CORTACTIN PHOSPHORYLATION; DENDRITIC SPINE; FH1 DOMAIN; ARG	Both Arp2/3 complex and the Abl2/Arg nonreceptor tyrosine kinase are essential to form and maintain diverse actin-based structures in cells, including cell edge protrusions in fibroblasts and cancer cells and dendritic spines in neurons. The ability of Arg to promote cell edge protrusions in fibroblasts does not absolutely require kinase activity, raising the question of how Arg might modulate actin assembly and turnover in the absence of kinase function. Arg has two distinct actin-binding domains and interacts physically and functionally with cortactin, an activator of the Arp2/3 complex. However, it was not known whether and how Arg influences actin filament stability, actin branch formation, or cofilin-mediated actin severing or how cortactin influences these reactions of Arg with actin. Arg or cortactin bound to actin filaments stabilizes them from depolymerization. Low concentrations of Arg and cortactin cooperate to stabilize filaments by slowing depolymerization. Arg stimulates formation of actin filament branches by Arp2/3 complex and cortactin. An Arg mutant lacking the C-terminal calponin homology actin-binding domain stimulates actin branch formation by the Arp2/3 complex, indicative of autoinhibition. Arg Delta CH can stimulate the Arp2/3 complex even in the absence of cortactin. Arg greatly potentiates cofilin severing of actin filaments, and cortactin attenuates this enhanced severing. The ability of Arg to stabilize filaments, promote branching, and increase severing requires the internal (I/L) WEQ actin-binding domain. These activities likely underlie important roles that Arg plays in the formation, dynamics, and stability of actin-based cellular structures.	[Courtemanche, Naomi; Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06511 USA; [Gifford, Stacey M.; Simpson, Mark A.; Pollard, Thomas D.; Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Koleske, Anthony J.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA; [Koleske, Anthony J.] Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, 219 Prospect St, New Haven, CT 06511 USA.	thomas.pollard@yale.edu; anthony.koleske@yale.edu			National Institutes of Health [CA-133346, GM-100411, GM-026338, NS-089439]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA133346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026338, T32GM007223, R01GM100411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS089439, R01NS089662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-133346 and GM-100411 (to A. J. K.), GM-026338 (to T. D. P.), and NS-089439 (to A. J. K. and T. D. P.).; Supported by a postdoctoral fellowship from the Leukemia and Lymphoma Society.	BAMBURG JR, 1980, FEBS LETT, V121, P178, DOI 10.1016/0014-5793(80)81292-0; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Courtemanche N, 2012, J BIOL CHEM, V287, P7812, DOI 10.1074/jbc.M111.322958; De La Cruz Enrique M, 2009, Biophys Rev, V1, P51, DOI 10.1007/s12551-009-0008-5; Galkin VE, 2005, J MOL BIOL, V346, P565, DOI 10.1016/j.jmb.2004.11.078; Gifford SM, 2014, J BIOL CHEM, V289, P19704, DOI 10.1074/jbc.M114.556480; Helgeson LA, 2013, ELIFE, V2, DOI 10.7554/eLife.00884; HENKEMEYER M, 1990, CELL, V63, P949, DOI 10.1016/0092-8674(90)90498-4; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; HUXLEY HE, 1967, J MOL BIOL, V30, P383, DOI 10.1016/S0022-2836(67)80046-9; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Kempiak SJ, 2005, J BIOL CHEM, V280, P5836, DOI 10.1074/jbc.M410713200; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Kowalski JR, 2005, J CELL SCI, V118, P79, DOI 10.1242/jcs.01586; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Lin YC, 2013, J NEUROSCI, V33, P1846, DOI 10.1523/JNEUROSCI.4284-12.2013; Liu WZ, 2012, ACTA CRYSTALLOGR F, V68, P154, DOI 10.1107/S1744309111056132; MacGrath SM, 2012, BIOCHEMISTRY-US, V51, P6644, DOI 10.1021/bi300722t; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Miller MM, 2010, BIOCHEMISTRY-US, V49, P2227, DOI 10.1021/bi901721u; Moresco EMY, 2005, J NEUROSCI, V25, P6105, DOI 10.1523/JNEUROSCI.1432-05.2005; Oser M, 2010, J CELL SCI, V123, P3662, DOI 10.1242/jcs.068163; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Pant K, 2006, J MOL BIOL, V359, P840, DOI 10.1016/j.jmb.2006.03.065; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Peacock JG, 2010, CYTOSKELETON, V67, P666, DOI 10.1002/cm.20479; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Sfakianos MK, 2007, J NEUROSCI, V27, P10982, DOI 10.1523/JNEUROSCI.0793-07.2007; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; van Rossum AGSH, 2003, J BIOL CHEM, V278, P45672, DOI 10.1074/jbc.M306688200; Wang YX, 2001, P NATL ACAD SCI USA, V98, P14865, DOI 10.1073/pnas.251249298; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417	45	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4038	4046		10.1074/jbc.M114.608117	http://dx.doi.org/10.1074/jbc.M114.608117			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25540195	Green Published, hybrid			2022-12-26	WOS:000349458400016
J	Al-Sobhi, MM; Hussain, Z; Al-Zahrani, B				Al-Sobhi, Mashail M.; Hussain, Zawar; Al-Zahrani, Bander			General Randomized Response Techniques Using Polya's Urn Process as a Randomization Device	PLOS ONE			English	Article							MODEL; EPIDEMICS; CARRIERS; SPREAD	In this paper, interesting improvements in [1] and [2] randomized response techniques have been proposed. The proposed randomized response technique applies Polya's urn process (see [3]) to obtain data from respondents. One of the suggested technique requires reporting the number of draws to observe a fixed number of cards of certain type. On the contrary, the number of cards of a certain type is to be reported in case of second proposed randomized response model. Based on the information collected through the suggested techniques, two different unbiased estimators of proportion of a sensitive attribute have been suggested. A detailed comparative simulation study has also been done. The results are also supported by means of a small scale survey.	[Al-Sobhi, Mashail M.] Umm Alqura Univ, Dept Math, Mecca 21421, Saudi Arabia; [Hussain, Zawar] Quaid I Azam Univ, Dept Stat, Islamabad 45320, Pakistan; [Al-Zahrani, Bander] King Abdulaziz Univ, Dept Stat, Jeddah 80203, Saudi Arabia	Umm Al Qura University; Quaid I Azam University; King Abdulaziz University	Hussain, Z (corresponding author), Quaid I Azam Univ, Dept Stat, Islamabad 45320, Pakistan.	zhlangah@yahoo.com	Hussain, Zawar/I-1616-2012		Institute of Scientific Research and Revival of Islamic Heritage at Umm Alqura University [43305030]	Institute of Scientific Research and Revival of Islamic Heritage at Umm Alqura University	Funding: The work has been funded by the Institute of Scientific Research and Revival of Islamic Heritage at Umm Alqura University (grant#43305030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang HJ, 2001, METRIKA, V53, P269, DOI 10.1007/s001840100109; Christofides TC, 2003, METRIKA, V57, P195, DOI 10.1007/s001840200216; DIETZ K, 1966, J APPL PROBAB, V3, P375, DOI 10.2307/3212126; Faucounau J, 1975, MATH SCI HUMAINES, V52, P55; FOLSOM RE, 1973, J AM STAT ASSOC, V68, P525, DOI 10.2307/2284771; Gi-Sung Lee K-HH, 2012, J KOREAN DATA ANAL S, V15, P1755; Gjestvang CR, 2006, J R STAT SOC B, V68, P523, DOI 10.1111/j.1467-9868.2006.00554.x; GREENBERG BG, 1969, J AM STAT ASSOC, V64, P520, DOI 10.2307/2283636; Grewal, 2013, INT J CONT MATH SCI, V8, DOI [10.12988/ijcms.2013.13025, DOI 10.12988/ijcms.2013.13025]; Guerriero M, 2007, J STAT PLAN INFER, V137, P2184, DOI 10.1016/j.jspi.2006.07.004; Horvitz DG, 1967, P SOC STAT SECT AM S, P65; Johnson N.L., 1977, URN MODELS THEIR APP; Kim J., 1978, GROUP, V1, P351; KRYSCIO RJ, 1974, BIOMETRIKA, V61, P200, DOI 10.1093/biomet/61.1.200; KUK AYC, 1990, BIOMETRIKA, V77, P436, DOI 10.2307/2336828; LIU PT, 1976, J AM STAT ASSOC, V71, P72, DOI 10.2307/2285733; Mahmoud H., 2008, POLYA URN MODELS; MANGAT NS, 1990, BIOMETRIKA, V77, P439, DOI 10.2307/2336829; MANGAT NS, 1994, J ROY STAT SOC B MET, V56, P93; MOORS JJA, 1971, J AM STAT ASSOC, V66, P627, DOI 10.2307/2283543; Odumade O, 2009, COMMUN STAT-SIMUL C, V38, P473, DOI 10.1080/03610910802536736; Perri P. F, 2008, MODEL ASSISTED STAT, V3, P233, DOI DOI 10.3233/MAS-2008-3307; Rosenberger W. F., 2002, SEQUENTIAL ANAL, V21, P1; Singh S, 2013, METRON, V71, P3, DOI 10.1007/s40300-013-0002-3; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137; WEISS GEORGE H., 1965, BIOMETRICS, V21, P481, DOI 10.2307/2528105	26	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115612	10.1371/journal.pone.0115612	http://dx.doi.org/10.1371/journal.pone.0115612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541936	gold, Green Published, Green Submitted			2022-12-26	WOS:000347239900059
J	Cao, C; Ding, QL; Lv, D; Dong, Z; Sun, SF; Chen, ZB; Shen, HH; Deng, ZC				Cao, Chao; Ding, Qunli; Lv, Dan; Dong, Zhe; Sun, Shifang; Chen, Zhongbo; Shen, Huahao; Deng, Zaichun			Vascular Endothelial Growth Factor Genotypes and Haplotypes Contribute to the Susceptibility of Obstructive Sleep Apnea Syndrome	PLOS ONE			English	Article							FACTOR GENE; GASTRIC-CANCER; VEGF GENE; POLYMORPHISM; HYPOXIA; RISK; ASSOCIATION; POPULATION; INFLAMMATION; EXPRESSION	Background: To investigate whether VEGF polymorphisms (-460T/C, +405G/C, and +936C/T)/haplotypes influence the susceptibility of obstructive sleep apnea (OSA). Method: A prospective case-control study was conducted to evaluate the genetic effects of VEGF polymorphisms on the development of OSA. 150 patients and 225 healthy controls were recruited for this study and their genotypes were determined by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). The odds ratios (OR) and 95% confidence intervals (CI) were calculated by logistic regression analysis. Result: Our study showed that the -460C allele (C vs. T: OR=1.95, 95% CI=1.38-2.76) and +936T allele (T vs. C: OR=1.48, 95% CI=1.02-2.15) were associated with an increased OSA risk, whereas +405C allele was associated with a decreased susceptibility to OSA (C vs. G: OR=0.61, 95% CI=0.45-0.83). Compared with the most common haplotype CCT, CGC (OR=2.22, 95% CI=1.19-4.13) and TGC (OR=3.83, 95% CI=1.56-9.40) were associated with a significantly increased risk of OSA. Conclusion: These observations implied that VEGF gene polymorphisms might be associated with the susceptibility to OSA. These results need to be validated by other independent studies, especially in diverse ethnic populations.	[Cao, Chao; Ding, Qunli; Lv, Dan; Sun, Shifang; Chen, Zhongbo; Deng, Zaichun] Ningbo Univ, Affiliated Hosp, Sch Med, Dept Resp Med, Ningbo 315020, Zhejiang, Peoples R China; [Cao, Chao; Lv, Dan; Shen, Huahao] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Resp & Crit Care Med, Hangzhou 310009, Zhejiang, Peoples R China; [Dong, Zhe] Zhejiang Univ, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China	Ningbo University; Zhejiang University; Zhejiang University	Deng, ZC (corresponding author), Ningbo Univ, Affiliated Hosp, Sch Med, Dept Resp Med, Ningbo 315020, Zhejiang, Peoples R China.	dengzaichun982136@hotmail.com			grant of Natural Science Foundation of Ningbo [2012A610257]	grant of Natural Science Foundation of Ningbo	This work was supported by grant of Natural Science Foundation of Ningbo (No. 2012A610257, Z Deng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2013, SLEEP BREATH, V17, P597, DOI 10.1007/s11325-012-0726-y; Awata T, 2002, DIABETES, V51, P1635, DOI 10.2337/diabetes.51.5.1635; Bhushan B, 2009, RESP MED, V103, P386, DOI 10.1016/j.rmed.2008.10.001; Buck D, 2010, SLEEP MED, V11, P213, DOI 10.1016/j.sleep.2009.06.009; Cao C, 2010, ARCH MED RES, V41, P548, DOI 10.1016/j.arcmed.2010.09.006; Chae YS, 2006, ONCOLOGY-BASEL, V71, P266, DOI 10.1159/000106788; Chen WH, 2012, AM J OTOLARYNG, V33, P31, DOI 10.1016/j.amjoto.2010.12.005; Ciftci TU, 2011, ANN SAUDI MED, V31, P14, DOI 10.4103/0256-4947.75772; Ding Q, 2014, SLEEP BREAT IN PRESS; Garvey JF, 2009, EUR RESPIR J, V33, P1195, DOI 10.1183/09031936.00111208; Gozal D, 2002, SLEEP, V25, P59, DOI 10.1093/sleep/25.1.59; Kaczmarek E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070559; Kataoka N, 2006, CANCER EPIDEM BIOMAR, V15, P1148, DOI 10.1158/1055-9965.EPI-05-0871; Ke Q, 2008, MOL CARCINOGEN, V47, P647, DOI 10.1002/mc.20435; Koyama RG, 2009, SLEEP MED, V10, P1107, DOI 10.1016/j.sleep.2008.12.012; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Ma J, 2007, J HUAZHONG U SCI-MED, V27, P157, DOI 10.1007/s11596-007-0212-0; Mishra HK, 2013, SLEEP BREATH, V17, P1029, DOI 10.1007/s11325-012-0795-y; Ogus C, 2010, BIOCHEM GENET, V48, P516, DOI 10.1007/s10528-010-9335-2; Papaioannou AI, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-128; Peled N, 2007, RESPIRATION, V74, P50, DOI 10.1159/000095675; Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Stevens A, 2003, CANCER RES, V63, P812; Sun SF, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0410-x; Takahashi S, 2005, RESP MED, V99, P1125, DOI 10.1016/j.rmed.2005.02.027; Teramoto S, 2003, INTERNAL MED, V42, P681, DOI 10.2169/internalmedicine.42.681; Vincenti V, 1996, CIRCULATION, V93, P1493, DOI 10.1161/01.CIR.93.8.1493; Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3	30	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e114582	10.1371/journal.pone.0114582	http://dx.doi.org/10.1371/journal.pone.0114582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541696	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900013
J	Timme, N; Ito, S; Myroshnychenko, M; Yeh, FC; Hiolski, E; Hottowy, P; Beggs, JM				Timme, Nicholas; Ito, Shinya; Myroshnychenko, Maxym; Yeh, Fang-Chin; Hiolski, Emma; Hottowy, Pawel; Beggs, John M.			Multiplex Networks of Cortical and Hippocampal Neurons Revealed at Different Timescales	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; SLICE CULTURES; ORGANOTYPIC CULTURES; SYNAPTIC DEVELOPMENT; BRAIN CONNECTIVITY; CEREBRAL-CORTEX; NEURAL ACTIVITY; HUB NEURONS; ORGANIZATION; FREQUENCY	Recent studies have emphasized the importance of multiplex networks - interdependent networks with shared nodes and different types of connections - in systems primarily outside of neuroscience. Though the multiplex properties of networks are frequently not considered, most networks are actually multiplex networks and the multiplex specific features of networks can greatly affect network behavior (e. g. fault tolerance). Thus, the study of networks of neurons could potentially be greatly enhanced using a multiplex perspective. Given the wide range of temporally dependent rhythms and phenomena present in neural systems, we chose to examine multiplex networks of individual neurons with time scale dependent connections. To study these networks, we used transfer entropy -an information theoretic quantity that can be used to measure linear and nonlinear interactions - to systematically measure the connectivity between individual neurons at different time scales in cortical and hippocampal slice cultures. We recorded the spiking activity of almost 12,000 neurons across 60 tissue samples using a 512-electrode array with 60 micrometer inter-electrode spacing and 50 microsecond temporal resolution. To the best of our knowledge, this preparation and recording method represents a superior combination of number of recorded neurons and temporal and spatial recording resolutions to any currently available in vivo system. We found that highly connected neurons ("hubs'') were localized to certain time scales, which, we hypothesize, increases the fault tolerance of the network. Conversely, a large proportion of non-hub neurons were not localized to certain time scales. In addition, we found that long and short time scale connectivity was uncorrelated. Finally, we found that long time scale networks were significantly less modular and more disassortative than short time scale networks in both tissue types. As far as we are aware, this analysis represents the first systematic study of temporally dependent multiplex networks among individual neurons.	[Timme, Nicholas; Yeh, Fang-Chin; Beggs, John M.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Ito, Shinya] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Myroshnychenko, Maxym] Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA; [Hiolski, Emma] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Hottowy, Pawel] AGH Univ Sci & Technol, PL-30059 Krakow, Poland	Indiana University System; Indiana University Bloomington; University of California System; University of California Santa Cruz; Indiana University System; Indiana University Bloomington; University of California System; University of California Santa Cruz; AGH University of Science & Technology	Timme, N (corresponding author), Indiana Univ, Dept Phys, Bloomington, IN 47405 USA.	nmtimme@umail.iu.edu	Hottowy, Pawel/R-4981-2019	Timme, Nicholas/0000-0002-7127-4418	National Science Foundation [090813, 1058291, IIS 0904413, CNS-0723054, CNS-0521433]	National Science Foundation(National Science Foundation (NSF))	This research was supported by National Science Foundation (http://www.nsf.gov) grants 090813 (JMB), 1058291 (JMB), and IIS 0904413 (Alan Litke). Via the use of computing resources at Indiana University, this material is based upon work supported by the National Science Foundation under Grant Nos. CNS-0723054 and CNS-0521433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Akam T, 2014, NAT REV NEUROSCI, V15, P111, DOI 10.1038/nrn3668; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Amblard PO, 2011, J COMPUT NEUROSCI, V30, P7, DOI 10.1007/s10827-010-0231-x; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Baker RE, 1997, DEV BRAIN RES, V98, P21, DOI 10.1016/S0165-3806(96)00163-0; Bausch SB, 2000, J NEUROPHYSIOL, V84, P2918, DOI 10.1152/jn.2000.84.6.2918; Baxter GJ, 2014, UNDERST COMPLEX SYST, P37, DOI 10.1007/978-3-319-03518-5_2; Bedo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088940; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besserve M, 2010, J COMPUT NEUROSCI, V29, P547, DOI 10.1007/s10827-010-0236-5; Bianconi G, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062806; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; BOLZ J, 1990, NATURE, V346, P359, DOI 10.1038/346359a0; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Brummitt CD, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.045102; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Bullmore E, 2009, NAT REV NEUROSCI, V10, DOI 10.1038/nrn2618; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Buzsaki G., 2006, RHYTHMS BRAIN; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cardillo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01344; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Cossart R, 2014, CURR OPIN NEUROBIOL, V26, P51, DOI 10.1016/j.conb.2013.12.002; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; D'Agostino G, 2014, UNDERST COMPLEX SYST, pVII; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Douw L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-103; Downes JH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002522; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Feldt S, 2011, TRENDS NEUROSCI, V34, P225, DOI 10.1016/j.tins.2011.02.007; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2011, NEUROIMAGE, V56, P1202, DOI 10.1016/j.neuroimage.2010.12.039; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Gerhard F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003138; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; Gire DH, 2013, NEURON, V78, P416, DOI 10.1016/j.neuron.2013.04.033; Gomez-Gardenes J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00620; Goni J, 2014, P NATL ACAD SCI USA, V111, P833, DOI 10.1073/pnas.1315529111; GOTZ M, 1992, J NEUROBIOL, V23, P783, DOI 10.1002/neu.480230702; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grewe BF, 2014, NEUROMETHODS, V85, P133, DOI 10.1007/978-1-62703-785-3_9; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Grinstein G, 2005, P NATL ACAD SCI USA, V102, P9948, DOI 10.1073/pnas.0504127102; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Gutierrez R, 1999, BRAIN RES, V815, P304, DOI 10.1016/S0006-8993(98)01101-9; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Horn A, 2014, NEUROIMAGE, V102, P142, DOI 10.1016/j.neuroimage.2013.09.069; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Ito S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105324; Ito SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027431; Izquierdo EJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002890; Johnson S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.108702; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Klostermann O, 1999, NEUROSCIENCE, V92, P1243, DOI 10.1016/S0306-4522(99)00009-3; Koenig T, 2005, PHILOS T R SOC B, V360, P1015, DOI 10.1098/rstb.2005.1649; Kuhnert MT, 2012, CHAOS, V22, DOI 10.1063/1.4729185; Kurant M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.138701; Lee KM, 2014, UNDERST COMPLEX SYST, P53, DOI 10.1007/978-3-319-03518-5_3; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; LEIMAN AL, 1986, BRAIN RES, V365, P205, DOI 10.1016/0006-8993(86)91631-8; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; Lizier JT, 2011, J COMPUT NEUROSCI, V30, P85, DOI 10.1007/s10827-010-0271-2; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; Ma CF, 2013, COGN NEURODYNAMICS, V7, P253, DOI 10.1007/s11571-012-9239-4; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Mielke JG, 2005, DEV BRAIN RES, V160, P275, DOI 10.1016/j.devbrainres.2005.09.009; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MULLER D, 1993, DEV BRAIN RES, V71, P93, DOI 10.1016/0165-3806(93)90109-N; Nakhnikian A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089443; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, P13982, DOI 10.1073/pnas.1305062110; Panzeri S, 2010, TRENDS NEUROSCI, V33, P111, DOI 10.1016/j.tins.2009.12.001; Pena F, 2010, CURR MED CHEM, V17, P987, DOI 10.2174/092986710790820679; Picardo MA, 2011, NEURON, V71, P695, DOI 10.1016/j.neuron.2011.06.018; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Quilichini PP, 2012, NEURON, V74, P57, DOI 10.1016/j.neuron.2012.01.026; Rolston JD, 2007, NEUROSCIENCE, V148, P294, DOI 10.1016/j.neuroscience.2007.05.025; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rykhlevskaia E, 2008, PSYCHOPHYSIOLOGY, V45, P173, DOI 10.1111/j.1469-8986.2007.00621.x; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sasaki T, 2008, J NEUROPHYSIOL, V100, P1668, DOI 10.1152/jn.00084.2008; Scholvinck ML, 2013, NEUROIMAGE, V80, P297, DOI 10.1016/j.neuroimage.2013.04.010; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Sharott A, 2005, J PHYSIOL-LONDON, V562, P951, DOI 10.1113/jphysiol.2004.073189; Shimono M, 2015, CEREB CORTEX, V25, P3743, DOI 10.1093/cercor/bhu252; Song C, 2013, J NEUROSCI, V33, P18781, DOI 10.1523/JNEUROSCI.4201-12.2013; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Staal JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022040; Stetter O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002653; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Valdes-Sosa PA, 2011, NEUROIMAGE, V58, P339, DOI 10.1016/j.neuroimage.2011.03.058; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wang Z, 2013, NEURON, V78, P1116, DOI 10.1016/j.neuron.2013.04.023; Wibral M, 2014, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-3-642-54474-3; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006; Wollstadt P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102833; Yuan WJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022818; Yuan WJ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016116; ZIMMER J, 1984, J COMP NEUROL, V228, P432, DOI 10.1002/cne.902280310; Zubler F, 2015, BRAIN TOPOGR, V28, P305, DOI 10.1007/s10548-014-0370-x	139	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115764	10.1371/journal.pone.0115764	http://dx.doi.org/10.1371/journal.pone.0115764			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536059	gold, Green Published			2022-12-26	WOS:000348563300072
J	Xiao, YM; Fu, HJ; Han, XJ; Hu, XX; Gu, HY; Chen, YL; Wei, Q; Hu, QS				Xiao, Yongmei; Fu, Hongjun; Han, Xiaojie; Hu, Xiaoxia; Gu, Huaiyu; Chen, Yilin; Wei, Qing; Hu, Qiansheng			Role of Synaptic Structural Plasticity in Impairments of Spatial Learning and Memory Induced by Developmental Lead Exposure in Wistar Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CELL-ADHESION MOLECULES; SEQUENTIAL-CHANGES; DENTATE GYRUS; STEM-CELLS; PSA-NCAM; HIPPOCAMPUS; DEFICITS; NEUROGENESIS; CHILDREN	Lead (Pb) is found to impair cognitive function. Synaptic structural plasticity is considered to be the physiological basis of synaptic functional plasticity and has been recently found to play important roles in learning and memory. To study the effect of Pb on spatial learning and memory at different developmental stages, and its relationship with alterations of synaptic structural plasticity, postnatal rats were randomly divided into three groups: Control; Pre-weaning Pb (Parents were exposed to 2 mM PbCl2 3 weeks before mating until weaning of pups); Post-weaning Pb (Weaned pups were exposed to 2 mM PbCl2 for 9 weeks). The spatial learning and memory of rats was measured by Morris water maze (MWM) on PND 85-90. Rat pups in Pre-weaning Pb and Post-weaning Pb groups performed significantly worse than those in Control group (p<0.05). However, there was no significant difference in the performance of MWM between the two Pb-exposure groups. Before MWM (PND 84), the number of neurons and synapses significantly decreased in Pre-weaning Pb group, but not in Post-weaning Pb group. After MWM (PND 91), the number of synapses in Pre-weaning Pb group increased significantly, but it was still less than that of Control group (p<0.05); the number of synapses in Post-weaning Pb group was also less than that of Control group (p<0.05), although the number of synapses has no differences between Post-weaning Pb and Control groups before MWM. In both Pre-weaning Pb and Post-weaning Pb groups, synaptic structural parameters such as thickness of postsynaptic density (PSD), length of synaptic active zone and synaptic curvature increased significantly while width of synaptic cleft decreased significantly compared to Control group (p<0.05). Our data demonstrated that both early and late developmental Pb exposure impaired spatial learning and memory as well as synaptic structural plasticity in Wistar rats.	[Xiao, Yongmei; Han, Xiaojie; Hu, Xiaoxia; Chen, Yilin; Wei, Qing; Hu, Qiansheng] Sun Yat Sen Univ, Sch Publ Hlth, Dept Prevent Med, Guangzhou 510080, Guangdong, Peoples R China; [Fu, Hongjun] Jackson Lab, Bar Harbor, ME 04609 USA; [Gu, Huaiyu] Sun Yat Sen Univ, Sch Med, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Jackson Laboratory; Sun Yat Sen University	Hu, QS (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Prevent Med, Guangzhou 510080, Guangdong, Peoples R China.	huqsh@mail.sysu.edu.cn	FU, HONGJUN/H-4498-2011; Hu, Qian/GWZ-7617-2022; Fu, Hongjun/ABB-3558-2021	FU, HONGJUN/0000-0001-5346-7075; 	National Basic Research Program of China [2012CB525003]; National Natural Science Foundation of China [81072271]; Fundamental Research Funds for the Central Universities [09ykpy58]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Basic Research Program of China [2012CB525003], the National Natural Science Foundation of China [No. 81072271], and the Fundamental Research Funds for the Central Universities [No. 09ykpy58]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranowska-Bosiacka I, 2013, TOXICOLOGY, V303, P187, DOI 10.1016/j.tox.2012.10.027; BELLINGER D, 1991, PEDIATRICS, V87, P219; BELLINGER D, 1987, NEW ENGL J MED, V316, P1037, DOI 10.1056/NEJM198704233161701; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Cao XJ, 2008, DEV PSYCHOBIOL, V50, P307, DOI 10.1002/dev.20287; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; DIETRICH KN, 1991, NEUROTOXICOL TERATOL, V13, P203, DOI 10.1016/0892-0362(91)90012-L; Dribben WH, 2011, NEUROTOXICOL TERATOL, V33, P473, DOI 10.1016/j.ntt.2011.05.006; EDELMAN GM, 1991, ANNU REV BIOCHEM, V60, P155, DOI 10.1146/annurev.bi.60.070191.001103; FERRER I, 1994, NEUROSCI LETT, V182, P77, DOI 10.1016/0304-3940(94)90210-0; Gilbert ME, 2005, TOXICOL SCI, V86, P365, DOI 10.1093/toxsci/kfi156; GULDNER FH, 1980, NEUROSCI LETT, V17, P27, DOI 10.1016/0304-3940(80)90056-7; Han XJ, 2014, BIOL PHARM BULL, V37, P466, DOI 10.1248/bpb.b13-00892; Hidalgo A, 2003, MECH DEVELOP, V120, P1311, DOI 10.1016/j.mod.2003.06.004; Hu QS, 2008, NEUROTOXICOLOGY, V29, P675, DOI 10.1016/j.neuro.2008.04.002; Huang FN, 2004, NEUROTOXICOLOGY, V25, P1001, DOI 10.1016/j.neuro.2004.03.010; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Jaako-Movits K, 2005, INT J DEV NEUROSCI, V23, P627, DOI 10.1016/j.ijdevneu.2005.07.005; Jett DA, 1997, PHARMACOL BIOCHEM BE, V57, P271, DOI 10.1016/S0091-3057(96)00350-4; JONES DG, 1978, BRAIN RES, V147, P47, DOI 10.1016/0006-8993(78)90771-0; Klemann CJHM, 2011, SYNAPSE, V65, P1222, DOI 10.1002/syn.20962; Kuhlmann AC, 1997, NEUROSCI LETT, V233, P101, DOI 10.1016/S0304-3940(97)00633-2; Lanphear BP, 2000, PUBLIC HEALTH REP, V115, P521, DOI 10.1093/phr/115.6.521; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Liu MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043924; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Margeta MA, 2010, MOL CELL NEUROSCI, V43, P261, DOI 10.1016/j.mcn.2009.11.009; MARKUS EJ, 1989, SYNAPSE, V3, P1, DOI 10.1002/syn.890030102; Muller Dominique, 2002, Current Molecular Medicine (Hilversum), V2, P605, DOI 10.2174/1566524023362041; MULLER LJ, 1984, NEUROSCIENCE, V12, P1045, DOI 10.1016/0306-4522(84)90003-4; Murphy KJ, 1999, J NEUROCHEM, V72, P2099, DOI 10.1046/j.1471-4159.1999.0722099.x; Patrick L, 2006, ALTERN MED REV, V11, P2; Plusquellec P, 2007, NEUROTOXICOL TERATOL, V29, P527, DOI 10.1016/j.ntt.2007.07.002; Ruan DY, 2000, CHEMOSPHERE, V41, P165, DOI 10.1016/S0045-6535(99)00406-3; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Surkan PJ, 2007, NEUROTOXICOLOGY, V28, P1170, DOI 10.1016/j.neuro.2007.07.007; Verina T, 2007, NEUROSCIENCE, V145, P1037, DOI 10.1016/j.neuroscience.2006.12.040; Weeks ACW, 2001, SYNAPSE, V40, P74, DOI 10.1002/1098-2396(200104)40:1<74::AID-SYN1028>3.0.CO;2-D; Weeks ACW, 2000, SYNAPSE, V36, P286, DOI 10.1002/(SICI)1098-2396(20000615)36:4<286::AID-SYN5>3.0.CO;2-T; Xu XH, 2013, HORM BEHAV, V63, P766, DOI 10.1016/j.yhbeh.2013.03.004; Yang YX, 2003, EXP NEUROL, V184, P489, DOI 10.1016/S0014-4886(03)00272-3	43	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115556	10.1371/journal.pone.0115556	http://dx.doi.org/10.1371/journal.pone.0115556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536363	gold, Green Published, Green Submitted			2022-12-26	WOS:000348563300049
J	Cheng, Z; Xu, ZL; Zhang, L; Wang, XW				Cheng, Zhe; Xu, Zaoli; Zhang, Lei; Wang, Xinwei			Thermophysical Properties of Lignocellulose: A Cell-Scale Study Down to 41K	PLOS ONE			English	Article							THERMAL-CONDUCTIVITY; HEAT-CAPACITY; THERMODYNAMIC PROPERTIES; ONION EPIDERMIS; BIOMASS; PYROLYSIS; COMBUSTION; ANISOTROPY; GROWTH; ENERGY	Thermal energy transport is of great importance in lignocellulose pyrolysis for biofuels. The thermophysical properties of lignocellulose significantly affect the overall properties of bio-composites and the related thermal transport. In this work, cell-scale lignocellulose (mono-layer plant cells) is prepared to characterize their thermal properties from room temperature down to similar to 40 K. The thermal conductivities of cell-scale lignocellulose along different directions show a little anisotropy due to the cell structure anisotropy. It is found that with temperature going down, the volumetric specific heat of the lignocellulose shows a slower decreasing trend against temperature than microcrystalline cellulose, and its value is always higher than that of microcrystalline cellulose. The thermal conductivity of lignocellulose decreases with temperature from 243 K to 317 K due to increasing phonon-phonon scatterings. From 41 K to 243 K, the thermal conductivity rises with temperature and its change mainly depends on the heat capacity's change.	[Cheng, Zhe; Xu, Zaoli; Wang, Xinwei] Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA; [Zhang, Lei] Hubei Univ Technol, Dept Foreign Language, Wuhan 430065, Hunan, Peoples R China	Iowa State University; Hubei University of Technology	Wang, XW (corresponding author), Iowa State Univ, Dept Mech Engn, 2010 Black Engn Bldg, Ames, IA 50011 USA.	xwang3@iastate.edu	Cheng, Zhe/AAT-2105-2021; Cheng, Zhe/N-3703-2016; Wang, Xinwei/AAH-4694-2019	Cheng, Zhe/0000-0001-7827-2979; Cheng, Zhe/0000-0001-7827-2979; 	Army Research Office [W911NF-12-1-0272]; Office of Naval Research [N000141210603]; National Science Foundation [CBET1235852, CMMI1264399]; Eastern Scholar Program of Shanghai, China	Army Research Office; Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Eastern Scholar Program of Shanghai, China	Support of this work by Army Research Office (W911NF-12-1-0272), Office of Naval Research (N000141210603), and National Science Foundation (CBET1235852, CMMI1264399) is gratefully acknowledged. X. W. thanks the partial support of the "Eastern Scholar'' Program of Shanghai, China.	Alsina OLS, 2005, POLYM TEST, V24, P81, DOI 10.1016/j.polymertesting.2004.07.005; Averous L, 2006, CARBOHYD POLYM, V66, P480, DOI 10.1016/j.carbpol.2006.04.004; Beck JV, 1992, HEAT CONDUCTION USIN; Blokhin AV, 2011, J CHEM ENG DATA, V56, P3523, DOI 10.1021/je200270t; CHEN HS, 1969, J APPL PHYS, V40, P4214, DOI 10.1063/1.1657175; Dobircau L, 2009, COMPOS PART A-APPL S, V40, P329, DOI 10.1016/j.compositesa.2008.11.004; Feng X, 2011, ACTA MATER, V59, P1934, DOI 10.1016/j.actamat.2010.11.059; Feng XH, 2011, THIN SOLID FILMS, V519, P5700, DOI 10.1016/j.tsf.2011.03.043; Guo JQ, 2007, J APPL PHYS, V101, DOI 10.1063/1.2714679; Gupta M, 2003, FUEL, V82, P919, DOI 10.1016/S0016-2361(02)00398-8; Incropera FP., 2011, FUNDAMENTALS HEAT MA; Kerstens S, 2001, PLANT PHYSIOL, V127, P381, DOI 10.1104/pp.010423; Kumar J, 2011, BIOSENS BIOELECTRON, V26, P4399, DOI 10.1016/j.bios.2011.04.049; Kutschera U, 2008, ANN BOT-LONDON, V101, P615, DOI 10.1093/aob/mcn015; Le Digabel F, 2004, J APPL POLYM SCI, V93, P428, DOI 10.1002/app.20426; Leadbetter AJ, 1969, J PHYS C SOLID STATE, V2; Lee J, 1997, J BIOTECHNOL, V56, P1, DOI 10.1016/S0168-1656(97)00073-4; Liang XH, 2000, FUEL, V79, P1477, DOI 10.1016/S0016-2361(99)00286-0; Lin H, 2013, SMALL, V9, P2585, DOI 10.1002/smll.201202877; Liu G, 2014, J VISUALIZED EXPT, V83; Mettler MS, 2012, ENERG ENVIRON SCI, V5, P7797, DOI 10.1039/c2ee21679e; Naik AD, 2010, SMALL, V6, P2842, DOI 10.1002/smll.201001527; Park BK, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807471; RAMIRES MLV, 1995, J PHYS CHEM REF DATA, V24, P1377, DOI 10.1063/1.555963; Sakuratani T, 1979, J AGR METEOROLOGY; Shimazaki Y, 2007, BIOMACROMOLECULES, V8, P2976, DOI 10.1021/bm7004998; Singha AS, 2009, INT J POLYM MATER, V58, P21, DOI 10.1080/00914030802461857; Stankovic SB, 2008, POLYM TEST, V27, P41, DOI 10.1016/j.polymertesting.2007.08.003; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Suslov D, 2006, J EXP BOT, V57, P2183, DOI 10.1093/jxb/erj177; Suslov D, 2009, J EXP BOT, V60, P4175, DOI 10.1093/jxb/erp251; Wang F, 2010, BIOSENS BIOELECTRON, V25, P2238, DOI 10.1016/j.bios.2010.02.033; Wang L, 2001, J NON-CRYST SOLIDS, V296, P139, DOI 10.1016/S0022-3093(01)00902-4; Yapici F, 2011, BIORESOURCES, V6, P2757; YOKOKAWA H, 1979, J PHYS CHEM SOLIDS, V40, P445, DOI 10.1016/0022-3697(79)90060-X; Zabaniotou A, 2008, INT J HYDROGEN ENERG, V33, P2433, DOI 10.1016/j.ijhydene.2008.02.080	36	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114821	10.1371/journal.pone.0114821	http://dx.doi.org/10.1371/journal.pone.0114821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532131	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100025
J	Das, D; Das, D; Padinhateeri, R				Das, Dipjyoti; Das, Dibyendu; Padinhateeri, Ranjith			Force-Induced Dynamical Properties of Multiple Cytoskeletal Filaments Are Distinct from that of Single Filaments	PLOS ONE			English	Article							ACTIN POLYMERIZATION; ATP-HYDROLYSIS; RATE CONSTANTS; STALL FORCE; INSTABILITY; MICROTUBULES; MODEL; GTP; CATASTROPHES; GENERATION	How cytoskeletal filaments collectively undergo growth and shrinkage is an intriguing question. Collective properties of multiple bio-filaments (actin or microtubules) undergoing hydrolysis have not been studied extensively earlier within simple theoretical frameworks. In this paper, we study the collective dynamical properties of multiple filaments under force, and demonstrate the distinct properties of a multi-filament system in comparison to a single filament. Comparing stochastic simulation results with recent experimental data, we show that multifilament collective catastrophes are slower than catastrophes of single filaments. Our study also shows further distinctions as follows: (i) force-dependence of the cap-size distribution of multiple filaments are quantitatively different from that of single filaments, (ii) the diffusion constant associated with the system length fluctuations is distinct for multiple filaments, and (iii) switching dynamics of multiple filaments between capped and uncapped states and the fluctuations therein are also distinct. We build a unified picture by establishing interconnections among all these collective phenomena. Additionally, we show that the collapse times during catastrophes can be sharp indicators of collective stall forces exceeding the additive contributions of single filaments.	[Das, Dipjyoti; Das, Dibyendu] Indian Inst Technol, Dept Phys, Mumbai 400076, Maharashtra, India; [Padinhateeri, Ranjith] Indian Inst Technol, Dept Biosci & Bioengn, Mumbai 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Das, D (corresponding author), Indian Inst Technol, Dept Phys, Mumbai 400076, Maharashtra, India.	dipjyoti@phy.iitb.ac.in; dibyendu@phy.iitb.ac.in; ranjithp@iitb.ac.in	Das, Dipjyoti/GYE-1057-2022	Das, Dipjyoti/0000-0002-5947-9090	CSIR India (JRF award) [09/087(0572)/2009-EMR-I]; IYBA, Department of Biotechnology India [BT/01/1YBAl2009]	CSIR India (JRF award); IYBA, Department of Biotechnology India	This work was supported by CSIR India (JRF award no. 09/087(0572)/2009-EMR-I) and IYBA, Department of Biotechnology India (No: BT/01/1YBAl2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041907; Bowne-Anderson H, 2013, BIOESSAYS, V35, P452, DOI 10.1002/bies.201200131; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Brun L, 2009, P NATL ACAD SCI USA, V106, P21173, DOI 10.1073/pnas.0910774106; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Dipjyoti D, 2014, NEW J PHYS, V16; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; DOGTEROM M, 1993, PHYS REV LETT, V70, P1347, DOI 10.1103/PhysRevLett.70.1347; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Emanuel M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061907; Flyvbjerg H, 1996, PHYS REV E, V54, P5538, DOI 10.1103/PhysRevE.54.5538; FLYVBJERG H, 1994, PHYS REV LETT, V73, P2372, DOI 10.1103/PhysRevLett.73.2372; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; Fujiwara I, 2002, NAT CELL BIOL, V4, P666, DOI 10.1038/ncb841; FYGENSON DK, 1994, PHYS REV E, V50, P1579, DOI 10.1103/PhysRevE.50.1579; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; HILL TL, 1981, P NATL ACAD SCI-BIOL, V78, P5613, DOI 10.1073/pnas.78.9.5613; Howard J, 2001, MECH MOTOR PROTEINS; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Jegou A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001161; Jemseena V, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032717; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Krawczyk J, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/28006; Laan L, 2008, P NATL ACAD SCI USA, V105, P8920, DOI 10.1073/pnas.0710311105; Li X, 2013, J PHYS CHEM B, V117, P9217, DOI 10.1021/jp404794f; Li X, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.048102; MELKI R, 1990, BIOCHEMISTRY-US, V29, P8921, DOI 10.1021/bi00490a007; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Padinhateeri R, 2012, BIOPHYS J, V102, P1274, DOI 10.1016/j.bpj.2011.12.059; PANTALONI D, 1985, P NATL ACAD SCI USA, V82, P7207, DOI 10.1073/pnas.82.21.7207; Phillips R., 2009, PHYS BIOL CELL; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Ramachandran S, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4817193; Ranjith P, 2010, BIOPHYS J, V98, P1418, DOI 10.1016/j.bpj.2009.12.4306; Ranjith P, 2009, BIOPHYS J, V96, P2146, DOI 10.1016/j.bpj.2008.12.3920; Schaus TE, 2008, BIOPHYS J, V95, P1393, DOI 10.1529/biophysj.107.125005; Stukalin EB, 2006, BIOPHYS J, V90, P2673, DOI 10.1529/biophysj.105.074211; Stukalin EB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1858859; Tsekouras K, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/10/103032; van Doorn GS, 2000, EUR BIOPHYS J BIOPHY, V29, P2, DOI 10.1007/s002490050245; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; VanBuren V, 2002, P NATL ACAD SCI USA, V99, P6035, DOI 10.1073/pnas.092504999; Vandecandelaere A, 1999, BIOCHEMISTRY-US, V38, P8179, DOI 10.1021/bi9830765; Vavylonis D, 2005, P NATL ACAD SCI USA, V102, P8543, DOI 10.1073/pnas.0501435102; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wu ZH, 2012, BIOPHYS J, V102, P2687, DOI 10.1016/j.bpj.2012.05.003; Zelinski B, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012703	51	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114014	10.1371/journal.pone.0114014	http://dx.doi.org/10.1371/journal.pone.0114014			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531397	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100008
J	Nile, DL; Brown, AE; Kumaheri, MA; Blair, HR; Heggie, A; Miwa, S; Cree, LM; Payne, B; Chinnery, PF; Brown, L; Gunn, DA; Walker, M				Nile, Donna L.; Brown, Audrey E.; Kumaheri, Meutia A.; Blair, Helen R.; Heggie, Alison; Miwa, Satomi; Cree, Lynsey M.; Payne, Brendan; Chinnery, Patrick F.; Brown, Louise; Gunn, David A.; Walker, Mark			Age-Related Mitochondrial DNA Depletion and the Impact on Pancreatic Beta Cell Function	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; COPY NUMBER; TRANSCRIPTION FACTOR; DIABETES-MELLITUS; GLUCOSE-TOLERANCE; US POPULATION; LINE; MTDNA; MAINTENANCE; DYSFUNCTION	Type 2 diabetes is characterised by an age-related decline in insulin secretion. We previously identified a 50% age-related decline in mitochondrial DNA (mtDNA) copy number in isolated human islets. The purpose of this study was to mimic this degree of mtDNA depletion in MIN6 cells to determine whether there is a direct impact on insulin secretion. Transcriptional silencing of mitochondrial transcription factor A, TFAM, decreased mtDNA levels by 40% in MIN6 cells. This level of mtDNA depletion significantly decreased mtDNA gene transcription and translation, resulting in reduced mitochondrial respiratory capacity and ATP production. Glucose-stimulated insulin secretion was impaired following partial mtDNA depletion, but was normalised following treatment with glibenclamide. This confirms that the deficit in the insulin secretory pathway precedes K+ channel closure, indicating that the impact of mtDNA depletion is at the level of mitochondrial respiration. In conclusion, partial mtDNA depletion to a degree comparable to that seen in aged human islets impaired mitochondrial function and directly decreased insulin secretion. Using our model of partial mtDNA depletion following targeted gene silencing of TFAM, we have managed to mimic the degree of mtDNA depletion observed in aged human islets, and have shown how this correlates with impaired insulin secretion. We therefore predict that the age-related mtDNAdepletion in human islets is not simply a biomarker of the aging process, but will contribute to the age-related risk of type 2 diabetes.	[Nile, Donna L.; Brown, Audrey E.; Kumaheri, Meutia A.; Blair, Helen R.; Heggie, Alison; Walker, Mark] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Miwa, Satomi] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Cree, Lynsey M.] Univ Auckland, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, Auckland 1142, New Zealand; [Payne, Brendan; Chinnery, Patrick F.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Brown, Louise; Gunn, David A.] Unilever R&D, Bedford MK44 1LQ, England	Newcastle University - UK; Newcastle University - UK; University of Auckland; Newcastle University - UK; Unilever	Walker, M (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	mark.walker@ncl.ac.uk	Payne, Brendan/I-1233-2016	Payne, Brendan/0000-0002-3101-3512; Gunn, David/0000-0001-9866-3221; Cree, Lynsey/0000-0003-2090-1589; Nile, Donna/0000-0002-4415-9502; Brown, Audrey/0000-0002-0222-4214; Chinnery, Patrick/0000-0002-7065-6617; Miwa, Satomi/0000-0002-1239-1198	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G529991/1]; Unilever; Newcastle National Institute for Health Research Biomedical Research Centre (NIHR BRC); Medical Research Council [G0800470] Funding Source: researchfish; National Institute for Health Research [CL-2013-01-004] Funding Source: researchfish; MRC [G0800470] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Unilever(Unilever); Newcastle National Institute for Health Research Biomedical Research Centre (NIHR BRC); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) Industrial CASE Studentship (grant reference BB/G529991/1) and as such, financial support was provided by Unilever. The authors acknowledge support of the Newcastle National Institute for Health Research Biomedical Research Centre (NIHR BRC). Co-authors Dr. David Gunn and Dr. Louise Brown are employed by Unilever R&D. Unilever R&D provided support in the form of salaries for authors Dr. David Gunn and Dr. Louise Brown, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Babu DA, 2007, MOL GENET METAB, V92, P43, DOI 10.1016/j.ymgme.2007.06.008; Basu R, 2003, DIABETES, V52, P1738, DOI 10.2337/diabetes.52.7.1738; Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; GROOP LC, 1992, DIABETES CARE, V15, P737, DOI 10.2337/diacare.15.6.737; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Hayakawa T, 1998, J BIOL CHEM, V273, P20300, DOI 10.1074/jbc.273.32.20300; Ihm SH, 2006, DIABETES, V55, P1361, DOI 10.2337/db05-1333; ISHIHARA H, 1994, J BIOL CHEM, V269, P3081; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; Koeck T, 2011, CELL METAB, V13, P80, DOI 10.1016/j.cmet.2010.12.007; Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; Lynn S, 2003, DIABETOLOGIA, V46, P296, DOI 10.1007/s00125-002-1018-z; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Maassen JA, 2001, EXP CLIN ENDOCR DIAB, V109, P127, DOI 10.1055/s-2001-14834; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Ohgaki K, 2007, J BIOCHEM, V141, P201, DOI 10.1093/jb/mvm020; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; RUDENSKI AS, 1988, DIABETIC MED, V5, P36, DOI 10.1111/j.1464-5491.1988.tb00938.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Sorensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Tsuruzoe K, 1998, DIABETES, V47, P621, DOI 10.2337/diabetes.47.4.621; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wollheim CB, 2000, DIABETOLOGIA, V43, P265, DOI 10.1007/s001250050044	48	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115433	10.1371/journal.pone.0115433	http://dx.doi.org/10.1371/journal.pone.0115433			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532126	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100065
J	Shiraishi, Y; Fujimoto, A; Furuta, M; Tanaka, H; Chiba, K; Boroevich, KA; Abe, T; Kawakami, Y; Ueno, M; Gotoh, K; Ariizumi, S; Shibuya, T; Nakano, K; Sasaki, A; Maejima, K; Kitada, R; Hayami, S; Shigekawa, Y; Marubashi, S; Yamada, T; Kubo, M; Ishikawa, O; Aikata, H; Arihiro, K; Ohdan, H; Yamamoto, M; Yamaue, H; Chayama, K; Tsunoda, T; Miyano, S; Nakagawa, H				Shiraishi, Yuichi; Fujimoto, Akihiro; Furuta, Mayuko; Tanaka, Hiroko; Chiba, Ken-ichi; Boroevich, Keith A.; Abe, Tetsuo; Kawakami, Yoshiiku; Ueno, Masaki; Gotoh, Kunihito; Ariizumi, Shun-ichi; Shibuya, Tetsuo; Nakano, Kaoru; Sasaki, Aya; Maejima, Kazuhiro; Kitada, Rina; Hayami, Shinya; Shigekawa, Yoshinobu; Marubashi, Shigeru; Yamada, Terumasa; Kubo, Michiaki; Ishikawa, Osamu; Aikata, Hiroshi; Arihiro, Koji; Ohdan, Hideki; Yamamoto, Masakazu; Yamaue, Hiroki; Chayama, Kazuaki; Tsunoda, Tatsuhiko; Miyano, Satoru; Nakagawa, Hidewaki			Integrated Analysis of Whole Genome and Transcriptome Sequencing Reveals Diverse Transcriptomic Aberrations Driven by Somatic Genomic Changes in Liver Cancers	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; MUTATIONS; SUPPRESSES; ALIGNMENT; TRANSLOCATIONS	Recent studies applying high-throughput sequencing technologies have identified several recurrently mutated genes and pathways in multiple cancer genomes. However, transcriptional consequences from these genomic alterations in cancer genome remain unclear. In this study, we performed integrated and comparative analyses of whole genomes and transcriptomes of 22 hepatitis B virus (HBV)-related hepatocellular carcinomas (HCCs) and their matched controls. Comparison of whole genome sequence (WGS) and RNA-Seq revealed much evidence that various types of genomic mutations triggered diverse transcriptional changes. Not only splice-site mutations, but also silent mutations in coding regions, deep intronic mutations and structural changes caused splicing aberrations. HBV integrations generated diverse patterns of virus-human fusion transcripts depending on affected gene, such as TERT, CDK15, FN1 and MLL4. Structural variations could drive overexpression of genes such as WNT ligands, with/without creating gene fusions. Furthermore, by taking account of genomic mutations causing transcriptional aberrations, we could improve the sensitivity of deleterious mutation detection in known cancer driver genes (TP53, AXIN1, ARID2, RPS6KA3), and identified recurrent disruptions in putative cancer driver genes such as HNF4A, CPS1, TSC1 and THRAP3 in HCCs. These findings indicate genomic alterations in cancer genome have diverse transcriptomic effects, and integrated analysis of WGS and RNA-Seq can facilitate the interpretation of a large number of genomic alterations detected in cancer genome.	[Shiraishi, Yuichi; Chiba, Ken-ichi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo 1088639, Japan; [Fujimoto, Akihiro; Furuta, Mayuko; Nakano, Kaoru; Sasaki, Aya; Maejima, Kazuhiro; Kitada, Rina; Nakagawa, Hidewaki] RIKEN, Ctr Integrat Med Sci, Lab Genome Sequencing Anal, Yokohama, Kanagawa 2300045, Japan; [Fujimoto, Akihiro; Boroevich, Keith A.; Abe, Tetsuo; Tsunoda, Tatsuhiko] RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa 2300045, Japan; [Tanaka, Hiroko; Shibuya, Tetsuo; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo 1088639, Japan; [Kawakami, Yoshiiku; Aikata, Hiroshi; Chayama, Kazuaki] Hiroshima Univ, Sch Med, Dept Med & Mol Sci, Hiroshima 7348551, Japan; [Ueno, Masaki; Hayami, Shinya; Shigekawa, Yoshinobu; Yamaue, Hiroki] Wakayama Med Univ, Dept Surg 2, Wakayama 6418510, Japan; [Gotoh, Kunihito; Marubashi, Shigeru; Yamada, Terumasa; Ishikawa, Osamu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Tokyo 5378511, Japan; [Ariizumi, Shun-ichi; Yamamoto, Masakazu] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Tokyo 1628666, Japan; [Arihiro, Koji] Hiroshima Univ, Dept Anat Pathol, Sch Med, Hiroshima 7348551, Japan; [Ohdan, Hideki] Hiroshima Univ, Sch Med, Dept Surg Gastroenterol, Hiroshima 7348551, Japan; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa 2300045, Japan	University of Tokyo; RIKEN; RIKEN; University of Tokyo; Hiroshima University; Wakayama Medical University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Tokyo Women's Medical University; Hiroshima University; Hiroshima University; RIKEN	Nakagawa, H (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Genome Sequencing Anal, Yokohama, Kanagawa 2300045, Japan.	hidewaki@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015; Hayami, Shinya/Y-3354-2019; Tsunoda, Tatsuhiko/K-2061-2014; Chayama, Kazuaki/B-2493-2016; Ohdan, Hideki/G-4719-2019	Hayami, Shinya/0000-0001-8392-2382; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Ohdan, Hideki/0000-0002-9066-1288; Chayama, Kazuaki/0000-0002-5530-5341; Miyano, Satoru/0000-0002-1753-6616; Boroevich, Keith/0000-0001-7095-7332	RIKEN President's Fund; Princess Takamatsu Cancer Research Fund; Takeda Science Foundation; Integrative Systems Understanding of Cancer for Advanced Diagnosis, Therapy and Prevention;  [24700272]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	RIKEN President's Fund; Princess Takamatsu Cancer Research Fund; Takeda Science Foundation(Takeda Science Foundation (TSF)); Integrative Systems Understanding of Cancer for Advanced Diagnosis, Therapy and Prevention; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding for this work came from the RIKEN President's Fund 2011, the Princess Takamatsu Cancer Research Fund, Takeda Science Foundation, Grand-in Aid for Scientific Research on Innovative Areas (Integrative Systems Understanding of Cancer for Advanced Diagnosis, Therapy and Prevention), and Grant-in-Aid for Young Scientists (B) 24700272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Ding D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003065; Dyomin VG, 1997, P NATL ACAD SCI USA, V94, P5728, DOI 10.1073/pnas.94.11.5728; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Flanagan SE, 2013, AM J HUM GENET, V92, P131, DOI 10.1016/j.ajhg.2012.11.017; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu HY, 2011, AM J PATHOL, V178, P652, DOI 10.1016/j.ajpath.2010.10.023; Liu JF, 2012, GENOME RES, V22, P2315, DOI 10.1101/gr.140988.112; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739; Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Paterlini-Brechot P, 2003, ONCOGENE, V22, P3911, DOI 10.1038/sj.onc.1206492; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Shiraishi Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt126; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	36	55	57	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114263	10.1371/journal.pone.0114263	http://dx.doi.org/10.1371/journal.pone.0114263			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526364	Green Submitted, Green Published, gold			2022-12-26	WOS:000347186200002
J	Zabetakis, D; Olson, MA; Anderson, GP; Legler, PM; Goldman, ER				Zabetakis, Dan; Olson, Mark A.; Anderson, George P.; Legler, Patricia M.; Goldman, Ellen R.			Evaluation of Disulfide Bond Position to Enhance the Thermal Stability of a Highly Stable Single Domain Antibody	PLOS ONE			English	Article							HEAVY-CHAIN ANTIBODIES; STABILIZATION; FRAGMENTS; IDENTIFICATION; REPERTOIRE; REGIONS; TOXIN; TOOL; VHH	Single domain antibodies are the small recombinant variable domains derived from camelid heavy-chain-only antibodies. They are renowned for their stability, in large part due to their ability to refold following thermal or chemical denaturation. In addition to refolding after heat denaturation, A3, a high affinity anti-Staphylococcal Enterotoxin B single domain antibody, possesses a melting temperature of similar to 84 degrees C, among the highest reported for a single domain antibody. In this work we utilized the recently described crystal structure of A3 to select locations for the insertion of a second disulfide bond and evaluated the impact that the addition of this second bond had on the melting temperature. Four double-disulfide versions of A3 were constructed and each was found to improve the melting temperature relative to the native structure without reducing affinity. Placement of the disulfide bond at a previously published position between framework regions 2 and 3 yielded the largest improvement (>6 degrees C), suggesting this location is optimal, and seemingly provides a universal route to raise the melting temperature of single domain antibodies. This study further demonstrates that even single domain antibodies with extremely high melting points can be further stabilized by addition of disulfide bonds.	[Zabetakis, Dan; Anderson, George P.; Legler, Patricia M.; Goldman, Ellen R.] US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA; [Olson, Mark A.] USAMRIID, Dept Cell Biol & Biochem, Frederick, MD 21702 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; United States Army Medical Research Institute of Infectious Diseases	Goldman, ER (corresponding author), US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA.	ellen.goldman@nrl.navy.mil	Anderson, George P/D-2461-2011	Anderson, George P/0000-0001-7545-9893	Defense Threat Reduction Agency [CBCALL12-LS6-2-0036]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the Defense Threat Reduction Agency (CBCALL12-LS6-2-0036). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Achour I, 2008, J IMMUNOL, V181, P2001, DOI 10.4049/jimmunol.181.3.2001; Anderson GP, 2012, ANAL CHEM, V84, P5198, DOI 10.1021/ac300864j; Compton JR, 2011, PROTEINS, V79, P1048, DOI 10.1002/prot.22933; Conrath KE, 2003, DEV COMP IMMUNOL, V27, P87, DOI 10.1016/S0145-305X(02)00071-X; De Genst E, 2006, DEV COMP IMMUNOL, V30, P187, DOI 10.1016/j.dci.2005.06.010; Dona V, 2010, J AGR FOOD CHEM, V58, P918, DOI 10.1021/jf902973c; Eyer L, 2012, VET MED-CZECH, V57, P439, DOI 10.17221/6336-VETMED; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; George J, 2014, PROTEINS, V82, P3101, DOI 10.1002/prot.24671; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Goldman ER, 2014, PROTEIN EXPRES PURIF, V95, P226, DOI 10.1016/j.pep.2014.01.003; Govaert J, 2012, J BIOL CHEM, V287, P1970, DOI 10.1074/jbc.M111.242818; Graef RR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-86; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; Hagihara Y, 2014, BBA-PROTEINS PROTEOM, V1844, P2016, DOI 10.1016/j.bbapap.2014.07.005; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Harmsen MM, 2000, MOL IMMUNOL, V37, P579, DOI 10.1016/S0161-5890(00)00081-X; Hussack G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028218; Kim DY, 2012, PROTEIN ENG DES SEL, V25, P581, DOI 10.1093/protein/gzs055; Kim HJ, 2012, ANAL CHEM, V84, P1165, DOI 10.1021/ac2030255; Lee MS, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3603964; Lee MS, 2010, J CHEM THEORY COMPUT, V6, P2477, DOI 10.1021/ct100062b; Liu JL, 2014, MOL IMMUNOL, V59, P194, DOI 10.1016/j.molimm.2014.02.014; Miklos AE, 2012, CHEM BIOL, V19, P449, DOI 10.1016/j.chembiol.2012.01.018; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; Perchiacca JM, 2014, PROTEIN ENG DES SEL, V27, P29, DOI 10.1093/protein/gzt058; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; Turner KB, 2014, PROTEIN ENG DES SEL, V27, P89, DOI 10.1093/protein/gzu001; van der Linden R, 2000, J IMMUNOL METHODS, V240, P185, DOI 10.1016/S0022-1759(00)00188-5; van der Linden RHJ, 2000, J BIOTECHNOL, V80, P261, DOI 10.1016/S0168-1656(00)00274-1; Walper SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106263; Wang N, 2009, PROTEINS, V76, P99, DOI 10.1002/prot.22319; Wang YR, 2013, ANAL CHEM, V85, P8298, DOI 10.1021/ac4015885; Yeh IC, 2008, J PHYS CHEM B, V112, P15064, DOI 10.1021/jp802469g; Zabetakis D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077678; Zarebski LM, 2005, J MOL BIOL, V349, P814, DOI 10.1016/j.jmb.2005.03.072	39	31	34	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115405	10.1371/journal.pone.0115405	http://dx.doi.org/10.1371/journal.pone.0115405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526640	Green Submitted, Green Published, gold			2022-12-26	WOS:000347186200025
J	Clements, GR; Lynam, AJ; Gaveau, D; Yap, WL; Lhota, S; Goosem, M; Laurance, S; Laurance, WF				Clements, Gopalasamy Reuben; Lynam, Antony J.; Gaveau, David; Yap, Wei Lim; Lhota, Stanislav; Goosem, Miriam; Laurance, Susan; Laurance, William F.			Where and How Are Roads Endangering Mammals in Southeast Asia's Forests?	PLOS ONE			English	Article							NATIONAL-PARK; PROTECTED AREA; CONSERVATION; IMPACTS; BIODIVERSITY; MITIGATION; ELEPHANTS; INDONESIA; SUMATRA; HABITAT	Habitat destruction and overhunting are two major drivers of mammal population declines and extinctions in tropical forests. The construction of roads can be a catalyst for these two threats. In Southeast Asia, the impacts of roads on mammals have not been well-documented at a regional scale. Before evidence-based conservation strategies can be developed to minimize the threat of roads to endangered mammals within this region, we first need to locate where and how roads are contributing to the conversion of their habitats and illegal hunting in each country. We interviewed 36 experts involved in mammal research from seven Southeast Asian countries to identify roads that are contributing the most, in their opinion, to habitat conversion and illegal hunting. Our experts highlighted 16 existing and eight planned roads - these potentially threaten 21% of the 117 endangered terrestrial mammals in those countries. Apart from gathering qualitative evidence from the literature to assess their claims, we demonstrate how species-distribution models, satellite imagery and animal-sign surveys can be used to provide quantitative evidence of roads causing impacts by (1) cutting through habitats where endangered mammals are likely to occur, (2) intensifying forest conversion, and (3) contributing to illegal hunting and wildlife trade. To our knowledge, ours is the first study to identify specific roads threatening endangered mammals in Southeast Asia. Further through highlighting the impacts of roads, we propose 10 measures to limit road impacts in the region.	[Clements, Gopalasamy Reuben; Goosem, Miriam; Laurance, Susan; Laurance, William F.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia; [Clements, Gopalasamy Reuben; Goosem, Miriam; Laurance, Susan; Laurance, William F.] James Cook Univ, Coll Marine & Environm Sci, Cairns, Qld, Australia; [Clements, Gopalasamy Reuben] Univ Malaysia Terengganu, Kenyir Res Inst, Kuala Terengganu, Malaysia; [Clements, Gopalasamy Reuben] Panthera, New York, NY USA; [Clements, Gopalasamy Reuben] Rimba, Selangor, Malaysia; [Clements, Gopalasamy Reuben] Univ Nottingham, Sch Geog, Selangor, Malaysia; [Clements, Gopalasamy Reuben] Monash Univ, Sch Sci, Selangor, Malaysia; [Lynam, Antony J.] Wildlife Conservat Soc, Ctr Global Conservat, New York, NY USA; [Gaveau, David] Ctr Int Forestry Res, Bogor, Indonesia; [Yap, Wei Lim] World Wide Fund Nat Malaysia, Petaling Jaya, Selangor, Malaysia; [Lhota, Stanislav] Czech Univ Life Sci, Dept Husb & Ethol, Prague, Czech Republic	James Cook University; James Cook University; Universiti Malaysia Terengganu; University of Nottingham Malaysia; Monash University; Monash University Sunway; Wildlife Conservation Society; CGIAR; Center for International Forestry Research (CIFOR); Czech University of Life Sciences Prague	Clements, GR (corresponding author), James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia.	mailtoreuben@myrimba.org	Laurance, Susan/G-6021-2011; Laurance, William F/B-2709-2012; Lynam, Antony/H-3036-2015; Goosem, Miriam/D-8677-2012	Laurance, Susan/0000-0002-2831-2933; Laurance, William F/0000-0003-4430-9408; Lynam, Antony/0000-0002-8395-7902; Goosem, Miriam/0000-0001-9332-022X; Clements, Gopalasamy Reuben/0000-0002-9715-4385	United States Fish and Wildlife Service Rhino and Tiger Conservation Fund [96200-0-G279]; Rufford Small Grant for Nature Conservation [8320-1]; Universiti Malaya Research Grant [RG359-12HNE]; Cleveland Metroparks Zoo and Cleveland Zoological Society Asian Seed Grant; IDEA WILD; James Cook University Graduate Research Scheme and James Cook University Postgraduate Research Scholarship; Australian Research Council	United States Fish and Wildlife Service Rhino and Tiger Conservation Fund; Rufford Small Grant for Nature Conservation; Universiti Malaya Research Grant; Cleveland Metroparks Zoo and Cleveland Zoological Society Asian Seed Grant; IDEA WILD; James Cook University Graduate Research Scheme and James Cook University Postgraduate Research Scholarship; Australian Research Council(Australian Research Council)	GRC received funding support from the United States Fish and Wildlife Service Rhino and Tiger Conservation Fund (96200-0-G279), Rufford Small Grant for Nature Conservation (8320-1), Universiti Malaya Research Grant (RG359-12HNE), Cleveland Metroparks Zoo and Cleveland Zoological Society Asian Seed Grant, IDEA WILD, James Cook University Graduate Research Scheme and James Cook University Postgraduate Research Scholarship. GRC and WFL also received support from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldwaik SZ, 2012, LANDSCAPE URBAN PLAN, V106, P103, DOI 10.1016/j.landurbplan.2012.02.010; [Anonymous], 2009, NEW STRAITS TIMES; [Anonymous], 2011, NEW STRAITS TIMES; Asian Development Bank, 2005, GREAT MEK SUBR BIOD; Asian Development Bank, 2008, PERF EV REP; Asian Development Bank, 2010, HIV PREV INFR MIT RI; Austin Sean C., 2007, Acta Zoologica Sinica, V53, P373; Aziz SA, 2010, FRONT ECOL ENVIRON, V8, P178, DOI 10.1890/10.WB.014; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bennett EL, 2008, HUNTING WILDLIFE TRO; Bennett EL, 2011, ORYX, V45, P476, DOI 10.1017/S003060531000178X; Blake S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003546; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Caldecott J.O., 2005, WORLD ATLAS GREAT AP; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; Channa P., 2009, STATUS HABITAT YELLO; Chapron G, 2008, J APPL ECOL, V45, P1667, DOI 10.1111/j.1365-2664.2008.01538.x; Clements GR, 2012, INTEGR ZOOL, V7, P400, DOI 10.1111/j.1749-4877.2012.00314.x; Clements Gopalasamy Reuben, 2012, Malaysian Naturalist, V65, P56; Clements GR, 2010, CONSERV BIOL, V24, P1437, DOI 10.1111/j.1523-1739.2010.01584.x; Clements GR, 2013, THESIS JAMES COOK U; Colon CP, 2002, J ZOOL, V257, P473, DOI 10.1017/S0952836902001073; *DEP WILDL NAT PAR, 2008, NAT TIG ACT PLAN MAL; Down to Earth, 2002, AC PUSH LEUS ROAD PL; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fahrig L, 2009, ECOL SOC, V14; Gaveau DLA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101654; Gaveau DLA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034013; Goosem M, 2001, WILDLIFE RES, V28, P351, DOI 10.1071/WR99093; Goosem Miriam, 1997, P241; Goosem Miriam, 2001, Ecological Management & Restoration, V2, P196, DOI 10.1046/j.1442-8903.2001.00084.x; Government of Laos, 2000, OV QUANT PART POV ST; Gray DD, 2006, HO CHI MINH TRAIL VI; Grieser-Johns A., 2005, GOING GOING GONE ILL; Gubbi S, 2012, CURR SCI INDIA, V102, P1047; International Centre for Environmental Management, 2003, LAO PDR NAT REP PROT; Jepson P, 2002, NAT AREA J, V22, P28; Johnson Arlyne, 2006, P232; Jones S, 2006, IDS BULL-I DEV STUD, V37, P28, DOI 10.1111/j.1759-5436.2006.tb00268.x; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Laurance WF, 2001, CONSERV BIOL, V15, P4, DOI 10.1046/j.1523-1739.2001.00_11-2.x; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Laurance WF, 2006, CONSERV BIOL, V20, P1251, DOI 10.1111/j.1523-1739.2006.00420.x; Laurance WF, 2014, NATURE, V513, P229, DOI 10.1038/nature13717; Laurance WF, 2013, NATURE, V495, P308, DOI 10.1038/495308a; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lesbarreres D, 2012, TRENDS ECOL EVOL, V27, P374, DOI 10.1016/j.tree.2012.01.015; Linkie M, 2003, ORYX, V37, P41, DOI 10.1017/S0030605303000103; Linkie M, 2008, BIOL CONSERV, V141, P2410, DOI 10.1016/j.biocon.2008.07.002; Long B, 2007, SMALL CARNIV CONSERV, V34, P39; Lynam A. J., 2003, NATL TIGER ACTION PL; Lynam AJ, 2006, ENVIRON MANAGE, V37, P30, DOI 10.1007/s00267-004-0273-9; Lynam AJ, 2013, LAW ENFORCEMENT ACTI; Lynam AJ, 1999, WILDLIFE CONSERVATIO, V102, P36; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Marris G, 2002, ENV BASELINE STUDY R; Martin Esmond, 2000, Biologist (London), V47, P27; Meijaard E, 2008, ECOL RES, V23, P21, DOI 10.1007/s11284-007-0342-7; Meijaard E, 2004, MAKE WILDLIFE CONSER; Ministry of Forestry, 2007, STRAT ACT PLAN SUM T; Nepstad D, 2001, FOREST ECOL MANAG, V154, P395, DOI 10.1016/S0378-1127(01)00511-4; Oswell AH., 2010, BIG CAT TRADE MYANMA; Peh KSH, 2011, BIOSCIENCE, V61, P27, DOI 10.1525/bio.2011.61.1.8; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Quintero JD, 2010, SMART GREEN INFRASTR; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Reid J, 2013, FINANCIAL MECH ENV C; Reuters, 2001, VIETN NEW HIGHW MAY; Robertson Y., 2002, BRIEFING DOCUMENT RO; Robichaud R, 2001, REV NATL PROTECTED A; Roger E, 2011, POPUL ECOL, V53, P215, DOI 10.1007/s10144-010-0209-6; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Shepherd C., 2008, WILD CAT TRADE MYANM; Shepherd CR, 2008, BIODIVERS CONSERV, V17, P35, DOI 10.1007/s10531-007-9228-9; Shepherd CR, 2007, TRANSPORT INFRASTRUC; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Singleton I., 2004, ORANGUTAN POPULATION; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Solichin S, 2002, THESIS U FREIBURG; Suarez E, 2009, ANIM CONSERV, V12, P364, DOI 10.1111/j.1469-1795.2009.00262.x; Sunderlin W. D, 2002, WHICH WAY FORWARD PE, P246; Taylor BD, 2010, WILDLIFE RES, V37, P320, DOI 10.1071/WR09171; TRAFFIC, 2001, NEW DOC SHEDS LIGHT; Travers H, 2011, INVESTIGATION DRIVER; van Beukering PJH, 2003, ECOL ECON, V44, P43, DOI 10.1016/S0921-8009(02)00224-0; van der Grift EA, 2013, BIODIVERS CONSERV, V22, P425, DOI 10.1007/s10531-012-0421-0; Vanthomme H, 2013, CONSERV BIOL, V27, P281, DOI 10.1111/cobi.12017; Varma S, 2008, ORYX, V42, P92, DOI 10.1017/S0030605308010090; Vayda Andrew P., 1996, BUGIS SETTLERS E KAL; Vidya TNC, 2010, BIOL CONSERV, V143, P1891, DOI 10.1016/j.biocon.2010.04.043; Weston Nigel, 2011, Australian Mammalogy, V33, P93, DOI 10.1071/AM11003; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; Wijedasa LS, 2012, REMOTE SENS-BASEL, V4, P2595, DOI 10.3390/rs4092595; Wildlife Conservation Society, 1999, SURV ASS CONS SUM TI; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; World Bank, 2013, DAT ROADS PAV TOT RO; Wulder MA, 2011, REMOTE SENS ENVIRON, V115, P747, DOI 10.1016/j.rse.2010.11.002; Zaw M, 2005, OPEN BORDERS DEMAND	105	151	156	4	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115376	10.1371/journal.pone.0115376	http://dx.doi.org/10.1371/journal.pone.0115376			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521297	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000348845600039
J	Gong, C; Fujino, K; Monteiro, LJ; Gomes, AR; Drost, R; Davidson-Smith, H; Takeda, S; Khoo, US; Jonkers, J; Sproul, D; Lam, EWF				Gong, C.; Fujino, K.; Monteiro, L. J.; Gomes, A. R.; Drost, R.; Davidson-Smith, H.; Takeda, S.; Khoo, U. S.; Jonkers, J.; Sproul, D.; Lam, E. W-F			FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer	ONCOGENE			English	Article							HISTONE METHYLTRANSFERASE EZH2; POLYCOMB TARGET GENES; DNA METHYLATION; CELL FATE; PROGNOSTIC-SIGNIFICANCE; ALPHA EXPRESSION; DIFFERENTIATION; INHIBITION; GATA-3; PROLIFERATION	FOXA1 expression correlates with the breast cancer luminal subtype and patient survival. RNA and protein analysis of a panel of breast cancer cell lines revealed that BRCA1 deficiency is associated with the downregulation of FOXA1 expression. Knockdown of BRCA1 resulted in the downregulation of FOXA1 expression and enhancement of FOXA1 promoter methylation in MCF-7 breast cancer cells, whereas the reconstitution of BRCA1 in Brca1-deficent mouse mammary epithelial cells (MMECs) promoted Foxa1 expression and methylation. These data suggest that BRCA1 suppresses FOXA1 hypermethylation and silencing. Consistently, the treatment of MMECs with the DNA methylation inhibitor 5-aza-2'-deoxycitydine induced Foxa1 mRNA expression. Furthermore, treatment with GSK126, an inhibitor of EZH2 methyltransferase activity, induced FOXA1 expression in BRCA1-deficient but not in BRCA1-reconstituted MMECs. Likewise, the depletion of EZH2 by small interfering RNA enhanced FOXA1 mRNA expression. Chromatin immunoprecipitation (ChIP) analysis demonstrated that BRCA1, EZH2, DNA methyltransferases (DNMT) 1/3a/3b and H3K27me3 are recruited to the endogenous FOXA1 promoter, further supporting the hypothesis that these proteins interact to modulate FOXA1 methylation and repression. Further co-immunoprecipitation and ChIP analysis showed that both BRCA1 and DNMT3b form complexes with EZH2 but not with each other, consistent with the notion that BRCA1 binds to EZH2 and negatively regulates its methyltransferase activity. We also found that EZH2 promotes and BRCA1 impairs the deposit of the gene silencing histone mark H3K27me3 on the FOXA1 promoter. These associations were validated in a familial breast cancer patient cohort. Integrated analysis of the global gene methylation and expression profiles of a set of 33 familial breast tumours revealed that FOXA1 promoter methylation is inversely correlated with the transcriptional expression of FOXA1 and that BRCA1 mutation breast cancer is significantly associated with FOXA1 methylation and downregulation of FOXA1 expression, providing physiological evidence to our findings that FOXA1 expression is regulated by methylation and chromatin silencing and that BRCA1 maintains FOXA1 expression through suppressing FOXA1 gene methylation in breast cancer.	[Gong, C.; Fujino, K.; Monteiro, L. J.; Gomes, A. R.; Lam, E. W-F] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London W12 0NN, England; [Gong, C.; Khoo, U. S.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Fujino, K.; Takeda, S.] Juntendo Univ, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo, Japan; [Drost, R.; Jonkers, J.] Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [Drost, R.; Jonkers, J.] Netherlands Canc Inst, Canc Genom Ctr Netherlands, Amsterdam, Netherlands; [Davidson-Smith, H.; Sproul, D.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland	Imperial College London; University of Hong Kong; Juntendo University; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Edinburgh	Lam, EWF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, ICTEM, Hammersmith Hosp Campus,Room 134,1st Floor, London W12 0NN, England.	eric.lam@imperial.ac.uk	Jonkers, Jos/AAG-3246-2019; Lam, Eric W-F/AAW-8566-2020; Khoo, Ui Soon/K-2041-2019; Khoo, Ui Soon/C-4293-2009; Monteiro, Lara J/AAU-8518-2020; Khoo, Ui Soon/C-1345-2014	Jonkers, Jos/0000-0002-9264-9792; Lam, Eric W-F/0000-0003-1274-3576; Khoo, Ui Soon/0000-0003-2200-7505; Khoo, Ui Soon/0000-0003-2200-7505; Takeda, Satoru/0000-0001-9547-1435	Breast Cancer Campaign; Cancer Research UK; Joint Imperial College London and University of Hong Kong; Research and Conference Grants from the University of Hong Kong (CRCG) [201007176118]; Biotechnology and Biological Sciences Research Council [BBS/B/03785] Funding Source: researchfish; Cancer Research UK [12011] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1234732] Funding Source: researchfish; Breast Cancer Campaign [2012NovPhD016, 2012MayPR070] Funding Source: researchfish	Breast Cancer Campaign; Cancer Research UK(Cancer Research UK); Joint Imperial College London and University of Hong Kong; Research and Conference Grants from the University of Hong Kong (CRCG); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Breast Cancer Campaign	This work is funded by grants from the Breast Cancer Campaign and Cancer Research UK. CG is a recipient of the Joint Imperial College London and University of Hong Kong studentship. We also thank Kevin Brennan and James M Flanagan (Department of Surgery and Cancer, Imperial College London) for their help with pyrosequencing. USK is supported by Research and Conference Grants from the University of Hong Kong (CRCG)(201007176118).	Albergaria A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2327; Bae WK, 2014, MOL CELL ENDOCRINOL, V382, P593, DOI 10.1016/j.mce.2013.05.002; Bernardo GM, 2013, ONCOGENE, V32, P554, DOI 10.1038/onc.2012.62; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Buckley NE, 2013, NUCLEIC ACIDS RES, V41, P8601, DOI 10.1093/nar/gkt626; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Ehrlich M, 2013, EPIGENOMICS-UK, V5, P553, DOI 10.2217/epi.13.43; Flanagan JM, 2010, AM J HUM GENET, V86, P420, DOI 10.1016/j.ajhg.2010.02.008; Gonzalez ME, 2011, CANCER RES, V71, P2360, DOI 10.1158/0008-5472.CAN-10-1933; Habashy HO, 2008, EUR J CANCER, V44, P1541, DOI 10.1016/j.ejca.2008.04.020; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Hsu NC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056256; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li JL, 2013, NAT NEUROSCI, V16, P1745, DOI 10.1038/nn.3564; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Liu ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040943; Martins-Taylor K, 2012, EPIGENETICS-US, V7, P71, DOI 10.4161/epi.7.1.18750; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mehta RJ, 2012, BREAST CANCER RES TR, V131, P881, DOI 10.1007/s10549-011-1482-6; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; Myatt SS, 2014, ONCOGENE, V33, P4316, DOI 10.1038/onc.2013.546; Nakshatri H, 2007, EXPERT OPIN THER TAR, V11, P507, DOI 10.1517/14728222.11.4.507; Nakshatri H, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001008; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; Puppe J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2354; Reddington JP, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r25; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sekiya T, 2009, GENE DEV, V23, P804, DOI 10.1101/gad.1775509; Tkocz D, 2012, ONCOGENE, V31, P3667, DOI 10.1038/onc.2011.531; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Velichutina I, 2010, BLOOD, V116, P5247, DOI 10.1182/blood-2010-04-280149; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang L, 2013, EMBO J, V32, P1584, DOI 10.1038/emboj.2013.95; Wilson BJ, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-49; Wu L, 2013, BREAST CANCER RES TR, V142, P619, DOI 10.1007/s10549-013-2774-9	47	29	33	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2015	34	39					5012	5024		10.1038/onc.2014.421	http://dx.doi.org/10.1038/onc.2014.421			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9RC	25531315	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-26	WOS:000361693300002
J	Dong, B; Li, H; Singh, AB; Cao, AQ; Liu, JW				Dong, Bin; Li, Hai; Singh, Amar Bahadur; Cao, Aiqin; Liu, Jingwen			Inhibition of PCSK9 Transcription by Berberine Involves Down-regulation of Hepatic HNF1 alpha Protein Expression through the Ubiquitin-Proteasome Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; LDL RECEPTOR; PLASMA PCSK9; LIVER; CHOLESTEROL; ATORVASTATIN; FENOFIBRATE; MECHANISM; BINDING; TARGET	Our previous in vitro studies have identified hepatocyte nuclear factor 1 alpha (HNF1 alpha) as an obligated trans-activator for PCSK9 gene expression and demonstrated its functional involvement in the suppression of PCSK9 expression by berberine (BBR), a natural cholesterol-lowering compound. In this study, we investigated the mechanism underlying the inhibitory effect of BBR on HNF1 alpha-mediated PCSK9 transcription. Administration of BBR to hyperlipidemic mice and hamsters lowered circulating PCSK9 concentrations and hepatic PCSK9 mRNA levels without affecting the gene expression of HNF1 alpha. However, hepatic HNF1 alpha protein levels were markedly reduced in BBR-treated animals as compared with the control. Using HepG2 cells as a model system, we obtained evidence that BBR treatment let to accelerated degradation of HNF1 alpha protein. By applying inhibitors to selectively block the ubiquitin proteasome system (UPS) and autophagy-lysosomal pathway, we show that HNF1 alpha protein content in HepG2 cells was not affected by bafilomycin A1 treatment, but it was dose-dependently increased by UPS inhibitors bortezomib and MG132. Bortezomib treatment elevated HNF1 alpha and PCSK9 cellular levels with concomitant reductions of LDL receptor protein. More-over, HNF1 alpha protein displayed a multiubiquitination ladder pattern in cells treated withBBRor overexpressing ubiquitin. By expressing GFP-HNF1 alpha fusion protein in cells, we observed that blocking UPS resulted in accumulation of GFP-HNF1 alpha in cytoplasm. Importantly, we show that the BBR reducing effects on HNF1 alpha protein and PCSK9 gene transcription can be eradicated by proteasome inhibitors. Altogether, our studies using BBR as a probe uncovered a new aspect of PCSK9 regulation by ubiquitin- induced proteasomal degradation of HNF1 alpha.	[Dong, Bin; Li, Hai; Singh, Amar Bahadur; Cao, Aiqin; Liu, Jingwen] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Liu, JW (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	Jingwen.Liu@va.gov	Singh, Amar B/I-2253-2014	Singh, Amar B/0000-0002-7677-2424	National Institutes of Health, NCCIH [1R01 AT002543-01A1, 1R01AT006336-01A1]; Department of Veterans Affairs (Office of Research and Development, Medical Research Service); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002543] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006336] Funding Source: NIH RePORTER	National Institutes of Health, NCCIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs (Office of Research and Development, Medical Research Service)(US Department of Veterans Affairs); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health, NCCIH, Grants 1R01 AT002543-01A1 and 1R01AT006336-01A1. This work was also supported by the Department of Veterans Affairs (Office of Research and Development, Medical Research Service).	Armendariz AD, 2009, CURR OPIN LIPIDOL, V20, P106, DOI 10.1097/MOL.0b013e3283295ee9; Astudillo AM, 2011, J BIOL CHEM, V286, P35299, DOI 10.1074/jbc.M111.277137; Cameron J, 2008, ATHEROSCLEROSIS, V201, P266, DOI 10.1016/j.atherosclerosis.2008.02.004; Cao AQ, 2011, J LIPID RES, V52, P518, DOI 10.1194/jlr.M010603; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Costet P, 2010, ATHEROSCLEROSIS, V212, P246, DOI 10.1016/j.atherosclerosis.2010.05.027; Dong B, 2014, ATHEROSCLEROSIS, V235, P449, DOI 10.1016/j.atherosclerosis.2014.05.931; Dong B, 2013, J LIPID RES, V54, P1241, DOI 10.1194/jlr.M032599; Dong B, 2010, J LIPID RES, V51, P1486, DOI 10.1194/jlr.M003566; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hershko A, 2005, ANGEW CHEM INT EDIT, V44, P5932, DOI 10.1002/anie.200501724; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huang L, 2009, CURR MED CHEM, V16, P931, DOI 10.2174/092986709787581860; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lambert G, 2008, CLIN CHEM, V54, P1038, DOI 10.1373/clinchem.2007.099747; Li H, 2012, BIOCHEM J, V443, P757, DOI 10.1042/BJ20111645; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Ling H, 2014, CARDIOVASC THER, V32, P82, DOI 10.1111/1755-5922.12056; Matsui C, 2012, J VIROL, V86, P12903, DOI 10.1128/JVI.01418-12; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; MENDEL DB, 1991, J BIOL CHEM, V266, P677; Park IN, 2004, MOL PHARMACOL, V65, P1475, DOI 10.1124/mol.65.6.1475; Peterson AS, 2008, J LIPID RES, V49, P1595, DOI 10.1194/jlr.CX00001-JLR200; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pontoglio M, 2001, J EXP MED, V194, P1683, DOI 10.1084/jem.194.11.1683; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Raal F, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000028; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shih DQ, 2001, DIABETES, V50, P2472, DOI 10.2337/diabetes.50.11.2472; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Singh AB, 2014, J LIPID RES, V55, P1397, DOI 10.1194/jlr.M049429; Thompson JL, 2013, ANN PHARMACOTHER, V47, P56, DOI 10.1345/aph.1R561; Welder G, 2010, J LIPID RES, V51, P2714, DOI 10.1194/jlr.M008144; Wu MH, 2012, ATHEROSCLEROSIS, V224, P401, DOI 10.1016/j.atherosclerosis.2012.08.012; Yoshizawa K, 2014, CANCER SCI, V105, P195, DOI 10.1111/cas.12335; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	42	99	105	3	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4047	4058		10.1074/jbc.M114.597229	http://dx.doi.org/10.1074/jbc.M114.597229			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25540198	Green Published, hybrid			2022-12-26	WOS:000349458400017
J	Langlois, C; Ramboarina, S; Cukkemane, A; Auzat, I; Chagot, B; Gilquin, B; Ignatiou, A; Petitpas, I; Kasotakis, E; Paternostre, M; White, HE; Orlova, EV; Baldus, M; Tavares, P; Zinn-Justin, S				Langlois, Chantal; Ramboarina, Stephanie; Cukkemane, Abhishek; Auzat, Isabelle; Chagot, Benjamin; Gilquin, Bernard; Ignatiou, Athanasios; Petitpas, Isabelle; Kasotakis, Emmanouil; Paternostre, Maite; White, Helen E.; Orlova, Elena V.; Baldus, Marc; Tavares, Paulo; Zinn-Justin, Sophie			Bacteriophage SPP1 Tail Tube Protein Self-assembles into beta-Structure-rich Tubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERVER; IDENTIFICATION; REVEALS; ORIGIN; PHAGES; C-13; DNA	The majority of known bacteriophages have long tails that serve for bacterial target recognition and viral DNA delivery into the host. These structures form a tube from the viral capsid to the bacterial cell. The tube is formed primarily by a helical array of tail tube protein (TTP) subunits. In phages with a contractile tail, the TTP tube is surrounded by a sheath structure. Here, we report the first evidence that a phage TTP, gp17.1 of siphophage SPP1, self-assembles into long tubes in the absence of other viral proteins. gp17.1 does not exhibit a stable globular structure when monomeric in solution, even if it was confidently predicted to adopt the beta-sandwich fold of phage lambda TTP. However, Fourier transform infrared and nuclear magnetic resonance spectroscopy analyses showed that its beta-sheet content increases significantly during tube assembly, suggesting that gp17.1 acquires a stable beta-sandwich fold only after self-assembly. EM analyses revealed that the tube is formed by hexameric rings stacked helicoidally with the same organization and helical parameters found for the tail of SPP1 virions. These parameters were used to build a pseudo-atomic model of the TTP tube. The large loop spanning residues 40-56 is located on the inner surface of the tube, at the interface between adjacent monomers and hexamers. In line with our structural predictions, deletion of this loop hinders gp17.1 tube assembly in vitro and interferes with SPP1 tail assembly during phage particle morphogenesis in bacteria.	[Langlois, Chantal; Ramboarina, Stephanie; Chagot, Benjamin; Gilquin, Bernard; Kasotakis, Emmanouil; Paternostre, Maite; Zinn-Justin, Sophie] CEA, UMR CNRS 8221, Lab Biol Struct & Radiobiol, F-91191 Gif Sur Yvette, France; [Langlois, Chantal; Ramboarina, Stephanie; Chagot, Benjamin; Gilquin, Bernard; Kasotakis, Emmanouil; Paternostre, Maite; Zinn-Justin, Sophie] CEA, CEA IBITECS, F-91191 Gif Sur Yvette, France; [Cukkemane, Abhishek; Baldus, Marc] Univ Utrecht, Dept Chem, NMR Spect Grp, Bijvoet Ctr Biomol Res,Fac Med, NL-3584 CH Utrecht, Netherlands; [Cukkemane, Abhishek] Tuljaram Chaturchand Coll, Dept Microbiol, Baramati 413102, India; [Auzat, Isabelle; Petitpas, Isabelle; Tavares, Paulo] CNRS, Ctr Rech Gif, CNRS UPR3296, Unite Virol Mol & Struct, F-91198 Gif Sur Yvette, France; [Ignatiou, Athanasios; White, Helen E.; Orlova, Elena V.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Utrecht University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of London; Birkbeck University London	Zinn-Justin, S (corresponding author), CEA, UMR CNRS 8221, Lab Biol Struct & Radiobiol, Saclay Bat 144, F-91191 Gif Sur Yvette, France.	sophie.zinn@cea.fr	Baldus, Marc/C-2737-2009; Chagot, Benjamin/AAC-6495-2019; Orlova, Elena/CAF-8290-2022; Kasotakis, Emmanouil/M-4980-2016	Baldus, Marc/0000-0001-7068-5613; Chagot, Benjamin/0000-0002-9153-0060; Kasotakis, Emmanouil/0000-0002-7263-1384; Tavares, Paulo/0000-0002-2566-4546; Orlova, Elena/0000-0003-3371-415X; cukkemane, abhishek/0000-0002-1532-6869; Paternostre, Maite/0000-0002-3303-8959	French Agence Nationale de la Recherche Program [ANR-09-BLAN-0149-01]; French National Infrastructure FRISBI Program; European Community's Seventh Framework Program, BioNMR Project [211800]; Commissariat a l'Energie Atomique-Eurotalents grant; Netherlands Organization for Scientific Research [700.26.121, 700.10.443]; BBSRC [BB/F012705/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F012705/1, B17360, 1350992] Funding Source: researchfish	French Agence Nationale de la Recherche Program(French National Research Agency (ANR)); French National Infrastructure FRISBI Program; European Community's Seventh Framework Program, BioNMR Project; Commissariat a l'Energie Atomique-Eurotalents grant; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by French Agence Nationale de la Recherche Program Grant ANR-09-BLAN-0149-01 (to P. T. and S. Z. J.), French National Infrastructure FRISBI Program, and European Community's Seventh Framework Program, BioNMR Project Contract 211800.; Supported by a Commissariat a l'Energie Atomique-Eurotalents grant.; Supported by the Netherlands Organization for Scientific Research Grants 700.26.121 and 700.10.443.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Auzat I, 2008, MOL MICROBIOL, V70, P557, DOI 10.1111/j.1365-2958.2008.06435.x; Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/00268979809483251; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; BEHRENS B, 1979, MOL GEN GENET, V175, P351, DOI 10.1007/BF00397235; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; CHAI S, 1992, J MOL BIOL, V224, P87, DOI 10.1016/0022-2836(92)90578-8; Davidson AR, 2012, ADV EXP MED BIOL, V726, P115, DOI 10.1007/978-1-4614-0980-9_6; Douzi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086918; Droge A, 2000, J MOL BIOL, V296, P103, DOI 10.1006/jmbi.1999.3449; Effantin G, 2013, STRUCTURE, V21, P298, DOI 10.1016/j.str.2012.12.017; Fokine A, 2013, J MOL BIOL, V425, P1731, DOI 10.1016/j.jmb.2013.02.012; Fraser JS, 2007, CURR OPIN MICROBIOL, V10, P382, DOI 10.1016/j.mib.2007.05.018; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Gradmann S, 2012, J BIOMOL NMR, V54, P377, DOI 10.1007/s10858-012-9681-y; HAIMA P, 1987, MOL GEN GENET, V209, P335, DOI 10.1007/BF00329663; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Isidro A, 2004, MOL MICROBIOL, V51, P949, DOI 10.1046/j.1365-2958.2003.03880.x; Jobichen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012910; Katsura I, 1990, Adv Biophys, V26, P1, DOI 10.1016/0065-227X(90)90004-D; KING J, 1971, J MOL BIOL, V58, P693, DOI 10.1016/0022-2836(71)90034-9; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; LEGRICE SFJ, 1990, METHOD ENZYMOL, V185, P201; Lopes A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1027; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MORAN CP, 1982, MOL GEN GENET, V186, P339, DOI 10.1007/BF00729452; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sassi M, 2013, J VIROL, V87, P8099, DOI 10.1128/JVI.01209-13; Seidel K, 2004, PHYS CHEM CHEM PHYS, V6, P5090, DOI 10.1039/b411689e; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; STEWART M, 1988, J ELECTRON MICR TECH, V9, P325, DOI 10.1002/jemt.1060090404; van Heel M, 2001, COLD SPRING HARB SYM, V66, P77, DOI 10.1101/sqb.2001.66.77; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; Veesler D, 2010, J BIOL CHEM, V285, P36666, DOI 10.1074/jbc.M110.157529; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	42	19	20	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3836	3849		10.1074/jbc.M114.613166	http://dx.doi.org/10.1074/jbc.M114.613166			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525268	Green Published, hybrid			2022-12-26	WOS:000349456000054
J	Downey, JS; Mashburn-Warren, L; Ayala, EA; Senadheera, DB; Hendrickson, WK; McCall, LW; Sweet, JG; Cvitkovitch, DG; Spatafora, GA; Goodman, SD				Downey, Jennifer S.; Mashburn-Warren, Lauren; Ayala, Eduardo A.; Senadheera, Dilani B.; Hendrickson, Whitney K.; McCall, Lathan W.; Sweet, Julie G.; Cvitkovitch, Dennis G.; Spatafora, Grace A.; Goodman, Steven D.			In vitro Manganese-Dependent Cross-Talk between Streptococcus mutans VicK and GcrR: Implications for Overlapping Stress Response Pathways	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; GLUCOSYLTRANSFERASE GTFBC OPERON; SIGNAL-TRANSDUCTION SYSTEM; BIOFILM FORMATION; 2-COMPONENT SYSTEM; GENETIC COMPETENCE; REGULATORY SYSTEM; EXPRESSION; VIRULENCE; GROWTH	Streptococcus mutans, a major acidogenic component of the dental plaque biofilm, has a key role in caries etiology. Previously, we demonstrated that the VicRK two-component signal transduction system modulates biofilm formation, oxidative stress and acid tolerance responses in S. mutans. Using in vitro phosphorylation assays, here we demonstrate for the first time, that in addition to activating its cognate response regulator protein, the sensor kinase, VicK can transphosphorylate a non-cognate stress regulatory response regulator, GcrR, in the presence of manganese. Manganese is an important micronutrient that has been previously correlated with caries incidence, and which serves as an effector of SloR-mediated metalloregulation in S. mutans. Our findings supporting regulatory effects of manganese on the VicRK, GcrR and SloR, and the cross-regulatory networks formed by these components are more complex than previously appreciated. Using DNaseI footprinting we observed overlapping DNA binding specificities for VicR and GcrR in native promoters, consistent with these proteins being part of the same transcriptional regulon. Our results also support a role for SloR as a positive regulator of the vicRK two component signaling system, since its transcription was drastically reduced in a SloR-deficient mutant. These findings demonstrate the regulatory complexities observed with the S. mutans manganese-dependent response, which involves cross-talk between non-cognate signal transduction systems (VicRK and GcrR) to modulate stress response pathways.	[Downey, Jennifer S.; Ayala, Eduardo A.] Univ So Calif, Div Biomed Sci, Herman Ostrow Sch Dent, Los Angeles, CA USA; [Mashburn-Warren, Lauren; Goodman, Steven D.] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH USA; [Senadheera, Dilani B.; Cvitkovitch, Dennis G.] Univ Toronto, Fac Dent, Dent Res Inst, Toronto, ON, Canada; [Hendrickson, Whitney K.; McCall, Lathan W.; Sweet, Julie G.; Spatafora, Grace A.] Middlebury Coll, Dept Biol, Middlebury, VT 05753 USA	University of Southern California; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Toronto	Spatafora, GA (corresponding author), Middlebury Coll, Dept Biol, Middlebury, VT 05753 USA.	spatafor@middlebury.edu; steven.goodman@nationwidechildrens.org	Goodman, Steven/C-5732-2013; H, W/AAM-2887-2020; Cvitkovitch, Dennis/AAF-9311-2020	Spatafora, Grace/0000-0003-2043-4853; Hendrickson, Whitney/0000-0003-4603-2879	National Institutes 6 of Health [5R01DE013230-09, 5R01DE014711-09]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013230] Funding Source: NIH RePORTER	National Institutes 6 of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the following grants funded by the National Institutes 6 of Health: 5R01DE013230-09 to S. D. G. & D. G. C. and 5R01DE014711-09 to G. A. S. & S. D. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the mansucript.	Adkins B L, 1970, N Y State Dent J, V36, P618; Ahn SJ, 2007, J BACTERIOL, V189, P8519, DOI 10.1128/JB.01180-07; Ahn SJ, 2007, J BACTERIOL, V189, P6293, DOI 10.1128/JB.00546-07; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; ARCHIBALD FS, 1981, J BACTERIOL, V146, P928, DOI 10.1128/JB.146.3.928-936.1981; Arirachakaran P, 2007, CARIES RES, V41, P497, DOI 10.1159/000110882; Ayala E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108027; Banas JA, 2004, FRONT BIOSCI-LANDMRK, V9, P1267, DOI 10.2741/1305; BELLI WA, 1991, APPL ENVIRON MICROB, V57, P1134, DOI 10.1128/AEM.57.4.1134-1138.1991; Biswas S, 2006, J BACTERIOL, V188, P988, DOI 10.1128/JB.188.3.988-998.2006; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Chong P, 2008, J BACTERIOL, V190, P4478, DOI 10.1128/JB.01961-07; Clausen VA, 2003, J MOL MICROB BIOTECH, V5, P252, DOI 10.1159/000071077; Dalton TL, 2006, J BACTERIOL, V188, P77, DOI 10.1128/JB.188.1.77-85.2006; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Deng DM, 2007, J DENT RES, V86, P606, DOI 10.1177/154405910708600705; Dmitriev A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020127; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Dunning DW, 2008, MICROBIOL-SGM, V154, P1132, DOI 10.1099/mic.0.2007/012492-0; Duque C, 2011, INFECT IMMUN, V79, P786, DOI 10.1128/IAI.00725-10; Eguchi Y, 2011, ANTIMICROB AGENTS CH, V55, P1475, DOI 10.1128/AAC.01646-10; Fabret C, 1998, J BACTERIOL, V180, P6375; Fozo EM, 2004, J BACTERIOL, V186, P4152, DOI 10.1128/JB.186.13.4152-4158.2004; Froehlich BJ, 2009, J BACTERIOL, V191, P673, DOI 10.1128/JB.01256-08; Fujiwara T, 2002, J DENT RES, V81, P109, DOI 10.1177/154405910208100205; Goodman SD, 2000, PLASMID, V43, P85, DOI 10.1006/plas.1999.1444; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Gryllos I, 2003, P NATL ACAD SCI USA, V100, P4227, DOI 10.1073/pnas.0636231100; Guckes KR, 2013, P NATL ACAD SCI USA, V110, P16592, DOI 10.1073/pnas.1315320110; Hamilton IR, 1998, ORAL MICROBIOL IMMUN, V13, P292, DOI 10.1111/j.1399-302X.1998.tb00710.x; Hanna MN, 2001, J BACTERIOL, V183, P5964, DOI 10.1128/JB.183.20.5964-5973.2001; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Idone V, 2003, INFECT IMMUN, V71, P4351, DOI 10.1128/IAI.71.8.4351-4360.2003; Jakubovics NS, 2002, MICROBIOL-SGM, V148, P3255, DOI 10.1099/00221287-148-10-3255; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; Kitten T, 2000, INFECT IMMUN, V68, P4441, DOI 10.1128/IAI.68.8.4441-4451.2000; KOBAYASHI H, 1986, J BIOL CHEM, V261, P627; Kremer BHA, 2001, J BACTERIOL, V183, P2543, DOI 10.1128/JB.183.8.2543-2552.2001; Li YH, 2002, J BACTERIOL, V184, P6333, DOI 10.1128/JB.184.22.6333-6342.2002; Li YH, 2001, J BACTERIOL, V183, P897, DOI 10.1128/JB.183.3.897-908.2001; Li YH, 2001, MICROBIOL-SGM, V147, P2841, DOI 10.1099/00221287-147-10-2841; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; LULU, 1992, INFECT IMMUN, V60, P3807; Mattos-Graner RO, 2006, J BACTERIOL, V188, P3813, DOI 10.1128/JB.01845-05; Mattos-Graner RO, 2004, J CLIN MICROBIOL, V42, P4586, DOI 10.1128/JCM.42.10.4586-4592.2004; Monchois V, 1999, FEMS MICROBIOL REV, V23, P131, DOI 10.1016/S0168-6445(98)00041-2; Ong CLY, 2013, INFECT IMMUN, V81, P421, DOI 10.1128/IAI.00805-12; Paik S, 2003, J BACTERIOL, V185, P5967, DOI 10.1128/JB.185.20.5967-5975.2003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quivey RG, 2000, ADV MICROB PHYSIOL, V42, P239, DOI 10.1016/S0065-2911(00)42004-7; Rolerson E, 2006, J BACTERIOL, V188, P5033, DOI 10.1128/JB.00155-06; Senadheera D, 2009, J BACTERIOL, V191, P6415, DOI 10.1128/JB.00793-09; Senadheera DB, 2012, J BACTERIOL, V194, P1307, DOI 10.1128/JB.06071-11; Senadheera MD, 2007, J BACTERIOL, V189, P1451, DOI 10.1128/JB.01161-06; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Shaw W V, 1975, Methods Enzymol, V43, P737; Spatafora G, 2001, MICROBIOL-SGM, V147, P1599, DOI 10.1099/00221287-147-6-1599; Stipp RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058271; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; Wagner C, 2002, INFECT IMMUN, V70, P6121, DOI 10.1128/IAI.70.11.6121-6128.2002; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Wayne KJ, 2012, MOL MICROBIOL, V86, P645, DOI 10.1111/mmi.12006; WEXLER DL, 1993, INFECT IMMUN, V61, P1259, DOI 10.1128/IAI.61.4.1259-1267.1993; Zeng L, 2008, MOL MICROBIOL, V70, P197, DOI 10.1111/j.1365-2958.2008.06403.x	72	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115975	10.1371/journal.pone.0115975	http://dx.doi.org/10.1371/journal.pone.0115975			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536343	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300094
J	Gonzalez-Granado, JM; Navarro-Puche, A; Molina-Sanchez, P; Blanco-Berrocal, M; Viana, R; de Mora, JF; Andres, V				Gonzalez-Granado, Jose M.; Navarro-Puche, Ana; Molina-Sanchez, Pedro; Blanco-Berrocal, Marta; Viana, Rosa; Font de Mora, Jaime; Andres, Vicente			Sorting Nexin 6 Enhances Lamin A Synthesis and Incorporation into the Nuclear Envelope	PLOS ONE			English	Article							A-TYPE LAMINS; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; CHROMATIN ORGANIZATION; MULTIPLE MECHANISMS; MUSCULAR-DYSTROPHY; C-FOS; CELLS; TRANSPORT; RETROMER	Nuclear lamins are important structural and functional proteins in mammalian cells, but little is known about the mechanisms and cofactors that regulate their traffic into the nucleus. Here, we demonstrate that trafficking of lamin A, but not lamin B1, and its assembly into the nuclear envelope are regulated by sorting nexin 6 (SNX6), a major component of the retromer that targets proteins and other molecules to specific subcellular locations. SNX6 interacts with lamin A in vitro and in vivo and links it to the outer surface of the endoplasmic reticulum in human and mouse cells. SNX6 transports its lamin A cargo to the nuclear envelope in a process that takes several hours. Lamin A protein levels in the nucleus augment or decrease, respectively, upon gain or loss of SNX6 function. We further show that SNX6-dependent lamin A nuclear import occurs across the nuclear pore complex via a RAN-GTP-dependent mechanism. These results identify SNX6 as a key regulator of lamin A synthesis and incorporation into the nuclear envelope.	[Gonzalez-Granado, Jose M.; Navarro-Puche, Ana; Molina-Sanchez, Pedro; Blanco-Berrocal, Marta; Andres, Vicente] Ctr Nacl Invest Cardiovasc, Dept Atherothrombosis Imaging & Epidemiol, Madrid, Spain; [Viana, Rosa] CSIC, Inst Biomed Valencia, Valencia, Spain; [Font de Mora, Jaime] Univ Catolica Valencia San Vicente Martir, Fac Med, Fdn Invest Hosp La Fe, Valencia, Spain; [Font de Mora, Jaime] Univ Catolica Valencia San Vicente Martir, Fac Med, Inst Valenciano Patol, Valencia, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Universidad Catolica de Valencia San Vicente Martir; Universidad Catolica de Valencia San Vicente Martir	Andres, V (corresponding author), Ctr Nacl Invest Cardiovasc, Dept Atherothrombosis Imaging & Epidemiol, Madrid, Spain.	vandres@cnic.es	Molina-Sánchez, Pedro/AAA-5721-2022; Andres, Vicente/I-6440-2014; de Mora, Jaime Font/H-6304-2015; de Mora, Jaime Font/AAK-7591-2021; Viana, Rosa/L-1922-2014; Gonzalez-Granado, Jose M/A-2952-2015; LARIJANI, Professor Banafshe/H-3909-2015	Andres, Vicente/0000-0002-0125-7209; de Mora, Jaime Font/0000-0002-6816-2095; de Mora, Jaime Font/0000-0002-6816-2095; Viana, Rosa/0000-0002-0036-0669; Gonzalez-Granado, Jose M/0000-0002-1177-869X; LARIJANI, Professor Banafshe/0000-0003-4735-1169; MOLINA SANCHEZ, PEDRO/0000-0003-1108-5145	Ministerio de Economia y Competitividad (MINECO); Fondo Europeo de Desarrollo Regional (FEDER) [SAF2010-16044]; Instituto de Salud Carlos III (ISCIII) [RD12/0042/0028]; Progeria Research Foundation; European Commission [317916-Liphos]; Sara Borrell ISCIII program [CP11/00145]; Miguel Servet ISCIII program [CP11/00145]; MINECO; Fundacion Pro-CNIC	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Progeria Research Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Sara Borrell ISCIII program; Miguel Servet ISCIII program; MINECO(Spanish Government); Fundacion Pro-CNIC	Work in VA's laboratory is supported by the Ministerio de Economia y Competitividad (MINECO) and Fondo Europeo de Desarrollo Regional (FEDER) (SAF2010-16044), Instituto de Salud Carlos III (ISCIII) (RD12/0042/0028), The Progeria Research Foundation, and the European Commission (Grant No 317916-Liphos). JMGG received salary support from the Sara Borrell and Miguel Servet (CP11/00145) ISCIII programs. The Centro Nacional de Investigaciones Cardiovasculares (CNIC) is supported by MINECO and Fundacion Pro-CNIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RL, 2013, CELL, V152, P1218, DOI 10.1016/j.cell.2013.02.042; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Braunagel SC, 2007, P NATL ACAD SCI USA, V104, P9307, DOI 10.1073/pnas.0703186104; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Broers JLV, 1999, J CELL SCI, V112, P3463; Burke B, 2013, NAT REV MOL CELL BIO, V14, P13, DOI 10.1038/nrm3488; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Carlton JG, 2005, CURR BIOL, V15, pR819, DOI 10.1016/j.cub.2005.10.012; Carroll P, 2001, DEV DYNAM, V221, P431, DOI 10.1002/dvdy.1163; Cavet ME, 2008, FASEB J, V22, P3607, DOI 10.1096/fj.07-094086; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Coppi MV, 1997, FEBS LETT, V405, P281, DOI 10.1016/S0014-5793(97)00182-8; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; Domart MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051150; FEY EG, 1984, J CELL BIOL, V98, P1973, DOI 10.1083/jcb.98.6.1973; FISKUM G, 1985, CELL CALCIUM, V6, P25, DOI 10.1016/0143-4160(85)90032-6; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; Fuster JJ, 2010, FASEB J, V24, P2998, DOI 10.1096/fj.09-138255; Georgatos SD, 1997, J CELL SCI, V110, P2129; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Goldberg MW, 2008, J CELL SCI, V121, P215, DOI 10.1242/jcs.022020; Goldberg MW, 2008, BIOCHEM SOC T, V36, P1339, DOI 10.1042/BST0361339; Gonzalez Jose M, 2011, Front Biosci (Schol Ed), V3, P1133; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Ibiza S, 2008, P NATL ACAD SCI USA, V105, P10507, DOI 10.1073/pnas.0711062105; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Kazgan N, 2010, MOL BIOL CELL, V21, P3433, DOI 10.1091/mbc.E10-04-0347; Kilic F, 1999, FEBS LETT, V450, P61, DOI 10.1016/S0014-5793(99)00482-2; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Lattanzi G, 2007, J CELL BIOCHEM, V102, P1149, DOI 10.1002/jcb.21467; Levine T, 2005, CURR OPIN CELL BIOL, V17, P362, DOI 10.1016/j.ceb.2005.06.005; Malik P, 2010, CELL MOL LIFE SCI, V67, P1353, DOI 10.1007/s00018-010-0257-2; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Massie C, 2006, NAT REV CANCER, V6, P403, DOI 10.1038/nrc1882; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Niu Y, 2013, NAT CELL BIOL, V15, P417, DOI 10.1038/ncb2710; Ohba T, 2004, J CELL BIOL, V167, P1051, DOI 10.1083/jcb.200409149; Okada H, 2010, FASEB J, V24, P2783, DOI 10.1096/fj.09-146357; Ostlund C, 2006, BIOCHEMISTRY-US, V45, P1374, DOI 10.1021/bi052156n; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Raharjo WH, 2001, J CELL SCI, V114, P4447; Saksena S, 2004, P NATL ACAD SCI USA, V101, P12537, DOI 10.1073/pnas.0404934101; Saksena S, 2006, NAT STRUCT MOL BIOL, V13, P500, DOI 10.1038/nsmb1098; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Small SA, 2008, ARCH NEUROL-CHICAGO, V65, P323, DOI 10.1001/archneurol.2007.64; SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Tapley EC, 2011, MOL BIOL CELL, V22, P1739, DOI 10.1091/mbc.E10-08-0733; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; van Weering JRT, 2012, EMBO J, V31, P4466, DOI 10.1038/emboj.2012.283; Verges M, 2007, FRONT BIOSCI-LANDMRK, V12, P3825, DOI 10.2741/2355; Verstraeten VLRM, 2007, CURR MED CHEM, V14, P1231; VINDELOV LL, 1977, VIRCHOWS ARCH B, V24, P227; Wilson KL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000554; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Xia WF, 2013, J CELL BIOL, V200, P821, DOI 10.1083/jcb.201207154; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zuleger N, 2008, BIOCHEM SOC T, V36, P1373, DOI 10.1042/BST0361373	74	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115571	10.1371/journal.pone.0115571	http://dx.doi.org/10.1371/journal.pone.0115571			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535984	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300051
J	Wang, D; Ren, M; Guo, JM; Yang, G; Long, XH; Hu, R; Shen, WJ; Wang, XF; Zeng, KB				Wang, Dan; Ren, Min; Guo, Jiamei; Yang, Guang; Long, Xianghua; Hu, Rong; Shen, Wenjing; Wang, Xuefeng; Zeng, Kebin			The Inhibitory Effects of Npas4 on Seizures in Pilocarpine-Induced Epileptic Rats	PLOS ONE			English	Article							PAS DOMAIN PROTEIN; SYNAPTIC REORGANIZATION; NEURAL ACTIVITY; SYNAPSIN-I; PHOSPHORYLATION; IDENTIFICATION; TRANSCRIPTION; EXCITABILITY; EXPRESSION; OUTGROWTH	To explore the effects of neuronal Per-Arnt-Sim domain protein 4 (Npas4) on seizures in pilocarpine-induced epileptic rats, Npas4 expression was detected by double-label immunofluorescence, immunohistochemistry, and Western blotting in the brains of pilocarpine-induced epileptic model rats at 6 h, 24 h, 72 h, 7 d, 14 d, 30 d, and 60 d after status epilepticus. Npas4 was localized primarily in the nucleus and in the cytoplasm of neurons. The Npas4 protein levels increased in the acute phase of seizures (between 6 h and 72 h) and decreased in the chronic phases (between 7 d and 60 d) in the rat model. Npas4 expression was knocked down by specific siRNA interference. Then, the animals were treated with pilocarpine, and the effects on seizures were evaluated on the 7th day. The onset latencies of pilocarpine-induced seizures were decreased, while the seizure frequency, duration and attack rate increased in these rats. Our study indicates that Npas4 inhibits seizure attacks in pilocarpine-induced epileptic rats.	[Wang, Dan; Ren, Min; Yang, Guang; Long, Xianghua; Hu, Rong; Shen, Wenjing; Wang, Xuefeng; Zeng, Kebin] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing Key Lab Neurol, Chongqing, Peoples R China; [Guo, Jiamei] Chongqing Med Univ, Affiliated Hosp 1, Dept Psychiat, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Zeng, KB (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing Key Lab Neurol, Chongqing, Peoples R China.	zkebin2008@aliyun.com			Chongqing Health Bureau Fund, China [2011-2-118]; Science Foundation of Chongqing Science and Technology Commission, China [CSTC2012jjA10065]; National Key Clinical Specialty Discipline Construction Program of China	Chongqing Health Bureau Fund, China; Science Foundation of Chongqing Science and Technology Commission, China; National Key Clinical Specialty Discipline Construction Program of China	The study was supported by Chongqing Health Bureau Fund, China (No. 2011-2-118 to KBZ), a grant from Science Foundation of Chongqing Science and Technology Commission, China (No. CSTC2012jjA10065 to KBZ), and the National Key Clinical Specialty Discipline Construction Program of China to Department of Neurology, the First Affiliated Hospital of Chongqing Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataie Z, 2013, ADV PHARM BULL, V3, P353, DOI 10.5681/apb.2013.057; Bersten DC, 2014, BBA-GENE REGUL MECH, V1839, P13, DOI 10.1016/j.bbagrm.2013.11.004; Bonanomi D, 2005, J NEUROSCI, V25, P7299, DOI 10.1523/JNEUROSCI.1573-05.2005; Brenner RP, 2004, J CLIN NEUROPHYSIOL, V21, P319; Brunskill EW, 1999, MECH DEVELOP, V88, P237, DOI 10.1016/S0925-4773(99)00182-3; Butz M, 2009, BRAIN RES REV, V60, P287, DOI 10.1016/j.brainresrev.2008.12.023; Bykhovskaia M, 2011, SEMIN CELL DEV BIOL, V22, P387, DOI 10.1016/j.semcdb.2011.07.003; Cavazos JE, 2006, EPILEPSY BEHAV, V8, P483, DOI 10.1016/j.yebeh.2006.01.011; Flood WD, 2004, EUR J NEUROSCI, V20, P1819, DOI 10.1111/j.1460-9568.2004.03646.x; Fornasiero EF, 2010, CELL MOL LIFE SCI, V67, P1383, DOI 10.1007/s00018-009-0227-8; Jutrast MJ, 2010, CURR OPIN NEUROBIOL, V20, P150, DOI 10.1016/j.conb.2010.02.006; Kanter-Schlifke I, 2007, NEUROREPORT, V18, P845, DOI 10.1097/WNR.0b013e32811e1506; Klaric TS, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt453; Leslie JH, 2011, PROG NEUROBIOL, V94, P223, DOI 10.1016/j.pneurobio.2011.05.002; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Majores M, 2007, EPILEPSIA, V48, P4, DOI 10.1111/j.1528-1167.2007.01062.x; Malas S, 2003, NEUROSCIENCE, V119, P421, DOI 10.1016/S0306-4522(03)00158-1; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Ooe N, 2009, J BIOL CHEM, V284, P1057, DOI 10.1074/jbc.M805196200; Pantakani DVK, 2008, J NEUROCHEM, V106, P613, DOI 10.1111/j.1471-4159.2008.05414.x; Pitkanen A, 2007, EPILEPSIA, V48, P13, DOI 10.1111/j.1528-1167.2007.01063.x; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Seifert G, 2010, BRAIN RES REV, V63, P212, DOI 10.1016/j.brainresrev.2009.10.004; Shamloo M, 2006, EUR J NEUROSCI, V24, P2705, DOI 10.1111/j.1460-9568.2006.05172.x; Shupliakov O, 2011, SEMIN CELL DEV BIOL, V22, P393, DOI 10.1016/j.semcdb.2011.07.006; Sim SY, 2013, J NEUROSCI, V33, P7928, DOI 10.1523/JNEUROSCI.1571-12.2013; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; Talathi SS, 2009, NEUROSCI LETT, V455, P145, DOI 10.1016/j.neulet.2009.03.057; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Wang LA, 2010, NEUROCHEM INT, V57, P899, DOI 10.1016/j.neuint.2010.09.009; Xu YL, 2012, AM J PATHOL, V180, P1950, DOI 10.1016/j.ajpath.2012.01.024; Yun J, 2013, J BIOL CHEM, V288, P2655, DOI 10.1074/jbc.M112.413310; Zeng KB, 2009, NEUROCHEM RES, V34, P899, DOI 10.1007/s11064-008-9856-9; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	38	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115801	10.1371/journal.pone.0115801	http://dx.doi.org/10.1371/journal.pone.0115801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536221	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300075
J	Andres, C; Aguilar, J; Gonzalez-Ramirez, R; Elias-Vinas, D; Felix, R; Delgado-Lezama, R				Andres, Carmen; Aguilar, Justo; Gonzalez-Ramirez, Ricardo; Elias-Vinas, David; Felix, Ricardo; Delgado-Lezama, Rodolfo			Extrasynaptic alpha(6) Subunit-Containing GABA(A) Receptors Modulate Excitability in Turtle Spinal Motoneurons	PLOS ONE			English	Article							GRANULE CELLS; MESSENGER-RNAS; TONIC INHIBITION; CORD; ACTIVATION; DIVERSITY; NEURONS	Motoneurons are furnished with a vast repertoire of ionotropic and metabotropic receptors as well as ion channels responsible for maintaining the resting membrane potential and involved in the regulation of the mechanisms underlying its membrane excitability and firing properties. Among them, the GABA(A) receptors, which respond to GABA binding by allowing the flow of Cl- ions across the membrane, mediate two distinct forms of inhibition in the mature nervous system, phasic and tonic, upon activation of synaptic or extrasynaptic receptors, respectively. In a previous work we showed that furosemide facilitates the monosynaptic reflex without affecting the dorsal root potential. Our data also revealed a tonic inhibition mediated by GABA(A) receptors activated in motoneurons by ambient GABA. These data suggested that the high affinity GABA(A) extrasynaptic receptors may have an important role in motor control, though the molecular nature of these receptors was not determined. By combining electrophysiological, immunofluorescence and molecular biology techniques with pharmacological tools here we show that GABA(A) receptors containing the alpha(6) subunit are expressed in adult turtle spinal motoneurons and can function as extrasynaptic receptors responsible for tonic inhibition. These results expand our understanding of the role of GABA(A) receptors in motoneuron tonic inhibition.	[Andres, Carmen; Aguilar, Justo; Delgado-Lezama, Rodolfo] IPN, CINVESTAV, Dept Fisiol Biofis & Neurociencias, Mexico City 07738, DF, Mexico; [Gonzalez-Ramirez, Ricardo] Hosp Gen Dr Manuel Gea Gonzalez, Dept Biol Mol Histocompatibilidad, Mexico City, DF, Mexico; [Elias-Vinas, David] IPN, CINVESTAV, Dept Bioelect, Mexico City 07738, DF, Mexico; [Felix, Ricardo] IPN, CINVESTAV, Dept Biol Celular, Mexico City 07738, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Delgado-Lezama, R (corresponding author), IPN, CINVESTAV, Dept Fisiol Biofis & Neurociencias, Mexico City 07738, DF, Mexico.	rdelgado@fisio.cinvestav.mx	González-Ramírez, Ricardo/O-1792-2014; Felix, Ricardo/A-6989-2008	González-Ramírez, Ricardo/0000-0003-1399-8036; Felix, Ricardo/0000-0002-5383-7176	National Council for Science and Technology (Conacyt) [128125, 128707]	National Council for Science and Technology (Conacyt)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from The National Council for Science and Technology (Conacyt) to RDL (128125) and RF (128707). http://www.conacyt.mx/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista W, 2010, J PHYSIOL-LONDON, V588, P2621, DOI 10.1113/jphysiol.2010.188979; Bohlhalter S, 1996, J NEUROSCI, V16, P283, DOI 10.1523/jneurosci.16-01-00283.1996; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Castro A, 2011, NEUROSCIENCE, V192, P74, DOI 10.1016/j.neuroscience.2011.06.073; Castro A, 2011, BIOCHEM BIOPH RES CO, V412, P26, DOI 10.1016/j.bbrc.2011.07.026; Delgado-Lezama R, 2004, J NEUROPHYSIOL, V91, P40, DOI 10.1152/jn.00569.2003; Delgado-Lezama R, 2013, CURR PHARM DESIGN, V19, P4485, DOI 10.2174/1381612811319240013; Drummond GB, 2009, J PHYSIOL-LONDON, V587, P713, DOI 10.1113/jphysiol.2008.167387; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Hochman DW, 2000, J NEUROPHYSIOL, V83, P406, DOI 10.1152/jn.2000.83.1.406; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V398, P575, DOI 10.1113/jphysiol.1988.sp017058; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; KORPI ER, 1995, MOL PHARMACOL, V47, P283; Loeza-Alcocer E, 2013, J NEUROPHYSIOL, V110, P2175, DOI 10.1152/jn.00330.2013; MA W, 1993, J COMP NEUROL, V338, P337, DOI 10.1002/cne.903380303; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; PERSOHN E, 1991, NEUROSCIENCE, V42, P497, DOI 10.1016/0306-4522(91)90392-2; Petri S, 2005, J NEUROL SCI, V238, P25, DOI 10.1016/j.jns.2005.06.005; Pinard A, 2010, ADV PHARMACOL, V58, P231, DOI 10.1016/S1054-3589(10)58010-4; Ruano D, 2000, NEUROREPORT, V11, P3169, DOI 10.1097/00001756-200009280-00025; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Thompson SA, 1999, MOL PHARMACOL, V55, P993, DOI 10.1124/mol.55.6.993; Wall MJ, 2003, NEUROPHARMACOLOGY, V44, P56, DOI 10.1016/S0028-3908(02)00331-3; WISDEN W, 1991, MOL BRAIN RES, V10, P179, DOI 10.1016/0169-328X(91)90109-B	29	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115378	10.1371/journal.pone.0115378	http://dx.doi.org/10.1371/journal.pone.0115378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531288	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845100057
J	Canham, M; Charsou, C; Stewart, J; Moncur, S; Hoodless, L; Bhatia, R; Cong, DD; Cubie, H; Busby-Earle, C; Williams, A; McLoughlin, V; Campbell, JDM; Cuschieri, K; Howie, S				Canham, Maurice; Charsou, Chara; Stewart, June; Moncur, Sharon; Hoodless, Laura; Bhatia, Ramya; Cong, Duanduan; Cubie, Heather; Busby-Earle, Camille; Williams, Alistair; McLoughlin, Victoria; Campbell, John D. M.; Cuschieri, Kate; Howie, Sarah			Increased Cycling Cell Numbers and Stem Cell Associated Proteins as Potential Biomarkers for High Grade Human Papillomavirus plus ve Pre-Neoplastic Cervical Disease	PLOS ONE			English	Article							P53 HOMOLOG P63; PROSPECTIVE IDENTIFICATION; CANCER; EXPRESSION; SOX2; PODOCALYXIN; CARCINOMA; BREAST; EZRIN; MARKERS	High risk (oncogenic) human papillomavirus (HPV) infection causes cervical cancer. Infections are common but most clear naturally. Persistent infection can progress to cancer. Pre-neoplastic disease (cervical intraepithelial neoplasia/CIN) is classified by histology (CIN1-3) according to severity. Cervical abnormalities are screened for by cytology and/or detection of high risk HPV but both methods are imperfect for prediction of which women need treatment. There is a need to understand the host virus interactions that lead to different disease outcomes and to develop biomarker tests for accurate triage of infected women. As cancer is increasingly presumed to develop from proliferative, tumour initiating, cancer stem cells (CSCs), and as other oncogenic viruses induce stem cell associated gene expression, we evaluated whether presence of mRNA (detected by qRT-PCR) or proteins (detected by flow cytometry and antibody based proteomic microarray) from stem cell associated genes and/or increased cell proliferation (detected by flow cytometry) could be detected in well-characterised, routinely collected cervical samples from high risk HPV+ve women. Both cytology and histology results were available for most samples with moderate to high grade abnormality. We found that stem cell associated proteins including human chorionic gonadotropin, the oncogene TP63 and the transcription factor SOX2 were upregulated in samples from women with CIN3 and that the stem cell related, cell surface, protein podocalyxin was detectable on cells in samples from a subset of women with CIN3. SOX2, TP63 and human gonadotrophin mRNAs were upregulated in high grade disease. Immunohistochemistry showed that SOX2 and TP63 proteins clearly delineated tumour cells in invasive squamous cervical cancer. Samples from women with CIN3 showed increased proliferating cells. We believe that these markers may be of use to develop triage tests for women with high grade cervical abnormality to distinguish those who may progress to cancer from those who may be treated more conservatively.	[Canham, Maurice; Bhatia, Ramya; Cubie, Heather] Univ Edinburgh, Human Papillomavirus Grp, Edinburgh, Midlothian, Scotland; [Canham, Maurice; Campbell, John D. M.] Univ Edinburgh, Med Res Council Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Charsou, Chara; Stewart, June; Moncur, Sharon; Hoodless, Laura; Cong, Duanduan; Howie, Sarah] Univ Edinburgh, Med Res Council Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Busby-Earle, Camille] Royal Infirm Edinburgh NHS Trust, Simpson Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Williams, Alistair] Univ Edinburgh, Simpson Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [McLoughlin, Victoria; Campbell, John D. M.] Natl Sci Lab, Scottish Natl Blood Transfus Serv, Edinburgh, Midlothian, Scotland; [Cuschieri, Kate] Royal Infirm Edinburgh NHS Trust, Scottish Human Papillomavirus Reference Lab, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Howie, S (corresponding author), Univ Edinburgh, Med Res Council Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.	s.e.m.howie@ed.ac.uk	Campbell, John/A-5792-2011	Campbell, John/0000-0002-6752-3493; Canham, Maurice/0000-0003-1620-8044; Hoodless, Laura/0000-0002-9679-0611; Howie, Sarah/0000-0001-7291-3499	Chief Scientist Office, Scotland [ETM/145]; Medical Research Council [1586600] Funding Source: researchfish; Chief Scientist Office [CZB/4/658] Funding Source: researchfish; MRC [G0901697] Funding Source: UKRI	Chief Scientist Office, Scotland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by grant number ETM/145 from the Chief Scientist Office, Scotland (http://www.cso.scot.nhs.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Auvinen E, 2013, NEOPLASMA, V60, P56, DOI 10.4149/neo_2013_008; Badcock G, 1999, CANCER RES, V59, P4715; Barbareschi M, 2001, AM J SURG PATHOL, V25, P1054, DOI 10.1097/00000478-200108000-00010; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Cipollone JA, 2012, CLIN EXP METASTAS, V29, P239, DOI 10.1007/s10585-011-9446-0; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cuschieri K, 2013, DIAGN MOL PATHOL, V22, P85, DOI 10.1097/PDM.0b013e31827f3f7e; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Forse CL, 2013, BREAST CANCER RES TR, V137, P709, DOI 10.1007/s10549-012-2392-y; Hameed A, 1999, INT J GYNECOL PATHOL, V18, P381, DOI 10.1097/00004347-199910000-00014; Hsu YH, 2010, AM J PATHOL, V176, P3050, DOI 10.2353/ajpath.2010.090539; Huang CF, 2014, J ORAL PATHOL MED, V43, P492, DOI 10.1111/jop.12159; Iles RK, 2007, MOL CELL ENDOCRINOL, V260, P264, DOI 10.1016/j.mce.2006.02.019; Ji J, 2010, HUM PATHOL, V41, P1438, DOI 10.1016/j.humpath.2009.11.021; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim YT, 2005, YONSEI MED J, V46, P597, DOI 10.3349/ymj.2005.46.5.597; Kondo S, 2011, J VIROL, V85, P11255, DOI 10.1128/JVI.00188-11; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Ma RS, 2014, J CLIN ENDOCR METAB, V99, pE400, DOI 10.1210/jc.2013-3545; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Machida K, 2012, J GASTROEN HEPATOL, V27, P19, DOI 10.1111/j.1440-1746.2011.07010.x; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Orlando RA, 2001, J AM SOC NEPHROL, V12, P1589, DOI 10.1681/ASN.V1281589; Pinto AE, 2011, PATHOL RES PRACT, V207, P623, DOI 10.1016/j.prp.2011.07.007; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quade BJ, 2001, GYNECOL ONCOL, V80, P24, DOI 10.1006/gyno.2000.5953; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Ramsey MR, 2013, J CLIN INVEST, V123, P3525, DOI 10.1172/JCI68899; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sanada Y, 2006, PANCREAS, V32, P164, DOI 10.1097/01.mpa.0000202947.80117.a0; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schopperle WM, 2007, STEM CELLS, V25, P723, DOI 10.1634/stemcells.2005-0597; Schopperle WM, 2010, BIOCHEM BIOPH RES CO, V398, P372, DOI 10.1016/j.bbrc.2010.06.074; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shah RB, 2002, AM J SURG PATHOL, V26, P1161, DOI 10.1097/00000478-200209000-00006; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Sun D, 2014, WORLD J GASTROENTERO, V20, P6974, DOI 10.3748/wjg.v20.i22.6974; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tan J, 2011, TUMOR BIOL, V32, P1241, DOI 10.1007/s13277-011-0228-8; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Wang L, 2013, MOL CELL BIOCHEM, V379, P7, DOI 10.1007/s11010-013-1621-y; Wang TY, 2001, HUM PATHOL, V32, P479, DOI 10.1053/hupa.2001.24324; Watanabe H, 2014, J CLIN INVEST, V124, P1636, DOI 10.1172/JCI71545; Yang CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099412; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yasuoka H, 2012, J CLIN PATHOL, V65, P399, DOI 10.1136/jclinpath-2011-200359; Zhang JW, 2013, INT J GYNECOL CANCER, V23, P318, DOI 10.1097/IGC.0b013e31827f6f06; Zhu D, 2014, INT J GYNECOL CANCER, V24, P643, DOI 10.1097/IGC.0000000000000122; ZUR HH, 2009, VIROLOGY, V384, P260, DOI DOI 10.1016/J.VIROL.2008.11.046	59	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115379	10.1371/journal.pone.0115379	http://dx.doi.org/10.1371/journal.pone.0115379			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531390	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100058
J	Corre, G; Stockholm, D; Arnaud, O; Kaneko, G; Vinuelas, J; Yamagata, Y; Thi, MANN; Kupiec, JJ; Beslon, G; Gandrillon, O; Paldi, A				Corre, Guillaume; Stockholm, Daniel; Arnaud, Ophelie; Kaneko, Gael; Vinuelas, Jose; Yamagata, Yoshiaki; Thi My Anh Neildez-Nguyen; Kupiec, Jean-Jacques; Beslon, Guillaume; Gandrillon, Olivier; Paldi, Andras			Stochastic Fluctuations and Distributed Control of Gene Expression Impact Cellular Memory	PLOS ONE			English	Article							NOISE	Despite the stochastic noise that characterizes all cellular processes the cells are able to maintain and transmit to their daughter cells the stable level of gene expression. In order to better understand this phenomenon, we investigated the temporal dynamics of gene expression variation using a double reporter gene model. We compared cell clones with transgenes coding for highly stable mRNA and fluorescent proteins with clones expressing destabilized mRNA-s and proteins. Both types of clones displayed strong heterogeneity of reporter gene expression levels. However, cells expressing stable gene products produced daughter cells with similar level of reporter proteins, while in cell clones with short mRNA and protein half-lives the epigenetic memory of the gene expression level was completely suppressed. Computer simulations also confirmed the role of mRNA and protein stability in the conservation of constant gene expression levels over several cell generations. These data indicate that the conservation of a stable phenotype in a cellular lineage may largely depend on the slow turnover of mRNA-s and proteins.	[Corre, Guillaume; Stockholm, Daniel; Thi My Anh Neildez-Nguyen; Paldi, Andras] Univ Evry Val dEssonne, INSERM, UMR 951, F-91002 Evry, France; [Corre, Guillaume; Stockholm, Daniel; Thi My Anh Neildez-Nguyen; Paldi, Andras] Ecole Prat Hautes Etud, Paris, France; [Arnaud, Ophelie; Kaneko, Gael; Vinuelas, Jose; Gandrillon, Olivier] Univ Lyon 1, Ctr Genet & Physiol Mol & Cellulaire CGPhiMC, CNRS, UMR5534, F-69622 Lyon, France; [Kaneko, Gael; Beslon, Guillaume] Univ Lyon, INSA Lyon, Lab InfoRmat Image & Syst Informat LIRIS, INRIA,CNRS UMR5205, F-69621 Lyon, France; [Kupiec, Jean-Jacques] Ecole Normale Super, Ctr Cavailles, F-75005 Paris, France; [Yamagata, Yoshiaki] Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynaecol, Ube, Yamaguchi 755, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Inria; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Yamaguchi University	Paldi, A (corresponding author), Univ Evry Val dEssonne, INSERM, UMR 951, F-91002 Evry, France.	paldi@genethon.fr	corre, guillaume/T-9696-2019; Corre, Guillaume/G-8392-2015	corre, guillaume/0000-0002-0755-8336; Corre, Guillaume/0000-0002-0755-8336; Beslon, Guillaume/0000-0001-8562-0732	Agence National de Recherche, grant Stochagene, Genethon [BSV6 014 02]; Genopole Research-Evry; University Evry Val d'Essonne; Conseil General de l'Essonne; Region Ile de France; AXA PhD fellowship; Department of Obstetrics and Gynaecology, Yamaguchi University Graduate School of Medicine, Ube, Japan	Agence National de Recherche, grant Stochagene, Genethon(French National Research Agency (ANR)); Genopole Research-Evry; University Evry Val d'Essonne; Conseil General de l'Essonne(General Electric); Region Ile de France(Region Ile-de-France); AXA PhD fellowship(AXA Research Fund); Department of Obstetrics and Gynaecology, Yamaguchi University Graduate School of Medicine, Ube, Japan	Agence National de Recherche, grant Stochagene grant no. BSV6 014 02, Genethon. Equipment funds were from Genopole Research-Evry, University Evry Val d'Essonne, Conseil General de l'Essonne and from Region Ile de France. GC was a recipient of an AXA PhD fellowship. YY was financed by Department of Obstetrics and Gynaecology, Yamaguchi University Graduate School of Medicine, Ube, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Benjamin D, 2006, MOL BIOSYST, V2, P561, DOI 10.1039/b609448a; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Golubev A, 2012, BIOESSAYS, V34, P311, DOI 10.1002/bies.201100119; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kitsera N, 2007, BIOTECHNIQUES, V43, P222, DOI 10.2144/000112479; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Neildez-Nguyen TMA, 2008, DIFFERENTIATION, V76, P33, DOI 10.1111/j.1432-0436.2007.00219.x; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Schwanhausser B, 2013, BIOESSAYS, V35, P597, DOI 10.1002/bies.201300017; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Team RDCao, 2005, R LANG ENV STAT COMP; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Vinayagam A, 2014, NAT METHODS, V11, P94, DOI [10.1038/nmeth.2733, 10.1038/NMETH.2733]; Vinuelas J, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-15; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	20	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115574	10.1371/journal.pone.0115574	http://dx.doi.org/10.1371/journal.pone.0115574			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531401	gold, Green Published			2022-12-26	WOS:000348845100078
J	Liu, M; Li, Y; Zhang, YQ; Zhao, XL; Zhai, B; Zhang, QY; Wang, LJ; Zhao, Y; Li, HH; Wang, QS; Gao, CJ; Huang, WR; Yu, L				Liu, Mingjuan; Li, Yan; Zhang, Yongqing; Zhao, Xiaoli; Zhai, Bing; Zhang, Qingyi; Wang, Lijun; Zhao, Yu; Li, Honghua; Wang, Quanshun; Gao, Chunji; Huang, Wenrong; Yu, Li			Secondary Antifungal Prophylaxis in Hematological Malignancy Patients with Previous Invasive Fungal Disease: A Retrospective Analysis	PLOS ONE			English	Article							CELL TRANSPLANT RECIPIENTS; RISK-FACTORS; LEUKEMIA PATIENTS; INFECTION; ASPERGILLOSIS; EPIDEMIOLOGY; VORICONAZOLE; SCT; EFFICACY; IMPACT	Background: Invasive fungal disease (IFD) causes morbidity and mortality in patients with hematological malignancy. Recurrence of IFD after chemotherapy or hematopoietic stem cell transplantation (HSCT) is associated with poor prognosis. The present study aimed to investigate the efficacy of different strategies of secondary antifungal prophylaxis (SAP) for IFD and choose an appropriate SAP regimen. Methods: Clinical data of patients with previous IFD who underwent chemotherapy or HSCT between Jan 2008 and Jun 2013 were retrospectively reviewed and followed up to 180 days post-chemotherapy or HSCT. The clinical characteristics and diagnosis were analyzed according to the diagnostic criteria for IFD. The efficacy of different strategies for SAP and risk factors influencing the failure of SAP were evaluated. Results: Of the 164 patients enrolled, 121 patients received SAP regimen (73.78%), and IFD recurred in 40 patients: 16.5% (20/121) in SAP group and 46.5% (20/43) in non-SAP group. In SAP group, 58 received SAP agents which were proven effective for their previous IFD, while other 63 patients received other broad-spectrum antifungal agents. There was no significant difference in the recurrence rates between these two subgroups (13.8% (8/58) vs 19.0% (12/63), P=0.437). The IFD recurrence rates were statistically significant between patients with allogeneic HSCTand chemotherapy or autologous HSCT (25% vs 8.2%, P=0.013). Multivariate analysis indicated that allogeneic HSCT was the independent risk factor of IFD recurrence after SAP. Conclusions: Secondary antifungal prophylaxis is necessary to prevent IFD recurrence in patients with hematological malignancy, especially for patients in the setting of allogeneic HSCT.	[Liu, Mingjuan; Li, Yan; Zhao, Xiaoli; Zhai, Bing; Zhang, Qingyi; Wang, Lijun; Zhao, Yu; Li, Honghua; Wang, Quanshun; Gao, Chunji; Huang, Wenrong; Yu, Li] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing 100853, Peoples R China; [Liu, Mingjuan; Li, Yan; Zhao, Xiaoli; Zhai, Bing; Zhang, Qingyi; Wang, Lijun; Zhao, Yu; Li, Honghua; Wang, Quanshun; Gao, Chunji; Huang, Wenrong; Yu, Li] Chinese Peoples Liberat Army Gen Hosp, BMT Ctr, Beijing 100853, Peoples R China; [Liu, Mingjuan; Zhang, Yongqing] Chinese Peoples Liberat Army, Hosp 309, Dept Hematol, Beijing 100091, Peoples R China; [Li, Yan; Huang, Wenrong] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Hainan Branch, Sanya City 572013, Hainan, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Huang, WR (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, 28 Fuxing Rd, Beijing 100853, Peoples R China.	huangwr301@163.com; chunhuiliyu@yahoo.com		Yu, Li/0000-0001-6872-2665	National Basic Research Program of China [2005CB522400]; National Natural Science Foundation of China [90919044, 30971297, 81170518, 81270611]; Capital Medical Development Scientific Research Fund [SF2001-5001-07]; National Public Health Grant Research Foundation [201202017]; capital of the public health project [Z111107067311070]; Technology Innovation Nursery Foundation [13KMM01]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Medical Development Scientific Research Fund; National Public Health Grant Research Foundation; capital of the public health project; Technology Innovation Nursery Foundation	This work was supported by grants from the National Basic Research Program of China (2005CB522400), National Natural Science Foundation of China (90919044, 30971297, 81170518, 81270611), Capital Medical Development Scientific Research Fund (SF2001-5001-07), National Public Health Grant Research Foundation (201202017), the capital of the public health project (Z111107067311070) and Technology Innovation Nursery Foundation (13KMM01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki ZS, 2008, TRANSPL P, V40, P1579, DOI 10.1016/j.transproceed.2008.03.149; Allinson K, 2008, J ANTIMICROB CHEMOTH, V61, P734, DOI 10.1093/jac/dkm521; Auberger J, 2008, INT J HEMATOL, V88, P508, DOI 10.1007/s12185-008-0184-2; Avivi I, 2004, AM J HEMATOL, V75, P6, DOI 10.1002/ajh.10447; Cahuayme-Zuniga L, 2012, MED MYCOL, V50, P543, DOI 10.3109/13693786.2011.631152; Chinese Invasive Fungal Infections Cooperative Group, 2010, CHINESE J INTERN MED, V49, P451; Cordonnier C, 2004, BONE MARROW TRANSPL, V33, P943, DOI 10.1038/sj.bmt.1704469; Cordonnier C, 2010, HAEMATOL-HEMATOL J, V95, P1762, DOI 10.3324/haematol.2009.020073; Cornely OA, 2008, INFECTION, V36, P296, DOI 10.1007/s15010-008-7357-z; Cornely OA, 2008, J ANTIMICROB CHEMOTH, V61, P939, DOI 10.1093/jac/dkn027; de Fabritiis P, 2007, BONE MARROW TRANSPL, V40, P245, DOI 10.1038/sj.bmt.1705720; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; El-Cheikh J, 2010, LEUKEMIA LYMPHOMA, V51, P1705, DOI 10.3109/10428194.2010.500433; Fukuda T, 2004, BIOL BLOOD MARROW TR, V10, P494, DOI 10.1016/j.bbmt.2004.02.006; Georgiadou SP, 2013, BONE MARROW TRANSPL, V48, P141, DOI 10.1038/bmt.2012.89; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Lee Ji Yean, 2012, Korean J Hematol, V47, P255, DOI 10.5045/kjh.2012.47.4.255; Li Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-255; Li Yan, 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V21, P161, DOI 10.7534/j.issn.1009-2137.2013.01.033; Liu F, 2013, TRANSPL INFECT DIS, V15, P243, DOI 10.1111/tid.12068; Maertens J, 2011, BONE MARROW TRANSPL, V46, P709, DOI 10.1038/bmt.2010.175; Masamoto Y, 2011, J CHEMOTHERAPY, V23, P17, DOI 10.1179/joc.2011.23.1.17; Maschmeyer G, 2007, DRUGS, V67, P1567, DOI 10.2165/00003495-200767110-00004; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Offner F, 1998, CLIN INFECT DIS, V26, P1098, DOI 10.1086/520274; Salmenniemi U, 2013, BONE MARROW TRANSPL, V48, P1262, DOI 10.1038/bmt.2013.45; Sipsas NV, 2006, CLIN INFECT DIS, V42, P1584, DOI 10.1086/503844; Song A, 2010, INT J HEMATOL, V92, P725, DOI 10.1007/s12185-010-0723-5; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; Vehreschild JJ, 2009, INT J ANTIMICROB AG, V34, P446, DOI 10.1016/j.ijantimicag.2009.06.025; Zhang P, 2009, BONE MARROW TRANSPL, V43, P533, DOI 10.1038/bmt.2008.356	31	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115461	10.1371/journal.pone.0115461	http://dx.doi.org/10.1371/journal.pone.0115461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531544	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100070
J	Song, LW; Yang, MC; Knoff, JN; Wu, TC; Hung, CF				Song, Liwen; Yang, Ming-Chieh; Knoff, Jayne; Wu, T. -C.; Hung, Chien-Fu			Cancer Immunotherapy Employing an Innovative Strategy to Enhance CD4+T Cell Help in the Tumor Microenvironment	PLOS ONE			English	Article							CROSS-PRESENTATION; ANTIGENIC PEPTIDE; IMMUNE-RESPONSES; VACCINE POTENCY; CPG DNA; ADJUVANT; RADIOTHERAPY; COMBINATION; DELIVERY	Chemotherapy and/or radiation therapy are widely used as cancer treatments, but the antitumor effects they produce can be enhanced when combined with immunotherapies. Chemotherapy kills tumor cells, but it also releases tumor antigen and allows the cross-presentation of the tumor antigen to trigger antigen-specific cell-mediated immune responses. Promoting CD4+ T helper cell immune responses can be used to enhance the cross-presentation of the tumor antigen following chemotherapy. The pan HLA-DR binding epitope (PADRE peptide) is capable of generating antigen-specific CD4+ T cells that bind various MHC class II molecules with high affinity and has been widely used in conjunction with vaccines to improve their potency by enhancing CD4+ T cell responses. Here, we investigated whether intratumoral injection of PADRE and the adjuvant CpG into HPV16 E7-expressing TC-1 tumors following cisplatin chemotherapy could lead to potent antitumor effects and antigen-specific cell-mediated immune responses. We observed that treatment with all three agents produced the most potent antitumor effects compared to pairwise combinations. Moreover, treatment with cisplatin, CpG and PADRE was able to control tumors at a distant site, indicating that our approach is able to induce cross-presentation of the tumor antigen. Treatment with cisplatin, CpG and PADRE also enhanced the generation of PADRE-specific CD4+ T cells and E7-specific CD8+ T cells and decreased the number of MDSCs in tumor loci. The treatment regimen presented here represents a universal approach to cancer control.	[Song, Liwen] Tongji Univ, Shanghai Peoples Hosp 10, Dept Obstet & Gynecol, Shanghai 200092, Peoples R China; [Song, Liwen] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China; [Song, Liwen] Shanghai Inst Planned Parenthood Res, Dept Pharmacol & Toxicol, Shanghai, Peoples R China; [Song, Liwen; Knoff, Jayne; Wu, T. -C.; Hung, Chien-Fu] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Wu, T. -C.] Johns Hopkins Med Inst, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; [Wu, T. -C.] Johns Hopkins Med Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Wu, T. -C.; Hung, Chien-Fu] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Yang, Ming-Chieh] Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan	Tongji University; Fudan University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Kaohsiung Veterans General Hospital	Hung, CF (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.	chung2@jhmi.edu		Bissonette, Jayne/0000-0001-8376-9242	National Institutes of Health/National Cancer Institute Cervical Cancer [SPORE P50CA098252, 2R01CA114425-06]; NATIONAL CANCER INSTITUTE [P50CA098252, R01CA114425] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute Cervical Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health/National Cancer Institute Cervical Cancer SPORE P50CA098252 and 2R01CA114425-06 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Carpentier AF, 1999, CANCER RES, V59, P5429; Chuang TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108808; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Gray RC, 2007, J LEUKOCYTE BIOL, V81, P1075, DOI 10.1189/jlb.1006606; Hung CF, 2007, MOL THER, V15, P1211, DOI 10.1038/sj.mt.6300121; Kang TH, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-48; Kang TH, 2013, CANCER RES, V73, P2493, DOI 10.1158/0008-5472.CAN-12-4241; Kang TH, 2013, MOL THER, V21, P542, DOI 10.1038/mt.2012.233; Kim D, 2008, GENE THER, V15, P677, DOI 10.1038/sj.gt.3303102; Kuchtey J, 2005, J IMMUNOL, V175, P2244, DOI 10.4049/jimmunol.175.4.2244; La Rosa C, 2012, J INFECT DIS, V205, P1294, DOI 10.1093/infdis/jis107; Lee S, 2010, CANCER IMMUNOL IMMUN, V59, P1073, DOI 10.1007/s00262-010-0834-0; Lin KY, 1996, CANCER RES, V56, P21; Link BK, 2006, J IMMUNOTHER, V29, P558, DOI 10.1097/01.cji.0000211304.60126.8f; Meng YX, 2005, INT J CANCER, V116, P992, DOI 10.1002/ijc.21131; Peng SW, 2013, CANCER IMMUNOL IMMUN, V62, P171, DOI 10.1007/s00262-012-1322-5; Shirota H, 2014, EXPERT REV VACCINES, V13, P299, DOI 10.1586/14760584.2014.863715; Sinha P, 2011, BLOOD, V117, P5381, DOI 10.1182/blood-2010-11-321752; Wierecky J, 2006, CANCER RES, V66, P5910, DOI 10.1158/0008-5472.CAN-05-3905; Wu A, 2011, GENE THER, V18, P304, DOI 10.1038/gt.2010.151; Wu CY, 2014, CLIN CANCER RES, V20, P644, DOI 10.1158/1078-0432.CCR-13-1334; Wu CY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-88; Zoglmeier C, 2011, CLIN CANCER RES, V17, P1765, DOI 10.1158/1078-0432.CCR-10-2672	26	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115711	10.1371/journal.pone.0115711	http://dx.doi.org/10.1371/journal.pone.0115711			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531529	gold, Green Submitted, Green Published			2022-12-26	WOS:000348845100100
J	Zhang, WY; Xu, YC; Li, WL; Yang, L; Yue, X; Zhang, XS; Zhao, XY				Zhang, Wei Yang; Xu, Yong Chao; Li, Wen Lan; Yang, Long; Yue, Xun; Zhang, Xian Sheng; Zhao, Xiang Yu			Transcriptional Analyses of Natural Leaf Senescence in Maize	PLOS ONE			English	Article							HARVESTING-COMPLEX-II; E3 UBIQUITIN LIGASE; CELL-DEATH; CHLOROPHYLL BREAKDOWN; PLANT SENESCENCE; GENE-EXPRESSION; HYPERSENSITIVE RESPONSE; WRKY53 TRANSCRIPTION; REGULATORY CASCADE; ARABIDOPSIS LEAVES	Leaf senescence is an important biological process that contributes to grain yield in crops. To study the molecular mechanisms underlying natural leaf senescence, we harvested three different developmental ear leaves of maize, mature leaves (ML), early senescent leaves (ESL), and later senescent leaves (LSL), and analyzed transcriptional changes using RNA-sequencing. Three sets of data, ESL vs. ML, LSL vs. ML, and LSL vs. ESL, were compared, respectively. In total, 4,552 genes were identified as differentially expressed. Functional classification placed these genes into 18 categories including protein metabolism, transporters, and signal transduction. At the early stage of leaf senescence, genes involved in aromatic amino acids (AAAs) biosynthetic process and transport, cellular polysaccharide biosynthetic process, and the cell wall macromolecule catabolic process, were up-regulated. Whereas, genes involved in amino acid metabolism, transport, apoptosis, and response to stimulus were up-regulated at the late stage of leaf senescence. Further analyses reveals that the transport-related genes at the early stage of leaf senescence potentially take part in enzyme and amino acid transport and the genes upregulated at the late stage are involved in sugar transport, indicating nutrient recycling mainly takes place at the late stage of leaf senescence. Comparison between the data of natural leaf senescence in this study and previously reported data for Arabidopsis implies that the mechanisms of leaf senescence in maize are basically similar to those in Arabidopsis. A comparison of natural and induced leaf senescence in maize was performed. Athough many basic biological processes involved in senescence occur in both types of leaf senescence, 78.07% of differentially expressed genes in natural leaf senescence were not identifiable in induced leaf senescence, suggesting that differences in gene regulatory network may exist between these two leaf senescence programs. Thus, this study provides important information for understanding the mechanism of leaf senescence in maize.	[Zhang, Wei Yang; Li, Wen Lan; Zhang, Xian Sheng; Zhao, Xiang Yu] Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Xu, Yong Chao; Yang, Long] Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China; [Yue, Xun] Shandong Agr Univ, Coll Informat Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Shandong Agricultural University	Zhao, XY (corresponding author), Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	zhxy@sdau.edu.cn	zhang, xian/GYA-0290-2022	Yang, Long/0000-0002-9990-8398	Key Projects of National Plant Transgenic Genes of China [2013ZX08003-003]; Ministry of Agriculture of the People's Republic of China	Key Projects of National Plant Transgenic Genes of China; Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs)	This work was financially supported by grants from the Key Projects of National Plant Transgenic Genes of China (To XSZ and XYZ, Project no. 2013ZX08003-003) from Ministry of Agriculture of the People's Republic of China (http://english.agri.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI MI, 2011, INT J RECENT TRENDS, V1, P110; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Balazadeh S, 2008, PLANT BIOLOGY, V10, P63, DOI 10.1111/j.1438-8677.2008.00088.x; Balazadeh S, 2011, MOL PLANT, V4, P346, DOI 10.1093/mp/ssq080; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Brusslan JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033151; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Cai SQ, 2008, PLANT PHYSIOL, V146, P1305, DOI 10.1104/pp.107.110908; Cantu D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-492; D'haeseleer K, 2010, PLANT CELL PHYSIOL, V51, P1416, DOI 10.1093/pcp/pcq104; Dietz KJ, 2003, INT REV CYTOL, V228, P141, DOI 10.1016/S0074-7696(03)28004-9; Doyle EA, 2007, PLANT CELL ENVIRON, V30, P388, DOI 10.1111/j.1365-3040.2006.01624.x; Du YY, 2008, J INTEGR PLANT BIOL, V50, P1318, DOI 10.1111/j.1744-7909.2008.00741.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eason JR, 2000, POSTHARVEST BIOL TEC, V18, P81, DOI 10.1016/S0925-5214(99)00058-7; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Farage-Barhom S, 2008, J EXP BOT, V59, P3247, DOI 10.1093/jxb/ern176; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Gepstein S, 2003, PLANT J, V36, P629, DOI 10.1046/j.1365-313X.2003.01908.x; Grassl J, 2012, J PROTEOME RES, V11, P5443, DOI 10.1021/pr300691k; Gregersen PL, 2013, PLANT MOL BIOL, V82, P603, DOI 10.1007/s11103-013-0013-8; Gregersen PL., 2011, MOL PHYSL BASIS NUTR, P83, DOI DOI 10.1002/9780470960707; Griffiths CM, 1997, PLANT MOL BIOL, V34, P815, DOI 10.1023/A:1005896713830; Guiboileau A, 2010, CR BIOL, V333, P382, DOI 10.1016/j.crvi.2010.01.016; Guo Y, 2004, PLANT CELL ENVIRON, V27, P521, DOI 10.1111/j.1365-3040.2003.01158.x; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Guo YF, 2011, PLANT PHYSIOL, V156, P1612, DOI 10.1104/pp.111.177022; He YH, 2001, PLANT MOL BIOL, V47, P595, DOI 10.1023/A:1012211011538; Heber U, 2006, J EXP BOT, V57, P1211, DOI 10.1093/jxb/erj104; Hickman R, 2013, PLANT J, V75, P26, DOI 10.1111/tpj.12194; Himelblau E, 2000, CURR OPIN PLANT BIOL, V3, P205, DOI 10.1016/S1369-5266(00)00065-0; Hinderhofer K, 2001, PLANTA, V213, P469, DOI 10.1007/s004250000512; Hortensteiner S, 2002, J EXP BOT, V53, P927, DOI 10.1093/jexbot/53.370.927; Hou K, 2013, PLANT PHYSIOL, V161, P1002, DOI 10.1104/pp.112.212787; Jan A, 2013, PLANT PHYSIOL, V161, P1202, DOI 10.1104/pp.112.205385; Jia YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065687; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kim YS, 2013, PLANT CELL PHYSIOL, V54, P1660, DOI 10.1093/pcp/pct113; Kinoshita T, 1999, PLANT J, V19, P43, DOI 10.1046/j.1365-313X.1999.00497.x; Koyama T, 2013, PLANT PHYSIOL, V162, P991, DOI 10.1104/pp.113.218115; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lim PO, 2007, PLANT J, V52, P1140, DOI 10.1111/j.1365-313X.2007.03317.x; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Lin JF, 2004, PLANT J, V39, P612, DOI 10.1111/j.1365-313X.2004.02160.x; Liu L, 2008, PLANT MOL BIOL, V67, P37, DOI 10.1007/s11103-008-9300-1; LOHMAN KN, 1994, PHYSIOL PLANTARUM, V92, P322, DOI 10.1111/j.1399-3054.1994.tb05343.x; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Masclaux-Daubresse C, 2007, PLANT PHYSIOL, V143, P434, DOI 10.1104/pp.106.091355; Matallana-Ramirez LP, 2013, MOL PLANT, V6, P1438, DOI 10.1093/mp/sst012; McLellan H, 2009, NEW PHYTOL, V183, P408, DOI 10.1111/j.1469-8137.2009.02865.x; Miao Y, 2008, PLANT BIOLOGY, V10, P110, DOI 10.1111/j.1438-8677.2008.00083.x; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; Miao Y, 2010, PLANT J, V63, P179, DOI 10.1111/j.1365-313X.2010.04233.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakabayashi K, 1999, PLANT CELL PHYSIOL, V40, P504, DOI 10.1093/oxfordjournals.pcp.a029571; Noh YS, 1999, PLANT MOL BIOL, V41, P181, DOI 10.1023/A:1006342412688; Park JH, 1998, PLANT MOL BIOL, V37, P445, DOI 10.1023/A:1005958300951; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Pourtau N, 2006, PLANTA, V224, P556, DOI 10.1007/s00425-006-0243-y; Pruzinska A, 2005, PLANT PHYSIOL, V139, P52, DOI 10.1104/pp.105.065870; Quirino BF, 2001, PLANT MOL BIOL, V46, P447, DOI 10.1023/A:1010639015959; Raab S, 2009, PLANT J, V59, P39, DOI 10.1111/j.1365-313X.2009.03846.x; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Robinson WD, 2012, NEW PHYTOL, V196, P1024, DOI 10.1111/nph.12006; ROBINSONBEERS K, 1992, PLANT CELL, V4, P1237, DOI 10.1105/tpc.4.10.1237; Rolletschek H, 2005, PLANT PHYSIOL, V137, P1236, DOI 10.1104/pp.104.056523; Sakuraba Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5636; Sakuraba Y, 2013, BIOCHEM BIOPH RES CO, V430, P32, DOI 10.1016/j.bbrc.2012.11.050; Sakuraba Y, 2012, PLANT CELL, V24, P507, DOI 10.1105/tpc.111.089474; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sekhon RS, 2012, PLANT PHYSIOL, V159, P1730, DOI 10.1104/pp.112.199224; SMART CM, 1995, PHYSIOL PLANTARUM, V93, P673, DOI 10.1111/j.1399-3054.1995.tb05116.x; Smykowski A, 2010, PLANT PHYSIOL, V153, P1321, DOI 10.1104/pp.110.157180; Soudry E, 2005, J EXP BOT, V56, P695, DOI 10.1093/jxb/eri054; Suzuki M, 2004, PLANT J, V37, P750, DOI 10.1111/j.1365-313X.2004.02003.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Van der Graaff E, 2006, PLANT PHYSIOL, V141, P776, DOI 10.1104/pp.106.079293; Vescovi M, 2012, J EXP BOT, V63, P2825, DOI 10.1093/jxb/ers008; Veyres N, 2008, PLANT J, V55, P665, DOI 10.1111/j.1365-313X.2008.03541.x; Vogelmann K, 2012, PLANT PHYSIOL, V159, P1477, DOI 10.1104/pp.112.196220; Wagner R, 2011, NEW PHYTOL, V191, P449, DOI 10.1111/j.1469-8137.2011.03684.x; Weaver LM, 1999, PLANT PHYSIOL, V119, P1209, DOI 10.1104/pp.119.4.1209; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Woo HR, 2010, J EXP BOT, V61, P3947, DOI 10.1093/jxb/erq206; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Wu XY, 2012, J INTEGR PLANT BIOL, V54, P936, DOI 10.1111/jipb.12005; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; Yoshida S, 2001, PLANT CELL PHYSIOL, V42, P170, DOI 10.1093/pcp/pce021; Zelisko A, 2005, P NATL ACAD SCI USA, V102, P13699, DOI 10.1073/pnas.0503472102; Zhang BY, 2012, MOL CELLS, V34, P367, DOI 10.1007/s10059-012-0111-5; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang KW, 2013, P NATL ACAD SCI USA, V110, P14807, DOI 10.1073/pnas.1302702110; Zhang KW, 2012, PLANT PHYSIOL, V158, P961, DOI 10.1104/pp.111.190876; Zhang Q, 2012, PLANT MOL BIOL REP, V30, P539, DOI 10.1007/s11105-011-0366-6; Zhang ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042936; Zheng MS, 2005, PLANT SCI, V168, P415, DOI 10.1016/j.plantsci.2004.09.016; Zhou CJ, 2009, PLANT PHYSIOL, V150, P167, DOI 10.1104/pp.108.133439; Zhou X, 2011, MOL CELLS, V31, P303, DOI 10.1007/s10059-011-0047-1	105	37	41	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115617	10.1371/journal.pone.0115617	http://dx.doi.org/10.1371/journal.pone.0115617			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532107	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845100085
J	Hu, QY; Fink, E; Grant, CK; Elder, JH				Hu, Qiong-Ying; Fink, Elizabeth; Grant, Chris K.; Elder, John H.			Selective Interaction of Heparin with the Variable Region 3 within Surface Glycoprotein of Laboratory-Adapted Feline Immunodeficiency Virus	PLOS ONE			English	Article							CD4(+) T-CELLS; SULFATE PROTEOGLYCANS; TUMOR-GROWTH; BINDING; INHIBITION; INFECTION; HIV-1; ANGIOGENESIS; METASTASIS; SYNDECANS	Heparan sulfate proteoglycans (HSPG) can act as binding receptors for certain laboratory-adapted (TCA) strains of feline immunodeficiency virus (FIV) and human immunodeficiency virus (HIV). Heparin, a soluble heparin sulfate (HS), can inhibit TCA HIV and FIV entry mediated by HSPG interaction in vitro. In the present study, we further determined the selective interaction of heparin with the V3 loop of TCA of FIV. Our current results indicate that heparin selectively inhibits infection by TCA strains, but not for field isolates (FS). Heparin also specifically interferes with TCA surface glycoprotein (SU) binding to CXCR4, by interactions with HSPG binding sites on the V3 loop of the FIV envelope protein. Peptides representing either the Nor C-terminal side of the V3 loop and containing HSPG binding sites were able to compete away the heparin block of TCA SU binding to CXCR4. Heparin does not interfere with the interaction of SU with anti-V3 antibodies that target the CXCR4 binding region or with the interaction between FS FIV and anti-V3 antibodies since FS SU has no HSPG binding sites within the HSPG binding region. Our data show that heparin blocks TCA FIV infection or entry not only through its competition of HSPG on the cell surface interaction with SU, but also by its interference with CXCR4 binding to SU. These studies aid in the design and development of heparin derivatives or analogues that can inhibit steps in virus infection and are informative regarding the HSPG/SU interaction.	[Hu, Qiong-Ying] Taizhou Univ, Sch Med, Taizhou, Zhejiang, Peoples R China; [Hu, Qiong-Ying; Fink, Elizabeth; Elder, John H.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Grant, Chris K.] Custom Monoclonals Int Inc, W Sacramento, CA USA	Taizhou University; Scripps Research Institute	Elder, JH (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	jelder@scripps.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01 AI25825]; Custom Monoclonals International, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025825] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Custom Monoclonals International, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (R01 AI25825). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Chris K. Grant is employed by Custom Monoclonals International, Inc. which provided support in the form of salary for author CKG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Basu A, 2007, J VIROL, V81, P3933, DOI 10.1128/JVI.02622-06; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; BOACKLE RJ, 1983, MOL IMMUNOL, V20, P1157, DOI 10.1016/0161-5890(83)90139-6; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Borsig L, 2010, THROMB RES, V125, pS66, DOI 10.1016/S0049-3848(10)70017-7; Budge PJ, 2004, J ANTIMICROB CHEMOTH, V54, P299, DOI 10.1093/jac/dkh355; Clayette P, 1996, AIDS RES HUM RETROV, V12, P63, DOI 10.1089/aid.1996.12.63; Couchman JR, 2001, INT REV CYTOL, V207, P113; de Parseval A, 2005, J BIOL CHEM, V280, P39493, DOI 10.1074/jbc.M504233200; de Parseval A, 2005, NAT STRUCT MOL BIOL, V12, P60, DOI 10.1038/nsmb872; de Parseval A, 2004, J VIROL, V78, P9132, DOI 10.1128/JVI.78.17.9132-9143.2004; de Parseval A, 2004, P NATL ACAD SCI USA, V101, P13044, DOI 10.1073/pnas.0404006101; de Parseval A, 2004, J VIROL, V78, P2597, DOI 10.1128/JVI.78.5.2597-2600.2004; de Parseval A, 2001, J VIROL, V75, P4528, DOI 10.1128/JVI.75.10.4528-4539.2001; de Rozieres S, 2004, J VIROL, V78, P8971, DOI 10.1128/JVI.78.17.8971-8982.2004; De Rozieres S, 2008, J VIROL, V82, P7953, DOI 10.1128/JVI.00337-08; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; deParseval A, 1997, J VIROL, V71, P5742, DOI 10.1128/JVI.71.8.5742-5749.1997; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; FOLKMAN J, 1983, SCIENCE, V221, P719, DOI 10.1126/science.6192498; Fuster MM, 2010, PROG MOL BIOL TRANSL, V93, P179, DOI 10.1016/S1877-1173(10)93009-3; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Gallay P, 2004, MICROBES INFECT, V6, P617, DOI 10.1016/j.micinf.2004.02.004; Giffin MJ, 2008, J MED CHEM, V51, P6263, DOI 10.1021/jm800149m; Harbrecht U, 2011, HAMOSTASEOLOGIE, V31, P21, DOI 10.5482/ha-1149; Horvath CAJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-11; Hu Qiong-Ying, 2012, Retrovirology (Auckl), V2012, P1; Hu QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010689; Hu QY, 2011, J VIROL; Johnston JC, 1999, J VIROL, V73, P4991, DOI 10.1128/JVI.73.6.4991-5000.1999; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Laubli H, 2009, CANCER INVEST, V27, P474, DOI 10.1080/07357900802647136; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Lerner DL, 1998, VET IMMUNOL IMMUNOP, V65, P277, DOI 10.1016/S0165-2427(98)00162-7; Li JP, 2009, THROMB HAEMOSTASIS, V102, P823, DOI 10.1160/TH09-02-0091; Liu DF, 2002, SEMIN THROMB HEMOST, V28, P67, DOI 10.1055/s-2002-20565; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; NORTH TW, 1995, NAT MED, V1, P410, DOI 10.1038/nm0595-410; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Park K, 2008, PHARM RES-DORDR, V25, P2786, DOI 10.1007/s11095-008-9643-y; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; PERSSON E, 1990, SCAND J CLIN LAB INV, V50, P43, DOI 10.3109/00365519009091563; PHILLIPS TR, 1990, J VIROL, V64, P4605, DOI 10.1128/JVI.64.10.4605-4613.1990; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Rider CC, 1997, GLYCOCONJUGATE J, V14, P639, DOI 10.1023/A:1018596728605; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Sanderson RD, 2004, MATRIX BIOL, V23, P341, DOI 10.1016/j.matbio.2004.08.004; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Stringer SE, 2006, BIOCHEM SOC T, V34, P451, DOI 10.1042/BST0340451; Sundstrom M, 2008, J VIROL, V82, P9134, DOI 10.1128/JVI.00394-08; TALBOTT RL, 1989, P NATL ACAD SCI USA, V86, P5743, DOI 10.1073/pnas.86.15.5743; Vaheri A, 2007, APMIS, V115, P565; Van Rompay KKA, 2010, ANTIVIR RES, V85, P159, DOI 10.1016/j.antiviral.2009.07.008; Villanueva R, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-218	58	5	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115252	10.1371/journal.pone.0115252	http://dx.doi.org/10.1371/journal.pone.0115252			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521480	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845600029
J	Ikeda, T; Hirata, S; Takamatsu, K; Haruta, M; Tsukamoto, H; Ito, T; Uchino, M; Ando, Y; Nagafuchi, S; Nishimura, Y; Senju, S				Ikeda, Tokunori; Hirata, Shinya; Takamatsu, Koutaro; Haruta, Miwa; Tsukamoto, Hirotake; Ito, Takaaki; Uchino, Makoto; Ando, Yukio; Nagafuchi, Seiho; Nishimura, Yasuharu; Senju, Satoru			Suppression of Th1-Mediated Autoimmunity by Embryonic Stem Cell-Derived Dendritic Cells	PLOS ONE			English	Article							NONOBESE DIABETIC MICE; GLUTAMIC-ACID DECARBOXYLASE; REGULATORY T-CELLS; CENTRAL-NERVOUS-SYSTEM; NOD MOUSE MODEL; MULTIPLE-SCLEROSIS; IN-VIVO; ADOPTIVE TRANSFER; IMMUNE-RESPONSE; GENE-EXPRESSION	We herein demonstrate the immune-regulatory effect of embryonic stem cell-derived dendritic cells (ES-DCs) using two models of autoimmune disease, namely non-obese diabetic (NOD) mice and experimental autoimmune encephalomyelitis (EAE). Treatment of pre-diabetic NOD mice with ES-DCs exerted almost complete suppression of diabetes development during the observation period for more than 40 weeks. The prevention of diabetes by ES-DCs was accompanied with significant reduction of insulitis and decreased number of Th1 and Th17 cells in the spleen. Development of EAE was also inhibited by the treatment with ES-DCs, and the therapeutic effect was obtained even if ES-DCs were administrated after the onset of clinical symptoms. Treatment of EAE-induced mice with ES-DCs reduced the infiltration of inflammatory cells into the spinal cord and suppressed the T cell response to the myelin antigen. Importantly, the ES-DC treatment did not affect T cell response to an exogenous antigen. As the mechanisms underlying the reduction of the number of infiltrating Th1 cells, we observed the inhibition of differentiation and proliferation of Th1 cells by ES-DCs. Furthermore, the expression of VLA-4 alpha on Th1 cells was significantly inhibited by ES-DCs. Considering the recent advances in human induced pluripotent stem cell-related technologies, these results suggest a clinical application for pluripotent stem cell-derived dendritic cells as a therapy for T cell-mediated autoimmune diseases.	[Ikeda, Tokunori; Takamatsu, Koutaro; Haruta, Miwa; Tsukamoto, Hirotake; Nishimura, Yasuharu; Senju, Satoru] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan; [Ikeda, Tokunori; Takamatsu, Koutaro; Haruta, Miwa; Senju, Satoru] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Hirata, Shinya] Kumamoto Univ, Grad Sch Med Sci, Dept Hematol, Kumamoto, Japan; [Takamatsu, Koutaro; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Japan; [Ito, Takaaki] Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Kumamoto, Japan; [Uchino, Makoto] Jonan Hosp, Kumamoto, Japan; [Nagafuchi, Seiho] Kyushu Univ, Dept Med Sci & Technol, Grad Sch Med Sci, Fukuoka 812, Japan	Kumamoto University; Japan Science & Technology Agency (JST); Kumamoto University; Kumamoto University; Kumamoto University; Kyushu University	Ikeda, T (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan.	ryousei@kumamoto-u.ac.jp	Tsukamoto, Hirotake/S-2448-2019; Tsukamoto, Hirotake/GRJ-7436-2022; Ikeda, Tokunori/S-6043-2019	Tsukamoto, Hirotake/0000-0003-3214-1652; Ando, Yukio/0000-0001-7115-9105	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25870540, 23659158, 26290057, 23650609, 24300334]; Japan Science and Technology Agency (JST), Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST), Japan(Japan Science & Technology Agency (JST))	This work was supported by Grants Numbers 25870540 (to TI), 23659158 and 26290057 (to SS), and 23650609 and 24300334 (to YN) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI, grants from the Japan Science and Technology Agency (JST), Japan, http://www.jst.go.jp/EN/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ablamunits V, 2012, DIABETES, V61, P145, DOI 10.2337/db11-1033; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Archambault AS, 2006, J NEUROIMMUNOL, V181, P122, DOI 10.1016/j.jneuroim.2006.08.012; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Baeke F, 2012, DIABETOLOGIA, V55, P2723, DOI 10.1007/s00125-012-2630-1; Besin G, 2008, DIABETES, V57, P2107, DOI 10.2337/db08-0171; Birk OS, 1996, P NATL ACAD SCI USA, V93, P1032, DOI 10.1073/pnas.93.3.1032; BURKLY LC, 1994, DIABETES, V43, P529, DOI 10.2337/diabetes.43.4.529; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Cheatem D, 2009, CLIN IMMUNOL, V131, P260, DOI 10.1016/j.clim.2008.12.001; Chen W, 2001, J IMMUNOL, V167, P4926, DOI 10.4049/jimmunol.167.9.4926; CLARESALZLER MJ, 1992, J CLIN INVEST, V90, P741, DOI 10.1172/JCI115946; Comabella M, 2010, NAT REV NEUROL, V6, P499, DOI 10.1038/nrneurol.2010.112; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Feili-Hariri M, 2002, EUR J IMMUNOL, V32, P2021, DOI 10.1002/1521-4141(200207)32:7<2021::AID-IMMU2021>3.0.CO;2-J; Fujii S, 1998, HUM IMMUNOL, V59, P607, DOI 10.1016/S0198-8859(98)00058-5; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Han GC, 2005, J IMMUNOL, V174, P4516, DOI 10.4049/jimmunol.174.8.4516; Hirata S, 2005, J IMMUNOL, V174, P1888, DOI 10.4049/jimmunol.174.4.1888; Hirata S, 2007, J IMMUNOL, V178, P918, DOI 10.4049/jimmunol.178.2.918; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Ikeda T, 2010, J IMMUNOL, V185, P5259, DOI 10.4049/jimmunol.0902797; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kayagaki N, 1999, J IMMUNOL, V163, P1906; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Lionakis MS, 2003, LANCET, V362, P1828, DOI 10.1016/S0140-6736(03)14904-5; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; Machen J, 2004, J IMMUNOL, V173, P4331, DOI 10.4049/jimmunol.173.7.4331; Matsuyoshi H, 2004, J IMMUNOL, V172, P776, DOI 10.4049/jimmunol.172.2.776; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Nagafuchi S, 1999, FEBS LETT, V455, P101, DOI 10.1016/S0014-5793(99)00801-7; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Quinn A, 2001, J IMMUNOL, V166, P2982, DOI 10.4049/jimmunol.166.5.2982; Quinn A, 1996, J AUTOIMMUN, V9, P365, DOI 10.1006/jaut.1996.0049; RABINOVITCH A, 1995, J IMMUNOL, V154, P4874; Rioux JD, 2005, NATURE, V435, P584, DOI 10.1038/nature03723; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Senju S, 2003, BLOOD, V101, P3501, DOI 10.1182/blood-2002-07-2254; Senju S, 2007, STEM CELLS, V25, P2720, DOI 10.1634/stemcells.2007-0321; Senju S, 2009, STEM CELLS, V27, P1021, DOI 10.1002/stem.33; Solvason N, 2008, J IMMUNOL, V181, P8298, DOI 10.4049/jimmunol.181.12.8298; Steinbrink K, 2002, BLOOD, V99, P2468, DOI 10.1182/blood.V99.7.2468; Steinman L, 2013, NAT MED, V19, P139, DOI 10.1038/nm.3088; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Tan CS, 2010, LANCET NEUROL, V9, P425, DOI 10.1016/S1474-4422(10)70040-5; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; TREMBLEAU S, 1995, J EXP MED, V181, P817, DOI 10.1084/jem.181.2.817; Verginis P, 2005, J IMMUNOL, V174, P7433, DOI 10.4049/jimmunol.174.11.7433; YANG XD, 1993, P NATL ACAD SCI USA, V90, P10494, DOI 10.1073/pnas.90.22.10494; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	65	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115198	10.1371/journal.pone.0115198	http://dx.doi.org/10.1371/journal.pone.0115198			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522369	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845600025
J	Mjorud, M; Rosvik, J; Rokstad, AMM; Kirkevold, M; Engedal, K				Mjorud, Marit; Rosvik, Janne; Rokstad, Anne Marie Mork; Kirkevold, Marit; Engedal, Knut			Variables Associated with Change in Quality of Life among Persons with Dementia in Nursing Homes: A 10 Months Follow-Up Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DEPRESSIVE SYMPTOMS; PEOPLE; CARE; PREVALENCE; SCALE; CHALLENGES; RESIDENTS	Aim: To investigate variables associated with change in quality of life (QOL), measured by QUALID scale and three subscales; tension, sadness and wellbeing, among dementia patients in nursing homes. Method: A 10 months follow-up study including 198 (female 156, 79%) nursing home patients, mean age 87 (s.d 7.7) years. Scales applied; quality of life in late stage dementia (QUALID) scale and three subscales (wellbeing, sadness and tension), neuropsychiatric inventory questionnaire 10 items (NPI-10-Q), clinical dementia rating (CDR) scale, physical self-maintenance (PSMS) scale and a scale of general medical health. Use of psychotropic medication, gender and age was collected from the patient's records. Results: Mean baseline QUALID score: 20.6 (s.d. 7.0), follow-up score: 22.9 (s.d. 7.4), mean change 2.8 (s.d. 7.4). QOL improved in 30.8%, were unchanged in 14.7%, deteriorated in 54.6% of patients. A regression analysis revealed that change in QUALID score was significantly associated with: QUALID baseline score (beta -.381, p-value. 000), change in NPI score (beta. 421, p-value. 000), explained variance 38.1%. Change in score on wellbeing subscale associated with: change in PSMS score (beta. 185, p-value. 019), wellbeing baseline score (beta -.370, p-value. 000), change in NPI score (beta. 186, p-value. 017), explained variance 25.3%. Change in score on tension subscale associated with: change in CDR sum-of-boxes (beta. 214, p-value. 003), change in NPI score (beta. 270, p-value. 000), tension baseline score (beta -.423, p-value. 000), explained variance 34.6%. Change in score on sadness subscale associated with: change in NPI score (beta. 404, p-value. 000), sadness baseline score (beta -.438, p-value.000), explained variance 38.8%. Conclusion: The results imply that a lower baseline score (better QOL) results in a larger change in QOL (towards worse QOL). Change in QOL is mostly associated with change in neuropsychiatric symptoms. In almost 50% of patients QOL did not deteriorate.	[Mjorud, Marit; Rosvik, Janne; Engedal, Knut] Vestfold Hosp Trust, Norwegian Ctr Ageing & Hlth, Tonsberg, Norway; [Rokstad, Anne Marie Mork] Vestfold Hosp Trust, Molde Univ Coll, Norwegian Ctr Ageing & Hlth, Tonsberg, Norway; [Kirkevold, Marit] Univ Oslo, Dept Nursing Sci, Inst Hlth & Soc, Oslo, Norway	Molde University College; University of Oslo	Mjorud, M (corresponding author), Vestfold Hosp Trust, Norwegian Ctr Ageing & Hlth, Tonsberg, Norway.	marit.mjorud@aldringoghelse.no		Mjorud, Marit/0000-0002-2604-4074	Norwegian Centre for Aging and Health	Norwegian Centre for Aging and Health	Study funded by the Norwegian Centre for Aging and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson K, 2012, GERONTOLOGIST, V52, P632, DOI 10.1093/geront/gnr137; Banerjee S, 2009, INT J GERIATR PSYCH, V24, P15, DOI 10.1002/gps.2090; Barca ML, 2011, DEMENT GERIATR COGN, V31, P435, DOI 10.1159/000328969; Barca ML, 2008, INT J GERIATR PSYCH, V23, P1058, DOI 10.1002/gps.2033; Barca ML, 2010, J AFFECT DISORDERS, V120, P141, DOI 10.1016/j.jad.2009.04.028; Beer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015621; Beerens HC, 2014, J AM MED DIR ASSOC, V15, P54, DOI 10.1016/j.jamda.2013.09.010; Beerens HC, 2013, INT J NURS STUD, V50, P1259, DOI 10.1016/j.ijnurstu.2013.02.005; Bjorklof GH, 2013, DEMENT GERIATR COGN, V35, P121, DOI 10.1159/000346633; Castro-Monteiro E, 2014, QUAL LIFE RES; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Garre-Olmo J, 2010, QUAL LIFE RES, V19, P445, DOI 10.1007/s11136-010-9594-8; Gerritsen DL, 2005, AGING MENT HEALTH, V9, P135, DOI 10.1080/13607860412331336797; Gonzalez-Velez AE, 2014, GERIATR GERONTOL INT; Helvik AS, 2010, AGING MENT HEALTH, V14, P861, DOI 10.1080/13607861003801003; Hoe J, 2009, ALZ DIS ASSOC DIS, V23, P285, DOI 10.1097/WAD.0b013e318194fc1e; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Kirkevold O, 2005, USE RESTRAINTS NORWE; Kok JS, 2013, DEMENT GER COGN D EX, V3, P360, DOI 10.1159/000353441; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Leon-Salas B, 2013, ARCH GERONTOL GERIAT, V57, P257, DOI 10.1016/j.archger.2013.04.013; Lyketsos CG, 2003, INT J GERIATR PSYCH, V18, P275, DOI 10.1002/gps.796; Lyketsos CG, 1997, J NEUROPSYCH CLIN N, V9, P556; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Mjorud M, 2014, AGING MENT HEALTH, P1; Mjorud M, 2014, DEMENT GERIATR COGN, V37, P265, DOI 10.1159/000356497; Moyle W, 2013, EXPERT REV PHARM OUT, V13, P109, DOI [10.1586/ERP.12.84, 10.1586/erp.12.84]; Moyle W, 2012, CURR OPIN PSYCHIATR, V25, P480, DOI 10.1097/YCO.0b013e32835a1ccf; Moyle W, 2011, AGING MENT HEALTH, V15, P970, DOI 10.1080/13607863.2011.583620; Moyle W, 2010, INT J OLDER PEOPLE N, V5, P245, DOI 10.1111/j.1748-3743.2010.00230.x; Nakanishi K, 2011, DEMENT GERIATR COGN, V32, P39, DOI 10.1159/000329443; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; Rabins PV, 2007, INT PSYCHOGERIATR, V19, P401, DOI 10.1017/S1041610207004863; Roen I, 2009, RELIABILITY VALIDITY; Rokstad AMM, 2013, DEMENT GERIATR COGN, V36, P340, DOI 10.1159/000354366; Selbaek G, 2007, INT J GERIATR PSYCH, V22, P843, DOI 10.1002/gps.1749; Selbaek G, 2014, INT PSYCHOGERIATR, V26, P81, DOI 10.1017/S1041610213001609; Selwood A, 2005, INT J GERIATR PSYCH, V20, P232, DOI 10.1002/gps.1271; van de Ven-Vakhteeva J, 2013, INT J GERIATR PSYCH, V28, P530, DOI 10.1002/gps.3858; Verkaik R, 2007, INT J GERIATR PSYCH, V22, P1063, DOI 10.1002/gps.1809; Vogel A, 2012, INT PSYCHOGERIATR, V24, P82, DOI 10.1017/S1041610211001128; Weiner M F, 2000, J Am Med Dir Assoc, V1, P114; Wetzels RB, 2010, DEMENT GERIATR COGN, V29, P189, DOI 10.1159/000280437; WHO, 2012, ICD 10 CLASS MENT BE; Yeager CA, 2008, PSYCHOL REP, V102, P718, DOI 10.2466/PR0.102.3.718-722	47	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115248	10.1371/journal.pone.0115248	http://dx.doi.org/10.1371/journal.pone.0115248			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA4AC	25521336	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845600028
J	Kluth, M; Stindt, J; Droge, C; Linnemann, D; Kubitz, R; Schmitt, L				Kluth, Marianne; Stindt, Jan; Droege, Carola; Linnemann, Doris; Kubitz, Ralf; Schmitt, Lutz			A Mutation within the Extended X Loop Abolished Substrate-induced ATPase Activity of the Human Liver ATP-binding Cassette (ABC) Transporter MDR3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; FAMILIAL INTRAHEPATIC CHOLESTASIS; PICHIA-PASTORIS CELLS; SALT EXPORT PUMP; MULTIDRUG-RESISTANCE; FUNCTIONAL-CHARACTERIZATION; CANALICULAR MEMBRANE; DRUG-BINDING; EXPRESSION; PURIFICATION	The human multidrug resistance protein 3 (MDR3/ABCB4) belongs to the ubiquitous family of ATP-binding cassette (ABC) transporters and is located in the canalicular membrane of hepatocytes. There it flops the phospholipids of the phosphatidylcholine (PC) family from the inner to the outer leaflet. Here, we report the characterization of wild type MDR3 and the Q1174E mutant, which was identified previously in a patient with progressive familial intrahepatic cholestasis type 3 (PFIC-3). We expressed different variants of MDR3 in the yeast Pichia pastoris, purified the proteins via tandem affinity chromatography, and determined MDR3-specific ATPase activity in the presence or absence of phospholipids. The ATPase activity of wild type MDR3 was stimulated 2-fold by liver PC or 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine lipids. Furthermore, the cross-linking of MDR3 with a thiol-reactive fluorophore blocked ATP hydrolysis and exhibited no PC stimulation. Similarly, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin lipids did not induce an increase of wild type MDR3 ATPase activity. The phosphate analogues beryllium fluoride and aluminum fluoride led to complete inhibition of ATPase activity, whereas orthovanadate inhibited exclusively the PC-stimulated ATPase activity of MDR3. The Q1174E mutation is located in the nucleotide-binding domain in direct proximity of the leucine of the ABC signature motif and extended the X loop, which is found in ABC exporters. Our data on the Q1174E mutant demonstrated basal ATPase activity, but PC lipids were incapable of stimulating ATPase activity highlighting the role of the extended X loop in the cross-talk of the nucleotide-binding domain and the transmembrane domain.	[Kluth, Marianne; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; [Stindt, Jan; Droege, Carola; Linnemann, Doris; Kubitz, Ralf] Univ Hosp, Dept Gastroenterol Hepatol & Infectiol, D-40225 Dusseldorf, Germany; [Schmitt, Lutz] Univ Dusseldorf, Cluster Excellence Plant Sci, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Schmitt, L (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany.	lutz.schmitt@hhu.de		Stindt, Jan/0000-0002-8760-1989	Deutsche Forschungsgemeinschaft through the Clinical Research Group 217 TP 3; Deutsche Forschungsgemeinschaft through the Clinical Research Group 217 TP 1; Deutsche Forschungsgemeinschaft through the Collaborative Research Center [974 TP B3]	Deutsche Forschungsgemeinschaft through the Clinical Research Group 217 TP 3(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft through the Clinical Research Group 217 TP 1(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft through the Collaborative Research Center(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through the Clinical Research Group 217 TP 3 (to L. S.) and TP 1 (to R. K.) and the Collaborative Research Center 974 TP B3 (to R. K. and L. S.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BUSCHMAN E, 1994, CANCER RES, V54, P4892; BUSCHMAN E, 1991, MOL CELL BIOL, V11, P595, DOI 10.1128/MCB.11.2.595; Chang SY, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4832740; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DOIGE CA, 1993, BIOCHIM BIOPHYS ACTA, V1146, P65, DOI 10.1016/0005-2736(93)90339-2; Dzagania T, 2012, GENE, V506, P141, DOI 10.1016/j.gene.2012.06.029; Elferink RPJO, 2007, PFLUG ARCH EUR J PHY, V453, P601, DOI 10.1007/s00424-006-0062-9; Elferink RPJO, 2000, SEMIN LIVER DIS, V20, P293, DOI 10.1055/s-2000-9385; Ellinger P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060620; Gabriel MP, 2003, BIOCHEMISTRY-US, V42, P7780, DOI 10.1021/bi0341049; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Groen A, 2011, GASTROENTEROLOGY, V141, P1927, DOI 10.1053/j.gastro.2011.07.042; Gros P, 1993, Int Rev Cytol, V137C, P169; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Infed N, 2011, BBA-BIOMEMBRANES, V1808, P2313, DOI 10.1016/j.bbamem.2011.05.016; Ishigami M, 2013, BBA-MOL CELL BIOL L, V1831, P683, DOI 10.1016/j.bbalip.2012.12.016; Januchowski R, 2014, BIOMED PHARMACOTHER, V68, P111, DOI 10.1016/j.biopha.2013.09.004; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Johnson BJH, 2010, BIOCHEMISTRY-US, V49, P3403, DOI 10.1021/bi902064g; Keitel V, 2005, HEPATOLOGY, V41, P1160, DOI 10.1002/hep.20682; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; Kubitz R, 2004, GASTROENTEROLOGY, V126, P541, DOI 10.1053/j.gastro.2003.11.003; Kubitz R, 2011, Z GASTROENTEROL, V49, P728, DOI 10.1055/s-0031-1273427; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Loo TW, 1999, BBA-BIOMEMBRANES, V1461, P315, DOI 10.1016/S0005-2736(99)00165-0; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; McDevitt CA, 2009, ADV DRUG DELIVER REV, V61, P57, DOI 10.1016/j.addr.2008.07.004; Morita S, 2007, HEPATOLOGY, V46, P188, DOI 10.1002/hep.21591; Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Pohl A, 2005, BBA-MOL CELL BIOL L, V1733, P29, DOI 10.1016/j.bbalip.2004.12.007; Pozza A, 2006, CELL MOL LIFE SCI, V63, P1912, DOI 10.1007/s00018-006-6159-7; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Russell PL, 2006, BIOCHEM J, V399, P315, DOI 10.1042/BJ20060015; Sankaran B, 1997, BIOCHEMISTRY-US, V36, P6847, DOI 10.1021/bi970034s; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Scholz C, 2011, J BIOL CHEM, V286, P13346, DOI 10.1074/jbc.M110.216416; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; SMITH AJ, 1994, FEBS LETT, V354, P263, DOI 10.1016/0014-5793(94)01135-4; Smith AJ, 2000, J BIOL CHEM, V275, P23530, DOI 10.1074/jbc.M909002199; Smith AJ, 1998, HEPATOLOGY, V28, P530, DOI 10.1002/hep.510280234; Srinivasan V, 2014, SCIENCE, V343, P1137, DOI 10.1126/science.1246729; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; Urbatsch IL, 2001, J BIOL CHEM, V276, P26980, DOI 10.1074/jbc.M010829200; Urbatsch IL, 2001, ARCH BIOCHEM BIOPHYS, V388, P171, DOI 10.1006/abbi.2001.2299; VANDERBLIEK AM, 1988, GENE, V71, P401, DOI 10.1016/0378-1119(88)90057-1; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zaitseva J, 2005, BIOCHEM SOC T, V33, P990, DOI 10.1042/BST0330990; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122	60	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4896	4907		10.1074/jbc.M114.588566	http://dx.doi.org/10.1074/jbc.M114.588566			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25533467	hybrid, Green Published			2022-12-26	WOS:000350042000034
J	Han, HJ; Kursula, P				Han, Huijong; Kursula, Petri			The Olfactomedin Domain from Gliomedin Is a beta-Propeller with Unique Structural Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNELS; CRYSTAL-STRUCTURE; SODIUM-CHANNELS; MYOCILIN; PROTEIN; GLAUCOMA; NODES; EXPRESSION; BINDING; SYSTEM	All members of the olfactomedin (OLF) family have a conserved extracellular OLF domain, for which a structure has not been available. We present here the crystal structure of the OLF domain from gliomedin. Gliomedin is a protein expressed by Schwann cells in peripheral nerves, important for the formation of the nodes of Ranvier. Gliomedin interacts with neuronal cell adhesion molecules, such as neurofascin, but the structural details of the interaction are not known. The structure of the OLF domain presents a five-bladed beta-propeller fold with unusual geometric properties. The symmetry of the structure is not 5-fold, but rather reveals a twisted arrangement. The conserved top face of the gliomedin OLF domain is likely to be important for binding to neuronal ligands. Our results provide a structural basis for the functions of gliomedin in Schwann cells, enable the understanding of the role of the gliomedin OLF domain in autoimmune neuropathies, and unravel the locations of human disease-causing mutations in other OLF family members, including myocilin.	[Han, Huijong; Kursula, Petri] Univ Oulu, Fac Biochem & Mol Med, Oulu 90014, Finland; [Han, Huijong; Kursula, Petri] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland; [Han, Huijong; Kursula, Petri] German Electron Synchrotron DESY, D-22607 Hamburg, Germany; [Kursula, Petri] Univ Bergen, Dept Biomed, N-5020 Bergen, Norway	University of Oulu; University of Oulu; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Bergen	Kursula, P (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5020 Bergen, Norway.	petri.kursula@biomed.uib.no	Kursula, Petri/AAF-4563-2020	Kursula, Petri/0000-0001-8529-3751; Han, Huijong/0000-0002-1197-3014	European Community [283570]; Academy of Finland; Sigrid Juselius Foundation; Emil Aaltonen Foundation; Research and Science Foundation of the City of Hamburg	European Community(European Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen Foundation; Research and Science Foundation of the City of Hamburg	This work was supported by European Community Seventh Framework Programme FP7/2007-2013 under BioStruct-X Grant 283570 and by grants from the Academy of Finland, the Sigrid Juselius Foundation, the Emil Aaltonen Foundation, and the Research and Science Foundation of the City of Hamburg.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amor V, 2014, J NEUROSCI, V34, P5089, DOI 10.1523/JNEUROSCI.4752-13.2014; Anholt RRH, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00006; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Aroca-Aguilar JD, 2005, J BIOL CHEM, V280, P21043, DOI 10.1074/jbc.M501340200; Aroca-Aguilar JD, 2008, MOL VIS, V14, P2097; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burns JN, 2011, BIOCHEMISTRY-US, V50, P5824, DOI 10.1021/bi200231x; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chen CKM, 2011, TRENDS BIOCHEM SCI, V36, P553, DOI 10.1016/j.tibs.2011.07.004; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Desmazieres A, 2014, J NEUROSCI, V34, P5083, DOI 10.1523/JNEUROSCI.4662-13.2014; Devaux JJ, 2012, AM J PATHOL, V181, P1402, DOI 10.1016/j.ajpath.2012.06.034; Devaux JJ, 2012, J PERIPHER NERV SYST, V17, P62, DOI 10.1111/j.1529-8027.2012.00372.x; Dismuke WM, 2012, BIOCHEMISTRY-US, V51, P3606, DOI 10.1021/bi300073r; Donegan RK, 2012, J BIOL CHEM, V287, P43370, DOI 10.1074/jbc.M112.408906; DUGANDZIJANOVAKOVIC S, 1995, J NEUROSCI, V15, P492; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Eshed Y, 2007, J CELL BIOL, V177, P551, DOI 10.1083/jcb.200612139; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Han HJ, 2014, ACTA CRYSTALLOGR F, V70, P1536, DOI 10.1107/S2053230X14020305; Hao Q, 2004, J APPL CRYSTALLOGR, V37, P498, DOI 10.1107/S0021889804008696; Hill SE, 2014, J MOL BIOL, V426, P921, DOI 10.1016/j.jmb.2013.12.002; Hillier BJ, 2003, J CELL BIOL, V160, P597, DOI 10.1083/jcb.200210053; Hillier BJ, 2007, BIOCHEM CELL BIOL, V85, P552, DOI 10.1139/O07-055; Hollup SM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-52; Huang WL, 2010, J MOL BIOL, V401, P374, DOI 10.1016/j.jmb.2010.06.012; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kwon HS, 2014, J NEUROSCI, V34, P5539, DOI 10.1523/JNEUROSCI.4731-13.2014; Kwon HS, 2013, J BIOL CHEM, V288, P26357, DOI 10.1074/jbc.M112.446138; Labasque M, 2011, J BIOL CHEM, V286, P42426, DOI 10.1074/jbc.M111.266353; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Margraf T, 2009, NUCLEIC ACIDS RES, V37, pW480, DOI 10.1093/nar/gkp431; McDowell CM, 2012, EXP EYE RES, V100, P65, DOI 10.1016/j.exer.2012.04.016; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy I, 2003, BIOCHEM BIOPH RES CO, V302, P554, DOI 10.1016/S0006-291X(03)00198-0; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Notturno F, 2014, J NEUROIMMUNOL, V276, P207, DOI 10.1016/j.jneuroim.2014.09.001; Occhi S, 2005, J NEUROSCI, V25, P9418, DOI 10.1523/JNEUROSCI.2068-05.2005; Ohlmann A, 2003, GLIA, V43, P128, DOI 10.1002/glia.10233; Orwig SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016347; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Resch ZT, 2009, EXP EYE RES, V88, P704, DOI 10.1016/j.exer.2008.08.011; Ricard CS, 2001, EXP EYE RES, V73, P433, DOI 10.1006/exer.2001.1063; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Vabnick I, 1996, J NEUROSCI, V16, P4914; Vollrath D, 2006, EXP EYE RES, V82, P1030, DOI 10.1016/j.exer.2005.10.007; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yam GHF, 2007, AM J PATHOL, V170, P100, DOI 10.2353/ajpath.2007.060806; YOKOE H, 1993, P NATL ACAD SCI USA, V90, P4655, DOI 10.1073/pnas.90.10.4655; Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172	72	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3612	3621		10.1074/jbc.M114.627547	http://dx.doi.org/10.1074/jbc.M114.627547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525261	Green Published, hybrid			2022-12-26	WOS:000349456000034
J	Markwart, R; Condotta, SA; Requardt, RP; Borken, F; Schubert, K; Weigel, C; Bauer, M; Griffith, TS; Forster, M; Brunkhorst, FM; Badovinac, VP; Rubio, I				Markwart, Robby; Condotta, Stephanie A.; Requardt, Robert P.; Borken, Farina; Schubert, Katja; Weigel, Cynthia; Bauer, Michael; Griffith, Thomas S.; Foerster, Martin; Brunkhorst, Frank M.; Badovinac, Vladimir P.; Rubio, Ignacio			Immunosuppression after Sepsis: Systemic Inflammation and Sepsis Induce a Loss of Naive T-Cells but No Enduring Cell-Autonomous Defects in T-Cell Function	PLOS ONE			English	Article							IMPROVES SURVIVAL; CECAL LIGATION; INTENSIVE-CARE; SEPTIC SHOCK; MURINE MODEL; CYTOMEGALOVIRUS REACTIVATION; POLYMICROBIAL SEPSIS; BACTERIAL CLEARANCE; INDUCED APOPTOSIS; EFFECTOR FUNCTION	Sepsis describes the life-threatening systemic inflammatory response (SIRS) of an organism to an infection and is the leading cause of mortality on intensive care units (ICU) worldwide. An acute episode of sepsis is characterized by the extensive release of cytokines and other mediators resulting in a dysregulated immune response leading to organ damage and/or death. This initial pro-inflammatory burst often transits into a state of immune suppression characterised by loss of immune cells and T-cell dysfunction at later disease stages in sepsis survivors. However, despite these appreciations, the precise nature of the evoked defect in T-cell immunity in post-acute phases of SIRS remains unknown. Here we present an in-depth functional analysis of T-cell function in post-acute SIRS/sepsis. We document that T-cell function is not compromised on a per cell basis in experimental rodent models of infection-free SIRS (LPS or CpG) or septic peritonitis. Transgenic antigen-specific T-cells feature an unaltered cytokine response if challenged in vivo and ex vivo with cognate antigens. Isolated CD4(+)/CD8(+) T-cells from post-acute septic animals do not exhibit defects in T-cell receptor-mediated activation at the the level of receptor-proximal signalling, activation marker upregulation or expansion. However, SIRS/sepsis induced transient lymphopenia and gave rise to an environment of immune attenuation at post acute disease stages. Thus, systemic inflammation has an acute impact on T-cell numbers and adaptive immunity, but does not cause major cell-autonomous enduring functional defects in T-cells.	[Markwart, Robby; Requardt, Robert P.; Borken, Farina; Schubert, Katja; Weigel, Cynthia; Bauer, Michael; Brunkhorst, Frank M.; Rubio, Ignacio] Jena Univ Hosp, CSCC, Integrated Res & Treatment Ctr, Jena, Germany; [Condotta, Stephanie A.; Badovinac, Vladimir P.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Bauer, Michael] Jena Univ Hosp, Dept Anaesthesiol & Intens Care Med, Jena, Germany; [Griffith, Thomas S.] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN USA; [Griffith, Thomas S.] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA; [Foerster, Martin] Jena Univ Hosp, Clin Internal Med, Jena, Germany; [Brunkhorst, Frank M.] Jena Univ Hosp, Ctr Clin Studies, Jena, Germany; [Rubio, Ignacio] Jena Univ Hosp, Ctr Mol Biomed, Inst Mol Cell Biol, Jena, Germany	Friedrich Schiller University of Jena; University of Iowa; Friedrich Schiller University of Jena; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Rubio, I (corresponding author), Jena Univ Hosp, CSCC, Integrated Res & Treatment Ctr, Jena, Germany.	ignacio.rubio@med.uni-jena.de	Griffith, Thomas/ABF-8225-2020; badovinac, Vladimir/O-7760-2015	Badovinac, Vladimir/0000-0003-3180-2439; Markwart, Robby/0000-0003-0338-3433; Bauer, Michael/0000-0002-1521-3514; Weigel, Cynthia/0000-0003-3132-4203	Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1002]; U.S. National Institutes of Health [AI83286, AI114543]; American Heart Association; U.S. Department of Veterans Affairs Merit Review Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083286, R01AI114543] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001324] Funding Source: NIH RePORTER	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); U.S. Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	Funding: This work was supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1002 (IR), by U.S. National Institutes of Health grants AI83286 and AI114543 (VPB), an award from American Heart Association (SAC), and a U.S. Department of Veterans Affairs Merit Review Award (TSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Arndt B, 2013, J IMMUNOL METHODS, V387, P276, DOI 10.1016/j.jim.2012.11.006; Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157; Ben-Sasson SZ, 2011, CYTOKINE, V56, P122, DOI 10.1016/j.cyto.2011.07.006; Ben-Sasson SZ, 2013, J EXP MED, V210, P491, DOI 10.1084/jem.20122006; Berg NN, 1998, J IMMUNOL, V161, P2919; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Boomer JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11404; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Bosmann M, 2011, SHOCK, V36, P396, DOI 10.1097/SHK.0b013e3182295f5f; BROOKE MS, 1965, NATURE, V206, P635, DOI 10.1038/206635a0; Cabrera-Perez J, 2014, J LEUKOCYTE BIOL, V96, P767, DOI 10.1189/jlb.5MR0114-067R; Carson WF, 2010, EUR J IMMUNOL, V40, P998, DOI 10.1002/eji.200939739; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chung CS, 2006, AM J PHYSIOL-REG I, V291, pR1338, DOI 10.1152/ajpregu.00283.2006; Chung CS, 2010, SHOCK, V34, P150, DOI 10.1097/SHK.0b013e3181cf70fb; Condotta SA, 2013, CRIT REV IMMUNOL, V33, P23, DOI 10.1615/CritRevImmunol.2013006721; Condotta SA, 2013, J IMMUNOL, V190, P1991, DOI 10.4049/jimmunol.1202379; Condotta SA, 2012, ADV IMMUNOL, V113, P51, DOI 10.1016/B978-0-12-394590-7.00005-1; Croker BA, 2014, CURR OPIN IMMUNOL, V26, P128, DOI 10.1016/j.coi.2013.12.002; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Cuthbertson BH, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-116; De AK, 1997, CLIN IMMUNOL IMMUNOP, V82, P73, DOI 10.1006/clin.1996.4289; Duong S, 2014, J IMMUNOL, V192, P3618, DOI 10.4049/jimmunol.1303460; Enoh VT, 2008, SHOCK, V29, P56, DOI 10.1097/shk.0b013e318070c8b9; Enoh VT, 2007, SHOCK, V27, P507, DOI 10.1097/SHK.0b013e31802b5d9f; ERTEL W, 1992, SURGERY, V111, P177; Fry DE, 2012, AM SURGEON, V78, P1; Gentile LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094404; Gonnert FA, 2012, SHOCK, V37, P399, DOI 10.1097/SHK.0b013e31824a670b; Gonnert FA, 2011, J SURG RES, V170, pE123, DOI 10.1016/j.jss.2011.05.019; Gurung P, 2011, J IMMUNOL, V187, P2148, DOI 10.4049/jimmunol.1101180; Heidecke CD, 2000, CHIRURG, V71, P159, DOI 10.1007/s001040050028; Heininger A, 2011, CRIT CARE, V15, DOI 10.1186/cc10069; Heuer JG, 2005, J IMMUNOL, V174, P7141, DOI 10.4049/jimmunol.174.11.7141; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2005, J IMMUNOL, V174, P5110, DOI 10.4049/jimmunol.174.8.5110; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Inoue S, 2013, CRIT CARE MED, V41, P810, DOI 10.1097/CCM.0b013e318274645f; Inoue S, 2011, SHOCK, V36, P38, DOI 10.1097/SHK.0b013e3182168cce; Inoue S, 2010, J IMMUNOL, V184, P1401, DOI 10.4049/jimmunol.0902307; Kasten KR, 2010, INFECT IMMUN, V78, P4714, DOI 10.1128/IAI.00456-10; Kessel A, 2009, J AUTOIMMUN, V32, P211, DOI 10.1016/j.jaut.2009.02.014; Kuhlhorn F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065109; Lambeck S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00284; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Marshall JC, 2005, SHOCK, V24, P1, DOI 10.1097/01.shk.0000191383.34066.4b; Marshall JC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001341; Martin MD, 2011, J IMMUNOL, V187, P2923, DOI 10.4049/jimmunol.1100698; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; McAleer JP, 2008, CRIT REV IMMUNOL, V28, P281; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Mohr A, 2012, EUR J IMMUNOL, V42, P341, DOI 10.1002/eji.201141692; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Myhren H, 2010, CRIT CARE, V14, DOI 10.1186/cc8870; Nolz JC, 2012, P NATL ACAD SCI USA, V109, P6199, DOI 10.1073/pnas.1118868109; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; Recknagel P, 2013, LIVER INT, V33, P283, DOI 10.1111/liv.12012; Reim D, 2009, SHOCK, V31, P245, DOI 10.1097/SHK.0b013e31817fd02c; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Roth G, 2003, BIOCHEM BIOPH RES CO, V308, P840, DOI 10.1016/S0006-291X(03)01482-7; Stromberg PE, 2009, FASEB J, V23, P1817, DOI 10.1096/fj.08-119024; Suffredini AF, 2011, JAMA-J AM MED ASSOC, V306, P194, DOI 10.1001/jama.2011.909; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Tschoep J, 2008, J LEUKOCYTE BIOL, V83, P581, DOI 10.1189/jlb.0707507; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; van Schaik SM, 2007, EUR J IMMUNOL, V37, P3101, DOI 10.1002/eji.200737295; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Wang XQ, 2008, J IMMUNOL, V180, P6703, DOI 10.4049/jimmunol.180.10.6703; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Zhang Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10059; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354	82	46	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e0115094	10.1371/journal.pone.0115094	http://dx.doi.org/10.1371/journal.pone.0115094			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541945	gold, Green Submitted, Green Published			2022-12-26	WOS:000347239900023
J	Park, JC; Kim, JS; Park, SH; Webster, MJ; Lee, S; Song, WY; Han, Y				Park, Justin C.; Kim, Jin Sung; Park, Sung Ho; Webster, Matthew J.; Lee, Soyoung; Song, William Y.; Han, Youngyih			Four Dimensional Digital Tomosynthesis Using on-Board Imager for the Verification of Respiratory Motion	PLOS ONE			English	Article							CONE-BEAM-CT; GUIDED RADIATION-THERAPY; POSITIONING VERIFICATION; PROSTATE-CANCER; RECONSTRUCTION; RADIOTHERAPY; SYSTEM; MODEL; ARTIFACTS; ALGORITHM	Purpose: To evaluate respiratory motion of a patient by generating four-dimensional digital tomosynthesis (4D DTS), extracting respiratory signal from patients' on-board projection data, and ensuring the feasibility of 4D DTS as a localization tool for the targets which have respiratory movement. Methods and Materials: Four patients with lung and liver cancer were included to verify the feasibility of 4D-DTS with an on-board imager. CBCT acquisition (650670 projections) was used to reconstruct 4D DTS images and the breath signal of the patients was generated by extracting the motion of diaphragm during data acquisition. Based on the extracted signal, the projection data was divided into four phases: peak-exhale phase, mid-inhale phase, peak-inhale phase, and mid-exhale phase. The binned projection data was then used to generate 4D DTS, where the total scan angle was assigned as +/- 22.5 degrees from rotation center, centered on 0 degrees and 180 degrees for coronal "half-fan'' 4D DTS, and 90 degrees and 270 degrees for sagittal "half-fan'' 4D DTS. The result was then compared with 4D CBCT which we have also generated with the same phase distribution. Results: The motion of the diaphragm was evident from the 4D DTS results for peak-exhale, mid-inhale, peak-inhale and mid-exhale phase assignment which was absent in 3D DTS. Compared to the result of 4D CBCT, the view aliasing effect due to arbitrary angle reconstruction was less severe. In addition, the severity of metal artifacts, the image distortion due to presence of metal, was less than that of the 4D CBCT results. Conclusion: We have implemented on-board 4D DTS on patients data to visualize the movement of anatomy due to respiratory motion. The results indicate that 4D-DTS could be a promising alternative to 4D CBCT for acquiring the respiratory motion of internal organs just prior to radiotherapy treatment.	[Park, Justin C.; Lee, Soyoung] Univ Florida, Dept Radiat Oncol, Gainesville, FL USA; [Kim, Jin Sung; Han, Youngyih] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Park, Sung Ho] Ulsan Univ Hosp, Dept Neurosurg, Ulsan, South Korea; [Webster, Matthew J.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Song, William Y.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Radiat Oncol & Med Biophys, Toronto, ON, Canada	State University System of Florida; University of Florida; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan; Ulsan University Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Kim, JS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea.	jinsung.k@gmail.com			National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2013M2A2A7043507]; Ministry of Education, Science and Technology [NRF-2011-0022021]; Samsung Medical Center grant [GFO1130081]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Samsung Medical Center grant(Samsung)	This research was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2013M2A2A7043507), Ministry of Education, Science and Technology (NRF-2011-0022021) and Samsung Medical Center grant [GFO1130081]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balter JM, 1996, INT J RADIAT ONCOL, V36, P167, DOI 10.1016/S0360-3016(96)00275-1; Bissonnette JP, 2009, INT J RAD ONCOL BIOL; Byrne TE, 2005, MED DOSIM, V30, P155, DOI 10.1016/j.meddos.2005.03.005; Chang JW, 2006, MED PHYS, V33, P2354, DOI 10.1118/1.2207136; Dietrich L, 2006, PHYS MED BIOL, V51, P2939, DOI 10.1088/0031-9155/51/11/017; Dobbins JT, 2008, J THORAC IMAG, V23, P86, DOI 10.1097/RTI.0b013e318173e162; Dzyubak O, 2014, MED PHYS, V41, DOI 10.1118/1.4896101; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Godfrey DJ, 2006, MED PHYS, V33, P655, DOI 10.1118/1.2170398; Herman MG, 2005, SEMIN RADIAT ONCOL, V15, P157, DOI 10.1016/j.semradonc.2005.01.002; Islam MK, 2006, MED PHYS, V33, P1573, DOI 10.1118/1.2198169; Jia X, 2012, MED PHYS, V39, P5592, DOI 10.1118/1.4745559; Kupelian PA, 2008, INT J RADIAT ONCOL, V70, P1151, DOI 10.1016/j.ijrobp.2007.07.2371; Li T, 2007, MED PHYS, V34, P3688, DOI 10.1118/1.2767144; Lujan AE, 2003, MED PHYS, V30, P2643, DOI 10.1118/1.1609057; Maltz JS, 2009, MED PHYS, V36, P1624, DOI 10.1118/1.3110067; Maurer J, 2008, MED PHYS, V35, P3574, DOI 10.1118/1.2953561; Morin O, 2006, MED DOSIM, V31, P51, DOI 10.1016/j.meddos.2005.12.009; Oelfke U, 2006, MED DOSIM, V31, P62, DOI 10.1016/j.meddos.2005.12.008; Oldham M, 2005, RADIOTHER ONCOL, V75, P271, DOI 10.1016/j.radonc.2005.03.026; Park JC, 2013, MED PHYS, V40, DOI 10.1118/1.4829504; Park JC, 2012, MED PHYS, V39, P6431, DOI 10.1118/1.4754658; Park JC, 2012, MED PHYS, V39, P1207, DOI 10.1118/1.3679865; Park JC, 2011, TECHNOL CANCER RES T, V10, P295, DOI 10.7785/tcrt.2012.500206; Pouliot J, 2005, INT J RADIAT ONCOL, V61, P552, DOI 10.1016/j.ijrobp.2004.10.011; Ren L, 2008, MED PHYS, V35, P664, DOI 10.1118/1.2831903; Santoro J, 2010, MED PHYS, V37, P1237, DOI 10.1118/1.3312276; Shimizu S, 2000, INT J RADIAT ONCOL, V46, P1127, DOI 10.1016/S0360-3016(99)00352-1; Smitsmans MHP, 2005, INT J RADIAT ONCOL, V63, P975, DOI 10.1016/j.ijrobp.2005.07.973; Sonke JJ, 2005, MED PHYS, V32, P1176, DOI 10.1118/1.1869074; Wang G, 2002, MED PHYS, V29, P1807, DOI 10.1118/1.1494989; Yan H, 2007, MED PHYS, V34, P3768, DOI 10.1118/1.2779945; Yoo S, 2009, INT J RADIAT ONCOL, V73, P296, DOI 10.1016/j.ijrobp.2008.09.006; Zhang J, 2007, MED PHYS, V34, P2607, DOI 10.1118/1.2761583; Zhang J, 2009, INT J RADIAT ONCOL, V73, P952, DOI 10.1016/j.ijrobp.2008.10.036; Zhang QH, 2010, MED PHYS, V37, P2901, DOI 10.1118/1.3397460; Zhang YB, 2007, INT J RADIAT ONCOL, V67, P924, DOI 10.1016/j.ijrobp.2006.09.045	37	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115795	10.1371/journal.pone.0115795	http://dx.doi.org/10.1371/journal.pone.0115795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541710	gold, Green Submitted, Green Published			2022-12-26	WOS:000347239900088
J	Li, SB; Huang, J; Zhou, RC; Xu, SR; Jin, YX				Li Shubin; Huang Juan; Zhou RenChao; Xu ShiRu; Jin YuanXiao			Fungal Endophytes of Alpinia officinarum Rhizomes: Insights on Diversity and Variation across Growth Years, Growth Sites, and the Inner Active Chemical Concentration	PLOS ONE			English	Article							PRIMARY SUCCESSION GRADIENT; MOLECULAR PHYLOGENY; HOST-PLANT; T-RFLP; COMMUNITIES; TRAITS; ROOTS	In the present study, the terminal-restriction fragment length polymorphism (T-RFLP) technique, combined with the use of a clone library, was applied to assess the baseline diversity of fungal endophyte communities associated with rhizomes of Alpinia officinarum Hance, a medicinal plant with a long history of use. A total of 46 distinct T-RFLP fragment peaks were detected using HhaI or MspI mono-digestion-targeted, amplified fungal rDNA ITS sequences from A. officinarum rhizomes. Cloning and sequencing of representative sequences resulted in the detection of members of 10 fungal genera: Pestalotiopsis, Sebacina, Penicillium, Marasmius, Fusarium, Exserohilum, Mycoleptodiscus, Colletotrichum, Meyerozyma, and Scopulariopsis. The T-RFLP profiles revealed an influence of growth year of the host plant on fungal endophyte communities in rhizomes of this plant species; whereas, the geographic location where A. officinarum was grown contributed to only limited variation in the fungal endophyte communities of the host tissue. Furthermore, non-metric multidimensional scaling (NMDS) analysis across all of the rhizome samples showed that the fungal endophyte community assemblages in the rhizome samples could be grouped according to the presence of two types of active indicator chemicals: total volatile oils and galangin. Our present results, for the first time, address a diverse fungal endophyte community is able to internally colonize the rhizome tissue of A. officinarum. The diversity of the fungal endophytes found in the A. officinarum rhizome appeared to be closely correlated with the accumulation of active chemicals in the host plant tissue. The present study also provides the first systematic overview of the fungal endophyte communities in plant rhizome tissue using a culture-independent method.	[Li Shubin; Huang Juan; Zhou RenChao; Xu ShiRu; Jin YuanXiao] S China Normal Univ, Coll Life Sci, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China	South China Normal University	Li, SB (corresponding author), S China Normal Univ, Coll Life Sci, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China.	shuli_1990@126.com			National Natural Science Foundation of China [31070003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Natural Science Foundation of China (Grant No. 31070003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JK, 2005, CAN J BOT, V83, P356, DOI [10.1139/b05-008, 10.1139/B05-008]; Balint M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053987; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Blaalid R, 2012, MOL ECOL, V21, P1897, DOI 10.1111/j.1365-294X.2011.05214.x; Camarinha-Silva A, 2012, FEMS MICROBIOL ECOL, V79, P98, DOI 10.1111/j.1574-6941.2011.01197.x; Debbab A, 2012, FUNGAL DIVERS, V57, P45, DOI 10.1007/s13225-012-0191-8; Ding T, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-1; Dutta, 2010, EUROPEAN J BIOL SCI, V2, P8; Gazis R, 2010, FUNGAL ECOL, V3, P240, DOI 10.1016/j.funeco.2009.12.001; Hazalin NAMN, 2012, PHYTOMEDICINE, V19, P609, DOI 10.1016/j.phymed.2012.01.007; Hu FY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-18; Hubbard M, 2014, J APPL MICROBIOL, V116, P109, DOI 10.1111/jam.12311; [蒋妮 Jiang Ni], 2012, [植物保护, Plant Protection], V38, P104; Khan AL, 2015, CRIT REV BIOTECHNOL, V35, P62, DOI 10.3109/07388551.2013.800018; Ko TWK, 2011, FUNGAL DIVERS, V50, P113, DOI 10.1007/s13225-011-0130-0; Koo HJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-27; Kusari P, 2013, FUNGAL DIVERS, V60, P137, DOI 10.1007/s13225-012-0216-3; Kusari S, 2013, PHYTOCHEMISTRY, V91, P81, DOI 10.1016/j.phytochem.2012.07.021; Kwasna H, 2008, APPL SOIL ECOL, V40, P44, DOI 10.1016/j.apsoil.2008.03.005; Lamit LJ, 2014, AM J BOT, V101, P467, DOI 10.3732/ajb.1400034; Langenfeld A, 2013, FUNGAL BIOL-UK, V117, P124, DOI 10.1016/j.funbio.2012.12.005; Lee J, 2009, J ETHNOPHARMACOL, V126, P258, DOI 10.1016/j.jep.2009.08.033; Liu QF, 2012, J ETHNOPHARMACOL, V143, P772, DOI 10.1016/j.jep.2012.06.019; Liu Zhun, 2013, Mycosystema, V32, P812; Lu W, 2006, CHINA PHARM, V15, P19; Mei L, 2014, MICROB ECOL, V67, P402, DOI 10.1007/s00248-013-0319-8; Miller KI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035953; Mishra A, 2012, MICROB ECOL, V64, P388, DOI 10.1007/s00248-012-0029-7; National Pharmacopoeia Committee, 2010, CHINESE PHARMACOPOEI; Nongalleima K., 2013, International Journal of PharmTech Research, V5, P301; Persoh D, 2013, FUNGAL DIVERS, V60, P55, DOI 10.1007/s13225-013-0225-x; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Qadri M, 2014, MICROB ECOL, V67, P877, DOI 10.1007/s00248-014-0379-4; Rajala T, 2013, FUNGAL BIOL-UK, V117, P182, DOI 10.1016/j.funbio.2013.01.006; Rao K, 2011, APPL BIOCHEM BIOTECH, V165, P1366, DOI 10.1007/s12010-011-9353-5; Rao S, 2013, CURR MICROBIOL, V66, P185, DOI 10.1007/s00284-012-0256-7; Rivera-Orduna FN, 2011, FUNGAL DIVERS, V47, P65, DOI 10.1007/s13225-010-0045-1; Saunders M, 2010, EVOL APPL, V3, P525, DOI 10.1111/j.1752-4571.2010.00141.x; Saunders M, 2009, NEW PHYTOL, V182, P229, DOI 10.1111/j.1469-8137.2008.02746.x; Sivakumar AS, 2011, CHEM-BIOL INTERACT, V193, P141, DOI 10.1016/j.cbi.2011.06.003; Sun JJ, 2014, APPL MICROBIOL BIOT, V98, P3143, DOI 10.1007/s00253-013-5300-4; Sun LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049867; Tao L, 2006, S AFR J BOT, V72, P163, DOI 10.1016/j.sajb.2005.06.007; Tejesvi MV, 2010, FUNGAL DIVERS, V41, P125, DOI 10.1007/s13225-009-0016-6; van Dorst J, 2014, FEMS MICROBIOL ECOL, V89, P316, DOI 10.1111/1574-6941.12308; White JF, 2010, PHYSIOL PLANTARUM, V138, P440, DOI 10.1111/j.1399-3054.2009.01332.x; Xu L, 2008, LETT APPL MICROBIOL, V46, P68, DOI 10.1111/j.1472-765X.2007.02264.x; Yu M, 2009, J PLANT PATHOL, V91, P417; Yuan ZL, 2010, APPL ENVIRON MICROB, V76, P1642, DOI 10.1128/AEM.01911-09; Zhang D, 2013, FOOD CHEM, V141, P347, DOI 10.1016/j.foodchem.2013.02.082; Zimmerman NB, 2012, P NATL ACAD SCI USA, V109, P13022, DOI 10.1073/pnas.1209872109	51	7	8	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115289	10.1371/journal.pone.0115289	http://dx.doi.org/10.1371/journal.pone.0115289			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536070	gold, Green Published, Green Submitted			2022-12-26	WOS:000348563300035
J	Poortinga, S; Van den Akker-Scheek, I; Bulstra, SK; Stewart, RE; Stevens, M				Poortinga, Sietske; Van den Akker-Scheek, Inge; Bulstra, Sjoerd K.; Stewart, Roy E.; Stevens, Martin			Preoperative Physical Activity Level Has No Relationship to the Degree of Recovery One Year after Primary Total Hip or Knee Arthroplasty: A Cohort Study	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; HEALTH; REPLACEMENT; EXERCISE; ADULTS; CARE	Background: When it comes to prevalidation, it is assumed that a higher preoperative level of physical activity leads to better postoperative recovery. However current literature is inconclusive about the effect of prevalidation on functional recovery of patients with primary osteoarthritis (OA) who underwent a THA or TKA. Therefore the aim of this study is to analyse one of the major assumptions underlying the potential effectiveness of prevalidation namely the relationship between preoperative physical activity level and postoperative recovery one year after THA or TKA in a group of 658 OA patients. Methods and Results: From 2006 to 2012, 1061 patients underwent a primary THA or TKA at University Medical Center Groningen. Preoperative and one-year postoperative patients filled in the SQUASH questionnaire to get an impression of their physical activity level, and the WOMAC questionnaire to obtain insight into degree of recovery. Missing data were multiply imputed. No relationship was found between the preoperative total (B-coefficient=0.03, CI95% = -0.033-0.093) and leisure-time physical activity level (B-coefficient=0.042, CI95% = -0.009-0.093) neither for preoperative compliance with the Dutch Recommendation for Health-Enhancing Physical Activity (B-coefficient=0.002, CI95% = -0.053-0.057), and the degree of recovery one year after surgery. Conclusion: The preoperative physical activity level had no relation with the degree of recovery one year after THA or TKA. The results do not support one of the major assumptions behind prevalidation, which assumes that a higher preoperative physical activity level will lead to a better recovery after THA or TKA.	[Poortinga, Sietske; Van den Akker-Scheek, Inge; Bulstra, Sjoerd K.; Stevens, Martin] Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands; [Stewart, Roy E.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Sci, Groningen, Netherlands	University of Groningen; University of Groningen	Stevens, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands.	m.stevens@umcg.nl	Stevens, Martin/A-5196-2013	Stevens, Martin/0000-0001-8183-6894; Stewart, Roy/0000-0001-9227-433X; van den Akker-Scheek, Inge/0000-0002-1614-8419				Ackerman IN, 2004, AUST J PHYSIOTHER, V50, P25, DOI 10.1016/S0004-9514(14)60245-2; Bauman A, 2009, J PHYS ACT HEALTH, V6, pS5, DOI 10.1123/jpah.6.s1.s5; Bouchard C, 1990, P INT C EX FITN HLTH; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dauty M, 2007, Ann Readapt Med Phys, V50, P462, DOI 10.1016/j.annrmp.2007.04.012; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hoogeboom TJ, 2010, CLIN REHABIL, V24, P901, DOI 10.1177/0269215510371427; Katz JN, 2006, BEST PRACT RES CL RH, V20, P145, DOI 10.1016/j.berh.2005.09.003; Oosting E, 2012, ARCH PHYS MED REHAB, V93, P610, DOI 10.1016/j.apmr.2011.11.006; Rijksinstituut voor Volksgezondheid en Millieu RIVM, 2013, NAT KOMP VOLKSG ARTR; Rooks DS, 2006, ARTHRIT RHEUM-ARTHR, V55, P700, DOI 10.1002/art.22223; Roorda LD, 2004, ANN RHEUM DIS, V63, P36, DOI 10.1136/ard.2002.001784; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Rubin DB, 2009, MULTIPLE IMPUTATION, V307; Wagenmakers R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-141; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; Whitney JAD, 2002, APPL NURS RES, V15, P19, DOI 10.1053/apnr.2002.29519	17	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115559	10.1371/journal.pone.0115559	http://dx.doi.org/10.1371/journal.pone.0115559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535744	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300050
J	Shimoda, N; Hirose, K; Kaneto, R; Izawa, T; Yokoi, H; Hashimoto, N; Kikuchi, Y				Shimoda, Nobuyoshi; Hirose, Kentaro; Kaneto, Reiya; Izawa, Toshiaki; Yokoi, Hayato; Hashimoto, Naohiro; Kikuchi, Yutaka			No Evidence for AID/MBD4-Coupled DNA Demethylation in Zebrafish Embryos	PLOS ONE			English	Article							METHYLATION; AID; GENOME; GLYCOSYLASE; DEAMINASE; CELLS; MBD4; MICE; IDENTIFICATION; ACTIVATION	The mechanisms responsible for active DNA demethylation remain elusive in Metazoa. A previous study that utilized zebrafish embryos provided a potent mechanism for active demethylation in which three proteins, AID, MBD4, and GADD45 are involved. We recently found age-dependent DNA hypomethylation in zebrafish, and it prompted us to examine if AID and MBD4 could be involved in the phenomenon. Unexpectedly, however, we found that most of the findings in the previous study were not reproducible. First, the injection of a methylated DNA fragment into zebrafish eggs did not affect either the methylation of genomic DNA, injected methylated DNA itself, or several loci tested or the expression level of aid, which has been shown to play a role in demethylation. Second, aberrant methylation was not observed at certain CpG islands following the injection of antisense morpholino oligonucleotides against aid and mbd4. Furthermore, we demonstrated that zebrafish MBD4 cDNA lacked a coding region for the methyl-CpG binding domain, which was assumed to be necessary for guidance to target regions. Taken together, we concluded that there is currently no evidence to support the proposed roles of AID and MBD4 in active demethylation in zebrafish embryos.	[Shimoda, Nobuyoshi; Hashimoto, Naohiro] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Dept Regenerat Med, Obu, Aichi 4748522, Japan; [Hirose, Kentaro; Kaneto, Reiya; Kikuchi, Yutaka] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Higashihiroshima, Hiroshima 7398526, Japan; [Izawa, Toshiaki] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Yokoi, Hayato] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan	National Center for Geriatrics & Gerontology; Hiroshima University; Max Planck Society; Tohoku University	Shimoda, N (corresponding author), Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Dept Regenerat Med, 35 Gengo, Obu, Aichi 4748522, Japan.	shimoda@ncgg.go.jp	Izawa, Toshiaki/AAN-6792-2021; Izawa, Toshiaki/U-1389-2019; Izawa, Toshiaki/AAU-9160-2021; Yokoi, Hayato/H-6521-2011; Deng, Dajun/D-4605-2009	Yokoi, Hayato/0000-0003-1020-6160; Deng, Dajun/0000-0001-5161-5943; Kikuchi, Yutaka/0000-0001-5688-7358	MEXT (KAKENHI) [23616002]; Grants-in-Aid for Scientific Research [24780178] Funding Source: KAKEN	MEXT (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research from the MEXT (KAKENHI 23616002; http://www.mext.go.jp/) to YK.	Abdouni H, 2013, NUCLEIC ACIDS RES, V41, P5457, DOI 10.1093/nar/gkt212; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Collas P, 1998, NUCLEIC ACIDS RES, V26, P4454, DOI 10.1093/nar/26.19.4454; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Engel N, 2009, EPIGENETICS-US, V4, P98, DOI 10.4161/epi.4.2.7858; Etard C, 2010, J CELL BIOL, V189, P527, DOI 10.1083/jcb.200912125; Fritz EL, 2013, NAT IMMUNOL, V14, P749, DOI 10.1038/ni.2616; Ge L, 2014, MOL CELL BIOL, V34, P989, DOI 10.1128/MCB.01061-13; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jiricny J, 2008, CELL, V135, P1167, DOI 10.1016/j.cell.2008.12.008; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Kumar R, 2013, NATURE, V500, P89, DOI 10.1038/nature12299; Leung T, 2006, BLOOD, V108, P160, DOI 10.1182/blood-2005-09-3706; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Martin CC, 1999, DEV BIOL, V206, P189, DOI 10.1006/dbio.1998.9105; Mei J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004979; Mhanni AA, 2001, GENESIS, V30, P213, DOI 10.1002/gene.1067; Mikl MC, 2005, MOL CELL BIOL, V25, P7270, DOI 10.1128/MCB.25.16.7270-7277.2005; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Petronzelli F, 2000, J BIOL CHEM, V275, P32422, DOI 10.1074/jbc.M004535200; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rangam G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043279; Sabag O, 2014, NAT STRUCT MOL BIOL, V21, P110, DOI 10.1038/nsmb.2734; Shimoda N, 2005, DEV DYNAM, V233, P1509, DOI 10.1002/dvdy.20455; Shimoda N, 2014, AGE, V36, P103, DOI 10.1007/s11357-013-9548-5; Wakae K, 2006, INT IMMUNOL, V18, P41, DOI 10.1093/intimm/dxh347; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wong E, 2002, P NATL ACAD SCI USA, V99, P14937, DOI 10.1073/pnas.232579299; Zhu B, 2000, NUCLEIC ACIDS RES, V28, P4157, DOI 10.1093/nar/28.21.4157	42	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114816	10.1371/journal.pone.0114816	http://dx.doi.org/10.1371/journal.pone.0114816			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536520	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300022
J	Cai, WK; Andres, DA				Cai, Weikang; Andres, Douglas A.			mTORC2 Is Required for Rit-Mediated Oxidative Stress Resistance	PLOS ONE			English	Article							NOONAN SYNDROME; SIGNALING PATHWAY; NEURONAL DIFFERENTIATION; GROWTH-CONTROL; SMALL GTPASES; P38 MAPK; COMPLEX; PROTEIN; SIN1; TOR	Rit, a member of the Ras family of GTPases, has been shown to promote cell survival in response to oxidative stress, in part by directing an evolutionarily conserved p38 MAPK-Akt survival cascade. Aberrant Rit signaling has recently been implicated as a driver mutation in human cancer, adding importance to the characterization of critical Rit effector pathways. However, the mechanism by which Rit-p38 signaling regulated Akt activity was unknown. Here, we identify mTORC2 as a critical downstream mediator of Rit-dependent survival signaling in response to reactive oxygen species (ROS) stress. Rit interacts with Sin1 (MAPKAP1), and Rit loss compromises ROS-dependent mTORC2 complex activation, blunting mTORC2-mediated phosphorylation of Akt kinase. Taken together, our findings demonstrate that the p38/mTORC2/Akt signaling cascade mediates Rit-dependent oxidative stress survival. Inhibition of this previously unrecognized cascade should be explored as a potential therapy of Rit-dependent malignancies.	[Cai, Weikang; Andres, Douglas A.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA	University of Kentucky	Andres, DA (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.	dandres@uky.edu	Cai, Weikang/K-2394-2019	Cai, Weikang/0000-0001-5638-0805	National Institutes of Health (NIH) [NS045103, P20 GM103486]; Kentucky Spinal Cord and Head Injury Research Trust [12-1A]; University of Kentucky Research Professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS045103, R01NS045103] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Spinal Cord and Head Injury Research Trust; University of Kentucky Research Professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) NS045103 (DAA) and P20 GM103486 (DAA), Kentucky Spinal Cord and Head Injury Research Trust Grant 12-1A (DAA), and University of Kentucky Research Professorship (DAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2013, AM J HUM GENET, V93, P173, DOI 10.1016/j.ajhg.2013.05.021; Berger AH, 2014, ONCOGENE, V33, P4418, DOI 10.1038/onc.2013.581; Bertola DR, 2014, AM J MED GENET A, V164, P2952, DOI 10.1002/ajmg.a.36722; Cai HQ, 2010, J CELL BIOL, V190, P233, DOI 10.1083/jcb.201001129; Cai WK, 2011, MOL BIOL CELL, V22, P3231, DOI 10.1091/mbc.E11-05-0400; Chen PC, 2014, P NATL ACAD SCI USA, V111, P11473, DOI 10.1073/pnas.1324128111; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Duran RV, 2012, EMBO REP, V13, P121, DOI 10.1038/embor.2011.257; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gomez-Segui I, 2013, LEUKEMIA, V27, P1943, DOI 10.1038/leu.2013.179; Gos M, 2014, AM J MED GENET A, V164, P2310, DOI 10.1002/ajmg.a.36646; Ikeda K, 2008, CELL CYCLE, V7, P358, DOI 10.4161/cc.7.3.5245; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Lamming DW, 2014, FASEB J, V28, P300, DOI 10.1096/fj.13-237743; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee S, 1999, MOL BIOL CELL, V10, P2829, DOI 10.1091/mbc.10.9.2829; Li Y, 2003, J BIOL CHEM, V278; Liu LH, 2011, J CELL BIOL, V194, P815, DOI 10.1083/jcb.201102090; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Makino C, 2006, GENES CELLS, V11, P1239, DOI 10.1111/j.1365-2443.2006.01016.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Niles BJ, 2014, CELL REP, V6, P541, DOI 10.1016/j.celrep.2013.12.040; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Rusyn EV, 2000, ONCOGENE, V19, P4685, DOI 10.1038/sj.onc.1203836; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; Shi GX, 2013, CELL SIGNAL, V25, P2060, DOI 10.1016/j.cellsig.2013.06.002; Shi GX, 2011, MOL CELL BIOL, V31, P1938, DOI 10.1128/MCB.01380-10; Shi GX, 2005, J BIOL CHEM, V280, P37599, DOI 10.1074/jbc.M507364200; Shimada K, 2013, MOL CELL, V51, P829, DOI 10.1016/j.molcel.2013.08.019; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026; Thomanetz V, 2013, J CELL BIOL, V201, P293, DOI 10.1083/jcb.201205030; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wilkinson MG, 1999, EMBO J, V18, P4210, DOI 10.1093/emboj/18.15.4210; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168	41	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115602	10.1371/journal.pone.0115602	http://dx.doi.org/10.1371/journal.pone.0115602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531880	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100083
J	Penet, L; Guyader, S; Petro, D; Salles, M; Busslere, F				Penet, Laurent; Guyader, Sebastien; Petro, Dalila; Salles, Michele; Busslere, Francois			Direct Splash Dispersal Prevails over Indirect and Subsequent Spread during Rains in Colletotrichum gloeosporioides Infecting Yams	PLOS ONE			English	Article							RUST SPORES; SIMULATED RAIN; ACUTATUM; WIND; ANTHRACNOSE; INTENSITY; SURVIVAL; INOCULUM; DISEASE; TRITICI	Plant pathogens have evolved many dispersal mechanisms, using biotic or abiotic vectors or a combination of the two. Rain splash dispersal is known from a variety of fungi, and can be an efficient driver of crop epidemics, with infectious strains propagating rapidly among often genetically homogenous neighboring plants. Splashing is nevertheless a local dispersal process and spores taking the droplet ride seldom move farther than a few decimeters. In this study, we assessed rain splash dispersal of conidia of the yam anthracnose agent, Colletotrichum gloeosporioides, in an experimental setting using a rain simulator, with emphasis on the impact of soil contamination (i.e., effect of re-splashing events). Spores dispersed up to 50 cm from yam leaf inoculum sources, though with an exponential decrease with increasing distance. While few spores were dispersed via re-splash from spore-contaminated soil, the proportion deposited via this mechanism increased with increasing distance from the initial source. We found no soil contamination carryover from previous rains, suggesting that contamination via re-splashing from contaminated soils mainly occurred within single rains. We conclude that most dispersal occurs from direct splashing, with a weaker contribution of indirect dispersal via re-splash.	[Penet, Laurent; Guyader, Sebastien; Petro, Dalila; Salles, Michele; Busslere, Francois] INRA, ASTRO Agrosyst Trop, UR1321, F-97170 Petit Bourg, Guadeloupe, France	INRAE	Penet, L (corresponding author), INRA, ASTRO Agrosyst Trop, UR1321, F-97170 Petit Bourg, Guadeloupe, France.	laurent.penet@antilles.inra.fr		Penet, Laurent/0000-0003-1512-6303	AGROECOTROP project; European Union (Fond Europeen de Developpement Regional); Guadeloupe Regional Council; AGROECOTROP project; European Union (Fond Europeen de Developpement Regional); Guadeloupe Regional Council	AGROECOTROP project; European Union (Fond Europeen de Developpement Regional); Guadeloupe Regional Council; AGROECOTROP project; European Union (Fond Europeen de Developpement Regional); Guadeloupe Regional Council	This work was funded as part of AGROECOTROP project, co-financed by the European Union (Fond Europeen de Developpement Regional) and the Guadeloupe Regional Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahimera N, 2004, PHYTOPATHOLOGY, V94, P1189, DOI 10.1094/PHYTO.2004.94.11.1189; AYLOR DE, 1990, ANNU REV PHYTOPATHOL, V28, P73, DOI 10.1146/annurev.py.28.090190.000445; Aylor DE, 1999, AGR FOREST METEOROL, V97, P275, DOI 10.1016/S0168-1923(99)00072-6; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cai L, 2011, TROP PLANT PATHOL, V36, P205, DOI 10.1590/S1982-56762011000400001; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Cornet D, 2014, EUR J AGRON, V55, P100, DOI 10.1016/j.eja.2014.02.002; DAG O, 2014, AID AN R PACKAGE TO; FITT BDL, 1989, ANNU REV PHYTOPATHOL, V27, P241, DOI 10.1146/annurev.py.27.090189.001325; FITZELL RD, 1984, ANN APPL BIOL, V104, P53, DOI 10.1111/j.1744-7348.1984.tb05586.x; Freeman S, 2002, PLANT DIS, V86, P965, DOI 10.1094/PDIS.2002.86.9.965; FURBISH DJ, 2007, J GEOPHYS RES, V112; Geagea L, 1999, PLANT PATHOL, V48, P472, DOI 10.1046/j.1365-3059.1999.00372.x; Geagea L, 2000, AGR FOREST METEOROL, V101, P53, DOI 10.1016/S0168-1923(99)00155-0; Green K. R., 1994, THESIS; GREGORY PH, 1959, J GEN MICROBIOL, V20, P328, DOI 10.1099/00221287-20-2-328; Hooper D., 2008, ARTICLES, V2, DOI DOI 10.1080/10705519909540118; Horberg HM, 2002, EUR J PLANT PATHOL, V108, P73, DOI 10.1023/A:1013936624884; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Huber L, 1997, AGR FOREST METEOROL, V87, P201, DOI 10.1016/S0168-1923(97)00016-6; Hyde KD, 2009, FUNGAL DIVERS, V39, P147; KLIEJUNAS JT, 1976, PHYTOPATHOLOGY, V66, P457, DOI 10.1094/Phyto-66-457; Lacey J, 1996, MYCOL RES, V100, P641, DOI 10.1016/S0953-7562(96)80194-8; LI DW, 1994, GRANA, V33, P166, DOI 10.1080/00173139409428995; Lovell DJ, 2004, PLANT PATHOL, V53, P11, DOI 10.1046/j.1365-3059.2003.00939.x; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; Madden LV, 1996, PHYTOPATHOLOGY, V86, P864, DOI 10.1094/Phyto-86-864; MCCARTNEY HA, 1994, GRANA, V33, P76, DOI 10.1080/00173139409427835; MILLS PR, 1992, FEMS MICROBIOL LETT, V98, P137, DOI 10.1016/0378-1097(92)90145-E; MITCHELL RJ, 1992, FUNCT ECOL, V6, P123, DOI 10.2307/2389745; Ntahimpera N, 1999, PHYTOPATHOLOGY, V89, P555, DOI 10.1094/PHYTO.1999.89.7.555; Ntahimpera N, 1998, PHYTOPATHOLOGY, V88, P536, DOI 10.1094/PHYTO.1998.88.6.536; OOKA JJ, 1977, PHYTOPATHOLOGY, V67, P1023, DOI 10.1094/Phyto-67-1023; Petraitis PS, 1996, FUNCT ECOL, V10, P421, DOI 10.2307/2389934; Pietravalle S, 2001, AGR FOREST METEOROL, V109, P171, DOI 10.1016/S0168-1923(01)00267-2; R Core Team, 2012, R LANG ENV STAT COMP; REYNOLDS KM, 1987, PHYTOPATHOLOGY, V77, P921, DOI 10.1094/Phyto-77-921; Ripoche A, 2008, APPL SOIL ECOL, V38, P270, DOI 10.1016/j.apsoil.2007.10.015; Sache I, 2000, AGRONOMIE, V20, P757, DOI 10.1051/agro:2000102; Saint-Jean S, 2006, AGR FOREST METEOROL, V141, P257, DOI 10.1016/j.agrformet.2006.10.009; Van Dijk AIJM, 2003, HYDROL PROCESS, V17, P153, DOI 10.1002/hyp.1154; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; YANG X, 1990, PHYTOPATHOLOGY, V80, P1115, DOI 10.1094/Phyto-80-1115; YANG X, 1990, PHYTOPATHOLOGY, V80, P590, DOI 10.1094/Phyto-80-590; YANG XB, 1992, PHYTOPATHOLOGY, V82, P1219, DOI 10.1094/Phyto-82-1219	46	22	23	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115757	10.1371/journal.pone.0115757	http://dx.doi.org/10.1371/journal.pone.0115757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532124	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100105
J	Xu, HT; Zhao, L; Fang, QJ; Sun, JM; Zhang, SY; Zhan, C; Liu, SJ; Zhang, YB				Xu, Haitao; Zhao, Liang; Fang, Qiuju; Sun, Jianmin; Zhang, Songyan; Zhan, Chao; Liu, Shujie; Zhang, Yubao			MiR-338-3p Inhibits Hepatocarcinoma Cells and Sensitizes These Cells to Sorafenib by Targeting Hypoxia-Induced Factor 1 alpha	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; INDUCIBLE FACTOR-1-ALPHA; GENE-EXPRESSION; DOWN-REGULATION; CANCER-CELLS; MDR1 GENE; PROLIFERATION; ANGIOGENESIS; RESISTANCE	Hypoxia is a common feature of solid tumors and an important contributor to anti-tumor drug resistance. Hypoxia inducible factor-1 (HIF-1) is one of the key mediators of the hypoxia signaling pathway, and was recently proven to be required for sorafenib resistance in hepatocarcinoma (HCC). MicroRNAs have emerged as important posttranslational regulators in HCC. It was reported that miR-338-3p levels are associated with clinical aggressiveness of HCC. However, the roles of miR-338-3p in HCC disease and resistance to its therapeutic drugs are unknown. In this study, we found that miR-338-3p was frequently down-regulated in 14 HCC clinical samples and five cell lines. Overexpression of miR-338-3p inhibited HIF-1 alpha 3'-UTR luciferase activity and HIF-1 alpha protein levels in HepG2, SMMC-7721, and Huh7 cells. miR-338-3p significantly reduced cell viability and induced cell apoptosis of HCC cells. Additionally, HIF-1 alpha overexpression rescued and HIF-1a knock-down abrogated the anti-HCC activity of miR-338-3p. Furthermore, miR-338-p sensitized HCC cells to sorafenib in vitro and in a HCC subcutaneous nude mice tumor model by inhibiting HIF-1 alpha. Collectively, miR-338-3p inhibits HCC tumor growth and sensitizes HCC cells to sorafenib by down-regulating HIF-1 alpha. Our data indicate that miR-338-3p could be a potential candidate for HCC therapeutics.	[Xu, Haitao; Zhao, Liang; Sun, Jianmin; Zhang, Songyan; Zhan, Chao; Zhang, Yubao] Harbin Med Univ Canc Hosp, Dept Hepatopancreatobiliary Surg, Harbin, Heilongjiang, Peoples R China; [Fang, Qiuju] Heilongjiang Prov Hosp, Dept Internal Med, Harbin, Heilongjiang, Peoples R China; [Liu, Shujie] Harbin Med Univ Canc Hosp, Dept Operat, Harbin, Heilongjiang, Peoples R China		Zhang, YB (corresponding author), Harbin Med Univ Canc Hosp, Dept Hepatopancreatobiliary Surg, Harbin, Heilongjiang, Peoples R China.	zhyb88077@sina.com			Natural Science Foundation of Heilongjiang Province [2009026]	Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was supported by the Natural Science Foundation of Heilongjiang Province (No. 2009026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asghar U, 2012, J HEPATOL, V56, P686, DOI 10.1016/j.jhep.2011.07.031; Baek JH, 2000, ONCOGENE, V19, P4621, DOI 10.1038/sj.onc.1203814; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Chen X, 2013, FEBS LETT, V587, P3729, DOI 10.1016/j.febslet.2013.09.044; Comerford KM, 2002, CANCER RES, V62, P3387; Dvorak AM, 1996, J LEUKOCYTE BIOL, V59, P100, DOI 10.1002/jlb.59.1.100; DVORAK HF, 1992, ANN NY ACAD SCI, V667, P101, DOI 10.1111/j.1749-6632.1992.tb51603.x; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Fardel O, 1996, GEN PHARMACOL, V27, P1283, DOI 10.1016/S0306-3623(96)00081-X; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fu XY, 2012, INT J MOL SCI, V13, P8514, DOI 10.3390/ijms13078514; Goldstein LJ, 1996, EUR J CANCER, V32A, P1039, DOI 10.1016/0959-8049(96)00100-1; Gwak GY, 2005, J HEPATOL, V42, P358, DOI 10.1016/j.jhep.2004.11.020; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Huang XH, 2011, J PATHOL, V225, P463, DOI 10.1002/path.2877; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin SK, 1998, MOL CELL BIOL, V18, P4377, DOI 10.1128/MCB.18.7.4377; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kim KW, 1998, CANCER RES, V58, P348; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Li P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066782; Liang YJ, 2013, HEPATOLOGY, V57, P1847, DOI 10.1002/hep.26224; Liu LP, 2012, CLIN CANCER RES, V18, P5662, DOI 10.1158/1078-0432.CCR-12-0552; Livraghi T, 2011, SCAND J SURG, V100, P22, DOI 10.1177/145749691110000105; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Mazure NM, 2001, TUMOR BIOL, V22, P310, DOI 10.1159/000050632; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Ogretmen B, 1999, BIOCHEMISTRY-US, V38, P2189, DOI 10.1021/bi982236+; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Palmer DH, 2008, NEW ENGL J MED, V359, P2498; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Poller B, 2011, MOL PHARMACEUT, V8, P571, DOI 10.1021/mp1003898; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Powis G, 2004, MOL CANCER THER, V3, P647; Roberts WG, 1997, CANCER RES, V57, P765; Rosmorduc O, 2010, SEMIN LIVER DIS, V30, P258, DOI 10.1055/s-0030-1255355; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Tak E, 2011, J HEPATOL, V54, P328, DOI 10.1016/j.jhep.2010.06.045; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; VAUPEL P, 1977, MICROVASC RES, V13, P399, DOI 10.1016/0026-2862(77)90106-6; Won KY, 2013, HUM PATHOL, V44, P1648, DOI 10.1016/j.humpath.2013.01.016; Wu XZ, 2007, J GASTROEN HEPATOL, V22, P1178, DOI 10.1111/j.1440-1746.2007.04997.x; Xue Q, 2014, JPN J CLIN ONCOL, V44, P13, DOI 10.1093/jjco/hyt181; Yang W, 2011, CANCER BIOTHER RADIO, V26, P565, DOI 10.1089/cbr.2011.0955; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	59	64	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115565	10.1371/journal.pone.0115565	http://dx.doi.org/10.1371/journal.pone.0115565			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531114	Green Submitted, gold, Green Published			2022-12-26	WOS:000348845100076
J	Huang, H; Koelle, P; Fendler, M; Schroettle, A; Czihal, M; Hoffmann, U; Kuhlencordt, PJ				Huang, Hua; Koelle, Pirkko; Fendler, Markus; Schroettle, Angelika; Czihal, Michael; Hoffmann, Ulrich; Kuhlencordt, Peter Jan			Niacin Reverses Migratory Macrophage Foam Cell Arrest Mediated by oxLDL In Vitro	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; EXTENDED-RELEASE NIACIN; FOCAL ADHESION; TYROSINE PHOSPHORYLATION; OXIDATIVE STRESS; LIPID PEROXIDES; NICOTINIC-ACID; KNOCKOUT MICE; PLASMA	Introduction: Niacin reduces vascular oxidative stress and down regulates inducible nitric oxide synthase, an enzyme mediating proatherosclerotic effects in part by increasing oxidative stress. Here, we evaluate whether Niacin reverses the redox sensitive migratory arrest of macrophages in response to oxidised(ox) LDL uptake. Material and Methods: Migration of RAW264.7 cells, a murine macrophage cell line and bone marrow derived macrophages from wildtype and iNOS knockout mice was quantified using a modified Boyden chamber. Unstimulated cells or cells preincubated with oxLDL or non-oxidised (n)LDL were treated with Nicotinic acid or Nicotinamide. Nitric oxide, peroxynitrite and ROS production were assessed using electron paramagnetic resonance (ESR). Additionally, flow cytometry analysis of apoptosis, fokal adhesion kinase (FAK), phalloidin, CD36, F4/80 macrophage marker and iNOS gene expression (PCR) were assessed. Results: Migration of Nicotinic acid, Nicotinamide treated cells or unstimulated cells did not differ (P>0.05). oxLDL treatment significantly reduced migration vs. unstimulated cells (p,0.05). In contrast, migratory arrest in response to oxLDL treatment was reversed by co-incubation with Nicotinic acid and Nicotinamide. The oxLDL-induced peroxynitrite formation in RAW264.7 cells was abolished by Niacin and glutathion (GSH) oxidation was significantly reduced. However, nitric oxide (NO)- and reactive oxygen species (ROS) production induced by oxLDL were not affected by Niacin treatment of RAW264.7 cells. In addition, Nicotinic acid and Nicotinamide reduced actin polymerization, a marker for migratory arrest. Discussion: Our data shows that oxLDL induced inhibition of macrophage migration in vitro can be reversed by Niacin. Furthermore, Niacin reduces peroxynitite formation and improves antioxidant GSH.	[Huang, Hua; Koelle, Pirkko; Fendler, Markus; Schroettle, Angelika; Czihal, Michael; Hoffmann, Ulrich; Kuhlencordt, Peter Jan] Univ Hosp Munich, Div Vasc Med, Med Clin & Policlin 4, Munich, Germany	University of Munich	Kuhlencordt, PJ (corresponding author), Univ Hosp Munich, Div Vasc Med, Med Clin & Policlin 4, Munich, Germany.	peter.kuhlencordt@med.uni-muenchen.de	Hoffmann, Ulrich/AAF-9798-2020		Merck, Sharp Dhome; Essex Pharma GmbH	Merck, Sharp Dhome; Essex Pharma GmbH	This work was supported by a grant from Merck, Sharp & Dhome and Essex Pharma GmbH to P.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hijji M, 2013, AM J CARDIOL, V112, P1697, DOI 10.1016/j.amjcard.2013.07.030; Bellocq A, 1998, J BIOL CHEM, V273, P5086, DOI 10.1074/jbc.273.9.5086; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; Chen JQ, 2003, ARTERIOSCL THROM VAS, V23, P97, DOI 10.1161/01.ATV.0000040223.74255.5A; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; Digby JE, 2010, ATHEROSCLEROSIS, V209, P89, DOI 10.1016/j.atherosclerosis.2009.08.045; Feussner A, 1997, EUR J CLIN CHEM CLIN, V35, P687; Ganji SH, 2009, ATHEROSCLEROSIS, V202, P68, DOI 10.1016/j.atherosclerosis.2008.04.044; Giordano A, 2002, FEBS LETT, V514, P135, DOI 10.1016/S0014-5793(02)02245-7; Grotto D, 2007, J PHARMACEUT BIOMED, V43, P619, DOI 10.1016/j.jpba.2006.07.030; Huang H, 2014, ATHEROSCLEROSIS, V235, P213, DOI 10.1016/j.atherosclerosis.2014.04.020; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Kolodziejska KE, 2005, P NATL ACAD SCI USA, V102, P4854, DOI 10.1073/pnas.0500485102; Kuhlencordt PJ, 2001, CIRCULATION, V103, P3099, DOI 10.1161/01.CIR.103.25.3099; Kuhnast S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066467; Kuzkaya N, 2005, BIOCHEM PHARMACOL, V70, P343, DOI 10.1016/j.bcp.2005.05.009; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Navarro-Lerida I, 2004, J BIOL CHEM, V279, P55682, DOI 10.1074/jbc.M406621200; Orr AW, 2004, J BIOL CHEM, V279, P48983, DOI 10.1074/jbc.M404881200; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pan JM, 1996, BIOCHEM J, V314, P889, DOI 10.1042/bj3140889; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Ponnuswamy P, 2009, AM J PATHOL, V174, P2400, DOI 10.2353/ajpath.2009.080730; Rubbo H, 1996, CHEM RES TOXICOL, V9, P809, DOI 10.1021/tx960037q; Saini R, 2006, J LEUKOCYTE BIOL, V79, P519, DOI 10.1189/jlb.0605320; Sharma M, 2011, CURR OPIN CARDIOL, V26, P420, DOI 10.1097/HCO.0b013e3283499ef1; Silverstein Roy L, 2010, Trans Am Clin Climatol Assoc, V121, P206; Soskic SS, 2011, OPEN CARDIOVASC MED, V5, P153, DOI 10.2174/1874192401105010153; STEINBRECHER UP, 1987, J BIOL CHEM, V262, P3603; STOSSEL TP, 1994, SCI AM, V271, P54, DOI 10.1038/scientificamerican0994-54; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Taylor AJ, 2009, NEW ENGL J MED, V361, P2113, DOI 10.1056/NEJMoa0907569; Taylor W R, 1999, Curr Hypertens Rep, V1, P96, DOI 10.1007/s11906-999-0079-5; The AIM-HIGH Investigators, 2013, EUROPEAN HEART J, V34, P1279; Vaca P, 2003, TRANSPL P, V35, P2021, DOI 10.1016/S0041-1345(03)00735-8; Wu BJ, 2010, ARTERIOSCL THROM VAS, V30, P968, DOI 10.1161/ATVBAHA.109.201129; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125	43	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114643	10.1371/journal.pone.0114643	http://dx.doi.org/10.1371/journal.pone.0114643			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521578	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845600005
J	Riters, LV; Stevenson, SA; DeVries, MS; Cordes, MA				Riters, Lauren V.; Stevenson, Sharon A.; DeVries, M. Susan; Cordes, Melissa A.			Reward Associated with Singing Behavior Correlates with Opioid-Related Gene Expression in the Medial Preoptic Nucleus in Male European Starlings	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; STURNUS-VULGARIS; SOCIAL-BEHAVIOR; ZEBRA FINCH; DOPAMINERGIC SYSTEM; INCENTIVE SALIENCE; UNDIRECTED SONG; SEXUAL REWARD; BRAIN; AREA	Birdsong consists of species-specific learned vocal sequences that are used primarily to attract mates and to repel competitors during the breeding season. However, many birds continue to sing at times when vocal production has no immediate or obvious impact on conspecific behavior. The mechanisms that ensure that animals produce important behaviors in contexts in which the function of these behaviors is not immediate or obvious are not known. One possibility is that animals engage in such behaviors because they are associated with pleasure. Here we examined the hypothesis that male European starlings sing outside of the breeding season in part because the act of singing in this context is facilitated and/or maintained by opioid-mediated reward. We measured song-associated reward using a conditioned place preference (CPP) test in male starlings producing fall, non-breeding season-typical song. We used quantitative real time PCR to measure expression of the enkephalin opioid precursor preproenkephalin (PENK) and mu opioid receptors (MOR) in the medial preoptic nucleus (POM; a region in which opioids are implicated in both reward and starling fall song) and additionally the song control region HVC as a control. Starlings developed a strong preference for a place that had been paired previously with the act of producing fall-typical song, indicating that fall song production was associated with a positive affective state. Both PENK and MOR mRNA expression in the POM, but not HVC, correlated positively with both individual reward state (as reflected in CPP) and undirected singing behavior. These results suggest that singing induces opioid receptor and enkephalin expression in the POM and consequent reward, and/or that opioid release in the POM induced by individual or environmental factors (e.g., the presence of food, safety of a flock or the absence of predators) induces a positive affective state which then facilitates singing behavior.	[Riters, Lauren V.; Stevenson, Sharon A.; DeVries, M. Susan; Cordes, Melissa A.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Riters, LV (corresponding author), Univ Wisconsin, Dept Zool, 428 Birge Hall, Madison, WI 53706 USA.	LVRiters@wisc.edu			National Institute of Mental Health [R01MH080225]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080225] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health, R01MH080225, to LVR.http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGMO A, 1993, BEHAV NEUROSCI, V107, P812, DOI 10.1037/0735-7044.107.5.812; AGMO A, 1991, BRAIN RES, V550, P343, DOI 10.1016/0006-8993(91)91339-3; AGMO A, 1990, BEHAV NEUROSCI, V104, P177, DOI 10.1037/0735-7044.104.1.177; Ahmed M, 2014, J PEDIAT HEMATOL ONC, V36, P152, DOI 10.1097/MPH.0000000000000024; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Barbano MF, 2007, PSYCHOPHARMACOLOGY, V191, P497, DOI 10.1007/s00213-006-0521-1; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge KC, 2013, CURR OPIN NEUROBIOL, V23, P294, DOI 10.1016/j.conb.2013.01.017; Bodnar RJ, 2013, PEPTIDES, V50, P55, DOI 10.1016/j.peptides.2013.10.001; CARDEN SE, 1990, BEHAV NEUROSCI, V104, P457, DOI 10.1037/0735-7044.104.3.457; Catchpole Clive K, 2003, BIRD SONG BIOL THEME; CHANG KJ, 1982, NATURE, V296, P446, DOI 10.1038/296446a0; CHENG MF, 1994, J NEUROBIOL, V25, P361, DOI 10.1002/neu.480250403; Clift SM, 2001, J R SOC PROMO HEALTH, V121, P248, DOI 10.1177/146642400112100409; Darwin C, 1882, DESCENT MAN SELECTIO; Dawson A, 1997, J REPROD FERTIL, V111, P1; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Dunbar RIM, 2012, P ROY SOC B-BIOL SCI, V279, P1161, DOI 10.1098/rspb.2011.1373; Dunn AM, 1996, ETHOLOGY, V102, P529; EAST M, 1982, ORNIS SCAND, V13, P85, DOI 10.2307/3676194; Eens M, 1997, ADV STUD BEHAV, V26, P355, DOI 10.1016/S0065-3454(08)60384-8; Feare C.J., 1984, STARLING; GISPEN WH, 1976, NATURE, V264, P794, DOI 10.1038/264794a0; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Gulledge CC, 1999, J COMP NEUROL, V404, P505; Hara E, 2007, EUR J NEUROSCI, V25, P3406, DOI 10.1111/j.1460-9568.2007.05600.x; Harrison LM, 1998, PEPTIDES, V19, P1603, DOI 10.1016/S0196-9781(98)00126-0; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; Heimovics SA, 2009, NEUROSCIENCE, V159, P962, DOI 10.1016/j.neuroscience.2009.01.042; Heimovics SA, 2008, PHYSIOL BEHAV, V95, P258, DOI 10.1016/j.physbeh.2008.06.009; Heimovics SA, 2011, HORM BEHAV, V60, P529, DOI 10.1016/j.yhbeh.2011.08.001; Holveck MJ, 2007, ANIM BEHAV, V74, P297, DOI 10.1016/j.anbehav.2006.08.016; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Jesse F, 2012, BEHAV PROCESS, V91, P262, DOI 10.1016/j.beproc.2012.09.006; KATZ RJ, 1979, NEUROSCI LETT, V13, P209, DOI 10.1016/0304-3940(79)90043-0; Kelm-Nelson CA, 2013, BRAIN RES, V1527, P29, DOI 10.1016/j.brainres.2013.06.010; Kelm-Nelson CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046721; Khurshid N, 2010, BEHAV BRAIN RES, V208, P359, DOI 10.1016/j.bbr.2009.12.003; Khurshid N, 2009, J CHEM NEUROANAT, V37, P158, DOI 10.1016/j.jchemneu.2008.12.001; King AP, 2005, ETHOLOGY, V111, P101, DOI 10.1111/j.1439-0310.2004.01039.x; Kleitz-Nelson HK, 2010, BEHAV NEUROSCI, V124, P300, DOI 10.1037/a0018767; Ko HJ, 2011, GERIATR GERONTOL INT, V11, P267, DOI 10.1111/j.1447-0594.2010.00680.x; Kreutz G, 2004, J BEHAV MED, V27, P623, DOI 10.1007/s10865-004-0006-9; Kubikova L, 2010, J CHEM NEUROANAT, V39, P112, DOI 10.1016/j.jchemneu.2009.10.004; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Lehrer P. M., 1994, BEHAV PSYCHOL APPROA, P191; MARLER P, 1990, PHILOS T ROY SOC B, V329, P109, DOI 10.1098/rstb.1990.0155; PANKSEPP J, 1980, NEUROSCI BIOBEHAV R, V4, P473, DOI 10.1016/0149-7634(80)90036-6; PANKSEPP J, 1981, BRAIN RES BULL, V7, P405, DOI 10.1016/0361-9230(81)90038-1; PANKSEPP J, 1980, PHARMACOL BIOCHEM BE, V13, P673, DOI 10.1016/0091-3057(80)90011-8; PANKSEPP J, 1979, PHARMACOL BIOCHEM BE, V11, P131, DOI 10.1016/0091-3057(79)90002-9; Panksepp J, 2007, BEHAV BRAIN RES, V182, P231, DOI 10.1016/j.bbr.2007.02.015; Panksepp J, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P67; Paredes RG, 2009, ILAR J, V50, P15, DOI 10.1093/ilar.50.1.15; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfaus JG, 2001, HORM BEHAV, V40, P291, DOI 10.1006/hbeh.2001.1686; Riters LV, 2012, FRONT NEUROENDOCRIN, V33, P194, DOI 10.1016/j.yfrne.2012.04.002; Riters LV, 2012, PHYSIOL BEHAV, V106, P87, DOI 10.1016/j.physbeh.2012.01.010; Riters LV, 2011, NEUROSCI BIOBEHAV R, V35, P1837, DOI 10.1016/j.neubiorev.2010.12.017; Riters LV, 2010, J CHEM NEUROANAT, V39, P141, DOI 10.1016/j.jchemneu.2009.03.008; Riters LV, 2000, HORM BEHAV, V38, P250, DOI 10.1006/hbeh.2000.1623; Riters LV, 2005, BEHAV NEUROSCI, V119, P245, DOI 10.1037/0735-7044.119.1.245; Robertson SA, 2005, J VET PHARMACOL THER, V28, P453, DOI 10.1111/j.1365-2885.2005.00677.x; Sakata JT, 2012, J EXP BIOL, V215, P201, DOI 10.1242/jeb.056911; Sasaki A, 2006, J NEUROSCI, V26, P9010, DOI 10.1523/JNEUROSCI.1335-06.2006; Skingley A, 2010, Nurs Stand, V24, P35; Stephens R, 2009, NEUROREPORT, V20, P1056, DOI 10.1097/WNR.0b013e32832e64b1; Stevenson TJ, 2012, J CHEM NEUROANAT, V43, P87, DOI 10.1016/j.jchemneu.2011.12.001; Tenk CM, 2009, HORM BEHAV, V55, P93, DOI 10.1016/j.yhbeh.2008.08.012; Trezza V, 2010, TRENDS PHARMACOL SCI, V31, P463, DOI 10.1016/j.tips.2010.06.008; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; WEST MJ, 1988, NATURE, V334, P244, DOI 10.1038/334244a0	74	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115285	10.1371/journal.pone.0115285	http://dx.doi.org/10.1371/journal.pone.0115285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521590	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845600030
J	Sanz, R; Ferraro, GB; Fournier, AE				Sanz, Ricardo; Ferraro, Gino B.; Fournier, Alyson E.			IgLON Cell Adhesion Molecules Are Shed from the Cell Surface of Cortical Neurons to Promote Neuronal Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURITE OUTGROWTH; MEMBRANE-PROTEIN; MIGRATION; METALLOPROTEINASES; INHIBITORS; CLEAVAGE; SYSTEM; FAMILY; ADAM; L1	Matrix metalloproteinases and a disintegrin and metalloproteinases are members of the zinc endopeptidases, which cleave components of the extracellular matrix as well as cell surface proteins resulting in degradation or release of biologically active fragments. Surface ectodomain shedding affects numerous biological processes, including survival, axon outgrowth, axon guidance, and synaptogenesis. In this study, we evaluated the role of metalloproteinases in regulating cortical neurite growth. We found that treatment of mature cortical neurons with panmetalloproteinase inhibitors or with tissue inhibitors of metal-loproteinase-3 reduced neurite outgrowth. Through mass spectrometry, we characterized the metalloproteinase-sensitive cell surface proteome of mature cortical neurons. Members of the IgLON family of glycosylphosphatidylinositol-anchored neural cell adhesion molecules were identified and validated as proteins that were shed from the surface of mature cortical neurons in a metalloproteinase-dependent manner. Introduction of two members of the IgLON family, neurotrimin and NEGR1, in early embryonic neurons was sufficient to confer sensitivity to metalloproteinase inhibitors in neurite outgrowth assays. Outgrowth experiments on immobilized IgLON proteins revealed a role for all IgLON family members in promoting neurite extension from cortical neurons. Together, our findings support a role for metalloproteinase-dependent shedding of IgLON family members in regulating neurite outgrowth from mature cortical neurons.	[Sanz, Ricardo; Ferraro, Gino B.; Fournier, Alyson E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Fournier, AE (corresponding author), McGill Univ, Montreal Neurol Inst, BT-109,3801 Rue Univ, Montreal, PQ H3A 2B4, Canada.	alyson.fournier@mcgill.ca			Canadian Institutes of Health Research; McGill Program in Neuroengineering; Canada Research Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill Program in Neuroengineering; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by grants from the Canadian Institutes of Health Research and the McGill Program in Neuroengineering and by a Canada Research Chair (to A.E.F.).	Akeel M, 2011, BRAIN RES, V1374, P27, DOI 10.1016/j.brainres.2010.12.028; Bajor M, 2013, NEUROCHEM RES, V38, P1113, DOI 10.1007/s11064-012-0919-6; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Brennaman LH, 2008, MOL CELL NEUROSCI, V37, P781, DOI 10.1016/j.mcn.2008.01.006; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chen S, 2001, J NEUROCYTOL, V30, P927, DOI 10.1023/A:1020673318536; DAVIES B, 1993, CANCER RES, V53, P2087; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Diestel S, 2005, J NEUROCHEM, V95, P1777, DOI 10.1111/j.1471-4159.2005.03475.x; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Fambrough D, 1996, P NATL ACAD SCI USA, V93, P13233, DOI 10.1073/pnas.93.23.13233; Ferraro GB, 2011, J BIOL CHEM, V286, P31418, DOI 10.1074/jbc.M111.249169; Galko MJ, 2000, SCIENCE, V289, P1365, DOI 10.1126/science.289.5483.1365; Gil OD, 1998, J NEUROSCI, V18, P9312; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; Hashimoto T, 2009, CELL BIOCHEM FUNCT, V27, P496, DOI 10.1002/cbf.1600; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; HORTON HL, 1988, J NEUROSCI, V8, P4653; Houri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073296; Huang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071553; Huebner EA, 2011, J BIOL CHEM, V286, P18026, DOI 10.1074/jbc.M110.208108; Itoh S, 2008, BIOCHEMISTRY-US, V47, P10132, DOI 10.1021/bi8009778; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kajiwara Y, 2009, BIOL PSYCHIAT, V66, P918, DOI 10.1016/j.biopsych.2009.05.033; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kimura Y, 2001, DEV GROWTH DIFFER, V43, P257; Kolodkin Alex L, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001727; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Lee H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0158; Lodge AP, 2000, MOL BRAIN RES, V82, P84, DOI 10.1016/S0169-328X(00)00184-4; Malinverno M, 2010, J NEUROSCI, V30, P16343, DOI 10.1523/JNEUROSCI.1984-10.2010; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; McNamee CJ, 2011, CELL BIOCHEM FUNCT, V29, P114, DOI 10.1002/cbf.1730; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Minhas HM, 2013, AM J MED GENET A, V161A, P787, DOI 10.1002/ajmg.a.35841; Miyata S, 2003, NEUROSCIENCE, V117, P645, DOI 10.1016/S0306-4522(02)00873-4; Nash M, 2009, MOL NEUROBIOL, V40, P224, DOI 10.1007/s12035-009-8083-y; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Park MJ, 2000, NEUROSCI LETT, V290, P201, DOI 10.1016/S0304-3940(00)01358-6; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pischedda F, 2014, MOL CELL PROTEOMICS, V13, P733, DOI 10.1074/mcp.M113.031716; Prasad A, 2012, G3-GENES GENOM GENET, V2, P1665, DOI 10.1534/g3.112.004689; Reed J, 2004, J CELL SCI, V117, P3961, DOI 10.1242/jcs.01261; Romi E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5058; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; Saura CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019430; Schmidt ERE, 2014, NEURON, V83, P372, DOI 10.1016/j.neuron.2014.05.036; Shichi K, 2011, J PHARMACOL EXP THER, V338, P701, DOI 10.1124/jpet.110.178079; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; STRUYK AF, 1995, J NEUROSCI, V15, P2141, DOI 10.1523/JNEUROSCI.15-03-02141.1995; Tanaka M, 2007, J CELL SCI, V120, P2179, DOI 10.1242/jcs.008607; Tanaka Y, 2002, BIOCHEM BIOPH RES CO, V299, P472, DOI 10.1016/S0006-291X(02)02681-5; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Vaillant C, 2003, MOL CELL NEUROSCI, V24, P395, DOI 10.1016/S1044-7431(03)00196-9; Webber CA, 2002, J NEUROSCI, V22, P8091; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Yamada M, 2007, BRAIN RES, V1165, P5, DOI 10.1016/j.brainres.2007.04.062; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; ZACCO A, 1990, J NEUROSCI, V10, P73; Zolkiewska A, 2008, CELL MOL LIFE SCI, V65, P2056, DOI 10.1007/s00018-008-7586-4	64	58	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4330	4342		10.1074/jbc.M114.628438	http://dx.doi.org/10.1074/jbc.M114.628438			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25538237	hybrid, Green Published			2022-12-26	WOS:000349458400042
J	Bower, KJ; McGinley, JL; Miller, KJ; Clark, RA				Bower, Kelly J.; McGinley, Jennifer L.; Miller, Kimberly J.; Clark, Ross A.			Instrumented Static and Dynamic Balance Assessment after Stroke Using Wii Balance Boards: Reliability and Association with Clinical Tests	PLOS ONE			English	Article							SIT-TO-STAND; POSTURAL CONTROL; PRESSURE MEASURES; INDIVIDUALS; POSTSTROKE; VALIDITY; PERFORMANCE; SYSTEM; GAIT	Background and Objectives: The Wii Balance Board (WBB) is a globally accessible device that shows promise as a clinically useful balance assessment tool. Although the WBB has been found to be comparable to a laboratory-grade force platform for obtaining centre of pressure data, it has not been comprehensively studied in clinical populations. The aim of this study was to investigate the measurement properties of tests utilising the WBB in people after stroke. Methods: Thirty individuals who were more than three months post-stroke and able to stand unsupported were recruited from a single outpatient rehabilitation facility. Participants performed standardised assessments incorporating the WBB and customised software (static stance with eyes open and closed, static weight-bearing asymmetry, dynamic mediolateral weight shifting and dynamic sit-to-stand) in addition to commonly employed clinical tests (10 Metre Walk Test, Timed Up and Go, Step Test and Functional Reach) on two testing occasions one week apart. Test-retest reliability and construct validity of the WBB tests were investigated. Results: All WBB-based outcomes were found to be highly reliable between testing occasions (ICC =0.82 to 0.98). Correlations were poor to moderate between WBB variables and clinical tests, with the strongest associations observed between task-related activities, such as WBB mediolateral weight shifting and the Step Test. Conclusions: The WBB, used with customised software, is a reliable and potentially useful tool for the assessment of balance and weight-bearing asymmetry following stroke. Future research is recommended to further investigate validity and responsiveness.	[Bower, Kelly J.; McGinley, Jennifer L.] Univ Melbourne, Dept Physiotherapy, Melbourne, Vic, Australia; [Bower, Kelly J.] Royal Melbourne Hosp, Dept Physiotherapy, Melbourne, Vic, Australia; [Miller, Kimberly J.] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Bower, Kelly J.; Clark, Ross A.] Australian Catholic Univ, Sch Exercise Sci, Melbourne, Vic, Australia	University of Melbourne; Royal Melbourne Hospital; University of British Columbia; Australian Catholic University	Bower, KJ (corresponding author), Univ Melbourne, Dept Physiotherapy, Melbourne, Vic, Australia.	kelly.bower@mh.org.au	Clark, Ross A/R-5664-2018; Clark, Ross/K-7613-2019	Clark, Ross A/0000-0002-7291-8553; Clark, Ross/0000-0002-7291-8553; McGinley, Jennifer/0000-0003-3775-9267; Miller, Kimberly/0000-0002-9826-7269	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding: This study was funded in part by a National Health and Medical Research Council postgraduate scholarship (https://www.nhmrc.gov.au/) awarded to author KB. The authors received no additional specific funding for this work.	Barra J, 2009, NEUROLOGY, V72, P1582, DOI 10.1212/WNL.0b013e3181a4123a; Batchelor FA, 2012, INT J STROKE, V7, P482, DOI 10.1111/j.1747-4949.2012.00796.x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bower KJ, 2014, CLIN REHABIL, V28, P912, DOI 10.1177/0269215514527597; Chang JO, 2013, CLIN J SPORT MED; Cheng PT, 1998, ARCH PHYS MED REHAB, V79, P1043, DOI 10.1016/S0003-9993(98)90168-X; Chien CW, 2007, ARCH PHYS MED REHAB, V88, P374, DOI 10.1016/j.apmr.2006.11.019; Chou SW, 2003, AM J PHYS MED REHAB, V82, P42, DOI 10.1097/01.PHM.0000043769.93584.4D; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Clark RA, 2011, GAIT POSTURE, V34, P288, DOI 10.1016/j.gaitpost.2011.04.010; de Haart M, 2005, ARCH PHYS MED REHAB, V86, P755, DOI 10.1016/j.apmr.2004.10.010; de Oliveira CB, 2008, J REHABIL RES DEV, V45, P1215, DOI 10.1682/JRRD.2007.09.0150; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P1138, DOI 10.1053/apmr.2002.33644; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Frykberg GE, 2007, J REHABIL MED, V39, P448, DOI 10.2340/16501977-0071; Geurts ACH, 2005, GAIT POSTURE, V22, P267, DOI 10.1016/j.gaitpost.2004.10.002; Gray VL, 2014, GAIT POSTURE, V40, P198, DOI 10.1016/j.gaitpost.2014.03.191; Hill KD, 1996, PHYSIOTHER CAN, V48, P257, DOI DOI 10.3138/PTC.48.4.257; Holmes JD, 2013, CLIN REHABIL, V27, P361, DOI 10.1177/0269215512458684; Huurnink A, 2013, J BIOMECH, V46, P1392, DOI 10.1016/j.jbiomech.2013.02.018; Hyndman D, 2009, NEUROREHAB NEURAL RE, V23, P847, DOI 10.1177/1545968309338192; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Kamphuis JF, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/692137; Karlsson A, 2000, CLIN BIOMECH, V15, P365, DOI 10.1016/S0268-0033(99)00096-0; Leroux A, 2006, AM J PHYS MED REHAB, V85, P820, DOI 10.1097/01.phm.0000233179.64769.8c; Liston RAL, 1996, ARCH PHYS MED REHAB, V77, P425, DOI 10.1016/S0003-9993(96)90028-3; Lomaglio MJ, 2005, GAIT POSTURE, V22, P126, DOI 10.1016/j.gaitpost.2004.08.002; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Nardone A, 2009, GAIT POSTURE, V30, P5, DOI 10.1016/j.gaitpost.2009.02.006; Niam S, 1999, ARCH PHYS MED REHAB, V80, P1227, DOI 10.1016/S0003-9993(99)90020-5; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Sawacha Z, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-95; Scaglioni-Solano P, 2014, INT J REHABIL RES, V37, P138, DOI 10.1097/MRR.0000000000000046; Sullivan JE, 2013, PHYS THER, V93, P1383, DOI 10.2522/ptj.20120492; van Bloemendaal M, 2012, DISABIL REHABIL, V34, P2207, DOI 10.3109/09638288.2012.680649; Visser JE, 2008, CLIN NEUROPHYSIOL, V119, P2424, DOI 10.1016/j.clinph.2008.07.220	40	31	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115282	10.1371/journal.pone.0115282	http://dx.doi.org/10.1371/journal.pone.0115282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541939	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900032
J	Salomaki, H; Heinaniemi, M; Vahatalo, LH; Ailanen, L; Eerola, K; Ruohonen, ST; Pesonen, U; Koulu, M				Salomaki, Henriikka; Heinaniemi, Merja; Vahatalo, Laura H.; Ailanen, Liisa; Eerola, Kim; Ruohonen, Suvi T.; Pesonen, Ullamari; Koulu, Markku			Prenatal Metformin Exposure in a Maternal High Fat Diet Mouse Model Alters the Transcriptome and Modifies the Metabolic Responses of the Offspring	PLOS ONE			English	Article							WHITE ADIPOSE-TISSUE; GESTATIONAL DIABETES-MELLITUS; ACTIVATED PROTEIN-KINASE; GLUCOSE-TOLERANCE; RESPIRATORY-CHAIN; BROWN ADIPOCYTES; OBESE MICE; MECHANISM; EXPRESSION; INSULIN	Aims: Despite the wide use of metformin in metabolically challenged pregnancies, the long-term effects on the metabolism of the offspring are not known. We studied the long-term effects of prenatal metformin exposure during metabolically challenged pregnancy in mice. Materials and Methods: Female mice were on a high fat diet (HFD) prior to and during the gestation. Metformin was administered during gestation from E0.5 to E17.5. Male and female offspring were weaned to a regular diet (RD) and subjected to HFD at adulthood (10-11 weeks). Body weight and several metabolic parameters (e.g. body composition and glucose tolerance) were measured during the study. Microarray and subsequent pathway analyses on the liver and subcutaneous adipose tissue of the male offspring were performed at postnatal day 4 in a separate experiment. Results: Prenatal metformin exposure changed the offspring's response to HFD. Metformin exposed offspring gained less body weight and adipose tissue during the HFD phase. Additionally, prenatal metformin exposure prevented HFD-induced impairment in glucose tolerance. Microarray and annotation analyses revealed metformin-induced changes in several metabolic pathways from which electron transport chain (ETC) was prominently affected both in the neonatal liver and adipose tissue. Conclusion: This study shows the beneficial effects of prenatal metformin exposure on the offspring's glucose tolerance and fat mass accumulation during HFD. The transcriptome data obtained at neonatal age indicates major effects on the genes involved in mitochondrial ATP production and adipocyte differentiation suggesting the mechanistic routes to improved metabolic phenotype at adulthood.	[Salomaki, Henriikka; Vahatalo, Laura H.; Ailanen, Liisa; Eerola, Kim; Ruohonen, Suvi T.; Pesonen, Ullamari; Koulu, Markku] Univ Turku, Inst Biomed, Dept Pharmacol Drug Dev & Therapeut, FI-20014 Turku, Finland; [Salomaki, Henriikka; Vahatalo, Laura H.; Ailanen, Liisa; Eerola, Kim] Univ Turku, Drug Res Doctoral Programme, Turku, Finland; [Heinaniemi, Merja] Univ Eastern Finland, Inst Biomed, Sch Med, FI-70211 Kuopio, Finland; [Vahatalo, Laura H.; Ailanen, Liisa; Eerola, Kim; Ruohonen, Suvi T.] Univ Turku, Turku Ctr Dis Modeling, FI-20014 Turku, Finland	University of Turku; University of Turku; University of Eastern Finland; University of Turku	Koulu, M (corresponding author), Univ Turku, Inst Biomed, Dept Pharmacol Drug Dev & Therapeut, FI-20014 Turku, Finland.	markku.koulu@utu.fi	Eerola, Kim/L-8819-2019	Pesonen, Ullamari/0000-0002-9962-212X	Academy of Finland [134131, 252441]; FinPharma Doctoral Program	Academy of Finland(Academy of Finland); FinPharma Doctoral Program	This study was supported by the Academy of Finland http://www.aka.fi/en-GB/A/ (grants 134131 and 252441 to MK and STR, respectively) and FinPharma Doctoral Program http//fpdp.fi/index.php?id=42(grant to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Caton PW, 2011, DIABETES OBES METAB, V13, P1097, DOI 10.1111/j.1463-1326.2011.01466.x; Cho NH, 2000, J PEDIATR-US, V136, P587, DOI 10.1067/mpd.2000.105129; COETZEE EJ, 1979, DIABETOLOGIA, V16, P241, DOI 10.1007/BF01221950; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Dominguez E, 2014, NAT CHEM BIOL, V10, P113, DOI 10.1038/nchembio.1429; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fukui Y, 2000, DIABETES, V49, P759, DOI 10.2337/diabetes.49.5.759; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Goh JEL, 2011, DIABETIC MED, V28, P1082, DOI 10.1111/j.1464-5491.2011.03361.x; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hou M, 2010, BIOCHEM BIOPH RES CO, V397, P537, DOI 10.1016/j.bbrc.2010.05.152; Hundal RS, 2003, DRUGS, V63, P1879, DOI 10.2165/00003495-200363180-00001; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Ijas H, 2011, BJOG-INT J OBSTET GY, V118, P880, DOI 10.1111/j.1471-0528.2010.02763.x; Koenen TB, 2011, DIABETES, V60, P517, DOI 10.2337/db10-0266; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Levin BE, 2006, PHILOS T R SOC B, V361, P1107, DOI 10.1098/rstb.2006.1851; Liang CY, 2010, METABOLISM, V59, P943, DOI 10.1016/j.metabol.2009.10.015; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lu XD, 2012, ENDOCRINOLOGY, V153, P3123, DOI 10.1210/en.2012-1151; Maida A, 2011, DIABETOLOGIA, V54, P339, DOI 10.1007/s00125-010-1937-z; Morin-Papunen L, 2012, J CLIN ENDOCR METAB, V97, P1492, DOI 10.1210/jc.2011-3061; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Rowan JA, 2008, NEW ENGL J MED, V358, P2003, DOI 10.1056/NEJMoa0707193; Rowan JA, 2011, DIABETES CARE, V34, P2279, DOI 10.2337/dc11-0660; Salomaki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056594; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Tertti K, 2013, DIABETES OBES METAB, V15, P246, DOI 10.1111/dom.12017; Tertti Kristiina, 2008, Rev Diabet Stud, V5, P95, DOI 10.1900/RDS.2008.5.95; Tong JF, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.3; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wei EH, 2010, CELL METAB, V11, P183, DOI 10.1016/j.cmet.2010.02.005; World Obesity, CHILDH OB; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	53	40	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115778	10.1371/journal.pone.0115778	http://dx.doi.org/10.1371/journal.pone.0115778			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541979	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900086
J	Hu, JC; Mathias-Santos, C; Greene, CJ; King-Lyons, ND; Rodrigues, JF; Hajishengallis, G; Ferreira, LCS; Connell, TD				Hu, John C.; Mathias-Santos, Camila; Greene, Christopher J.; King-Lyons, Natalie D.; Rodrigues, Juliana F.; Hajishengallis, George; Ferreira, Luis C. S.; Connell, Terry D.			Intradermal Administration of the Type II Heat-Labile Enterotoxins LT-IIb and LT-IIc of Enterotoxigenic Escherichia coli Enhances Humoral and CD8(+) T Cell Immunity to a Co-Administered Antigen	PLOS ONE			English	Article							CHOLERA-TOXIN; GANGLIOSIDE-BINDING; DIFFERENTIATION; IMMUNIZATION; VACCINATION; ADJUVANTS; VARIANT	Vaccinations are extremely effective at combating infectious diseases. Many conserved antigen (Ag) targets, however, are poorly immunogenic. Protein subunit vaccines frequently elicit only humoral immune responses and fail to confer protection against serious intracellular pathogens. These barriers to vaccine development are often overcome by the use of appropriate adjuvants. Heat-labile enterotoxins (HLT) produced by enterotoxigenic strains of Escherichia coli are potent adjuvants when administered by mucosal or systemic routes. The efficacy of the type II HLT, however, has not been well-defined when administered by the intradermal (ID) route. Using a murine ID immunization model, the adjuvant properties of LT-IIb and LT-IIc, two type II HLTs, were compared with those of LT-I, a prototypical type I HLT. While all three HLTadjuvants enhanced Ag-specific humoral responses to similar levels, LT-IIb and LT-IIc, in contrast to LT-I, induced a more vigorous Ag-specific CD8(+) T cell response and proffered faster clearance of Listeria monocytogenes in a challenge model. Additionally, LT-IIb and LT-IIc induced distinct differences in the profiles of the Ag-specific CD8(+) T cell responses. While LT-IIc stimulated a robust and rapid primary CD8(+) T cell response, LT-IIb exhibited slower CD8(+) T cell expansion and contraction kinetics with the formation of higher percentages of effector memory cells. In comparison to LT-I and LT-IIc, LT-IIb evoked better long-term protection after immunization. Furthermore, LT-IIb and LT-IIc enhanced the total number of dendritic cells (DC) in the draining lymph node (DLN) and expression of costimulatory molecules CD80, CD86, and CD40 on DCs. In contrast to LT-I, LT-IIb and LT-IIc induced less edema, cellular infiltrates, and general inflammation at the site of ID injection. Thus, LT-IIb and LT-IIc are attractive comprehensive ID adjuvants with unique characteristic that enhance humoral and cellular immunity to a co-administered protein Ag.	[Hu, John C.; Greene, Christopher J.; King-Lyons, Natalie D.; Connell, Terry D.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Hu, John C.; Greene, Christopher J.; King-Lyons, Natalie D.; Connell, Terry D.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA; [Mathias-Santos, Camila; Rodrigues, Juliana F.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil; [Hajishengallis, George] Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Universidade de Sao Paulo; University of Pennsylvania	Connell, TD (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	connell@buffalo.edu	Hajishengallis, George N./K-1117-2019; Ferreira, Luis Carlos S/M-3954-2014; LYONS, NATALIE/K-8058-2019; Rodrigues, Juliana/AAC-3512-2019	Hajishengallis, George N./0000-0001-7392-8852; Ferreira, Luis Carlos S/0000-0002-4883-1693; 	U.S. Dept. of Health [DE13833, DE017138, DE015254]; John R. Oishei Foundation; Sao Paulo Research Foundation - FAPESP; National Council for Scientific and Technological Development (CNPq); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017138, R01DE015254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE013833, R01DE013833] Funding Source: NIH RePORTER	U.S. Dept. of Health; John R. Oishei Foundation; Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by the following: T.D.C. - U.S. Dept. of Health, (DE13833, DE017138); T.D.C. - The John R. Oishei Foundation; G.H. - U.S. Dept. of Health, (DE015254); L.C.S.F. - Sao Paulo Research Foundation - FAPESP; and L.C.S.F. - The National Council for Scientific and Technological Development (CNPq).	Arce S, 2005, INFECT IMMUN, V73, P2718, DOI 10.1128/IAI.73.5.2718-2727.2005; Barnighausen T, 2011, VACCINE, V29, P2371, DOI 10.1016/j.vaccine.2010.11.090; Berenson CS, 2010, GLYCOBIOLOGY, V20, P41, DOI 10.1093/glycob/cwp141; Bloom DE, 2011, ADV EXP MED BIOL, V697, P1, DOI 10.1007/978-1-4419-7185-2_1; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Connell TD, 2007, EXPERT REV VACCINES, V6, P821, DOI 10.1586/14760584.6.5.821; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Greene CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069678; Hajishengallis G, 2013, VET IMMUNOL IMMUNOP, V152, P68, DOI 10.1016/j.vetimm.2012.09.034; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Koup RA, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007252; Lasaro MA, 2009, FEMS IMMUNOL MED MIC, V55, P93, DOI 10.1111/j.1574-695X.2008.00506.x; Levine OS, 2011, LANCET, V378, P439, DOI 10.1016/S0140-6736(11)60406-6; Liang SA, 2010, IMMUNOL INVEST, V39, P449, DOI 10.3109/08820130903563998; Lu FJ, 2013, VACCINE, V31, P3979, DOI 10.1016/j.vaccine.2013.05.107; Martin M, 2000, INFECT IMMUN, V68, P281, DOI 10.1128/IAI.68.1.281-287.2000; Mathias-Santos C, 2011, CLIN VACCINE IMMUNOL, V18, P1243, DOI 10.1128/CVI.00012-11; Meza-Sanchez D, 2011, EUR J IMMUNOL, V41, P2894, DOI 10.1002/eji.201040997; Nawar HF, 2011, VACCINE, V29, P721, DOI 10.1016/j.vaccine.2010.11.020; Nawar HF, 2010, INFECT IMMUN, V78, P4705, DOI 10.1128/IAI.00730-10; Nawar HF, 2010, CLIN VACCINE IMMUNOL, V17, P969, DOI 10.1128/CVI.00076-10; Nicolas JF, 2008, EXPERT REV VACCINES, V7, P1201, DOI 10.1586/14760584.7.8.1201; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Vitoriano-Souza J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040745; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Zoeteweij JP, 2006, J IMMUNOL, V177, P1197, DOI 10.4049/jimmunol.177.2.1197	27	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e113978	10.1371/journal.pone.0113978	http://dx.doi.org/10.1371/journal.pone.0113978			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536061	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300009
J	Huang, YS; Wen, XF; Yang, ZY; Wu, YL; Lu, Y; Zhou, LF				Huang, Yan-Shan; Wen, Xiao-Fang; Yang, Zhi-Yu; Wu, Yi-Liang; Lu, You; Zhou, Lin-Fu			Development and Characterization of a Novel Fusion Protein of a Mutated Granulocyte Colony-Stimulating Factor and Human Serum Albumin in Pichia pastoris	PLOS ONE			English	Article							BINDING; GLYCOSYLATION; MUTAGENESIS; EXPRESSION; WARFARIN; CELLS	The purpose of the present work was to develop a novel, long-acting and potent human serum albumin/granulocyte colony stimulating factor (HSA/G-CSF) therapeutic fusion protein. The novel fusion protein, called HMG, was constructed by genetically fusing mutated human derived G-CSF (mG-CSF) to the C-terminal of HSA and then prepared in Pichia pastoris. The molecular mass of HMG was about 85 kDa and the isoelectric point was 5.3. Circular dichroism spectroscopy suggested that mG-CSF retained nearly all of its native secondary structure, regardless of fusion. The binding capabilities of mG-CSF moiety to G-CSF receptor and HSA moiety to warfarin showed very little change after fusing. The bioactivity of HMG (11.0 x 10(6) IU/mg) was more than twice that of rHSA/G-CSF (4.6 x 10(6) IU/mg). A mutation was made at the 718th amino acid of HMG, substituting Ala for Thr, to investigate the glycosylation of HMG expressed in P. pastoris. Data indicated that HMG was modified at Thr718, speculatively with the addition of a mannose chain. In conclusion, a novel HSA/G-CSF fusion protein was successfully constructed based on a mutated G-CSF. This protein showed more potent bioactivity than rHSA/G-CSF and thus may be a suitable long-acting G-CSF.	[Huang, Yan-Shan; Wen, Xiao-Fang; Zhou, Lin-Fu] Zhejiang Univ, Med Biotechnol Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Zhi-Yu; Wu, Yi-Liang; Lu, You] Jiangsu T Mab Biopharmaceut Co Ltd, Taizhou, Jiangsu, Peoples R China	Zhejiang University	Zhou, LF (corresponding author), Zhejiang Univ, Med Biotechnol Lab, Hangzhou 310003, Zhejiang, Peoples R China.	239zlf@zju.edu.cn	Khan, Rizwan Hasan/F-8276-2014	Khan, Rizwan Hasan/0000-0002-9965-8982	National Natural Science Foundation of China [81273418]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81273418, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amet N, 2009, PHARM RES-DORDR, V26, P523, DOI 10.1007/s11095-008-9767-0; Apte-Deshpande A, 2009, J BIOTECHNOL, V143, P44, DOI 10.1016/j.jbiotec.2009.06.002; Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Bai Y, 2006, PHARM RES-DORDR, V23, P2116, DOI 10.1007/s11095-006-9059-5; Bhagavan NV, 2003, CLIN CHEM, V49, P581, DOI 10.1373/49.4.581; Bretthauer RK, 1999, BIOTECHNOL APPL BIOC, V30, P193; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gong B, 2014, J CHROMATOGR B, V945, P135, DOI 10.1016/j.jchromb.2013.11.031; Huang YS, 2010, EUR J PHARM BIOPHARM, V74, P435, DOI 10.1016/j.ejpb.2009.12.002; KUGA T, 1989, BIOCHEM BIOPH RES CO, V159, P103, DOI 10.1016/0006-291X(89)92410-8; Lam JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001009; MAES V, 1982, MOL PHARMACOL, V21, P100; OHEDA M, 1988, J BIOCHEM-TOKYO, V103, P544, DOI 10.1093/oxfordjournals.jbchem.a122305; Peters Jr. T., 1995, ALL ALBUMIN BIOCH GE; Petersen CE, 2002, PROTEINS, V47, P116, DOI 10.1002/prot.10068; Reinhard Fleer AF, 1997, FUSION POLYPEPTIDES	17	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115840	10.1371/journal.pone.0115840	http://dx.doi.org/10.1371/journal.pone.0115840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535738	Green Published, gold, Green Submitted			2022-12-26	WOS:000348563300077
J	Baral, S; Ketende, S; Green, JL; Chen, PA; Grosso, A; Sithole, B; Ntshangase, C; Yam, E; Kerrigan, D; Kennedy, CE; Adams, D				Baral, Stefan; Ketende, Sosthenes; Green, Jessie L.; Chen, Ping-An; Grosso, Ashley; Sithole, Bhekie; Ntshangase, Cebisile; Yam, Eileen; Kerrigan, Deanna; Kennedy, Caitlin E.; Adams, Darrin			Reconceptualizing the HIV Epidemiology and Prevention Needs of Female Sex Workers (FSW) in Swaziland	PLOS ONE			English	Article							TRANSMISSION; RISK; CARE; AFRICA	Background: HIV is hyperendemic in Swaziland with a prevalence of over 25% among those between the ages of 15 and 49 years old. The HIV response in Swaziland has traditionally focused on decreasing HIV acquisition and transmission risks in the general population through interventions such as male circumcision, increasing treatment uptake and adherence, and risk-reduction counseling. There is emerging data from Southern Africa that key populations such as female sex workers ( FSW) carry a disproportionate burden of HIV even in generalized epidemics such as Swaziland. The burden of HIV and prevention needs among FSW remains unstudied in Swaziland. Methods: A respondent-driven-sampling survey was completed between August-October, 2011 of 328 FSW in Swaziland. Each participant completed a structured survey instrument and biological HIV and syphilis testing according to Swazi Guidelines. Results: Unadjusted HIV prevalence was 70.3% (n = 223/317) among a sample of women predominantly from Swaziland (95.2%, n = 300/316) with a mean age of 21(median 25) which was significantly higher than the general population of women. Approximately one-half of the FSW(53.4%, n = 167/313) had received HIV prevention information related to sex work in the previous year, and about one-in-ten had been part of a previous research project(n = 38/313). Rape was common with nearly 40% (n = 123/314) reporting at least one rape; 17.4% (n = 23/314) reported being raped 6 or more times. Reporting blackmail (34.8%, n = 113/314) and torture(53.2%, n = 173/314) was prevalent. Conclusions: While Swaziland has a highly generalized HIV epidemic, reconceptualizing the needs of key populations such as FSW suggests that these women represent a distinct population with specific vulnerabilities and a high burden of HIV compared to other women. These women are understudied and underserved resulting in a limited characterization of their HIV prevention, treatment, and care needs and only sparse specific and competent programming. FSW are an important population for further investigation and rapid scale-up of combination HIV prevention including biomedical, behavioral, and structural interventions.	[Baral, Stefan; Ketende, Sosthenes; Chen, Ping-An; Grosso, Ashley] Johns Hopkins Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Dept Epidemiol, Key Populat Program, Baltimore, MD 21205 USA; [Green, Jessie L.] Populat Serv Int, Mbanane, Swaziland; [Sithole, Bhekie] Rock Of Hope, Mbabane, Swaziland; [Ntshangase, Cebisile] Minist Hlth, Strateg Informat Div, Swaziland Natl AIDS Program, Mbabane, Swaziland; [Yam, Eileen] Johns Hopkins Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Kennedy, Caitlin E.; Adams, Darrin] Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Kerrigan, Deanna] Johns Hopkins Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Baral, S (corresponding author), Johns Hopkins Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Dept Epidemiol, Key Populat Program, Baltimore, MD 21205 USA.	sbaral@jhu.edu	Grosso, Ashley/AAH-9924-2020; Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419; Grosso, Ashley/0000-0001-5759-7125	U.S. Agency for International Development [GHH-I-00-07-00032-00]; President's Emergency Plan for AIDS Relief	U.S. Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The USAID vertical bar Project SEARCH, Task Order No. 2, is funded by the U.S. Agency for International Development under Contract No. GHH-I-00-07-00032-00, beginning September 30, 2008, and supported by the President's Emergency Plan for AIDS Relief. The Research to Prevention (R2P) Project is led by the Johns Hopkins Center for Global Health and managed by the Johns Hopkins Bloomberg School of Public Health Center for Communication Programs (CCP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglemyer A, 2013, COCHRANE DB SYST REV, V4; Arnott J, 2009, RIGHTS RESCURE REPOR; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baggaley RF, 2010, CURR OPIN HIV AIDS, V5, P269, DOI 10.1097/COH.0b013e32833a51b2; Baggaley RF, 2008, INT J EPIDEMIOL, V37, P1255, DOI 10.1093/ije/dyn151; Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beyrer C, 2011, JAIDS-J ACQ IMM DEF, V57, pS96, DOI 10.1097/QAI.0b013e31821db944; Bicego GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077101; Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2002, AIDS BEHAV, V6, P55; Johnston L, 2010, AIDS BEHAV, V14, P922, DOI 10.1007/s10461-008-9362-8; Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9; Macro International Inc. Swaziland Central Statistical Office, 2008, SWAZ DEM HLTH SURV 2; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; Mtetwa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-698; Ngugi EN, 2012, SAHARA J-J SOC ASP H, V9, P148, DOI 10.1080/17290376.2012.743825; Reed JB, 2012, ESTIMATING NATL HIV; Salganik MJ, 2012, EPIDEMIOLOGY, V23, P148, DOI 10.1097/EDE.0b013e31823b6979; Schonlau M, 2012, STATA J, V12, P72, DOI 10.1177/1536867X1201200106; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Scorgie F, 2013, CULT HEALTH SEX, V15, P450, DOI 10.1080/13691058.2012.763187; Semugoma P, 2012, SAHARA J-J SOC ASP H, V9, P173, DOI 10.1080/17290376.2012.744177; SHIMS, 2012, SWAZ HIV INC MEAS SU; StataCorp, 2010, STAT STAT SOFTW REL; Swaziland National Emergency Response Council on HIV/AIDS, 2009, SWAZ HIV PREV RESP M; Tanser F, 2014, CURR OPIN HIV AIDS, V9, P115, DOI 10.1097/COH.0000000000000034; UNAIDS, 2012, REP GLOB AIDS EP; UNAIDS NERCHA Swaziland Ministry of Health UNICEF, 2010, MON DECL COMM HIV AI; UNFPA UNAIDS Swaziland Ministry of Health and Social Welfare Swaziland National Emergency Response Council on HIV/AIDS, 2007, SIT AN COMM SEX WORK; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Wright J, 2010, J PUBLIC HEALTH-UK, V32, P277, DOI 10.1093/pubmed/fdp129; Yam EA, 2013, SEX TRANSM DIS, V40, P406, DOI 10.1097/OLQ.0b013e318283c16d	34	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115465	10.1371/journal.pone.0115465	http://dx.doi.org/10.1371/journal.pone.0115465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531771	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100072
J	Cai, B; Allexandre, D; Rajagopalan, V; Jiang, ZG; Siemionow, V; Ranganathan, VK; Davis, MP; Walsh, D; Dai, KR; Yue, GH				Cai, Bin; Allexandre, Didier; Rajagopalan, Venkateswaran; Jiang, Zhiguo; Siemionow, Vlodek; Ranganathan, Vinoth K.; Davis, Mellar P.; Walsh, Declan; Dai, Kerong; Yue, Guang H.			Evidence of Significant Central Fatigue in Patients with Cancer-Related Fatigue during Repetitive Elbow Flexions till Perceived Exhaustion	PLOS ONE			English	Article							QUALITY-OF-LIFE; LOCALIZED PROSTATE-CANCER; HUMAN MUSCLE FATIGUE; BREAST-CANCER; RADIATION-THERAPY; RADIOTHERAPY; CONTRACTIONS; SURVIVORS; MECHANISMS; EXERCISE	Objective: To investigate whether fatigue induced by an intermittent motor task in patients with cancer-related fatigue (CRF) is more central or peripheral. Methods: Ten patients with CRF who were off chemo and radiation therapies and 14 age-matched healthy controls were enrolled. Participants completed a Brief Fatigue Inventory (BFI) and performed a fatigue task consisting of intermittent elbow-flexion contractions at submaximal (40% maximal voluntary contraction) intensity till self-perceived exhaustion. Twitch force was elicited by an electrical stimulation applied to the biceps brachii muscle. The relative degree of peripheral (muscle) vs. central contribution to fatigue induced by the intermittent motor task (IMT) was assessed using twitch force ratio (TFratio) defined as post IMT twitch force to pre IMT twitch force. The total number of trials (intermittent contractions) and total duration of all trials performed by each subject were also quantified. Results: BFI scores were higher (p<0.001) in CRF than controls, indicating greater feeling of fatigue in CRF patients than controls. A significantly smaller number of trials and shorter total duration of the trials (p<0.05) were observed in CRF than control participants. The TFratio (0.81 +/- 0.05) in CRF was higher (p<0.05) compared with that of controls (0.62 +/- 0.05), suggesting CRF patients experienced a significantly lower degree of muscle (peripheral) fatigue at the time of perceived exhaustion. Conclusion: Consistent with prior findings for fatigue under submaximal sustained contraction, our results indicate that motor fatigue in CRF is more of central than peripheral origin during IMT. Significant central fatigue in CRF patients limits their ability to prolong motor performance.	[Cai, Bin] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Rehabil Med, Shanghai 200011, Peoples R China; [Cai, Bin] Shanghai Jiao Tong Univ, Inst Rehabil Engn, Shanghai 200030, Peoples R China; [Allexandre, Didier; Rajagopalan, Venkateswaran; Jiang, Zhiguo; Yue, Guang H.] Kessler Fdn Res Ctr, Human Performance & Engn Lab, W Orange, NJ 07052 USA; [Siemionow, Vlodek; Yue, Guang H.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Ranganathan, Vinoth K.; Yue, Guang H.] Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44195 USA; [Davis, Mellar P.; Walsh, Declan] Cleveland Clin, Harry R Horvitz Ctr Palliat Med, Taussig Canc Inst, Cleveland, OH 44195 USA; [Dai, Kerong] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Orthopaed, Shanghai 200011, Peoples R China; [Dai, Kerong] Engn Res Ctr Digital Med & Clin Translat, Minist Educ, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Kessler Institute for Rehabilitation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Shanghai Jiao Tong University	Dai, KR (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Orthopaed, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.	krdai@163.com; GYue@kesslerfoundation.org	R, Venkateswaran/GOV-7176-2022	R, Venkateswaran/0000-0001-9040-0785; Walsh, (Thomas) Declan/0000-0002-9310-1729; Allexandre, Didier/0000-0002-0178-0956	National Institutes of Health (NIH) [R21CA165943]; NATIONAL CANCER INSTITUTE [R01CA189665, R21CA165943] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by a National Institutes of Health (NIH) grant (R21CA165943). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt CA, 2011, MUSCLE NERVE, V43, P415, DOI 10.1002/mus.21913; ANDREWS PLR, 2004, FATIGUE CANC, P51; Benwell NM, 2006, EXP BRAIN RES, V175, P626, DOI 10.1007/s00221-006-0579-3; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; Bower JE, 2005, PSYCHOSOM MED, V67, P277, DOI 10.1097/01.psy.0000155666.55034.c6; Bower JE, 2002, PSYCHOSOM MED, V64, P604, DOI 10.1097/00006842-200207000-00010; BRUERA E, 1988, J NATL CANCER I, V80, P282, DOI 10.1093/jnci/80.4.282; Cella D, 2001, J CLIN ONCOL, V19, P3385, DOI 10.1200/JCO.2001.19.14.3385; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Curt G A, 2000, Oncologist, V5, P353, DOI 10.1634/theoncologist.5-5-353; Di Lazzaro V, 2003, EXP BRAIN RES, V149, P535, DOI 10.1007/s00221-003-1408-6; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Janda M, 2000, CANCER-AM CANCER SOC, V89, P1322, DOI 10.1002/1097-0142(20000915)89:6<1322::AID-CNCR18>3.0.CO;2-D; Kisiel-Sajewicz K, 2012, J PAIN SYMPTOM MANAG, V44, P351, DOI 10.1016/j.jpainsymman.2011.08.007; Liu JZ, 2003, J NEUROPHYSIOL, V90, P300, DOI 10.1152/jn.00821.2002; Lou JS, 2012, PHYS MED REH CLIN N, V23, P11, DOI 10.1016/j.pmr.2011.11.003; Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N; Mock V, 2000, ONCOLOGY-NY, V14, P151; Mock Victoria, 2004, J Natl Cancer Inst Monogr, P112; Monga U, 2005, J REHABIL RES DEV, V42, P391, DOI 10.1682/JRRD.2004.06.0071; Monga U, 1997, ARCH PHYS MED REHAB, V78, P961, DOI 10.1016/S0003-9993(97)90058-7; Monga U, 1999, RADIAT ONCOL INVESTI, V7, P178, DOI 10.1002/(SICI)1520-6823(1999)7:3<178::AID-ROI7>3.0.CO;2-0; Monga U, 2007, ARCH PHYS MED REHAB, V88, P1416, DOI 10.1016/j.apmr.2007.08.110; Morrow GR, 2005, CANCER INVEST, V23, P229, DOI 10.1081/CNV-200055960; Morrow GR, 2002, SUPPORT CARE CANCER, V10, P389, DOI 10.1007/s005200100293; PIPER BF, 1993, SUPPORT CARE CANCER, V1, P285, DOI 10.1007/BF00364963; Ranieri F, 2012, NEUROMUSCULAR DISORD, V22, pS157, DOI 10.1016/j.nmd.2012.10.006; Rosler KM, 2009, EXP BRAIN RES, V197, P111, DOI 10.1007/s00221-009-1897-z; Ryan JL, 2007, ONCOLOGIST, V12, P22, DOI 10.1634/theoncologist.12-S1-22; Sogaard K, 2006, J PHYSIOL-LONDON, V573, P511, DOI 10.1113/jphysiol.2005.103598; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Vogelzang NJ, 1997, SEMIN HEMATOL, V34, P4; Vollestad NK, 1997, J NEUROSCI METH, V74, P219, DOI 10.1016/S0165-0270(97)02251-6; Wang XS, 2008, CLIN J ONCOL NURS, V12, P11, DOI 10.1188/08.CJON.S2.11-20; Yavuzsen T, 2009, J PAIN SYMPTOM MANAG, V38, P587, DOI 10.1016/j.jpainsymman.2008.12.003	36	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115370	10.1371/journal.pone.0115370	http://dx.doi.org/10.1371/journal.pone.0115370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532032	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100054
J	Langjahr, P; Diaz-Jimenez, D; De la Fuente, M; Rubio, E; Golenbock, D; Bronfman, FC; Quera, R; Gonzalez, MJ; Hermoso, MA				Langjahr, Patricia; Diaz-Jimenez, David; De la Fuente, Marjorie; Rubio, Estefhany; Golenbock, Douglas; Bronfman, Francisca C.; Quera, Rodrigo; Gonzalez, Maria-Julieta; Hermoso, Marcela A.			Metalloproteinase-Dependent TLR2 Ectodomain Shedding is Involved in Soluble Toll-Like Receptor 2 (sTLR2) Production	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; NEGATIVE REGULATION; MATRIX METALLOPROTEINASES; MONOCYTES; INHIBITOR; ADAM10; MACROPHAGES; EXPRESSION; PROTEIN; ALPHA	Toll-like receptor (TLR) 2, a type I membrane receptor that plays a key role in innate immunity, recognizes conserved molecules in pathogens, and triggering an inflammatory response. It has been associated with inflammatory and autoimmune diseases. Soluble TLR2 (sTLR2) variants have been identified in human body fluids, and the TLR2 ectodomain can negatively regulate TLR2 activation by behaving as a decoy receptor. sTLR2 generation does not involve alternative splicing mechanisms, indicating that this process might involve a post-translational modification of the full-length receptor; however, the specific mechanism has not been studied. Using CD14(+) peripheral human monocytes and the THP-1 monocytic leukemia-derived cell line, we confirm that sTLR2 generation increases upon treatment with pro-inflammatory agents and requires a post-translational mechanism. We also find that the constitutive and ligand-induced release of sTLR2 is sensitive to pharmacological metalloproteinase activator and inhibitors leading us to conclude that metalloproteinase TLR2 shedding contributes to soluble receptor production. By expressing human TLR2 in ADAM10- or ADAM17-deficient MEF cells, we find both enzymes to be implicated in TLR2 ectodomain shedding. Moreover, using a deletion mutant of the TLR2 juxtamembrane region, we demonstrate that this domain is required for sTLR2 generation. Functional analysis suggests that sTLR2 generated by metalloproteinase activation inhibits TLR2-induced cytokine production by this monocytic leukemia-derived cell line. The identification of the mechanisms involved in regulating the availability of soluble TLR2 ectodomain and cell surface receptors may contribute further research on TLR2-mediated processes in innate immunity and inflammatory disorders.	[Langjahr, Patricia; Diaz-Jimenez, David; De la Fuente, Marjorie; Rubio, Estefhany; Hermoso, Marcela A.] Univ Chile, Fac Med, Inst Biomed Sci, Disciplinary Program Immunol, Santiago, Chile; [Golenbock, Douglas] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Bronfman, Francisca C.] Pontificia Univ Catolica Chile, Fac Biol Sci, Millennium Nucleus Regenerat Biol MINREB, Dept Physiol, Santiago, Chile; [Quera, Rodrigo] Clin Las Condes, Gastroenterol Unit, Santiago, Chile; [Gonzalez, Maria-Julieta] Univ Chile, Fac Med, Inst Biomed Sci, Cell & Mol Biol Program, Santiago, Chile	Universidad de Chile; University of Massachusetts System; University of Massachusetts Worcester; Pontificia Universidad Catolica de Chile; Clinica Las Condes; Universidad de Chile	Hermoso, MA (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Disciplinary Program Immunol, Santiago, Chile.	mhermoso@med.uchile.cl	Hermoso, Marcela/L-1500-2014; Hermoso, Marcela A./AAF-6893-2021; Langjahr, Patricia/AEX-7806-2022	Hermoso, Marcela A./0000-0002-7936-7571; Langjahr, Patricia/0000-0001-9793-3373; Quera, Rodrigo/0000-0001-5854-0526	Fondo Nacional de Ciencia y Tecnologia (National Fund for Science and Technology; FONDECYT) [1080290, 1120577]	Fondo Nacional de Ciencia y Tecnologia (National Fund for Science and Technology; FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The sources of funding that have supported the work are Fondo Nacional de Ciencia y Tecnologia (National Fund for Science and Technology; FONDECYT) grants 1080290 and 1120577 (MAH) (www.fondecyt.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Arancibia S, 2011, J CELL MOL MED, V15, P339, DOI 10.1111/j.1582-4934.2009.00958.x; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Candia E, 2012, IMMUNOBIOLOGY; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Chockalingam A, 2011, EUR J IMMUNOL, V41, P2176, DOI 10.1002/eji.201041034; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; COLOTTA F, 1994, IMMUNOL TODAY, V15, P562, DOI 10.1016/0167-5699(94)90217-8; CROWE PD, 1995, J EXP MED, V181, P1205, DOI 10.1084/jem.181.3.1205; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Dulay AT, 2009, J IMMUNOL, V182, P7244, DOI 10.4049/jimmunol.0803517; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fields J, 2011, J NEUROCHEM, V118, P93, DOI 10.1111/j.1471-4159.2011.07203.x; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Gebbia JA, 2004, J INFECT DIS, V189, P113, DOI 10.1086/380414; Gibb DR, 2011, MOL IMMUNOL, V48, P1319, DOI 10.1016/j.molimm.2010.12.005; Gomez-Pina V, 2007, J IMMUNOL, V179, P4065, DOI 10.4049/jimmunol.179.6.4065; Haehnel V, 2002, J IMMUNOL, V168, P5629, DOI 10.4049/jimmunol.168.11.5629; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Heggelund L, 2004, AIDS, V18, P2437; Hundhausen C, 2007, J IMMUNOL, V178, P8064, DOI 10.4049/jimmunol.178.12.8064; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Iwami K, 2000, J IMMUNOL, V165, P6682, DOI 10.4049/jimmunol.165.12.6682; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kuroishi T, 2007, MOL IMMUNOL, V44, P1969, DOI 10.1016/j.molimm.2006.09.028; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; LeBouder E, 2003, J IMMUNOL, V171, P6680, DOI 10.4049/jimmunol.171.12.6680; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Levine SJ, 2004, J IMMUNOL, V173, P5343, DOI 10.4049/jimmunol.173.9.5343; Li CH, 2006, J LEUKOCYTE BIOL, V79, P867, DOI 10.1189/jlb.0905505; Li Yongming, 2010, BMC Res Notes, V3, P309, DOI 10.1186/1756-0500-3-309; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lim EK, 2013, J BIOL CHEM, V288, P21126, DOI 10.1074/jbc.M113.453514; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; MANN JS, 1993, BIOL REPROD, V48, P1006, DOI 10.1095/biolreprod48.5.1006; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Palsson-McDermott EM, 2007, IRISH J MED SCI, V176, P253, DOI 10.1007/s11845-007-0103-1; Raby AC, 2009, J IMMUNOL, V183, P506, DOI 10.4049/jimmunol.0802909; Roomi MW, 2014, INT J ONCOL, V44, P27, DOI 10.3892/ijo.2013.2159; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tsukada H, 2005, INT J MOL MED, V15, P519; Ueland T, 2006, J CARD FAIL, V12, P659, DOI 10.1016/j.cardfail.2006.07.002; ULISSE S, 1994, ENDOCRINOLOGY, V135, P2479, DOI 10.1210/en.135.6.2479; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; Weber ANR, 2004, J BIOL CHEM, V279, P34589, DOI 10.1074/jbc.M403830200; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Yang RB, 1999, J IMMUNOL, V163, P639; Yun MR, 2014, CELL SIGNAL, V26, P705, DOI 10.1016/j.cellsig.2013.12.010; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	54	26	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e104624	10.1371/journal.pone.0104624	http://dx.doi.org/10.1371/journal.pone.0104624			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531754	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100001
J	Raschle, NM; Smith, SA; Zuk, J; Dauvermann, MR; Figuccio, MJ; Gaab, N				Raschle, Nora Maria; Smith, Sara Ashley; Zuk, Jennifer; Dauvermann, Maria Regina; Figuccio, Michael Joseph; Gaab, Nadine			Investigating the Neural Correlates of Voice versus Speech-Sound Directed Information in Pre-School Children	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; SCANNER BACKGROUND-NOISE; CORTICAL REPRESENTATION; FUNCTIONAL-ANATOMY; BRAIN ACTIVATION; RIGHT-HEMISPHERE; AUDITORY-CORTEX; PERCEPTION; FMRI; IDENTIFICATION	Studies in sleeping newborns and infants propose that the superior temporal sulcus is involved in speech processing soon after birth. Speech processing also implicitly requires the analysis of the human voice, which conveys both linguistic and extra-linguistic information. However, due to technical and practical challenges when neuroimaging young children, evidence of neural correlates of speech and/ or voice processing in toddlers and young children remains scarce. In the current study, we used functional magnetic resonance imaging (fMRI) in 20 typically developing preschool children (average age = 5.8 y; range 5.2-6.8 y) to investigate brain activation during judgments about vocal identity versus the initial speech sound of spoken object words. FMRI results reveal common brain regions responsible for voice-specific and speech-sound specific processing of spoken object words including bilateral primary and secondary language areas of the brain. Contrasting voice-specific with speech-sound specific processing predominantly activates the anterior part of the right-hemispheric superior temporal sulcus. Furthermore, the right STS is functionally correlated with left-hemispheric temporal and right hemispheric prefrontal regions. This finding underlines the importance of the right superior temporal sulcus as a temporal voice area and indicates that this brain region is specialized, and functions similarly to adults by the age of five. We thus extend previous knowledge of voice-specific regions and their functional connections to the young brain which may further our understanding of the neuronal mechanism of speech-specific processing in children with developmental disorders, such as autism or specific language impairments.	[Raschle, Nora Maria; Smith, Sara Ashley; Zuk, Jennifer; Dauvermann, Maria Regina; Figuccio, Michael Joseph; Gaab, Nadine] Boston Childrens Hosp, Dept Dev Med, Div Dev Med, Labs Cognit Neurosci, Boston, MA 02115 USA; [Raschle, Nora Maria; Zuk, Jennifer; Dauvermann, Maria Regina; Gaab, Nadine] Harvard Univ, Sch Med, Boston, MA USA; [Raschle, Nora Maria] Psychiat Univ Clin Basel, Dept Child & Adolescent Psychiat, Basel, Switzerland; [Gaab, Nadine] Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Basel; Harvard University	Raschle, NM (corresponding author), Boston Childrens Hosp, Dept Dev Med, Div Dev Med, Labs Cognit Neurosci, Boston, MA 02115 USA.	nora.raschle@childrens.harvard.edu	Gaab, Nadine/AAD-9144-2022; Dauvermann, Maria/ABA-8847-2021; Smith, Sara/GVS-8735-2022	Dauvermann, Maria/0000-0002-2873-8512; Zuk, Jennifer/0000-0001-9113-3973; Gaab, Nadine/0000-0002-7548-413X	Eunice Kennedy Shriver National Institute of Child Health & Human Development [1R01HD065762-01/02/03]; Charles H. Hood Foundation; Boston Children's Hospital Pilot Grant; Swiss National Foundation; Janggen-Pohn Stiftung; National Institute of Health Institutional Training Grant [NIH T32 DC000038-22]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065762, P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000038] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Charles H. Hood Foundation; Boston Children's Hospital Pilot Grant; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Janggen-Pohn Stiftung; National Institute of Health Institutional Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (1R01HD065762-01/02/03 to N.G.); Charles H. Hood Foundation (to N.G.); Boston Children's Hospital Pilot Grant (to N.G.); the Swiss National Foundation (to N.M.R.); the Janggen-Pohn Stiftung (to N.M.R.); and the National Institute of Health Institutional Training Grant (NIH T32 DC000038-22 to J.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman NR, 2001, RADIOLOGY, V221, P56, DOI 10.1148/radiol.2211010074; Andics A, 2010, NEUROIMAGE, V52, P1528, DOI 10.1016/j.neuroimage.2010.05.048; Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 2011, BRIT J PSYCHOL, V102, P711, DOI 10.1111/j.2044-8295.2011.02041.x; Berl MM, 2010, BRAIN LANG, V114, P115, DOI 10.1016/j.bandl.2010.06.002; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bitan T, 2007, NEUROIMAGE, V38, P564, DOI 10.1016/j.neuroimage.2007.07.048; Blasi A, 2011, CURR BIOL, V21, P1220, DOI 10.1016/j.cub.2011.06.009; Bookheimer SY, 2000, MENT RETARD DEV D R, V6, P161, DOI 10.1002/1098-2779(2000)6:3<161::AID-MRDD2>3.0.CO;2-W; BOROD JC, 1990, J COMMUN DISORD, V23, P247, DOI 10.1016/0021-9924(90)90003-H; Bosch V, 2000, J MAGN RESON IMAGING, V11, P61, DOI 10.1002/(SICI)1522-2586(200001)11:1<61::AID-JMRI9>3.0.CO;2-C; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Charest I, 2012, CEREB CORTEX; COHEN MJ, 1994, BRAIN LANG, V47, P171, DOI 10.1006/brln.1994.1047; Dehaene S, 1997, NEUROREPORT, V8, P3809, DOI 10.1097/00001756-199712010-00030; Dehaene-Lambertz G, 1998, NEUROREPORT, V9, P1885, DOI 10.1097/00001756-199806010-00040; Dehaene-Lambertz G, 2002, SCIENCE, V298, P2013, DOI 10.1126/science.1077066; Dick AS, 2012, DEVELOPMENTAL SCI, V15, P165, DOI 10.1111/j.1467-7687.2011.01100.x; EcklundFlores L, 1996, DEV PSYCHOBIOL, V29, P205, DOI 10.1002/(SICI)1098-2302(199604)29:3<205::AID-DEV2>3.0.CO;2-V; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; Fecteau S, 2004, NEUROIMAGE, V23, P840, DOI 10.1016/j.neuroimage.2004.09.019; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Gaab N, 2003, NEUROIMAGE, V19, P1417, DOI 10.1016/S1053-8119(03)00224-6; Gaab N, 2008, HUM BRAIN MAPP, V29, P858, DOI 10.1002/hbm.20578; Gaab N, 2007, HUM BRAIN MAPP, V28, P703, DOI 10.1002/hbm.20298; Gaab N, 2007, HUM BRAIN MAPP, V28, P721, DOI 10.1002/hbm.20299; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Goncalves MS, 2001, NEUROIMAGE, V14, P1353, DOI 10.1006/nimg.2001.0954; Greimel E., 2012, BRAIN STRUCT FUNCT; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; Hailstone JC, 2011, BRAIN, V134, P2535, DOI 10.1093/brain/awr205; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; HARTMAN DE, 1976, J ACOUST SOC AM, V59, P713, DOI 10.1121/1.380894; Herholz SC, 2012, J COGNITIVE NEUROSCI, V24, P1382, DOI 10.1162/jocn_a_00216; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Homae F, 2006, NEUROSCI RES, V54, P276, DOI 10.1016/j.neures.2005.12.006; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; Iidaka Tetsuya, 2012, Brain and Nerve (Tokyo), V64, P737; Imaizumi S, 1997, VOCAL IDENTIFICATION; Kahn I, 2008, J NEUROPHYSIOL, V100, P129, DOI 10.1152/jn.00077.2008; Kaufman A. S., 1997, KBIT 2 KAUFMAN BRIEF; Kriegstein KV, 2004, NEUROIMAGE, V22, P948, DOI 10.1016/j.neuroimage.2004.02.020; Langer N, 2013, CEREB CORTEX; Langers DRM, 2011, BRAIN CONNECT, V1, P233, DOI 10.1089/brain.2011.0023; LASS NJ, 1976, J ACOUST SOC AM, V59, P675, DOI 10.1121/1.380917; Latinus M, 2011, CEREB CORTEX, V21, P2820, DOI 10.1093/cercor/bhr077; Lattner S, 2005, HUM BRAIN MAPP, V24, P11, DOI 10.1002/hbm.20065; Lavner Y, 2000, SPEECH COMMUN, V30, P9, DOI 10.1016/S0167-6393(99)00028-X; Linden DEJ, 2011, CEREB CORTEX, V21, P330, DOI 10.1093/cercor/bhq097; Loui P, 2012, NEUROIMAGE, V63, P632, DOI 10.1016/j.neuroimage.2012.07.030; Lu LH, 2009, CEREB CORTEX, V19, P2595, DOI 10.1093/cercor/bhp011; Marsh R, 2008, J AM ACAD CHILD PSY, V47, P1233, DOI 10.1097/CHI.0b013e318185e703; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; McGettigan C, 2013, J COGNITIVE NEUROSCI, V25, P1875, DOI 10.1162/jocn_a_00427; Mende-Siedlecki P., 2012, SOC COGN AFFECT NEUR; Meyer M, 2005, COGNITIVE BRAIN RES, V24, P291, DOI 10.1016/j.cogbrainres.2005.02.008; Mier D, 2010, PSYCHOL MED, V40, P1607, DOI 10.1017/S0033291709992133; Nath AR, 2011, J NEUROSCI, V31, P13963, DOI 10.1523/JNEUROSCI.2605-11.2011; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Pell MD, 2003, COGN AFFECT BEHAV NE, V3, P275, DOI 10.3758/CABN.3.4.275; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Petkov CI, 2009, NEUROSCIENTIST, V15, P419, DOI 10.1177/1073858408326430; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Raschle N. M., 2009, JOVE, V29; Raschle N, 2012, ANN NY ACAD SCI, V1252, P43, DOI 10.1111/j.1749-6632.2012.06457.x; Raschle NM, 2012, P NATL ACAD SCI USA, V109, P2156, DOI 10.1073/pnas.1107721109; Redcay E, 2008, NEUROSCI BIOBEHAV R, V32, P123, DOI 10.1016/j.neubiorev.2007.06.004; Rogier O, 2010, INT J PSYCHOPHYSIOL, V75, P44, DOI 10.1016/j.ijpsycho.2009.10.013; Saxe R, 2006, SOC NEUROSCI-UK, V1, pI, DOI 10.1080/17470910601117463; SCHERER KR, 1995, J VOICE, V9, P235, DOI 10.1016/S0892-1997(05)80231-0; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Semel E, 2000, CHILD EVALUATION LAN; Shultz S, 2012, J COGNITIVE NEUROSCI, V24, P1224, DOI 10.1162/jocn_a_00208; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Talairach J, 1988, COPLANAR STEREOTAXIE; Thomason ME, 2005, NEUROIMAGE, V25, P824, DOI 10.1016/j.neuroimage.2004.12.026; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Van der Wyk BC, 2012, DEV COGN NEUROSCI; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; VANDERLELY HKJ, 2000, VERB AGREEMENT TENSE; VANDOMMELEN WA, 1990, LANG SPEECH, V33, P259, DOI 10.1177/002383099003300302; VANLANCKER DR, 1989, J CLIN EXP NEUROPSYC, V11, P665, DOI 10.1080/01688638908400923; VANLANCKER DR, 1988, CORTEX, V24, P195, DOI 10.1016/S0010-9452(88)80029-7; von Kriegstein K, 2003, COGNITIVE BRAIN RES, V17, P48, DOI 10.1016/S0926-6410(03)00079-X; von Kriegstein K, 2010, J NEUROSCI, V30, P629, DOI 10.1523/JNEUROSCI.2742-09.2010; Wang YY, 2014, BRAIN CONNECT, V4, P273, DOI 10.1089/brain.2013.0190; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wolf M., 2005, RAN RAS RAPID AUTOMA; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834	97	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115549	10.1371/journal.pone.0115549	http://dx.doi.org/10.1371/journal.pone.0115549			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532132	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100075
J	Malone, SL; Staudhammer, CL; Oberbauer, SF; Olivas, P; Ryan, MG; Schedlbauer, JL; Loescher, HW; Starr, G				Malone, Sparkle L.; Staudhammer, Christina L.; Oberbauer, Steven F.; Olivas, Paulo; Ryan, Michael G.; Schedlbauer, Jessica L.; Loescher, Henry W.; Starr, Gregory			El Nino Southern Oscillation (ENSO) Enhances CO2 Exchange Rates in Freshwater Marsh Ecosystems in the Florida Everglades	PLOS ONE			English	Article							CARBON-DIOXIDE; PRECIPITATION; PATTERNS; TEMPERATURE; VEGETATION; FREQUENCY; PHENOLOGY; DROUGHT; FORESTS; BALANCE	This research examines the relationships between El Nino Southern Oscillation (ENSO), water level, precipitation patterns and carbon dioxide (CO2) exchange rates in the freshwater wetland ecosystems of the Florida Everglades. Data was obtained over a 5-year study period (2009-2013) from two freshwater marsh sites located in Everglades National Park that differ in hydrology. At the short-hydroperiod site (Taylor Slough; TS) and the long-hydroperiod site (Shark River Slough; SRS) fluctuations in precipitation patterns occurred with changes in ENSO phase, suggesting that extreme ENSO phases alter Everglades hydrology which is known to have a substantial influence on ecosystem carbon dynamics. Variations in both ENSO phase and annual net CO2 exchange rates co-occurred with changes in wet and dry season length and intensity. Combined with site-specific seasonality in CO2 exchanges rates, El Nino and La Nina phases magnified season intensity and CO2 exchange rates at both sites. At TS, net CO2 uptake rates were higher in the dry season, whereas SRS had greater rates of carbon sequestration during the wet season. As La Nina phases were concurrent with drought years and extended dry seasons, TS became a greater sink for CO2 on an annual basis (-11 to -110 g CO2 m(-2) yr(-1)) compared to El Nino and neutral years (-5 to -43.5 g CO2 m(-2) yr(-1)). SRS was a small source for CO2 annually (1.81 to 80 g CO2 m(-2) yr(-1)) except in one exceptionally wet year that was associated with an El Nino phase (-16 g CO2 m(-2) yr(-1)). Considering that future climate predictions suggest a higher frequency and intensity in El Nino and La Nina phases, these results indicate that changes in extreme ENSO phases will significantly alter CO2 dynamics in the Florida Everglades.	[Malone, Sparkle L.; Staudhammer, Christina L.; Starr, Gregory] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Malone, Sparkle L.; Ryan, Michael G.] US Forest Serv, Rocky Mt Res Stn, Ft Collins, CO USA; [Olivas, Paulo; Schedlbauer, Jessica L.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Ryan, Michael G.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Schedlbauer, Jessica L.] W Chester Univ, Dept Biol, W Chester, PA 19380 USA; [Loescher, Henry W.] Natl Ecol Observ Network Inc, Boulder, CO 80301 USA; [Loescher, Henry W.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA	University of Alabama System; University of Alabama Tuscaloosa; United States Department of Agriculture (USDA); United States Forest Service; State University System of Florida; Florida International University; Colorado State University; Pennsylvania State System of Higher Education (PASSHE); West Chester University of Pennsylvania; University of Colorado System; University of Colorado Boulder	Malone, SL (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	sparklelmalone@fs.fed.us	Malone, Sparkle/ABH-8402-2020; Ryan, Michael G/A-9805-2008	Malone, Sparkle/0000-0001-9034-1076; Ryan, Michael G/0000-0002-2500-6738; Staudhammer, Christina/0000-0003-1887-418X; Olivas, Paulo/0000-0002-6308-4470	National Science Foundations (NSF) Division of Atmospheric and Geospace Sciences (AGS) Atmospheric Chemistry program [1233006]; Department of Energy's (DOE) National Institute for Climate Change Research (NICCR) [07-SC-NICCR-1059]; US Department of Education Graduate Assistantships in Areas of National Need (GAANN); National Science Foundation (NSF) through the Florida Coastal Everglades Long Term Ecological Research program under Cooperative Agreements [DBI-0620409, DEB-9910514]; Direct For Biological Sciences [1202716] Funding Source: National Science Foundation; Div Atmospheric & Geospace Sciences [1233006] Funding Source: National Science Foundation; Division Of Environmental Biology [1237517] Funding Source: National Science Foundation	National Science Foundations (NSF) Division of Atmospheric and Geospace Sciences (AGS) Atmospheric Chemistry program; Department of Energy's (DOE) National Institute for Climate Change Research (NICCR)(United States Department of Energy (DOE)); US Department of Education Graduate Assistantships in Areas of National Need (GAANN)(US Department of Education); National Science Foundation (NSF) through the Florida Coastal Everglades Long Term Ecological Research program under Cooperative Agreements(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for the research was provided by the National Science Foundations (NSF) Division of Atmospheric and Geospace Sciences (AGS) Atmospheric Chemistry program through grant 1233006 [GS SFO], the Department of Energy's (DOE) National Institute for Climate Change Research (NICCR) through grant 07-SC-NICCR-1059 [GS SFO], and the US Department of Education Graduate Assistantships in Areas of National Need (GAANN) grant [SLM]. This research was also supported by the National Science Foundation (NSF) through the Florida Coastal Everglades Long Term Ecological Research program under Cooperative Agreements DBI-0620409 and DEB-9910514 [GS SFO]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; [Anonymous], 1994, EVERGLADES ECOSYSTEM, DOI DOI 10.1201/9781466571754; Aubinet M, 2000, ADV ECOL RES, V30, P113, DOI 10.1016/S0065-2504(08)60018-5; Barr J.G., 2010, J GEOPHYS RES-BIOGEO, P115, DOI DOI 10.1002/(ISSN)1525-2027; Beckage B, 2003, ECOLOGY, V84, P3124, DOI 10.1890/02-0183; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; Brocklebank JC, 2003, SAS SYSTEM FORECASTI; Chen E, 1992, ECOSYSTEMS FLORIDA; Childers DL, 2006, HYDROBIOLOGIA, V569, P531, DOI 10.1007/s10750-006-0154-8; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Clark KL, 1999, ECOL APPL, V9, P936, DOI 10.1890/1051-0761(1999)009[0936:ECONEO]2.0.CO;2; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Clement R, 1999, EDIRE; Cubasch U, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P525; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Duever M. J., 1994, EVERGLADES ECOSYSTEM; Duever MJ, 1978, 4 NAT SCI FDN ROCK F, P534; Foken T, 2004, AGR FOREST METEOROL, V127, P223, DOI 10.1016/j.agrformet.2004.07.015; Foken T, 1996, AGR FOREST METEOROL, V78, P83, DOI 10.1016/0168-1923(95)02248-1; Godfrey R.K., 1979, AQUATIC WETLAND PLAN; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Goulden ML, 1996, GLOBAL CHANGE BIOL, V2, P169, DOI 10.1111/j.1365-2486.1996.tb00070.x; HANSON K, 1991, Florida Scientist, V54, P160; Hashimoto H, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004959; Hintze J, 2004, NUMBER CRUNCHING STA; Jimenez KL, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002117; Kiladis GN, 1989, J CLIMATE, V2, P1069, DOI 10.1175/1520-0442(1989)002<1069:GCAAWE>2.0.CO;2; Kljun N, 2004, BOUND-LAY METEOROL, V112, P503, DOI 10.1023/B:BOUN.0000030653.71031.96; Kljun N, 2002, BOUND-LAY METEOROL, V103, P205, DOI 10.1023/A:1014556300021; Latif M, 2009, P NATL ACAD SCI USA, V106, P20578, DOI 10.1073/pnas.0710860105; Li L., 2011, CLIM DYNAM, V39, P1401, DOI [10.1007/s00382-011-1214-y, DOI 10.1007/S00382-011-1214-Y]; Livezey RE, 1997, J CLIMATE, V10, P1787, DOI 10.1175/1520-0442(1997)010<1787:TROTPN>2.0.CO;2; Loescher H. W, 2006, J GEOPHYS RES ATMOSP, V111; LOVELESS CM, 1959, ECOLOGY, V40, P1, DOI 10.2307/1929916; Malone SL, 2014, J GEOPHYS RES-BIOGEO, V119, P1487, DOI 10.1002/2014JG002700; Malone SL, 2013, GLOBAL CHANGE BIOL, V19, P2511, DOI 10.1111/gcb.12211; Mason SJ, 2001, B AM METEOROL SOC, V82, P619, DOI 10.1175/1520-0477(2001)082<0619:PPAAWE>2.3.CO;2; Massman WJ, 2004, ATMOS ENVIRON, V38, P2323, DOI 10.1016/j.atmosenv.2003.09.079; Meyers S.D., 1995, EOS T AM GEOPHYS UNI, V76, P533, DOI [10.1029/95EO00326, DOI 10.1029/95EO00326]; Moses CS, 2013, J PALEOLIMNOL, V49, P5, DOI 10.1007/s10933-012-9635-0; Nuttle WK, 1997, WETLANDS, V17, P82, DOI 10.1007/BF03160720; Obeysekera J., 1999, URBAN ECOSYST, V3, P223, DOI DOI 10.1023/A:1009552500448; Palmer W.C., 1965, WEATHER BUREAU RES P; Pankratz A., 2009, FORECASTING UNIVARIA; Patricia L, 2003, TASK VEG SC, V39, P75; Piechota TC, 1996, WATER RESOUR RES, V32, P1359, DOI 10.1029/96WR00353; Radford AE, 1968, MANUAL VASCULAR FLOR; Randerson JT, 1999, GEOPHYS RES LETT, V26, P2765, DOI 10.1029/1999GL900500; REICH PB, 1995, CAN J BOT, V73, P164, DOI 10.1139/b95-020; Rolim SG, 2005, OECOLOGIA, V142, P238, DOI 10.1007/s00442-004-1717-x; ROPELEWSKI CF, 1986, MON WEATHER REV, V114, P2352, DOI 10.1175/1520-0493(1986)114<2352:NAPATP>2.0.CO;2; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Sanchez-Azofeifa A, 2003, TASK VEG SC, V39, P121; Schedlbauer JL, 2012, WETLANDS, V32, P801, DOI 10.1007/s13157-012-0311-y; Schedlbauer JL, 2010, AGR FOREST METEOROL, V150, P994, DOI 10.1016/j.agrformet.2010.03.005; Schmidt N, 2001, J CLIMATE, V14, P615, DOI 10.1175/1520-0442(2001)014<0615:EIOSRA>2.0.CO;2; SCHOTANUS P, 1983, BOUND-LAY METEOROL, V26, P81, DOI 10.1007/BF00164332; Sittel MC, 1994, TECHNICAL REPORT; Stanton EA, 2007, FLORIDA CLIMATE CHAN; Svoboda M, 2000, DROUGHT NETWORK NEWS; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; Veldkamp E, 2000, SOIL SCI SOC AM J, V64, P1549, DOI 10.2136/sssaj2000.6451549x; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Whiting GJ, 2001, TELLUS B, V53, P521, DOI 10.1034/j.1600-0889.2001.530501.x	65	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115058	10.1371/journal.pone.0115058	http://dx.doi.org/10.1371/journal.pone.0115058			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521299	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845600015
J	Hernanda, PY; Chen, K; Das, AM; Sideras, K; Wang, W; Li, J; Cao, W; Bots, SJA; Kodach, LL; de Man, RA; Ijzermans, JNM; Janssen, HLA; Stubbs, AP; Sprengers, D; Bruno, MJ; Metselaar, HJ; Hagen, TLM; Kwekkeboom, J; Peppelenbosch, MP; Pan, Q				Hernanda, P. Y.; Chen, K.; Das, A. M.; Sideras, K.; Wang, W.; Li, J.; Cao, W.; Bots, S. J. A.; Kodach, L. L.; de Man, R. A.; Ijzermans, J. N. M.; Janssen, H. L. A.; Stubbs, A. P.; Sprengers, D.; Bruno, M. J.; Metselaar, H. J.; Ten Hagen, T. L. M.; Kwekkeboom, J.; Peppelenbosch, M. P.; Pan, Q.			SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma	ONCOGENE			English	Article							BONE MORPHOGENETIC PROTEINS; GROWTH-FACTOR-BETA; TGF-BETA; COLORECTAL-CANCER; SIGNALING PATHWAYS; PANCREATIC-CANCER; SUPPRESSOR GENE; CELL-MIGRATION; EXPRESSION; LIVER	Further understanding of the molecular biology and pathogenesis of hepatocellular carcinoma (HCC) is crucial for future therapeutic development. SMAD4, recognized as an important tumor suppressor, is a central mediator of transforming growth factor beta (TGFB) and bone morphogenetic protein (BMP) signaling. This study investigated the role of SMAD4 in HCC. Nuclear localization of SMAD4 was observed in a cohort of 140 HCC patients using tissue microarray. HCC cell lines were used for functional assay in vitro and in immune-deficient mice. Nuclear SMAD4 levels were significantly increased in patient HCC tumors as compared with adjacent tissues. Knockdown of SMAD4 significantly reduced the efficiency of colony formation and migratory capacity of HCC cells in vitro and was incompatible with HCC tumor initiation and growth in mice. Knockdown of SMAD4 partially conferred resistance to the anti-growth effects of BMP ligand in HCC cells. Importantly, simultaneous elevation of SMAD4 and phosphorylated SMAD2/3 is significantly associated with poor patient outcome after surgery. Although high levels of SMAD4 can also mediate an antitumor function by coupling with phosphorylated SMAD1/5/8, this signaling, however, is absent in majority of our HCC patients. In conclusion, this study revealed a highly non-canonical tumor-promoting function of SMAD4 in HCC. The drastic elevation of nuclear SMAD4 in sub-population of HCC tumors highlights its potential as an outcome predictor for patient stratification and a target for personalized therapeutic development.	[Hernanda, P. Y.; Chen, K.; Sideras, K.; Wang, W.; Li, J.; Cao, W.; Bots, S. J. A.; Kodach, L. L.; de Man, R. A.; Janssen, H. L. A.; Sprengers, D.; Bruno, M. J.; Metselaar, H. J.; Kwekkeboom, J.; Peppelenbosch, M. P.; Pan, Q.] Erasmus Univ, Med Ctr, Erasmus MC Canc Inst, Dept Gastroenterol & Hepatol, NL-3015 CE Rotterdam, Netherlands; [Hernanda, P. Y.; Chen, K.; Sideras, K.; Wang, W.; Li, J.; Cao, W.; Bots, S. J. A.; Kodach, L. L.; de Man, R. A.; Janssen, H. L. A.; Sprengers, D.; Bruno, M. J.; Metselaar, H. J.; Kwekkeboom, J.; Peppelenbosch, M. P.; Pan, Q.] Postgrad Sch Mol Med, NL-3015 CE Rotterdam, Netherlands; [Hernanda, P. Y.] Wijaya Kusuma Univ, Biomol Res Ctr, Lab Med Genet, Surabaya, Indonesia; [Chen, K.] Zhejiang Sci Tech Univ, Coll Life Sci, BioX Ctr, Hangzhou, Zhejiang, Peoples R China; [Das, A. M.; Ten Hagen, T. L. M.] Erasmus Univ, Med Ctr, Dept Surg, Lab Expt Surg Oncol Sect Surg Oncol, NL-3015 CE Rotterdam, Netherlands; [Ijzermans, J. N. M.] Erasmus Univ, Med Ctr, Dept Surg, NL-3015 CE Rotterdam, Netherlands; [Janssen, H. L. A.] Univ Hlth Network, Div Gastroenterol, Toronto, ON, Canada; [Stubbs, A. P.] Erasmus Univ, Med Ctr, Dept Bioinformat, NL-3015 CE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Zhejiang Sci-Tech University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Erasmus University Rotterdam; Erasmus MC	Pan, Q (corresponding author), Erasmus Univ, Med Ctr, Erasmus MC Canc Inst, Dept Gastroenterol & Hepatol, Room Na 617,sGravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	q.pan@erasmusmc.nl	Peppelenbosch, Maikel P./U-5304-2019	Kodach, Liudmila/0000-0003-2487-3204; Sideras, Kostandinos/0000-0002-4698-2105; hernanda, pratika yuhyi/0000-0003-2025-2136; Pan, Qiuwei/0000-0001-9982-6184; Peppelenbosch, Maikel/0000-0001-9112-6028	Daniel den Hoed Foundation; Netherlands Organization for Scientific Research (NWO/ZonMw) [916-13-032]; Dutch Digestive Foundation (MLDS) [CDG 1304]; European Association for the Study of the Liver (EASL); Science and Technology Department Commonwealth Technology Applied Research Project of Zhejiang Province, China [2012F82G2060018]; National Nature Science Foundation of China [81272687]	Daniel den Hoed Foundation; Netherlands Organization for Scientific Research (NWO/ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Dutch Digestive Foundation (MLDS); European Association for the Study of the Liver (EASL); Science and Technology Department Commonwealth Technology Applied Research Project of Zhejiang Province, China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the support from the Daniel den Hoed Foundation for a Centennial Award fellowship (to Q Pan), the Netherlands Organization for Scientific Research (NWO/ZonMw) for a VENI grant (no. 916-13-032) (to Q Pan), the Dutch Digestive Foundation (MLDS) for a career development grant (no. CDG 1304) (to Q Pan) and the European Association for the Study of the Liver (EASL) for a Sheila Sherlock Fellowship (to Q Pan). Support from the Science and Technology Department Commonwealth Technology Applied Research Project (no. 2012F82G2060018) of Zhejiang Province, China and the National Nature Science Foundation of China (No. 81272687) (to K Chen) is gratefully acknowledged. We thank Dr Ron Smits from Erasmus Medical Center Rotterdam for critical reading of the manuscript and thank Dr Jie Xu from the Animal Care at Hangzhou Normal University, Hangzhou, China for helping with the animal experiments.	Abou-Shady M, 1999, AM J SURG, V177, P209, DOI 10.1016/S0002-9610(99)00012-4; Argani P, 2001, CANCER, V91, P1332; Caputo V, 2012, AM J HUM GENET, V90, P161, DOI 10.1016/j.ajhg.2011.12.011; Carreira AC, 2014, J DENT RES, V93, P335, DOI 10.1177/0022034513518561; Chiu CY, 2012, MOL CANCER RES, V10, P415, DOI 10.1158/1541-7786.MCR-11-0293; Das AM, 2014, ANGIOGENESIS, V17, P163, DOI 10.1007/s10456-013-9385-2; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Furukawa F, 2003, HEPATOLOGY, V38, P879, DOI 10.1053/jhep.2003.50384; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hahn SA, 1996, CANCER RES, V56, P490; HAHN SA, 1995, CANCER RES, V55, P4670; Hardwick JC, 2008, NAT REV CANCER, V8, P806, DOI 10.1038/nrc2467; Hernanda PY, 2013, CARCINOGENESIS, V34, P2330, DOI 10.1093/carcin/bgt210; Hiwatashi K, 2009, ANN SURG ONCOL, V16, P3176, DOI 10.1245/s10434-009-0614-2; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Itatani Y, 2013, GASTROENTEROLOGY, V145, P1064, DOI 10.1053/j.gastro.2013.07.033; Kang YK, 2002, HUM PATHOL, V33, P877, DOI 10.1053/hupa.2002.127444; Kocabayoglu Peri, 2013, Front Biosci (Schol Ed), V5, P217; Kodach LL, 2008, CANCER, V112, P300, DOI 10.1002/cncr.23160; Kodach LL, 2007, GASTROENTEROLOGY, V133, P1272, DOI 10.1053/j.gastro.2007.08.021; Korsse SE, 2013, CARCINOGENESIS, V34, P1611, DOI 10.1093/carcin/bgt068; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Li Q, 2013, CANCER SCI, V104, P398, DOI 10.1111/cas.12093; Maegdefrau U, 2012, EXP MOL PATHOL, V92, P74, DOI 10.1016/j.yexmp.2011.10.004; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuzaki K, 2007, HEPATOLOGY, V46, P48, DOI 10.1002/hep.21672; Matsuzaki K, 2013, CYTOKINE GROWTH F R, V24, P385, DOI 10.1016/j.cytogfr.2013.06.002; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Mullauer L, 1996, HEPATOLOGY, V23, P840, DOI 10.1002/hep.510230427; Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765; Pan QW, 2008, ACTA ONCOL, V47, P135, DOI 10.1080/02841860701403053; Pan QW, 2011, FEBS LETT, V585, P1025, DOI 10.1016/j.febslet.2011.02.035; Pedroza-Gonzalez A, 2013, HEPATOLOGY, V57, P183, DOI 10.1002/hep.26013; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Piek E, 2001, ADV CANCER RES, V83, P1, DOI 10.1016/S0065-230X(01)83001-3; Sakai H, 2012, CLIN EXP METASTAS, V29, P327, DOI 10.1007/s10585-012-9453-9; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Tangkijvanich P, 2000, J CLIN GASTROENTEROL, V31, P302, DOI 10.1097/00004836-200012000-00007; Thawani JP, 2010, NEUROSURGERY, V66, P233, DOI 10.1227/01.NEU.0000363722.42097.C2; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; van Horssen R, 2006, J CELL BIOCHEM, V99, P1536, DOI 10.1002/jcb.20994; Virtanen S, 2011, EXP CELL RES, V317, P2136, DOI 10.1016/j.yexcr.2011.06.001; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wang L, 2012, INT J CANCER, V131, P1941, DOI 10.1002/ijc.27444; Xu XL, 2006, J CLIN INVEST, V116, P1843, DOI 10.1172/JCI27282; Yao L, 2012, ASIAN PAC J CANCER P, V13, P1297, DOI 10.7314/APJCP.2012.13.4.1297; Zhang BX, 2010, GASTROENTEROLOGY, V138, P969, DOI 10.1053/j.gastro.2009.11.004; Zhang LX, 2012, CANCER RES, V72, P4276, DOI 10.1158/0008-5472.CAN-12-1013	52	51	53	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2015	34	39					5055	5068		10.1038/onc.2014.425	http://dx.doi.org/10.1038/onc.2014.425			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9RC	25531314				2022-12-26	WOS:000361693300006
J	Yoo, BH; Masson, O; Li, Y; Khan, IA; Gowda, PS; Rosen, KV				Yoo, B. H.; Masson, O.; Li, Y.; Khan, I. A.; Gowda, P. S.; Rosen, K. V.			Anoikis of colon carcinoma cells triggered by beta-catenin loss can be enhanced by tumor necrosis factor receptor 1 antagonists	ONCOGENE			English	Article							NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; DOWN-REGULATION; GROWTH-FACTOR; INDUCED RESISTANCE; APC MUTATIONS; UP-REGULATION; TNF RECEPTOR; IN-VIVO; APOPTOSIS	Detachment of non-malignant epithelial cells from the extracellular matrix causes their apoptosis, a phenomenon called anoikis. By contrast, carcinoma cells are anoikis-resistant, and this resistance is thought to be critical for tumor progression. Many oncogenes trigger not only anti-but also pr-apoptotic signals. The proapoptotic events represent an aspect of a phenomenon called oncogenic stress, which acts as a safeguard mechanism blocking tumor initiation. In cells that become malignant, oncogene-induced antiapoptotic signals outbalance the proapoptotic ones. It is now thought that treatments blocking the antiapoptotic events but preserving the proapoptotic signals can be particularly effective in killing tumor cells. Whether or not oncogenes induce any proanoikis signals that can be used for enhancing the efficiency of approaches aimed at triggering anoikis of cancer cells has never been explored. beta-Catenin is a major oncoprotein that is often activated in colorectal cancer and promotes tumor progression via mechanisms that are understood only in part. We found here that beta-catenin triggers both anti-and proanoikis signals in colon cancer cells. We observed that the antianoikis signals prevail and the cells become anoikis-resistant. We further established that one proanoikis signal in these cells is triggered by beta-catenin-induced downregulation of an apoptosis inhibitor tumor necrosis factor receptor 1 (TNFR1) and subsequent reduction of the activity of a transcription factor NF-kappa B (nuclear factor-kappa B), a mediator of TNFR1 signaling. We also found that the effect of beta-catenin on TNFR1 requires the presence of transcription factor TCF1, a beta-catenin effector. We demonstrated that ablation of beta-catenin in colon cancer cells triggers their anoikis and that this anoikis is enhanced even further if low TNFR1 or NF-kappa B activity is artificially preserved in the beta-catenin-deprived cells. Thus, inhibition of TNFR1 or NF-kappa B activity can be expected to enhance the efficiency of approaches aimed at blocking beta-catenin-driven anoikis resistance of colon carcinoma cells.	Dalhousie Univ, Dept Pediat, Halifax, NS B3H 3J5, Canada; Dalhousie Univ, Dept Biochem, Halifax, NS B3H 3J5, Canada; Dalhousie Univ, Dept Mol Biol, Halifax, NS B3H 3J5, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Rosen, KV (corresponding author), Atlantic Res Ctr, Room C-304,CRC,5849 Univ Ave,POB 15000, Halifax, NS B3H 4R2, Canada.	kirill.rosen@dal.ca		Rosen, Kirill/0000-0002-4317-9907	Canadian Institutes of Health Research/Nova Scotia Regional Partnership Program (CIHR/NS RPP) [125109]; IWK Health Centre	Canadian Institutes of Health Research/Nova Scotia Regional Partnership Program (CIHR/NS RPP)(Canadian Institutes of Health Research (CIHR)); IWK Health Centre	This study was supported by the Canadian Institutes of Health Research/Nova Scotia Regional Partnership Program (CIHR/NS RPP) Grant 125109 held by KR. KR was a recipient of the CIHR/NS RPP New Investigator Salary award. YL and PSG were recipients of the IWK Health Centre Post Doctoral Fellowship. BHY was a recipient of the IWK Health Centre Research Associateship.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Anson M, 2012, J CLIN INVEST, V122, P586, DOI 10.1172/JCI43937; Au PYB, 2005, ONCOGENE, V24, P3196, DOI 10.1038/sj.onc.1208516; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; Blattner C, 2000, MOL CELL BIOL, V20, P3616, DOI 10.1128/MCB.20.10.3616-3625.2000; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; Brasse-Lagnel C, 2007, FEBS J, V274, P5250, DOI 10.1111/j.1742-4658.2007.06047.x; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Coll ML, 2002, ONCOGENE, V21, P2908, DOI 10.1038/sj.onc.1205388; DECOSTER E, 1995, J BIOL CHEM, V270, P18473, DOI 10.1074/jbc.270.31.18473; Delage B, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.83; Derouet M, 2007, NEOPLASIA, V9, P536, DOI 10.1593/neo.07217; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Frankel A, 2001, CANCER RES, V61, P4837; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; Haigis KM, 2011, NAT GENET, V43, P177, DOI 10.1038/ng0311-177; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hsu DK, 1996, AM J PATHOL, V148, P1661; Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; Jobin C, 1998, J IMMUNOL, V160, P410; Joneson T, 1999, MOL CELL BIOL, V19, P5892; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; KEMPER O, 1993, GENE, V134, P209, DOI 10.1016/0378-1119(93)90095-K; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Kim HRC, 1999, CANCER RES, V59, P4148; Kitamura T, 2005, AM J PHYSIOL-CELL PH, V289, pC82, DOI 10.1152/ajpcell.00486.2004; Kohler EM, 2009, HUM MOL GENET, V18, P213, DOI 10.1093/hmg/ddn338; Kontermann RE, 2008, J IMMUNOTHER, V31, P225, DOI 10.1097/CJI.0b013e31816a88f9; Kumler I, 2014, CANCER TREAT REV, V40, P259, DOI 10.1016/j.ctrv.2013.09.002; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Li HB, 2009, J BIOL CHEM, V284, P2012, DOI 10.1074/jbc.M805612200; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Liu YC, 1996, EXP CELL RES, V228, P206, DOI 10.1006/excr.1996.0318; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Liu ZP, 2005, J BIOL CHEM, V280, P37383, DOI 10.1074/jbc.M503724200; LJUBIMOV AV, 1992, INT J CANCER, V50, P562, DOI 10.1002/ijc.2910500412; Lobito AA, 2006, BLOOD, V108, P1320, DOI 10.1182/blood-2005-11-006783; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Mahon PC, 2007, CANCER RES, V67, P6786, DOI 10.1158/0008-5472.CAN-07-0440; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; RAK J, 1995, J CELL BIOL, V131, P1587, DOI 10.1083/jcb.131.6.1587; Ratti M, 2014, ANTI-CANCER DRUG, V25, P127, DOI 10.1097/CAD.0000000000000035; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rosen K, 1998, CURR BIOL, V8, P1331, DOI 10.1016/S0960-9822(07)00564-7; Rosen K, 2000, J CELL BIOL, V149, P447, DOI 10.1083/jcb.149.2.447; Rosen K, 2002, J BIOL CHEM, V277, P46123, DOI 10.1074/jbc.M207883200; Rosen K, 2001, J BIOL CHEM, V276, P37273, DOI 10.1074/jbc.M106424200; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Scotlandi K, 2002, CANCER GENE THER, V9, P296, DOI 10.1038/sj.cgt.7700442; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Tulchinsky E, 1997, J BIOL CHEM, V272, P4828, DOI 10.1074/jbc.272.8.4828; Van Herreweghe F, 2010, CELL MOL LIFE SCI, V67, P1567, DOI 10.1007/s00018-010-0283-0; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Yan SR, 2005, ONCOGENE, V24, P6482, DOI 10.1038/sj.onc.1208810; Yoo BH, 2012, INT J CANCER, V131, P357, DOI 10.1002/ijc.26368; Yoshimura H, 2003, ANTICANCER RES, V23, P85; Yun K, 2009, J IMMUNOL, V183, P5129, DOI 10.4049/jimmunol.0802744	77	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 17	2015	34	38					4939	4951		10.1038/onc.2014.415	http://dx.doi.org/10.1038/onc.2014.415			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9QZ	25531320				2022-12-26	WOS:000361693000004
J	Bourdin, B; Shakeri, B; Tetreault, MP; Sauve, R; Lesage, S; Parent, L				Bourdin, Benoite; Shakeri, Behzad; Tetreault, Marie-Philippe; Sauve, Remy; Lesage, Sylvie; Parent, Lucie			Functional Characterization of Ca-V alpha 2 delta Mutations Associated with Sudden Cardiac Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channel; Cardiac Muscle; Cardiovascular Disease; Flow Cytometry; Fluorescence; Patch Clamp	CALCIUM-CHANNEL GENE; SUBUNIT REGULATION; HEART-DISEASE; ION-CHANNEL; EXPRESSION; QT; ARRHYTHMIA; IDENTIFICATION; INACTIVATION; DISRUPTION	Background: Missense mutations in Ca(V)21, an auxiliary subunit of cardiac L-type Ca(V)1.2 channels, are associated with arrhythmias. Results: The reduction in the cell surface density of Ca(V)21 D550Y/Q917H was sufficient to impair Ca(V)1.2 currents. Conclusion: Defects in the cell surface trafficking of Ca(V)21 mutants down-regulate L-type currents. Significance:CACNA2D1 genetic variants may trigger arrhythmias by reducing L-type Ca2+ currents. L-type Ca2+ channels play a critical role in cardiac rhythmicity. These ion channels are oligomeric complexes formed by the pore-forming Ca(V)1 with the auxiliary Ca-V and Ca(V)2 subunits. Ca(V)2 increases the peak current density and improves the voltage-dependent activation gating of Ca(V)1.2 channels without increasing the surface expression of the Ca(V)1 subunit. The functional impact of genetic variants of CACNA2D1 (the gene encoding for Ca(V)2), associated with shorter repolarization QT intervals (the time interval between the Q and the T waves on the cardiac electrocardiogram), was investigated after recombinant expression of the full complement of L-type Ca(V)1.2 subunits in human embryonic kidney 293 cells. By performing side-by-side high resolution flow cytometry assays and whole-cell patch clamp recordings, we revealed that the surface density of the Ca(V)2 wild-type protein correlates with the peak current density. Furthermore, the cell surface density of Ca(V)2 mutants S755T, Q917H, and S956T was not significantly different from the cell surface density of the Ca(V)2 wild-type protein expressed under the same conditions. In contrast, the cell surface expression of Ca(V)2 D550Y, Ca(V)2 S709N, and the double mutant D550Y/Q917H was reduced, respectively, by approximate to 30-33% for the single mutants and by 60% for the latter. The cell surface density of D550Y/Q917H was more significantly impaired than protein stability, suggesting that surface trafficking of Ca(V)2 was disrupted by the double mutation. Co-expression with D550Y/Q917H significantly decreased Ca(V)1.2 currents as compared with results obtained with Ca(V)2 wild type. It is concluded that D550Y/Q917H reduced inward Ca2+ currents through a defect in the cell surface trafficking of Ca(V)2. Altogether, our results provide novel insight in the molecular mechanism underlying the modulation of Ca(V)1.2 currents by Ca(V)2.	[Bourdin, Benoite; Shakeri, Behzad; Tetreault, Marie-Philippe; Sauve, Remy; Parent, Lucie] Univ Montreal, Dept Physiol, Montreal Heart Inst, Res Ctr, Montreal, PQ H3C 3J7, Canada; [Lesage, Sylvie] Univ Montreal, Dept Microbiol Infectiol & Immunol, Ctr Rech, Hop Maisonneuve Rosemont, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Parent, L (corresponding author), Univ Montreal, Dept Physiol, Downtown Stn, POB 6128, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca		Lesage, Sylvie/0000-0002-0968-2795	Canadian Institutes of Health Research [130256]; Canadian Heart and Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported by Operating Grant 130256 from the Canadian Institutes of Health Research and a grant from the Canadian Heart and Stroke Foundation (to L. P.).	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; Arking DE, 2014, NAT GENET, V46, P826, DOI 10.1038/ng.3014; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bourdin B, 2010, J BIOL CHEM, V285, P22851, DOI 10.1074/jbc.M110.111062; Burashnikov E, 2010, HEART RHYTHM, V7, P1872, DOI 10.1016/j.hrthm.2010.08.026; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; CARL SL, 1995, J CELL BIOL, V129, P673, DOI 10.1083/jcb.129.3.673; Cassidy JS, 2014, P NATL ACAD SCI USA, V111, P8979, DOI 10.1073/pnas.1403731111; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cerrone M, 2012, CURR OPIN CARDIOL, V27, P242, DOI 10.1097/HCO.0b013e328352429d; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Depil K, 2011, J BIOL CHEM, V286, P31557, DOI 10.1074/jbc.M111.255273; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Fuller-Bicer GA, 2009, AM J PHYSIOL-HEART C, V297, pH117, DOI 10.1152/ajpheart.00122.2009; Gaborit N, 2005, CIRCULATION, V112, P471, DOI 10.1161/CIRCULATIONAHA.104.506857; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gillis J, 2012, AM J MED GENET A, V158A, P182, DOI 10.1002/ajmg.a.34355; Gyoerke S, 2007, J CLIN INVEST, V117, P1758, DOI 10.1172/JCI32496; Napolitano C, 2011, CIRC RES, V108, P607, DOI 10.1161/CIRCRESAHA.110.224279; Parent L, 1997, J MEMBRANE BIOL, V160, P127, DOI 10.1007/s002329900302; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Platano D, 2000, BIOPHYS J, V78, P2959, DOI 10.1016/S0006-3495(00)76835-4; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosati B, 2011, J PHYSIOL-LONDON, V589, P3275, DOI 10.1113/jphysiol.2011.210237; Rosati B, 2008, PHYSIOL GENOMICS, V35, P262, DOI 10.1152/physiolgenomics.00159.2007; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Shakeri B, 2012, J BIOL CHEM, V287, P32835, DOI 10.1074/jbc.M112.387233; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Sivagangabalan G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082179; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Templin C, 2011, EUR HEART J, V32, P1077, DOI 10.1093/eurheartj/ehr076; Tester David J, 2014, Methodist Debakey Cardiovasc J, V10, P29; Van Petegem F, 2008, STRUCTURE, V16, P280, DOI 10.1016/j.str.2007.11.010; Venetucci L, 2012, NAT REV CARDIOL, V9, P561, DOI 10.1038/nrcardio.2012.93; Wall-Lacelle S, 2011, J BIOL CHEM, V286, P27197, DOI 10.1074/jbc.M111.237412; Wilde AAM, 2010, HEART RHYTHM, V7, P1883, DOI 10.1016/j.hrthm.2010.10.008; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9	45	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2854	2869		10.1074/jbc.M114.597930	http://dx.doi.org/10.1074/jbc.M114.597930			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25527503	Green Published, hybrid			2022-12-26	WOS:000349310700026
J	Lee, SH; Johnson, D; Luong, R; Sun, ZJ				Lee, Suk Hyung; Johnson, Daniel; Luong, Richard; Sun, Zijie			Crosstalking between Androgen and PI3K/AKT Signaling Pathways in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; Androgen; Androgen Receptor; Mouse; Phosphatidylinositide 3-Kinase (PI 3-kinase); Prostate Cancer	TUMOR-SUPPRESSOR GENE; MOUSE PROSTATE; EARLY-ONSET; C-MET; PTEN; RECEPTOR; CASTRATION; EXPRESSION; DELETION; PTEN/MMAC1	Background: An interaction between androgen and PI3K/AKT pathways has been implicated in prostate cancer cells. Results: Conditional expression of AR transgene represses PI3K/Akt activation, and Pten loss results in reduced AR expression and transcriptional activity. Conclusion: Both androgen and PI3K/AKT pathways inversely regulate each other in prostate cancer cells. Significance: Interplay between androgen and PI3K/AKT pathways may directly contribute to prostate tumorigenesis. Both androgen action and PI3K medicated signaling pathways have been implicated in prostate tumorigenesis. Our androgen receptor (AR) conditional transgenic mice developed murine prostatic intraepithelial neoplasia (mPIN) and prostatic adenocarcinoma lesions recapitulating human prostate cancer development and progression. Role of transgenic AR contributing to malignancy was demonstrated by high degree of transgenic AR expression in atypical and tumor cells in mPIN as well as prostatic adenocarcinoma lesions of the transgenic mice, but not in adjacent normal tissue. Interestingly, reduced PI3K/Akt activation also appeared in these mouse atypical and tumor cells, suggesting an interaction between androgen and PI3K/AKT pathways. In this study, we further investigated this interaction. We showed that the androgen depletion or knockdown of AR expression results in elevated levels of active phosphorylated AKT in prostate cancer cells. Castration of conditional Pten knock-out mice showed increased Akt, phosphorylated Akt, and pS6 expression in the mouse prostate. Using a series of newly generated Ar reporter and Pten knock-out compound mice, we showed that Pten loss directly represses endogenous Ar expression in prostatic epithelial cells. Moreover, Pten loss and PI3K/Akt activation reduced Ar-mediated transcription in purified Pten-null cells. This study provides novel evidence demonstrating interplay between androgen and PI3K pathways, as well as introduces unique and relevant mouse models for further studies of PI3K and AR pathways in the context of prostate tumorigenesis.	[Lee, Suk Hyung; Johnson, Daniel; Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Luong, Richard] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Sun, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Urol, S287,Grant Bldg, Stanford, CA 94305 USA.	zsun@stanford.edu		Johnson, Daniel/0000-0003-4669-037X	National Cancer Institute [R01CA070297, R01CA151623, U01CA166894, R21CA190021]; NATIONAL CANCER INSTITUTE [R01CA070297, P30CA124435, R01CA151623, R21CA190021, U01CA166894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104941] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service Grants R01CA070297, R01CA151623, U01CA166894, and R21CA190021 from the National Cancer Institute.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cairns P, 1997, CANCER RES, V57, P4997; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Grieshammer U, 2008, GENESIS, V46, P69, DOI 10.1002/dvg.20366; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Johnson DT, 2013, J BIOL CHEM, V288, P3727, DOI 10.1074/jbc.M112.417568; Koivisto P, 1997, CANCER RES, V57, P314; Kwak MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053476; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; Lee J, 2007, NUCLEIC ACIDS RES, V35, P4523, DOI 10.1093/nar/gkm476; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; SANCHEZ ER, 1990, BIOCHEMISTRY-US, V29, P5145, DOI 10.1021/bi00473a021; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; SUGIMURA Y, 1986, BIOL REPROD, V34, P973, DOI 10.1095/biolreprod34.5.973; Sullivan W. P., 1992, J STEROID BIOCHEM, V43, P37; Suzuki H, 1998, CANCER RES, V58, P204; THALMANN GN, 1994, CANCER RES, V54, P2577; Tu WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-556; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Wang SI, 1998, CLIN CANCER RES, V4, P811; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Zhu CF, 2011, J BIOL CHEM, V286, P33478, DOI 10.1074/jbc.M111.269894	44	56	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2759	2768		10.1074/jbc.M114.607846	http://dx.doi.org/10.1074/jbc.M114.607846			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25527506	Green Published, hybrid			2022-12-26	WOS:000349310700018
J	Ohara, K; Fukuda, T; Okada, H; Kitao, S; Ishida, Y; Kato, K; Takahashi, C; Katayama, M; Uchida, K; Tominaga, M				Ohara, Kazuaki; Fukuda, Takafumi; Okada, Hiroyuki; Kitao, Sayoko; Ishida, Yuko; Kato, Kyoko; Takahashi, Chika; Katayama, Mikio; Uchida, Kunitoshi; Tominaga, Makoto			Identification of Significant Amino Acids in Multiple Transmembrane Domains of Human Transient Receptor Potential Ankyrin 1 (TRPA1) for Activation by Eudesmol, an Oxygenized Sesquiterpene in Hop Essential Oil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channel; Mutagenesis; Natural Product; Terpenoid; Transient Receptor Potential Channels (TRP Channels)	ODOR-ACTIVE COMPOUNDS; HUMULUS-LUPULUS L.; TYROSINE RESIDUES; COVALENT MODIFICATION; CHANNELS; SENSITIVITY; MENTHOL; BEER; DETERMINANTS; VARIETIES	Background: Transient receptor potential ankyrin 1 (TRPA1) is activated by many spicy compounds by unknown mechanisms. Results: The amino acids critical for the activation of TRPA1 by the hop-derived sesquiterpene -eudesmol were identified. Conclusion: Multiple transmembrane domains are crucial for -eudesmol-derived TRPA1 activation. Significance: New insight for activation mechanism of TRPA1 is revealed by our study. Transient receptor potential ankyrin 1 (TRPA1) is a calcium-permeable non-selective cation channel that is activated by various noxious or irritant substances in nature, including spicy compounds. Many TRPA1 chemical activators have been reported; however, only limited information is available regarding the amino acid residues that contribute to the activation by non-electrophilic activators, whereas activation mechanisms by electrophilic ligands have been well characterized. We used intracellular Ca2+ measurements and whole-cell patch clamp recordings to show that eudesmol, an oxygenated sesquiterpene present at high concentrations in the essential oil of hop cultivar Hallertau Hersbrucker, could activate human TRPA1. Gradual activation of inward currents with outward rectification by eudesmol was observed in human embryonic kidney-derived 293 cells expressing human TRPA1. This activation was completely blocked by a TRPA1-specific inhibitor, HC03-0031. We identified three critical amino acid residues in human TRPA1 in putative transmembrane domains 3, 4, and 5, namely threonine at 813, tyrosine at 840, and serine at 873, for activation by -eudesmol in a systematic mutational study. Our results revealed a new TRPA1 activator in hop essential oil and provide a novel insight into mechanisms of human TRPA1 activation by non-electrophilic chemicals.	[Ohara, Kazuaki; Fukuda, Takafumi; Okada, Hiroyuki; Kitao, Sayoko; Ishida, Yuko; Kato, Kyoko; Takahashi, Chika; Katayama, Mikio] Krin Co Ltd, Res Lab Hlth Sci & Food Technol, Yokohama, Kanagawa 2360004, Japan; [Uchida, Kunitoshi; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB)	Ohara, K (corresponding author), Krin Co Ltd, Res Lab Hlth Sci & Food Technol, Kanazawa Ku, 1-13-5 Fukuura, Yokohama, Kanagawa 2360004, Japan.	Kazuaki_Ohara@kirin.co.jp						Amin J, 1997, MOL PHARMACOL, V51, P833, DOI 10.1124/mol.51.5.833; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; des Gachons CP, 2011, J NEUROSCI, V31, P999, DOI 10.1523/JNEUROSCI.1374-10.2011; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Eyres GT, 2007, J AGR FOOD CHEM, V55, P6252, DOI 10.1021/jf070739t; Goiris K, 2002, J I BREWING, V108, P86, DOI 10.1002/j.2050-0416.2002.tb00129.x; Gros J, 2012, J AGR FOOD CHEM, V60, P7805, DOI 10.1021/jf301478m; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Kishimoto T, 2005, J AGR FOOD CHEM, V53, P4701, DOI 10.1021/jf050072f; Kishimoto T, 2006, J AGR FOOD CHEM, V54, P8855, DOI 10.1021/jf061342c; Komatsu T, 2012, PFLUG ARCH EUR J PHY, V463, P549, DOI 10.1007/s00424-011-1069-4; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Lummis SCR, 2012, ACS CHEM NEUROSCI, V3, P186, DOI 10.1021/cn200103n; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Nagatomo K, 2008, P NATL ACAD SCI USA, V105, P17373, DOI 10.1073/pnas.0809769105; Nagatomo K, 2010, BIOPHYS J, V99, P3609, DOI 10.1016/j.bpj.2010.10.014; Nilius B, 2013, REV PHYSIOL BIOCH P, V164, P1, DOI 10.1007/112_2013_11; Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717; Price KL, 2004, J BIOL CHEM, V279, P23294, DOI 10.1074/jbc.M314075200; Saito S, 2014, MOL BIOL EVOL, V31, P708, DOI 10.1093/molbev/msu001; Steinberg X, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00171; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Takaishi M, 2014, J PHYSIOL SCI, V64, P47, DOI 10.1007/s12576-013-0289-0; Takoi K, 2009, J AGR FOOD CHEM, V57, P2493, DOI 10.1021/jf8034622; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692	32	23	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3161	3171		10.1074/jbc.M114.600932	http://dx.doi.org/10.1074/jbc.M114.600932			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25525269	Green Published, hybrid			2022-12-26	WOS:000349310700050
J	Laiho, A; Elo, LL				Laiho, Asta; Elo, Laura L.			A Note on an Exon-Based Strategy to Identify Differentially Expressed Genes in RNA-Seq Experiments	PLOS ONE			English	Article							STATISTICAL-METHODS; REPRODUCIBILITY; ANNOTATION	RNA-sequencing (RNA-seq) has rapidly become the method of choice in many genome-wide transcriptomic studies. To meet the high expectations posed by this technology, powerful computational techniques are needed to translate the measurements into biological and biomedical understanding. A number of statistical procedures have already been developed to identify differentially expressed genes between distinct sample groups. With these methods statistical testing is typically performed after the data has been summarized at the gene level. As an alternative strategy, developed with the aim to improve the results, we demonstrate a method in which statistical testing at the exon level is performed prior to the summary of the results at the gene level. Using publicly available RNA-seq datasets as case studies, we illustrate how this exon-based strategy can improve the performance of the widely used differential expression software packages as compared to the conventional gene-based strategy. In particular, we show how it enables robust detection of moderate but systematic changes that are missed when relying on single gene-level summary counts only.	[Laiho, Asta; Elo, Laura L.] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Laiho, Asta; Elo, Laura L.] Abo Akad Univ, Turku, Finland; [Elo, Laura L.] Univ Turku, Dept Math & Stat, Turku, Finland	University of Turku; Abo Akademi University; University of Turku	Laiho, A (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.	asta.laiho@btk.fi; laliel@utu.fi	Elo, Laura/A-9449-2015	Elo, Laura/0000-0001-5648-4532	Academy of Finland [127575]; JDRF [2-2013-32]	Academy of Finland(Academy of Finland); JDRF(Juvenile Diabetes Research Foundation)	This work was supported by the Academy of Finland, http://www.aka.fi, grant number 127575 to L.L.E.; and JDRF, http://jdrf.org, grant number 2-2013-32 to L.L.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS S, 2010, GENOME BIOL, V11; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Eksi R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003314; Elo LL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni193; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; Kvam VM, 2012, AM J BOT, V99, P248, DOI 10.3732/ajb.1100340; Laajala E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r77; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lemon WJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r67; Li HD, 2014, PROTEOMICS; Li J, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/527610; Liu XJ, 2006, BIOINFORMATICS, V22, P2107, DOI 10.1093/bioinformatics/btl361; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Seyednasrollah F, 2013, BRIEF BIOINFORM; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450	34	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115964	10.1371/journal.pone.0115964	http://dx.doi.org/10.1371/journal.pone.0115964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541961	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900119
J	Peng, QL; Yang, S; Lao, XJ; Li, RL; Chen, ZP; Wang, J; Qin, X; Li, S				Peng, Qiliu; Yang, Shi; Lao, Xianjun; Li, Ruolin; Chen, Zhiping; Wang, Jian; Qin, Xue; Li, Shan			Association of Single Nucleotide Polymorphisms in VDR and DBP Genes with HBV-Related Hepatocellular Carcinoma Risk in a Chinese Population	PLOS ONE			English	Article							D-BINDING PROTEIN; D-RECEPTOR VDR; BONE-MINERAL DENSITY; BREAST-CANCER RISK; VITAMIN-D; COLORECTAL-CANCER; PROSTATE-CANCER; FOKI; SUSCEPTIBILITY; VARIANTS	Background: Polymorphisms of genes encoding components of the vitamin D pathway including vitamin D receptor (VDR) and vitamin D binding protein (DBP) have been widely investigated because of the complex role played by vitamin D in cancer tumorogenesis. In this study, we investigated the association between VDR and DBP gene polymorphisms and HBV-related HCC risk in a Chinese population. Methods: Study subjects were divided into three groups: 184 HBV patients with HCC, 296 HBV patients without HCC, and 180 healthy controls. The VDR rs2228570, and rs3782905 and the DBP rs7041 polymorphisms were genotyped using PCR-RFLP and the VDR rs11568820 polymorphism was genotyped by PCR-SSP, respectively. DNA sequencing was performed to validate the genotype results. Results: We found that there were significant differences in the genotype and allele frequencies of the VDR rs2228570 and DBP rs7041 polymorphisms between HBV patients with HCC and healthy controls. The rs2228570 T allele was associated with a significant increased HBV-related HCC risk as compared with the C allele. The rs2228570 TT and TT/TC genotypes were correlated with a significant increased HBV-related HCC risk when compared with the wild-type CC homozygote. Similarly, the rs7041 G allele was associated with a significant increased HBV-related HCC risk as compared with the T allele. The rs7041 GG and GG/TG genotypes were correlated with a significant increased HBV-related HCC risk when compared with the wild-type TT homozygote. However, we did not observe any significant effect of VDR rs11568820, and rs3782905 polymorphisms on HBV-related HCC risk in this population. In haplotype analysis, we also did not find any significant differences in haplotype frequencies of the VDR gene between HBV patients with HCC and the healthy controls. Conclusions: We conclude that the VDR rs2228570 and DBP rs7041 polymorphisms may contribute to increased susceptibility to HBV-related HCC in the Chinese population. Due to the marginal significance, further large and well-designed studies in diverse ethnic populations are needed to confirm our results.	[Peng, Qiliu; Yang, Shi; Lao, Xianjun; Wang, Jian; Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Li, Ruolin] Guangxi Med Univ, Affiliated Hosp 1, Dept Med Res, Nanning, Guangxi, Peoples R China; [Chen, Zhiping] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Qin, X (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	qinxue919@126.com; lis8858@126.com			National Natural Science Foundation of China [81260302]; Guangxi education and innovation projects for graduate student [YCBZ2014031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi education and innovation projects for graduate student	The study was supported by the National Natural Science Foundation of China (No. 81260302) and the Guangxi education and innovation projects for graduate student in 2014 (No. YCBZ2014031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LN, 2011, CANCER EPIDEM BIOMAR, V20, P1708, DOI 10.1158/1055-9965.EPI-11-0300; Anic GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102966; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Bai YH, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-125; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Beilfuss A, 2014, GUT; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Chen YZ, 2013, J IMMUNOL, V190, P3687, DOI 10.4049/jimmunol.1203273; Chishimba L, 2010, THORAX, V65, P456, DOI 10.1136/thx.2009.128793; Dalessandri KM, 2012, J AM COLL SURGEONS, V215, P652, DOI 10.1016/j.jamcollsurg.2012.06.413; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fu BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061423; Gu HY, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0827-x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaabachi W, 2014, MOL BIOL REP; Kaabachi W, 2014, MOL BIOL REP, V41, P6545, DOI 10.1007/s11033-014-3538-2; Kidd LCR, 2005, PROSTATE, V64, P272, DOI 10.1002/pros.20204; Kuper H, 2000, INT J CANCER, V85, P498, DOI 10.1002/(SICI)1097-0215(20000215)85:4&lt;498::AID-IJC9&gt;3.0.CO;2-F; Mohapatra S, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-37; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Pibiri F, 2014, CANCER CAUSE CONTROL, V25, P561, DOI 10.1007/s10552-014-0361-y; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Poynter JN, 2010, CANCER EPIDEM BIOMAR, V19, P525, DOI 10.1158/1055-9965.EPI-09-0662; Rasool Sabha, 2014, Oncol Res Treat, V37, P345, DOI 10.1159/000362859; Sarkissyan M, 2014, CANCER-AM CANCER SOC, V120, P1387, DOI 10.1002/cncr.28565; Seng KC, 2008, EUR J HUM GENET, V16, P554, DOI 10.1038/ejhg.2008.12; Shafia S, 2013, BLOOD CELL MOL DIS, V51, P56, DOI 10.1016/j.bcmd.2013.02.001; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shui IM, 2012, JNCI-J NATL CANCER I, V104, P690, DOI 10.1093/jnci/djs189; Sinotte M, 2009, AM J CLIN NUTR, V89, P634, DOI 10.3945/ajcn.2008.26445; Slattery ML, 2007, NUTR REV, V65, pS102, DOI 10.1111/j.1753-4887.2007.tb00332.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; WALTERS MR, 1992, ENDOCR REV, V13, P719, DOI 10.1210/er.13.4.719; Wang W, 2014, INT J MOL EPIDEMIOL, V5, P31; Zhao XZ, 2014, ARCH DERMATOL RES, V306, P545, DOI 10.1007/s00403-014-1464-8; Zhou HY, 2009, CLIN ENDOCRINOL, V70, P938, DOI 10.1111/j.1365-2265.2008.03413.x; Zhou LQ, 2012, INT J CLIN EXP MED, V5, P72	39	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116026	10.1371/journal.pone.0116026	http://dx.doi.org/10.1371/journal.pone.0116026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541958	gold, Green Submitted, Green Published			2022-12-26	WOS:000347239900131
J	Perez-Trallero, E; Esnal, O; Marimon, JM				Perez-Trallero, Emilio; Esnal, Olatz; Marimon, Jose M.			Progressive Decrease in the Potential Usefulness of Meningococcal Serogroup B Vaccine (4CMenB, Bexsero (R)) in Gipuzkoa, Northern Spain	PLOS ONE			English	Article							MULTICOMPONENT VACCINE; STRAIN COVERAGE; DIVERSITY; IDENTIFICATION; CANDIDATE; ANTIGENS; PROTEIN; PORA; NADA	The effectiveness of a vaccine is determined not only by the immunogenicity of its components, but especially by how widely it covers the disease-causing strains circulating in a given region. Because vaccine coverage varies over time, this study aimed to detect possible changes that could affect vaccine protection during a specific period in a southern European region. The 4CMenB vaccine is licensed for use in Europe, Canada, and Australia and is mainly directed against Neisseria meningitidis serogroup B. This vaccine contains four main immunogenic components: three recombinant proteins, FHbp, Nhba and NadA, and an outer membrane vesicle [PorA P1.4]. The allelic distribution of FHbp, Nhba, NadA, and PorA antigens in 82 invasive isolates (B and non-B serogroups) isolated from January 2008 to December 2013 were analyzed. 4CMenB was likely protective against 61.8% and 50% of serogroup B and non-B meningococci, respectively, in the entire period, but between 2012 and 2013, the predicted protection fell below 45% (42.1% for serogroup B isolates). The observed decreasing trend in the predicted protection during the 6 years of the study (X-2 for trend = 4.68, p=0.03) coincided with a progressive decrease of several clonal complexes (e. g., cc11, cc32 and cc41/44), which had one or more antigens against which the vaccine would offer protection.	[Perez-Trallero, Emilio; Marimon, Jose M.] Hosp Donostia IIS Biodonostia, Microbiol Serv, San Sebastian, Spain; [Perez-Trallero, Emilio; Marimon, Jose M.] Hosp Donostia IIS Biodonostia, Reference Lab Meningococcal Infect Basque Country, San Sebastian, Spain; [Perez-Trallero, Emilio; Esnal, Olatz; Marimon, Jose M.] Biomed Res Ctr Network Resp Dis CIBERES, San Sebastian, Spain; [Perez-Trallero, Emilio] Univ Basque Country UPV EHU, Fac Med, San Sebastian, Spain	University Hospital Donostia; University Hospital Donostia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBERESP; University of Basque Country	Perez-Trallero, E (corresponding author), Hosp Donostia IIS Biodonostia, Microbiol Serv, San Sebastian, Spain.	mikrobiol@terra.com	MARIMON, JOSE MARIA/AAM-5581-2021	MARIMON, JOSE MARIA/0000-0002-2787-7094	Education Department of the Basque Country Government to the UPV/EHU [IT656-13]	Education Department of the Basque Country Government to the UPV/EHU	This work was supported by a grant from the Education Department of the Basque Country Government to the UPV/EHU (IT656-13). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, Prescrire Int, V23, P201; [Anonymous], CLON COMPL ASS SER B; [Anonymous], NEISS PORA VAR REGIO; Bambini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065043; Bettinger JA, 2013, VACCINE, V32, P124, DOI 10.1016/j.vaccine.2013.03.063; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Galloway Y, 2009, INT J EPIDEMIOL, V38, P413, DOI 10.1093/ije/dyn228; Giuliani MM, 2010, VACCINE, V28, P5023, DOI 10.1016/j.vaccine.2010.05.014; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Holst J, 2014, VACCINE, V32, P2722, DOI 10.1016/j.vaccine.2014.02.068; Hong E, 2013, VACCINE, V31, P1113, DOI 10.1016/j.vaccine.2012.12.022; Jacobsson S, 2006, VACCINE, V24, P2161, DOI 10.1016/j.vaccine.2005.11.006; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; Lucidarme J, 2009, J CLIN MICROBIOL, V47, P3577, DOI 10.1128/JCM.00936-09; McNeil LK, 2013, MICROBIOL MOL BIOL R, V77, P234, DOI 10.1128/MMBR.00056-12; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Rodriguez AP, 1999, MEM I OSWALDO CRUZ, V94, P433, DOI 10.1590/S0074-02761999000400002; Sacchi CT, 1998, CLIN DIAGN LAB IMMUN, V5, P845, DOI 10.1128/CDLI.5.6.845-855.1998; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Tzanakaki G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-111; Vicente D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008501; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9	25	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e0116024	10.1371/journal.pone.0116024	http://dx.doi.org/10.1371/journal.pone.0116024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541709	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900130
J	Kipreos, ET				Kipreos, Edward T.			Implications of an Absolute Simultaneity Theory for Cosmology and Universe Acceleration	PLOS ONE			English	Article							RELATIVISTIC TIME GAINS; WORLD ATOMIC CLOCKS; LORENTZ INVARIANCE; EARTHS ROTATION; HYDROGEN-MASER; IA SUPERNOVAE; ONE-WAY; LIGHT; SPEED; VELOCITY	An alternate Lorentz transformation, Absolute Lorentz Transformation (ALT), has similar kinematics to special relativity yet maintains absolute simultaneity in the context of a preferred reference frame. In this study, it is shown that ALT is compatible with current experiments to test Lorentz invariance only if the proposed preferred reference frame is locally equivalent to the Earth-centered non-rotating inertial reference frame, with the inference that in an ALT framework, preferred reference frames are associated with centers of gravitational mass. Applying this theoretical framework to cosmological data produces a scenario of universal time contraction in the past. In this scenario, past time contraction would be associated with increased levels of blueshifted light emissions from cosmological objects when viewed from our current perspective. The observation that distant Type Ia supernovae are dimmer than predicted by linear Hubble expansion currently provides the most direct evidence for an accelerating universe. Adjusting for the effects of time contraction on a redshift-distance modulus diagram produces a linear distribution of supernovae over the full redshift spectrum that is consistent with a non-accelerating universe.	Univ Georgia, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Kipreos, ET (corresponding author), Univ Georgia, Athens, GA 30602 USA.	ekipreos@uga.edu						Ahmed MF, 2012, INDIAN J PHYS, V86, P835, DOI 10.1007/s12648-012-0112-4; Alley C, 1983, QUANTUM OPTICS EXPT, V94, P363; Amanullah R, 2010, ASTROPHYS J, V716, P712, DOI 10.1088/0004-637X/716/1/712; ANDERSON R, 1994, AM J PHYS, V62, P975, DOI 10.1119/1.17656; Ashby Neil, 2003, Living Rev Relativ, V6, P1, DOI 10.12942/lrr-2003-1; BAILEY J, 1977, NATURE, V268, P301, DOI 10.1038/268301a0; Bocquet JP, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.241601; Bunn EF, 2009, AM J PHYS, V77, P688, DOI 10.1119/1.3129103; CHAMPENEY DC, 1963, PHYS LETT, V7, P241, DOI 10.1016/0031-9163(63)90312-3; Chodorowski MJ, 2011, MON NOT R ASTRON SOC, V413, P585, DOI 10.1111/j.1365-2966.2010.18154.x; Chodorowski MJ, 2007, CONCEPTS PHYS, V4, P17; Davis TM, 2004, PUBL ASTRON SOC AUST, V21, P97, DOI 10.1071/AS03040; Eagle A, 1938, PHILOS MAG, V26, P410; Einstein A, 1905, ANN PHYS-BERLIN, V17, P891; Freedman WL, 2010, ANNU REV ASTRON ASTR, V48, P673, DOI 10.1146/annurev-astro-082708-101829; Frieman JA, 2008, ANNU REV ASTRON ASTR, V46, P385, DOI 10.1146/annurev.astro.46.060407.145243; FRISCH DH, 1963, AM J PHYS, V31, P342, DOI 10.1119/1.1969508; Goldhaber G, 1997, NATO ADV SCI I C-MAT, V486, P777; Gurzadyan VG, 2007, NUOVO CIMENTO B, V122, P515, DOI [10.1393/ncb/i2007-10393-7, 10.1393/neb/i2007-10393-7]; Gurzadyan VC, 2005, MOD PHYS LETT A, V20, P19, DOI 10.1142/S0217732305016294; HAFELE JC, 1972, SCIENCE, V177, P168, DOI 10.1126/science.177.4044.168; HAFELE JC, 1972, SCIENCE, V177, P166, DOI 10.1126/science.177.4044.166; Hubble E, 1929, P NATL ACAD SCI USA, V15, P168, DOI 10.1073/pnas.15.3.168; Janssen M, 2002, PHYS PERSPECT, V4, P421, DOI 10.1007/s000160200003; Katzir S, 2005, PHYS PERSPECT, V7, P268, DOI 10.1007/s00016-004-0234-y; Kowalski M, 2008, ASTROPHYS J, V686, P749, DOI 10.1086/589937; KRISHER TP, 1990, PHYS REV D, V42, P731, DOI 10.1103/PhysRevD.42.731; Larmor J., 1900, AETHER AND MATTER; Leibundgut B, 1996, ASTROPHYS J, V466, pL21, DOI 10.1086/310164; Lorentz H. A., 1895, VERSUCH THEORIE ELEK, P89; MANSOURI R, 1977, GEN RELAT GRAVIT, V8, P497, DOI 10.1007/BF00762634; MANSOURI R, 1977, GEN RELAT GRAVIT, V8, P809, DOI 10.1007/BF00759585; MANSOURI R, 1977, GEN RELAT GRAVIT, V8, P515, DOI 10.1007/BF00762635; Mattingly D, 2005, LIVING REV RELATIV, V8, DOI 10.12942/lrr-2005-5; Melia F, 2012, MON NOT R ASTRON SOC, V422, P1418, DOI 10.1111/j.1365-2966.2012.20714.x; Metromnia, 2005, DEM REL FLYING AT CL; Michelson AA, 1925, ASTROPHYS J, V61, P137, DOI 10.1086/142878; Michelson AA, 1925, ASTROPHYS J, V61, P140, DOI 10.1086/142879; MURDOCH HS, 1977, Q J ROY ASTRON SOC, V18, P242; Narlikar JV, 2001, ANNU REV ASTRON ASTR, V39, P211, DOI 10.1146/annurev.astro.39.1.211; National Physical Laboratory, 2011, NPL NEWS; Nussbaumer H, 2009, DISCOVERING THE EXPANDING UNIVERSE, P1; Pascual-Sanchez JF, 2007, ANN PHYS-BERLIN, V16, P258, DOI 10.1002/andp.200610229; Peebles PJE, 2012, ANNU REV ASTRON ASTR, V50, P1, DOI 10.1146/annurev-astro-081811-125526; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Pospelov M, 2004, PHYS TODAY, V57, P40, DOI 10.1063/1.1784301; POST EJ, 1967, REV MOD PHYS, V39, P475, DOI 10.1103/RevModPhys.39.475; Preikschat E, 1968, THESIS U BIRMINGHAM; Puccini GD, 2002, NUOVO CIMENTO B, V117, P283; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; RIIS E, 1988, PHYS REV LETT, V60, P81, DOI 10.1103/PhysRevLett.60.81; Rindler W., 1977, ESSENTIAL RELATIVITY; Ryden B, 2003, INTRO COSMOLOGY; Sereno M, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.064031; Smoot GF, 2007, REV MOD PHYS, V79, P1349, DOI 10.1103/RevModPhys.79.1349; Tangherlini, 1961, SUPPL NUOVO CIMENTO, V20, P1; Tangherlini F. R., 1958, THESIS STANFORD U; Tangherlini F.R, 2014, J MOD PHYS, V5, P230; TURNER KC, 1964, PHYS REV B, V134, pB252, DOI 10.1103/PhysRev.134.B252; VESSOT RFC, 1980, PHYS REV LETT, V45, P2081, DOI 10.1103/PhysRevLett.45.2081; VESSOT RFC, 1979, GEN RELAT GRAVIT, V10, P181, DOI 10.1007/BF00759854; Weinberg S., 2008, COSMOLOGY; Whittaker E., 1910, HIST THEORIES AETHER	63	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115550	10.1371/journal.pone.0115550	http://dx.doi.org/10.1371/journal.pone.0115550			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536116	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300047
J	Maro, JC; Fryback, DG; Lieu, TA; Lee, GM; Martin, DB				Maro, Judith C.; Fryback, Dennis G.; Lieu, Tracy A.; Lee, Grace M.; Martin, David B.			Responding to Vaccine Safety Signals during Pandemic Influenza: A Modeling Study	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; SWINE-FLU; IMMUNIZATION-PROGRAM; SCHOOL CLOSURE; ADVERSE EVENTS; UNITED-STATES; H1N1; SURVEILLANCE; SIMULATION; MITIGATION	Background: Managing emerging vaccine safety signals during an influenza pandemic is challenging. Federal regulators must balance vaccine risks against benefits while maintaining public confidence in the public health system. Methods: We developed a multi-criteria decision analysis model to explore regulatory decision-making in the context of emerging vaccine safety signals during a pandemic. We simulated vaccine safety surveillance system capabilities and used an age-structured compartmental model to develop potential pandemic scenarios. We used an expert-derived multi-attribute utility function to evaluate potential regulatory responses by combining four outcome measures into a single measure of interest: 1) expected vaccination benefit from averted influenza; 2) expected vaccination risk from vaccine-associated febrile seizures; 3) expected vaccination risk from vaccine-associated Guillain-Barre Syndrome; and 4) expected change in vaccine-seeking behavior in future influenza seasons. Results: Over multiple scenarios, risk communication, with or without suspension of vaccination of high-risk persons, were the consistently preferred regulatory responses over no action or general suspension when safety signals were detected during a pandemic influenza. On average, the expert panel valued near-term vaccine-related outcomes relative to long-term projected outcomes by 3:1. However, when decision-makers had minimal ability to influence near-term outcomes, the response was selected primarily by projected impacts on future vaccine-seeking behavior. Conclusions: The selected regulatory response depends on how quickly a vaccine safety signal is identified relative to the peak of the pandemic and the initiation of vaccination. Our analysis suggested two areas for future investment: efforts to improve the size and timeliness of the surveillance system and behavioral research to understand changes in vaccine-seeking behavior.	[Maro, Judith C.; Lee, Grace M.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02138 USA; [Maro, Judith C.; Lee, Grace M.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Fryback, Dennis G.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA; [Lieu, Tracy A.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Martin, David B.] Food & Drug Adm, Ctr Biol Evaluat & Res, Silver Spring, MD USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Wisconsin System; University of Wisconsin Madison; Kaiser Permanente	Maro, JC (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02138 USA.	jmaro@mit.edu		Maro, Judith/0000-0001-9900-2142	Mini-Sentinel Contract; U.S. Food and Drug Administration (USFDA) through the Department of Health and Human Services [HHSF223200910006I]	Mini-Sentinel Contract; U.S. Food and Drug Administration (USFDA) through the Department of Health and Human Services	This project is supported by the Mini-Sentinel Contract, which is funded by the U.S. Food and Drug Administration (USFDA) through the Department of Health and Human Services Contract Number HHSF223200910006I. The funders had no role in data collection and analysis. The USFDA reviewed and approved this report before submission.	Armstrong PK, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000016; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Blyth CC, 2014, VACCINE, V32, P4075, DOI 10.1016/j.vaccine.2014.05.055; Bohmer MM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-938; Brown ST, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-353; Bults M, 2011, VACCINE, V29, P6226, DOI 10.1016/j.vaccine.2011.06.075; Chao DL, 2011, AM J EPIDEMIOL, V173, P1121, DOI 10.1093/aje/kwq497; Conway JM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-932; Cooley P, 2011, J URBAN HEALTH, V88, P982, DOI 10.1007/s11524-011-9603-4; Davey VJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002606; Dodd CN, 2013, VACCINE, V31, P4448, DOI 10.1016/j.vaccine.2013.06.032; European Medicines Agency, 2010, BENEFIT RISK METHODO; FIELDING JE, 1978, AM J LAW MED, V4, P35; Gaydos JC, 2006, EMERG INFECT DIS, V12, P23, DOI 10.3201/eid1201.050965; Geroski PA, 2000, RES POLICY, V29, P603, DOI 10.1016/S0048-7333(99)00092-X; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hilleman MR, 1996, JAMA-J AM MED ASSOC, V275, P241, DOI 10.1001/jama.275.3.241; Horney JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011226; Iskander J, 2013, EMERG INFECT DIS, V19, P879, DOI 10.3201/eid1906.121478; Keeney R. L., 1976, DECISIONS WITH MULTI; Keeney RL, 2011, J RISK UNCERTAINTY, V43, P1, DOI 10.1007/s11166-011-9121-5; Keeney RL, 2013, FOUNDATIONS FOR GROU; Kenah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019515; Knipl DH, 2011, MATH BIOSCI ENG, V8, P123, DOI 10.3934/mbe.2011.8.123; Knobler SL, 2005, THE THREAT OF PANDEM; Krause R, 2006, EMERG INFECT DIS, V12, P40, DOI 10.3201/eid1201.051132; Lee BY, 2011, HUM VACCINES, V7, P115, DOI 10.4161/hv.7.1.13740; Lee BY, 2010, VACCINE, V28, P4875, DOI 10.1016/j.vaccine.2010.05.002; Lee GM, 2011, AM J PREV MED, V41, P121, DOI 10.1016/j.amepre.2011.04.004; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Maro JC, 2013, EPIDEMIOLOGY, V24, P692, DOI 10.1097/EDE.0b013e31829dde59; Matrajt L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002964; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Nguyen M, 2012, PHARMACOEPIDEM DR S, V21, P291, DOI 10.1002/pds.2323; National Research Council, 1978, THE SWINE FLU AFFAIR; Peres R, 2010, INT J RES MARK, V27, P91, DOI 10.1016/j.ijresmar.2009.12.012; Petousis-Harris H, 2012, VACCINE, V30, P4945, DOI 10.1016/j.vaccine.2012.05.052; Poland GA, 2010, VACCINE, V28, pD3, DOI 10.1016/j.vaccine.2010.08.024; Potter MA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-977; Salmon DA, 2013, LANCET, V381, P1461, DOI 10.1016/S0140-6736(12)62189-8; Salmon DA, 2011, PEDIATRICS, V127, pS78, DOI 10.1542/peds.2010-1722L; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Sencer DJ, 2011, CLIN INFECT DIS, V52, pS4, DOI 10.1093/cid/ciq006; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Stoto MA, 2002, PUBLIC HEALTH REP, V117, P546, DOI 10.1016/S0033-3549(04)50199-1; Tse A, 2012, VACCINE, V30, P2024, DOI 10.1016/j.vaccine.2012.01.027; Wagner M, 2011, ONLINE J PUBLIC HEAL, V3, DOI [10.5210/ojphi.v3i3.3798, DOI 10.5210/OJPHI.V3I3.3798]; WECHT CH, 1978, AM J LAW MED, V3, P425; WHO, 2009, PANDEMIC INFLUENZA P; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yih WK, 2012, AM J EPIDEMIOL, V175, P1120, DOI 10.1093/aje/kws197; Yih WK, 2013, ACCESSING THE FRESHE	56	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115553	10.1371/journal.pone.0115553	http://dx.doi.org/10.1371/journal.pone.0115553			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25536228	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300048
J	Vonck, S; Staelens, AS; Mesens, T; Tomsin, K; Gyselaers, W				Vonck, Sharona; Staelens, Anneleen Simone; Mesens, Tinne; Tomsin, Kathleen; Gyselaers, Wilfried			Hepatic Hemodynamics and Fetal Growth: A Relationship of Interest for Further Research	PLOS ONE			English	Article							MATERNAL CARDIAC-FUNCTION; IMPEDANCE CARDIOGRAPHY; VENOUS HEMODYNAMICS; NORMAL-PREGNANCY; PREECLAMPSIA; OUTPUT; RELIABILITY; LIMITATIONS; HEART	Background: It is well known that hepatic hemodynamics is an important physiologic mechanism in the regulation of cardiac output (CO). It has been reported that maternal cardiac output relates to neonatal weight at birth. Aims: In this study, we assessed the correlation between maternal hepatic vein Doppler flow parameters, cardiac output and neonatal birth weight. Methods: Healthy women with uncomplicated second or third trimester pregnancy attending the outpatient antenatal clinic of Ziekenhuis Oost-Limburg in Genk (Belgium), had a standardized combined electrocardiogram-Doppler ultrasound with Impedance Cardiography, for measurement of Hepatic Vein Impedance Index (HVI = [maximum velocity - minimum velocity]/maximum velocity), venous pulse transit time (VPTT = time interval between corresponding ECG and Doppler wave characteristics) and cardiac output (heart rate x stroke volume). After delivery, a population-specific birth weight chart, established from a cohort of 27000 neonates born in the index hospital, was used to define customized birth weight percentiles (BW%). Correlations between HVI, VPTT, CO and BW% were calculated using Spearman's rho, linear regression analysis and R-2 goodness of fit in SPSS 22.0. Results: A total of 73 women were included. There was a negative correlation between HVI and VPTT (rho = -0.719, p<0.001). Both HVI and VPTT correlated with CO (rho = -0.403, p<0.001 and rho=0.332, p<0.004 resp.) and with BW% (rho=-0.341, p<0.003 and rho=0.296, p<0.011 resp.) Conclusion: Our data illustrate that the known contribution of hepatic hemodynamics in the regulation of cardiac output is also true for women with uncomplicated pregnancies. Our study is the first to illustrate a potential link between maternal hepatic hemodynamics and neonatal birth weight. Whether this link is purely associative or whether hepatic vascular physiology has a direct impact on fetal growth is to be evaluated in more extensive clinical and experimental research.	[Vonck, Sharona; Staelens, Anneleen Simone; Gyselaers, Wilfried] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium; [Vonck, Sharona; Staelens, Anneleen Simone; Mesens, Tinne; Tomsin, Kathleen; Gyselaers, Wilfried] Ziekenhuis Oost Limburg, Dept Obstet Gynaecol, Genk, Belgium; [Gyselaers, Wilfried] Hasselt Univ, Dept Physiol, Hasselt, Belgium	Hasselt University; East Limburg Hospital; Hasselt University	Vonck, S (corresponding author), Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium.	sharona.vonck@zol.be	Vonck, Sharona/AAM-9019-2021		Agency for Innovation by Science and Technology (IWT) in Brussels, Belgium; Limburg Clinical Research Project (LCRP) at Hasselt University, Belgium	Agency for Innovation by Science and Technology (IWT) in Brussels, Belgium; Limburg Clinical Research Project (LCRP) at Hasselt University, Belgium	This research is funded by a Ph.D. grant from the Agency for Innovation by Science and Technology (IWT) in Brussels, Belgium and part of the Limburg Clinical Research Project (LCRP) at Hasselt University, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamfo JEAK, 2007, ULTRASOUND OBST GYN, V29, P51, DOI 10.1002/uog.3901; Boron W, 2005, MED PHYSL, P448; Bosio PM, 1999, OBSTET GYNECOL, V94, P978, DOI 10.1016/S0029-7844(99)00430-5; CLARK SL, 1994, OBSTET GYNECOL, V83, P669; Desai DK, 2004, OBSTET GYNECOL, V104, P20, DOI 10.1097/01.AOG.0000128170.15161.1d; DUVEKOT JJ, 1995, ACTA OBSTET GYN SCAN, V74, P693, DOI 10.3109/00016349509021176; DUVEKOT JJ, 1993, AM J OBSTET GYNECOL, V169, P1382, DOI 10.1016/0002-9378(93)90405-8; Gelman S, 2008, ANESTHESIOLOGY, V108, P735, DOI 10.1097/ALN.0b013e3181672607; Gelson E, 2011, OBSTET GYNECOL, V117, P886, DOI 10.1097/AOG.0b013e31820cab69; GUYTON AC, 1968, ANESTHESIOLOGY, V29, P314, DOI 10.1097/00000542-196803000-00016; GUYTON AC, 1959, AM J PHYSIOL, V196, P1008, DOI 10.1152/ajplegacy.1959.196.5.1008; Gyselaers W, 2011, ULTRASOUND OBST GYN, V38, P123, DOI 10.1002/uog.9061; Gyselaers W., 2014, ULTRASOUND OBSTET GY; Gyselaers W, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-212; Klabunde R., 2011, CARDIOVASCULAR PHYSL, P60; Laut W, 2009, CAPACITANCE HEPATIC; LAUTT WW, 1976, AM J PHYSIOL, V231, P292, DOI 10.1152/ajplegacy.1976.231.2.292; Matsunaga T, 1984, Nihon Sanka Fujinka Gakkai Zasshi, V36, P795; Moertl MG, 2012, PHYSIOL MEAS, V33, P1015, DOI 10.1088/0967-3334/33/6/1015; Oben J, 2014, J MATERN FETAL NEONA; Staelens A, 2013, EXPERT REV MED DEVIC, V10, P765, DOI 10.1586/17434440.2013.853466; Staelens ASE, 2014, ULTRASOUND MED BIOL, V40, P1722, DOI 10.1016/j.ultrasmedbio.2014.01.014; Tomsin K, 2013, FACTS VIEWS VIS OBGY, V5, P116; Tomsin K, 2012, Ultraschall Med, V33, pE119, DOI 10.1055/s-0029-1245698; Tomsin K, 2012, J OBSTET GYNAECOL, V32, P630, DOI 10.3109/01443615.2012.673036; Tomsin K, 2013, EUR J OBSTET GYN R B, V169, P218, DOI 10.1016/j.ejogrb.2013.03.016; Tomsin K, 2013, CLIN EXP PHARMACOL P, V40, P438, DOI 10.1111/1440-1681.12105; Tomsin K, 2012, REPROD SCI, V19, P431, DOI 10.1177/1933719111424440; Tomsin K, 2011, CLIN PHYSIOL FUNCT I, V31, P145, DOI 10.1111/j.1475-097X.2010.00993.x; Turan OM, 2008, ULTRASOUND OBST GYN, V32, P849, DOI 10.1002/uog.5354; Valensise H, 2003, ACTA DIABETOL, V40, pS216, DOI 10.1007/s00592-003-0070-6; Vasapollo B, 2004, ULTRASOUND OBST GYN, V24, P23, DOI 10.1002/uog.1095	32	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115594	10.1371/journal.pone.0115594	http://dx.doi.org/10.1371/journal.pone.0115594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536071	Green Published, Green Submitted, gold			2022-12-26	WOS:000348563300053
J	Bailey, KM; Cornnell, HH; Ibrahim-Hashim, A; Wojtkowiak, JW; Hart, CP; Zhang, XM; Leos, R; Martinez, GV; Baker, AF; Gillies, RJ				Bailey, Kate M.; Cornnell, Heather H.; Ibrahim-Hashim, Arig; Wojtkowiak, Jonathan W.; Hart, Charles P.; Zhang, Xiaomeng; Leos, Rafael; Martinez, Gary V.; Baker, Amanda F.; Gillies, Robert J.			Evaluation of the "Steal" Phenomenon on the Efficacy of Hypoxia Activated Prodrug TH-302 in Pancreatic Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR OXYGENATION; IN-VIVO; TIRAPAZAMINE; METABOLISM; CISPLATIN; HYDRALAZINE; METASTASES; RADIATION; DEFECTS	Pancreatic ductal adenocarcinomas are desmoplastic and hypoxic, both of which are associated with poor prognosis. Hypoxia-activated prodrugs (HAPs) are specifically activated in hypoxic environments to release cytotoxic or cytostatic effectors. TH-302 is a HAP that is currently being evaluated in a Phase III clinical trial in pancreatic cancer. Using animal models, we show that tumor hypoxia can be exacerbated using a vasodilator, hydralazine, improving TH-302 efficacy. Hydralazine reduces tumor blood flow through the "steal" phenomenon, in which atonal immature tumor vasculature fails to dilate in coordination with normal vasculature. We show that MIA PaCa-2 tumors exhibit a "steal" effect in response to hydralazine, resulting in decreased tumor blood flow and subsequent tumor pH reduction. The effect is not observed in SU.86.86 tumors with mature tumor vasculature, as measured by CD31 and smooth muscle actin (SMA) immunohistochemistry staining. Combination therapy of hydralazine and TH-302 resulted in a reduction in MIA PaCa-2 tumor volume growth after 18 days of treatment. These studies support a combination mechanism of action for TH-302 with a vasodilator that transiently increases tumor hypoxia.	[Bailey, Kate M.; Cornnell, Heather H.; Ibrahim-Hashim, Arig; Wojtkowiak, Jonathan W.; Zhang, Xiaomeng; Martinez, Gary V.; Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Imaging & Metab, Tampa, FL 33612 USA; [Bailey, Kate M.; Cornnell, Heather H.; Ibrahim-Hashim, Arig; Wojtkowiak, Jonathan W.; Zhang, Xiaomeng; Martinez, Gary V.; Gillies, Robert J.] Res Inst, Tampa, FL 33612 USA; [Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL 33612 USA; [Leos, Rafael; Baker, Amanda F.] Univ Arizona, Coll Med, Arizona Canc Ctr, Hematol Oncol Sect, Tucson, AZ 85724 USA; [Hart, Charles P.] Threshold Pharmaceut, San Francisco, CA 94080 USA; [Bailey, Kate M.] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Arizona Center Cancer Care; University of Arizona; State University System of Florida; University of South Florida	Gillies, RJ (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Imaging & Metab, Tampa, FL 33612 USA.	Robert.Gillies@Moffitt.org		Hart, Charles/0000-0003-4440-726X	 [R01CA125627-02];  [R01CA077575-10];  [P30CA076292-16];  [P30CA023074-35]; NATIONAL CANCER INSTITUTE [R01CA077575, R01CA125627, P30CA076292, P30CA023074] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants R01CA125627-02; R01CA077575-10; P30CA076292-16 (Robert J. Gillies) and P30CA023074-35 (Amanda F. Baker). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi E, 1999, ONCOL RES, V11, P179; Bhujwalla Z M, 1990, NMR Biomed, V3, P178, DOI 10.1002/nbm.1940030406; BHUJWALLA ZM, 1990, RADIOTHER ONCOL, V19, P281, DOI 10.1016/0167-8140(90)90155-P; Bhujwalla ZM, 1996, MAGN RESON MED, V36, P204, DOI 10.1002/mrm.1910360206; Borad MJ, 2012, P 103 ANN M AM ASS C, pLB; Brizel DM, 1996, CANCER RES, V56, P941; Cairns RA, 2007, P NATL ACAD SCI USA, V104, P9445, DOI 10.1073/pnas.0611662104; Cardenas-Rodriguez J, 2012, MAGN RESON IMAGING, V30, P1002, DOI 10.1016/j.mri.2012.02.015; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Dorie MJ, 1997, CANCER CHEMOTH PHARM, V39, P361, DOI 10.1007/s002800050584; Duan JX, 2008, J MED CHEM, V51, P2412, DOI 10.1021/jm701028q; Erkan MM, 2009, NEOPLASIA, V11, P497, DOI 10.1593/neo.81618; GATENBY RA, 1988, INT J RADIAT ONCOL, V14, P831, DOI 10.1016/0360-3016(88)90002-8; Gatzemeier U, 1998, BRIT J CANCER, V77, P15, DOI 10.1038/bjc.1998.431; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hicks KO, 2010, CLIN CANCER RES, V16, P4946, DOI 10.1158/1078-0432.CCR-10-1439; Hicks KO, 1998, INT J RADIAT ONCOL, V42, P641, DOI 10.1016/S0360-3016(98)00268-5; HORSMAN MR, 1995, BRIT J CANCER, V72, P1474, DOI 10.1038/bjc.1995.532; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kyle AH, 1999, CANCER CHEMOTH PHARM, V43, P213, DOI 10.1007/s002800050886; Le QTX, 2009, J CLIN ONCOL, V27, P3014, DOI 10.1200/JCO.2008.21.3868; Liu Q, 2012, CANCER CHEMOTH PHARM, V69, P1487, DOI 10.1007/s00280-012-1852-8; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Matsumoto S, 2014, ANTIOXIDANTS REDOX S; Meng FY, 2012, MOL CANCER THER, V11, P740, DOI 10.1158/1535-7163.MCT-11-0634; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Reddy SB, 2009, EXPERT OPIN INV DRUG, V18, P77, DOI [10.1517/13543780802567250, 10.1517/13543780802567250 ]; Rischin D, 2010, J CLIN ONCOL, V28, P2989, DOI 10.1200/JCO.2009.27.4449; Saito K, 2012, MAGN RESON MED, V67, P801, DOI 10.1002/mrm.23065; SECOMB TW, 1995, ACTA ONCOL, V34, P313, DOI 10.3109/02841869509093981; Society AC, 2014, CANC FACTS FIG 2014; Sun JD, 2012, CLIN CANCER RES, V18, P758, DOI 10.1158/1078-0432.CCR-11-1980; Takakusagi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107995; TEICHER BA, 1994, CANCER METAST REV, V13, P139, DOI 10.1007/BF00689633; TROTTER MJ, 1989, INT J RADIAT ONCOL, V17, P785, DOI 10.1016/0360-3016(89)90067-9; Van der Heijden MS, 2004, AM J PATHOL, V165, P651, DOI 10.1016/S0002-9440(10)63329-9; Weinmann M, 2004, FASEB J, V18, P1906, DOI 10.1096/fj.04-1918fje; Wojtkowiak JW, 2014, CANC METABO IN PRESS; Zhang XM, 2010, J NUCL MED, V51, P1167, DOI 10.2967/jnumed.109.068981	40	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e113586	10.1371/journal.pone.0113586	http://dx.doi.org/10.1371/journal.pone.0113586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532146	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845100005
J	Gordon, KA; Deighton, MR; Abbasalipour, P; Papsin, BC				Gordon, Karen A.; Deighton, Michael R.; Abbasalipour, Parvaneh; Papsin, Blake C.			Perception of Binaural Cues Develops in Children Who Are Deaf through Bilateral Cochlear Implantation	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; UNILATERAL HEARING-LOSS; PLACE-OF-STIMULATION; SOUND LOCALIZATION; ELECTRICAL-STIMULATION; SPEECH-LANGUAGE; USERS; LATERALIZATION; SENSITIVITY; INHIBITION	There are significant challenges to restoring binaural hearing to children who have been deaf from an early age. The uncoordinated and poor temporal information available from cochlear implants distorts perception of interaural timing differences normally important for sound localization and listening in noise. Moreover, binaural development can be compromised by bilateral and unilateral auditory deprivation. Here, we studied perception of both interaural level and timing differences in 79 children/adolescents using bilateral cochlear implants and 16 peers with normal hearing. They were asked on which side of their head they heard unilaterally or bilaterally presented click-or electrical pulse- trains. Interaural level cues were identified by most participants including adolescents with long periods of unilateral cochlear implant use and little bilateral implant experience. Interaural timing cues were not detected by new bilateral adolescent users, consistent with previous evidence. Evidence of binaural timing detection was, for the first time, found in children who had much longer implant experience but it was marked by poorer than normal sensitivity and abnormally strong dependence on current level differences between implants. In addition, children with prior unilateral implant use showed a higher proportion of responses to their first implanted sides than children implanted simultaneously. These data indicate that there are functional repercussions of developing binaural hearing through bilateral cochlear implants, particularly when provided sequentially; nonetheless, children have an opportunity to use these devices to hear better in noise and gain spatial hearing.	[Gordon, Karen A.; Deighton, Michael R.; Abbasalipour, Parvaneh; Papsin, Blake C.] Hosp Sick Children, Archies Cochlear Implant Lab, Toronto, ON M5G 1X8, Canada; [Gordon, Karen A.; Papsin, Blake C.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Gordon, KA (corresponding author), Hosp Sick Children, Archies Cochlear Implant Lab, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	karen.gordon@utoronto.ca			Canadian Institutes of Health Research Team Grant	Canadian Institutes of Health Research Team Grant(Canadian Institutes of Health Research (CIHR))	Funding provided by a Canadian Institutes of Health Research Team Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein LR, 2002, J ACOUST SOC AM, V112, P1026, DOI 10.1121/1.1497620; Bernstein LR, 2001, J NEUROSCI RES, V66, P1035, DOI 10.1002/jnr.10103; Bierer JA, 2010, EAR HEAR; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Chadha NK, 2011, OTOL NEUROTOL, V32, P1057, DOI 10.1097/MAO.0b013e3182267de7; Colburn HS, 2009, JARO-J ASSOC RES OTO, V10, P91, DOI 10.1007/s10162-008-0141-z; Geers AE, 2004, ARCH OTOLARYNGOL, V130, P634, DOI 10.1001/archotol.130.5.634; Geers AE, 2013, J SPEECH LANG HEAR R, V56, P643, DOI 10.1044/1092-4388(2012/11-0347); Gordon KA, 2006, AUDIOL NEURO-OTOL, V11, P7, DOI 10.1159/000088851; Gordon KA, 2012, COCHLEAR IMPLANTS IN; Gordon KA, 2008, OTOL NEUROTOL, V29, P193, DOI 10.1097/mao.0b013e318162514c; Gordon KA, 2013, BRAIN, V136, P1609, DOI 10.1093/brain/awt052; Gordon KA, 2012, J NEUROSCI, V32, P4212, DOI 10.1523/JNEUROSCI.5741-11.2012; Gordon KA, 2010, OTOL NEUROTOL, V31, P1293, DOI 10.1097/MAO.0b013e3181e8f965; Gordon KA, 2009, OTOL NEUROTOL, V30, P319, DOI 10.1097/MAO.0b013e31819a8f4c; Gordon Karen Ann, 2012, Cochlear Implants Int, V13, P220, DOI 10.1179/1754762811Y.0000000022; Goupell MJ, 2013, J ACOUST SOC AM, V133, P2272, DOI 10.1121/1.4792936; Graham John, 2009, Cochlear Implants Int, V10, P119, DOI 10.1179/cim.2009.10.3.119; Grieco-Calub TM, 2010, EAR HEARING, V31, P645, DOI 10.1097/AUD.0b013e3181e50a1d; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Hopyan T, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00425; Illg A, 2013, OTOL NEUROTOL, V34, P682, DOI 10.1097/MAO.0b013e31828bb75e; Ingham NJ, 2005, J NEUROSCI, V25, P6187, DOI 10.1523/JNEUROSCI.0146-05.2005; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Kan A, 2013, J ACOUST SOC AM, V134, P2923, DOI 10.1121/1.4820889; Kerber S, 2012, EAR HEARING, V33, P445, DOI 10.1097/AUD.0b013e318257607b; Kral A, 2013, BRAIN, V136, P180, DOI 10.1093/brain/aws305; Kral A, 2010, NEW ENGL J MED, V363, P1438, DOI 10.1056/NEJMra0911225; Lieu JEC, 2013, B-ENT, V9, P107; Lieu JEC, 2004, ARCH OTOLARYNGOL, V130, P524, DOI 10.1001/archotol.130.5.524; Lieu JEC, 2010, PEDIATRICS, V125, pE1348, DOI 10.1542/peds.2009-2448; Litovsky RY, 2012, J AM ACAD AUDIOL, V23, P476, DOI 10.3766/jaaa.23.6.9; Litovsky RY, 2010, J ACOUST SOC AM, V127, P400, DOI 10.1121/1.3257546; Loizou PC, 2009, J ACOUST SOC AM, V125, P372, DOI 10.1121/1.3036175; Magnusson AK, 2005, J PHYSIOL-LONDON, V568, P497, DOI 10.1113/jphysiol.2005.094763; Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326; Papsin BC, 2008, CURR OPIN OTOLARYNGO, V16, P69, DOI 10.1097/MOO.0b013e3282f5e97c; Papsin BC, 2007, NEW ENGL J MED, V357, P2380, DOI 10.1056/NEJMct0706268; Salloum CAM, 2010, EAR HEARING, V31, P441, DOI 10.1097/AUD.0b013e3181d4f228; Takesian AE, 2009, FUTUR NEUROL, V4, P331, DOI 10.2217/FNL.09.5; Van Deun L, 2010, EAR HEARING, V31, P702, DOI 10.1097/AUD.0b013e3181e40dfe; van Hoesel RJM, 2012, HEARING RES, V288, P100, DOI 10.1016/j.heares.2011.11.014; van Hoesel RJM, 2009, JARO-J ASSOC RES OTO, V10, P557, DOI 10.1007/s10162-009-0175-x; van Hoesel RJM, 2004, AUDIOL NEURO-OTOL, V9, P234, DOI 10.1159/000078393; van Hoesel RJM, 2003, J ACOUST SOC AM, V113, P1617, DOI 10.1121/1.1539520; Vandali A, 2013, HEARING RES, V302, P32, DOI 10.1016/j.heares.2013.05.004; VANDENHONERT C, 1986, HEARING RES, V21, P109, DOI 10.1016/0378-5955(86)90033-X; VANDENHONERT C, 1984, HEARING RES, V14, P225, DOI 10.1016/0378-5955(84)90052-2; Xu H, 2010, J NEUROSCI, V30, P331, DOI 10.1523/JNEUROSCI.4554-09.2010; ZWISLOCKI J, 1956, J ACOUST SOC AM, V28, P860, DOI 10.1121/1.1908495	50	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114841	10.1371/journal.pone.0114841	http://dx.doi.org/10.1371/journal.pone.0114841			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531107	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100026
J	Guerriero, E; Sorice, A; Capone, F; Napolitano, V; Colonna, G; Storti, G; Castello, G; Costantini, S				Guerriero, Eliana; Sorice, Angela; Capone, Francesca; Napolitano, Virginia; Colonna, Giovanni; Storti, Gabriella; Castello, Giuseppe; Costantini, Susan			Vitamin C Effect on Mitoxantrone-Induced Cytotoxicity in Human Breast Cancer Cell Lines	PLOS ONE			English	Article							HISTONE H2AX PHOSPHORYLATION; ASCORBIC-ACID; INDUCED CARDIOTOXICITY; MULTIPLE-SCLEROSIS; IN-VITRO; DEATH; DOXORUBICIN; MECHANISMS; EXPRESSION; APOPTOSIS	In recent years the use of natural dietary antioxidants to minimize the cytotoxicity and the damage induced in normal tissues by antitumor agents is gaining consideration. In literature, it is reported that vitamin C exhibits some degree of antineoplastic activity whereas Mitoxantrone (MTZ) is a synthetic anti-cancer drug with significant clinical effectiveness in the treatment of human malignancies but with severe side effects. Therefore, we have investigated the effect of vitamin C alone or combined with MTZ on MDA-MB231 and MCF7 human breast cancer cell lines to analyze their dose-effect on the tumor cellular growth, cellular death, cell cycle and cell signaling. Our results have evidenced that there is a dose-dependence on the inhibition of the breast carcinoma cell lines, MCF7 and MDA-MB231, treated with vitamin C and MTZ. Moreover, their combination induces: i) a cytotoxic effect by apoptotic death, ii) a mild G2/M elongation and iii) H2AX and mild PI3K activation. Hence, the formulation of vitamin C with MTZ induces a higher cytotoxicity level on tumor cells compared to a disjointed treatment. We have also found that the vitamin C enhances the MTZ effect allowing the utilization of lower chemotherapic concentrations in comparison to the single treatments.	[Guerriero, Eliana; Sorice, Angela; Capone, Francesca; Napolitano, Virginia; Castello, Giuseppe; Costantini, Susan] IRCCS, Fdn Giovanni Pascale, Ist Nazl Studio & Cura Tumori, Ctr Ric Oncol Mercogliano, I-80131 Naples, Italy; [Colonna, Giovanni] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, I-80138 Naples, Italy; [Storti, Gabriella] SG Moscati Hosp, Dept Oncohematol, I-83100 Avellino, Italy	IRCCS Fondazione Pascale; Universita della Campania Vanvitelli; San Giuseppe Moscati Hospital	Costantini, S (corresponding author), IRCCS, Fdn Giovanni Pascale, Ist Nazl Studio & Cura Tumori, Ctr Ric Oncol Mercogliano, I-80131 Naples, Italy.	s.costantini@istitutotumori.na.it	Capone, Francesca/AAS-7458-2021; Colonna, Giovanni/AAY-3568-2021; Costantini, Susan/J-9914-2018	Costantini, Susan/0000-0002-7538-4657; Sorice, Angela/0000-0003-4900-6107; Colonna, Giovanni/0000-0002-0473-1455; Capone, Francesca/0000-0002-5402-6228				Anders CK, 2013, HEMATOL ONCOL CLIN N, V27, P737, DOI 10.1016/j.hoc.2013.05.003; Avasarala JR, 2003, MULT SCLER, V9, P59, DOI 10.1191/1352458503ms896oa; BAADER SL, 1994, ANTICANCER RES, V14, P221; Banath JP, 2003, CANCER RES, V63, P4347; Bruck TB, 2011, BIOCHIMIE, V93, P217, DOI 10.1016/j.biochi.2010.09.015; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Du J, 2012, BBA-REV CANCER, V1826, P443, DOI 10.1016/j.bbcan.2012.06.003; Du JA, 2010, CLIN CANCER RES, V16, P509, DOI 10.1158/1078-0432.CCR-09-1713; Fan JT, 2011, J NAT PROD, V74, P2069, DOI 10.1021/np2002918; Griffiths Carrie L, 2012, J Pharm Pract, V25, P319, DOI 10.1177/0897190012442062; Guerriero E, 2011, MOLECULES, V16, P6365, DOI 10.3390/molecules16086365; Hahm E, 2007, J CELL BIOCHEM, V102, P1002, DOI 10.1002/jcb.21336; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; HENDERSON IC, 1989, J CLIN ONCOL, V7, P560, DOI 10.1200/JCO.1989.7.5.560; Hong SW, 2007, ONCOL REP, V18, P811; Huang X, 2003, CELL CYCLE, V2, P614, DOI 10.4161/cc.2.6.565; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Jiao XY, 2013, BREAST CANCER RES TR, V139, P717, DOI 10.1007/s10549-013-2607-x; Kang JS, 2005, J CELL PHYSIOL, V204, P192, DOI 10.1002/jcp.20286; KAO TL, 1993, CANCER LETT, V70, P101, DOI 10.1016/0304-3835(93)90080-S; Khan SN, 2010, BIOSCIENCE REP, V30, P375, DOI 10.1042/BSR20090119; Kim J, 2012, FREE RADICAL BIO MED, V53, P1607, DOI 10.1016/j.freeradbiomed.2012.07.079; Krishnaja AP, 2003, TERATOGEN CARCIN MUT, P99, DOI 10.1002/tcm.10064; Kurbacher CM, 1996, CANCER LETT, V103, P183, DOI 10.1016/0304-3835(96)04212-7; LEE YS, 1994, CANCER LETT, V78, P19, DOI 10.1016/0304-3835(94)90026-4; Ma Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007154; Mamede AC, 2011, NUTR CANCER, V63, P479, DOI 10.1080/01635581.2011.539315; Maramag C, 1997, PROSTATE, V32, P188, DOI 10.1002/(SICI)1097-0045(19970801)32:3<188::AID-PROS5>3.0.CO;2-H; Neuhaus O, 2006, PHARMACOL THERAPEUT, V109, P198, DOI 10.1016/j.pharmthera.2005.07.002; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rossato LG, 2013, ARCH TOXICOL, V87, P1809, DOI 10.1007/s00204-013-1040-6; Seifrtova M, 2011, FOLIA BIOL-PRAGUE, V57, P74; Seiter Karen, 2005, Expert Opin Drug Saf, V4, P219, DOI 10.1517/14740338.4.2.219; Sorice A, 2014, MINI-REV MED CHEM, V14, P444, DOI 10.2174/1389557514666140428112602; Tate CR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3192; Toh YM, 2011, CLIN CANCER RES, V17, P5026, DOI 10.1158/1078-0432.CCR-11-0235; Verrax J, 2008, BIOCHEM PHARMACOL, V76, P1644, DOI 10.1016/j.bcp.2008.09.024; Vibet S, 2007, DRUG METAB DISPOS, V35, P822, DOI 10.1124/dmd.106.013474; Wang JH, 2012, CHEM BIOL DRUG DES, V80, P909, DOI 10.1111/cbdd.12038; YANAGISAWASHIOTA F, 1995, ANTICANCER RES, V15, P259; Zhao H, 2008, CYTOM PART A, V73A, P480, DOI 10.1002/cyto.a.20574; Zordoky BNM, 2014, BBA-GEN SUBJECTS, V1840, P1943, DOI 10.1016/j.bbagen.2014.01.023	44	38	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115287	10.1371/journal.pone.0115287	http://dx.doi.org/10.1371/journal.pone.0115287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531443	Green Submitted, gold, Green Published			2022-12-26	WOS:000348845100049
J	Stavros, F; Yang, A; Leon, A; Nuttall, M; Rasmussen, HS				Stavros, Fiona; Yang, Alex; Leon, Alejandro; Nuttall, Mark; Rasmussen, Henrik S.			Characterization of Structure and Function of ZS-9, alpha K+ Selective Ion Trap	PLOS ONE			English	Article							HEART-FAILURE; HYPERKALEMIA; POTASSIUM; SPIRONOLACTONE; ZIRCONIUM; MORTALITY; RESIN	Hyperkalemia, a condition in which serum potassium ions (K+) exceed 5.0 mmol/L, is a common electrolyte disorder associated with substantial morbidity. Current methods of managing hyperkalemia, including organic polymer resins such as sodium polystyrene sulfonate (SPS), are poorly tolerated and/or not effective. Sodium zirconium cyclosilicate (ZS-9) is under clinical development as an orally administered, non-absorbed, novel, inorganic microporous zirconium silicate compound that selectively removes excess K+ in vivo. The development, structure and ion exchange properties of ZS-9 and its hypothesized mechanism of action are described. Based on calculation of the interatomic distances between the atoms forming the ZS-9 micropores, the size of the pore opening was determined to be similar to 3 angstrom (similar to diameter of unhydrated K+). Unlike nonspecific organic polymer resins like SPS, the ZS-9 K+ exchange capacity (KEC) was unaffected by the presence of calcium (Ca2+) or magnesium ions (Mg2+) and showed. 25-fold selectivity for K+ over either Ca2+ or Mg2+. Conversely, the selectivity of SPS for K+ was only 0.2-0.3 times its selectivity for Ca2+ or Mg2+ in mixed ionic media. It is hypothesized that the high K+ specificity of ZS-9 is attributable to the chemical composition and diameter of the micropores, which possibly act in an analogous manner to the selectivity filter utilized by physiologic K+ channels. This hypothesized mechanism of action is supported by the multi-ion exchange studies. The effect of pH on the KEC of ZS-9 was tested in different media buffered to mimic different portions of the human gastrointestinal tract. Rapid K+ uptake was observed within 5 minutes - mainly in the simulated small intestinal and large intestinal fluids, an effect that was sustained for up to 1 hour. If approved, ZS-9 will represent a novel, first-in-class therapy for hyperkalemia with improved capacity, selectivity, and speed for entrapping K+ when compared to currently available options.	[Stavros, Fiona; Leon, Alejandro; Nuttall, Mark; Rasmussen, Henrik S.] ZS Pharma Inc, Coppell, TX 75019 USA; [Yang, Alex] Xelay Acumen Inc, Belmont, CA USA		Stavros, F (corresponding author), ZS Pharma Inc, Coppell, TX 75019 USA.	fstavros@zspharma.com			ZS Pharma, Inc.	ZS Pharma, Inc.	These studies were funded by ZS Pharma, Inc. http://www.zspharma.com/. The funder had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Agar JWM, 2010, NEPHROLOGY, V15, P406, DOI 10.1111/j.1440-1797.2010.01321.x; [Anonymous], 2014, SUMM REP DET ZIRC SI; Ash S, 2014, KIDNEY INT IN PRESS; Ash SR, 2009, SEMIN DIALYSIS, V22, P615, DOI 10.1111/j.1525-139X.2009.00657.x; Bem D, 2001, ASAIO J, V47, P151; Bem D, 1999, Patent No. [005891417A, 005891417]; Bem D, 1999, Patent No. [005888472A, 005888472]; Bem DS, 1999, MATER RES SOC SYMP P, V549, P73; BERLYNE GM, 1966, LANCET, V1, P169; Derthoo D, 2013, ACTA CARDIOL, V68, P51, DOI 10.1080/AC.68.1.2959632; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Elliott MJ, 2010, CAN MED ASSOC J, V182, P1631, DOI 10.1503/cmaj.100461; EMMETT M, 1995, GASTROENTEROLOGY, V108, P752, DOI 10.1016/0016-5085(95)90448-4; Fang J, 2000, J GEN INTERN MED, V15, P885, DOI 10.1046/j.1525-1497.2000.91021.x; Fulton TB, DIFFUSION TRANSPORT; Gennari FJ, 2002, CRIT CARE CLIN, V18, P273, DOI 10.1016/S0749-0704(01)00009-4; Kim HJ, 2002, NEPHRON, V92, P33, DOI 10.1159/000065375; Kosiborod M, 2014, JAMA-J AM MED ASSOC, V312, P2223, DOI 10.1001/jama.2014.15688; Lee DBN, 2010, ASAIO J, V56, P550, DOI 10.1097/MAT.0b013e3181e73f20; Lehnhardt A, 2011, PEDIATR NEPHROL, V26, P377, DOI 10.1007/s00467-010-1699-3; Marieb EN, 2010, HUMAN ANATOMY PHYSL; Matoba S, 1999, CIRCULATION, V99, P817, DOI 10.1161/01.CIR.99.6.817; National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI), 2002, CLIN PRACT GUID BON; Navaneethan SD, 2009, CLIN J AM SOC NEPHRO, V4, P542, DOI 10.2215/CJN.04750908; Packham DK, 2015, NEW ENGL J MED, V372, P222, DOI 10.1056/NEJMoa1411487; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; SCHROEDER HA, 1966, J CHRON DIS, V19, P573, DOI 10.1016/0021-9681(66)90095-6; Sterns RH, 2010, J AM SOC NEPHROL, V21, P733, DOI 10.1681/ASN.2010010079; Stevens Marc S., 2000, International Urology and Nephrology, V32, P177; Svensson M, 2004, J CARD FAIL, V10, P297, DOI 10.1016/j.cardfail.2003.10.012; Tamirisa KP, 2004, AM HEART J, V148, P971, DOI 10.1016/j.ahj.2004.10.005; Volkov AG, 1997, BIOELECTROCH BIOENER, V42, P153, DOI 10.1016/S0302-4598(96)05097-0; Watson M, 2010, CLIN J AM SOC NEPHRO, V5, P1723, DOI 10.2215/CJN.03700410; Yang A, 2014, AM J KIDNEY DIS, V63, pA115	34	104	114	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114686	10.1371/journal.pone.0114686	http://dx.doi.org/10.1371/journal.pone.0114686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531770	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100022
J	Gory-Faure, S; Windscheid, V; Brocard, J; Montessuit, S; Tsutsumi, R; Denarier, E; Fukata, Y; Bosc, C; Delaroche, J; Collomb, N; Fukata, M; Martinou, JC; Pernet-Gallay, K; Andrieux, A				Gory-Faure, Sylvie; Windscheid, Vanessa; Brocard, Jacques; Montessuit, Sylvie; Tsutsumi, Ryouhei; Denarier, Eric; Fukata, Yuko; Bosc, Christophe; Delaroche, Julie; Collomb, Nora; Fukata, Masaki; Martinou, Jean-Claude; Pernet-Gallay, Karin; Andrieux, Annie			Non-Microtubular Localizations of Microtubule-Associated Protein 6 (MAP6)	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; ABNORMAL INTERACTION; GOLGI LOCALIZATION; STOP PROTEIN; TAU-PROTEIN; RICH DOMAIN; MOUSE; ACTIN; STABILITY; INTERACTS	MAP6 proteins (MAP6s), which include MAP6-N (also called Stable Tubule Only Polypeptide, or STOP) and MAP6d1 (MAP6 domain-containing protein 1, also called STOP-Like protein 21 kD, or SL21), bind to and stabilize microtubules. MAP6 deletion in mice severely alters integrated brain functions and is associated with synaptic defects, suggesting that MAP6s may also have alternative cellular roles. MAP6s reportedly associate with the Golgi apparatus through palmitoylation of their N-terminal domain, and specific isoforms have been shown to bind actin. Here, we use heterologous systems to investigate several biochemical properties of MAP6 proteins. We demonstrate that the three N-terminal cysteines of MAP6d1 are palmitoylated by a subset of DHHC-type palmitoylating enzymes. Analysis of the subcellular localization of palmitoylated MAP6d1, including electron microscopic analysis, reveals possible localization to the Golgi and the plasma membrane but no association with the endoplasmic reticulum. Moreover, we observed localization of MAP6d1 to mitochondria, which requires the N-terminus of the protein but does not require palmitoylation. We show that endogenous MAP6d1 localized at mitochondria in mature mice neurons as well as at the outer membrane and in the intermembrane space of purified mouse mitochondria. Last, we found that MAP6d1 can multimerize via a microtubule-binding module. Interestingly, most of these properties of MAP6d1 are shared by MAP6-N. Together, these results describe several properties of MAP6 proteins, including their intercellular localization and multimerization activity, which may be relevant to neuronal differentiation and synaptic functions.	[Gory-Faure, Sylvie; Windscheid, Vanessa; Brocard, Jacques; Denarier, Eric; Bosc, Christophe; Delaroche, Julie; Collomb, Nora; Pernet-Gallay, Karin; Andrieux, Annie] INSERM, U836, Grenoble, France; [Gory-Faure, Sylvie; Windscheid, Vanessa; Brocard, Jacques; Denarier, Eric; Bosc, Christophe; Delaroche, Julie; Collomb, Nora; Pernet-Gallay, Karin; Andrieux, Annie] Univ Grenoble Alpes, Grenoble Inst Neurosci, Grenoble, France; [Montessuit, Sylvie; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, Geneva, Switzerland; [Tsutsumi, Ryouhei; Fukata, Masaki] Natl Inst Physiol Sci, Dept Cell Physiol, Div Membrane Physiol, Okazaki, Aichi, Japan; [Denarier, Eric; Andrieux, Annie] CEA, Inst Rech Technol & Sci Vivant, Grp Physiopathol Cytosquelette, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Geneva; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); CEA	Gory-Faure, S (corresponding author), INSERM, U836, BP170, Grenoble, France.	sylvie.gory-faure@ujf-grenoble.fr; annie.andrieux@ujf-grenoble.fr	Denarier, Eric/H-3555-2017; Bosc, Christophe/P-3401-2017; ANDRIEUX, ANNIE/B-2134-2017; Denarier, Eric/X-6137-2019; Bosc, Christophe/Q-8877-2019; Fukata, Masaki/AAZ-2476-2021; Brocard, Jacques/I-3135-2017	Denarier, Eric/0000-0002-4169-397X; Bosc, Christophe/0000-0002-3195-6692; ANDRIEUX, ANNIE/0000-0002-4022-6405; Denarier, Eric/0000-0002-4169-397X; Bosc, Christophe/0000-0002-3195-6692; Fukata, Masaki/0000-0001-5200-9806; Brocard, Jacques/0000-0002-0752-5737; Gory, Sylvie/0000-0001-5743-8079; PERNET GALLAY, Karin/0000-0003-3468-3316; Tsutsumi, Ryouhei/0000-0002-1704-0362; Fukata, Yuko/0000-0001-7724-8643; martinou, Jean-claude/0000-0002-9847-2051; Delaroche, Julie/0000-0003-2529-0270	INSERM; CEA; Grenoble Alpes University; French National Research Agency [2010Blan120201 CBioS]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); Grenoble Alpes University; French National Research Agency(French National Research Agency (ANR))	This work was supported by INSERM, CEA, Grenoble Alpes University, and French National Research Agency Awards 2010Blan120201 CBioS (to AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguezzoul M, 2003, GENOMICS, V81, P623, DOI 10.1016/S0888-7543(03)00053-3; Amadoro G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.001; Arama J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035488; BAAS PW, 1991, J NEUROSCI RES, V30, P134, DOI 10.1002/jnr.490300115; Baratier J, 2006, J BIOL CHEM, V281, P19561, DOI 10.1074/jbc.M509602200; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Barth J, 2011, EXPERT REV PROTEOMIC, V8, P211, DOI [10.1586/EPR.11.7, 10.1586/epr.11.7]; Bosc C, 1996, P NATL ACAD SCI USA, V93, P2125, DOI 10.1073/pnas.93.5.2125; Bosc C, 2001, J BIOL CHEM, V276, P30904, DOI 10.1074/jbc.M011614200; Boulay AC, 2013, BIOCHIMIE, V95, P799, DOI 10.1016/j.biochi.2012.11.016; Bouquet C, 2007, MOL CELL NEUROSCI, V36, P235, DOI 10.1016/j.mcn.2007.07.002; Brenner E, 2007, J NEUROSCI RES, V85, P3487, DOI 10.1002/jnr.21200; Chauvin S, 2008, BIOL CELL; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Chu CT, 2013, AUTOPHAGY, V10; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Couegnas A, 2007, J NEUROSCI RES, V85, P1515, DOI 10.1002/jnr.21278; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Da Cruz S, 2008, BBA-MOL CELL RES, V1783, P904, DOI 10.1016/j.bbamcr.2008.02.006; Delphin C, 2012, J BIOL CHEM, V287, P35127, DOI 10.1074/jbc.M112.398339; Denarier E, 1998, P NATL ACAD SCI USA, V95, P6055, DOI 10.1073/pnas.95.11.6055; Denarier E, 1998, BIOCHEM BIOPH RES CO, V243, P791, DOI 10.1006/bbrc.1998.8179; Deng N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000117; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DuBoff B, 2012, NEURON, V75, P618, DOI 10.1016/j.neuron.2012.06.026; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Farias GA, 2002, J CELL BIOCHEM, V85, P315, DOI 10.1002/jcb.10133; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Galiano MR, 2004, J NEUROSCI RES, V78, P329, DOI 10.1002/jnr.20260; Gorini G, 2010, FEBS LETT, V584, P845, DOI 10.1016/j.febslet.2009.12.061; Gory-Faure S, 2006, J BIOL CHEM, V281, P28387, DOI 10.1074/jbc.M603380200; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; He HJ, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-81; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; JOB D, 1984, BIOCHEMISTRY-US, V23, P3025, DOI 10.1021/bi00308a028; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Levy AD, 2011, MOL BIOL CELL, V22, P1930, DOI 10.1091/mbc.E10-10-0824; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Makrides V, 2003, J BIOL CHEM, V278, P33298, DOI 10.1074/jbc.M305207200; Manczak M, 2012, HUM MOL GENET, V21, P5131, DOI 10.1093/hmg/dds360; Manczak M, 2012, HUM MOL GENET, V21, P2538, DOI 10.1093/hmg/dds072; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ochoa CD, 2011, AM J PHYSIOL-LUNG C, V300, pL132, DOI 10.1152/ajplung.00185.2010; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; PIROLLET F, 1992, BIOCHEMISTRY-US, V31, P8849, DOI 10.1021/bi00152a022; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; WEHLAND J, 1983, J CELL BIOL, V97, P1476, DOI 10.1083/jcb.97.5.1476; Yu JZ, 2006, FASEB J, V20, P1452, DOI 10.1096/fj.05-5206com	59	6	6	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114905	10.1371/journal.pone.0114905	http://dx.doi.org/10.1371/journal.pone.0114905			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526643	Green Published, Green Submitted, gold			2022-12-26	WOS:000347186200009
J	Tsuber, V; Kadamov, Y; Tarasenko, L				Tsuber, Viktoriia; Kadamov, Yunus; Tarasenko, Lydia			Activation of Antioxidant Defenses in Whole Saliva by Psychosocial Stress Is More Manifested in Young Women than in Young Men	PLOS ONE			English	Article							SECRETORY IMMUNOGLOBULIN-A; ORAL ACADEMIC EXAMINATION; OXIDATIVE DNA-DAMAGE; SEX-DIFFERENCES; ALPHA-AMYLASE; PSYCHOLOGICAL STRESS; FREE-RADICALS; SIALIC-ACID; FLOW-RATE; SUPEROXIDE-DISMUTASE	Psychosocial stress has been long known to have deleterious effects on health. Nevertheless, an exposure to moderate stressors enhances resilience and promotes health benefits. Male and female organisms differ in many aspects of health and disease. The aim of this study was to investigate antioxidant activity and oxidative damage in saliva in a psychosocial stress paradigm in men and women. Here, we show that an acute stressor of moderate strength augments antioxidant activity and decreases oxidative damage in whole saliva of young people. An examination stress caused a significant increase of catalase activity, accompanied by a decrease of levels of oxidized proteins. Levels of thiobarbituric acid-reacting substances did not increase at stress, indicating that lipid peroxidation was not activated. The stress-induced alterations were more manifested in young women compared to young men. Thus, antioxidant protective mechanisms are more activated by a moderate stressor in young women than in young men.	[Tsuber, Viktoriia; Kadamov, Yunus; Tarasenko, Lydia] Ukrainian Med Stomatol Acad, Dept Med Bioorgan & Biol Chem, Poltava, Ukraine	Poltava State Medical University	Tsuber, V (corresponding author), Ukrainian Med Stomatol Acad, Dept Med Bioorgan & Biol Chem, Poltava, Ukraine.	victoriya.tsuber@gmail.com		Tsuber, Viktoriia/0000-0001-7362-7275				Amirmozafari Nour, 2013, J Oral Biol Craniofac Res, V3, P78, DOI 10.1016/j.jobcr.2013.05.004; Aschbacher K, 2013, PSYCHONEUROENDOCRINO; Azarbayjani MA, 2011, J HUM SPORT EXERC, V6, P385, DOI 10.4100/jhse.2011.62.19; Baggio G, 2013, CLIN CHEM LAB MED, V51, P713, DOI 10.1515/cclm-2012-0849; Bakke M, 2004, GERONTOLOGY, V50, P383, DOI 10.1159/000080176; BENARYEH H, 1986, BIOCHEM MED METAB B, V36, P260, DOI 10.1016/0885-4505(86)90134-9; Benschop RJ, 1996, FASEB J, V10, P517, DOI 10.1096/fasebj.10.4.8647351; Borras C, 2005, AGING CELL, V4, P113, DOI 10.1111/j.1474-9726.2005.00151.x; Bosch JA, 2003, PSYCHOSOM MED, V65, P245, DOI 10.1097/01.PSY.0000058376.50240.2D; Bosch JA, 1996, PSYCHOSOM MED, V58, P374, DOI 10.1097/00006842-199607000-00010; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Buege J A, 1978, Methods Enzymol, V52, P302; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; CECONI C, 1988, MOL CELL BIOCHEM, V81, P131; Chaplin TM, 2008, ALCOHOL CLIN EXP RES, V32, P1242, DOI 10.1111/j.1530-0277.2008.00679.x; Cohen S, 2012, J APPL SOC PSYCHOL, V42, P1320, DOI 10.1111/j.1559-1816.2012.00900.x; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Forte LFDP, 2010, J ORAL PATHOL MED, V39, P765, DOI 10.1111/j.1600-0714.2010.00933.x; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Dhabhar FS, 2003, ANN NY ACAD SCI, V992, P205, DOI 10.1111/j.1749-6632.2003.tb03151.x; Eggers-Lura H, 1949, ENZYME SPEICHELS ZAH; Eguchi H, 2005, GLYCOBIOLOGY, V15, P1094, DOI 10.1093/glycob/cwj003; Erfani A, 2013, SPORT MED J, V35; Gidron Y, 2006, BIOL PSYCHOL, V72, P291, DOI 10.1016/j.biopsycho.2005.11.011; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; GRISHAM MB, 1987, AM J PHYSIOL, V253, pG93, DOI 10.1152/ajpgi.1987.253.1.G93; GUEMOURI L, 1991, CLIN CHEM, V37, P1932; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; HENRY RJ, 1957, ANAL CHEM, V29, P1491, DOI 10.1021/ac60130a028; HESS EL, 1957, J CLIN INVEST, V36, P449, DOI 10.1172/JCI103442; Hucklebridge F, 2000, BIOL PSYCHOL, V53, P25, DOI 10.1016/S0301-0511(00)00040-5; Ide T, 2002, ARTERIOSCL THROM VAS, V22, P438, DOI 10.1161/hq0302.104515; Iijima R, 2004, FEBS LETT, V561, P163, DOI 10.1016/S0014-5793(04)00164-4; Irie M, 2003, BIOCHEM BIOPH RES CO, V311, P1014, DOI 10.1016/j.bbrc.2003.10.105; Irie M, 2001, JPN J CANCER RES, V92, P367, DOI 10.1111/j.1349-7006.2001.tb01104.x; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Kang DH, 1996, BRAIN BEHAV IMMUN, V10, P164, DOI 10.1006/brbi.1996.0015; KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447; Kardash VV, 2003, CONCEPTUAL METHODOLO; Kardash W, 2000, DIFFERENTIAL DIAGNOS; KAUL N, 1993, J PHARMACOL TOX MET, V30, P55, DOI 10.1016/1056-8719(93)90008-3; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kivlighan KT, 2006, PSYCHONEUROENDOCRINO, V31, P703, DOI 10.1016/j.psyneuen.2006.01.007; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kumsta R, 2007, BIOL PSYCHIAT, V62, P863, DOI 10.1016/j.biopsych.2007.04.013; Kunsch C, 1999, CIRC RES, V85, P753, DOI 10.1161/01.RES.85.8.753; Lacey K, 2000, PSYCHONEUROENDOCRINO, V25, P339, DOI 10.1016/S0306-4530(99)00059-1; Liu JK, 1997, ANAL BIOCHEM, V245, P161, DOI 10.1006/abio.1996.9990; Lovallo WR, 2006, PHARMACOL BIOCHEM BE, V83, P441, DOI 10.1016/j.pbb.2006.03.005; Mayne ST, 2003, J NUTR, V133, p933S, DOI 10.1093/jn/133.3.933S; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; MORSE DR, 1982, J HUM STRESS, V8, P31, DOI 10.1080/0097840X.1982.9936117; Naito Y., 2005, Current Drug Targets - Inflammation and Allergy, V4, P511, DOI 10.2174/1568010054526269; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2005, INT J PSYCHOPHYSIOL, V55, P333, DOI 10.1016/j.ijpsycho.2004.09.009; Naumova EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051323; NICKERSON JF, 1957, P SOC EXP BIOL MED, V95, P405; Ogasawara Y, 2007, FEBS LETT, V581, P2473, DOI 10.1016/j.febslet.2007.04.062; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Otte C, 2005, PSYCHONEUROENDOCRINO, V30, P80, DOI 10.1016/j.psyneuen.2004.06.002; Poulsen HE, 2012, FREE RADICAL BIO MED, V52, P1353, DOI 10.1016/j.freeradbiomed.2012.01.009; Queiroz CS, 2002, EUR J ORAL SCI, V110, P337, DOI 10.1034/j.1600-0722.2002.21320.x; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Ring C, 2002, BIOL PSYCHOL, V59, P1, DOI 10.1016/S0301-0511(01)00128-4; Rohleder N, 2001, PSYCHOSOM MED, V63, P966, DOI 10.1097/00006842-200111000-00016; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Sapolsky, 1997, Stress, V2, P1; Schoofs D, 2008, STRESS, V11, P52, DOI 10.1080/10253890701453943; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Shear MK, 1989, MEASURING MENTAL ILL, P113; SINGAL PK, 1983, ADV EXP MED BIOL, V161, P391; Singal PK, 1998, CARDIOVASC RES, V40, P426, DOI 10.1016/S0008-6363(98)00244-2; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Spielberger CD, 1987, STATE TRAIT INVENTOR; Stadtman ER, 2004, CURR MED CHEM, V11, P1105, DOI 10.2174/0929867043365341; Takai N, 2004, ARCH ORAL BIOL, V49, P963, DOI 10.1016/j.archoralbio.2004.06.007; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van Stegeren A, 2006, PSYCHONEUROENDOCRINO, V31, P137, DOI 10.1016/j.psyneuen.2005.05.012; Vileikyte L, 2007, CLIN DERMATOL, V25, P49, DOI 10.1016/j.clindermatol.2006.09.005; Vina Jose, 2005, Sci Aging Knowledge Environ, V2005, ppe17, DOI 10.1126/sageke.2005.23.pe17; Walter MF, 2004, J AM COLL CARDIOL, V44, P1996, DOI 10.1016/j.jacc.2004.08.029	85	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115048	10.1371/journal.pone.0115048	http://dx.doi.org/10.1371/journal.pone.0115048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8WK	25525800	Green Published, Green Submitted, gold			2022-12-26	WOS:000347186200010
J	Takeda-Kawaguchi, T; Sugiyama, K; Chikusa, S; Iida, K; Aoki, H; Tamaoki, N; Hatakeyama, D; Kunisada, T; Shibata, T; Fusaki, N; Tezuka, K				Takeda-Kawaguchi, Tomoko; Sugiyama, Ken; Chikusa, Shunji; Iida, Kazuki; Aoki, Hitomi; Tamaoki, Naritaka; Hatakeyama, Daijiro; Kunisada, Takahiro; Shibata, Toshiyuki; Fusaki, Noemi; Tezuka, Ken-ichi			Derivation of iPSCs after Culture of Human Dental Pulp Cells under Defined Conditions	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SENDAI-VIRUS; INDUCTION	Human dental pulp cells (hDPCs) are a promising resource for regenerative medicine and tissue engineering and can be used for derivation of induced pluripotent stem cells (iPSCs). However, current protocols use reagents of animal origin (mainly fetal bovine serum, FBS) that carry the potential risk of infectious diseases and unwanted immunogenicity. Here, we report a chemically defined protocol to isolate and maintain the growth and differentiation potential of hDPCs. hDPCs cultured under these conditions showed significantly less primary colony formation than those with FBS. Cell culture under stringently defined conditions revealed a donor-dependent growth capacity; however, once established, the differentiation capabilities of the hDPCs were comparable to those observed with FBS. DNA array analyses indicated that the culture conditions robustly altered hDPC gene expression patterns but, more importantly, had little effect on neither pluripotent gene expression nor the efficiency of iPSC induction. The chemically defined culture conditions described herein are not perfect serum replacements, but can be used for the safe establishment of iPSCs and will find utility in applications for cell-based regenerative medicine.	[Takeda-Kawaguchi, Tomoko; Sugiyama, Ken; Iida, Kazuki; Tamaoki, Naritaka; Hatakeyama, Daijiro; Shibata, Toshiyuki] Gifu Univ, Grad Sch Med, Dept Oral & Maxillofacial Sci, Gifu, Japan; [Chikusa, Shunji; Aoki, Hitomi; Kunisada, Takahiro; Tezuka, Ken-ichi] Gifu Univ, Grad Sch Med, Dept Tissue & Organ Dev, Gifu, Japan; [Fusaki, Noemi] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Gifu University; Gifu University; Keio University	Tezuka, K (corresponding author), Gifu Univ, Grad Sch Med, Dept Tissue & Organ Dev, Gifu, Japan.	tezuka@gifu-u.ac.jp	Fusaki, Noemi/U-1628-2019; Tezuka, Ken-ichi/B-3836-2012	Kunisada, Takahiro/0000-0003-1651-2716	Ministry of Education, Science, and Culture of Japan [22592181]; JST Yamanaka iPS Cell Project	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST Yamanaka iPS Cell Project	This work was supported by grants from the Ministry of Education, Science, and Culture of Japan (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm; grant number: 22592181 TK), and the JST Yamanaka iPS Cell Project (http://www.jst.go.jp; TK, TS, KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235; Eloit M, 1999, Dev Biol Stand, V99, P9; ERICKSON GA, 1991, DEV BIOLOGICALS, V75, P173; Escobedo-Lucea C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067870; Ferro F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041774; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Iida K, 2013, J DENT RES, V92, P905, DOI 10.1177/0022034513502204; Iida K, 2010, ARCH ORAL BIOL, V55, P648, DOI 10.1016/j.archoralbio.2010.06.005; Knight R, 2010, TRANSFUS APHER SCI, V43, P387, DOI 10.1016/j.transci.2010.09.003; Lizier NF, 2013, INTECH, P131; Oda Y, 2010, J BIOL CHEM, V285, P29270, DOI 10.1074/jbc.M109.055889; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Shah G, 1999, Dev Biol Stand, V99, P17; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takeda T, 2008, J DENT RES, V87, P676, DOI 10.1177/154405910808700716; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; van der Valk J, 2004, TOXICOL IN VITRO, V18, P1, DOI 10.1016/j.tiv.2003.08.009; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wessman S J, 1999, Dev Biol Stand, V99, P3; Willkommen H, 1999, Dev Biol Stand, V99, P131; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314	27	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115392	10.1371/journal.pone.0115392	http://dx.doi.org/10.1371/journal.pone.0115392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521610	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845600042
J	Johnson, JL; Jones, MB; Cobb, BA				Johnson, Jenny L.; Jones, Mark B.; Cobb, Brian A.			Polysaccharide A from the Capsule of Bacteroides fragilis Induces Clonal CD4(+) T Cell Expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSCESS FORMATION; NITRIC-OXIDE; ANTIGEN; PROTECTION; GLYCOSYLATION; MODULATION	For 3 decades, the view of MHCII-dependent antigen presentation has been completely dominated by peptide antigens despite our 2004 discovery in which MHCII was shown to present processed fragments of zwitterionic capsular polysaccharides to T cells. Published findings further demonstrate that polysaccharide A (PSA) from the capsule of Bacteroides fragilis is a potent activator of CD4(+) T cells and that these T cells have important biological functions, especially in the maintenance of immunological homeostasis. However, little is known about the nature of T cell recognition of the polysaccharide-MHCII complex or the phenotype of the resulting activated cells. Here, we use next-generation sequencing of the alpha beta T cell receptor of CD4(+) T cells from mice stimulated with PSA in comparison with protein antigen simulation and non-immunized controls and found that PSA immunization induced clonal expansion of a small subset of suppressive CD4(+) CD45RB(low) effector/memory T cells. Moreover, the sequences of the complementarity-determining region 3 (CDR3) loop from top clones indicate a lack of specific variable beta and joining region use and average CDR3loop length. There was also a preference for a zwitterionic motif within the CDR3 loop sequences, aligning well with the known requirement for a similar motif within PSA to enable T cell activation. These data support a model in which PSA, and possibly other T cell-dependent polysaccharide antigens, elicits a clonal and therefore specific CD4(+) T cell response often characterized by pairing dual-charged CDR3 loop sequences with dual-charged PSA.	[Johnson, Jenny L.; Jones, Mark B.; Cobb, Brian A.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University	Cobb, BA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	brian.cobb@case.edu		Johnson, Jenny/0000-0002-5939-4521	National Institutes of Health [GM082916, OD004225]; American Asthma Foundation [10-0187]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082916] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants GM082916 and OD004225 (to B. A. C.). This work was also supported by American Asthma Foundation Grant 10-0187 (to B. A. C.).	Blaser MJ, 2014, J CLIN INVEST, V124, P4162, DOI 10.1172/JCI78366; Brubaker JO, 1999, J IMMUNOL, V162, P2235; CHOI YW, 1989, P NATL ACAD SCI USA, V86, P8941, DOI 10.1073/pnas.86.22.8941; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; Cobb BA, 2008, GLYCOBIOLOGY, V18, P707, DOI 10.1093/glycob/cwn050; Kreisman LSC, 2007, GLYCOBIOLOGY, V17, P46, DOI 10.1093/glycob/cwl056; Kreisman LSC, 2011, J BIOL CHEM, V286, P8810, DOI 10.1074/jbc.M110.206011; Lewis CJ, 2011, EUR J IMMUNOL, V41, P2562, DOI 10.1002/eji.201141396; Marrero I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076546; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Ruiz-Perez B, 2005, P NATL ACAD SCI USA, V102, P16753, DOI 10.1073/pnas.0505688102; Ryan SO, 2014, GLYCOBIOLOGY, V24, P262, DOI 10.1093/glycob/cwt107; Ryan SO, 2012, SEMIN IMMUNOPATHOL, V34, P425, DOI 10.1007/s00281-012-0309-9; Ryan SO, 2011, J EXP MED, V208, P1041, DOI 10.1084/jem.20100508; Stingele F, 2004, J IMMUNOL, V172, P1483, DOI 10.4049/jimmunol.172.3.1483; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; TZIANABOS AO, 1993, SCIENCE, V262, P416, DOI 10.1126/science.8211161; TZIANABOS AO, 1992, J BIOL CHEM, V267, P18230; Tzianabos AO, 1995, J CLIN INVEST, V96, P2727, DOI 10.1172/JCI118340; TZIANABOS AO, 1994, INFECT IMMUN, V62, P4881, DOI 10.1128/IAI.62.11.4881-4886.1994; Tzianabos AO, 1998, J INFECT DIS, V178, P200, DOI 10.1086/515594; Tzianabos AO, 2001, P NATL ACAD SCI USA, V98, P9365, DOI 10.1073/pnas.161175598; Velez CD, 2009, IMMUNOLOGY, V127, P73, DOI 10.1111/j.1365-2567.2008.02924.x; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Young NM, 2011, GLYCOBIOLOGY, V21, P1266, DOI 10.1093/glycob/cwr018	27	49	55	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5007	5014		10.1074/jbc.M114.621771	http://dx.doi.org/10.1074/jbc.M114.621771			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25540199	Green Published, hybrid			2022-12-26	WOS:000350042000042
J	Law, AL; Parinot, C; Chatagnon, J; Gravez, B; Sahel, JA; Bhattacharya, SS; Nandrot, EF				Law, Ah-Lai; Parinot, Celia; Chatagnon, Jonathan; Gravez, Basile; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Nandrot, Emeline F.			Cleavage of Mer Tyrosine Kinase (MerTK) from the Cell Surface Contributes to the Regulation of Retinal Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER SEGMENT PHAGOCYTOSIS; ARREST-SPECIFIC GENE; APOPTOTIC CELLS; PIGMENT-EPITHELIUM; ALPHA-V-BETA-5 INTEGRIN; MEDIATED PHAGOCYTOSIS; DYSTROPHY PHENOTYPE; SOLUBLE FORM; MICE LACKING; PROTEIN-S	Phagocytosis of apoptotic cells by macrophages and spent photoreceptor outer segments (POS) by retinal pigment epithelial (RPE) cells requires several proteins, including MerTK receptors and associated Gas6 and protein S ligands. In the retina, POS phagocytosis is rhythmic, and MerTK is activated promptly after light onset via the alpha v beta 5 integrin receptor and its ligand MFG-E8, thus generating a phagocytic peak. The phagocytic burst is limited in time, suggesting a down-regulation mechanism that limits its duration. Our previous data showed that MerTK helps control POS binding of integrin receptors at the RPE cell surface as a negative feedback loop. Our present results show that a soluble form of MerTK (sMerTK) is released in the conditioned media of RPE-J cells during phagocytosis and in the interphotoreceptor matrix of the mouse retina during the morning phagocytic peak. In contrast to macrophages, the two cognate MerTK ligands have an opposite effect on phagocytosis and sMerTK release, whereas the integrin ligand MFG-E8 markedly increases both phagocytosis and sMerTK levels. sMerTK acts as a decoy receptor blocking the effect of both MerTK ligands. Interestingly, stimulation of sMerTK release decreases POS binding. Conversely, blocking MerTK cleavage increased mostly POS binding by RPE cells. Therefore, our data suggest that MerTK cleavage contributes to the acute regulation of RPE phagocytosis by limiting POS binding to the cell surface.	[Law, Ah-Lai; Parinot, Celia; Chatagnon, Jonathan; Gravez, Basile; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Nandrot, Emeline F.] Univ Paris 06, INSERM, U968, UMR S968,Inst Vis, F-75012 Paris, France; [Law, Ah-Lai; Parinot, Celia; Chatagnon, Jonathan; Gravez, Basile; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Nandrot, Emeline F.] Univ Paris 06, Sorbonne Univ, UMR S968, Inst Vis, F-75012 Paris, France; [Law, Ah-Lai; Parinot, Celia; Chatagnon, Jonathan; Gravez, Basile; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Nandrot, Emeline F.] CNRS, UMR 7210, F-75012 Paris, France; [Sahel, Jose-Alain] INSERM, Ctr Hosp Natl Ophtalmol Quinze Vingts, Direct Hosp & Offre Soins, Ctr Invest Clin 1423, F-75012 Paris, France; [Bhattacharya, Shomi S.] UCL, Inst Ophthalmol, London WC1E 6BT, England; [Nandrot, Emeline F.] Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Seville 41092, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Nandrot, EF (corresponding author), Inst Vis, 17 Rue Moreau, F-75012 Paris, France.	emeline.nandrot@inserm.fr	Sahel, Jose-Alain/F-3172-2017; Nandrot, Emeline F./AAN-3925-2020; Bhattacharya, Shom/N-2926-2016	Sahel, Jose-Alain/0000-0002-4831-1153; Bhattacharya, Shom/0000-0002-1601-6344; Nandrot, Emeline/0000-0003-3087-078X	INSERM; Universite Pierre et Marie Curie-Paris6; CNRS; Department de Paris	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Pierre et Marie Curie-Paris6; CNRS(Centre National de la Recherche Scientifique (CNRS)); Department de Paris	We thank Stephane Fouquet (Imaging Facility, Institut de la Vision) and Quentin Rieu for help with confocal microscopy. The Institut de la Vision is funded by INSERM, Universite Pierre et Marie Curie-Paris6, CNRS, and Department de Paris.	BOESZEBATTAGLIA K, 1992, EXP EYE RES, V54, P821, DOI 10.1016/0014-4835(92)90040-Y; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Burstyn-Cohen T, 2012, NEURON, V76, P1123, DOI 10.1016/j.neuron.2012.10.015; Chen J, 1997, ONCOGENE, V14, P2033, DOI 10.1038/sj.onc.1201039; Cheong HS, 2007, RHEUMATOLOGY, V46, P209, DOI 10.1093/rheumatology/kel182; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Costa M, 1996, J CELL PHYSIOL, V168, P737, DOI 10.1002/(SICI)1097-4652(199609)168:3<737::AID-JCP27>3.0.CO;2-U; Cummings CT, 2013, CLIN CANCER RES, V19, P5275, DOI 10.1158/1078-0432.CCR-12-1451; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Dickhout JG, 2008, ARTERIOSCL THROM VAS, V28, P1413, DOI 10.1161/ATVBAHA.108.169144; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hall MO, 2005, EXP EYE RES, V81, P581, DOI 10.1016/j.exer.2005.03.017; HALL MO, 1987, EXP EYE RES, V45, P907, DOI 10.1016/S0014-4835(87)80105-7; Hall MO, 2001, EXP EYE RES, V73, P509, DOI 10.1006/exer.2001.1062; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Heaney ML, 1996, BLOOD, V87, P847, DOI 10.1182/blood.V87.3.847.bloodjournal873847; Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411, DOI 10.1093/oxfordjournals.jbchem.a022622; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Ling L, 1996, J BIOL CHEM, V271, P18355, DOI 10.1074/jbc.271.31.18355; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; McHenry CL, 2004, INVEST OPHTH VIS SCI, V45, P1456, DOI 10.1167/iovs.03-0909; Nandrot E, 2000, NEUROBIOL DIS, V7, P586, DOI 10.1006/nbdi.2000.0328; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Nandrot EF, 2012, BIOL CELL, V104, P326, DOI 10.1111/boc.201100076; Parinot C, 2014, JOVE-J VIS EXP, DOI 10.3791/52100; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Ruggiero L, 2012, P NATL ACAD SCI USA, V109, P8145, DOI 10.1073/pnas.1121101109; Ryeom SW, 1996, J BIOL CHEM, V271, P20536, DOI 10.1074/jbc.271.34.20536; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Tibrewal N, 2008, J BIOL CHEM, V283, P3618, DOI 10.1074/jbc.M706906200; Tschernutter M, 2006, BRIT J OPHTHALMOL, V90, P718, DOI 10.1136/bjo.2005.084897; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; Wavre-Shapton ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057769; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; YOUNG RW, 1977, J ULTRA MOL STRUCT R, V61, P172, DOI 10.1016/S0022-5320(77)80084-1	50	35	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4941	4952		10.1074/jbc.M114.628297	http://dx.doi.org/10.1074/jbc.M114.628297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25538233	Green Published, hybrid			2022-12-26	WOS:000350042000037
J	Li, XJ; Goodwin, CB; Nabinger, SC; Richine, BM; Yang, ZY; Hanenberg, H; Ohnishi, H; Matozaki, T; Feng, GS; Chan, RJ				Li, Xing Jun; Goodwin, Charles B.; Nabinger, Sarah C.; Richine, Briana M.; Yang, Zhenyun; Hanenberg, Helmut; Ohnishi, Hiroshi; Matozaki, Takashi; Feng, Gen-Sheng; Chan, Rebecca J.			Protein-tyrosine Phosphatase Shp2 Positively Regulates Macrophage Oxidative Burst	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE MYELOMONOCYTIC LEUKEMIA; NADPH OXIDASE ACTIVITY; ENCODING GP91(PHOX); FC-RECEPTOR; ACTIVATION; PTPN11; MUTATIONS; PATHWAY; KINASE; DOMAIN	Macrophages are vital to innate immunity and express pattern recognition receptors and integrins for the rapid detection of invading pathogens. Stimulation of Dectin-1 and complement receptor 3 (CR3) activates Erk- and Akt-dependent production of reactive oxygen species (ROS). Shp2, a protein-tyrosine phosphatase encoded by Ptpn11, promotes activation of Ras-Erk and PI3K-Akt and is crucial for hematopoietic cell function; however, no studies have examined Shp2 function in particulate-stimulated ROS production. Maximal Dectin-1-stimulated ROS production corresponded kinetically to maximal Shp2 and Erk phosphorylation. Bone marrow-derived macrophages (BMMs) from mice with a conditionally deleted allele of Ptpn11 (Shp2(flox/flox); Mx1Cre+) produced significantly lower ROS levels compared with control BMMs. Although YFP-tagged phosphatase dead Shp2-C463A was strongly recruited to the early phagosome, its expression inhibited Dectin-1- and CR3-stimulated phospho-Erk and ROS levels, placing Shp2 phosphatase function and Erk activation upstream of ROS production. Further, BMMs expressing gain of function Shp2-D61Y or Shp2-E76K and peritoneal exudate macrophages from Shp2D61Y/+; Mx1Cre + mice produced significantly elevated levels of Dectin-1- and CR3-stimulated ROS, which was reduced by pharmacologic inhibition of Erk. SIRP alpha (signal regulatory protein alpha) is a myeloid inhibitory immunoreceptor that requires tyrosine phosphorylation to exert its inhibitory effect. YFP-Shp2C463A-expressing cells have elevated phospho-SIRP alpha levels and an increased Shp2-SIRP alpha interaction compared with YFP-WT Shp2-expressing cells. Collectively, these findings indicate that Shp2 phosphatase function positively regulates Dectin-1-and CR3-stimulated ROS production in macrophages by dephosphorylating and thus mitigating the inhibitory function of SIRP alpha and by promoting Erk activation.	[Li, Xing Jun; Hanenberg, Helmut; Chan, Rebecca J.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Li, Xing Jun; Goodwin, Charles B.; Richine, Briana M.; Hanenberg, Helmut; Chan, Rebecca J.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Goodwin, Charles B.; Nabinger, Sarah C.; Richine, Briana M.; Hanenberg, Helmut; Chan, Rebecca J.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Yang, Zhenyun] West Coast Univ, Los Angeles, CA 91606 USA; [Hanenberg, Helmut] Univ Dusseldorf, Dept Otorhinolaryngol & Head Neck Surg, D-40225 Dusseldorf, Germany; [Ohnishi, Hiroshi] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gunma 3718514, Japan; [Matozaki, Takashi] Kobe Univ, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Feng, Gen-Sheng] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Heinrich Heine University Dusseldorf; Gunma University; Kobe University; University of California System; University of California San Diego	Li, XJ (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.	xl9@iu.edu; rchan@iu.edu			National Institutes of Health [RO1 CA134777]; Showalter Research Trust; Riley Children's Foundation; Indiana University-Purdue University Indianapolis Office of the Vice Chancellor for Research; NATIONAL CANCER INSTITUTE [R01CA134777, P30CA082709] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007910, R01HL129763] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26291022] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Research Trust; Riley Children's Foundation; Indiana University-Purdue University Indianapolis Office of the Vice Chancellor for Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA134777 (to R. J. C.). This work was also supported by funds from the Showalter Research Trust (to X. J. L.), the Riley Children's Foundation, and the Indiana University-Purdue University Indianapolis Office of the Vice Chancellor for Research.	Chan G, 2011, BLOOD, V117, P4253, DOI 10.1182/blood-2010-11-319517; Chan G, 2009, BLOOD, V113, P4414, DOI 10.1182/blood-2008-10-182626; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Cunha C, 2010, BLOOD, V116, P5394, DOI 10.1182/blood-2010-04-279307; Dewas C, 2000, J IMMUNOL, V165, P5238, DOI 10.4049/jimmunol.165.9.5238; Dinauer Mary C, 2005, Hematology Am Soc Hematol Educ Program, P89; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Goodridge HS, 2012, TRAFFIC, V13, P1062, DOI 10.1111/j.1600-0854.2012.01382.x; Goodwin CB, 2012, HAEMATOL-HEMATOL J, V97, P1042, DOI 10.3324/haematol.2011.046896; GREENBERG S, 1990, J EXP MED, V172, P1853, DOI 10.1084/jem.172.6.1853; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Gu HH, 2003, J CELL BIOL, V161, P1151, DOI 10.1083/jcb.200212158; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Huang H, 2012, GENE DEV, V26, P1587, DOI 10.1101/gad.192054.112; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Laplante MA, 2003, J HYPERTENS, V21, P927, DOI 10.1097/00004872-200305000-00017; Li XJ, 2010, J BIOL CHEM, V285, P35169, DOI 10.1074/jbc.M110.164475; Li XJ, 2009, MOL BIOL CELL, V20, P1520, DOI 10.1091/mbc.E08-06-0620; Lindsey S, 2007, J BIOL CHEM, V282, P2237, DOI 10.1074/jbc.M608642200; Liu Dong-Sheng, 2011, SENSORS, V11, P6494, DOI DOI 10.1109/W; Lorenzana A, 2002, J PEDIAT HEMATOL ONC, V24, P136, DOI 10.1097/00043426-200202000-00016; Mackey-Lawrence NM, 2012, MUCOSAL IMMUNOL, V5, P472, DOI 10.1038/mi.2012.40; Makni-Maalej K, 2013, BIOCHEM PHARMACOL, V85, P92, DOI 10.1016/j.bcp.2012.10.010; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Minakami R, 2006, INT J HEMATOL, V84, P193, DOI 10.1532/IJH97.06133; Miyake A, 2008, GENES CELLS, V13, P209, DOI 10.1111/j.1365-2443.2007.01161.x; Moritake H, 2009, PEDIATR BLOOD CANCER, V53, P1324, DOI 10.1002/pbc.22253; Nabinger SC, 2013, LEUKEMIA, V27, P398, DOI 10.1038/leu.2012.308; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Noguchi T, 1996, J BIOL CHEM, V271, P27652, DOI 10.1074/jbc.271.44.27652; Pinkel D, 1998, BLOOD, V91, P365, DOI 10.1182/blood.V91.1.365.365_365_367; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Qu CK, 1998, MOL CELL BIOL, V18, P6075, DOI 10.1128/MCB.18.10.6075; Qu CK, 1997, MOL CELL BIOL, V17, P5499, DOI 10.1128/MCB.17.9.5499; Stasia MJ, 2008, SEMIN IMMUNOPATHOL, V30, P209, DOI 10.1007/s00281-008-0121-8; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Taylor RM, 2004, J IMMUNOL, V173, P7349, DOI 10.4049/jimmunol.173.12.7349; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; Torres M, 1999, ARCH BIOCHEM BIOPHYS, V366, P231, DOI 10.1006/abbi.1999.1225; van Beek EM, 2012, CELL REP, V2, P748, DOI 10.1016/j.celrep.2012.08.027; Yang ZY, 2009, MOL CELL BIOL, V29, P4376, DOI 10.1128/MCB.01330-08; You M, 2001, J EXP MED, V193, P101, DOI 10.1084/jem.193.1.101; Zeng MY, 2013, BLOOD, V121, P3473, DOI 10.1182/blood-2012-10-461913; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zhu C, 2008, J LEUKOCYTE BIOL, V83, P680, DOI 10.1189/jlb.0807514; Zhu HH, 2011, BLOOD, V117, P5350, DOI 10.1182/blood-2011-01-333476	55	20	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3894	3909		10.1074/jbc.M114.614057	http://dx.doi.org/10.1074/jbc.M114.614057			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25538234	Green Published, hybrid			2022-12-26	WOS:000349458400002
J	Bergo, A; Strollo, M; Gai, M; Barbiero, I; Stefanelli, G; Sertic, S; Gigli, CC; Di Cunto, F; Kilstrup-Nielsen, C; Landsberger, N				Bergo, Anna; Strollo, Marta; Gai, Marta; Barbiero, Isabella; Stefanelli, Gilda; Sertic, Sarah; Gigli, Clementina Cobolli; Di Cunto, Ferdinando; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta			Methyl-CpG Binding Protein 2 (MeCP2) Localizes at the Centrosome and Is Required for Proper Mitotic Spindle Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL GENE-EXPRESSION; RETT-SYNDROME; MOUSE MODEL; HISTONE DEACETYLASE; LINKED MECP2; CHROMATIN; PHOSPHORYLATION; TRANSCRIPTION; MUTATIONS; CELLS	Mutations in MECP2 cause a broad spectrum of neuropsychiatric disorders of which Rett syndrome represents the best defined condition. Both neuronal and non-neuronal functions of the methyl-binding protein underlie the related pathologies. Nowadays MeCP2 is recognized as a multifunctional protein that modulates its activity depending on its protein partners and posttranslational modifications. However, we are still missing a comprehensive understanding of all MeCP2 functions and their involvement in the related pathologies. The study of human mutations often offers the possibility of clarifying the functions of a protein. Therefore, we decided to characterize a novel MeCP2 phospho-isoform (Tyr-120) whose relevance was suggested by a Rett syndrome patient carrying a Y120D substitution possibly mimicking a constitutively phosphorylated state. Unexpectedly, we found MeCP2 and its Tyr-120 phospho-isoform enriched at the centrosome both in dividing and postmitotic cells. The molecular and functional connection of MeCP2 to the centrosome was further reinforced through cellular and biochemical approaches. We show that, similar to many centrosomal proteins, MeCP2 deficiency causes aberrant spindle geometry, prolonged mitosis, and defects in microtubule nucleation. Collectively, our data indicate a novel function of MeCP2 that might reconcile previous data regarding the role of MeCP2 in cell growth and cytoskeleton stability and that might be relevant to understand some aspects of MeCP2-related conditions. Furthermore, they link the Tyr-120 residue and its phosphorylation to cell division, prompting future studies on the relevance of Tyr-120 for cortical development.	[Bergo, Anna; Strollo, Marta; Barbiero, Isabella; Stefanelli, Gilda; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta] Univ Insubria, Dept Theoret & Appl Sci, Sect Biomed Res, I-21052 Busto Arsizio, Italy; [Gai, Marta; Di Cunto, Ferdinando] Univ Turin, Ctr Mol Biotechnol, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy; [Sertic, Sarah] Univ Milan, Dept Life Sci, I-20133 Milan, Italy; [Gigli, Clementina Cobolli; Landsberger, Nicoletta] Ist Sci San Raffaele, Div Neurosci, San Raffaele Rett Res Unit, I-20132 Milan, Italy	University of Insubria; University of Turin; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Landsberger, N (corresponding author), Univ Insubria, Via Manara 7, I-21052 Busto Arsizio, Italy.	landsben@uninsubria.it	Sertic, Sarah/AAD-8972-2021; Di Cunto, Ferdinando/K-5575-2016	SERTIC, SARAH/0000-0003-1458-410X; stefanelli, gilda/0000-0001-7034-8174; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077; Landsberger, Nicoletta/0000-0003-0820-3155; di cunto, ferdinando/0000-0001-9367-6357	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG-10319]; Telethon [GGP10032, GGP12094]; Ministero della Salute; Fondation Jerome Lejeune; Italian Association proRETT Ricerca; ProRETT Ricerca, an Italian association of parents	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); Ministero della Salute(Ministry of Health, Italy); Fondation Jerome Lejeune; Italian Association proRETT Ricerca; ProRETT Ricerca, an Italian association of parents	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) Grant IG-10319 (to N. L.), by Telethon Grants GGP10032 (to N. L.) and GGP12094 (to F. D. C.), by Ministero della Salute (Ricerca finalizzata 2008-Bando Malattie Rare) (to N. L.), by a Fondation Jerome Lejeune grant (to F. D. C.), by the Italian Association proRETT Ricerca, and by ProRETT Ricerca, an Italian association of parents.	Adams VH, 2007, J BIOL CHEM, V282, P15057, DOI 10.1074/jbc.M700855200; Agarwal N, 2011, HUM MOL GENET, V20, P4187, DOI 10.1093/hmg/ddr346; Alvarez-Saavedra M, 2010, HUM MOL GENET, V19, P2177, DOI 10.1093/hmg/ddq096; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Ausio J, 2014, TRENDS MOL MED, V20, P487, DOI 10.1016/j.molmed.2014.03.004; Azimzadeh J, 2009, J CELL BIOL, V185, P101, DOI 10.1083/jcb.200808082; Babbio F, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-19; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Balmer D, 2002, HUM GENET, V110, P545, DOI 10.1007/s00439-002-0724-4; Bedogni F, 2014, NEUROSCI BIOBEHAV R, V46, P187, DOI 10.1016/j.neubiorev.2014.01.011; Bellini E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00236; Bracaglia G, 2009, EMBO REP, V10, P1327, DOI 10.1038/embor.2009.217; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Cheval H, 2012, HUM MOL GENET, V21, P3806, DOI 10.1093/hmg/dds208; Damen D, 2013, BIOL CHEM, V394, P1595, DOI 10.1515/hsz-2013-0193; De Filippis B, 2010, GENES BRAIN BEHAV, V9, P213, DOI 10.1111/j.1601-183X.2009.00551.x; Delaval B, 2011, NAT CELL BIOL, V13, P461, DOI 10.1038/ncb2202; Delepine C, 2013, FEBS LETT, V587, P245, DOI 10.1016/j.febslet.2012.11.033; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Inui K, 2001, BRAIN DEV-JPN, V23, P212, DOI 10.1016/S0387-7604(01)00197-8; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Klose RJ, 2004, J BIOL CHEM, V279, P46490, DOI 10.1074/jbc.M408284200; Kudo S, 2003, J MED GENET, V40, P487, DOI 10.1136/jmg.40.7.487; Li HD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6601; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; Marschik PB, 2013, RES DEV DISABIL, V34, P1236, DOI 10.1016/j.ridd.2013.01.014; Mazzorana M, 2011, CURR CANCER DRUG TAR, V11, P600, DOI 10.2174/156800911795655949; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Minh VCN, 2012, J NEUROSCI, V32, P10021, DOI 10.1523/JNEUROSCI.1316-12.2012; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Nagai K, 2005, DEV BRAIN RES, V157, P103, DOI 10.1016/j.devbrainres.2005.03.011; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Reber S, 2011, METHODS MOL BIOL, V777, P107, DOI 10.1007/978-1-61779-252-6_8; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Roux JC, 2012, NEUROBIOL DIS, V45, P786, DOI 10.1016/j.nbd.2011.11.002; Rusconi L, 2008, J BIOL CHEM, V283, P30101, DOI 10.1074/jbc.M804613200; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Thambirajah AA, 2009, BIOESSAYS, V31, P561, DOI 10.1002/bies.200800220; Webb R, 2009, ARTHRITIS RHEUM-US, V60, P1076, DOI 10.1002/art.24360; Yaqinuddin A, 2008, BIOSCIENCE REP, V28, P319, DOI 10.1042/BSR20080032; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	52	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3223	3237		10.1074/jbc.M114.608125	http://dx.doi.org/10.1074/jbc.M114.608125			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25527496	Green Published, hybrid			2022-12-26	WOS:000349456000004
J	Hamm, DC; Bondra, ER; Harrison, MM				Hamm, Danielle C.; Bondra, Eliana R.; Harrison, Melissa M.			Transcriptional Activation Is a Conserved Feature of the Early Embryonic Factor Zelda That Requires a Cluster of Four Zinc Fingers for DNA Binding and a Low-complexity Activation Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-ZYGOTIC TRANSITION; CELL-FREE FORMATION; DROSOPHILA-MELANOGASTER; GENE; REGIONS; REPRESSION; BLASTODERM; PHYLOGENY; SEQUENCES; THOUSANDS	Delayed transcriptional activation of the zygotic genome is a nearly universal phenomenon in metazoans. Immediately following fertilization, development is controlled by maternally deposited products, and it is not until later stages that widespread activation of the zygotic genome occurs. Although the mechanisms driving this genome activation are currently unknown, the transcriptional activator Zelda (ZLD) has been shown to be instrumental in driving this process in Drosophila melanogaster. Here we define functional domains of ZLD required for both DNA binding and transcriptional activation. We show that the C-terminal cluster of four zinc fingers mediates binding to TAG team DNA elements in the promoters of early expressed genes. All four zinc fingers are required for this activity, and splice isoforms lacking three of the four zinc fingers fail to activate transcription. These truncated splice isoforms dominantly suppress activation by the full-length, embryonically expressed isoform. We map the transcriptional activation domain of ZLD to a central region characterized by low complexity. Despite relatively little sequence conservation within this domain, ZLD orthologs from Drosophila virilis, Anopheles gambiae, and Nasonia vitripennis activate transcription in D. melanogaster cells. Transcriptional activation by these ZLD orthologs suggests that ZLD functions through conserved interactions with a protein cofactor(s). We have identified distinct DNA-binding and activation domains within the critical transcription factor ZLD that controls the initial activation of the zygotic genome.	[Hamm, Danielle C.; Bondra, Eliana R.; Harrison, Melissa M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Harrison, MM (corresponding author), Univ Wisconsin, Dept Biomol Chem, 420 Henry Mall 1135, Madison, WI 53706 USA.	mharrison3@wisc.edu		Hamm, Danielle/0000-0003-2966-7389	March of Dimes; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111694] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Basil O'Connor Starter Scholar Research Award from the March of Dimes (to M. M. H.) and by a National Science Foundation predoctoral fellowship (to D. C. H.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Biedler JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033933; Bradley RK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000343; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; Foo SM, 2014, CURR BIOL, V24, P1341, DOI 10.1016/j.cub.2014.04.032; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Giannios P, 2013, BIOCHEM BIOPH RES CO, V438, P329, DOI 10.1016/j.bbrc.2013.07.071; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Harrison MM, 2010, DEV BIOL, V345, P248, DOI 10.1016/j.ydbio.2010.06.026; Huntley MA, 2002, PROTEINS, V48, P134, DOI 10.1002/prot.10150; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Iwaki T, 2003, BIOTECHNIQUES, V35, P482, DOI 10.2144/03353bm08; JIANG J, 1992, EMBO J, V11, P3147, DOI 10.1002/j.1460-2075.1992.tb05387.x; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; KEYES LN, 1992, CELL, V68, P933, DOI 10.1016/0092-8674(92)90036-C; KIROV N, 1993, EMBO J, V12, P3193, DOI 10.1002/j.1460-2075.1993.tb05988.x; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Paris M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003748; Pearson JC, 2012, DEV BIOL, V366, P420, DOI 10.1016/j.ydbio.2012.04.001; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Staudt N, 2006, MOL BIOL CELL, V17, P2356, DOI 10.1091/mbc.E05-11-1056; Struffi P, 2011, DEVELOPMENT, V138, P4291, DOI 10.1242/dev.065987; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; ten Bosch JR, 2006, DEVELOPMENT, V133, P1967, DOI 10.1242/dev.02373; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wrischnik LA, 2003, GENETICS, V165, P2007	40	25	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3508	3518		10.1074/jbc.M114.602292	http://dx.doi.org/10.1074/jbc.M114.602292			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25538246	Green Published, hybrid			2022-12-26	WOS:000349456000025
J	Itou, H; Yagura, M; Shirakihara, Y; Itoh, T				Itou, Hiroshi; Yagura, Masaru; Shirakihara, Yasuo; Itoh, Tateo			Structural Basis for Replication Origin Unwinding by an Initiator Primase of Plasmid ColE2-P9 DUPLEX DNA UNWINDING BY A SINGLE PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REP PROTEIN; SPECIFICITY DETERMINANTS; CRYSTAL-STRUCTURE; COLE3 PLASMIDS; STRANDED-DNA; REFINEMENT; MECHANISM; INSIGHTS; COMPLEX	Duplex DNA is generally unwound by protein oligomers prior to replication. The Rep protein of plasmid ColE2-P9 (34 kDa) is an essential initiator for plasmid DNA replication. This protein binds the replication origin (Ori) in a sequence-specific manner as a monomer and unwinds DNA. Here we present the crystal structure of the DNA-binding domain of Rep (E2Rep-DBD) in complex with Ori DNA. The structure unveils the basis for Ori-specific recognition by the E2Rep-DBD and also reveals that it unwinds DNA by the concerted actions of its three contiguous structural modules. The structure also shows that the functionally unknown PriCT domain, which forms a compact module, plays a central role in DNA unwinding. The conservation of the PriCT domain in the C termini of some archaeo-eukaryotic primases indicates that it probably plays a similar role in these proteins. Thus, this is the first report providing the structural basis for the functional importance of the conserved PriCT domain and also reveals a novel mechanism for DNA unwinding by a single protein.	[Itou, Hiroshi; Shirakihara, Yasuo] Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan; [Yagura, Masaru] Natl Inst Genet, Dept Cell Genet, Mishima, Shizuoka 4118540, Japan; [Itoh, Tateo] Shinshu Univ, Fac Sci, Dept Biol, Matsumoto, Nagano 3908621, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Shinshu University	Itou, H (corresponding author), Natl Inst Genet, Struct Biol Ctr, Yata 1111, Mishima, Shizuoka 4118540, Japan.	hitou@nig.ac.jp			Japan Society for the Promotion of Science KAKENHI [25840027]; Grants-in-Aid for Scientific Research [25840027] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 25840027 (to H. I.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aoki K, 2007, J BACTERIOL, V189, P2392, DOI 10.1128/JB.01695-06; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boulikas T, 1996, J CELL BIOCHEM, V60, P297, DOI 10.1002/(SICI)1097-4644(19960301)60:3<297::AID-JCB2>3.0.CO;2-R; CARRERA P, 1994, NUCLEIC ACIDS RES, V22, P3671, DOI 10.1093/nar/22.18.3671; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Duderstadt KE, 2013, CURR OPIN STRUC BIOL, V23, P144, DOI 10.1016/j.sbi.2012.11.012; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giraldo R, 2004, PLASMID, V52, P69, DOI 10.1016/j.plasmid.2004.06.002; Giraldo R, 2003, NAT STRUCT BIOL, V10, P565, DOI 10.1038/nsb937; Han M, 2007, J BACTERIOL, V189, P1061, DOI 10.1128/JB.01455-06; Han M., 2007, THESIS SHINSHU U MAT; Han M, 2007, BIOCHEM BIOPH RES CO, V353, P306, DOI 10.1016/j.bbrc.2006.12.015; HORII T, 1988, MOL GEN GENET, V212, P225, DOI 10.1007/BF00334689; ITOH T, 1989, MOL GEN GENET, V219, P249, DOI 10.1007/BF00261184; Iyer LM, 2005, NUCLEIC ACIDS RES, V33, P3875, DOI 10.1093/nar/gki702; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; KIDO M, 1991, NUCLEIC ACIDS RES, V19, P2875, DOI 10.1093/nar/19.11.2875; KINGSBURY D T, 1970, Biochemical and Biophysical Research Communications, V41, P1538, DOI 10.1016/0006-291X(70)90562-0; Komori H, 1999, EMBO J, V18, P4597, DOI 10.1093/emboj/18.17.4597; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Le Chatelier E, 2001, J BIOL CHEM, V276, P10234, DOI 10.1074/jbc.M010118200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura A, 2007, P NATL ACAD SCI USA, V104, P18484, DOI 10.1073/pnas.0705623104; Neuwald AF, 1999, GENOME RES, V9, P27; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozaki S, 2012, NUCLEIC ACIDS RES, V40, P1648, DOI 10.1093/nar/gkr832; Schumacher MA, 2014, P NATL ACAD SCI USA, V111, P9121, DOI 10.1073/pnas.1406065111; Shinohara M, 1996, J MOL BIOL, V257, P290, DOI 10.1006/jmbi.1996.0163; Swan MK, 2006, P NATL ACAD SCI USA, V103, P18481, DOI 10.1073/pnas.0609046103; TAKECHI S, 1995, NUCLEIC ACIDS RES, V23, P4196, DOI 10.1093/nar/23.20.4196; TAKECHI S, 1995, EMBO J, V14, P5141, DOI 10.1002/j.1460-2075.1995.tb00196.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Yagura M, 2006, J BACTERIOL, V188, P999, DOI 10.1128/JB.188.3.999-1010.2006; Yagura M, 2006, BIOCHEM BIOPH RES CO, V345, P872, DOI 10.1016/j.bbrc.2006.04.168; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965; YASUEDA H, 1989, MOL GEN GENET, V215, P209, DOI 10.1007/BF00339719; Zannis-Hadjopoulos M, 1999, J CELL BIOCHEM, P1	46	5	5	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3601	3611		10.1074/jbc.M114.595645	http://dx.doi.org/10.1074/jbc.M114.595645			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25538245	hybrid, Green Published			2022-12-26	WOS:000349456000033
J	Rivetti, I; Fraschetti, S; Lionello, P; Zambianchi, E; Boero, F				Rivetti, Irene; Fraschetti, Simonetta; Lionello, Piero; Zambianchi, Enrico; Boero, Ferdinando			Global Warming and Mass Mortalities of Benthic Invertebrates in the Mediterranean Sea	PLOS ONE			English	Article							CLIMATE-CHANGE; LIGURIAN SEA; SPECIES RICHNESS; MARINE; BIODIVERSITY; TEMPERATURE; POPULATIONS; INCREASES; CNIDARIA; DISEASE	Satellite data show a steady increase, in the last decades, of the surface temperature (upper few millimetres of the water surface) of the Mediterranean Sea. Reports of mass mortalities of benthic marine invertebrates increased in the same period. Some local studies interpreted the two phenomena in a cause-effect fashion. However, a basin-wide picture of temperature changes combined with a systematic assessment on invertebrate mass mortalities was still lacking. Both the thermal structure of the water column in the Mediterranean Sea over the period 1945-2011 and all documented invertebrate mass mortality events in the basin are analysed to ascertain if: 1-documented mass mortalities occurred under conditions of positive temperature trends at basin scale, and 2-atypical thermal conditions were registered at the smaller spatial and temporal scale of mass mortality events. The thermal structure of the shallow water column over the last 67 years was reconstructed using data from three public sources: MEDAR-MEDATLAS, World Ocean Database, MFS-VOS programme. A review of the mass mortality events of benthic invertebrates at Mediterranean scale was also carried out. The analysis of in situ temperature profiles shows that the Mediterranean Sea changed in a nonhomogeneous fashion. The frequency of mass mortalities is increasing. The areas subjected to these events correspond to positive thermal anomalies. Statistically significant temperature trends in the upper layers of the Mediterranean Sea show an increase of up to 0.07 degrees C/yr for a large fraction of the basin. Mass mortalities are consistent with both the temperature increase at basin scale and the thermal changes at local scale, up to 5.2 degrees C. Our research supports the existence of a causal link between positive thermal anomalies and observed invertebrate mass mortalities in the Mediterranean Sea, invoking focused mitigation initiatives in sensitive areas.	[Rivetti, Irene; Fraschetti, Simonetta; Lionello, Piero; Boero, Ferdinando] Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali, CoNISMa, Lecce, Italy; [Lionello, Piero; Boero, Ferdinando] CMCC Euromediterranean Ctr Climate Change, Lecce, Italy; [Zambianchi, Enrico] Univ Napoli Parthenope, CoNISMa, Dipartimento Sci Ambiente, Naples, Italy; [Boero, Ferdinando] CNR, Ist Sci Marine, Genoa, Italy	CoNISMa; University of Salento; Centro Euro-Mediterraneo sui Cambiamenti Climatici (CMCC); CoNISMa; Parthenope University Naples; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Rivetti, I (corresponding author), Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali, CoNISMa, Lecce, Italy.	irene.rivetti@unisalento.it	lionello, piero/B-4370-2010; Fraschetti, Simonetta/R-8716-2019	lionello, piero/0000-0002-0779-5681; Fraschetti, Simonetta/0000-0002-1780-1651; zambianchi, enrico/0000-0001-5474-7466; Boero, Ferdinando/0000-0002-6317-2710	Centro Euro Mediterraneo sui Cambiamenti Climatici; flagship italian project RITMARE; European Community's 7th Framework Programmes (FP7) [287844, 287600]; Italian Ministry of the Research PRIN TETRIS	Centro Euro Mediterraneo sui Cambiamenti Climatici; flagship italian project RITMARE; European Community's 7th Framework Programmes (FP7); Italian Ministry of the Research PRIN TETRIS	IR was supported by the Centro Euro Mediterraneo sui Cambiamenti Climatici (www.cmcc.it).The research leading to these results received financial support from the flagship italian project RITMARE (http://www.ritmare.it/).The research also received funding from the European Community's 7th Framework Programmes (FP7/2007-2013) for the project COCONET Grant agreement No. 287844, http://www.coconet-fp7.eu/) and PERSEUS Grant agreement No. 287600, http://www.perseus-net.eu/site/content.php). The support by the European Union from VECTORS http://www.marine-vectors.eu/) and from the Italian Ministry of the Research PRIN TETRIS is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, J ICRU, V8, P5, DOI 10.1093/jicru/ndn022; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Bensoussan N, 2010, ESTUAR COAST SHELF S, V87, P431, DOI 10.1016/j.ecss.2010.01.008; Bertocci I, 2005, ECOLOGY, V86, P2061, DOI 10.1890/04-1698; BETHOUX JP, 1990, NATURE, V347, P660, DOI 10.1038/347660a0; Bethoux JP, 1999, PROG OCEANOGR, V44, P131, DOI 10.1016/S0079-6611(99)00023-3; Bethoux JP, 1999, J MARINE SYST, V20, P33, DOI 10.1016/S0924-7963(98)00069-4; Betti F, 2012, MAR ECOL-EVOL PERSP, V33, P49, DOI [10.1111/j.1439-0485.2012.00525.x, 10.1111/j.1439-0485.2011.00456.x]; BHAUD M, 1995, J THERM BIOL, V20, P91, DOI 10.1016/0306-4565(94)00031-D; Bianchi C. N., 1994, B MUS I BIOL U GEN, V58-59, P181; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; Bianchi Carlo Nike, 1993, Porcupine Newsletter, V5, P156; Boero F, 2015, REND LINCEI-SCI FIS, V26, P3, DOI 10.1007/s12210-014-0340-y; Boudouresque CF, 2002, MAR POLLUT BULL, V44, P32, DOI 10.1016/S0025-326X(01)00150-3; Brankart JM, 2001, J PHYS OCEANOGR, V31, P2307, DOI 10.1175/1520-0485(2001)031<2307:ACOTML>2.0.CO;2; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2005, AQUAT CONSERV, V15, P147, DOI 10.1002/aqc.661; Cerrano C, 2008, CHEM ECOL, V24, P73, DOI 10.1080/02757540801979648; Cerrano C, 2006, ITAL J ZOOL, V73, P355, DOI 10.1080/11250000600911675; Chevaldonne P, 2003, ECOL LETT, V6, P371, DOI 10.1046/j.1461-0248.2003.00439.x; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coma R, 2006, MAR ECOL PROG SER, V327, P51, DOI 10.3354/meps327051; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Corriero G., 1996, THALASSIA SALENT, V22, P51; Criado-Aldeanueva F, 2008, GLOBAL PLANET CHANGE, V60, P563, DOI 10.1016/j.gloplacha.2007.07.003; Crisci C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023814; Cupido R, 2008, AQUAT CONSERV, V18, P984, DOI 10.1002/aqc.904; Danovaro R, 2001, TRENDS ECOL EVOL, V16, P505, DOI 10.1016/S0169-5347(01)02215-7; Despalatovic M., 2008, CIESM WORKS MONOGR, P35; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; Ferrier-Pages C, 2013, LIMNOL OCEANOGR, V58, P1409, DOI 10.4319/lo.2013.58.4.1409; Fichaut M, 2003, ELSEV OCEANOGR SERIE, V69, P645; Fonda Umani Serena, 2008, CIESM Workshop Monographs, V35, P59; Galil BS, 2008, HYDROBIOLOGIA, V606, P105, DOI 10.1007/s10750-008-9342-z; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garrabou J, 2001, MAR ECOL PROG SER, V217, P263, DOI 10.3354/meps217263; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Gouretski V, 2010, DEEP-SEA RES PT I, V57, P812, DOI 10.1016/j.dsr.2010.03.011; Gravili C, 2013, MAR ECOL-EVOL PERSP, V34, P41, DOI 10.1111/maec.12023; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harmelin JG, 1984, 306 FAO, P99; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Hiddink JG, 2008, GLOBAL CHANGE BIOL, V14, P453, DOI 10.1111/j.1365-2486.2007.01518.x; Huete-Stauffer C, 2011, MAR ECOL-EVOL PERSP, V32, P107, DOI 10.1111/j.1439-0485.2011.00429.x; Hughes AR, 2007, ECOL LETT, V10, P849, DOI 10.1111/j.1461-0248.2007.01075.x; Ishii M, 2009, J OCEANOGR, V65, P287, DOI 10.1007/s10872-009-0027-7; Johnson DR, 2013, 23 NODC; Krahmann G, 1998, GEOPHYS RES LETT, V25, P4209, DOI 10.1029/1998GL900143; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Lopes RHC., 2011, INT ENCY STAT SCI, P718, DOI [DOI 10.1007/978-3-642-04898-2_326, 10.1007/978-3-642-04898-2_326]; Manzella GMR, 2007, OCEAN SCI, V3, P245, DOI 10.5194/os-3-245-2007; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; Munda G., 2008, SOCIAL MULTICRITERIA; Nykjaer L, 2009, CLIM RES, V39, P11, DOI 10.3354/cr00794; OBRIEN ST, 1992, CLIMATIC CHANGE, V22, P175, DOI 10.1007/BF00143026; Occhipinti-Ambrogi A, 2003, MAR POLLUT BULL, V46, P542, DOI 10.1016/S0025-326X(02)00363-6; Painter SC, 2003, CONT SHELF RES, V23, P1507, DOI 10.1016/j.csr.2003.08.008; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parry ML, 2007, CLIMATE CHANGE 2007; Puce S, 2009, MAR ECOL-EVOL PERSP, V30, P313, DOI 10.1111/j.1439-0485.2009.00283.x; Raper S.C.B., 1993, CLIMATE SEA EVE CHAN, P192; Reseghetti F, 2007, OCEAN SCI, V3, P59, DOI 10.5194/os-3-59-2007; Riera F, 1995, PEIXOS BALEARS; Rixen M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022702; Rodolfo-Metalpa R, 2005, ITAL J ZOOL, V72, P271, DOI 10.1080/11250000509356685; Rodolfo-Metalpa R, 2006, MAR BIOL, V150, P45, DOI 10.1007/s00227-006-0329-x; ROHLING EJ, 1992, J GEOPHYS RES-OCEANS, V97, P11191, DOI 10.1029/92JC00767; Romano JC, 2000, CR ACAD SCI III-VIE, V323, P415, DOI 10.1016/S0764-4469(00)00141-4; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Sparnocchia S, 2006, ANN GEOPHYS-GERMANY, V24, P443, DOI 10.5194/angeo-24-443-2006; Stabili L, 2012, MICROB ECOL, V64, P802, DOI 10.1007/s00248-012-0068-0; Streftaris N, 2006, MEDITERR MAR SCI, V7, P87, DOI 10.12681/mms.180; Torrents O, 2008, J EXP MAR BIOL ECOL, V357, P7, DOI 10.1016/j.jembe.2007.12.006; Vargas-Yanez M, 2009, SCI MAR, V73, P7, DOI 10.3989/scimar.2009.73n1007; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120	83	91	95	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115655	10.1371/journal.pone.0115655	http://dx.doi.org/10.1371/journal.pone.0115655			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535973	gold, Green Submitted, Green Published			2022-12-26	WOS:000348563300060
J	Boulanger, J; Stenhouse, GB				Boulanger, John '; Stenhouse, Gordon B.			The Impact of Roads on the Demography of Grizzly Bears in Alberta	PLOS ONE			English	Article							HABITAT SELECTION; BRITISH-COLUMBIA; BODY-CONDITION; MORTALITY; SURVIVAL; FRAGMENTATION; POPULATIONS; DISTURBANCE; MOUNTAINS; INVENTORY	One of the principal factors that have reduced grizzly bear populations has been the creation of human access into grizzly bear habitat by roads built for resource extraction. Past studies have documented mortality and distributional changes of bears relative to roads but none have attempted to estimate the direct demographic impact of roads in terms of both survival rates, reproductive rates, and the interaction of reproductive state of female bears with survival rate. We applied a combination of survival and reproductive models to estimate demographic parameters for threatened grizzly bear populations in Alberta. Instead of attempting to estimate mean trend we explored factors which caused biological and spatial variation in population trend. We found that sex and age class survival was related to road density with subadult bears being most vulnerable to road-based mortality. A multi-state reproduction model found that females accompanied by cubs of the year and/or yearling cubs had lower survival rates compared to females with two year olds or no cubs. A demographic model found strong spatial gradients in population trend based upon road density. Threshold road densities needed to ensure population stability were estimated to further refine targets for population recovery of grizzly bears in Alberta. Models that considered lowered survival of females with dependant offspring resulted in lower road density thresholds to ensure stable bear populations. Our results demonstrate likely spatial variation in population trend and provide an example how demographic analysis can be used to refine and direct conservation measures for threatened species.	[Boulanger, John '] Integrated Ecol Res, Nelson, BC, Canada; [Stenhouse, Gordon B.] Foothills Res Inst, Hinton, AB, Canada		Boulanger, J (corresponding author), Integrated Ecol Res, Nelson, BC, Canada.	boulange@ecological.bc.ca	Margalida, Antoni/A-2723-2011	Margalida, Antoni/0000-0002-0576-3993; Boulanger, John/0000-0001-8222-1445	Foothills Research Institute; National Science and Engineering Research Council (NSERC); Canadian Forestry Company (CANFOR); Conoco Phillips; Shell Canada Ltd.; Suncor Energy Inc.; Sundance Forest Industry Ltd.; Talisman Energy Inc.; TransCanada Pipelines Ltd.; Weyerhaeuser Company Ltd.; Foothills Research Institute Grizzly Bear Project	Foothills Research Institute; National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Forestry Company (CANFOR); Conoco Phillips; Shell Canada Ltd.; Suncor Energy Inc.; Sundance Forest Industry Ltd.; Talisman Energy Inc.; TransCanada Pipelines Ltd.; Weyerhaeuser Company Ltd.; Foothills Research Institute Grizzly Bear Project	Funding for this work was from the Foothills Research Institute, National Science and Engineering Research Council (NSERC), Canadian Forestry Company (CANFOR), Conoco Phillips, Shell Canada Ltd., Suncor Energy Inc., Sundance Forest Industry Ltd., Talisman Energy Inc., TransCanada Pipelines Ltd., Weyerhaeuser Company Ltd. and other research partners of the Foothills Research Institute Grizzly Bear Project. The full list of research partners and funders of the Foothill Research Institute are: Ainsworth Lumber, Alberta Biodiversity Monitoring Program, Alberta Conservation Association, Alberta Upstream Oil and Gas Research Fund, Alberta Energy Regulator, Alberta Ecotrust, Alberta Environment Sustainable Research and Development (Government of Alberta), Alberta Fish and Game, Alberta Newsprint, Alberta Advanced Education and Technology (Innovation and Science), Alberta Innovates -Biosolutions, Alberta Upstream Petroleum Research Fund, Anadarko Anderson Exploration Ltd., Anderson Resources Ltd., BP Canada Energy Company, Banff National Park, BC Oil & Gas Commission, Buchanan Lumber-Tolko, Burlington Resources Ltd., Canada Centre for Remote Sensing, Canadian Hunter, Canadian Wildlife Service, Canfor, Cardinal River Operations, Canadian Forest Service, Conoco Phillips Ltd.,	Alberta Grizzly Bear Recovery Team, 2008, ALB GRIZZL BEAR REC; Alberta Sustainable Resource Development Alberta Conservation Association, 2010, 37 ALB SUST RES DEV; Archibald W.R., 1987, INT C BEAR RES MAN, V7, P251; Ben-David M, 2004, OECOLOGIA, V138, P465, DOI 10.1007/s00442-003-1442-x; Benn B, 2002, URSUS, V13, P213; Berland A, 2008, FOREST ECOL MANAG, V256, P1875, DOI 10.1016/j.foreco.2008.07.019; Boulanger J, 2013, WILDLIFE BIOL, V19, P274, DOI 10.2981/12-088; Bourbonnais ML, 2013, PLOS ONE, V8, DOI [10.1371/journal.po, 10.1371/journal.pone.0083768]; BOYCE M.S., 2001, INT ASS BEAR RES MAN, V4; BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; Burnham K. P., 1998, MODEL SELECTION INFE; Canadian Council on Animal Care, 2003, CCAC GUID CAR US WIL; Caswell H, 1989, MATRIX POPULATION MO; Cattet M, 2008, J MAMMAL, V89, P973, DOI 10.1644/08-MAMM-A-095.1; Cattet MRL, 2003, J WILDLIFE DIS, V39, P649, DOI 10.7589/0090-3558-39.3.649; Cattet MRL, 2003, URSUS-SERIES, V14, P88; Cattet MRL, 2002, CAN J ZOOL, V80, P1156, DOI 10.1139/Z02-103; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; Franklin SE, 2001, CAN J REMOTE SENS, V27, P579, DOI 10.1080/07038992.2001.10854899; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; Graham K, 2010, URSUS, V21, P43, DOI 10.2192/09GR010.1; Harris RB, 2011, URSUS, V22, P24, DOI 10.2192/URSUS-D-10-00028.1; Hood GM, 2009, POPTOOLS VERSION 3 0; Kennedy RE, 2014, FRONT ECOL ENVIRON, V12, P339, DOI 10.1890/130066; Linke J, 2009, PHOTOGRAMM ENG REM S, V75, P981, DOI 10.14358/PERS.75.8.981; Macbeth BJ, 2010, CAN J ZOOL, V88, P925; Mace RD, 1996, J APPL ECOL, V33, P1395, DOI 10.2307/2404779; Mace RD, 2012, J WILDLIFE MANAGE, V76, P119, DOI 10.1002/jwmg.250; Manly B.F.J., 1997, RANDOMIZATION MONTE; McDermid GJ, 2009, FOREST ECOL MANAG, V257, P2262, DOI 10.1016/j.foreco.2009.03.005; McDermid GJ, 2005, PROG PHYS GEOG, V29, P449, DOI 10.1191/0309133305pp455ra; MCLELLAN BN, 1989, CAN J ZOOL, V67, P1856, DOI 10.1139/z89-264; McLellan BN, 1999, J WILDLIFE MANAGE, V63, P911, DOI 10.2307/3802805; Nielsen S.E., 2009, J CONSERVATION PLANN, V5, P38; Nielsen SE, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-31; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Nielsen SE, 2004, FOREST ECOL MANAG, V199, P51, DOI 10.1016/j.foreco.2004.04.014; Northrup JM, 2012, J APPL ECOLOGY; Proctor MF, 2005, P ROY SOC B-BIOL SCI, V272, P2409, DOI 10.1098/rspb.2005.3246; Proctor MF, 2002, URSUS, V13, P153; Proctor MF, 2012, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.6; Roever CL, 2008, FOREST ECOL MANAG, V256, P1262, DOI 10.1016/j.foreco.2008.06.006; Roever CL, 2008, GRIZZLY BEARS FOREST; Runge JP, 2006, AM NAT, V167, P925, DOI 10.1086/503531; Schwartz CC, 2005, WILDLIFE MONOGRAPHS, V161; Schwartz CC, 2008, URSUS, V19, P1, DOI 10.2192/07GR003R.1; Schwartz CC, 2010, J WILDLIFE MANAGE, V74, P654, DOI 10.2193/2009-206; Stewart B. P., 2009, CANADIAN J REMOTE SE, V35, P509; Steyaert SMJG, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0624; Theberge JC, 2002, SCALE DEPENDENT SELE; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White GC, 2000, METH C CONS, P288	55	59	59	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115535	10.1371/journal.pone.0115535	http://dx.doi.org/10.1371/journal.pone.0115535			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532035	gold, Green Published			2022-12-26	WOS:000348845100074
J	Jin, X; Nowell, CS; Ulyanchenko, S; Stenhouse, FH; Blackburn, CC				Jin, Xin; Nowell, Craig S.; Ulyanchenko, Svetlana; Stenhouse, Frances H.; Blackburn, C. Clare			Long-Term Persistence of Functional Thymic Epithelial Progenitor Cells In Vivo under Conditions of Low FOXN1 Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; DIFFERENTIATION; IDENTIFICATION; ORGANOGENESIS; COMMITMENT; GENERATION; INVOLUTION; AIRE	Normal thymus function reflects interactions between developing T-cells and several thymic stroma cell types. Within the stroma, key functions reside in the distinct cortical and medullary thymic epithelial cell (TEC) types. It has been demonstrated that, during organogenesis, all TECs can be derived from a common thymic epithelial progenitor cell (TEPC). The properties of this common progenitor are thus of interest. Differentiation of both cTEC and mTEC depends on the epithelial-specific transcription factor FOXN1, although formation of the common TEPC from which the TEC lineage originates does not require FOXN1. Here, we have used a revertible severely hypomorphic allele of Foxn1, Foxn1(R), to test the stability of the common TEPC in vivo. By reactivating Foxn1 expression postnatally in Foxn1(R/-) mice we demonstrate that functional TEPCs can persist in the thymic rudiment until at least 6 months of age, and retain the potential to give rise to both cortical and medullary thymic epithelial cells (cTECs and mTECs). These data demonstrate that the TEPC-state is remarkably stable in vivo under conditions of low Foxn1 expression, suggesting that manipulation of FOXN1 activity may prove a valuable method for long term maintenance of TEPC in vitro.	[Jin, Xin; Nowell, Craig S.; Ulyanchenko, Svetlana; Stenhouse, Frances H.; Blackburn, C. Clare] Univ Edinburgh, Sch Biol Sci, MRC Ctr Regenerat Med, Inst Stem Cell Res, Edinburgh EH16 4UU, Midlothian, Scotland	University of Edinburgh	Blackburn, CC (corresponding author), Univ Edinburgh, Sch Biol Sci, MRC Ctr Regenerat Med, Inst Stem Cell Res, SCRM Bldg,5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	c.blackburn@ed.ac.uk	Blackburn, Clare/AAM-7954-2020; Blackburn, Clare/B-2847-2009	Blackburn, Clare/0000-0002-6326-640X; Blackburn, Clare/0000-0002-6326-640X; Ulyanchenko, Svetlana/0000-0003-3124-9178	Leukaemia and Lymphoma Research [10014]; School of Biological Sciences, University of Edinburgh; Medical Research Council (MRC Centre) [G0300058, MR/K017047/1]; European Union [200720, EU223098]; Medical Research Council [G0300058, MR/L012766/1, MR/K017047/1] Funding Source: researchfish; MRC [MR/K017047/1, G0300058, MR/L012766/1] Funding Source: UKRI	Leukaemia and Lymphoma Research; School of Biological Sciences, University of Edinburgh(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC Centre)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Leukaemia and Lymphoma Research grant number 10014 (CCB) School of Biological Sciences, University of Edinburgh, PhD studentship to XJ Medical Research Council (MRC Centre grant, G0300058 and renewal MR/K017047/1, CCB; MRC studentship to CSN) European Union Seventh Framework Programme (FP7/2007-2013) collaborative project EuroSyStem (CCB, FHS and CSN) under grant agreement number 200720 European Union Seventh Framework Programme (FP7/2007-2013) collaborative project Optistem (CCB, FHS, SU and CSN) under grant agreement number EU223098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Bredenkamp N, 2014, DEVELOPMENT, V141, P1627, DOI 10.1242/dev.103614; Chinn IK, 2012, SEMIN IMMUNOL, V24, P309, DOI 10.1016/j.smim.2012.04.005; Depreter MGL, 2008, P NATL ACAD SCI USA, V105, P961, DOI 10.1073/pnas.0711170105; Dudakov JA, 2010, TRENDS IMMUNOL, V31, P191, DOI 10.1016/j.it.2010.02.002; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; GODFREY DI, 1990, IMMUNOLOGY, V70, P66; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Gordon J, 2011, DEVELOPMENT, V138, P3865, DOI 10.1242/dev.059998; Griffith AV, 2012, AGING CELL, V11, P169, DOI 10.1111/j.1474-9726.2011.00773.x; Guy-Grand D, 2003, J EXP MED, V197, P333, DOI 10.1084/jem.20021639; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Jenkinson WE, 2007, BLOOD, V109, P954, DOI 10.1182/blood-2006-05-023143; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2000, J IMMUNOL, V164, P1881, DOI 10.4049/jimmunol.164.4.1881; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; MILLER JF, 1961, LANCET, V2, P748; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; Nowell Craig S, 2007, Methods Mol Biol, V380, P125; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; Rossi SW, 2007, EUR J IMMUNOL, V37, P2411, DOI 10.1002/eji.200737275; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Zook EC, 2011, BLOOD, V118, P5723, DOI 10.1182/blood-2011-03-342097	30	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114842	10.1371/journal.pone.0114842	http://dx.doi.org/10.1371/journal.pone.0114842			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531271	Green Submitted, Green Published, gold			2022-12-26	WOS:000348845100027
J	Zangle, TA; Teitell, MA; Reed, J				Zangle, Thomas A.; Teitell, Michael A.; Reed, Jason			Live Cell Interferometry Quantifies Dynamics of Biomass Partitioning during Cytokinesis	PLOS ONE			English	Article							SIZE HOMEOSTASIS; PAR PROTEINS; DIVISION; MITOSIS; MECHANISMS; SPINDLE; GROWTH; CYTOSKELETON; MICROSCOPY; SEPARATION	The equal partitioning of cell mass between daughters is the usual and expected outcome of cytokinesis for self-renewing cells. However, most studies of partitioning during cell division have focused on daughter cell shape symmetry or segregation of chromosomes. Here, we use live cell interferometry (LCI) to quantify the partitioning of daughter cell mass during and following cytokinesis. We use adherent and non-adherent mouse fibroblast and mouse and human lymphocyte cell lines as models and show that, on average, mass asymmetries present at the time of cleavage furrow formation persist through cytokinesis. The addition of multiple cytoskeleton-disrupting agents leads to increased asymmetry in mass partitioning which suggests the absence of active mass partitioning mechanisms after cleavage furrow positioning.	[Zangle, Thomas A.; Teitell, Michael A.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Zangle, Thomas A.; Teitell, Michael A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Teitell, Michael A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Broad Stem Cell Res Ctr, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Reed, Jason] Virginia Commonwealth Univ, Dept Phys, Richmond, VA 23284 USA; [Reed, Jason] VCU Massey Canc Ctr, Richmond, VA USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Virginia Commonwealth University; Virginia Commonwealth University	Zangle, TA (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	tzangle@ucla.edu; jcreed@vcu.edu		Zangle, Thomas/0000-0001-5899-3517	National Institutes of Health [K25CA157940, R01CA90571, R01CA156674, R01GM073981, P01GM081621, R01CA185189, R01GM094388]; NantWorks, LLC - University of California Discovery Biotechnology Award [Bio07-10663]; California Institute for Regenerative Medicine Basic Biology 1 Award [RB1-01397]; Broad Stem Cell Research Center at UCLA; Caltech-UCLA Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE [R01CA185189, K25CA157940, R01CA090571, R01CA156674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621, R01GM073981, R01GM094388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NantWorks, LLC - University of California Discovery Biotechnology Award; California Institute for Regenerative Medicine Basic Biology 1 Award; Broad Stem Cell Research Center at UCLA; Caltech-UCLA Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by National Institutes of Health awards K25CA157940 (TAZ), R01CA90571, R01CA156674, R01GM073981, P01GM081621 (MAT), R01CA185189 (MAT and JR), and R01GM094388 (JR), by a NantWorks, LLC - University of California Discovery Biotechnology Award (Bio07-10663) (MAT), by a California Institute for Regenerative Medicine Basic Biology 1 Award (RB1-01397) (MAT), by the Broad Stem Cell Research Center at UCLA (TAZ and MAT), and by a Translational Acceleration Grant from the Caltech-UCLA Joint Center for Translational Medicine (www.jctm.caltech.edu) (MAT). The funders had no role in study design, decision to publish, or preparation of the manuscript.	Afonso O, 2014, SCIENCE, V345, P332, DOI 10.1126/science.1251121; BARER R, 1954, Q J MICROSC SCI, V95, P399; BARER R, 1952, NATURE, V169, P366, DOI 10.1038/169366b0; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Coelho M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001886; Coelho M, 2013, CURR BIOL, V23, P1844, DOI 10.1016/j.cub.2013.07.084; Conlon IJ, 2001, NAT CELL BIOL, V3, P918, DOI 10.1038/ncb1001-918; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Effler JC, 2007, CELL CYCLE, V6, P30, DOI 10.4161/cc.6.1.3674; Effler JC, 2006, CURR BIOL, V16, P1962, DOI 10.1016/j.cub.2006.08.027; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Ghiglia D.C., 1998, 2 DIMENSIONAL PHASE, V1st; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; GRADY L, 2006, IEEE T PATTERN ANAL, V0028, P00001, DOI DOI 10.1109/TPAMI.2006.233; Kafri R, 2013, NATURE, V494, P480, DOI 10.1038/nature11897; Kiyomitsu T, 2013, CELL, V154, P391, DOI 10.1016/j.cell.2013.06.010; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Koonin EV, 2013, CELL, V152, P942, DOI 10.1016/j.cell.2013.02.008; Kotak S, 2013, CURR OPIN CELL BIOL, V25, P741, DOI 10.1016/j.ceb.2013.07.008; Mammoto A, 2009, CURR OPIN CELL BIOL, V21, P864, DOI 10.1016/j.ceb.2009.08.001; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Mohan K, 2012, EXP CELL RES, V318, P1428, DOI 10.1016/j.yexcr.2012.03.028; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Pardo M, 2003, SCIENCE, V300, P1569, DOI 10.1126/science.1084671; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; Reed J, 2011, BIOPHYS J, V101, P1025, DOI 10.1016/j.bpj.2011.07.022; Ross K. F. A., 1967, PHASE CONTRAST INTER; Stevermann L, 2012, CURR OPIN CELL BIOL, V24, P816, DOI 10.1016/j.ceb.2012.10.005; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sung YJ, 2013, P NATL ACAD SCI USA, V110, P16687, DOI 10.1073/pnas.1315290110; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Topham CH, 2013, CURR OPIN CELL BIOL, V25, P780, DOI 10.1016/j.ceb.2013.07.003; Tse HTK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038986; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Zangle TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068916; Zangle TA, 2013, BIOPHYS J, V105, P593, DOI 10.1016/j.bpj.2013.06.041; Zar JH., 2010, BIOSTAT ANAL, V5th; Zernicka-Goetz MZ, 2005, NAT REV MOL CELL BIO, V6, P919, DOI 10.1038/nrm1782	40	14	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115726	10.1371/journal.pone.0115726	http://dx.doi.org/10.1371/journal.pone.0115726			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531652	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100101
J	Zhang, ZC; Huang, JW; Li, MH; Sui, YX; Wang, S; Liu, LR; Xu, LX; Yan, RF; Song, XK; Li, XR				Zhang, ZhenChao; Huang, JingWei; Li, MengHui; Sui, YuXia; Wang, Shuai; Liu, LianRui; Xu, LiXin; Yan, RuoFeng; Song, XiaoKai; Li, XiangRui			Identification and Molecular Characterization of Microneme 5 of Eimeria acervulina	PLOS ONE			English	Article							ANTICOCCIDIAL DRUGS; PROTECTIVE IMMUNITY; COAGULATION-FACTOR; DNA IMMUNIZATION; FACTOR-XI; TENELLA; PROTEIN; RESPONSES; ANTIGEN; COCCIDIOSIS	In the present study, the microneme 5 gene of Eimeria acervulina (E. acervulina) (EaMIC5) was cloned and characterized. Specific primers for the rapid amplification of cDNA ends (RACE) were designed based on the expressed sequence tag (EST, GenBank Accession No. EH386430.1) to amplify the 3'-and 5'-ends of EaMIC5. The full length cDNA of this gene was obtained by overlapping the sequences of 3'-and 5'-extremities and amplification by reverse transcription PCR. Sequence analysis revealed that the open reading frame (ORF) of EaMIC5 was 336 bp and encoded a protein of 111 amino acids with 12.18 kDa. The ORF was inserted into pET-32a (+) to produce recombinant EaMIC5. Using western blotting assay, the recombinant protein was successfully recognized by the sera of chicks experimentally infected with E. acervulina, while the native protein in the somatic extract of sporozoites was as well detected by sera from rats immunized with the recombinant protein of EaMIC5. Immunofluorescence analysis using antibody against recombinant protein EaMIC5 indicated that this protein was expressed in the sporozoites and merozoites stages of E. acervulina. Animal challenge experiments demonstrated that the recombinant protein of EaMIC5 could significantly increase the average body weight gains, decrease the mean lesion scores and the oocyst outputs of the immunized chickens, and presented anticoccidial index (ACI) more than 160. All the above results suggested that the EaMIC5 was a novel E. acervulina antigen and could be an effective candidate for the development of a new vaccine against this parasite.	[Zhang, ZhenChao; Huang, JingWei; Li, MengHui; Sui, YuXia; Wang, Shuai; Liu, LianRui; Xu, LiXin; Yan, RuoFeng; Song, XiaoKai; Li, XiangRui] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Li, XR (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	Lixiangrui@njau.edu.cn			National Natural Science Foundation of P.R. China [31372428]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was funded by a grant from the National Natural Science Foundation of P.R. China (No. 31372428) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal A, 2013, J BIOL CHEM, V288, P1590, DOI 10.1074/jbc.M112.411934; Blake DP, 2012, MOL BIOCHEM PARASIT, V184, P48, DOI 10.1016/j.molbiopara.2012.03.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown PJ, 2000, MOL BIOCHEM PARASIT, V107, P91, DOI 10.1016/S0166-6851(00)00179-1; Brydges SD, 2006, EUKARYOT CELL, V5, P2174, DOI 10.1128/EC.00163-06; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Carruthers Vern B., 2008, V47, P33; CHAPMAN HD, 1989, RES VET SCI, V46, P114, DOI 10.1016/S0034-5288(18)31129-9; Chapman HD, 1998, INT J PARASITOL, V28, P1141, DOI 10.1016/S0020-7519(98)00024-1; CHUNG DW, 1986, BIOCHEMISTRY-US, V25, P2410, DOI 10.1021/bi00357a017; Friedrich N, 2010, J BIOL CHEM, V285, P2064, DOI 10.1074/jbc.M109.060988; FUJIKAWA K, 1986, BIOCHEMISTRY-US, V25, P2417, DOI 10.1021/bi00357a018; Gadde U, 2011, POULTRY SCI, V90, P2243, DOI 10.3382/ps.2011-01558; Graat EAM, 1998, PREV VET MED, V33, P297, DOI 10.1016/S0167-5877(97)00008-1; JEFFERS TK, 1974, AVIAN DIS, V18, P331, DOI 10.2307/1589101; JOHNSON J, 1970, EXP PARASITOL, V28, P30, DOI 10.1016/0014-4894(70)90063-9; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kim DK, 2012, AVIAN DIS, V56, P97, DOI 10.1637/9720-031711-Reg.1; Klotz C, 2007, VACCINE, V25, P6625, DOI 10.1016/j.vaccine.2007.06.048; Lai L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002296; Lee SH, 2012, AVIAN DIS, V56, P402, DOI 10.1637/9906-082411-ResNote.1; Lillehoj HS, 2005, AVIAN DIS, V49, P112, DOI 10.1637/7249-073004R; LILLEHOJ HS, 1990, IMMUNOLOGY, V71, P127; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; MARTIN A, 1995, AVIAN DIS, V39, P538, DOI 10.2307/1591807; Merck Sharp & Dohme Company Ltd, 1998, MSD TECHN BOOKL, P2; MOREHOUSE NF, 1970, EXP PARASITOL, V28, P25, DOI 10.1016/0014-4894(70)90062-7; Peek HW, 2003, AVIAN PATHOL, V32, P391, DOI 10.1080/0307945031000121149; Periz J, 2007, J BIOL CHEM, V282, P16891, DOI 10.1074/jbc.M702407200; Qi NS, 2013, PARASITOL RES, V112, P2281, DOI 10.1007/s00436-013-3389-0; ROSE ME, 1983, PARASITE IMMUNOL, V5, P479, DOI 10.1111/j.1365-3024.1983.tb00762.x; Saouros S, 2012, J BIOL CHEM, V287, P36029, DOI 10.1074/jbc.M112.389825; Sasai K, 2008, J PARASITOL, V94, P1432, DOI 10.1645/GE-1558.1; Shah MAA, 2010, VET PARASITOL, V169, P185, DOI 10.1016/j.vetpar.2009.12.035; Shah MAA, 2010, EXP PARASITOL, V124, P330, DOI 10.1016/j.exppara.2009.11.010; Shah MAA, 2010, PARASITOL RES, V107, P747, DOI 10.1007/s00436-010-1940-9; Shah MAA, 2011, RES VET SCI, V90, P72, DOI 10.1016/j.rvsc.2010.05.003; Song HY, 2010, VET PARASITOL, V173, P219, DOI 10.1016/j.vetpar.2010.06.030; Song HY, 2010, EXP PARASITOL, V126, P224, DOI 10.1016/j.exppara.2010.05.015; Song XK, 2009, VET PARASITOL, V159, P30, DOI 10.1016/j.vetpar.2008.10.015; Talebi A, 2005, EXP PARASITOL, V110, P342, DOI 10.1016/j.exppara.2005.03.026; TOMKINSON BE, 1989, J IMMUNOL, V142, P2230; Willsie SK, 1996, J LEUKOCYTE BIOL, V59, P813, DOI 10.1002/jlb.59.6.813; Xu QM, 2008, VET PARASITOL, V156, P319, DOI 10.1016/j.vetpar.2008.05.025; Yanming S, 2007, PARASITE IMMUNOL, V29, P319, DOI 10.1111/j.1365-3024.2007.00949.x; Zajkowska J, 2001, INFECTION, V29, P71, DOI 10.1007/s15010-001-1078-x; Zhu HL, 2012, MOL BIOCHEM PARASIT, V186, P21, DOI 10.1016/j.molbiopara.2012.09.002; Zhu HL, 2012, PARASITOLOGY, V139, P1711, DOI 10.1017/S0031182012001163	48	24	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115411	10.1371/journal.pone.0115411	http://dx.doi.org/10.1371/journal.pone.0115411			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531898	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845100063
J	Ellis, LD; Soo, EC; Achenbach, JC; Morash, MG; Soanes, KH				Ellis, Lee D.; Soo, Evelyn C.; Achenbach, John C.; Morash, Michael G.; Soanes, Kelly H.			Use of the Zebrafish Larvae as a Model to Study Cigarette Smoke Condensate Toxicity	PLOS ONE			English	Article							GENE-EXPRESSION CHANGES; EARLY DRUG DISCOVERY; DEVELOPMENTAL NEUROTOXICITY; LOCOMOTOR-ACTIVITY; EMBRYOS; TOXICOLOGY; INDUCTION; VALPROATE; RECEPTOR; AIRWAY	The smoking of tobacco continues to be the leading cause of premature death worldwide and is linked to the development of a number of serious illnesses including heart disease, respiratory diseases, stroke and cancer. Currently, cell line based toxicity assays are typically used to gain information on the general toxicity of cigarettes and other tobacco products. However, they provide little information regarding the complex disease-related changes that have been linked to smoking. The ethical concerns and high cost associated with mammalian studies have limited their widespread use for in vivo toxicological studies of tobacco. The zebrafish has emerged as a low-cost, high-throughput, in vivo model in the study of toxicology. In this study, smoke condensates from 2 reference cigarettes and 6 Canadian brands of cigarettes with different design features were assessed for acute, developmental, cardiac, and behavioural toxicity (neurotoxicity) in zebrafish larvae. By making use of this multifaceted approach we have developed an in vivo model with which to compare the toxicity profiles of smoke condensates from cigarettes with different design features. This model system may provide insights into the development of smoking related disease and could provide a cost-effective, high-throughput platform for the future evaluation of tobacco products.	[Ellis, Lee D.; Achenbach, John C.; Morash, Michael G.; Soanes, Kelly H.] Natl Res Council Canada, Aquat & Crop Resource Dev, Halifax, NS B3H 3Z1, Canada; [Soo, Evelyn C.] Hlth Canada, Div Sci, Off Res & Surveillance, Controlled Subst & Tobacco Directorate, Ottawa, ON K1A 0K9, Canada	International Business Machines (IBM); National Research Council Canada; Health Canada	Soo, EC (corresponding author), Hlth Canada, Div Sci, Off Res & Surveillance, Controlled Subst & Tobacco Directorate, 150 Tunneys Pasture Driveway, Ottawa, ON K1A 0K9, Canada.	evelyn.soo@hc-sc.gc.ca		Morash, Michael/0000-0002-2530-3855; Achenbach, John/0000-0002-0267-8398	Health Canada under the Federal Tobacco Control Strategy; National Research Council Canada	Health Canada under the Federal Tobacco Control Strategy; National Research Council Canada	This work was supported by Health Canada under the Federal Tobacco Control Strategy and the National Research Council Canada. Health Canada contributed to study design, decision to publish and preparation of the manuscript. The National Research Council contributed to study design, data collection and analysis, decision to publish and preparation of the manuscript.	Abbott LC, 2012, CRIT REV TOXICOL, V42, P279, DOI 10.3109/10408444.2012.658506; Alderton W.K., 2013, DRUG DISCOV TODAY, V10, pE43, DOI [10.1016/j.ddmod.2012.02.006, DOI 10.1016/J.DDMOD.2012.02.006]; Antal S, 2009, IN VIVO, V23, P267; Bailey J, 2013, BIRTH DEFECTS RES C, V99, P14, DOI 10.1002/bdrc.21027; Baliunas Dolly, 2007, Chronic Dis Can, V27, P154; Barros TP, 2008, BRIT J PHARMACOL, V154, P1400, DOI 10.1038/bjp.2008.249; Berghmans Stephane, 2008, Journal of Pharmacological and Toxicological Methods, V58, P59, DOI 10.1016/j.vascn.2008.05.130; Centers for Disease Control and Prevention, 2011, TOB BRAND PREF; Counts ME, 2005, REGUL TOXICOL PHARM, V41, P185, DOI 10.1016/j.yrtph.2004.12.002; Cowden J, 2012, REPROD TOXICOL, V33, P165, DOI 10.1016/j.reprotox.2011.11.111; Dhillon SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060552; Dukovcic SR, 2010, J APPL TOXICOL, V30, P574, DOI 10.1002/jat.1528; Fan CY, 2010, NEUROTOXICOL TERATOL, V32, P91, DOI 10.1016/j.ntt.2009.04.065; Guo XQ, 2011, MUTAGENESIS, V26, P273, DOI 10.1093/mutage/geq083; HAAG HB, 1959, ARCHIV OTOLARYNGOL, V69, P261; Health Canada, 1991, T115 HLTH CAN; Health Canada, 2011, CAN TOB MON SURV CTU; Incardona JP, 2006, TOXICOL APPL PHARM, V217, P308, DOI 10.1016/j.taap.2006.09.018; International Organization for Standardization, 2004, 101852004 ISO; International Standard Organization, 2012, 33082012 ISO; Irons TD, 2010, NEUROTOXICOL TERATOL, V32, P84, DOI 10.1016/j.ntt.2009.04.066; ISO, 1999, ICS, V65, P160; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Kuo WH, 2005, CHEM-BIOL INTERACT, V155, P31, DOI 10.1016/j.cbi.2005.04.008; Lesser C., 2003, U.S. Patent, Patent No. [6,530,377 B1, 6530377]; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; McGee SP, 2013, TOXICOL SCI, V133, P144, DOI 10.1093/toxsci/kft020; Milan DJ, 2006, AM J PHYSIOL-HEART C, V291, pH269, DOI 10.1152/ajpheart.00960.2005; Muth-Kohne E, 2012, NEUROTOXICOL TERATOL, V34, P413, DOI 10.1016/j.ntt.2012.04.006; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Oates AC, 2001, BLOOD, V98, P1792, DOI 10.1182/blood.V98.6.1792; Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018; Park MJ, 2013, TOXICOL LETT, V216, P9, DOI 10.1016/j.toxlet.2012.10.018; Perkins AC, 1996, P NATL ACAD SCI USA, V93, P12267, DOI 10.1073/pnas.93.22.12267; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; *PHYS SMOK FREE CA, 1999, ENG CAN CIG; Pruvot B, 2012, REPROD TOXICOL, V34, P568, DOI 10.1016/j.reprotox.2012.07.010; Rehm J., 2006, COSTS SUBSTANCES ABU; Seguin B. P., 2012, SRNTS 18 ANN M 13 16; Sipes NS, 2011, BIRTH DEFECTS RES C, V93, P256, DOI 10.1002/bdrc.20214; Siu M, 2013, TOB CONTROL, V22, DOI 10.1136/tobaccocontrol-2012-050450; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Sridhar S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-259; Staddon JER, 2010, J EXP ANAL BEHAV, V94, P261, DOI 10.1901/jeab.2010.94-261; Svoboda KR, 2002, J NEUROSCI, V22, P10731; U. S. Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; US Department of Health and Human Services, 2004, HLTH CONS SMOK; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; World Health Organization, 2019, WHO REPORT GLOBAL TO; Zellner D, 2011, NEUROTOXICOL TERATOL, V33, P674, DOI 10.1016/j.ntt.2011.06.007	50	34	34	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115305	10.1371/journal.pone.0115305	http://dx.doi.org/10.1371/journal.pone.0115305			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526262	Green Submitted, Green Published, gold			2022-12-26	WOS:000347186200022
J	Ye, WJ; Paul, D; Gao, LN; Seckute, J; Sangaiah, R; Jayaraj, K; Zhang, ZF; Kaminski, PA; Ealick, SE; Gold, A; Ball, LM				Ye, Wenjie; Paul, Debamita; Gao, Lina; Seckute, Jolita; Sangaiah, Ramiah; Jayaraj, Karupiah; Zhang, Zhenfa; Kaminski, P. Alexandre; Ealick, Steven E.; Gold, Avram; Ball, Louise M.			Ethenoguanines Undergo Glycosylation by Nucleoside 2 '-Deoxyribosyltransferases at Non-Natural Sites	PLOS ONE			English	Article							TRANS-N-DEOXYRIBOSYLASE; LACTOBACILLUS-HELVETICUS; ENZYMATIC-SYNTHESIS; SOFTWARE; PURINE; ADDUCTS; BASES; N2,3-ETHENOGUANINE; 1,N2-ETHENOGUANINE; PURIFICATION	Deoxyribosyl transferases and functionally related purine nucleoside phosphorylases are used extensively for synthesis of non-natural deoxynucleosides as pharmaceuticals or standards for characterizing and quantitating DNA adducts. Hence exploring the conformational tolerance of the active sites of these enzymes is of considerable practical interest. We have determined the crystal structure at 2.1 A resolution of Lactobacillus helveticus purine deoxyribosyl transferase (PDT) with the tricyclic purine 8,9-dihydro-9-oxoimidazo[2,1-b] purine (N-2,3-ethenoguanine) at the active site. The active site electron density map was compatible with four orientations, two consistent with sites for deoxyribosylation and two appearing to be unproductive. In accord with the crystal structure, Lactobacillus helveticus PDT glycosylates the 8,9-dihydro-9-oxoimidazo[2,1-b] purine at N7 and N1, with a marked preference for N7. The activity of Lactobacillus helveticus PDT was compared with that of the nucleoside 2'-deoxyribosyltransferase enzymes (DRT Type II) from Lactobacillus leichmannii and Lactobacillus fermentum, which were somewhat more effective in the deoxyribosylation than Lactobacillus helveticus PDT, glycosylating the substrate with product profiles dependent on the pH of the incubation. The purine nucleoside phosphorylase of Escherichia coli, also commonly used in ribosylation of non-natural bases, was an order of magnitude less efficient than the transferase enzymes. Modeling based on published active-site structures as templates suggests that in all cases, an active site Phe is critical in orienting the molecular plane of the purine derivative. Adventitious hydrogen bonding with additional active site residues appears to result in presentation of multiple nucleophilic sites on the periphery of the acceptor base for ribosylation to give a distribution of nucleosides. Chemical glycosylation of O-9-benzylated 8,9-dihydro-9-oxoimidazo[2,1-b] purine also resulted in N7 and N1 ribosylation. Absent from the enzymatic and chemical glycosylations is the natural pattern of N3 ribosylation, verified by comparison of spectroscopic and chromatographic properties with an authentic standard synthesized by an unambiguous route.	[Ye, Wenjie; Gao, Lina; Sangaiah, Ramiah; Jayaraj, Karupiah; Zhang, Zhenfa; Gold, Avram; Ball, Louise M.] Univ N Carolina, Dept Environm Sci & Engn, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Paul, Debamita; Seckute, Jolita; Ealick, Steven E.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Kaminski, P. Alexandre] Inst Pasteur, UMR CNRS, Unite Chim & Biocatalyse, Paris, France	University of North Carolina; University of North Carolina Chapel Hill; Cornell University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gold, A (corresponding author), Univ N Carolina, Dept Environm Sci & Engn, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.	golda@email.unc.edu		Kaminski, Pierre Alexandre/0000-0001-9841-6837	National Institutes of Health (NIH) [P42-ES05948, P30ES010126, GM73220]; National Institute of General Medical Sciences at NIH [GM103403]; U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005948, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073220, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences at NIH; U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grants P42-ES05948 and P30ES010126 (LMB) and GM73220 (SEE). The crystal structure is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award GM103403 from the National Institute of General Medical Sciences at NIH. Use of the Advanced Photon Source is supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anand R, 2004, BIOCHEMISTRY-US, V43, P2384, DOI 10.1021/bi035723k; Armstrong SR, 1996, STRUCTURE, V4, P97, DOI 10.1016/S0969-2126(96)00013-5; Barth C, 2004, Z NATURFORSCH B, V59, P802; BECK W, 1963, J BIOL CHEM, V238, P702; Bennett EM, 2003, J BIOL CHEM, V278, P47110, DOI 10.1074/jbc.M304622200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DANZIN C, 1974, EUR J BIOCHEM, V48, P255, DOI 10.1111/j.1432-1033.1974.tb03763.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fresco-Taboada A, 2013, APPL MICROBIOL BIOT, V97, P3773, DOI 10.1007/s00253-013-4816-y; Gros L, 2003, MUTAT RES-FUND MOL M, V531, P219, DOI 10.1016/j.mrfmmm.2003.07.008; GUENGERICH FP, 1993, CHEM RES TOXICOL, V6, P635, DOI 10.1021/tx00035a008; HOFFER M, 1960, CHEM BER-RECL, V93, P2777, DOI 10.1002/cber.19600931204; HOLGUINH.J, 1972, FEBS LETT, V20, P171, DOI 10.1016/0014-5793(72)80785-3; HUANG MC, 1983, ARCH BIOCHEM BIOPHYS, V222, P133, DOI 10.1016/0003-9861(83)90510-6; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kaminski PA, 2002, J BIOL CHEM, V277, P14400, DOI 10.1074/jbc.M111995200; Kaminski PA, 2008, J BIOL CHEM, V283, P20053, DOI 10.1074/jbc.M802706200; KHAZANCHI R, 1993, J ORG CHEM, V58, P2552, DOI 10.1021/jo00061a033; Konstantinova ID, 2013, SYNTHESIS-STUTTGART, V45, P272, DOI 10.1055/s-0032-1317782; KRENITSKY TA, 1986, J MED CHEM, V29, P138, DOI 10.1021/jm00151a022; KUSMIEREK JT, 1989, CHEM RES TOXICOL, V2, P230, DOI 10.1021/tx00010a003; LEE H, 1990, TETRAHEDRON LETT, V31, P6773, DOI 10.1016/S0040-4039(00)97168-5; Liang SH, 2010, J BIOSCI BIOENG, V110, P165, DOI 10.1016/j.jbiosc.2010.01.017; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Muller M, 1996, CHEM RES TOXICOL, V9, P1140, DOI 10.1021/tx9600661; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riegelhaupt PM, 2010, MOL BIOCHEM PARASIT, V169, P40, DOI 10.1016/j.molbiopara.2009.10.001; Roivainen J, 2007, NUCLEOS NUCLEOT NUCL, V26, P905, DOI 10.1080/15257770701506343; SANGAIAH R, 1992, TETRAHEDRON LETT, V33, P5487, DOI 10.1016/S0040-4039(00)61124-3; SATTSANGI PD, 1977, J ORG CHEM, V42, P3292, DOI 10.1021/jo00440a020; Schrodinger LLC, 2011, MACR VERS 9 9; Serra I, 2013, CHEMPLUSCHEM, V78, P157, DOI 10.1002/cplu.201200278; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047	37	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115082	10.1371/journal.pone.0115082	http://dx.doi.org/10.1371/journal.pone.0115082			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521390	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845600016
J	Zhu, JH; Hua, RX; Jiang, J; Zhao, LQ; Sun, XW; Luan, JW; Lang, YG; Sun, YQ; Shang, K; Peng, SY; Ma, JQ				Zhu, Jinhong; Hua, Rui-Xi; Jiang, Jing; Zhao, Li-Qin; Sun, Xiuwei; Luan, Jinwei; Lang, Yaoguo; Sun, Yanqi; Shang, Kun; Peng, Shiyun; Ma, Jianqun			Association Studies of ERCC1 Polymorphisms with Lung Cancer Susceptibility: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							DNA-REPAIR GENES; SINGLE NUCLEOTIDE POLYMORPHISMS; CHINESE POPULATION; RISK; HAPLOTYPES; CAPACITY; SMOKING	Background: Excision repair cross-complimentary group 1 (ERCC1) is an essential component of the nucleotide excision repair system that is responsible for repairing damaged DNA. Functional genetic variations in the ERCC1 gene may alter DNA repair capacity and modulate cancer risk. The putative roles of ERCC1 gene polymorphisms in lung cancer susceptibility have been widely investigated. However, the results remain controversial. Objectives: An updated meta-analysis was conducted to explore whether lung cancer risk could be attributed to the following ERCC1 polymorphisms: rs11615 (T>C), rs3212986 (C>A), rs3212961 (A>C), rs3212948 (G>C), rs2298881 (C>A). Methods: Several major databases (MEDLINE, EMBASE and Scopus) and the Chinese Biomedical database were searched for eligible studies. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were used to measure the strength of associations. Results: Sixteen studies with 10,106 cases and 13,238 controls were included in this meta-analysis. Pooled ORs from 11 eligible studies (8,215 cases vs. 11,402 controls) suggested a significant association of ERCC1 rs11615 with increased risk for lung cancer (homozygous: CC versus TT, OR = 1.24, 95% CI: 1.04-1.48, P = 0.02). However, such an association was disproportionately driven by a single study. Removal of that study led to null association. Moreover, initial analyses suggested that ERCC1 rs11615 exerts a more profound effect on the susceptibility of non-smokers to lung cancer than that of smokers. Moreover, no statistically significant association was found between remaining ERCC1 polymorphisms of interest and lung cancer risk, except for rs3212948 variation (heterozygous: CG vs. GG, OR = 0.78, 95% CI: 0.67-0.90, P = 0.001; dominant: CG/CC vs. GG, OR = 0.79, 95% CI: 0.69-0.91, P= 0.001). Conclusion: Overall, this meta-analysis suggests that ERCC1 rs3212948 G>C, but not others, is a lung cancer risk-associated polymorphism. Carefully designed studies with large sample size involving different ethnicity, smoking status, and cancer types are needed to validate these findings.	[Zhu, Jinhong] Harbin Med Univ, Canc Hosp, Mol Epidemiol Lab, Harbin, Heilongjiang, Peoples R China; [Hua, Rui-Xi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Jing; Sun, Xiuwei] Harbin Med Univ, Canc Hosp, Dept Oncol, Harbin, Heilongjiang, Peoples R China; [Zhao, Li-Qin] Univ South China, Affiliated Hosp 1, Dept Hematol, Hengyang, Hunan, Peoples R China; [Luan, Jinwei] Harbin Med Univ, Canc Hosp, Dept Radiol, Harbin, Heilongjiang, Peoples R China; [Lang, Yaoguo; Sun, Yanqi; Ma, Jianqun] Harbin Med Univ, Canc Hosp, Dept Thorac Surg, Harbin, Heilongjiang, Peoples R China; [Shang, Kun] Capital Med Univ, Xuanwu Hosp, Dept Nucl Med, Beijing, Peoples R China; [Peng, Shiyun] Harbin Med Univ, Canc Hosp, Dept Lab Med, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Sun Yat Sen University; Harbin Medical University; University of South China; Harbin Medical University; Harbin Medical University; Capital Medical University; Harbin Medical University	Peng, SY (corresponding author), Harbin Med Univ, Canc Hosp, Dept Lab Med, Harbin, Heilongjiang, Peoples R China.	hydzlyyjyk@126.com; jianqunma@gmail.com	Zhang, Min/ACY-2759-2022; Thakolwiboon, Smathorn/S-1183-2019; Zhu, Jianhui/H-4665-2011	Zhang, Min/0000-0003-3331-3583; , Jianqun/0000-0002-7021-1298; Hua, Rui-Xi/0000-0001-5319-656X; Zhu, Jianhui/0000-0002-0051-7777; Zhu, Jinhong/0000-0002-0408-3101; Thakolwiboon, Smathorn/0000-0003-0607-904X	Heilongjiang Education Department of China [1252HQ016]; Harbin Medical University Cancer Hospital	Heilongjiang Education Department of China; Harbin Medical University Cancer Hospital	This research was supported by a grant (1252HQ016) funded by Heilongjiang Education Department of China and a grant funded by Harbin Medical University Cancer Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao C, 2011, CHINESE MED J-PEKING, V124, P2203, DOI 10.3760/cma.j.issn.0366-6999.2011.14.022; Deng QH, 2011, MED ONCOL, V28, P667, DOI 10.1007/s12032-010-9507-2; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gorlova OY, 2008, CANCER EPIDEM BIOMAR, V17, P1322, DOI 10.1158/1055-9965.EPI-07-2591; He J, 2013, INT J CANCER, V133, P1765, DOI 10.1002/ijc.28089; He J, 2012, HUM GENET, V131, P1235, DOI 10.1007/s00439-012-1152-8; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Jones NR, 2011, CANCER EPIDEMIOL, V35, P175, DOI 10.1016/j.canep.2010.08.007; Kang H, 2011, MODERN ONCOLOGY, V19, P1275; Kazma R, 2012, CARCINOGENESIS, V33, P1059, DOI 10.1093/carcin/bgs116; Kietthubthew S, 2006, INT J HYG ENVIR HEAL, V209, P21, DOI 10.1016/j.ijheh.2005.06.002; Li YC, 2007, EUR J HUM GENET, V15, P967, DOI 10.1038/sj.ejhg.5201855; Ma HX, 2007, PHARMACOGENET GENOM, V17, P417, DOI 10.1097/01.fpc.0000239975.77088.17; MANTEL N, 1959, J NATL CANCER I, V22, P719; Matullo G, 2006, CARCINOGENESIS, V27, P997, DOI 10.1093/carcin/bgi280; Sakoda LC, 2012, INT J MOL EPIDEMIOL, V3, P1; Shen HB, 2003, INT J CANCER, V107, P84, DOI 10.1002/ijc.11346; Shen M, 2005, INT J CANCER, V116, P768, DOI 10.1002/ijc.21117; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Vogel U, 2004, MUTAT RES-FUND MOL M, V546, P65, DOI 10.1016/j.mrfmmm.2003.11.001; Yin JY, 2008, MUTAT RES-FUND MOL M, V641, P12, DOI 10.1016/j.mrfmmm.2008.02.004; Yin JY, 2012, LUNG CANCER, V76, P286, DOI 10.1016/j.lungcan.2012.01.001; Yin JY, 2011, MUTAT RES-FUND MOL M, V713, P1, DOI 10.1016/j.mrfmmm.2011.05.003; Yin JY, 2006, CANCER GENET CYTOGEN, V164, P66, DOI 10.1016/j.cancergencyto.2005.07.003; Yin JY, 2005, BIOCHEM GENET, V43, P543, DOI 10.1007/s10528-005-8170-3; Yin ZH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-439; Yu DK, 2008, CLIN CANCER RES, V14, P2878, DOI 10.1158/1078-0432.CCR-07-1612; Zhang LQ, 2012, MUTAGENESIS, V27, P67, DOI 10.1093/mutage/ger062; Zhang Zengli, 2008, Zhongguo Fei Ai Za Zhi, V11, P183, DOI 10.3779/j.issn.1009-3419.2008.02.022; Zhou W, 2005, CANCER EPIDEM BIOMAR, V14, P491, DOI 10.1158/1055-9965.EPI-04-0612; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	32	85	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97616	10.1371/journal.pone.0097616	http://dx.doi.org/10.1371/journal.pone.0097616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	25536077	gold, Green Published, Green Submitted			2022-12-26	WOS:000340948600051
J	Fisman, D; Patrozou, E; Carmeli, Y; Perencevich, E; Tuite, AR; Mermel, LA				Fisman, David; Patrozou, Eleni; Carmeli, Yehuda; Perencevich, Eli; Tuite, Ashleigh R.; Mermel, Leonard A.		Geographical Variability Bacteremi	Geographical Variability in the Likelihood of Bloodstream Infections Due to Gram-Negative Bacteria: Correlation with Proximity to the Equator and Health Care Expenditure	PLOS ONE			English	Article							SEASONAL-VARIATION; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; EPIDEMIOLOGY; SUMMER	Objective: Infections due to Gram-negative bacteria exhibit seasonal trends, with peak infection rates during warmer months. We hypothesized that the likelihood of a bloodstream infection due to Gram-negative bacteria increases with proximity to the equator. We tested this hypothesis and identified geographical, climatic and social factors associated with this variability. Design: We established a network of 23 international centers in 22 cities. Setting: De-identified results of positive blood cultures from 2007-2011 and data sources for geographic, climatic and socioeconomic factors were assembled for each center. Participants: Patients at the 23 centers with positive blood cultures. Main outcome: Due to variability in the availability of total culture volumes across sites, our primary outcome measure was the fraction of positive blood cultures that yielded Gram-negative bacteria; sources of variability in this outcome measure were explored using meta-regression techniques. Results: The mean fraction of bacteremia associated with Gram-negative bacteria was 48.4% (range 26.4% to 61.8%). Although not all sites displayed significant seasonality, the overall P-value for seasonal oscillation was significant (P<0.001). In univariate meta-regression models, temperature, latitude, latitude squared, longitude, per capita gross domestic product and percent of gross domestic product spent on healthcare were all associated with the fraction of bacteremia due to Gram-negative bacteria. In multivariable models, only percent of gross domestic product spent on healthcare and distance from the equator (ie. latitude squared) were significantly associated with the fraction of bacteremia due to Gram-negative bacteria. Conclusions: The likelihood of bacteremia due to Gram-negative bacteria varies markedly between cities, in a manner that appears to have both geographic (latitude) and socioeconomic (proportion gross domestic product devoted to health spending) determinants. Thus, the optimal approach to initial management of suspected bacteremia may be geographically specific. The rapid emergence of highly antibiotic-resistant Gram-negative pathogens may have geographically specific impacts.	[Fisman, David; Tuite, Ashleigh R.] Univ Toronto, Dalla Lana Fac Publ Hlth, Toronto, ON, Canada; [Patrozou, Eleni] Hygeia Gen Hosp, Athens, Greece; [Carmeli, Yehuda] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Epidemiol, IL-69978 Tel Aviv, Israel; [Perencevich, Eli] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA USA; [Perencevich, Eli] Iowa City Vet Hlth Care Syst, Iowa City, IA USA; [Mermel, Leonard A.] Brown Univ, Warren Alpert Med Sch, Dept Med, Providence, RI 02912 USA; [Mermel, Leonard A.] Rhode Isl Hosp, Div Infect Dis, Providence, RI USA	University of Toronto; Hygeia Hospital; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Mermel, LA (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Med, Providence, RI 02912 USA.	lmermel@lifespan.org	Brites, Carlos/D-1353-2013; Mermel, Leonard/Z-1475-2019; Korman, Tony/I-3099-2013	Brites, Carlos/0000-0002-4673-6991; Edmond, Michael/0000-0002-4144-8974; El Kholy, Amani/0000-0002-0645-7664; Camargo, Luis Fernando Aranha/0000-0002-3888-8661; QUIROS, RODOLFO/0000-0002-5820-380X; Miyakis, Spiros/0000-0003-4268-1599; Perencevich, Eli/0000-0002-3721-3355; Korman, Tony/0000-0002-6155-8353	Astrellas; TheravanceBasilia; Merck, Sharp and Dohme; AstraZeneca	Astrellas; TheravanceBasilia; Merck, Sharp and Dohme(Merck & Company); AstraZeneca(AstraZeneca)	Dr. Mermel has received research funding from Astrellas and Theravance. Dr. Carmelli has served as a consultant for Merck, Sharp and Dohme, Johnson & Johnson, AstraZeneca, Rempex, Durata, Achaogen, and Basilia. His institution has received research funding from Basilia, and he has received payment for lectures from Merck, Sharp and Dohme, and AstraZeneca. Drs. Perencevich, Fisman, Tuite, and Patrozou have no conflicts of interest. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Al-Hasan MN, 2009, CLIN MICROBIOL INFEC, V15, P947, DOI 10.1111/j.1469-0691.2009.02877.x; Alcorn K, 2013, AM J INFECT CONTROL, V41, P1205, DOI 10.1016/j.ajic.2013.05.019; Anderson DJ, 2008, J INFECT DIS, V197, P752, DOI 10.1086/527486; Fortaleza CMCB, 2014, INFECT CONT HOSP EP, V35, P85, DOI 10.1086/674392; de Kraker MEA, 2013, CLIN MICROBIOL INFEC, V19, P860, DOI 10.1111/1469-0691.12028; Deeks J, 1995, SYSTEMATIC REV HLTH, VBMJ Publishing Group, P313; Eber MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025298; Fisman DN, 2002, CLIN INFECT DIS, V35, P1368, DOI 10.1086/344271; Greer A, 2008, CAN MED ASSOC J, V178, P715, DOI 10.1503/cmaj.081325; Hanon FX, 2002, SCAND J INFECT DIS, V34, P520, DOI 10.1080/00365540110080827; Jackson AL, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-74; Kang CI, 2004, ANTIMICROB AGENTS CH, V48, P4574, DOI 10.1128/AAC.48.12.4574-4581.2004; Kuster SP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001042; McDonald LC, 1999, CLIN INFECT DIS, V29, P1133, DOI 10.1086/313441; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Naumova EN, 2007, STAT IND TECHNOL, P437, DOI 10.1007/978-0-8176-4542-7_28; Perencevich EN, 2008, INFECT CONT HOSP EP, V29, P1124, DOI 10.1086/592698; Richet H, 2012, CLIN MICROBIOL INFEC, V18, P934, DOI 10.1111/j.1469-0691.2012.03954.x; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P51; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Suzuki TA, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1037; Tuite Ashleigh R, 2013, CMAJ Open, V1, pE43, DOI 10.9778/cmajo.20120002	22	77	77	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114548	10.1371/journal.pone.0114548	http://dx.doi.org/10.1371/journal.pone.0114548			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25642358	Green Published, gold, Green Submitted			2022-12-26	WOS:000348845600003
J	Zhu, JH; Thakolwiboon, S; Liu, XH; Zhang, M; Lubman, DM				Zhu, Jianhui; Thakolwiboon, Smathorn; Liu, Xinhua; Zhang, Min; Lubman, David M.			Overexpression of CD90 (Thy-1) in Pancreatic Adenocarcinoma Present in the Tumor Microenvironment	PLOS ONE			English	Article							CANCER STEM-CELLS; ENDOTHELIAL-CELLS; PROGENITOR CELLS; EXPRESSION; POPULATION; FIBROBLASTS; LIVER	CD90 (Thy-1) plays important roles in oncogenesis and shows potential as a candidate marker for cancer stem cells (CSCs) in various malignancies. Herein, we investigated the expression of CD90 in pancreatic adenocarcinoma (PDAC), with a comparison to normal pancreas and non-malignant pancreatic disease, by immunohistochemical (IHC) analysis of tissue microarrays containing 183 clinical tissue specimens. Statistical analysis was performed to evaluate the correlation between CD90 expression and the major clinicopathological factors after adjustment of age and gender. The IHC data showed that CD90 was significantly overexpressed in PDAC and its metastatic cancers as compared to chronic pancreatitis and benign islet tumors, while it was negati ve in normal pancreas and 82.7% of adjacent normal pancreas tissues. The abundant CD90 expression was predominantly present in PDAC stroma, such as fibroblasts and vascular endothelial cells, which could serve as a promising marker to distinguish pancreatic adenocarcinoma from normal pancreas and non-malignant pancreatic diseases. Double immunostaining of CD90 with CD24, a CSC marker for PDAC, showed that there was little overlap between these two markers. However, CD90(+) fibroblast cells were clustered around CD24(+) malignant ducts, suggesting that CD90 may be involved in the tumor-stroma interactions and promote pancreatic cancer development. Furthermore, CD90 mostly overlapped with alpha-smooth muscle actin (alpha SMA, a marker of activated pancreatic stellate cells (PSCs)) in PDAC stroma, which demonstrated that CD90(+) stromal cells consist largely of activated PSCs. Double immunostaining of CD90 and a vascular endothelial cell marker CD31 demonstrated that CD90 expression on vascular endothelial cells was significantly increased in PDACs as compared to normal pancreas and non-malignant pancreatic diseases. Our findings suggest that CD90 could serve as a promising marker for pancreatic adenocarcinoma where desmoplastic stroma plays an important role in tumor growth and angiogenesis.	[Zhu, Jianhui; Thakolwiboon, Smathorn; Liu, Xinhua; Lubman, David M.] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA; [Thakolwiboon, Smathorn] Mahidol Univ, Fac Med, Dept Med, Siriraj Hosp, Bangkok 10700, Thailand; [Liu, Xinhua] Shanghai Univ Tradit Chinese Med, Expt Ctr Sci & Technol, Shanghai 201203, Peoples R China; [Zhang, Min] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Mahidol University; Shanghai University of Traditional Chinese Medicine; University of Michigan System; University of Michigan	Lubman, DM (corresponding author), Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA.	dmlubman@umich.edu	Zhang, Min/ACY-2759-2022; Thakolwiboon, Smathorn/S-1183-2019; Zhu, Jianhui/H-4665-2011	Zhang, Min/0000-0003-3331-3583; , Jianqun/0000-0002-7021-1298; Hua, Rui-Xi/0000-0001-5319-656X; Zhu, Jianhui/0000-0002-0051-7777; Zhu, Jinhong/0000-0002-0408-3101; Thakolwiboon, Smathorn/0000-0003-0607-904X	National Cancer Institute [1R01CA154455]; National Institutes of Health [R01 GM 49500]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Cancer Institute grant 1R01CA154455 (DML) and the National Institutes of Health grant R01 GM 49500 (DML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwaheeb S, 2005, J CLIN PATHOL, V58, P987, DOI 10.1136/jcp.2004.025221; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Bartholin L, 2012, PANCREATIC CANC TUMO; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; CRAIG W, 1993, J EXP MED, V177, P1331, DOI 10.1084/jem.177.5.1331; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; Davies Karen, 2009, Curr Gastroenterol Rep, V11, P119; Dennis JE, 2007, STEM CELLS, V25, P2575, DOI 10.1634/stemcells.2007-0204; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; Foygel K, 2013, GASTROENTEROLOGY, V145, P885, DOI 10.1053/j.gastro.2013.06.011; Guillot-Delost M, 2012, J IMMUNOL, V188, P981, DOI 10.4049/jimmunol.1101592; He JT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010744; Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jacob J, 2004, PANCREATOLOGY, V4, P454, DOI 10.1159/000079824; Jiang J, 2012, ONCOGENE, V31, P671, DOI 10.1038/onc.2011.282; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Rasheed ZA, 2012, PATHOLOGY PANCREATIC; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Saalbach A, 1999, CELL TISSUE RES, V298, P307, DOI 10.1007/s004419900079; Samaniego R, 2013, J INVEST DERMATOL, V133, P2255, DOI 10.1038/jid.2013.88; Schubert K, 2013, AM J PATHOL, V182, P266, DOI 10.1016/j.ajpath.2012.10.003; Scognamiglio G, 2014, AM J CLIN PATHOL, V141, P841, DOI 10.1309/AJCP8Y0EBQMKWQEI; Subramaniam KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068923; Sukowati CHC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076830; Tang KH, 2013, CANCER RES, V73, P2322, DOI 10.1158/0008-5472.CAN-12-2991; VIDAL M, 1990, EMBO J, V9, P833, DOI 10.1002/j.1460-2075.1990.tb08180.x; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Yamashita T, 2013, HEPATOLOGY, V57, P1484, DOI 10.1002/hep.26168; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zhu JH, 2013, J PROTEOME RES, V12, P2791, DOI 10.1021/pr400139c; Zhu JH, 2012, J PROTEOME RES, V11, P2272, DOI 10.1021/pr201059g	34	85	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115507	10.1371/journal.pone.0115507	http://dx.doi.org/10.1371/journal.pone.0115507			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536077	gold, Green Published, Green Submitted			2022-12-26	WOS:000348563300046
